<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6002110\results\search\tropicalVirus\results.xml">
   <result pre="Life Sciences : Microbiology : Virology: Viral Evolution Persistence of" exact="Yellow fever" post="virus outside the Amazon Basin, causing epidemics in Southeast"/>
   <result pre="in Southeast Brazil, from 2016 to 2018 Persistent circulation of" exact="Yellow fever" post="virus in Southeast Brazil, from 2016 to 2018 de"/>
   <result pre="provided the original author and source are credited.pntd.0006538.pdf Abstract Background" exact="Yellow fever" post="(YF) is endemic in the Brazilian Amazon Basin, and"/>
   <result pre="(NHPs) reported until April 2018. Previous studies have demonstrated that" exact="Yellow fever" post="virus (YFV) causing outbreaks in 2017 formed a monophyletic"/>
   <result pre="group. Methodology/Principal findings Aiming to decipher the origin of the" exact="YFV" post="responsible for the recent epidemics, we obtained nucleotide sequences"/>
   <result pre="responsible for the recent epidemics, we obtained nucleotide sequences of" exact="YFV" post="detected in humans (n = 6) and NHPs (n"/>
   <result pre="results in the light of epidemiological records (official numbers of" exact="YFV" post="cases at each Brazilian Federative unit, reported by the"/>
   <result pre="reported by the Brazilian Ministry of Health). Nucleotide sequences of" exact="YFV" post="from Southeast Brazil from 2016 to 2018 were highly"/>
   <result pre="cluster characterized by two synapomorphies (amino acid substitutions) that contained" exact="YFV" post="only associated with NHP what should be further investigated."/>
   <result pre="congruent with epidemiological and temporal patterns of the ongoing epidemic." exact="YFV" post="isolates detected in 2016, in São Paulo state were"/>
   <result pre="in a period that was coincident with the reemergence of" exact="YFV" post="in the Midwest region of Brazil. Conclusions The results"/>
   <result pre="of Brazil. Conclusions The results demonstrated a single introduction of" exact="YFV" post="in the Southeast region and the silent viral circulation"/>
   <result pre="Southeast region, possibly in São Paulo state. The persistence of" exact="YFV" post="in the Southeast region, causing epidemics from 2016 to"/>
   <result pre="that this region presents suitable ecological and climatic conditions for" exact="YFV" post="maintenance during the epidemic and interepidemic seasons. This fact"/>
   <result pre="areas historically associated with YF outbreaks outside the Amazon Basin." exact="YFV" post="persistence in Southeast Brazil should be carefully considered in"/>
   <result pre="health, especially for public health decision-makers and researchers. Author summary" exact="Yellow fever" post="(YF) is endemic in the Brazilian Amazon Basin, but"/>
   <result pre="so far. To better understand the origin and dynamics of" exact="YFV" post="associated with these epidemics, we studied part of the"/>
   <result pre="obtained from humans and NHPs, in 2016 to 2018. All" exact="YFV" post="grouped within a single group, indicating a single event"/>
   <result pre="before the first outbreak was detected (2016). The persistence of" exact="YFV" post="in the Southeast, causing epidemics from 2016 to 2018"/>
   <result pre="to 2018 indicates that this region presents suitable conditions for" exact="YFV" post="maintenance, during the epidemic and non-epidemic periods. This fact"/>
   <result pre="and non-epidemic periods. This fact may represent a risk for" exact="YFV" post="establishment in Southeast Brazil. This information should be carefully"/>
   <result pre="are within the paper and its Supporting Information files. Introduction" exact="Yellow fever" post="virus (YFV) (family Flaviviridae, genus Flavivirus) is the etiologic"/>
   <result pre="occurring between December and May [2]. It is believed that" exact="YFV" post="is disseminated to other areas outside the Amazon Basin"/>
   <result pre="transmission during the outbreak caused by a monophyletic group of" exact="YFV" post="subdivided into two subclusters [11,12], with an ancestor estimated"/>
   <result pre="estimated to exist in 2016 [11,13]. These studies suggested that" exact="YFV" post="dissemination occurred from Venezuela to the Southeast region of"/>
   <result pre="[11,13]. To better understand the origin and dynamics of recent" exact="YFV" post="epidemics in Brazil, we performed evolutionary analysis of YFV"/>
   <result pre="recent YFV epidemics in Brazil, we performed evolutionary analysis of" exact="YFV" post="detected from human and NHPs from the Southeast region."/>
   <result pre="each one, as the samples were collected and received for" exact="YFV" post="molecular diagnosis and analysis, in different parts of the"/>
   <result pre="was harvested, collected and kept at -70°C until RNA extraction." exact="YFV" post="molecular investigation For each NHP (n = 10), fragments"/>
   <result pre="in 2017), using QIAmp Viral RNA Mini Kit (Qiagen, USA)." exact="YFV" post="RNA investigation was performed by real-time PCR preceded by"/>
   <result pre="Using specific primers, targeting CprM and envelope regions of the" exact="YFV" post="genome [15], partial sequences were amplified and sequenced by"/>
   <result pre="for phylogenetic and evolutionary analyses. The first dataset included 60" exact="YFV" post="nucleotide (nt) sequences, spanning 1,038 nt (from the nt"/>
   <result pre="the time of the most recent common ancestor (MRCA) of" exact="YFV" post="causing the outbreaks in 2000–01, 2008–09, and the current"/>
   <result pre="in FigTree v.1.4.3 [26]. Epidemiological data of retrospective cases of" exact="YFV" post="in humans and NHPs (date and place where the"/>
   <result pre="samples tested positive by RT-qPCR, confirming the infection by YFV." exact="YFV" post="nt sequences (n = 16) spanning 1,259 nt from"/>
   <result pre="obtained (Genbank accession numbers: MG838679—MG838688, MH001693—MH001695 and MH015342-MH015344). Sequences of" exact="YFV" post="collected in 2017 and 2018 were highly conserved (99.8–100%"/>
   <result pre="Fig). BR-YFVs within the lineage BR-YFV_2016–18 were closely related to" exact="YFV" post="from Venezuela (Fig 1 and S3 Fig). BR-YFVs from"/>
   <result pre="lineage BR-YFV_2016/18 was subdivided into different clusters (Fig 1) with" exact="YFV" post="from 2016 in a basal position within the lineage."/>
   <result pre="and humans (Fig 1). Fig 1 Bayesian phylogenetic analyses of" exact="Yellow fever" post="virus. The maximum clade credibility tree inferred using 60"/>
   <result pre="fever virus. The maximum clade credibility tree inferred using 60" exact="Yellow fever" post="virus sequences (1,038 nt) from South America is shown."/>
   <result pre="circles drawn in scale in the nodes. Clades containing Brazilian" exact="Yellow fever" post="virus from outbreaks 2000–01, 2008–09 and the current (2016–2018)"/>
   <result pre="Terminal branches in orange, pink and black represent sequences of" exact="Yellow fever" post="virus from Venezuela, Bolivia, and Brazil, respectively. South African"/>
   <result pre="São Paulo state. The asterisk (*) denotes the cluster of" exact="Yellow fever" post="virus obtained from non-human primates which had two amino"/>
   <result pre="BR-YFV lineages, we used the second dataset that contained more" exact="YFV" post="sequences from previous outbreaks. The lineage BR-YFV_2008/09 had the"/>
   <result pre="Discussion Here we aimed to decipher the origin of the" exact="YFV" post="responsible for more than 593 deaths in Brazil, from"/>
   <result pre="lineage called BR-YFV_2016/18, confirming a single event of introduction of" exact="YFV" post="in the Southeast region, causing the ongoing outbreak. After"/>
   <result pre="(two amino acid substitutions in the deduced envelope protein), grouped" exact="YFV" post="strains associated with NHPs. These synapomorphies were not associated"/>
   <result pre="colleagues (2018) [12] also observed the presence of a basal" exact="YFV" post="group (from 2017) associated with NHPs. These data may"/>
   <result pre="from Venezuela, and in fact, some studies have proposed that" exact="YFV" post="causing the recent outbreak was probably introduced into Brazil,"/>
   <result pre="in Brazil), we obtained some insights about the origin of" exact="YFV" post="outbreaks outside the Amazon Basin, in Brazil. The MRCA"/>
   <result pre="from July 2014 to January 2016) that was coincident to" exact="YFV" post="reemergence and circulation in the Midwest region. In July"/>
   <result pre="of Goiás (n = 2) [29]. Based on epidemiological records," exact="YFV" post="was possibly introduced into the Midwest region (18 confirmed"/>
   <result pre="in the Midwest region. These facts support the hypothesis that" exact="YFV" post="causing those outbreaks (2016–18, and 2008–09) would have been"/>
   <result pre="fact, Brazilian health authorities already postulated that the detection of" exact="YFV" post="in the Midwest region should be fully addressed with"/>
   <result pre="that the Midwest region may be a hot spot for" exact="YFV" post="emerging outside the Amazon Basin. The gap (1 to"/>
   <result pre="BR-YFV_2008/09, and BR-YFV_2016/18) and the detection of SYV demonstrate that" exact="YFV" post="is maintained in a silent circulation outside the Amazon"/>
   <result pre="3 years. Recent outbreaks in Brazil also confirmed the intense" exact="YFV" post="circulation during epidemic periods [29] and non-epidemics periods [2,30]"/>
   <result pre="the Amazon Basin present suitable ecological and climatic conditions for" exact="YFV" post="maintenance, even during interepidemic periods. In fact, based on"/>
   <result pre="Rio de Janeiro) as an area of high receptivity to" exact="YFV" post="transmission. In previous outbreaks, the numbers of human and"/>
   <result pre="neighbor states is still unclear, but the silent circulation of" exact="YFV" post="might have contributed to the geographic dissemination until the"/>
   <result pre="epidemiological aspects. Finally, the results support a single introduction of" exact="YFV" post="in the Southeast region, approximately in 2015, and viral"/>
   <result pre="classified as an area of high receptivity to YF transmission." exact="Yellow fever" post="surveillance, including human, sentinel animals and entomological surveillance, coupled"/>
   <result pre="here for additional data file. S2 Fig Phylogenetic analyses of" exact="Yellow fever" post="virus (maximum likelihood). The tree was inferred using 60"/>
   <result pre="fever virus (maximum likelihood). The tree was inferred using 60" exact="Yellow fever" post="virus sequences (1,038 nt) from South America, and the"/>
   <result pre="(values are represented by circles drawn into scale at nodes)." exact="Yellow fever" post="virus strains from South American Genotypes are shown in"/>
   <result pre="here for additional data file. S3 Fig Phylogenetic analyses of" exact="Yellow fever" post="virus (based on dataset 2). The maximum clade credibility"/>
   <result pre="dataset 2). The maximum clade credibility tree inferred using 125" exact="Yellow fever" post="virus sequences (651 nt) from South America is shown."/>
   <result pre="and red, respectively. Terminal branches in orange represent sequences of" exact="Yellow fever" post="virus from Venezuela, pink from Colombia, purple from Trinidad"/>
   <result pre="skyline demographic model. The asterisk (*) denotes the cluster of" exact="Yellow fever" post="virus obtained from non-human primates which had two amino"/>
   <result pre="Click here for additional data file. S3 Table Information of" exact="Yellow fever" post="virus sequences included into dataset 1. YFV: Yellow fever"/>
   <result pre="of Yellow fever virus sequences included into dataset 1. YFV:" exact="Yellow fever" post="virus. ID: identification. This dataset included 60 YFV nucleotide"/>
   <result pre="YFV: Yellow fever virus. ID: identification. This dataset included 60" exact="YFV" post="nucleotide (nt) sequences, spanning 1,038 nt (from the nucleotide"/>
   <result pre="Click here for additional data file. S4 Table Information of" exact="Yellow fever" post="virus sequences included into dataset 2. YFV: Yellow fever"/>
   <result pre="of Yellow fever virus sequences included into dataset 2. YFV:" exact="Yellow fever" post="virus. ID: identification. This dataset contained 125 sequences spanning"/>
   <result pre="Biológicas/UFMG and Laboratório de Vírus-UFMG. References References 1VasconcelosPF da C." exact="Yellow fever" post="in Brazil: thoughts and hypotheses on the emergence in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6002135\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and life sciences : Organisms :"/>
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Tropical Diseases"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Earth Sciences : Geomorphology : Topography :"/>
   <result pre="improve these predictions. The approach was applied to the 2015–2017" exact="Zika" post="virus epidemics in three islands of the French West"/>
   <result pre="on average, range: 0.4 to 1.5) using information on past" exact="CHIKV" post="epidemics in the same places. Likewise, the 97.5% upper"/>
   <result pre="emerging Aedes-transmitted outbreaks. Author summary In December, 2015, Aedes mosquito-transmitted" exact="Zika" post="outbreaks started in the French West Indies, about two"/>
   <result pre="virus in West Africa [4–10], chikungunya virus (CHIKV) [11] and" exact="Zika" post="virus (ZIKV) [12–14] in the Americas. These analyses often"/>
   <result pre="for required epidemiological parameters [27]. The method is illustrated with" exact="ZIKV" post="outbreaks in the French West Indies between December, 2015"/>
   <result pre="between December, 2015 and February, 2017, using historical data regarding" exact="CHIKV" post="and ZIKV epidemics in French Polynesia and the French"/>
   <result pre="2015 and February, 2017, using historical data regarding CHIKV and" exact="ZIKV" post="epidemics in French Polynesia and the French West Indies"/>
   <result pre="to epidemic progress. Methods Data Surveillance data on the 2015–2017" exact="ZIKV" post="epidemics in Guadeloupe, Martinique and Saint-Martin was collected by"/>
   <result pre="by the local health authorities (Fig 1) [28]. Cases of" exact="ZIKV" post="infection were defined as &quot;a rash with or without"/>
   <result pre="of &quot;high epidemic activity�?. Fig 1 (A) Weekly number of" exact="Zika" post="virus (ZIKV) cases reported by the surveillance systems in"/>
   <result pre="in 2013–2015 (S2 Dataset ( D 2 )) and of" exact="ZIKV" post="then CHIKV in French Polynesia in 2013–2015 (S3 Dataset"/>
   <result pre="(S2 Dataset ( D 2 )) and of ZIKV then" exact="CHIKV" post="in French Polynesia in 2013–2015 (S3 Dataset ( D"/>
   <result pre="on the spread of emerging Aedes-transmitted diseases in similar locations." exact="CHIKV" post="epidemics occured in the same three islands during 2013–2015."/>
   <result pre="were reported by the same surveillance system. Surveillance data on" exact="CHIKV" post="epidemics in the French West Indies was available from"/>
   <result pre="( D 2 )) [30]. Finally, we also selected the" exact="ZIKV" post="and CHIKV epidemics that occured in six islands or"/>
   <result pre="2 )) [30]. Finally, we also selected the ZIKV and" exact="CHIKV" post="epidemics that occured in six islands or archipelagoes of"/>
   <result pre="in the French West Indies [31, 32]. Epidemic model The" exact="ZIKV" post="outbreaks in Guadeloupe, Martinique and Saint-Martin were modelled separately"/>
   <result pre="gamma distributions with mean 2.5 weeks (standard deviation: 0.7) for" exact="ZIKV" post="and with mean 1.6 weeks (sd: 0.6) for CHIKV."/>
   <result pre="where subscript X refers to disease (X = C for" exact="CHIKV" post="or X = Z for ZIKV), R 0 ,"/>
   <result pre="the supplementary appendix. Informative and non-informative prior distributions To analyze" exact="Zika" post="epidemics, the reproduction ratio R 0 , Z ,"/>
   <result pre="datasets in three steps. We first analysed jointly the three" exact="CHIKV" post="epidemics in dataset D 2 using model 1, introducing"/>
   <result pre="We obtained the posterior distributions of these parameters for the" exact="CHIKV" post="outbreaks in each island π ( R 0 ,"/>
   <result pre="structure as above and introducing relative transmissibility and reporting of" exact="ZIKV" post="with respect to CHIKV as R 0 , Z"/>
   <result pre="introducing relative transmissibility and reporting of ZIKV with respect to" exact="CHIKV" post="as R 0 , Z = β R 0"/>
   <result pre="rate π ( β �? | D 3 ) of" exact="ZIKV" post="with respect to CHIKV in the French West Indies."/>
   <result pre="�? | D 3 ) of ZIKV with respect to" exact="CHIKV" post="in the French West Indies. In a third step,"/>
   <result pre="10.1371/journal.pntd.0006526.t001Table 1 Prior distributions choice and design for modelling a" exact="Zika" post="virus outbreak in the French West Indies. Non-informative (NI)"/>
   <result pre="description, actually combining island-specific distributions for transmission and reporting of" exact="CHIKV" post="with relative ratios β R 0 and β�? of"/>
   <result pre="CHIKV with relative ratios β R 0 and β�? of" exact="ZIKV" post="to CHIKV. The R priors, on the contrary, were"/>
   <result pre="results are reported in the supplementary appendix. Fitting and predicting" exact="ZIKV" post="epidemics We fitted model 1 to ZIKV data separately"/>
   <result pre="Fitting and predicting ZIKV epidemics We fitted model 1 to" exact="ZIKV" post="data separately in Martinique, Guadeloupe and Saint-Martin using the"/>
   <result pre="a higher value means a better accuracy or sharpness. Results" exact="ZIKV" post="epidemics in the French West Indies The timecourse of"/>
   <result pre="epidemics in the French West Indies The timecourse of the" exact="ZIKV" post="epidemics in Guadeloupe, Martinique and Saint-Martin between December, 2015"/>
   <result pre="cases per 1,000 inhabitants). Prior information from past epidemics The" exact="CHIKV" post="epidemics observed in the same three islands of the"/>
   <result pre="Indies during 2013–2015 are shown in Fig 1B, and the" exact="CHIKV" post="and ZIKV epidemics observed in French Polynesia during 2013–2015"/>
   <result pre="2013–2015 are shown in Fig 1B, and the CHIKV and" exact="ZIKV" post="epidemics observed in French Polynesia during 2013–2015 in Fig"/>
   <result pre="distributions on the reproduction ratio and reporting rates for the" exact="ZIKV" post="epidemics in the French West Indies defining the NI,"/>
   <result pre="reproduction number R 0 , Z (panel B) during the" exact="Zika" post="virus epidemics in the French West Indies: Non-informative, regional"/>
   <result pre="future incidence Fig 3 shows the future course of the" exact="ZIKV" post="epidemics predicted using data available two weeks after date"/>
   <result pre="(S1 Appendix). Fig 3 Predictive distribution of weekly incidence of" exact="Zika" post="virus infections in Guadeloupe, Martinique and Saint-Martin using either"/>
   <result pre="A) and the reporting rate �?Z (panel B) throughout the" exact="ZIKV" post="epidemics of the French West Indies. Colours correspond to"/>
   <result pre="interventions. Here, we compared several approaches to provide forecasts for" exact="ZIKV" post="epidemics from an early point in a retrospective analysis"/>
   <result pre="on historical data on past epidemics was used. The three" exact="ZIKV" post="outbreaks in the French West Indies provided an ideal"/>
   <result pre="to improve prediction of Aedes-transmitted diseases using historical data. Indeed," exact="CHIKV" post="outbreaks had been observed in the same locations about"/>
   <result pre="observed in the same locations about two years before ZIKV," exact="CHIKV" post="is also transmitted by Aedes mosquitoes, and both viruses"/>
   <result pre="time in the modelling. Having established the many similarities between" exact="ZIKV" post="and CHIKV epidemics regarding transmission and reporting, we assumed"/>
   <result pre="the modelling. Having established the many similarities between ZIKV and" exact="CHIKV" post="epidemics regarding transmission and reporting, we assumed that information"/>
   <result pre="a priori distributions on model parameters [27]. Historical data on" exact="CHIKV" post="epidemics was therefore used to build informative a priori"/>
   <result pre="models to obtain information about (i) transmissibility and reporting during" exact="CHIKV" post="outbreaks in the French West Indies and (ii) relative"/>
   <result pre="French West Indies and (ii) relative transmissibility and reporting between" exact="ZIKV" post="and CHIKV in French Polynesia, rather than from a"/>
   <result pre="Indies and (ii) relative transmissibility and reporting between ZIKV and" exact="CHIKV" post="in French Polynesia, rather than from a global joint"/>
   <result pre="knowledge. The &quot;Local�? priors corresponded with estimates for the previous" exact="CHIKV" post="epidemic in the same island, therefore including island-specific epidemic"/>
   <result pre="dengue [52] or by assesssing the spatio-temporal coherence of chikungunya," exact="Zika" post="and dengue [53]. Also, using informative priors to make"/>
   <result pre="been done before. For instance, a priori information from the" exact="ZIKV" post="epidemics in French Polynesia has been used to support"/>
   <result pre="to support the early forecasts of health-care requirements for the" exact="ZIKV" post="epidemic in Martinique [38]. In this case, however, authors"/>
   <result pre="in a sensitivity analysis: the direct use of information from" exact="ZIKV" post="in French Polynesia, or alternatively the direct use of"/>
   <result pre="French Polynesia, or alternatively the direct use of information from" exact="CHIKV" post="in the French West Indies, without adjusting for ZIKV,"/>
   <result pre="cities, even years apart [54]. For Aedes-transmitted diseases, comparisons of" exact="ZIKV" post="and dengue virus outbreaks [55] and of ZIKV with"/>
   <result pre="comparisons of ZIKV and dengue virus outbreaks [55] and of" exact="ZIKV" post="with CHIKV outbreaks [44] in the same locations have"/>
   <result pre="ZIKV and dengue virus outbreaks [55] and of ZIKV with" exact="CHIKV" post="outbreaks [44] in the same locations have highlighted similarities"/>
   <result pre="CHIKV, some cases of sexual transmission have been reported for" exact="ZIKV" post="[56, 57]. Yet, no epidemics were seen in locations"/>
   <result pre="example in metropolitan France, despite the introductions of several hundreds" exact="ZIKV" post="infected cases [58]. This justifies the use of CHIKV"/>
   <result pre="hundreds ZIKV infected cases [58]. This justifies the use of" exact="CHIKV" post="epidemic data to provide prior information on ZIKV in"/>
   <result pre="use of CHIKV epidemic data to provide prior information on" exact="ZIKV" post="in the epidemic context considered here. More generally, documenting,"/>
   <result pre="information. In particular, informed with epidemiological records of the recent" exact="CHIKV" post="and ZIKV epidemics, our approach could be applied to"/>
   <result pre="particular, informed with epidemiological records of the recent CHIKV and" exact="ZIKV" post="epidemics, our approach could be applied to potential future"/>
   <result pre="Dataset D 1 . Weekly number of reported cases of" exact="Zika" post="virus infection in the French West Indies (2015–2017). (CSV)"/>
   <result pre="Dataset D 3 . Weekly number of reported cases of" exact="Zika" post="virus and chikungunya virus infection in French Polynesia (2013–2015)."/>
   <result pre="2014;19(28):20854doi: 10.2807/1560-7917.ES2014.19.28.2085425060573 12PerkinsAT, SirajAS, RuktanonchaiCW, KraemerMUG, TatemAJ. Model-based projections of" exact="Zika" post="virus infections in childbearing women in the Americas. Nature"/>
   <result pre="10.1038/nmicrobiol.2016.12627562260 13ZhangQ, SunK, ChinazziM, PionttiAPy, DeanNE, RojasDP, et al.Spread of" exact="Zika" post="virus in the Americas. Proceedings of the National Academy"/>
   <result pre="Villamil-GómezWE, Rodríguez-MoralesAJ. Preliminary estimation of the basic reproduction number of" exact="Zika" post="virus infection during Colombia epidemic, 2015–2016. Travel medicine and"/>
   <result pre="BiQ, et al.Times to key events in the course of" exact="Zika" post="infection and their implications: a systematic review and pooled"/>
   <result pre="AdelaideY, AubertL, BarrauM, et al.Dynamique et ampleur des épidémies de" exact="Zika" post="en Martinique et en Guadeloupe de décembre 2015 à"/>
   <result pre="GhawchéF, SignateA, et al.Real-time assessment of health-care requirements during the" exact="Zika" post="virus epidemic in Martinique. American journal of epidemiology. 2017;186(10):1194–1203."/>
   <result pre="10.1111/j.1467-9868.2007.00587.x 40FergusonNM, CucunubáZM, DorigattiI, Nedjati-GilaniGL, DonnellyCA, BasáñezMG, et al.Countering the" exact="Zika" post="epidemic in Latin America. Science. 2016;353(6297):353–354. doi: 10.1126/science.aag021927417493 41MarcombeS,"/>
   <result pre="et al.Pyrethroid Resistance Reduces the Efficacy of Space Sprays for" exact="Dengue" post="Control on the Island of Martinique (Caribbean). PLoS Negl"/>
   <result pre="2006;48(3):432–435. doi: 10.1198/004017005000000661 44RiouJ, PolettoC, BoëllePY. A comparative analysis of" exact="Chikungunya" post="and Zika transmission. Epidemics. 2017;19:43–52. doi: 10.1016/j.epidem.2017.01.00128139388 45ViboudC, SunK,"/>
   <result pre="10.1198/004017005000000661 44RiouJ, PolettoC, BoëllePY. A comparative analysis of Chikungunya and" exact="Zika" post="transmission. Epidemics. 2017;19:43–52. doi: 10.1016/j.epidem.2017.01.00128139388 45ViboudC, SunK, GaffeyR, AjelliM,"/>
   <result pre="to Characterize Transmissibility and Forecast Patterns and Final Burden of" exact="Zika" post="Epidemics. PLoS Currents. 2016;8doi: 10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b958327366586 47CDC. New Flu Activity"/>
   <result pre="Forecaster for 2015–16; 2016. Available from: https://www.cdc.gov/flu/spotlights/flu-activity-forecasts-2016-2017.htm. 48collab: DARPA. Forecasting" exact="Chikungunya" post="Challenge, Challenge Description on InnoCentive Site; 2014 Available from:"/>
   <result pre="Pavia-RuzN, HladishTJ, LenhartA, et al.Spatio-temporal coherence of dengue, chikungunya and" exact="Zika" post="outbreaks in Merida, Mexico. PLoS neglected tropical diseases. 2018;12(3):e0006298doi:"/>
   <result pre="KucharskiAJ, CamachoA, EggoRM, YakobL, EdmundsWJ. Comparative analysis of dengue and" exact="Zika" post="outbreaks reveals differences by setting and virus. PLoS Negl"/>
   <result pre="2016;10(2):e0005173doi: 10.1371/journal.pntd.000517327926933 56AlthausCL, LowN. How Relevant Is Sexual Transmission of" exact="Zika" post="Virus?PLOS Medicine. 2016;13(10):e1002157doi: 10.1371/journal.pmed.100215727780196 57AllardA, AlthouseBM, Hébert-DufresneL, ScarpinoSV. The"/>
   <result pre="AlthouseBM, Hébert-DufresneL, ScarpinoSV. The risk of sustained sexual transmission of" exact="Zika" post="is underestimated. PLOS Pathogens. 2017;13(9):e1006633doi: 10.1371/journal.ppat.100663328934370 58SeptfonsA, Leparc-GoffartI, CouturierE,"/>
   <result pre="58SeptfonsA, Leparc-GoffartI, CouturierE, FrankeF, DeniauJ, BalestierA, et al.Travel-associated and autochthonous" exact="Zika" post="virus infection in mainland France, 1 January to 15"/>
   <result pre="DefilippoF, PierroA, AlbieriA, et al.Mosquito, bird and human surveillance of" exact="West Nile" post="and Usutu viruses in Emilia-Romagna Region (Italy) in 2010."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6083217\results\search\tropicalVirus\results.xml">
   <result pre="pmcid: 6083217 doi: 10.3389/fmicb.2018.01797 : Microbiology: Mini Review Role of" exact="Zika" post="Virus prM Protein in Viral Pathogenicity and Use in"/>
   <result pre="permitted which does not comply with these terms. Abstract Recent" exact="Zika" post="virus (ZIKV) epidemics necessitate the urgent development of effective"/>
   <result pre="vaccines, which can be accelerated by an enhanced understanding of" exact="ZIKV" post="biology. One of the ZIKV structural proteins, precursor membrane"/>
   <result pre="by an enhanced understanding of ZIKV biology. One of the" exact="ZIKV" post="structural proteins, precursor membrane (prM), plays an important role"/>
   <result pre="be implicated in the neurovirulence of ZIKV. Most vaccines targeting" exact="ZIKV" post="include prM as the immunogen. Here, we review progress"/>
   <result pre="the immunogen. Here, we review progress in our understanding of" exact="ZIKV" post="prM protein and its application in ZIKV vaccine development."/>
   <result pre="our understanding of ZIKV prM protein and its application in" exact="ZIKV" post="vaccine development. ZIKV prM viral pathogenicity vaccine epidemic Funding"/>
   <result pre="ZIKV prM protein and its application in ZIKV vaccine development." exact="ZIKV" post="prM viral pathogenicity vaccine epidemic Funding Ministry of Science"/>
   <result pre="Technology, Taiwan10.13039/501100004663MOST 105-2628-B-039-006-MY3 fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="Zika" post="virus (ZIKV) was first isolated in 1947 from a"/>
   <result pre="isolated in 1947 from a rhesus monkey taken from the" exact="Zika" post="Forest in Uganda (Dick et al., 1952). Prior to"/>
   <result pre="Uganda (Dick et al., 1952). Prior to the emergence of" exact="ZIKV" post="epidemics, there had been only a few reported cases"/>
   <result pre="epidemics, there had been only a few reported cases of" exact="ZIKV" post="infection in humans in Africa and Asia, most of"/>
   <result pre="al., 1981; Adekolu-John and Fagbami, 1983). A major outbreak of" exact="ZIKV" post="was reported on Yap Island in 2007, which infected"/>
   <result pre="2014 and 2015, respectively (ECDC, 2014; Hennessey et al., 2016)." exact="Zika" post="virus outbreaks from 2015 onward have been of major"/>
   <result pre="declared an urgent need to fully understand the lifecycle of" exact="ZIKV" post="and its infection dynamics in order to develop effective"/>
   <result pre="vaccines and therapeutic targets to prevent future outbreaks (WHO, 2016)." exact="Zika" post="virus is mainly transmitted to humans through mosquito-borne vectors"/>
   <result pre="also been reported (Song et al., 2017). Phylogenetic analyses of" exact="ZIKV" post="identified African and Asian lineages, with the Asian lineage"/>
   <result pre="now? Secondly, despite being initially isolated from Africa, why do" exact="ZIKV" post="strains of the African lineage not cause epidemics? Thirdly,"/>
   <result pre="in neural cells than African strains. A phylogenetic analysis of" exact="ZIKV" post="strains responsible for recent epidemics in Asia has further"/>
   <result pre="giving rise to several biological phenotypes (Zhu et al., 2016)." exact="Zika" post="virus has biological similarities to other flaviviruses, such as"/>
   <result pre="Zika virus has biological similarities to other flaviviruses, such as" exact="West Nile" post="virus, Japanese encephalitis virus (JEV) and dengue virus. ZIKV"/>
   <result pre="West Nile virus, Japanese encephalitis virus (JEV) and dengue virus." exact="ZIKV" post="has an approximately 11 kb positive-stranded RNA genome, with"/>
   <result pre="ingress and egress of host cells (Li et al., 2008)." exact="ZIKV" post="virion assembly involves: (i) prM interaction with E protein"/>
   <result pre="homodimers and facilitating virion maturation. Recent studies have revealed that" exact="ZIKV" post="has a similar structure to other known flaviviruses (Kostyuchenko"/>
   <result pre="the function of prM during the viral lifecycle may incapacitate" exact="ZIKV" post="infectivity and pathogenicity. ZIKV prM and E proteins are"/>
   <result pre="during the viral lifecycle may incapacitate ZIKV infectivity and pathogenicity." exact="ZIKV" post="prM and E proteins are being used as antibody-activating"/>
   <result pre="are being used as antibody-activating epitopes in most of the" exact="ZIKV" post="vaccines currently undergoing clinical trials (WHO, 2018). This short"/>
   <result pre="highlight recent advances in our understanding of the role of" exact="ZIKV" post="prM protein in virus pathogenicity and its use in"/>
   <result pre="pathogenicity and its use in vaccine development. Pre-Epidemic and Epidemic" exact="ZIKV" post="Strain prM Proteins and Their Pathogenicities Zika virus has"/>
   <result pre="Pre-Epidemic and Epidemic ZIKV Strain prM Proteins and Their Pathogenicities" exact="Zika" post="virus has been categorized into pre-epidemic and epidemic strains"/>
   <result pre="et al., 1981; Adekolu-John and Fagbami, 1983). Epidemic strains represent" exact="ZIKV" post="isolates linked to human infections from outbreaks on Yap"/>
   <result pre="2017; Bos et al., 2018). A recent genomic analysis of" exact="ZIKV" post="strains revealed two amino acid substitutions in ZIKV prM"/>
   <result pre="analysis of ZIKV strains revealed two amino acid substitutions in" exact="ZIKV" post="prM protein isolated from strains contributing to epidemics in"/>
   <result pre="sequenced epidemic strains, nine amino acid substitutions were identified in" exact="ZIKV" post="prM protein (Zhu et al., 2016). Another study found"/>
   <result pre="study found 10 amino acid substitutions between pre-epidemic and epidemic" exact="ZIKV" post="prM proteins (Bos et al., 2018) (Table 1). These"/>
   <result pre="(Table 1). These genomic variations might have been driven by" exact="ZIKV" post="adopting an urban-based transmission cycle targeting humans as hosts"/>
   <result pre="genome to enable it to maintain its replication efficiency. Epidemic" exact="ZIKV" post="strains, including those associated with neurovirulence, have been shown"/>
   <result pre="have driven the amino acid substitutions and protein evolution of" exact="ZIKV" post="prM proteins (Ramaiah et al., 2017). Table 1 Summary"/>
   <result pre="prM proteins (Ramaiah et al., 2017). Table 1 Summary of" exact="ZIKV" post="prM amino acid substitutions. Pre-epidemic amino acid residue Epidemic"/>
   <result pre="acid residue Epidemic amino acid residue Amino acid position in" exact="ZIKV" post="prM Amino acid position in ZIKV polyprotein Reference I"/>
   <result pre="Amino acid position in ZIKV prM Amino acid position in" exact="ZIKV" post="polyprotein Reference I V 3 161 Bos et al.,"/>
   <result pre="al. (2017) studied the effects of the commonly observed epidemic" exact="ZIKV" post="amino acid substitutions in C, prM, E, NS1, and"/>
   <result pre="examined, a serine to asparagine amino acid substitution (S139N) of" exact="ZIKV" post="prM protein, which is observed in most human epidemic"/>
   <result pre="contributed to the recently observed congenital birth defects associated with" exact="ZIKV" post="outbreaks in Brazil (Krauer et al., 2017). The contributions"/>
   <result pre="et al., 2017). The contributions of other prM substitutions to" exact="ZIKV" post="neurovirulence remain to be studied in depth as Yuan"/>
   <result pre="completely prevent it. Another study suggested that the highly thermostable" exact="ZIKV" post="E protein, unlike DENV E protein, may also be"/>
   <result pre="study suggested that the highly thermostable ZIKV E protein, unlike" exact="DENV" post="E protein, may also be associated with neurovirulence (Kostyuchenko"/>
   <result pre="changed structurally when the virus was incubated at 37°C, whereas" exact="ZIKV" post="virus particles remained structurally stable, most likely due to"/>
   <result pre="likely due to the tightly packed and complex interactions of" exact="ZIKV" post="E dimers. The ability of ZIKV to survive harsh"/>
   <result pre="and complex interactions of ZIKV E dimers. The ability of" exact="ZIKV" post="to survive harsh conditions may explain why the virus"/>
   <result pre="prM amino acid substitutions to E protein thermostability and consequent" exact="ZIKV" post="structural biology are not yet well known. However, changes"/>
   <result pre="be empirically tested. Perspectives for the Use of prM in" exact="ZIKV" post="Vaccine Development The ZIKV viral envelope is comprised of"/>
   <result pre="for the Use of prM in ZIKV Vaccine Development The" exact="ZIKV" post="viral envelope is comprised of two viral proteins, the"/>
   <result pre="have become major targets of vaccine design and development against" exact="ZIKV" post="infections (Table 2) (WHO, 2018). These structural proteins have"/>
   <result pre="been targeted because they are: (i) non-replicating subunits of the" exact="ZIKV" post="genome so they present a safer candidate profile for"/>
   <result pre="Grifoni et al., 2017; Goo et al., 2018). Table 2" exact="ZIKV" post="vaccine candidates undergoing clinical trialsa. Sponsor/Developer Platform Immunogen Adjuvant"/>
   <result pre="trials according to the World Health Organization (WHO, 2018). The" exact="ZIKV" post="vaccines currently under development are mainly based on purified"/>
   <result pre="al., 2018; Modjarrad et al., 2018). Importantly, none of these" exact="ZIKV" post="vaccine approaches have achieved success in terms of generating"/>
   <result pre="vaccine could provide complete protection in mice against challenge with" exact="ZIKV" post="strains linked to major clinical complications. That study also"/>
   <result pre="protection, evidencing the important role of prM protein in enhancing" exact="ZIKV" post="immunogenicity. The ZIKV prM-E DNA vaccine resulted in a"/>
   <result pre="important role of prM protein in enhancing ZIKV immunogenicity. The" exact="ZIKV" post="prM-E DNA vaccine resulted in a higher titer of"/>
   <result pre="phenomenon has also been reported in another study using a" exact="ZIKV" post="prM-E immunogen as a vaccine candidate (Yi et al.,"/>
   <result pre="This outcome may be due to the structural nature of" exact="ZIKV" post="E protein as it is the main viral protein"/>
   <result pre="has also shown the ability to confer full protection against" exact="ZIKV" post="challenge in humanized DRAG mice that have robust antibody"/>
   <result pre="vaccine produced by immunizing mice with VLPs that incorporates full-length" exact="ZIKV" post="structural proteins (C-prM-E) can also endow full protection against"/>
   <result pre="ZIKV structural proteins (C-prM-E) can also endow full protection against" exact="ZIKV" post="and induces production of more ZIKV-neutralizing antibodies than DNA"/>
   <result pre="than DNA vaccines (Garg et al., 2017). A chimeric live-attenuated" exact="ZIKV" post="prM-E vaccine candidate, using a commercialized JEV vaccine as"/>
   <result pre="prM-E was replaced with the corresponding prM-E from an Asian" exact="ZIKV" post="strain. Another approach using chimeric ZIKV with DENV prM-E"/>
   <result pre="prM-E from an Asian ZIKV strain. Another approach using chimeric" exact="ZIKV" post="with DENV prM-E proteins or a chimeric DENV with"/>
   <result pre="an Asian ZIKV strain. Another approach using chimeric ZIKV with" exact="DENV" post="prM-E proteins or a chimeric DENV with ZIKV prM-E"/>
   <result pre="using chimeric ZIKV with DENV prM-E proteins or a chimeric" exact="DENV" post="with ZIKV prM-E proteins revealed robust protection in immunized"/>
   <result pre="ZIKV with DENV prM-E proteins or a chimeric DENV with" exact="ZIKV" post="prM-E proteins revealed robust protection in immunized mice through"/>
   <result pre="2017). This vaccine uses an RNA replicon vector to package" exact="ZIKV" post="prM-E protein for expression in BHK21 cells. Protein expression"/>
   <result pre="dendrimer nanoparticle (MDNP) RNA vaccine. Modified mRNA vaccines based on" exact="ZIKV" post="prM-E proteins have also been developed (Pardi et al.,"/>
   <result pre="by the host innate immune system. The modified mRNAs encoding" exact="ZIKV" post="prM-E proteins are then encapsulated in lipid nanoparticles for"/>
   <result pre="SVPs that can induce production of neutralizing antibodies. These modified" exact="ZIKV" post="mRNA vaccines use non-self-amplifying mRNA that cannot integrate into"/>
   <result pre="These mRNA vaccines have exhibited robust immunization and protection against" exact="ZIKV" post="infection in both immunocompromised AG129 and C56BL/6 mice. ZIKV"/>
   <result pre="against ZIKV infection in both immunocompromised AG129 and C56BL/6 mice." exact="ZIKV" post="mRNA vaccine concepts are currently undergoing clinical trials and"/>
   <result pre="to be an important milestone in combating current and future" exact="ZIKV" post="outbreaks. Concluding Remarks Zika virus has become a major"/>
   <result pre="milestone in combating current and future ZIKV outbreaks. Concluding Remarks" exact="Zika" post="virus has become a major public health concern, with"/>
   <result pre="and purifying selection pressures might have facilitated modifications of the" exact="ZIKV" post="genome that enhance its replication efficiency and reduce host"/>
   <result pre="has been linked to increased neurovirulence, suggesting that alterations of" exact="ZIKV" post="prM protein may enhance viral virulence. Further studies on"/>
   <result pre="efficiency. Various platforms have been employed to generate vaccines against" exact="ZIKV" post="infections, including purified inactivated virus, plasmid DNA, and mRNA"/>
   <result pre="and E proteins are utilized. In contrast, sole use of" exact="ZIKV" post="prM protein in vaccines against ZIKV has not yet"/>
   <result pre="contrast, sole use of ZIKV prM protein in vaccines against" exact="ZIKV" post="has not yet proven as effective as prM-E combinations."/>
   <result pre="more likely to result in another epidemic. Furthermore, whether the" exact="ZIKV" post="vaccines currently under development can be effective against future"/>
   <result pre="Additional focused studies on the molecular and structural biology of" exact="ZIKV" post="prM may accelerate our ability to tackle this emerging"/>
   <result pre="Trop. Med. Hyg77149–151. 10.1016/0035-9203(83)90053-66306872 AtkinsonB.HearnP.AfroughB.LumleyS.CarterD.AaronsE. J.et al. (2016). Detection of" exact="Zika" post="virus in Semen.Emerg. Infect. Dis22:940. 10.3201/eid2205.16010727088817 BosS.ViranaickenW.TurpinJ.El-KalamouniC.RocheM.Krejbich-TrototP.et al. (2018)."/>
   <result pre="(2018). The structural proteins of epidemic and historical strains of" exact="Zika" post="virus differ in their ability to initiate viral infection"/>
   <result pre="W.KhanO. F.LingJ.AndersonD. G.et al. (2017). An RNA nanoparticle vaccine against" exact="Zika" post="virus elicits antibody and CD8+ T cell responses in"/>
   <result pre="and potential.Ann. N. Y. Acad. Sci.951272–285. 10.1111/j.1749-6632.2001.tb02703.x11797784 CounotteM.Egli-GanyD.RiesenM.AbrahaM.PorgoT.WangJ.et al. (2018)." exact="Zika" post="virus infection as a cause of congenital brain abnormalities"/>
   <result pre="peer review]. DaiL.SongJ.LuX.DengY. Q.MusyokiA. M.ChengH.et al. (2016). Structures of the" exact="Zika" post="virus envelope protein and its complex with a flavivirus"/>
   <result pre="human T and B cells.PLoS One6:e19826. 10.1371/journal.pone.001982621611197 DickG. W. (1952)." exact="Zika" post="virus. II. Pathogenicity and physical properties.Trans. R. Soc. Trop."/>
   <result pre="Soc. Trop. Med. Hyg.46521–534. 10.1016/0035-9203(52)90043-612995441 DickG. W.KitchenS. F.HaddowA. J. (1952)." exact="Zika" post="virus. I. Isolations and serological specificity.Trans. R. Soc. Trop."/>
   <result pre="10.1016/0035-9203(52)90042-412995440 DuffyM. R.ChenT. H.HancockW. T.PowersA. M.KoolJ. L.LanciottiR. S.et al. (2009)." exact="Zika" post="virus outbreak on Yap Island, Federated States of Micronesia.N."/>
   <result pre="Engl. J. Med.3602536–2543. 10.1056/NEJMoa080571519516034 collab: ECDC (2014). Rapid risk assessment:" exact="Zika" post="virus Infection Outbreak, French Polynesia. Available at: https://ecdc.europa.eu/en/publications-data/rapid-risk-assessment-zika-virus-infection-outbreak-french-polynesia#no-link [accessed"/>
   <result pre="2018]. FayeO.FreireC. C.IamarinoA.FayeO.de OliveiraJ. V.DialloM.et al. (2014). Molecular evolution of" exact="Zika" post="virus during its emergence in the 20(th) century.PLoS Negl."/>
   <result pre="B.JoshiA. (2017). Development of virus-like-particle vaccine and reporter assay for" exact="Zika" post="virus.J. Virol.91: e00834-17. 10.1128/jvi.00834-1728794019 GaudinskiM. R.HouserK. V.MorabitoK. M.HuZ.YamshchikovG.RothwellR. S.et"/>
   <result pre="M.HuZ.YamshchikovG.RothwellR. S.et al. (2018). Safety, tolerability, and immunogenicity of two" exact="Zika" post="virus DNA vaccine candidates in healthy adults: randomised, open-label,"/>
   <result pre="10.1016/s0140-6736(17)33105-729217376 GooL.DeMasoC. R.PelcR. S.LedgerwoodJ. E.GrahamB. S.KuhnR. J.et al. (2018). The" exact="Zika" post="virus envelope protein glycan loop regulates virion antigenicity.Virology515191–202. 10.1016/j.virol.2017.12.03229304471"/>
   <result pre="loop regulates virion antigenicity.Virology515191–202. 10.1016/j.virol.2017.12.03229304471 GourinatA. C.O’ConnorO.CalvezE.GoarantC.Dupont-RouzeyrolM. (2015). Detection of" exact="Zika" post="virus in urine.Emerg. Infect. Dis.2184–86. 10.3201/eid2101.14089425530324 GrifoniA.PhamJ.SidneyJ.O’RourkeP. H.PaulS.PetersB.et al."/>
   <result pre="(2017). Prior dengue virus exposure shapes T cell immunity to" exact="Zika" post="virus in humans.J. Virol.10.1128/jvi.01469-17 [Epub ahead of print]. 28978707"/>
   <result pre="humans.J. Virol.10.1128/jvi.01469-17 [Epub ahead of print]. 28978707 HennesseyM.FischerM.StaplesJ. E. (2016)." exact="Zika" post="virus spreads to new areas – Region of the"/>
   <result pre="2016.MMWR Morb. Mortal. Wkly. Rep.6555–58. 10.15585/mmwr.mm6503e126820163 KauffmanE. B.KramerL. D. (2017)." exact="Zika" post="virus mosquito vectors: competence, biology, and vector control.J. Infect."/>
   <result pre="X.ZhangS.FibriansahG.NgT. S.OoiJ. S.et al. (2016). Structure of the thermally stable" exact="Zika" post="virus.Nature533425–428. 10.1038/nature1799427093288 KrauerF.RiesenM.ReveizL.OladapoO. T.Martinez-VegaR.PorgoT.V.et al. (2017). Zika virus infection"/>
   <result pre="the thermally stable Zika virus.Nature533425–428. 10.1038/nature1799427093288 KrauerF.RiesenM.ReveizL.OladapoO. T.Martinez-VegaR.PorgoT.V.et al. (2017)." exact="Zika" post="virus infection as a cause of congenital brain abnormalities"/>
   <result pre="guillain-barre syndrome: systematic review.PLoS Med.14:e1002203. 10.1371/journal.pmed.100220328045901 KwongJ. C.DruceJ. D.LederK. (2013)." exact="Zika" post="virus infection acquired during brief travel to Indonesia.Am. J."/>
   <result pre="LaroccaR. A.AbbinkP.PeronJ. P.ZanottoP. M.IampietroM. J.Badamchi-ZadehA.et al. (2016). Vaccine protection against" exact="Zika" post="virus from Brazil.Nature536474–478. 10.1038/nature1895227355570 LazearH. M.GoveroJ.SmithA. M.PlattD. J.FernandezE.MinerJ. J.et"/>
   <result pre="M.GoveroJ.SmithA. M.PlattD. J.FernandezE.MinerJ. J.et al. (2016). A mouse model of" exact="Zika" post="virus pathogenesis.Cell Host Microbe19720–730. 10.1016/j.chom.2016.03.01027066744 LiL.LokS. M.YuI. M.ZhangY.KuhnR. J.ChenJ.et"/>
   <result pre="L.WangH. J.HuangX. Y.QiuY. F.JiX.et al. (2018). Development of a chimeric" exact="Zika" post="vaccine using a licensed live-attenuated flavivirus vaccine as backbone.Nat."/>
   <result pre="as backbone.Nat. Commun.9:673. 10.1038/s41467-018-02975-w29445153 LinH. H.YipB. S.HuangL. M.WuS. C. (2018)." exact="Zika" post="virus structural biology and progress in vaccine development.Biotechnol. Adv.3647–53."/>
   <result pre="and immunogenicity results from three trials of a purified inactivated" exact="Zika" post="virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical"/>
   <result pre="placebo-controlled clinical trials.Lancet391563–571. 10.1016/s0140-6736(17)33106-929217375 MussoD.RocheC.NhanT. X.RobinE.TeissierA.Cao-LormeauV. M. (2015). Detection of" exact="Zika" post="virus in saliva.J. Clin. Virol.6853–55. 10.1016/j.jcv.2015.04.02126071336 OehlerE.WatrinL.LarreP.Leparc-GoffartI.LastereS.ValourF.et al. (2014)."/>
   <result pre="Zika virus in saliva.J. Clin. Virol.6853–55. 10.1016/j.jcv.2015.04.02126071336 OehlerE.WatrinL.LarreP.Leparc-GoffartI.LastereS.ValourF.et al. (2014)." exact="Zika" post="virus infection complicated by Guillain-Barre syndrome–case report, French Polynesia,"/>
   <result pre="Aided Mol. Des.311009–1019. 10.1007/s10822-017-0076-829064083 PardiN.HoganM. J.PelcR. S.MuramatsuH.AndersenH.DeMasoC. R.et al. (2017)." exact="Zika" post="virus protection by a single low-dose nucleoside-modified mRNA vaccination.Nature543248–251."/>
   <result pre="of protein evolution in the genome of pre-epidemic and epidemic" exact="Zika" post="virus.Infect. Genet. Evol.5174–85. 10.1016/j.meegid.2017.03.01228315476 RichnerJ. M.HimansuS.DowdK. A.ButlerS. L.SalazarV.FoxJ. M.et"/>
   <result pre="G.et al. (2016). The 3.8 A resolution cryo-EM structure of" exact="Zika" post="virus.Science352467–470. 10.1126/science.aaf531627033547 SmithburnK. C. (1952). Neutralizing antibodies against certain"/>
   <result pre="in East Africa.J. Immunol.69223–234. 14946416 SongB. H.YunS. I.WoolleyM.LeeY. M. (2017)." exact="Zika" post="virus: history, epidemiology, transmission, and clinical presentation.J. Neuroimmunol.30850–64. 10.1016/j.jneuroim.2017.03.00128285789"/>
   <result pre="G.WuA.OuyangS.LiC.BrasilP.et al. (2016). From mosquitos to humans: genetic evolution of" exact="Zika" post="Virus.Cell Host Microbe19561–565. 10.1016/j.chom.2016.04.00627091703 WetsmanN. (2017). The missing pieces:"/>
   <result pre="Host Microbe19561–565. 10.1016/j.chom.2016.04.00627091703 WetsmanN. (2017). The missing pieces: Lack of" exact="Zika" post="data from Africa complicates search for answers.Nat. Med.23904–906. 10.1038/nm0817-90428777794"/>
   <result pre="the International Health Regulations (2005) (IHR 2005) Emergency Committee on" exact="Zika" post="virus and Observed Increase in Neurological Disorders and Neonatal"/>
   <result pre="Available at: http://www.who.int/immunization/research/vaccine_pipeline_tracker_spreadsheet/en/ [Accessed 11 May, 2018]. WuY.LiuQ.ZhouJ.XieW.ChenC.WangZ.et al. (2017)." exact="Zika" post="virus evades interferon-mediated antiviral response through the co-operation of"/>
   <result pre="in vitro.Cell Discov.3:17006. 10.1038/celldisc.2017.628417013 XieX.YangY.MuruatoA. E.ZouJ.ShanC.NunesB. T.et al. (2017). Understanding" exact="Zika" post="virus stability and developing a chimeric vaccine through functional"/>
   <result pre="al. (2017). A DNA vaccine protects human immune cells against" exact="Zika" post="virus infection in humanized mice.EBioMedicine2587–94. 10.1016/j.ebiom.2017.10.00629033368 YoshiiK.IgarashiM.IchiiO.YokozawaK.ItoK.KariwaH.et al. (2012)."/>
   <result pre="al. (2017). A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephaly.Science358933–936. 10.1126/science.aam712028971967 ZanlucaC.Dos SantosC. N."/>
   <result pre="virus contributes to fetal microcephaly.Science358933–936. 10.1126/science.aam712028971967 ZanlucaC.Dos SantosC. N. (2016)." exact="Zika" post="virus – an overview.Microbes Infect.18295–301. 10.1016/j.micinf.2016.03.00326993028 ZhuZ.ChanJ. F.TeeK. M.ChoiG."/>
   <result pre="C.et al. (2016). Comparative genomic analysis of pre-epidemic and epidemic" exact="Zika" post="virus strains for virological factors potentially associated with the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6091172\results\search\tropicalVirus\results.xml">
   <result pre="reinfection and the cost to make an STI diagnosis [11]" exact="Human papilloma virus" post="(HPV) •Condoms •Up to 50% [12] •Circumcision •50% [13]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6109282\results\search\tropicalVirus\results.xml">
   <result pre="Including Tropical Diseases1678-9199BioMed CentralLondon pmcid: 6109282162 doi: 10.1186/s40409-018-0162-y : Review" exact="Yellow fever" post="in Africa and the Americas: a historical and epidemiological"/>
   <result pre="data made available in this article, unless otherwise stated. Abstract" exact="Yellow fever" post="was transported during the slave trade in the 15th"/>
   <result pre="emergence or reemergence of vector-borne diseases encompasses many intricate factors." exact="Yellow fever" post="outbreaks occur if at least three conditions are fulfilled:"/>
   <result pre="deliver some recommendations for improving the prevention of epidemics. Keywords" exact="Yellow fever" post="Aedes aegypti Haemagogus sp., Sabethes sp. Vector Arbovirus Epidemiology"/>
   <result pre="installment of a sylvatic cycle of the virus. Fig. 4" exact="Yellow fever" post="genotypes (adapted from [30, 31, 85–87, 89, 113]) However,"/>
   <result pre="areas [90]. Finally, the role of the recent dengue and" exact="Zika" post="epidemics, transmission of which is ensured by the same"/>
   <result pre="development is high. The recent epidemics of dengue, chikungunya and" exact="Zika" post="in Brazil demonstrated the limits of this strategy [133]."/>
   <result pre="be 11.1–15.6 per million vaccinated persons, including 6.6 YFV-AND and" exact="YFV" post="–AVD cumulated, with wide variations depending on the country"/>
   <result pre="to Brazil, the major vector of the dengue, chikungunya and" exact="Zika" post="virusesPLoS Negl Trop Dis2017117e000565310.1371/journal.pntd.000565328742801 93.ReiterPAedes albopictus and the world"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6134710\results\search\tropicalVirus\results.xml">
   <result pre="the competence of Ae. aegypti populations from Madeira to transmit" exact="DENV" post="or CHIKV remains unknown. This study aimed to assess"/>
   <result pre="of Ae. aegypti populations from Madeira to transmit DENV or" exact="CHIKV" post="remains unknown. This study aimed to assess experimentally the"/>
   <result pre="to transmit these viruses. Results By orally exposing mosquitoes to" exact="CHIKV" post="(NC/2011-568) and DENV-2 (Bangkok), the vector competence of two"/>
   <result pre="were similarly infected and ensured the dissemination and transmission of" exact="CHIKV" post="at the same rates. With DENV-2, viral dissemination was"/>
   <result pre="of temperate European Ae. aegypti populations from Madeira to transmit" exact="DENV" post="and CHIKV. As our results suggest, there is a"/>
   <result pre="there is a potential risk for the local transmission of" exact="DENV" post="and CHIKV if introduced to Madeira or continental Europe"/>
   <result pre="a potential risk for the local transmission of DENV and" exact="CHIKV" post="if introduced to Madeira or continental Europe where Aedes"/>
   <result pre="for chikungunya virus (CHIKV; genus Alphavirus, family Togaviridae) [7, 8]." exact="Dengue" post="and chikungunya are serious public health issues in tropical"/>
   <result pre="virus family has different serotypes, lineages and genotypes [9, 10]." exact="Dengue" post="is caused by four genetically distinct DENV serotypes (1,"/>
   <result pre="genotypes [9, 10]. Dengue is caused by four genetically distinct" exact="DENV" post="serotypes (1, 2, 3 and 4) and generally lead"/>
   <result pre="self-limited febrile illness characterised by a headache, fever and rash." exact="CHIKV" post="causes an acute febrile illness characterised by severe arthralgia"/>
   <result pre="illness characterised by severe arthralgia [11]. Phylogenetic analysis suggests that" exact="CHIKV" post="lineages can be classified into three distinct genotypes: Asian,"/>
   <result pre="distinct genotypes: Asian, West African and Eastern/Central/Southern African (ECSA). Both" exact="DENV" post="and CHIKV infections have a large proportion of asymptomatic"/>
   <result pre="Asian, West African and Eastern/Central/Southern African (ECSA). Both DENV and" exact="CHIKV" post="infections have a large proportion of asymptomatic cases contributing"/>
   <result pre="arboviral outbreaks in Madeira is real since imported cases of" exact="DENV" post="and Zika virus (ZIKV) were detected in citizens returning"/>
   <result pre="in Madeira is real since imported cases of DENV and" exact="Zika" post="virus (ZIKV) were detected in citizens returning from DENV-"/>
   <result pre="local Ae. aegypti populations from Madeira were experimentally susceptible to" exact="ZIKV" post="[19]. This study aims to assess the ability of"/>
   <result pre="of Ae. aegypti populations from Madeira Island to experimentally transmit" exact="CHIKV" post="and DENV. The results obtained will provide a solid"/>
   <result pre="The F1 generation was used for experimental infections. Viral strains" exact="CHIKV" post="(NC/2011-568) was isolated in 2011 from a patient by"/>
   <result pre="base position 226 in the E1 envelope glycoprotein (GenBank: HE806461)." exact="DENV" post="belonging to serotype 2 (DENV-2) was isolated in 1974"/>
   <result pre="time-points: 3, 6, 9 and 14 days post-infection (dpi) for" exact="CHIKV" post="and 7 and 14 dpi for DENV-2. To estimate"/>
   <result pre="(DENV), plates were stained using hyper-immune ascetic fluid specific to" exact="CHIKV" post="or DENV as the primary antibody. Alexa Fluor 488"/>
   <result pre="were stained using hyper-immune ascetic fluid specific to CHIKV or" exact="DENV" post="as the primary antibody. Alexa Fluor 488 goat anti-mouse"/>
   <result pre="Results Aedes aegypti from Madeira Island is highly susceptible to" exact="CHIKV" post="infection The susceptibility of Ae. aegypti from Madeira Island"/>
   <result pre="infection The susceptibility of Ae. aegypti from Madeira Island for" exact="CHIKV" post="was studied using a viral strain belonging to Asian"/>
   <result pre="[10]. Our results showed that local Ae. aegypti can transmit" exact="CHIKV" post="very efficiently: Funchal and Paúl do Mar populations were"/>
   <result pre="and Paúl do Mar populations were both highly susceptible to" exact="CHIKV" post="infection, with similar infection rates [Chi-square test: P &amp;gt;"/>
   <result pre="different days after exposure of Ae. aegypti from Madeira to" exact="CHIKV" post="NC/2011-568 strain Days post-infection Funchal Paúl do Mar IR"/>
   <result pre="the number of mosquitoes analysed To measure the ability of" exact="CHIKV" post="to cross the mosquito midgut barrier, dissemination rate (DR)"/>
   <result pre="Z = 2.62, P = 0.009). The maximum number of" exact="CHIKV" post="was detected at 6 dpi with 5.77 ± 0.53"/>
   <result pre="for the Paúl do Mar strain. Fig. 1 Dissemination of" exact="CHIKV" post="in Ae. aegypti from Madeira Island. Mosquitoes were sacrificed,"/>
   <result pre="refer to the standard deviation To evaluate the ability of" exact="CHIKV" post="to reach the salivary glands and be transmitted through"/>
   <result pre="was evaluated by quantifying the viral load in mosquito saliva." exact="CHIKV" post="particles reached its maximum at 14 dpi for both"/>
   <result pre="df = 3, P = 0.30)]. Fig. 2 Transmission of" exact="CHIKV" post="in the saliva of Ae. aegypti from Madeira Island."/>
   <result pre="than in heads (Figs. 3, 4). The maximum number of" exact="DENV" post="particles in saliva was reached at 14 dpi: 1.81"/>
   <result pre="n the number of mosquitoes analysed Fig. 3 Dissemination of" exact="DENV" post="in Ae. aegypti from Madeira Island. Mosquitoes were sacrificed,"/>
   <result pre="bars refer to the standard deviation Fig. 4 Transmission of" exact="DENV" post="in the saliva of Ae. aegypti from Madeira Island."/>
   <result pre="populations for the transmission of two arboviruses of medical importance," exact="CHIKV" post="and DENV. Since its arrival in 2005, Ae. aegypti"/>
   <result pre="that the local Ae. aegypti populations are very susceptible to" exact="CHIKV" post="and DENV-2 infections. Regarding CHIKV, our results showed that"/>
   <result pre="transmit this virus suggesting that the extrinsic incubation period of" exact="CHIKV" post="with this vector population was short, as expected [7]."/>
   <result pre="most of the inhabitants live and work. In addition to" exact="CHIKV" post="risk assessment, vector competence for DENV-2 transmission was also"/>
   <result pre="increasing concern that a new serotype will arrive in Madeira." exact="Dengue" post="secondary infection might lead to severe clinical symptoms and"/>
   <result pre="Madeira Island could be a stepping-stone for the introduction of" exact="ZIKV" post="into Europe. The main factors are present: the vector"/>
   <result pre="[19], and a naïve human population. Vector competence studies for" exact="ZIKV" post="were also performed using the same Ae. aegypti population"/>
   <result pre="viral strains or genotypes circulating in areas neighbouring Madeira Island." exact="CHIKV" post="and DENV are two arboviruses with the highest potential"/>
   <result pre="or genotypes circulating in areas neighbouring Madeira Island. CHIKV and" exact="DENV" post="are two arboviruses with the highest potential to be"/>
   <result pre="people with the two South American countries, the risk of" exact="CHIKV" post="autochthonous cases on Madeira Island remains high. As previously"/>
   <result pre="Island remains high. As previously stated, the Asian genotype of" exact="CHIKV" post="was used for the oral infections in Ae. aegypti"/>
   <result pre="used for the oral infections in Ae. aegypti from Madeira." exact="CHIKV" post="has had a severe impact in the Americas since"/>
   <result pre="recorded in the Andean region [34]. As with CHIKV, all" exact="DENV" post="serotypes can be introduced to Madeira by a viremic"/>
   <result pre="of the Ae. aegypti populations of Madeira. Differences observed in" exact="DENV" post="dissemination between Ae. aegypti from Funchal and Paúl do"/>
   <result pre="complete failure of the vector control programmes. Our results with" exact="CHIKV" post="and DENV suggest that it is crucial for Madeira"/>
   <result pre="of the vector control programmes. Our results with CHIKV and" exact="DENV" post="suggest that it is crucial for Madeira Island to"/>
   <result pre="expansion of vector-borne pathogens, mosquito vectors and viremic people. Abbreviations" exact="CHIKV" post="Chikungunya virus DENV Dengue virus ZIKV Zika virus ATP"/>
   <result pre="of vector-borne pathogens, mosquito vectors and viremic people. Abbreviations CHIKV" exact="Chikungunya" post="virus DENV Dengue virus ZIKV Zika virus ATP Adenosine"/>
   <result pre="pathogens, mosquito vectors and viremic people. Abbreviations CHIKV Chikungunya virus" exact="DENV" post="Dengue virus ZIKV Zika virus ATP Adenosine triphosphate FBS"/>
   <result pre="mosquito vectors and viremic people. Abbreviations CHIKV Chikungunya virus DENV" exact="Dengue" post="virus ZIKV Zika virus ATP Adenosine triphosphate FBS Fetal"/>
   <result pre="and viremic people. Abbreviations CHIKV Chikungunya virus DENV Dengue virus" exact="ZIKV" post="Zika virus ATP Adenosine triphosphate FBS Fetal bovine serum"/>
   <result pre="viremic people. Abbreviations CHIKV Chikungunya virus DENV Dengue virus ZIKV" exact="Zika" post="virus ATP Adenosine triphosphate FBS Fetal bovine serum dpi"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6142641\results\search\tropicalVirus\results.xml">
   <result pre="pathogens are of concerns to the public health. Most recently," exact="Zika" post="virus has been found with confounding situation in Asian"/>
   <result pre="infectious viruses like Ebola virus, SARS, MERS, Dengue, Chicken Guinea," exact="West Nile" post="and Japanese encephalitis have created panic owing to their"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6196792\results\search\tropicalVirus\results.xml">
   <result pre="The rapid worldwide spread of chikungunya (CHIKV), dengue (DENV), and" exact="Zika" post="(ZIKV) viruses have raised great international concern. Knowledge about"/>
   <result pre="these triple epidemics. Our results show that CHIKV, DENV-1–4, and" exact="ZIKV" post="followed a similar path prior to their first introductions"/>
   <result pre="Introduction Mosquito-borne viruses such as chikungunya (CHIKV), dengue (DENV), and" exact="Zika" post="(ZIKV) viruses have rapidly spread across the globe in"/>
   <result pre="in countries of the Southern Hemisphere including Brazil [1, 2]." exact="DENV" post="and ZIKV are members of the genus Flavivirus within"/>
   <result pre="of the Southern Hemisphere including Brazil [1, 2]. DENV and" exact="ZIKV" post="are members of the genus Flavivirus within the Flaviviridae"/>
   <result pre="virus (YFV), Japanese encephalitis virus (JEV), Spondweni virus (SPOV), and" exact="West Nile" post="virus (WNV) [3]. CHIKV is a member of the"/>
   <result pre="(JEV), Spondweni virus (SPOV), and West Nile virus (WNV) [3]." exact="CHIKV" post="is a member of the Alphavirus genus in the"/>
   <result pre="Alphavirus genus in the family Togaviridae [4]. DENV, ZIKV, and" exact="CHIKV" post="genomes consist of a +ssRNA of approximately 11 kb in"/>
   <result pre="Clinically, it is often difficult to differentiate DENV, CHIKV, and" exact="ZIKV" post="infections as they have similar manifestations, which include fever,"/>
   <result pre="methods, such as real-time reverse transcription polymerase chain reaction [8]." exact="CHIKV" post="causes a febrile illness characterized by sudden onset, backache,"/>
   <result pre="characterized by sudden onset, backache, headache, photophobia, and rash; unlike" exact="DENV" post="and ZIKV fever, CHIKV infection is associated with high"/>
   <result pre="sudden onset, backache, headache, photophobia, and rash; unlike DENV and" exact="ZIKV" post="fever, CHIKV infection is associated with high rates of"/>
   <result pre="backache, headache, photophobia, and rash; unlike DENV and ZIKV fever," exact="CHIKV" post="infection is associated with high rates of symptomatic infections"/>
   <result pre="infections and with recurrent polyarthralgias, which can be disabling [6]." exact="CHIKV" post="has only one serotype, but four viral genotypes have"/>
   <result pre="West African, Asian, and the Indian Ocean lineage (IOL)) [9]." exact="Dengue" post="is the most prevalent arboviral disease of humans worldwide."/>
   <result pre="caused by four closely related but antigenically distinct serotypes of" exact="DENV" post="(DENV-1–4). For DENV-1 and DENV-2, five and six genotypes"/>
   <result pre="been subdivided into four genotypes [11]. Initially discovered in 1947," exact="ZIKV" post="was a relatively unknown pathogen until 2007, when a"/>
   <result pre="Yap Island, a part of the Federated States of Micronesia." exact="ZIKV" post="reemerged in 2013 in French Polynesia and rapidly disseminated"/>
   <result pre="Pacific [12–14]. In March 2015, Brazil reported autochthonous transmission of" exact="ZIKV" post="for the first time in mainland South America and"/>
   <result pre="America and the virus has since spread throughout the Americas." exact="ZIKV" post="infection has already been reported in approximately 60 countries"/>
   <result pre="are now considered at risk of infection [16]. The Brazilian" exact="ZIKV" post="epidemic changed the world's perspective on this neglected virus"/>
   <result pre="newborns [17, 18]. There is by now compelling evidence that" exact="ZIKV" post="is involved in the etiology of this condition, as"/>
   <result pre="myelitis, meningoencephalitis, and Guillain-Barré syndrome (GBS) have been associated with" exact="ZIKV" post="infection [20, 21]. To date, there is a single"/>
   <result pre="ZIKV infection [20, 21]. To date, there is a single" exact="ZIKV" post="serotype, but two major viral lineages (African and Asian)"/>
   <result pre="genome sequences [22]. Previous evolutionary analyses have demonstrated that the" exact="ZIKV" post="strains circulating in Brazil belong to the Asian lineage"/>
   <result pre="unclear and very disputed. One of the hypotheses is that" exact="ZIKV" post="entered in Brazil during the 2014 World Cup (June"/>
   <result pre="circulating virus in Brazil [24, 25]. Another hypothesis states that" exact="ZIKV" post="introduction followed an international canoe event in August of"/>
   <result pre="Pacific countries [12]. Molecular clock and phylogenetic analysis of seven" exact="ZIKV" post="sequences from patients in Brazil suggest a single introduction"/>
   <result pre="May and December 2013, coinciding with increased air travel from" exact="ZIKV" post="endemic areas and outbreaks in the Pacific Ocean [23]."/>
   <result pre="suggested a common entry route into South America for the" exact="CHIKV" post="Asian genotype and for some lineages of DENV-1, 2,"/>
   <result pre="the spatial arrangements of these viruses. Our data suggests that" exact="ZIKV" post="followed a similar route as CHIKV and DENV until"/>
   <result pre="Our data suggests that ZIKV followed a similar route as" exact="CHIKV" post="and DENV until its first emergence on mainland South"/>
   <result pre="suggests that ZIKV followed a similar route as CHIKV and" exact="DENV" post="until its first emergence on mainland South America, placing"/>
   <result pre="each DENV-1–4 (DENV-1 (1560), DENV-2 (1132), DENV-3 (857), DENV-4 (161))," exact="CHIKV" post="(262), and ZIKV (63), phylogenetic reconstructions were performed with"/>
   <result pre="(1560), DENV-2 (1132), DENV-3 (857), DENV-4 (161)), CHIKV (262), and" exact="ZIKV" post="(63), phylogenetic reconstructions were performed with all complete genomes"/>
   <result pre="test support values with 1000 replications [39]. To complement our" exact="ZIKV" post="analysis due to the increasing amount of new ZIKV"/>
   <result pre="our ZIKV analysis due to the increasing amount of new" exact="ZIKV" post="genomes available monthly in the databases analyzed, we constructed"/>
   <result pre="we constructed an updated phylogenetic tree. We downloaded all full" exact="ZIKV" post="genomes from the ViPR database [40] deposited until May"/>
   <result pre="and severe disease outcomes associated with the CHIKV, DENV, and" exact="ZIKV" post="epidemics in several countries of South America and the"/>
   <result pre="circulating in Brazil (Figure 1). Considering only the Asian genotype," exact="CHIKV" post="caused an outbreak in the Caribbean (Martinique) in 2013"/>
   <result pre="in 2013 [32] and in September 2014 autochthonous and nonautochthonous" exact="CHIKV" post="Asian-genotype infections were reported in Oiapoque (northern Brazil) and"/>
   <result pre="Brazil) and Recife (northeastern Brazil) [9]. The analyses suggest that" exact="CHIKV" post="from Martinique reached the north and northeast of Brazil"/>
   <result pre="northeast of Brazil in 2014 (Figure 1). In Latin America," exact="DENV" post="resurged during the 1960s in the Caribbean and Venezuela"/>
   <result pre="This path was also followed by DENV-4 in 1981 [48]." exact="DENV" post="outbreaks were commonly reported in port cities from the"/>
   <result pre="2, we analyzed the flows and dispersion of the main" exact="DENV" post="genotypes between Central and South American countries as detailed"/>
   <result pre="genotype V. We observed two well-supported and independent introductions of" exact="DENV" post="from the Asian region (Indian sequences are the most"/>
   <result pre="introduced into the Americas via Cambodia (KHM), thus representing a" exact="DENV" post="of Asian origin (Figure 2(d)). We also believe that"/>
   <result pre="that genotype II followed the same route. The complexity of" exact="DENV" post="population dynamics in South America may be associated with"/>
   <result pre="be associated with the multiple introduction and dissemination of new" exact="DENV" post="variants in this region, vector density [5], and the"/>
   <result pre="entrance events and corresponding outbreaks are due to the highest" exact="DENV" post="diversity present in the Caribbean region which increases the"/>
   <result pre="I and II) in Figure 2. On the other hand," exact="ZIKV" post="was only detected in South America in 2015, and"/>
   <result pre="to map its transmission dynamics. Here, possible pathways taken by" exact="ZIKV" post="to reach different countries in mainland South America were"/>
   <result pre="transmission route. Our MST analysis centers on the 2014 Haitian" exact="ZIKV" post="strain [54] as the most closely related to the"/>
   <result pre="[54] as the most closely related to the French Polynesian" exact="ZIKV" post="isolate and thus as the most likely source of"/>
   <result pre="frequency of clades and nodes clustering, demonstrates that all Brazilian" exact="ZIKV" post="isolates presented high phylogenetic relationships with several isolates from"/>
   <result pre="the Caribbean region (Figure 3(b)), reinforcing this important link for" exact="ZIKV" post="spread across the Americas. Our results suggest multiple and"/>
   <result pre="spread across the Americas. Our results suggest multiple and simultaneous" exact="ZIKV" post="introductions into South America, as shown in the time-scaled"/>
   <result pre="phylogenetic tree (Figure 3(c)). Intriguingly, however, is a 2014 Haitian" exact="ZIKV" post="isolate (GenBank accession number KU509998) clustering with French Polynesian"/>
   <result pre="bottom of the tree and from which other South American" exact="ZIKV" post="isolates appear to have descended from. The subsequent dynamics"/>
   <result pre="possibly triggered successive events responsible for the generation of different" exact="ZIKV" post="variants, as exhibited by the multiple clades in the"/>
   <result pre="MCC tree (Figure 3(c)). Thus, the presence of multiple modern" exact="ZIKV" post="variants circulating in South America could be considered as"/>
   <result pre="Few base substitutions per site were found between and within" exact="ZIKV" post="variants, but they were sufficient to allow the division"/>
   <result pre="variants, but they were sufficient to allow the division of" exact="ZIKV" post="isolates into different clades (Supplementary Tables S1 and S2)."/>
   <result pre="Tables S1 and S2). Taken together, these results suggest that" exact="ZIKV" post="followed the same route of the Asian genotype of"/>
   <result pre="ZIKV followed the same route of the Asian genotype of" exact="CHIKV" post="and DENV-1–4: from Asia to Oceania, then emerging in"/>
   <result pre="matches in July 2014. Before this event, imported cases of" exact="CHIKV" post="were confirmed with most being travelers arriving from Haiti"/>
   <result pre="arriving from Haiti and the Dominican Republic. Among the imported" exact="CHIKV" post="cases, there were Brazilian military officers who were on"/>
   <result pre="After the event, an explosion of officially confirmed cases of" exact="CHIKV" post="and ZIKV took place in Brazil. The migration of"/>
   <result pre="event, an explosion of officially confirmed cases of CHIKV and" exact="ZIKV" post="took place in Brazil. The migration of thousands of"/>
   <result pre="of new pathogens [53]. Our results identified the 2014 Haitian" exact="ZIKV" post="strain [54] as the most closely related to the"/>
   <result pre="Polynesian isolate placing Haiti as a possible entry point of" exact="ZIKV" post="into the Americas, following the same path as DENV"/>
   <result pre="of ZIKV into the Americas, following the same path as" exact="DENV" post="and CHIKV as previously stated [56]. It is important"/>
   <result pre="into the Americas, following the same path as DENV and" exact="CHIKV" post="as previously stated [56]. It is important to note"/>
   <result pre="note that this single Haitian genomic sequence could suggest that" exact="ZIKV" post="arrived in the Caribbean islands but did not spread"/>
   <result pre="from there, which is in agreement with the absence of" exact="ZIKV" post="epidemics data from the Caribbean islands back in 2014/2015."/>
   <result pre="from the USA who travelled to Haiti (KX051563_2016_02_05_USA) confirms that" exact="ZIKV" post="is still circulating in the Caribbean islands [55]. The"/>
   <result pre="this strain could be explained by the further spread of" exact="ZIKV" post="from Brazil to the Caribbean islands after the Brazilian"/>
   <result pre="with all available genomes until May 2017 confirmed that this" exact="ZIKV" post="strain is closely related with the 2014 Haitian ZIKV"/>
   <result pre="this ZIKV strain is closely related with the 2014 Haitian" exact="ZIKV" post="sample, that is, this genome confirms that ZIKV first"/>
   <result pre="2014 Haitian ZIKV sample, that is, this genome confirms that" exact="ZIKV" post="first offset in the Americas is still circulating in"/>
   <result pre="tree). This introduction boosted the generation of modern South American" exact="ZIKV" post="variants, exhibited by the multiple and statistically well-defined clades"/>
   <result pre="This has led us to propose a subclassification of the" exact="ZIKV" post="Asian lineage into at least six variants (ZIKV-I to"/>
   <result pre="Materials Supplementary Materials Bayesian tree built using as input all" exact="ZIKV" post="genome sequences described in the Materials and Methods section"/>
   <result pre="at VIPR until May 2017. This analysis confirms that the" exact="ZIKV" post="first offset in the Americas keeps circulating in the"/>
   <result pre="the Caribbean Islands. The analysis was performed with 285 full" exact="ZIKV" post="genomes showing the African and Asian genotypes. Orange branches"/>
   <result pre="African and Asian genotypes. Orange branches are genomes previous to" exact="ZIKV" post="epidemics, green branches are genomes from Brazilian samples, and"/>
   <result pre="genomes from Brazilian samples, and samples with blue names are" exact="ZIKV" post="genomes from Haiti. The red collapsed clade denotes the"/>
   <result pre="red collapsed clade denotes the polytomic clade responsible for the" exact="ZIKV" post="epidemics in the Americas and exportation to other parts"/>
   <result pre="world. LINK Click here for additional data file. References 1PattersonJ.SammonM.GargM.Dengue," exact="Zika" post="and chikungunya: emerging arboviruses in the New WorldWestern Journal"/>
   <result pre="of General Virology201697226927310.1099/jgv.0.00038126684466 14TognarelliJ.UlloaS.VillagraE.et al.A report on the outbreak of" exact="Zika" post="virus on Easter Island, South Pacific, 2014Archives of Virology2016161366566810.1007/s00705-015-2695-526611910"/>
   <result pre="for Disease Control and PreventionAll Countries &amp;amp; Territories with Active" exact="Zika" post="Virus Transmission2016Centers for Disease Control and Prevention 16MessinaJ. P.KraemerM."/>
   <result pre="16MessinaJ. P.KraemerM. U. G.BradyO. J.et al.Mapping global environmental suitability for" exact="Zika" post="viruseLife2016510.7554/eLife.15272 17MlakarJ.KorvaM.TulN.et al.Zika virus associated with microcephalyNew England Journal"/>
   <result pre="V. B.XimenesR. A. . A.Miranda-FilhoD. . B.et al.Association between microcephaly," exact="Zika" post="virus infection, and other risk factors in Brazil: final"/>
   <result pre="Medicine2017141, artilce e100220310.1371/journal.pmed.100220328045901 20Cao-LormeauV. M.BlakeA.MonsS.et al.Guillain-Barré syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control studyLancet2016387100271531153910.1016/S0140-6736(16)00562-626948433 21YoshiharaT.MoritaM.IshiiT.Ultrastructure"/>
   <result pre="early epidemiological and genetic findingsScience2016352628334534910.1126/science.aaf503627013429 24SalvadorF. S.FujitaD. M.Entry routes for" exact="Zika" post="virus in Brazil after 2014 World Cup: new possibilitiesTravel"/>
   <result pre="P.SantosG. I. V.SantosC. N. D.LuzK.First report of autochthonous transmission of" exact="Zika" post="virus in BrazilMemórias do Instituto Oswaldo Cruz2015110456957210.1590/0074-0276015019226061233 26de MeloF."/>
   <result pre="dataPLOS Neglected Tropical Diseases2016104, article e000468710.1371/journal.pntd.000468727111294 55IovineN. M.LednickyJ.CherabuddiK.et al.Coinfection with" exact="Zika" post="and Dengue-2 viruses in a traveler returning from Haiti,"/>
   <result pre="path of dengue and chikungunya?Lancet2015386999024324410.1016/S0140-6736(15)61273-926194519 Figure 1 Phylogenetic reconstructions of" exact="CHIKV" post="whole genome sequences. Bayesian MCC tree enforcing a strict"/>
   <result pre="branches in blue and red represent Central/East African and Asian" exact="CHIKV" post="genotypes, respectively. Abbreviation: CAR = Central African Republic. Figure 2 Bayesian"/>
   <result pre="of countries and the horizontal blue bars represent phylogenetic uncertainty." exact="DENV" post="genotypes and lineages are indicated in each panel by"/>
   <result pre="the spatiotemporal spread pattern of ZIKV. The transmission networks during" exact="ZIKV" post="outbreaks as well as its origin and spread are"/>
   <result pre="bold indicate ZIKV-associated microcephaly and those in italics indicate that" exact="ZIKV" post="was imported from Venezuela to China (b). Time-scaled Bayesian"/>
   <result pre="Venezuela to China (b). Time-scaled Bayesian MCC phylogenetic tree of" exact="ZIKV" post="full-length genome sequences enforcing a relaxed molecular clock. The"/>
   <result pre="clades that help to elucidate the dynamics and dissemination of" exact="ZIKV" post="to different countries. Roman numerals in front of the"/>
   <result pre="front of the yellow rectangles represent our hypothesis for different" exact="ZIKV" post="variants that are currently circulating in South America. The"/>
   <result pre="and arrows highlight the entry routes of DENV, CHIKV, and" exact="ZIKV" post="into mainland South America. On the bottom left, there"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6200010\results\search\tropicalVirus\results.xml">
   <result pre="Letter: Investigating the Role of Easter Island in Migration of" exact="Zika" post="Virus from South Pacific to Americas Investigating the Role"/>
   <result pre="Americas Investigating the Role of Easter Island in Migration of" exact="Zika" post="Virus from South Pacific to Americas Investigating the Role"/>
   <result pre="Americas Investigating the Role of Easter Island in Migration of" exact="Zika" post="Virus from South Pacific to Americas DelatorreEdsonFernándezJorgeBelloGonzalo[], [], Address"/>
   <result pre="Abstract The role of Easter Island in the dissemination of" exact="Zika" post="virus from the Pacific islands into the Americas remains"/>
   <result pre="Pacific islands into the Americas remains unclear. We analyzed new" exact="Zika" post="virus sequences from Eastern Island and found that Zika"/>
   <result pre="new Zika virus sequences from Eastern Island and found that" exact="Zika" post="virus was independently disseminated from French Polynesia into the"/>
   <result pre="Americas and Easter Island at around the same time. Keywords:" exact="Zika" post="virus epidemics phylogeny Pacific Islands Americas viruses vector-borne infections"/>
   <result pre="vector-borne infections mosquitoborne South Pacific Easter Island migration French Polynesia" exact="Zika" post="virus is a mosquitoborne flavivirus associated with several recent"/>
   <result pre="the Pacific region and the Americas. Phylogeographic studies indicate that" exact="Zika" post="virus strains circulating in South Pacific islands and Latin"/>
   <result pre="South Pacific into Latin America (1–5). However, whether the ancestral" exact="Zika" post="virus strain introduced into the Americas arose directly from"/>
   <result pre="another South Pacific island is unclear. In early 2014, a" exact="Zika" post="virus outbreak occurred in Easter Island (6), months before"/>
   <result pre="in Easter Island (6), months before the first identification of" exact="Zika" post="virus in Brazil (7). Easter Island is located at"/>
   <result pre="Easter Island a potential staging post in the spread of" exact="Zika" post="virus from French Polynesia to continental America. This hypothesis"/>
   <result pre="tested this hypothesis by using a more comprehensive dataset of" exact="Zika" post="virus sequences from the South Pacific. Blood samples from"/>
   <result pre="virus sequences from the South Pacific. Blood samples from suspected" exact="Zika" post="virus–infected human patients who visited the emergency unit of"/>
   <result pre="diseases. The complete E and partial NS5 genes of 7" exact="Zika" post="virus strains were obtained as previously described (6). The"/>
   <result pre="as previously described (6). The concatenated fragments were aligned with" exact="Zika" post="virus Asian genotype sequences available in GenBank and used"/>
   <result pre="Appendix). The overall timescale of the phylogenetic tree estimated for" exact="Zika" post="virus Asian genotype strains was fully consistent with previous"/>
   <result pre="&amp;gt;0.94) encloses strains from Easter Island and the Cook Islands." exact="Zika" post="virus strains from Fiji, American Samoa, Samoa, Tonga, and"/>
   <result pre="French Polynesia was the most probable source location of the" exact="Zika" post="virus clade I strains introduced into the Americas (PSP"/>
   <result pre="Easter Island (PSP &amp;gt;0.77), refuting the hypothesis of introduction of" exact="Zika" post="virus into the Americas through Easter Island. The source"/>
   <result pre="&amp;gt;0.34) or Easter Island (PSP &amp;gt;0.37). Our analyses indicate that" exact="Zika" post="virus was introduced into Easter Island, New Caledonia, the"/>
   <result pre="time (BCI 2013.6–2014.8), supporting a much longer period of undetected" exact="Zika" post="virus transmission in the Americas (≈15 months) (7,8) than"/>
   <result pre="(7,8) than in those South Pacific islands (&amp;lt;1 month) (8)." exact="Zika" post="virus also spread from French Polynesia into Samoa, Fiji,"/>
   <result pre="mid-2014, coinciding with a peak in the number of suspected" exact="Zika" post="cases in French Polynesia. The long period of cryptic"/>
   <result pre="in French Polynesia. The long period of cryptic circulation of" exact="Zika" post="virus in the Americas, the early detection of Zika"/>
   <result pre="of Zika virus in the Americas, the early detection of" exact="Zika" post="virus in the Caribbean in December 2014 (4), and"/>
   <result pre="territories into French Polynesia during 2013–2014 support the hypothesis that" exact="Zika" post="virus might have been introduced to and circulated in"/>
   <result pre="Pacific and the Caribbean region. Technical Appendix Geographic dissemination of" exact="Zika" post="virus Asian genotype throughout South Pacific and the Americas,"/>
   <result pre="J, Bello G. Role of Easter Island in migration of" exact="Zika" post="virus from South Pacific to Americas. Emerg Infect Dis."/>
   <result pre="research interests include the evolution and phylodynamics of viruses, including" exact="Zika" post="virus. References References 1. FariaNR, AzevedoRDSDS, KraemerMUG, SouzaR, CunhaMS,"/>
   <result pre="ThézéJ, de JesusJG, GiovanettiM, et al.Establishment and cryptic transmission of" exact="Zika" post="virus in Brazil and the Americas.Nature. 2017;546:406–10. 10.1038/nature2240128538727 3."/>
   <result pre="LagosJ, AguayoC, FasceR, et al.A report on the outbreak of" exact="Zika" post="virus on Easter Island, South Pacific, 2014.Arch Virol. 2016;161:665–8."/>
   <result pre="South Pacific, 2014.Arch Virol. 2016;161:665–8. 10.1007/s00705-015-2695-526611910 7. CamposGS, BandeiraAC, SardiSI." exact="Zika" post="virus outbreak, Bahia, Brazil.Emerg Infect Dis. 2015;21:1885–6. 10.3201/eid2110.15084726401719 8."/>
   <result pre="Brazil.Emerg Infect Dis. 2015;21:1885–6. 10.3201/eid2110.15084726401719 8. PetersenLR, JamiesonDJ, PowersAM, HoneinMA." exact="Zika" post="Virus.N Engl J Med. 2016;374:1552–63. 10.1056/NEJMra160211327028561 9. Cao-LormeauV-M, RocheC,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6205565\results\search\tropicalVirus\results.xml">
   <result pre="in massive outbreaks with worldwide impacts (such as Ebola virus," exact="Zika" post="virus and Chikungunya virus). Research on emerging infectious diseases"/>
   <result pre="with worldwide impacts (such as Ebola virus, Zika virus and" exact="Chikungunya" post="virus). Research on emerging infectious diseases needs to be"/>
   <result pre="indicated suboptimal (less than 95%) vaccination coverage among children surveyed." exact="Yellow fever" post="virus is a mosquito-borne Flavivirus (family Flaviviridae) causing infection"/>
   <result pre="lack of sustained vaccination in the human population. Fig. 1" exact="Yellow fever" post="risks in Africa and vaccination recommendations. Table 2 Emerging"/>
   <result pre="455 cases, 5045 deaths Sustained vaccination in human population http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/Country_slides_measles.pdf?ua=1" exact="Yellow fever" post="virus •Nigeria (2000) •Guinea, Liberia (2000–2001) •Côte d’Ivoire (2001–2003)"/>
   <result pre="Niger (2016) Sustained vaccination in animals; vector-control measures [47], http://www.who.int/news-room/fact-sheets/detail/rift-valley-fever" exact="Zika" post="virus •First outbreak detected: Cabo Verde (2015) Vector-control measures"/>
   <result pre="virus •First outbreak detected: Cabo Verde (2015) Vector-control measures [48]" exact="Chikungunya" post="virus •Kenya (2004): largest outbreak (almost half a million)"/>
   <result pre="(http://www.who.int/news-room/fact-sheets/detail/rift-valley-fever) [47]. Fig. 2 Rift Valley Fever risks in Africa." exact="Zika" post="virus is another Flavivirus (family Flaviridae) transmitted by Aedes"/>
   <result pre="1947 in a febrile sentinel rhesus macaque monkey in the" exact="Zika" post="forest on the shores of Lake Victoria (Uganda) [48]."/>
   <result pre="in Uganda. Overall, data currently support a silent transmission of" exact="Zika" post="virus among humans, mosquitoes and animals throughout tropical Africa"/>
   <result pre="second epidemic affected Polynesia in 2013. The first outbreak of" exact="Zika" post="virus in Africa was detected in 2015 in Cabo"/>
   <result pre="Africa was detected in 2015 in Cabo Verde (Fig. 3)." exact="Zika" post="virus exhibited two unique features among the arboviruses: sexual"/>
   <result pre="after its emergence in the Americas [48]. The link between" exact="Zika" post="virus and severe malformations of the central nervous system"/>
   <result pre="Polynesia [48]. Genetic differences between African and Asian/American strains of" exact="Zika" post="virus and appearance of the ‘pathogenic clone’ may explain"/>
   <result pre="appearance of the ‘pathogenic clone’ may explain the emergence of" exact="Zika" post="virus infections in South America and Asia [48], [49]."/>
   <result pre="infections in South America and Asia [48], [49]. Fig. 3" exact="Zika" post="virus risks in Africa. Chikungunya virus, an Alphavirus (family"/>
   <result pre="Asia [48], [49]. Fig. 3 Zika virus risks in Africa." exact="Chikungunya" post="virus, an Alphavirus (family Togaviridae), first reported in Tanzania"/>
   <result pre="the area of Kédougou in 2015 (Fig. 4). Fig. 4" exact="Chikungunya" post="virus risks in Africa. Many other diseases deserve to"/>
   <result pre="outbreak in SudanPLoS Negl Trop Dis52011e122921980543 48GublerD.J.VasilakisN.MussoD.History and emergence of" exact="Zika" post="virusJ Infect Dis216Suppl. 102017S860S86729267917 49FreireC.C.M.PalmisanoG.BraconiC.T.CugolaF.R.RussoF.B.Beltrao-BragaP.C.NS1 codon usage adaptation to"/>
   <result pre="Dis216Suppl. 102017S860S86729267917 49FreireC.C.M.PalmisanoG.BraconiC.T.CugolaF.R.RussoF.B.Beltrao-BragaP.C.NS1 codon usage adaptation to humans in pandemic" exact="Zika" post="virusMem Inst Oswaldo Cruz1132018e170385 50WahidB.AliA.RafiqueS.IdreesM.Global expansion of chikungunya virus:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6247931\results\search\tropicalVirus\results.xml">
   <result pre="such as the West African Ebola epidemic and the ongoing" exact="Zika" post="epidemic in the Americas. The rapid evolution of these"/>
   <result pre="that supports this geographic reconstruction. Fig. 1. Genomic epidemiology of" exact="Zika" post="virus as of Oct 2017 (live display at nextstrain.org/zika)."/>
   <result pre="e1006390–e1006316.28617868 FariaN.R.et al. (2017) Epidemic establishment and cryptic transmission of" exact="Zika" post="virus in Brazil and the Americas. Nature, 546, 406–410.28538727"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6251852\results\search\tropicalVirus\results.xml">
   <result pre="TherRheumatology and Therapy2198-65762198-6584Springer HealthcareCheshire pmcid: 6251852121 doi: 10.1007/s40744-018-0121-7 : Review" exact="Chikungunya" post="Infection: A Re-emerging Epidemic PaulBinoy J.1http://orcid.org/0000-0003-2521-2272SadanandShajitshajitsadanand@gmail.com2[1], 0000 0001 0353"/>
   <result pre="6304grid.253527.4Government Medical College, epub: 2018-7-7pmc-release: 2018-7-7collection: 2018-1252317326received: 2018-5-10(C) , Abstract" exact="Chikungunya" post="(CHIK) is an arboviral infection caused by the chikungunya"/>
   <result pre="the menace of CHIK across the globe. Keywords Arboviral infection" exact="Chikungunya" post="Inflammatory arthritis Introduction Chikungunya (CHIK) is an arboviral infection"/>
   <result pre="across the globe. Keywords Arboviral infection Chikungunya Inflammatory arthritis Introduction" exact="Chikungunya" post="(CHIK) is an arboviral infection caused by the chikungunya"/>
   <result pre="driving scientists to undertake extensive research into the evolution of" exact="CHIKV" post="and the factors affecting the prolonged morbidity caused by"/>
   <result pre="in 1973 in Maharashtra (Fig. 1). A distinctive feature of" exact="CHIKV" post="is that it causes explosive outbreaks before apparently disappearing"/>
   <result pre="11]. Fig. 1 Countries which have reported the occurrence of" exact="Chikungunya" post="(both recently and historically). Source U.S. Centers for Disease"/>
   <result pre="1973 [13] and then by a period of quiescence when" exact="CHIKV" post="seemed to have disappeared from India. After a gap"/>
   <result pre="as Delhi. A mutation found in the E1 protein of" exact="CHIKV" post="(A226V) removes the requirement of this virus for cholesterol"/>
   <result pre="aegypti [12–14]. Additional adaptive mutations have also been identified in" exact="CHIKV" post="that involve E2 and E3 substitutions; these enhance the"/>
   <result pre="enhance the initial infection of the Ae. albopictus midgut by" exact="CHIKV" post="leading to greater vector competence [47]. After 2006, suspected"/>
   <result pre="2017 reported from different parts of the country [15]. Etiology" exact="Chikungunya" post="virus Chikungunya virus was first isolated in Tanzania by"/>
   <result pre="from different parts of the country [15]. Etiology Chikungunya virus" exact="Chikungunya" post="virus was first isolated in Tanzania by Ross and"/>
   <result pre="seen in Asia but is also now found in Africa." exact="CHIKV" post="is maintained in nature by the sylvatic cycle, with"/>
   <result pre="[19]. However a mutation found in the E1 protein of" exact="CHIKV" post="(A226V) has enabled this virus to eliminate its cholesterol"/>
   <result pre="Ae. albopictus has also been enhanced by adaptive mutations in" exact="CHIKV" post="involving E2 and E3 substitutions which enhance the initial"/>
   <result pre="enhance the initial infection of the Ae. albopictus midgut by" exact="CHIKV" post="[47]. The persistence of the CHIKV virus in urban"/>
   <result pre="Ae. albopictus midgut by CHIKV [47]. The persistence of the" exact="CHIKV" post="virus in urban cycle is thought to be the"/>
   <result pre="thought to be the result of the continuous introduction of" exact="CHIKV" post="to immunologically naive populations. Vertical transmission from an infected"/>
   <result pre="After subcutaneous inoculation through the bite of an infected mosquito," exact="CHIKV" post="disseminates through the lymph nodes and microvasculature. The entry"/>
   <result pre="a major source of INFs, are readily infected by the" exact="CHIKV" post="and they play a pivotal role in several cellular"/>
   <result pre="the responses of both the Th1- and Th2-type cytokines to" exact="CHIKV" post="[22, 23]. It is hypothesized that type 1 IFNs"/>
   <result pre="IFNs (IFN-γ), which are produced in the early stages of" exact="CHIKV" post="infection, further promote the transition from innate to adaptive"/>
   <result pre="It has also been shown that CD4 + T cells induced by" exact="CHIKV" post="infection are the major producers of IFN-γ and that"/>
   <result pre="has been speculated to be associated with persistent arthritis in" exact="CHIKV" post="[26]. Clinical Features Clinical manifestations of CHIK are variable,"/>
   <result pre="(Table 1). Table 1 Clinical clues which help to differentiate" exact="Chikungunya" post="and Dengue fever Clinical feature Chikungunya Dengue fever High"/>
   <result pre="Table 1 Clinical clues which help to differentiate Chikungunya and" exact="Dengue" post="fever Clinical feature Chikungunya Dengue fever High fever Present"/>
   <result pre="which help to differentiate Chikungunya and Dengue fever Clinical feature" exact="Chikungunya" post="Dengue fever High fever Present Present Myalgia Less common"/>
   <result pre="help to differentiate Chikungunya and Dengue fever Clinical feature Chikungunya" exact="Dengue" post="fever High fever Present Present Myalgia Less common More"/>
   <result pre="(100–200 IU/L) Moderate elevation (100–500 IU/L) Serology IgM CHIK IgM" exact="Dengue" post="PCR CHIK RT-PCR Dengue RT-PCR ESR Erythrocyte sedimentation rate,"/>
   <result pre="(100–500 IU/L) Serology IgM CHIK IgM Dengue PCR CHIK RT-PCR" exact="Dengue" post="RT-PCR ESR Erythrocyte sedimentation rate, CRP C-reactive protein, SGOT"/>
   <result pre="acute and convalescent phase sera or to detect IgM anti" exact="CHIKV" post="antibodies in acute phase sera, in the absence of"/>
   <result pre="other agents producing a similar disease syndrome (in which case" exact="CHIKV" post="infection would have occurred up to months earlier and"/>
   <result pre="(ELISA) and immune-chromatographic tests are two common techniques for estimating" exact="CHIKV" post="titres in blood [33]. The ELISA is generally quite"/>
   <result pre="gold standard for serology. Nucleic Acid Detection—PCR Early diagnosis of" exact="CHIKV" post="is possible by nucleic acid detection techniques, such as"/>
   <result pre="date, no vaccines have been approved for the prevention of" exact="CHIKV" post="infection [7]. Chloroquine phosphate (CQ) has been used effectively"/>
   <result pre="[7]. Chloroquine phosphate (CQ) has been used effectively to manage" exact="CHIKV" post="arthritis [36]. In a previous study, the authors used"/>
   <result pre="fusion, binding and cell-to-cell transmission [45, 46]. Challenges for Future" exact="Chikungunya" post="infection is an important threat to mankind in view"/>
   <result pre="Trop Dis.20137e213710.1371/journal.pntd.000213723556021 7.Mathew A, Ganapati A, Kabeerdoss J, et al." exact="Chikungunya" post="infection: a global public health menace. Curr Allergy Asthma"/>
   <result pre="decade. 2012. p. 221–42. 14.CHERIANSWALIMBEAJADHAVSGANDHESHUNDEKARSMISHRAAARANKALLEVEvolutionary rates and timescale comparison of" exact="Chikungunya" post="viruses inferred from the whole genome/E1 gene with special"/>
   <result pre="subcontinentInfection, Genetics and Evolution200991162310.1016/j.meegid.2008.09.004 15.National Vector Borne Disease Control Programme." exact="Chikungunya" post="fever. 2017. http://nvbdcp.gov.in/chikun-status.html. Accessed 30 Dec 2017. 16.KhanAMMoritaKParquetMCHasibiFEdwardGMIgarshiAMathange. Complete"/>
   <result pre="http://nvbdcp.gov.in/chikun-status.html. Accessed 30 Dec 2017. 16.KhanAMMoritaKParquetMCHasibiFEdwardGMIgarshiAMathange. Complete nucleotide sequence of" exact="Chikungunya" post="virus and evidence for an internal polyadenylation siteJ Gen"/>
   <result pre="Severe DiseasePLoS Pathogens200842e2910.1371/journal.ppat.004002918282093 23.ZieglerSALuLTravassosRAXiaoSYTeshRBAn animal model for studying pathogenesis of" exact="Chikungunya" post="virus infectionAm J Trop Med200879113313910.4269/ajtmh.2008.79.133 24.SchilteCCoudercTChretienFet al.Type I IFN"/>
   <result pre="in acute ChikungunyaPLoS One201424e11130510.1371/journal.pone.0111305 27.National Vector Borne Disease Control Programme." exact="Chikungunya" post="fever—national guidelines. nvbdcp.gov.in/Doc/National-Guidelines-Clinical-Management-Chikungunya-2016.pdf. 28.PaulBPannarkadyGMoniSThachilEClinical profile and long-term sequelae of"/>
   <result pre="Chikungunya fever—national guidelines. nvbdcp.gov.in/Doc/National-Guidelines-Clinical-Management-Chikungunya-2016.pdf. 28.PaulBPannarkadyGMoniSThachilEClinical profile and long-term sequelae of" exact="Chikungunya" post="feverIndian J Rheumatol.201161121910.1016/S0973-3698(11)60024-1 29.collab: National Institute of Communicable Disease,"/>
   <result pre="testing at a national reference laboratory since the emergence of" exact="Chikungunya" post="virus in the AmericasClin Vaccine Immunol20152229129710.1128/CVI.00720-1425540275 34.PatelPAbd El WahedAFayeOet"/>
   <result pre="transcription recombinase polymerase amplification assay for rapid detection of the" exact="Chikungunya" post="virusPLoS Negl Trop Dis.201610e000495310.1371/journal.pntd.000495327685649 35.ParidaMMSanthoshSRDashPKet al.Rapid and real-time detection"/>
   <result pre="virusPLoS Negl Trop Dis.201610e000495310.1371/journal.pntd.000495327685649 35.ParidaMMSanthoshSRDashPKet al.Rapid and real-time detection of" exact="Chikungunya" post="virus by reverse transcription loopmediated isothermal amplification assayJ Clin"/>
   <result pre="isothermal amplification assayJ Clin Microbiol20074535135710.1128/JCM.01734-0617135444 36.BrightonSWChloroquine phosphate treatment of chronic" exact="Chikungunya" post="arthritis. An open pilot studyS Afr Med J1984662172186087474 37.ChopraASalujaMVenugopalanAEffectiveness"/>
   <result pre="and persistent presentations), November 2014Med Mal Infect.20154524326310.1016/j.medmal.2015.05.00726119684 41.RavichandranRManianMRibavirin therapy for" exact="Chikungunya" post="arthritisJ Infect Dev Ctries.2008214014210.3855/T2.2.14019738340 42.RulliNERolphMSSrikiatkhachornAAnantapreechaSGuglielmottiAMahalingamSProtection from arthritis and myositis"/>
   <result pre="of Aedes aegypti and Aedes albopictus and vectorial capacity for" exact="Chikungunya" post="virusJ Infect Dis2016214suppl_5S453S45810.1093/infdis/jiw28527920173 48.RossRWThe Newala epidemic. III. The virus:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6256408\results\search\tropicalVirus\results.xml">
   <result pre="in the rest of the Americas. After the introduction of" exact="West Nile" post="virus in 1999, activity of SLEV decreased considerably in"/>
   <result pre="(8). Drought has also been linked to urban SLE and" exact="West Nile" post="virus (WNV) epidemics involving vectors in the Cx. pipiens"/>
   <result pre="it an excellent vector of SLEV (11). The introduction of" exact="WNV" post="into the United States in 1999 promoted debate about"/>
   <result pre="States in 1999 promoted debate about how the presence of" exact="WNV" post="would affect the continued transmission of SLEV, given the"/>
   <result pre="studies demonstrated that house finches (Haemorhous mexicanus) experimentally infected with" exact="WNV" post="developed neutralizing immunity that prevented infection after rechallenge with"/>
   <result pre="WNV developed neutralizing immunity that prevented infection after rechallenge with" exact="WNV" post="or SLEV (12). In contrast, house finches first exposed"/>
   <result pre="lower subsequent viremias after rechallenge with WNV. This suggests that" exact="WNV" post="could competitively exclude SLEV from amplification in shared avian"/>
   <result pre="in Florida decreased notably following the introduction and establishment of" exact="WNV" post="(13). For competitive exclusion to suppress SLEV transmission, considerable"/>
   <result pre="to suppress SLEV transmission, considerable host overlap between SLEV and" exact="WNV" post="must occur. In Florida, avian species in the families"/>
   <result pre="doves were found to be 1 of the least competent" exact="WNV" post="hosts of 25 bird species examined experimentally (15). Even"/>
   <result pre="species examined experimentally (15). Even if mourning doves are poor" exact="WNV" post="hosts, being exposed to WNV may provide cross neutralization"/>
   <result pre="if mourning doves are poor WNV hosts, being exposed to" exact="WNV" post="may provide cross neutralization to SLEV and preempt amplification"/>
   <result pre="preempt amplification of SLEV, provided that doves are exposed to" exact="WNV" post="early in the transmission season. In California, sparrows, finches,"/>
   <result pre="white-crowned sparrow (Zonotrichia leucophrys) are considered major amplifying hosts of" exact="WNV" post="and SLEV (1,16). As in Florida, host overlap of"/>
   <result pre="WNV and SLEV (1,16). As in Florida, host overlap of" exact="WNV" post="and SLEV likely contributed to the initial disappearance of"/>
   <result pre="threshold for infection of Cx. tarsalis, the principal vector of" exact="WNV" post="and SLEV throughout much of California (16). Further work"/>
   <result pre="of the United States outside California. Since the introduction of" exact="WNV" post="into the United States, human SLE cases continue to"/>
   <result pre="in mosquitoes, or seroconversions in sentinel chickens (42). In 2003," exact="WNV" post="activity was first detected in the state (17). During"/>
   <result pre="result of a lack of surveillance because the invasion of" exact="WNV" post="led to a ≈6-fold statewide increase in mosquito pool"/>
   <result pre="infectious diseases worldwide. Mosquitoborne viruses, including dengue (emerged in 1990)," exact="WNV" post="(emerged in 1999), chikungunya (2013), and Zika viruses (2015),"/>
   <result pre="(emerged in 1990), WNV (emerged in 1999), chikungunya (2013), and" exact="Zika" post="viruses (2015), have emerged as public health threats in"/>
   <result pre="encephalitis virus, Florida.Emerg Infect Dis. 2002;8:575–80. 10.3201/eid0806.01041712023912 9. EpsteinPR, DefilippoC." exact="West Nile" post="virus and drought.Glob Change Hum Health. 2001;2:105–7. 10.1023/A:1015089901425 10."/>
   <result pre="mosquito.Am Entomol. 1994;40:162–7. 10.1093/ae/40.3.162 12. FangY, ReisenWK. Previous infection with" exact="West Nile" post="or St. Louis encephalitis viruses provides cross protection during"/>
   <result pre="Trop Med Hyg. 2006;75:480–5. 10.4269/ajtmh.2006.75.48016968925 13. OttendorferCL. Impact of the" exact="West Nile" post="virus on the natural history of St. Louis encephalitis"/>
   <result pre="North American birds with the New York 1999 strain of" exact="West Nile" post="virus.Emerg Infect Dis. 2003;9:311–22. 10.3201/eid0903.02062812643825 16. ReisenWK, ChilesRE, MartinezVM,"/>
   <result pre="10.1603/0022-2585-40.6.96814765678 17. ReisenWK, LothropHD, WheelerSS, KennsingtonM, GutierrezA, FangY, et al.Persistent" exact="West Nile" post="virus transmission and the apparent displacement St. Louis encephalitis"/>
   <result pre="AguilarJJ, KomarN, et al.Activity patterns of St. Louis encephalitis and" exact="West Nile" post="viruses in free ranging birds during a human encephalitis"/>
   <result pre="FischerM, et al.Concurrent outbreaks of St. Louis encephalitis virus and" exact="West Nile" post="virus disease—Arizona, 2015.MMWR Morb Mortal Wkly Rep. 2015;64:1349–50.26656306 49."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6264817\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Tropical Diseases"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : People and Places : Geographical Locations: Asia"/>
   <result pre="medium, provided the original author and source are credited.pone.0207554.pdf Abstract" exact="Chikungunya" post="virus (CHIKV) has caused several major epidemics globally over"/>
   <result pre="heavy burden to healthcare systems. The two main vectors for" exact="CHIKV" post="are Aedes aegypti and Aedes albopictus (Asian tiger mosquito);"/>
   <result pre="however, many other mosquito species have been described as competent" exact="CHIKV" post="vectors in scientific literature. With climate change, globalization and"/>
   <result pre="climate change, globalization and unfettered urban planning affecting many areas," exact="CHIKV" post="poses a significant public health risk to many countries."/>
   <result pre="from published scientific literature on a priori defined aspects of" exact="CHIKV" post="and its competent vectors. After developing a sensitive and"/>
   <result pre="data was extracted from 1920 relevant articles. Results show that" exact="CHIKV" post="research is reported predominantly in areas after major epidemics"/>
   <result pre="major epidemics have occurred. There has been an upsurge in" exact="CHIKV" post="publications since 2011, especially after first reports of CHIKV"/>
   <result pre="in CHIKV publications since 2011, especially after first reports of" exact="CHIKV" post="emergence in the Americas. A list of hosts and"/>
   <result pre="be involved in the sylvatic and urban transmission cycles of" exact="CHIKV" post="has been compiled in this scoping review. In addition,"/>
   <result pre="compiled in this scoping review. In addition, a repository of" exact="CHIKV" post="mutations associated with evolutionary fitness and adaptation has been"/>
   <result pre="been uploaded to Dryad and are accessible at https://doi.org/10.5061/dryad.qd65020. Introduction" exact="Chikungunya" post="disease is caused by chikungunya virus (CHIKV), a mosquito-borne"/>
   <result pre="both hallmark features of the disease. The proportion of asymptomatic" exact="CHIKV" post="infections during epidemics has been reported to be between"/>
   <result pre="exanthema with a saddleback fever pattern, symptoms also seen with" exact="Dengue" post="virus (DENV) and Zika virus (ZIKV) infections [6]. This"/>
   <result pre="fever pattern, symptoms also seen with Dengue virus (DENV) and" exact="Zika" post="virus (ZIKV) infections [6]. This makes CHIKV diagnosis difficult,"/>
   <result pre="virus (DENV) and Zika virus (ZIKV) infections [6]. This makes" exact="CHIKV" post="diagnosis difficult, particularly since there are many reports of"/>
   <result pre="difficult, particularly since there are many reports of co-circulating CHIKV," exact="DENV" post="and ZIKV in many areas with co-infected patients [7–14]."/>
   <result pre="since there are many reports of co-circulating CHIKV, DENV and" exact="ZIKV" post="in many areas with co-infected patients [7–14]. CHIKV is"/>
   <result pre="DENV and ZIKV in many areas with co-infected patients [7–14]." exact="CHIKV" post="is an enveloped, positive strand RNA virus with a"/>
   <result pre="the virus provide evidence that the West African lineage of" exact="CHIKV" post="originated in Africa and subsequently moved into Asia where"/>
   <result pre="Asia where it evolved into a distinct Asian lineage. The" exact="CHIKV" post="isolate from the epidemic in Reunion Island in 2005"/>
   <result pre="be the outcome of two separate introductions of two individual" exact="CHIKV" post="lineages; Asian and ECSA [21–23]. CHIKV is maintained in"/>
   <result pre="introductions of two individual CHIKV lineages; Asian and ECSA [21–23]." exact="CHIKV" post="is maintained in a sylvatic cycle involving wild primates"/>
   <result pre="in countries with human epidemics [24]. The urban cycle of" exact="CHIKV" post="has been responsible for several large CHIKV epidemics in"/>
   <result pre="urban cycle of CHIKV has been responsible for several large" exact="CHIKV" post="epidemics in countries spanning many continents. During the 2005–2006"/>
   <result pre="third of the population in Reunion Island were infected with" exact="CHIKV" post="(34.3%) resulting in many severe clinical cases, while case-fatality"/>
   <result pre="following the Indian Ocean Islands epidemics [27–29]. In late 2013," exact="CHIKV" post="emerged in the Caribbean for the first time and"/>
   <result pre="other islands in close proximity [30–33]. Around the same time," exact="CHIKV" post="also spread across South and Central America causing major"/>
   <result pre="vectors were already established. The two main competent vectors of" exact="CHIKV" post="are considered to be Aedes aegypti and Aedes albopictus,"/>
   <result pre="cool temperatures. These mosquitoes were responsible for all the recorded" exact="CHIKV" post="epidemics until the Indian Ocean Islands epidemic in 2005–2006"/>
   <result pre="Ae. albopictus the propensity to emerge as a highly competent" exact="CHIKV" post="vector with enhanced transmission capability [37–38]. Ae. albopictus mosquitoes"/>
   <result pre="will expand into new areas. A scoping review (ScR) on" exact="CHIKV" post="and its competent vectors was conducted to identify, characterize,"/>
   <result pre="scientific community, and facilitate decision-making on mitigation of chikungunya and/or" exact="CHIKV" post="competent vectors. Methods A ScR protocol was created a"/>
   <result pre="economic burden, prevention and control strategies, risk factors for developing" exact="CHIKV" post="infection, societal attitudes and perceptions regarding CHIKV infection, in"/>
   <result pre="factors for developing CHIKV infection, societal attitudes and perceptions regarding" exact="CHIKV" post="infection, in humans and other vertebrate hosts.�? And, &quot;What"/>
   <result pre="for transmission of CHIKV, what are the parameters for effective" exact="CHIKV" post="transmission and vector competence, what ecological risk factors contribute"/>
   <result pre="transmission and vector competence, what ecological risk factors contribute to" exact="CHIKV" post="competent vector abundance, and what vector mitigation strategies can"/>
   <result pre="abundance, and what vector mitigation strategies can prevent and control" exact="CHIKV" post="vectors?�? Search strategy A comprehensive and stringent search algorithm"/>
   <result pre="chikungunya research and the other to capture additional research on" exact="CHIKV" post="vectors: (Chikungunya OR CHIK OR CHIKV) OR (alphavirus AND"/>
   <result pre="or more aspects of the review question: i.e., information on" exact="CHIKV" post="and chikungunya disease, competence parameters of CHIKV vectors, or"/>
   <result pre="i.e., information on CHIKV and chikungunya disease, competence parameters of" exact="CHIKV" post="vectors, or control of CHIKV vectors. Articles in languages"/>
   <result pre="chikungunya disease, competence parameters of CHIKV vectors, or control of" exact="CHIKV" post="vectors. Articles in languages other than English, French, Spanish"/>
   <result pre="if they did not report on: 1) the impact of" exact="CHIKV" post="on humans, hosts or vectors, 2) CHIKV studies including"/>
   <result pre="the impact of CHIKV on humans, hosts or vectors, 2)" exact="CHIKV" post="studies including phylogeny and molecular characterization of genetic determinants"/>
   <result pre="characterization of genetic determinants for fitness and other evolutionary markers," exact="CHIKV" post="pathogenesis and infection mechanisms, 3) mitigation strategies to prevent"/>
   <result pre="and infection mechanisms, 3) mitigation strategies to prevent and control" exact="CHIKV" post="infections including strategies for CHIKV vector prevention and control,"/>
   <result pre="strategies to prevent and control CHIKV infections including strategies for" exact="CHIKV" post="vector prevention and control, 4) clinical aspects of CHIKV"/>
   <result pre="for CHIKV vector prevention and control, 4) clinical aspects of" exact="CHIKV" post="infection and risk factors contributing to such infections, and"/>
   <result pre="behavioural and physiologic, as well as environmental factors associated with" exact="CHIKV" post="transmission, 6) economic burden of chikungunya disease, or 7)"/>
   <result pre="of chikungunya disease, or 7) modeling studies on chikungunya or" exact="CHIKV" post="vectors. Articles that did not meet the inclusion criteria"/>
   <result pre="In vitro studies examining pathogenesis and/or immunomodulatory mechanisms associated with" exact="CHIKV" post="infection in hosts and vectors were identified at the"/>
   <result pre="articles (764/2326; 33%) reported on signs, symptoms and diagnosis of" exact="CHIKV" post="in humans. Treatment for chikungunya in humans was reported"/>
   <result pre="was reported in 283/2326 (12%) studies, and mitigation strategies against" exact="CHIKV" post="in both humans and vectors comprised 323/2326 (14%) studies."/>
   <result pre="(18%) vector studies with relevance to vector competence for transmitting" exact="CHIKV" post="and vector behavioural characteristics, while 256/2326 (11%) studies examined"/>
   <result pre="Also included were 208/2326 (9%) studies describing surveillance programs for" exact="CHIKV" post="in humans, other hosts and vectors. The accuracy of"/>
   <result pre="CHIKV in humans, other hosts and vectors. The accuracy of" exact="CHIKV" post="diagnostic tests was evaluated in 167/2326 (7%) studies. Research"/>
   <result pre="areas with fewer studies included modeling studies with relevance to" exact="CHIKV" post="and/or its vectors; 103/2326 (4%), social impact examining knowledge,"/>
   <result pre="406/2326 (17%) articles on pathogenesis and immunity related pathways of" exact="CHIKV" post="infection. Results from CHIKV vector studies (410/2326; 18%) on"/>
   <result pre="pathogenesis and immunity related pathways of CHIKV infection. Results from" exact="CHIKV" post="vector studies (410/2326; 18%) on important competence and behavioural"/>
   <result pre="39%) Epidemiology 848 24 37 134 − − Burden of" exact="CHIKV" post="562 17 34 73 − − Risk factors 70"/>
   <result pre="Epidemic investigations 141 1 3 47 − − Travel related" exact="CHIKV" post="215 − − 16 − − Co-infection 109 −"/>
   <result pre="related 2 − − − − − Signs, Symptoms of" exact="CHIKV" post="infection (n = 764; 33%) and CHIKV diagnostics (n"/>
   <result pre="Signs, Symptoms of CHIKV infection (n = 764; 33%) and" exact="CHIKV" post="diagnostics (n = 687; 30%) Diagnosis 687 − −"/>
   <result pre="chikungunya disease 29 − − − − − Knowledge on" exact="CHIKV" post="vectors 27 − − − − − Attitudes towards"/>
   <result pre="not extracted Publications by continent and time Generally, interest in" exact="CHIKV" post="research increased in regions soon after they were affected"/>
   <result pre="Islands. Many of the articles that reported on the major" exact="CHIKV" post="epidemic in Reunion Island and other nearby Indian Ocean"/>
   <result pre="in both France and the affected islands. There were major" exact="CHIKV" post="epidemics reported in India and Southeast Asia from 2006"/>
   <result pre="have described various aspects of these epidemics. Autochthonous transmission of" exact="CHIKV" post="was reported in Italy [56]; and France [57] between"/>
   <result pre="reported on these locally transmitted outbreaks. Since the emergence of" exact="CHIKV" post="in the Americas, there have been several reports on"/>
   <result pre="in the Americas, there have been several reports on autochthonous" exact="CHIKV" post="transmission in newly affected areas [58–59]. Fig 2 Publications"/>
   <result pre="affected areas [58–59]. Fig 2 Publications (n = 2326) on" exact="CHIKV" post="or its competent vectors by decade of publication and"/>
   <result pre="category represented by bubble size and reported with corresponding bubbles." exact="Chikungunya" post="virus Of the 1920 studies fully characterized in this"/>
   <result pre="1920 studies fully characterized in this ScR, lineage of the" exact="CHIKV" post="strains isolated or used in experiments was reported in"/>
   <result pre="gene mutations that contribute to evolutionary adaptation and fitness of" exact="CHIKV" post="have been reported in scientific literature [62–65]. A repository"/>
   <result pre="results gathered in this ScR; S1 Table. Diagnostic testing for" exact="CHIKV" post="Data were captured from three types of testing for"/>
   <result pre="CHIKV, predominantly in humans (687/2326; 30%), to: 1) diagnose active" exact="CHIKV" post="infection in patients, 2) screen sample populations of hosts"/>
   <result pre="patients, 2) screen sample populations of hosts for antibodies to" exact="CHIKV" post="to detect prior exposure and 3) studies related to"/>
   <result pre="diagnosis, mostly in resource limited countries with large ongoing epidemics." exact="CHIKV" post="diagnosis in humans reported in the earliest research was"/>
   <result pre="on the number of studies reporting on each category of" exact="CHIKV" post="tests are available in S2 Table. The vast majority"/>
   <result pre="available in S2 Table. The vast majority of studies reported" exact="CHIKV" post="testing on blood or cerebrospinal fluid (CSF); S2 Table."/>
   <result pre="(CSF); S2 Table. Uncommon samples that were successfully tested for" exact="CHIKV" post="included corneas [66], oral secretions [67–69], peritoneal, gastric and"/>
   <result pre="There were 167/2326 (7%) studies on determining the accuracy of" exact="CHIKV" post="tests by comparing the sensitivity and specificity of one"/>
   <result pre="is not easily accessible or feasible. Diagnostic accuracy studies for" exact="CHIKV" post="included 15/167 (9%) articles assessing virus isolation and culture"/>
   <result pre="serological tests, and 88/167 (53%) on molecular tests; S3 Table." exact="CHIKV" post="in non-human vertebrate hosts Chikungunya infection was studied in"/>
   <result pre="on molecular tests; S3 Table. CHIKV in non-human vertebrate hosts" exact="Chikungunya" post="infection was studied in non-human primates (NHPs) (51/1920; 3%"/>
   <result pre="and domestic pets (8/1920; 0.4% studies); Table 1. Surveillance for" exact="CHIKV" post="in animals was identified in 7/208 (3%) surveillance studies;"/>
   <result pre="studies were conducted during non-epidemic periods and investigated exposure to" exact="CHIKV" post="infection. Epidemiological studies on potential sylvatic hosts for CHIKV"/>
   <result pre="to CHIKV infection. Epidemiological studies on potential sylvatic hosts for" exact="CHIKV" post="The potential contribution of non-human vertebrate hosts towards sylvatic"/>
   <result pre="potential contribution of non-human vertebrate hosts towards sylvatic transmission of" exact="CHIKV" post="was investigated in 12 observational studies (Table 1) with"/>
   <result pre="investigated in many articles; ** Possible sylvatic host Transmission of" exact="CHIKV" post="in non-human vertebrate hosts Very few studies have been"/>
   <result pre="transmission, but evidence from Africa has shown cyclic surges in" exact="CHIKV" post="circulating among arboreal mosquitoes and vertebrate host populations [81]."/>
   <result pre="vertebrate host populations [81]. A study on sylvatic transmission of" exact="CHIKV" post="among Bornean orangutans was inconclusive as there was no"/>
   <result pre="Bornean orangutans was inconclusive as there was no evidence for" exact="CHIKV" post="infection in the orangutans or humans from the local"/>
   <result pre="their type 1 interferon response (IRF3/7-/-) were able to transmit" exact="CHIKV" post="mouse-to-mouse without an arthropod vector. In addition, results from"/>
   <result pre="viral RNA and infectious virus, which could potentially lead to" exact="CHIKV" post="transmission without a vector [67]. The observational studies above"/>
   <result pre="provide data on possible sylvatic hosts and the ecology of" exact="CHIKV" post="within the studied areas. Many experimental studies were conducted"/>
   <result pre="understand the potential contribution of diverse non-human vertebrate hosts to" exact="CHIKV" post="transmission by investigating the susceptibility of these hosts to"/>
   <result pre="studies is defined as an animal that exhibits symptoms of" exact="CHIKV" post="infection and/or detectible levels of viremia within the experimental"/>
   <result pre="of NHP species, some rodents and bats were susceptible to" exact="CHIKV" post="infection, while most wild birds, domestic and farm animals"/>
   <result pre="10.1371/journal.pone.0207554.t003Table 3 Results from challenge trials investigating host susceptibility to" exact="CHIKV" post="in non-human vertebrate hosts. Reference Susceptible host Not Susceptible"/>
   <result pre="in non-human vertebrate hosts. Reference Susceptible host Not Susceptible to" exact="CHIKV" post="[87] Mice (A129) deficient in alpha/beta interferon signaling [88]"/>
   <result pre="[105] Infant mice, Rhesus monkeys, rabbits, guinea pigs Adult mice," exact="CHIKV" post="in humans Chikungunya in humans was studied in 1159/2326"/>
   <result pre="Rhesus monkeys, rabbits, guinea pigs Adult mice, CHIKV in humans" exact="Chikungunya" post="in humans was studied in 1159/2326 (50%) articles: 1040"/>
   <result pre="in humans There were 126/208 (61%) surveillance articles reporting on" exact="CHIKV" post="in humans (Table 1), including 36/126 (29%) articles on"/>
   <result pre="travel-related syndromic surveillance and 2/126 (2%) articles on surveillance for" exact="CHIKV" post="in the blood donor system. Active surveillance for CHIKV"/>
   <result pre="for CHIKV in the blood donor system. Active surveillance for" exact="CHIKV" post="in humans during epidemics was reported in 26/126 (21%)"/>
   <result pre="public health staff going door-to-door in impoverished neighbourhoods to identify" exact="CHIKV" post="cases [106–108]. Monitoring programs in epidemic settings were reported"/>
   <result pre="a rigid action plan. Passive surveillance, mainly syndromic surveillance for" exact="CHIKV" post="during epidemics was reported in 14/126 (11%) articles where"/>
   <result pre="non-epidemic settings, there were 43/126 (34%) active surveillance articles for" exact="CHIKV" post="in humans, 17/126 (13%) articles on monitoring programs, and"/>
   <result pre="117/848 (14%) epidemic investigations and 242/848 (29%) prevalence surveys. Human" exact="CHIKV" post="prevalence results representing the burden of CHIKV during epidemics"/>
   <result pre="prevalence surveys. Human CHIKV prevalence results representing the burden of" exact="CHIKV" post="during epidemics were reported in 16/242 (6.6%) studies, while"/>
   <result pre="while 134/242 (55%) studies investigated the presence of antibodies against" exact="CHIKV" post="in populations after an epidemic. Incidence was reported in"/>
   <result pre="reported in 51/848 (6%) studies with 12/848 (1%) studies reporting" exact="CHIKV" post="incidence during epidemics, while attack rates were reported in"/>
   <result pre="were reported in 31/848 (4%) studies soon after the epidemic." exact="CHIKV" post="related mortality was reported in 36/848 (4%) studies and"/>
   <result pre="with a pre-existing chronic morbidity [109–110]. The viremic period for" exact="CHIKV" post="infection was reported in 30 studies and ranged from"/>
   <result pre="to twelve days. One study reported evidence of possible sequential" exact="CHIKV" post="infection [112]. Risk factors for developing chikungunya infection in"/>
   <result pre="was reported as a risk factor in 215/345 (62%) studies." exact="Chikungunya" post="incidence was reported to be highest in individuals aged"/>
   <result pre="as Type 2 diabetes, cardiovascular disease [114–117] and obesity [118–119]." exact="CHIKV" post="epidemics Over 70 chikungunya epidemics have occurred in several"/>
   <result pre="large epidemics increased steadily since the E1:A226V mutation occurred in" exact="CHIKV" post="when Ae. albopictus became another and more efficient competent"/>
   <result pre="Over half the population was reported to be infected with" exact="CHIKV" post="during a 2007 epidemic in Kerala, India [124–125]. Several"/>
   <result pre="subcontinent from 2006 onwards (39/141; 28%). Epidemic investigation reports after" exact="CHIKV" post="emergence in the Caribbean and South America also indicated"/>
   <result pre="of exposure [92, 126–127]. These results depict the spread of" exact="CHIKV" post="over time, either as an emerging pathogen in a"/>
   <result pre="public health risk in previously affected regions. 10.1371/journal.pone.0207554.t004Table 4 Human" exact="CHIKV" post="epidemics reported between 1959 and 2016. Continent Country Epidemic"/>
   <result pre="[250] Travel-related chikungunya There were 215/1159 (19%) articles reporting travel-related" exact="CHIKV" post="infections; Table 1. These results included 74/215 (34%) studies"/>
   <result pre="of chikungunya infection among travelers. Clinical manifestation of acute phase" exact="CHIKV" post="infection in humans A total of 764/2326 (33%) articles"/>
   <result pre="case series reports; Table 1. The commonly accepted triad of" exact="CHIKV" post="symptoms is fever (539/764, 71%), itchy rash (410/764, 54%)"/>
   <result pre="however, the literature reports many other frequently reported symptoms of" exact="CHIKV" post="including: headache (291/764, 38%), myalgia or muscle ache (246/764,"/>
   <result pre="15%); Fig 3. Although described more often in association with" exact="DENV" post="infections, 57/764 (7%) articles reported retro-orbital pain, 107/764 (14%)"/>
   <result pre="Number of studies reporting each sign or symptom of clinical" exact="CHIKV" post="disease in humans*. *Multiple signs and symptoms reported in"/>
   <result pre="and neurological conditions (95/764, 12%) [254–256]; S4 Table. Sequelae following" exact="CHIKV" post="infection in humans There were 239/764 (21%) articles describing"/>
   <result pre="a potential marker of chronic chikungunya disease [257]. Co-infections with" exact="CHIKV" post="in humans Chikungunya co-infections with either single or multiple"/>
   <result pre="of chronic chikungunya disease [257]. Co-infections with CHIKV in humans" exact="Chikungunya" post="co-infections with either single or multiple co-infecting pathogens were"/>
   <result pre="from the Americas that reported triple concurrent co-infections with CHIKV," exact="DENV" post="and ZIKV, all viruses that are transmitted by the"/>
   <result pre="by the same vectors [9,14, 258–259]. Other co-infections reported with" exact="CHIKV" post="were Japanese Encephalitis, West Nile Virus, Tuberculosis, Human Immunodeficiency"/>
   <result pre="[9,14, 258–259]. Other co-infections reported with CHIKV were Japanese Encephalitis," exact="West Nile" post="Virus, Tuberculosis, Human Immunodeficiency Virus (HIV), Leptospirosis, Yellow Fever,"/>
   <result pre="and Pseudomonas aeruginosa. A complete list of co-infections reported with" exact="CHIKV" post="is compiled in S5 Table. Treatment for chikungunya infections"/>
   <result pre="compiled in S5 Table. Treatment for chikungunya infections in humans" exact="Chikungunya" post="disease is generally managed through supportive treatment and treatment"/>
   <result pre="and chronic symptoms of chikungunya was assessed in experimental studies." exact="CHIKV" post="transmission in humans All the major epidemics reported in"/>
   <result pre="major epidemics reported in Table 4 were due to the" exact="CHIKV" post="urban transmission cycle where the virus is reported to"/>
   <result pre="and sub-tropical regions of the world. Other potential modes of" exact="CHIKV" post="transmission have been reported, including human exposure through infected"/>
   <result pre="needle pricks with infected blood (3/1159; 0.3%); Table 1. Accidental" exact="CHIKV" post="transmission was reported in three articles; two in laboratory"/>
   <result pre="infected patient [263]. No studies investigated human sexual transmission of" exact="CHIKV" post="as is frequently reported for ZIKV. One study found"/>
   <result pre="is frequently reported for ZIKV. One study found evidence of" exact="CHIKV" post="transmission through corneal grafts and the authors propose banning"/>
   <result pre="corneal grafts and the authors propose banning cornea donations in" exact="CHIKV" post="endemic areas [66]. Several studies (49/1159; 4%) reported mother-to-child"/>
   <result pre="Several studies (49/1159; 4%) reported mother-to-child or vertical transmission of" exact="CHIKV" post="and many investigated fetal outcomes in neonates infected in"/>
   <result pre="(27%) studies reported on neonates alone. The impact of congenital" exact="CHIKV" post="infection in neonates was reported in 16/49 (33%) studies"/>
   <result pre="studies and 6/49 (12%) studies investigated pregnancy outcomes due to" exact="CHIKV" post="infection [5, 264–267]. One article recommended close monitoring of"/>
   <result pre="[265]. Public knowledge, attitudes and perceptions of chikungunya disease and" exact="CHIKV" post="vectors Knowledge, attitudes and perceptions about CHIKV, mosquito-borne diseases"/>
   <result pre="28%). Several studies evaluated knowledge on chikungunya disease (29/46; 63%)," exact="CHIKV" post="vectors (27/46; 59%) and behavioral mitigation practices for CHIKV"/>
   <result pre="63%), CHIKV vectors (27/46; 59%) and behavioral mitigation practices for" exact="CHIKV" post="(33/46; 72%). A single study examined willingness to pay"/>
   <result pre="A single study examined willingness to pay for protection against" exact="CHIKV" post="[268]. Economic burden of CHIKV A total of 23/2326"/>
   <result pre="to pay for protection against CHIKV [268]. Economic burden of" exact="CHIKV" post="A total of 23/2326 (1%) studies investigated the economic"/>
   <result pre="the cost effectiveness of interventions to prevent the transmission of" exact="CHIKV" post="through blood transfusions in Canada; Table 1, S7 Table."/>
   <result pre="1, S7 Table. Publications on the economic burden due to" exact="CHIKV" post="were predominantly from countries impacted by major epidemics and"/>
   <result pre="strategies in general [272]. Mitigation strategies to prevent and control" exact="CHIKV" post="and its vectors A total of 323/2326 (14%) articles"/>
   <result pre="and control strategies for CHIKV, mainly focusing on vaccination against" exact="CHIKV" post="(78/323; 24%), personal protective measures (79/323; 25%), the use"/>
   <result pre="on two potential vaccine candidates. One demonstrated complete immunity against" exact="CHIKV" post="in mice and NHPs [273], while the other, a"/>
   <result pre="clinical trial and is suggested as an option for emergency" exact="CHIKV" post="vaccinations, in addition to being a potential vaccine candidate"/>
   <result pre="to teach the general public or targeted population group about" exact="CHIKV" post="(12 articles), personal and/or behavioral protective measures (7 articles),"/>
   <result pre="protection interventions (38/79, 48%). Insecticidal use: Insecticide use to control" exact="CHIKV" post="vector populations was reported in 156/323 (48%) articles. Ten"/>
   <result pre="use of lethal ovitraps as a successful mitigation strategy against" exact="CHIKV" post="vectors [275–276]. The use of larvivorous fish, beetles, nematodes"/>
   <result pre="Dominant Lethal mosquitoes (RIDL) as an effective strategy to mitigate" exact="CHIKV" post="transmission through vectors. Infection of mosquito vectors with bacteria"/>
   <result pre="Infection of mosquito vectors with bacteria for controlling or reducing" exact="CHIKV" post="replication was reported in 23/51 (45%) studies, with 12/51"/>
   <result pre="investigating the role of Bacillus thuringiensis for effective control of" exact="CHIKV" post="transmission through CHIKV carrying vectors. One study investigated silver"/>
   <result pre="of Bacillus thuringiensis for effective control of CHIKV transmission through" exact="CHIKV" post="carrying vectors. One study investigated silver particles synthesized by"/>
   <result pre="including quantitative risk assessment articles on chikungunya disease or competent" exact="CHIKV" post="vectors. Exposure to CHIKV, illness, or costs attributed to"/>
   <result pre="outcome modeled in 58/103 (56%) articles, 1/103 (1%) article modeled" exact="CHIKV" post="spread through birds [285], while 70/103 (68%) modeled CHIKV"/>
   <result pre="modeled CHIKV spread through birds [285], while 70/103 (68%) modeled" exact="CHIKV" post="vectors; mainly Ae. aegypti, Ae. albopictus, or both. Of"/>
   <result pre="reproductive numbers or the magnitude of the threat posed by" exact="CHIKV" post="to the general population. Modeling results were relevant to"/>
   <result pre="programs (28/103, 27%), or evaluation of the economic burden of" exact="CHIKV" post="outbreaks (6/103, 6%). Other studies included travel associated importation"/>
   <result pre="donation (9/103; 9%) and a single model on spread of" exact="CHIKV" post="through transportation of cargo (1/103; 1%). Many modeling studies"/>
   <result pre="more than one of the above mentioned categories. Discussion Although" exact="CHIKV" post="was first isolated in 1953, it is postulated that"/>
   <result pre="back to the eighteenth century could have been caused by" exact="CHIKV" post="and had been incorrectly attributed to DENV [134, 286]."/>
   <result pre="been caused by CHIKV and had been incorrectly attributed to" exact="DENV" post="[134, 286]. Our chronological analysis of published CHIKV epidemic"/>
   <result pre="attributed to DENV [134, 286]. Our chronological analysis of published" exact="CHIKV" post="epidemic reports depicts the emergence and re-emergence of CHIKV"/>
   <result pre="published CHIKV epidemic reports depicts the emergence and re-emergence of" exact="CHIKV" post="across continents over time. A single mutation in the"/>
   <result pre="over time. A single mutation in the viral genome of" exact="CHIKV" post="resulted in advantageous changes to the virus by increasing"/>
   <result pre="temperature, subsequently changing the global distribution and risk profile of" exact="CHIKV" post="[19]. Transmission Many studies report sylvatic transmission in Africa,"/>
   <result pre="have adapted to new hosts and vectors in areas where" exact="CHIKV" post="has expanded recently, thereby introducing a substantial risk for"/>
   <result pre="CHIKV has expanded recently, thereby introducing a substantial risk for" exact="CHIKV" post="to initiate a sylvatic cycle in the Americas [287]."/>
   <result pre="may contribute to the sylvatic transmission cycle and maintenance of" exact="CHIKV" post="in endemic areas. Future research can focus on filling"/>
   <result pre="understanding of the roles of various hosts and vectors in" exact="CHIKV" post="transmission cycles contributing to the spread, emergence and maintenance"/>
   <result pre="transmission cycles contributing to the spread, emergence and maintenance of" exact="CHIKV" post="globally, as this knowledge is important for developing effective"/>
   <result pre="mitigation strategies and more accurate risk analyses. Vertical transmission of" exact="CHIKV" post="was observed in humans [146,149, 244, 288]. The impact"/>
   <result pre="observed in humans [146,149, 244, 288]. The impact of intra-uterine" exact="CHIKV" post="infection on the fetus and neonates is not clearly"/>
   <result pre="to congenitally acquired chikungunya [267]. Another study examining outcomes of" exact="CHIKV" post="infection to the fetus during each trimester of pregnancy"/>
   <result pre="[290]. Microcephaly is believed to be an outcome associated with" exact="ZIKV" post="infections [291]. We acknowledge that this could be a"/>
   <result pre="We acknowledge that this could be a coincidental finding, but" exact="CHIKV" post="associated microcephaly certainly warrants future research given that CHIKV"/>
   <result pre="but CHIKV associated microcephaly certainly warrants future research given that" exact="CHIKV" post="and ZIKV co-circulate in many regions. There has been"/>
   <result pre="associated microcephaly certainly warrants future research given that CHIKV and" exact="ZIKV" post="co-circulate in many regions. There has been no research"/>
   <result pre="of CHIKV, despite evidence for this with ZIKV. Interestingly, viable" exact="CHIKV" post="has been isolated from an individual’s semen and urine"/>
   <result pre="one study provided experimental evidence for the presence of infectious" exact="CHIKV" post="in human saliva [67], so the possibility of sexual"/>
   <result pre="human saliva [67], so the possibility of sexual transmission of" exact="CHIKV" post="in humans needs to be clearly elucidated. The risk"/>
   <result pre="to be clearly elucidated. The risk of viremic travelers importing" exact="CHIKV" post="into non-endemic regions with competent vectors is quite high,"/>
   <result pre="importations into the Americas [54, 59]. In non-endemic areas where" exact="CHIKV" post="vectors are present, it is important for public health"/>
   <result pre="strategies such as personal protection against vectors and vector mitigation." exact="CHIKV" post="diagnostics Although there are diagnostic tests to confirm clinical"/>
   <result pre="clinical diagnosis, there is evidence for antigenic cross reactivity between" exact="CHIKV" post="and other alphaviruses [292–293]. A rapid, field-ready and cost"/>
   <result pre="gold standard diagnostic test with high sensitivity and specificity for" exact="CHIKV" post="has not been reported in the literature and would"/>
   <result pre="A wide array of samples have been successfully tested for" exact="CHIKV" post="using currently available tests. While the most common sample"/>
   <result pre="sequelae post-CHIKV infection [110] and that initial clinical manifestation of" exact="CHIKV" post="illness can predict progression to chronic arthritis [294]. The"/>
   <result pre="to chronic arthritis [294]. The list of pre-existing morbidities in" exact="CHIKV" post="patients compiled from the literature can broadly be categorized"/>
   <result pre="and convalescent phases, as well as chronic morbidities associated with" exact="CHIKV" post="infection. Many articles from India reporting on epidemics from"/>
   <result pre="blindness [299–300]. Five studies described acute disseminated encephalomyelitis (ADEM) in" exact="CHIKV" post="patients from India [256, 301–304]. It remains to be"/>
   <result pre="Barré Syndrome (GBS) is a relatively new complication associated with" exact="CHIKV" post="infection reported in the literature since the Indian Ocean"/>
   <result pre="in the literature since the Indian Ocean Island epidemics of" exact="CHIKV" post="[27, 156, 247, 305–306]. A study on a chikungunya"/>
   <result pre="genomic changes that contribute to higher virulence in the virus." exact="ZIKV" post="which often co-circulates with CHIKV has also been reported"/>
   <result pre="higher virulence in the virus. ZIKV which often co-circulates with" exact="CHIKV" post="has also been reported to be associated with GBS"/>
   <result pre="with analgesics, steroids and NSAIDs that alleviate the symptoms of" exact="CHIKV" post="rather than specifically target the virus. Chloroquine, an antimalarial,"/>
   <result pre="the virus. Chloroquine, an antimalarial, was often prescribed to manage" exact="CHIKV" post="symptoms, even though its efficacy in alleviating symptoms during"/>
   <result pre="[260]. Some studies reported the use of antibiotics to treat" exact="CHIKV" post="infections [30, 308–311], but their efficacy as an effective"/>
   <result pre="an effective treatment option was not evaluated in any study." exact="CHIKV" post="lineages and genomic plasticity Many outbreaks in India have"/>
   <result pre="plasticity Many outbreaks in India have been linked to different" exact="CHIKV" post="lineages [312–313]. Since there is evidence for two separate"/>
   <result pre="two separate virus introductions in Brazil with different lineages of" exact="CHIKV" post="during the same epidemic period [21, 23, 314], it"/>
   <result pre="can also occur elsewhere. With many reports of co-circulating CHIKV," exact="DENV" post="and ZIKV [8, 249, 259], it would be interesting"/>
   <result pre="occur elsewhere. With many reports of co-circulating CHIKV, DENV and" exact="ZIKV" post="[8, 249, 259], it would be interesting to examine"/>
   <result pre="endemic areas. There has been a lot of research on" exact="CHIKV" post="mutations and phylogeny for investigating the evolutionary relatedness of"/>
   <result pre="CHIKV mutations and phylogeny for investigating the evolutionary relatedness of" exact="CHIKV" post="isolates across epidemics in different geographical areas, as well"/>
   <result pre="risk areas for chikungunya and also highlights the plasticity of" exact="CHIKV" post="and its potential to mutate, adapt and emerge or"/>
   <result pre="species [316], and if this occurs, public health risks from" exact="CHIKV" post="could increase globally. At the same time, there is"/>
   <result pre="same time, there is also evidence of genetic stability in" exact="CHIKV" post="isolates, where isolates that share a common origin but"/>
   <result pre="regions maintained a high degree of identity [18, 318]. Several" exact="CHIKV" post="mutations associated with adaptation and fitness were reported in"/>
   <result pre="One of the challenges of estimating the true burden of" exact="CHIKV" post="is due to a high proportion of asymptomatic and"/>
   <result pre="considered with caution. A complete understanding of whether co-infections with" exact="CHIKV" post="can lead to altered symptoms or sequelae is also"/>
   <result pre="is also required. One study reported evidence of possible sequential" exact="CHIKV" post="infection [112] and more studies are needed to validate"/>
   <result pre="infection [112] and more studies are needed to validate this." exact="CHIKV" post="epidemics can result in great financial burdens to affected"/>
   <result pre="result in great financial burdens to affected countries. The 2014" exact="CHIKV" post="epidemic in Colombia was estimated to cost at least"/>
   <result pre="economy [238]. It is imperative for countries at risk for" exact="CHIKV" post="to have effective and efficient surveillance systems and mitigation"/>
   <result pre="epidemics. The best way to mitigate public health risks from" exact="CHIKV" post="is by preventing exposure to the virus through personal"/>
   <result pre="conclusion, this ScR identified and characterized all available literature on" exact="CHIKV" post="and allowed us to capture important information from the"/>
   <result pre="capture important information from the many epidemic waves observed with" exact="CHIKV" post="infection over time. We have reported important observations relating"/>
   <result pre="to trends in disease manifestation, long term sequelae associated with" exact="CHIKV" post="infection, plasticity of the viral genome, important epidemiological characteristics,"/>
   <result pre="research on treatment strategies, mitigation methods for preventing or controlling" exact="CHIKV" post="disease and/or CHIKV vectors. Global evidence on treating and"/>
   <result pre="strategies, mitigation methods for preventing or controlling CHIKV disease and/or" exact="CHIKV" post="vectors. Global evidence on treating and preventing CHIKV can"/>
   <result pre="disease and/or CHIKV vectors. Global evidence on treating and preventing" exact="CHIKV" post="can be used to inform future public health initiatives."/>
   <result pre="to inform policy-makers and researchers on the evidence base for" exact="CHIKV" post="and point to where additional research is needed to"/>
   <result pre="Click here for additional data file. S1 Protocol ScR on" exact="Chikungunya" post="infections—Protocol. (DOCX) LINK Click here for additional data file."/>
   <result pre="Click here for additional data file. S1 Table List of" exact="CHIKV" post="genetic variants for fitness and adaptation. (DOCX) LINK Click"/>
   <result pre="their assistance with library services. References References 1GudoES, BlackJF, CliffJL." exact="Chikungunya" post="in Mozambique: A Forgotten History. PLoS Negl Trop Dis20161117;10(11):e000500110.1371/journal.pntd.000500127855168"/>
   <result pre="Rong, ChanYokeFun, HatimAhmad, HairiNoran Naqiah, AsiahAyob, et al.Seroprevalence survey of" exact="Chikungunya" post="virus in Bagan Panchor, Malaysia. Am J Trop Med"/>
   <result pre="KyawWM, TanA, et al.Correlation of clinical illness with viremia in" exact="Zika" post="virus disease during an outbreak in Singapore. BMC Infectious"/>
   <result pre="an outbreak in Singapore. BMC Infectious Diseases2018;18(201). 7AliU, IsahakI, RahmanMM." exact="Chikungunya" post="confused with dengue in Malaysia: Clinical, serological and molecular"/>
   <result pre="PeraltaJM. Molecular and serological techniques to detect co-circulation of DENV," exact="ZIKV" post="and CHIKV in suspected dengue-like syndrome patients. J Clin"/>
   <result pre="and serological techniques to detect co-circulation of DENV, ZIKV and" exact="CHIKV" post="in suspected dengue-like syndrome patients. J Clin Virol20169;82:108–111. 10.1016/j.jcv.2016.07.01727479173"/>
   <result pre="disease caused by co-circulation and co-infection of dengue, chikungunya and" exact="Zika" post="in the Americas. Travel Med Infect Dis2016May-Jun;14(3):177–179. 10.1016/j.tmaid.2016.05.00427224471 11CareyDE."/>
   <result pre="Zika in the Americas. Travel Med Infect Dis2016May-Jun;14(3):177–179. 10.1016/j.tmaid.2016.05.00427224471 11CareyDE." exact="Chikungunya" post="and dengue: a case of mistaken identity?J Hist Med"/>
   <result pre="Indonesiana2009;41(2):75–80. 19390126 13EdwardsT, SignorLD, WilliamsC, DonisE, CuevasLE, AdamsER. Co-infections with" exact="Chikungunya" post="and Dengue Viruses, Guatemala, 2015. Emerg Infect Dis201611;22(11):2003–2005. 10.3201/eid2211.16101727767914"/>
   <result pre="13EdwardsT, SignorLD, WilliamsC, DonisE, CuevasLE, AdamsER. Co-infections with Chikungunya and" exact="Dengue" post="Viruses, Guatemala, 2015. Emerg Infect Dis201611;22(11):2003–2005. 10.3201/eid2211.16101727767914 14Villamil-GomezWE, Rodriguez-MoralesAJ,"/>
   <result pre="ChenRB, TsetsarkinKA, AdamsAP, GarciaTI, SallAA, et al.Genome-scale phylogenetic analyses of" exact="Chikungunya" post="virus reveal independent emergences of recent epidemics and various"/>
   <result pre="CerqueiraE, Maia de LimaM, PybusO, Carlos Junior AlcantaraL. Epidemiology of" exact="Chikungunya" post="Virus in Bahia, Brazil, 2014–2015. PLoS Curr201621;8: 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b227330849 22KautzTF,"/>
   <result pre="KraemerMUG, de OliveiraLF, et al.Emergence and potential for spread of" exact="Chikungunya" post="virus in Brazil; 10.1186/s12916-015-0348-xBMC Medicine2015;13(1).25976325 24TownsonH, NathanMB. Resurgence of"/>
   <result pre="19535840 28NoridahO, ParanthamanV, NayarSK, MaslizaM, RanjitK, NorizahI, et al.Outbreak of" exact="Chikungunya" post="due to virus of Central/East African genotype in Malaysia."/>
   <result pre="GanesakumarSRB, RamachandranV, RamakrishnanR, et al.Treatment practices &amp;amp; laboratory investigations during" exact="Chikungunya" post="outbreaks in South India. Indian J Med Res2011;133(5):546–547. 4"/>
   <result pre="Commun Dis Intell Q Rep2013630;37(2):E136–43. 24168087 36TilstonN, SkellyC, WeinsteinP. Pan-European" exact="Chikungunya" post="surveillance: designing risk stratified surveillance zones. International Journal of"/>
   <result pre="PLoS Pathog200712;3(12):e20110.1371/journal.ppat.003020118069894 38VazeilleM, MoutaillerS, CoudrierD, RousseauxC, KhunH, HuerreM, et al.Two" exact="Chikungunya" post="isolates from the outbreak of La Reunion (Indian Ocean)"/>
   <result pre="and Meta-Analyses: The PRISMA Statement. Ann Intern Med2009;6(7):264–269. 46MowattL, JacksonST." exact="Chikungunya" post="in the Caribbean: An Epidemic in the Making. Infect"/>
   <result pre="An Epidemic in the Making. Infect Dis Ther2014923. 47RoquesP, GrasG." exact="Chikungunya" post="fever: focus on peripheral markers of pathogenesis. J Infect"/>
   <result pre="there a risk of chikungunya transmission in Canada? (Special Issue:" exact="Chikungunya" post="virus.). Canada Communicable Disease Report2015;41(1):11–14. 11 ref. 29769915 50StraetemansM."/>
   <result pre="maladies transmissibles = European communicable disease bulletin2008;13(7). 51WeitzelA, RegaPP, BorkCE." exact="Chikungunya" post="virus: An emerging condition in the industrialized world. Journal"/>
   <result pre="RaoPV. Rapid and real-time assays for detection and quantification of" exact="Chikungunya" post="virus. Future Virology2008;3(2):179–192. 53KarPK, NagpalBN, DuaVK, GhoshSK, RaghavendraK, BhattRM,"/>
   <result pre="to December 2013. Eurosurveillance; 2014 0752;19(13):2; 12 ref. 55KaurP, ChuJJH." exact="Chikungunya" post="virus: An update on antiviral development and challenges. Drug"/>
   <result pre="in US. BMJ2014;349. 59YactayoS, StaplesJE, MillotV, CibrelusL, Ramon-PardoP. Epidemiology of" exact="Chikungunya" post="in the Americas. J Infect Dis20161215;214(suppl 5):S441–S445. 10.1093/infdis/jiw39027920170 60BocanegraC,"/>
   <result pre="60BocanegraC, AntonA, SulleiroE, PouD, SalvadorF, RoureS, et al.Imported cases of" exact="Chikungunya" post="in Barcelona in relation to the current American outbreak."/>
   <result pre="in Nicaragua, 2014–2015. Am J Trop Med Hyg20162;94(2):400–403. 10.4269/ajtmh.15-049726643533 62FaillouxA-." exact="Chikungunya" post="virus adaptation to a mosquito vector correlates with only"/>
   <result pre="novel epistatic mutations (E1:K211E and E2:V264A) in structural proteins of" exact="Chikungunya" post="virus enhance fitness in Aedes aegypti. Virology201610;497:59–68. 10.1016/j.virol.2016.06.02527423270 64RodasJD,"/>
   <result pre="CamachoE, PaterninaL, GuzmanH, DiazFJ, et al.Genetic Characterization of Northwestern Colombian" exact="Chikungunya" post="Virus Strains from the 2014–2015 Epidemic. Am J Trop"/>
   <result pre="ref. 10.1093/infdis/jis29622706183 67GardnerJ, RuddPA, ProwNA, BelarbiE, RoquesP, LarcherT, et al.Infectious" exact="Chikungunya" post="Virus in the Saliva of Mice, Monkeys and Humans."/>
   <result pre="One2015108;10(10):e013948110.1371/journal.pone.013948126447467 68BandeiraAC, CamposGS, SardiSI, RochaVF, RochaGC. Neonatal encephalitis due to" exact="Chikungunya" post="vertical transmission: First report in Brazil. IDCases2016725;5:57–59. 10.1016/j.idcr.2016.07.00827500084 69MussoD,"/>
   <result pre="in saliva and urine. Virol J2016616;13:102-016-0556-9. 70KeeACL, YangS, TambyahP. Atypical" exact="Chikungunya" post="virus infections in immunocompromised patients. Emerging Infectious Diseases2010;16(6):1038–1040. 10"/>
   <result pre="BenhamouL, JaffarBandjeeMC, RiviereJP, et al.Severe bullous skin lesions associated with" exact="Chikungunya" post="virus infection in small infants. Eur J Pediatr2010;169(1):67–72. 10.1007/s00431-009-0986-019401826"/>
   <result pre="LaurentP, FianuA, PerrauJ, GiganJ, et al.Molecular and serological diagnosis of" exact="Chikungunya" post="virus infection. Pathologie Biologie2007;55(10):490–494. 30 ref. 10.1016/j.patbio.2007.07.00217920211 73IborraC, Thia-Thiong-FatC,"/>
   <result pre="10.1016/j.patbio.2007.07.00217920211 73IborraC, Thia-Thiong-FatC, AssouereM-, FiteS. Febrile bullous eruptions revealing a" exact="Chikungunya" post="infection: Report of 6 cases. Nouvelles Dermatologiques2007;26(4 SPEC. ISS.):6–8."/>
   <result pre="74BandeiraAC, CamposGS, RochaVF, SouzaBS, SoaresMB, OliveiraAA, et al.Prolonged shedding of" exact="Chikungunya" post="virus in semen and urine: A new perspective for"/>
   <result pre="IDCases2016114;6:100–103. 10.1016/j.idcr.2016.10.00727882301 75McIntoshBM, PatersonHE, McGillivrayG, DeSousaJ. Further Studies on the" exact="Chikungunya" post="Outbreak in Southern Rhodesia in 1962. I. Mosquitoes, Wild"/>
   <result pre="Bull Soc Pathol Exot Filiales1969;62(2):253–259. 4996397 77McCraeAWR, HendersonBE, KiryaBG, SempalaSDK." exact="Chikungunya" post="virus in the entebbe area of Uganda: Isolations and"/>
   <result pre="A.A. Balkema; 1976. 79McIntoshBM, JuppPG, Dos SantosI. Rural epidemic of" exact="Chikungunya" post="in South Africa with involvement of Aedes (Diceromyia) furcifer"/>
   <result pre="NitatpattanaN, WajjwalkuW, PongsopawijitP, KaewchotS, YoksanS, et al.Dengue, Japanese encephalitis and" exact="Chikungunya" post="virus antibody prevalence among captive monkey (Macaca nemestrina) colonies"/>
   <result pre="10.3201/eid2109.15043926291585 87Weger-LucarelliJ, ChuH, AliotaMT, PartidosCD, OsorioJE. A novel MVA vectored" exact="Chikungunya" post="virus vaccine elicits protective immunity in mice. PLoS Negl"/>
   <result pre="Dis2014724;8(7):e297010.1371/journal.pntd.000297025058320 88MyersRM, CareyDE. Concurrent isolation from patient of two arboviruses," exact="Chikungunya" post="and dengue type 2. Science1967915;157(3794):1307–1308. 6038994 89BedekarSD, PavriKM. Studies"/>
   <result pre="and dengue type 2. Science1967915;157(3794):1307–1308. 6038994 89BedekarSD, PavriKM. Studies with" exact="Chikungunya" post="virus. I. Susceptibility of birdsand small mammals. Indian J"/>
   <result pre="SarkarJK. Susceptibility of new born and adult laboratory animals to" exact="Chikungunya" post="virus. Indian J Med Res1969;57(7):1157–1164. 5357148 91TiawsirisupS, NavavichitPRW, RatpiyapapornHemmarat."/>
   <result pre="infection of mice and baby chickens with Thailand strain of" exact="Chikungunya" post="virus. Thai Journal of Veterinary Medicine2012;42(2):353–358. 19 ref. 92HugoLE,"/>
   <result pre="of Veterinary Medicine2012;42(2):353–358. 19 ref. 92HugoLE, ProwNA, TangB, DevineG, SuhrbierA." exact="Chikungunya" post="virus transmission between Aedes albopictus and laboratory mice. Parasit"/>
   <result pre="in North American Mammals and Birds After Experimental Infection with" exact="Chikungunya" post="Viruses. Am J Trop Med Hyg20163;94(3):504–506. 10.4269/ajtmh.15-069626666699 94JuppPG, McIntoshBM."/>
   <result pre="Med Hyg1961;55(1):63–68.13774008 100PaulSD, SinghKR. Experimental infection of Macaca radiata with" exact="Chikungunya" post="virus and transmission of virus by mosquitoes. Indian J"/>
   <result pre="mosquitoes. Indian J Med Res1968;56(6):802–811. 4971384 101WeinbrenMP. The occurrence of" exact="Chikungunya" post="virus in Uganda. II. In man on the. Trans"/>
   <result pre="LercheNW, LuciwPA, ReisenWK, et al.Comparative pathogenesis of epidemic and enzootic" exact="Chikungunya" post="viruses in a pregnant Rhesus macaque model. Am J"/>
   <result pre="burden of dengue and chikungunya from the Americas to Asia.)." exact="Dengue" post="Bulletin; 201034:40–45 14 ref. 108KannanM, RajendranR, SunishIP, BalasubramaniamR, ArunachalamN,"/>
   <result pre="ref. 19491425 109EconomopoulouA, DominguezM, HelynckB, SissokoD, WichmannO, QuenelP, et al.Atypical" exact="Chikungunya" post="virus infections: clinical manifestations, mortality and risk factors for"/>
   <result pre="113FeldsteinLR, EllisEM, Rowhani-RahbarA, HalloranME, EllisBR. The First Reported Outbreak of" exact="Chikungunya" post="in the U.S. Virgin Islands, 2014–2015. Am J Trop"/>
   <result pre="J Trop Med Hyg2016127;95(6):1345–1350. 10.4269/ajtmh.16-032027729569 115PertiT, Lucero-ObusanCA, SchirmerPL, WintersMA, HolodniyM." exact="Chikungunya" post="Fever Cases Identified in the Veterans Health Administration System,"/>
   <result pre="ArankalleVA, WadiaRS, KulkarniRahul, ShahSV, et al.Systemic involvements and fatalities during" exact="Chikungunya" post="epidemic in India, 2006. Journal of Clinical Virology2009;46(2):145–149. 18"/>
   <result pre="outbreak, Madagascar. Emerging Infectious Diseases2012;18(11):1780–1786. 26 ref. 10.3201/eid1811.11103623092548 120SetbonM, RaudeJ." exact="Chikungunya" post="on Réunion Island: Social, environmental and behavioural factors in"/>
   <result pre="Tropicale2011;72(Special):66–71. 27 ref. 123de LamballerieX, LeroyE, CharrelRN, TtsetsarkinK, HiggsS, GouldEA." exact="Chikungunya" post="virus adapts to tiger mosquito via evolutionary convergence: a"/>
   <result pre="124VijayakumarKP, Nair AnishTS, GeorgeB, LawrenceT, MuthukkuttySC, RamachandranR. Clinical Profile of" exact="Chikungunya" post="Patients during the Epidemic of 2007 in Kerala, India."/>
   <result pre="SimmonsM, et al.Clinical and Serological Insights from the Asian Lineage" exact="Chikungunya" post="Outbreak in Grenada, 2014: An Observational Study. Am J"/>
   <result pre="J Trop Med Hyg2016105;95(4):890–893. 10.4269/ajtmh.16-012227527629 128RodgerLM. An outbreak of suspected" exact="Chikungunya" post="fever in Northern Rhodesia. South African medical journal ="/>
   <result pre="vir geneeskunde1961;35:126–128. 13742532 129MCIntoshBM, HarwinRM, PatersonHE, WestwaterML. An Epidemic of" exact="Chikungunya" post="in South-Eastern Southern Rhodesia. Cent Afr J Med19639;43:351–359. 130HalsteadSB,"/>
   <result pre="Southern Rhodesia. Cent Afr J Med19639;43:351–359. 130HalsteadSB, UdomsakdiS, SingharajP, NisalakA." exact="Dengue" post="chikungunya virus infection in man in Thailand, 1962–1964. 3."/>
   <result pre="Some entomological and epidemiological observations on the 1964 outbreak of" exact="Chikungunya" post="fever in South India. Indian J Med Res1967;55(1):1–12. 6036047"/>
   <result pre="African Medical Journal1979;56(4):130–132. 494034 140SaluzzoJF, CornetM, DigoutteJP. Outbreak of a" exact="Chikungunya" post="virus epidemic in western Senegal in 1982. Dakar Med1983;28(3):497–500."/>
   <result pre="11944696 142MuyembeTamfumJJ, PeyrefitteCN, YogoleloR, BasisyaEM, KoyangeD, PukutaE, et al.Epidemics of" exact="Chikungunya" post="virus in 1999 and 2000 in the Democratic Republic"/>
   <result pre="15693148 144SergonK, NjugunaC, KalaniR, OfulaV, OnyangoC, KonongoiLS, et al.Seroprevalence of" exact="Chikungunya" post="virus (CHIKV) infection on Lamu Island, Kenya, October 2004."/>
   <result pre="Trop Med Hyg2008;78(2):333–337. 24 ref. 18256441 145CordelH, collab: Investigation Group." exact="Chikungunya" post="outbreak on Reunion: update. Euro Surveill200632;11(3):E060302.3. 146PaquetC, QuatresousI, SoletJL,"/>
   <result pre="2006. Euro Surveill200622;11(2):E060202.3. 147QuatresousI, collab: Investigation Group. E-alert 27 January:" exact="Chikungunya" post="outbreak in Reunion, a French overseas department. Euro Surveill200622;11(2):E060202.1."/>
   <result pre="Reunion: situation on 8 January 2006. (Infection par le virus" exact="Chikungunya" post="a l’Ile de la Reunion) [French]. Bulletin Epidemiologique Hebdomadaire"/>
   <result pre="17978079 151SergonK, YahayaAA, BrownJ, BedjaSA, MlindasseM, AgataN, et al.Seroprevalence of" exact="Chikungunya" post="virus infection on Grande Comore Island, Union of the"/>
   <result pre="10.1016/j.neurol.2008.06.00918835614 157SissokoD, MalvyD, GiryC, DelmasG, PaquetC, GabrieP, et al.Outbreak of" exact="Chikungunya" post="fever in Mayotte, Comoros archipelago, 2005–2006. Trans R Soc"/>
   <result pre="ref. 10.3201/eid1407.07152118598641 162KumarasamyV, PrathapaS, ZuridahH, ChemYK, NorizahI, ChuaKB. Re-emergence of" exact="Chikungunya" post="virus in Malaysia. Med J Malaysia2006;61(2):221–225. 10 ref. 16898316"/>
   <result pre="virus in Malaysia. Med J Malaysia2006;61(2):221–225. 10 ref. 16898316 163SelvavinayagamTS." exact="Chikungunya" post="fever outbreak in Vellore, South India. Indian Journal of"/>
   <result pre="KhamgaonkarMB. Clinico-epidemiological profile of fever cases admitted during epidemics of" exact="Chikungunya" post="fever. J Commun Dis2007;39(1):33–35. 6 ref. 18338714 165JainSK, KumarKaushal,"/>
   <result pre="Dis2007;39(1):33–35. 6 ref. 18338714 165JainSK, KumarKaushal, BhattacharyaD, VenkateshS, JainDC, ShivLal." exact="Chikungunya" post="viral disease in district Bhilwara (Rajasthan) India. J Commun"/>
   <result pre="ref. 169DwibediBhagirathi, MohapatraNamita, BeuriaMK, KerkettaAS, SabatJyotsna, KarSK, et al.Emergence of" exact="Chikungunya" post="virus infection in Orissa, India. Vector Borne and Zoonotic"/>
   <result pre="clinical manifestations, and long-term outcomes of a major outbreak of" exact="Chikungunya" post="in a Hamlet in Sri Lanka, in 2007: A"/>
   <result pre="in Sri Lanka. Asian Pacific Journal of Tropical Disease2014;4(2):131–134. 175NairPMC." exact="Chikungunya" post="in neonates. Indian Pediatr2008;45(7):605. 176SharmaRS, Showkath AliMK, DhillonGPS. Epidemiological"/>
   <result pre="an outbreak of chikungunya in Lakshadweep Islands, India, during 2007." exact="Dengue" post="Bulletin2008;32:178–185. 177SanthoshSR, DashPK, ParidaMM, KhanM, TiwariM, RaoPVL. Comparative full"/>
   <result pre="full genome analysis revealed E1: A226V shift in 2007 Indian" exact="Chikungunya" post="virus isolates. Virus Res2008;135(1):36–41. 30 ref. 10.1016/j.virusres.2008.02.00418384900 178GoelMK, MalikJS,"/>
   <result pre="26 ref. 182LiumbrunoGM, CalteriD, PetropulacosK, MattiviA, PoC, MaciniP, et al.The" exact="Chikungunya" post="epidemic in Italy and its repercussion on the blood"/>
   <result pre="et al.Aedes albopictus mosquito: the main vector of the 2007" exact="Chikungunya" post="outbreak in Gabon. PLos One2009(March):e4691. 27 ref. 186LeroyEM, NkogheD,"/>
   <result pre="188BhatRM, RaiYashaswi, RameshAmitha, NandakishoreB, SukumarD, MartisJacintha, et al.Mucocutaneous manifestations of" exact="Chikungunya" post="fever: a study from an epidemic in coastal Karnataka."/>
   <result pre="Indian J Dermatol2011;56(3):290–294. 12 ref. 10.4103/0019-5154.8248321772590 189First identified outbreak of" exact="Chikungunya" post="in Bangladesh, 2008. HSB (Health Science Bulletin)2009;7(1):En1-En6, Benga1-6. 8"/>
   <result pre="Diseases2009;15(8):1243–1249. 21 ref. 10.3201/eid1508.08148619751586 191LeoYS, ChowALP, TanLiKiang, LyeDC, LinLi, NgLC." exact="Chikungunya" post="outbreak, Singapore, 2008. Emerging Infectious Diseases2009;15(5):836–837. 10 ref. 10.3201/eid1505.08139019402989"/>
   <result pre="Infectious Diseases2009;15(5):836–837. 10 ref. 10.3201/eid1505.08139019402989 192WinMK, ChowA, DimatatacF, GoCJ, LeoYS." exact="Chikungunya" post="fever in Singapore: acute clinical and laboratory features, and"/>
   <result pre="196TheamboonlersA, RianthavornP, PraianantathavornK, WuttirattanakowitN, PoovorawanY. Clinical and molecular characterization of" exact="Chikungunya" post="virus in South Thailand. Jpn J Infect Dis2009;62(4):303–305. 13"/>
   <result pre="Jpn J Infect Dis2009;62(4):303–305. 13 ref. 19628911 197ChusriS, SiripaitoonP, SilpapojakulK." exact="Chikungunya" post="outbreak in Southern Thailand, December 2008 to October 2009."/>
   <result pre="30 ref. 10.1093/trstmh/trt08324052594 199ChakravartiA, MalikS, TiwariS, AshrafA. A study of" exact="Chikungunya" post="outbreak in Delhi. J Commun Dis201112;43(4):259–263. 23781642 200PatilSS, PatilSR,"/>
   <result pre="200PatilSS, PatilSR, DurgawalePM, PatilAG. A study of the outbreak of" exact="Chikungunya" post="fever. J Clin Diagn Res20136;7(6):1059–1062. 10.7860/JCDR/2013/5330.306123905103 201ShoukryNM, ElwanMA, MorsyTA."/>
   <result pre="203NkogheD, KassaRF, CaronM, GrardG, MomboI, BikiéB, et al.Clinical forms of" exact="Chikungunya" post="in Gabon, 2010. PLoS Neglected Tropical Diseases2012;6(2). 204ZhangQiaoLi, HeJianFeng,"/>
   <result pre="204ZhangQiaoLi, HeJianFeng, WuDe, WangZiJun, ZhongXinGuang, ZhongHaoJie, et al.Maiden outbreak of" exact="Chikungunya" post="in Dongguan City, Guangdong Province, China: epidemiological characteristics. PLoS"/>
   <result pre="207D’OrtenzioE, GrandadamM, BalleydierE, JaffarBandjeeMC, MichaultA, BrottetE, et al.A226V strains of" exact="Chikungunya" post="virus, Reunion Island, 2010. Emerging Infectious Diseases2011;17(2):309–311. 10 ref."/>
   <result pre="19 ref. 23287142 210BhagwatiC, MM, MehtaKD, YSG. Profile of The" exact="Chikungunya" post="Infection: A Neglected Vector Borne Disease which is Prevalent"/>
   <result pre="Rajkot District. J Clin Diagn Res20136;7(6):1008–1011. 10.7860/JCDR/2013/5307.305723905091 211An outbreak of" exact="Chikungunya" post="in Dohar Upazila, Bangladesh, 2011. HSB (Health Science Bulletin)2012;10(4):1–8"/>
   <result pre="ChakrabortyA, RahmanM, Nasreen BanuN, RahmanMM, HasanSM, et al.An Outbreak of" exact="Chikungunya" post="in Rural Bangladesh, 2011. PLoS Negl Trop Dis2015710;9(7):e000390710.1371/journal.pntd.000390726161995 213DupontRouzeyrolM,"/>
   <result pre="217SyAK, Saito-ObataM, MedadoIA, TohmaK, DapatC, Segubre-MercadoE, et al.Molecular Characterization of" exact="Chikungunya" post="Virus, Philippines, 2011–2013. Emerg Infect Dis20165;22(5):887–890. 10.3201/eid2205.15126827088593 218HorwoodP, BandeG,"/>
   <result pre="10.5365/WPSAR.2013.4.2.00324015365 219HorwoodPF, ReimerLJ, DaginaR, SusapuM, BandeG, KatuseleM, et al.Outbreak of" exact="Chikungunya" post="virus infection, Vanimo, Papua New Guinea. Emerging Infectious Diseases2013;19(9):1535–1538."/>
   <result pre="10.3201/eid1909.13013023965757 220SoulaphyC, SouliphoneP, PhanthavongK, PhonekeoD, PhimmasineS, KhamphaphongphaneB, et al.Emergence of" exact="Chikungunya" post="in Moonlapamok and Khong Districts, Champassak Province,the Lao People’s"/>
   <result pre="FishD, DurhamDP, Ndeffo MbahML, et al.Spatial and Temporal Clustering of" exact="Chikungunya" post="Virus Transmission in Dominica. PLoS Negl Trop Dis2015814;9(8):e000397710.1371/journal.pntd.000397726274813 228KendrickK,"/>
   <result pre="229DumpalaSuguna, KondaguntaNagaraj, MalhotraVM, VennaGP, JothulaKY. An outbreak investigation of suspected" exact="Chikungunya" post="fever in Nalgonda District, Telangana state. Journal of Clinical"/>
   <result pre="Weekly Rep2014;63(48):1121–1128. 19 ref. 235AhmedS, FrancisL, RickettsRP, ChristianT, Polson-EdwardsK, OlowokureB." exact="Chikungunya" post="virus outbreak, dominica, 2014. Emerg Infect Dis20155;21(5):909–911. 10.3201/eid2105.14181325898214 236Jimenez-CanizalesCE,"/>
   <result pre="Drug Discov2015414. 237Campo CareyAR, Martinez DuranME, Benavides OcampoM, Constanza CuellarN." exact="Chikungunya" post="outbreak in the municipality of San Juan Nepomuceno, Bolivar,"/>
   <result pre="10.1093/trstmh/trv09426626342 239MattarS, MirandaJ, PinzonH, TiqueV, BolanosA, AponteJ, et al.Outbreak of" exact="Chikungunya" post="virus in the north Caribbean area of Colombia: clinical"/>
   <result pre="ref. 242Cardona-OspinaJA, Henao-SanMartinV, Paniz-MondolfiAE, Rodriguez-MoralesAJ. Mortality and fatality due to" exact="Chikungunya" post="virus infection in Colombia. J Clin Virol20159;70:14–15. 10.1016/j.jcv.2015.07.00126305812 243Castillo"/>
   <result pre="DM, Herrera Gutierrez N, Cochero Bustamante S. Research cases of" exact="Chikungunya" post="fever virus in communities, September 2014, Ovejas, Sucre. 2015;."/>
   <result pre="2014, Ovejas, Sucre. 2015;. Accessed 11, 20. 244PimentelR, SkewesRammR, MoyaJ." exact="Chikungunya" post="in the Dominican Republic: lessons learned in the first"/>
   <result pre="ErasmusJH, Kiaty-FigueroaL, et al.Molecular Virologic and Clinical Characteristics of a" exact="Chikungunya" post="Fever Outbreak in La Romana, Dominican Republic, 2014. PLoS"/>
   <result pre="BestC, BenskinG. Epidemiology, Clinical and Laboratory Features and Course of" exact="Chikungunya" post="among a Cohort of Children during the First Caribbean"/>
   <result pre="in Rural Haiti: The Importance of a Field Diagnosis of" exact="Chikungunya" post="Virus in Remote Locations. 2015;. Accessed 11, 15. 249PessoaR,"/>
   <result pre="in Pernambuco, Brazil, Revealed a Cocirculation of Zika, Chikungunya, and" exact="Dengue" post="Virus Type 1. Medicine (Baltimore)20163;95(12):e3201.27015222 250Genderen FT, Krishnadath I,"/>
   <result pre="I, Sno R, Grunberg MG, Zijlmans W, Adhin MR. First" exact="Chikungunya" post="outbreak in Suriname; clinical and epidemiological features. 2016;. Accessed"/>
   <result pre="population. J Ophthalmic Inflamm Infect2013115;3(1):14-5760-3-14. 254HayekS, RousseauA, BouthryE, PratCM, LabetoulleM." exact="Chikungunya" post="Virus Infection and Bilateral Stromal Keratouveitis. JAMA Ophthalmol201549. 255KashyapRS,"/>
   <result pre="receptor-induced cytokine profiles in the blood and cerebrospinal fluid of" exact="Chikungunya" post="patients. Neuroimmunomodulation2014;21(6):338–346. 10.1159/00035824024776821 256DasSuman, SarkarNirmalya, MajumderJayitri, ChatterjeeKaushani, BholanathA. Acute"/>
   <result pre="Multiplex Reverse Transcription PCR for Detection of Zika, Chikungunya, and" exact="Dengue" post="Viruses. Emerg Infect Dis20167;22(7):1295–1297. 10.3201/eid2207.16032627184629 259WaggonerJJ, GreshL, VargasMJ, BallesterosG,"/>
   <result pre="et al.Viremia and Clinical Presentation in Nicaraguan Patients Infected With" exact="Zika" post="Virus, Chikungunya Virus, and Dengue Virus. Clin Infect Dis20161215;63(12):1584–1590."/>
   <result pre="and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus," exact="Chikungunya" post="Virus, and Dengue Virus. Clin Infect Dis20161215;63(12):1584–1590. 10.1093/cid/ciw58927578819 260d"/>
   <result pre="in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and" exact="Dengue" post="Virus. Clin Infect Dis20161215;63(12):1584–1590. 10.1093/cid/ciw58927578819 260d LamballerieX, BoissonV, ReynierJC,"/>
   <result pre="276LorenziOD, MajorC, AcevedoV, Perez-PadillaJ, RiveraA, BiggerstaffBJ, et al.Reduced Incidence of" exact="Chikungunya" post="Virus Infection in Communities with Ongoing Aedes Aegypti Mosquito"/>
   <result pre="Tropical Medicine and Health2008;36(2):107–110. 9 ref. 282ThaungU, Khai MingC, TheinMyint." exact="Dengue" post="haemorrhagic fever in Burma. Southeast Asian J Trop Med"/>
   <result pre="host-seeking behavior. PLoS Comput Biol2012;8(5):e100250010.1371/journal.pcbi.100250022615546 286PileJC, HenchalEA, ChristopherGW, SteeleKE, PavlinJA." exact="Chikungunya" post="in a North American traveler. Journal of Travel Medicine1999;6(2):137–139."/>
   <result pre="Trop Dis2017;11(6). 288Villamil-GomezW, Alba-SilveraL, Menco-RamosA, Gonzalez-VergaraA, Molinares-PalaciosT, Barrios-CorralesM, et al.Congenital" exact="Chikungunya" post="Virus Infection in Sincelejo, Colombia: A Case Series. J"/>
   <result pre="chikungunya infection. Ceylon Med J20096;54(2):47–50. 19670548 290PeterR, KrishnanL, AnandrajV, KuruvilaS." exact="Chikungunya" post="in a newborn. Journal of Clinical Neonatology 2015 0142015;4(2):145–146."/>
   <result pre="Vieira, MontarroyosUlisses Ramos, de MeloAna Paula Lopeset al.Association between microcephaly," exact="Zika" post="virus infection, and other risk factors in Brazil: final"/>
   <result pre="Kaur S, Lee WWL, et al. Sero-prevalence and cross-reactivity of" exact="Chikungunya" post="virus specific anti-E2EP3 antibodies in arbovirus-infected patients. 2015;. Accessed"/>
   <result pre="Virology2010;47(1):85–88. 15 ref. 10.1016/j.jcv.2009.11.01420004145 295MishraAK, GeorgeAA, SadhasivM, SathyendraS. Sign in" exact="Chikungunya" post="Fever. Journal of Association of Physicians of India2016;64:74. 296VasaniR,"/>
   <result pre="CastroJS. Nasal Skin Necrosis: An Unexpected New Finding in Severe" exact="Chikungunya" post="Fever. Clin Infect Dis201611;62(1):78–81. 10.1093/cid/civ71826423381 299SebastianMR, LodhaR, KabraSK. Chikungunya"/>
   <result pre="Severe Chikungunya Fever. Clin Infect Dis201611;62(1):78–81. 10.1093/cid/civ71826423381 299SebastianMR, LodhaR, KabraSK." exact="Chikungunya" post="infection in children. Indian J Pediatr20092;76(2):185–189. 10.1007/s12098-009-0049-619330307 300Rampal, ShardaM,"/>
   <result pre="Indian J Pediatr20092;76(2):185–189. 10.1007/s12098-009-0049-619330307 300Rampal, ShardaM, MeenaH. Neurological complications in" exact="Chikungunya" post="fever. J Assoc Physicians India200711;55:765–769. 18290551 301PaulBJ, PannarkadyG, MoniSP,"/>
   <result pre="301PaulBJ, PannarkadyG, MoniSP, ThachilEJ. Clinical profile and long-term sequelae of" exact="Chikungunya" post="fever. Indian Journal of Rheumatology2011;6(1 SUPPL.):12–19. 302TaraphdarD, RoyBK, ChatterjeeS."/>
   <result pre="Chikungunya fever. Indian Journal of Rheumatology2011;6(1 SUPPL.):12–19. 302TaraphdarD, RoyBK, ChatterjeeS." exact="Chikungunya" post="virus infection amongst the acute encephalitis syndrome cases in"/>
   <result pre="303MaityP, RoyP, BasuA, DasB, GhoshUS. A case of ADEM following" exact="Chikungunya" post="fever. J Assoc Physicians India20145;62(5):441–442. 25438499 304Mohamed MusthafaAK, AbdurahimanP,"/>
   <result pre="25438499 304Mohamed MusthafaAK, AbdurahimanP, JoseJ. A case of ADEM following" exact="Chikungunya" post="fever. Journal of Association of Physicians of India2008;56(JUNE):473. 305LemantJ,"/>
   <result pre="India2008;56(JUNE):473. 305LemantJ, BoissonV, WinerA, ThibaultL, AndreH, TixierF, et al.Serious acute" exact="Chikungunya" post="virus infection requiring intensive care during the Reunion Island"/>
   <result pre="307BenoîtRozé, FatihaNajioullah, FergéJean-Louis, DorléansFrédérique, ApetseKossivi, BarnayJose-Luiset al.Guillain-Barré Syndrome Associated With" exact="Zika" post="Virus Infection in Martinique in 2016: A Prospective Study."/>
   <result pre="Clinical Infectious Diseases2017;65(9):146210.1093/cid/cix58829020245 308BhuvaneshwariS, ManjariK, BhuvaneswariK. Usage of antimicrobials in" exact="Chikungunya" post="at a tertiary care hospital. International Journal of Pharmaceutical"/>
   <result pre="310PrasadSS, VenugopalK, AnushaB, DadapeerS, HamidullaSD, ManasaT, et al.A study on" exact="Chikungunya" post="prevalence during 2009 in the state of Andhra Pradesh,"/>
   <result pre="Chemical Sciences2012;10(1):175–181. 20 ref. 311MukadamAM, ChauhanKG, TopiaSY, BhiseKS. Occurrence of" exact="Chikungunya" post="and prescribing patterns for its treatment in Maharashtra state."/>
   <result pre="SimonettiFR, GalliM, et al.Origin, evolution, and phylogeography of recent epidemic" exact="CHIKV" post="strains. Infect Genet Evol20123;12(2):392–398. 10.1016/j.meegid.2011.12.01522244786 316VazeilleM, ZouacheK, Vega-RuaA, ThibergeJM,"/>
   <result pre="KamarajT, JosephR, JambulingamP. Genotyping of virus involved in the 2006" exact="Chikungunya" post="outbreak in South India (Kerala and Puducherry). Curr Sci2007;93(10):1412–1416."/>
   <result pre="Which Bends Up: A Case Report and Literature Review of" exact="Chikungunya" post="Virus. J Gen Intern Med20165;31(5):576–581. 10.1007/s11606-015-3459-326194641 320DayakarS., GoudI.K, PillaiH,"/>
   <result pre="320DayakarS., GoudI.K, PillaiH, RemadeviV., DharmaseelanS., NairR.R, et al.Molecular Diagnosis of" exact="Chikungunya" post="virus (CHIKV) and Dengue virus (DENV) and its concomitant"/>
   <result pre="DharmaseelanS., NairR.R, et al.Molecular Diagnosis of Chikungunya virus (CHIKV) and" exact="Dengue" post="virus (DENV) and its concomitant circulation in South Indian"/>
   <result pre="MascarenhasM, et al.Assessment of the Probability of Autochthonous Transmission of" exact="Chikungunya" post="Virus in Canada under Recent and Projected Climate Change."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6293476\results\search\tropicalVirus\results.xml">
   <result pre="pmcid: 6293476 doi: 10.1093/ofid/ofy315ofy315 : Brief Reports Rev-erb Agonist Inhibits" exact="Chikungunya" post="and O’nyong’nyong Virus Replication HwangJesse1JiangAlfred1FikrigErol12[1], [2], Correspondence: E. Fikrig,"/>
   <result pre="medium, provided the original work is properly cited.ofy315.pdf Abstract Abstract" exact="Chikungunya" post="virus (CHIKV), an alphavirus spread by Aedes spp. mosquitos,"/>
   <result pre="a subset of patients. Due to recent global epidemics of" exact="CHIKV" post="and the potential for related viruses to cause outbreaks,"/>
   <result pre="inflammatory response in cultured murine macrophages exposed to alphavirus-infected cells." exact="Chikungunya" post="O’nyong’nyong Rev-erb antiviral Funding National Institutes of Health10.13039/1000000024T32HL007974 National"/>
   <result pre="Institutes of Health10.13039/1000000024T32HL007974 National Heart, Lung, and Blood Institute10.13039/1000000504T32HL007974 page-count:" exact="Chikungunya" post="virus (CHIKV) is a mosquito-borne arbovirus that belongs to"/>
   <result pre="that belongs to the alphavirus genus [1]. After mosquito bite," exact="CHIKV" post="replicates locally in the skin, causes viremia, and disseminates"/>
   <result pre="There are no approved vaccines or therapeutics against CHIKV. Although" exact="CHIKV" post="normally causes sporadic outbreaks, large epidemics have been documented."/>
   <result pre="alphaviruses have not caused large outbreaks on the scale of" exact="CHIKV" post="epidemics. An exception is ONNV, which is transmitted by"/>
   <result pre="in vivo, we tested the effects of Rev-erbα/β ligands on" exact="CHIKV" post="and ONNV replication. We report that cultured cells exposed"/>
   <result pre="and Antibodies Details are listed in the Supplementary Data. Viruses" exact="CHIKV" post="strain 181/25 was obtained from infectious clone plasmid pSinRep5-181/25ic"/>
   <result pre="using TransIT-mRNA transfection reagent (Mirus Bio). ONNV strain SG650 and" exact="Zika" post="virus strain FSS13025 were obtained from the University of"/>
   <result pre="antagonist function [10]. Huh7 cells, which are highly permissive for" exact="CHIKV" post="replication, were infected with CHIKV (MOI 1) and treated"/>
   <result pre="which are highly permissive for CHIKV replication, were infected with" exact="CHIKV" post="(MOI 1) and treated with the 3 compounds (10"/>
   <result pre="5 (Figure 1B). Figure 1.  Effect of Rev-erb ligands on" exact="Chikungunya" post="virus (CHIKV) replication. A, Huh7 cells were infected with"/>
   <result pre="Chikungunya virus (CHIKV) replication. A, Huh7 cells were infected with" exact="CHIKV" post="(MOI 1) and treated with indicated compounds (10 µM)"/>
   <result pre="titered at 24 hpi. B, Huh7 cells were infected with" exact="CHIKV" post="(MOI 5) and treated with different concentrations of SR9009"/>
   <result pre="12, and 24 hpi. D, Huh7 cells were infected with" exact="CHIKV" post="(MOI 5) and treated with SR9009 at 1 hpi."/>
   <result pre="complexes where viral RNA is synthesized. Cells were infected with" exact="CHIKV" post="and treated with SR9009 as before. At 12 hpi,"/>
   <result pre="of VSV proteins (Supplementary Figure 7). Thus, SR9009 preferentially blocks" exact="CHIKV" post="translation. ONNV is the arthritogenic alphavirus most closely related"/>
   <result pre="translation. ONNV is the arthritogenic alphavirus most closely related to" exact="CHIKV" post="and has the potential to spread from Africa [4]."/>
   <result pre="failed to appreciably inhibit VSV replication and only moderately affected" exact="Zika" post="virus replication, with a 6-fold reduction at the highest"/>
   <result pre="MOI 5), GFP-expressing vesicular stomatitis virus (VSV-GFP; MOI 0.5), or" exact="Zika" post="virus (ZIKV; MOI 3) and treated with increasing doses"/>
   <result pre="alphavirus replication, Rev-erb agonist may also downregulate host inflammation. DISCUSSION" exact="Chikungunya" post="virus circulates in a sylvatic cycle between nonhuman primates"/>
   <result pre="warranted to determine if Rev-erb agonists can suppress arthritogenesis after" exact="CHIKV" post="infection in vivo. Plasma levels of SR9009 have been"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6331147\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="West Nile" post="virus : Biology and life sciences : Microbiology :"/>
   <result pre="Medical microbiology : Microbial pathogens : Viral pathogens : Flaviviruses:" exact="West Nile" post="virus : Medicine and health sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial pathogens : Viral pathogens : Flaviviruses:" exact="West Nile" post="virus : Biology and life sciences : Organisms :"/>
   <result pre="sciences : Organisms : Viruses : Viral pathogens : Flaviviruses:" exact="West Nile" post="virus Molecular characterization of viruses associated with encephalitis in"/>
   <result pre="virus 1, 2, 3 and 4, yellow fever virus and" exact="West Nile" post="virus), Alphavirus (NS5 region) and enterovirus by RT- PCR"/>
   <result pre="CSFs positive for human herpesviruses, 2 for enteroviruses, 2 for" exact="DENV" post="and 1 for SLEV. Detection of arboviruses, even though"/>
   <result pre="total number of annual cases [1]. In the West, the" exact="West Nile" post="virus (WNV) is the most frequent agent of arbovirus"/>
   <result pre="have also been reported at low frequency in Brazil [6,7]." exact="Chikungunya" post="virus (CHIKV) was first reported in Central America in"/>
   <result pre="2014 was present in most countries in South America [8–13]." exact="Zika" post="virus (ZIKV) was first reported in Brazil in 2014,"/>
   <result pre="were performed according to the protocols Callahan et al., for" exact="DENV" post="serotypes 1, 3 and 4 [19]; Johnson et al.,"/>
   <result pre="serotypes 1, 3 and 4 [19]; Johnson et al., for" exact="DENV" post="serotype 2 [20]; Mantel et al., for yellow fever"/>
   <result pre="serotype 2 [20]; Mantel et al., for yellow fever virus-" exact="YFV" post="[21]; and Briese et al., for WNV in the"/>
   <result pre="yellow fever virus- YFV [21]; and Briese et al., for" exact="WNV" post="in the NS5 region [22]. Real–time PCR for enteroviruses"/>
   <result pre="followed by enteroviruses (7 cases). Three arbovirus infections, two of" exact="DENV" post="and one case of SLEV were also identified. In"/>
   <result pre="Data Arboviruses N (%) Herpesvirus N (%) Enterovirus Unknown (Variables)" exact="DENV" post="SLEV HSV-1 EBV CMV HHV-6 VZV N (%) etiology"/>
   <result pre="and 2 who tested positive for virus. Enterovirus Herpesvirus SLEV" exact="DENV" post="Group 1 Group 2 Group 1 Group 2 Group"/>
   <result pre="subjects in our study was 2.4%, including 4 cases of" exact="DENV" post="and 2 of SLEV. This occurrence is lower than"/>
   <result pre="et al., SLEV was detected in three patients co-infected with" exact="DENV" post="serotype 4 in the cities of Cuiabá and Várzea"/>
   <result pre="and Várzea Grande, one of whom had triple co-infection with" exact="DENV" post="subtype1 [4,34–37]. The small number of identified SLEV infections"/>
   <result pre="distribution of SLEV in Brazil [29]. The arrival of the" exact="WNV" post="has been expected in Brazil since its appearance in"/>
   <result pre="yet a cause of encephalitis in São Paulo. Epidemics of" exact="DENV" post="and ZIKV have been recent occurrences in Brazil and"/>
   <result pre="cause of encephalitis in São Paulo. Epidemics of DENV and" exact="ZIKV" post="have been recent occurrences in Brazil and they are"/>
   <result pre="Emerg Infect Dis. 2008; 14: 667–9. 10.3201/eid1404.07118518394292 8CamposGS, BandeiraAC, SardiSI." exact="Zika" post="virus outbreak, Bahia, Brazil. Emerg Infect Dis. 2015; 21:"/>
   <result pre="SantosGIV, SantosCND, LuzK. The first report of autochtonous transmission of" exact="Zika" post="virus in Brazil. Mem Inst Oswaldo Cruz. 2015; 110:"/>
   <result pre="Methods. 2008; 151: 40–6. 10.1016/j.jviromet.2008.03.02618501437 22BrieseT, GlassWG, LipkinWI. Detection of" exact="West Nile" post="virus sequences in cerebrospinal fluid. Lancet. 2000; 355: 1614–5."/>
   <result pre="281–5. doi: /S0036-46652005000500008 16302112 38VieiraMACS, AguiarAAX, BorbaAS, GuimarãesHCL, EulálioKD, Albuquerque-NetoLL." exact="West Nile" post="Fever in Brazil: sporadic case, silent endemic disease or"/>
   <result pre="57: 27610.1590/S0036-4665201500030001726200972 39VieiraMACS, RomanoAPM, BorbaAS, SilvaEVP, ChiangJO, EulálioKDet al.Case report:" exact="West Nile" post="Virus Encephalitis: The first human case recorded in Brazil."/>
   <result pre="2015; 93: 377–9. 40FujitaDM, SalvadorFS, NaliLHDS. The silent spread of" exact="West Nile" post="virus in Brazil: non-human positive case in a beach"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6336248\results\search\tropicalVirus\results.xml">
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Biology and life sciences : Organisms :"/>
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Sciences : Biochemistry : Proteins : Immune System Proteins: Antibodies" exact="Chikungunya" post="as a paradigm for emerging viral diseases: Evaluating disease"/>
   <result pre="viral diseases: Evaluating disease impact and hurdles to vaccine development" exact="Chikungunya" post="fever disease impact and vaccine development RezzaGiovanni1http://orcid.org/0000-0001-8016-8556WeaverScott C.2*[1], Department"/>
   <result pre="medium, provided the original author and source are credited.pntd.0006919.pdf Abstract" exact="Chikungunya" post="fever (CHIKF) is an emerging infectious disease caused by"/>
   <result pre="received no specific funding for this work. fig-count: table-count: page-count:" exact="Chikungunya" post="virus (CHIKV) is an RNA alphavirus belonging to the"/>
   <result pre="identified in Tanzania in 1952. During epidemics and endemic circulation," exact="CHIKV" post="is transmitted by Aedes aegypti and, to a lesser"/>
   <result pre="to a lesser extent, by A. albopictus mosquitoes. Infection with" exact="CHIKV" post="typically causes a self-limiting febrile illness, chikungunya fever (CHIKF),"/>
   <result pre="involve severe neurologic sequelae in fetuses and infants [1, 2]." exact="CHIKV" post="is enzootic in Africa, where transmission involves different arboreal"/>
   <result pre="probably occur in many regions of Sub-Saharan Africa. In Asia," exact="CHIKV" post="is endemic and causes recurrent and sometimes large epidemics,"/>
   <result pre="the Indian subcontinent and in Southeast Asia [1–3]. In 2004," exact="CHIKV" post="reemerged to cause large outbreaks, which began on the"/>
   <result pre="[6]. In 2013, autochthonous (locally originating) chains of transmission of" exact="CHIKV" post="were identified for the first time in the Americas"/>
   <result pre="were identified for the first time in the Americas [7]." exact="CHIKV" post="has expanded its range of activity to include temperate"/>
   <result pre="of CHIKF were reported (http://www.who.int/denguecontrol/arbo-viral/other_arboviral_chikungunya/en/). Furthermore, the global impact of" exact="CHIKV" post="is constantly growing, due to the introduction and spread"/>
   <result pre="cases, a completely naïve population (Fig 1). The capacity of" exact="CHIKV" post="to adapt to a new mosquito vector has been"/>
   <result pre="World map with countries where autochthonous (locally initiated) chains of" exact="CHIKV" post="transmission have been identified. Data from World Health Organization"/>
   <result pre="Indian outbreaks [1], and fatal encephalitis has been reported with" exact="CHIKV" post="infection both in Italy [8] and in La Reunion,"/>
   <result pre="[20]. These findings provide evidence of severe disease associated with" exact="CHIKV" post="infection, which may have a high impact in terms"/>
   <result pre="mosquito-borne viruses such as dengue, Zika, and even yellow fever," exact="CHIKV" post="typically causes symptomatic infection, and consequently outbreaks are accompanied"/>
   <result pre="Unfortunately, little information is available on the economic costs of" exact="CHIKV" post="infection. Healthcare costs during the La Reunion in 2005"/>
   <result pre="live-attenuated candidates, genetically engineered complementary DNA (cDNA) clone-based, rationally attenuated" exact="CHIKV" post="strains were more recently developed and successfully tested in"/>
   <result pre="employed a picornavirus-derived internal ribosome entry site to replace the" exact="CHIKV" post="subgenomic promoter [41]. This replacement is highly stable after"/>
   <result pre="neutralizing antibody responses and protects mice and NHPs against virulent" exact="CHIKV" post="challenge, including weight change, fever, and viremia in cynomolgus"/>
   <result pre="this Indian Ocean lineage-derived strain also extends to Asian/American lineage" exact="CHIKV" post="strains [43]. Other clone-derived, rationally attenuated CHIKF vaccine candidates"/>
   <result pre="Medical Research Institute of Infectious Diseases, University of Maryland Live-attenuated" exact="CHIKV" post="strain 1 Completed Phase 2 [32, 33] VRC-CHKVLP059-00-VP (PXVX0317"/>
   <result pre="US National Institutes of Health, PaxVax Virus-like particle assembled from" exact="CHIKV" post="proteins expressed in mammalian cells 2 Phase 2 (NCT02562482,"/>
   <result pre="Inst. Pasteur, Themis Bioscience Recombinant live- attenuated measles vaccine expressing" exact="CHIKV" post="virus-like particles derived from the structural protein genes 2"/>
   <result pre="Phase 2 (NCT03101111, NCT02861586) [44, 63] VLA1553 Valneva, Austria Recombinant" exact="CHIKV" post="with nsP3 deletion 1 Recruiting for Phase 1 (NCT03382964)"/>
   <result pre="1 (NCT03382964) [38, 64] VAL-181388 Moderna Therapeutics mRNA encoding the" exact="CHIKV" post="structural proteins Not reported Recruiting for Phase 1 (NCT03325075)"/>
   <result pre="[58] CHIKV/IRES University of Texas Medical Branch, Takeda Pharmaceuticals Recombinant" exact="CHIKV" post="with subgenomic promoter replaced by internal ribosome entry site"/>
   <result pre="attenuated measles virus strain as a vector to express the" exact="CHIKV" post="structural proteins [44]. In a Phase 1 trial, this"/>
   <result pre="clinical trials. Expression via electroporation of mammalian cells of the" exact="CHIKV" post="structural polyprotein ORF in a DNA plasmid form produces"/>
   <result pre="These VLPs elicit neutralizing antibodies against envelope proteins from diverse" exact="CHIKV" post="strains, and immunized NHPs produce high-titer neutralizing antibodies that"/>
   <result pre="(Table 1). Nucleic acid-based vaccines Finally, nucleic acid-based vaccines against" exact="CHIKV" post="are under development. These vaccines have clear advantages, from"/>
   <result pre="proven safety records. However, based on initial results with DNA" exact="Zika" post="vaccines that were generated within a few months of"/>
   <result pre="generated within a few months of the recognition of congenital" exact="Zika" post="Syndrome, these vaccines require multiple doses and immunity is"/>
   <result pre="include cities with histories of recurrent dengue outbreaks (dengue and" exact="CHIKV" post="share the same human-amplified transmission cycles, so regions susceptible"/>
   <result pre="impossible to realize [57]. For example, if human antibodies against" exact="CHIKV" post="developed from individuals vaccinated in phase 1 and 2"/>
   <result pre="58]. Although there is strong evidence that neutralizing antibodies against" exact="CHIKV" post="protect against infection and disease, the lack of compete"/>
   <result pre="[62]. Conclusion In summary, the burden of disease caused by" exact="CHIKV" post="is very high, due to the expanding geographic range"/>
   <result pre="stakeholders. Key learning points The burden of disease due to" exact="CHIKV" post="is high due to recurrent epidemics and outbreaks in"/>
   <result pre="due to recurrent epidemics and outbreaks in previously CHIKV-free areas" exact="CHIKV" post="causes a major public health impact, especially due to"/>
   <result pre="that can be highly debilitating Because mosquito control programs against" exact="CHIKV" post="vectors have limited efficacy in controlling transmission, an effective"/>
   <result pre="2014/08/19. doi: 10.1016/S0140-6736(14)61185-5. PubMed PMID: 25132507. Weaver SC, Lecuit M." exact="Chikungunya" post="virus and the global spread of a mosquito-borne disease."/>
   <result pre="considerations in development of vaccines to prevent disease caused by" exact="Chikungunya" post="virus. Vaccine. 2017;35(37):4851–8. doi: 10.1016/j.vaccine.2017.07.065. PubMed PMID: 28760614. References"/>
   <result pre="arbovirosis. The Lancet infect. Dis. 2007;7(5):319–27. 10.1016/S1473-3099(07)70107-X .17448935 2WeaverSC, LecuitM." exact="Chikungunya" post="virus and the global spread of a mosquito-borne disease."/>
   <result pre="2006. WHO Weekly Epidemiol. Record. 2006;81:105–116. 5CharrelRN, de LamballerieX, RaoultD." exact="Chikungunya" post="outbreaks—the globalization of vectorborne diseases. N Engl J Med."/>
   <result pre="El-SawafG, FaggioniG, VescioF, Al AmeriR, De SantisR, et al.Co-circulation of" exact="Dengue" post="and Chikungunya Viruses, Al Hudaydah, Yemen, 2012. Emerg infect"/>
   <result pre="VescioF, Al AmeriR, De SantisR, et al.Co-circulation of Dengue and" exact="Chikungunya" post="Viruses, Al Hudaydah, Yemen, 2012. Emerg infect Dis. 2014;20(8):1351–4."/>
   <result pre="2018 Dec 21]. 11ErasmusJH, RossiSL, WeaverSC. Development of Vaccines for" exact="Chikungunya" post="Fever. J Infect Dis. 2016;214(suppl 5):S488–S96. 10.1093/infdis/jiw27127920179 12PowersAM. Vaccine"/>
   <result pre="2016;214(suppl 5):S488–S96. 10.1093/infdis/jiw27127920179 12PowersAM. Vaccine and Therapeutic Options To Control" exact="Chikungunya" post="Virus. Clinical microbiology reviews. 2018;31(1). 10.1128/CMR.00104-16 .29237708 13YangS, FinkD,"/>
   <result pre="considerations in development of vaccines to prevent disease caused by" exact="Chikungunya" post="virus. Vaccine. 2017;35(37):4851–8. 10.1016/j.vaccine.2017.07.065 .28760614 14TsetsarkinKA, ChenR, WeaverSC. Interspecies"/>
   <result pre="mapping. Euro Surveill. 2008;13(7). Epub 2008/05/01. .18445418 18ArpinoC, CuratoloP, RezzaG." exact="Chikungunya" post="and the nervous system: what we do and do"/>
   <result pre="SookhareeaC, et al.Increase in cases of Guillain-Barre syndrome during a" exact="Chikungunya" post="outbreak, French Polynesia, 2014 to 2015. Euro Surveill. 2015;20(48):3007910.2807/1560-7917.ES.2015.20.48.30079"/>
   <result pre="10.1016/S1473-3099(07)70294-3 .18156079 22SissokoD, MalvyD, EzzedineK, RenaultP, MoscettiF, LedransM, et al.Post-epidemic" exact="Chikungunya" post="disease on Reunion Island: course of rheumatic manifestations and"/>
   <result pre="10.1016/j.jinf.2012.04.005 .22522292 25SoumahoroMK, BoellePY, GauzereBA, AtsouK, PelatC, LambertB, et al.The" exact="Chikungunya" post="epidemic on La Reunion Island in 2005–2006: a cost-of-illness"/>
   <result pre="burden of dengue and chikungunya from the Americas to Asia." exact="Dengue" post="Bulletin 2010; 34. WHO Regional Office for South-East Asia,"/>
   <result pre="New Haven EliScholar, USA: Yale University; 2016. 28EckelsKH, HarrisonVR, HetrickFM." exact="Chikungunya" post="virus vaccine prepared by Tween-ether extraction. Appl Microbiol. 1970;19(2):321–5."/>
   <result pre="29HarrisonVR, EckelsKH, BartelloniPJ, HamptonC. Production and evaluation of a formalin-killed" exact="Chikungunya" post="vaccine. J Immunol. 1971;107(3):643–7. Epub 1971/09/01. .4999088 30TiwariM, ParidaM,"/>
   <result pre="adapted formalin inactivated vaccine derived from novel ECSA genotype of" exact="Chikungunya" post="virus. Vaccine. 2009;27(18):2513–22. 10.1016/j.vaccine.2009.02.062 .19368794 31KumarM, SudeepAB, ArankalleVA. Evaluation"/>
   <result pre=".11304054 34GorchakovR, WangE, LealG, ForresterNL, PlanteK, RossiSL, et al.Attenuation of" exact="Chikungunya" post="virus vaccine strain 181/clone 25 is determined by two"/>
   <result pre="J Infect Dis. 1998;177(3):634–41. 9498442 36WeaverSC, OsorioJE, LivengoodJA, ChenR, StinchcombDT." exact="Chikungunya" post="virus and prospects for a vaccine. Expert Rev Vaccines."/>
   <result pre="a vaccine. Expert Rev Vaccines. 2012;11(9):1087–101. Epub 2012/11/16. 10.1586/erv.12.8423151166 37PowersAM." exact="Chikungunya" post="virus control: is a vaccine on the horizon?Lancet. 2014"/>
   <result pre=".25132506 38HallengardD, KakoulidouM, LullaA, KummererBM, JohanssonDX, MutsoM, et al.Novel attenuated" exact="Chikungunya" post="vaccine candidates elicit protective immunity in C57BL/6 mice. J"/>
   <result pre="of adaptive immunity to CHIKV/IRES a novel candidate vaccine against" exact="Chikungunya" post="in the A129 mouse model. Vaccine. 2013;31(33):3353–60. Epub 2013/06/04."/>
   <result pre="Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated" exact="Chikungunya" post="Vaccine Candidate. PLoS Negl Trop Dis. 2015;9(9):e000400710.1371/journal.pntd.000400726340754 43LangsjoenRM, HallerSL,"/>
   <result pre="al.Utilization of an Eilat Virus-Based Chimera for Serological Detection of" exact="Chikungunya" post="Infection. PLoS Negl Trop Dis. 2015;9(10):e000411910.1371/journal.pntd.000411926492074 48ErasmusJH, AugusteAJ, KaelberJT,"/>
   <result pre="SunS, HoldawayHA, KongWP, et al.A virus-like particle vaccine for epidemic" exact="Chikungunya" post="virus protects nonhuman primates against infection. Nat Med. 2010;16(3):334–8."/>
   <result pre="chikungunya virus. Vaccine Development and Therapy. 2013;3:35–46. 54WhiteheadSS, SubbaraoK. Which" exact="Dengue" post="Vaccine Approach Is the Most Promising, and Should We"/>
   <result pre="Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to" exact="Dengue" post="Virus Revealed by Vaccination. Cold Spring Harb Perspect Biol."/>
   <result pre="against chikungunya?Pathog Glob Health. 2015;109(4):170–3. 10.1179/2047773215Y.000000001725971340 61RezzaG. Vaccines against chikungunya," exact="Zika" post="and other emerging Aedes mosquito-borne viruses: unblocking existing bottlenecks."/>
   <result pre="LumFM, KummererBM, LullaA, LullaV, Garcia-ArriazaJ, et al.Prime-boost immunization strategies against" exact="Chikungunya" post="virus. J Virol. 2014;88(22):13333–43. 10.1128/JVI.01926-1425210177 65Chikungunya: Villepin refuse la"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6346475\results\search\tropicalVirus\results.xml">
   <result pre="doi: 10.3201/eid2502.180258 : Research Letter: Research Letter: Little Evidence of" exact="Zika" post="Virus Infection in Wild Long-Tailed Macaques, Peninsular Malaysia Little"/>
   <result pre="Infection in Wild Long-Tailed Macaques, Peninsular Malaysia Little Evidence of" exact="Zika" post="Virus Infection in Wild Long-Tailed Macaques, Peninsular Malaysia Little"/>
   <result pre="Infection in Wild Long-Tailed Macaques, Peninsular Malaysia Little Evidence of" exact="Zika" post="Virus Infection in Wild Long-Tailed Macaques, Peninsular Malaysia ChuaChong"/>
   <result pre="trapped in Peninsular Malaysia in 2009, 2010, and 2016 for" exact="Zika" post="virus RNA and antibodies. None were positive for RNA,"/>
   <result pre="neutralizing antibodies. Long-tailed macaques are unlikely to be reservoirs for" exact="Zika" post="virus in Malaysia. Keywords: Zika virus nonhuman primates Malaysia"/>
   <result pre="unlikely to be reservoirs for Zika virus in Malaysia. Keywords:" exact="Zika" post="virus nonhuman primates Malaysia Macaca fascicularis macaque neutralizing antibodies"/>
   <result pre="virus PRNT FRNT plaque reduction neutralization test sylvatic cycle viruses" exact="Zika" post="virus, first isolated from a rhesus macaque (Macaca mulatta)"/>
   <result pre="first isolated from a rhesus macaque (Macaca mulatta) in the" exact="Zika" post="Forest in Uganda, reemerged in the Pacific Islands and"/>
   <result pre="serious congenital syndromes (1). The role of animal reservoirs for" exact="Zika" post="virus is unclear, although in Africa, nonhuman primates (NHPs)"/>
   <result pre="by Aedes mosquitoes. The presence of a sylvatic cycle for" exact="Zika" post="virus in Africa is supported by a seroprevalence of"/>
   <result pre="role of NHPs in sylvatic cycles in Asia. In Malaysia," exact="Zika" post="virus seropositivity has been reported in residents (3,4), monkeys"/>
   <result pre="risk for exposure to monkey-associated zoonotic pathogens. We therefore evaluated" exact="Zika" post="virus prevalence in long-tailed macaques (M. fascicularis), the most"/>
   <result pre="89 acquired in March and August 2016, coinciding with the" exact="Zika" post="virus global epidemics. After extracting viral RNA from samples"/>
   <result pre="tested samples with sufficient serum volume (n = 228) for" exact="Zika" post="virus envelope gene by real-time PCR (7); none were"/>
   <result pre="(7); none were positive. We tested all 234 samples for" exact="Zika" post="virus neutralizing antibody by 50% plaque reduction neutralization test"/>
   <result pre="Vero cells (Appendix). In total, 6 (2.6%) samples had screening" exact="Zika" post="virus PRNT50 titers ≥20 (Table); we confirmed results with"/>
   <result pre="PRNT50 titers ≥20 (Table); we confirmed results with a 50%" exact="Zika" post="virus focus reduction neutralization test (FRNT50), and samples had"/>
   <result pre="to or within 1 dilution of the PRNT50 titer. Table" exact="Zika" post="virus, DENV-1, and DENV-2 neutralization titers of serum samples"/>
   <result pre="and age group, ID no. Town/city, state, coordinates Neutralization titers" exact="Zika" post="virus PRNT50 Zika virus FRNT50 DENV-1 FRNT50 DENV-2 FRNT50"/>
   <result pre="ID no. Town/city, state, coordinates Neutralization titers Zika virus PRNT50" exact="Zika" post="virus FRNT50 DENV-1 FRNT50 DENV-2 FRNT50 October–November 2009 and"/>
   <result pre="the first batch (n = 234) that were positive by" exact="Zika" post="virus PRNT50 and further tested by FRNT50. Because flavivirus"/>
   <result pre="by FRNT50. A sample was considered to have evidence of" exact="Zika" post="virus neutralizing antibody if the Zika virus PRNT50 titer"/>
   <result pre="to have evidence of Zika virus neutralizing antibody if the" exact="Zika" post="virus PRNT50 titer was ≥20 and DENV-1 and DENV-2"/>
   <result pre="DENV-2 FRNT50 titers were &amp;lt;20 (2 samples) or if the" exact="Zika" post="virus PRNT50 titer was ≥20 and 4-fold greater than"/>
   <result pre="6 samples fulfilled these criteria; the remaining 3 contained detectable" exact="Zika" post="virus, DENV-1, and DENV-2 antibodies, indicating past flavivirus infection"/>
   <result pre="an indeterminate type. Thus, 3 (1.3%) of 234 samples were" exact="Zika" post="virus seropositive, although we did not test for other"/>
   <result pre="although we did not test for other flaviviruses. The 3" exact="Zika" post="virus–seropositive monkeys were captured 35 km away (in Bukit"/>
   <result pre="164 km away (in Manong, Perak) from Bentong (Pahang), where" exact="Zika" post="virus was first isolated outside of Africa in 1966"/>
   <result pre="1966 (5). Of note, 5 of 6 samples with detectable" exact="Zika" post="virus antibodies were collected in 2016, when human Zika"/>
   <result pre="detectable Zika virus antibodies were collected in 2016, when human" exact="Zika" post="virus cases were occurring in Malaysia and neighboring Thailand"/>
   <result pre="in Malaysia and neighboring Thailand and Singapore. The rate of" exact="Zika" post="virus antibody detection was higher in the 2016 collection"/>
   <result pre="that wild long-tailed macaques in Peninsular Malaysia are exposed to" exact="Zika" post="virus but at low levels, without evidence of viremia."/>
   <result pre="finding suggests that long-tailed macaques are unlikely involved in maintaining" exact="Zika" post="virus sylvatic cycles in Malaysia, although the long-term dynamics"/>
   <result pre="virus sylvatic cycles in Malaysia, although the long-term dynamics of" exact="Zika" post="virus antibodies and infection (including shedding) in macaques is"/>
   <result pre="an animal can be designated a reservoir (8). Despite intense" exact="Zika" post="outbreaks in humans, no active Zika virus infection and"/>
   <result pre="reservoir (8). Despite intense Zika outbreaks in humans, no active" exact="Zika" post="virus infection and a low seroprevalence (2.9%) with low"/>
   <result pre="are poorly understood in wild macaques. Also, the circulation of" exact="Zika" post="virus in macaques could be affected by the sylvatic"/>
   <result pre="of other endemic flaviviruses. In conclusion, the low seroprevalence of" exact="Zika" post="virus antibodies in long-tailed macaques reinforces the need to"/>
   <result pre="other NHPs and mammals as reservoirs in Malaysia to elucidate" exact="Zika" post="virus transmission and emergence. Appendix Research methods for determining"/>
   <result pre="and emergence. Appendix Research methods for determining neutralizing titers against" exact="Zika" post="and dengue viruses in serum samples from long-tailed macaques"/>
   <result pre="JJ, Sitam FT, Verasahib K, et al. Little evidence of" exact="Zika" post="virus infection in wild long-tailed macaques, Peninsular Malaysia. Emerg"/>
   <result pre="responses to arbovirus infection. References References 1. DickGW, KitchenSF, HaddowAJ." exact="Zika" post="virus. I. Isolations and serological specificity.Trans R Soc Trop"/>
   <result pre="2. BuechlerCR, BaileyAL, WeilerAM, BarryGL, BreitbachME, StewartLM, et al.Seroprevalence of" exact="Zika" post="virus in wild African green monkeys and baboons. mSphere."/>
   <result pre="Med Hyg. 2001;64:310–6. 10.4269/ajtmh.2001.64.31011463123 5. MarchetteNJ, GarciaR, RudnickA. Isolation of" exact="Zika" post="virus from Aedes aegypti mosquitoes in Malaysia.Am J Trop"/>
   <result pre="LavenJJ, VelezJO, LambertAJ, JohnsonAJ, et al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007.Emerg"/>
   <result pre="evidence for infection of urban and peri-urban nonhuman primates with" exact="Zika" post="and chikungunya viruses in Brazil. mSphere. 2018;3:e00523–17. 10.1128/mSphere.00523-1729404420 10."/>
   <result pre="YoungE, LopezCA, BaricRS, et al.Lack of durable cross-neutralizing antibodies against" exact="Zika" post="virus from dengue virus infection.Emerg Infect Dis. 2017;23:773–81. 10.3201/eid2305.16163028418292"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6356382\results\search\tropicalVirus\results.xml">
   <result pre="degradation has occurred in the brain of mice infected with" exact="West Nile" post="virus, or Zika virus as well [25,26]. Interestingly, no"/>
   <result pre="the brain of mice infected with West Nile virus, or" exact="Zika" post="virus as well [25,26]. Interestingly, no obvious difference in"/>
   <result pre="contact mice. Contact transmission has also been demonstrated with the" exact="Zika" post="virus in guinea pigs in which 100% of the"/>
   <result pre="studies. Aerosol transmission was previously assessed with respect to the" exact="West Nile" post="virus (WNV), duck tembusu, and St. Louis Encephalitis virus"/>
   <result pre="and St. Louis Encephalitis virus (SLEV), all closely related flaviviruses." exact="WNV" post="has been well documented for its potential for aerosol"/>
   <result pre="encephalitis virus in BALB/c mice modelMicrobes Infect.2008101210121710.1016/j.micinf.2008.06.01518691668 25.AliotaM.T.CaineE.A.WalkerE.C.LarkinK.E.CamachoE.OsorioJ.E.Characterization of Lethal" exact="Zika" post="Virus Infection in AG129 MicePLoS Negl. Trop. Dis.201610e000468210.1371/journal.pntd.000468227093158 26.NirY.BeemerA.GoldwasserR.A.West"/>
   <result pre="Pathol.1965464434495317964 27.SunE.ZhaoJ.TaoY.XuQ.QinY.WangW.WeiP.WuD.Antibodies generated by immunization with the NS1 protein of" exact="West Nile" post="virus confer partial protection against lethal Japanese encephalitis virus"/>
   <result pre="protective immune responseVaccine1999173102310810.1016/S0264-410X(99)00137-110462246 30.DengY.Q.ZhangN.N.LiX.F.WangY.Q.TianM.QiuY.F.FanJ.W.HaoJ.N.HuangX.Y.DongH.L.et al.Intranasal infection and contact transmission of" exact="Zika" post="virus in guinea pigsNat. Commun.20178164810.1038/s41467-017-01923-429162827 31.NirY.D.Airborne West Nile virus"/>
   <result pre="contact transmission of Zika virus in guinea pigsNat. Commun.20178164810.1038/s41467-017-01923-429162827 31.NirY.D.Airborne" exact="West Nile" post="virus infectionAm. J. Trop. Med. Hyg.1959853753910.4269/ajtmh.1959.8.53714427299 32.KlenkK.SnowJ.MorganK.BowenR.StephensM.FosterF.GordyP.BeckettS.KomarN.GublerD.et al.Alligators as"/>
   <result pre="Nile virus infectionAm. J. Trop. Med. Hyg.1959853753910.4269/ajtmh.1959.8.53714427299 32.KlenkK.SnowJ.MorganK.BowenR.StephensM.FosterF.GordyP.BeckettS.KomarN.GublerD.et al.Alligators as" exact="West Nile" post="virus amplifiersEmerg. Infect. Dis.2004102150215510.3201/eid1012.04026415663852 33.ReaganR.L.YanceyF.S.ChangS.C.BruecknerA.L.Transmission of West Nile (B956"/>
   <result pre="al.Alligators as West Nile virus amplifiersEmerg. Infect. Dis.2004102150215510.3201/eid1012.04026415663852 33.ReaganR.L.YanceyF.S.ChangS.C.BruecknerA.L.Transmission of" exact="West Nile" post="(B956 strain) and Semliki Forest virus (MBB26146-M-404744-958 strain) to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6360178\results\search\tropicalVirus\results.xml">
   <result pre="Abstract Several mosquito-borne Flaviviruses such as Japanese encephalitis virus (JEV)," exact="West Nile" post="virus (WNV), Dengue Virus (DENV), and Zika virus (ZIKV)"/>
   <result pre="such as Japanese encephalitis virus (JEV), West Nile virus (WNV)," exact="Dengue" post="Virus (DENV), and Zika virus (ZIKV) can cause severe"/>
   <result pre="virus (JEV), West Nile virus (WNV), Dengue Virus (DENV), and" exact="Zika" post="virus (ZIKV) can cause severe clinical disease. Being zoonotic,"/>
   <result pre="various mammals, while others have restricted host affinity, such as" exact="Dengue" post="virus (DENV) only known to infect primates (Go et"/>
   <result pre="The fact that several Flaviviruses have recently emerged, such as" exact="West Nile" post="virus (WNV) and Zika virus (ZIKV) in the Americas,"/>
   <result pre="have recently emerged, such as West Nile virus (WNV) and" exact="Zika" post="virus (ZIKV) in the Americas, and WNV and Usutu"/>
   <result pre="virus (WNV) and Zika virus (ZIKV) in the Americas, and" exact="WNV" post="and Usutu virus (USUV) in Europe represents a serious"/>
   <result pre="et al., 2017). The recent identification of human cases of" exact="DENV" post="after local transmission in different countries of Europe (France"/>
   <result pre="infections ranges from inapparent infection to severe disease. For example," exact="WNV" post="and JEV can cause particularly severe disease in horses."/>
   <result pre="lines rather than the species of origin, as documented for" exact="ZIKV" post="(Chan et al., 2016). This may be due to"/>
   <result pre="involved in innate immune responses against arboviruses as demonstrated for" exact="DENV" post="(Schmid and Harris, 2014; Schmid et al., 2014). Considering"/>
   <result pre="kindly provided by Prof. Remi Charrel, Aix-Marseille Université, Marseille, France)," exact="WNV" post="NY99 (GenBank DQ211652.1; kindly donated by Prof. Martin Groschup,"/>
   <result pre="provided by Dr. Katja Fink, Singapore Immunology Network, SIgN, Singapore)," exact="ZIKV" post="strain PR-2015 (Asian lineage, PRVABC59; GenBank KX377337; obtained from"/>
   <result pre="pMoDC showed the highest susceptibility to USUV followed by JEV," exact="WNV" post="and SPOV, and the lowest infectivity was found with"/>
   <result pre="SPOV, and the lowest infectivity was found with DENV-3 and" exact="ZIKV" post="(Figure 1A). With hMoDC, highest susceptibilities were found with"/>
   <result pre="and WESSV showed a higher preference for porcine cells, while" exact="ZIKV" post="for hMoDC (Figure 1H). Figure 1 Comparative susceptibility of"/>
   <result pre="titers (Figures 2B,E). For hMoDC we found an increase for" exact="ZIKV" post="and WESSV titers over time (Figures 2D,F). The species"/>
   <result pre="a clear advantage for replication in hMoDC. Surprisingly, SPOV and" exact="ZIKV" post="better replicated in porcine cells (Figure 2H). Figure 2"/>
   <result pre="but significantly induced following challenge with USUV, SPOV followed by" exact="ZIKV" post="and DENV (Figure 3B). In hMoDC, also low levels"/>
   <result pre="induced following challenge with USUV, SPOV followed by ZIKV and" exact="DENV" post="(Figure 3B). In hMoDC, also low levels of dead"/>
   <result pre="of the tested viruses with the exceptions of DENV-3 and" exact="ZIKV" post="(Figure 3C). At 48 hpi in hMoDC, USUV infection"/>
   <result pre="the highest levels of cell death followed by JEV and" exact="WNV" post="(Figure 3E). Interestingly, the correlation between cell death and"/>
   <result pre="only USUV induced IFN-β, at 48 hpi also JEV and" exact="WNV" post="induced significant levels of IFN-β secretion (Figures 4C,D). Interestingly,"/>
   <result pre="WNV induced significant levels of IFN-β secretion (Figures 4C,D). Interestingly," exact="ZIKV" post="and DENV never induced any IFN-β secretion in MoDC"/>
   <result pre="significant levels of IFN-β secretion (Figures 4C,D). Interestingly, ZIKV and" exact="DENV" post="never induced any IFN-β secretion in MoDC (Figures 4A–D)."/>
   <result pre="it is not surprising that many mosquito-borne Flaviviruses, such as" exact="WNV" post="and JEV can infect a wide range of vertebrate"/>
   <result pre="virus across the blood-brain barrier (Lannes et al., 2017). For" exact="WNV" post="we found that despite of low numbers of WNV-infected"/>
   <result pre="would not play an important role as amplifying host for" exact="WNV" post="(Ilkal et al., 1994; Teehee et al., 2005), a"/>
   <result pre="al., 2015). This clearly demonstrated that pigs are susceptible to" exact="WNV" post="and a role of this species in the epidemiology"/>
   <result pre="the epidemiology cannot be excluded. Interestingly, our study showed that" exact="WNV" post="infected and replicated to high titers in hMoDC without"/>
   <result pre="previously published data (Rawle et al., 2015) could indicate that" exact="WNV" post="has undergone a certain degree of adaptation to human"/>
   <result pre="pig. This would be in line with surveillance data for" exact="WNV" post="and USUV. Although antibodies against both viruses were found"/>
   <result pre="results are in line with previous field observations, supporting that" exact="DENV" post="vertebrate hosts are mainly restricted to primates (Chen and"/>
   <result pre="some authors suggested that other vertebrates could be hosts for" exact="DENV" post="in the rainforest, or that pigs could be used"/>
   <result pre="of E protein expressing pMoDC was low, porcine cells supported" exact="ZIKV" post="replication well, in absence of any detectable IFN-β and"/>
   <result pre="viremia between 3 and 5 days after intra-dermal inoculation with" exact="ZIKV" post="(Darbellay et al., 2017a,b). In accordance to previously published"/>
   <result pre="In accordance to previously published work, our data show that" exact="ZIKV" post="replicates in hMoDC in a donor dependent manner and"/>
   <result pre="et al., 2018). Although SPOV is genetically closely related to" exact="ZIKV" post="(Haddow et al., 2016), pMoDC were more susceptible to"/>
   <result pre="pMoDC were more susceptible to the infection by SPOV than" exact="ZIKV" post="and the virus efficiently replicated in swine cells. The"/>
   <result pre="TNF and IFN type I secretion during the infection by" exact="DENV" post="or JEV (Sooryanarain et al., 2012; Schmid et al.,"/>
   <result pre="Villordo et al., 2016). For other Flaviviruses, such as JEV," exact="DENV" post="or ZIKV, NS2A, NS4A, NS4B or NS5 proteins were"/>
   <result pre="10.1001/jama.287.18.239111988060 BowenJ. R.QuickeK. M.MaddurM. S.O'NealJ. T.McDonaldC. E.FedorovaN. B.et al.. (2017)." exact="Zika" post="virus antagonizes type I interferon responses during infection of"/>
   <result pre="(2015). Variation in interferon sensitivity and induction between Usutu and" exact="West Nile" post="(lineages 1 and 2) viruses. Virology485, 189–198. 10.1016/j.virol.2015.07.01526280469 CaoS.LiY.YeJ.YangX.ChenL.LiuX.et"/>
   <result pre="K.et al.. (2016). Differential cell line susceptibility to the emerging" exact="Zika" post="virus: implications for disease pathogenesis, non-vector-borne human transmission and"/>
   <result pre="quo vadis?Viruses3, 1562–1608. 10.3390/v309156221994796 ChuJ. J.NgM. L. (2004). Interaction of" exact="West Nile" post="virus with alpha v beta 3 integrin mediates virus"/>
   <result pre="virus. Onderstepoort J. Vet. Res.49, 19–22. 6289220 DarbellayJ.CoxB.LaiK.Delgado-OrtegaM.WhelerC.WilsonD.et al. (2017a)." exact="Zika" post="virus causes persistent infection in porcine conceptuses and may"/>
   <result pre="10.1016/j.ebiom.2017.09.02129097124 DarbellayJ.LaiK.BabiukS.BerhaneY.AmbagalaA.WhelerC.et al.. (2017b). Neonatal pigs are susceptible to experimental" exact="Zika" post="virus infection. Emerg. Microbes Infect.6:e6. 10.1038/emi.2016.13328196970 de ThoisyB.DussartP.KazanjiM. (2004)."/>
   <result pre="in 2013. One Health3, 23–28. 10.1016/j.onehlt.2017.02.00128616499 Escribano-RomeroE.LupulovicD.Merino-RamosT.BlazquezA. B.LazicG.LazicS.et al.. (2015)." exact="West Nile" post="virus serosurveillance in pigs, wild boars, and roe deer"/>
   <result pre="Viruses9:E124. 10.3390/v905012428531165 GibbsS. E.MarleneeN. L.RominesJ.KavanaughD.CornJ. L.StallknechtD. E. (2006). Antibodies to" exact="West Nile" post="virus in feral swine from Florida, Georgia, and Texas,"/>
   <result pre="PLoS Negl. Trop. Dis.10:e0005083. 10.1371/journal.pntd.000508327783682 HamelR.DejarnacO.WichitS.EkchariyawatP.NeyretA.LuplertlopN.et al.. (2015). Biology of" exact="Zika" post="virus infection in human skin cells. J. Virol.89, 8880–8896."/>
   <result pre="(1994). Experimental studies on the susceptibility of domestic pigs to" exact="West Nile" post="virus followed by Japanese encephalitis virus infection and vice"/>
   <result pre="encephalitis virus. Cell. Microbiol.13, 1358–1370. 10.1111/j.1462-5822.2011.01624.x21707907 ManokaranG.FinolE.WangC.GunaratneJ.BahlJ.OngE. Z.et al.. (2015)." exact="Dengue" post="subgenomic RNA binds TRIM25 to inhibit interferon expression for"/>
   <result pre="pathogen attack. Vet. Immunol. Immunopathol.128, 7–15. 10.1016/j.vetimm.2008.10.29019036457 MichelF.FischerD.EidenM.FastC.ReuschelM.MullerK.et al.. (2018)." exact="West Nile" post="virus and usutu virus monitoring of wild birds in"/>
   <result pre="J.SetohY. X.EdmondsJ. H.KhromykhA. A. (2015). Comparison of attenuated and virulent" exact="West Nile" post="virus strains in human monocyte-derived dendritic cells as a"/>
   <result pre="LSECtin. Arch. Virol.159, 2023–2031. 10.1007/s00705-014-2042-224623090 SilveiraG. F.MeyerF.DelfraroA.MosimannA. L.ColuchiN.VasquezC.et al.. (2011)." exact="Dengue" post="virus type 3 isolated from a fatal case with"/>
   <result pre="TeeheeM. L.BunningM. L.StevensS.BowenR. A. (2005). Experimental infection of pigs with" exact="West Nile" post="virus. Arch. Virol.150, 1249–1256. 10.1007/s00705-004-0478-515770358 ThongtanT.WikanN.WintachaiP.RattanarungsanC.SrisomsapC.CheepsunthornP.et al.. (2012). Characterization"/>
   <result pre="of human dendritic cells by African and Asian strains of" exact="Zika" post="virus. Sci. Rep.8:5440. 10.1038/s41598-018-23734-329615676 VillordoS. M.CarballedaJ. M.FilomatoriC. V.GamarnikA. V."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6366427\results\search\tropicalVirus\results.xml">
   <result pre="than 34 countries in sub-Saharan Africa and Middle East [10–14]." exact="YFV" post="originated in Africa and spread with the slave trade"/>
   <result pre="in haemorrhage, high fever, encephalitis, meningitis, or even death [20]." exact="Chikungunya" post="fever is viral infection often characterized by acute febrile"/>
   <result pre="is divided into acute and chronic phases. In 2016, several" exact="CHIKV" post="outbreaks have been reported from different locations in Sudan,"/>
   <result pre="2003 in US suspected cases of haemorrhagic illness were reported," exact="YFV" post="was identified as the causative agent of the outbreak"/>
   <result pre="nearly 15% had jaundice. Since few years back dengue and" exact="YFV" post="outbreaks occur in eastern region in Africa especially in"/>
   <result pre="the patients’ serum samples were screened for DFV [35] and" exact="YFV" post="using rapid strip tests, IgM antibodies against DENV and"/>
   <result pre="[35] and YFV using rapid strip tests, IgM antibodies against" exact="DENV" post="and YFV were negative in all suspected cases. 2.2."/>
   <result pre="YFV using rapid strip tests, IgM antibodies against DENV and" exact="YFV" post="were negative in all suspected cases. 2.2. Elution and"/>
   <result pre="(Tm = 65.6–70.9) and reverse primer, 5′-TTGCACCAACAGTCAATGTCTTCAGGTTC-3′ (Tm = 59.9–67.2);" exact="CHIKV" post="(CHIK PnsP1): forward primer, 5´- TAGAGCAGGAAATTGACCCC-3′ (Tm = 59.9–67.2)"/>
   <result pre="3 s and an annealing at 60°C for RVFV and" exact="CHIKV" post="and at 65°C for hantavirus. Negative and positive controls"/>
   <result pre="arboviruses (adults and children) using real-time PCR P &amp;lt; 0.009**." exact="CHIKV" post="was the dominant virus (39.5 %) causing unknown fever,"/>
   <result pre="accurate diagnostic methods for these viral diseases are urgently required." exact="CHIKV" post="infection had occurred in Africa in antiquity, there have"/>
   <result pre="several recorded outbreaks in several African countries including Sudan [9,22]." exact="CHIKV" post="infection was the most dominant infection in the present"/>
   <result pre="difference between the number of adults and children infected with" exact="CHIKV" post="(P value = 0.009, P ˂ 0.05) (Figure 1);"/>
   <result pre="however, the positivity rate was low 17.8% in comparison of" exact="CHIKV" post="in this study. The endemic areas of SINV reflect"/>
   <result pre="high (61.3%, P ˂ 0.05). In conclusion, we observed that" exact="CHIKV" post="was the predominant virus causing unknown fever outbreak in"/>
   <result pre="indicates vulnerability of Eastern and Central Sudan to infection with" exact="Chikungunya" post="virus. Vector Borne Zoonotic Dis. 2016;16(4):290–291.26974266 [22]GouldLH, OsmanMS, FarnonEC,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6369168\results\search\tropicalVirus\results.xml">
   <result pre="as a Model for Human NiV The recent Ebola and" exact="Zika" post="epidemics highlighted how poorly prepared we were to deal"/>
   <result pre="ring vaccination cluster-randomised trial. Lancet (2015) 386:857–66. 10.1016/S0140-6736(15)61117-526248676 49.PardiNHoganMJPelcRSMuramatsuHAndersenHDeMasoCRet al.." exact="Zika" post="virus protection by a single low-dose nucleoside-modified mRNA vaccination."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6369503\results\search\tropicalVirus\results.xml">
   <result pre="clearance of a mosquito densovirus contaminant from laboratory stocks of" exact="Zika" post="virus CataneoAllan Henrique Depieri1KuczeraDiogo1MosimannAna Luiza Pamplona1SilvaEmanuele Guimarães2Ferreira�?lvaro Gil Araújo2MarquesJoão"/>
   <result pre="terms of the Creative Commons Attribution License Abstract BACKGROUND The" exact="Zika" post="virus (ZIKV) epidemics that affected South America in 2016"/>
   <result pre="The transient and low viraemia observed in the course of" exact="ZIKV" post="infection is a challenge for viral isolation from patient"/>
   <result pre="OBJECTIVES Here, we report the contamination of two widely used" exact="ZIKV" post="strains by Brevidensovirus, here designated as mosquito densovirus (MDV)."/>
   <result pre="immunological techniques were used to analyse the MDV contamination of" exact="ZIKV" post="stocks. Also, virus passages in mammalian cell line and"/>
   <result pre="and infecting susceptible mice were used to MDV clearance from" exact="ZIKV" post="stocks. FINDINGS MDV contamination was confirmed by molecular and"/>
   <result pre="We applied two protocols that successfully eliminated MDV contamination from" exact="ZIKV" post="stocks, and these protocols can be widely applied in"/>
   <result pre="mammalian cell line and infecting susceptible mice prior to re-isolating" exact="ZIKV" post="from the animals’ blood serum. MDV elimination was confirmed"/>
   <result pre="MAIN CONCLUSIONS Since the putative impact of viral contaminants in" exact="ZIKV" post="strains generally used for research purposes is unknown, researchers"/>
   <result pre="Key words: arbovirus isolation contamination C6/36 cultures densovirus vertebrate cells" exact="Zika" post="virus fig-count: table-count: equation-count: ref-count: In the past few"/>
   <result pre="fig-count: table-count: equation-count: ref-count: In the past few years, human" exact="Zika" post="virus (ZIKV) infection has caused an increase in public"/>
   <result pre="scientific research aimed at understanding the mechanisms by which the" exact="ZIKV" post="interacts with its host to cause new clinical presentations."/>
   <result pre="its host to cause new clinical presentations. Between 1947, when" exact="ZIKV" post="was first reported in a Uganda forest, and 2015,3"/>
   <result pre="regarding ZIKV. However, recent outbreaks and clinical manifestations associated with" exact="ZIKV" post="infection resulted in more than 4,500 Zika-related published medical/scientific"/>
   <result pre="2016/2018 period. This increase in research was beneficial to the" exact="ZIKV" post="field and added to our understanding of this new,"/>
   <result pre="different Brevidensovirus, here designated as mosquito densovirus (MDV), contaminating two" exact="ZIKV" post="strains; one strain is of African origin, and the"/>
   <result pre="also provide two simple strategies to remove MDV contamination from" exact="ZIKV" post="strains using vertebrate cells as a bottleneck for MDV"/>
   <result pre="replication. MATERIALS AND METHODS Virus stocks production - Two different" exact="ZIKV" post="strains were recently sent to our laboratory. The ZIKV"/>
   <result pre="different ZIKV strains were recently sent to our laboratory. The" exact="ZIKV" post="strain of Asian origin was named strain A, and"/>
   <result pre="information on viral passage history we identified both samples of" exact="ZIKV" post="strains A and strain B as zero (P.0). Both"/>
   <result pre="multiplicity of infection (MOI) of 0.01 for viral stock production." exact="ZIKV" post="titration using foci forming assay - ZIKV virus titers"/>
   <result pre="viral stock production. ZIKV titration using foci forming assay -" exact="ZIKV" post="virus titers were determined by the foci forming immunodetection"/>
   <result pre="viral nucleic acids from C6/36 cell supernatants infected with each" exact="ZIKV" post="strain were isolated using the RNeasy Mini kit (QIAGEN)."/>
   <result pre="cells was extracted using TRIzol reagent (Invitrogen). Blood samples from" exact="ZIKV" post="infected mice were collected one to four days post"/>
   <result pre="the presence of densovirus in the mosquitoes that fed on" exact="ZIKV" post="infected mice, the total nucleic acids from individual mosquitoes"/>
   <result pre="could be used to detect MDV contamination (data not shown)." exact="Zika" post="virus detection by RT-PCR - ZIKV genomic RNA was"/>
   <result pre="contamination (data not shown). Zika virus detection by RT-PCR -" exact="ZIKV" post="genomic RNA was detected by RT-PCR (364 bp) using"/>
   <result pre="(5’-GCTGGDGCRGACACHGGRACT-3’) and ZIKVENVR (5’-RTCYACYGCCATYTGGRCTG-3’) as previously described.15,16 RNA from the" exact="ZIKV" post="strain ZV BR2015/15261 isolate (South Brazil, 2016) was used"/>
   <result pre="isolate (South Brazil, 2016) was used as a control for" exact="ZIKV" post="E gene amplification. Immunofluorescence assay for ZIKV and MDV"/>
   <result pre="a control for ZIKV E gene amplification. Immunofluorescence assay for" exact="ZIKV" post="and MDV detection - C6/36 cells (2x104 cells/well) were"/>
   <result pre="a 96-well plate and infected (in triplicate) with P.0 of" exact="ZIKV" post="strain A and strain B at an MOI of"/>
   <result pre="of 1. The MOI was based on the titration of" exact="ZIKV" post="strain A and strain B in C6/36 using a"/>
   <result pre="antibody that recognises the E protein (4G2; ATCC® HB-112™; see" exact="ZIKV" post="titration using foci forming assay). After 72 h, the"/>
   <result pre="under accession numbers, MH720336 and MH720337, respectively. MDV removal from" exact="ZIKV" post="samples - As MDV does not infect vertebrate cells,"/>
   <result pre="does not infect vertebrate cells, we performed serial passages of" exact="ZIKV" post="strain A P.0 and strain B P.0 in A549"/>
   <result pre="in 24 well plates) were infected with 100 µL of" exact="ZIKV" post="strain A P.0 or strain B P.0 for 90"/>
   <result pre="three passages in A549 cells, the cell culture supernatant of" exact="ZIKV" post="strain A P.3/A549 and strain B P.3/A549 was passaged"/>
   <result pre="from cell supernatants, and RT-PCR and PCR were performed for" exact="ZIKV" post="and MDV, respectively. Additionally, ZIKV strain A was used"/>
   <result pre="and PCR were performed for ZIKV and MDV, respectively. Additionally," exact="ZIKV" post="strain A was used to infect A129 mice using"/>
   <result pre="dpi Ae. aegypti females (5-7-day-old) were allowed to feed on" exact="ZIKV" post="infected animals. MDV RT-PCR was performed on mosquitoes at"/>
   <result pre="were used to test for the presence of MDV. Additionally," exact="ZIKV" post="was titrated in mice sera (using foci forming assay"/>
   <result pre="C6/36 cells) three days after infection in order to quantify" exact="ZIKV" post="recovery. Fig. 1: mosquito densovirus (MDV) coinfection in Zika"/>
   <result pre="quantify ZIKV recovery. Fig. 1: mosquito densovirus (MDV) coinfection in" exact="Zika" post="virus (ZIKV) strains A P.0 and B P.0. (A)"/>
   <result pre="P.0 and B P.0. (A) Cytopathic effects in C6/36 MDV-contaminated" exact="ZIKV" post="strain A and strain B cells compared to mock-infected"/>
   <result pre="transcription-PCR (RT-PCR) amplification of a 364 bp fragment of the" exact="ZIKV" post="E gene in strain A and strain B (P.0)."/>
   <result pre="strain A and strain B (P.0). (C) Immunofluorescence assay of" exact="ZIKV" post="strain A and strain B (P.0) infected C6/36 cells"/>
   <result pre="MDV BR/07 at an MOG of 1 for 72 h." exact="ZIKV" post="infection to confirm MDV elimination - C6/36 cells were"/>
   <result pre="infected with a low [0.01] to high [10] MOI of" exact="ZIKV" post="strain A P.3/C6/36 and ZIKV strain B P.3/C6/36. After"/>
   <result pre="to high [10] MOI of ZIKV strain A P.3/C6/36 and" exact="ZIKV" post="strain B P.3/C6/36. After 72 h, the supernatants and"/>
   <result pre="the ethics committee at UFMG (CEUA 337/2016). RESULTS Two different" exact="ZIKV" post="strains (referred to as strain A and strain B)"/>
   <result pre="PCR, we amplified a segment of the MDV genome in" exact="ZIKV" post="strains A and B to confirm coinfection with MDV"/>
   <result pre="also performed. The immunofluorescence assay confirmed the presence of the" exact="ZIKV" post="E-antigen in the cytoplasm and coinfection of both ZIKV"/>
   <result pre="the ZIKV E-antigen in the cytoplasm and coinfection of both" exact="ZIKV" post="strains A and B with MDV (Fig. 1C). Furthermore,"/>
   <result pre="B P.0 suggests that different MDV strains were coinfecting the" exact="ZIKV" post="strains. To address this, we determined the nucleotide sequence"/>
   <result pre="sequence (from PCR product) of the MDV present in both" exact="ZIKV" post="strains. Despite the short viral genomic region analysed (265"/>
   <result pre="nucleotide identity was 95.4% between the MDVs present in each" exact="ZIKV" post="strain, which confirmed different viral strains. This could be"/>
   <result pre="explained by 1) the different passage history of the two" exact="ZIKV" post="strains; 2) divergent evolution of both MDV strains due"/>
   <result pre="these hypotheses once we do not have information on the" exact="ZIKV" post="strain A and B passage history before samples were"/>
   <result pre="be detrimental to mosquitoes.21,22 Once we confirmed contamination of each" exact="ZIKV" post="strain with MDV, we focused on strategies to eliminate"/>
   <result pre="MDV, we focused on strategies to eliminate it from the" exact="ZIKV" post="samples to prevent interference with future experiments. It was"/>
   <result pre="infect vertebrate cells,6 so we performed serial passages of the" exact="ZIKV" post="strains A and B using a ZIKV-susceptible A549 lung"/>
   <result pre="ZIKV-susceptible A549 lung epithelial cell line.23 After three passages of" exact="ZIKV" post="strains A and B in A549 cells, the MDV"/>
   <result pre="in cell culture supernatants using PCR, while detection of a" exact="ZIKV" post="envelope gene was successful (Fig. 2A). Additionally, PCR for"/>
   <result pre="successful (Fig. 2A). Additionally, PCR for MDV and RT-PCR for" exact="ZIKV" post="were performed after each passage (P1, P2 and P3)"/>
   <result pre="not shown). Additionally, to confirm the exclusion of MDV from" exact="ZIKV" post="strains, we performed three additional passages of ZIKV strain"/>
   <result pre="MDV from ZIKV strains, we performed three additional passages of" exact="ZIKV" post="strain A P.3/A549 and strain B P.3/A549 using the"/>
   <result pre="was extracted from the supernatants, and RT-PCR and PCR for" exact="ZIKV" post="and MDV, respectively, were performed (Fig. 2B). These results"/>
   <result pre="(Fig. 2B). These results demonstrated that successive passages of MDV-contaminated" exact="ZIKV" post="strains in A549 cells are effective for removing MDV"/>
   <result pre="in A549 cells are effective for removing MDV contamination from" exact="ZIKV" post="samples (Fig. 2). An immunofluorescence assay was also used"/>
   <result pre="to confirm MDV exclusion from each ZIKV-strain (Fig. 2C). Additionally," exact="ZIKV" post="titration after each passage in cell culture showed a"/>
   <result pre="ZIKV titration after each passage in cell culture showed a" exact="ZIKV" post="recovery rate between 104 to 107 FFU/mL (data not"/>
   <result pre="removal of MDV (Figs 1A and 2D). As infection with" exact="ZIKV" post="induces cytopathic effects on C6/36 even after the elimination"/>
   <result pre="2D). To further confirm the elimination of MDV from each" exact="ZIKV" post="strain, C6/36 cells were infected with a different MOI"/>
   <result pre="strain, C6/36 cells were infected with a different MOI of" exact="ZIKV" post="strain A P.3/C6/36 and ZIKV strain B P.3/C6/36. After"/>
   <result pre="with a different MOI of ZIKV strain A P.3/C6/36 and" exact="ZIKV" post="strain B P.3/C6/36. After 72 h, the supernatants and"/>
   <result pre="high MOI [10], MDV was no longer detected in these" exact="ZIKV" post="stocks. These results confirmed the efficiency of this protocol"/>
   <result pre="of this protocol in the removal of MDV contamination from" exact="ZIKV" post="strains (Fig. 2E). TABLE Nucleotide identity matrix comparing the"/>
   <result pre="identity matrix comparing the two mosquito densovirus (MDV) presented on" exact="Zika" post="virus (ZIKV)-isolates GU452720 ZIKV strain A FJ805445 ZIKV strain"/>
   <result pre="two mosquito densovirus (MDV) presented on Zika virus (ZIKV)-isolates GU452720" exact="ZIKV" post="strain A FJ805445 ZIKV strain B GU452720 100% 98.4%"/>
   <result pre="presented on Zika virus (ZIKV)-isolates GU452720 ZIKV strain A FJ805445" exact="ZIKV" post="strain B GU452720 100% 98.4% 97.3% 96.2% ZIKV strain"/>
   <result pre="A FJ805445 ZIKV strain B GU452720 100% 98.4% 97.3% 96.2%" exact="ZIKV" post="strain A 98.4% 100% 96.6% 95.4% FJ805445 97.3% 96.6%"/>
   <result pre="A 98.4% 100% 96.6% 95.4% FJ805445 97.3% 96.6% 100% 98.8%" exact="ZIKV" post="strain B 96.2% 95.4% 98.8% 100% GU452720: mosquito densovirus"/>
   <result pre="densovirus 0507JS11. Fig. 2: mosquito densovirus (MDV) clearance from the" exact="Zika" post="virus (ZIKV) strains A and B (P.0). Agarose gels"/>
   <result pre="MDV and reverse transcription-PCR (RT-PCR) amplification of a 364 bp" exact="ZIKV" post="E gene fragment in ZIKV strain A and strain"/>
   <result pre="amplification of a 364 bp ZIKV E gene fragment in" exact="ZIKV" post="strain A and strain B after three passages in"/>
   <result pre="(P.3/C6/36) (B). (C) Immunofluorescence assay in C6/36 cells infected with" exact="ZIKV" post="strain A and strain B (P.3/C6/36) after three passages"/>
   <result pre="(clone 94DL1). (D) Cytopathic effects on C6/36 cells infected with" exact="ZIKV" post="strain A and strain B after three passages in"/>
   <result pre="multiplicity of infections (MOIs) (0.01, 0.1, 1 and 10) of" exact="ZIKV" post="strain A and strain B after three passages in"/>
   <result pre="the blood of A129 mice infected with 4x106 PFU of" exact="Zika" post="virus (ZIKV) strain A at different days post infection"/>
   <result pre="aegypti mosquitoes that fed on infected animals. As a control," exact="ZIKV" post="strain A stocks and C6/36 cells (pellets and culture"/>
   <result pre="biological replica. (D) Immunofluorescence assay of C6/36 cells infected with" exact="ZIKV" post="strain A recovered from mice sera three days post-infection."/>
   <result pre="h. As an alternative protocol, we also hypothesised that passing" exact="ZIKV" post="isolates in susceptible mice would eliminate MDV. To test"/>
   <result pre="receptor KO (A129) mice were infected with contaminated stocks of" exact="ZIKV" post="strain A (Fig. 3A). Blood was collected from one"/>
   <result pre="MDV was tested in mice and mosquitoes, and we confirmed" exact="ZIKV" post="RNA using RT-PCR (data not shown). Additionally, ZIKV was"/>
   <result pre="we confirmed ZIKV RNA using RT-PCR (data not shown). Additionally," exact="ZIKV" post="was recovered from mice sera at higher titers three"/>
   <result pre="confirmed the elimination of MDV contamination and the recovery of" exact="ZIKV" post="strain A (Fig. 3D). DISCUSSION The exchange of biological"/>
   <result pre="contaminated cell cultures used for virus propagation prior to both" exact="ZIKV" post="strains being exhaustively shared between laboratories. Although MDV infection"/>
   <result pre="the biological control of arboviral infections.11,13 Given the similarities between" exact="DENV" post="and ZIKV, it is plausible that MDV and ZIKV"/>
   <result pre="between DENV and ZIKV, it is plausible that MDV and" exact="ZIKV" post="coinfection may affect in vitro and in vivo ZIKV"/>
   <result pre="and ZIKV coinfection may affect in vitro and in vivo" exact="ZIKV" post="infections. Conversely, studies using the C6/36 cell line and"/>
   <result pre="open question. Regarding the protocol used for MDV clearance from" exact="ZIKV" post="stocks, additional care should be considered. First, it has"/>
   <result pre="cell culture or mice, which could introduce genetic mutations in" exact="ZIKV" post="genome. It has been shown that a single passage"/>
   <result pre="single passage in cells could influence the genetic diversity of" exact="Chikungunya" post="virus.29 Furthermore, successive passages of ZIKV in vertebrate (Vero"/>
   <result pre="the genetic diversity of Chikungunya virus.29 Furthermore, successive passages of" exact="ZIKV" post="in vertebrate (Vero cells) or invertebrate (C6/36 cells) cells"/>
   <result pre="identified associated with plaque size that might have influence on" exact="ZIKV" post="biology.30 Since coinfections are not limited to ZIKV strains,"/>
   <result pre="influence on ZIKV biology.30 Since coinfections are not limited to" exact="ZIKV" post="strains, researchers who work in the arbovirology field should"/>
   <result pre="community of the potential presence of mosquito virus contaminants in" exact="ZIKV" post="strains/stocks. We also suggest two simple strategies to efficiently"/>
   <result pre="suggest two simple strategies to efficiently eliminate MDV contamination from" exact="ZIKV" post="strains/stocks, in vitro and in vivo passages in vertebrate"/>
   <result pre="models, respectively. Finally, the potential interference of MDV contamination in" exact="ZIKV" post="isolates needs further analysis. ACKNOWLEDGEMENTS To the Program for"/>
   <result pre="pathology and therapeutic usesBasel: Karger20001232 15FayeOFayeODupressoirAWeidmannMNdiayeMSallAAOne-step RT-PCR for detection of" exact="Zika" post="virusJ Clin Virol20084319610118674965 16ZanlucaCde MeloVCAMosimannALPdos SantosGIVdos SantosCNDLuzKFirst report of"/>
   <result pre="Virol20084319610118674965 16ZanlucaCde MeloVCAMosimannALPdos SantosGIVdos SantosCNDLuzKFirst report of autochthonous transmission of" exact="Zika" post="virus in BrazilMem Inst Oswaldo Cruz2015110456957226061233 17ThompsonJDHigginsDGGibsonTJCLUSTAL W: improving"/>
   <result pre="mosquitoesAdv Virus Res20066836139216997017 23FrumenceERocheMKrejbich-TrototPEl-KalamouniCNativelBRondeauPet al.The South Pacific epidemic strain of" exact="Zika" post="virus replicates efficiently in human epithelial A549 cells leading"/>
   <result pre="genomic elementsPLoS Negl Trop Dis2016101 30MoserLABoylanBTMoreiraFRMyersLJSvensonELFedorovaNBet al.Growth and adaptation of" exact="Zika" post="virus in mammalian and mosquito cellsPLoS Negl Trop Dis20181211"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6370234\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Research and Analysis Methods : Research Assessment:"/>
   <result pre="syndrome Does prior dengue virus exposure worsen clinical outcomes of" exact="Zika" post="virus infection? A systematic review, pooled analysis and lessons"/>
   <result pre="learned Does prior dengue virus exposure worsen clinical outcomes of" exact="Zika" post="virus infection? MaselJenniferData curationInvestigationMethodologyProject administrationWriting – original draft1McCrackenMichael K.Data"/>
   <result pre="available under the Creative Commons CC0 public domain dedication.pntd.0007060.pdf Abstract" exact="Zika" post="virus (ZIKV) recently caused a pandemic complicated by Guillain-Barre"/>
   <result pre="a pandemic complicated by Guillain-Barre syndrome (GBS) and birth defects." exact="ZIKV" post="is structurally similar to the dengue viruses (DENV) and"/>
   <result pre="and in vitro studies suggest antibody dependent enhancement occurs in" exact="ZIKV" post="infections preceded by DENV; however, the clinical significance of"/>
   <result pre="to DENV-naïve hosts, is associated with a greater risk of" exact="ZIKV" post="clinical complications or greater ZIKV peak viremia in vivo."/>
   <result pre="with a greater risk of ZIKV clinical complications or greater" exact="ZIKV" post="peak viremia in vivo. We identified 1146 studies in"/>
   <result pre="study indicated no increase in the risk of GBS in" exact="ZIKV" post="infections with prior DENV exposure. Two additional human studies"/>
   <result pre="in the risk of GBS in ZIKV infections with prior" exact="DENV" post="exposure. Two additional human studies showed a small increase"/>
   <result pre="exposure. Two additional human studies showed a small increase in" exact="ZIKV" post="viremia in those with prior DENV exposure; however, this"/>
   <result pre="a small increase in ZIKV viremia in those with prior" exact="DENV" post="exposure; however, this was not statistically significant nor was"/>
   <result pre="only weak evidence of a 0.39 log10 GE/mL rise in" exact="ZIKV" post="viremia in DENV experienced rhesus macaques compared to those"/>
   <result pre="of a 0.39 log10 GE/mL rise in ZIKV viremia in" exact="DENV" post="experienced rhesus macaques compared to those with no DENV"/>
   <result pre="in DENV experienced rhesus macaques compared to those with no" exact="DENV" post="exposure (p = 0.22). Using a customized quality grading"/>
   <result pre="human studies have offered high quality measurement of both acute" exact="ZIKV" post="and antecedent DENV infections. In conclusion, limited human and"/>
   <result pre="offered high quality measurement of both acute ZIKV and antecedent" exact="DENV" post="infections. In conclusion, limited human and NHP studies indicate"/>
   <result pre="NHP studies indicate a small and non-statistically significant increase in" exact="ZIKV" post="viremia in DENV-experienced versus DENV-naïve hosts; however, there is"/>
   <result pre="is no evidence that even a possible small increase in" exact="ZIKV" post="viremia would correlate with a change in ZIKV clinical"/>
   <result pre="increase in ZIKV viremia would correlate with a change in" exact="ZIKV" post="clinical phenotype. More data derived from larger sample sizes"/>
   <result pre="major relevance for clinical prognosis and vaccine design. Author summary" exact="Zika" post="virus (ZIKV) is a mosquito borne virus that recently"/>
   <result pre="high-order animal literature to synthesize the current evidence about whether" exact="ZIKV" post="outcomes are worse in those with previous DENV exposure."/>
   <result pre="about whether ZIKV outcomes are worse in those with previous" exact="DENV" post="exposure. We further undertook a pooled analysis across the"/>
   <result pre="We summarize that, in humans and in non-human primates, prior" exact="DENV" post="exposure may lead to a small increase in ZIKV"/>
   <result pre="prior DENV exposure may lead to a small increase in" exact="ZIKV" post="viral load during infection. However, we do not show"/>
   <result pre="However, we do not show that any possible increase in" exact="ZIKV" post="viral replication is associated with a higher rate of"/>
   <result pre="ZIKV viral replication is associated with a higher rate of" exact="Zika" post="complications or Zika clinical severity. We further graded the"/>
   <result pre="is associated with a higher rate of Zika complications or" exact="Zika" post="clinical severity. We further graded the quality of these"/>
   <result pre="and indicate that substantial improvements in the immunological measurement of" exact="ZIKV" post="and DENV exposure in humans are needed to answer"/>
   <result pre="that substantial improvements in the immunological measurement of ZIKV and" exact="DENV" post="exposure in humans are needed to answer these and"/>
   <result pre="are within the manuscript and its Supporting Information files. Introduction" exact="Zika" post="virus is a flavivirus primarily transmitted by Aedes aegypti"/>
   <result pre="by Guillain-Barre syndrome (GBS), microcephaly and other birth defects [1]." exact="ZIKV" post="was first discovered in Uganda in 1947 and was"/>
   <result pre="asymptomatic infection [4, 5]. In 2015 and 2016 an explosive" exact="ZIKV" post="outbreak spread through South America, Central America, and the"/>
   <result pre="retrospect during the French Polynesia outbreak, it became evident that" exact="ZIKV" post="was associated with GBS and congenital Zika syndrome (CZS)"/>
   <result pre="became evident that ZIKV was associated with GBS and congenital" exact="Zika" post="syndrome (CZS) [5, 7]. Congenital infections were associated with"/>
   <result pre="reports as early as 2011, it was also observed that" exact="ZIKV" post="infection could be transmitted sexually during the neotropical epidemic"/>
   <result pre="be transmitted sexually during the neotropical epidemic [9–12]. Although the" exact="ZIKV" post="pandemic has now waned in the Americas [13], there"/>
   <result pre="regions, some of which have already evidently experienced long term" exact="ZIKV" post="circulation as well as substantial recent outbreaks, in addition"/>
   <result pre="cohorts [14–16]. An especially striking feature of the most recent" exact="ZIKV" post="outbreak is the breadth of phenotypes, ranging from asymptomatic"/>
   <result pre="severe complications such as GBS and CZS [17]. Investigators studying" exact="ZIKV" post="noted that the virus shares its vector and geographic"/>
   <result pre="For example, geographic regions of Northern Brazil that experienced substantial" exact="ZIKV" post="case burdens are also known to have a DENV"/>
   <result pre="substantial ZIKV case burdens are also known to have a" exact="DENV" post="seroprevalence exceeding 90% in adults [19]. Sequential DENV infections"/>
   <result pre="have a DENV seroprevalence exceeding 90% in adults [19]. Sequential" exact="DENV" post="infections with different serotypes are associated with more severe"/>
   <result pre="serotypes are associated with more severe disease than infections in" exact="DENV" post="immune patients. This is believed by many investigators to"/>
   <result pre="thereby facilitating viral entry and leading to increased viremia [20]." exact="ZIKV" post="and DENV have substantial proteomic homology, and the humoral"/>
   <result pre="viral entry and leading to increased viremia [20]. ZIKV and" exact="DENV" post="have substantial proteomic homology, and the humoral immunological interactions"/>
   <result pre="ZIKV, in particular the cross reactivity of antibodies generated by" exact="DENV" post="exposure [21, 22]. Early in the ZIKV Americas epidemic,"/>
   <result pre="antibodies generated by DENV exposure [21, 22]. Early in the" exact="ZIKV" post="Americas epidemic, several in vitro and murine studies suggested"/>
   <result pre="epidemic, several in vitro and murine studies suggested that prior" exact="DENV" post="infection may not only fail to cross-neutralize ZIKV but"/>
   <result pre="that prior DENV infection may not only fail to cross-neutralize" exact="ZIKV" post="but also may lead to ZIKV ADE, greater ZIKV"/>
   <result pre="only fail to cross-neutralize ZIKV but also may lead to" exact="ZIKV" post="ADE, greater ZIKV viremia and, therefore, perhaps increased clinical"/>
   <result pre="cross-neutralize ZIKV but also may lead to ZIKV ADE, greater" exact="ZIKV" post="viremia and, therefore, perhaps increased clinical morbidity upon subsequent"/>
   <result pre="ZIKV viremia and, therefore, perhaps increased clinical morbidity upon subsequent" exact="ZIKV" post="exposure. Priyamvada et al showed that both DENV-exposed sera"/>
   <result pre="monoclonal antibodies from DENV-infected individuals in Thailand enhanced in vitro" exact="ZIKV" post="infection in the U937 cell lines [23]. Dejnirattisai et"/>
   <result pre="the U937 cell lines [23]. Dejnirattisai et al noted that" exact="DENV" post="experienced human sera collected from Thailand potently cross-reacted, poorly"/>
   <result pre="sera collected from Thailand potently cross-reacted, poorly neutralized and induced" exact="ZIKV" post="ADE in ZIKV PF13 or HD78788 inoculated U937 myeloid"/>
   <result pre="Thailand potently cross-reacted, poorly neutralized and induced ZIKV ADE in" exact="ZIKV" post="PF13 or HD78788 inoculated U937 myeloid cell lines [24]."/>
   <result pre="from DENV-3 exposed humans led to the enhanced replication of" exact="ZIKV" post="PE/243 in FcγRII-expressing K562 cell lines [19]. Bardinha et"/>
   <result pre="Bardinha et al also showed in vitro evidence of DENV-induced" exact="ZIKV" post="ADE using Puerto Rican DENV experienced donor sera in"/>
   <result pre="in vitro evidence of DENV-induced ZIKV ADE using Puerto Rican" exact="DENV" post="experienced donor sera in ZIKV infected K562 cell lines,"/>
   <result pre="ZIKV ADE using Puerto Rican DENV experienced donor sera in" exact="ZIKV" post="infected K562 cell lines, and further showed evidence that"/>
   <result pre="human hosts led to increased morbidity and paralysis in PRVABC59" exact="ZIKV" post="infections compared to those that received control plasma. These"/>
   <result pre="contrast to earlier in vitro data which indicated that cross-reactive" exact="DENV" post="antibodies from human natural infections actually neutralized a range"/>
   <result pre="antibodies from human natural infections actually neutralized a range of" exact="ZIKV" post="strains [26]. Since these early studies, which generated alarm"/>
   <result pre="animal evidence and provided a current consensus on whether prior" exact="DENV" post="infection is indeed a risk factor for worsened ZIKV"/>
   <result pre="prior DENV infection is indeed a risk factor for worsened" exact="ZIKV" post="clinical outcomes such as GBS, CZS or whether prior"/>
   <result pre="ZIKV clinical outcomes such as GBS, CZS or whether prior" exact="DENV" post="exposure changes possible laboratory proxies of severity such as"/>
   <result pre="DENV exposure changes possible laboratory proxies of severity such as" exact="ZIKV" post="viremia or inflammatory cytokine profiles. Resolving this question is"/>
   <result pre="question is critical for both clinical prognosis of those with" exact="ZIKV" post="infection as well as DENV vaccine implementation in areas"/>
   <result pre="clinical prognosis of those with ZIKV infection as well as" exact="DENV" post="vaccine implementation in areas endemic to both ZIKV and"/>
   <result pre="well as DENV vaccine implementation in areas endemic to both" exact="ZIKV" post="and DENV [28]. We therefore undertook a systematic review"/>
   <result pre="DENV vaccine implementation in areas endemic to both ZIKV and" exact="DENV" post="[28]. We therefore undertook a systematic review to determine"/>
   <result pre="infection with DENV, as compared to those with no prior" exact="DENV" post="infection, is associated with a greater risk of ZIKV"/>
   <result pre="prior DENV infection, is associated with a greater risk of" exact="ZIKV" post="complications (including neurological and teratogenic outcomes), greater ZIKV peak"/>
   <result pre="risk of ZIKV complications (including neurological and teratogenic outcomes), greater" exact="ZIKV" post="peak viremia, greater area-under-the-curve (AUC) of viremia or other"/>
   <result pre="area-under-the-curve (AUC) of viremia or other putative laboratory proxies of" exact="ZIKV" post="severity. While a meta-analysis of human data was not"/>
   <result pre="of existing studies, in particular the validity of how acute" exact="ZIKV" post="and prior DENV exposure were measured. Collectively, our findings"/>
   <result pre="in particular the validity of how acute ZIKV and prior" exact="DENV" post="exposure were measured. Collectively, our findings offer a timely"/>
   <result pre="a timely update in the current understanding of how clinical" exact="ZIKV" post="outcomes are changed by prior DENV exposure, emphasize caution"/>
   <result pre="understanding of how clinical ZIKV outcomes are changed by prior" exact="DENV" post="exposure, emphasize caution in how in vitro and small"/>
   <result pre="for improved sero-diagnostic methods in areas experiencing syndemics of DENV," exact="ZIKV" post="and other medically important flaviviruses. Methods We followed PRISMA"/>
   <result pre="primate (NHP) studies in which the outcomes of those with" exact="ZIKV" post="infection preceded by DENV exposure, was compared to the"/>
   <result pre="which the outcomes of those with ZIKV infection preceded by" exact="DENV" post="exposure, was compared to the outcomes of those with"/>
   <result pre="DENV exposure, was compared to the outcomes of those with" exact="ZIKV" post="infection without prior DENV infection. ZIKV infection was defined"/>
   <result pre="to the outcomes of those with ZIKV infection without prior" exact="DENV" post="infection. ZIKV infection was defined as molecular detection in"/>
   <result pre="outcomes of those with ZIKV infection without prior DENV infection." exact="ZIKV" post="infection was defined as molecular detection in blood, urine,"/>
   <result pre="biological human specimen, and/or positive serology consistent with acute infection." exact="DENV" post="exposure was defined as a documented prior clinically or"/>
   <result pre="was defined as a documented prior clinically or laboratory diagnosed" exact="DENV" post="infection, known experimental inoculation with DENV (for example, in"/>
   <result pre="clinically or laboratory diagnosed DENV infection, known experimental inoculation with" exact="DENV" post="(for example, in NHPs), or serology consistent with prior"/>
   <result pre="DENV (for example, in NHPs), or serology consistent with prior" exact="DENV" post="exposure. We included studies which measured any of the"/>
   <result pre="in conjunction with non-neutralizing antibodies or other laboratory evidence of" exact="Zika" post="severity, fetal microcephaly, fetal loss or other malformation, CZS,"/>
   <result pre="evaluating the quality of how prior dengue exposure and current" exact="ZIKV" post="infection was determined (S1 Table). No review investigator graded"/>
   <result pre="the study methods presented in a reproducible way? Was prior" exact="DENV" post="exposure measured in a valid way? Was acute ZIKV"/>
   <result pre="prior DENV exposure measured in a valid way? Was acute" exact="ZIKV" post="exposure measured in a valid way? Were clinical outcomes"/>
   <result pre="of patients with ZIKV-associated GBS during the 2013–2014 French Polynesia" exact="ZIKV" post="outbreak, which coincided with a substantial increase in the"/>
   <result pre="in the incidence of GBS and an apparent co-circulation of" exact="DENV" post="serotypes 1 and 3 in French Polynesia [5]. The"/>
   <result pre="= 70) consisted of age-matched patients with RT-PCR confirmed acute" exact="ZIKV" post="infection with no neurological complications. The investigators measured DENV"/>
   <result pre="acute ZIKV infection with no neurological complications. The investigators measured" exact="DENV" post="and ZIKV exposure using several assays, not all of"/>
   <result pre="infection with no neurological complications. The investigators measured DENV and" exact="ZIKV" post="exposure using several assays, not all of which were"/>
   <result pre="specimen from the GBS and CTR2 group underwent testing for" exact="ZIKV" post="using a RT-PCR assay. A single acute specimen from"/>
   <result pre="specimen from the GBS and CTR1 group was tested for" exact="DENV" post="and ZIKV IgM using an indirect immunofluorescence assay. Single"/>
   <result pre="the GBS and CTR1 group was tested for DENV and" exact="ZIKV" post="IgM using an indirect immunofluorescence assay. Single acute specimens"/>
   <result pre="from the GBS, CTR1 and CTR2 groups were tested for" exact="ZIKV" post="and DENV IgG using a recombinant-antigen based microsphere immunoassay."/>
   <result pre="GBS, CTR1 and CTR2 groups were tested for ZIKV and" exact="DENV" post="IgG using a recombinant-antigen based microsphere immunoassay. In addition,"/>
   <result pre="specimens from the GBS and CTR1 groups were tested for" exact="ZIKV" post="and DENV neutralizing antibodies using a microseroneutralization assay. While"/>
   <result pre="the GBS and CTR1 groups were tested for ZIKV and" exact="DENV" post="neutralizing antibodies using a microseroneutralization assay. While serial ZIKV"/>
   <result pre="and DENV neutralizing antibodies using a microseroneutralization assay. While serial" exact="ZIKV" post="and DENV serology was performed in the GBS group,"/>
   <result pre="neutralizing antibodies using a microseroneutralization assay. While serial ZIKV and" exact="DENV" post="serology was performed in the GBS group, logistic regression"/>
   <result pre="the GBS group, logistic regression analysis to determine whether prior" exact="DENV" post="exposure was more likely in ZIKV+/GBS+ cases compared to"/>
   <result pre="single time-point serological measurement. None of the GBS group were" exact="ZIKV" post="RT-PCR positive (0 of the 41 tested from the"/>
   <result pre="IgM and were also anti-DENV IgM negative. By combining these" exact="ZIKV" post="IgM results with the ZIKV IgG results, the authors"/>
   <result pre="IgM negative. By combining these ZIKV IgM results with the" exact="ZIKV" post="IgG results, the authors determined that 97.6% of the"/>
   <result pre="the microneutralization assay, 100% of the GBS group were deemed" exact="ZIKV" post="exposed. Of this GBS+/ZIKV+ group (n = 42), the"/>
   <result pre="group (n = 42), the majority (40/42 or 95.2%) were" exact="DENV" post="IgG+. No statistically significant difference in DENV IgG+ positivity"/>
   <result pre="or 95.2%) were DENV IgG+. No statistically significant difference in" exact="DENV" post="IgG+ positivity was observed in GBS cases compared with"/>
   <result pre="cases compared with control group 1 which had 87/98 (88.8%)" exact="DENV" post="IgG+ individuals (OR = 2.0; 95% CI = 0.4–19.9;"/>
   <result pre="= 0.62). Similarly, no statistically significant difference was observed in" exact="DENV" post="IgG+ GBS cases when compared with the CTR2 group"/>
   <result pre="with the CTR2 group that was comprised of 58/70 (82.9%)" exact="DENV" post="IgG+ individuals (OR = 6.04; 95% CI = 0.81–269.5;"/>
   <result pre="CI = 0.81–269.5; p = 0.10). Terzian et al described" exact="ZIKV" post="viral load and cytokine responses in patients presenting with"/>
   <result pre="viral load and cytokine responses in patients presenting with acute" exact="ZIKV" post="infection in Sao Paulo, Brazil in early 2016 [41]."/>
   <result pre="in early 2016 [41]. They sampled 45 patients with acute" exact="ZIKV" post="infection at a single time point, with acute ZIKV"/>
   <result pre="acute ZIKV infection at a single time point, with acute" exact="ZIKV" post="infection determined by testing for ZIKV, DENV and CHIKV"/>
   <result pre="point, with acute ZIKV infection determined by testing for ZIKV," exact="DENV" post="and CHIKV by RT-PCR. Prior DENV status was ascertained"/>
   <result pre="acute ZIKV infection determined by testing for ZIKV, DENV and" exact="CHIKV" post="by RT-PCR. Prior DENV status was ascertained by a"/>
   <result pre="by testing for ZIKV, DENV and CHIKV by RT-PCR. Prior" exact="DENV" post="status was ascertained by a commercial DENV IgG ELISA"/>
   <result pre="by RT-PCR. Prior DENV status was ascertained by a commercial" exact="DENV" post="IgG ELISA assay. ZIKV viral load was measured by"/>
   <result pre="status was ascertained by a commercial DENV IgG ELISA assay." exact="ZIKV" post="viral load was measured by quantitative PCR. Cytokine profiles"/>
   <result pre="load was measured by quantitative PCR. Cytokine profiles in acute" exact="ZIKV" post="infections were estimated using a multiplex bead analysis assay"/>
   <result pre="IL-13, and IL-17. Of those 45 patients with molecularly confirmed" exact="ZIKV" post="infection, 35 were DENV IgG positive and 10 were"/>
   <result pre="those 45 patients with molecularly confirmed ZIKV infection, 35 were" exact="DENV" post="IgG positive and 10 were DENV IgG negative, indicating"/>
   <result pre="ZIKV infection, 35 were DENV IgG positive and 10 were" exact="DENV" post="IgG negative, indicating the majority had prior DENV exposure."/>
   <result pre="10 were DENV IgG negative, indicating the majority had prior" exact="DENV" post="exposure. Those acute ZIKV infections which were DENV IgG+"/>
   <result pre="negative, indicating the majority had prior DENV exposure. Those acute" exact="ZIKV" post="infections which were DENV IgG+ did have higher median"/>
   <result pre="had prior DENV exposure. Those acute ZIKV infections which were" exact="DENV" post="IgG+ did have higher median viral load than those"/>
   <result pre="did have higher median viral load than those who were" exact="DENV" post="IgG-, but the difference in median VL (log10 PFU/ml)"/>
   <result pre="IgG-, but the difference in median VL (log10 PFU/ml) between" exact="DENV" post="IgG +/- subjects was small (&quot;least significant difference of"/>
   <result pre="adequately powered to detect a greater than 10-fold difference in" exact="ZIKV" post="viremia between the 2 groups. While there was evidence"/>
   <result pre="While there was evidence that IL-1β activation was correlated with" exact="ZIKV" post="viral load, there was no statistically significant difference in"/>
   <result pre="and IL-9 levels in a comparative analysis of acute PCR-confirmed" exact="DENV" post="infections who were DENV IgG- compared to those who"/>
   <result pre="a comparative analysis of acute PCR-confirmed DENV infections who were" exact="DENV" post="IgG- compared to those who were DENV IgG positive"/>
   <result pre="infections who were DENV IgG- compared to those who were" exact="DENV" post="IgG positive (with a statistical significance corresponding to p-values"/>
   <result pre="data. Halai et al studied 131 pregnant women with acute" exact="ZIKV" post="infection, as part of a prospective cohort of 345"/>
   <result pre="medical care in Rio de Janeiro with new onset rash." exact="ZIKV" post="infection was confirmed by RT-PCR on serum and/or urine."/>
   <result pre="was confirmed by RT-PCR on serum and/or urine. A standardized" exact="ZIKV" post="clinical severity score was developed and applied. The score"/>
   <result pre="rash, duration of illness, duration of fever, and multisystem involvement." exact="DENV" post="status was ascertained by IgG ELISA. ZIKV viremia was"/>
   <result pre="and multisystem involvement. DENV status was ascertained by IgG ELISA." exact="ZIKV" post="viremia was measured by PCR cycle threshold (CT) and"/>
   <result pre="pregnancy, and adverse birth outcomes occurred in 46.4% of those" exact="ZIKV" post="infected participants with available birth outcome data. Prior DENV"/>
   <result pre="those ZIKV infected participants with available birth outcome data. Prior" exact="DENV" post="exposure was measured by a single specimen obtained at"/>
   <result pre="by a single specimen obtained at the time of acute" exact="ZIKV" post="infection using a commercial DENV IgG serological assay. Median"/>
   <result pre="at the time of acute ZIKV infection using a commercial" exact="DENV" post="IgG serological assay. Median ZIKV RNA by PCR CT"/>
   <result pre="ZIKV infection using a commercial DENV IgG serological assay. Median" exact="ZIKV" post="RNA by PCR CT was 31 in DENV IgG+"/>
   <result pre="assay. Median ZIKV RNA by PCR CT was 31 in" exact="DENV" post="IgG+ women and 32 for DENV IgG- (that is,"/>
   <result pre="CT was 31 in DENV IgG+ women and 32 for" exact="DENV" post="IgG- (that is, higher viremia in the DENV IgG+"/>
   <result pre="32 for DENV IgG- (that is, higher viremia in the" exact="DENV" post="IgG+ group); however, this difference was not statistically significant"/>
   <result pre="not statistically significant (p = 0.153). In those positive for" exact="DENV" post="IgG, the median clinical severity score was 7 (moderate"/>
   <result pre="from the median clinical severity score of 7.5 in the" exact="DENV" post="IgG negative group (p = 0.166). Additionally, being positive"/>
   <result pre="IgG negative group (p = 0.166). Additionally, being positive for" exact="DENV" post="IgG+ was not associated with adverse birth outcomes (p"/>
   <result pre="OR 0.78, CI 0.255–2.397) [42]. The two human studies where" exact="ZIKV" post="viral loads were described (Terzian et al and Halai"/>
   <result pre="Two NHP studies met inclusion criteria. McCracken et al described" exact="ZIKV" post="viremia and RNAemia in six rhesus macaques previously experimentally"/>
   <result pre="and RNAemia in six rhesus macaques previously experimentally infected with" exact="DENV" post="in addition to 14 rhesus macaques groups who were"/>
   <result pre="determined by seronegativity to DENV, ZIKV, Japanese encephalitis virus (JEV)," exact="West Nile" post="Virus (WNV) and yellow fever virus (YFV)[30]. In the"/>
   <result pre="(WNV) and yellow fever virus (YFV)[30]. In the DENV-exposed group," exact="DENV" post="exposure occurred &amp;gt;420 days prior to experimental Brazil-ZIKV2015 infection."/>
   <result pre="investigators confirmed DENV-experienced NHP sera obtained day 0 before NHP" exact="ZIKV" post="inoculation recapitulated ADE ZIKV infection profiles in vitro in"/>
   <result pre="sera obtained day 0 before NHP ZIKV inoculation recapitulated ADE" exact="ZIKV" post="infection profiles in vitro in FcγR-bearing U937 and K562"/>
   <result pre="in vitro in FcγR-bearing U937 and K562 cell lines. After" exact="ZIKV" post="inoculation, serial sera and plasma were collected for ten"/>
   <result pre="serial sera and plasma were collected for ten days and" exact="ZIKV" post="viremia/RNAemia was measured by RT-qPCR assay. No statistically significant"/>
   <result pre="assay. No statistically significant differences in magnitude or duration of" exact="ZIKV" post="viremia/RNAemia was observed between the DENV-exposed and DENV-naïve groups"/>
   <result pre="groups [30]. This study also quantitatively measured the presence of" exact="ZIKV" post="in urine, cerebrospinal fluid, vaginal swabs and saliva and"/>
   <result pre="association between flavivirus exposure history and RT-qPCR confirmed presence of" exact="ZIKV" post="in these other compartments. Finally, the investigators noted no"/>
   <result pre="clinical endpoints, histopathology, biochemistry or hematological indices measured in the" exact="DENV" post="naïve and DENV exposed groups, although they acknowledged that"/>
   <result pre="biochemistry or hematological indices measured in the DENV naïve and" exact="DENV" post="exposed groups, although they acknowledged that a NHP model"/>
   <result pre="that a NHP model is a limited proxy for human" exact="ZIKV" post="disease [30]. Pantoja and colleagues compared the ZIKV viral"/>
   <result pre="for human ZIKV disease [30]. Pantoja and colleagues compared the" exact="ZIKV" post="viral kinetics of n = 4 experimentally ZIKV H/PF/2013"/>
   <result pre="compared the ZIKV viral kinetics of n = 4 experimentally" exact="ZIKV" post="H/PF/2013 inoculated rhesus macaques with a history of experimental"/>
   <result pre="This was compared to a group of n = 4" exact="ZIKV" post="rhesus infected macaques with no prior DENV or ZIKV"/>
   <result pre="n = 4 ZIKV rhesus infected macaques with no prior" exact="DENV" post="or ZIKV exposure [43]. Like McCracken et al, they"/>
   <result pre="4 ZIKV rhesus infected macaques with no prior DENV or" exact="ZIKV" post="exposure [43]. Like McCracken et al, they too confirmed"/>
   <result pre="exposure [43]. Like McCracken et al, they too confirmed that" exact="DENV" post="immune sera elicited ADE of a ZIKV strain in-vitro."/>
   <result pre="too confirmed that DENV immune sera elicited ADE of a" exact="ZIKV" post="strain in-vitro. Sera specimens were collected on days 1–10,"/>
   <result pre="specimens were collected on days 1–10, 15, and 30 after" exact="ZIKV" post="inoculation and ZIKV viremia was measured by qRT-PCR. While"/>
   <result pre="on days 1–10, 15, and 30 after ZIKV inoculation and" exact="ZIKV" post="viremia was measured by qRT-PCR. While they observed a"/>
   <result pre="measured by qRT-PCR. While they observed a shorter duration of" exact="ZIKV" post="viremia in DENV-exposed NHP (25 vs 31 viremia days),"/>
   <result pre="DENV-experienced and DENV-naive groups, nor was there correlation between peak" exact="ZIKV" post="titer and day minus-30 (pre-challenge) DENV sero-titers [43]. No"/>
   <result pre="there correlation between peak ZIKV titer and day minus-30 (pre-challenge)" exact="DENV" post="sero-titers [43]. No difference in urine and saliva ZIKV"/>
   <result pre="(pre-challenge) DENV sero-titers [43]. No difference in urine and saliva" exact="ZIKV" post="PCR positivity was noted between the DENV exposed and"/>
   <result pre="urine and saliva ZIKV PCR positivity was noted between the" exact="DENV" post="exposed and DENV naïve groups. While a detailed comparison"/>
   <result pre="ZIKV PCR positivity was noted between the DENV exposed and" exact="DENV" post="naïve groups. While a detailed comparison of cytokine levels"/>
   <result pre="cytokine levels between the two groups did suggest that prior" exact="DENV" post="exposure modulated ZIKV cytokine profiles, this conclusion was subject"/>
   <result pre="the two groups did suggest that prior DENV exposure modulated" exact="ZIKV" post="cytokine profiles, this conclusion was subject to both small"/>
   <result pre="a consideration in comparing biochemistry, hematological and clinical markers of" exact="ZIKV" post="infection between the DENV exposed and DENV naïve cohorts."/>
   <result pre="biochemistry, hematological and clinical markers of ZIKV infection between the" exact="DENV" post="exposed and DENV naïve cohorts. There were only minor"/>
   <result pre="clinical markers of ZIKV infection between the DENV exposed and" exact="DENV" post="naïve cohorts. There were only minor differences in these"/>
   <result pre="statistically significant drop in neutrophil count at day 7 post" exact="ZIKV" post="inoculation in the DENV exposed group, (ii) a statistically"/>
   <result pre="neutrophil count at day 7 post ZIKV inoculation in the" exact="DENV" post="exposed group, (ii) a statistically significant increase in the"/>
   <result pre="increase in the percent monocyte distribution at day 7 post" exact="ZIKV" post="inoculation in the DENV exposed group, and (iii) a"/>
   <result pre="monocyte distribution at day 7 post ZIKV inoculation in the" exact="DENV" post="exposed group, and (iii) a non-statistically significant trend toward"/>
   <result pre="non-statistically significant trend toward higher ALT values one week after" exact="ZIKV" post="inoculation in the DENV naïve group. Non-human primate study"/>
   <result pre="higher ALT values one week after ZIKV inoculation in the" exact="DENV" post="naïve group. Non-human primate study pooled-analysis The NHP study"/>
   <result pre="same way in ZIKV-inoculated rhesus macaques with and without known" exact="DENV" post="exposure. As either study may have been underpowered to"/>
   <result pre="study may have been underpowered to detect small increases in" exact="ZIKV" post="viremia due to prior DENV exposure, we undertook a"/>
   <result pre="to detect small increases in ZIKV viremia due to prior" exact="DENV" post="exposure, we undertook a pooled-analysis to increase the effective"/>
   <result pre="published data points from Pantoja et al (n = 4" exact="DENV" post="naïve NHP, n = 2 DENV-1 exposed NHP and"/>
   <result pre="NHPs in this pooled dataset had a mean and median" exact="ZIKV" post="peak RNAemia of 6.61 and 6.80 log10 genome equivalents/mL"/>
   <result pre="skewness of the data after log transformation. The mean peak" exact="ZIKV" post="RNAemia was higher in the DENV-exposed group (6.86 log10"/>
   <result pre="t-test, p = 0.22 two sided t-test). The median peak" exact="ZIKV" post="RNAemia was also higher in the DENV-exposed group (6.88"/>
   <result pre="The caveats to interpreting this pooled result include differences in" exact="ZIKV" post="strains used, reproducibility of RNAemia/viremia measurements between the two"/>
   <result pre="between the two studies and differences in time intervals between" exact="DENV" post="and ZIKV exposure. Nevertheless, these results would be consistent"/>
   <result pre="two studies and differences in time intervals between DENV and" exact="ZIKV" post="exposure. Nevertheless, these results would be consistent with the"/>
   <result pre="seen in the eligible human studies that an increase in" exact="ZIKV" post="viremia in those with prior DENV exposure is possible,"/>
   <result pre="that an increase in ZIKV viremia in those with prior" exact="DENV" post="exposure is possible, but of a magnitude unlikely to"/>
   <result pre="eligible human studies we have identified data suggesting that prior" exact="DENV" post="infection may lead to greater ZIKV viremia compared to"/>
   <result pre="data suggesting that prior DENV infection may lead to greater" exact="ZIKV" post="viremia compared to those without prior DENV infection in"/>
   <result pre="lead to greater ZIKV viremia compared to those without prior" exact="DENV" post="infection in both humans and NHPs [41, 42]. However,"/>
   <result pre="GBS or a composite &quot;clinical severity score�? in those with" exact="ZIKV" post="infections who had previously been infected with DENV, when"/>
   <result pre="previously been infected with DENV, when compared to those acute" exact="ZIKV" post="infections with no prior DENV infection [5, 41, 42]."/>
   <result pre="when compared to those acute ZIKV infections with no prior" exact="DENV" post="infection [5, 41, 42]. In addition, Terzian et al"/>
   <result pre="in inflammatory cytokines associated with the trend toward higher median" exact="ZIKV" post="viral loads in DENV IgG+ individuals [41]. Taken together,"/>
   <result pre="with the trend toward higher median ZIKV viral loads in" exact="DENV" post="IgG+ individuals [41]. Taken together, the current evidence from"/>
   <result pre="current evidence from human and NHP studies suggests that prior" exact="DENV" post="infection may cause a small rise in subsequent ZIKV"/>
   <result pre="prior DENV infection may cause a small rise in subsequent" exact="ZIKV" post="viremia but that this is likely not clinically relevant."/>
   <result pre="and secondary infections [28]. It may be that enhancement of" exact="ZIKV" post="replication would be more likely to occur several years"/>
   <result pre="to occur several years post-DENV exposure as cross-neutralizing titers of" exact="DENV" post="wane over time [28]. The human studies identified in"/>
   <result pre="systematic review did not ascribe a time dimension to prior" exact="DENV" post="exposure and therefore may have missed an effect that"/>
   <result pre="time-dependent. This could be explicitly examined should further outbreaks of" exact="ZIKV" post="occur in the Americas or in other regions with"/>
   <result pre="occur in the Americas or in other regions with syndemic" exact="DENV" post="circulation that may be at risk of major ZIKV"/>
   <result pre="syndemic DENV circulation that may be at risk of major" exact="ZIKV" post="epidemics [14]. The choice of serological assay used in"/>
   <result pre="most of the human studies examining the role of prior" exact="DENV" post="exposure on ZIKV outcomes was the major limitation in"/>
   <result pre="human studies examining the role of prior DENV exposure on" exact="ZIKV" post="outcomes was the major limitation in interpreting these data."/>
   <result pre="study. For this reason, it is difficult to infer that" exact="DENV" post="and not some other related flavivirus infection and/or flavivirus"/>
   <result pre="and/or flavivirus vaccine product was the cause of the positive" exact="DENV" post="IgG results. This could cause misclassification bias of the"/>
   <result pre="The paucity of eligible studies is remarkable given that the" exact="ZIKV" post="pandemic caused over 583,000 suspected and 223,000 confirmed ZIKV"/>
   <result pre="the ZIKV pandemic caused over 583,000 suspected and 223,000 confirmed" exact="ZIKV" post="autochthonous cases across 49 countries and territories in the"/>
   <result pre="Our systematic review also prompts further study into whether prior" exact="ZIKV" post="exposure may worsen DENV clinical outcomes. The global ZIKV"/>
   <result pre="prompts further study into whether prior ZIKV exposure may worsen" exact="DENV" post="clinical outcomes. The global ZIKV outbreak has resulted in"/>
   <result pre="prior ZIKV exposure may worsen DENV clinical outcomes. The global" exact="ZIKV" post="outbreak has resulted in a large population primed with"/>
   <result pre="ZIKV outbreak has resulted in a large population primed with" exact="ZIKV" post="within DENV endemic areas and it is unclear how"/>
   <result pre="has resulted in a large population primed with ZIKV within" exact="DENV" post="endemic areas and it is unclear how ZIKV exposure"/>
   <result pre="ZIKV within DENV endemic areas and it is unclear how" exact="ZIKV" post="exposure on a population level will shape future DENV"/>
   <result pre="how ZIKV exposure on a population level will shape future" exact="DENV" post="epidemics and clinical DENV outcomes in this region, a"/>
   <result pre="a population level will shape future DENV epidemics and clinical" exact="DENV" post="outcomes in this region, a reverse of the study"/>
   <result pre="in this work. While existing data so far suggests that" exact="ZIKV" post="circulation in the Americas was associated with a contemporaneous"/>
   <result pre="in the Americas was associated with a contemporaneous reduction in" exact="DENV" post="cases [47], it remains to be seen whether waning"/>
   <result pre="DENV cases [47], it remains to be seen whether waning" exact="ZIKV" post="antibodies over time may subsequently cause DENV infections with"/>
   <result pre="seen whether waning ZIKV antibodies over time may subsequently cause" exact="DENV" post="infections with higher viral loads and therefore trigger particularly"/>
   <result pre="infections with higher viral loads and therefore trigger particularly large" exact="DENV" post="epidemics, a phenomenon seen when DENV serotypes sequentially circulate"/>
   <result pre="therefore trigger particularly large DENV epidemics, a phenomenon seen when" exact="DENV" post="serotypes sequentially circulate through a geographic region [48]. Indeed,"/>
   <result pre="through a geographic region [48]. Indeed, data exists suggesting that" exact="ZIKV" post="itself may promote ADE during a subsequent DENV infection,"/>
   <result pre="suggesting that ZIKV itself may promote ADE during a subsequent" exact="DENV" post="infection, with a study of NHP observing higher peak"/>
   <result pre="a study of NHP observing higher peak DENV-2 viremia in" exact="ZIKV" post="exposed rhesus macaques [9]. Further studies, ideally leveraging prospective"/>
   <result pre="data file. References References 1PlourdeAR, BlochEM. A Literature Review of" exact="Zika" post="Virus. Emerging infectious diseases. 2016;22(7):1185–92. 10.3201/eid2207.15199027070380 2FagbamiAH. Zika virus"/>
   <result pre="Review of Zika Virus. Emerging infectious diseases. 2016;22(7):1185–92. 10.3201/eid2207.15199027070380 2FagbamiAH." exact="Zika" post="virus infections in Nigeria: virological and seroepidemiological investigations in"/>
   <result pre="MonsS, LastereS, RocheC, VanhomwegenJ, et al.Guillain-Barre Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control study. Lancet"/>
   <result pre="6FergusonNM, CucunubaZM, DorigattiI, Nedjati-GilaniGL, DonnellyCA, BasanezMG, et al.EPIDEMIOLOGY. Countering the" exact="Zika" post="epidemic in Latin America. Science (New York, NY). 2016;353(6297):353–4."/>
   <result pre="7Schuler-FacciniL, RibeiroEM, FeitosaIM, HorovitzDD, CavalcantiDP, PessoaA, et al.Possible Association Between" exact="Zika" post="Virus Infection and Microcephaly—Brazil, 2015. MMWR Morbidity and mortality"/>
   <result pre="VenturaCV, FonsecaEB, et al.Characterizing the Pattern of Anomalies in Congenital" exact="Zika" post="Syndrome for Pediatric Clinicians. JAMA pediatrics. 2017;171(3):288–95. 10.1001/jamapediatrics.2016.398227812690 9AliotaMT,"/>
   <result pre="Virus Network. Antiviral Res. 2017;144:223–46. 10.1016/j.antiviral.2017.06.00128595824 10PetersenLR, JamiesonDJ, PowersAM, HoneinMA." exact="Zika" post="Virus. The New England journal of medicine. 2016;374(16):1552–63. 10.1056/NEJMra160211327028561"/>
   <result pre="of medicine. 2016;374(16):1552–63. 10.1056/NEJMra160211327028561 11PosenHJ, KeystoneJS, GubbayJB, MorrisSK. Epidemiology of" exact="Zika" post="virus, 1947–2007. BMJ global health. 2016;1(2):e00008710.1136/bmjgh-2016-00008728588942 12FoyBD, KobylinskiKC, Chilson"/>
   <result pre="BlitvichBJ, Travassos da RosaA, HaddowAD, et al.Probable non-vector-borne transmission of" exact="Zika" post="virus, Colorado, USA. Emerging infectious diseases. 2011;17(5):880–2. 10.3201/eid1705.10193921529401 13https://www.paho.org/hq/index.php?option=com_content&amp;amp;view=article&amp;amp;id=12390&amp;amp;Itemid=42090&amp;amp;lang=en"/>
   <result pre="25 2018. 14SirajAS, PerkinsTA. Assessing the population at risk of" exact="Zika" post="virus in Asia—is the emergency really over?2017;2(3):e00030910.1136/bmjgh-2017-00030929082009 15Outbreak of"/>
   <result pre="Zika virus in Asia—is the emergency really over?2017;2(3):e00030910.1136/bmjgh-2017-00030929082009 15Outbreak of" exact="Zika" post="virus infection in Singapore: an epidemiological, entomological, virological, and"/>
   <result pre="10.1016/S1473-3099(17)30249-928527892 16PetterssonJH, BohlinJ. Re-visiting the evolution, dispersal and epidemiology of" exact="Zika" post="virus in Asia. 2018;7(1):7910.1038/s41426-018-0082-529739925 17LesslerJ, ChaissonLH, KucirkaLM, BiQ, GrantzK,"/>
   <result pre="KucirkaLM, BiQ, GrantzK, SaljeH, et al.Assessing the global threat from" exact="Zika" post="virus. Science (New York, NY). 2016;353(6300):aaf8160. 18KraemerMU, SinkaME, DudaKA,"/>
   <result pre="de CarvalhoOV, de MendoncaLR, et al.Dengue Virus-Specific Antibodies Enhance Brazilian" exact="Zika" post="Virus Infection. The Journal of infectious diseases. 2017;215(5):781–5. 10.1093/infdis/jiw63828039355"/>
   <result pre="Nature. 2016;536(7614):48–53. 10.1038/nature1893827338953 22PriyamvadaL, HudsonW, AhmedR, WrammertJ. Humoral cross-reactivity between" exact="Zika" post="and dengue viruses: implications for protection and pathology. Emerging"/>
   <result pre="antibody responses after dengue virus infection are highly cross-reactive to" exact="Zika" post="virus. Proceedings of the National Academy of Sciences of"/>
   <result pre="10.1038/ni.351527339099 25BardinaSV, BunducP, TripathiS, DuehrJ, FrereJJ, BrownJA, et al.Enhancement of" exact="Zika" post="virus pathogenesis by preexisting antiflavivirus immunity. Science (New York,"/>
   <result pre="et al.Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from" exact="Dengue" post="Patients Are Protective against Zika Virus. mBio. 2016;7(4). 27DurbinAP."/>
   <result pre="Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against" exact="Zika" post="Virus. mBio. 2016;7(4). 27DurbinAP. Dengue Antibody and Zika: Friend"/>
   <result pre="Dengue Patients Are Protective against Zika Virus. mBio. 2016;7(4). 27DurbinAP." exact="Dengue" post="Antibody and Zika: Friend or Foe?Trends in immunology. 2016;37(10):635–6."/>
   <result pre="Friend or Foe?Trends in immunology. 2016;37(10):635–6. 10.1016/j.it.2016.08.00627599407 28MahalingamS, TeixeiraMM, HalsteadSB." exact="Zika" post="enhancement: a reality check. The Lancet Infectious diseases. 2017;17(7):686–8."/>
   <result pre="De La BarreraR, et al.Impact of prior flavivirus immunity on" exact="Zika" post="virus infection in rhesus macaques. PLoS Pathog. 2017;13(8):e100648710.1371/journal.ppat.100648728771605 31http://prisma-statement.org/,"/>
   <result pre="HarrisE. Recent advances in understanding the adaptive immune response to" exact="Zika" post="virus and the effect of previous flavivirus exposure. EMBO"/>
   <result pre="2018;19(2):206–24. 10.15252/embr.20174530229282215 35RothanHA, BidokhtiMRM, ByrareddySN. Current concerns and perspectives on" exact="Zika" post="virus co-infection with arboviruses and HIV. Journal of autoimmunity."/>
   <result pre="A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance" exact="Zika" post="Disease?Trends in microbiology. 2018;26(3):186–90. 10.1016/j.tim.2017.10.00429122447 37https://academic.oup.com/ofid/issue/4/suppl_1 accessed July 25"/>
   <result pre="Cytokine Response Profile Does Not Support Antibody-Dependent Enhancement in Dengue-Primed" exact="Zika" post="Virus-Infected Patients. Clinical infectious diseases: an official publication of"/>
   <result pre="Nielsen-SainesK, MoreiraML, de SequeiraPC, JuniorJPP, de Araujo ZinA, et al.Maternal" exact="Zika" post="Virus Disease Severity, Virus Load, Prior Dengue Antibodies, and"/>
   <result pre="ZinA, et al.Maternal Zika Virus Disease Severity, Virus Load, Prior" exact="Dengue" post="Antibodies, and Their Relationship to Birth Outcomes. Clinical infectious"/>
   <result pre="44BalmasedaA, StettlerK, Medialdea-CarreraR, ColladoD, JinX, ZambranaJV, et al.Antibody-based assay discriminates" exact="Zika" post="virus infection from other flaviviruses. 2017;114(31):8384–9. 10.1073/pnas.170498411428716913 45https://consise.tghn.org/about/working-group-projects/, accessed"/>
   <result pre="other flaviviruses. 2017;114(31):8384–9. 10.1073/pnas.170498411428716913 45https://consise.tghn.org/about/working-group-projects/, accessed August 20, 2018 46SaenzC." exact="Zika" post="virus: ethics preparedness for old and new challenges. The"/>
   <result pre="47RibeiroGS, KikutiM, TauroLB, NascimentoLCJ, CardosoCW, CamposGS, et al.Does immunity after" exact="Zika" post="virus infection cross-protect against dengue?The Lancet Global health. 2018;6(2):e140–e1."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6372163\results\search\tropicalVirus\results.xml">
   <result pre="and large-scale epidemics and epizootics. Apart from viruses such as" exact="West Nile" post="virus and Rift Valley fever virus that are well-known"/>
   <result pre="have remained largely neglected. Before the turn of the century," exact="West Nile" post="virus, chikungunya virus, and Zika virus were among these"/>
   <result pre="turn of the century, West Nile virus, chikungunya virus, and" exact="Zika" post="virus were among these neglected viruses until they reminded"/>
   <result pre="arthropod-borne viral diseases: A global prospective on dengue, chikungunya and" exact="Zika" post="fevers. Acta Trop. 2017;166:155–63. 10.1016/j.actatropica.2016.11.02027876643 3BirdBH, KsiazekTG, NicholST, MacLachlanNJ."/>
   <result pre="Med Parasitol. 1975;69:49–64. 1124969 16van EedenC, SwanepoelR, VenterM. Antibodies against" exact="West Nile" post="and Shuni viruses in veterinarians, South Africa. Emerging Infect"/>
   <result pre="18VogelsCBF, GöertzGP, PijlmanGP, KoenraadtCJM. Vector competence of European mosquitoes for" exact="West Nile" post="virus. Emerg Microbes Infect. 2017;6:e9610.1038/emi.2017.8229116220 19KenneyJL, BraultAC. The role"/>
   <result pre="activity and aboveground hybridization between the two biotypes of the" exact="West Nile" post="virus vector Culex pipiens. Vector Borne Zoonotic Dis. 2015;15:619–26."/>
   <result pre="competence of northern European Culex pipiens biotypes and hybrids for" exact="West Nile" post="virus is differentially affected by temperature. Parasit Vectors. 2016;9:39310.1186/s13071-016-1677-027388451"/>
   <result pre="of northern and southern European Culex pipiens pipiens mosquitoes for" exact="West Nile" post="virus across a gradient of temperatures. Med Vet Entomol."/>
   <result pre="2017;31:358–64. 10.1111/mve.1225128752627 29GöertzGP, VogelsCBF, GeertsemaC, KoenraadtCJM, PijlmanGP. Mosquito co-infection with" exact="Zika" post="and chikungunya virus allows simultaneous transmission without affecting vector"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6373929\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Anatomy :"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Dengue" post="Fever Potential for sylvatic and urban Aedes mosquitoes from"/>
   <result pre="available under the Creative Commons CC0 public domain dedication.pntd.0007043.pdf Abstract" exact="Dengue" post="fever (DEN) is the most common arboviral disease in"/>
   <result pre="with DEN outbreaks reported in all regions. In Senegal, all" exact="DENV" post="serotypes have been reported. These important changes in the"/>
   <result pre="experimental oral infection. Whole bodies and wings/legs were tested for" exact="DENV" post="presence by cell culture assays and saliva samples were"/>
   <result pre="vectors Ae. furcifer, Ae. taylori and Ae. luteocephalus. Author summary" exact="Dengue" post="fever remains a major public health problem in all"/>
   <result pre="are within the paper and its Supporting Information files. Introduction" exact="Dengue" post="fever (DEN) is the most common arboviral disease in"/>
   <result pre="million are inapparent and only 96 million are symptomatic [1]." exact="Dengue" post="fever causes a wide clinical spectrum similar for the"/>
   <result pre="similar for the four serotypes. The different clinical manifestations of" exact="DENV" post="infection range from asymptomatic to several symptomatic forms ranging"/>
   <result pre="symptomatic forms ranging in severity from classical dengue fever, to" exact="Dengue" post="Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). Dengue"/>
   <result pre="from classical dengue fever, to Dengue Hemorrhagic Fever (DHF) and" exact="Dengue" post="Shock Syndrome (DSS). Dengue viruses are transmitted to humans"/>
   <result pre="to Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS)." exact="Dengue" post="viruses are transmitted to humans by mosquitoes of the"/>
   <result pre="[2] in contrast to Asia and South America where endemic/epidemic" exact="DENV" post="strains circulating in peridomestic cycles are most common, and"/>
   <result pre="caused by DENV-2 have occurred in East Africa. The others" exact="DENV" post="serotypes (1, 3 and 4) are only known from"/>
   <result pre="Ouagadougou and Louga respectively (S1 Table) [9,10,11,12,13,14,15,16,17,18,19,20,21,22,23]. In Senegal all" exact="DENV" post="serotypes have been reported (S2 Table). These important changes"/>
   <result pre="occurring in a context where there is no vaccine against" exact="DENV" post="recommended for all populations. Furthermore, there is a significant"/>
   <result pre="populations. Furthermore, there is a significant gap of knowledge on" exact="DENV" post="vector bionomics and transmission dynamics in Africa to effectively"/>
   <result pre="and control epidemics. The vector competence of mosquitoes associated with" exact="DENV" post="in nature is poorly characterized. Except for DENV-2 [24,25]"/>
   <result pre="high infection and dissemination rates with DENV-1. However, the oral" exact="DENV" post="doses used were low and transmission potential was not"/>
   <result pre="chosen based on their abundance, anthrophophilic behavior and association with" exact="DENV" post="in nature. For each population, several larval habitats were"/>
   <result pre="strain (S-162 TvP-3622), and DENV-4 strain SH 38549. 10.1371/journal.pntd.0007043.t002Table 2" exact="Dengue" post="virus strains used for this study. DENV strains Reference"/>
   <result pre="38549. 10.1371/journal.pntd.0007043.t002Table 2 Dengue virus strains used for this study." exact="DENV" post="strains Reference Host origin Year of collection Location Passage"/>
   <result pre="dengue-specific hyperimmune mouse ascitic fluid. Mouse hyperimmune sera (MIAF) to" exact="DENV" post="were prepared in adult mice; using 10% crude homogenates"/>
   <result pre="100 μL of DMEM supplemented with 5% FBS. Detection of" exact="DENV" post="in the mosquito body but not the wings/legs indicated"/>
   <result pre="as well as wings/legs of infected bodies were tested for" exact="DENV" post="after homogenization in 400 μl of MEM containing 5%"/>
   <result pre="were cultured in 24-well plates containing Vero cell monolayers and" exact="DENV" post="was detected by focus forming assays and immunostaining described"/>
   <result pre="presence/absence revelation. Saliva of infected wings/legs were tested to detect" exact="DENV" post="presence by real-time RT-PCR using an internal control of"/>
   <result pre="Extraction Kit (QIAgen, Heiden, Germany), according to the manufacturer’s protocol." exact="Dengue" post="virus RNAs extracted from mosquito saliva were amplified using"/>
   <result pre="experiment with Ae. furcifer, we observed 5 days after oral" exact="DENV" post="exposure a high mortality rate. Based on this observation,"/>
   <result pre="exposed to uninfected blood meals to assess the effect of" exact="DENV" post="on mortality. The uninfected blood meals used as the"/>
   <result pre="Ae. aegypti from Dakar, then surviving mosquitoes were tested for" exact="DENV" post="infection as described above. 10.1371/journal.pntd.0007043.t003Table 3 Sample size for"/>
   <result pre="for Statistical Computing, Vienna, Austria) [29]. Results The titers of" exact="DENV" post="stocks used ranged between 107 and 108 PFU/ml and"/>
   <result pre="71 Ae. furcifer and 22 Ae. luteocephalus was tested after" exact="DENV" post="exposure and incubation for 7 or 15 days. For"/>
   <result pre="Ae. taylori, our analysis did not reveal any effect between" exact="DENV" post="serotypes and the mosquito population survival rate (p ="/>
   <result pre="p = 0.378 respectively). But survivals were significantly different between" exact="DENV" post="serotypes for Ae. aegypti Dakar (p &amp;lt;0.001) and Ae."/>
   <result pre="mortality was higher for Ae. aegypti from Dakar exposed to" exact="DENV" post="versus unexposed. Also, survival of this population was more"/>
   <result pre="DENV-1 than by DENV-4 and DENV-3. Our results showed that" exact="DENV" post="infection also affected the survival of Ae. aegypti from"/>
   <result pre="from St. Louis. Survival of mosquitoes exposed to all three" exact="DENV" post="was reduced compared to negative controls from the 6th"/>
   <result pre="Ae. aegypti from Kedougou was significantly affected by all three" exact="DENV" post="serotypes. Survival of Ae. taylori exposed to DENV-4 or"/>
   <result pre="at all dpbm, but there was no significant difference between" exact="DENV" post="serotypes. While mosquitoes exposed to DENV-1 showed reduced survival"/>
   <result pre="were not able to test Ae. furcifer with the African" exact="DENV" post="strains after an early experiment performed with DENV-4 and"/>
   <result pre="dpbm only. Furthermore, only the RT-PCR was used to detect" exact="DENV" post="genomes whether infectious particles or not for 2 reasons:"/>
   <result pre="vector and we have been focused on the detection of" exact="DENV" post="in the different compartments of the mosquitoes and in"/>
   <result pre="can serve as a single control for each of the" exact="DENV" post="serotypes and genotypes. Beyond the current scope of the"/>
   <result pre="integrating at least one laboratory susceptible mosquito strain for each" exact="DENV" post="serotype. Our results showed high infection and disseminated infection"/>
   <result pre="Our results showed high infection and disseminated infection rates with" exact="DENV" post="serotypes 1, 3 and 4, both for Ae. aegypti"/>
   <result pre="their maximum values later. Ae. aegypti mosquitoes from Dakar develop" exact="DENV" post="infection earlier than populations from Kedougou and St. Louis"/>
   <result pre="aegypti from Dakar, Kedougou and St. Louis to the 3" exact="DENV" post="serotypes significantly increases mortality compared to negative control cohorts"/>
   <result pre="Adverse effects on the fitness of Ae. aegypti due to" exact="DENV" post="infection were also reported previously [46]. We also found"/>
   <result pre="surprising because this species is not normally adapted to this" exact="DENV" post="serotype, which is not known to circulate in the"/>
   <result pre="showed the highest potential transmission rates. Supporting information S1 Table" exact="Dengue" post="outbreaks in Africa in the last two decades. (DOC)"/>
   <result pre="(DOC) LINK Click here for additional data file. S2 Table" exact="Dengue" post="in Senegal. (DOC) LINK Click here for additional data"/>
   <result pre="considerations. Emerg Infect Dis9: 36210.3201/eid0903.02021912643833 5GublerD, SatherG, KunoG, CabralJ (1986)" exact="Dengue" post="3 virus transmission in Africa. The Am J Trop"/>
   <result pre="Trop Med Hyg35: 1280–1284. 3789276 6AmarasingheA, KuritskJN, LetsonGW, MargolisHS (2011)" exact="Dengue" post="virus infection in Africa. Emerg Infect Dis17: 1349–1354. 10.3201/eid1708.10151521801609"/>
   <result pre="Clinical and Epidemiological Characterization of the First Recognized Outbreak of" exact="Dengue" post="Virus-Type 2 in Mozambique, 2014. Am J Trop Med"/>
   <result pre="413–416. 10.4269/ajtmh.15-054326643534 10ChipwazaB, MugasaJP, SelemaniM, AmuriM, MoshaF, et al. (2014)" exact="Dengue" post="and Chikungunya fever among viral diseases in outpatient febrile"/>
   <result pre="10ChipwazaB, MugasaJP, SelemaniM, AmuriM, MoshaF, et al. (2014) Dengue and" exact="Chikungunya" post="fever among viral diseases in outpatient febrile children in"/>
   <result pre="Development (EJHD)28. 14MalikA, EarhartK, MoharebE, SaadM, SaeedM, et al. (2011)" exact="Dengue" post="hemorrhagic fever outbreak in children in Port Sudan. J"/>
   <result pre="Health4: 1–6.21338953 15SeidahmedO, SiamH, SoghaierM, AbubakrM, OsmanH, et al. (2012)" exact="Dengue" post="vector control and surveillance during a major outbreak in"/>
   <result pre="Sea area in Sudan. 16Kyobe BosaH, MontgomeryJM, KimuliI, LutwamaJ (2014)" exact="Dengue" post="fever outbreak in Mogadishu, Somalia 2011: Co-circulation of three"/>
   <result pre="Poverty5: 2310.1186/s40249-016-0120-227044528 21TarnagdaZ, CisséA, BicabaBW, DiagbougaS, SagnaT, et al. (2018)" exact="Dengue" post="Fever in Burkina Faso, 2016. Emerg Infect Dis24: 17010.3201/eid2401.17097329260685"/>
   <result pre="3 infection, Senegal, 2009. Emerg Infect Dis20: 45610.3201/eid2003.12188524572297 23OrganizationWH (2009)" exact="Dengue" post="in Africa: emergence of DENV-3, Côte d’Ivoire, 2008. Wkly"/>
   <result pre="al. (2016) Real-time RT-PCR assays for detection and genotyping of" exact="West Nile" post="virus lineages circulating in Africa. Vect Born Zoo Dis16:"/>
   <result pre="Hyg15: 989–993. 5959114 37ColtonL, BiggerstaffBJ, JohnsonA, NasciRS (2005) Quantification of" exact="West Nile" post="virus in vector mosquito saliva. J Am Mosquit Control"/>
   <result pre="TurellMJ, DohmDJ, BlowJA, CarranzaMT, et al. (2007) Experimental transmission of" exact="West Nile" post="virus by Culex nigripalpus from Honduras. Vect Born Zoo"/>
   <result pre="sylvatic dengue viruses. J Virol74: 3227–3234. 10708439 50collab: Cornet M(1993)" exact="Dengue" post="Virus in AfricaMonograph on Dengue and Dengue Hemorrhagic Fever,"/>
   <result pre="3227–3234. 10708439 50collab: Cornet M(1993) Dengue Virus in AfricaMonograph on" exact="Dengue" post="and Dengue Hemorrhagic Fever, SEARO 22. WHO, Geneva."/>
   <result pre="50collab: Cornet M(1993) Dengue Virus in AfricaMonograph on Dengue and" exact="Dengue" post="Hemorrhagic Fever, SEARO 22. WHO, Geneva."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6375641\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="West Nile" post="virus : Biology and life sciences : Microbiology :"/>
   <result pre="Medical microbiology : Microbial pathogens : Viral pathogens : Flaviviruses:" exact="West Nile" post="virus : Medicine and health sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial pathogens : Viral pathogens : Flaviviruses:" exact="West Nile" post="virus : Biology and life sciences : Organisms :"/>
   <result pre="sciences : Organisms : Viruses : Viral pathogens : Flaviviruses:" exact="West Nile" post="virus : Biology and life sciences : Molecular biology"/>
   <result pre="Sciences : Microbiology : Virology: Viral Replication Comparative fitness of" exact="West Nile" post="virus isolated during California epidemics Fitness of West Nile"/>
   <result pre="of West Nile virus isolated during California epidemics Fitness of" exact="West Nile" post="virus isolated from California epidemics WorwaGabriellaConceptualizationData curationFormal analysisFunding acquisitionInvestigationMethodologySupervisionWriting"/>
   <result pre="available under the Creative Commons CC0 public domain dedication.pntd.0007135.pdf Abstract" exact="West Nile" post="virus (WNV) has been circulating in California since its"/>
   <result pre="repeated outbreaks affecting public, wildlife and veterinary health. Epidemics of" exact="WNV" post="are difficult to predict due to the multitude of"/>
   <result pre="dynamics among avian and mosquito hosts. Typically, high levels of" exact="WNV" post="amplification are required for outbreaks to occur, and therefore"/>
   <result pre="in increased mosquito infection prevalence. In our previous study, most" exact="WNV" post="isolates made from California during 2007–08 showed increased fitness"/>
   <result pre="2003 California strain. Herein, we evaluated the competitive fitness of" exact="WNV" post="strains isolated during California epidemics in 2004, 2005, 2007,"/>
   <result pre="replicated more efficiently than did COAV997-5nt based on quantification of" exact="WNV" post="RNA copies in sera, thereby demonstrating increased competitive fitness."/>
   <result pre="isolates did not have a fitness advantage over COAV997-5nt. Collectively," exact="WNV" post="isolates from outbreaks demonstrated relatively greater avian, but not"/>
   <result pre="results indicated that ecological rather than viral factors may facilitate" exact="WNV" post="amplification to outbreak levels, but monitoring viral phenotypes through"/>
   <result pre="provide insight into altered replication and transmission potential among emerging" exact="WNV" post="strains. Author summary West Nile virus (WNV) is the"/>
   <result pre="replication and transmission potential among emerging WNV strains. Author summary" exact="West Nile" post="virus (WNV) is the cause of the largest mosquito-borne"/>
   <result pre="cases to date, including &amp;gt;2000 deaths. Since the detection of" exact="WNV" post="in California in 2003, repeated outbreaks have been associated"/>
   <result pre="California in 2003, repeated outbreaks have been associated with explosive" exact="WNV" post="amplification in local mosquito and bird populations. Along with"/>
   <result pre="climatic and ecological factors, vector-host-pathogen interactions are potential drivers of" exact="WNV" post="epidemics and warrant study. Here, we evaluated the competitive"/>
   <result pre="warrant study. Here, we evaluated the competitive fitness of five" exact="WNV" post="isolates made during Californian outbreaks from 2004–2012 by co-infection"/>
   <result pre="Data Availability All relevant data are within the paper. Introduction" exact="West Nile" post="virus (WNV; Flavivirus, Flaviviridae) naturally cycles among competent avian"/>
   <result pre="serve as both amplification and bridge vectors [1]. Outbreaks of" exact="WNV" post="in North America generally have occurred during the warm"/>
   <result pre="mammals [1]. Since its invasion of California in 2003 [2]," exact="WNV" post="has not only adapted to and persisted in diverse"/>
   <result pre="of California now have experienced either year-round or repeated seasonal" exact="WNV" post="activity [3]. Epidemics have been associated with intense WNV"/>
   <result pre="seasonal WNV activity [3]. Epidemics have been associated with intense" exact="WNV" post="amplification and historically have followed a three-year pattern of"/>
   <result pre="introduction, rapid amplification and then subsidence [7]. Factors linked to" exact="WNV" post="outbreaks have included above average temperatures and drought conditions,"/>
   <result pre="relate to phenotypic differences between enzootic and epidemic isolates of" exact="WNV" post="that enhance avian host and vector infection, facilitating transmission[10]."/>
   <result pre="efficient mosquito infection [10] and have been a hallmark of" exact="WNV" post="epidemics in North America [11]. Avian virulence in American"/>
   <result pre="in the NS3 and NS1-2B proteins [12–14]. After the 2004" exact="WNV" post="epidemic in Los Angeles, elevated passerine seroprevalence and corvid"/>
   <result pre="elevated passerine seroprevalence and corvid de-population were associated with limited" exact="WNV" post="transmission during successive years [4]. However, the progressive loss"/>
   <result pre="of passerine flock immunity and corvid population recovery led to" exact="WNV" post="resurgence in 2008 and again in 2011 [4]. Alternatively,"/>
   <result pre="previously shown for House Sparrows (HOSPs; Passer domesticus) and increased" exact="WNV" post="virulence leading to stable host competence [15]. Interestingly, the"/>
   <result pre="Culex spp. populations from California for the NY99 strain of" exact="WNV" post="did not change significantly during WNV outbreak years compared"/>
   <result pre="the NY99 strain of WNV did not change significantly during" exact="WNV" post="outbreak years compared to non-outbreak years [16], suggesting that"/>
   <result pre="diversity encoding for increased replicative phenotypes [20]. Enzootic isolates of" exact="WNV" post="collected between 2007–08 from different regions of California possessed"/>
   <result pre="compared to an isolate made during the initial introduction of" exact="WNV" post="into California in 2003 [21]. Included in this study"/>
   <result pre="NY99 phenotype [22]. As a follow-up to these findings, five" exact="WNV" post="isolates made during epidemics from 2004–2012 were assessed herein"/>
   <result pre="facilitate amplification and thus be predictive of future outbreaks. Methods" exact="WNV" post="isolates from California epidemics Isolates of WNV were made"/>
   <result pre="future outbreaks. Methods WNV isolates from California epidemics Isolates of" exact="WNV" post="were made from mosquito pool homogenates collected as part"/>
   <result pre="Mosquito-Borne Encephalitis Virus Surveillance Program that had tested positive for" exact="WNV" post="RNA by qRT-PCR [23]. One homogenate each was selected"/>
   <result pre="were summarized in Table 1. 10.1371/journal.pntd.0007135.t001Table 1 Mosquito pools containing" exact="WNV" post="collected during 2004–2012 California epidemics. Isolate Region Collection date"/>
   <result pre="SAYO-12-772 Sacramento,Sacramento County 5/23/2012 tarsalis 18.5 9.0±0.11 a Mean±SEM infectious" exact="WNV" post="titer of replicate Vero cell culture supernatants indicated as"/>
   <result pre="a reference strain in competitions against all the wild type" exact="WNV" post="isolates, because its fitness previously has been well characterized"/>
   <result pre="in July 2003 from Imperial Valley, California, early in the" exact="WNV" post="invasion of southeast California. Replicative fitness was assessed through"/>
   <result pre="and Game collecting permit SC-002281. Culex mosquitoes from which the" exact="WNV" post="isolates were made were collected with dry-ice baited traps"/>
   <result pre="Mosquito and Vector Control District in Bakersfield. Experiments with infectious" exact="WNV" post="were performed in an animal biosafety level 3 facility"/>
   <result pre="SAYO-12-772 3.4±0.24 0.19 66 38 44 a Mean±SEM titer of" exact="WNV" post="(log10 PFU per mosquito) determined by Vero cell plaque"/>
   <result pre="expectorant collection. d Percentage of bodies that tested positive for" exact="WNV" post="RNA by qRT-PCR for either the outbreak isolate, COAV997-5nt"/>
   <result pre="per group. e Percentage of expectorants that tested positive for" exact="WNV" post="RNA by qRT-PCR for either the outbreak isolate, COAV997-5nt"/>
   <result pre="175±9.5 0.29 SAYO-12-772 6 175±27 0.20 a Mean±SEM PFU of" exact="WNV" post="in 50 μl of inocula administered to HOFIs as"/>
   <result pre="of each competition group. Blood meals were composed of heparinized" exact="WNV" post="seronegative chicken blood spiked with 8 log10 PFU per"/>
   <result pre="each group of Cx. tarsalis (Table 2). The number of" exact="WNV" post="RNA copies present in each blood meal was expressed"/>
   <result pre="(Table 2) determined based on the percentage of bodies containing" exact="WNV" post="RNA (outbreak isolate and/or COAV997-5nt). For each competition group"/>
   <result pre="in sera through 6 dpi (Fig 3B). Mortality following acute" exact="WNV" post="infection was low and without significant differences among the"/>
   <result pre="the current study was to evaluate the replicative fitness of" exact="WNV" post="isolated during five California outbreaks from 2004 to 2012"/>
   <result pre="and viral RNA loads were significantly lower compared to previous" exact="WNV" post="isolates [21], presumably due to decreased competence of HOFIs"/>
   <result pre="1 and 2). Salivary glands are the final site of" exact="WNV" post="replication within Cx. tarsalis and secretion of infectious virus"/>
   <result pre="and secretion of infectious virus in the expectorant determines potential" exact="WNV" post="transmission during subsequent blood feeding on susceptible hosts [28,"/>
   <result pre="enzootic California isolates evaluated from 2007–08 [21] and to the" exact="WNV" post="NY99 strain in HOFIs collected during 2003 [30]. Although"/>
   <result pre="rates were not elevated in HOFIs in the current competitions," exact="WNV" post="outbreak isolates (except for SAYO-05-912) replicated to higher RNA"/>
   <result pre="when co-infected with the same stock of COAV997-5nt, wild type" exact="WNV" post="of similar fitness, and using the same challenge protocol"/>
   <result pre="HOFI population as a consequence of rising natural resistance against" exact="WNV" post="and/or a result of host-pathogen co-evolution previously observed in"/>
   <result pre="in 1999, high avian virulence and mortality were hallmarks of" exact="WNV" post="infection, with HOFIs developing viremias up to 8 log10"/>
   <result pre="isolates [15]. Between 2003 and 2012, there was a 22%" exact="WNV" post="infection prevalence in dead California HOFIs [11] and a"/>
   <result pre="and a decline in population abundance since the arrival of" exact="WNV" post="in the state [31], possibly increasing selection pressure on"/>
   <result pre="could be one reason for observing reduced HOFI competence for" exact="WNV" post="in the current study. Our competition model has the"/>
   <result pre="competition model has the advantage of revealing fitness differences among" exact="WNV" post="strains through intra-host competition, therefore minimizing the confounding effects"/>
   <result pre="high-competence hosts and vectors. Collectively, the competitive fitness of outbreak" exact="WNV" post="isolates associated with five California epidemics between 2004 and"/>
   <result pre="that additional ecological and environmental factors were necessary to trigger" exact="WNV" post="amplification to epidemic levels. Similar to the 2012 WNV"/>
   <result pre="trigger WNV amplification to epidemic levels. Similar to the 2012" exact="WNV" post="epidemic in the Dallas-Fort Worth area which was not"/>
   <result pre="the Dallas-Fort Worth area which was not tied to increased" exact="WNV" post="virulence[32], above-average temperatures and reduced rainfall may have enhanced"/>
   <result pre="for rearing uninfected Culex tarsalis. References References 1ReisenWK. Ecology of" exact="West Nile" post="virus in North America. Viruses. 2013;5(9):2079–105. 10.3390/v509207924008376 2ReisenW, LothropH,"/>
   <result pre="2004;10(8):1369–78. 10.3201/eid1008.04007715496236 3ReisenWK, LothropHD, WheelerSS, KennsingtonM, GutierrezA, FangY, et al.Persistent" exact="West Nile" post="virus transmission and the apparent displacement St. Louis encephalitis"/>
   <result pre="2003–2006. J Med Entomol. 2008;45(3):494–508. 18533445 4KwanJL, KluhS, MadonMB, ReisenWK." exact="West Nile" post="virus emergence and persistence in Los Angeles, California, 2003–2008."/>
   <result pre="2010;83(2):400–12. 10.4269/ajtmh.2010.10-007620682890 5ReisenWK, CarrollBD, TakahashiR, FangY, GarciaS, MartinezVM, et al.Repeated" exact="West Nile" post="virus epidemic transmission in Kern County, California, 2004–2007. J"/>
   <result pre="of aerial spraying of mosquito adulticide in reducing incidence of" exact="West Nile" post="Virus, California, 2005. Emerg Infect Dis. 2008;14(5):747–54. 10.3201/eid1405.07134718439356 7HayesEB,"/>
   <result pre="KomarN, NasciRS, MontgomerySP, O’LearyDR, CampbellGL. Epidemiology and transmission dynamics of" exact="West Nile" post="virus disease. Emerg Infect Dis. 2005;11(8):1167–73. 10.3201/eid1108.050289a16102302 8HartleyDM, BarkerCM,"/>
   <result pre="GaffHD, ReisenWK. Effects of temperature on emergence and seasonality of" exact="West Nile" post="virus in California. Am J Trop Med Hyg. 2012;86(5):884–94."/>
   <result pre="and mosquito (Diptera: Culicidae) vector competence determine the efficiency of" exact="West Nile" post="and St. Louis encephalitis virus transmission. J Med Entomol."/>
   <result pre="Med Entomol. 2005;42(3):367–75. 15962789 11FossL, PadgettK, ReisenWK, KjemtrupA, OgawaJ, KramerV." exact="West Nile" post="Virus-Related Trends in Avian Mortality in California, USA, 2003–12."/>
   <result pre="12BraultAC, LangevinSA, BowenRA, PanellaNA, BiggerstaffBJ, MillerBR, et al.Differential virulence of" exact="West Nile" post="strains for American crows. Emerg Infect Dis. 2004;10(12):2161–8. 10.3201/eid1012.04048615663854"/>
   <result pre="HuangCY, LangevinSA, KinneyRM, BowenRA, RameyWN, et al.A single positively selected" exact="West Nile" post="viral mutation confers increased virogenesis in American crows. Nat"/>
   <result pre="Bosco-LauthA, BowenRA, WheelerSS, ReisenWK, FelixTA, et al.Evidence for co-evolution of" exact="West Nile" post="Virus and house sparrows in North America. PLoS Negl"/>
   <result pre="variation in Culex (Diptera: Culicidae) vector competence enable outbreaks of" exact="West Nile" post="virus in California?J Med Entomol. 2008;45(6):1126–38. 19058638 17BrackneyDE, BeaneJE,"/>
   <result pre="Med Entomol. 2008;45(6):1126–38. 19058638 17BrackneyDE, BeaneJE, EbelGD. RNAi targeting of" exact="West Nile" post="virus in mosquito midguts promotes virus diversification. PLoS Pathog."/>
   <result pre="18GrubaughND, FauverJR, RuckertC, Weger-LucarelliJ, Garcia-LunaS, MurrietaRA, et al.Mosquitoes Transmit Unique" exact="West Nile" post="Virus Populations during Each Feeding Episode. Cell Rep. 2017;19(4):709–18."/>
   <result pre="Cell Rep. 2017;19(4):709–18. 10.1016/j.celrep.2017.03.07628445723 19DeardorffER, FitzpatrickKA, JerzakGV, ShiPY, KramerLD, EbelGD." exact="West Nile" post="virus experimental evolution in vivo and the trade-off hypothesis."/>
   <result pre="FreyM, DuggalNK, BraultAC, ReisenWK. Increases in the competitive fitness of" exact="West Nile" post="virus isolates after introduction into California. Virology. 2018;514:170–81. 10.1016/j.virol.2017.11.01729195094"/>
   <result pre="North American birds with the New York 1999 strain of" exact="West Nile" post="virus. Emerg Infect Dis. 2003;9(3):311–22. 10.3201/eid0903.02062812643825 23BraultAC, FangY, ReisenWK."/>
   <result pre="the Detection of Western Equine Encephalomyelitis, St. Louis Encephalitis, and" exact="West Nile" post="Viral RNA in Mosquito Pools (Diptera: Culicidae). J Med"/>
   <result pre="superior detection of single nucleotide polymorphisms as genetic markers for" exact="West Nile" post="virus compared to Luminex(R) and quantitative sequencing. J Virol"/>
   <result pre="2014;195:76–85. 10.1016/j.jviromet.2013.09.01424121135 25WorwaG, WheelerSS, BraultAC, ReisenWK. Comparing competitive fitness of" exact="West Nile" post="virus strains in avian and mosquito hosts. PLoS One."/>
   <result pre="28GoddardLB, RothAE, ReisenWK, ScottTW. Vector competence of California mosquitoes for" exact="West Nile" post="virus. Emerg Infect Dis. 2002;8(12):1385–91. 10.3201/eid0812.02053612498652 29ThiemannTC, LemenagerDA, KluhS,"/>
   <result pre="J Med Entomol. 2012;49(4):903–16. 22897051 30FangY, ReisenWK. Previous infection with" exact="West Nile" post="or St. Louis encephalitis viruses provides cross protection during"/>
   <result pre="31WheelerSS, BarkerCM, FangY, ArmijosMV, CarrollBD, HustedS, et al.Differential Impact of" exact="West Nile" post="Virus on California Birds. Condor. 2009;111(1):1–20. 10.1525/cond.2009.08001320589226 32DuggalNK, D’AntonM,"/>
   <result pre="D’AntonM, XiangJ, SeiferthR, DayJ, NasciR, et al.Sequence analyses of 2012" exact="West Nile" post="virus isolates from Texas fail to associate viral genetic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6378603\results\search\tropicalVirus\results.xml">
   <result pre="infection rates of Aedes aegypti during the first epidemics of" exact="Chikungunya" post="(2014) and Zika (2016) in areas with and without"/>
   <result pre="Aedes aegypti during the first epidemics of Chikungunya (2014) and" exact="Zika" post="(2016) in areas with and without vector control in"/>
   <result pre="R. Barrera et al. BarreraR.https://orcid.org/0000-0001-9140-1480rbarrera@cdc.gov1AmadorM.1AcevedoV.1BeltranM.2MuñozJ. L.2[1], Entomology and Ecology Team," exact="Dengue" post="BranchCenters for Disease Control and PreventionSan JuanPuerto Rico[2], Molecular"/>
   <result pre="for Disease Control and PreventionSan JuanPuerto Rico[2], Molecular Diagnostic Laboratory," exact="Dengue" post="BranchCenters for Disease Control and PreventionSan JuanPuerto Rico *"/>
   <result pre="JuanPuerto Rico * Correspondence: Roberto Barrera, Entomology and Ecology Team," exact="Dengue" post="Branch, Centers for Disease Control and Prevention, 1324 Calle"/>
   <result pre="In Puerto Rico, the first records of the transmission of" exact="Chikungunya" post="(CHIKV) and Zika (ZIKV) viruses were confirmed in May"/>
   <result pre="the first records of the transmission of Chikungunya (CHIKV) and" exact="Zika" post="(ZIKV) viruses were confirmed in May 2014 and December"/>
   <result pre="confirmed in May 2014 and December 2015, respectively. Transmission of" exact="CHIKV" post="peaked in September 2014, whereas that of ZIKV peaked"/>
   <result pre="Transmission of CHIKV peaked in September 2014, whereas that of" exact="ZIKV" post="peaked in August 2016. The emergence of these mosquito�?transmitted"/>
   <result pre="findings of a previous study carried out during the 2014" exact="CHIKV" post="epidemic. Findings in two communities protected against Ae. aegypti"/>
   <result pre="Mosquito pools were collected to detect viral RNA of ZIKV," exact="CHIKV" post="and dengue virus. In areas without vector control, mosquito"/>
   <result pre="In areas without vector control, mosquito densities and rates of" exact="ZIKV" post="detection in 2016 were significantly higher, similarly to those"/>
   <result pre="in 2016 were significantly higher, similarly to those observed for" exact="CHIKV" post="in 2014. The density of Ae. aegypti in treated"/>
   <result pre="which is similar to the putative adult female threshold for" exact="CHIKV" post="transmission. No significant differences in mosquito density or infection"/>
   <result pre="No significant differences in mosquito density or infection rates with" exact="ZIKV" post="and CHIKV at the same sites between years were"/>
   <result pre="differences in mosquito density or infection rates with ZIKV and" exact="CHIKV" post="at the same sites between years were observed. Although"/>
   <result pre="2016 was significantly wetter, mosquito densities were similar. Aedes aegypti" exact="Chikungunya" post="dengue mosquito control Zika Funding US Centers for Disease"/>
   <result pre="mosquito densities were similar. Aedes aegypti Chikungunya dengue mosquito control" exact="Zika" post="Funding US Centers for Disease Control and Prevention fig-count:"/>
   <result pre="2013; Messina et al., 2016]. The recent geographical expansions of" exact="Chikungunya" post="virus (CHIKV) (Wahid et al., 2017) and Zika virus"/>
   <result pre="expansions of Chikungunya virus (CHIKV) (Wahid et al., 2017) and" exact="Zika" post="virus (ZIKV) (Gubler et al., 2017), which have transmission"/>
   <result pre="al., 2018). The co�?circulation and co�?infection of humans with DENV," exact="CHIKV" post="and ZIKV have already been reported (Carrillo�?Hernandez et al.,"/>
   <result pre="The co�?circulation and co�?infection of humans with DENV, CHIKV and" exact="ZIKV" post="have already been reported (Carrillo�?Hernandez et al., 2018). The"/>
   <result pre="reported (Carrillo�?Hernandez et al., 2018). The main vector of DENV," exact="CHIKV" post="and ZIKV in urban epidemics in tropical and subtropical"/>
   <result pre="et al., 2018). The main vector of DENV, CHIKV and" exact="ZIKV" post="in urban epidemics in tropical and subtropical areas is"/>
   <result pre="is high, and viruses are frequently introduced. The introduction of" exact="CHIKV" post="and ZIKV into naïve human populations in the Americas"/>
   <result pre="and viruses are frequently introduced. The introduction of CHIKV and" exact="ZIKV" post="into naïve human populations in the Americas provides an"/>
   <result pre="conservative estimation of the maximum mosquito densities required to prevent" exact="DENV" post="outbreaks in endemic areas because the densities of Ae."/>
   <result pre="have been recommended as reference data in strategies to prevent" exact="DENV" post="transmission (Brown, 1977). However, a number of studies have"/>
   <result pre="transmission (Brown, 1977). However, a number of studies have reported" exact="DENV" post="transmission in contexts in which the Breteau index was"/>
   <result pre="(Bowman et al., 2014). Studies in Cuba and Taiwan suggested" exact="DENV" post="transmission took place when Breteau indices were close to"/>
   <result pre="infections or xenomonitoring (Barrera et al., 2017). The invasions of" exact="CHIKV" post="and ZIKV in immunologically naïve human populations also provide"/>
   <result pre="xenomonitoring (Barrera et al., 2017). The invasions of CHIKV and" exact="ZIKV" post="in immunologically naïve human populations also provide opportunities to"/>
   <result pre="and other environmental parameters. Comparisons of epidemics of dengue and" exact="Zika" post="concluded that reproduction numbers were similar when data for"/>
   <result pre="between viruses (Funk et al., 2016). Similarly, a comparison of" exact="Chikungunya" post="and Zika epidemics suggested similar transmission potential in the"/>
   <result pre="(Funk et al., 2016). Similarly, a comparison of Chikungunya and" exact="Zika" post="epidemics suggested similar transmission potential in the same areas"/>
   <result pre="incidences of arboviruses in Ae. aegypti following the invasions of" exact="CHIKV" post="in 2014 and ZIKV in 2016. The AGO trap"/>
   <result pre="Ae. aegypti following the invasions of CHIKV in 2014 and" exact="ZIKV" post="in 2016. The AGO trap is a black plastic"/>
   <result pre="(Mackay et al., 2013). Recently, the surveillance trap�?based presence of" exact="CHIKV" post="in female Ae. aegypti and mosquito density were found"/>
   <result pre="(Barrera et al., 2017). An investigation into the prevalence of" exact="CHIKV" post="antibodies in the residents of these communities revealed 50%"/>
   <result pre="were to elucidate whether Ae. aegypti densities were associated with" exact="ZIKV" post="infection rates in female adult mosquitoes, how differences in"/>
   <result pre="of arboviruses, and whether natural infection rates of mosquitoes with" exact="CHIKV" post="and ZIKV differed in the same locations with and"/>
   <result pre="and whether natural infection rates of mosquitoes with CHIKV and" exact="ZIKV" post="differed in the same locations with and without vector"/>
   <result pre="La Margarita were used for both communities. Detection of DENV," exact="CHIKV" post="and ZIKV in mosquitoes Mosquito pools (1–20 female Ae."/>
   <result pre="were used for both communities. Detection of DENV, CHIKV and" exact="ZIKV" post="in mosquitoes Mosquito pools (1–20 female Ae. aegypti) collected"/>
   <result pre="2014 and 2016 were prepared. During 2014, detection of only" exact="DENV" post="and CHIKV RNA was attempted following adapted reverse transcription"/>
   <result pre="2016 were prepared. During 2014, detection of only DENV and" exact="CHIKV" post="RNA was attempted following adapted reverse transcription polymerase chain"/>
   <result pre="following adapted reverse transcription polymerase chain reaction (RT�?PCR) protocols because" exact="ZIKV" post="had not yet been detected in the Americas (Lanciotti"/>
   <result pre="trioplex RT�?PCR was used to simultaneously detect RNA of DENV," exact="CHIKV" post="and ZIKV (Barrera et al., 2018; Santiago et al.,"/>
   <result pre="was used to simultaneously detect RNA of DENV, CHIKV and" exact="ZIKV" post="(Barrera et al., 2018; Santiago et al., 2018). Viral"/>
   <result pre="et al., 2018). Viral RNA of several arboviruses, including DENV," exact="CHIKV" post="and ZIKV, can be detected in dried mosquitoes at"/>
   <result pre="reported as per 1000 mosquitoes. Any pair of IRs (e.g." exact="CHIKV" post="vs. ZIKV IR per site) was considered not significantly"/>
   <result pre="per 1000 mosquitoes. Any pair of IRs (e.g. CHIKV vs." exact="ZIKV" post="IR per site) was considered not significantly different (α"/>
   <result pre="number of positive pools, infection rate (per 1000 mosquitoes) with" exact="Chikungunya" post="(CHIKV), dengue (DENV) or Zika (ZIKV) viruses, and vector"/>
   <result pre="rate (per 1000 mosquitoes) with Chikungunya (CHIKV), dengue (DENV) or" exact="Zika" post="(ZIKV) viruses, and vector index (per 1000 mosquitoes) in"/>
   <result pre="mosquito pools/week positive for the presence of viral RNA of" exact="Chikungunya" post="(CHIKV), dengue (DENV) or Zika (ZIKV) viruses, and accumulated"/>
   <result pre="presence of viral RNA of Chikungunya (CHIKV), dengue (DENV) or" exact="Zika" post="(ZIKV) viruses, and accumulated rainfall during the third and"/>
   <result pre="mosquito pools/week positive for the presence of viral RNA of" exact="Chikungunya" post="(CHIKV), dengue (DENV) or Zika (ZIKV) viruses, and accumulated"/>
   <result pre="presence of viral RNA of Chikungunya (CHIKV), dengue (DENV) or" exact="Zika" post="(ZIKV) viruses, and accumulated rainfall during the third and"/>
   <result pre="(Playa). There were no statistical differences between sites in overall" exact="CHIKV" post="IR in samples taken during June–December in 2014 (1.75–2.48"/>
   <result pre="2014 (Figs 1 and 3). Some of the results of" exact="CHIKV" post="infection in mosquitoes for these study sites have been"/>
   <result pre="and are shown here to facilitate comparisons with the 2016" exact="ZIKV" post="and DENV results. Figure 3 Infection rates (mosquitoes per"/>
   <result pre="shown here to facilitate comparisons with the 2016 ZIKV and" exact="DENV" post="results. Figure 3 Infection rates (mosquitoes per 1000)/trap/week of"/>
   <result pre="3 Infection rates (mosquitoes per 1000)/trap/week of Aedes aegypti with" exact="Chikungunya" post="(CHIKV), dengue (DENV) or Zika (ZIKV) viruses in (A,"/>
   <result pre="1000)/trap/week of Aedes aegypti with Chikungunya (CHIKV), dengue (DENV) or" exact="Zika" post="(ZIKV) viruses in (A, B) two untreated and (C,"/>
   <result pre="mosquitoes/1000 mosquitoes; P &amp;gt; 0.05) (Table 1, Fig. 3). Weekly" exact="ZIKV" post="IRs varied widely, reaching maximums of 10, 0, 20"/>
   <result pre="Villodas, respectively (Fig. 3). Overall IRs of Ae. aegypti with" exact="CHIKV" post="in 2014 and ZIKV in 2016 did not differ"/>
   <result pre="Overall IRs of Ae. aegypti with CHIKV in 2014 and" exact="ZIKV" post="in 2016 did not differ significantly among sites (P"/>
   <result pre="Margarita and 2 in Villodas) sites (Table 1). In 2016," exact="ZIKV" post="was detected in mosquitoes as early as March in"/>
   <result pre="La Margarita, a treated site (Table 1).Overall mosquito IRs with" exact="DENV" post="(0.15–0.67) were lower than those with CHIKV or ZIKV,"/>
   <result pre="mosquito IRs with DENV (0.15–0.67) were lower than those with" exact="CHIKV" post="or ZIKV, but given the small number of occurrences,"/>
   <result pre="were performed (Table 1). Average VIs were also lower for" exact="DENV" post="(0.7–2.1). Dengue virus was detected in April 2016 in"/>
   <result pre="(Table 1). Average VIs were also lower for DENV (0.7–2.1)." exact="Dengue" post="virus was detected in April 2016 in Playa (three"/>
   <result pre="(one pool) (Figs 1 and 2). Discussion In the Americas," exact="CHIKV" post="has been circulating since 2013 (Zeller et al., 2016)"/>
   <result pre="has been circulating since 2013 (Zeller et al., 2016) and" exact="ZIKV" post="since 2013 (Ayllon et al., 2017) or 2014 (Faria"/>
   <result pre="DENVs. Fewer mosquitoes are needed to cause local transmission of" exact="DENV" post="when herd immunity in the human population is low"/>
   <result pre="et al., 2000). In the current study, the presence of" exact="ZIKV" post="in Ae. aegypti during its emergence in Puerto Rico"/>
   <result pre="Puerto Rico in 2016 was compared with the presence of" exact="CHIKV" post="in 2014 (Barrera et al., 2017) in females of"/>
   <result pre="different mosquito densities and levels of vector control. For both" exact="CHIKV" post="in 2014 and ZIKV in 2016, mosquito densities and"/>
   <result pre="levels of vector control. For both CHIKV in 2014 and" exact="ZIKV" post="in 2016, mosquito densities and rates of virus detection"/>
   <result pre="in several consecutive weeks) were found. A serologic study of" exact="CHIKV" post="antibodies in residents of the four communities showed that"/>
   <result pre="al., 2016). A vector density threshold that seemed protective against" exact="CHIKV" post="of less than three female Ae. aegypti/SAGO trap/week was"/>
   <result pre="study were also below that threshold and a similarly low" exact="ZIKV" post="incidence in Ae. aegypti was found. As DENVs have"/>
   <result pre="(data not shown). The results also seem to indicate that" exact="ZIKV" post="detections in that location were less clustered in time"/>
   <result pre="in that location were less clustered in time (weeks) than" exact="CHIKV" post="detections in 2014, when average mosquito density was 30%"/>
   <result pre="or fraction of pools of female Ae. aegypti positive for" exact="CHIKV" post="or ZIKV did not differ significantly between years in"/>
   <result pre="of pools of female Ae. aegypti positive for CHIKV or" exact="ZIKV" post="did not differ significantly between years in the four"/>
   <result pre="the transmission potentials of Ae. aegypti�?borne arboviruses, such as DENV," exact="CHIKV" post="and ZIKV, are similar in the same locations (Funk"/>
   <result pre="to the whole island, the finding of similar IRs for" exact="CHIKV" post="and ZIKV may relate to the fact that similar"/>
   <result pre="whole island, the finding of similar IRs for CHIKV and" exact="ZIKV" post="may relate to the fact that similar proportions of"/>
   <result pre="fact that similar proportions of people (20–25%) were infected with" exact="CHIKV" post="in 2014 and ZIKV in 2016 in Puerto Rico"/>
   <result pre="of people (20–25%) were infected with CHIKV in 2014 and" exact="ZIKV" post="in 2016 in Puerto Rico (Hills et al., 2017)."/>
   <result pre="samples, and analytic methodologies. Overall IRs of Ae. aegypti with" exact="CHIKV" post="(7–12 per 1000) and ZIKV (5–19 per 1000) sampled"/>
   <result pre="IRs of Ae. aegypti with CHIKV (7–12 per 1000) and" exact="ZIKV" post="(5–19 per 1000) sampled using sentinel AGO traps for"/>
   <result pre="= 38; ZIKV, IR = 25). Previous studies have reported" exact="CHIKV" post="IRs comparable with those observed here (4–32 per 1000)"/>
   <result pre="et al., 2015; Dzul�?Manzanilla et al., 2015). Previous reports of" exact="ZIKV" post="IRs in Ae. aegypti were higher than those observed"/>
   <result pre="per 1000) (Diallo et al., 2014). In the present study," exact="DENV" post="IRs were very low (0.15–0.67 per 1000), virus detections"/>
   <result pre="low (0.15–0.67 per 1000), virus detections were infrequent, and no" exact="DENV" post="was detected in 2014 in the same study sites."/>
   <result pre="in 2014 in the same study sites. During the 2010" exact="DENV" post="epidemic in Puerto Rico, a higher IR (26 per"/>
   <result pre="et al., 2012). It is interesting to note that although" exact="CHIKV" post="and ZIKV were introduced into Puerto Rico at different"/>
   <result pre="2012). It is interesting to note that although CHIKV and" exact="ZIKV" post="were introduced into Puerto Rico at different times of"/>
   <result pre="their overall incidences in Ae. aegypti were similar. For example," exact="CHIKV" post="was confirmed in May 2014 (Sharp et al., 2016),"/>
   <result pre="in 2014 that peak in rainfall was practically absent. Subsequently," exact="CHIKV" post="spread rapidly throughout the island and started to fade"/>
   <result pre="December 2014, when it is typically cooler and drier. The" exact="CHIKV" post="epidemic peaked in September 2014 in Puerto Rico during"/>
   <result pre="CHIKV�?positive pools were observed in the study sites (September–October 2014)." exact="Zika" post="virus was first detected in December 2015 and the"/>
   <result pre="and most positive pools were identified during May–July 2016. Clearly," exact="ZIKV" post="had a longer period of circulation than CHIKV throughout"/>
   <result pre="2016. Clearly, ZIKV had a longer period of circulation than" exact="CHIKV" post="throughout 2016 before the advent of the cooler and"/>
   <result pre="usually wane (Barrera, 2010). However, it should be noted that" exact="ZIKV" post="was able to gain a foothold and eventually spread"/>
   <result pre="the drier and cooler season (December 2015 to March 2016)." exact="Zika" post="outbreaks in French Polynesia, Colombia and the State of"/>
   <result pre="T., Campos, R.M., Brasil, P.et al (2017) Early evidence for" exact="Zika" post="virus circulation among Aedes aegypti mosquitoes, Rio de Janeiro,"/>
   <result pre="and vectors. Parasites and Vectors, 11, 29.29316963 Brown, A.W.A. (1977)" exact="Yellow fever," post="dengue and dengue haemorrhagic fever In: Howe, G. M."/>
   <result pre="London, U.K. Burkhalter, K.L. &amp;amp; Savage, H.M. (2017) Detection of" exact="Zika" post="virus in desiccated mosquitoes by real�?time reverse transcription PCR"/>
   <result pre="M. (2018) Co�?circulation and simultaneous co�?infection of dengue, chikungunya, and" exact="Zika" post="viruses in patients with febrile syndrome at the Colombian–Venezuelan"/>
   <result pre="9, e0004043. Diallo, D., Sall, A.A., Diagne, C.T.et al (2014)" exact="Zika" post="virus emergence in mosquitoes in southeastern Senegal, 2011. PLoS"/>
   <result pre="J., Claro, I.M.et al (2017) Establishment and cryptic transmission of" exact="Zika" post="virus in Brazil and the Americas. Nature, 546, 406–410.28538727"/>
   <result pre=". A Review of Entomological Sampling Methods and Indicators for" exact="Dengue" post="Vectors. Special Programme for Research and Training in Tropical"/>
   <result pre="A.J., Camacho, A.et al (2016) Comparative analysis of dengue and" exact="Zika" post="outbreaks reveals differences by setting and virus. PLoS Neglected"/>
   <result pre="Vasilakis, N. &amp;amp; Musso, D. (2017) History and emergence of" exact="Zika" post="virus. Journal of Infectious Diseases, 216, S860–S867.29267917 Guerbois, M.,"/>
   <result pre="Guerbois, M., Fernandez�?Salas, I., Azar, S.R.et al (2016) Outbreak of" exact="Zika" post="virus infection, Chiapas State, Mexico, 2015, and first confirmed"/>
   <result pre="Zhao, S. &amp;amp; Ruan, S. (2017) A comparison study of" exact="Zika" post="virus outbreaks in French Polynesia, Colombia and the State"/>
   <result pre="Hills, S.L., Fischer, M. &amp;amp; Petersen, L.R. (2017) Epidemiology of" exact="Zika" post="virus infection. Journal of Infectious Diseases, 216, S868–S874.29267914 Jones,"/>
   <result pre="the vector index and geographic information system to prospectively inform" exact="West Nile" post="virus interventions. Journal of the American Mosquito Control Association,"/>
   <result pre="Control Association, 27, 315–319.22017098 Kauffman, E.B. &amp;amp; Kramer, L.D. (2017)" exact="Zika" post="virus mosquito vectors: competence, biology, and vector control. Journal"/>
   <result pre="22, 229–238.17019768 Lanciotti, R.S., Kosoy, O.L., Laven, J.J.et al (2007)" exact="Chikungunya" post="virus in U.S. travelers returning from India. Emerging Infectious"/>
   <result pre="M., Faria, N.R.et al (2017) Epidemiological and ecological determinants of" exact="Zika" post="virus transmission in an urban setting. eLife, 6, 29820."/>
   <result pre="M.U., Brady, O.J.et al (2016) Mapping global environmental suitability for" exact="Zika" post="virus. eLife, 5, e15272. Paploski, I.A., Rodrigues, M.S., Mugabe,"/>
   <result pre="&amp;amp; Boelle, P.Y. (2017) A comparative analysis of chikungunya and" exact="Zika" post="transmission. Epidemics, 19, 43–52.28139388 Sanchez, L., Vanlerberghe, V., Alfonso,"/>
   <result pre="69–76.28288924 collab: World Health Organization (2012) . Global Strategy for" exact="Dengue" post="Prevention and Control 2012–2020. WHO, Geneva. Yoon, I.K., Getis,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6400443\results\search\tropicalVirus\results.xml">
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Dengue" post="Fever : Biology and life sciences : Organisms :"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : People and Places : Geographical Locations :"/>
   <result pre="Infectious Diseases: Infectious Disease Control Epidemiological and clinical characteristics of" exact="Dengue" post="virus outbreaks in two regions of China, 2014 –"/>
   <result pre="virus outbreaks in two regions of China, 2014 – 2015" exact="Dengue" post="virus outbreaks in China, 2014 and 2015 CaoJiaqiConceptualizationData curationFormal"/>
   <result pre="medium, provided the original author and source are credited.pone.0213353.pdf Abstract" exact="Dengue" post="virus (DENV), a single-stranded RNA virus and Flaviviridae family"/>
   <result pre="member, is transmitted by Aedes aegypti and Aedes albopictus mosquitoes." exact="DENV" post="causes dengue fever, which may progress to severe dengue."/>
   <result pre="were IgM antibody-positive for DENV, and 69(51.88%) were positive for" exact="DENV" post="RNA. From these cases, 47(41.96%) were classified as primary"/>
   <result pre="isolated recently in Southeast Asian countries. Our results indicate that" exact="DENV" post="is no longer an imported virus and is now"/>
   <result pre="is now endemic in China. An extensive seroepidemiological study of" exact="DENV" post="and the implementation of vector control measures against it"/>
   <result pre="are within the manuscript and its Supporting Information files. Introduction" exact="Dengue" post="virus (DENV), a Flavivirus genus member of the Flaviviridae"/>
   <result pre="approximately 390 million people are estimated to be infected with" exact="DENV" post="each year, and disease manifestations occur in around 96"/>
   <result pre="96 million people [1]. The clinical signs and symptoms of" exact="DENV" post="infections can manifest themselves as mild fever, hemorrhagic fever,"/>
   <result pre="situation that poses a great threat to human health. The" exact="DENV" post="genome comprises a single strand of positive-sense RNA encoding"/>
   <result pre="of positive-sense RNA encoding three structural and seven nonstructural proteins." exact="DENV" post="is divided into four serotypes (DENV-1, -2, -3 and"/>
   <result pre="I–III and the sylvatic genotype [16]. The geographic distribution of" exact="DENV" post="infection on mainland China based on a number of"/>
   <result pre="the present study, we analyzed the envelope gene profile of" exact="DENV" post="and characterized the sero-prevalence, serotype distribution, type of infection,"/>
   <result pre="(The Third Affiliated Hospital of SUN YAT-SEN University). During the" exact="DENV" post="outbreaks, 105 whole blood specimens collected in Xishuangbanna (November"/>
   <result pre="with suspected dengue virus infection were screened for evidence of" exact="DENV" post="infections from 1 to 14 days after presentation at"/>
   <result pre="least one of the following diagnostic tests: NS1 antigen (Panbio" exact="Dengue" post="Early ELISA kit), anti-dengue immunoglobulin M (IgM) (Panbio Dengue"/>
   <result pre="(Panbio Dengue Early ELISA kit), anti-dengue immunoglobulin M (IgM) (Panbio" exact="Dengue" post="IgM Capture ELISA kit) or reverse-transcriptase real-time polymerase chain"/>
   <result pre="genome copy numbers for each sample were determined using the" exact="DENV" post="general-type real-time RT-PCR Liferiver kit (Shanghai ZJ Bio-Tech Co,"/>
   <result pre="dengue antigen detection. The preliminary screening for the presence of" exact="DENV" post="NS1 protein in patients’ sera was performed using the"/>
   <result pre="NS1 protein in patients’ sera was performed using the Panbio" exact="Dengue" post="Early ELISA kit (Alere, Brisbane, Australia) to detect the"/>
   <result pre="Anti-dengue IgG and IgM detection was performed using the Panbio" exact="Dengue" post="IgM and IgG Capture ELISA kit, which was also"/>
   <result pre="of the world. The sequences obtained were aligned with other" exact="DENV" post="sequences available in the GenBank database (www.ncbi.nlm.nih.gov). To identify"/>
   <result pre="Of the 112 confirmed dengue cases, 92 patients (82.14%) were" exact="DENV" post="IgM positive whereas 74 of the 94 available serum"/>
   <result pre="and 38 years (range, 18–81) for those with secondary infections." exact="DENV" post="RNA prevalence, viremia levels, and antibodies in the suspected"/>
   <result pre="cases Serotyping RT-qPCR was performed to estimate the prevalence of" exact="DENV" post="RNA in the samples. As shown in Fig 2A,"/>
   <result pre="the 133 serum samples, 69 (51.88%) were positive for reverse-transcribed" exact="DENV" post="DNA. In Xishuangbanna, eight samples (14.04%) from the isolates"/>
   <result pre="viral titer corresponding to the day of fever when the" exact="DENV" post="RNA was isolated from each patient. As shown in"/>
   <result pre="with no significant difference. Fig 2 Serotyping and quantitating of" exact="DENV" post="in the two study areas. (A) A comparison of"/>
   <result pre="to the onset day of fever in patients from which" exact="DENV" post="RNA was isolated. The serological characteristics of the serum"/>
   <result pre="an enzyme-linked immunosorbent assay. As shown in Fig 3, recent" exact="DENV" post="infection rates in Xishuangbanna (84.4%) and Guangzhou (76.2%) detected"/>
   <result pre="infection rates in Xishuangbanna (84.4%) and Guangzhou (76.2%) detected by" exact="DENV" post="IgM were much higher than past DENV infection rates"/>
   <result pre="(76.2%) detected by DENV IgM were much higher than past" exact="DENV" post="infection rates in these two study areas [Xishuangbanna (34.10%)"/>
   <result pre="by DENV-IgG. The viremia levels were significantly higher in the" exact="DENV" post="IgM seronegative samples than those for the DENV IgM"/>
   <result pre="in the DENV IgM seronegative samples than those for the" exact="DENV" post="IgM positive sera samples (p &amp;lt;0.01) (Fig 4A). Fig"/>
   <result pre="levels of dengue patients as estimated by RT-qPCR. (A) in" exact="DENV" post="IgM positive vs DENV IgM negative patients. (B) and"/>
   <result pre="as estimated by RT-qPCR. (A) in DENV IgM positive vs" exact="DENV" post="IgM negative patients. (B) and in primary vs secondary"/>
   <result pre="DENV IgM negative patients. (B) and in primary vs secondary" exact="DENV" post="infections. (C) in Guangzhou and Xishuangbanna regions. To find"/>
   <result pre="viral load with IgM positivity, infection type and serotypes of" exact="DENV" post="in different study areas, we analyzed in Fig 4."/>
   <result pre="laboratory parameters, infection types (serotypes of DENV, primary or secondary" exact="DENV" post="infections), and the clinical manifestations of the disease. As"/>
   <result pre="showed that the commonest age group for primary and secondary" exact="DENV" post="infection cases were 40–49 years and 20–39 years, respectively."/>
   <result pre="significant differences between the clinical features and the serotypes of" exact="DENV" post="infected, even though there were no differences in age,"/>
   <result pre="infections (S1 Table). Fig 5 Distributions of primary and secondary" exact="DENV" post="infections among patients in different age groups. Fig 6"/>
   <result pre="(A) white blood cell counts and (B) platelet counts in" exact="DENV" post="positive patients with primary or secondary DENV infection at"/>
   <result pre="platelet counts in DENV positive patients with primary or secondary" exact="DENV" post="infection at different onset days after fever. 10.1371/journal.pone.0213353.t001Table 1"/>
   <result pre="ND: Nodate Phylogenetic analysis The envelope gene sequences from 19" exact="DENV" post="isolates were obtained from samples from the study areas"/>
   <result pre="are identical to the KX056459 isolate from Yunnan. Fig 7" exact="DENV" post="phylogenetic trees. (A) The DENV-1 tree was constructed using"/>
   <result pre="exists between virulence and genetic diversity in this virus. Discussion" exact="Dengue" post="fever is an acute, emerging infectious disease caused by"/>
   <result pre="antibodies compared with the IgM positive ones. The presence of" exact="DENV" post="specific IgM antibodies may help with virion clearance through"/>
   <result pre="study indicated that some primary infections are associated with severe" exact="DENV" post="cases [38]. Many factors, such as genetic background, underlying"/>
   <result pre="fever during a primary infection [39]. In conclusion, during the" exact="DENV" post="outbreaks in Guangdong Province and Yunnan in 2014–2015, the"/>
   <result pre="new data to better understanding the pathogenic potential of distinct" exact="DENV" post="serotypes in human populations. Therefore, elucidating the immune responses"/>
   <result pre="responses to dengue fever and the pathogenic mechanisms used by" exact="DENV" post="are important scientific endeavors. Our phylogenetic analysis showed that"/>
   <result pre="that during the outbreaks in the two Chinese regions the" exact="DENV" post="serotypes we detected shared high homology with the isolates"/>
   <result pre="the clinical signs and symptoms associated with primary vs secondary" exact="DENV" post="infections. (DOCX) LINK Click here for additional data file."/>
   <result pre="DesedaC, ChotpitayasunondhT, DietzeR, et al.Efficacy and Long-Term Safety of a" exact="Dengue" post="Vaccine in Regions of Endemic Disease. N Engl J"/>
   <result pre="HeJ, ZhengK, Li LJL. Analysis on the epidemiologic features of" exact="Dengue" post="fever in Guangdong province, 1990–2000. Zhonghua Liu Xing Bing"/>
   <result pre="Virol. United States; 2013;85: 1258–1266. 10.1002/jmv.2357723595687 40WuJ-Y, LunZ-R, JamesAA, ChenX-G." exact="Dengue" post="Fever in mainland China. Am J Trop Med Hyg."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410043\results\search\tropicalVirus\results.xml">
   <result pre="The recent explosive pandemic of chikungunya virus (CHIKV) followed by" exact="Zika" post="(ZIKV) virus infections occurring throughout many countries represents the"/>
   <result pre="the clinical picture associated with these acute arbovirus infections, including" exact="Dengue" post="(DENV), CHIKV and ZIKV, ranges from classical febrile illness"/>
   <result pre="picture associated with these acute arbovirus infections, including Dengue (DENV)," exact="CHIKV" post="and ZIKV, ranges from classical febrile illness to life-threatening"/>
   <result pre="ZIKV, ranges from classical febrile illness to life-threatening disease. Whereas" exact="ZIKV" post="and CHIKV-mediated infections have previously been recognized as relatively"/>
   <result pre="previously been recognized as relatively benign diseases, in contrast to" exact="Dengue" post="fever, recent epidemic events have brought waves of increased"/>
   <result pre="two major families: (i) the Flaviviridae (genus flavivirus) which includes" exact="West Nile" post="(WNV), yellow fever (YFV), dengue (DENV) and Zika (ZIKV)"/>
   <result pre="includes West Nile (WNV), yellow fever (YFV), dengue (DENV) and" exact="Zika" post="(ZIKV) viruses and (ii) the Togaviridae (genus alphavirus) to"/>
   <result pre="viruses and (ii) the Togaviridae (genus alphavirus) to which belong" exact="Chikungunya" post="(CHIKV), Ross River (RRV) and Sindbis (SINV) viruses [1,2]."/>
   <result pre="humans [4]. In contrast to the typically sylvatic outbreaks of" exact="CHIKV" post="that occur in Africa, a single amino acid mutation"/>
   <result pre="amino acid mutation in the E1 envelop protein adapted the" exact="CHIKV" post="to Ae. albopictus, a vector that readily adapts to"/>
   <result pre="these infectious diseases with a staggering economic burden. For example," exact="DENV" post="causes more than 50 million infections yearly with more"/>
   <result pre="associated with neurological disorders and neonatal malformations in Latin America," exact="YFV" post="outbreaks in Angola and Brazil, WNV in North America,"/>
   <result pre="malformations in Latin America, YFV outbreaks in Angola and Brazil," exact="WNV" post="in North America, as well as the emergence of"/>
   <result pre="WNV in North America, as well as the emergence of" exact="CHIKV" post="from sub-Saharan Africa in the not-too-distant past and its"/>
   <result pre="the dermis, which represents the first stage of infection. Both" exact="DENV" post="and ZIKV have been shown to infect dermal dendritic"/>
   <result pre="which represents the first stage of infection. Both DENV and" exact="ZIKV" post="have been shown to infect dermal dendritic cells (DCs)"/>
   <result pre="dendritic cells (DCs) and although there are no reports of" exact="YFV" post="infecting Langerhans cells, it can nevertheless infect myeloid DCs."/>
   <result pre="nevertheless infect myeloid DCs. Viral entry into susceptible cells during" exact="ZIKV" post="infection is mediated by DC-SIGN but appears to be"/>
   <result pre="DC-SIGN but appears to be DC-SIGN-independent in the case of" exact="DENV" post="and YFV [8]. It has been shown that CHIKV"/>
   <result pre="appears to be DC-SIGN-independent in the case of DENV and" exact="YFV" post="[8]. It has been shown that CHIKV is able"/>
   <result pre="of DENV and YFV [8]. It has been shown that" exact="CHIKV" post="is able to replicate in epithelial and endothelial cells"/>
   <result pre="(Figure 2). In a zebrafish model, it was shown that" exact="CHIKV" post="rapidly disseminates to various organs within approximately 14 h"/>
   <result pre="prominent and prolonged arthralgia with CIKV infection, haemorrhagic fever with" exact="DENV" post="infection and microcephaly and other neurological manifestations with ZIKV"/>
   <result pre="with DENV infection and microcephaly and other neurological manifestations with" exact="ZIKV" post="infection [1,6,16]. It is however important to note that"/>
   <result pre="by arboviruses induces a long-term protection, as recently demonstrated for" exact="CHIKV" post="[17]. DENV is an excellent example of the opposite"/>
   <result pre="induces a long-term protection, as recently demonstrated for CHIKV [17]." exact="DENV" post="is an excellent example of the opposite situation, with"/>
   <result pre="long-term protection against infection by other serotypes. Furthermore, heterotypic secondary" exact="DENV" post="infection, with a DENV type distinct from the primary"/>
   <result pre="by other serotypes. Furthermore, heterotypic secondary DENV infection, with a" exact="DENV" post="type distinct from the primary infecting type, is the"/>
   <result pre="the primary infecting type, is the greatest risk factor for" exact="Dengue" post="haemorrhagic fever/dengue shock syndrome (DHF/DSS) [18]. It has been"/>
   <result pre="anti-DENV antibodies is directly associated with the severity of secondary" exact="DENV" post="disease in humans. 1.3. NK Cells: A Critical First-Line"/>
   <result pre="helicase motif 1b region of related flaviviruses, including DENGV, ZIKV," exact="YFV" post="and Japanese encephalitis viruses, to KIR2DS2. The other activating"/>
   <result pre="encompassing over 2 million suspected infections from the arrival of" exact="CHIKV" post="in 2013, an alphavirus associated with chronic and debilitating"/>
   <result pre="debilitating polyarthralgias (Pan American Health Organization 2017. http://www.paho.org/hq/index.php?option=com_topics&amp;amp;view=readall&amp;amp;cid=5927&amp;amp;Itemid=40931&amp;amp;lang=en). In 2008," exact="CHIKV" post="was listed as a US National Institute of Allergy"/>
   <result pre="role of NK cells was mostly examined in detail for" exact="CHIKV" post="infection. Although we and others have shown that NK"/>
   <result pre="NK cells mount an early and efficient protective response following" exact="CHIKV" post="infection, their contribution to viral-induced pathology has been reported"/>
   <result pre="been previously observed in other viral infections [20,50]. More intriguingly," exact="CHIKV" post="infection skews the NK cell receptor repertoire toward expression"/>
   <result pre="individuals. Similar observations have been made in the context of" exact="CHIKV" post="[45], Hantavirus [52] and viral hepatitis B and C"/>
   <result pre="animal models [59,60]. It is clear that NK cells in" exact="CHIKV" post="infection are strongly cytotoxic without producing IFN-γ, thereby suggesting"/>
   <result pre="of infection [45]. Thus, in an experimental mouse model of" exact="CHIKV" post="infection, extension of oedema was correlated with high NK"/>
   <result pre="cells appear to be beneficial in the acute phase of" exact="CHIKV" post="infection. Nevertheless, NK cells could contribute to immunopathologic mechanisms"/>
   <result pre="single vaccination (http://www.who.int/mediacentre/factsheets/fs100/en/). However, despite the success of this vaccine," exact="YFV" post="continues to circulate in the tropical jungles of Africa"/>
   <result pre="and South America and re-emerges regularly to infect naïve persons." exact="WNV" post="is even more widely dispersed because it infects a"/>
   <result pre="5 years, the virus had dispersed throughout the Americas [65]." exact="DENV" post="fever remains an important disease caused by four closely"/>
   <result pre="remains an important disease caused by four closely related viruses," exact="DENV" post="1–4, for which no DENV-specific therapies are available. The"/>
   <result pre="for which no DENV-specific therapies are available. The sole approved" exact="DENV" post="vaccine elicits protection in people with prior DENV exposure"/>
   <result pre="sole approved DENV vaccine elicits protection in people with prior" exact="DENV" post="exposure but not in naïve individuals in which it"/>
   <result pre="in which it has been associated with more cases of" exact="DENV" post="haemorrhagic fever upon subsequent infection [66]. Another important question"/>
   <result pre="first cell types to be infected by flaviviruses such as" exact="DENV" post="or ZIKV. The DCs are specialized in the production"/>
   <result pre="tissue-specific localizations are consistent with the generally accepted finding of" exact="DENV" post="infection that often results in &quot;petechiae�? following resolution of"/>
   <result pre="viral load in the brains of CXCR3-deficient mice infected by" exact="DENV" post="[72]. NK cells have been studied, to various extent,"/>
   <result pre="studied, to various extent, in several flavivirus infections, including DENV," exact="WNV" post="and ZIKV. Generally, in these infections, an early and"/>
   <result pre="dengue disease [15,73] and was also observed in children with" exact="DENV" post="haemorrhagic fever [58]. In addition, an extensive phenotypic study"/>
   <result pre="receptors NKp30, NKp44, NKp46 and NKG2D in patients infected by" exact="DENV" post="[73,74] or WNV [75]. A transient increase in the"/>
   <result pre="NKp46 and NKG2D in patients infected by DENV [73,74] or" exact="WNV" post="[75]. A transient increase in the frequency of adaptive"/>
   <result pre="previously described for CHIKV, whereas the most prominent response in" exact="WNV" post="infection was observed among CD56dimCD16− NK cells, an intermediate"/>
   <result pre="was observed that the activation state of NK cells in" exact="DENV" post="infection was short-lived [46], suggesting that there is no"/>
   <result pre="imprint on the NK cell repertoire, as previously observed in" exact="CHIKV" post="infection [45]. It is important to note that following"/>
   <result pre="compared with healthy controls [33,79,80]. Mechanistically, KIR molecules interact with" exact="DENV" post="peptides presented on HLA molecules. As observed in many"/>
   <result pre="was demonstrated between KIR3DL1 and a conserved NS1 peptide of" exact="DENV" post="presented by HLA-B57 [82]. By contrast, a peptide on"/>
   <result pre="As in several other human viral infections (e.g., CMV, hantavirus," exact="CHIKV" post="and HIV-1), we observed an early accumulation of NKG2C+"/>
   <result pre="infection [46]. Of note, in other flavivirus infections, such as" exact="WNV" post="and tick-borne encephalitis (TBEV), another flavivirus transmitted to humans"/>
   <result pre="Consistently, a direct interaction of NKp44 and protein E of" exact="DENV" post="and WNV has been observed [87]. These data suggest"/>
   <result pre="direct interaction of NKp44 and protein E of DENV and" exact="WNV" post="has been observed [87]. These data suggest that this"/>
   <result pre="activity, leading to the inhibition of NK cell function. In" exact="WNV" post="infections, this modulation is associated with upregulation of NKG2D"/>
   <result pre="be inhibited by blocking IFN-β [89]. Other flaviviruses such as" exact="WNV" post="are associated with activation of NF-κB, as shown after"/>
   <result pre="of NF-κB, as shown after infection of IFNAR(−/−) cells by" exact="WNV" post="[90]. Furthermore, it was reported that HLA-E is upregulated"/>
   <result pre="[90]. Furthermore, it was reported that HLA-E is upregulated in" exact="ZIKV" post="but not in DENV-infected NK cells, suggesting a differential"/>
   <result pre="human NK cells was found to be important in controlling" exact="DENV" post="replication in the absence of cytotoxicity [70]. Upregulation of"/>
   <result pre="of IFN-γ production by NK cells was also observed in" exact="WNV" post="infection both before and after NK cell expansion [92]."/>
   <result pre="microenvironment were associated with lower viral loads following vaccination against" exact="YFV" post="[78]. Nevertheless, it is important to note that an"/>
   <result pre="was reported in liver biopsies of patients who died of" exact="YFV" post="[93]. There are two mechanisms by which a viral"/>
   <result pre="school children in Thailand prior to a secondary infection with" exact="DENV" post="appeared to correlate with neutralizing Ab titres and immune"/>
   <result pre="examined in patients infected by DENV. Similarly, NK cells control" exact="WNV" post="infection by detecting and lysing NS1-expressing-infected cells through ADCC"/>
   <result pre="secondary infections by another serotype, when serotype-specific neutralizing antibodies to" exact="DENV" post="are present; the four DENV serotypes share 70% sequence"/>
   <result pre="when serotype-specific neutralizing antibodies to DENV are present; the four" exact="DENV" post="serotypes share 70% sequence homology and thus cross-reactivity is"/>
   <result pre="underlying mechanism of elevated immune-pathology associated with severe forms of" exact="DENV" post="[98,99]. This can cause antibody-dependent enhancement (ADE), in which"/>
   <result pre="Diversity, Identity and Cell EntryFront. Immunol.20189218010.3389/fimmu.2018.0218030319635 9.Van Duijl-RichterM.K.HoornwegT.E.Rodenhuis-ZybertI.A.SmitJ.M.Early Events in" exact="Chikungunya" post="Virus Infection-From Virus Cell Binding to Membrane FusionViruses201573647367410.3390/v707279226198242 10.PalhaN.Guivel-BenhassineF.BriolatV.LutfallaG.SourisseauM.EllettF.WangC.H.LieschkeG.J.HerbomelP.SchwartzO.et"/>
   <result pre="Cell Binding to Membrane FusionViruses201573647367410.3390/v707279226198242 10.PalhaN.Guivel-BenhassineF.BriolatV.LutfallaG.SourisseauM.EllettF.WangC.H.LieschkeG.J.HerbomelP.SchwartzO.et al.Real-time whole-body visualization of" exact="Chikungunya" post="Virus infection and host interferon response in zebrafishPLoS Pathog.20139e100361910.1371/journal.ppat.100361924039582"/>
   <result pre="Infect. Dis.201616e119e12610.1016/S1473-3099(16)30010-X27282424 17.AuerswaldH.BoussiouxC.InS.MaoS.OngS.HuyR.LeangR.ChanM.DuongV.LyS.et al.Broad and long-lasting immune protection against various" exact="Chikungunya" post="genotypes demonstrated by participants in a cross-sectional study in"/>
   <result pre="class-I and inhibitory KIR genotypes in Gabonese patients infected by" exact="Chikungunya" post="or Dengue type-2 virusesPLoS ONE20149e10879810.1371/journal.pone.010879825264760 34.BoudreauJ.E.HsuK.C.Natural killer cell education"/>
   <result pre="inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or" exact="Dengue" post="type-2 virusesPLoS ONE20149e10879810.1371/journal.pone.010879825264760 34.BoudreauJ.E.HsuK.C.Natural killer cell education in human"/>
   <result pre="cell memory in infection, inflammation and cancerNat. Rev. Immunol.20161611212310.1038/nri.2015.926806484 43.HotezP.J.MurrayK.O.Dengue," exact="West Nile" post="virus, chikungunya, Zika-and now Mayaro?PLoS Negl. Trop. Dis.201711e000546210.1371/journal.pntd.000546228859086 44.Acosta-AmpudiaY.MonsalveD.M.RodríguezY.PachecoY.AnayaJ.M.Ramírez-SantanaC.Mayaro:"/>
   <result pre="toward cytotoxicityPLoS Pathog.20117e100226810.1371/journal.ppat.100226821966274 46.PetitdemangeC.WauquierN.DevilliersH.YsselH.MomboI.CaronM.NkoghéD.DebréP.LeroyE.VieillardV.Longitudinal Analysis of Natural Killer Cells in" exact="Dengue" post="Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected"/>
   <result pre="Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to" exact="Chikungunya" post="and Chikungunya/Dengue Virus-Infected PatientsPLoS Negl. Trop. Dis.201610e000449910.1371/journal.pntd.000449926938618 47.ThanapatiS.DasR.TripathyA.S.Phenotypic and"/>
   <result pre="stages of chikungunya infectionFront. Microbiol.2015689510.3389/fmicb.2015.0089526388848 48.FoxJ.M.DiamondM.S.Immune-Mediated Protection and Pathogenesis of" exact="Chikungunya" post="VirusJ. Immunol.20161974210421810.4049/jimmunol.160142627864552 49.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.DenizotM.GuichardE.RiberaA.HenniT.et al.Persistent chronic inflammation and"/>
   <result pre="Immunol.20161974210421810.4049/jimmunol.160142627864552 49.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.DenizotM.GuichardE.RiberaA.HenniT.et al.Persistent chronic inflammation and infection by" exact="Chikungunya" post="arthritogenic alphavirus in spite of a robust host immune"/>
   <result pre="CancerCold Spring Harb. Perspect. Biol.20181010a02953810.1101/cshperspect.a029538 61.TeoT.H.HerZ.TanJ.J.LumF.M.LeeW.W.ChanY.H.OngR.Y.KamY.W.Leparc-GoffartI.GallianP.et al.Caribbean and La Réunion" exact="Chikungunya" post="Virus Isolates Differ in Their Capacity To Induce Proinflammatory"/>
   <result pre="osteoarthritisOsteoarthr. Cartil.2017251708171810.1016/j.joca.2017.06.00728668542 64.StrodeG.K.Yellow FeverMcGraw-HillNew York, NY, USA1951 65.JiaX.Y.BrieseT.JordanI.RambautA.ChiH.C.MackenzieJ.S.HallR.A.ScherretJ.LipkinW.I.Genetic analysis of" exact="West Nile" post="New York 1999 encephalitis virusLancet19993541971197210.1016/S0140-6736(99)05384-210622305 66.NgonoA.E.ShrestaS.Immune Response to Dengue"/>
   <result pre="West Nile New York 1999 encephalitis virusLancet19993541971197210.1016/S0140-6736(99)05384-210622305 66.NgonoA.E.ShrestaS.Immune Response to" exact="Dengue" post="and ZikaAnnu. Rev. Immunol.20183627930810.1146/annurev-immunol-042617-05314229345964 67.BecquartP.WauquierN.NkogheD.Ndjoyi-MbiguinoA.PadillaC.SourisM.LeroyE.M.Acute dengue virus 2 infection"/>
   <result pre="hemorrhagic feverJ. Infect. Dis.19991801429143510.1086/31507210515800 75.YaoY.Strauss-AlbeenD.M.ZhouJ.Q.MalawistaA.GarciaM.N.MurrayK.O.BlishC.A.MontgomeryR.R.The natural killer cell response to" exact="West Nile" post="virus in young and old individuals with or without"/>
   <result pre="al.NKp44 receptor mediates interaction of the envelope glycoproteins from the" exact="West Nile" post="and dengue viruses with NK cellsJ. Immunol.20091832610262110.4049/jimmunol.080280619635919 88.LobigsM.MüllbacherA.RegnerM.MHC class"/>
   <result pre="MoleculesJ. Virol.201791e00785-1710.1128/JVI.00785-1728878071 90.ChengY.KingN.J.KessonA.M.Major histocompatibility complex class I (MHC-I) induction by" exact="West Nile" post="virus: Involvement of 2 signaling pathways in MHC-I up-regulationJ."/>
   <result pre="up-regulationJ. Infect. Dis.200418965866810.1086/38150114767820 91.DrewsE.AdamA.HtooP.TownsleyE.MathewA.Upregulation of HLA-E by dengue and not" exact="Zika" post="virusesClin. Transl. Immunol.20187e103910.1002/cti2.1039 92.ZhangM.DanielS.HuangY.ChanceyC.HuangQ.LeiY.F.GrinevA.MostowskiH.RiosM.DaytonA.Anti-West Nile virus activity of in"/>
   <result pre="cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of" exact="West Nile" post="Virus-infected cellsJ. Virol.2007819551955510.1128/JVI.00879-0717582005 98.KhandiaR.MunjalA.DhamaK.KarthikK.TiwariR.MalikY.S.SinghR.K.ChaicumpaW.Modulation of Dengue/Zika Virus Pathogenicity by"/>
   <result pre="by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in" exact="Zika" post="Virus InfectionFront. Immunol.2018959710.3389/fimmu.2018.0059729740424 99.CastanhaP.M.S.NascimentoE.J.M.BragaC.CordeiroM.T.de CarvalhoO.V.de MendonçaL.R.AzevedoE.A.N.FrançaR.F.O.DhaliaR.MarquesE.T.A.Enhancement of Zika Infection"/>
   <result pre="Enhancement in Zika Virus InfectionFront. Immunol.2018959710.3389/fimmu.2018.0059729740424 99.CastanhaP.M.S.NascimentoE.J.M.BragaC.CordeiroM.T.de CarvalhoO.V.de MendonçaL.R.AzevedoE.A.N.FrançaR.F.O.DhaliaR.MarquesE.T.A.Enhancement of" exact="Zika" post="Infection by Dengue-Specific Antibodies Does Not Alter the Production"/>
   <result pre="enhancement of dengue virusesAdv. Virus Res.20036042146714689700 101.SunP.WilliamsM.NagabhushanaN.MorrisonB.J.Combating Antibody-dependent Enhancement of" exact="Dengue" post="Viral infection in Peripheral Blood Monocytes by NK Cell-mediated"/>
   <result pre="(BAGV), Bamaga virus (BGV), Banzi virus (BANV), Bouboui virus (BOUV)," exact="Dengue" post="virus (DENV), Israel Turkey meningoencephalomyelitis (ITV), Japanese encephalitis virus"/>
   <result pre="(TMUV), T’Ho virus (THOV), Usutu virus (USUV), Wesselsbron virus (WESSV)," exact="West Nile" post="virus (WNV), yellow fever virus (YFV) and Zika virus"/>
   <result pre="(WESSV), West Nile virus (WNV), yellow fever virus (YFV) and" exact="Zika" post="virus (ZIKV). Alphaviruses: Barmah forest virus (BFV), Chikungunya virus"/>
   <result pre="(YFV) and Zika virus (ZIKV). Alphaviruses: Barmah forest virus (BFV)," exact="Chikungunya" post="virus (CHIKV), Mayaro virus (MAYV), O’nyong-nyong virus (ONNV), Ross"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410217\results\search\tropicalVirus\results.xml">
   <result pre="VirusesVirusesvirusesViruses1999-4915MDPI pmcid: 6410217 doi: 10.3390/v11020175viruses-11-00175 : Review Tropism of the" exact="Chikungunya" post="Virus https://orcid.org/0000-0002-2948-4243MatusaliGiulia*ColavitaFrancesca*BordiLiciaLalleEleonorahttps://orcid.org/0000-0002-1076-2979IppolitoGiuseppeCapobianchiMaria R.https://orcid.org/0000-0001-9819-236XCastillettiConcetta[], licia.bordi@inmi.iteleonora.lalle@inmi.itgiuseppe.ippolito@inmi.itmaria.capobianchi@inmi.itconcetta.castilletti@inmi.it *Correspondence: giulia.matusali@inmi.it (G.M.); francesca.colavita@inmi.it (F.C.)"/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Chikungunya" post="virus (CHIKV) is a re-emerging mosquito-borne virus that displays"/>
   <result pre="involving mosquito vectors and human or vertebrate animal hosts. Although" exact="CHIKV" post="was first isolated in 1953, its pathogenesis was only"/>
   <result pre="studied after its re-emergence in 2004. The unexpected spread of" exact="CHIKV" post="to novel tropical and non-tropical areas, in some instances"/>
   <result pre="agent and its associated diseases. The comprehension of the exact" exact="CHIKV" post="target cells and organs, mechanisms of pathogenesis, and spectrum"/>
   <result pre="tropism arthropod vectors animal hosts pathogenesis vertical transmission 1. Introduction" exact="Chikungunya" post="virus (CHIKV), a mosquito-borne alphavirus of the Togaviridae family,"/>
   <result pre="Culex spp. mosquitoes in 1953 [1]. In the late 1950s," exact="CHIKV" post="was described in Uganda, the sub-Saharan region, and in"/>
   <result pre="Southern Africa [2]. Based on the phylogenetic analysis of the" exact="CHIKV" post="sequences from these early African outbreaks, they were grouped"/>
   <result pre="is thought to have moved from Africa to Asia, where" exact="CHIKV" post="outbreaks were initially confused with dengue epidemics. Genetic analyses"/>
   <result pre="outbreaks were initially confused with dengue epidemics. Genetic analyses of" exact="CHIKV" post="isolated from 1958 to 1973 in Asia placed them"/>
   <result pre="large epidemic in Réunion Island in 2005 [5]. Cases of" exact="CHIKV" post="(IOL lineage) have been described in Europe since 2007,"/>
   <result pre="coming back from India [6]. Since then, autochthonous cases of" exact="CHIKV" post="fever have occurred in France, Croatia, Spain, and Italy."/>
   <result pre="in France, Croatia, Spain, and Italy. In the Pacific region," exact="CHIKV" post="(Asian lineage) was first detected in early 2011 in"/>
   <result pre="Micronesia and French Polynesia [7,8]. In the Western Hemisphere, Asian" exact="CHIKV" post="was initially identified in the Caribbean, precisely in Saint"/>
   <result pre="the ECSA isolates detected in Angola [8,9]. The most recent" exact="CHIKV" post="outbreak was reported in Sudan, affecting seven states, with"/>
   <result pre="State [10,11] (see [12] for a more extensive review on" exact="CHIKV" post="epidemics). 2. Invertebrate and Vertebrate Animal Hosts 2.1. Invetebrate"/>
   <result pre="of human diseases, and account for the vast majority of" exact="CHIKV" post="transmission to humans through the urban transmission cycle (i.e.,"/>
   <result pre="A226V E1) was considered responsible for the increased fitness of" exact="CHIKV" post="in Ae albopictus and the consequent acquisition of a"/>
   <result pre="mosquito [16,17], and allowed for the substantial geographic expansion of" exact="CHIKV" post="throughout sub-Saharan Africa and Southeast Asia, and into Europe"/>
   <result pre="Southeast Asia, and into Europe [18]. It is noteworthy that" exact="CHIKV" post="isolated from some of the European autochthonous cases lacked"/>
   <result pre="other mosquitoes have been found to be incidentally infected by" exact="CHIKV" post="in Africa, including Culex spp., Anopheles spp., and Mansonia"/>
   <result pre="Data from laboratory-based competence assays further enlarge the spectrum of" exact="CHIKV" post="potential vectors. Results from nine studies demonstrated a full"/>
   <result pre="vectors. Results from nine studies demonstrated a full competence for" exact="CHIKV" post="transmission of mosquitoes captured in Africa (Ae fulgens, Ae"/>
   <result pre="Ae notoscriptus) [33,34,35,36,37,38]. Moreover, one study demonstrated the presence of" exact="CHIKV" post="in the saliva of Culex gelidus mosquitoes after intrathoracic"/>
   <result pre="inoculation [39], while other researchers observed a low rate of" exact="CHIKV" post="transmission for Ae koreicus, a mosquito new to Europe"/>
   <result pre="mosquito vectors display different degrees of vector competence for different" exact="CHIKV" post="isolates, and the nsP3 viral protein seems to be"/>
   <result pre="protein seems to be a determinant of vector specificity [41]." exact="CHIKV" post="is horizontally transmitted to vectors during a blood meal"/>
   <result pre="vectors during a blood meal on a viremic host with" exact="CHIKV" post="viral titers ranging from 103–105 plaque-forming units per ml"/>
   <result pre="replicates. There are two mechanisms proposed for the dissemination of" exact="CHIKV" post="from the midgut to secondary organs, as follows: (i)"/>
   <result pre="abdomen to the head), eventually reaching the salivary glands [33,50]." exact="CHIKV" post="replicates and is stored in the acinar cells of"/>
   <result pre="where it apparently does not cause a cytopathic effect [51,52,53,54]." exact="CHIKV" post="infection of the fat bodies of the Aedes species,"/>
   <result pre="for other arboviruses (e.g., dengue virus 2 (DENV 2) and" exact="Zika" post="virus (ZIKV)) [49,55], is currently undetermined. On the contrary,"/>
   <result pre="isolation from the legs and wings indicate the presence of" exact="CHIKV" post="in these districts [56] (see Figure 1 for CHIKV"/>
   <result pre="of CHIKV in these districts [56] (see Figure 1 for" exact="CHIKV" post="mosquito tissue tropism). Interestingly, the ovary is also infected"/>
   <result pre="the virus persisting in eggs [62]. The transovarial transmission of" exact="CHIKV" post="through eggs potentially leads to virus survival in adverse"/>
   <result pre="desiccation during the dry season) [63,64]. On the other hand," exact="CHIKV" post="seems to perturb the egg-laying pathway—resulting in a lower"/>
   <result pre="the human population may occur. In Africa, during inter-epidemic periods," exact="CHIKV" post="is believed to be preserved via a sylvatic transmission"/>
   <result pre="the Pacific) and Europe in the amplification and survival of" exact="CHIKV" post="has been poorly investigated to date. Indeed, the majority"/>
   <result pre="(Table 1). In the early studies carried out in Senegal," exact="CHIKV" post="was isolated from non-human primates (NHPs) (i.e., Cercopithecus aethiops,"/>
   <result pre="rattus) (reviewed in [65] and [66,67,69]). Notably, neutralizing antibodies against" exact="CHIKV" post="were measured in one forest buffalo (Syncerus caffer nanus)"/>
   <result pre="one report was published on the infection and seroprevalence of" exact="CHIKV" post="in American NHPs [79]. The American study showed low"/>
   <result pre="of non-human-vertebrates’ natural infection, experimental investigations on host susceptibility to" exact="CHIKV" post="were mostly conducted in NHPs and rodents, with the"/>
   <result pre="order to assess the onset of viremia and seroconversion upon" exact="CHIKV" post="infection. The animals with detectable CHIKV viremia were some"/>
   <result pre="viremia and seroconversion upon CHIKV infection. The animals with detectable" exact="CHIKV" post="viremia were some mammals (i.e., hamsters, C57BL/6 mice, and"/>
   <result pre="birds and non-primate mammals are competent reservoirs for CHIKV. 3." exact="CHIKV" post="Cellular Receptors Viral tropism is defined as the capacity"/>
   <result pre="for viral attachment molecules being of undeniable importance [83]. The" exact="CHIKV" post="protein that facilitates cell binding is the E2 glycoprotein,"/>
   <result pre="the E2 glycoprotein, while the related cellular receptor/s crucial for" exact="CHIKV" post="entry has/have yet to be recognized [83]. Given the"/>
   <result pre="and cell types [83]. The first molecule indicated as a" exact="CHIKV" post="receptor in 2012 was Prohibitin 1 (PHB1), a multifunctional"/>
   <result pre="In microglial cells, PHB1 was shown to co-immunoprecipitate with the" exact="CHIKV" post="E2 protein, and the number of infected cells was"/>
   <result pre="entry by pre-incubating HEK-293T cells with flavaglines (prohubitin ligands) before" exact="CHIKV" post="infection. This pre-treatment reduced both the percentage of infected"/>
   <result pre="through a genome-wide screening for the cellular factors required for" exact="CHIKV" post="entry, identified the cell adhesion molecule Mxra8. They demonstrated"/>
   <result pre="molecule Mxra8. They demonstrated that blocking this molecule prior to" exact="CHIKV" post="infection significantly reduced the number of human primary synovial"/>
   <result pre="reduction .ca) [86]. In a mouse model of in vivo" exact="CHIKV" post="infection, the administration of the Mxr8a-Fc protein or blocking"/>
   <result pre="Mxr8a-Fc protein or blocking antibodies reduced both foot swelling and" exact="CHIKV" post="infection with a differential efficiency, based on treatment kinetics"/>
   <result pre="Nevertheless, the lack of Mxra8 on the membranes of some" exact="CHIKV" post="target cells (e.g., keratinocytes) indicates that this factor can"/>
   <result pre="molecules, T-cell immunoglobulin and mucin domain-1 (TIM-1), recently involved in" exact="ZIKV" post="entry, and Glycosaminoglycans (GAGs), important for the efficient infection"/>
   <result pre="and Venezuelan equine encephalitis virus (VEEV)), have been implicated in" exact="CHIKV" post="attachment (reviewed in [83]) to human cells, while HSC70"/>
   <result pre="HSC70 and ATP synthase beta subunit have been suggested as" exact="CHIKV" post="binding factors in mosquito cells [87,88]. Overall, a plethora"/>
   <result pre="plethora of cell membrane molecules have been indicated as putative" exact="CHIKV" post="binding/entry factors, but no definitive identification has been established."/>
   <result pre="been established. 4. Human Infection Following an infected mosquito bite," exact="CHIKV" post="is introduced into the human skin and into the"/>
   <result pre="or suspected (sexual transmission). 4.1. Stages and Clinical Signs of" exact="Chikungunya" post="Infection One major challenge for clinicians, nowadays, is to"/>
   <result pre="to differentiate the clinical signs of chikungunya from those of" exact="Zika" post="and dengue fever, especially when these viruses are co-circulating."/>
   <result pre="and dengue fever, especially when these viruses are co-circulating. Unlike" exact="ZIKV" post="and DENV, whose infections are asymptomatic in about 62%"/>
   <result pre="asymptomatic in about 62% and 75% of individuals, respectively [89,90]," exact="CHIKV" post="causes symptoms in a high majority (72% to 95%)"/>
   <result pre="a high majority (72% to 95%) of infected people [91,92]." exact="CHIKV" post="infects humans through the bite of Aedes spp. mosquito"/>
   <result pre="and range from photophobia to retro-orbital pain and conjunctivitis [95]." exact="Chikungunya" post="chronic disease is characterized by the persistence or relapse"/>
   <result pre="the pooled prevalence of chronic inflammatory rheumatism (CIR) associated to" exact="CHIKV" post="infection was 40.2% [98]. A growing number of atypical"/>
   <result pre="organs. Economopoulou and colleagues reported that during the large 2005–2006" exact="CHIKV" post="outbreak on the Reunion Island, the proportion of atypical"/>
   <result pre="proportion of atypical cases (defined as patients with laboratory confirmed" exact="CHIKV" post="infection and symptoms other than fever and arthralgia) was"/>
   <result pre="is important to mention the neurological complications (approximately 0.1% of" exact="CHIKV" post="infection develops neurological disorders), most commonly encephalitis and encephalopathy,"/>
   <result pre="disorders), most commonly encephalitis and encephalopathy, prompted the investigation of" exact="CHIKV" post="tropism for the central nervous system (CNS) [107]. Acute"/>
   <result pre="a variety of agents, including arboviruses, has been associated to" exact="CHIKV" post="infection [107,110,111,112]. The tropism of CHIKV in the nervous"/>
   <result pre="has been associated to CHIKV infection [107,110,111,112]. The tropism of" exact="CHIKV" post="in the nervous system will be further detailed in"/>
   <result pre="production [113], and the effect of these cytokines in controlling" exact="CHIKV" post="replication has been extensively investigated. IFN-I and IFN stimulated"/>
   <result pre="and the role of IFN-I response in the context of" exact="CHIKV" post="infection is evidenced by the full susceptibility to severe"/>
   <result pre="CHIKV infection is evidenced by the full susceptibility to severe" exact="CHIKV" post="infection of IFN-type-I receptors deficient (IFNAR -/-), in contrast"/>
   <result pre="in contrast to adult wild-type (wt) mice [115]. In vitro," exact="CHIKV" post="does not directly stimulate IFN-I production in immune cells."/>
   <result pre="the peak of IFN correlated with the decline in the" exact="CHIKV" post="load. This prompt inhibition avoided CHIKV dissemination [115]. In"/>
   <result pre="the decline in the CHIKV load. This prompt inhibition avoided" exact="CHIKV" post="dissemination [115]. In infected patients and NHPs, the viral"/>
   <result pre="This can be in part due to the counteraction of" exact="CHIKV" post="proteins. Indeed, the viral nonstructural protein 2 (nsP2) has"/>
   <result pre="production and spread [120], but in vitro experiments demonstrated that" exact="CHIKV" post="is able to hide in apoptotic blebs and infect"/>
   <result pre="tumor necrosis factor (TNFα)) in the plasma of acutely infected" exact="CHIKV" post="patients and NHPs [116,122,123,124,125,126,127]. Notably, IL-6, IL-1b, and TNFα"/>
   <result pre="other cytokines/chemokines have been indicated as forming a generic acute" exact="CHIKV" post="signature in a meta-analysis conducted in all patient cohorts"/>
   <result pre="growth factors [130]. Another factor involved in the modulation of" exact="CHIKV" post="pathogenesis is the interferon regulatory factor 1 (IRF-1), which"/>
   <result pre="regulatory factor 1 (IRF-1), which in an IFN-independent manner, restricts" exact="CHIKV" post="replication in muscle cells and contrasts the infiltration of"/>
   <result pre="tissues of mice [131]. Monocytes/macrophages also have a role in" exact="CHIKV" post="pathogenesis, both secreting inflammatory mediators, migrating to distal districts,"/>
   <result pre="4.3.4). Natural killer (NK) cells showed activated profiles during acute" exact="CHIKV" post="[132], and NK cells’ infiltration in the synovial tissue"/>
   <result pre="[129]. Adaptive immunity is mediated by B and T cells." exact="CHIKV" post="induces a robust humoral response leading to the production"/>
   <result pre="biopsy from a neonatal fatal case [142]. In these cells," exact="CHIKV" post="infection determines a strong antiviral IFN-type-I (IFN-I) response, alongside"/>
   <result pre="results were obtained by another research group, who used IOL" exact="CHIKV" post="strains encoding GFP or mCherry reporter genes to infect"/>
   <result pre="by epithelial cells). The susceptibility of primary human keratinocytes to" exact="CHIKV" post="was recently confirmed by Zhang et al. [86], where"/>
   <result pre="mouse model supports a role for these antiviral pathways in" exact="CHIKV" post="restriction. Along with the dermal fibroblasts and keratinocytes, melanocytes"/>
   <result pre="the dermal fibroblasts and keratinocytes, melanocytes are also permissive for" exact="CHIKV" post="[148], while the infection of dermal macrophages is only"/>
   <result pre="other anatomical districts has been characterized in NHP models, where" exact="CHIKV" post="travels from the site of infection (i.e., the skin)"/>
   <result pre="cells producing viral particles were primary monocyte-derived-macrophages [140]. Since then," exact="CHIKV" post="tropism for blood cells has been more extensively studied,"/>
   <result pre="(CXCL9), IL1β, and TNFα) in the plasma of acutely infected" exact="CHIKV" post="patients was found to correlate with high viral titers"/>
   <result pre="[122,123,124,125,126,127]. Similar findings in NHPs further validate these models of" exact="CHIKV" post="infection/pathogenesis [116]. Interestingly, viral replication dynamics in PBMCs experimentally"/>
   <result pre="[116]. Interestingly, viral replication dynamics in PBMCs experimentally infected with" exact="CHIKV" post="and DENV resulted in a significant reduction of CHIKV"/>
   <result pre="viral replication dynamics in PBMCs experimentally infected with CHIKV and" exact="DENV" post="resulted in a significant reduction of CHIKV progeny and"/>
   <result pre="with CHIKV and DENV resulted in a significant reduction of" exact="CHIKV" post="progeny and a moderate enhancement of DENV production. Co-infection"/>
   <result pre="significant reduction of CHIKV progeny and a moderate enhancement of" exact="DENV" post="production. Co-infection also led to higher levels of IL-6"/>
   <result pre="the two arboviral diseases [152]. The effect of co-infections on" exact="CHIKV" post="tropism and pathogenesis is ill-defined and should be further"/>
   <result pre="be further investigated both in humans and animal models. Finally," exact="CHIKV" post="can also associate to red blood cells and platelets,"/>
   <result pre="Muscle, Joint, and Bone During the acute and subacute phase," exact="CHIKV" post="reaches the muscle and joint compartments where it gives"/>
   <result pre="acutely infected and the other relapsing) were stained positive for" exact="CHIKV" post="antigens in fusiform curved shape cells co-labelling with specific"/>
   <result pre="Nevertheless, primary human myoblasts were found to be permissive to" exact="CHIKV" post="in a more recent study [156], and skeletal muscle"/>
   <result pre="antigens in a fatal neonatal case [142]. The ability of" exact="CHIKV" post="to infect progenitor cells and to induce skeletal muscle"/>
   <result pre="muscle as a site of viral persistence. The other distinctive" exact="CHIKV" post="clinical syndrome is arthralgia, which is generally of symmetric"/>
   <result pre="distal synovial joints more commonly affected than the proximal [129]." exact="CHIKV" post="RNA and proteins have been identified in the synovial"/>
   <result pre="[129,149,155,157,158], and both synovial fibroblasts and macrophages are susceptible to" exact="CHIKV" post="[86,129,142,159]. The histological analysis of a chronic patient’s biopsy"/>
   <result pre="of a chronic patient’s biopsy showed the active replication of" exact="CHIKV" post="in joint macrophages’ infiltration of activated NK cells and"/>
   <result pre="Together with joint inflammation, cartilage degradation also takes place in" exact="CHIKV" post="infected individuals. In humans, the presence of elevated levels"/>
   <result pre="collagenosis and fibrosis were observed [125,161,162]. A direct effect of" exact="CHIKV" post="on cartilage is suggested by viral replication in human"/>
   <result pre="by viral replication in human primary chondrocytes [86] and in" exact="CHIKV" post="inoculated immunodeficient (IRF3/7−/−) mice [145]. Bone loss is another"/>
   <result pre="immunodeficient (IRF3/7−/−) mice [145]. Bone loss is another hallmark of" exact="CHIKV" post="arthritis, and osteoblasts are a site of CHIKV replication"/>
   <result pre="hallmark of CHIKV arthritis, and osteoblasts are a site of" exact="CHIKV" post="replication and persistence [86,163,164,165]. Ex vivo infection of human"/>
   <result pre="joints (CCL2, CCL7, and CCL8) and in the serum of" exact="CHIKV" post="patients (CCL2) [122,123,129,165] favors an osteoclastogenic and chemo-attractive microenvironment."/>
   <result pre="CHIKV-infected animals [125,166,167], and by the ability of supernatants of" exact="CHIKV" post="infected synovial fibroblasts to induce migration and differentiation into"/>
   <result pre="the clearance of the virus [167] (see Figure 2 for" exact="CHIKV" post="tropism in muscle, joint, and bone). 4.3.3. Infection of"/>
   <result pre="muscle, joint, and bone). 4.3.3. Infection of the Nervous System" exact="CHIKV" post="is not considered to be a true neurotropic virus"/>
   <result pre="in the 1960s and 1970s [168,169,170]. Upon the re-emergence of" exact="CHIKV" post="in the Indian Ocean in 2005, a growing number"/>
   <result pre="few brain autopsies analyzed for histopathological studies, the presence of" exact="CHIKV" post="antigens was not evaluated [171]. As a consequence, the"/>
   <result pre="not evaluated [171]. As a consequence, the target cells of" exact="CHIKV" post="in the human brain remain unknown. Nevertheless, the in"/>
   <result pre="and microglial cells [176,177] to CHIKV. The apoptosis observed in" exact="CHIKV" post="infected neuroblastoma cells and astrocytes suggests a direct implication"/>
   <result pre="infection of oligodendrocytes was evidenced in vitro [178,179,180]. In NHPs," exact="CHIKV" post="RNA was detected in the brain during the acute"/>
   <result pre="of human and animal origin can, in some instances, produce" exact="CHIKV" post="infective particles [140,181,182]. The mechanisms by which CHIKV affects"/>
   <result pre="instances, produce CHIKV infective particles [140,181,182]. The mechanisms by which" exact="CHIKV" post="affects the human nervous system remain ill defined. It"/>
   <result pre="In the nervous system, the eye may be injured in" exact="CHIKV" post="patients. Ocular diseases present mainly as retro-orbital pain or"/>
   <result pre="mainly as retro-orbital pain or conjunctivitis at the time of" exact="CHIKV" post="systemic illness, and predominantly as uveitis, retinitis, or optic"/>
   <result pre="reported three times [187,188,189], and in a laboratory screening of" exact="CHIKV" post="infection of corneal donors, infectious viral particles and RNA"/>
   <result pre="the eye tissue from four donors [189]. The characterization of" exact="CHIKV" post="positive cells in the human eye revealed the infection"/>
   <result pre="muscle fibers [189]. Based on these results, the risk of" exact="CHIKV" post="iatrogenic transmission through corneal transplantation must be taken into"/>
   <result pre="Target Organs The wide range of secondary organs targeted by" exact="CHIKV" post="may explain the rare consequences of chikungunya infection, and"/>
   <result pre="was developed by Labadie and coworkers [166], who inoculated a" exact="CHIKV" post="IOL isolate into 15 cynomolgus macaques (Macaca fascicularis). High"/>
   <result pre="liver, and heart have been found to be positive for" exact="CHIKV" post="in another NHP model [190], and viral RNA has"/>
   <result pre="findings suggest that kidneys and lungs are also targeted by" exact="CHIKV" post="[140,177,190,192]. Both human and animal derived kidney epithelial and"/>
   <result pre="for viral assays [140,177,192]. Nevertheless, the exact target cells of" exact="CHIKV" post="in human secondary target organs (e.g., the kidney, liver,"/>
   <result pre="fluid specimens such as saliva and urine. In the saliva," exact="CHIKV" post="seems to originate from oral bleeding [193], while whether"/>
   <result pre="2017, we screened 1414 serum specimens for the presence of" exact="CHIKV" post="RNA, and 196 of these resulted positive. For some"/>
   <result pre="Target Organs upon Non-Arthropod-Borne Transmission Cases of mother to child" exact="CHIKV" post="transmission have been reported, and a recent systematic review"/>
   <result pre="fetuses [198]. In a cohort study from the same epidemics," exact="CHIKV" post="RNA was again detected in the amniotic fluid (4/23"/>
   <result pre="(19/462) [199], and a fatal Brazilian fetal case of the" exact="Zika" post="virus and CHIKV co-infection presented with CHIV RNA in"/>
   <result pre="a fatal Brazilian fetal case of the Zika virus and" exact="CHIKV" post="co-infection presented with CHIV RNA in the placenta [200]."/>
   <result pre="to infection in vitro [142,201]. Nowadays, the hypothesized mechanism of" exact="CHIKV" post="vertical transmission is the passage of the virus from"/>
   <result pre="knock-out mouse model [142]. However, recent research showed in vitro" exact="CHIKV" post="replication in human fetal membranes (from the second trimester),"/>
   <result pre="dissect the mechanisms and to reveal the risk factors of" exact="CHIKV" post="mother to child transmission. Another non-arthropod-borne route under investigation"/>
   <result pre="is the sexually driven spreading. Indeed, since the discovery of" exact="ZIKV" post="sexual transmission, great efforts have been made to understand"/>
   <result pre="tract, and whether they can be passed through sexual intercourse." exact="CHIKV" post="RNA was detected in the seminal fluid of one"/>
   <result pre="symptoms [203]. To our knowledge, together with the detection of" exact="CHIKV" post="RNA in the CVF, which we show in Table"/>
   <result pre="in Table 2, these are the only reported cases of" exact="CHIKV" post="detection in genital fluids, and the tropism of the"/>
   <result pre="investigated. 4.4. Preventive and Therapeutic Strategies Despite the fact that" exact="CHIKV" post="causes disease around the globe, with a significant impact"/>
   <result pre="in the case of severe and persistent joint pain) [204]." exact="CHIKV" post="infection may not always present specific manifestations, and it"/>
   <result pre="it may co-exist with other infectious diseases, like dengue or" exact="Zika" post="fever [205]. Thus, careful clinical management in the absence"/>
   <result pre="and the increased risk of bleeding manifestations in cases of" exact="DENV" post="(co-)infection [206]. To find an effective treatment for CHIKV,"/>
   <result pre="IFN-α, and Sofosbuvir, may have a positive effect in controlling" exact="CHIKV" post="replication [8,207,208,209,210]. Chloroquine (CQ), a common antimalarial medicine, was"/>
   <result pre="medicine, was widely used to treat rheumatoid arthritis-like symptoms, following" exact="CHIKV" post="infection during the Reunion Island outbreak [204,211]. Although CQ"/>
   <result pre="infection during the Reunion Island outbreak [204,211]. Although CQ inhibits" exact="CHIKV" post="replication in vitro [212,213], it showed no or a"/>
   <result pre="vitro [212,213], it showed no or a moderate effect on" exact="CHIKV" post="acute and chronic symptoms in humans [211,214], and in"/>
   <result pre="in humans [211,214], and in NHPs, it even determined enhanced" exact="CHIKV" post="replication and delayed cellular and humoral response [214]. Immunotherapy"/>
   <result pre="points after infection [208,215]. Because of the limited diversity between" exact="CHIKV" post="strains, vaccine strategy represents the best preventive measure to"/>
   <result pre="been developed and tested [216]. TSI-GSD-218 was the first live-attenuated" exact="CHIKV" post="vaccine reported in trial, and was made using CHIK"/>
   <result pre="on cDNA expression plasmid transfected into human cells, and containing" exact="CHIKV" post="structural proteins), and the viral vectored vaccines (VVV), which"/>
   <result pre="lethality (RIDL), and Wolbachia-infected males) [220]. 5. Conclusions Before 2004," exact="CHIKV" post="caused small outbreaks in confined regions within Africa and"/>
   <result pre="better characterized, and several syndromes have been newly associated to" exact="CHIKV" post="infection. The expansion to novel regions and the drastic"/>
   <result pre="by ex vivo findings. Nevertheless, the exact cellular receptors for" exact="CHIKV" post="need to be definitively established. At the tissue level,"/>
   <result pre="CHIKV need to be definitively established. At the tissue level," exact="CHIKV" post="is amplified at the site of infection, the skin,"/>
   <result pre="the skeletal muscle and the synovial joints. At these sites," exact="CHIKV" post="may persist for several months, giving rise to chronic"/>
   <result pre="of the inflammatory pathways triggered by the virus. Moreover, as" exact="CHIKV" post="is often co-circulating with other arthropod-borne pathogens, it is"/>
   <result pre="properties and relationship to the epidemicJ. Hyg.19565417719110.1017/S002217240004444213346078 2.WeinbrenM.P.The occurrence of" exact="Chikungunya" post="virus in Uganda. II. In man on the Entebbe"/>
   <result pre="distant evolutionary relationshipsJ. Gen. Virol.20008147147910.1099/0022-1317-81-2-47110644846 4.VolkS.M.ChenR.TsetsarkinK.A.AdamsA.P.GarciaT.I.SallA.A.NasarF.SchuhA.J.HolmesE.C.HiggsS.et al.Genome-Scale Phylogenetic Analyses of" exact="Chikungunya" post="Virus Reveal Independent Emergences of Recent Epidemics and Various"/>
   <result pre="Epidemics and Various Evolutionary RatesJ. Virol.2010846497650410.1128/JVI.01603-0920410280 5.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.-C.LavenirR.PardigonN.ReynesJ.-M.PettinelliF.et al.Genome Microevolution of" exact="Chikungunya" post="Viruses Causing the Indian Ocean OutbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 6.RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA.PanningM.CordioliP.FortunaC.BorosS.MaguranoF.et al.Infection"/>
   <result pre="Silva AzevedoR.D.S.da SilvaD.E.A.da SilvaE.V.P.et al.Emergence and potential for spread of" exact="Chikungunya" post="virus in BrazilBMC Med.20151310210.1186/s12916-015-0348-x25976325 10.MohamedN.MagzoubM.MohamedR.E.H.AleanizyF.S.AlqahtaniF.Y.NourB.Y.M.AlkarsanyM.M.S.Prevalence and identification of arthropod-"/>
   <result pre="of Aedes (Stegomyia) hensilli Farner as an epidemic vector of" exact="Chikungunya" post="virus on Yap Island, Federated States of Micronesia, 2013Am."/>
   <result pre="therapyAntiviral Res.20139934537010.1016/j.antiviral.2013.06.00923811281 19.Vega-RuaA.ZouacheK.CaroV.DiancourtL.DelaunayP.GrandadamM.FaillouxA.-B.High Efficiency of Temperate Aedes albopictus to Transmit" exact="Chikungunya" post="and Dengue Viruses in the Southeast of FrancePLoS ONE20138e5971610.1371/journal.pone.005971623527259"/>
   <result pre="19.Vega-RuaA.ZouacheK.CaroV.DiancourtL.DelaunayP.GrandadamM.FaillouxA.-B.High Efficiency of Temperate Aedes albopictus to Transmit Chikungunya and" exact="Dengue" post="Viruses in the Southeast of FrancePLoS ONE20138e5971610.1371/journal.pone.005971623527259 20.GrandadamM.CaroV.PlumetS.ThibergeJ.-M.SouarèsY.FaillouxA.-B.TolouH.J.BudelotM.CosseratD.Leparc-GoffartI.et al.Chikungunya"/>
   <result pre="Infect. Dis.20182417818010.3201/eid2401.171605 22.TsetsarkinK.A.WeaverS.C.Sequential Adaptive Mutations Enhance Efficient Vector Switching by" exact="Chikungunya" post="Virus and Its Epidemic EmergencePLoS Pathog.20117e100241210.1371/journal.ppat.100241222174678 23.TsetsarkinK.A.ChenR.YunR.RossiS.L.PlanteK.S.GuerboisM.ForresterN.PerngG.C.SreekumarE.LealG.et al.Multi-peaked adaptive"/>
   <result pre="mosquitoesNat. Commun.20145408410.1038/ncomms508424933611 24.Arias-GoetaC.MoussonL.RougeonF.FaillouxA.B.Dissemination and Transmission of the E1-226V Variant of" exact="Chikungunya" post="Virus in Aedes albopictus Are Controlled at the Midgut"/>
   <result pre="with chikungunya virusTrans. R. Soc. Trop. Med. Hyg.198175151910.1016/0035-9203(81)90005-56115488 27.DialloM.ThonnonJ.Traore-lamizanaM.FontenilleD.Vectors of" exact="Chikungunya" post="virus in Senegal: Current data and transmission cyclesAm. J."/>
   <result pre="relation to the epidemicAnn. Trop. Med. Parasitol.196458455110.1080/00034983.1964.1168621314147664 29.WeinbrenM.P.HaddowA.J.WilliamsM.C.The occurrence of" exact="Chikungunya" post="virus in Uganda. I. Isolation from mosquitoesTrans. R. Soc."/>
   <result pre="Isolation from mosquitoesTrans. R. Soc. Trop. Med. Hyg.19585225325710.1016/0035-9203(58)90084-113556869 30.DialloD.DiaI.DiagneC.T.GayeA.DialloM.Emergences of" exact="Chikungunya" post="and Zika in AfricaChikungunya and Zika VirusesHiggsS.VanlandinghamD.L.PowersA.M.ElsevierAmsterdam, The Netherlands2018871339780128118658"/>
   <result pre="mosquitoesTrans. R. Soc. Trop. Med. Hyg.19585225325710.1016/0035-9203(58)90084-113556869 30.DialloD.DiaI.DiagneC.T.GayeA.DialloM.Emergences of Chikungunya and" exact="Zika" post="in AfricaChikungunya and Zika VirusesHiggsS.VanlandinghamD.L.PowersA.M.ElsevierAmsterdam, The Netherlands2018871339780128118658 31.BrèsP.CamicasJ.L.CornetM.RobinY.TauffliebR.Epidemiology of"/>
   <result pre="Med. Hyg.19585225325710.1016/0035-9203(58)90084-113556869 30.DialloD.DiaI.DiagneC.T.GayeA.DialloM.Emergences of Chikungunya and Zika in AfricaChikungunya and" exact="Zika" post="VirusesHiggsS.VanlandinghamD.L.PowersA.M.ElsevierAmsterdam, The Netherlands2018871339780128118658 31.BrèsP.CamicasJ.L.CornetM.RobinY.TauffliebR.Epidemiology of arbovirus diseases in SenegalBull."/>
   <result pre="Aedes aegypti and Aedes polynesiensis Populations from French Polynesia for" exact="Chikungunya" post="VirusPLoS Negl. Trop. Dis.201610e000469410.1371/journal.pntd.000469427144888 36.MendenhallI.H.ManuelM.MoorthyM.LeeT.T.M.LowD.H.W.MisséD.GublerD.J.EllisB.R.OoiE.E.PomponJ.Peridomestic Aedes malayensis and Aedes"/>
   <result pre="Trop. Dis.20171111110.1371/journal.pntd.000569828662031 38.van den HurkA.F.Hall-MendelinS.PykeA.T.SmithG.A.MackenzieJ.S.Vector Competence of Australian Mosquitoes for" exact="Chikungunya" post="VirusVector-Borne Zoonotic Dis.20101048949510.1089/vbz.2009.010619877822 39.SudeepA.B.GhodkeY.S.GeorgeR.P.IngaleV.S.DhaigudeS.D.GokhaleM.D.Vectorial capacity of Culex gelidus (Theobald)"/>
   <result pre="Cellular Factors and Functions in Mediating the Infectious entry of" exact="Chikungunya" post="VirusPLoS Negl. Trop. Dis.20137e205010.1371/journal.pntd.000205023409203 44.DongS.BalaramanV.KantorA.M.LinJ.GrantD.A.G.HeldN.L.FranzA.W.E.Chikungunya virus dissemination from the"/>
   <result pre="orally infected Aedes aegypti mosquitoesBMC Microbiol.20077910.1186/1471-2180-7-917263893 50.ZieglerS.A.NuckolsJ.McGeeC.E.HuangY.S.VanlandinghamD.L.TeshR.B.HiggsS.In Vivo Imaging of" exact="Chikungunya" post="Virus in Mice and Aedes Mosquitoes Using a Renilla"/>
   <result pre="Body Organ Culture System in Aedes Aegypti, a Vector of" exact="Zika" post="VirusJ. Vis. Exp.201710.3791/5550828872112 56.WongH.V.ChanY.F.SamI.-C.SulaimanW.Y.W.VythilingamI.Chikungunya Virus Infection of Aedes MosquitoesChikungunya"/>
   <result pre="57.SirisenaP.D.N.N.KumarA.SunilS.Evaluation of Aedes aegypti (Diptera: Culicidae) Life Table Attributes Upon" exact="Chikungunya" post="Virus Replication Reveals Impact on Egg-Laying PathwaysJ. Med. Entomol.2018551580158710.1093/jme/tjy09729931258"/>
   <result pre="of Experimental Vertical Transmission of Emerging Novel ECSA Genotype of" exact="Chikungunya" post="Virus in Aedes aegyptiPLoS Negl. Trop. Dis.20148e299010.1371/journal.pntd.000299025080107 62.WongH.V.VythilingamI.SulaimanW.Y.W.LullaA.MeritsA.ChanY.F.SamI.C.Detection of"/>
   <result pre="Trop. Med. Hyg.2017971399140410.4269/ajtmh.17-012629016323 68.OsterriethP.RatheE.Deleplanque-LiegeoisP.[Simultaneous isolation of the yellow fever and" exact="Chikungunya" post="viruses at Bili (Haut-Uele, Belgian Congo)]Ann. la Soc. Belge"/>
   <result pre="virus in macaques, MalaysiaEmerg. Infect. Dis.2015211683168510.3201/eid2109.15043926291585 75.NakgoiK.NitatpattanaN.WajjwalkuW.PongsopawijitP.KaewchotS.YoksanS.SiripolwatV.SourisM.GonzalezJ.P.Dengue, Japanese encephalitis and" exact="Chikungunya" post="virus antibody prevalence among captive monkey (Macaca nemestrina) colonies"/>
   <result pre="Evidence for Infection of Urban and Peri-urban Nonhuman Primates with" exact="Zika" post="and Chikungunya Viruses in BrazilmSphere20183e00523-1710.1128/mSphere.00523-1729404420 80.Bosco-LauthA.M.HartwigA.E.BowenR.A.Reptiles and amphibians as"/>
   <result pre="Infection of Urban and Peri-urban Nonhuman Primates with Zika and" exact="Chikungunya" post="Viruses in BrazilmSphere20183e00523-1710.1128/mSphere.00523-1729404420 80.Bosco-LauthA.M.HartwigA.E.BowenR.A.Reptiles and amphibians as potential reservoir"/>
   <result pre="infection with chikungunya virusesAm. J. Trop. Med. Hyg.20169450450610.4269/ajtmh.15-069626666699 82.McIntoshB.M.Antibody against" exact="Chikungunya" post="virus in wild primates in Southern AfricaS. Afr. J."/>
   <result pre="binding to membrane fusionViruses201573647367410.3390/v707279226198242 84.WintachaiP.WikanN.KuadkitkanA.JaimipukT.UbolS.PulmanausahakulR.AuewarakulP.KasinrerkW.WengW.Y.PanyasrivanitM.et al.Identification of prohibitin as a" exact="Chikungunya" post="virus receptor proteinJ. Med. Virol.2012841757177010.1002/jmv.2340322997079 85.WintachaiP.ThuaudF.BasmadjianC.RoytrakulS.UbolS.DésaubryL.SmithD.R.Assessment of flavaglines as"/>
   <result pre="chikungunya virus entry into insect cellsArch. Virol.20141593353336410.1007/s00705-014-2210-425168043 89.HabyM.M.PinartM.EliasV.ReveizL.Prevalence of asymptomatic" exact="Zika" post="virus infection: A systematic reviewBull. World Health Organ.20189640210.2471/BLT.17.20154129904223 90.BhattS.GethingP.W.BradyO.J.MessinaJ.P.FarlowA.W.MoyesC.L.DrakeJ.M.BrownsteinJ.S.HoenA.G.SankohO.et"/>
   <result pre="al.The global distribution and burden of dengueNature201349650450710.1038/nature1206023563266 91.AyuS.M.LaiL.R.ChanY.F.HatimA.HairiN.N.AyobA.SamI.-C.Seroprevalence survey of" exact="Chikungunya" post="virus in Bagan Panchor, MalaysiaAm. J. Trop. Med. Hyg.2010831245124810.4269/ajtmh.2010.10-027921118929"/>
   <result pre="February 2019) 94.RahmanM.JakariaS.K.SayedB.KabirA.K.M.H.MallikU.HasanR.SiddiqueA.B.HossainA.UddinN.HassanM.et al.Clinical and Laboratory Characteristics of an Acute" exact="Chikungunya" post="Outbreak in Bangladesh in 2017Am. J. Trop. Med. Hyg.201910040541010.4269/ajtmh.18-063630526743"/>
   <result pre="Inflammatory Arthritis: A Systematic Review and Meta-AnalysisArthritis Care Res.2016681849185810.1002/acr.2290027015439 99.EconomopoulouA.DominguezM.HelynckB.SissokoD.WichmannO.QuenelP.GermonneauP.QuatresousI.Atypical" exact="Chikungunya" post="virus infections: Clinical manifestations, mortality and risk factors for"/>
   <result pre="of IL-6 and Type-I IFN in a Lethal Case of" exact="Chikungunya" post="Virus Infection in an Elderly Man During the 2017"/>
   <result pre="A case seriesPediatr. Dermatol.20183539239610.1111/pde.1345029573443 106.DuttaP.SharmaA.A case of atypical ophthalmoplegia after" exact="Chikungunya" post="feverInt. Ophthalmol.20183883783910.1007/s10792-017-0529-z28397145 107.MehtaR.GerardinP.de BritoC.A.A.SoaresC.N.FerreiraM.L.B.SolomonT.The neurological complications of chikungunya virus:"/>
   <result pre="chikungunya virus: A systematic reviewRev. Med. Virol.201828e197810.1002/rmv.197829671914 108.ShardaM.MeenaH.Neurological complications in" exact="Chikungunya" post="feverJ. Assoc. Phys. India200755765769 109.SinghS.S.ManimundaS.P.SugunanA.P.VijayachariP.Four cases of acute flaccid"/>
   <result pre="Microbiol.201781610.3389/fmicb.2017.0004228197127 112.MehtaR.SoaresC.N.Medialdea-CarreraR.EllulM.da SilvaM.T.T.Rosala-HallasA.JardimM.R.BurnsideG.PamplonaL.BhojakM.et al.The spectrum of neurological disease associated with" exact="Zika" post="and chikungunya viruses in adults in Rio de Janeiro,"/>
   <result pre="action on nonhematopoietic cellsJ. Exp. Med.201020742944210.1084/jem.2009085120123960 116.BroeckelR.HaeseN.MessaoudiI.StreblowD.Nonhuman Primate Models of" exact="Chikungunya" post="Virus Infection and Disease (CHIKV NHP Model)Pathogens2015466268110.3390/pathogens403066226389957 117.FrosJ.J.LiuW.J.ProwN.A.GeertsemaC.LigtenbergM.VanlandinghamD.L.SchnettlerE.VlakJ.M.SuhrbierA.KhromykhA.A.et al.Chikungunya"/>
   <result pre="118.JonesP.H.MaricM.MadisonM.N.MauryW.RollerR.J.OkeomaC.M.BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by" exact="CHIKV" post="non-structural protein 1 (nsP1)Virology2013438374910.1016/j.virol.2013.01.01023411007 119.ColavitaF.MusumeciG.CagliotiC.Human osteoblast-like cells are permissive"/>
   <result pre="non-structural protein 1 (nsP1)Virology2013438374910.1016/j.virol.2013.01.01023411007 119.ColavitaF.MusumeciG.CagliotiC.Human osteoblast-like cells are permissive for" exact="Zika" post="virus replicationJ. Rheumatol.20184544310.3899/jrheum.17083529496921 120.KvansakulM.Viral Infection and ApoptosisViruses2017935610.3390/v912035629168732 121.Krejbich-TrototP.DenizotM.HoarauJ.-J.Jaffar-BandjeeM.-C.DasT.GasqueP.Chikungunya virus"/>
   <result pre="invade host cell defensesFASEB J.20112531432510.1096/fj.10-16417820881210 122.ChowA.HerZ.OngE.K.S.ChenJ.M.DimatatacF.KwekD.J.C.BarkhamT.YangH.RéniaL.LeoY.S.et al.Persistent arthralgia induced by" exact="Chikungunya" post="virus infection is associated with interleukin-6 and granulocyte macrophage"/>
   <result pre="factorJ. Infect. Dis.201120314915710.1093/infdis/jiq04221288813 123.KelvinA.A.BannerD.SilviG.MoroM.L.SpataroN.GaibaniP.CavriniF.PierroA.RossiniG.CameronM.J.et al.Inflammatory Cytokine Expression Is Associated with" exact="Chikungunya" post="Virus Resolution and Symptom SeverityPLoS Negl. Trop. Dis.20115e127910.1371/journal.pntd.000127921858242 124.MichlmayrD.PakT.R.RahmanA.H.AmirE.D.KimE.Kim-SchulzeS.SuprunM.StewartM.G.ThomasG.P.BalmasedaA.et"/>
   <result pre="al.Multiple Immune Factors Are Involved in Controlling Acute and Chronic" exact="Chikungunya" post="Virus InfectionPLoS Negl. Trop. Dis.20148e335410.1371/journal.pntd.000335425474568 126.ReddyV.ManiR.S.DesaiA.RaviV.Correlation of plasma viral"/>
   <result pre="Trop. Dis.20148e335410.1371/journal.pntd.000335425474568 126.ReddyV.ManiR.S.DesaiA.RaviV.Correlation of plasma viral loads and presence of" exact="Chikungunya" post="IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus"/>
   <result pre="presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute" exact="Chikungunya" post="virus infectionJ. Med. Virol.2014861393140110.1002/jmv.2387524523146 127.VenugopalanA.GhorpadeR.P.ChopraA.Cytokines in Acute ChikungunyaPLoS ONE20149e11130510.1371/journal.pone.011130525343623"/>
   <result pre="ChikungunyaPLoS ONE20149e11130510.1371/journal.pone.011130525343623 128.NgL.F.P.ChowA.SunY.-J.KwekD.J.C.LimP.-L.DimatatacF.NgL.-C.OoiE.-E.ChooK.-H.HerZ.et al.IL-1β, IL-6, and RANTES as Biomarkers of" exact="Chikungunya" post="SeverityPLoS ONE20094e426110.1371/journal.pone.000426119156204 129.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.DenizotM.GuichardE.RiberaA.HenniT.et al.Persistent Chronic Inflammation and"/>
   <result pre="ONE20094e426110.1371/journal.pone.000426119156204 129.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.DenizotM.GuichardE.RiberaA.HenniT.et al.Persistent Chronic Inflammation and Infection by" exact="Chikungunya" post="Arthritogenic Alphavirus in Spite of a Robust Host Immune"/>
   <result pre="130.TengT.-S.KamY.-W.LeeB.HapuarachchiH.C.WimalA.NgL.-C.NgL.F.P.A Systematic Meta-analysis of Immune Signatures in Patients With Acute" exact="Chikungunya" post="Virus InfectionJ. Infect. Dis.20152111925193510.1093/infdis/jiv04925635123 131.NairS.PoddarS.ShimakR.M.DiamondM.S.Interferon Regulatory Factor 1 Protects"/>
   <result pre="Virus InfectionJ. Infect. Dis.20152111925193510.1093/infdis/jiv04925635123 131.NairS.PoddarS.ShimakR.M.DiamondM.S.Interferon Regulatory Factor 1 Protects against" exact="Chikungunya" post="Virus-Induced Immunopathology by Restricting Infection in Muscle CellsJ. Virol.20179110.1128/JVI.01419-17"/>
   <result pre="of chikungunya pathogenesisAntiviral Res.201512016517410.1016/j.antiviral.2015.06.00926092642 134.HawmanD.W.StoermerK.A.MontgomeryS.A.PalP.OkoL.DiamondM.S.MorrisonT.E.Chronic Joint Disease Caused by Persistent" exact="Chikungunya" post="Virus Infection Is Controlled by the Adaptive Immune ResponseJ."/>
   <result pre="ResponseJ. Virol.201387138781388810.1128/JVI.02666-1324131709 135.TeoT.-H.LumF.-M.ClaserC.LullaV.LullaA.MeritsA.ReniaL.NgL.F.P.A Pathogenic Role for CD4+ T Cells during" exact="Chikungunya" post="Virus Infection in MiceJ. Immunol.201319025926910.4049/jimmunol.120217723209328 136.PartidosC.D.WegerJ.BrewooJ.SeymourR.BorlandE.M.LedermannJ.P.PowersA.M.WeaverS.C.StinchcombD.T.OsorioJ.E.Probing the attenuation and"/>
   <result pre="with compromised interferon (IFN) signalingVaccine2011293067307310.1016/j.vaccine.2011.01.07621300099 137.MallilankaramanK.ShedlockD.J.BaoH.KawalekarO.U.FagoneP.RamanathanA.A.FerraroB.StabenowJ.VijayachariP.SundaramS.G.et al.A DNA Vaccine against" exact="Chikungunya" post="Virus Is Protective in Mice and Induces Neutralizing Antibodies"/>
   <result pre="Trop. Dis.20137e234310.1371/journal.pntd.000234323936572 139.EkchariyawatP.HamelR.BernardE.WichitS.SurasombatpattanaP.TalignaniL.ThomasF.ChoumetV.YsselH.DesprèsP.et al.Inflammasome signaling pathways exert antiviral effect against" exact="Chikungunya" post="virus in human dermal fibroblastsInfect. Genet. Evol.20153240140810.1016/j.meegid.2015.03.02525847693 140.SourisseauM.SchilteC.CasartelliN.TrouilletC.Guivel-BenhassineF.RudnickaD.Sol-FoulonN.Le RouxK.PrevostM.C.FsihiH.et"/>
   <result pre="stepVirology201547611010.1016/j.virol.2014.11.01325496825 145.RuddP.A.WilsonJ.GardnerJ.LarcherT.BabaritC.LeT.T.AnrakuI.KumagaiY.LooY.-M.GaleM.et al.Interferon Response Factors 3 and 7 Protect against" exact="Chikungunya" post="Virus Hemorrhagic Fever and ShockJ. Virol.2012869888989810.1128/JVI.00956-1222761364 146.HondaK.YanaiH.NegishiH.AsagiriM.SatoM.MizutaniT.ShimadaN.OhbaY.TakaokaA.YoshidaN.et al.IRF-7 is"/>
   <result pre="Infect. Dis.2006121493149910.3201/eid1210.06061017176562 150.HerZ.MalleretB.ChanM.OngE.K.S.WongS.C.KwekD.J.C.TolouH.LinR.T.P.TambyahP.A.ReniaL.et al.Active Infection of Human Blood Monocytes by" exact="Chikungunya" post="Virus Triggers an Innate Immune ResponseJ. Immunol.20101845903591310.4049/jimmunol.090418120404274 151.Ruiz SilvaM.Van"/>
   <result pre="treated with amotosalen/ultraviolet A light or amustaline/glutathioneTransfusion20185874875710.1111/trf.1444229322519 154.TsetsarkinK.A.Sampson-JohannesA.SawyerL.KinseyJ.HiggsS.VanlandinghamD.L.Photochemical Inactivation of" exact="Chikungunya" post="Virus in Human Apheresis Platelet Components by Amotosalen and"/>
   <result pre="155.OzdenS.HuerreM.RiviereJ.P.CoffeyL.L.AfonsoP.V.MoulyV.de MonredonJ.RogerJ.C.El AmraniM.YvinJ.L.et al.Human Muscle Satellite Cells as Targets of" exact="Chikungunya" post="Virus InfectionPLoS ONE20072e52710.1371/journal.pone.000052717565380 156.LohachanakulJ.PhukliaW.ThannagithM.ThongsakulprasertT.SmithD.R.UbolS.Differences in response of primary human"/>
   <result pre="primary human myoblasts to infection with recent epidemic strains of" exact="Chikungunya" post="virus isolated from patients with and without myalgiaJ. Med."/>
   <result pre="Infect. Dis.201220645545710.1093/infdis/jis36822634878 164.GoupilB.A.McNultyM.A.MartinM.J.McCrackenM.K.ChristoffersonR.C.MoresC.N.Novel Lesions of Bones and Joints Associated with" exact="Chikungunya" post="Virus Infection in Two Mouse Models of Disease: New"/>
   <result pre="Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by" exact="Chikungunya" post="Virus InfectionJ. Virol.20158958159310.1128/JVI.02034-1425339772 166.LabadieK.LarcherT.JoubertC.ManniouiA.DelacheB.BrochardP.GuigandL.DubreilL.LebonP.VerrierB.et al.Chikungunya disease in nonhuman primates"/>
   <result pre="MiceJ. Virol.2010848021803210.1128/JVI.02603-0920519386 168.MazaudR.SalaünJ.J.MontaboneH.GoubeP.BazillioR.Acute neurologic and sensorial disorders in dengue and" exact="Chikungunya" post="feverBull. Soc. Pathol. Exot. Filiales19716422305109175 169.ArpinoC.CuratoloP.RezzaG.Chikungunya and the nervous"/>
   <result pre="and 1 case with autopsy findingsAm. J. Neuroradiol.2008291636163710.3174/ajnr.A113318566010 172.DhanwaniR.KhanM.BhaskarA.S.B.SinghR.PatroI.K.RaoP.V.L.ParidaM.M.Characterization of" exact="Chikungunya" post="virus infection in human neuroblastoma SH-SY5Y cells: Role of"/>
   <result pre="re-emerging arbovirusVirology200939318319710.1016/j.virol.2009.07.02419732931 174.AbrahamR.MudaliarP.PadmanabhanA.SreekumarE.Induction of Cytopathogenicity in Human Glioblastoma Cells by" exact="Chikungunya" post="VirusPLoS ONE20138e7585410.1371/journal.pone.007585424086645 175.AbrahamR.SinghS.NairS.R.HulyalkarN.V.SurendranA.JaleelA.SreekumarE.Nucleophosmin (NPM1)/B23 in the Proteome of Human"/>
   <result pre="175.AbrahamR.SinghS.NairS.R.HulyalkarN.V.SurendranA.JaleelA.SreekumarE.Nucleophosmin (NPM1)/B23 in the Proteome of Human Astrocytic Cells Restricts" exact="Chikungunya" post="Virus ReplicationJ. Proteome Res.2017164144415510.1021/acs.jproteome.7b0051328959884 176.AbereB.WikanN.UbolS.AuewarakulP.PaemaneeA.KittisenachaiS.RoytrakulS.SmithD.R.Proteomic analysis of chikungunya virus"/>
   <result pre="responses engaged by astrocytes, microglia and resident dendritic cells against" exact="Chikungunya" post="neuroinfectionJ. Gen. Virol.20159629431010.1099/vir.0.071175-025351727 180.FraisierC.KorakaP.BelghaziM.BakliM.GranjeaudS.PophillatM.LimS.M.OsterhausA.MartinaB.CamoinL.et al.Kinetic Analysis of Mouse Brain"/>
   <result pre="Virol.20159629431010.1099/vir.0.071175-025351727 180.FraisierC.KorakaP.BelghaziM.BakliM.GranjeaudS.PophillatM.LimS.M.OsterhausA.MartinaB.CamoinL.et al.Kinetic Analysis of Mouse Brain Proteome Alterations Following" exact="Chikungunya" post="Virus Infection before and after Appearance of Clinical SymptomsPLoS"/>
   <result pre="Appearance of Clinical SymptomsPLoS ONE20149e9139710.1371/journal.pone.009139724618821 181.LimP.J.ChuJ.J.H.A Polarized Cell Model for" exact="Chikungunya" post="Virus Infection: Entry and Egress of Virus Occurs at"/>
   <result pre="185.SalceanuS.O.RamanV.Recurrent chikungunya retinitisBMJ Case Rep.2018201810.1136/bcr-2017-22286430150331 186.Ulloa-PadillaJ.P.DavilaP.J.IzquierdoN.J.Garcia-RodriguezO.JimenezI.Z.Ocular Symptoms and Signs of" exact="Chikungunya" post="Fever in Puerto RicoP. R. Health Sci. J.201837838729905918 187.MahendradasP.ShettyR.MalathiJ.MadhavanH.N.Chikungunya"/>
   <result pre="chikungunya virus in saliva and urineVirol. J.20161310210.1186/s12985-016-0556-927306056 196.Contopoulos-IoannidisD.Newman-LindsayS.ChowC.LaBeaudA.D.Mother-to-child transmission of" exact="Chikungunya" post="virus: A systematic review and meta-analysisPLoS Negl. Trop. Dis.20181212010.1371/journal.pntd.000651029897898"/>
   <result pre="meta-analysisPLoS Negl. Trop. Dis.20181212010.1371/journal.pntd.000651029897898 197.GérardinP.BarauG.MichaultA.BintnerM.RandrianaivoH.ChokerG.LengletY.TouretY.BouveretA.GrivardP.et al.Multidisciplinary Prospective Study of Mother-to-Child" exact="Chikungunya" post="Virus Infections on the Island of La RéunionPLoS Med.20085e6010.1371/journal.pmed.005006018351797"/>
   <result pre="Island of La RéunionPLoS Med.20085e6010.1371/journal.pmed.005006018351797 198.TouretY.RandrianaivoH.MichaultA.SchuffeneckerI.KauffmannE.LengletY.BarauG.FourmaintrauxA.Early maternal-fetal transmission of the" exact="Chikungunya" post="virusPresse Med.2006351656165810.1016/S0755-4982(06)74874-617086120 199.GrivardP.Le RouxK.LaurentP.FianuA.PerrauJ.GiganJ.HoarauG.GrondinN.StaikowskyF.FavierF.et al.Molecular and serological diagnosis of"/>
   <result pre="Chikungunya virusPresse Med.2006351656165810.1016/S0755-4982(06)74874-617086120 199.GrivardP.Le RouxK.LaurentP.FianuA.PerrauJ.GiganJ.HoarauG.GrondinN.StaikowskyF.FavierF.et al.Molecular and serological diagnosis of" exact="Chikungunya" post="virus infectionPathol. Biol.20075549049410.1016/j.patbio.2007.07.00217920211 200.Prata-BarbosaA.Cleto-YamaneT.L.RobainaJ.R.GuastavinoA.B.de Magalhães-BarbosaM.C.BrindeiroR.D.M.MedronhoR.A.da CunhaA.J.L.A.Co-infection with Zika and"/>
   <result pre="diagnosis of Chikungunya virus infectionPathol. Biol.20075549049410.1016/j.patbio.2007.07.00217920211 200.Prata-BarbosaA.Cleto-YamaneT.L.RobainaJ.R.GuastavinoA.B.de Magalhães-BarbosaM.C.BrindeiroR.D.M.MedronhoR.A.da CunhaA.J.L.A.Co-infection with" exact="Zika" post="and Chikungunya viruses associated with fetal death—A case reportInt."/>
   <result pre="Chikungunya virus infectionPathol. Biol.20075549049410.1016/j.patbio.2007.07.00217920211 200.Prata-BarbosaA.Cleto-YamaneT.L.RobainaJ.R.GuastavinoA.B.de Magalhães-BarbosaM.C.BrindeiroR.D.M.MedronhoR.A.da CunhaA.J.L.A.Co-infection with Zika and" exact="Chikungunya" post="viruses associated with fetal death—A case reportInt. J. Infect."/>
   <result pre="fetal demise in miceSci. Transl. Med.201810eaao709010.1126/scitranslmed.aao709029386359 203.BandeiraA.C.CamposG.S.RochaV.F.D.SouzaB.S.D.F.SoaresM.B.P.OliveiraA.A.de AbreuY.C.MenezesG.S.SardiS.I.Prolonged shedding of" exact="Chikungunya" post="virus in semen and urine: A new perspective for"/>
   <result pre="public health concern?PLOS Biol.201917e300013010.1371/journal.pbio.300013030668574 206.WHO Guidelines on Clinical Management of" exact="Chikungunya" post="FeverAvailable online: http://www.who.int/iris/handle/10665/205178(accessed on 19 February 2019) 207.SilvaJ.V.J.Ludwig-BegallL.F.Oliveira-FilhoE.F.D.OliveiraR.A.S.Durães-CarvalhoR.LopesT.R.R.SilvaD.E.A.GilL.H.V.G.A scoping"/>
   <result pre="online: http://www.who.int/iris/handle/10665/205178(accessed on 19 February 2019) 207.SilvaJ.V.J.Ludwig-BegallL.F.Oliveira-FilhoE.F.D.OliveiraR.A.S.Durães-CarvalhoR.LopesT.R.R.SilvaD.E.A.GilL.H.V.G.A scoping review of" exact="Chikungunya" post="virus infection: Epidemiology, clinical characteristics, viral co-circulation complications, and"/>
   <result pre="PedrosaC.et al.Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits" exact="Chikungunya" post="Virus ReplicationAntimicrob. Agents Chemother.201863e01389-1810.1128/AAC.01389-1830455237 210.FrancoE.J.RodriquezJ.L.PomeroyJ.J.HanrahanK.C.BrownA.N.The effectiveness of antiviral agents"/>
   <result pre="in Patients With Early Persistent Musculoskeletal Pain and Arthritis Following" exact="Chikungunya" post="Virus InfectionArthritis Rheumatol.20146631932610.1002/art.3822124504804 212.de LamballerieX.NinoveL.CharrelR.N.Antiviral treatment of chikungunya virus"/>
   <result pre="Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against" exact="Chikungunya" post="VirusCell Host Microbe201518869510.1016/j.chom.2015.06.00926159721 216.Reyes-SandovalA.51 years in of Chikungunya clinical"/>
   <result pre="Activity against Chikungunya VirusCell Host Microbe201518869510.1016/j.chom.2015.06.00926159721 216.Reyes-SandovalA.51 years in of" exact="Chikungunya" post="clinical vaccine development: A historical perspectiveHum. Vaccin. Immunother.201910.1080/21645515.2019.157414930735447 217.PlanteK.WangE.PartidosC.D.WegerJ.GorchakovR.TsetsarkinK.BorlandE.M.PowersA.M.SeymourR.StinchcombD.T.et"/>
   <result pre="clinical vaccine development: A historical perspectiveHum. Vaccin. Immunother.201910.1080/21645515.2019.157414930735447 217.PlanteK.WangE.PartidosC.D.WegerJ.GorchakovR.TsetsarkinK.BorlandE.M.PowersA.M.SeymourR.StinchcombD.T.et al.Novel" exact="Chikungunya" post="Vaccine Candidate with an IRES-Based Attenuation and Host Range"/>
   <result pre="an IRES-Based Attenuation and Host Range Alteration MechanismPLoS Pathog.20117e100214210.1371/journal.ppat.100214221829348 218.WangE.KimD.Y.WeaverS.C.FrolovI.Chimeric" exact="Chikungunya" post="Viruses Are Nonpathogenic in Highly Sensitive Mouse Models but"/>
   <result pre="LamballerieX.Random Codon Re-encoding Induces Stable Reduction of Replicative Fitness of" exact="Chikungunya" post="Virus in Primate and Mosquito CellsPLoS Pathog.20139e100317210.1371/journal.ppat.100317223436995 220.AcheeN.L.GriecoJ.P.VatandoostH.SeixasG.PintoJ.Ching-NGL.MartinsA.J.JuntarajumnongW.CorbelV.GouagnaC.et al.Alternative"/>
   <result pre="2 Examples of tissue and cell tropism of chikungunya virus." exact="Chikungunya" post="virus (CHIKV) infected cells in skin (A); skeletal muscle"/>
   <result pre="[70] Loxodonta africana Elephant Specific antibodies [70] viruses-11-00175-t002_Table 2Table 2" exact="Chikungunya" post="virus (CHIKV) RNA detection in biological fluids in viremic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410223\results\search\tropicalVirus\results.xml">
   <result pre="700,000 deaths annually. Mosquito-transmitted viruses, such as yellow fever, dengue," exact="West Nile," post="chikungunya, and Zika viruses, have re-emerged recently and remain"/>
   <result pre="viruses, such as yellow fever, dengue, West Nile, chikungunya, and" exact="Zika" post="viruses, have re-emerged recently and remain a public health"/>
   <result pre="caused recent epidemics are the flaviviruses, including yellow fever, dengue," exact="West Nile," post="and Zika, and the Toga viruses, which include Chikungunya."/>
   <result pre="by globalization and travel, which makes it easier to transmit" exact="YFV" post="across borders [4]. Dengue virus (DENV) distribution has been"/>
   <result pre="which makes it easier to transmit YFV across borders [4]." exact="Dengue" post="virus (DENV) distribution has been growing for the past"/>
   <result pre="occurred in Southeast Asia 30 years before that epidemic [6]." exact="West Nile" post="Virus (WNV) reached the Western Hemisphere in 1999 and"/>
   <result pre="[7]. By November 2018, as many as 1500 cases of" exact="WNV" post="infection were reported in the European Union, exceeding the"/>
   <result pre="total number of infections in the previous five years [8]." exact="Chikungunya" post="virus (CHIKV) reached the Americas in late 2013 and"/>
   <result pre="than 1.8 million suspected cases in 44 different countries [9]." exact="Zika" post="virus (ZIKV) has caused one of the most recent"/>
   <result pre="most recent epidemics to be considered a public health crisis." exact="ZIKV" post="was present for decades prior to 2007 outbreaks in"/>
   <result pre="In the United States and its territories, over 40,000 symptomatic" exact="ZIKV" post="infections were reported from 2015 through to October 2018"/>
   <result pre="recent reemergence and spread of arboviral diseases. Increased episodes of" exact="DENV" post="infections are rooted in global population growth, urbanization, lack"/>
   <result pre="and secondary dengue infection in island outbreaks [17]. During 2005" exact="Dengue" post="outbreak in Singapore ecological and immunological factors were indicated"/>
   <result pre="enzymatic activity of Oas1b. This allowed for greater replication of" exact="WNV" post="in neurons with the mutated enzyme and enhanced viral"/>
   <result pre="similar dominant negative OASL isozyme was more frequent in hospitalized" exact="WNV" post="patients than control subjects [21]. A splicing variant (rs10774671)"/>
   <result pre="an intron variant (rs34137742) of OAS1 were associated with severe" exact="WNV" post="infection [21,22,23]. Additionally, a variant of OAS3, OAS_R381, was"/>
   <result pre="an interferon-induced dynamin-like guanosine triphosphate (GTP)ase, were correlated with symptomatic" exact="WNV" post="infection; however, the mechanism is not well understood [23]."/>
   <result pre="host cells may also contribute to arboviral pathogenesis. Infection with" exact="CHIKV" post="activates Toll-like receptors (TLR) that initiate the innate immune"/>
   <result pre="developing fever, joint pains, and rash in those infected with" exact="CHIKV" post="[25]. The SNP in C-type lectin CLEC5A (rs1285933) might"/>
   <result pre="blood donations in Guadeloupe and Martinique found increased susceptibility to" exact="Chikungunya" post="infection in people with blood group A, Rh positive."/>
   <result pre="group A, Rh positive. This link between blood groups and" exact="CHIKV" post="susceptibility may be related to several factors that are"/>
   <result pre="differentiation, may also be related to brain abnormalities caused by" exact="ZIKV" post="infection. Polymorphisms in the 3′ UTR of these proteins"/>
   <result pre="correlated with susceptibility to symptomatic disease [36]. A study on" exact="WNV" post="in Greece found that the patients with DQA1*01:02 had"/>
   <result pre="HLA-DQ1 [37]. HLA-A*68 and C*08 could be associated with severe" exact="WNV" post="infection in Caucasians in Canada and the United States"/>
   <result pre="to infection outcomes. There is an increased likelihood of symptomatic" exact="WNV" post="infection in people with a C-C chemokine receptor 5"/>
   <result pre="to contain and clear the virus. In the CCR5∆32 carriers," exact="WNV" post="replication could not be controlled in the brain, leading"/>
   <result pre="instance, by the Bayesian method, the overall evolutionary rate of" exact="DENV" post="was 7.6 × 10−4 substitution/site/year [56]. The role of"/>
   <result pre="isolation and identification techniques. It allowed rapid monitoring of circulating" exact="DENV" post="strain and prediction of epidemic potential [58]. An epidemiological"/>
   <result pre="was not correlated with the transmission or the distribution of" exact="DENV" post="serotypes. It was proposed that the viral strain and"/>
   <result pre="of the virus [64]. However, some spontaneous mutations may make" exact="DENV" post="less advantageous in the host. One study investigating phylogenetic"/>
   <result pre="cause worse symptoms. Mutations in the domain III of the" exact="ZIKV" post="envelope protein may be an important factor in viral"/>
   <result pre="and D679E substitutions were only seen in the recent epidemic" exact="ZIKV" post="strains but not in pre-epidemic strains [70]. Mutation in"/>
   <result pre="membrane protein (prM) has been shown to intensify symptoms of" exact="ZIKV" post="infection. The S139N substitution arose before the 2013 outbreak"/>
   <result pre="flaviviruses including YFV, WNV, Japanese encephalitis, tick-borne encephalitis, DENV, and" exact="ZIKV" post="is secreted out of host cells and is present"/>
   <result pre="the 188th position (A188V) in NS1 of the recent American" exact="ZIKV" post="isolates enhanced viral infectivity and prevalence in mosquitos. This"/>
   <result pre="mutation made NS1 highly secretable in the mammalian host, increasing" exact="ZIKV" post="transmissibility from the host to vector. This could partly"/>
   <result pre="South America [78]. Aedes Aegypti was a primary vector for" exact="CHIKV" post="in India and other countries during the 2006 to"/>
   <result pre="protein E1 and V264A in E2 were reported to increase" exact="CHIKV" post="adaptation to Ae. Aegypti [79,80]. In the recent 2016"/>
   <result pre="CHIKV adaptation to Ae. Aegypti [79,80]. In the recent 2016" exact="CHIKV" post="outbreak in Brazil, researchers discovered two new substitutions in"/>
   <result pre="cholesterol to infect host cells. This is particularly critical for" exact="CHIKV" post="prevalence in Aedes albopictus mosquitoes that often have insufficient"/>
   <result pre="of the Indian Ocean lineage could enhance transovarial transmission of" exact="CHIKV" post="by Aedes albopictus [83]. These mutations together may account"/>
   <result pre="These mutations together may account for the rapid spread of" exact="CHIKV" post="by enhancing CHIKV prevalence in Aedes albopictus mosquitoes, a"/>
   <result pre="may account for the rapid spread of CHIKV by enhancing" exact="CHIKV" post="prevalence in Aedes albopictus mosquitoes, a vector populating in"/>
   <result pre="amino acid substitution in the NS3 helicase of North American" exact="WNV" post="increased virulence in American crow, a major natural reservoir"/>
   <result pre="increased virulence in American crow, a major natural reservoir for" exact="WNV" post="[85]. On the other hand, a V159A substitution in"/>
   <result pre="initial New York NY99 strain in 2002 as the prevalent" exact="WNV" post="strain in North America, reduced the extrinsic incubation period"/>
   <result pre="reduced the extrinsic incubation period in Culex spp. mosquitoes, facilitating" exact="WNV" post="prevalence in mosquitoes. These mutations, when combined together, may"/>
   <result pre="in mosquitoes. These mutations, when combined together, may contribute to" exact="WNV" post="rapid spread and persistence in North America [86,87]. Genome-wide"/>
   <result pre="in North America [86,87]. Genome-wide comparative analysis of the pre-epidemic" exact="ZIKV" post="strains (before the year 2007) and recent epidemic strains"/>
   <result pre="changes in the 3-terminal untranslated region (3′-UTR) stem-loop might increase" exact="ZIKV" post="transmissibility and virulence [88]. Additionally, the amount and function"/>
   <result pre="United States: Guidelines for detection, prevention, and controlViral. Immunol.20001346947510.1089/vim.2000.13.46911192293 8.ECDC" exact="West Nile" post="FeverAvailable online: https://ecdc.europa.eu/en/news-events/epidemiological-update-west-nile-fever-europe-number-infections-so-far-exceeds-total(accessed on 9 February 2019) 9.ShragaiT.TeslaB.MurdockC.HarringtonL.C.Zika and"/>
   <result pre="viruses in a changing worldAnn. N. Y. Acad. Sci.20171399617710.1111/nyas.1330628187236 10.CDC" exact="Zika" post="Cases in the United StatesAvailable online: https://www.cdc.gov/zika/reporting/case-counts.html(accessed on 9"/>
   <result pre="in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with" exact="West Nile" post="virus susceptibility in laboratory miceProc. Natl. Acad. Sci. USA200299113111131610.1073/pnas.17219539912186974"/>
   <result pre="genes for 2′-5′-oligoadenylate synthetase and RNase L inpatients hospitalized with" exact="West Nile" post="virus infectionJ. Infect. Dis.20051921741174810.1086/49734016235172 22.LimJ.K.LiscoA.McDermottD.H.HuynhL.WardJ.M.JohnsonB.JohnsonH.PapeJ.FosterG.A.KrysztofD.et al.Genetic variation in OAS1"/>
   <result pre="in OAS1 is a risk factor for initial infection with" exact="West Nile" post="virus in manPLoS Pathog.20095e100032110.1371/journal.ppat.100032119247438 23.BighamA.W.BuckinghamK.J.HusainS.EmondM.J.BofferdingK.M.GildersleeveH.RutherfordA.AstakhovaN.M.PerelyginA.A.BuschM.P.et al.Host genetic risk factors"/>
   <result pre="virus in manPLoS Pathog.20095e100032110.1371/journal.ppat.100032119247438 23.BighamA.W.BuckinghamK.J.HusainS.EmondM.J.BofferdingK.M.GildersleeveH.RutherfordA.AstakhovaN.M.PerelyginA.A.BuschM.P.et al.Host genetic risk factors for" exact="West Nile" post="virus infection and disease progressionPLoS ONE20116e2474510.1371/journal.pone.002474521935451 24.Simon-LoriereE.LinR.J.KalayanaroojS.M.ChuansumritA.CasademontI.LinS.Y.YuH.P.Lert-ItthipornW.ChaiyaratanaW.TangthawornchaikulN.et al.High Anti-Dengue"/>
   <result pre="Trop. Dis.20115e93410.1371/journal.pntd.000093421245921 31.MohsinS.N.MahmoodS.AmarA.GhafoorF.RazaS.M.SaleemM.Association of FcgammaRIIa Polymorphism with Clinical Outcome of" exact="Dengue" post="Infection: First Insight from PakistanAm. J. Trop. Med. Hyg.20159369169610.4269/ajtmh.15-019926240159"/>
   <result pre="dengue infection in a Mexican populationActa. Trop.2014138152210.1016/j.actatropica.2014.05.02124911936 34.GallianP.Leparc-GoffartI.RichardP.MaireF.FlusinO.DjoudiR.ChiaroniJ.CharrelR.TiberghienP.de LamballerieX.Epidemiology of" exact="Chikungunya" post="Virus Outbreaks in Guadeloupe and Martinique, 2014: An Observational"/>
   <result pre="Negl. Trop. Dis.201711e000525410.1371/journal.pntd.000525428081120 35.ChavaliP.L.StojicL.MeredithL.W.JosephN.NahorskiM.S.SanfordT.J.SweeneyT.R.KrishnaB.A.HosmilloM.FirthA.E.et al.Neurodevelopmental protein Musashi-1 interacts with the" exact="Zika" post="genome and promotes viral replicationScience2017357838810.1126/science.aam924328572454 36.WeiskopfD.AngeloM.A.de AzeredoE.L.SidneyJ.GreenbaumJ.A.FernandoA.N.BroadwaterA.KollaR.V.De SilvaA.D.de SilvaA.M.et"/>
   <result pre="al.Genetic Contribution of MHC Class II Genes in Susceptibility to" exact="West Nile" post="Virus InfectionPLoS ONE201611e016595210.1371/journal.pone.016595227812212 38.LanteriM.C.KaidarovaZ.PetersonT.CateS.CusterB.WuS.AgapovaM.LawJ.P.BielawnyT.PlummerF.et al.Association between HLA class I"/>
   <result pre="class I and class II alleles and the outcome of" exact="West Nile" post="virus infection: An exploratory studyPLoS ONE20116e2294810.1371/journal.pone.002294821829673 39.NguyenT.P.KikuchiM.VuT.Q.DoQ.H.TranT.T.VoD.T.HaM.T.VoV.T.CaoT.P.TranV.D.et al.Protective and"/>
   <result pre="CCR5 promotes leukocyte trafficking to the brain and survival in" exact="West Nile" post="virus infectionJ. Exp. Med.20052021087109810.1084/jem.2004253016230476 46.PerezA.B.SierraB.GarciaG.AguirreE.BabelN.AlvarezM.SanchezL.ValdesL.VolkH.D.GuzmanM.G.Tumor necrosis factor-alpha, transforming growth"/>
   <result pre="their Implications for Protection and Susceptibility to Severe Forms of" exact="Dengue" post="Fever in Patients in Sri LankaJ. Glob. Infect. Dis.2015715716426752870"/>
   <result pre="al.Alpha tryptase allele of Tryptase 1 (TPSAB1) gene associated with" exact="Dengue" post="Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS) in"/>
   <result pre="1 (TPSAB1) gene associated with Dengue Hemorrhagic Fever (DHF) and" exact="Dengue" post="Shock Syndrome (DSS) in Vietnam and PhilippinesHum. Immunol.20157631832310.1016/j.humimm.2015.03.00925797204 52.DangT.N.NakaI.Sa-NgasangA.AnantapreechaS.ChanamaS.WichukchindaN.SawanpanyalertP.PatarapotikulJ.TsuchiyaN.OhashiJ.A"/>
   <result pre="accompanies clade reintroductionJ. Gen. Virol.200687 Pt 488589310.1099/vir.0.81309-016528038 63.OhAinleM.BalmasedaA.MacalaladA.R.TellezY.ZodyM.C.SaboríoS.NuñezA.LennonN.J.BirrenB.W.GordonA.et al.Dynamics of" exact="Dengue" post="Disease Severity Determined by the Interplay Between Viral Genetics"/>
   <result pre="71.YuanL.HuangX.LiuZ.ZhangF.ZhuX.YuJ.JiX.XuY.LiG.LiC.et al.A single nucleotide mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephalyScience201735893393610.1126/science.aam712028971967 72.WinklerG.RandolphV.B.CleavesG.R.RyanT.E.StollarV.Evidence that the mature"/>
   <result pre="viral acquisition by mosquitoesNat. Microbiol.201611608710.1038/nmicrobiol.2016.8727562253 77.AlconS.TalarminA.DebruyneM.FalconarA.DeubelV.FlamandM.Enzyme-linked immunosorbent assay specific to" exact="Dengue" post="virus type 1 nonstructural protein NS1 reveals circulation of"/>
   <result pre="primary or secondary infectionsJ. Clin. Microbiol.20024037638110.1128/JCM.40.02.376-381.200211825945 78.LiuY.LiuJ.DuS.ShanC.NieK.ZhangR.LiX.F.ZhangR.WangT.QinC.F.et al.Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoesNature201754548248610.1038/nature2236528514450 79.SumathyK.EllaK.M.Genetic diversity of"/>
   <result pre="Zika virus infectivity in Aedes aegypti mosquitoesNature201754548248610.1038/nature2236528514450 79.SumathyK.EllaK.M.Genetic diversity of" exact="Chikungunya" post="virus, India 2006–2010: Evolutionary dynamics and serotype analysesJ. Med."/>
   <result pre="novel epistatic mutations (E1:K211E and E2:V264A) in structural proteins of" exact="Chikungunya" post="virus enhance fitness in Aedes aegyptiVirology2016497596810.1016/j.virol.2016.06.02527423270 81.SouzaT.M.AzeredoE.L.Badolato-CorreaJ.DamascoP.V.SantosC.Petitinga-PaivaF.NunesP.C.BarbosaL.S.CipitelliM.C.Chouin-CarneiroT.et al.First Report"/>
   <result pre="81.SouzaT.M.AzeredoE.L.Badolato-CorreaJ.DamascoP.V.SantosC.Petitinga-PaivaF.NunesP.C.BarbosaL.S.CipitelliM.C.Chouin-CarneiroT.et al.First Report of the East-Central South African Genotype of" exact="Chikungunya" post="Virus in Rio de Janeiro, BrazilPLoS Curr.2017910.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727 82.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.C.LavenirR.PardigonN.ReynesJ.M.PettinelliF.et al.Genome"/>
   <result pre="viruses causing the Indian Ocean outbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 83.NiyasK.P.AbrahamR.UnnikrishnanR.N.MathewT.NairS.ManakkadanA.IssacA.SreekumarE.Molecular characterization of" exact="Chikungunya" post="virus isolates from clinical samples and adult Aedes albopictus"/>
   <result pre="vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 85.BraultA.C.HuangC.Y.LangevinS.A.KinneyR.M.BowenR.A.RameyW.N.PanellaN.A.HolmesE.C.PowersA.M.MillerB.R.A single positively selected" exact="West Nile" post="viral mutation confers increased virogenesis in American crowsNat. Genet.2007391162116610.1038/ng209717694056"/>
   <result pre="virogenesis in American crowsNat. Genet.2007391162116610.1038/ng209717694056 86.EbelG.D.CarricaburuJ.YoungD.BernardK.A.KramerL.D.Genetic and phenotypic variation of" exact="West Nile" post="virus in New York, 2000–2003Am. J. Trop. Med. Hyg.20047149350010.4269/ajtmh.2004.71.49315516648"/>
   <result pre="2000–2003Am. J. Trop. Med. Hyg.20047149350010.4269/ajtmh.2004.71.49315516648 87.MoudyR.M.MeolaM.A.MorinL.L.EbelG.D.KramerL.D.A newly emergent genotype of" exact="West Nile" post="virus is transmitted earlier and more efficiently by Culex"/>
   <result pre="Trop. Med. Hyg.20077736537010.4269/ajtmh.2007.77.36517690414 88.ZhuZ.ChanJ.F.TeeK.M.ChoiG.K.LauS.K.WooP.C.TseH.YuenK.Y.Comparative genomic analysis of pre-epidemic and epidemic" exact="Zika" post="virus strains for virological factors potentially associated with the"/>
   <result pre="Infection Reference Type I IFN response OAS1B/C820T Increased susceptibility to" exact="WNV" post="infection [21] IRF3, MX1/SNPs Increased susceptibility to WNV infection"/>
   <result pre="susceptibility to WNV infection [21] IRF3, MX1/SNPs Increased susceptibility to" exact="WNV" post="infection [23] OAS1/TT, rs34137742 Increased susceptibility to WNV infection"/>
   <result pre="susceptibility to WNV infection [23] OAS1/TT, rs34137742 Increased susceptibility to" exact="WNV" post="infection [23] OAS3/SNP, rs2285933 Increased dengue infection [24] Viral"/>
   <result pre="dengue infection [24] Viral recognition TLR7, TLR8/SNPs Increased susceptibility to" exact="CHIKV" post="infection [25] CLEC5A-CT/TT (rs1285933) Increased risk for DENV diseases"/>
   <result pre="susceptibility to CHIKV infection [25] CLEC5A-CT/TT (rs1285933) Increased risk for" exact="DENV" post="diseases and TNF levels [26,27] CD209-336A/G Associated with DHF"/>
   <result pre="infection [31,32] Blood type Type A, RH+ Increased susceptibility to" exact="CHIKV" post="infection [34] Neuron progenitor cell growth and differentiation MSI1/wild"/>
   <result pre="[34] Neuron progenitor cell growth and differentiation MSI1/wild type Increasing" exact="ZIKV" post="replication by binding to 3′-UTR in neural precursors [35]"/>
   <result pre="precursors [35] MHC-I/II, T cell activation DQA1*01:02 Increased susceptibility to" exact="WNV" post="infection [37] HLA-A*24 Increased risk for DHF and DSS"/>
   <result pre="DHF [44] Chemokine, immune cell recruitment CCR5/∆32 Increased susceptibility to" exact="WNV" post="infection [45] Inflammatory cytokine, tumor necrosis alpha TNFA -308A"/>
   <result pre="enhance infectivity, pathogenicity, fitness, and transmissibility. Virus Gene/Mutation Outcome Reference" exact="DENV" post="NS2A 1998 DENV4 Puerto Rican epidemic strain [61] E/T359A"/>
   <result pre="humans, transmission by mosquitoes [66,67,89] NS5/A811V Increased disease severity [90]" exact="ZIKV" post="E/V603I, D679E Recently epidemic strains, unknown outcome [70] PrM/V153M"/>
   <result pre="secretability in the host blood, immune suppression in mosquitoes [78]" exact="CHIKV" post="E1/K211T Increased fitness in Ae. aegypti mosquitoes [79,81] E2/V264A"/>
   <result pre="replication [82] E2/L210Q Enhanced transovarial transmission by Ae. albopictus [83]" exact="WNV" post="NS3/T249P Increased adaption to American crow [85,91] E/V159A Increased"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6429326\results\search\tropicalVirus\results.xml">
   <result pre="Molecular Sciences1422-0067MDPI pmcid: 6429326 doi: 10.3390/ijms20051101ijms-20-01101 : Review Advances in" exact="Zika" post="Virus–Host Cell Interaction: Current Knowledge and Future Perspectives LeeJae"/>
   <result pre="BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Emerging mosquito-transmitted RNA viruses, such as" exact="Zika" post="virus (ZIKV) and Chikungunya represent human pathogens of an"/>
   <result pre="Emerging mosquito-transmitted RNA viruses, such as Zika virus (ZIKV) and" exact="Chikungunya" post="represent human pathogens of an immense global health problem."/>
   <result pre="human pathogens of an immense global health problem. In particular," exact="ZIKV" post="has emerged explosively since 2007 to cause a series"/>
   <result pre="South Pacific and most recently in the Americas. Although typical" exact="ZIKV" post="infections are asymptomatic, ZIKV infection during pregnancy is increasingly"/>
   <result pre="recently in the Americas. Although typical ZIKV infections are asymptomatic," exact="ZIKV" post="infection during pregnancy is increasingly associated with microcephaly and"/>
   <result pre="have established a remarkable progress on the pathogenic mechanisms of" exact="ZIKV" post="infection using in vitro and in vivo models. Here,"/>
   <result pre="ZIKV-mediated cell death mechanisms, host cell restriction factors that limit" exact="ZIKV" post="replication, and immune evasion mechanisms utilized by ZIKV. Understanding"/>
   <result pre="cellular level will contribute crucial insights into the development of" exact="ZIKV" post="therapeutics and vaccines. Zika virus cellular targets innate immune"/>
   <result pre="crucial insights into the development of ZIKV therapeutics and vaccines." exact="Zika" post="virus cellular targets innate immune evasion cell death 1."/>
   <result pre="as dengue virus (DENV), chikungunya, yellow fever virus (YFV), and" exact="Zika" post="virus (ZIKV) has become possible due to several factors"/>
   <result pre="autoimmune disorders in adults, and neurodevelopmental complications in newborns [2,3]." exact="ZIKV" post="belongs to the Flaviviridae family along with Japanese encephalitis"/>
   <result pre="to the Flaviviridae family along with Japanese encephalitis virus (JEV)," exact="West Nile" post="virus (WNV), and DENV, all of which are medically"/>
   <result pre="ticks. As of January 2018, PAHO has reported 223,477 confirmed" exact="ZIKV" post="cases that have cumulated worldwide between 2015 and 2018"/>
   <result pre="combat the infections [5]. As a result, international concern surrounding" exact="ZIKV" post="in terms of control, treatment, and prevention has classified"/>
   <result pre="a global threat to public health. Although most cases of" exact="ZIKV" post="infection result in asymptomatic or mild flu-like symptoms, such"/>
   <result pre="microcephaly and spontaneous abortion [6]. Up to date, diagnosis of" exact="ZIKV" post="infection has depended on molecular and serological testing, employing"/>
   <result pre="decline over time. Laboratory testing of infants suspected of congenital" exact="ZIKV" post="infection includes detection of viral RNA in serum and"/>
   <result pre="detection remain undetermined. Since the series of outbreaks in 2007," exact="ZIKV" post="infection has increasingly been associated with cases of neurological"/>
   <result pre="below the mean, is one clinical presentation of a congenital" exact="ZIKV" post="infection, and the World Health Organization has already established"/>
   <result pre="World Health Organization has already established an etiological link between" exact="ZIKV" post="infection and birth defects like microcephaly in Brazil [7,9]."/>
   <result pre="defects like microcephaly in Brazil [7,9]. Congenital abnormalities induced by" exact="ZIKV" post="infection have confirmed the possibility of vertical transmission. Despite"/>
   <result pre="neuropathogenesis remains unclear [7]. In addition to microcephaly, exposure to" exact="ZIKV" post="during pregnancy can result in visual and hearing impairments"/>
   <result pre="newborn [11]. Thus, the phenotypic spectrum of outcomes of pregnancy-associated" exact="ZIKV" post="infection has identified ZIKV as a dangerous and atypical"/>
   <result pre="phenotypic spectrum of outcomes of pregnancy-associated ZIKV infection has identified" exact="ZIKV" post="as a dangerous and atypical member among the flaviviruses."/>
   <result pre="the level of cellular mechanisms and interactions. 2. Structure of" exact="ZIKV" post="ZIKV is a single stranded, positive sense RNA virus"/>
   <result pre="level of cellular mechanisms and interactions. 2. Structure of ZIKV" exact="ZIKV" post="is a single stranded, positive sense RNA virus whose"/>
   <result pre="responsible for viral replication and assembly [5,13]. The structure of" exact="ZIKV" post="is similar to that of other flaviviruses. Flaviviral NS1"/>
   <result pre="flavivirus genus, NS5 plays an important role in viral replication." exact="ZIKV" post="NS5 contains an RNA dependent RNA polymerase (RdRp) domain,"/>
   <result pre="[16]. The envelope (E) protein, which mediates viral entry, of" exact="ZIKV" post="possesses a highly conserved fusion loop region that is"/>
   <result pre="target for antibodies generated against broad range of flaviviruses like" exact="DENV" post="and ZIKV [13,20]. Furthermore, transposon mutagenesis screening has demonstrated"/>
   <result pre="antibodies generated against broad range of flaviviruses like DENV and" exact="ZIKV" post="[13,20]. Furthermore, transposon mutagenesis screening has demonstrated the capacity"/>
   <result pre="[13,20]. Furthermore, transposon mutagenesis screening has demonstrated the capacity of" exact="ZIKV" post="to tolerate genetic diversity, as evident from ZIKV E"/>
   <result pre="capacity of ZIKV to tolerate genetic diversity, as evident from" exact="ZIKV" post="E gene’s tolerance of mutations, and this genetic flexibility"/>
   <result pre="promote host cell death. 3. Cellular Entry and Targets of" exact="ZIKV" post="Since 2016, scientific communities have dedicated rapid and extensive"/>
   <result pre="scientific communities have dedicated rapid and extensive research efforts on" exact="ZIKV" post="in terms of its molecular pathogenesis and associated cellular"/>
   <result pre="a comprehensive list of currently identified susceptible human cells to" exact="ZIKV" post="infection. ZIKV exhibits broad tropism, and the localization of"/>
   <result pre="list of currently identified susceptible human cells to ZIKV infection." exact="ZIKV" post="exhibits broad tropism, and the localization of its cellular"/>
   <result pre="and skin, to testis, kidney, and retina. The entry of" exact="ZIKV" post="is facilitated by the following phosphotidylserine receptors, such as"/>
   <result pre="the epidermis and dermis were primarily considered as targets for" exact="ZIKV" post="infection [25,26]. Upon entry of the host cell by"/>
   <result pre="infection [25,26]. Upon entry of the host cell by endocytosis," exact="ZIKV" post="releases a viral genome that undergoes replication and virion"/>
   <result pre="that undergoes replication and virion assembly for further infection [12]." exact="ZIKV" post="infection exhibits broad distribution and persistence in body tissues"/>
   <result pre="persistence in body tissues and fluids, a characteristic that distinguishes" exact="ZIKV" post="from other arthropod-transmitted flaviviruses. For example, the presence of"/>
   <result pre="ZIKV from other arthropod-transmitted flaviviruses. For example, the presence of" exact="ZIKV" post="has been detected in the amniotic fluid of pregnant"/>
   <result pre="[27]. As previously mentioned, microcephaly is a severe consequence of" exact="ZIKV" post="infection in the prenatal brain. Despite the existence of"/>
   <result pre="cells were preferentially targeted by ZIKV. Furthermore, the capability of" exact="ZIKV" post="to infect human neural progenitor cells (NPCs) has been"/>
   <result pre="neural progenitor cells (NPCs) has been confirmed in several studies." exact="ZIKV" post="exhibits preferential infection of neural progenitor cells, leading to"/>
   <result pre="and inhibition of NPC differentiation. All of these outcomes following" exact="ZIKV" post="infection are associated with delayed development and birth defects,"/>
   <result pre="as microcephaly in the mouse model [30]. Prenatal infection of" exact="ZIKV" post="has adverse pregnancy effects that range from congenital abnormalities"/>
   <result pre="the placenta possesses innate immunity to defend against infiltrating pathogens," exact="ZIKV" post="infection is able to overcome this defense and cross"/>
   <result pre="placental macrophages called Hofbauer cells may take part in spreading" exact="ZIKV" post="in the placenta and promoting vertical transmission of ZIKV"/>
   <result pre="spreading ZIKV in the placenta and promoting vertical transmission of" exact="ZIKV" post="[36]. In accordance, El Costa et al. identified the"/>
   <result pre="Hofbauer cells, suggesting that these cells provide a pathway for" exact="ZIKV" post="to reach fetal cells, resulting in a congenital infection"/>
   <result pre="these immune cells during pregnancy, especially in context of congenital" exact="ZIKV" post="infection, further research is needed to determine the exact"/>
   <result pre="further research is needed to determine the exact mechanism that" exact="ZIKV" post="employs to infect the placental immune cells and its"/>
   <result pre="a concerning threat to people who are outside of the" exact="ZIKV" post="epidemic-prone regions. Previous knowledge of flaviviruses as exclusively vector-borne"/>
   <result pre="as exclusively vector-borne diseases was contested when a case of" exact="ZIKV" post="infection resulted in a human-to-human transmission in 2008, between"/>
   <result pre="of samples from infected patients revealed infectious viral load of" exact="ZIKV" post="in semen [51]. Furthermore, the prolonged presence of ZIKV"/>
   <result pre="of ZIKV in semen [51]. Furthermore, the prolonged presence of" exact="ZIKV" post="RNA differentiates ZIKV from other flaviviruses because the immune"/>
   <result pre="semen [51]. Furthermore, the prolonged presence of ZIKV RNA differentiates" exact="ZIKV" post="from other flaviviruses because the immune response usually clears"/>
   <result pre="timeframe after symptom onset. Mansuy et al. describes cases of" exact="ZIKV" post="infection in which viral RNA was detected up to"/>
   <result pre="detection in urine and blood samples [51]. Sexual transmission of" exact="ZIKV" post="also results in a longer incubation period compared to"/>
   <result pre="may result from differences in the timing and/or site of" exact="ZIKV" post="infection, both factors that can affect the tropism and"/>
   <result pre="propagation mode exhibited by the virus. Immunohistochemistry has also detected" exact="ZIKV" post="in the head of spermatozoa, which does not express"/>
   <result pre="level of Axl, are hypothesized to be involved in transmitting" exact="ZIKV" post="to spermatozoa [57]. In Yockey et al. (2016), the"/>
   <result pre="(2016), the vagina was identified as another site susceptible to" exact="ZIKV" post="infection, and sustained a viral replication that was more"/>
   <result pre="robust than other organs [58]. Although rare, sexual transmission of" exact="ZIKV" post="cannot be overlooked as this route has implications on"/>
   <result pre="ZIKV cannot be overlooked as this route has implications on" exact="ZIKV" post="infection in relation to male fertility, pregnancy, and viral"/>
   <result pre="infection in relation to male fertility, pregnancy, and viral persistence." exact="ZIKV" post="infection is also capable of breaching the blood–retinal barrier,"/>
   <result pre="the ocular symptoms. Although an immune privilege organ, an ocular" exact="ZIKV" post="infection manifests as conjunctivitis and pan-uveitis, the former being"/>
   <result pre="iris, along with the optic nerve [60]. Ocular manifestations of" exact="ZIKV" post="infection demonstrate viral pathogenesis in previously uninvestigated sites. Despite"/>
   <result pre="pathogenesis in previously uninvestigated sites. Despite the tropism displayed by" exact="ZIKV" post="infection for specific regions of the eye, further studies"/>
   <result pre="outline the exact mechanisms of ZIKV-induced ocular disease. Evidence of" exact="ZIKV" post="infection persisting in organs such as the eyes and"/>
   <result pre="sites of viral replication and persistence [59,61,62]. Preferential targets of" exact="ZIKV" post="infection exhibited high expression levels of entry receptor genes,"/>
   <result pre="human fetal cerebral cortex provides a possible explanation for why" exact="ZIKV" post="selectively targets these neural stem cells and a potential"/>
   <result pre="interaction and kinase activity of Axl, accordingly, to ultimately inhibit" exact="ZIKV" post="infection [41]. It is interesting to note the dual"/>
   <result pre="against neurotropism [65,66]. Consequently, inhibiting Axl function to protect against" exact="ZIKV" post="infection may have adverse outcomes that require consideration when"/>
   <result pre="potential therapeutic targets. 4. Multiple Cell Death Pathways Induced by" exact="ZIKV" post="Infection In addition to antiviral responses, a virus infection"/>
   <result pre="studies have confirmed the occurrence of neuronal apoptosis following a" exact="ZIKV" post="infection in vivo and in vitro [68,69]. NSCs and"/>
   <result pre="In efforts to determine the reasons for the cell deaths," exact="ZIKV" post="structural envelope (E) protein, and its truncated forms, were"/>
   <result pre="Wu et al. also describes the potential inhibitory role of" exact="ZIKV" post="NS2B-NS3 (NS2B3) on apoptosis [71]. Overexpression of NS2B3 in"/>
   <result pre="suggests paraptosis as another form of cell death induced by" exact="ZIKV" post="infection, during which formation of large cytoplasmic vacuoles, which"/>
   <result pre="cellular death pathways have been suggested to be induced upon" exact="ZIKV" post="infection. It will be interesting to further study an"/>
   <result pre="the survival strategy. 5. Host Cell Restriction Factors that Limit" exact="ZIKV" post="Replication Through active interference with viral replication in various"/>
   <result pre="the host immune response. Belonging to the same flavivirus genus," exact="DENV" post="and ZIKV share similarities beyond phylogeny, including host immune"/>
   <result pre="immune response. Belonging to the same flavivirus genus, DENV and" exact="ZIKV" post="share similarities beyond phylogeny, including host immune responses. Proteins"/>
   <result pre="α, β, ε, τ, and δ) exhibited contradictory roles in" exact="DENV" post="pathogenesis, during which certain proteins were upregulated compared to"/>
   <result pre="[79,80,81,82,83]. In vitro studies of type III IFNs induction following" exact="DENV" post="infection demonstrated that IFN-λ has the inhibitory potential to"/>
   <result pre="infection demonstrated that IFN-λ has the inhibitory potential to control" exact="DENV" post="replication [84]. In Bayer et al., IFN- λ1 of"/>
   <result pre="of the type III IFN family (λ1-4) conferred protection against" exact="ZIKV" post="infection in placental trophoblasts, mediating antiviral signaling at the"/>
   <result pre="paracrine manner to protect other syncytiotrophoblasts and non-placental cells from" exact="ZIKV" post="infection [37]. According to Chaudhary et al., ZIKV infection"/>
   <result pre="cells from ZIKV infection [37]. According to Chaudhary et al.," exact="ZIKV" post="infection had differential effects on type I and type"/>
   <result pre="type II IFN responses, as demonstrated by the ability of" exact="ZIKV" post="NS5 to suppress type I and type III IFN"/>
   <result pre="inhibit viral replication of various pathogens including flaviviruses such as" exact="WNV" post="and DENV [88,89,90,91,92]. In Savidis et al., gain- and"/>
   <result pre="replication of various pathogens including flaviviruses such as WNV and" exact="DENV" post="[88,89,90,91,92]. In Savidis et al., gain- and loss-of function"/>
   <result pre="of ZIKV, and IFITM3 specifically inhibited the early stages of" exact="ZIKV" post="replication, evident from the significant decrease in the expression"/>
   <result pre="IFITM3 may be responsible for mounting an initial defense against" exact="ZIKV" post="infection even before the induction of interferon signaling and"/>
   <result pre="mechanism for the prevention and treatment of viral infections including" exact="ZIKV" post="[88,89,90,91,93]. Small non-coding RNAs are another potential restriction factor"/>
   <result pre="non-coding RNAs are another potential restriction factor that can limit" exact="ZIKV" post="replication. MicroRNA (miRNA) have been shown to have a"/>
   <result pre="MicroRNA (miRNA) have been shown to have a role during" exact="ZIKV" post="infection by regulating a broad spectrum of cellular processes"/>
   <result pre="study the antiviral role of differentially regulated small RNAs during" exact="ZIKV" post="infection. 6. Immune Evasion Mechanisms Utilized by ZIKV The"/>
   <result pre="RNAs during ZIKV infection. 6. Immune Evasion Mechanisms Utilized by" exact="ZIKV" post="The efficient replication of flaviviruses is associated with the"/>
   <result pre="molecules involved in innate immunity to establish efficient viral replication." exact="ZIKV" post="infection leads to the inhibition of type I IFN"/>
   <result pre="I IFN production and downstream interferon stimulated genes (ISGs) [97]." exact="ZIKV" post="NS1, NS4A, and NS4B proteins function as the main"/>
   <result pre="of TBK1/IRF3 pathways. Figure 2 describes diverse mechanisms by which" exact="ZIKV" post="evade innate immune responses. Nonstructural proteins have roles during"/>
   <result pre="replication and immune evasion, as seen during the pathogenesis of" exact="DENV" post="[98]. The amino acid differences in NS1 proteins may"/>
   <result pre="host immune response is differentially modulated to viruses such as" exact="ZIKV" post="in comparison to DENV. Furthermore, by interacting with host"/>
   <result pre="IFN-α and β signaling [100]. Furthermore, NS1 and NS4B of" exact="ZIKV" post="inhibit production of type I IFN by targeting TBK1,"/>
   <result pre="a manner independent of NS2B3-mediated Jak1 degradation. The focus on" exact="WNV" post="NS5 has been centered on its ability to inhibit"/>
   <result pre="of the mechanism for immune evasion [101,102]. Similarly, NS5 of" exact="ZIKV" post="directly interacts with and induces degradation of STAT2, which"/>
   <result pre="that has been targeted by various viruses closely related to" exact="DENV" post="[97,103]. In Kumar et al., immunoblot and confocal microscopy"/>
   <result pre="remained unchanged, the levels of STAT2 were nearly abrogated following" exact="ZIKV" post="infection [97]. While ZIKV NS5 is utilized for evasion"/>
   <result pre="of STAT2 were nearly abrogated following ZIKV infection [97]. While" exact="ZIKV" post="NS5 is utilized for evasion of type I IFN"/>
   <result pre="Akt-mTOR pathway has also been identified as a target of" exact="ZIKV" post="proteins NS4A and NS4B for neurogenesis inhibition and autophagy"/>
   <result pre="NS4A and NS4B for neurogenesis inhibition and autophagy induction [105]." exact="DENV" post="and ZIKV both induce autophagy through NS4 protein in"/>
   <result pre="NS4B for neurogenesis inhibition and autophagy induction [105]. DENV and" exact="ZIKV" post="both induce autophagy through NS4 protein in order to"/>
   <result pre="in enhanced viral replication. Taken together, the nonstructural proteins of" exact="ZIKV" post="work synergistically to restrict host antiviral response at multiple"/>
   <result pre="host immune system. 7. Vaccines and Therapeutics The reemergence of" exact="ZIKV" post="has posed a serious threat to global public health"/>
   <result pre="for the development of effective vaccines and therapeutic treatments against" exact="ZIKV" post="infection. Animal models have demonstrated the efficacy of various"/>
   <result pre="have advanced to human trials [106,107]. Furthermore, modified mRNA encoding" exact="ZIKV" post="prM-E and live-attenuated ZIKV with NS1 mutations studied in"/>
   <result pre="trials [106,107]. Furthermore, modified mRNA encoding ZIKV prM-E and live-attenuated" exact="ZIKV" post="with NS1 mutations studied in pregnant mice showed promising"/>
   <result pre="mice showed promising potential to protect against placental and fetal" exact="ZIKV" post="infection, preventing congenital ZIKV syndrome [107]. Richner et al."/>
   <result pre="to protect against placental and fetal ZIKV infection, preventing congenital" exact="ZIKV" post="syndrome [107]. Richner et al. demonstrated that vaccination with"/>
   <result pre="with the two previously described platforms protected against challenge with" exact="ZIKV" post="during pregnancy, as evident from the following: reduced level"/>
   <result pre="findings of current vaccine platforms that have sufficient immunity against" exact="ZIKV" post="infection in animal models, a more comprehensive evaluation of"/>
   <result pre="future. In addition to the lack of preventable methods against" exact="ZIKV" post="infection, the increased pathogenicity of the virus has triggered"/>
   <result pre="drugs that have already been FDA-approved is screened for potential" exact="ZIKV" post="inhibitors, has also risen as a viable alternative that"/>
   <result pre="potential through various screening methods [110,111,112]. Furthermore, the ability of" exact="ZIKV" post="to cross barriers into sites previously considered as immune"/>
   <result pre="exhibited potential antiviral activities against flaviviruses including ZIKV, DENV, and" exact="WNV" post="[113]. A member of the largest family of polyphenols,"/>
   <result pre="of polyphenols, the flavonoid isoquercitrin also demonstrated antiviral effect against" exact="ZIKV" post="by acting on viral entry [114]. A bacterially derived"/>
   <result pre="A bacterially derived nanchangmycin is another natural compound that inhibited" exact="ZIKV" post="entry in human osteosarcoma cells (U2OS), human brain microvascular"/>
   <result pre="[115]. Furthermore, berberine and emodin showed strong inhibitory effect on" exact="ZIKV" post="infectivity in vitro [116]. 8. Future Directions for ZIKV"/>
   <result pre="on ZIKV infectivity in vitro [116]. 8. Future Directions for" exact="ZIKV" post="Studies Although remarkable progress in ZIKV research has created"/>
   <result pre="8. Future Directions for ZIKV Studies Although remarkable progress in" exact="ZIKV" post="research has created opportunities for the development of vaccines"/>
   <result pre="of future perspectives: 1) what is the mechanism by which" exact="ZIKV" post="crosses the placenta and infects developing fetus? 2) What"/>
   <result pre="developing fetus? 2) What host and viral factors contribute to" exact="ZIKV" post="persistence in the placenta and other immune-privileged sites? 3)"/>
   <result pre="sites? 3) What are the roles of noncoding RNAs during" exact="ZIKV" post="infection? Although animal models provide useful platforms for supplementing"/>
   <result pre="virus–host cell interactions and mechanisms associated with increased virulence of" exact="ZIKV" post="will better aid in the design and development of"/>
   <result pre="pandemic: A review of the state of knowledge on the" exact="Zika" post="virusPublic Health Rev.2018391010.1186/s40985-018-0087-629785319 3.LazearH.M.DiamondM.S.Zika Virus: New Clinical Syndromes and"/>
   <result pre="American Health Organization (PAHO)Zika Cases and Congenital Syndrome Associated with" exact="Zika" post="Virus Reported by Countries and Territories in the Americas,"/>
   <result pre="clinical manifestation, diagnosis, therapeutic strategies, vaccine developments, and challenges of" exact="Zika" post="virus researchFront. Microbiol.20178176110.3389/fmicb.2017.0176128959246 6.PiersonT.C.DiamondM.S.The emergence of Zika virus and"/>
   <result pre="and challenges of Zika virus researchFront. Microbiol.20178176110.3389/fmicb.2017.0176128959246 6.PiersonT.C.DiamondM.S.The emergence of" exact="Zika" post="virus and its new clinical syndromesNature201856057310.1038/s41586-018-0446-y30158602 7.FaizanM.I.AbdullahM.AliS.NaqviI.H.AhmedA.ParveenS.Zika virus-induced microcephaly"/>
   <result pre="the Diagnosis, Evaluation, and Management of Infants with Possible Congenital" exact="Zika" post="Virus Infection—United StatesMMWR Morb. Mortal. Wkly. Rep.2017661089109910.15585/mmwr.mm6641a129049277 9.JaenischT.RosenbergerK.D.BritoC.BradyO.BrasilP.MarquesE.T.J.Risk of"/>
   <result pre="Infection—United StatesMMWR Morb. Mortal. Wkly. Rep.2017661089109910.15585/mmwr.mm6641a129049277 9.JaenischT.RosenbergerK.D.BritoC.BradyO.BrasilP.MarquesE.T.J.Risk of microcephaly after" exact="Zika" post="virus infection in Brazil, 2015 to 2016Bull. World Health"/>
   <result pre="2016Bull. World Health Organ.20179519110.2471/BLT.16.17860828250532 10.Alvarado-SocarrasJ.L.Idrovo�?.J.Contreras-GarcíaG.A.Rodriguez-MoralesA.J.AudcentT.A.Mogollon-MendozaA.C.Paniz-MondolfiA.Congenital microcephaly: A diagnostic challenge during" exact="Zika" post="epidemicsTravel Med. Inf. Dis.201823142010.1016/j.tmaid.2018.02.00229471046 11.PeloggiaA.AliM.NandaK.BahamondesL.Zika virus exposure in pregnancy"/>
   <result pre="and abusing the host cellCell Host Microbe2009531832810.1016/j.chom.2009.04.00119380111 13.DaiL.SongJ.LuX.DengY.-Q.MusyokiA.M.ChengH.ZhangY.YuanY.SongH.HaywoodJ.Structures of the" exact="Zika" post="virus envelope protein and its complex with a flavivirus"/>
   <result pre="1 protein: Risks and benefitsVirus Res.2014181536010.1016/j.virusres.2014.01.00124434336 16.ShiY.GaoG.F.Structural Biology of the" exact="Zika" post="VirusTrends Biochem. Sci.20174244345610.1016/j.tibs.2017.02.00928318966 17.AlconS.TalarminA.DebruyneM.FalconarA.DeubelV.FlamandM.Enzyme-linked immunosorbent assay specific to Dengue"/>
   <result pre="the Zika VirusTrends Biochem. Sci.20174244345610.1016/j.tibs.2017.02.00928318966 17.AlconS.TalarminA.DebruyneM.FalconarA.DeubelV.FlamandM.Enzyme-linked immunosorbent assay specific to" exact="Dengue" post="virus type 1 nonstructural protein NS1 reveals circulation of"/>
   <result pre="secondary infectionsJ. Clin. Microbiol.20024037638110.1128/JCM.40.02.376-381.200211825945 18.PhooW.W.LiY.ZhangZ.LeeM.Y.LohY.R.TanY.B.NgE.Y.N.LescarJ.KangC.LuoD.Structure of the NS2B-NS3 protease from" exact="Zika" post="virus after self-cleavageNat. Commun.201671341010.1038/ncomms1341027845325 19.HeinzF.X.StiasnyK.The Antigenic Structure of Zika"/>
   <result pre="from Zika virus after self-cleavageNat. Commun.201671341010.1038/ncomms1341027845325 19.HeinzF.X.StiasnyK.The Antigenic Structure of" exact="Zika" post="Virus and Its Relation to Other Flaviviruses: Implications for"/>
   <result pre="Fusion Loop of E ProteinPLoS ONE20116e001605910.1371/journal.pone.001605921264311 21.FultonB.O.SachsD.SchwarzM.C.PaleseP.EvansM.J.Transposon Mutagenesis of the" exact="Zika" post="Virus Genome Highlights Regions Essential for RNA Replication and"/>
   <result pre="suggesting two routes for vertical transmissionCell Host Microbe20162015516610.1016/j.chom.2016.07.00227443522 25.HamelR.DejarnacO.WichitS.EkchariyawatP.NeyretA.NatthanejL.Perera-LecoinM.SurasombatpattanaP.TalignaniL.ThomasF.Biology of" exact="Zika" post="virus infection in human skin cellsJ. Virol.201510.1128/JVI.00354-1526085147 26.KimJ.-A.SeongR.-K.SonS.W.ShinO.S.Insights into"/>
   <result pre="Infect. Dis.20162028228910.1016/j.bjid.2016.02.00627102780 28.NowakowskiT.J.PollenA.A.Di LulloE.Sandoval-EspinosaC.BershteynM.KriegsteinA.R.Expression analysis highlights AXL as a candidate" exact="Zika" post="virus entry receptor in neural stem cellsCell Stem Cell20161859159610.1016/j.stem.2016.03.01227038591"/>
   <result pre="damage and fetal demiseCell20161651081109110.1016/j.cell.2016.05.00827180225 31.SunX.HuaS.ChenH.-R.OuyangZ.EinkaufK.TseS.ArdK.CiaranelloA.YawetzS.SaxP.J.et al.Transcriptional changes during naturally acquired" exact="Zika" post="virus infection render dendritic cells highly conducive to viral"/>
   <result pre="render dendritic cells highly conducive to viral replicationCell Rep.2017213471348210.1016/j.celrep.2017.11.08729262327 32.FooS.-S.ChenW.ChanY.BowmanJ.W.ChangL.-C.ChoiY.YooJ.S.GeJ.ChengG.BonninA.Asian" exact="Zika" post="virus strains target CD14+ blood monocytes and induce M2-skewed"/>
   <result pre="pregnancyNat. Microbiol.20172155810.1038/s41564-017-0016-328827581 33.MichlmayrD.AndradeP.GonzalezK.BalmasedaA.HarrisE.CD14+ CD16+ monocytes are the main target of" exact="Zika" post="virus infection in peripheral blood mononuclear cells in a"/>
   <result pre="in a paediatric study in NicaraguaNat. Microbiol.20172146210.1038/s41564-017-0035-028970482 34.RosenbergA.Z.YuW.HillD.A.ReyesC.A.SchwartzD.A.Placental pathology of" exact="Zika" post="virus: Viral infection of the placenta induces villous stromal"/>
   <result pre="of inflammation characterize the placental pathology of fetuses with congenital" exact="Zika" post="virus infectionArch. Gynecol. Obstet.20172951361136810.1007/s00404-017-4361-528396992 36.SimoniM.K.JuradoK.A.AbrahamsV.M.FikrigE.GullerS.Zika virus infection of Hofbauer"/>
   <result pre="III interferons produced by human placental trophoblasts confer protection against" exact="Zika" post="virus infectionCell Host Microbe20161970571210.1016/j.chom.2016.03.00827066743 38.TabataT.PetittM.Puerta-GuardoH.MichlmayrD.HarrisE.PereiraL.Zika Virus Replicates in Proliferating"/>
   <result pre="Sites for Dissemination of InfectionJ. Infect. Dis.20182171202121310.1093/infdis/jix55229106643 39.ChengF.da SilvaS.R.HuangI.-C.JungJ.U.GaoS.-J.Suppression of" exact="Zika" post="virus infection and replication in endothelial cells and astrocytes"/>
   <result pre="Not Protect Human Neural Progenitor Cells and Cerebral Organoids from" exact="Zika" post="Virus InfectionCell Stem Cell20161970370810.1016/j.stem.2016.11.01127912091 41.MeertensL.LabeauA.DejarnacO.CiprianiS.SinigagliaL.Bonnet-MadinL.Le CharpentierT.HafirassouM.L.ZamborliniA.Cao-LormeauV.-M.Axl mediates ZIKA virus"/>
   <result pre="cells and modulates innate immune responsesCell Rep.20171832433310.1016/j.celrep.2016.12.04528076778 42.StefanikM.FormanovaP.BilyT.VancovaM.EyerL.PalusM.SalatJ.BraconiC.T.ZanottoP.M.A.GouldE.A.et al.Characterisation of" exact="Zika" post="virus infection in primary human astrocytesBMC Neurosci.201819510.1186/s12868-018-0407-229463209 43.RoachT.AlcendorD.J.Zika virus"/>
   <result pre="diseaseJ. Neuroinflamm.2017144310.1186/s12974-017-0824-728253931 44.BagasraO.AddankiK.C.GoodwinG.R.HughesB.W.PandeyP.McLeanE.Cellular targets and receptor of sexual transmission of" exact="Zika" post="virusAppl. Immunohistochem. Mol. Morphol.20172567968610.1097/PAI.000000000000058028968270 45.SalamA.P.HorbyP.Isolation of viable Zika virus"/>
   <result pre="transmission of Zika virusAppl. Immunohistochem. Mol. Morphol.20172567968610.1097/PAI.000000000000058028968270 45.SalamA.P.HorbyP.Isolation of viable" exact="Zika" post="virus from spermatozoaLancet Infect. Dis.20181814410.1016/S1473-3099(18)30020-3 46.KumarA.JovelJ.Lopez-OrozcoJ.LimontaD.AiroA.M.HouS.StryapuninaI.FibkeC.MooreR.B.HobmanT.C.J.Human Sertoli cells support"/>
   <result pre="spermatozoaLancet Infect. Dis.20181814410.1016/S1473-3099(18)30020-3 46.KumarA.JovelJ.Lopez-OrozcoJ.LimontaD.AiroA.M.HouS.StryapuninaI.FibkeC.MooreR.B.HobmanT.C.J.Human Sertoli cells support high levels of" exact="Zika" post="virus replication and persistenceSci. Rep.20188547710.1038/s41598-018-23899-x29615760 47.SiemannD.N.StrangeD.P.MaharajP.N.ShiP.-Y.VermaS.Zika virus infects human"/>
   <result pre="J. Med.20163741981198710.1056/NEJMsr160433827074377 49.CalvetG.AguiarR.S.MeloA.S.SampaioS.A.De FilippisI.FabriA.AraujoE.S.de SequeiraP.C.de MendonçaM.C.de OliveiraL.Detection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
   <result pre="first trimester of pregnancySci. Rep.201663529610.1038/srep3529627759009 52.FoyB.D.KobylinskiK.C.FoyJ.L.C.BlitvichB.J.da RosaA.T.HaddowA.D.LanciottiR.S.TeshR.B.Probable non–vector-borne transmission of" exact="Zika" post="virus, Colorado, USAEmerg. Infect. Dis.20111788010.3201/eid1705.10193921529401 53.CounotteM.J.KimC.R.WangJ.BernsteinK.DealC.D.BroutetN.J.N.LowN.Sexual transmission of Zika"/>
   <result pre="of Zika virus, Colorado, USAEmerg. Infect. Dis.20111788010.3201/eid1705.10193921529401 53.CounotteM.J.KimC.R.WangJ.BernsteinK.DealC.D.BroutetN.J.N.LowN.Sexual transmission of" exact="Zika" post="virus and other flaviviruses: A living systematic reviewPLoS Med.201815e100261110.1371/journal.pmed.100261130040845"/>
   <result pre="flaviviruses: A living systematic reviewPLoS Med.201815e100261110.1371/journal.pmed.100261130040845 54.ArsuagaM.BujalanceS.G.Díaz-MenéndezM.VázquezA.ArribasJ.R.Probable sexual transmission of" exact="Zika" post="virus from a vasectomised manLancet Infect. Dis.201616110710.1016/S1473-3099(16)30320-6 55.FouriéT.G.GrardG.Leparc-GoffartI.BriolantS.FontaineA.Variability of"/>
   <result pre="Zika virus from a vasectomised manLancet Infect. Dis.201616110710.1016/S1473-3099(16)30320-6 55.FouriéT.G.GrardG.Leparc-GoffartI.BriolantS.FontaineA.Variability of" exact="Zika" post="Virus Incubation Period in HumansOpen Forum Infect. Dis.20185ofy26110.1093/ofid/ofy26130397624 56.Krow-LucalE.R.BiggerstaffB.J.StaplesJ.Estimated"/>
   <result pre="Period in HumansOpen Forum Infect. Dis.20185ofy26110.1093/ofid/ofy26130397624 56.Krow-LucalE.R.BiggerstaffB.J.StaplesJ.Estimated Incubation Period for" exact="Zika" post="Virus DiseaseEmerg. Infect. Dis.20172384184510.3201/eid2305.16171528277198 57.MansuyJ.M.SuberbielleE.Chapuy-RegaudS.MengelleC.BujanL.MarchouB.DelobelP.Gonzalez-DuniaD.MalnouC.E.IzopetJ.Zika virus in semen and"/>
   <result pre="semen and spermatozoaLancet Infect. Dis.2016161106110710.1016/S1473-3099(16)30336-X27676340 58.YockeyL.J.VarelaL.RakibT.Khoury-HanoldW.FinkS.L.StutzB.Szigeti-BuckK.Van den PolA.LindenbachB.D.HorvathT.L.J.C.Vaginal exposure to" exact="Zika" post="virus during pregnancy leads to fetal brain infectionCell20161661247125610.1016/j.cell.2016.08.00427565347 59.MinerJ.J.SeneA.RichnerJ.M.SmithA.M.SantefordA.BanN.Weger-LucarelliJ.ManzellaF.RückertC.GoveroJ.J.C.Zika"/>
   <result pre="virus in the male reproductive tractViruses20181019810.3390/v1004019829659541 62.LazearH.M.GoveroJ.SmithA.M.PlattD.J.FernandezE.MinerJ.J.DiamondM.S.J.A mouse model of" exact="Zika" post="virus pathogenesisCell Host Microbe20161972073010.1016/j.chom.2016.03.01027066744 63.WangA.ThurmondS.IslasL.HuiK.HaiR.Zika virus genome biology and"/>
   <result pre="damage in central nervous system of fatal cases microcephaly by" exact="Zika" post="virusSci. Rep.20188110.1038/s41598-017-17765-529311619 73.WangW.LiG.DeW.LuoZ.PanP.TianM.WangY.XiaoF.LiA.WuK.et al.Zika virus infection induces host inflammatory"/>
   <result pre="and Fetal DevelopmentImmunity20184939741210.1016/j.immuni.2018.07.01730231982 77.YockeyL.J.JuradoK.A.AroraN.MilletA.RakibT.MilanoK.M.HastingsA.K.FikrigE.KongY.HorvathT.L.J.Type I interferons instigate fetal demise after" exact="Zika" post="virus infectionSci. Immunol.20183eaao168010.1126/sciimmunol.aao168029305462 78.SadlerA.J.WilliamsB.R.J.N.Interferon-inducible antiviral effectorsNat. Rev. Immunol.2008855910.1038/nri231418575461 79.ZhangH.HeZ.ZengW.PengH.-J.Roles"/>
   <result pre="effectorsNat. Rev. Immunol.2008855910.1038/nri231418575461 79.ZhangH.HeZ.ZengW.PengH.-J.Roles of Interferons in Pregnant Women with" exact="Dengue" post="Infection: Protective or Dangerous FactorsCan. J. Infect. Dis. Med."/>
   <result pre="in epithelial cellsVirol. J.20151215010.1186/s12985-015-0383-426411318 85.ChaudharyV.YuenK.-S.ChanJ.F.-W.ChanC.-P.WangP.-H.CaiJ.-P.ZhangS.LiangM.KokK.-H.ChanC.-P.Selective activation of interferon-γ signaling by" exact="Zika" post="virus NS5 proteinJ. Virol.201791e00163-1710.1128/JVI.00163-1728468880 86.BowenJ.R.QuickeK.M.MaddurM.S.O’NealJ.T.McDonaldC.E.FedorovaN.B.PuriV.ShabmanR.S.PulendranB.SutharM.S.Zika virus antagonizes type I"/>
   <result pre="tissue responses in the maternal-fetal interfaceJ. Virol.201791e01905-1610.1128/JVI.01905-1627974560 88.SavidisG.PerreiraJ.M.PortmannJ.M.MeranerP.GuoZ.GreenS.BrassA.L.J.C.The IFITMs inhibit" exact="Zika" post="virus replicationCell Rep.2016152323233010.1016/j.celrep.2016.05.07427268505 89.ChesarinoN.M.McMichaelT.M.YountJ.S.E3 ubiquitin ligase NEDD4 promotes influenza"/>
   <result pre="signalingEMBO Rep.2016171766177510.15252/embr.20164262727797853 98.SironiM.ForniD.ClericiM.CaglianiR.J.P.Nonstructural proteins are preferential positive selection targets in" exact="Zika" post="virus and related flavivirusesPLoS Negl. Trop. Dis.201610e000497810.1371/journal.pntd.000497827588756 99.MaJ.KetkarH.GengT.LoE.WangL.XiJ.SunQ.ZhuZ.CuiY.YangL.J.F.Zika Virus"/>
   <result pre="by the New York 99 strain and Kunjin subtype of" exact="West Nile" post="virus involves blockage of STAT1 and STAT2 activation by"/>
   <result pre="nonstructural proteinsJ. Virol.2005791934194210.1128/JVI.79.3.1934-1942.200515650219 102.LiuW.J.WangX.J.ClarkD.C.LobigsM.HallR.A.KhromykhA.A.A single amino acid substitution in the" exact="West Nile" post="virus nonstructural protein NS2A disables its ability to inhibit"/>
   <result pre="inhibit neurogenesis and induce autophagyCell Stem Cell20161966367110.1016/j.stem.2016.07.01927524440 106.DurbinA.P.Vaccine Development for" exact="Zika" post="Virus—Timelines and StrategiesSeminars in Reproductive MedicineThieme Medical PublishersStuttgart, Germany2016299304"/>
   <result pre="in Reproductive MedicineThieme Medical PublishersStuttgart, Germany2016299304 107.RichnerJ.M.JaggerB.W.ShanC.FontesC.R.DowdK.A.CaoB.HimansuS.CaineE.A.NunesB.T.MedeirosD.B.J.C.Vaccine mediated protection against" exact="Zika" post="virus-induced congenital diseaseCell201717027328310.1016/j.cell.2017.06.04028708997 108.MunjalA.KhandiaR.DhamaK.SachanS.KarthikK.TiwariR.MalikY.S.KumarD.SinghR.K.IqbalH.Advances in developing therapies to combat"/>
   <result pre="Zika virus-induced congenital diseaseCell201717027328310.1016/j.cell.2017.06.04028708997 108.MunjalA.KhandiaR.DhamaK.SachanS.KarthikK.TiwariR.MalikY.S.KumarD.SinghR.K.IqbalH.Advances in developing therapies to combat" exact="Zika" post="virus: Current knowledge and future perspectivesFront. Microbiol.20178146910.3389/fmicb.2017.0146928824594 109.SacramentoC.Q.De MeloG.R.De"/>
   <result pre="Microbiol.20178146910.3389/fmicb.2017.0146928824594 109.SacramentoC.Q.De MeloG.R.De FreitasC.S.RochaN.HoelzL.V.B.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.J.S.The clinically approved antiviral drug sofosbuvir inhibits" exact="Zika" post="virus replicationSci. Rep.201774092010.1038/srep4092028098253 110.DelvecchioR.HigaL.M.PezzutoP.ValadãoA.L.GarcezP.P.MonteiroF.L.LoiolaE.C.DiasA.A.SilvaF.J.AliotaM.T.Chloroquine, an endocytosis blocking agent, inhibits"/>
   <result pre="Zika virus replicationSci. Rep.201774092010.1038/srep4092028098253 110.DelvecchioR.HigaL.M.PezzutoP.ValadãoA.L.GarcezP.P.MonteiroF.L.LoiolaE.C.DiasA.A.SilvaF.J.AliotaM.T.Chloroquine, an endocytosis blocking agent, inhibits" exact="Zika" post="virus infection in different cell modelsViruses2016832210.3390/v812032227916837 111.BalasubramanianA.TeramotoT.KulkarniA.A.BhattacharjeeA.K.PadmanabhanR.Antiviral activities of"/>
   <result pre="activities of selected antimalarials against dengue virus type 2 and" exact="Zika" post="virusAntivir. Res.201713714115010.1016/j.antiviral.2016.11.01527889529 112.AkpovwaH.Chloroquine could be used for the treatment"/>
   <result pre="the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses" exact="West Nile" post="Virus, Zika Virus, and Dengue VirusFront. Microbiol.20178131410.3389/fmicb.2017.0131428744282 114.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid"/>
   <result pre="Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus," exact="Zika" post="Virus, and Dengue VirusFront. Microbiol.20178131410.3389/fmicb.2017.0131428744282 114.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes"/>
   <result pre="Gallate against the Flaviviruses West Nile Virus, Zika Virus, and" exact="Dengue" post="VirusFront. Microbiol.20178131410.3389/fmicb.2017.0131428744282 114.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes Initiation of Zika"/>
   <result pre="and Dengue VirusFront. Microbiol.20178131410.3389/fmicb.2017.0131428744282 114.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes Initiation of" exact="Zika" post="Virus Infection in Human CellsInt. J. Mol. Sci.201819109310.3390/ijms1904109329621184 115.RauschK.HackettB.A.WeinbrenN.L.ReederS.M.SadovskyY.HunterC.A.SchultzD.C.CoyneC.B.CherryS.Screening"/>
   <result pre="Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against" exact="Zika" post="VirusCell Rep.20171880481510.1016/j.celrep.2016.12.06828099856 116.BatistaM.N.BragaA.C.S.CamposG.R.F.SouzaM.M.MatosR.P.A.D.LopesT.Z.BittarC.Natural Products Isolated from Oriental Medicinal Herbs"/>
   <result pre="VirusCell Rep.20171880481510.1016/j.celrep.2016.12.06828099856 116.BatistaM.N.BragaA.C.S.CamposG.R.F.SouzaM.M.MatosR.P.A.D.LopesT.Z.BittarC.Natural Products Isolated from Oriental Medicinal Herbs Inactivate" exact="Zika" post="VirusViruses2019114910.3390/v1101004930641880 117.HuchM.KooB.-K.Modeling mouse and human development using organoid culturesDevelopment20151423113312510.1242/dev.11857026395140"/>
   <result pre="human placentaJ. Matern.-Fetal Neonatal Med.2016291046105410.3109/14767058.2015.103851826075842 Figure 1 The structure of" exact="Zika" post="virus (ZIKV) genome and its encoded proteins. The single"/>
   <result pre="NS5). Figure 2 Innate immune evasion mechanisms by ZIKV. During" exact="ZIKV" post="infection, viral RNA sensors and interferon-mediated signaling through downstream"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6430813\results\search\tropicalVirus\results.xml">
   <result pre="64308139256 doi: 10.1038/s41467-019-09256-0 : Article Aedes mosquitoes acquire and transmit" exact="Zika" post="virus by breeding in contaminated aquatic environments DuSenyan123LiuYang14LiuJianying1ZhaoJie1ChampagneClara5TongLiangqin1ZhangRenli3ZhangFuchun6http://orcid.org/0000-0002-0632-2807QinCheng-Feng7MaPing8ChenChun-Hong9LiangGuodong10LiuQiyong11ShiPei-Yong12http://orcid.org/0000-0002-7972-361XCazellesBernard513WangPenghua14TianHuaiyu+86-10-58804067tianhuaiyu@gmail.com15ChengGong+86-10-62788494gongcheng@mail.tsinghua.edu.cn123[1], 0000"/>
   <result pre="To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract" exact="Zika" post="virus (ZIKV) is a mosquito-borne flavivirus that predominantly circulates"/>
   <result pre="between humans and Aedes mosquitoes. Clinical studies have shown that" exact="Zika" post="viruria in patients persists for an extended period, and"/>
   <result pre="excreted. Here, we demonstrate that Aedes mosquitoes are permissive to" exact="ZIKV" post="infection when breeding in urine or sewage containing low"/>
   <result pre="larvae and pupae, including from field Aedes aegypti can acquire" exact="ZIKV" post="from contaminated aquatic systems, resulting in ZIKV infection of"/>
   <result pre="aegypti can acquire ZIKV from contaminated aquatic systems, resulting in" exact="ZIKV" post="infection of adult females. Adult mosquitoes can transmit infectious"/>
   <result pre="susceptible type I/II interferon receptor-deficient (ifnagr-/-) C57BL/6 (AG6) mice. Furthermore," exact="ZIKV" post="viruria from infected AG6 mice can causes mosquito infection"/>
   <result pre="Our studies suggest that infectious urine could be a natural" exact="ZIKV" post="source, which is potentially transmissible to mosquitoes when breeding"/>
   <result pre="environment. Here the authors show that Aedes mosquitoes can acquire" exact="ZIKV" post="by breeding in contaminated aquatic systems, and that these"/>
   <result pre="contaminated aquatic systems, and that these infected mosquitoes can transmit" exact="ZIKV" post="to susceptible mice. This suggests that human urine containing"/>
   <result pre="suggests that human urine containing aquatic environments could contribute to" exact="ZIKV" post="transmission. Introduction Zika virus (ZIKV) is a mosquito-borne virus"/>
   <result pre="urine containing aquatic environments could contribute to ZIKV transmission. Introduction" exact="Zika" post="virus (ZIKV) is a mosquito-borne virus belonging to the"/>
   <result pre="Aedes aegypti and Aedes albopictus are the primary vectors for" exact="ZIKV" post="transmission in nature1,2. Recent ZIKV epidemics in the Americas"/>
   <result pre="are the primary vectors for ZIKV transmission in nature1,2. Recent" exact="ZIKV" post="epidemics in the Americas resulted in more than 223,000"/>
   <result pre="syndrome in adults4, and microcephaly in neonates5, are associated with" exact="ZIKV" post="infection. As a mosquito-borne flavivirus, ZIKV is well known"/>
   <result pre="neonates5, are associated with ZIKV infection. As a mosquito-borne flavivirus," exact="ZIKV" post="is well known to survive in a transmission cycle"/>
   <result pre="humans6. After transmission by infected mosquitoes feeding on naive hosts," exact="ZIKV" post="rapidly develops viremia, which enables acquisition by other mosquitoes"/>
   <result pre="blood feeding. In addition to causing viremia in host blood," exact="ZIKV" post="has also been isolated from host semen, urine, saliva,"/>
   <result pre="saliva, amniotic fluid, breast milk, and cerebrospinal fluid7–10. Transmission of" exact="ZIKV" post="has also been suggested to occur via other nonvector"/>
   <result pre="congenital transmission, and blood transfusions11–13. Accumulating evidence indicates that infectious" exact="ZIKV" post="particles are excreted into urine14–16. To date, at least"/>
   <result pre="particles are excreted into urine14–16. To date, at least five" exact="ZIKV" post="infectious strains have been recovered and cultured from human"/>
   <result pre="recovered and cultured from human urine samples14,16–19, demonstrating that infectious" exact="ZIKV" post="is discharged by patient viruria. Another study reports an"/>
   <result pre="is discharged by patient viruria. Another study reports an infectious" exact="ZIKV" post="titer of 10 pfu/ml in the urine of a patient14."/>
   <result pre="of 10 pfu/ml in the urine of a patient14. In addition," exact="ZIKV" post="viruria may persist for several days. The equivalent of"/>
   <result pre="viruria may persist for several days. The equivalent of 12–20 pfu/ml" exact="ZIKV" post="was present in urine samples from three patients from"/>
   <result pre="patients from 5 to 26 days after the onset of" exact="Zika" post="symptoms20. Indeed, an adult may urinate 1000–2000 ml daily and,"/>
   <result pre="urinate 1000–2000 ml daily and, if infected by ZIKV, discharge infectious" exact="ZIKV" post="into the environment, including sewers, water pools, septic tanks,"/>
   <result pre="habitat of mosquitoes. We therefore investigated whether the urine from" exact="Zika" post="patients could be a ZIKV source that facilitates mosquito"/>
   <result pre="investigated whether the urine from Zika patients could be a" exact="ZIKV" post="source that facilitates mosquito infection in aquatic stages, and"/>
   <result pre="that both A. aegypti and A. albopictus are permissive to" exact="ZIKV" post="infection when breeding in urine or sewage containing low"/>
   <result pre="breeding in urine or sewage containing low concentrations of ZIKV." exact="ZIKV" post="viruria from infected AG6 mice leads to mosquito infection"/>
   <result pre="field A. aegypti breeding in infectious sewage can transmit infectious" exact="Zika" post="virions to naive AG6 mice, suggesting that ZIKV in"/>
   <result pre="transmit infectious Zika virions to naive AG6 mice, suggesting that" exact="ZIKV" post="in contaminated aquatic environments is transmissible by mosquitoes during"/>
   <result pre="transmissible by mosquitoes during breeding. Results Mosquitoes are permissive to" exact="ZIKV" post="infection when breeding Both A. aegypti and A. albopictus,"/>
   <result pre="albopictus, which live around human dwellings, are major vectors for" exact="ZIKV" post="transmission21. These Aedes species commonly breed in containers with"/>
   <result pre="and Puerto Rico24. We therefore wondered whether mosquitoes might acquire" exact="ZIKV" post="while breeding in aquatic conditions with human urine containing"/>
   <result pre="conditions with human urine containing infectious ZIKV. We first assessed" exact="ZIKV" post="stability in human urine. To mimic the conditions in"/>
   <result pre="To mimic the conditions in the human bladder, we incubated" exact="ZIKV" post="with eight fresh human urine samples (PRVABC59 strain, final"/>
   <result pre="urine samples (PRVABC59 strain, final titer was 1 × 105 pfu/ml) and incubated" exact="ZIKV" post="with phosphate-buffered saline (PBS) as a control. The mixture"/>
   <result pre="then maintained at 37 °C (human physiological temperature) for 48 h. Interestingly," exact="ZIKV" post="survivability varied significantly between individual urine samples. A titer"/>
   <result pre="survivability varied significantly between individual urine samples. A titer of" exact="ZIKV" post="(&amp;gt;102 pfu/ml) was detected in two samples at 24 h at"/>
   <result pre="(Fig. 1a). To mimic the natural post-excretion conditions, we incubated" exact="ZIKV" post="with the same eight fresh human urine samples (PRVABC59"/>
   <result pre="urine samples (PRVABC59 strain, final titer was 20 pfu/ml). Incubation of" exact="ZIKV" post="with PBS served as a control. The mixture was"/>
   <result pre="was then maintained at 28 °C for 48 h. A titer of" exact="ZIKV" post="was detected in one sample at 24 h at 28 °C"/>
   <result pre="(Fig. 1b). This result suggests that the extended stability of" exact="ZIKV" post="in human urine in the environment may provide a"/>
   <result pre="urine in the environment may provide a time window for" exact="ZIKV" post="infection during mosquito breeding. Fig. 1 Mosquitoes are permissive"/>
   <result pre="infection during mosquito breeding. Fig. 1 Mosquitoes are permissive to" exact="Zika" post="virus (ZIKV) infection during breeding. a, b ZIKV survivability"/>
   <result pre="permissive to Zika virus (ZIKV) infection during breeding. a, b" exact="ZIKV" post="survivability in human urine. ZIKV was incubated with fresh"/>
   <result pre="infection during breeding. a, b ZIKV survivability in human urine." exact="ZIKV" post="was incubated with fresh human urine or phosphate-buffered saline"/>
   <result pre="The PRVABC59 strain was used for the incubation. The initial" exact="ZIKV" post="titer was 1 × 105 or 20 pfu/ml. Data are presented as"/>
   <result pre="the similar results. F: female; M: male. c–e Acquisition of" exact="ZIKV" post="infection by Aedes mosquitoes breeding in infectious human urine."/>
   <result pre="representation. Freshly emerging mosquito pupae were used for breeding in" exact="ZIKV" post="urine. The urine from human Donor 3 (Fig. 1a)"/>
   <result pre="Donor 3 (Fig. 1a) was used in these experiments. Both" exact="ZIKV" post="prevalence and infectivity were determined in the A. aegypti"/>
   <result pre="(e). The mosquitoes were breeding from human urine with serial" exact="ZIKV" post="titration. The emerging adults were reared for an additional"/>
   <result pre="emerging adults were reared for an additional 8 days for" exact="ZIKV" post="detection by TaqMan quantitative PCR (qPCR). The number of"/>
   <result pre="first assessed the susceptibility of larval and pupal stages to" exact="ZIKV" post="infection in aquatic conditions. The fresh urine from Donor"/>
   <result pre="fresh urine from Donor 3 (Fig. 1a) was mixed with" exact="ZIKV" post="supernatant from infected Vero cells for A. aegypti larvae"/>
   <result pre="breeding (PRVABC59 strain, final titer was 20 pfu/ml). After exposure to" exact="ZIKV" post="urine, the larvae or pupae were transferred to a"/>
   <result pre="The emerging adult mosquitoes were reared for 8 days for" exact="ZIKV" post="detection by quantitative reverse transcription PCR (RT-qPCR). Intriguingly, both"/>
   <result pre="PCR (RT-qPCR). Intriguingly, both the larvae and pupae in the" exact="ZIKV" post="urine were permissive to ZIKV infection and carried ZIKV"/>
   <result pre="larvae and pupae in the ZIKV urine were permissive to" exact="ZIKV" post="infection and carried ZIKV throughout development to adults (Supplementary"/>
   <result pre="the ZIKV urine were permissive to ZIKV infection and carried" exact="ZIKV" post="throughout development to adults (Supplementary Fig. 1b). Notably, the"/>
   <result pre="mosquitoes emerging from pupae incubation presented the highest prevalence of" exact="ZIKV" post="infection, suggesting that the pupae might be more susceptible"/>
   <result pre="infection, suggesting that the pupae might be more susceptible to" exact="ZIKV" post="in urine. Both A. aegypti and A. albopictus have"/>
   <result pre="and A. albopictus have been shown to carry and transmit" exact="ZIKV" post="in several field surveillance reports1,2. We next investigated whether"/>
   <result pre="whether the different mosquito species breeding in human urine with" exact="ZIKV" post="might acquire an infection. In the first experiment, we"/>
   <result pre="(Jiangsu strain) with the ZIKV-positive urine, in which the final" exact="ZIKV" post="titers were 20, 2, and 0.2 pfu/ml (Fig. 1c). The"/>
   <result pre="adult mosquitoes were reared for 8 days and subjected to" exact="ZIKV" post="detection by RT-qPCR. For the A. aegypti Rockefeller strain,"/>
   <result pre="mosquitoes in the adult stage, breeding in 20 and 2 pfu/ml" exact="ZIKV" post="urine, respectively, were positive for ZIKV by RT-qPCR detection."/>
   <result pre="in 20 and 2 pfu/ml ZIKV urine, respectively, were positive for" exact="ZIKV" post="by RT-qPCR detection. However, none of the mosquitoes (0/129)"/>
   <result pre="mosquitoes (0/129) acquired the infection from human urine with 0.2 pfu/ml" exact="ZIKV" post="(Fig. 1d). Additionally, 2.7% (6/223) and 0.7% (1/149) of"/>
   <result pre="of adult A. albopictus mosquitoes breeding in 20 and 2 pfu/ml" exact="ZIKV" post="urine, respectively, showed positive detection of ZIKV (Fig. 1e)."/>
   <result pre="20 and 2 pfu/ml ZIKV urine, respectively, showed positive detection of" exact="ZIKV" post="(Fig. 1e). We next tested the infectivity of ZIKV"/>
   <result pre="of ZIKV (Fig. 1e). We next tested the infectivity of" exact="ZIKV" post="virions in mosquitoes breeding in ZIKV urine. In human"/>
   <result pre="tested the infectivity of ZIKV virions in mosquitoes breeding in" exact="ZIKV" post="urine. In human urine with 20 pfu/ml ZIKV, 2 of"/>
   <result pre="albopictus pools were positive for infectious ZIKV, as determined by" exact="ZIKV" post="culture in Vero cells. However, under similar experimental conditions"/>
   <result pre="sequencing to confirm that the cytopathic effects were caused by" exact="ZIKV" post="infection. Thus, we demonstrate that different Aedes mosquito species"/>
   <result pre="we demonstrate that different Aedes mosquito species are susceptible to" exact="ZIKV" post="infection when breeding in infectious aquatic systems. Table 1"/>
   <result pre="breeding in infectious aquatic systems. Table 1 Measurement of infectious" exact="ZIKV" post="particles in mosquitoes breeding in ZIKV urine Virus titer"/>
   <result pre="1 Measurement of infectious ZIKV particles in mosquitoes breeding in" exact="ZIKV" post="urine Virus titer Mosquito species Number of mosquito poolsa"/>
   <result pre="Aedes aegypti -Rockefeller 65 1 Aedes albopictus -Jiangsu 100 0" exact="ZIKV" post="Zika virus, pfu plaque-forming unit aTen mosquitoes per pool"/>
   <result pre="aegypti -Rockefeller 65 1 Aedes albopictus -Jiangsu 100 0 ZIKV" exact="Zika" post="virus, pfu plaque-forming unit aTen mosquitoes per pool We"/>
   <result pre="mosquitoes per pool We next assessed whether mosquitoes breeding in" exact="ZIKV" post="urine could transmit ZIKV to a naive host. A"/>
   <result pre="next assessed whether mosquitoes breeding in ZIKV urine could transmit" exact="ZIKV" post="to a naive host. A mosquito-mouse-mosquito transmission model has"/>
   <result pre="A mosquito-mouse-mosquito transmission model has previously been used for a" exact="ZIKV" post="transmission study25. We first reared the pupae of the"/>
   <result pre="C57BL/6 (AG6) mouse, which is an established animal model for" exact="ZIKV" post="infection25 (Fig. 2a). Notably, 3 out of the 17"/>
   <result pre="at least one day post infection (Fig. 2b). The infectious" exact="ZIKV" post="particles were also detected at the viremic peak by"/>
   <result pre="a field-derived A. aegypti strain, which was collected from the" exact="ZIKV" post="epidemic area of Paraiba, Brazil. RT-qPCR revealed that 2.3%"/>
   <result pre="(Brazil Paraiba strain), which bred in either 20 or 2 pfu/ml" exact="ZIKV" post="urine, respectively, were positive for ZIKV (Fig. 2d). Subsequently,"/>
   <result pre="either 20 or 2 pfu/ml ZIKV urine, respectively, were positive for" exact="ZIKV" post="(Fig. 2d). Subsequently, the emerged female A. aegypti mosquitoes"/>
   <result pre="infected mouse died at 10 days post feeding, indicating efficient" exact="ZIKV" post="transmission by the mosquitoes breeding in the ZIKV urine."/>
   <result pre="indicating efficient ZIKV transmission by the mosquitoes breeding in the" exact="ZIKV" post="urine. Fig. 2 Zika virus (ZIKV) is transmissible between"/>
   <result pre="by the mosquitoes breeding in the ZIKV urine. Fig. 2" exact="Zika" post="virus (ZIKV) is transmissible between AG6 mice and mosquitoes"/>
   <result pre="(ZIKV) is transmissible between AG6 mice and mosquitoes breeding in" exact="ZIKV" post="urine. a Schematic representation of the ZIKV transmission between"/>
   <result pre="mosquitoes breeding in ZIKV urine. a Schematic representation of the" exact="ZIKV" post="transmission between AG6 mice and mosquitoes breeding in the"/>
   <result pre="ZIKV transmission between AG6 mice and mosquitoes breeding in the" exact="ZIKV" post="urine. The A. aegypti pupae were breeding in the"/>
   <result pre="ZIKV urine. The A. aegypti pupae were breeding in the" exact="ZIKV" post="urine (final ZIKV titer was 20 pfu/ml). The urine from"/>
   <result pre="A. aegypti pupae were breeding in the ZIKV urine (final" exact="ZIKV" post="titer was 20 pfu/ml). The urine from human Donor 3"/>
   <result pre="mouse viremia was determined over a time course. b, c" exact="ZIKV" post="viremia in the mosquito-bitten AG6 mice. The A. aegypti"/>
   <result pre="Rockefeller strain was used in this experiment. d Acquisition of" exact="ZIKV" post="infection by a field A. aegypti Brazil Paraiba strain"/>
   <result pre="urine. With the same experimental procedure as Fig. 1c, both" exact="ZIKV" post="prevalence and infectivity were determined in the A. aegypti"/>
   <result pre="Brazil Paraiba strain breeding in human urine with a serial" exact="ZIKV" post="titration. The emerging adults were reared for 8 days"/>
   <result pre="The emerging adults were reared for 8 days for subsequent" exact="ZIKV" post="detection by TaqMan quantitative PCR (qPCR). The number of"/>
   <result pre="are represented as the ratios of mosquito infection. e, f" exact="ZIKV" post="viremia in the AG6 mice bitten by the A."/>
   <result pre="mosquitoes breeding in human urine. b, e The presence of" exact="ZIKV" post="RNA copies in whole blood was assessed using quantitative"/>
   <result pre="this transmission route for other arboviruses. In contrast to ZIKV," exact="Dengue" post="virus 2 (DENV2) rapidly lost its infectivity in fresh"/>
   <result pre="pupae breeding (Supplementary Fig. 3b). We tried to isolate infective" exact="DENV" post="virions from mosquitoes breeding in urine containing DENV2 using"/>
   <result pre="Fig. 3d, f). Clinical surveillance has shown a relatively low" exact="ZIKV" post="viremia (102–103 pfu/ml) in serum samples8,27,28, compared to that of"/>
   <result pre="ZIKV viremia (102–103 pfu/ml) in serum samples8,27,28, compared to that of" exact="Chikungunya" post="virus (CHIKV) and Dengue virus (DENV). Therefore, we assessed"/>
   <result pre="serum samples8,27,28, compared to that of Chikungunya virus (CHIKV) and" exact="Dengue" post="virus (DENV). Therefore, we assessed the vector competence of"/>
   <result pre="Aedes strains after oral feeding on a serial titration of" exact="ZIKV" post="(PRVABC59 strain). The mosquitoes were fed with human blood"/>
   <result pre="v/v) and supernatants from ZIKV-infected Vero cells (50% v/v). The" exact="ZIKV" post="load was determined from the midgut, the head, and"/>
   <result pre="strain, and the A. aegypti Brazil strain (Supplementary Fig. 4)." exact="ZIKV" post="in sewage can be acquired and transmitted by mosquitoes"/>
   <result pre="be acquired and transmitted by mosquitoes The prevalence of large" exact="ZIKV" post="epidemics has faded. There are a few Zika cases"/>
   <result pre="of large ZIKV epidemics has faded. There are a few" exact="Zika" post="cases currently being reported in the Americas and Southern"/>
   <result pre="amount of COD and NH3-N (Sample #10), had completely inactivated" exact="ZIKV" post="at the first time point of detection (1 h), while"/>
   <result pre="Nonetheless, the previous literature indicates that the number of infectious" exact="ZIKV" post="particles discharged in patient urine might be 10–20 pfu/ml14,20. We"/>
   <result pre="20 pfu/ml as the initial viral titer to further assess the" exact="ZIKV" post="stability in these sewage samples. Consistently, the samples with"/>
   <result pre="#10) completely inactivated the viruses within 30 min post incubation, while" exact="ZIKV" post="maintained its survivability for more than 3 h in Samples"/>
   <result pre="in cesspit liquids may act as a key determinant for" exact="ZIKV" post="survivability. These data indicate that ZIKV can survive in"/>
   <result pre="a key determinant for ZIKV survivability. These data indicate that" exact="ZIKV" post="can survive in sewage under certain conditions. In the"/>
   <result pre="ZIKV can survive in sewage under certain conditions. In the" exact="ZIKV" post="epidemic area of America, the COD concentration of sewage"/>
   <result pre="field A. aegypti mosquitoes breeding in the infectious sewage transmit" exact="Zika" post="virus (ZIKV) to hosts. a, b ZIKV survivability in"/>
   <result pre="infectious sewage transmit Zika virus (ZIKV) to hosts. a, b" exact="ZIKV" post="survivability in the sewage samples. The supernatant from ZIKV-infected"/>
   <result pre="mock. bn = 2 biologically independent samples. c, d Continuous supplementation of" exact="ZIKV" post="in the sewage. c Schematic representation. Either the sewage"/>
   <result pre="the sewage (Sample #5) or PBS (Mock) was used. d" exact="ZIKV" post="survivability in the infectious sewage. The mixtures were maintained"/>
   <result pre="independent biological replicates with the similar results. e Acquisition of" exact="ZIKV" post="infection by the A. aegypti Brazil Paraiba mosquitoes breeding"/>
   <result pre="aegypti Brazil Paraiba mosquitoes breeding in the infectious sewage. Both" exact="ZIKV" post="prevalence and infectivity in A. aegypti. The initial ZIKV"/>
   <result pre="Both ZIKV prevalence and infectivity in A. aegypti. The initial" exact="ZIKV" post="urine concentration was 20 pfu/ml. f–i ZIKV is transmissible between"/>
   <result pre="A. aegypti. The initial ZIKV urine concentration was 20 pfu/ml. f–i" exact="ZIKV" post="is transmissible between AG6 mice and mosquitoes breeding in"/>
   <result pre="breeding in the infectious sewage. f Schematic representation. g, h" exact="ZIKV" post="viremia in the mosquito-bitten AG6 mice. g The presence"/>
   <result pre="viremia in the mosquito-bitten AG6 mice. g The presence of" exact="ZIKV" post="genome in whole blood was assessed using quantitative PCR"/>
   <result pre="by a plaque assay. n = 2 detection replicates. i Prevalence of" exact="ZIKV" post="infection in the mosquitoes fed on a viremic AG6"/>
   <result pre="on a viremic AG6 mouse. e, i The mosquitoes for" exact="ZIKV" post="detection by TaqMan qPCR. The number of infected mosquitoes"/>
   <result pre="we continuously added either 1/10 or 1/100 dilution of 20 pfu/ml" exact="ZIKV" post="urine to the sewage sample (Sample #5) at 3 h"/>
   <result pre="3c). For continuous supplementation with a 1/10 dilution of 20 pfu/ml" exact="ZIKV" post="urine, the viral titer was maintained at ~1–2 pfu/ml (Fig."/>
   <result pre="mosquitoes were reared for 8 days before being subjected to" exact="ZIKV" post="detection by RT-qPCR. Intriguingly, 1.9% (4/206) of A. aegypti"/>
   <result pre="sewage with continuous supplementation of a 1/10 dilution of 20 pfu/ml" exact="ZIKV" post="urine (maintenance of 1–2 pfu/ml ZIKV), showed ZIKV RNA positivity."/>
   <result pre="dilution of 20 pfu/ml ZIKV urine (maintenance of 1–2 pfu/ml ZIKV), showed" exact="ZIKV" post="RNA positivity. Nonetheless, none of the mosquitoes were ZIKV-positive"/>
   <result pre="ZIKV-positive by quantitative PCR (qPCR) when breeding in a 1/100" exact="ZIKV" post="urine dilution (Fig. 3e). Consistently, 1 out of 78"/>
   <result pre="pool) from the sewage with a 1/10 dilution of 20 pfu/ml" exact="ZIKV" post="urine was positive for the isolation of infectious ZIKV"/>
   <result pre="20 pfu/ml ZIKV urine was positive for the isolation of infectious" exact="ZIKV" post="in Vero cells (Table 2). Table 2 Measurement of"/>
   <result pre="in Vero cells (Table 2). Table 2 Measurement of infectious" exact="ZIKV" post="particles in mosquitoes Continuous ZIKV urine supplementation Mosquito species"/>
   <result pre="Table 2 Measurement of infectious ZIKV particles in mosquitoes Continuous" exact="ZIKV" post="urine supplementation Mosquito species Number of mosquito poolsa Positive"/>
   <result pre="78 1 1:100 Dilution Aedes aegypti -Brazil Paraiba ND ND" exact="ZIKV" post="Zika virus, ND not determined aTen mosquitoes per pool"/>
   <result pre="1 1:100 Dilution Aedes aegypti -Brazil Paraiba ND ND ZIKV" exact="Zika" post="virus, ND not determined aTen mosquitoes per pool We"/>
   <result pre="whether the mosquitoes breeding in infectious sewage could maintain the" exact="ZIKV" post="transmission cycle between hosts and mosquitoes. The pupae of"/>
   <result pre="with viremia from days 3 to 5, 10–100% successfully acquired" exact="ZIKV" post="infection (Fig. 3i). Thus, we demonstrate that the field-derived"/>
   <result pre="we demonstrate that the field-derived A. aegypti mosquitoes from the" exact="ZIKV" post="epidemic areas can acquire ZIKV infection during breeding in"/>
   <result pre="A. aegypti mosquitoes from the ZIKV epidemic areas can acquire" exact="ZIKV" post="infection during breeding in infectious sewage in natural settings"/>
   <result pre="and subsequently transmit the infection to hosts by biting. Mouse" exact="ZIKV" post="viruria leads to mosquito infection The stability of ZIKV"/>
   <result pre="Mouse ZIKV viruria leads to mosquito infection The stability of" exact="ZIKV" post="varied dramatically in different human urine specimens (Fig. 1a,"/>
   <result pre="(Fig. 1a, b). We next assessed key factor(s) that determine" exact="ZIKV" post="stability in human urine. We noted that the pH"/>
   <result pre="that the pH values of human urine were correlated with" exact="ZIKV" post="survivability; a neutral or slightly alkaline condition favored ZIKV"/>
   <result pre="with ZIKV survivability; a neutral or slightly alkaline condition favored" exact="ZIKV" post="survival (Table 3). Consistently, these ZIKV-hostile urine samples became"/>
   <result pre="(Table 3). Consistently, these ZIKV-hostile urine samples became favorable for" exact="ZIKV" post="survival after their pH was adjusted to modest alkalinity"/>
   <result pre="sodium hydroxide (NaOH). In contrast, decreasing the urine pH destroyed" exact="ZIKV" post="viability (Fig. 4a). Using a larger number of urine"/>
   <result pre="larger number of urine samples, we confirmed the correlation of" exact="ZIKV" post="stability with pH values (r = 0.8214, P &amp;lt; 0.0001, linear regression with"/>
   <result pre="pH gradient assay demonstrated that a pH above 6.5 rendered" exact="ZIKV" post="stable in human urine (Fig. 4c). Indeed, it is"/>
   <result pre="viral entry. Overall, the pH value of human urine determines" exact="ZIKV" post="infectivity and likely subsequent transmissibility to mosquitoes. Table 3"/>
   <result pre="Protein (ng/µl) 0.05 0.05 0.04 0.05 0.20 0.05 0.08 0.05" exact="ZIKV" post="survivability at 37 °C (4 h pfu/0 h pfu) 0% 7.2% 41%"/>
   <result pre="pfu/0 h pfu) 0% 7.2% 41% 0% 0% 9.1% 0% 20%" exact="ZIKV" post="survivability at 28 °C (6 h pfu/0 h pfu) 0% 2.5% 49.25%"/>
   <result pre="pfu/0 h pfu) 0% 2.5% 49.25% 0% 0% 2% 0% 11%" exact="ZIKV" post="Zika virus, pfu plaque-forming unit Fig. 4 Correlation between"/>
   <result pre="pfu) 0% 2.5% 49.25% 0% 0% 2% 0% 11% ZIKV" exact="Zika" post="virus, pfu plaque-forming unit Fig. 4 Correlation between Zika"/>
   <result pre="ZIKV Zika virus, pfu plaque-forming unit Fig. 4 Correlation between" exact="Zika" post="virus (ZIKV) survivability and the pH value of human"/>
   <result pre="value of human urine. a Adjustment of pH value regulated" exact="ZIKV" post="survivability in human urine. The pH values of human"/>
   <result pre="biologically independent samples. Data are presented as the mean ± SEM. b" exact="ZIKV" post="survivability in human urine correlates with the pH value"/>
   <result pre="in Supplementary Table 4. c Determination of the correlation between" exact="ZIKV" post="survivability and the pH value in human urine. The"/>
   <result pre="from Donor 3 with gradient pH values were incubated with" exact="ZIKV" post="supernatant. The percentage of ZIKV survivability was defined as"/>
   <result pre="pH values were incubated with ZIKV supernatant. The percentage of" exact="ZIKV" post="survivability was defined as the ratio of the pfu"/>
   <result pre="as the mean ± SEM. a–c The urine samples were incubated with" exact="ZIKV" post="supernatant from infected Vero cells (the initial titer was"/>
   <result pre="initial titer was 1 × 105 pfu/ml) for 4 h at 37 °C. Subsequently, the" exact="ZIKV" post="titer was measured by a plaque assay. Source data"/>
   <result pre="is usually more acidic, with a pH lower than 6.533,34." exact="ZIKV" post="could not maintain its infectivity in regular mouse urine"/>
   <result pre="adjusted to &amp;gt;6.5, the mouse urine was able to maintain" exact="ZIKV" post="infectivity (Supplementary Fig. 5). Next, we infected the AG6"/>
   <result pre="(Supplementary Fig. 5). Next, we infected the AG6 mice with" exact="ZIKV" post="via intraperitoneal injection (100 pfu per mouse) and subsequently treated"/>
   <result pre="infected animals (Fig. 5c). Notably, there were almost no infectious" exact="ZIKV" post="particles in the urine of untreated infected mice; however,"/>
   <result pre="in the urine of untreated infected mice; however, 30–120 pfu/ml infectious" exact="ZIKV" post="was observed in the urine of NaHCO3-treated mice from"/>
   <result pre="We found that 1.1–5.0% of the mosquitoes were positive for" exact="ZIKV" post="RNA (Fig. 5e), demonstrating that ZIKV was transmitted from"/>
   <result pre="mosquitoes were positive for ZIKV RNA (Fig. 5e), demonstrating that" exact="ZIKV" post="was transmitted from animals to mosquitoes via urine. These"/>
   <result pre="from animals to mosquitoes via urine. These results indicate that" exact="ZIKV" post="might transmit between the mosquitoes emerging from a ZIKV"/>
   <result pre="that ZIKV might transmit between the mosquitoes emerging from a" exact="ZIKV" post="urine-contaminated water source and humans (Fig. 5f). Fig. 5"/>
   <result pre="diluted infected mouse urine. We infected the AG6 mice by" exact="Zika" post="virus (ZIKV) intrapleural injection (100 pfu per mouse) and subsequently"/>
   <result pre="8 days for quantitative reverse transcription PCR (RT-qPCR) detection. b" exact="ZIKV" post="viremia in the infected AG6 mice. The viral load"/>
   <result pre="the urine of NaHCO3-treated infected AG6 mice. d Assessing the" exact="ZIKV" post="infectious particles in the urine of infected AG6 mice."/>
   <result pre="experiments. Data are presented as the mean ± SEM. e Mosquitoes acquired" exact="ZIKV" post="infection by breeding in diluted urine from NaHCO3-treated infected"/>
   <result pre="eclosion. The emerging adults were reared for 8 days for" exact="ZIKV" post="detection by RT-qPCR. The number of infected mosquitoes relative"/>
   <result pre="biological replicates. f Schematic representation of the host urination-mosquito breeding" exact="ZIKV" post="transmission route. A Zika patient may release urine daily,"/>
   <result pre="representation of the host urination-mosquito breeding ZIKV transmission route. A" exact="Zika" post="patient may release urine daily, resulting in various levels"/>
   <result pre="may release urine daily, resulting in various levels of infectious" exact="ZIKV" post="being excreted by patient urination in natural circumstances. The"/>
   <result pre="circumstances. The mosquitos breeding from the water systems contaminated by" exact="ZIKV" post="may acquire the infection. Therefore, viruria of infected hosts"/>
   <result pre="acquire the infection. Therefore, viruria of infected hosts may facilitate" exact="ZIKV" post="prevalence and transmission by mosquitoes. b–e Source data are"/>
   <result pre="Source data are provided as a Source Data file Discussion" exact="ZIKV" post="is a blood-borne pathogen that is known to be"/>
   <result pre="known to be transmitted by infected mosquitoes. Although mosquitoes transmit" exact="ZIKV" post="to and acquire it from humans primarily through blood"/>
   <result pre="our experiments mimicking natural settings demonstrate that mosquitoes may acquire" exact="ZIKV" post="from human urinal discharge and sewage during breeding. Our"/>
   <result pre="conclusions are supported by several lines of laboratory evidence. First," exact="ZIKV" post="may survive for up to 8 h in harsh environments,"/>
   <result pre="both lab-adapted and field mosquitoes were infected during hatching by" exact="ZIKV" post="in the urinal and sewage environments at concentrations as"/>
   <result pre="low as 1–2 pfu/ml. Third, the adult mosquitoes that hatched from" exact="ZIKV" post="urine/sewage were capable of transmitting ZIKV to mice and"/>
   <result pre="mosquitoes that hatched from ZIKV urine/sewage were capable of transmitting" exact="ZIKV" post="to mice and eliciting viremia. In favor of our"/>
   <result pre="recent clinical studies have shown the presence of 10–20 infectious" exact="ZIKV" post="particles per ml of ZIKV patient urine14,20. In particular,"/>
   <result pre="the presence of 10–20 infectious ZIKV particles per ml of" exact="ZIKV" post="patient urine14,20. In particular, cesspits are still commonly used"/>
   <result pre="particular, cesspits are still commonly used in areas with recent" exact="ZIKV" post="epidemics, including Brazil and the Pacific islands22,36,37. Poor public"/>
   <result pre="sanitary infrastructure may have created a physical environment for urinal" exact="ZIKV" post="to be acquired by mosquitoes. Nonetheless, these experimental studies"/>
   <result pre="conditions. Epidemiological studies will be needed to prove human viruria-mediated" exact="ZIKV" post="infection in mosquitoes. Our current result indicates that the"/>
   <result pre="Our current result indicates that the maintenance of a low" exact="ZIKV" post="titer in sewage can cause the infection of adult"/>
   <result pre="The infected mosquitoes derived from the infectious sewage can transmit" exact="ZIKV" post="to a host by biting. In a disease-outbreak scenario,"/>
   <result pre="habitat of mosquitoes. We therefore speculate a scenario during a" exact="Zika" post="outbreak in which the accumulating ZIKV infectious particles discharged"/>
   <result pre="a scenario during a Zika outbreak in which the accumulating" exact="ZIKV" post="infectious particles discharged by patients might be sufficient to"/>
   <result pre="from the Americas have an unexpectedly low vector competence for" exact="ZIKV" post="transmission by oral blood feeding38. Compared to that of"/>
   <result pre="ZIKV transmission by oral blood feeding38. Compared to that of" exact="CHIKV" post="and DENV, clinical surveillance has shown a relatively low"/>
   <result pre="CHIKV and DENV, clinical surveillance has shown a relatively low" exact="ZIKV" post="viremia (102–103 pfu/ml) present in human serum samples8,27,28. Intriguingly, the"/>
   <result pre="serum samples8,27,28. Intriguingly, the acquisition of human blood with 103–104 pfu/ml" exact="ZIKV" post="resulted in an inefficient infection and transmission by both"/>
   <result pre="transmission by both the lab-adapted and field-derived Aedes mosquitoes. Thus," exact="ZIKV" post="viremia alone might not account for its rapid spread,"/>
   <result pre="Puerto Rico24. Nonetheless, the epidemiological importance of cesspit breeding for" exact="ZIKV" post="transmission remains unclear. Further field surveillance is therefore needed"/>
   <result pre="were routinely reared at 28 °C as a standard condition25,39,40. The" exact="ZIKV" post="epidemic area in Brazil located in tropical regions, where"/>
   <result pre="at 28 °C might represent a realistic daytime condition in the" exact="ZIKV" post="epidemic area. Nonetheless, nighttime temperatures are also essential for"/>
   <result pre="likely to be substantially lower. Therefore, both mosquito breeding and" exact="ZIKV" post="stability under various temperature conditions remain to be further"/>
   <result pre="stability under various temperature conditions remain to be further investigated." exact="ZIKV" post="is well known to maintain a transmission cycle between"/>
   <result pre="and transmit ZIKV. Our study suggests that mosquitoes might acquire" exact="ZIKV" post="not only through feeding on a viremic host25 but"/>
   <result pre="on a viremic host25 but also through urine excreted by" exact="ZIKV" post="patients. In addition to ZIKV, the RNA of other"/>
   <result pre="of other flaviviruses, such as DENV26,42, yellow fever virus43, and" exact="West Nile" post="viruses (WNV)44 have also been found in infected human"/>
   <result pre="of infectious particles has been detected in the urine of" exact="WNV" post="patients45, suggesting that other flaviviruses in human urine might"/>
   <result pre="where Aedes mosquitoes breed48. This study offers laboratory evidence that" exact="ZIKV" post="could be transmitted to mosquitoes via human urine and"/>
   <result pre="preventing the dissemination of mosquito-borne flaviviral diseases by interrupting the" exact="ZIKV" post="transmission cycle. Methods Ethics statement Human urine was collected"/>
   <result pre="standard rearing procedures25,49,50. The DENV2 New Guinea C strain (M29095)," exact="ZIKV" post="PRVABC59 strain (KU501215), BATV YN92–4 strain51, and SINV MRE-16"/>
   <result pre="urine Fresh human urine from Donor 3 was mixed with" exact="ZIKV" post="supernatant from infected Vero cells. The mixture is named"/>
   <result pre="ZIKV supernatant from infected Vero cells. The mixture is named" exact="ZIKV" post="urine hereafter. ZIKV urine was used for breeding the"/>
   <result pre="infected Vero cells. The mixture is named ZIKV urine hereafter." exact="ZIKV" post="urine was used for breeding the pupae of A."/>
   <result pre="Paraiba strain) and A. albopictus (Jiangsu strain). After exposure to" exact="ZIKV" post="urine, the larvae or pupae were transferred to a"/>
   <result pre="used for this analysis are shown in Supplementary Table 5." exact="ZIKV" post="detection and viral isolation from mosquito pools The freshly"/>
   <result pre="pupae of A. aegypti and A. albopictus were reared in" exact="ZIKV" post="urine. The freshly emerging pupae of A. aegypti were"/>
   <result pre="aegypti were reared in either human urine or sewage with" exact="ZIKV" post="urine. Eight days after emerging, ten adult mosquitoes were"/>
   <result pre="using an iScript cDNA Synthesis Kit (170-8890, Bio-Rad). We amplified" exact="ZIKV" post="fragments by PCR. The PCR products were subjected to"/>
   <result pre="survivability in sewage samples Human urine (Donor #3) with 20 pfu/ml" exact="ZIKV" post="(PRVABC59 strain) was added to the sewage (Sample #5)"/>
   <result pre="control, at either 1:10 or 1:100 dilutions. Urine with 20 pfu/ml" exact="ZIKV" post="was continuously supplemented into sewage or PBS at 3-h"/>
   <result pre="incubated at 28 °C. Viral survivability was determined at 1 h post" exact="ZIKV" post="supplementation via a plaque assay. Briefly, the infectious sewage"/>
   <result pre="(Rockefeller strain) and A. aegypti (Brazil Paraiba strain) bred in" exact="ZIKV" post="urine. Eight days after adult mosquitoes emerged, 20 emerged"/>
   <result pre="viral genome was quantified via TaqMan qPCR amplification of the" exact="ZIKV" post="E gene. The number of infectious ZIKV particles in"/>
   <result pre="amplification of the ZIKV E gene. The number of infectious" exact="ZIKV" post="particles in plasma at the viremic period was determined"/>
   <result pre="at the viremic period was determined by a plaque assay." exact="ZIKV" post="transmission by mosquitoes breeding in sewage Pupae of A."/>
   <result pre="Paraiba strain) bred in the sewage with continuous supplementation of" exact="ZIKV" post="urine. Eight days after adult mosquitoes emerged, 30 emerged"/>
   <result pre="viral genome was quantified via TaqMan qPCR amplification of the" exact="ZIKV" post="E gene. The infectious ZIKV particles in plasma during"/>
   <result pre="TaqMan qPCR amplification of the ZIKV E gene. The infectious" exact="ZIKV" post="particles in plasma during the viremic period were determined"/>
   <result pre="mouse viruria model AG6 mice (6–8 weeks) were infected by" exact="ZIKV" post="intrapleural injection (100 pfu per mouse). The infected AG6 mice"/>
   <result pre="Linear regression analysis was used to assess the correlation between" exact="ZIKV" post="survivability and the urine pH value in human urine."/>
   <result pre="The authors declare no competing interests. References References 1.MarchetteNJGarciaRRudnickAIsolation of" exact="Zika" post="virus from Aedes aegypti mosquitoes in MalaysiaAm. J. Trop."/>
   <result pre="MalaysiaAm. J. Trop. Med. Hyg.19691841141510.4269/ajtmh.1969.18.4114976739 2.MussoDGublerDJZika virusClin. Microbiol. Rev.20162948752410.1128/CMR.00072-1527029595 3.WHO." exact="Zika" post="Cumulative Cases, 2017. http://www.paho.org/hq/index.php?option=com_docman&amp;amp;task=doc_view&amp;amp;Itemid=270&amp;amp;gid=43274&amp;amp;lang=en. Accessed 21 Dec 2017. 4.OehlerEet"/>
   <result pre="syndrome—case report, French Polynesia, December 2013Eur. Surveill.2014192072010.2807/1560-7917.ES2014.19.9.20720 5.CordeiroMTPenaLJBritoCAGilLHMarquesETPositive IgM for" exact="Zika" post="virus in the cerebrospinal fluid of 30 neonates with"/>
   <result pre="of 30 neonates with microcephaly in BrazilLancet20163871811181210.1016/S0140-6736(16)30253-7 6.BuenoMGMartinezNAbdallaLDuarteDSCChameMAnimals in the" exact="Zika" post="virus life cycle: what to expect from megadiverse Latin"/>
   <result pre="megadiverse Latin American CountriesPLoS Negl. Trop. Dis.201610e507310.1371/journal.pntd.0005073 7.MussoDet al.Detection of" exact="Zika" post="virus in salivaJ. Clin. Virol.201568535510.1016/j.jcv.2015.04.02126071336 8.GourinatACO’ConnorOCalvezEGoarantCDupont-RouzeyrolMDetection of Zika virus"/>
   <result pre="al.Detection of Zika virus in salivaJ. Clin. Virol.201568535510.1016/j.jcv.2015.04.02126071336 8.GourinatACO’ConnorOCalvezEGoarantCDupont-RouzeyrolMDetection of" exact="Zika" post="virus in urineEmerg. Infect. Dis.201521848610.3201/eid2101.14089425530324 9.Dupont-RouzeyrolMBironAO’ConnorOHuguonEDesclouxEInfectious Zika viral particles"/>
   <result pre="Virol.201568535510.1016/j.jcv.2015.04.02126071336 8.GourinatACO’ConnorOCalvezEGoarantCDupont-RouzeyrolMDetection of Zika virus in urineEmerg. Infect. Dis.201521848610.3201/eid2101.14089425530324 9.Dupont-RouzeyrolMBironAO’ConnorOHuguonEDesclouxEInfectious" exact="Zika" post="viral particles in breastmilkLancet2016387105110.1016/S0140-6736(16)00624-3 10.MussoDet al.Detection of Zika virus"/>
   <result pre="Dis.201521848610.3201/eid2101.14089425530324 9.Dupont-RouzeyrolMBironAO’ConnorOHuguonEDesclouxEInfectious Zika viral particles in breastmilkLancet2016387105110.1016/S0140-6736(16)00624-3 10.MussoDet al.Detection of" exact="Zika" post="virus RNA in semen of asymptomatic blood donorsClin. Microbiol."/>
   <result pre="asymptomatic blood donorsClin. Microbiol. Infect.201723100110.1016/j.cmi.2017.07.00628711704 11.FoyBDet al.Probable non-vector-borne transmission of" exact="Zika" post="virus, Colorado, USAEmerg. Infect. Dis.20111788088210.3201/eid1705.10193921529401 12.MussoDet al.Potential for Zika"/>
   <result pre="of Zika virus, Colorado, USAEmerg. Infect. Dis.20111788088210.3201/eid1705.10193921529401 12.MussoDet al.Potential for" exact="Zika" post="virus transmission through blood transfusion demonstrated during an outbreak"/>
   <result pre="2013 to February 2014Eur. Surveill.2014192076110.2807/1560-7917.ES2014.19.14.20761 13.MussoDet al.Potential sexual transmission of" exact="Zika" post="virusEmerg. Infect. Dis.20152135936110.3201/eid2102.14136325625872 14.BonaldoMCet al.Isolation of infective Zika virus"/>
   <result pre="transmission of Zika virusEmerg. Infect. Dis.20152135936110.3201/eid2102.14136325625872 14.BonaldoMCet al.Isolation of infective" exact="Zika" post="virus from urine and saliva of patients in BrazilPLoS"/>
   <result pre="patients in BrazilPLoS Negl. Trop. Dis.201610e481610.1371/journal.pntd.0004816 15.Roze, B. et al." exact="Zika" post="virus detection in cerebrospinal fluid from two patients with"/>
   <result pre="February 2016. Euro. Surveill. 21, 10.2807/1560-7917.ES.2016.21.16.30205 (2016). 16.ZhangFCLiXFDengYQTongYGQinCFExcretion of infectious" exact="Zika" post="virus in urineLancet Infect. Dis.20161664164210.1016/S1473-3099(16)30070-627184420 17.OliveiraMIet al.Isolation of infectious"/>
   <result pre="Zika virus in urineLancet Infect. Dis.20161664164210.1016/S1473-3099(16)30070-627184420 17.OliveiraMIet al.Isolation of infectious" exact="Zika" post="virus from a urine sample cultured in SIRC cells"/>
   <result pre="virusRev. Inst. Med. Trop. Sao Paulo201860e1529557985 18.FonsecaKet al.First case of" exact="Zika" post="virus infection in a returning Canadian travelerAm. J. Trop."/>
   <result pre="returning Canadian travelerAm. J. Trop. Med. Hyg.2014911035103810.4269/ajtmh.14-015125294619 19.HashimotoTet al.Importation of" exact="Zika" post="Virus from Vietnam to Japan, November 2016Emerg. Infect. Dis.2017231223122510.3201/eid2307.17051928445122"/>
   <result pre="from Vietnam to Japan, November 2016Emerg. Infect. Dis.2017231223122510.3201/eid2307.17051928445122 20.LustigYMendelsonEParanNMelamedSSchwartzEDetection of" exact="Zika" post="virus RNA in whole blood of imported Zika virus"/>
   <result pre="20.LustigYMendelsonEParanNMelamedSSchwartzEDetection of Zika virus RNA in whole blood of imported" exact="Zika" post="virus disease cases up to 2 months after symptom"/>
   <result pre="in Playa-Playita, Puerto RicoMed. Vet. Entomol.20102411712310.1111/j.1365-2915.2010.00864.x20374477 25.LiuYet al.Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoesNature201754548248610.1038/nature2236528514450 26.PoloniTRet al.Detection of"/>
   <result pre="al. Infection dynamics in a traveller with persistent shedding of" exact="Zika" post="virus RNA in semen for six months after returning"/>
   <result pre="28.WaggonerJJet al.Viremia and clinical presentation in Nicaraguan patients infected with" exact="Zika" post="virus, Chikungunya virus, and Dengue virusClin. Infect. Dis.2016631584159010.1093/cid/ciw58927578819 29.CDC."/>
   <result pre="and clinical presentation in Nicaraguan patients infected with Zika virus," exact="Chikungunya" post="virus, and Dengue virusClin. Infect. Dis.2016631584159010.1093/cid/ciw58927578819 29.CDC. 2018 Case"/>
   <result pre="in Nicaraguan patients infected with Zika virus, Chikungunya virus, and" exact="Dengue" post="virusClin. Infect. Dis.2016631584159010.1093/cid/ciw58927578819 29.CDC. 2018 Case Counts in the"/>
   <result pre="Counts in the US. https://www.cdc.gov/zika/reporting/2018-case-counts.html. Accessed 4 Dec 2018. 30.WHO." exact="Zika" post="Virus Infection: India. https://www.who.int/emergencies/diseases/zika/india-november-2018/en/. Accessed 2 Nov 2018. 31.HeinzFXet"/>
   <result pre="Aedes aegypti and Aedes albopictusMem. Inst. Oswaldo. Cruz.201711282983710.1590/0074-0276017018229211244 40.PomponJet al.A" exact="Zika" post="virus from America is more efficiently transmitted than an"/>
   <result pre="Nile virus detection in urineEmerg. Infect. Dis.2005111294129610.3201/eid1108.05023816102323 45.BarzonLet al.Isolation of" exact="West Nile" post="virus from urine samples of patients with acute infectionJ."/>
   <result pre="C-type lectin collaborates with a CD45 phosphatase homolog to facilitate" exact="West Nile" post="virus infection of mosquitoesCell201014271472510.1016/j.cell.2010.07.03820797779 51.WangFTet al.Sequencing and analysis of"/>
   <result pre="of the GABAergic systemNat. Commun.20178126210.1038/s41467-017-01244-629093445 53.BaiFet al.Antiviral peptides targeting the" exact="West Nile" post="virus envelope proteinJ. Virol.2007812047205510.1128/JVI.01840-0617151121"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6433249\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Biochemistry: Nucleic"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and life sciences : Organisms :"/>
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Molecular Biology"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Dengue" post="Fever An RT-PCR panel for rapid serotyping of dengue"/>
   <result pre="a field-deployable PCR system RT-PCR panel for rapid serotyping of" exact="DENV" post="1–4 http://orcid.org/0000-0003-2226-8916TsaiJih-JinConceptualizationFunding acquisitionSupervisionWriting – original draftWriting – review &amp;amp;"/>
   <result pre="– original draft6LiuLi-TehFormal analysisInvestigationVisualization17ChenChun-HongResourcesSupervisionWriting – review &amp;amp; editing58*[1], Center for" exact="Dengue" post="Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan[2],"/>
   <result pre="provided the original author and source are credited.pone.0214328.pdf Abstract Background" exact="Dengue" post="fever, a mosquito-borne disease, is caused by dengue virus"/>
   <result pre="of four singleplex DENV-1–4 serotyping reverse transcription-iiPCR (RT-iiPCR) reagents for" exact="DENV" post="subtyping on the mobile PCR system. The four RT-iiPCRs"/>
   <result pre="mobile PCR system. The four RT-iiPCRs did not react with" exact="Zika" post="virus and chikungunya virus; tests with serial dilutions of"/>
   <result pre="and chikungunya virus; tests with serial dilutions of the four" exact="DENV" post="serotypes made in human serum showed they had detection"/>
   <result pre="serotype showed that the four reagents detected specifically their target" exact="DENV" post="serotypes in mosquito. Conclusions/Significance With analytical and clinical performance"/>
   <result pre="field-deployable PCR system can serve as a useful tool for" exact="DENV" post="detection near points of needs. Funding Ministry of Health"/>
   <result pre="Data Availability All relevant data are within the manuscript. Introduction" exact="Dengue" post="virus (DENV), an enveloped virus with a single-stranded, positive"/>
   <result pre="and comprises mainly four serotypes (DENV-1, -2, -3, and -4)." exact="DENV" post="infection causes a wide range of clinical signs in"/>
   <result pre="fever, DF), to severe hemorrhagic fever/dengue shock syndromes (DHF/DSS) [1]." exact="Dengue" post="disease is a major public health problem in developing"/>
   <result pre="imported dengue cases in temperate region. Outbreaks of the four" exact="DENV" post="serotypes have been increasing reported in the tropics and"/>
   <result pre="the tropical-subtropical region of the Northern Hemisphere, has seen many" exact="DENV" post="outbreaks since the first half of 20th century. Since"/>
   <result pre="and -2 being the major serotype, respectively [4]. Diagnosis of" exact="DENV" post="infection cannot rely solely on clinical signs and symptoms"/>
   <result pre="with symptoms similar to those of other febrile-episode-inducing diseases [5]." exact="DENV" post="serotyping is important for disease management and public health"/>
   <result pre="the other serotypes [6]. In addition, antibody-mediated enhancement (ADE) of" exact="DENV" post="infection further complicates disease severity [7]. Chances for developing"/>
   <result pre="a wave of severe dengue epidemic in Sri Lanka [8–10]." exact="DENV" post="is transmitted to humans by mosquitoes (Aedes aegypti and"/>
   <result pre="(Aedes aegypti and A. albopictus). A. aegypti can pick up" exact="DENV" post="from people showing no symptoms or oligosymptom, resulting in"/>
   <result pre="in silent transmission [11]. A positive association was established between" exact="DENV" post="infection in humans and mosquitoes at very fine spatiotemporal"/>
   <result pre="one study [12, 13]. Timely on-site detection and serotyping of" exact="DENV" post="in human and mosquito can potentially alert front-line health"/>
   <result pre="in human [2, 14]. Current methods to aid diagnosis of" exact="DENV" post="infection include virus isolation (e.g. antigen detection immunofluorescence assay),"/>
   <result pre="[16]. PRNT, antigen detection immunofluorescence assay are able to determine" exact="DENV" post="serotypes [17], but they are both time-consuming, expensive, laborious,"/>
   <result pre="specificity and sensitivity, NATs were recommended for the detection of" exact="DENV" post="RNA by the World Health Organization [1]. Several multiplex"/>
   <result pre="another major obstacle. In order to bring early serotyping of" exact="DENV" post="to points of need (PON), a rapid, easy, mobile,"/>
   <result pre="to serve as a flexible mobile PON tool for rapid" exact="DENV" post="detection in human and mosquito. A pan-DENV-specific RT-iiPCR assay"/>
   <result pre="serotypes in human plasma and serum [32, 33]. Four singleplex" exact="DENV" post="serotyping RT-iiPCR reagents have become available recently for the"/>
   <result pre="3, and 4 serotypes separately on the POCKIT system, allowing" exact="DENV" post="serotyping near patients and soon after the mosquitoes are"/>
   <result pre="In this study, we evaluated the performance of the four" exact="DENV" post="serotyping reagents on the POCKIT and POCKIT Micro Plus"/>
   <result pre="Plus PCR devices for the detection of the respective target" exact="DENV" post="serotypes in human serum and mosquito samples. Materials and"/>
   <result pre="were propagated in the mosquito C6/36 cell line (A. albopictus)." exact="Zika" post="virus strains (MR766, PRVABC59) were from the American Type"/>
   <result pre="were from the American Type Culture Collection, Manassas, VA, USA." exact="Chikungunya" post="virus (CK9500004) was from the Taiwan Center of Disease"/>
   <result pre="of the preloaded extraction plate before starting the extraction program." exact="DENV" post="serotyping reverse transcription-insulated isothermal polymerase chain reaction The four"/>
   <result pre="DENV serotyping reverse transcription-insulated isothermal polymerase chain reaction The four" exact="DENV" post="serotyping RT-iiPCR reagents (POCKIT Dengue Virus Serotype 1 Reagent"/>
   <result pre="polymerase chain reaction The four DENV serotyping RT-iiPCR reagents (POCKIT" exact="Dengue" post="Virus Serotype 1 Reagent Set, POCKIT Dengue Virus Serotype"/>
   <result pre="RT-iiPCR reagents (POCKIT Dengue Virus Serotype 1 Reagent Set, POCKIT" exact="Dengue" post="Virus Serotype 2 Reagent Set, POCKIT Dengue Virus Serotype"/>
   <result pre="Reagent Set, POCKIT Dengue Virus Serotype 2 Reagent Set, POCKIT" exact="Dengue" post="Virus Serotype 3 Reagent Set, POCKIT Dengue Virus Serotype"/>
   <result pre="Reagent Set, POCKIT Dengue Virus Serotype 3 Reagent Set, POCKIT" exact="Dengue" post="Virus Serotype 4 Reagent Set; GeneReach) were performed as"/>
   <result pre="transcription-polymerase chain reaction To evaluate the performance of the four" exact="DENV" post="serotyping RT-iiPCR reagents in detecting DENV in serum samples,"/>
   <result pre="performance of the four DENV serotyping RT-iiPCR reagents in detecting" exact="DENV" post="in serum samples, side-by-side comparison with the multiplex CDC"/>
   <result pre="with the reference multiplex qRT-PCR by using their respective target" exact="DENV" post="serotypes. 10-fold serial dilutions (100, 10, 1, 0.1, and"/>
   <result pre="to that of the reference qRT-PCR in detecting their target" exact="DENV" post="serotypes. 10.1371/journal.pone.0214328.t001Table 1 Analytical Sensitivity of dengue virus serotype"/>
   <result pre="-3, -4 serotyping RT-iiPCR To assess the specificity of each" exact="DENV" post="serotyping RT-iiPCR reagent, the four DENV serotypes and two"/>
   <result pre="the specificity of each DENV serotyping RT-iiPCR reagent, the four" exact="DENV" post="serotypes and two other viruses (Zika virus MR766, Zika"/>
   <result pre="four DENV serotypes and two other viruses (Zika virus MR766," exact="Zika" post="virus PRVABC59, and chikungunya virus CK9500004) known to cause"/>
   <result pre="illness or skin rash illness were tested. All four singleplex" exact="DENV" post="serotyping RT-iiPCR reagents did not react with the other"/>
   <result pre="not react with the other three non-targeted dengue virus serotypes," exact="Zika" post="virus and chikungunya virus in the exclusivity test panel"/>
   <result pre="indicating that the reagents had excellent specificity for their target" exact="DENV" post="serotypes. 10.1371/journal.pone.0214328.t002Table 2 Analytical specificity of dengue virus serotype"/>
   <result pre="negative DENV4 1021021 1.9 x 105 negative negative negative positive" exact="ZIKV" post="PRVABC59 2.5 x 104 negative negative negative negative ZIKV"/>
   <result pre="positive ZIKV PRVABC59 2.5 x 104 negative negative negative negative" exact="ZIKV" post="MR766 1.2 x 105 negative negative negative negative CHIKV"/>
   <result pre="negative ZIKV MR766 1.2 x 105 negative negative negative negative" exact="CHIKV" post="1.4 x 105 negative negative negative negative DENV, dengue"/>
   <result pre="x 105 negative negative negative negative DENV, dengue virus; ZIKV," exact="Zika" post="virus; CHIKV, chikungunya virus; PFU, plaque forming unit; RT-iiPCR,"/>
   <result pre="-4 serotyping RT-iiPCR To evaluate the clinical performance of each" exact="DENV" post="serotyping RT-iiPCR reagent, 40 serum samples (about 20 DENV"/>
   <result pre="each DENV serotyping RT-iiPCR reagent, 40 serum samples (about 20" exact="DENV" post="serotype-positive and 20 DENV-negative) were tested for each respective"/>
   <result pre="mini method. Nucleic acid extracts were tested by the respective" exact="DENV" post="serotyping RT-iiPCR reagents and the reference multiplex qRT-PCR in"/>
   <result pre="had 97% overall agreement (CI95%, 89.8–97.5%), indicating that the four" exact="DENV" post="serotyping RT-iiPCR reagents on the POCKIT system had clinical"/>
   <result pre="to those of the reference qRT-PCR to detect their target" exact="DENV" post="serotypes in serum samples. 10.1371/journal.pone.0214328.t003Table 3 Clinical performance characteristics"/>
   <result pre="four serotyping RT-iiPCR reagents, it will be possible to performed" exact="DENV" post="serotyping soon after the mosquitoes are trapped on site"/>
   <result pre="of the four serotyping RT-iiPCR reagents to detect their target" exact="DENV" post="serotypes in mosquito specimens on the hand-held POCKIT Micro"/>
   <result pre="DENV-1, -2, -3, and -4 RT-iiPCR can detect their target" exact="DENV" post="serotypes but not the serotypes to be excluded (Table"/>
   <result pre="serotypes to be excluded (Table 4), indicating excellent specificity for" exact="DENV" post="serotypes in mosquito sample matrix. 10.1371/journal.pone.0214328.t004Table 4 Detection of"/>
   <result pre="is an urgent need for better surveillance and control of" exact="DENV" post="spread to help mitigate the global spread of epidemic"/>
   <result pre="of epidemic dengue. Accurate and rapid detection and serotyping of" exact="DENV" post="can help improve the recognition of severe dengue warning"/>
   <result pre="recognition of severe dengue warning signs in patients suspected of" exact="DENV" post="infection. Timely reporting on the detection and serotyping status"/>
   <result pre="infection. Timely reporting on the detection and serotyping status of" exact="DENV" post="in mosquito can serve as an alert to people"/>
   <result pre="and vector control programs to help mitigate the spread of" exact="DENV" post="infection. In this study, tests with clinical serum samples"/>
   <result pre="offered excellent analytical sensitivity and specificity to detect their target" exact="DENV" post="serotypes in human serum on the compact field-deployable POCKIT"/>
   <result pre="in mosquito samples on the hand-held POCKIT Micro Plus. In" exact="DENV" post="diagnosis, DENV serotyping is also important since DENV-2 and"/>
   <result pre="samples on the hand-held POCKIT Micro Plus. In DENV diagnosis," exact="DENV" post="serotyping is also important since DENV-2 and DENV-3 are"/>
   <result pre="than the other serotypes [6]. Furthermore, when patients with previous" exact="DENV" post="infection were infected with a heterotypic serotype, the chances"/>
   <result pre="RT-iiPCR/POCKIT system validated previously for the detection of all four" exact="DENV" post="serotypes in human plasma and serum [32, 33] is"/>
   <result pre="[32, 33] is useful in aiding the identification of acute" exact="DENV" post="infection, especially for remote regions with high burdens of"/>
   <result pre="DENV infection, especially for remote regions with high burdens of" exact="DENV" post="infection. However, this system could not differentiate between different"/>
   <result pre="DENV infection. However, this system could not differentiate between different" exact="DENV" post="serotypes. In this study, we showed that the four"/>
   <result pre="study, we showed that the four new RT-PCR reagents for" exact="DENV" post="serotyping can work on the same field-deployable PCR system"/>
   <result pre="to serve as tools to allow timely near-patient serotyping of" exact="DENV" post="in human and mosquitos to facilitate efficient disease management"/>
   <result pre="consistent to the performance of other molecular detection methods for" exact="DENV" post="[37–39]. As reported previously, RNA copy numbers were likely"/>
   <result pre="in the sample matrix [40–42]. To aid laboratory confirmation of" exact="DENV" post="infection during the first 5 to 6 days after"/>
   <result pre="5 to 6 days after symptomatic onset, detection methods for" exact="DENV" post="RNA have been recommended by WHO [1]. Among them,"/>
   <result pre="They have been shown to have great performance for detecting" exact="DENV" post="in both human and mosquitoes [44]. However, they do"/>
   <result pre="and simple PON tool for early detection and serotyping of" exact="DENV" post="in viremic patients as well as in infected mosquitoes,"/>
   <result pre="of these reagents on the mobile PCR laboratory system for" exact="DENV" post="subtyping in both human and mosquitoes are underway. We"/>
   <result pre="LinC-Y, ChenT-C, et al.Differences in Mortality and Clinical Manifestations of" exact="Dengue" post="Hemorrhagic Fever in Taiwan in Different Years: A Comparison"/>
   <result pre="Real-Time Multiplex RT-PCR Assay for Simultaneous Detection and Serotyping of" exact="Dengue" post="and Chikungunya Viruses. J Mol Diagn. 2015;17(6):722–8. 10.1016/j.jmoldx.2015.06.008 .26455921"/>
   <result pre="RT-PCR Assay for Simultaneous Detection and Serotyping of Dengue and" exact="Chikungunya" post="Viruses. J Mol Diagn. 2015;17(6):722–8. 10.1016/j.jmoldx.2015.06.008 .26455921 19AlmE, LindegrenG,"/>
   <result pre="transcription-insulated isothermal PCR for rapid and sensitive on-site detection of" exact="Zika" post="virus. BMC Infect Dis. 2018;17(1):778 Epub 2017/12/21. [pii]. 10.1186/s12879-017-2852-429258444"/>
   <result pre="32TsaiJ-J, LiuL-T, LinP-C, TsaiC-Y, ChouP-H, TsaiY-L, et al.Validation of POCKIT™" exact="Dengue" post="Virus Reagent Set for Rapid Detection of Dengue Virus"/>
   <result pre="of POCKIT™ Dengue Virus Reagent Set for Rapid Detection of" exact="Dengue" post="Virus in Human Serum on a Field-Deployable PCR System."/>
   <result pre="Reverse Transcription-Insulated Isothermal PCR Assay Intended for Point-of-Need Diagnosis of" exact="Dengue" post="Virus Infection by Use of the POCKIT Nucleic Acid"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6440137\results\search\tropicalVirus\results.xml">
   <result pre="made available in this article, unless otherwise stated. Abstract Background" exact="Dengue" post="fever (DF) is a common mosquito-borne viral infectious disease"/>
   <result pre="which is available to authorized users. Keywords Spatiotemporal pattern China" exact="Dengue" post="fever Generalized additive model Socioeconomic factor Environmental factor Funding"/>
   <result pre="the five official working languages of the United Nations. Background" exact="Dengue" post="fever (DF) is an acute infectious disease caused by"/>
   <result pre="(170–190 mm), or water bodies (ratio of approximately 0.15–0.2). Fig. 7" exact="Dengue" post="fever risk areas derived from the generalized additive models"/>
   <result pre="Border of Yunnan and Myanmar CLR Cultivated land ratio DF" exact="Dengue" post="fever ESRI Environmental Systems Research Institute FLR Forest land"/>
   <result pre="and meta-analysisFront Cell Infect Microbiol2017731710.3389/fcimb.2017.0031728748176 3.Rodriguez-MoralesAJRuizPTabaresJOssaCAYepes-EcheverryMCRamirez-JaramilloVet al.Mapping the ecoepidemiology of" exact="Zika" post="virus infection in urban and rural areas of Pereira,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6443840\results\search\tropicalVirus\results.xml">
   <result pre="terms.Editorial on the Research Topic Host-Pathogen Interactions During Arboviral Infections" exact="West Nile" post="virus dengue virus chikungunya virus tick-borne encephalitis virus Japanese"/>
   <result pre="dengue virus chikungunya virus tick-borne encephalitis virus Japanese encephalitis virus" exact="Zika" post="virus systems biology immunity fig-count: table-count: equation-count: ref-count: page-count:"/>
   <result pre="chikungunya viruses), or Flaviviridae (e.g., tick-borne encephalitis, dengue, Japanese encephalitis," exact="West Nile," post="Zika, and yellow fever viruses) (Hanley and Weaver, 2008)."/>
   <result pre="risk of infection with several flaviviruses: In the United States," exact="West Nile" post="virus (WNV) is the leading cause of arbovirus infections"/>
   <result pre="and caused over 2,000 confirmed cases in 2017 (ArboNET, 2018)." exact="Zika" post="virus (ZIKV), while previously considered a minimal threat to"/>
   <result pre="flaviviruses can cause severe complications in human patients: two-thirds of" exact="West Nile" post="virus cases are classified as neuroinvasive, Zika virus is"/>
   <result pre="two-thirds of West Nile virus cases are classified as neuroinvasive," exact="Zika" post="virus is associated with Guillain-Barré syndrome and microcephaly, and"/>
   <result pre="Moreover, diabetic individuals are at a higher risk for contracting" exact="West Nile" post="virus disease (Nash et al., 2001). Flavivirus infection is"/>
   <result pre="As reviewed by Ahlers and Goodman, while Culex mosquitoes transmit" exact="WNV" post="to dead-end mammalian hosts, birds are reservoirs for WNV."/>
   <result pre="activation that leads to adaptive immunity in mammals. In humans," exact="WNV" post="begins replicating in the skin at the site of"/>
   <result pre="(Driskell et al., 2014). Here, Wei et al. show that" exact="DENV" post="infects dermal papilla cells, leading to reduced cell viability"/>
   <result pre="is used to identify new strategies to combat arboviral infections." exact="Chikungunya" post="virus (CHIKV) is a re-emerging mosquito-borne arbovirus that has"/>
   <result pre="antibody-dependent enhancement (ADE), which may lead to disease exacerbation during" exact="ZIKV" post="infection. Specifically, the development of immunity to other flaviviral"/>
   <result pre="of immunity to other flaviviral infections, particularly DENV, with which" exact="ZIKV" post="co-circulates, or yellow fever virus, for which there is"/>
   <result pre="for which there is a vaccine, could facilitate ADE during" exact="ZIKV" post="infection. However, more epidemiological and animal model data must"/>
   <result pre="be analyzed before fully understanding the role of ADE during" exact="ZIKV" post="infection and pathogenesis. The findings from these studies could"/>
   <result pre="October 19, 2018). ChenC. C.JenkinsE.EppT.WaldnerC.CurryP. S.SoosC. (2013). Climate change and" exact="West Nile" post="virus in a highly endemic region of North America."/>
   <result pre="R.HollandJ. J. (London: Academic Press), 351–391. 10.1016/B978-0-12-374153-0.00016-3 JindalH.BhattB.MalikJ. S.shashikanthaS.K (2014)." exact="Dengue" post="vaccine: a valuable asset for the future. Hum. Vaccines"/>
   <result pre="Wkly. Rep.63, 521–526. 24941331 NashD.MostashariF.FineA.MillerJ.O'LearyD.MurrayK.et al.. (2001). The outbreak of" exact="West Nile" post="virus infection in the New York City area in"/>
   <result pre="10.1056/NEJM20010614344240111407341 ThamH.-W.BalasubramaniamV.OoiM. K.ChewM.-F. (2018). Viral determinants and vector competence of" exact="Zika" post="virus transmission. Front. Microbiol.9:1040. 10.3389/fmicb.2018.0104029875751"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6455116\results\search\tropicalVirus\results.xml">
   <result pre="doi: 10.1080/22221751.2018.1557988 : Article Heat shock protein 70 (Hsp70) mediates" exact="Zika" post="virus entry, replication, and egress from host cells Emerging"/>
   <result pre="medium, provided the original work is properly cited.temi-8-1557988.pdf Abstract ABSTRACT" exact="Zika" post="virus (ZIKV) is a historically neglected mosquito-borne flavivirus that"/>
   <result pre="flavivirus that has caused recent epidemics in the western hemisphere." exact="ZIKV" post="has been associated with severe symptoms including infant microcephaly"/>
   <result pre="microcephaly and Guillain-Barré syndrome, stimulating interest in understanding factors governing" exact="ZIKV" post="infection. Heat shock protein 70 (Hsp70) has been shown"/>
   <result pre="leading us to investigate the role of Hsp70 in the" exact="ZIKV" post="infection process. ZIKV infection induced Hsp70 expression in host"/>
   <result pre="investigate the role of Hsp70 in the ZIKV infection process." exact="ZIKV" post="infection induced Hsp70 expression in host cells 48-h post-infection."/>
   <result pre="cells 48-h post-infection. Inducing Hsp70 expression in mammalian cells increased" exact="ZIKV" post="production, whereas inhibiting Hsp70 activity reduced ZIKV viral RNA"/>
   <result pre="mammalian cells increased ZIKV production, whereas inhibiting Hsp70 activity reduced" exact="ZIKV" post="viral RNA production and virion release from the cell."/>
   <result pre="both on the cell surface where it could interact with" exact="ZIKV" post="during the initial stages of the infection process, and"/>
   <result pre="with viral RNA. Blocking cell surface-localized Hsp70 using antibodies decreased" exact="ZIKV" post="cell infection rates and production of infectious virus particles,"/>
   <result pre="entry, replication, and egress. Understanding the interactions between Hsp70 and" exact="ZIKV" post="may lead to novel therapeutics for ZIKV infection. KEYWORDS"/>
   <result pre="between Hsp70 and ZIKV may lead to novel therapeutics for" exact="ZIKV" post="infection. KEYWORDS Arbovirus receptor mosquito-borne heat shock Funding Penn"/>
   <result pre="and R01AI128201 to JLR. fig-count: table-count: equation-count: ref-count: page-count: Introduction" exact="Zika" post="virus (ZIKV) is a historically neglected mosquito-borne flavivirus first"/>
   <result pre="the western hemisphere in 2015–2016 [1–4]. For the first time," exact="ZIKV" post="infection has been associated with severe symptoms including microcephaly"/>
   <result pre="and Guillain-Barré syndrome in adults [5,6]. Considering the impacts of" exact="ZIKV" post="on infants exposed in utero and its rapid spread,"/>
   <result pre="and its rapid spread, the World Health Organization (WHO) declared" exact="ZIKV" post="a public health emergency of international concern [7]. The"/>
   <result pre="this outbreak has stimulated interest in determining the factors governing" exact="ZIKV" post="infection [8,9]. The binding of a virus to specific"/>
   <result pre="Axl, Tyro3, and TIM1 in the pathogenesis and entry of" exact="ZIKV" post="to the neuronal and placental cell population has been"/>
   <result pre="population has been described [12–15]. However, the understanding of the" exact="ZIKV" post="cellular infection process is still in its initial stages"/>
   <result pre="Hsp70 is an important factor in multiple stages of the" exact="ZIKV" post="cell infection process including viral entry, replication, and egress."/>
   <result pre="entry, replication, and egress. Understanding the interactions between Hsp70 and" exact="ZIKV" post="may lead to novel therapeutics for ZIKV infection. Results"/>
   <result pre="between Hsp70 and ZIKV may lead to novel therapeutics for" exact="ZIKV" post="infection. Results ZIKA virus infection induces the expression of"/>
   <result pre="induces the expression of Hsp70 We investigated the effect of" exact="ZIKV" post="infection on the expression of Hsp70. Huh7.5 cells were"/>
   <result pre="Hsp70 protein expression. Huh7.5 cells were infected with 3 MOI" exact="ZIKV" post="and Hsp70 assayed by western blot at 6, 12,"/>
   <result pre="as a housekeeping control. Hsp70 inhibitor MKT077 reduces production of" exact="ZIKV" post="infectious virus particles MKT077 is a potent allosteric inhibitor"/>
   <result pre="[24]. To investigate the potential role of Hsp70 in the" exact="ZIKV" post="infection process, we treated Huh7.5 human liver cells with"/>
   <result pre="have a role both at entry and post-entry levels of" exact="ZIKV" post="infection. Figure 2. Hsp70 inhibitor MKT077 inhibits infectious ZIKV"/>
   <result pre="of ZIKV infection. Figure 2. Hsp70 inhibitor MKT077 inhibits infectious" exact="ZIKV" post="production. Huh7.5 cells were infected with 0.1 MOI of"/>
   <result pre="denote standard error of the mean. Hsp70 expression positively regulates" exact="ZIKV" post="production We next induced expression of Hsp70 protein in"/>
   <result pre="the cells with ZIKV, and measured the production of infectious" exact="ZIKV" post="titre in the culture supernatant 48 h after infection. Upon"/>
   <result pre="(control) by western blot (Figure S2). Cells were infected with" exact="ZIKV" post="40 h post-transfection and culture supernatants tested for virus titre"/>
   <result pre="48 h post-infection. In both heat-treated and EGFP-Hsp70 overexpressed cells, infectious" exact="ZIKV" post="titre was significantly elevated compared to non-induced or EGFP"/>
   <result pre="(Figure 3). Figure 3. Heat shock 70 (Hsp70) protein facilitates" exact="ZIKV" post="infection. Heat induction (A) in Huh7.5 cells and EGFP-Hsp70"/>
   <result pre="denote standard error of the mean. Role of Hsp70 in" exact="ZIKV" post="entry process Although heat shock proteins are generally thought"/>
   <result pre="Cell nuclei = blue. Cell membrane = red. If Hsp70 plays a role in" exact="ZIKV" post="entry, using anti-Hsp70 antibody or other competitor to block"/>
   <result pre="or other competitor to block the interaction between Hsp70 and" exact="ZIKV" post="would be expected to reduce ZIKV entry. Since Vero"/>
   <result pre="interaction between Hsp70 and ZIKV would be expected to reduce" exact="ZIKV" post="entry. Since Vero cells are the cell line of"/>
   <result pre="been previously demonstrated to act as a cell receptor for" exact="ZIKV" post="[13] and which served as a positive control for"/>
   <result pre="similar extent as blocking Axl (Figure 5(A)). Figure 5. Blocking" exact="ZIKV" post="cellular attachment to Hsp70 reduces cell infection rates and"/>
   <result pre="beta-actin antibody = negative controls. After antibody treatment, cells were infected with" exact="ZIKV" post="and plaque reduction neutralization assay performed. (B) Competition of"/>
   <result pre="ZIKV and plaque reduction neutralization assay performed. (B) Competition of" exact="ZIKV" post="with recombinant human Hsp70 protein (rhHsp70) reduces Huh7.5 cellular"/>
   <result pre="Error bars denote 95% confidence intervals. NS = not significant. Competition for" exact="ZIKV" post="attachment with recombinant Hsp70 protein reduces ZIKV infection To"/>
   <result pre="significant. Competition for ZIKV attachment with recombinant Hsp70 protein reduces" exact="ZIKV" post="infection To further confirm the role of Hsp70 in"/>
   <result pre="ZIKV infection To further confirm the role of Hsp70 in" exact="ZIKV" post="cellular entry, we tested whether recombinant human Hsp70 (rhHsp70)"/>
   <result pre="competitor for the putative cell attachment protein(s) present on the" exact="ZIKV" post="infectious particle. ZIKV was incubated with rhHsp70 and then"/>
   <result pre="putative cell attachment protein(s) present on the ZIKV infectious particle." exact="ZIKV" post="was incubated with rhHsp70 and then used to infect"/>
   <result pre="rhHsp70 and then used to infect Huh7.5 cells, after which" exact="ZIKV" post="production was assayed by plaque assay. Incubating ZIKV with"/>
   <result pre="after which ZIKV production was assayed by plaque assay. Incubating" exact="ZIKV" post="with rhHsp70 reduced the amount of infectious virus in"/>
   <result pre="of infectious virus in the supernatant compared to BSA-incubated control" exact="ZIKV" post="(Figure 5(B)). Role of Hsp70 in ZIKV post-entry processes"/>
   <result pre="to BSA-incubated control ZIKV (Figure 5(B)). Role of Hsp70 in" exact="ZIKV" post="post-entry processes Interaction between Hsp70 and viral RNA: We"/>
   <result pre="presence of MKT077. Cells were infected with 6 MOI of" exact="ZIKV" post="in the presence of MKT077. The Y-axis represents the"/>
   <result pre="virus particles (Figure 7). Figure 7. Role of Hsp70 in" exact="ZIKV" post="release step. Titres of intra- and extra-cellular virus production"/>
   <result pre="0.5, 1, and 5 µM MKT077, Huh7.5 cells were infected with" exact="ZIKV" post="(0.1 MOI. Free virus (supernatants) and cell-associated viruses were"/>
   <result pre="crossing of the lines at 0.5 µM MKT007. Discussion Until recently," exact="ZIKV" post="was not considered a serious public health threat, and"/>
   <result pre="shown that Hsp70 is involved in multiple steps of the" exact="ZIKV" post="life cycle ranging from cell entry to replication and"/>
   <result pre="Axl, Tyro3, and TIM1 as major cellular players in the" exact="ZIKV" post="cell entry process. However, Cas9-mediated deletion of Axl-1 in"/>
   <result pre="cells and cerebral organoids did not protect these cells from" exact="ZIKV" post="infection indicating the multifactorial entry process of the virus"/>
   <result pre="multifactorial entry process of the virus [32], and suggesting that" exact="ZIKV" post="uses multiple classes of cell surface molecules as receptors"/>
   <result pre="phosphatidylserine [25]. Our experiments indicate that Hsp70 is involved in" exact="ZIKV" post="binding and entry into mammalian cells, highlighting its important"/>
   <result pre="particles. Antibody blocking of cell surface-localized Hsp70 or pre-incubation of" exact="ZIKV" post="with recombinant Hsp70 significantly reduced ZIKV infection. Specifically, reduction"/>
   <result pre="Hsp70 or pre-incubation of ZIKV with recombinant Hsp70 significantly reduced" exact="ZIKV" post="infection. Specifically, reduction in the viral plaque forming units"/>
   <result pre="one cellular factor acting as a cell surface receptor for" exact="ZIKV" post="attachment and invasion. Hsp70 and related proteins are part"/>
   <result pre="granules composed of cellular mRNAs and stalled pre-initiation complexes [41]." exact="DENV" post="and WNV are known to inhibit the formation of"/>
   <result pre="of cellular mRNAs and stalled pre-initiation complexes [41]. DENV and" exact="WNV" post="are known to inhibit the formation of SG. However,"/>
   <result pre="rapamycin kinase 1 (mTORC-1) and SQSTM1/p62-associated proteostasis [44,45]. Flaviviruses including" exact="ZIKV" post="utilize the cellular autophagy process for their replication [46]."/>
   <result pre="Co-localization of Hsp70 along with dsRNA indicates similar events during" exact="ZIKV" post="infection. Hsp70 is also in association with DNAJB1, which"/>
   <result pre="by interacting with MDA5/MAVS [47] that could be validated for" exact="ZIKV" post="infection in future studies. Finally, the decreased ratio of"/>
   <result pre="antiviral therapies [20,48,49]. In particular, the association between Hsp70 and" exact="ZIKV" post="suggests a critical role for this interaction during the"/>
   <result pre="As there is currently no effective therapy or vaccine for" exact="ZIKV" post="infection, novel therapies to reduce infection and severe clinical"/>
   <result pre="critical roles of Hsp70 in the infectious life cycle of" exact="ZIKV" post="validate Hsp70 as a potential target for future anti-ZIKV"/>
   <result pre="penicillin and streptomycin (Invitrogen) and 2 mM L-glutamine (Invitrogen). The MR766" exact="ZIKV" post="strain was obtained from BEI Resources, propagated in Vero"/>
   <result pre="plaque assays. Antibodies and chemical reagents: The E glycoprotein of" exact="ZIKV" post="was detected in cell lysates using anti-ZIKA E protein"/>
   <result pre="for 1 h, rinsed with sterile PBS, and incubated with 105 pfu" exact="ZIKV" post="particles, then processed as described above for plaque assays."/>
   <result pre="control). At 10 h post heat shock, cells were infected with" exact="ZIKV" post="at an MOI of 0.1. Culture supernatants were harvested"/>
   <result pre="Culture supernatants were harvested 48 h post-infection and titrated for infectious" exact="ZIKV" post="by plaque assay. Hsp70 overexpression: HEK 293 T cells grown"/>
   <result pre="and cells were harvested. The culture supernatants were titrated for" exact="ZIKV" post="by the focus-forming assay. The cell pellets were used"/>
   <result pre="cells. Competition assay: To block virus surface ligands, 105 PFU of" exact="ZIKV" post="were incubated with 1000 ng recombinant human Hsp70 (rhHsp70) protein"/>
   <result pre="(control) for 90 min on ice. Huh7.5 cells were infected with" exact="ZIKV" post="preparations at an MOI of 1 at 37°C with"/>
   <result pre="48 h at 37°C with 5% CO2. As described above, infectious" exact="ZIKV" post="particles in the culture supernatant were determined by plaque"/>
   <result pre="cell in 6 well plates were infected with 6 MOI" exact="ZIKV" post="and incubated with maintenance medium containing DMSO or MKT077"/>
   <result pre="the collected cells was extracted using Direct-Zol RNA purification kits." exact="ZIKV" post="capsid (F- 5’ CAA TCA AGC CAT CAC TGG"/>
   <result pre="2009 Software was used for relative quantification and to analyse" exact="ZIKV" post="RNA kinetics. Statistical analysis: Experiments with paired treatments were"/>
   <result pre="References 1LanciottiRS, KosoyOL, LavenJJ, et al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007."/>
   <result pre="et al.Ocular Findings in Infants with Microcephaly Associated with Presumed" exact="Zika" post="Virus Congenital Infection in Salvador, Brazil. JAMA Ophthalmol. 2016;134:529–535."/>
   <result pre="10.1056/NEJMoa1602412 9Cao-LormeauVM, BlakeA, MonsS, et al.Guillain-Barre Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control study. Lancet."/>
   <result pre="Di LulloE, et al.Expression Analysis Highlights AXL as a Candidate" exact="Zika" post="Virus Entry Receptor in Neural Stem Cells. Cell Stem"/>
   <result pre="Cell. 2016;18:591–596. doi: 10.1016/j.stem.2016.03.01227038591 14SavidisG, McDougallWM, MeranerP, et al.Identification of" exact="Zika" post="Virus and Dengue Virus Dependency Factors using Functional Genomics."/>
   <result pre="10.1016/j.stem.2016.03.01227038591 14SavidisG, McDougallWM, MeranerP, et al.Identification of Zika Virus and" exact="Dengue" post="Virus Dependency Factors using Functional Genomics. Cell Rep. 2016;16:232–246."/>
   <result pre="doi: 10.1128/JVI.79.8.4557-4567.200515795242 20TaguwaS, MaringerK, LiX, et al.Defining Hsp70 Subnetworks in" exact="Dengue" post="Virus Replication Reveals Key Vulnerability in Flavivirus Infection. Cell."/>
   <result pre="Not Protect Human Neural Progenitor Cells and Cerebral Organoids from" exact="Zika" post="Virus Infection. Cell Stem Cell. 2016;19:703–708. doi: 10.1016/j.stem.2016.11.01127912091 33GermiR,"/>
   <result pre="38FrumenceE, RocheM, Krejbich-TrototP, et al.The South Pacific epidemic strain of" exact="Zika" post="virus replicates efficiently in human epithelial A549 cells leading"/>
   <result pre="cerevisiae. RNA. 2015;21:1660–1671. doi: 10.1261/rna.053116.11526199455 42EmaraMM, BrintonMA.Interaction of TIA-1/TIAR with" exact="West Nile" post="and dengue virus products in infected cells interferes with"/>
   <result pre="ParnellLA, DiamondMS, et al.Inhibition of autophagy limits vertical transmission of" exact="Zika" post="virus in pregnant mice. J Exp Med. 2017;214:2303–2313. doi:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6455256\results\search\tropicalVirus\results.xml">
   <result pre="IFITM proteins mediate cellular resistance to influenza A H1N1 virus," exact="West Nile" post="virus, and Dengue virus. Cell. 2009;139:1243–1254. doi: 10.1016/j.cell.2009.12.01720064371 18Amini-Bavil-OlyaeeS,"/>
   <result pre="resistance to influenza A H1N1 virus, West Nile virus, and" exact="Dengue" post="virus. Cell. 2009;139:1243–1254. doi: 10.1016/j.cell.2009.12.01720064371 18Amini-Bavil-OlyaeeS, et al.The antiviral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6456646\results\search\tropicalVirus\results.xml">
   <result pre="papillomavirus (HPV) which resulted in histological regression and/or eliminated persistent" exact="HPV" post="infection and HPV-related cervical lesions (Kim et al., 2014;"/>
   <result pre="vaccine was developed that induced protective neutralizing antibodies (NAb) to" exact="Zika" post="virus (ZIKV) in mice (Larocca et al., 2016) and"/>
   <result pre="al., 2017) leading to the development of safe and immunogenic" exact="ZIKV" post="DNA vaccines for humans (Tebas et al., 2017; Gaudinski"/>
   <result pre="loaded nanoparticles (NP), adenovirus (Ad) vectors, adeno-associated virus (AAV), and" exact="HPV" post="pseudovirus (HPV PsV) have been developed to elicit localized"/>
   <result pre="(Holz et al., 2018). In the vagina, intravaginal delivery of" exact="HPV" post="PsV, and more recently Ad26 and Ad35 have been"/>
   <result pre="D.et al.. (2017). Durability and correlates of vaccine protection against" exact="Zika" post="virus in rhesus monkeys. Sci. Transl. Med.9:eaao4163. 10.1126/scitranslmed.aao416329237759 AckermanM."/>
   <result pre="S.BuckC. B.KinesR. C.PangY. Y.DayP. M.et al.. (2012). Intravaginal immunization with" exact="HPV" post="vectors induces tissue-resident CD8+ T cell responses. J. Clin."/>
   <result pre="M.HuZ.YamshchikovG.RothwellR. S.et al.. (2018). Safety, tolerability, and immunogenicity of two" exact="Zika" post="virus DNA vaccine candidates in healthy adults: randomised, open-label,"/>
   <result pre="T.HurS. Y.YangH. G.SeoY. B.HongS. R.et al.. (2014). Clearance of persistent" exact="HPV" post="infection and cervical lesion by therapeutic DNA vaccine in"/>
   <result pre="LaroccaR. A.AbbinkP.PeronJ. P.ZanottoP. M.IampietroM. J.Badamchi-ZadehA.et al.. (2016). Vaccine protection against" exact="Zika" post="virus from Brazil. Nature536, 474–478. 10.1038/nature1895227355570 LatimerB.ToporovskiR.YanJ.PankhongP.MorrowM. P.KhanA. S.et"/>
   <result pre="age of direct-acting antivirals?PLoS ONE11:e0156213. 10.1371/journal.pone.015621327224423 SunY.PengS.QiuJ.MiaoJ.YangB.JeangJ.et al.. (2015). Intravaginal" exact="HPV" post="DNA vaccination with electroporation induces local CD8+ T-cell immune"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6460799\results\search\tropicalVirus\results.xml">
   <result pre="of the most medically important mosquito-borne viruses, including dengue virus," exact="West Nile" post="virus and Zika virus. Despite the burden of these"/>
   <result pre="important mosquito-borne viruses, including dengue virus, West Nile virus and" exact="Zika" post="virus. Despite the burden of these pathogens on human"/>
   <result pre="fever virus (YFV), dengue virus (DENV), Japanese encephalitis virus (JEV)," exact="West Nile" post="virus (WNV) and Zika virus (ZIKV) [4]. DENV is"/>
   <result pre="(DENV), Japanese encephalitis virus (JEV), West Nile virus (WNV) and" exact="Zika" post="virus (ZIKV) [4]. DENV is considered the most important"/>
   <result pre="(JEV), West Nile virus (WNV) and Zika virus (ZIKV) [4]." exact="DENV" post="is considered the most important mosquito-borne virus, causing 390"/>
   <result pre="infections annually, and is primarily transmitted by Aedes aegypti [5]." exact="Dengue" post="epidemics have expanded significantly in the last few decades"/>
   <result pre="aegypti is also the primary vector for other flaviviruses, including" exact="YFV" post="and ZIKV. Zika virus infections are typically mild or"/>
   <result pre="the primary vector for other flaviviruses, including YFV and ZIKV." exact="Zika" post="virus infections are typically mild or asymptomatic, but have"/>
   <result pre="asymptomatic, but have been linked to Guillain-Barré syndromes in adults." exact="Zika" post="virus infections are also a major concern to pregnant"/>
   <result pre="as microcephaly in prenatally infected infants [7]. In February 2016," exact="ZIKV" post="epidemics were declared a public health emergency by the"/>
   <result pre="processes required for viral replication and dissemination were modulated during" exact="ZIKV" post="[47], DENV [48] WNV [49] and ONNV infections [50]."/>
   <result pre="for viral replication and dissemination were modulated during ZIKV [47]," exact="DENV" post="[48] WNV [49] and ONNV infections [50]. Besides the"/>
   <result pre="replication and dissemination were modulated during ZIKV [47], DENV [48]" exact="WNV" post="[49] and ONNV infections [50]. Besides the well-studied siRNA"/>
   <result pre="piRNAs was detected in Ae. aegypti and Ae. albopictus during" exact="CHIKV" post="infection [56] and in SINV infected Aedes cells [53]."/>
   <result pre="infection, but also in Ae. aegypti and Ae. albopictus during" exact="CHIKV" post="and ZIKV infections [30, 59]. The vDNAs then stimulate"/>
   <result pre="also in Ae. aegypti and Ae. albopictus during CHIKV and" exact="ZIKV" post="infections [30, 59]. The vDNAs then stimulate the RNAi"/>
   <result pre="DENV-2 infected mosquitoes [66]. Furthermore, cecropins exhibit antiviral activity against" exact="DENV" post="and CHIKV [66]. In Culex mosquitoes, Vago is a"/>
   <result pre="mosquitoes [66]. Furthermore, cecropins exhibit antiviral activity against DENV and" exact="CHIKV" post="[66]. In Culex mosquitoes, Vago is a secreted peptide"/>
   <result pre="pathway and overexpression of Vago reduces the viral load of" exact="WNV" post="in mosquitoes [28]. During SINV infection in Drosophila, two"/>
   <result pre="JAK-STAT pathway has been shown to mediate increased resistance to" exact="DENV" post="and ZIKV in infected Ae. aegypti [22, 25]. Genetically"/>
   <result pre="has been shown to mediate increased resistance to DENV and" exact="ZIKV" post="in infected Ae. aegypti [22, 25]. Genetically modifying Ae."/>
   <result pre="overexpress Dome and Hop renders the mosquitoes more resistant to" exact="DENV" post="infection, but not to CHIKV and ZIKV infections. These"/>
   <result pre="the mosquitoes more resistant to DENV infection, but not to" exact="CHIKV" post="and ZIKV infections. These studies suggest that Ae. aegypti"/>
   <result pre="more resistant to DENV infection, but not to CHIKV and" exact="ZIKV" post="infections. These studies suggest that Ae. aegypti possess varied"/>
   <result pre="secreted peptide known as Vago was upregulated in response to" exact="WNV" post="infection, subsequently activating the JAK-STAT pathway to control infection"/>
   <result pre="silencing of the tyrosine kinase complex, Dome and Hop increased" exact="DENV" post="infection, whereas knockdown of PIAS, a known negative regulator"/>
   <result pre="PIAS, a known negative regulator of the JAK-STAT pathway, decreased" exact="DENV" post="infection [22]. However, although the JAK-STAT pathway is increased"/>
   <result pre="However, although the JAK-STAT pathway is increased in response to" exact="DENV" post="infection in the mosquito, strains that were either resistant"/>
   <result pre="the mosquito, strains that were either resistant or susceptible to" exact="DENV" post="infection did not show a difference in viral infection,"/>
   <result pre="that the pathway was not involved in viral susceptibility to" exact="DENV" post="[69]. The majority of investigations into the JAK-STAT pathway"/>
   <result pre="post-infection and infection was not altered [68]. In contrast to" exact="ZIKV" post="and DENV, the JAK-STAT pathway was not activated by"/>
   <result pre="ZIKV and DENV, the JAK-STAT pathway was not activated by" exact="CHIKV" post="infection [70], nor was it involved in viral dissemination"/>
   <result pre="involved in viral dissemination [68]. Furthermore, in human host cells," exact="CHIKV" post="non-structural protein 2 has been shown to inhibit interferon"/>
   <result pre="not been elucidated. Together, this raises the possibility that the" exact="CHIKV" post="inhibitory mechanism acts directly on the JAK-STAT pathway and"/>
   <result pre="may be conserved in the mosquito immune system. Just as" exact="CHIKV" post="may inhibit the JAK-STAT pathway, SFV has also been"/>
   <result pre="to downregulate transcription of the JAK-STAT pathway [9]. Thus, both" exact="CHIKV" post="and SFV have developed mechanisms to avoid activation of"/>
   <result pre="found in Ae. aegypti, Cx. quinquefasciatus and An. gambiae. During" exact="DENV" post="infection of Ae. aegypti, the genes in the Toll"/>
   <result pre="salivary glands. Silencing of MYD88, caused a slight increase of" exact="DENV" post="viral titre in the midgut [66]. Upon viral infection,"/>
   <result pre="its downstream antimicrobial peptides is upregulated to control infection against" exact="DENV" post="[14, 75] and SINV [24], whereas in Culex mosquitoes,"/>
   <result pre="[14, 75] and SINV [24], whereas in Culex mosquitoes, following" exact="WNV" post="infection, the transcription factor Rel2 of the Imd pathway"/>
   <result pre="Imd pathway activates the secretion of an antiviral peptide against" exact="WNV" post="infection [28]. The Delta-Notch signaling pathway: a complementary pathway"/>
   <result pre="innate immunity in the mosquito, by limiting the replication of" exact="DENV" post="in Ae. aegypti mosquitoes [77]. Notch is a transmembrane"/>
   <result pre="the nucleus to activate downstream target genes [76, 78]. During" exact="DENV" post="infection, components of this pathway including Delta, Notch and"/>
   <result pre="Although the exact mechanism of how this signaling pathway limits" exact="DENV" post="replication is not known, this study showed that activation"/>
   <result pre="circulate within hemolymph, and are permissive to viral infection including" exact="DENV" post="[15], SINV [80] and WNV [81]. The hemocyte-mediated immune"/>
   <result pre="permissive to viral infection including DENV [15], SINV [80] and" exact="WNV" post="[81]. The hemocyte-mediated immune response is immediate and includes"/>
   <result pre="the fat body of Ae. aegypti, resulted in inhibition of" exact="DENV" post="infection in these transgenic mosquitoes, but this inhibitory effect"/>
   <result pre="transgenic mosquitoes, but this inhibitory effect was not observed for" exact="CHIKV" post="and ZIKV, indicating that different viruses elicited the JAK-STAT"/>
   <result pre="to facilitate viral replication. In Ae. aegypti cells, SINV and" exact="DENV" post="infection resulted in accumulation of lipid droplets (LDs) [88]."/>
   <result pre="involved in LD biogenesis and lipid metabolism are upregulated upon" exact="DENV" post="infection [88]. Interestingly, activation of immune signaling pathway, including"/>
   <result pre="Imd pathways enhanced LD content in mosquito midgut [88]. During" exact="DENV" post="infection, fatty acid synthase is recruited to the site"/>
   <result pre="acid synthase is recruited to the site of replication by" exact="DENV" post="nonstructural protein 3 to stimulate fatty acids synthesis [91]."/>
   <result pre="acids synthesis [91]. Furthermore, inhibition of fatty acid synthase decreased" exact="DENV" post="viral titers and thus serve as a potential antiviral"/>
   <result pre="also involved during viral infection of mosquitoes. For example, during" exact="DENV" post="infection, autophagy is activated to generate energy for viral"/>
   <result pre="to limit their ability to transmit important arboviruses including DENV," exact="CHIKV" post="and ZIKV. To date, ten countries, including Australia, Brazil"/>
   <result pre="Australia, Brazil and Vietnam, have participated in field trials for" exact="DENV" post="control by releasing Wolbachia-infected mosquitoes into the wild [104]."/>
   <result pre="the same field populations continue to demonstrate reduced susceptibility to" exact="DENV" post="under laboratory conditions [106]. Field and clinical studies in"/>
   <result pre="Vietnam showed that wMel-infected Ae. aegypti are not permissive to" exact="DENV" post="infection when the mosquitoes were fed with patient-derived viremic"/>
   <result pre="For example, Wolbachia-infection of Cx. tarsalis, which is a novel" exact="WNV" post="vector in North America, enhanced the infection rate of"/>
   <result pre="WNV vector in North America, enhanced the infection rate of" exact="WNV" post="[113]. Additionally, Wolbachia-infected Anopheles mosquitoes exhibited an enhanced susceptibility"/>
   <result pre="strategies. Abbreviations PRRs pattern recognition receptors PAMPs pathogen-associated molecular patterns" exact="YFV" post="yellow fever virus DENV dengue virus JEV Japanese encephalitis"/>
   <result pre="recognition receptors PAMPs pathogen-associated molecular patterns YFV yellow fever virus" exact="DENV" post="dengue virus JEV Japanese encephalitis virus WNV West Nile"/>
   <result pre="yellow fever virus DENV dengue virus JEV Japanese encephalitis virus" exact="WNV" post="West Nile virus ZIKV Zika virus CHIKV chikungunya virus"/>
   <result pre="fever virus DENV dengue virus JEV Japanese encephalitis virus WNV" exact="West Nile" post="virus ZIKV Zika virus CHIKV chikungunya virus SINV Sindbis"/>
   <result pre="dengue virus JEV Japanese encephalitis virus WNV West Nile virus" exact="ZIKV" post="Zika virus CHIKV chikungunya virus SINV Sindbis virus SFV"/>
   <result pre="virus JEV Japanese encephalitis virus WNV West Nile virus ZIKV" exact="Zika" post="virus CHIKV chikungunya virus SINV Sindbis virus SFV Semliki"/>
   <result pre="Japanese encephalitis virus WNV West Nile virus ZIKV Zika virus" exact="CHIKV" post="chikungunya virus SINV Sindbis virus SFV Semliki Forest virus"/>
   <result pre="Neurology2015211599161126633778 4.LauretiMNarayananDRodriguez-AndresJFazakerleyJKKedzierskiLFlavivirus receptors: diversity, identity, and cell entryFront Immunol.20189218010.3389/fimmu.2018.0218030319635 5.WHO." exact="Dengue" post="control strategies. 2017. http://www.who.int/denguecontrol/control_strategies/en/. Accessed 30 Mar 2018. 6.DashAPBhatiaRSunyotoTMouryaDTEmerging"/>
   <result pre="pipiens and Culex quinquefasciatus for African and European lineage 2" exact="West Nile" post="virusesAm J Trop Med Hyg.2018981863186910.4269/ajtmh.17-093529637885 9.FragkoudisRChiYSiuRWCBarryGAttarzadeh-YazdiGMeritsAet al.Semliki Forest virus"/>
   <result pre="Aedes aegyptiInsect Biochem Mol Biol.2005351293130710.1016/j.ibmb.2005.07.00616203210 25.Angleró-RodríguezYIMacLeodHJKangSCarlsonJSJupatanakulNDimopoulosGAedes aegypti molecular responses to" exact="Zika" post="virus: modulation of infection by the Toll and Jak/Stat"/>
   <result pre="against viral infection by apoptosis-dependent phagocytosisJ Immunol.2015195569610.4049/jimmunol.150061326546607 28.ParadkarPNTrinidadLVoyseyRDucheminJ-BWalkerPJSecreted Vago restricts" exact="West Nile" post="virus infection in Culex mosquito cells by activating the"/>
   <result pre="immunity in insectsCell Host Microbe.201823353–65e8 59.NagDKKramerLDPatchy DNA forms of the" exact="Zika" post="virus RNA genome are generated following infection in mosquito"/>
   <result pre="C-type lectin collaborates with a CD45 phosphatase homolog to facilitate" exact="West Nile" post="virus infection of mosquitoesCell.201014271472510.1016/j.cell.2010.07.03820797779 82.SigleLTHillyerJFEater and draper are involved"/>
   <result pre="by hypolipidemic drugs targeting the acetyl coenzyme A carboxylase impairs" exact="West Nile" post="virus replicationAntimicrob Agents Chemother.20166030710.1128/AAC.01578-1526503654 91.HeatonNSPereraRBergerKLKhadkaSLacountDJKuhnRJet al.Dengue virus nonstructural protein"/>
   <result pre="insect-specific flavivirus infection in Aedes aegypti mosquitoesEcol Evol.201885441545410.1002/ece3.406629938064 113.DodsonBLHughesGLPaulOMatacchieroACKramerLDRasgonJLWolbachia enhances" exact="West Nile" post="virus (WNV) infection in the mosquito Culex tarsalisPLoS Negl"/>
   <result pre="al.Striking diflubenzuron resistance in Culex pipiens, the prime vector of" exact="West Nile" post="VirusSci Rep.201771169910.1038/s41598-017-12103-128916816"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6463034\results\search\tropicalVirus\results.xml">
   <result pre="pmcid: 6463034 doi: 10.3390/jcm8030369jcm-08-00369 : Opinion The Scientific Response to" exact="Zika" post="Virus https://orcid.org/0000-0001-6015-3613Martín-AcebesMiguel A.*https://orcid.org/0000-0001-8269-5544SaizJuan-Carlos[], jcsaiz@inia.es *Correspondence: martin.mangel@inia.es; Tel.: +34-91-347-8770 epub:"/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Zika" post="virus (ZIKV) is a mosquito-borne pathogen that became renowned"/>
   <result pre="or cause mild illnesses, in a reduced number of cases," exact="ZIKV" post="can also produce severe complications that include neurological disorders"/>
   <result pre="a significant part of the scientific community were placed on" exact="ZIKV" post="research, which has resulted in an unpredicted escalation of"/>
   <result pre="this virus. The rapid response of the scientific community against" exact="ZIKV" post="highlights its enormous potential to counter attack a viral"/>
   <result pre="ZIKV. Nevertheless, there are still other arboviral threats different from" exact="ZIKV" post="that should not be forgotten. Zika virus epidemics scientific"/>
   <result pre="arboviral threats different from ZIKV that should not be forgotten." exact="Zika" post="virus epidemics scientific literature antiviral vaccines Zika virus (ZIKV)"/>
   <result pre="not be forgotten. Zika virus epidemics scientific literature antiviral vaccines" exact="Zika" post="virus (ZIKV) is a flavivirus transmitted by mosquitoes that"/>
   <result pre="association with neonatal malformations (i.e., microcephaly) in Brazil [1]. Although" exact="ZIKV" post="is responsible for congenital Zika syndrome, most infections are"/>
   <result pre="microcephaly) in Brazil [1]. Although ZIKV is responsible for congenital" exact="Zika" post="syndrome, most infections are asymptomatic or only cause mild"/>
   <result pre="pain, malaise, or headache. In a reduced number of cases," exact="ZIKV" post="can also produce severe complications that include neurological disorders"/>
   <result pre="efforts of the scientific community were conducted to rapidly understand" exact="ZIKV" post="biology and pathology, improve diagnostic methodologies, and develop specific"/>
   <result pre="prophylactic alternatives. In fact, bibliometric analyses of the impact of" exact="ZIKV" post="on scientific literature showed a huge increment in ZIKV-related"/>
   <result pre="this can be easily and rapidly visualized by searching for" exact="Zika" post="virus or ZIKV at PubMed, which is the most"/>
   <result pre="easily and rapidly visualized by searching for Zika virus or" exact="ZIKV" post="at PubMed, which is the most commonly used engine"/>
   <result pre="were performed for other medically relevant arthropod-borne viruses (arboviruses) namely," exact="Dengue" post="virus (DENV), Yellow fever virus (YFV), West Nile virus"/>
   <result pre="other medically relevant arthropod-borne viruses (arboviruses) namely, Dengue virus (DENV)," exact="Yellow fever" post="virus (YFV), West Nile virus (WNV), and Chikungunya virus"/>
   <result pre="viruses (arboviruses) namely, Dengue virus (DENV), Yellow fever virus (YFV)," exact="West Nile" post="virus (WNV), and Chikungunya virus (CHIKV), it was observed"/>
   <result pre="(DENV), Yellow fever virus (YFV), West Nile virus (WNV), and" exact="Chikungunya" post="virus (CHIKV), it was observed that the document count"/>
   <result pre="virus (CHIKV), it was observed that the document count for" exact="ZIKV" post="over the last three years extensively surpassed them. Remarkably,"/>
   <result pre="children [9]. Thus, it could seem that the response against" exact="ZIKV" post="has been overdimensioned in comparison to other viral threats."/>
   <result pre="clear is that the interest of the research community on" exact="ZIKV" post="grew to unexpected levels after the 2015 epidemic. This"/>
   <result pre="easily exemplified by the comparison of the research results for" exact="ZIKV" post="after the Brazilian outbreak in 2015 with other recent"/>
   <result pre="2015 with other recent viral outbreaks such as that of" exact="WNV" post="in 1999 in North America [10], CHIKV in 2004–2005"/>
   <result pre="as that of WNV in 1999 in North America [10]," exact="CHIKV" post="in 2004–2005 southwestern Indian Ocean region, India, and Southeast"/>
   <result pre="and reliable serological tests has been greatly expanded after the" exact="ZIKV" post="uprising in Brazil [13]. Moreover, important milestones of ZIKV"/>
   <result pre="the ZIKV uprising in Brazil [13]. Moreover, important milestones of" exact="ZIKV" post="research were rapidly achieved. One of them was the"/>
   <result pre="amenable animal models. Although non-human primates are naturally susceptible to" exact="ZIKV" post="infection, ethical, financial, and operative concerns limited their utilization"/>
   <result pre="immuno-deficient mice solved the problems with the &quot;resistance�? to peripheral" exact="ZIKV" post="infection in adult mice and provided useful animal models"/>
   <result pre="infection in adult mice and provided useful animal models for" exact="ZIKV" post="infection [14]. These mice models have contributed to the"/>
   <result pre="culture systems (brain organoids) also contributed to the understanding of" exact="ZIKV" post="pathology [15]. On combining clinical findings, animal, organoid, and"/>
   <result pre="[16]. However, it should be highlighted that critical questions about" exact="ZIKV" post="biology and its pathogenesis are not yet fully understood"/>
   <result pre="promising approaches for the rapid identification of drugs effective against" exact="ZIKV" post="was carried out by drug repositioning studies screening libraries"/>
   <result pre="suitable for pharmacological intervention. The structure of some of the" exact="ZIKV" post="proteins has been solved, which probably accelerates both drug"/>
   <result pre="that could be effective against other medically relevant flaviviruses like" exact="DENV" post="or WNV, and could even help to combat other"/>
   <result pre="drug licensed to combat any flavivirus. Moreover, antiviral therapies against" exact="ZIKV" post="will have to face extra challenges such as safety"/>
   <result pre="Japanese encephalitis, or tick-borne-encephalitis invite optimism. However, the experience with" exact="DENV" post="vaccination indicated that vaccine performance may depends on serostatus,"/>
   <result pre="Results from animal experimentation suggest that the immunological crosstalk between" exact="ZIKV" post="and other flaviviruses (i.e., DENV) could complicate massive utilization"/>
   <result pre="that induce a generation of cross-reactive antibodies that may enhance" exact="DENV" post="infection, although there are promising approaches to minimize this"/>
   <result pre="is anecdotal evidence showing that neutralizing antibodies if induced against" exact="ZIKV" post="and DENV at high titers could potentially prevent enhancement"/>
   <result pre="evidence showing that neutralizing antibodies if induced against ZIKV and" exact="DENV" post="at high titers could potentially prevent enhancement of infection"/>
   <result pre="enhancement of infection [26,27]. Thus, in order to develop safe" exact="ZIKV" post="vaccines, an important effort is urgently required to assess"/>
   <result pre="populations suitable for ZIKV-vaccination [28]. In summary, the response against" exact="ZIKV" post="highlights the enormous potential of the scientific community to"/>
   <result pre="will have affordable and effective prophylactic and therapeutic tools against" exact="ZIKV" post="in a reasonable period of time. Nevertheless, we would"/>
   <result pre="be remembered that there are still arboviral threats other than" exact="ZIKV" post="that should not be forgotten. Author Contributions Conceptualization, M.A.M.-A."/>
   <result pre="with Microcephaly, Stillbirths, and MiscarriageJ. Clin. Med.2018749610.3390/jcm712049630487475 2.PiersonT.C.DiamondM.S.The emergence of" exact="Zika" post="virus and its new clinical syndromesNature201856057358110.1038/s41586-018-0446-y30158602 3.SaizJ.C.Martin-AcebesM.A.Bueno-MariR.SalomonO.D.Villamil-JimenezL.C.HeukelbachJ.AlencarC.H.ArmstrongP.K.Ortiga-CarvalhoT.M.Mendez-OteroR.et al.Zika Virus:"/>
   <result pre="the Recent Epidemic?Front Microbiol.20178155410.3389/fmicb.2017.0155428878742 4.KurscheidtF.A.MesquitaC.S.S.DamkeG.DamkeE.CarvalhoA.SuehiroT.T.TeixeiraJ.J.V.da SilvaV.R.S.SouzaR.P.ConsolaroM.E.L.Persistence and clinical relevance of" exact="Zika" post="virus in the male genital tractNat. Rev. Urol.201810.1038/s41585-019-0149-730696994 5.Martinez-PulgarinD.F.Acevedo-MendozaW.F.Cardona-OspinaJ.A.Rodriguez-MoralesA.J.Paniz-MondolfiA.E.A"/>
   <result pre="male genital tractNat. Rev. Urol.201810.1038/s41585-019-0149-730696994 5.Martinez-PulgarinD.F.Acevedo-MendozaW.F.Cardona-OspinaJ.A.Rodriguez-MoralesA.J.Paniz-MondolfiA.E.A bibliometric analysis of global" exact="Zika" post="researchTravel Med. Infect. Dis.201614555710.1016/j.tmaid.2015.07.00526257029 6.AlbuquerqueP.C.CastroM.J.Santos-GandelmanJ.OliveiraA.C.PeraltaJ.M.RodriguesM.L.Bibliometric Indicators of the Zika"/>
   <result pre="global Zika researchTravel Med. Infect. Dis.201614555710.1016/j.tmaid.2015.07.00526257029 6.AlbuquerqueP.C.CastroM.J.Santos-GandelmanJ.OliveiraA.C.PeraltaJ.M.RodriguesM.L.Bibliometric Indicators of the" exact="Zika" post="OutbreakPLoS Negl. Trop. Dis.201711e000513210.1371/journal.pntd.000513228103326 7.de MeloM.C.DionalisioM.R.Ribas de FreitasA.R.Zika virus,"/>
   <result pre="J. Curr. Res.2017913 8.DelwicheF.A.Bibliometric Analysis of Scholarly Publications on the" exact="Zika" post="Virus, 1952–2016Sci. Tech. Libr.20183711312910.1080/0194262X.2018.1431589 9.KatzelnickL.C.ColomaJ.HarrisE.Dengue: knowledge gaps, unmet needs,"/>
   <result pre="Ebola: the 2014 epidemicGlobal Health2016125310.1186/s12992-016-0194-427624088 13.HerradaC.A.KabirM.A.AltamiranoR.AsgharW.Advances in Diagnostic Methods for" exact="Zika" post="Virus InfectionJ. Med. Device2018120408021408021110.1115/1.404108630662580 14.NazeraiL.Pravsgaard ChristensenJ.Randrup ThomsenA.A ’Furry-Tale’ of"/>
   <result pre="Zika Virus InfectionJ. Med. Device2018120408021408021110.1115/1.404108630662580 14.NazeraiL.Pravsgaard ChristensenJ.Randrup ThomsenA.A ’Furry-Tale’ of" exact="Zika" post="Virus Infection: What Have We Learned from Animal Models?Viruses2019112910.3390/v1101002930621317"/>
   <result pre="We Learned from Animal Models?Viruses2019112910.3390/v1101002930621317 15.SutarjonoB.Can We Better Understand How" exact="Zika" post="Leads to Microcephaly? A Systematic Review of the Effects"/>
   <result pre="to Microcephaly? A Systematic Review of the Effects of the" exact="Zika" post="Virus on Human Brain OrganoidsJ. Infect. Dis.201921973474510.1093/infdis/jiy57230256965 16.WenZ.SongH.MingG.L.How does"/>
   <result pre="Zika Virus on Human Brain OrganoidsJ. Infect. Dis.201921973474510.1093/infdis/jiy57230256965 16.WenZ.SongH.MingG.L.How does" exact="Zika" post="virus cause microcephaly?Genes Dev.20173184986110.1101/gad.298216.11728566536 17.SaizJ.C.Martin-AcebesM.A.The Race To Find Antivirals"/>
   <result pre="virus cause microcephaly?Genes Dev.20173184986110.1101/gad.298216.11728566536 17.SaizJ.C.Martin-AcebesM.A.The Race To Find Antivirals for" exact="Zika" post="VirusAntimicrob. Agents Chemother.201761e00411e0041710.1128/AAC.00411-1728348160 18.HasanS.S.SevvanaM.KuhnR.J.RossmannM.G.Structural biology of Zika virus and"/>
   <result pre="Find Antivirals for Zika VirusAntimicrob. Agents Chemother.201761e00411e0041710.1128/AAC.00411-1728348160 18.HasanS.S.SevvanaM.KuhnR.J.RossmannM.G.Structural biology of" exact="Zika" post="virus and other flavivirusesNat. Struct. Mol. Biol.201825132010.1038/s41594-017-0010-829323278 19.BoldescuV.BehnamM.A.M.VasilakisN.KleinC.D.Broad-spectrum agents"/>
   <result pre="flavivirusesNat. Struct. Mol. Biol.201825132010.1038/s41594-017-0010-829323278 19.BoldescuV.BehnamM.A.M.VasilakisN.KleinC.D.Broad-spectrum agents for flaviviral infections: dengue," exact="Zika" post="and beyondNat. Rev. Drug. Discov.20171656558610.1038/nrd.2017.3328473729 20.SalamA.P.RojekA.DunningJ.HorbyP.W.Clinical Trials of Therapeutics"/>
   <result pre="Discov.20171656558610.1038/nrd.2017.3328473729 20.SalamA.P.RojekA.DunningJ.HorbyP.W.Clinical Trials of Therapeutics for the Prevention of Congenital" exact="Zika" post="Virus Disease: Challenges and Potential SolutionsAnn. Intern. Med.201716672573210.7326/M16-253028319995 21.DiamondM.S.LedgerwoodJ.E.PiersonT.C.Zika"/>
   <result pre="of New ChallengesAnnu. Rev. Med.20187012113510.1146/annurev-med-040717-05112730388054 22.Wilder-SmithA.OoiE.E.HorstickO.WillsB.DengueLancet201939335036310.1016/S0140-6736(18)32560-130696575 23.GeorgeJ.ValiantW.G.MattapallilM.J.WalkerM.HuangY.S.VanlandinghamD.L.MisamoreJ.GreenhouseJ.WeissD.E.VerthelyiD.et al.Prior Exposure to" exact="Zika" post="Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus MacaquesSci."/>
   <result pre="Peak Dengue-2 Viremia in Rhesus MacaquesSci. Rep.201771049810.1038/s41598-017-10901-128874759 24.FowlerA.M.TangW.W.YoungM.P.MamidiA.ViramontesK.M.McCauleyM.D.CarlinA.F.SchooleyR.T.SwanstromJ.BaricR.S.et al.Maternally Acquired" exact="Zika" post="Antibodies Enhance Dengue Disease Severity in MiceCell Host Microbe20182474375010.1016/j.chom.2018.09.01530439343"/>
   <result pre="in Rhesus MacaquesSci. Rep.201771049810.1038/s41598-017-10901-128874759 24.FowlerA.M.TangW.W.YoungM.P.MamidiA.ViramontesK.M.McCauleyM.D.CarlinA.F.SchooleyR.T.SwanstromJ.BaricR.S.et al.Maternally Acquired Zika Antibodies Enhance" exact="Dengue" post="Disease Severity in MiceCell Host Microbe20182474375010.1016/j.chom.2018.09.01530439343 25.RichnerJ.M.HimansuS.DowdK.A.ButlerS.L.SalazarV.FoxJ.M.JulanderJ.G.TangW.W.ShrestaS.PiersonT.C.et al.Modified mRNA"/>
   <result pre="in MiceCell Host Microbe20182474375010.1016/j.chom.2018.09.01530439343 25.RichnerJ.M.HimansuS.DowdK.A.ButlerS.L.SalazarV.FoxJ.M.JulanderJ.G.TangW.W.ShrestaS.PiersonT.C.et al.Modified mRNA Vaccines Protect against" exact="Zika" post="Virus InfectionCell20171681114112510.1016/j.cell.2017.02.01728222903 26.ValiantW.G.LalaniT.YunH.C.KunzA.BurgessT.H.MattapallilJ.J.Human Serum with High Neutralizing Antibody Titers"/>
   <result pre="InfectionCell20171681114112510.1016/j.cell.2017.02.01728222903 26.ValiantW.G.LalaniT.YunH.C.KunzA.BurgessT.H.MattapallilJ.J.Human Serum with High Neutralizing Antibody Titers Against Both" exact="Zika" post="and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement"/>
   <result pre="Serum with High Neutralizing Antibody Titers Against Both Zika and" exact="Dengue" post="Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of Dengue"/>
   <result pre="and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of" exact="Dengue" post="Virus InfectionOpen Forum Infect. Dis.20185ofy15110.1093/ofid/ofy15130019003 27.ValiantW.G.HuangY.S.VanlandinghamD.L.HiggsS.LewisM.G.MattapallilJ.J.Zika convalescent macaques display"/>
   <result pre="or Phantom Menace?Front Cell Infect. Microbiol.201884410.3389/fcimb.2018.0004429497604 Figure 1 Impact of" exact="Zika" post="virus (ZIKV) on scientific literature. (A) The graph displays"/>
   <result pre="(A) The graph displays the number of search results for" exact="Zika" post="virus or ZIKV retrieved from PubMed using the &quot;Results"/>
   <result pre="displays the number of search results for Zika virus or" exact="ZIKV" post="retrieved from PubMed using the &quot;Results by year�? tool."/>
   <result pre="outbreak and 3–6 years after is compared. The outbreaks of" exact="ZIKV" post="in 2015 in South America, West Nile virus (WNV)"/>
   <result pre="compared. The outbreaks of ZIKV in 2015 in South America," exact="West Nile" post="virus (WNV) in 1999 in North America, Chikungunya virus"/>
   <result pre="America, West Nile virus (WNV) in 1999 in North America," exact="Chikungunya" post="virus (CHIKV) in 2004–2005 in the southwestern Indian Ocean"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6465516\results\search\tropicalVirus\results.xml">
   <result pre="Neurology1664-2295Frontiers Media S.A. pmcid: 6465516 doi: 10.3389/fneur.2019.00319 : Neurology: Review" exact="Zika" post="Virus Potentiates the Development of Neurological Defects and Microcephaly:"/>
   <result pre="comply with these terms. Abstract Since the beginning of the" exact="Zika" post="Virus (ZIKV) epidemic, thousands of cases presenting ZIKV symptoms"/>
   <result pre="of the Zika Virus (ZIKV) epidemic, thousands of cases presenting" exact="ZIKV" post="symptoms were recorded in Brazil, Colombia (South America), French"/>
   <result pre="other countries of Central and North America. In Brazil, during" exact="ZIKV" post="outbreak thousands of microcephaly cases occurred that caused a"/>
   <result pre="among scientists and researchers to confirm the suspected association between" exact="ZIKV" post="infection and microcephaly. In this review article we comprehensively"/>
   <result pre="this review article we comprehensively studied scientific literature to analyze" exact="ZIKV" post="relationship with microcephaly, recent experimental studies, challenge and shortcomings"/>
   <result pre="status of this association. The evidences supporting the association of" exact="ZIKV" post="infection with congenital microcephaly and fetal brain tissue damage"/>
   <result pre="mechanism and experimental studies. However, serious attention is required toward" exact="ZIKV" post="vaccine development, standardization of anthropometric techniques, centralization of data,"/>
   <result pre="data, and advance research to clearly understand the mechanism of" exact="ZIKV" post="infection causing microcephaly. Zika virus emerging infection microcephaly neurological"/>
   <result pre="to clearly understand the mechanism of ZIKV infection causing microcephaly." exact="Zika" post="virus emerging infection microcephaly neurological disorders public health fig-count:"/>
   <result pre="public health fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction The" exact="Zika" post="virus (ZIKV) is a mosquito-borne, single-stranded RNA, flavivirus that"/>
   <result pre="harsh conditions and temperature as high as 40°C (1, 2)." exact="ZIKV" post="natural transmission cycle mainly involves the genus Aedes mosquito"/>
   <result pre="contact (6) (Figure 1). The most common laboratory tests for" exact="Zika" post="virus confirmation constitute both RNA and antibody detection in"/>
   <result pre="confounding factors and ambiguities in previously reported data (9), the" exact="ZIKV" post="association with microcephaly was considered ambiguous. However, the World"/>
   <result pre="cohort and case-control studies claimed a strong scientific consensus that" exact="ZIKV" post="infection is cause of microcephaly, Guillain-Barré syndrome (GBS) and"/>
   <result pre="A recent Lancet report has also presented genuine facts that" exact="ZIKV" post="infection is the cause of congenital microcephaly (11). Figure"/>
   <result pre="infection is the cause of congenital microcephaly (11). Figure 1" exact="Zika" post="virus infection is transmitted to human population via mosquito"/>
   <result pre="and from mother to fetus. The geographically widespread epidemic of" exact="ZIKV" post="emerged as a profoundly important public health concern when"/>
   <result pre="brain injury, craniosynostosis, drugs, hypertensive disorders, intrauterine infections caused by" exact="West Nile" post="virus (WNV), and Chikungunya virus (CHIKV) (9), and other"/>
   <result pre="disorders, intrauterine infections caused by West Nile virus (WNV), and" exact="Chikungunya" post="virus (CHIKV) (9), and other prenatal viral infections e.g.,"/>
   <result pre="16). The number of suspected congenital microcephaly cases associated with" exact="ZIKV" post="in Brazil had increased to 2975 by January 2016,"/>
   <result pre="to 2975 by January 2016, and new cases of adult" exact="ZIKV" post="infection were being reported from countries throughout the Caribbean"/>
   <result pre="and South America (12). The World Health Organization (WHO) declared" exact="ZIKV" post="as Public Health Emergency of International Concern (PHEIC) on"/>
   <result pre="recorded congenital microcephaly cases soared up in the geographically widespread" exact="ZIKV" post="epidemic regions (7, 16, 17), causing a state of"/>
   <result pre="The purpose of this review article is to comprehend if" exact="ZIKV" post="can potentially cause microcephaly. For this purpose, we comprehensively"/>
   <result pre="to discuss about the widespread epidemic of ZIKV, pathology of" exact="ZIKV" post="related microcephaly, recent in vitro and in vivo experimental"/>
   <result pre="and in vivo experimental studies to understand the mechanism of" exact="ZIKV" post="infection, ambiguities in previously published data and ZIKV future"/>
   <result pre="mechanism of ZIKV infection, ambiguities in previously published data and" exact="ZIKV" post="future implications, its control strategies and hints of advance"/>
   <result pre="research to affirm this probationary link. ZIKA Virus Epidemics The" exact="ZIKV" post="was first discovered and isolated from the blood of"/>
   <result pre="from the blood of a sentinel rhesus monkey in the" exact="Zika" post="forest of Uganda, in 1947 (18). It was occasionally"/>
   <result pre="(2015) (7, 19). As per estimation, from 2007 to 2016," exact="ZIKV" post="outbreak has affected several regions of America, Africa, Southeast"/>
   <result pre="Caribbean and western pacific island (21). In the United States," exact="ZIKV" post="cases have been reported in American Samoa, US Virgin"/>
   <result pre="US Virgin Islands and Puerto Rico. In USA, the first" exact="ZIKV" post="associated congenital microcephaly case was reported in Hawaii, in"/>
   <result pre="in 2016 (21). Due to a high cross-reactivity rate of" exact="ZIKV" post="it is often misdiagnosed as DENV as happened in"/>
   <result pre="high cross-reactivity rate of ZIKV it is often misdiagnosed as" exact="DENV" post="as happened in the Yap Island. Its potential association"/>
   <result pre="French Polynesia, Brazil, America, Slovenia and Colombia (22). During the" exact="Zika" post="virus pandemic in the French Polynesia, an unexpected rise"/>
   <result pre="consulted physicians due to suspected infection (9). Among patients presenting" exact="ZIKV" post="like symptoms that visited health care units, 1.3 per"/>
   <result pre="cases were reported but no identification tests were performed as" exact="ZIKV" post="infection was not suspected (12). After the ZIKV epidemic,"/>
   <result pre="performed as ZIKV infection was not suspected (12). After the" exact="ZIKV" post="epidemic, 18 of the 27 states of Brazil reported"/>
   <result pre="ZIKV epidemic, 18 of the 27 states of Brazil reported" exact="ZIKV" post="autochthonous cases between April and November 2015. It caused"/>
   <result pre="The WHO issued an epidemiological alert about the relationship of" exact="ZIKV" post="infection with neurological syndromes and congenital microcephaly, after confirmation"/>
   <result pre="cases (16). It is estimated that in South America the" exact="ZIKV" post="epidemic has infected more than 1 million Brazilians until"/>
   <result pre="than 1 million Brazilians until 2015 (24). Clinical Manifestations of" exact="ZIKV" post="Infection Pathology studies have significantly contributed to the understanding"/>
   <result pre="the understanding of fetal/neonatal anatomic abnormalities and relationship between intrauterine" exact="ZIKV" post="infection and damage to cerebral tissue (12). Here we"/>
   <result pre="infection and damage to cerebral tissue (12). Here we discussed" exact="ZIKV" post="related microcephaly clinical manifestations to better understand the outcomes"/>
   <result pre="A retrospective review (March 2014–May 2015), was conducted to identify" exact="ZIKV" post="related brain abnormalities in French Polynesian neonates. It was"/>
   <result pre="whose blood samples were negative for virus (13), showed that" exact="ZIKV" post="can possibly cross the placental barrier (27). Cauchemez et"/>
   <result pre="(27). Cauchemez et al. calculated the risk of microcephaly during" exact="ZIKV" post="outbreak in French Polynesian outbreak (Sept, 2013, to July,"/>
   <result pre="10,000 cases (1%) of neonates and fetuses whose mothers got" exact="ZIKV" post="infection in their first trimesters had microcephaly, a prevalence"/>
   <result pre="(CT), 23 cases of microcephalic infants born to mothers showing" exact="ZIKV" post="symptoms during first or second trimesters were discussed by"/>
   <result pre="malformations were more commonly observed during the first trimester of" exact="ZIKV" post="infected mothers (12.7%) as compared to second (3.6%) and"/>
   <result pre="(99.7%) with French Polynesia, Sao Paolo, Brazil, Cambodia, and Micronesia" exact="ZIKV" post="strain (30). Similarly, cerebral examination of two microcephalic neonates"/>
   <result pre="calcifications, and necrosis. Here all reported mothers were symptomatic for" exact="ZIKV" post="infection during the first trimesters of their pregnancy and"/>
   <result pre="trimesters of their pregnancy and RT-PCR gave positive results for" exact="ZIKV" post="RNA in the brain and placental tissue samples (12)."/>
   <result pre="RNA in the brain and placental tissue samples (12). The" exact="ZIKV" post="intrauterine infection cases during third trimester, were also found"/>
   <result pre="dysmyelination and cortical hypogyration was claimed to be caused by" exact="ZIKV" post="infection as it attenuates the brain development (28). The"/>
   <result pre="and ultrasonography to get abnormal placental image (31). Amniocentesis for" exact="ZIKV" post="detection, on the contrary, is largely suggested especially in"/>
   <result pre="in case of asymptomatic fetuses despite lack of information about" exact="ZIKV" post="predictive positive value and amniotic fluid molecular detection (31)."/>
   <result pre="changes occurring to the brain, and pathophysiology of viremia in" exact="ZIKV" post="infected fetuses (27). Recently conducted animal experiments have confirmed"/>
   <result pre="infected fetuses (27). Recently conducted animal experiments have confirmed that" exact="ZIKV" post="can cause fetal demise, hydropsfetalis (32), and placental damage"/>
   <result pre="destroying central nervous system and causing severe pathological changes (27)." exact="ZIKV" post="Related in-vivo Studies Li et al. (34) used a"/>
   <result pre="Related in-vivo Studies Li et al. (34) used a contemporary" exact="ZIKV" post="strain on a mouse model to predict the ZIKV"/>
   <result pre="contemporary ZIKV strain on a mouse model to predict the" exact="ZIKV" post="relationship with microcephaly. Their findings suggested that ZIKV effectively"/>
   <result pre="predict the ZIKV relationship with microcephaly. Their findings suggested that" exact="ZIKV" post="effectively replicated in embryonic mouse brain and caused viral"/>
   <result pre="inhibited neural progenitor cells. This study supports the link between" exact="ZIKV" post="infection and microcephaly, as it closely mimicked the physiology"/>
   <result pre="on human neural Progenitor Stem cell (hNPCs) model establishes that" exact="ZIKV" post="is a neurotropic virus that directly targets developing embryonic"/>
   <result pre="a neurotropic virus that directly targets developing embryonic brain cells." exact="ZIKV" post="infection can increase cell death rate, it can further"/>
   <result pre="progression and cause attenuated hNPC growth (35). To mimic the" exact="ZIKV" post="infection Rossi et al. (36) designed interferon (IFN) alpha"/>
   <result pre="designed interferon (IFN) alpha receptors lacking mice models. They detected" exact="ZIKV" post="in brain after 3 days post-infection and caused neurologic"/>
   <result pre="diseases after 6 days post-infection, indicating the neurotropic nature of" exact="ZIKV" post="(36). ZIKV inoculation to pregnant mice resulted in infection"/>
   <result pre="6 days post-infection, indicating the neurotropic nature of ZIKV (36)." exact="ZIKV" post="inoculation to pregnant mice resulted in infection of embryonic"/>
   <result pre="lateral ventricles cavity (22, 36, 37). In a similar study," exact="ZIKV" post="injected to pregnant mice produced some animals with restricted"/>
   <result pre="viremia, when intraperitoneal inoculation of pregnant mice was performed (39)." exact="ZIKV" post="Related in-vitro Studies Researchers have successfully conducted experiments to"/>
   <result pre="in-vitro Studies Researchers have successfully conducted experiments to investigate the" exact="ZIKV" post="pathogenesis and its affinity for neurons and neural stem"/>
   <result pre="mouse, rats, and nonhuman primates have broadened our understanding about" exact="ZIKV" post="teratogenic effect on fetal brain. Dang et al. (41)"/>
   <result pre="effect on fetal brain. Dang et al. (41) investigated the" exact="ZIKV" post="and microcephaly relationship by using cerebral organoids derived human"/>
   <result pre="organoids derived human embryonic stem cells. Authors have demonstrated that" exact="ZIKV" post="is capable to disturb cell fate and restrict organoids"/>
   <result pre="al. (42) used human-induced pluripotent stem cells to investigate the" exact="ZIKV" post="infection consequences on brain development in the first trimester"/>
   <result pre="trimester with advance 3D culture models. The results illustrated that" exact="ZIKV" post="can potentially cause death of human neural stem cells"/>
   <result pre="cell volume (43). For the mechanism of human brain injury," exact="ZIKV" post="is thought to reduce the formation of brain matter"/>
   <result pre="teratogenic effect and spectrum of fetal brain malformation induced by" exact="ZIKV" post="is very broad and difficult to detect in clinical"/>
   <result pre="macaque (Macaca nemestrina) nonhuman primate model, it is demonstrated that" exact="ZIKV" post="can potentially target and destroy fetal neural stem cells,"/>
   <result pre="astrocytes and glial cell lines support the previous research that" exact="ZIKV" post="most likely infect neural stem cells, oligodendrocyte precursor cells,"/>
   <result pre="macrolide antibiotic drug azithromycin can potentially protect brain cells from" exact="ZIKV" post="infection by declining viral proliferation and its cytopathic effects"/>
   <result pre="in human astrocytes and glial cell lines (45). Challenges in" exact="ZIKV" post="Related Studies Despite the evidences supporting ZIKV association with"/>
   <result pre="(45). Challenges in ZIKV Related Studies Despite the evidences supporting" exact="ZIKV" post="association with microcephaly and neonatal/fetal brain congenital abnormalities, scientists"/>
   <result pre="can potentially cause microcephaly (31, 46). Furthermore, approximately 80% of" exact="ZIKV" post="infected patients either had no symptoms or symptoms similar"/>
   <result pre="either had no symptoms or symptoms similar to that of" exact="DENV" post="and CHIKV that were co-circulating during ZIKV outbreak in"/>
   <result pre="no symptoms or symptoms similar to that of DENV and" exact="CHIKV" post="that were co-circulating during ZIKV outbreak in Brazil. Only"/>
   <result pre="to that of DENV and CHIKV that were co-circulating during" exact="ZIKV" post="outbreak in Brazil. Only 44% of reported cases were"/>
   <result pre="normal, showing a degree of over-reporting (46). Presenting or lacking" exact="ZIKV" post="like symptoms during pregnancy does not affirm that fetus"/>
   <result pre="even if this hypothesis is considered true the ratio of" exact="ZIKV" post="related microcephaly cases are still ambiguous (1). An American"/>
   <result pre="reported case showed that pregnant women who got infected with" exact="ZIKV" post="during 2nd and 3rd trimesters still delivered healthy babies"/>
   <result pre="1st trimester of pregnancy has the highest risk of laboratory-confirmed" exact="ZIKV" post="transmission and microcephaly as compared to 2nd and 3rd"/>
   <result pre="is cautious and necessary for correctly diagnosing microcephaly ascribed to" exact="ZIKV" post="because incorrect diagnosis may exaggerate, limit or reverse this"/>
   <result pre="cohorts (39). Ruling out other viral infections to confirm the" exact="ZIKV" post="link with microcephaly is quite important (32), as during"/>
   <result pre="link with microcephaly is quite important (32), as during previous" exact="ZIKV" post="epidemic in the Pacific Islands, no severe consequences during"/>
   <result pre="Pacific Islands, no severe consequences during pregnancy were documented (47)." exact="ZIKV" post="symptomatic mothers might be misdiagnosed as other viral diseases"/>
   <result pre="be misdiagnosed as other viral diseases (11, 47), for instance," exact="West Nile" post="virus (WNV), Japanese encephalitis viruses, Dengue virus (DENV) and"/>
   <result pre="47), for instance, West Nile virus (WNV), Japanese encephalitis viruses," exact="Dengue" post="virus (DENV) and the yellow fever virus (46) that"/>
   <result pre="yellow fever virus (46) that are genetically similar to ZIKV." exact="ZIKV" post="was not a reportable neurological disease until 2015, it"/>
   <result pre="used in predicting the course of a microcephaly outbreak (46)." exact="ZIKV" post="epidemic in Cape Verde (2015–2016), probably caused by African"/>
   <result pre="causing any neurological disorder (20). Calvet et al. report on" exact="ZIKV" post="genomic RNA detection by next-generation sequencing and quantitative RT-PCR"/>
   <result pre="quantitative RT-PCR is not enough as it only confirms that" exact="ZIKV" post="is a cause of congenital infection (50), while no"/>
   <result pre="infection (50), while no recombination events were indicated in the" exact="ZIKV" post="sequenced genome, as genetic mutations for phenotypic changes has"/>
   <result pre="for other closely related flaviviruses (1). Since the exposure of" exact="ZIKV" post="and its confirmation as a potential cause of microcephaly,"/>
   <result pre="first diagnosed, and maternal clinical symptoms appeared. In Brazil, the" exact="ZIKV" post="epidemic could predict profound increase in the number of"/>
   <result pre="5–10 months later. During this time maternal laboratory tests for" exact="ZIKV" post="confirmation could be done in order to exclude any"/>
   <result pre="Americas (39). Brasil et al. claimed a positive association of" exact="ZIKV" post="with microcephaly, i.e., 4/42 cases among the exposure group"/>
   <result pre="the exposure group vs. 0/16 among the non-exposure group, without" exact="ZIKV" post="laboratory confirmation and laboratory exclusion tests (31), for instance,"/>
   <result pre="(39). Moreover, it is highly important to reexamine specimens from" exact="DENV" post="epidemics and use of virus isolations or RT-PCR for"/>
   <result pre="use of virus isolations or RT-PCR for laboratory diagnosis of" exact="DENV" post="infections as an essential component of laboratory testing algorithms"/>
   <result pre="as an essential component of laboratory testing algorithms (51). If" exact="ZIKV" post="is encountered as a first flavivirus the chances of"/>
   <result pre="chances of cross-reactivity decreases; the result will be opposite if" exact="ZIKV" post="causes a secondary flavivirus infection, because serological test results"/>
   <result pre="will be positive for DENV. If a population infected with" exact="ZIKV" post="has a background immunity for DENV or any other"/>
   <result pre="a population infected with ZIKV has a background immunity for" exact="DENV" post="or any other flavivirus, DENV cross-reactivity IgM assay may"/>
   <result pre="has a background immunity for DENV or any other flavivirus," exact="DENV" post="cross-reactivity IgM assay may lead to false results and"/>
   <result pre="assay may lead to false results and misdiagnosed cases of" exact="ZIKV" post="(51). Current and Future Implications of ZIKV Above all,"/>
   <result pre="misdiagnosed cases of ZIKV (51). Current and Future Implications of" exact="ZIKV" post="Above all, some important answers need to be explored"/>
   <result pre="need to be explored in order to understand the emerging" exact="Zika" post="virus (ZIKV), which remained obscure until the recent epidemic"/>
   <result pre="epidemics in the Americas. Clinical isolates collected from the recent" exact="ZIKV" post="epidemic in the Americas were hyper infectious in mosquitoes"/>
   <result pre="NS1 antigenaemia. Higher NS1 antigenaemia expression in infected hosts promotes" exact="ZIKV" post="infectivity and prevalence in mosquitoes, which could have facilitated"/>
   <result pre="prevalence in mosquitoes, which could have facilitated transmission during recent" exact="ZIKV" post="epidemics (52). Similarly, a single amino acid substitution at"/>
   <result pre="serine to asparagine (S139N) in the viral polyprotein significantly increased" exact="ZIKV" post="infectivity in both mouse and human neural progenitor cells"/>
   <result pre="its subsequent propagation to the Americas. The functional adaption of" exact="ZIKV" post="has made it more infectious to human NPCs, by"/>
   <result pre="NPCs, by contributing to the increased microcephaly rate in recent" exact="ZIKV" post="epidemics (53). Is it possible that genetic alterations of"/>
   <result pre="crucial to explore the full spectrum of abnormalities caused by" exact="ZIKV" post="and solid reason of neurotropism. Although evidences are supporting"/>
   <result pre="ZIKV and solid reason of neurotropism. Although evidences are supporting" exact="ZIKV" post="relationship with microcephaly and other brain injuries, yet information"/>
   <result pre="aforementioned questions to address and understand unpredictable and rapidly growing" exact="ZIKV" post="infection. It requires serious attention toward advance research, vaccine"/>
   <result pre="public and private sectors to look for innovative ways of" exact="ZIKV" post="treatment and prevention. It is essential to explore the"/>
   <result pre="and prevention. It is essential to explore the association of" exact="ZIKV" post="infection and microcephaly, especially keeping in view the 80%"/>
   <result pre="the 80% asymptomatic cases of ZIKV. Maternal clinical symptoms of" exact="ZIKV" post="can validate the diagnosis, but fetal and maternal laboratory"/>
   <result pre="Advance studies should be done to evaluate the persistence of" exact="ZIKV" post="in asymptomatic men and prolonged genital shedding (54, 55),"/>
   <result pre="prolonged genital shedding (54, 55), that may have implications for" exact="ZIKV" post="genomic RNA detection (56). In pregnant women (symptomatic or"/>
   <result pre="be eliminated (57). At present no commercial test to diagnose" exact="Zika" post="virus infection. The reverse transcription polymerase chain reaction (RT-PCR)"/>
   <result pre="reverse transcription polymerase chain reaction (RT-PCR) is performed to detect" exact="ZIKV" post="RNA in the laboratory. Antiviral immunoglobulin M (IgM) antibodies"/>
   <result pre="RNA in the laboratory. Antiviral immunoglobulin M (IgM) antibodies of" exact="ZIKV" post="that appears at the end of the first week"/>
   <result pre="or IgM enzyme linked immunosorbent assay (ELISA). Cross reaction of" exact="ZIKV" post="with other Flaviviruses can be eliminated by using PRNT"/>
   <result pre="complicated epidemiological context of the concurrent circulating CHIKV, DENV, and" exact="ZIKV" post="co-infections cannot be ignored. In French Polynesia, ZIKV infection"/>
   <result pre="DENV, and ZIKV co-infections cannot be ignored. In French Polynesia," exact="ZIKV" post="infection was associated with autoimmune and neurological complications in"/>
   <result pre="with autoimmune and neurological complications in the presence of co-circulating" exact="DENV" post="(19). Further studies, genuine laboratory and clinical differential diagnostic"/>
   <result pre="incidence of severe cases (5, 19, 48). The number of" exact="ZIKV" post="related publications, guidelines, clinical cases, recommendations and circulating data"/>
   <result pre="neurological malformations risks, especially in the regions where existence of" exact="Zika" post="virus, its vectors or local transmission is suspected (20)."/>
   <result pre="vectors or local transmission is suspected (20). Adequate counseling of" exact="ZIKV" post="infected pregnant women and those preparing for pregnancy are"/>
   <result pre="or delay their pregnancies (59). Control and prevention strategies for" exact="ZIKV" post="infection should also include increased use of insect repellent"/>
   <result pre="transmission through experimental studies (9, 40). The virological study of" exact="CHIKV" post="can shed light on the isolated strains of ZIKV"/>
   <result pre="of CHIKV can shed light on the isolated strains of" exact="ZIKV" post="from Brazil, as the global epidemic and distribution of"/>
   <result pre="similar. Phylogenetic analysis has shown that the Brazilian strains of" exact="ZIKV" post="have evolved in a mixed way. A study suggested"/>
   <result pre="presented 99% resemblance with French Polynesian strain in 2013. Brazilian" exact="Zika" post="virus strains coming from Asian lineage had alteration in"/>
   <result pre="Despite the tremendous novel work is now underway to develop" exact="ZIKV" post="vaccines, the important challenges still remain for the preclinical"/>
   <result pre="JEV, and DENV) (62), and use of currently available preclinical" exact="ZIKV" post="vaccine data can pave road to develop effective ZIKV"/>
   <result pre="preclinical ZIKV vaccine data can pave road to develop effective" exact="ZIKV" post="vaccine. ZIKV clinical vaccines development is efficient, focused and"/>
   <result pre="vaccine data can pave road to develop effective ZIKV vaccine." exact="ZIKV" post="clinical vaccines development is efficient, focused and uniquely collaborative,"/>
   <result pre="clinical trials have been initiated within the first year of" exact="ZIKV" post="epidemic (63). Recombinant DNA technology that plays an important"/>
   <result pre="kits, and therapeutics (64) should be considered to clinically develop" exact="ZIKV" post="vaccine. Perhaps this technology can help to design a"/>
   <result pre="to design a targeted antiviral vaccine, and thoroughly explain the" exact="ZIKV" post="molecular interaction with the hosts (58). Specially, DNA and"/>
   <result pre="and purified inactivated virus (PIV) vaccines are more attractive for" exact="ZIKV" post="infection by keeping in view the theoretical safety benefit"/>
   <result pre="supposed to play a pivotal role in vaccine development against" exact="ZIKV" post="infection in future (63). Nanotechnology and Zika Virus: Treatment"/>
   <result pre="vaccine development against ZIKV infection in future (63). Nanotechnology and" exact="Zika" post="Virus: Treatment and Diagnosis Nanotechnology is used for the"/>
   <result pre="Treatment and Diagnosis Nanotechnology is used for the diagnosis of" exact="Zika" post="virus (ZIKV) and dengue virus (DENV) infections; multiplexed assay"/>
   <result pre="(IgA and IgG) are more specific against NS1 antigen of" exact="ZIKV" post="infection in comparison to IgM cross reactivity method (65)."/>
   <result pre="drug or a vaccine in market that is effective against" exact="ZIKV" post="infection. However, one pharmaceutical company demonstrated clinical trials with"/>
   <result pre="(HPV); and is expected to show some antiviral activity against" exact="ZIKV" post="in trials (67, 68). Different antiviral nano-medicines have different"/>
   <result pre="and check the effectiveness of the similar antiviral nanomedicines against" exact="ZIKV" post="in near future. For example, inactivated virosomal (liposome) and"/>
   <result pre="which may show positive outcomes to treat ZIKV. Conclusions Apart" exact="West Nile" post="virus (78), thousands of congenital microcephaly cases, fetal brain"/>
   <result pre="brain tissue damage and neurological syndromes have been associated with" exact="ZIKV" post="infection. Unfortunately, the epidemics of this mosquito born, and"/>
   <result pre="standardized diagnostic test facilities, the incidence in the geographically widespread" exact="ZIKV" post="epidemic regions is higher. Animals studies showed that ZIKV"/>
   <result pre="widespread ZIKV epidemic regions is higher. Animals studies showed that" exact="ZIKV" post="is a neurotropic virus. It directly targets the developing"/>
   <result pre="apoptosis, cell-cycle arrest, and dysregulate hNPCs. During pregnancy in mice," exact="ZIKV" post="inoculation resulted in stunted heads, restricted intrauterine growth, and"/>
   <result pre="studies are needed toward advance research and vaccine development for" exact="ZIKV" post="treatment and prevention. Author Contributions RS conceived and wrote"/>
   <result pre="of Henan Province of China for MX. References References MussoDGublerDJ." exact="Zika" post="virus. Clin Microbiol Rev. (2016) 29:487–524. 10.1128/CMR.00072-1527029595 SaizJ-CVázquez-Calvo�?BlázquezABMerino-RamosTEscribano-RomeroEMartín-AcebesMAZika virus:"/>
   <result pre="newcomer. Front Microbiol. (2016) 7:49610.3389/fmicb.2016.0049627148186 FayeOFreireCCMIamarinoAFayeOde OliveiraJVCDialloMet al.Molecular evolution of" exact="Zika" post="virus during its emergence in the 20th century. PLoS"/>
   <result pre="(2014) 8:e263610.1371/journal.pntd.000263624421913 D'OrtenzioEMatheronSde LamballerieXHubertBPiorkowskiGMaquartMet al.. Evidence of sexual transmission of" exact="Zika" post="virus. N Engl J Med. (2016) 374:2195–8. 10.1056/NEJMc160444927074370 MussoDNhanT-XEmergence"/>
   <result pre="virus. N Engl J Med. (2016) 374:2195–8. 10.1056/NEJMc160444927074370 MussoDNhanT-XEmergence of" exact="Zika" post="virus. Clin Microbiol Open Access. (2015). 4:1–4. 10.4172/2327-5073.1000222 RabaanAABazziAMAl-AhmedSHAl-GhaithMHAl-TawfiqJA."/>
   <result pre="Clin Microbiol Open Access. (2015). 4:1–4. 10.4172/2327-5073.1000222 RabaanAABazziAMAl-AhmedSHAl-GhaithMHAl-TawfiqJA. Overview of" exact="Zika" post="infection, epidemiology, transmission and control measures. J Infect Public"/>
   <result pre="10.1016/j.jiph.2016.05.00727283926 deAraújo TVBRodriguesLCde Alencar XimenesRAde Barros Miranda-FilhoDMontarroyosURde MeloAPLet al.Association between" exact="Zika" post="virus infection and microcephaly in Brazil, January to May,"/>
   <result pre="case-control study. Lancet Infect Dis. (2016) 16:1356–63. 10.1016/S1473-3099(16)30318-827641777 OnoratiMLiZLiuFSousaAMMNakagawaNLiMet al.." exact="Zika" post="virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial"/>
   <result pre="glia. Cell Rep. (2016) 16:2576–92. 10.1016/j.celrep.2016.08.03827568284 CauchemezSBesnardMBompardPDubTGuillemette-ArturPEyrolle-GuignotDet al.. Association between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013–15: a retrospective"/>
   <result pre="OrganizationWHZika Virus, Microcephaly and Guillain-Barré Syndrome Situation Report. (2016) VenturaCVMaiaMBravo-FilhoVGóisALBelfortR." exact="Zika" post="virus in Brazil and macular atrophy in a child"/>
   <result pre="child with microcephaly. Lancet. (2016) 387:228. 10.1016/S0140-6736(16)00006-426775125 Paz-BaileyGRosenbergESDoyleKMunoz-JordanJSantiagoGAKleinLet al.Persistence of" exact="Zika" post="virus in body fluids—preliminary report. N Engl J Med."/>
   <result pre="J Med. (2017) 379:1234–43. 10.1056/NEJMoa161310828195756 Oliveira MeloASMalingerGXimenesRSzejnfeldPOAlves SampaioSBispo de FilippisAM." exact="Zika" post="virus intrauterine infection causes fetal brain abnormality and microcephaly:"/>
   <result pre="the Child Neurology Society. Neurology. (2009) 73:887–97. 10.1212/WNL.0b013e3181b783f719752457 DriggersRWHoC-YKorhonenEMKuivanenSJääskeläinenAJSmuraTet al.." exact="Zika" post="virus infection with prolonged maternal viremia and fetal brain"/>
   <result pre="do not know. Pathog Glob Health. (2016) 110:262–8. 10.1080/20477724.2016.123480427690200 DickGWA." exact="Zika" post="virus (II). Pathogenicity and physical properties. Trans R Soc"/>
   <result pre="(1952) 46:521–34. 10.1016/0035-9203(52)90043-612995441 ZanlucaCMeloVCMosimannALSantosGISantosCNLuzK. First report of autochthonous transmission of" exact="Zika" post="virus in Brazil. Mem Inst Oswaldo Cruz. (2015) 110:569–72."/>
   <result pre="Brazil. Mem Inst Oswaldo Cruz. (2015) 110:569–72. 10.1590/0074-0276015019226061233 BroutetNKrauerFRiesenMKhalakdinaAAlmironMAldighieriSet al.." exact="Zika" post="virus as a cause of neurologic disorders. N Engl"/>
   <result pre="10.4103/jpgm.JPGM_80_1728695873 WangLValderramosSGWuAOuyangSLiCBrasilPet al.. From mosquitos to humans: genetic evolution of" exact="Zika" post="virus. Cell Host Microbe. (2016) 19:561–5. 10.1016/j.chom.2016.04.00627091703 RodriguesLC. Microcephaly"/>
   <result pre="virus. Cell Host Microbe. (2016) 19:561–5. 10.1016/j.chom.2016.04.00627091703 RodriguesLC. Microcephaly and" exact="Zika" post="virus infection. Lancet. (2016) 387:2070–2. 10.1016/S0140-6736(16)00742-X26993880 WeistKHögbergLD. ECDC publishes"/>
   <result pre="10.2807/1560-7917.ES.2016.21.46.3039927918266 SchwartzDA. Autopsy and postmortem studies are concordant: pathology of" exact="Zika" post="virus infection is neurotropic in fetuses and infants with"/>
   <result pre="transplacental transmission. Arch Pathol Lab Med. (2016) 141:68–72. 10.5858/arpa.2016-0343-OA27557413 AlvaradoMGSchwartzDA." exact="Zika" post="virus infection in pregnancy, microcephaly, and maternal and fetal"/>
   <result pre="Arch Pathol Lab Med. (2016) 141:26–32. 10.5858/arpa.2016-0382-RA27636525 AliotaMTCaineEAWalkerECLarkinKECamachoEOsorioJECharacterization of lethal" exact="Zika" post="virus infection in AG129 mice. PLoS Negl Trop Dis."/>
   <result pre="der LindenAPenaLJet al.. Computed tomographic findings in microcephaly associated with" exact="Zika" post="virus. N Engl J Med. (2016) 374:2193–5. 10.1056/NEJMc160361727050112 HoenBSchaubBFunkALArdillonVBoullardMCabiéAet"/>
   <result pre="J Med. (2016) 374:2193–5. 10.1056/NEJMc160361727050112 HoenBSchaubBFunkALArdillonVBoullardMCabiéAet al.. Pregnancy outcomes after" exact="ZIKV" post="infection in French territories in the Americas. N Engl"/>
   <result pre="Americas. N Engl J Med. (2018) 378:985–94. 10.1056/NEJMoa170948129539287 MlakarJKorvaMTulNPopovićMPoljšak-PrijateljMMrazJet al.." exact="Zika" post="virus associated with microcephaly. N Engl J Med. (2016)"/>
   <result pre="N Engl J Med. (2016) 374:951–8. 10.1056/NEJMoa160065126862926 BrasilPPereiraJPJr.MoreiraMERibeiro NogueiraRMDamascenoLWakimotoMet al.." exact="Zika" post="virus infection in pregnant women in Rio de Janeiro."/>
   <result pre="N Engl J Med. (2016) 375:2321–2334. 10.1056/NEJMoa160241226943629 SarnoMSacramentoGAKhouriRdoRosário MSCostaFArchanjoGet al.." exact="Zika" post="virus infection and stillbirths: a case of hydrops fetalis,"/>
   <result pre="demise. PLoS Negl Trop Dis. (2016) 10:e0004517. 10.1371/journal.pntd.000451726914330 MinerJJCaoBGoveroJSmithAMFernandezECabreraOHet al.." exact="Zika" post="virus infection during pregnancy in mice causes placental damage"/>
   <result pre="in mice. Cell Stem Cell. (2016) 19:120–6. 10.1016/j.stem.2016.04.01727179424 TangHHammackCOgdenSCWenZQianXLiYet al.." exact="Zika" post="virus infects human cortical neural progenitors and attenuates their"/>
   <result pre="RossiSLTeshRBAzarSRMuruatoAEHanleyKAAugusteAJet al.. Characterization of a novel murine model to study" exact="Zika" post="virus. Am J Trop Med Hyg. (2016) 94:1362–9. 10.4269/ajtmh.16-011127022155"/>
   <result pre="virus. Am J Trop Med Hyg. (2016) 94:1362–9. 10.4269/ajtmh.16-011127022155 WangJ-NLingF." exact="Zika" post="virus infection and microcephaly: evidence for a causal link."/>
   <result pre="Res Public Health. (2016) 13:1031. 10.3390/ijerph1310103127775637 CugolaFRFernandesIRRussoFBFreitasBCDiasJLMGuimarãesKPet al.. The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental models. Nature."/>
   <result pre="models. Nature. (2016) 534:267–71. 10.1038/nature1829627279226 WuK-YZuoG-LLiX-FYeQDengY-QHuangX-Yet al.. Vertical transmission of" exact="Zika" post="virus targeting the radial glial cells affects cortex development"/>
   <result pre="mice. Cell Res. (2016) 26:645–54. 10.1038/cr.2016.5827174054 Adams WaldorfKMNelsonBRStencel-BaerenwaldJEStudholmeCKapurRPArmisteadBet al.. Congenital" exact="Zika" post="virus infection as a silent pathology with loss of"/>
   <result pre="the fetal brain. Nat Med. (2018) 24:368–74. 10.1038/nm.448529400709 DangJTiwariSKLichinchiGQinYPatilVSEroshkinAMet al.." exact="Zika" post="virus depletes neural progenitors in human cerebral organoids through"/>
   <result pre="Cell Stem Cell. (2016) 19:258–65. 10.1016/j.stem.2016.04.01427162029 GarcezPPLoiolaECMadeiro da CostaRHigaLMTrindadePDelvecchioRet al.." exact="Zika" post="virus impairs growth in human neurospheres and brain organoids."/>
   <result pre="352:816–8. 10.1126/science.aaf611627064148 QianXNguyenHNSongMMHadionoCOgdenSCHammackCet al.. Brain-region-specific organoids using mini-bioreactors for modeling" exact="ZIKV" post="exposure. Cell. (2016) 165:1238–54. 10.1016/j.cell.2016.04.03227118425 TetroJAZika and microcephaly: causation,"/>
   <result pre="or coincidence. Microbes Infect. (2016) 18:167–8. 10.1016/j.micinf.2015.12.01026774330 RetallackHDi LulloEAriasCKnoppKALaurieMTSandoval-EspinosaCet al.." exact="Zika" post="virus cell tropism in the developing human brain and"/>
   <result pre="USA. (2016) 113:14408–14413. 10.1073/pnas.161802911327911847 TeixeiraMGCosta MdaCde OliveiraWKNunesMLRodriguesLC. The epidemic of" exact="Zika" post="virus–related microcephaly in Brazil: detection, control, etiology, and future"/>
   <result pre="future scenarios. Am J Public Health. (2016) 106:601–5. 10.2105/AJPH.2016.30311326959259 RasmussenSAJamiesonDJHoneinMAPetersenLR." exact="Zika" post="virus and birth defects—reviewing the evidence for causality. N"/>
   <result pre="N Engl J Med. (2016) 374:1981–7. 10.1056/NEJMsr160433827074377 MussoDRocheCNhanT-XRobinETeissierACao-LormeauV-M. Detection of" exact="Zika" post="virus in saliva. J Clin Virol. (2015) 68:53–5. 10.1016/j.jcv.2015.04.02126071336"/>
   <result pre="J Clin Virol. (2015) 68:53–5. 10.1016/j.jcv.2015.04.02126071336 Schuler-FacciniL. Possible association between" exact="Zika" post="virus infection and microcephaly—Brazil, 2015. MMWR Morb Mortal Wkly"/>
   <result pre="(2016) 65:59–62. 10.15585/mmwr.mm6503e226820244 CalvetGAguiarRSMeloASOSampaioSADe FilippisIFabriAet al.. Detection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
   <result pre="(2016) 16:653–60. 10.1016/S1473-3099(16)00095-526897108 LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.. Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007."/>
   <result pre="Infect Dis. (2008) 14:1232–9. 10.3201/eid1408.08028718680646 LiuYLiuJDuSShanCNieKZhangRet al.. Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoes. Nature. (2017) 545:482–6."/>
   <result pre="YuanLHuangX-YLiuZ-YZhangFZhuX-LYuJ-Yet al.. A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephaly. Science. (2017) 358:933–6. 10.1126/science.aam712028971967"/>
   <result pre="fetal microcephaly. Science. (2017) 358:933–6. 10.1126/science.aam712028971967 NicastriECastillettiCLiuzziGIannettaMCapobianchiMRIppolitoG. Persistent detection of" exact="Zika" post="virus RNA in semen for six months after symptom"/>
   <result pre="Haiti to Italy, February 2016. Eurosurveillance. (2016) 21:1–4. 10.2807/1560-7917.ES.2016.21.32.3031427541989 NicastriECastillettiCBalestraPGalganiSIppolitoG." exact="Zika" post="virus infection in the central nervous system and female"/>
   <result pre="during pregnancy on fetal development. Reproduction. (2013) 146:R151–62. 10.1530/REP-13-023223884862 HajraABandyopadhyayDHajraSK." exact="Zika" post="virus: a global threat to humanity: a comprehensive review"/>
   <result pre="N Am J Med Sci. (2016) 8:123–8. 10.4103/1947-2714.17911227114968 HamelRLiégeoisFWichitSPomponJDiopFTalignaniLet al.." exact="Zika" post="virus: epidemiology, clinical features and host-virus interactions. Microbes Infect."/>
   <result pre="PetersenLRJamiesonDJPowersAMHoneinMAZika virus. N Engl J Med. (2016) 374:1552–63. 10.1056/NEJMra160211327028561 HayesEB." exact="Zika" post="virus outside Africa. Emerg Infect Dis. (2009) 15:1347–50. 10.3201/eid1509.09044219788800"/>
   <result pre="outside Africa. Emerg Infect Dis. (2009) 15:1347–50. 10.3201/eid1509.09044219788800 Cao-LormeauV-MRocheCTeissierARobinEBerryA-LMalletH-Pet al.." exact="Zika" post="virus, French polynesia, South pacific, 2013. Emerg Infect Dis."/>
   <result pre="vaccination. J Virol. (2014) 88:13845–57. 10.1128/JVI.02086-1425253341 BarouchDHThomasSJMichaelNL. Prospects for a" exact="Zika" post="virus vaccine. Immunity. (2017) 46:176–82. 10.1016/j.immuni.2017.02.00528228277 KhanSUllahMWSiddiqueRNabiGMananSYousafMet al.. Role"/>
   <result pre="patient: successful recovery. Ital J Pediatr. (2018) 44:140. 10.1186/s13052-018-0574-x30458831 Abbreviations" exact="ZIKV" post="Zika Virus HC Head Circumference SD Standard Deviation DENV"/>
   <result pre="successful recovery. Ital J Pediatr. (2018) 44:140. 10.1186/s13052-018-0574-x30458831 Abbreviations ZIKV" exact="Zika" post="Virus HC Head Circumference SD Standard Deviation DENV Dengue"/>
   <result pre="Abbreviations ZIKV Zika Virus HC Head Circumference SD Standard Deviation" exact="DENV" post="Dengue Virus CHIKV Chikungunya Virus WNV West Nile Virus"/>
   <result pre="ZIKV Zika Virus HC Head Circumference SD Standard Deviation DENV" exact="Dengue" post="Virus CHIKV Chikungunya Virus WNV West Nile Virus YFV"/>
   <result pre="Virus HC Head Circumference SD Standard Deviation DENV Dengue Virus" exact="CHIKV" post="Chikungunya Virus WNV West Nile Virus YFV Yellow Fever"/>
   <result pre="HC Head Circumference SD Standard Deviation DENV Dengue Virus CHIKV" exact="Chikungunya" post="Virus WNV West Nile Virus YFV Yellow Fever Virus"/>
   <result pre="Circumference SD Standard Deviation DENV Dengue Virus CHIKV Chikungunya Virus" exact="WNV" post="West Nile Virus YFV Yellow Fever Virus purified inactivated"/>
   <result pre="SD Standard Deviation DENV Dengue Virus CHIKV Chikungunya Virus WNV" exact="West Nile" post="Virus YFV Yellow Fever Virus purified inactivated virus (PIV)"/>
   <result pre="DENV Dengue Virus CHIKV Chikungunya Virus WNV West Nile Virus" exact="YFV" post="Yellow Fever Virus purified inactivated virus (PIV) MRI Magnetic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6466164\results\search\tropicalVirus\results.xml">
   <result pre="Recent Updates on Mouse Models for Human Immunodeficiency, Influenza, and" exact="Dengue" post="Viral Infections KrishnakumarVinodhini1†DurairajanSiva Sundara Kumar1*†https://orcid.org/0000-0003-1401-8589AlagarasuKalichamy2LiMin3*DashAditya Prasad4[1], kvinodhini@cutn.ac.in[2], alagarasu@gmail.com[3], [4],"/>
   <result pre="in human peripheral blood mononuclear cells in vivo [99]. 4." exact="Dengue" post="Virus (DENV) Dengue is a vector-borne viral illness in"/>
   <result pre="blood mononuclear cells in vivo [99]. 4. Dengue Virus (DENV)" exact="Dengue" post="is a vector-borne viral illness in humans, and it"/>
   <result pre="Half of the world’s population is at risk for infection." exact="Dengue" post="virus (DENV) belongs to the family Flaviviridae and is"/>
   <result pre="the family Flaviviridae and is closely related to hepatitis C," exact="West Nile," post="Zika, [100] and Japanese encephalitis viruses. These family virus"/>
   <result pre="countries [102]. Availability of an appropriate small animal model for" exact="DENV" post="infection has been, and remains, a challenge. 4.1. Knockout"/>
   <result pre="been, and remains, a challenge. 4.1. Knockout Mouse Models of" exact="DENV" post="At the beginning of the 20th century, researchers struggled"/>
   <result pre="al. [105] first tested the utility of AG129 mice in" exact="DENV" post="vaccine trials. Their study reported that AG129 mice infected"/>
   <result pre="(D220) are being considered as an improved model to study" exact="DENV" post="infection and disease and for testing vaccines and antivirals,"/>
   <result pre="highlighted the role of the STAT-1 and STAT-2 protein in" exact="DENV" post="biology [109,110]. Mice lacking either STAT-1 or STAT-2 infected"/>
   <result pre="biology [109,110]. Mice lacking either STAT-1 or STAT-2 infected with" exact="DENV" post="possess a higher level of viral RNA compared to"/>
   <result pre="STAT2-dependent pathway in mediating transcription of the interferon-stimulated genes against" exact="DENV" post="in the absence of STAT-1 [111]. Mice lacking IFN"/>
   <result pre="(IRF)-3 and -7 have been shown to be infected with" exact="DENV" post="by the bite of infectious mosquitoes; infected mice were"/>
   <result pre="model is being used to understand the transmission dynamics of" exact="DENV" post="[112]. Triple KO mice lacking IRF-3, -5, and -7,"/>
   <result pre="in inducing IFN-γ, as well type I IFN, responses against" exact="DENV" post="[113]. Moreover, quadruplet KO mice-based experiments have revealed the"/>
   <result pre="role of this alternative pathway involving IRF-1 in resistance to" exact="DENV" post="[113]. The pathogenic role of CCR5, a chemokine receptor,"/>
   <result pre="to demonstrating the involvement of several cellular signalling pathways in" exact="DENV" post="infection. 4.2. Transgenic Mouse Models of DENV Transgenic mice"/>
   <result pre="signalling pathways in DENV infection. 4.2. Transgenic Mouse Models of" exact="DENV" post="Transgenic mice over-expressing human tumor necrosis factor (TNF)-α have"/>
   <result pre="to demonstrate the role of TNF-α in the development of" exact="DENV" post="encephalitis-like symptoms and neurotoxicity. Moreover, anti TNF-α antibodies reduced"/>
   <result pre="[115]. Since mice lacking the IFN-α/β receptor are susceptible to" exact="DENV" post="infection and demonstrate T cell responses against DENV infection,"/>
   <result pre="susceptible to DENV infection and demonstrate T cell responses against" exact="DENV" post="infection, studying T cell responses in the context of"/>
   <result pre="relevant to vaccine design [110]. 4.3. Humanized Mouse Models of" exact="DENV" post="Human cell responses to DENV infection can be studied"/>
   <result pre="4.3. Humanized Mouse Models of DENV Human cell responses to" exact="DENV" post="infection can be studied better in humanized mouse models"/>
   <result pre="human cord blood hematopoietic progenitor (CD34+) cells and infected with" exact="DENV" post="mimicking natural infection conditions have been used to demonstrate"/>
   <result pre="an attractive platform for assessing human immune responses to the" exact="DENV" post="vaccine [121,122]. However, humanized mice models predominantly develop IgM"/>
   <result pre="However, humanized mice models predominantly develop IgM in response to" exact="DENV" post="infection; only a few developed an IgG response because"/>
   <result pre="the observed results: (i) to test the safety of the" exact="DENV" post="vaccine in the recipient without pathology [120,127]; and (ii)"/>
   <result pre="pathology [120,127]; and (ii) to test the immunogenicity of the" exact="DENV" post="vaccine [126,128,129]. 5. Conclusions Indeed, it is not easy"/>
   <result pre="virus-specific CD8+ T cellsJ. Immunol.20091824865487310.4049/jimmunol.080197419342665 111.PerryS.T.BuckM.D.LadaS.M.SchindlerC.ShrestaS.STAT2 mediates innate immunity to" exact="Dengue" post="virus in the absence of STAT1 via the type"/>
   <result pre="FABP5. Anti inflammatory response against H1N1 influenza A [79] 3." exact="Dengue" post="129Sv(ev) (AG129 KO) Type I&amp;amp; II- IFN receptors deficient."/>
   <result pre="7 Antiviral role of IRF-1 by indcuing IFN responses against" exact="DENV" post="infection [113] viruses-11-00252-t002_Table 2Table 2 Transgenic mouse models for"/>
   <result pre="and control of a viral zoonosis of influenza [84,85] 3." exact="Dengue" post="C57BL/6J Tg HLA-A*02:01 and B10. Tg. HLA-DR3 Geness coding"/>
   <result pre="NOD/Shi-SCID-IL2rγnull (NOG). Humanized with huPBMCs. Evaluating vaccine safety [99] 3." exact="Dengue" post="RAG2−/−γc−/− mice Xenografted with human CD34+ hematopoietic stem cells"/>
   <result pre="Xenografted with human CD34+ hematopoietic stem cells Antibody responses against" exact="DENV" post="[119] NOD-SCID IL2rγ null Transplanation of purified cord blood"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6466311\results\search\tropicalVirus\results.xml">
   <result pre="font-style : italic;} VirusesVirusesvirusesViruses1999-4915MDPI pmcid: 6466311 doi: 10.3390/v11030294viruses-11-00294 : Review" exact="Chikungunya" post="in Infants and Children: Is Pathogenesis Increasing? https://orcid.org/0000-0001-7943-7181BarrKelli L.1*https://orcid.org/0000-0002-0564-9082VaidhyanathanVedana2[1],"/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Chikungunya" post="virus (CHIKV) was first extensively described in children during"/>
   <result pre="Asia during the mid-1960s. Prior to the 2005 emergence of" exact="CHIKV" post="on Reunion Island, CHIKV infection was usually described as"/>
   <result pre="Prior to the 2005 emergence of CHIKV on Reunion Island," exact="CHIKV" post="infection was usually described as a dengue-like illness with"/>
   <result pre="consequences from vertical and perinatal transmission were described and as" exact="CHIKV" post="continued to emerge in new areas over the next"/>
   <result pre="following review describes the global reemergence and the syndromes of" exact="Chikungunya" post="fever (CHIKF) in infants and children. The various manifestations"/>
   <result pre="may be associated with the emergence of new viral lineages." exact="Chikungunya" post="virus congenital infection perinatal infection neuroinvasive disease pathogenesis cutaneous"/>
   <result pre="infection perinatal infection neuroinvasive disease pathogenesis cutaneous lesions 1. Introduction" exact="Chikungunya" post="(CHIKV) is an alphavirus usually vectored by Aedes aegypti"/>
   <result pre="usually vectored by Aedes aegypti and Aedes albopictus mosquitoes [1]." exact="CHIKV" post="originated in Tanzania and is most closely related to"/>
   <result pre="related to o’nyong nyong virus, which originated in Uganda [2]." exact="CHIKV" post="is a small, enveloped virus with a single-stranded, positive-sense"/>
   <result pre="3 (E3), envelope 2 (E2), 6K, and envelope 1 (E1))." exact="CHIKV" post="can be classified into three genetic lineages based upon"/>
   <result pre="E1 gene [3]. Since first reported in Tanzania in 1952," exact="CHIKV" post="has been identified in multiple outbreaks as a cause"/>
   <result pre="disease in Asia [4,5,6,7,8,9,10,11]. Prior to the 2005 emergence of" exact="CHIKV" post="on Reunion Island, chikungunya fever (CHIKF) was commonly misdiagnosed"/>
   <result pre="and exhibit similar disease syndromes. In 2005, congenital and perinatal" exact="CHIKV" post="infections were reported following delivery to mothers with documented"/>
   <result pre="accompanied with symptoms of CHIKF [14,15,16]. Both congenital and perinatal" exact="CHIKV" post="transmissions are directly associated with infected mothers. In this"/>
   <result pre="expansion (Figure 1). There is a significant need to understand" exact="CHIKV" post="pathogenesis in children and neonates because the newly emergent"/>
   <result pre="in children and neonates because the newly emergent genotypes of" exact="CHIKV" post="cause multiple severe manifestations of infection, which can have"/>
   <result pre="be associated with the emergence of new viral lineages. 2." exact="CHIKV" post="in Neonates and Children during the 1900s CHIKF was"/>
   <result pre="tests were necessary for a definitive diagnosis. During the 1964" exact="CHIKV" post="outbreak in Madras, India, Jadhav et al. [17] describe"/>
   <result pre="outbreak in Madras, India, Jadhav et al. [17] describe pediatric" exact="CHIKV" post="infection in great detail. For 33 infants with a"/>
   <result pre="that the outbreaks in Thailand and Vietnam were caused by" exact="CHIKV" post="of the Asian lineage [25]. During the 1970s, additional"/>
   <result pre="for children and infants with CHIKF (Table 1). The 1974" exact="CHIKV" post="epidemic in Ibadan, Nigeria was caused by the West"/>
   <result pre="joint pain from which all children recovered [26,27]. During 1970–1972," exact="CHIKV" post="of Asian lineage caused hemorrhagic fever epidemics in children"/>
   <result pre="hemorrhagic fever was more commonly diagnosed in children infected with" exact="CHIKV" post="of the Asian lineage (Table 1). While genetic motifs"/>
   <result pre="there are other lineage-specific motifs that correlate with disease. 3." exact="CHIKV" post="in Neonates and Children after Re-Emergence Soon after the"/>
   <result pre="Neonates and Children after Re-Emergence Soon after the emergence of" exact="CHIKV" post="on Reunion Island, congenital transmission of CHIKV was hypothesized"/>
   <result pre="the emergence of CHIKV on Reunion Island, congenital transmission of" exact="CHIKV" post="was hypothesized following reports of CHIKF in infants 2–4"/>
   <result pre="infection [98,99]. Beginning in 2006, congenital and perinatal transmission of" exact="CHIKV" post="was reported in Reunion Island (Table 1) [14,15,16,98]. These"/>
   <result pre="apparent malformations. Lenglet et al. [14] also showed that congenital" exact="CHIKV" post="infection could result in miscarriage if it occurred within"/>
   <result pre="A226V mutation has been shown to enhance the transmission of" exact="CHIKV" post="in Ae. albopictus mosquitoes which has significantly increased the"/>
   <result pre="virus [106]. Viral pathogenesis studies of this variant showed that" exact="CHIKV" post="localized to neuronal cells of the cerebellum and induced"/>
   <result pre="A226V mutation in CHIKF cannot be defined. During the 2006–2007" exact="CHIKV" post="outbreak in Sri Lanka, children born to women infected"/>
   <result pre="outbreak in Sri Lanka, children born to women infected with" exact="CHIKV" post="during the first two trimesters of pregnancy had less"/>
   <result pre="mutations that formed a unique cluster, completely separate from other" exact="CHIKV" post="isolated in other areas of Sri Lanka and in"/>
   <result pre="which have yet to be characterized [40]. Conversely, the 2005" exact="CHIKV" post="outbreak in Karnataka, India, the 2006–2007 outbreak in Gabon,"/>
   <result pre="in Karnataka, India, the 2006–2007 outbreak in Gabon, the 2008–2009" exact="CHIKV" post="outbreak in Thailand, and the 2010 outbreaks in Senegal"/>
   <result pre="illness or undifferentiated fever with rash (Table 1) [34,41,44,45]. Furthermore," exact="CHIKV" post="infection of fetuses, neonates, or children caused no significant"/>
   <result pre="in these outbreak genomes that are contributing to disease. 4." exact="CHIKV" post="in Neonates and Children after Global Expansion With the"/>
   <result pre="awareness of the potentially serious consequences of neonatal and pediatric" exact="CHIKV" post="infections, much greater attention is now given to arboviral"/>
   <result pre="to arboviral infection in infants and children. The identification of" exact="CHIKV" post="in neonates has occurred more frequently in recent outbreaks"/>
   <result pre="occurs during delivery (Table 1) [102]. The recent increase in" exact="CHIKV" post="infections in children could be explained as a function"/>
   <result pre="are still used today and are gold standards for identifying" exact="CHIKV" post="as a causative agent [111,112]. It is far more"/>
   <result pre="Prior to the epidemics in 2005 and the emergence of" exact="CHIKV" post="in the Western Hemisphere, there were three distinct lineages"/>
   <result pre="in the Western Hemisphere, there were three distinct lineages of" exact="CHIKV" post="that were described [28]. These lineages are anchored to"/>
   <result pre="African strains the least pathogenic [113,114] With the spread of" exact="CHIKV" post="into South America and the Caribbean, and the invasion"/>
   <result pre="have been documented through efforts to track the movement of" exact="CHIKV" post="into new regions. 4.2.1. E1: A266V The 2005 outbreak"/>
   <result pre="new regions. 4.2.1. E1: A266V The 2005 outbreak strains of" exact="CHIKV" post="in Reunion Island possessed the E1: A266V mutation [3]."/>
   <result pre="easy to associate this mutation with severe disease, especially when" exact="CHIKV" post="with this mutation was isolated from neurologic and severe"/>
   <result pre="and severe cases [119]. This assumption was supported by other" exact="CHIKV" post="outbreaks with severe disease that also reported the E1"/>
   <result pre="K211E During November 2015 in Brazil, a newborn infected with" exact="CHIKV" post="ECSA K211E mutation developed a macular erythematous rash and"/>
   <result pre="are present in these outbreak isolates. 4.2.3. E2: V264A When" exact="CHIKV" post="emerged in the Middle East in 2011, it was"/>
   <result pre="nor the V264A are associated with increased human virulence, other" exact="CHIKV" post="isolated during this period in this area possessed mutations"/>
   <result pre="yet to be identified. 4.4. The Western Hemisphere Genotype of" exact="CHIKV" post="(CHIKV-WH) The CHIKV-WH genotype is a descendant of the"/>
   <result pre="since both amino acids have short non-polar side chains. Nevertheless," exact="CHIKV" post="with this genotype is linked to severe congenital and"/>
   <result pre="with this genotype is linked to severe congenital and neonatal" exact="CHIKV" post="disease. In Cartagena, Colombia, infants up to 24 months"/>
   <result pre="4.4.5. nsP1: K224N In 2015, a three-month old infected with" exact="CHIKV" post="was admitted to the emergency room after returning from"/>
   <result pre="and fluids with a diagnosis of septic shock secondary to" exact="CHIKV" post="infection [137]. The patient fully recovered and was discharged"/>
   <result pre="days [137]. This child was shown to be infected with" exact="CHIKV" post="with a K224N substitution of the nsP1 gene. The"/>
   <result pre="membrane associations [130,138]. How or if modifications to nsP1 affect" exact="CHIKV" post="virulence is unknown, but the substitution of a basic"/>
   <result pre="of Co-Infection Case reports have indicated that congenital co-infection of" exact="CHIKV" post="with another pathogen significantly increases the pathology of infection"/>
   <result pre="in children do not show increased pathology. Following the 2015" exact="CHIKV" post="and Zika outbreaks in Colombia, a 25-week pregnant mother"/>
   <result pre="do not show increased pathology. Following the 2015 CHIKV and" exact="Zika" post="outbreaks in Colombia, a 25-week pregnant mother was diagnosed"/>
   <result pre="Colombia, a 25-week pregnant mother was diagnosed with Toxoplasma gondii," exact="Zika" post="virus, and CHIKV-WH in her amniotic fluid [142]. Severe"/>
   <result pre="a three-year old patient from New Delhi was co-infected with" exact="CHIKV" post="ECSA, dengue, and Plasmodium vivax but fortunately was not"/>
   <result pre="In Haiti as well, school-age children co-infected with CHIKV-WH and" exact="Zika" post="virus did not exhibit worse disease than singly infected"/>
   <result pre="exhibit worse disease than singly infected patients [73]. 6. Conclusions" exact="CHIKV" post="has been reported as a cause of febrile illness"/>
   <result pre="children and neonates since the 1960s. Following the reemergence of" exact="CHIKV" post="in the regions surrounding the Indian Ocean and the"/>
   <result pre="the regions surrounding the Indian Ocean and the expansion of" exact="CHIKV" post="into the Western Hemisphere, CHIKV-WH infections in children and"/>
   <result pre="with more severe syndromes and sequelae (Table 1). Furthermore, congenital" exact="CHIKV" post="infection has evolved from causing minor, self-limiting disease to"/>
   <result pre="in multiple severe manifestations and death (Table 1). While severe" exact="CHIKV" post="disease can be linked to unique viral genotypes, the"/>
   <result pre="[131,132,133,138,139,140,145,146,147,148,149] This review highlights the limitations of our knowledge regarding" exact="CHIKV" post="pathogenesis. This is likely a result of the disconnect"/>
   <result pre="population. It is of interest that divergent and geographically distinct" exact="CHIKV" post="genotypes can induce similar disease syndromes. If a single"/>
   <result pre="evaluate functional mutations in a silent background. With over 6100" exact="CHIKV" post="sequences available on GenBank, we just need to look."/>
   <result pre="Southern Province, Tanganyika Territory, in 1952–53; an additional note on" exact="Chikungunya" post="virus isolations and serum antibodiesTrans. R. Soc. Trop. Med."/>
   <result pre="Norte de Santander, Colombia, 2014Biomédica20163636837727869384 65.FigueiredoM.L.FigueiredoL.T.Emerging alphaviruses in the Americas:" exact="Chikungunya" post="and mayaroRev. Soc. Bras. Med. Trop.20144767768310.1590/0037-8682-0246-201425626645 66.MattarS.MirandaJ.PinzonH.TiqueV.BolanosA.AponteJ.ArrietaG.GonzalezM.BarriosK.ContrerasH.et al.Outbreak of"/>
   <result pre="Consequences of congenital, perinatal, and pediatric chikungunya infections are increasing." exact="Chikungunya" post="infection in newborns, infants, and children documented since 1960"/>
   <result pre="Symptoms of chikungunya fever are associated with new viral genotypes." exact="Chikungunya" post="outbreaks with descriptions of chikungunya fever in children, infants,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6466451\results\search\tropicalVirus\results.xml">
   <result pre="Review The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic" exact="Chikungunya" post="Arthritis AmaralJ. Kennedy1TaylorPeter C.2TeixeiraMauro Martins3MorrisonThomas E. &quot;Tem�?4SchoenRobert T.5*[1], jkennedy-@hotmail.com[2],"/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Chikungunya" post="fever (CHIKF) is an emerging viral infection that has"/>
   <result pre="CCA. chikungunya virus chronic chikungunya arthritis pathogenesis methotrexate 1. Introduction" exact="Chikungunya" post="virus (CHIKV) is a small (60–70 nm, 12 Kb),"/>
   <result pre="assumed by many patients who experience disabling joint pain [4]." exact="CHIKV" post="was isolated in 1952 during an outbreak in the"/>
   <result pre="500,000 cases of CHIKF have been reported since 2014 [8]." exact="CHIKV" post="infection typically occurs in two phases. In the first"/>
   <result pre="based on favorable, albeit limited, clinical data [19,20,22]. 2. Chronic" exact="Chikungunya" post="Arthritis The transition from CHIKF to CCA is variable."/>
   <result pre="affected at the 18-month follow-up [23]. Rheumatic symptoms associated with" exact="CHIKV" post="infection include polyarthralgia, polyarthritis, morning stiffness, joint edema, and"/>
   <result pre="[13,30,33]. Similarly, Schilte et al. [25] studied 180 patients with" exact="CHIKV" post="arthritis of 36 months duration in whom the hands,"/>
   <result pre="while arthritis was unremitting in 20%–40%. Among 173 patients with" exact="CHIKV" post="evaluated at 27.5 months, Essackjee et al. [33] reported"/>
   <result pre="among 173 patients followed for more than 2 years after" exact="CHIKV" post="infection, 27 (15.6%) had some pre-existing musculoskeletal disease. In"/>
   <result pre="[43]. In addition, one study found that more severe initial" exact="CHIKV" post="infection predicted a greater likelihood of long-term arthritis [44]."/>
   <result pre="greater likelihood of long-term arthritis [44]. 3. Replication Cycle of" exact="Chikungunya" post="Virus The transmission cycle of CHIKV requires the infection"/>
   <result pre="3. Replication Cycle of Chikungunya Virus The transmission cycle of" exact="CHIKV" post="requires the infection of female mosquitoes through a virus-containing"/>
   <result pre="another vertebrate host during subsequent feeding [1,4]. The ability of" exact="CHIKV" post="to bind human cells and to replicate in cell"/>
   <result pre="and the general features are similar to other alphaviruses [45,46,47]." exact="CHIKV" post="is internalized into human target cells mainly as a"/>
   <result pre="the plasma membrane where virus assembly and egress occur [49,51]." exact="CHIKV" post="is highly cytopathic in human cell cultures, and the"/>
   <result pre="viral proteins and viral genomes [52,53,54]. Studies have shown that" exact="CHIKV" post="infection has been associated with extensive cell death and"/>
   <result pre="high levels of infectious virus [46,54]. In human cell cultures," exact="CHIKV" post="elicits an autophagic response that promotes viral replication [55,56,57]."/>
   <result pre="viral replication [55,56,57]. A study showed that the ability of" exact="CHIKV" post="to induce apoptosis depends on the ability of the"/>
   <result pre="study showed that blood monocytes were the main targets of" exact="CHIKV" post="during acute phase infection and that macrophages and B"/>
   <result pre="also infected with the virus, contrary to previous reports [60]." exact="CHIKV" post="infection rapidly results in the induction of type I"/>
   <result pre="the innate cellular immune response [61,62]. 4. Pathogenesis of Chronic" exact="Chikungunya" post="Arthritis There are intriguing similarities in the immunological phenotypes"/>
   <result pre="using non-human primates and mice demonstrated that the RNA and" exact="CHIKV" post="antigen remained detectable in musculoskeletal and other tissues for"/>
   <result pre="chronic arthritis may be related to persistent, replicating, transcriptionally active" exact="CHIKV" post="RNA [74]. In contrast, in an analysis of 33"/>
   <result pre="from patients with CCA [51,63,76]. 5. Methotrexate Therapy of Chronic" exact="Chikungunya" post="Arthritis To explain the anti-inflammatory properties of MTX, several"/>
   <result pre="fibroblasts (HSF). MTX alone did not increase the capacity of" exact="CHIKV" post="to infect and replicate in HSF [82]. This fact"/>
   <result pre="9.SimonF.W.JavelleE.OliverM.Leparc-GoffartI.MarimoutouC.Chikungunya Virus InfectionCurr. Infect. Dis. Rep.20111321822810.1007/s11908-011-0180-121465340 10.GayN.RoussetD.HucP.MatheusS.RosineJ.LedransM.NoëlH.Seroprevalence of Asian Lineage" exact="Chikungunya" post="Virus Infection on Saint Martin Island, 7 Months After"/>
   <result pre="14.TharmarajahK.MahalingamS.ZaidA.Chikungunya: Vaccines and therapeuticsF1000Research20176211410.12688/f1000research.12461.129259782 15.PowersA.M.Vaccine and Therapeutic Options To Control" exact="Chikungunya" post="VirusClin. Microbiol. Rev.201731e00104-1610.1128/CMR.00104-1629237708 16.ReisingerE.C.TschismarovR.BeublerE.WiedermannU.FirbasC.LoebermannM.RamsauerK.Immunogenicity, safety, and tolerability of the"/>
   <result pre="upJ. Assoc. Physicians India201159838621751641 23.ChangA.Y.EncinalesL.PorrasA.PachecoN.ReidS.P.MartinsK.A.SimonG.L.Frequency of Chronic Joint Pain Following" exact="Chikungunya" post="Virus InfectionArthritis Rheumatol.201810.1002/art.40384 24.BorgheriniG.PoubeauP.JossaumeA.GouixA.CotteL.MichaultA.PaganinF.Persistent Arthralgia Associated with Chikungunya Virus:"/>
   <result pre="Pain Following Chikungunya Virus InfectionArthritis Rheumatol.201810.1002/art.40384 24.BorgheriniG.PoubeauP.JossaumeA.GouixA.CotteL.MichaultA.PaganinF.Persistent Arthralgia Associated with" exact="Chikungunya" post="Virus: A Study of 88 Adult Patients on Reunion"/>
   <result pre="La Virginia, Risaralda, ColombiaF1000Research2016536010.12688/f1000research.8235.127081477 27.De AndradeD.C.JeanS.ClavelouP.DallelR.BouhassiraD.Chronic pain associated with the" exact="Chikungunya" post="Fever: Long lasting burden of an acute illnessBMC Infect"/>
   <result pre="Clinical Manifestations, and Long-Term Outcomes of a Major Outbreak of" exact="Chikungunya" post="in a Hamlet in Sri Lanka, in 2007: A"/>
   <result pre="in a naïve group of individuals 15 months following a" exact="Chikungunya" post="viral epidemic in south India: A population based observational"/>
   <result pre="Pract.2011651306131210.1111/j.1742-1241.2011.02792.x22093538 30.BouquillardÉ.CombeB.A report of 21 cases of rheumatoid arthritis following" exact="Chikungunya" post="fever. A mean follow-up of two yearsJoint. Bone Spine.20097665465710.1016/j.jbspin.2009.08.00519945329"/>
   <result pre="study of 39 cases in ColombiaClin. Rheumatol.20153583183210.1007/s10067-015-3041-826242471 36.MinerJ.J.Aw YeangH.X.FoxJ.M.TaffnerS.MalkovaO.N.OhS.T.KimA.H.J.DiamondM.S.LenschowD.J.YokoyamaW.M.Brief report:" exact="Chikungunya" post="viral arthritis in the united states: A mimic of"/>
   <result pre="Disease in EuropeReumatol. Clin. (English Edition).20151116116410.1016/j.reumae.2014.07.004 40.AmaralJ.K.SchoenR.T.A Case Report of" exact="Chikungunya" post="Fever, Rheumatoid Arthritis, and Felty’s SyndromeRheumatol. Ther.201810.1007/s40744-018-0103-9 41.AmaralJ.K.BinghamC.O.SchoenR.T.Successful Methotrexate"/>
   <result pre="Arthritis, and Felty’s SyndromeRheumatol. Ther.201810.1007/s40744-018-0103-9 41.AmaralJ.K.BinghamC.O.SchoenR.T.Successful Methotrexate Treatment of Chronic" exact="Chikungunya" post="ArthritisJ. Clin. Rheumatol.2018110.1097/rhu.0000000000000943 42.ZeanaC.KellyP.HerediaW.CifuentesA.FranchinG.PurswaniM.HagmannS.H.Post-chikungunya rheumatic disorders in travelers after"/>
   <result pre="Cellular Factors and Functions in Mediating the Infectious entry of" exact="Chikungunya" post="VirusPLoS Negl. Trop Dis.20137e205010.1371/journal.pntd.000205023409203 48.BernardE.SolignatM.GayB.ChazalN.HiggsS.DevauxC.BriantL.Endocytosis of Chikungunya Virus into"/>
   <result pre="Infectious entry of Chikungunya VirusPLoS Negl. Trop Dis.20137e205010.1371/journal.pntd.000205023409203 48.BernardE.SolignatM.GayB.ChazalN.HiggsS.DevauxC.BriantL.Endocytosis of" exact="Chikungunya" post="Virus into Mammalian Cells: Role of Clathrin and Early"/>
   <result pre="Role of Clathrin and Early Endosomal CompartmentsPLoS ONE20105e1147910.1371/journal.pone.001147920628602 49.WichitS.HamelR.BernardE.TalignaniL.DiopF.FerrarisP.MisséD.Imipramine Inhibits" exact="Chikungunya" post="Virus Replication in Human Skin Fibroblasts through Interference with"/>
   <result pre="CycleAdv. Virus. Res.199511315110.1016/s0065-3527(08)60059-77793323 51.OzdenS.HuerreM.RiviereJ.CoffeyL.L.AfonsoP.V.MoulyV.CeccaldiP.Human Muscle Satellite Cells as Targets of" exact="Chikungunya" post="Virus InfectionPLoS ONE.20072e52710.1371/journal.pone.000052717565380 52.SourisseauM.SchwartzO.Characterization of reemerging chikungunya virusPlos Pathog.200730804081710.1371/journal.ppat.0030089"/>
   <result pre="cell defensesFASEB J.20112531432510.1096/fj.10-16417820881210 55.JudithD.MostowyS.BouraiM.GangneuxN.LelekM.Lucas-HouraniM.LecuitM.Species-specific impact of the autophagy machinery on" exact="Chikungunya" post="virus infectionEMBO Rep.20131453454410.1038/embor.2013.5123619093 56.Krejbich-TrototP.GayB.Li-Pat-YuenG.HoarauJ.Jaffar-BandjeeM.BriantL.DenizotM.Chikungunya triggers an autophagic process which"/>
   <result pre="process which promotes viral replicationVirol. J.2011843210.1186/1743-422X-8-43221902836 57.TangB.L.The cell biology of" exact="Chikungunya" post="virus infectionCell Microbiol.2012141354136310.1111/j.1462-5822.2012.01825.x22686853 58.CallusB.A.VauxD.L.Caspase inhibitors: Viral, cellular and chemicalCell"/>
   <result pre="cellsJ. Exp. Med.201020742944210.1084/jem.2009085120123960 60.HerZ.MalleretB.ChanM.OngE.K.WongS.C.KwekD.J.NgL.F.Active Infection of Human Blood Monocytes by" exact="Chikungunya" post="Virus Triggers an Innate Immune ResponseJ. Immunol.20101845903591310.4049/jimmunol.090418120404274 61.ChirathawornC.L.PoovorawanY.LertmaharitS.WuttirattanakowitN.Cytokine levels"/>
   <result pre="virus infectionAsian Pac. J. Trop Med.2013663163410.1016/S1995-7645(13)60108-X23790334 62.MinerJ.J.LenschowD.J.Editorial: Lessons Learned From" exact="Chikungunya" post="in the AmericasArthritis Rheumatol.20187047747910.1002/art.4042129361204 63.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.GuichardE.RiberaA.HenniT.TalletF.et al.Persistent chronic"/>
   <result pre="64.ChaaitanyaI.K.MuruganandamN.SundaramS.G.KawalekarO.SugunanA.P.ManimundaS.P.GhosalS.R.MuthumaniK.VijayachariP.Role of pro-inflammatory cytokines and chemokines in chronic arthropathy in" exact="CHIKV" post="infectionViral. Immunol.20112426527110.1089/vim.2010.012321830898 65.ChowA.HerZ.OngE.K.ChenJ.DimatatacF.KwekD.J.NgL.F.Persistent Arthralgia Induced by Chikungunya Virus Infection"/>
   <result pre="chronic arthropathy in CHIKV infectionViral. Immunol.20112426527110.1089/vim.2010.012321830898 65.ChowA.HerZ.OngE.K.ChenJ.DimatatacF.KwekD.J.NgL.F.Persistent Arthralgia Induced by" exact="Chikungunya" post="Virus Infection is Associated with Interleukin-6 and Granulocyte Macrophage"/>
   <result pre="macrophagesJ. Clin. Invest.201012089490610.1172/JCI4010420179353 68.NgL.F.ChowA.SunY.KwekD.J.LimP.DimatatacF.LeoY.IL-1β, IL-6, and RANTES as Biomarkers of" exact="Chikungunya" post="SeverityPLoS ONE20094e426110.1371/journal.pone.000426119156204 69.SpadaroA.ScrivoR.RinaldiT.RiccieriV.Sili ScavalliA.TaccariE.ValesiniG.The role of Interleukin-12 in immune-mediated"/>
   <result pre="Dis.201812e000663410.1371/journal.pntd.000663430074983 Figure 1 Woman, 82 years old, 2 years after" exact="CHIKV" post="infection. Intense arthritis of metacarpophalangeal joints and wrist. Figure"/>
   <result pre="in the pathogenic process of acute and chronic phases of" exact="CHIKV" post="infection and likely mechanism of action of MTX therapy."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6467424\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Anatomy :"/>
   <result pre="Aedes aegypti and Aedes albopictus for an epidemic strain of" exact="Zika" post="virus Competence of Australian Ae. aegypti and Ae. albopictus"/>
   <result pre="virus Competence of Australian Ae. aegypti and Ae. albopictus for" exact="ZIKV" post="HugoLeon E.ConceptualizationFormal analysisInvestigationMethodologyWriting – original draftWriting – review &amp;amp;"/>
   <result pre="author and source are credited.pntd.0007281.pdf Abstract Background Recent epidemics of" exact="Zika" post="virus (ZIKV) in the Pacific and the Americas have"/>
   <result pre="Aedes (Ae.) aegypti and Ae. albopictus are known to transmit" exact="ZIKV" post="but variable vector competence has been observed between mosquito"/>
   <result pre="and different virus strains. Since Australia remains at risk of" exact="ZIKV" post="introduction, we evaluated the vector competence of local Ae."/>
   <result pre="local Ae. aegypti and Ae. albopictus for a Brazilian epidemic" exact="ZIKV" post="strain. In addition, we evaluated the impact of daily"/>
   <result pre="of daily temperature fluctuations around a mean of 28°C on" exact="ZIKV" post="transmission and extrinsic incubation period. Methodology/Principal findings Mosquitoes were"/>
   <result pre="period. Methodology/Principal findings Mosquitoes were orally challenged with a Brazilian" exact="ZIKV" post="strain (8.8 log CCID50/ml) and maintained at either 28°C"/>
   <result pre="temperature conditions. At 3, 7 and 14 days post-infection (dpi)," exact="ZIKV" post="RNA copies were quantified in mosquito bodies, as well"/>
   <result pre="disseminated infection rates in both vectors, the transmission rates of" exact="ZIKV" post="in saliva of Ae. aegypti (50–60%) were significantly higher"/>
   <result pre="titres in Ae. aegypti maintained at constant temperature conditions. For" exact="ZIKV" post="transmission to occur in Ae. aegypti, a disseminated virus"/>
   <result pre="Australian Ae. aegypti are better able to transmit a Brazilian" exact="ZIKV" post="strain than Ae. albopictus. The results are in agreement"/>
   <result pre="Ae. aegypti is the major vector of ZIKV. Author summary" exact="Zika" post="virus (ZIKV) is a mosquito-borne pathogen that generally causes"/>
   <result pre="microcephaly. In adults, it can cause Guillain-Barré syndrome. The recent" exact="ZIKV" post="epidemic in the Americas has been linked to the"/>
   <result pre="of Australian Ae. aegypti and Ae. albopictus mosquitoes for a" exact="ZIKV" post="epidemic strain, originating from the epicentre of the Brazilian"/>
   <result pre="Our results demonstrate that, although both species were susceptible to" exact="ZIKV" post="infection, Ae. aegypti is more likely to transmit virus."/>
   <result pre="and its Supporting Information files. Introduction Over the past decade," exact="Zika" post="virus (ZIKV) has caused unprecedented epidemics in the Western"/>
   <result pre="caused unprecedented epidemics in the Western Pacific and the Americas." exact="ZIKV" post="is a mosquito-borne, single-stranded RNA virus that belongs to"/>
   <result pre="Flaviviridae family [1]. First discovered in Uganda in 1947 [2]," exact="ZIKV" post="spread from equatorial Africa into Asia in 1960, producing"/>
   <result pre="the African and Asian lineages [3, 4]. Major epidemics of" exact="ZIKV" post="have occurred on Yap Island, Federated State of Micronesia"/>
   <result pre="[8–11], and most recently Latin America [12–15]. Although 80% of" exact="ZIKV" post="infections remain asymptomatic or cause a mild febrile illness"/>
   <result pre="[17, 18], and Guillain-Barré syndrome in adults [19, 20]. Although" exact="ZIKV" post="can be transmitted sexually [21], through blood transfusion [22],"/>
   <result pre="Africa, where it was first isolated from Ae. africanus [29]," exact="ZIKV" post="is mainly transmitted by sylvatic Aedes mosquitoes (Ae. furcifer,"/>
   <result pre="human infections implicated Ae. aegypti in the urban transmission of" exact="ZIKV" post="in Africa [26, 31, 32]. In Asia [4, 33,"/>
   <result pre="[35–37], Ae. aegypti is considered the main vector for human" exact="ZIKV" post="transmission. Although Ae. hensilli was suspected to be responsible"/>
   <result pre="transmission. Although Ae. hensilli was suspected to be responsible for" exact="ZIKV" post="transmission during the Yap outbreak [27], Ae. aegypti and"/>
   <result pre="French Polynesian outbreak [28]. Recent evidence of vertical transmission of" exact="ZIKV" post="in field-collected eggs of Ae. aegypti from Brazil suggests"/>
   <result pre="any area colonized by this species at risk of local" exact="ZIKV" post="transmission [43, 44]. Considerable variation in ZIKV vector competence,"/>
   <result pre="risk of local ZIKV transmission [43, 44]. Considerable variation in" exact="ZIKV" post="vector competence, similar to that reported for DENV [45–47],"/>
   <result pre="variation in ZIKV vector competence, similar to that reported for" exact="DENV" post="[45–47], has been observed in both Ae. aegypti and"/>
   <result pre="from across the globe [25, 48–54]. The transmission efficiency of" exact="ZIKV" post="is governed by interactions between mosquito strain [25, 53]"/>
   <result pre="local mosquito populations for ZIKV. Australia remains at risk of" exact="ZIKV" post="introduction due to its close proximity to the Western"/>
   <result pre="for transmission [61]. Despite 51 reports of imported cases of" exact="ZIKV" post="since 2014 (Queensland Government, Australia, accessed 8 October 2018),"/>
   <result pre="58, 59] and Ae. albopictus (Torres Strait islands) for Cambodian" exact="ZIKV" post="[48, 58, 59]. These studies demonstrated that Australian mosquito"/>
   <result pre="of the vector competence of Australian strains to isolates of" exact="ZIKV" post="from South America, despite the continent recording the largest"/>
   <result pre="largest epidemics with a high prevalence of the most severe" exact="ZIKV" post="disease manifestations [62]. To assess the public health risk"/>
   <result pre="manifestations [62]. To assess the public health risk imposed by" exact="ZIKV" post="to Australia, we determined the vector competence of local"/>
   <result pre="and Ae. albopictus (Torres Strait Islands) for a strain of" exact="ZIKV" post="isolated from a febrile patient from Paraiba state, at"/>
   <result pre="gland barrier to virus transmission in Ae. albopictus for this" exact="ZIKV" post="strain. Methods Mosquitoes Ae. aegypti eggs were obtained from"/>
   <result pre="sucrose solution on cotton wool pledgets. Virus strain The Brazilian" exact="ZIKV" post="strain KU365780 [63] used in this study was isolated"/>
   <result pre="the CCID50/ml in C6/36 cells. Mosquito per os exposure to" exact="ZIKV" post="Mosquito infection with ZIKV occurred in a Biosafety Level"/>
   <result pre="cells. Mosquito per os exposure to ZIKV Mosquito infection with" exact="ZIKV" post="occurred in a Biosafety Level 3 insectary at QIMR"/>
   <result pre="of 8.8 log CCID50/ml (C6/36 cells) for 1 h. Following" exact="ZIKV" post="inoculation, mosquitoes were maintained in environmental growth chambers (Panasonic),"/>
   <result pre="frozen at -80°C until further analysis. Quantitative RT-PCR to detect" exact="ZIKV" post="To determine the absolute number of ZIKV copies in"/>
   <result pre="RT-PCR to detect ZIKV To determine the absolute number of" exact="ZIKV" post="copies in each mosquito body or body part, a"/>
   <result pre="a control plasmid, containing a cloned copy of the targeted" exact="ZIKV" post="gene fragment (nucleotides 835 to 911, Genbank accession number"/>
   <result pre="Fisher Scientific, USA) according to the manufacturer’s protocol. The targeted" exact="ZIKV" post="fragment was amplified using CloneAmp HiFi PCR Premix (Takara,"/>
   <result pre="and run in parallel with the samples in all qRT-PCRs." exact="ZIKV" post="RNA from mosquitoes was amplified by one-step qRT-PCR using"/>
   <result pre="(Corbett Research, NSW, Australia). To calculate the total number of" exact="ZIKV" post="RNA copies present in each mosquito body or body"/>
   <result pre="present in each mosquito body or body part, the measured" exact="ZIKV" post="RNA copy numbers in 1μl were multiplied by the"/>
   <result pre="(i.e., 50 μl). Samples were scored positive for virus if" exact="ZIKV" post="amplification occurred in at least two technical replicates and"/>
   <result pre="limit of detection of the standard curve. Samples in which" exact="ZIKV" post="failed to amplify were classified as negative. The presence"/>
   <result pre="for each mosquito species to ensure maximum predictive power. The" exact="ZIKV" post="staining density (ratio of ZIKV/DNA positive pixel area) within"/>
   <result pre="post infection were performed using Sidak’s multiple comparison test. Results" exact="ZIKV" post="infection, dissemination and transmission High body infection percentages (number"/>
   <result pre="the fluctuating temperature regime (Table 1). At early time points," exact="ZIKV" post="was either generally not detectable in saliva, or transmission"/>
   <result pre="infectious at 3 dpi; however, in the constant temperature group," exact="ZIKV" post="was detected in the saliva of a single Ae."/>
   <result pre="of a single Ae. aegypti mosquito (5% transmission) (Table 1)." exact="ZIKV" post="was not detected in the saliva of Ae. albopictus"/>
   <result pre="found to contain infectious ZIKV. At the same time point," exact="ZIKV" post="was first detected in the saliva of Ae. albopictus"/>
   <result pre="(10% transmission), but not in the fluctuating temperature group. The" exact="ZIKV" post="transmission percentages of Ae. aegypti were significantly higher than"/>
   <result pre="infectious saliva at this time point (Table 1). Kinetics of" exact="ZIKV" post="RNA replication in bodies and wings and legs of"/>
   <result pre="points in both species (Fig 2, S1 Table). Fig 2" exact="ZIKV" post="RNA copies in Ae. aegypti and Ae. albopictus bodies."/>
   <result pre="copies in Ae. aegypti and Ae. albopictus bodies. Comparison of" exact="ZIKV" post="RNA copies in the bodies of Ae. aegypti and"/>
   <result pre="at 28°C constant or fluctuating temperature conditions. The amount of" exact="ZIKV" post="RNA copies in mosquito bodies were quantified by qRT-PCR"/>
   <result pre="All plots show the median value ± interquartile range (IQR)." exact="ZIKV" post="RNA was detected in the wings and legs of"/>
   <result pre="S2 Table). At early time points (3 dpi), levels of" exact="ZIKV" post="RNA were ~104 copies/ wings and legs in Ae."/>
   <result pre="legs in Ae. albopictus mosquitoes maintained at constant temperature. Thereafter," exact="ZIKV" post="RNA levels in Ae. albopictus marginally increased in both"/>
   <result pre="within each of the days post-infection sampled here. Fig 3" exact="ZIKV" post="RNA copies in Ae. aegypti and Ae. albopictus wings"/>
   <result pre="Ae. aegypti and Ae. albopictus wings and legs. Comparison of" exact="ZIKV" post="RNA copies in the wings and legs of Ae."/>
   <result pre="at 28°C constant or fluctuating temperature conditions. The amount of" exact="ZIKV" post="RNA copies in mosquito wings and legs were quantified"/>
   <result pre="show the median value ± interquartile range (IQR). Localization of" exact="ZIKV" post="in mosquito tissue To visualize ZIKV distribution in Ae."/>
   <result pre="range (IQR). Localization of ZIKV in mosquito tissue To visualize" exact="ZIKV" post="distribution in Ae. aegypti tissues over time, we performed"/>
   <result pre="recognising Flavivirus NS1 proteins (Figs 4A and 5). We quantified" exact="ZIKV" post="staining density (Fig 4B) through image analysis of the"/>
   <result pre="4B) through image analysis of the relative staining area of" exact="ZIKV" post="to DNA for individual organs/tissues (Fig 4C–4E). The ZIKV"/>
   <result pre="of ZIKV to DNA for individual organs/tissues (Fig 4C–4E). The" exact="ZIKV" post="staining density in mosquito midguts was visible from 3"/>
   <result pre="in mosquito midguts was visible from 3 dpi (Fig 4B)." exact="ZIKV" post="staining was detectable in tissue/organs surrounding midguts (&quot;body�? samples)"/>
   <result pre="7 dpi. By 10 dpi, all salivary glands had detectable" exact="ZIKV" post="staining. An analysis of the staining density within the"/>
   <result pre="for all tissues, the effect of time post infection on" exact="ZIKV" post="staining density was highly significant, whereas the effect of"/>
   <result pre="between 7 and 14 dpi for all tissues (Fig 4B)." exact="ZIKV" post="was also detected and quantified within the ovaries of"/>
   <result pre="surrounding oocytes (Fig 6B). Fig 4 In vivo distribution of" exact="ZIKV" post="infection in Ae. aegypti mosquitoes using immunofluorescence assay (IFA)"/>
   <result pre="with whole mosquito microscopy. Mosquitoes were examined by IFA for" exact="ZIKV" post="by staining with an anti-Flavivirus NS1 protein monoclonal antibody"/>
   <result pre="(A) An example of a whole mosquito body section showing" exact="ZIKV" post="infection in the midgut (m), head (h) and salivary"/>
   <result pre="by image analysis and were expressed as the area of" exact="ZIKV" post="staining divided by the area of DAPI staining for"/>
   <result pre="comparisons of the main effect of days post infection on" exact="ZIKV" post="staining density was carried out for each organ by"/>
   <result pre="by Sidak’s method. Lines join comparisons where significant increases in" exact="ZIKV" post="staining density had occurred for the main effect of"/>
   <result pre="effect of days post infection. (C-E) High resolution images of" exact="ZIKV" post="in infected mosquito midgut, head and salivary glands, respectively."/>
   <result pre="Whole Ae. aegypti mosquito sections showing infection and dissemination of" exact="ZIKV" post="throughout mosquito tissues over a 14 day incubation period."/>
   <result pre="Immunofluorescence staining was performed as described for Fig 4. Green," exact="ZIKV" post="infection. Blue, DNA. Fig 6 ZIKV infection in Ae."/>
   <result pre="for Fig 4. Green, ZIKV infection. Blue, DNA. Fig 6" exact="ZIKV" post="infection in Ae. aegypti ovaries. (A) Quantification of ZIKV"/>
   <result pre="6 ZIKV infection in Ae. aegypti ovaries. (A) Quantification of" exact="ZIKV" post="staining density relative to DNA over time, calculated as"/>
   <result pre="as described for Fig 4. (B) High resolution image of" exact="ZIKV" post="staining in the follicular epithelium of mature oocytes within"/>
   <result pre="follicular epithelium of mature oocytes within Ae. aegypti ovaries. Green," exact="ZIKV" post="infection. Blue, DNA. Post hoc comparisons of the main"/>
   <result pre="comparisons of the main effect of days post infection on" exact="ZIKV" post="staining density was carried out for each organ by"/>
   <result pre="by Sidak’s method. Lines join comparisons where significant increases in" exact="ZIKV" post="staining density had occurred for the main effect of"/>
   <result pre="main effect of days post infection. Thresholds for transmission of" exact="ZIKV" post="in mosquito saliva We found that a disseminated titre"/>
   <result pre="95% CI: 0.843–0.980) was necessary in Ae. albopictus to obtain" exact="ZIKV" post="infection in saliva, in the proportions (2/20 each at"/>
   <result pre="populations from north Queensland are susceptible to a Brazilian epidemic" exact="ZIKV" post="strain from Asian lineage, and able to transmit ZIKV"/>
   <result pre="epidemic ZIKV strain from Asian lineage, and able to transmit" exact="ZIKV" post="from 10 dpi. We also show that Torres Strait"/>
   <result pre="be reached for transmission of the prototype African strain of" exact="ZIKV" post="to occur [58]. The infectious titre of disseminated virus"/>
   <result pre="disseminated virus titre and transmission rate has been reported for" exact="ZIKV" post="[69] and DENV-1 [70], with high dissemination titres resulting"/>
   <result pre="vector competence of Ae. aegypti populations from north Queensland for" exact="Zika" post="has been reported [48, 58, 59]. Those populations were"/>
   <result pre="shown to be competent vectors for the African lineage of" exact="ZIKV" post="[58], but relatively inefficient vectors of a Western Pacific"/>
   <result pre="ZIKV [58], but relatively inefficient vectors of a Western Pacific" exact="ZIKV" post="strain belonging to the Asian ZIKV lineage [59]. Our"/>
   <result pre="of a Western Pacific ZIKV strain belonging to the Asian" exact="ZIKV" post="lineage [59]. Our data suggest that Ae. aegypti from"/>
   <result pre="northern Queensland in Australia may be less susceptible to Asian" exact="ZIKV" post="strains than to the prototype African strain [58]. Our"/>
   <result pre="oral challenges of Australian Ae. aegypti with a strain of" exact="ZIKV" post="from the Western Pacific [59] in which infection and"/>
   <result pre="Ae. aegypti with a lower titre of the Western Pacific" exact="ZIKV" post="strain (5.6 log CCID50) resulted in only 3% of"/>
   <result pre="allow viral transmission to occur. Although Ae. aegypti could transmit" exact="ZIKV" post="at moderate efficiency following challenge with a high titre,"/>
   <result pre="in Australia. A higher transmission rate (87%) of a Cambodian" exact="ZIKV" post="strain (Asian lineage) has been reported for Ae. aegypti"/>
   <result pre="dissemination and transmission rates were significantly lower for recently isolated" exact="ZIKV" post="strains from Africa and Asian lineages, compared with older"/>
   <result pre="lineages, compared with older African lineage isolates. In compatible combinations," exact="ZIKV" post="transmission occurred as early as 6 dpi [69]. Such"/>
   <result pre="Such genotype × genotype interactions have also been reported for" exact="DENV" post="transmission [71]. Our study is in agreement with proportions"/>
   <result pre="is in agreement with proportions of mosquitoes able to transmit" exact="ZIKV" post="at 14 dpi reported for American Ae. aegypti challenged"/>
   <result pre="challenged with Brazilian (75%), Puerto Rican (65%), and Malaysian (53%)" exact="ZIKV" post="strains [72]. Similar to a study of French Polynesian"/>
   <result pre="Polynesian Ae. aegypti [28], we found a significant increase in" exact="ZIKV" post="transmission percentages from early time points (3 and 7"/>
   <result pre="i.e. dengue [73]. Our results from immunofluorescence analysis indicate that" exact="ZIKV" post="transmission in Ae. aegypti potentially occurs from 10 dpi,"/>
   <result pre="9 days following an oral challenge with a New Caledonian" exact="ZIKV" post="strain [49]. In contrast, Ae. aegypti mosquitoes from Singapore"/>
   <result pre="aegypti mosquitoes from Singapore were able to transmit an Ugandan" exact="ZIKV" post="strain as early as 5 dpi [74]. Compared to"/>
   <result pre="were poor vectors for the Brazilian strain of ZIKV. The" exact="ZIKV" post="transmission percentages observed in our study are similar to"/>
   <result pre="reported for French and Italian Ae. albopictus mosquitoes challenged with" exact="ZIKV" post="from the Asian genotype [49, 54]. However, the infection"/>
   <result pre="reporting that all Ae. albopictus mosquitoes challenged with an Ugandan" exact="ZIKV" post="strain were infectious by 14 dpi [51]. Ae. albopictus"/>
   <result pre="previously been shown to be highly susceptible to a Cambodian" exact="ZIKV" post="strain, with a high prevalence (&amp;gt;75%) of virus in"/>
   <result pre="day 14 post-infection [48]. This suggests that the transmission of" exact="ZIKV" post="in this population of Ae. albopictus is highly virus"/>
   <result pre="specific vector/virus combination may therefore be more efficient at transmitting" exact="ZIKV" post="than another. The extrinsic incubation period, which is the"/>
   <result pre="determinant of transmission efficiency [75]. We established the kinetics of" exact="ZIKV" post="infection, dissemination and transmission in Ae. aegypti by measuring"/>
   <result pre="percentages observed in Ae. albopictus. Possible explanations for the lower" exact="ZIKV" post="transmission percentages at 14 dpi for Ae. albopictus, compared"/>
   <result pre="midgut [76]. Ae. albopictus may therefore be more competent for" exact="ZIKV" post="transmission under field conditions of frequent feeding, suggesting the"/>
   <result pre="and Ae. albopictus remains to be determined. Last, we observed" exact="ZIKV" post="staining in mosquito ovarian tissue, limited to the follicular"/>
   <result pre="only take mean temperature values into account, recent evidence for" exact="DENV" post="shows that diurnal temperature range (DTR) plays an important"/>
   <result pre="Ae. aegypti are more competent for a Brazilian strain of" exact="ZIKV" post="than Ae. albopictus, confirming that Ae. aegypti is the"/>
   <result pre="vector of Asian lineage ZIKV. The risk of emergence of" exact="ZIKV" post="in Australia is potentially high due to the presence"/>
   <result pre="experiments. In the absence of an effective vaccine and as" exact="ZIKV" post="transmission is primarily vector-borne, mosquito control is likely to"/>
   <result pre="bacterium Wolbachia pipientis has shown potential for the biocontrol of" exact="ZIKV" post="[79] and other human pathogenic flaviviruses and alphaviruses [80,"/>
   <result pre="populations [82]. Our data could be beneficial for modelling likely" exact="ZIKV" post="transmission dynamics in north Queensland and addressing emerging ZIKV"/>
   <result pre="likely ZIKV transmission dynamics in north Queensland and addressing emerging" exact="ZIKV" post="threats to Australia. Supporting information S1 Table ZIKV titres"/>
   <result pre="addressing emerging ZIKV threats to Australia. Supporting information S1 Table" exact="ZIKV" post="titres in Ae. aegypti and Ae. albopictus bodies. Number"/>
   <result pre="(DOCX) LINK Click here for additional data file. S2 Table" exact="ZIKV" post="titres in Ae. aegypti and Ae. albopictus wings and"/>
   <result pre="S3 Table Summary of the statistical significance of factors affecting" exact="ZIKV" post="staining density in different mosquito tissues. The effects of"/>
   <result pre="of days post infection, temperature regime and their interaction on" exact="ZIKV" post="staining density were examined for different mosquito tissue by"/>
   <result pre="Health, Ananindeua, Pará State, Brazil, for the provision of the" exact="Zika" post="virus strain. We also thank Andrew van den Hurk"/>
   <result pre="preparation of this manuscript. References References 1AtifM, AzeemM, SarwarMR, BashirA." exact="Zika" post="virus disease: a current review of the literature. Infection."/>
   <result pre="of the literature. Infection. 2016;44: 695–705. 10.1007/s15010-016-0935-627510169 2DickGWA, KitchenSF, HaddowAJ." exact="Zika" post="Virus. 1. Isolations and serological specificity. Trans R Soc"/>
   <result pre="FreireCCM, IamarinoA, FayeO, de OliveiraJVC, DialloM, et al.Molecular evolution of" exact="Zika" post="virus during its emergence in the 20th century. PloS"/>
   <result pre="Negl Trop Dis. 2014;8: e263610.1371/journal.pntd.000263624421913 4MarchetteNJ, GarciaR, RudnickA. Isolation of" exact="Zika" post="virus from Aedes Aegypti mosquitoes in Malaysia. Am J"/>
   <result pre="LavenJJ, VelezJO, LambertAJ, JohnsonAJ, et al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007."/>
   <result pre="Infect Dis. 2008;14: 1232–239. 10.3201/eid1408.08028718680646 7JouannicJM, FriszerS, Leparc-GoffartI, GarelC, Eyrolle-GuignotD." exact="Zika" post="virus infection in French Polynesia. Lancet. 2016;387: 1051–1052. 8MussoD,"/>
   <result pre="Lancet. 2016;387: 1051–1052. 8MussoD, NillesEJ, Cao-LormeauVM. Rapid spread of emerging" exact="Zika" post="virus in the Pacific area. Clin Microbiol Infect. 2014;20:"/>
   <result pre="LagosJ, AguayoC, FasceR, et al.A report on the outbreak of" exact="Zika" post="virus on Easter Island, South Pacific, 2014. Arch Virol."/>
   <result pre="10.1007/s00705-015-2695-526611910 10Dupont-RouzeyrolM, O’ConnorO, CalvezE, DauresM, JohnM, GrangeonJP, et al.Co-infection with" exact="Zika" post="and dengue viruses in 2 Patients, New Caledonia, 2014."/>
   <result pre="HoyD, DuituturagaS, BenyonE, et al.Concurrent outbreaks of dengue, chikungunya and" exact="Zika" post="virus infections—an unprecedented epidemic wave of mosquito-borne viruses in"/>
   <result pre="Morb Mortal Wkly Rep. 2017;66: 329–334. 10.15585/mmwr.mm6612a428358795 13CamposGS, BandeiraAC, SardiSI." exact="Zika" post="virus outbreak, Bahia, Brazil. Emerg Infect Dis. 2015;21: 1885–1886."/>
   <result pre="SantosGIV, dos SantosCND, LuzK. First report of autochthonous transmission of" exact="Zika" post="virus in Brazil. Mem Inst Oswaldo Cruz. 2015;110: 569–572."/>
   <result pre="15PetersenE, WilsonME, TouchS, McCloskeyB, MwabaP, BatesM, et al.Rapid spread of" exact="Zika" post="virus in the Americas—implications for public health preparedness for"/>
   <result pre="Infect Dis. 2016;44: 11–15. 10.1016/j.ijid.2016.02.00126854199 16ChanJFW, ChoiGKY, YipCCY, ChengVCC, YuenKY." exact="Zika" post="fever and congenital Zika syndrome: an unexpected emerging arboviral"/>
   <result pre="10.1016/j.ijid.2016.02.00126854199 16ChanJFW, ChoiGKY, YipCCY, ChengVCC, YuenKY. Zika fever and congenital" exact="Zika" post="syndrome: an unexpected emerging arboviral disease. J Infect. 2016;72:"/>
   <result pre="10.1056/NEJMoa160065126862926 18CauchemezS, BesnardM, BompardP, DubT, Guillemette-ArturP, Eyrolle-GuignotD, et al.Association between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013–15: a retrospective"/>
   <result pre="MonsS, LastereS, RocheC, VanhomwegenJ, et al.Guillain-Barre Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control study. Lancet."/>
   <result pre="NobregaME, VargasA, et al.Increased rates of Guillain-Barre Syndrome associated with" exact="Zika" post="virus outbreak in the Salvador metropolitan area, Brazil. PloS"/>
   <result pre="Dis. 2017;11: e000586910.1371/journal.pntd.000586928854206 21StassenL, ArmitageCW, van der HeideDJ, BeagleyKW, FrentiuFD." exact="Zika" post="virus in the male reproductive tract. Viruses. 2018;10: pii:"/>
   <result pre="E19810.3390/v1004019829659541 22Barjas-CastroML, AngeramiRN, CunhaMS, SuzukiA, NogueiraJS, RoccoIM, et al.Probable transfusion-transmitted" exact="Zika" post="virus in Brazil. TRANSFUSION. 2016;56: 1684–1688. 10.1111/trf.1368127329551 23BlohmGM, LednickyJA,"/>
   <result pre="MarquezM, WhiteSK, LoebJC, PachecoCA, et al.Evidence for mother-to-child transmission of" exact="Zika" post="virus through breast milk. Clin Infect Dis. 2018;66: 1120–1121."/>
   <result pre="Clin Infect Dis. 2018;66: 1120–1121. 10.1093/cid/cix96829300859 24EpelboinY, TalagaS, EpelboinL, DusfourI." exact="Zika" post="virus: an updated review of competent or naturally infected"/>
   <result pre="of Aedes aegypti and Aedes albopictus from the Americas to" exact="Zika" post="virus. PloS Negl Trop Dis. 2016;10: e000454310.1371/journal.pntd.000454326938868 26DialloD, SallAA,"/>
   <result pre="et al.Aedes hensilli as a potential vector of chikungunya and" exact="Zika" post="viruses. PloS Negl Trop Dis. 2014;8: e318810.1371/journal.pntd.000318825299181 28RichardV, PaoaafaiteT,"/>
   <result pre="competence of French Polynesian Aedes aegypti and Aedes polynesiensis for" exact="Zika" post="virus. PloS Negl Trop Dis. 2016;11: e0005024. 29WeinbrenMP, WilliamsMC."/>
   <result pre="Zika virus. PloS Negl Trop Dis. 2016;11: e0005024. 29WeinbrenMP, WilliamsMC." exact="Zika" post="virus: further isolations in the Zika area, and some"/>
   <result pre="2016;11: e0005024. 29WeinbrenMP, WilliamsMC. Zika virus: further isolations in the" exact="Zika" post="area, and some studies on the strains isolated. Trans"/>
   <result pre="FayeO, DialloD, DialloM, WeidmannM, SallAA. Quantitative real-time PCR detection of" exact="Zika" post="virus and evaluation with field-caught Mosquitoes. Virol J. 2013;10:"/>
   <result pre="and evaluation with field-caught Mosquitoes. Virol J. 2013;10: 31110.1186/1743-422X-10-31124148652 31FagbamiAH." exact="Zika" post="virus-infections in Nigeria—virological and seroepidemiological investigations in Oyo State."/>
   <result pre="investigations in Oyo State. J Hyg (Lond). 1979;83: 213–219.489960 32SimpsonDIH." exact="Zika" post="virus infection in man. Trans R Soc Trop Med"/>
   <result pre="Soc Trop Med Hyg. 1964;58: 335–338. 14175744 33OlsonJG, KsiazekTG, SuhandimanTriwibowo." exact="Zika" post="virus, a cause of fever in Central Java, Indonesia."/>
   <result pre="Med Hyg. 1981;75: 389–393. 6275577 34WiwanitkitV. The current status of" exact="Zika" post="virus in Southeast Asia. Epidemiol Health2016;38: e201602610.4178/epih.e201602627336445 35Ferreira-de-BritoA, RibeiroIP,"/>
   <result pre="et al.First detection of natural infection of Aedes aegypti with" exact="Zika" post="virus in Brazil and throughout South America. Mem Inst"/>
   <result pre="10.1590/0074-0276016033227706382 36GuerboisM, Fernandez-SalasI, AzarSR, Danis-LozanoR, Alpuche-ArandaCM, LealG, et al.Outbreak of" exact="Zika" post="virus infection, Chiapas State, Mexico, 2015, and first confirmed"/>
   <result pre="Vazquez-PichardoM, Cruz-RamirezE, Ramirez-GonzalezJE, et al.Evidence of the presence of the" exact="Zika" post="virus in Mexico since early 2015. Virus Genes. 2016;52:"/>
   <result pre="NascimentoVAD, SouzaVC, MonteiroDCDS, TerrazasWCM, et al.Evidence of vertical transmission of" exact="Zika" post="virus in field-collected eggs of Aedes aegypti in the"/>
   <result pre="Infect. 2009;11: 1177–1185. 10.1016/j.micinf.2009.05.00519450706 40PaupyC, KassaFK, CaronM, NkogheD, LeroyEM. A" exact="Chikungunya" post="Outbreak Associated with the Vector Aedes albopictus in Remote"/>
   <result pre="PloS Genet. 2013;9: e100362110.1371/journal.pgen.100362123935524 48DucheminJB, MeePT, LynchSE, VedururuR, TrinidadL, ParadkarP." exact="Zika" post="vector transmission risk in temperate Australia: a vector competence"/>
   <result pre="study. Virol J. 2017;14: 10810.1186/s12985-017-0772-y28599659 49JupilleH, SeixasG, MoussonL, SousaCA, FaillouxAB." exact="Zika" post="virus, a new threat for Europe?PloS Negl Trop Dis."/>
   <result pre="of Aedes aegypti, Ae. albopictus, and Culex quinquefasciatus mosquitoes as" exact="Zika" post="virus vectors, China. Emerg Infect Dis. 2017;23: 1085–1091. 10.3201/eid2307.16152828430562"/>
   <result pre="NgLC, TanCH. Aedes (Stegomyia) albopictus (Skuse): a potential vector of" exact="Zika" post="virus in Singapore. PloS Negl Trop Dis. 2013;7: e234810.1371/journal.pntd.000234823936579"/>
   <result pre="of Aedes albopictus and of Aedes aegypti (Paea Strain) with" exact="Zika" post="virus reveals low transmission rates to these vectors’ saliva."/>
   <result pre="vector competency of Aedes albopictus populations from the Americas for" exact="Zika" post="virus. Am J Trop Med Hyg. 2017;97: 330–339. 10.4269/ajtmh.16-096928829735"/>
   <result pre="et al.Experimental studies of susceptibility of Italian Aedes albopictus to" exact="Zika" post="virus. Euro Surveill. 2016;21: 6–9.26876980 55Weger-LucarelliJ, RuckertC, ChotiwanN, NguyenC,"/>
   <result pre="et al.Vector competence of American mosquitoes for three strains of" exact="Zika" post="virus. PloS Negl Trop Dis. 2016;10: e000510110.1371/journal.pntd.000510127783679 56PomponJ, Morales-VargasR,"/>
   <result pre="2016;10: e000510110.1371/journal.pntd.000510127783679 56PomponJ, Morales-VargasR, ManuelM, TanCH, VialT, TanJH, et al.A" exact="Zika" post="virus from America is more efficiently transmitted than an"/>
   <result pre="121510.1038/s41598-017-01282-628450714 57CiotaAT, BialosukniaSM, ZinkSD, BrecherM, EhrbarDJ, MorrissetteMN, et al.Effects of" exact="Zika" post="virus strain and Aedes mosquito species on vector competence."/>
   <result pre="mosquito species incriminates Aedes aegypti as the potential vector of" exact="Zika" post="virus in Australia. PloS Negl Trop Dis. 2016;10: e000495910.1371/journal.pntd.000495927643685"/>
   <result pre="RitchieSA, MooreFAJ, van den HurkAF. Characterization of a Western Pacific" exact="Zika" post="virus strain in Australian Aedes aegypti. Vector Borne Zoonotic"/>
   <result pre="JansenCC, MontgomeryBL, HarleyD, et al.Epidemic potential for local transmission of" exact="Zika" post="virus in 2015 and 2016 in Queensland, Australia. PLoS"/>
   <result pre="Curr. 20161213. 62LoweR, BarcellosC, BrasilP, CruzOG, HonorioNA, KuperH, et al.The" exact="Zika" post="virus epidemic in Brazil: from discovery to future implications."/>
   <result pre="Sci USA. 2006;103: 18060–18065. 10.1073/pnas.060487510317110448 67HugoLE, ProwNA, TangB, DevineG, SuhrbierA." exact="Chikungunya" post="virus transmission between Aedes albopictus and laboratory mice. Parasit"/>
   <result pre="RoussetD, FayeO, RichardV, et al.Differential transmission of Asian and African" exact="Zika" post="virus lineages by Aedes aegypti from New Caledonia. Emerg"/>
   <result pre="Aedes aegypti, Culex tarsalis, and Culex quinquefasciatus from California for" exact="Zika" post="virus. PloS Negl Trop Dis. 2018;12: e000652410.1371/journal.pntd.000652429927940 73LambrechtsL, PaaijmansKP,"/>
   <result pre="TanCH. Oral susceptibility of Singapore Aedes (Stegomyia) aegypti (Linnaeus) to" exact="Zika" post="Virus. PloS Negl Trop Dis. 2012;6: e179210.1371/journal.pntd.000179222953014 75ConwayMJ, ColpittsTM,"/>
   <result pre="79DutraHLC, RochaMN, DiasFBS, MansurSB, CaragataEP, MoreiraLA. Wolbachia blocks currently circulating" exact="Zika" post="virus isolates in Brazilian Aedes aegypti mosquitoes. Cell Host"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6472721\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Tropical Diseases"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : People and Places : Geographical Locations :"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus Epidemiological trend of chikungunya outbreak in Pakistan: 2016–2018"/>
   <result pre="through mosquitoes, has posed a serious public health challenge worldwide." exact="Chikungunya" post="virus (CHIKV), which mainly invades tropical and subtropical regions,"/>
   <result pre="of increasingly frequent chikungunya cases, first detected in December 2016." exact="Chikungunya" post="infection is not new to Pakistan, as the presence"/>
   <result pre="to restricted vector activity. We hereby present an update on" exact="CHIKV" post="testing at National Institute of Health in Islamabad, the"/>
   <result pre="us to screen samples for two additional flaviviruses (dengue and" exact="Zika" post="virus), making this the first ever study on Zika"/>
   <result pre="and Zika virus), making this the first ever study on" exact="Zika" post="virus screening from Pakistan. Out of a total 1,549"/>
   <result pre="109 (7%) patients, respectively, without a single patient positive for" exact="Zika" post="virus. Our data further reflect the importance of population"/>
   <result pre="transmission in Pakistan. Likewise, even though this is the first" exact="CHIKV" post="outbreak reported at a vast geographical scale in Pakistan,"/>
   <result pre="and control measures are still below par. The very recent" exact="CHIKV" post="outbreak, initially perceived as a &quot;mysterious�? pathogen [3], is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6473099\results\search\tropicalVirus\results.xml">
   <result pre="IFITM proteins mediate cellular resistance to influenza A H1N1 virus," exact="West Nile" post="virus, and dengue virus. Cell. (2009) 139:1243–54. 10.1016/j.cell.2009.12.01720064371 82.ShapiraSDGat-ViksIShumBODricotAde"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6473713\results\search\tropicalVirus\results.xml">
   <result pre="pmcid: 6473713 doi: 10.3390/tropicalmed4010043tropicalmed-04-00043 : Communication The First Outbreak of" exact="Dengue" post="Fever in Greater Darfur, Western Sudan https://orcid.org/0000-0002-9516-9508AhmedAyman12*EldumaAdel3MagboulBabiker4HigaziTarig5AliYousif4[1], [2], [3],"/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Dengue" post="virus (DENV) is an arthropod-borne virus (arbovirus) transmitted by"/>
   <result pre="virus (arbovirus) transmitted by the Aedes mosquitoes, mainly Aedes aegypti." exact="Dengue" post="fever is a rapidly growing disease with expanding geographical"/>
   <result pre="by PCR. We identified 32 (15.7%) dengue viral infections, six" exact="West Nile" post="virus infections, and three Crimean–Congo viral infections. Dengue infections"/>
   <result pre="six West Nile virus infections, and three Crimean–Congo viral infections." exact="Dengue" post="infections were found in four out of the five"/>
   <result pre="the associated risk factors in the region. dengue outbreak emergence" exact="West Nile" post="virus (WNV) hemorrhagic fever Crimean–Congo hemorrhagic fever (CCHF) epidemic"/>
   <result pre="fever (CCHF) epidemic Aedes aegypti Greater Darfur Sudan 1. Introduction" exact="Dengue" post="fever (DF) is a mosquito-borne viral disease caused by"/>
   <result pre="Aedes aegypti with other species of Aedes mosquito involved [1,2]." exact="Dengue" post="infection has different clinical presentations ranged from a self-limiting"/>
   <result pre="form of dengue hemorrhagic fever or dengue shock syndrome [1,3]." exact="Dengue" post="is a rapidly expanding arboviral infection currently present in"/>
   <result pre="annually and 3.97 billion people at risk of infection [4,5,6]." exact="Dengue" post="virus transmission is influenced by several factors, including climate"/>
   <result pre="facilitate the spread of the vectors and introduction of the" exact="DENV" post="into new areas [8,9,10,11,12]. Unplanned urbanization and high human"/>
   <result pre="high human population density play a major role in the" exact="DENV" post="transmission and outbreaks [13,14,15]. DF is a global public"/>
   <result pre="by the human population density, susceptibility, and previous exposure to" exact="DENV" post="and the density of the mosquito vectors [1,16,17]. In"/>
   <result pre="sub-coastal areas of the Red Sea and Kassala states [20,21,22,23,24]." exact="Yellow fever" post="and Crimean–Congo hemorrhagic fever are endemic in Darfur and"/>
   <result pre="first outbreak of dengue and dengue hemorrhagic fever along with" exact="West Nile" post="virus and Crimean–Congo hemorhagic fever infections in the greater"/>
   <result pre="fever (YF), Rift Valley fever (RVF), Crimean–Congo Hemorrhagic Fever (CCHF)," exact="West Nile" post="virus (WNV), chikungunya virus (CHIKV), and Zika virus (ZIKV)."/>
   <result pre="Fever (CCHF), West Nile virus (WNV), chikungunya virus (CHIKV), and" exact="Zika" post="virus (ZIKV). Arboviral-specific enzyme-linked immunosorbent assays (IgM capture ELISA)"/>
   <result pre="using blood samples left from previous analyses, up to 5" exact="DENV" post="positive samples were pooled together for the DENV serotype"/>
   <result pre="to 5 DENV positive samples were pooled together for the" exact="DENV" post="serotype analysis. All serological and molecular assays were done"/>
   <result pre="cases from the West Darfur state. Six (2.9%) cases of" exact="West Nile" post="virus (WNV) were detected in samples from the states"/>
   <result pre="were identified in East Darfur (Table 1). No cases of" exact="Zika" post="virus (ZIKV), yellow fever (YF), chikungunya virus (CHIKV), or"/>
   <result pre="no association between infection and gender. Limited serotype analysis of" exact="DENV" post="serotypes revealed that both DENV-1 and DENV-3 exist in"/>
   <result pre="in the Darfur area and we confirmed the presence of" exact="DENV" post="in all states of Darfur, except East Darfur. We"/>
   <result pre="between areas, and the refusal rate for blood donation. The" exact="DENV" post="might be present in East Darfur, but we failed"/>
   <result pre="East Darfur, but we failed to detect it because most" exact="DENV" post="infections are mild or asymptomatic [3]. The majority (75%)"/>
   <result pre="mild or asymptomatic [3]. The majority (75%) of the detected" exact="DENV" post="infections presented with bleeding, suggesting the involvement of dengue"/>
   <result pre="according to the guidelines of the World Health Organization [2]." exact="Dengue" post="fever in Sudan has been localized to eastern Sudan"/>
   <result pre="has a recent history of yellow fever epidemics [25,29], but" exact="DENV" post="has only been detected in a few cases in"/>
   <result pre="be attributed to the start of treatment before confirmation of" exact="DENV" post="infection. Most of these cases were treated as severe"/>
   <result pre="Darfur is a possible scenario for the introduction of the" exact="DENV" post="into the area, as some of those troops are"/>
   <result pre="dengue fever endemic areas [18,27]. Another possible scenario for introducing" exact="DENV" post="into the area is through immigrants from neighboring countries"/>
   <result pre="was our inability to run a full serotype analysis of" exact="DENV" post="and investigating the co-infection possibility. In addition, this survey"/>
   <result pre="New EditionWorld Health OrganizationGeneva, Switzerland2009 3.EndyT.P.AndersonK.B.NisalakA.YoonI.-K.GreenS.RothmanA.L.ThomasS.J.JarmanR.G.LibratyD.H.GibbonsR.V.Determinants of Inapparent and Symptomatic" exact="Dengue" post="Infection in a Prospective Study of Primary School Children"/>
   <result pre="21st CenturyTrop. Med. Health20113931110.2149/tmh.2011-S0522500131 16.Brathwaite DickO.San MartínJ.L.MontoyaR.H.del DiegoJ.ZambranoB.DayanG.H.The History of" exact="Dengue" post="Outbreaks in the AmericasAm. J. Trop. Med. Hyg.20128758459310.4269/ajtmh.2012.11-077023042846 17.BradyO.J.SmithD.L.ScottT.W.HayS.I.Dengue"/>
   <result pre="States, Sudan, 2012J. Infect. Dev. Ctries201610242910.3855/jidc.634226829534 30.HamidZ.HamidT.AlsedigK.AbdallahT.ElaagipA.AhmedA.KhalidF.Abdel HamidM.Molecular Investigation of" exact="Dengue" post="virus serotype 2 Circulation in Kassala State, SudanJpn. J."/>
   <result pre="to 16 February 2016. State Suspected Cases Samples Collected (Percentage)" exact="DENV" post="WNV CCHFV Negative Central Darfur 74 55 (74%) 5"/>
   <result pre="16 February 2016. State Suspected Cases Samples Collected (Percentage) DENV" exact="WNV" post="CCHFV Negative Central Darfur 74 55 (74%) 5 0"/>
   <result pre="204 (36%) 32 6 3 163 DENV: dengue virus; WNV:" exact="West Nile" post="virus; CCHFV: Crimean–Congo hemorrhagic fever virus. tropicalmed-04-00043-t002_Table 2Table 2"/>
   <result pre="and sex ratio of confirmed arboviral infections. Age Group DF" exact="WNV" post="CCHF F:M 0–10 years 12 0 0 1:2 11–25"/>
   <result pre="1:0 Total 32 6 3 - DF: dengue fever; WNV:" exact="West Nile" post="virus; CCHFV: Crimean–Congo hemorrhagic fever. F:M = Female to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6474636\results\search\tropicalVirus\results.xml">
   <result pre="virus instead or modify the HIV genomeSIVmac or SHIVs [33,34]" exact="Dengue" post="virus Mouse Innate immunity Modify miceCreate transgenic mice that"/>
   <result pre="virusTick-borne encephalitis virusUsutu virusWesselsbron virusWest Nile virusYellow fever virusZika virus" exact="Dengue" post="virus 1–4Hepatitis C virus Orthomyxoviridaezoonotic orthomyxoviruses typically associated with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6489371\results\search\tropicalVirus\results.xml">
   <result pre="and 2017-2018 transmission seasons. It is unclear, however, whether the" exact="YFV" post="would persist in the coastal Atlantic Forest of RJ"/>
   <result pre="conduct a real-time surveillance and assess the potential persistence of" exact="YFV" post="in the coastal Atlantic Forest of RJ during the"/>
   <result pre="Using this integrative strategy, we detected the first evidence of" exact="YFV" post="re-emergence in the third transmission season (2018-2019) in a"/>
   <result pre="monkey from the central region of the RJ state. The" exact="YFV" post="detected in 2019 has the molecular signature associated with"/>
   <result pre="2019 has the molecular signature associated with the current SE" exact="YFV" post="outbreak and exhibited a close phylogenetic relationship with the"/>
   <result pre="YFV outbreak and exhibited a close phylogenetic relationship with the" exact="YFV" post="lineage that circulated in the same Atlantic Forest fragment"/>
   <result pre="to urban areas. MAIN CONCLUSIONS Collectively, our data revealed that" exact="YFV" post="transmission persisted at the same Atlantic Forest area for"/>
   <result pre="and emergence of YF virus (YFV) lineages.2,3 In Brazil, the" exact="YFV" post="is enzootic/endemic in the Amazon Region, which is in"/>
   <result pre="sylvatic origin.1,2 Epidemiological records gathered since the discovery of the" exact="YFV" post="sylvatic cycle in Brazil in the early 1930s, as"/>
   <result pre="1930s, as well as recent phylogenetic analyses of South American" exact="YFV" post="samples have reinforced this concept.1 The epidemic character of"/>
   <result pre="territory would be a consequence of the continuous reintroductions of" exact="YFV" post="from the endemic region in the Amazon, as the"/>
   <result pre="hosts.1,4,5 In the last two decades, a gradual expansion of" exact="YFV" post="has been observed towards the coast of SE and"/>
   <result pre="revealed that RJ was highly receptive and vulnerable to sylvatic" exact="YFV" post="transmission.8 In late 2016 and early 2017, the virus"/>
   <result pre="were affected in sequence, initiating the largest epidemic of sylvatic" exact="YFV" post="ever recorded in the country.9,10,11,12 The affected area encompasses"/>
   <result pre="with the highest human population densities in the country, low" exact="YFV" post="vaccination coverage and high Aedes aegypti infestation raising concern"/>
   <result pre="high Aedes aegypti infestation raising concern about the risks of" exact="YFV" post="re-urbanisation.4,13,14 In March 2017, RJ reported the first human"/>
   <result pre="season (July 2016 to June 2017), a total of 25" exact="YFV" post="human cases, including eight deaths, and 25 confirmed epizootics"/>
   <result pre="2017 to June 2018), and despite vaccination efforts, 282 human" exact="YFV" post="cases (including 97 deaths) and 71 confirmed epizootics were"/>
   <result pre="these epizootics originated from areas without any epidemiological evidence of" exact="YFV" post="circulation. Interestingly, all these epizootics occurred in marmosets (genus"/>
   <result pre="of the 55 municipalities affected by the outbreak recorded confirmed" exact="YFV" post="infections in humans and NHPs, respectively, for more than"/>
   <result pre="potential tool for the early detection of the emergence of" exact="YFV" post="and assures quick responses; it could also protect the"/>
   <result pre="the aforementioned laboratory tools, we promptly detected the re-emergence of" exact="YFV" post="transmission in 2019 in an area where the outbreak"/>
   <result pre="YF case was reported in RJ and whose last detected" exact="YFV" post="circulation was recorded in early 2017. The animal was"/>
   <result pre="calculated using the molecular evolutionary genetics analysis (MEGA) 7.0 program." exact="YFV" post="dataset assembly - The complete polyprotein open reading frame"/>
   <result pre="in length] of the genome of the newly generated 2019" exact="YFV" post="from the Casimiro de Abreu municipality was combined with"/>
   <result pre="the Casimiro de Abreu municipality was combined with all American" exact="YFV" post="sequences available in GenBank on January 2019 (www.ncbi.nlm.nih.gov/genbank/) with"/>
   <result pre="support was estimated with the approximate likelihood-ratio test (aLRT). Only" exact="YFV" post="sequences classified as South American I genotype (SA-I) were"/>
   <result pre="analysis - The ancestral CDS of the node encompassing all" exact="YFV" post="sequences from RJ closely related to the 2019 YFV"/>
   <result pre="all YFV sequences from RJ closely related to the 2019" exact="YFV" post="strain was reconstructed by Bayesian inference as described above,"/>
   <result pre="Environment agency (INEA 012/2016 and 019/2018). RESULTS RT-qPCR analysis detected" exact="YFV" post="RNA in the serum and whole blood collected from"/>
   <result pre="diagnosis was further confirmed by sequencing the complete genome of" exact="YFV" post="(GenBank accession number: MK533792). However, the 278 mosquitoes (one"/>
   <result pre="monkey tested negative for YFV. The identity between the RJ155" exact="YFV" post="and the YFV sequenced in the 2016-2017 transmission season"/>
   <result pre="for YFV. The identity between the RJ155 YFV and the" exact="YFV" post="sequenced in the 2016-2017 transmission season from the neighbouring"/>
   <result pre="we noticed six amino acid alterations not only in the" exact="YFV" post="samples from bordering municipalities, but also in case of"/>
   <result pre="samples from bordering municipalities, but also in case of all" exact="YFV" post="genomes described so far in the ongoing outbreak (Table)."/>
   <result pre="The amino acid variations mainly map at the following non-structural" exact="YFV" post="proteins: C 103 (R); NS1 51 (D); NS3 (G);"/>
   <result pre="from Morro de São João in comparison with previous circulating" exact="YFV" post="in Casimiro de Abreu, and in the bordering municipalities"/>
   <result pre="(Macaé and Silva Jardim) in the Rio de Janeiro state" exact="YFV" post="sample / polyprotein position 103 829 1744 2897 3128"/>
   <result pre="I T The ML phylogenetic analysis revealed that the RJ155" exact="YFV" post="2019 genome showed the highest support values (aLRT ="/>
   <result pre="highest support values (aLRT = 1) when clustered with other" exact="YFV" post="strains from the ongoing outbreak in SE Brazil [Supplementary"/>
   <result pre="Bayesian MCC tree supports at least four independent introductions of" exact="YFV" post="into RJ from ES and confirmed at least two"/>
   <result pre="two viral transmission chains in RJ9 (Fig. 3). The RJ155" exact="YFV" post="clustered within the RJ transmission chain here called YFVRJ-I"/>
   <result pre="July 2016-March 2017]. The YFVRJ-I clade also comprises an older" exact="YFV" post="sample from Casimiro de Abreu (March 2017) obtained from"/>
   <result pre="das Ostras (Fig. 1). These results clearly support that the" exact="YFV" post="has persisted in the Atlantic Forest area of RJ"/>
   <result pre="in the Atlantic Forest area of RJ for three consecutive" exact="YFV" post="transmission seasons (2016-2017, 2017-2018, and 2018-2019). Fig. 4: reconstructed"/>
   <result pre="Santo state. To examine the genetic divergence of the RJ155" exact="YFV" post="relative to previous virus samples, we plotted the root-to-tip"/>
   <result pre="divergence and time of sampling (R2 = 0.94). The RJ155" exact="YFV" post="showed a low deviation from the mean regression line,"/>
   <result pre="from the mean regression line, with residuals comparable with other" exact="YFV" post="genomes sampled previously. The RJ155 showed a low mean"/>
   <result pre="(C) Normalised dN-dS values by codon position across the complete" exact="YFV" post="CDS (structural and non-structural genes are coloured blue and"/>
   <result pre="analysis. DISCUSSION The present work describes the first record of" exact="YFV" post="circulation in RJ in 2019, which essentially consists of"/>
   <result pre="of the previous transmission season. In turn, we report a" exact="YFV" post="infection in a howler monkey from the north-coastal zone,"/>
   <result pre="SE Brazil. Moreover, our phylogeographic and evolutionary analyses showed that" exact="YFV" post="may persist in this zone for at least three"/>
   <result pre="the need for new introduction. These data unprecedentedly demonstrate that" exact="YFV" post="can be locally maintained in the Atlantic Forest for"/>
   <result pre="1930s and 1940s, the authors concluded that in this region," exact="YFV" post="spread in the form of an intermittent wave from"/>
   <result pre="persistence. Here, we demonstrated that besides spreading to new areas," exact="YFV" post="was able to persist in the same zone for"/>
   <result pre="the Atlantic Forest may have contributed to the maintenance of" exact="YFV" post="circulation in such a zone for at least three"/>
   <result pre="affected by the expanding wave. Such &quot;virgin islands,�? where the" exact="YFV" post="has not circulated, may serve as new focal points"/>
   <result pre="of NHP diversity and abundance may have also contributed to" exact="YFV" post="persistence in RJ. Previous studies have concluded that YFV"/>
   <result pre="to YFV persistence in RJ. Previous studies have concluded that" exact="YFV" post="typically remains during only one, but not for more"/>
   <result pre="SE region.5,35,38,39,40 Taylor and Fonseca-Cunha,36 while describing the 1934-1936 sylvatic" exact="YFV" post="epidemic in the SE, claimed that &quot;the virus appeared"/>
   <result pre="enable an almost perennial circulation of the virus. In fact," exact="YFV" post="had disappeared spontaneously from the coastal Atlantic Forest for"/>
   <result pre="of NHP genera are highly associated with the risk of" exact="YFV" post="outbreak.42,43 YFV was also likely maintained in RJ through"/>
   <result pre="genera are highly associated with the risk of YFV outbreak.42,43" exact="YFV" post="was also likely maintained in RJ through vertical transmission"/>
   <result pre="of mosquitoes.8Ae. albopictus is considered a probable bridge vector for" exact="YFV" post="at the urban area-forest interface in Brazil;47,49 its contact"/>
   <result pre="an important risk factor for YF re-urbanisation in the SE.1" exact="YFV" post="evolution in fragmented habitats through vertical transmission in the"/>
   <result pre="genetic drift, as previously observed for YFV.50 Arthropod-borne viruses like" exact="YFV" post="are characterised by higher levels of negative selection pressure"/>
   <result pre="cycle involving phylogenetically divergent hosts.51 Our study clearly supports that" exact="YFV" post="circulation may be soundless in the coastal SE and"/>
   <result pre="actions, which can have serious consequences. The local persistence of" exact="YFV" post="and the possibility of seasonal re-emergences reinforce the need"/>
   <result pre="alert the state and municipal health systems in RJ about" exact="YFV" post="re-emergence within 48 hours allowing the authorities to take"/>
   <result pre="and is funded by grants from Preventing and Combating the" exact="Zika" post="Virus, MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit (Grants 426767/2018-7 and 88881.130684/2016-01), MCTI/FINEP/FNDCT 01/2016 -"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6502353\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="biology techniques : Sequencing techniques: RNA sequencing RNA recombination at" exact="Chikungunya" post="virus 3'UTR as an evolutionary mechanism that provides adaptability"/>
   <result pre="3'UTR as an evolutionary mechanism that provides adaptability Evolution of" exact="Chikungunya" post="virus http://orcid.org/0000-0002-0728-5227FilomatoriClaudia V.ConceptualizationFormal analysisFunding acquisitionInvestigationMethodologyProject administrationResourcesSupervisionValidationVisualizationWriting – original draftWriting"/>
   <result pre="which has resulted in the recent expansion of re-emergent viruses." exact="Chikungunya" post="virus is an important human pathogen transmitted by mosquitoes"/>
   <result pre="Europe and the Americas. Here, we examined the evolution of" exact="CHIKV" post="in different hosts and uncovered host-specific requirements of the"/>
   <result pre="CHIKV in different hosts and uncovered host-specific requirements of the" exact="CHIKV" post="3’UTR. Sequence repeats are conserved at the CHIKV 3’UTR"/>
   <result pre="of the CHIKV 3’UTR. Sequence repeats are conserved at the" exact="CHIKV" post="3’UTR but vary in copy number among viral lineages."/>
   <result pre="detected during host switch. We propose that RNA recombination accelerates" exact="CHIKV" post="adaptability, allowing the virus to overcome genetic bottlenecks within"/>
   <result pre="host. These studies highlight the role of 3’UTR plasticity on" exact="CHIKV" post="evolution, providing a new paradigm to explain the significance"/>
   <result pre="and it has resulted in re-emergence of many RNA viruses." exact="Chikungunya" post="virus (CHIKV) is an arthropod borne virus that after"/>
   <result pre="America, producing about 1.7 million infections [10–14]. Explosive spread of" exact="CHIKV" post="has been associated with adaptation of viral lineages to"/>
   <result pre="infect the mosquito Aedes albopictus [15]. On the other hand," exact="CHIKV" post="strains that arrived to the Americas in December 2013"/>
   <result pre="non-structural proteins ORF and sequence duplications at the 3’UTR [17]." exact="CHIKV" post="is an alphavirus in the Togaviridae family of viruses"/>
   <result pre="due to different evolutionary selective pressures. One interesting feature about" exact="CHIKV" post="3’UTR is that it contains short sequence repetitions named"/>
   <result pre="common ancestor that suffered historical events of duplication. Sequences of" exact="CHIKV" post="DRs are relatively conserved between closely related lineages, indicating"/>
   <result pre="have functional significance [20]. The molecular bases that lead to" exact="CHIKV" post="genetic diversity and to viral replacements in nature are"/>
   <result pre="concert with host selective pressures to shape the composition of" exact="CHIKV" post="populations remains unclear. Sequence comparisons of RNA viruses from"/>
   <result pre="during continuous host cycling. We found that the 3’UTR of" exact="CHIKV" post="populations is highly dynamic in cell culture and during"/>
   <result pre="natural isolates. Genetic diversity of viral populations depends both on" exact="CHIKV" post="lineage and the infected host cell, indicating that CHIKV"/>
   <result pre="on CHIKV lineage and the infected host cell, indicating that" exact="CHIKV" post="3’UTR is under conflicting selective pressures in mosquito and"/>
   <result pre="pressures in mosquito and mammalian cells. Our studies suggest that" exact="CHIKV" post="uses genetic recombination at the 3’UTR to generate virus"/>
   <result pre="to generate virus populations with diverse 3’UTRs. This strategy allows" exact="CHIKV" post="to overcome bottlenecks in nature, driving the generation of"/>
   <result pre="Altogether, our findings provide important insights into the function of" exact="CHIKV" post="3’UTR plasticity for host cell adaptation, pointing out a"/>
   <result pre="adaptation, pointing out a central role of RNA recombination on" exact="CHIKV" post="ongoing evolution. Results 3’UTR heterogeneity of re-emergent natural isolates"/>
   <result pre="evolution. Results 3’UTR heterogeneity of re-emergent natural isolates Three major" exact="CHIKV" post="lineages have been defined based on their geographic distribution:"/>
   <result pre="in less populated areas of Africa. Interestingly, ECSA and Asian" exact="CHIKV" post="lineages differ at their 3’UTRs. ECSA lineage contains two"/>
   <result pre="(DR3) (Fig 1A) [21]. Fig 1 The 3’UTR of re-emerging" exact="CHIKV" post="isolates. (A) Schematic representation (top) and nucleotide conservation plot"/>
   <result pre="Schematic representation (top) and nucleotide conservation plot (bottom) of the" exact="CHIKV" post="complete genome and of the 3’UTR from the original"/>
   <result pre="plots for DR1 (top), DR2 (middle) and SLY (bottom) at" exact="CHIKV" post="3’UTR. Sequence alignments were generated and analyzed using MAFFT"/>
   <result pre="3’ sequences from 17 different natural isolates involved in recent" exact="CHIKV" post="outbreaks (Fig 1B). In 2005, a CHIKV derived from"/>
   <result pre="involved in recent CHIKV outbreaks (Fig 1B). In 2005, a" exact="CHIKV" post="derived from ECSA lineage expanded the infection in La"/>
   <result pre="continent. More recently, in 2016, a new autochthonous transmission of" exact="CHIKV" post="derived from ECSA lineage was described in Brazil and"/>
   <result pre="arrived to America in 2013, contain longer 3’UTRs. Some American" exact="CHIKV" post="isolates (such as the Caribbean) bear 3’UTRs that have"/>
   <result pre="DRs are conserved between Asian and ECSA derived viruses. Importantly," exact="CHIKV" post="from different phylogenetic origins and bearing distinct 3’UTRs co-circulate"/>
   <result pre="evolve in the near future to define the course of" exact="CHIKV" post="epidemics. CHIKVs bearing Caribbean 3’UTR have an advantage to"/>
   <result pre="3’UTR have an advantage to replicate in mosquito cells Ongoing" exact="CHIKV" post="epidemics are caused by viruses from ECSA and Asian"/>
   <result pre="both in their coding and non-coding regions. As mentioned, the" exact="CHIKV" post="responsible for 2005–2006 epidemics in La Reunion Island (CHIKV-LR;"/>
   <result pre="in Aedes albopictus [15,35], which is not present in the" exact="CHIKV" post="that arrived to America [CHIKV-Caribbean (Cbn); Asian-derived]. Besides, both"/>
   <result pre="in C6/36 and p&amp;lt;0.05 in human fibroblasts. (C) Expression of" exact="CHIKV" post="proteins in C6/36 and BHK cells transfected with RNAs"/>
   <result pre="as a function of time after RNA transfection using specific" exact="CHIKV" post="antibodies (left) and virus growth curves (right). Error bars"/>
   <result pre="cells Our observations regarding the differences in the replication of" exact="CHIKV" post="bearing the 3’UTR of LR or Cbn lineages raise"/>
   <result pre="address these questions, we investigated whether viral populations of re-emerging" exact="CHIKV" post="are prone to change during passaging in cell culture."/>
   <result pre="left) and mammalian (BHK, right) cells after the transfection of" exact="CHIKV" post="RNAs bearing the 3’UTRs of two viral variants obtained"/>
   <result pre="more stable than Cbn 3’UTR. Altogether, these experiments show that" exact="CHIKV" post="lineages have different potential to generate genetic variability at"/>
   <result pre="recombination Viral variants carrying deletions at their 3’UTR appeared in" exact="CHIKV" post="populations. However, little is known about the molecular mechanism"/>
   <result pre="strand generates a chimeric RNA molecule. Given the fact that" exact="CHIKV" post="contains various copies of sequence repetitions at its 3’UTR,"/>
   <result pre="first evidence that RNA recombination occurs at the 3’UTR of" exact="CHIKV" post="by means of template switching driven by sequence homology"/>
   <result pre="in mammalian and mosquito cells Even though we found that" exact="CHIKV" post="is prone to loose DR copies by genome recombination,"/>
   <result pre="3’UTRs, suggesting a functional role for duplication of DRs in" exact="CHIKV" post="replication. To examine the requirements of DRs for replication"/>
   <result pre="cells, respectively (Fig 5A). One day post-transfection, the number of" exact="CHIKV" post="positive cells were 33%, 35%, 5% and 0% for"/>
   <result pre="number of DRs and the replication rate. Dynamics of mammalian-adapted" exact="CHIKV" post="populations during host switch CHIKV populations are subjected to"/>
   <result pre="replication rate. Dynamics of mammalian-adapted CHIKV populations during host switch" exact="CHIKV" post="populations are subjected to diversification during host cell adaptation."/>
   <result pre="positively selected in the host. Collectively, these findings indicate that" exact="CHIKV" post="3’UTR is a major determinant for rapid adaptation to"/>
   <result pre="mutants occurs. RNA recombination occurs between the 3’UTR of different" exact="CHIKV" post="lineages We demonstrated that emergence of viral variants in"/>
   <result pre="replication in mosquito cells. Given the fact that variants of" exact="CHIKV" post="carrying different but relatively conserved 3’UTRs co-circulate in the"/>
   <result pre="of RNA recombination events between the 3’UTRs of different re-emergent" exact="CHIKV" post="lineages, we compared the 3’UTR of individual sequences with"/>
   <result pre="from different lineages. Discussion Here, we followed the evolution of" exact="CHIKV" post="3’UTR during viral transmission with the aim of deciphering"/>
   <result pre="repetitions for virus adaptation. Our experiments reveal that populations of" exact="CHIKV" post="are greatly dynamic and the copy number of sequence"/>
   <result pre="requirements and the underlying mechanism that maintain sequence duplications during" exact="CHIKV" post="host cycling. Although there are evidences that support that"/>
   <result pre="and natural selection act concertedly to shape the composition of" exact="CHIKV" post="populations (Fig 8). One example is the outcome of"/>
   <result pre="selection on the transmission cycle of CHIKV. Schematic representation of" exact="CHIKV" post="populations during transmission. Blue and red circles represent wild"/>
   <result pre="of immune responses [39,40]. Evidence so far suggests that during" exact="CHIKV" post="infection no sfRNAs are produced [41]. In turn, alphavirus"/>
   <result pre="be the target for antiviral responses in mammalian cells: (i)" exact="CHIKV" post="3’UTR is specifically recognized by RIG-I receptors, that sense"/>
   <result pre="to elucidate whether immune escape is the driving force for" exact="CHIKV" post="3’UTR evolution. It is well known that the repertoire"/>
   <result pre="Following this line of thought, we explain the evolution of" exact="CHIKV" post="during host switch under two possible scenarios: &quot;tight�? or"/>
   <result pre="selected in mosquitoes, working as an efficient strategy to rescue" exact="CHIKV" post="from &quot;tight�? genetic bottlenecks or even providing an advantage"/>
   <result pre="be established between in vitro and in vivo models of" exact="CHIKV" post="replication. CHIKV propagates and grows to high titers in"/>
   <result pre="between in vitro and in vivo models of CHIKV replication." exact="CHIKV" post="propagates and grows to high titers in mosquito and"/>
   <result pre="to high titers in mosquito and mammalian cells. In nature," exact="CHIKV" post="quickly disseminates and viral genome reaches up to 107−109"/>
   <result pre="2 days after infection. Comparable effects of 3’UTR deletions on" exact="CHIKV" post="replication were also observed in C6/36 cells and mosquitoes"/>
   <result pre="found that a similar deletion in the Caribbean lineage of" exact="CHIKV" post="(see Fig 3D) did not produce infectious viruses after"/>
   <result pre="detected recombination events when viruses containing the 3’UTR from different" exact="CHIKV" post="lineages coexist in the same cell. During outbreaks, coinfections"/>
   <result pre="may occur in mosquitoes that are simultaneously infected with different" exact="CHIKV" post="lineages, resulting in the emergence of new viral variants."/>
   <result pre="genomes to recombine within mosquitoes could clearly have implications on" exact="CHIKV" post="epidemiology and evolution. Evidence for RNA recombination during natural"/>
   <result pre="and evolution. Evidence for RNA recombination during natural evolution of" exact="CHIKV" post="can be also identified in nature. For instance, the"/>
   <result pre="RNA copy-choice recombination between strands from the same or different" exact="CHIKV" post="lineages is responsible for genome diversification. In mammalian hosts,"/>
   <result pre="of redundant DRs; while in mosquito vectors, they might allow" exact="CHIKV" post="to overcome &quot;tight�? genetic bottlenecks. Uncovering the mechanisms that"/>
   <result pre="diversity will certainly contribute to understand the unique potential of" exact="CHIKV" post="to adapt to new environments. Materials and methods Sequence"/>
   <result pre="and methods Sequence alignment, repeated pattern identification and structural analysis" exact="CHIKV" post="3’UTR sequences were downloaded from GenBank database and aligned"/>
   <result pre="to the poly(A) tail plus the last 7 nucleotides of" exact="CHIKV" post="genomes. PCR reactions were carried out using primers 115"/>
   <result pre="were performed for each parental/chimeric mix. Viral RNAs of CHIKV-LR," exact="CHIKV" post="LR/3’Cbn, CHIKV-Cbn and CHIKV-Cbn/3’LR were obtained by in vitro"/>
   <result pre="quantified. Based on the RNA concentration, mixes of CHIKV-LR and" exact="CHIKV" post="LR/3’Cbn (9:1), or CHIKV-Cbn and CHIKV-Cbn/3’LR (1:9) were used"/>
   <result pre="days old female mosquitoes were fed with 105 PFU of" exact="CHIKV" post="diluted in preached human blood (iCareB platform, Institut Pasteur)."/>
   <result pre="2008–68 COL 1. Supporting information S1 Fig Nucleotide sequences of" exact="CHIKV" post="3’UTRs during adaptation to mosquito cells. Alignment of nucleotide"/>
   <result pre="here for additional data file. S2 Fig Nucleotide sequences of" exact="CHIKV" post="3’UTRs during adaptation to mammalian cells. Alignment of nucleotide"/>
   <result pre="sites in individual clones. Individual clones of pGEM-T Easy containing" exact="CHIKV" post="3’UTRs were used as template for PCR reactions with"/>
   <result pre="monoclonal antibody CHK-152. We are grateful to Marco Vignuzzi for" exact="Chikungunya" post="virus cDNA clones. We are grateful to Cecilia Frecha"/>
   <result pre="859–864. 8666162 10ThaikrueaL, CharearnsookO, ReanphumkarnkitS, DissomboonP, PhonjanR, et al. (1997)" exact="Chikungunya" post="in Thailand: a re-emerging disease?Southeast Asian J Trop Med"/>
   <result pre="(2013) A novel DANP-coupled hairpin RT-PCR for rapid detection of" exact="Chikungunya" post="virus. J Mol Diagn15: 227–233. 10.1016/j.jmoldx.2012.10.00423313361 15TsetsarkinKA, VanlandinghamDL, McGeeCE,"/>
   <result pre="ChenR, MatheusS, et al. (2016) Whole-Genome Sequencing Analysis from the" exact="Chikungunya" post="Virus Caribbean Outbreak Reveals Novel Evolutionary Genomic Elements. PLoS"/>
   <result pre="(ECSA) lineage. Virol J10: 16910.1186/1743-422X-10-16923721429 21ChenR, WangE, TsetsarkinKA, WeaverSC (2013)" exact="Chikungunya" post="virus 3' untranslated region: adaptation to mosquitoes and a"/>
   <result pre="Pathog9: e100359110.1371/journal.ppat.100359124009512 22MorleyVJ, NovalMG, ChenR, WeaverSC, VignuzziM, et al. (2018)" exact="Chikungunya" post="virus evolution following a large 3'UTR deletion results in"/>
   <result pre="LambrechtsL (2016) Genetic Drift, Purifying Selection and Vector Genotype Shape" exact="Dengue" post="Virus Intra-host Genetic Diversity in Mosquitoes. PLoS Genet12: e100611110.1371/journal.pgen.100611127304978"/>
   <result pre="Trends Microbiol24: 270–283. 10.1016/j.tim.2016.01.00226850219 27VillordoSM, FilomatoriCV, Sanchez-VargasI, BlairCD, GamarnikAV (2015)" exact="Dengue" post="virus RNA structure specialization facilitates host adaptation. PLoS Pathog11:"/>
   <result pre="Pathog11: e100460410.1371/journal.ppat.100460425635835 28FilomatoriCV, CarballedaJM, VillordoSM, AguirreS, PallaresHM, et al. (2017)" exact="Dengue" post="virus genomic variation associated with mosquito adaptation defines the"/>
   <result pre="Virol84: 6497–6504. 10.1128/JVI.01603-0920410280 30PowersAM, BraultAC, TeshRB, WeaverSC (2000) Re-emergence of" exact="Chikungunya" post="and O'nyong-nyong viruses: evidence for distinct geographical lineages and"/>
   <result pre="CasottoME, et al. (2017) Autochthonous Transmission of East/Central/South African Genotype" exact="Chikungunya" post="Virus, Brazil. Emerg Infect Dis23: 1737–1739. 10.3201/eid2310.16185528930027 32Costa-da-SilvaAL, IoshinoRS,"/>
   <result pre="(2017) First Report of the East-Central South African Genotype of" exact="Chikungunya" post="Virus in Rio de Janeiro, Brazil. PLoS Curr9. 34WhiteSK,"/>
   <result pre="ElbadryMA, et al. (2018) A new &quot;American&quot; subgroup of African-lineage" exact="Chikungunya" post="virus detected in and isolated from mosquitoes collected in"/>
   <result pre="EngleM, et al. (2011) The naturally attenuated Kunjin strain of" exact="West Nile" post="virus shows enhanced sensitivity to the host type I"/>
   <result pre="Commun8: 1541210.1038/ncomms1541228524874 63ZambranoH, WaggonerJJ, AlmeidaC, RiveraL, BenjaminJQ, et al. (2016)" exact="Zika" post="Virus and Chikungunya Virus CoInfections: A Series of Three"/>
   <result pre="WaggonerJJ, AlmeidaC, RiveraL, BenjaminJQ, et al. (2016) Zika Virus and" exact="Chikungunya" post="Virus CoInfections: A Series of Three Cases from a"/>
   <result pre="10.4269/ajtmh.16-032327402518 64Villamil-GomezWE, Gonzalez-CamargoO, Rodriguez-AyubiJ, Zapata-SerpaD, Rodriguez-MoralesAJ (2016) Dengue, chikungunya and" exact="Zika" post="co-infection in a patient from Colombia. J Infect Public"/>
   <result pre="viruses. BMC Infect Dis16: 8410.1186/s12879-016-1417-226936191 66JainJ, DubeySK, ShrinetJ, SunilS (2017)" exact="Dengue" post="Chikungunya co-infection: A live-in relationship??Biochem Biophys Res Commun492: 608–616."/>
   <result pre="BMC Infect Dis16: 8410.1186/s12879-016-1417-226936191 66JainJ, DubeySK, ShrinetJ, SunilS (2017) Dengue" exact="Chikungunya" post="co-infection: A live-in relationship??Biochem Biophys Res Commun492: 608–616. 10.1016/j.bbrc.2017.02.00828189673"/>
   <result pre="Development of a highly protective combination monoclonal antibody therapy against" exact="Chikungunya" post="virus. PLoS Pathog9: e100331210.1371/journal.ppat.100331223637602"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6504110\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and life sciences : Molecular biology"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Genetics :"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Research and Analysis Methods : Database and"/>
   <result pre="Databases Application of a targeted-enrichment methodology for full-genome sequencing of" exact="Dengue" post="1-4, Chikungunya and Zika viruses directly from patient samples"/>
   <result pre="of a targeted-enrichment methodology for full-genome sequencing of Dengue 1-4," exact="Chikungunya" post="and Zika viruses directly from patient samples Targeted-enrichment sequencing"/>
   <result pre="targeted-enrichment methodology for full-genome sequencing of Dengue 1-4, Chikungunya and" exact="Zika" post="viruses directly from patient samples Targeted-enrichment sequencing for Dengue,"/>
   <result pre="Zika viruses directly from patient samples Targeted-enrichment sequencing for Dengue," exact="Chikungunya" post="and Zika viruses in patient samples KamarajUma SangumathiData curationFormal"/>
   <result pre="directly from patient samples Targeted-enrichment sequencing for Dengue, Chikungunya and" exact="Zika" post="viruses in patient samples KamarajUma SangumathiData curationFormal analysisInvestigationMethodologySoftwareWriting –"/>
   <result pre="source are credited.pntd.0007184.pdf Abstract The frequency of epidemics caused by" exact="Dengue" post="viruses 1–4, Zika virus and Chikungunya viruses have been"/>
   <result pre="Abstract The frequency of epidemics caused by Dengue viruses 1–4," exact="Zika" post="virus and Chikungunya viruses have been on an upward"/>
   <result pre="of epidemics caused by Dengue viruses 1–4, Zika virus and" exact="Chikungunya" post="viruses have been on an upward trend in recent"/>
   <result pre="= 170) and another taken during the 2016 outbreak of" exact="Zika" post="virus in Singapore (n = 162). Results from these"/>
   <result pre="where we recovered full genomes for both viruses. Author summary" exact="Dengue" post="viruses 1–4 (DENV1-4), Zika virus (ZIKV) and Chikungunya virus"/>
   <result pre="genomes for both viruses. Author summary Dengue viruses 1–4 (DENV1-4)," exact="Zika" post="virus (ZIKV) and Chikungunya virus (CHIKV) are tropical and"/>
   <result pre="Author summary Dengue viruses 1–4 (DENV1-4), Zika virus (ZIKV) and" exact="Chikungunya" post="virus (CHIKV) are tropical and subtropical viruses that share"/>
   <result pre="are difficult to distinguish. With the recent outbreaks of DENV," exact="ZIKV" post="and CHIKV globally, a single methodology able to simultaneously"/>
   <result pre="to distinguish. With the recent outbreaks of DENV, ZIKV and" exact="CHIKV" post="globally, a single methodology able to simultaneously distinguish these"/>
   <result pre="in Sri Lanka and Singapore taken during recent dengue and" exact="Zika" post="outbreaks, respectively. Herein, we present the results of this"/>
   <result pre="are within the manuscript and its Supporting Information files. Introduction" exact="Dengue" post="viruses 1–4 (DENV1-4), Zika virus (ZIKV) and Chikungunya virus"/>
   <result pre="and its Supporting Information files. Introduction Dengue viruses 1–4 (DENV1-4)," exact="Zika" post="virus (ZIKV) and Chikungunya virus (CHIKV) are viruses spread"/>
   <result pre="files. Introduction Dengue viruses 1–4 (DENV1-4), Zika virus (ZIKV) and" exact="Chikungunya" post="virus (CHIKV) are viruses spread by the Aedes aegypti"/>
   <result pre="are among the foremost arboviral threats to humans today [1]." exact="DENV" post="and ZIKV are flaviviruses with positive-sense, single-stranded RNA genomes"/>
   <result pre="the foremost arboviral threats to humans today [1]. DENV and" exact="ZIKV" post="are flaviviruses with positive-sense, single-stranded RNA genomes of ~11"/>
   <result pre="NS3, NS4A, NS4B and NS5) [2,3]. There are four different" exact="DENV" post="serotypes (DENV1-4) that share 60–75% identity at the amino"/>
   <result pre="infections yearly [4]. Evidence suggests that the geographic distribution of" exact="DENV" post="is increasing [5] and poses a threat to travelers"/>
   <result pre="travelers visiting affected regions [6].There is a single serotype of" exact="ZIKV" post="that can be further broken down into two primary"/>
   <result pre="the African and the Asian/American. At the time of writing," exact="ZIKV" post="had spread to 86 countries [7], and is a"/>
   <result pre="when transmitted vertically from an infected mother during pregnancy [8]." exact="CHIKV" post="is an alphavirus with three major lineages, all of"/>
   <result pre="of which comprise a single serotype [9]. The genome of" exact="CHIKV" post="is a positive-sense, single-stranded RNA genome of ~11.6 kb"/>
   <result pre="five structural proteins (C, E3, E2, 6k and E1) [9]." exact="CHIKV" post="has seen resurgence in the tropical and subtropical world"/>
   <result pre="based clustering approach on the available genetic information for DENV1-4," exact="ZIKV" post="and CHIKV in the NCBI database. We have then"/>
   <result pre="approach on the available genetic information for DENV1-4, ZIKV and" exact="CHIKV" post="in the NCBI database. We have then applied our"/>
   <result pre="large cohorts: a collection of blood samples from the 2012–2015" exact="DENV" post="epidemic in Sri Lanka (n = 170) and samples"/>
   <result pre="= 170) and samples collected during the 2016 outbreak of" exact="ZIKV" post="in Singapore (n = 162) [27,28]. Results BaitMaker: An"/>
   <result pre="baits targeting all the genomic variation across different strains. For" exact="DENV" post="serotypes 1, 2, 3 and 4, there were more"/>
   <result pre="Table). Using BaitMaker-Conserved mode we generated conserved baits for each" exact="DENV" post="serotype (65 baits total). As these baits are not"/>
   <result pre="we were working with at the time (S2 Table). For" exact="ZIKV" post="and CHIKV, there were fewer available sequences in the"/>
   <result pre="The resulting panels for these viruses were 67 baits for" exact="ZIKV" post="and 53 baits for CHIKV covering both conserved and"/>
   <result pre="viruses were 67 baits for ZIKV and 53 baits for" exact="CHIKV" post="covering both conserved and variable regions of the respective"/>
   <result pre="enrichment methodology To create a virus capture panel targeting DENV1-4," exact="CHIKV" post="and ZIKV simultaneously, we pooled the 87 baits (65"/>
   <result pre="To create a virus capture panel targeting DENV1-4, CHIKV and" exact="ZIKV" post="simultaneously, we pooled the 87 baits (65 targeting the"/>
   <result pre="variable regions) specific to DENV1-4, the 67 baits specific to" exact="ZIKV" post="and the 53 baits specific to CHIKV for a"/>
   <result pre="baits specific to ZIKV and the 53 baits specific to" exact="CHIKV" post="for a total of 207 baits. To assess whether"/>
   <result pre="cells with DENV1, 2, 3 or 4, Vero cells with" exact="ZIKV" post="and BHK-21 cells with CHIKV. To simulate a higher"/>
   <result pre="mapped to the viral genome following enrichment in the DENV1-4," exact="CHIKV" post="and ZIKV samples (Fig 2, S1 Fig and S3"/>
   <result pre="the viral genome following enrichment in the DENV1-4, CHIKV and" exact="ZIKV" post="samples (Fig 2, S1 Fig and S3 Table). Fig"/>
   <result pre="Genome coverage plots of unenriched and enriched samples of DENV1," exact="ZIKV" post="and CHIKV. The top panel (A, C, E) are"/>
   <result pre="assay, a 1:4 serial dilution of total RNA extracted from" exact="ZIKV" post="infected Vero cells was prepared. In order to keep"/>
   <result pre="the depth of coverage and breadth of genome covered in" exact="ZIKV" post="dilution series. Ct indicates ZIKV viral titers of the"/>
   <result pre="breadth of genome covered in ZIKV dilution series. Ct indicates" exact="ZIKV" post="viral titers of the samples. The x-axis represents the"/>
   <result pre="the DengueTools study in Sri Lanka [28]. The proportion of" exact="DENV" post="reads relative to the host genome for different samples"/>
   <result pre="1 Sequencing information of unenriched and enriched clinical samples with" exact="DENV" post="infection. Sample number Clinical virus sample Unenriched sample (%"/>
   <result pre="andNCBI sequence ID 1 05K4172 EDEN DENV1 77.45 99.6 0.11" exact="DENV" post="type 1 strain D1/SG/05K4172DK1/2005 (EU081261.1) 2 06K2352 EDEN DENV2"/>
   <result pre="strain BA05i (AY858035.2) 3 05K4176 EDEN DENV3 31.03 98.2 0.5" exact="DENV" post="type 3 strain D3/SG/05K4176DK1/2005 (EU081219.1) 4 SL558 Sri Lanka"/>
   <result pre="of a national response effort to the first outbreak of" exact="ZIKV" post="in Singapore (S2 Fig) [27,39]. During the course of"/>
   <result pre="cohort where we were able to recover both DENV3 and" exact="ZIKV" post="from the same patient (Fig 4). Fig 4 Co-infection"/>
   <result pre="same patient (Fig 4). Fig 4 Co-infection of DENV3 and" exact="ZIKV" post="identified in one clinical subject by using the DENV,"/>
   <result pre="ZIKV identified in one clinical subject by using the DENV," exact="CHIKV" post="and ZIKV baits panel. From the outermost circle the"/>
   <result pre="in one clinical subject by using the DENV, CHIKV and" exact="ZIKV" post="baits panel. From the outermost circle the plot reads"/>
   <result pre="the outermost circle the plot reads as the DENV3 and" exact="ZIKV" post="viral genomes, corresponding depth of coverage and the locations"/>
   <result pre="size on the genome enrichment of the samples in both" exact="DENV" post="and ZIKV cohorts (S5 Fig). We found that when"/>
   <result pre="the genome enrichment of the samples in both DENV and" exact="ZIKV" post="cohorts (S5 Fig). We found that when the library"/>
   <result pre="which is required to capture a complete genome. Discussion DENV," exact="ZIKV" post="and CHIKV together represent the most significant arboviral threats"/>
   <result pre="required to capture a complete genome. Discussion DENV, ZIKV and" exact="CHIKV" post="together represent the most significant arboviral threats to humans"/>
   <result pre="morbidity and mortality is poorly understood. Full-genome sequencing of DENV1-4," exact="ZIKV" post="and CHIKV directly from clinical samples is not a"/>
   <result pre="mortality is poorly understood. Full-genome sequencing of DENV1-4, ZIKV and" exact="CHIKV" post="directly from clinical samples is not a routine practice"/>
   <result pre="to a cohort (n = 162) collected during the 2016" exact="Zika" post="outbreak in Singapore. We were able to obtain full"/>
   <result pre="Importantly, we have combined bait panels for all four DENVs," exact="ZIKV" post="and CHIKV into a single assay and have detected"/>
   <result pre="have combined bait panels for all four DENVs, ZIKV and" exact="CHIKV" post="into a single assay and have detected a co-infection"/>
   <result pre="of a DENV/ZIKV co-infection indicates that the global prevalence of" exact="ZIKV" post="and CHIKV could be higher than current estimates. Clinical"/>
   <result pre="DENV/ZIKV co-infection indicates that the global prevalence of ZIKV and" exact="CHIKV" post="could be higher than current estimates. Clinical management for"/>
   <result pre="could be higher than current estimates. Clinical management for DENV," exact="ZIKV" post="and CHIKV is largely supportive in nature with the"/>
   <result pre="higher than current estimates. Clinical management for DENV, ZIKV and" exact="CHIKV" post="is largely supportive in nature with the vast majority"/>
   <result pre="samples. Materials and methods Ethics statement Investigations described for the" exact="Zika" post="samples were conducted as part of outbreak response operations"/>
   <result pre="greater than 3/4th of the maximum sequence length found for" exact="DENV" post="in NCBI database. Some of the sequences deposited in"/>
   <result pre="nucleotide sliding window for the set of sequences within each" exact="DENV" post="serotype. This k-mer approach ensures that for identical 120"/>
   <result pre="for DENV3 and 16 for DENV4. However, few regions in" exact="DENV" post="genome were highly variable, and therefore we designed 22"/>
   <result pre="explicitly targeting a selected reference genome from South East Asian" exact="DENV" post="cohort. Exhaustive mode To capture regions of greater diversity"/>
   <result pre="that the baits are not designed against vector sequence. For" exact="CHIKV" post="and ZIKV, we designed baits such that they would"/>
   <result pre="18 nucleotides (85% identity) and 12 nucleotides (90% identity) for" exact="CHIKV" post="and ZIKV, respectively. For remaining regions with no baits,"/>
   <result pre="this region. Viral culture and clinical sample preparation DENV1-4 and" exact="ZIKV" post="were cultured in 2x105 HuH7 and Vero cells, respectively,"/>
   <result pre="respectively, for 48 h or until cytopathic effects were observed." exact="CHIKV" post="was cultured in 2x105 BHK21 cells for 20 h."/>
   <result pre="and cooled on ice before the addition of the DENV," exact="CHIKV" post="and ZIKV bait pool. A total amount of 3"/>
   <result pre="on ice before the addition of the DENV, CHIKV and" exact="ZIKV" post="bait pool. A total amount of 3 pmol of"/>
   <result pre="(Bonferroni-corrected p-value &amp;gt; 0.05). LoFreq has previously been applied to" exact="DENV" post="datasets, and its SNV predictions on these datasets have"/>
   <result pre="genomic coverage of the clinical samples enriched by the DENV," exact="CHIKV" post="and ZIKV baits panel: A) 143 DENV1 samples, B)"/>
   <result pre="of the clinical samples enriched by the DENV, CHIKV and" exact="ZIKV" post="baits panel: A) 143 DENV1 samples, B) 27 DENV4"/>
   <result pre="143 DENV1 samples, B) 27 DENV4 samples and C) 162" exact="ZIKV" post="samples. The standard error is represented as a lighter"/>
   <result pre="from DENV1 (n = 143), DENV-4 (n = 27), and" exact="ZIKV" post="(n = 162) cohort was used for this analysis."/>
   <result pre="in Fig 2 (consisting of DENV1, 2, 3 and 4," exact="CHIKV" post="and ZIKV) was used to group the baits and"/>
   <result pre="binding identity. It should be noted however, that although the" exact="ZIKV" post="bait binds at a lower efficiency, it is contributing"/>
   <result pre="bait. The range of library sizes for DENV1, DENV4, and" exact="ZIKV" post="cohort samples are between 80–374 nt (median 203), 38–379"/>
   <result pre="contrast, there is a weak positive correlation in the Singapore" exact="ZIKV" post="outbreak cohort samples due to the larger library size"/>
   <result pre="to the larger library size and number of baits targeting" exact="ZIKV" post="is relatively higher (at &amp;gt;85% identity, DENV1 = 22,"/>
   <result pre="higher (at &amp;gt;85% identity, DENV1 = 22, DENV4 = 20," exact="ZIKV" post="= 50). The black line represents the LOWESS (locally"/>
   <result pre="in detail for unenriched and enriched experiment (Fig 1), the" exact="ZIKV" post="dilution series experiment (Fig 2) and a DENV2 dilution"/>
   <result pre="and clinicians. J Travel Med23. 6FergusonRW, HendersonSJ, LeeEA, JungP (2016)" exact="Dengue" post="in Peace Corps Volunteers, 2000–14. J Travel Med23. 7WHO"/>
   <result pre="in Peace Corps Volunteers, 2000–14. J Travel Med23. 7WHO (2018)" exact="Zika" post="virus (ZIKV) Classification table. 8MlakarJ, KorvaM, TulN, PopovicM, Poljsak-PrijateljM,"/>
   <result pre="Classification table. 8MlakarJ, KorvaM, TulN, PopovicM, Poljsak-PrijateljM, et al. (2016)" exact="Zika" post="Virus Associated with Microcephaly. N Engl J Med374: 951–958."/>
   <result pre="Engl J Med374: 951–958. 10.1056/NEJMoa160065126862926 9TsetsarkinKA, ChenR, ShermanMB, WeaverSC (2011)" exact="Chikungunya" post="virus: evolution and genetic determinants of emergence. Curr Opin"/>
   <result pre="DialloM, WeidmannM, et al. (2013) Quantitative real-time PCR detection of" exact="Zika" post="virus and evaluation with field-caught mosquitoes. Virol J10: 31110.1186/1743-422X-10-31124148652"/>
   <result pre="VelezJO, LambertAJ, et al. (2008) Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007."/>
   <result pre="TripathiNK, LakshmiV, et al. (2007) Rapid and real-time detection of" exact="Chikungunya" post="virus by reverse transcription loop-mediated isothermal amplification assay. J"/>
   <result pre="Pathog3: e20110.1371/journal.ppat.003020118069894 17ManokaranG, FinolE, WangC, GunaratneJ, BahlJ, et al. (2015)" exact="Dengue" post="subgenomic RNA binds TRIM25 to inhibit interferon expression for"/>
   <result pre="GublerDJ, et al. (2016) Insights into the molecular evolution of" exact="Dengue" post="virus type 4 in Puerto Rico over two decades"/>
   <result pre="10.1016/j.virol.2010.05.03320663532 23NaccacheSN, ThezeJ, SardiSI, SomasekarS, GreningerAL, et al. (2016) Distinct" exact="Zika" post="Virus Lineage in Salvador, Bahia, Brazil. Emerg Infect Dis22:"/>
   <result pre="Target-enrichment strategies for next-generation sequencing. Nat Methods7: 111–118. 10.1038/nmeth.141920111037 27Singapore" exact="Zika" post="StudyG (2017) Outbreak of Zika virus infection in Singapore:"/>
   <result pre="Nat Methods7: 111–118. 10.1038/nmeth.141920111037 27Singapore Zika StudyG (2017) Outbreak of" exact="Zika" post="virus infection in Singapore: an epidemiological, entomological, virological, and"/>
   <result pre="Dis. 28TisseraH, AmarasingheA, GunasenaS, DeSilvaAD, YeeLW, et al. (2016) Laboratory-Enhanced" exact="Dengue" post="Sentinel Surveillance in Colombo District, Sri Lanka: 2012–2014. PLoS"/>
   <result pre="7910.1186/s12864-015-1284-z25758772 35LowJG, OoiEE, TolfvenstamT, LeoYS, HibberdML, et al. (2006) Early" exact="Dengue" post="infection and outcome study (EDEN)—study design and preliminary findings."/>
   <result pre="Trop Dis5: e119110.1371/journal.pntd.000119121655307 37VitaranaT, JayakuruWS, WithaneN (1997) Historical Account of" exact="Dengue" post="Haemorrhagic Fever in Sri Lanka. Dengue Bulletin21: 2. 38SirisenaPD,"/>
   <result pre="(1997) Historical Account of Dengue Haemorrhagic Fever in Sri Lanka." exact="Dengue" post="Bulletin21: 2. 38SirisenaPD, NoordeenF (2014) Evolution of dengue in"/>
   <result pre="39Maurer-StrohS, MakTM, NgYK, PhuahSP, HuberRG, et al. (2016) South-east Asian" exact="Zika" post="virus strain linked to cluster of cases in Singapore,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6514695\results\search\tropicalVirus\results.xml">
   <result pre="difficult-to-treat populations have limited the widespread use of these drugs." exact="DENV" post="infection on the other hand, has no available antiviral"/>
   <result pre="of the virus life cycle, either directly or indirectly. 2.1.2." exact="Dengue" post="Virus Using in silico drug development approach against the"/>
   <result pre="al. docked 2750 phytochemicals from different medicinal plants to the" exact="DENV" post="NS4B protein and identified nine phytochemicals possessing potential inhibitory"/>
   <result pre="marianum [18]. This result suggests that silibinin could potentially inhibit" exact="DENV" post="viral replication. Given that molecular docking analysis is only"/>
   <result pre="no effective treatment or preventive vaccines against important togaviruses including" exact="Chikungunya" post="virus (CHIKV) and Mayaro virus (MAYV). Both CHIKV and"/>
   <result pre="togaviruses including Chikungunya virus (CHIKV) and Mayaro virus (MAYV). Both" exact="CHIKV" post="and MAYV belong to the alphavirus genus and are"/>
   <result pre="investigated the antiviral effect of several flavonoids including silymarin against" exact="CHIKV" post="using a CPE reduction assay and RT-PCR analysis [28]."/>
   <result pre="inhibited CHIKV-induced CPE. Mechanistic studies further demonstrated that silymarin inhibited" exact="CHIKV" post="infection by targeting the post-entry steps of the viral"/>
   <result pre="cell-to-cell spread and attenuation of HCV infection of PHHs [15]" exact="Dengue" post="virus (DENV) Silymarin Docking to NS4B All three silymarin"/>
   <result pre="silymarin derivatives docked with high binding affinity (≥−8 kal/mol) to" exact="DENV" post="NS4B [18] Influenza A virus (IAV) Silymarin CPE reduction"/>
   <result pre="vitro; Legalon® SIL additionally blocked HIV infection of T-cells [27]" exact="Chikungunya" post="virus (CHIKV) Silymarin CPE inhibition assay, RT-PCR and Western"/>
   <result pre="Silymarin CPE inhibition assay, RT-PCR and Western blot Inhibition of" exact="CHIKV" post="replication and proteinsynthesis [28] Mayaro virus (MAYV) Silymarin CPE"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6515236\results\search\tropicalVirus\results.xml">
   <result pre="Medicinal Plant from Reunion Island, Inhibits the Early Stages of" exact="Dengue" post="and Zika Virus Infection https://orcid.org/0000-0003-3857-0378ClainElodie1HaddadJuliano G.1KoishiAndrea C.2SinigagliaLaura34RachidiWalid5https://orcid.org/0000-0001-8926-4050DesprèsPhilippe1N. Duarte dos"/>
   <result pre="from Reunion Island, Inhibits the Early Stages of Dengue and" exact="Zika" post="Virus Infection https://orcid.org/0000-0003-3857-0378ClainElodie1HaddadJuliano G.1KoishiAndrea C.2SinigagliaLaura34RachidiWalid5https://orcid.org/0000-0001-8926-4050DesprèsPhilippe1N. Duarte dos SantosClaudia2GuiraudPascale1https://orcid.org/0000-0001-6103-6048JouvenetNolwenn3https://orcid.org/0000-0003-4673-6614El KalamouniChaker1*[1],"/>
   <result pre="re-emergence of viral infections transmitted by vectors, such as the" exact="Zika" post="virus (ZIKV) and Dengue virus (DENV), is a cause"/>
   <result pre="transmitted by vectors, such as the Zika virus (ZIKV) and" exact="Dengue" post="virus (DENV), is a cause for international concern. These"/>
   <result pre="endemic medicinal plant from Reunion Island, inhibits the infection of" exact="ZIKV" post="in vitro without exhibiting cytotoxic effects. The extract was"/>
   <result pre="without exhibiting cytotoxic effects. The extract was active against different" exact="ZIKV" post="African and Asian strains, including an epidemic one. Time-of-drug-addition"/>
   <result pre="virus serotypes. Due to its potency and ability to target" exact="ZIKV" post="and DENV particles, P. mauritianum may be of value"/>
   <result pre="Due to its potency and ability to target ZIKV and" exact="DENV" post="particles, P. mauritianum may be of value for identifying"/>
   <result pre="for identifying and characterizing antiviral compounds to fight medically-important flaviviruses." exact="Zika" post="virus Dengue virus antiviral activity natural compounds nutraceuticals Psiloxylon"/>
   <result pre="and characterizing antiviral compounds to fight medically-important flaviviruses. Zika virus" exact="Dengue" post="virus antiviral activity natural compounds nutraceuticals Psiloxylon mauritianum 1."/>
   <result pre="antiviral activity natural compounds nutraceuticals Psiloxylon mauritianum 1. Introduction The" exact="Zika" post="virus (ZIKV) and Dengue virus (DENV) are mosquito-borne enveloped"/>
   <result pre="nutraceuticals Psiloxylon mauritianum 1. Introduction The Zika virus (ZIKV) and" exact="Dengue" post="virus (DENV) are mosquito-borne enveloped viruses belonging to the"/>
   <result pre="step is necessary for the establishment of the infection [6,7]." exact="Dengue" post="fever, caused by 4 viral serotypes (DENV 1–4), is"/>
   <result pre="currently taking place in the French overseas region Reunion Island." exact="ZIKV" post="causes important outbreaks in the South Pacific, Americas and"/>
   <result pre="in the South Pacific, Americas and South-East Asia. The recent" exact="ZIKV" post="epidemics in French Polynesia and South America were associated"/>
   <result pre="neurological defects in adults such as the Guillain-Barré syndrome [8,9,10,11]." exact="ZIKV" post="infection is now identified as a sexually transmitted illness"/>
   <result pre="illness as well [12,13]. Phylogenetic studies allowed the division of" exact="ZIKV" post="into African and Asian lineages [14]. Since 2007, the"/>
   <result pre="Since 2007, the leading cause of major epidemics is the" exact="ZIKV" post="Asian genotype [15]. Medicinal plants, which have been used"/>
   <result pre="green tea, delphinidin, and curcumin, have been found to inhibit" exact="ZIKV" post="and DENV infection [24,25,26,27]. We recently reported that a"/>
   <result pre="delphinidin, and curcumin, have been found to inhibit ZIKV and" exact="DENV" post="infection [24,25,26,27]. We recently reported that a polyphenol-rich extract"/>
   <result pre="Aphloia theiformis, an indigenous medicinal plant from Reunion Island, prevents" exact="ZIKV" post="and DENV infection through an inhibition of the virus"/>
   <result pre="an indigenous medicinal plant from Reunion Island, prevents ZIKV and" exact="DENV" post="infection through an inhibition of the virus entry steps"/>
   <result pre="mauritianum extract, we decided to evaluate its ability to inhibit" exact="ZIKV" post="and DENV infection. In the present study, we showed"/>
   <result pre="we decided to evaluate its ability to inhibit ZIKV and" exact="DENV" post="infection. In the present study, we showed that P."/>
   <result pre="even at a cytotoxic concentration. 2.2. P. mauritianum Extract Inhibits" exact="ZIKV" post="Attachment to Mammalian Cell Surface To assess the antiviral"/>
   <result pre="previously described [28], using a chimeric molecular clone of the" exact="ZIKV" post="strain MR766 expressing a GFP reporter gene (ZIKVGFP) [32]."/>
   <result pre="into the ability of the plant extract to prevent a" exact="ZIKV" post="infection by potentially interacting with ZIKV receptors or inducing"/>
   <result pre="extract to prevent a ZIKV infection by potentially interacting with" exact="ZIKV" post="receptors or inducing an immuno-stimulating effect. The ‘adsorption’ experimental"/>
   <result pre="efficient at inhibiting the intracellular replication and polyprotein processing/synthesis of" exact="ZIKV" post="[4]. When 100 µg mL−1 of P. mauritianum extract"/>
   <result pre="P. mauritianum extract (100 µg mL−1). The amount of attached" exact="ZIKV" post="particles was determined by RT-qPCR. EGCG, which is known"/>
   <result pre="determined by RT-qPCR. EGCG, which is known to inhibit the" exact="ZIKV" post="attachment [27,28,33], was used as a positive control. Our"/>
   <result pre="Thus, the treatment with the P. mauritianum extract significantly affects" exact="ZIKV" post="binding to the cell surface (Figure 2C). We also"/>
   <result pre="inactivation assay to determine if the P. mauritianum extract neutralizes" exact="ZIKV" post="infectivity. Briefly, ZIKVGFP particles were incubated for 1 h"/>
   <result pre="curve, the concentration of P. mauritianum that inhibits 50% of" exact="ZIKV" post="infection (IC50) was estimated at 19.5 ± 4.8 µg"/>
   <result pre="extract is mediated by an interaction between the extract and" exact="ZIKV" post="particles. 2.3. P. mauritianum Extract Inhibits Infection of African"/>
   <result pre="mauritianum Extract Inhibits Infection of African and Asian Lineages of" exact="ZIKV" post="To further validate the potential anti-ZIKV activities of the"/>
   <result pre="The cells treated with EGCG, which is known to inhibit" exact="ZIKV" post="entry [26,28,33], were used as positive controls. The FISH"/>
   <result pre="The extract was as potent as EGCG in inhibiting the" exact="ZIKV" post="infection (Figure 4B,C). In this assay, ZIKV-PF13 was as"/>
   <result pre="extract. 2.4. P. mauritianum Extract Exerts Antiviral Activity against Four" exact="DENV" post="Serotypes We next wondered if the P. mauritianum extract"/>
   <result pre="The treatment with IFN-α 2A, which is known to block" exact="DENV" post="replication [35], was used as a positive control. The"/>
   <result pre="µg mL−1) was pre-incubated with the four different serotypes of" exact="DENV" post="for 1 h at 37 °C prior to infection."/>
   <result pre="which are extensively used in Flaviviridae research and relevant for" exact="DENV" post="infection [36,37], were used to perform these experiments. The"/>
   <result pre="the reduction of the number of E-positive cells to the" exact="DENV" post="infectivity. A decrease of up to 2 log of"/>
   <result pre="infectivity. A decrease of up to 2 log of the" exact="DENV" post="infectivity was observed upon DENV-3 and -4 infections when"/>
   <result pre="P. mauritianum extract exhibits potent antiviral activity against the four" exact="DENV" post="serotypes. 3. Discussion Despite the recent ZIKV emergence worldwide"/>
   <result pre="against the four DENV serotypes. 3. Discussion Despite the recent" exact="ZIKV" post="emergence worldwide and its subsequent classification as a major"/>
   <result pre="we evaluated the antiviral activity of Psiloxylon mauritianum extract against" exact="ZIKV" post="and DENV. Our data demonstrate that non-toxic concentrations of"/>
   <result pre="concentrations of P. mauritianum (100 µg mL−1) significantly reduced the" exact="ZIKV" post="infection in Vero cells, regardless of the ZIKV strains"/>
   <result pre="reduced the ZIKV infection in Vero cells, regardless of the" exact="ZIKV" post="strains tested (historic and epidemic strains). We also demonstrated"/>
   <result pre="mauritianum extract prevents the infection of human cells by four" exact="DENV" post="serotypes. We showed that P. mauritianum extract acts on"/>
   <result pre="probably via a direct interaction with the outer membrane of" exact="ZIKV" post="particles. This type of interaction was previously described between"/>
   <result pre="This type of interaction was previously described between EGCG and" exact="ZIKV" post="or DENV particles [26,27,28]. We propose that the active"/>
   <result pre="of interaction was previously described between EGCG and ZIKV or" exact="DENV" post="particles [26,27,28]. We propose that the active compounds of"/>
   <result pre="polyphenol-rich extract from Reunion Island medicinal plant Aphloia theiformis inhibits" exact="ZIKV" post="and DENV infection [28]. Thus, it would be of"/>
   <result pre="from Reunion Island medicinal plant Aphloia theiformis inhibits ZIKV and" exact="DENV" post="infection [28]. Thus, it would be of great interest"/>
   <result pre="candidate for the development of new antiviral drugs to fight" exact="ZIKV" post="and DENV infections. In conclusion, our data demonstrated that"/>
   <result pre="the development of new antiviral drugs to fight ZIKV and" exact="DENV" post="infections. In conclusion, our data demonstrated that the extract"/>
   <result pre="could be an important source for antiviral drugs to treat" exact="Zika" post="and Dengue fever in patients. 4. Materials and Methods"/>
   <result pre="an important source for antiviral drugs to treat Zika and" exact="Dengue" post="fever in patients. 4. Materials and Methods 4.1. Cells,"/>
   <result pre="2% Tryptose Phosphate Browth (Gibco). The clinical isolate PF-25013-18 of" exact="ZIKV" post="has been previously described [34,49]. ZIKVMC-MR766NIID and the GFP-expressing"/>
   <result pre="(ZIKVGFP) are molecular clones of the ancestral strain MR766 of" exact="ZIKV" post="[32]. DENV-1/FGA/89 was isolated in 1989 from a South"/>
   <result pre="Galler (Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; GenBank: KU513442)." exact="DENV" post="stocks were grown in C6/36 cells and titrated by"/>
   <result pre="assay. Vero cells were infected with a MOI of 1." exact="ZIKV" post="strains were amplified on Vero cells. The anti-pan flavivirus"/>
   <result pre="stained 1 h at room temperature in the dark for" exact="ZIKV" post="using 4G2-Alexa Fluor 594 (1:1000 in PBS-BSA 2%). The"/>
   <result pre="Vero cell monolayer seeded in 6-well plates. As a comparison," exact="ZIKV" post="was mixed with P. mauritanum, diluted immediately to 50-fold"/>
   <result pre="by Fluorescence In Situ Hybridization (FISH) and Confocal Analysis The" exact="ZIKV" post="strains were pre-incubated for 1 h at 37 °C"/>
   <result pre="USA) in PBS-BSA 0.5% overnight at 4 °C. After immunostaining," exact="ZIKV" post="plus strand RNA was detected using Alexa-Fluor 546-conjugated probe"/>
   <result pre="recognizing the regions between nt 2 and 1144 of the" exact="ZIKV" post="genome (Thermo Fisher Scientific). The samples were processed following"/>
   <result pre="cell line CMC Carboxymethyl cellulose COMET Single Cell gel electrophoresis" exact="DENV" post="Dengue virus DMSO Dimethyl sulfoxide DNA Desoxyribonucleic Acid EDTA"/>
   <result pre="line CMC Carboxymethyl cellulose COMET Single Cell gel electrophoresis DENV" exact="Dengue" post="virus DMSO Dimethyl sulfoxide DNA Desoxyribonucleic Acid EDTA Ethylenediaminetetraacetic"/>
   <result pre="Paraformaldehyde PFU Plaque forming unit RNA Ribonucleic Acid TRIS Tris(hydroxymethyl)aminomethane" exact="ZIKV" post="Zika virus References References 1.MittalR.NguyenD.DebsL.H.PatelA.P.LiuG.JhaveriV.M.KayS.-I.MittalJ.BandstraE.S.YounisR.T.et al.Zika Virus: An Emerging"/>
   <result pre="PFU Plaque forming unit RNA Ribonucleic Acid TRIS Tris(hydroxymethyl)aminomethane ZIKV" exact="Zika" post="virus References References 1.MittalR.NguyenD.DebsL.H.PatelA.P.LiuG.JhaveriV.M.KayS.-I.MittalJ.BandstraE.S.YounisR.T.et al.Zika Virus: An Emerging Global"/>
   <result pre="development for disease preventionPathog. Glob. Health201811210.1080/20477724.2018.1514136 3.FayeO.FreireC.C.M.IamarinoA.FayeO.De OliveiraJ.V.C.DialloM.ZanottoP.M.A.SallA.A.Molecular Evolution of" exact="Zika" post="Virus during Its Emergence in the 20th CenturyPLoS Negl."/>
   <result pre="virus entry and infectionVirology2014468–47056558010.1016/j.virol.2014.09.009 8.Cao-LormeauV.-M.BlakeA.MonsS.LastèreS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-Barré Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 9.CauchemezS.BesnardM.BompardP.DubT.Guillemette-ArturP.Eyrolle-GuignotD.SaljeH.Van"/>
   <result pre="in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 9.CauchemezS.BesnardM.BompardP.DubT.Guillemette-ArturP.Eyrolle-GuignotD.SaljeH.Van KerkhoveM.D.AbadieV.GarelC.et al.Association between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013–15: A retrospective"/>
   <result pre="in French Polynesia, 2013–15: A retrospective studyLancet20163872125213210.1016/S0140-6736(16)00651-626993883 10.ChenJ.LiangY.YiP.XuL.HawkinsH.K.RossiS.L.SoongL.CaiJ.MenonR.SunJ.Outcomes of Congenital" exact="Zika" post="Disease Depend on Timing of Infection and Maternal-Fetal Interferon"/>
   <result pre="al.Zika virus disease-associated Guillain-Barré syndrome—Barranquilla, Colombia 2015–2016J. Neurol. Sci.201738127227710.1016/j.jns.2017.09.00128991697 12.DuggalN.K.RitterJ.M.PestoriusS.E.ZakiS.R.DavisB.S.ChangG.J.BowenR.A.BraultA.C.Frequent" exact="Zika" post="Virus Sexual Transmission and Prolonged Viral RNA Shedding in"/>
   <result pre="virus infection damages the testes in miceNature201654043844210.1038/nature2055627798603 14.HaddowA.D.SchuhA.J.YasudaC.Y.KasperM.R.HeangV.HuyR.GuzmanH.TeshR.B.WeaverS.C.Genetic Characterization of" exact="Zika" post="Virus Strains: Geographic Expansion of the Asian LineagePLoS Negl."/>
   <result pre="Model.201669789110.1016/j.jmgm.2016.08.01127588363 17.PowersC.N.SetzerW.N.An In-Silico Investigation of Phytochemicals as Antiviral Agents Against" exact="Dengue" post="FeverComb. Chem. High Throughput Screen.20161951653610.2174/138620731966616050612371527151482 18.FortinH.VigorC.Lohézic-Le DévéhatF.RobinV.Le BosséB.BoustieJ.AmorosM.In vitro"/>
   <result pre="J. Antimicrob. Agents20185262262810.1016/j.ijantimicag.2018.07.01730063998 21.LaniR.HassandarvishP.ShuM.-H.PhoonW.H.ChuJ.J.H.HiggsS.VanlandinghamD.Abu BakarS.ZandiK.Antiviral activity of selected flavonoids against" exact="Chikungunya" post="virusAntivir. Res.2016133506110.1016/j.antiviral.2016.07.00927460167 22.LeeJ.K.ShinO.S.Advances in Zika Virus–Host Cell Interaction: Current"/>
   <result pre="activity of selected flavonoids against Chikungunya virusAntivir. Res.2016133506110.1016/j.antiviral.2016.07.00927460167 22.LeeJ.K.ShinO.S.Advances in" exact="Zika" post="Virus–Host Cell Interaction: Current Knowledge and Future PerspectivesInt. J."/>
   <result pre="PerspectivesInt. J. Mol. Sci.201920110110.3390/ijms20051101 23.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DespresP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes Initiation of" exact="Zika" post="Virus Infection in Human CellsInt. J. Mol. Sci.201819109310.3390/ijms19041093 24.BalasubramanianA.PilankattaR.TeramotoT.SajithA.M.NwuliaE.KulkarniA.PadmanabhanR.Inhibition"/>
   <result pre="Sci.201819109310.3390/ijms19041093 24.BalasubramanianA.PilankattaR.TeramotoT.SajithA.M.NwuliaE.KulkarniA.PadmanabhanR.Inhibition of dengue virus by curcuminoidsAntivir. Res2019162717810.1016/j.antiviral.2018.12.00230529358 25.MounceB.C.CesaroT.CarrauL.ValletT.VignuzziM.Curcumin inhibits" exact="Zika" post="and chikungunya virus infection by inhibiting cell bindingAntivir. Res.201714214815710.1016/j.antiviral.2017.03.01428343845"/>
   <result pre="Res.201714214815710.1016/j.antiviral.2017.03.01428343845 26.SharmaN.MuraliA.SinghS.K.GiriR.Epigallocatechin gallate, an active green tea compound inhibits the" exact="Zika" post="virus entry into host cells via binding the envelope"/>
   <result pre="the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses" exact="West Nile" post="Virus, Zika Virus, and Dengue VirusFront. Microbiol.2017810.3389/fmicb.2017.0131428144237 28.ClainE.SinigagliaL.KoishiA.C.GorgetteO.GadeaG.ViranaickenW.Krejbich-TrototP.MavinguiP.DesprèsP.Nunes Duarte"/>
   <result pre="Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus," exact="Zika" post="Virus, and Dengue VirusFront. Microbiol.2017810.3389/fmicb.2017.0131428144237 28.ClainE.SinigagliaL.KoishiA.C.GorgetteO.GadeaG.ViranaickenW.Krejbich-TrototP.MavinguiP.DesprèsP.Nunes Duarte Dos SantosC.et"/>
   <result pre="Gallate against the Flaviviruses West Nile Virus, Zika Virus, and" exact="Dengue" post="VirusFront. Microbiol.2017810.3389/fmicb.2017.0131428144237 28.ClainE.SinigagliaL.KoishiA.C.GorgetteO.GadeaG.ViranaickenW.Krejbich-TrototP.MavinguiP.DesprèsP.Nunes Duarte Dos SantosC.et al.Extract from Aphloia"/>
   <result pre="Aphloia theiformis, an edible indigenous plant from Reunion Island, impairs" exact="Zika" post="virus attachment to the host cell surfaceSci. Rep.2018810.1038/s41598-018-29183-229311689 29.MahomoodallyM.KorumtolleeH.ChadyZ.Psiloxylon"/>
   <result pre="Health2019191010.1186/s12903-018-0694-030634966 32.GadeaG.BosS.Krejbich-TrototP.ClainE.ViranaickenW.El-KalamouniC.MavinguiP.DesprèsP.A robust method for the rapid generation of recombinant" exact="Zika" post="virus expressing the GFP reporter geneVirology201649715716210.1016/j.virol.2016.07.01527471954 33.CarneiroB.M.BatistaM.N.BragaA.C.S.NogueiraM.L.RahalP.The green tea"/>
   <result pre="the GFP reporter geneVirology201649715716210.1016/j.virol.2016.07.01527471954 33.CarneiroB.M.BatistaM.N.BragaA.C.S.NogueiraM.L.RahalP.The green tea molecule EGCG inhibits" exact="Zika" post="virus entryVirology201649621521810.1016/j.virol.2016.06.01227344138 34.FrumenceE.RocheM.Krejbich-TrototP.El-KalamouniC.NativelB.RondeauP.MisséD.GadeaG.ViranaickenW.DesprèsP.The South Pacific epidemic strain of Zika"/>
   <result pre="inhibits Zika virus entryVirology201649621521810.1016/j.virol.2016.06.01227344138 34.FrumenceE.RocheM.Krejbich-TrototP.El-KalamouniC.NativelB.RondeauP.MisséD.GadeaG.ViranaickenW.DesprèsP.The South Pacific epidemic strain of" exact="Zika" post="virus replicates efficiently in human epithelial A549 cells leading"/>
   <result pre="its glycolytic activitySci. Rep.2019910.1038/s41598-019-39157-730626887 37.TricotT.HelsenN.KapteinS.J.F.NeytsJ.VerfaillieC.M.Human stem cell-derived hepatocyte-like cells support" exact="Zika" post="virus replication and provide a relevant model to assess"/>
   <result pre="extract, a traditional Brazilian medicinal plantJ. Ethnopharmacol.201214447448210.1016/j.jep.2012.08.04723041699 49.HamelR.DejarnacO.WichitS.EkchariyawatP.NeyretA.LuplertlopN.Perera-LecoinM.SurasombatpattanaP.TalignaniL.ThomasF.et al.Biology of" exact="Zika" post="Virus Infection in Human Skin CellsJ. Virol.2015898880889610.1128/JVI.00354-1526085147 Figure 1"/>
   <result pre="(*** p &amp;lt; 0.001). Figure 2 P. mauritianum extract inhibits" exact="ZIKV" post="attachment to the cell surface. (A) Schematic representation of"/>
   <result pre="significant). Figure 3 P. mauritianum extract inhibits the production of" exact="ZIKV" post="ssRNA. ZIKV-MR766 particles were incubated with the P. mauritianum"/>
   <result pre="independent experiments. Scale bars are 20 μm. (B) Quantification of" exact="ZIKV" post="ssRNA spots counted per field (fields contained on average"/>
   <result pre="of the P. mauritianum extract against the African and Asian" exact="ZIKV" post="lineages. ZIKV-MR766 or ZIKV-PF13 were incubated with the P."/>
   <result pre="(A) The cells were processed for an immunofluorescence assay. The" exact="ZIKV" post="E protein (red) and nuclei (blue) were visualized by"/>
   <result pre="reduces the viral progeny production of the African and Asian" exact="ZIKV" post="lineages. (A) ZIKV-MR766 or (B) ZIKV-PF13 were incubated with"/>
   <result pre="6 The P. mauritianum extract inhibits the infection of four" exact="DENV" post="clinical isolates representative of the four serotypes. Four DENV"/>
   <result pre="four DENV clinical isolates representative of the four serotypes. Four" exact="DENV" post="serotypes (DENV-1, 2, 3 and 4) were pre-incubated with"/>
   <result pre="°C. (A) Huh7.5 cells were infected for 48 h with" exact="DENV" post="at the different MOI 0.2, 2, 0.5 and 2"/>
   <result pre="at the different MOI 0.2, 2, 0.5 and 2 for" exact="DENV" post="1–4, respectively. Recombinant IFN-α 2A (200 IU mL−1) was"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6518302\results\search\tropicalVirus\results.xml">
   <result pre="(http://creativecommons.org/licenses/by/4.0/). Abstract In 2015–2016, South America went through the largest" exact="Zika" post="epidemic in recorded history. One important aspect of this"/>
   <result pre="We propose a mathematical model for the transmission of the" exact="Zika" post="virus including sexual transmission via all forms of sexual"/>
   <result pre="inference of the model’s parameters using data from the 2016" exact="Zika" post="epidemic in Rio de Janeiro. epidemiology ℛ0 vector-borne disease"/>
   <result pre="available to validate theoretical considerations raised by the modeling [3,4]." exact="Zika" post="virus (ZIKV) was originally isolated from samples from the"/>
   <result pre="Zika virus (ZIKV) was originally isolated from samples from the" exact="Zika" post="forest in Uganda obtained from a rhesus monkey in"/>
   <result pre="1952–1954 [6], spreading slowly across the Asian continent. Before 2007," exact="ZIKV" post="was not considered a disease of substantial concern to"/>
   <result pre="isolated cases involving small populations had been reported worldwide [7]." exact="ZIKV" post="transmission had previously only been documented in regions of"/>
   <result pre="microcephaly were reported in Pernambuco. In November, after confirmation of" exact="ZIKV" post="presence in the amniotic fluid of pregnant women in"/>
   <result pre="association between the virus infection and microcephaly was confirmed [6]." exact="ZIKV" post="spread rapidly throughout Brazil, and in less than a"/>
   <result pre="that in 2015 alone, there were between 440,000 and 1,300,000" exact="Zika" post="cases in Brazil, resulting in the largest ZIKV epidemic"/>
   <result pre="and 1,300,000 Zika cases in Brazil, resulting in the largest" exact="ZIKV" post="epidemic reported so far [10]. Although ZIKV is a"/>
   <result pre="in the largest ZIKV epidemic reported so far [10]. Although" exact="ZIKV" post="is a flavivirus transmitted to humans primarily through the"/>
   <result pre="presence of a infectious viral load in the semen after" exact="Zika" post="infection [12], indicating that we are dealing with a"/>
   <result pre="and from women to men have also been reported [15,16]." exact="Zika" post="transmission has been modeled mathematically before [17,18,19]. In this"/>
   <result pre="the current understanding of the mechanisms behind the transmission of" exact="ZIKV" post="and its consequences to human health, we expect our"/>
   <result pre="Finally, we fit the model to data from the 2016" exact="Zika" post="epidemic in Rio de Janeiro to estimate some of"/>
   <result pre="demonstrate that this model is able to explain a real" exact="Zika" post="epidemic with different burdens for women and men. 2."/>
   <result pre="S ( t ) , respectively, are exposed to the" exact="Zika" post="virus with a β S sexual transmission rate and"/>
   <result pre="male-to-female transmission. We assume permanent and perfect immunity against new" exact="ZIKV" post="infections after the first infection; therefore, recovered individual are"/>
   <result pre="model, we fitted the model to the observed incidence of" exact="Zika" post="in men and women in the 2016 epidemic in"/>
   <result pre="in Rio de Janeiro [14]. We calculated the prevalence of" exact="Zika" post="for both sexes by dividing the weekly-reported number of"/>
   <result pre="τ l 2 4 μ τ l If we disregard" exact="Zika" post="sexual transmission between individuals of the same sex and"/>
   <result pre="u r , was added, corresponding to the underreporting of" exact="Zika" post="in men relative to women: M I o ("/>
   <result pre="transmission of Zika. The model accommodates all known forms of" exact="Zika" post="sexual transmission, as well as vectorial transmission. Vectorial transmission"/>
   <result pre="women. This lack of a more complete knowledge of the" exact="ZIKV" post="transmission cycle is the main limitation of our results."/>
   <result pre="have found that the asymmetrical nature of sexual transmission of" exact="ZIKV" post="can lead to a larger burden on women when"/>
   <result pre="sexual and vectorial transmission. This effect has been observed in" exact="Zika" post="incidence data [14,17,26,27], but it was frequently confounded with"/>
   <result pre="sexual partners [28], the amplification of the sexual transmission of" exact="Zika" post="in this community can be quite large if this"/>
   <result pre="is included. Moreover, with effective male-to-male transmission, sustained transmission of" exact="ZIKV" post="becomes possible without the vector. In Figure 6, the"/>
   <result pre="important factor in the determination of the long-term dynamics of" exact="Zika" post="in a population is the parameter K L ,"/>
   <result pre=", which represents how capable men are at sexually transmitting" exact="ZIKV" post="after the viremic period (Figure 3), when compared to"/>
   <result pre="has been confirmed that some men can test positive for" exact="ZIKV" post="RNA in the semen months after the viremic period"/>
   <result pre="models in sexually transmitted disease epidemiologySex. Transmitted Infect.20027871210.1136/sti.78.1.7 5.LuceyD.R.GostinL.O.The Emerging" exact="Zika" post="PandemicJAMA201631586510.1001/jama.2016.090426818622 6.NunesM.L.CarliniC.R.MarinowicD.NetoF.K.FioriH.H.ScottaM.C.ZanellaP.L.�?.SoderR.B.da CostaJ.C.Microcephaly and Zika virus: A clinical and"/>
   <result pre="epidemiologySex. Transmitted Infect.20027871210.1136/sti.78.1.7 5.LuceyD.R.GostinL.O.The Emerging Zika PandemicJAMA201631586510.1001/jama.2016.090426818622 6.NunesM.L.CarliniC.R.MarinowicD.NetoF.K.FioriH.H.ScottaM.C.ZanellaP.L.�?.SoderR.B.da CostaJ.C.Microcephaly and" exact="Zika" post="virus: A clinical and epidemiological analysis of the current"/>
   <result pre="a newly emerging arbovirusLancet Infect. Dis.201616e119e12610.1016/S1473-3099(16)30010-X27282424 8.AbushoukA.I.NegidaA.AhmedH.An updated review of" exact="Zika" post="virusJ. Clin. Virol.201684535810.1016/j.jcv.2016.09.01227721110 9.ZanlucaC.de MeloV.C.A.MosimannA.L.P.dos SantosG.I.V.dos SantosC.N.D.LuzK.First report of"/>
   <result pre="Virol.201684535810.1016/j.jcv.2016.09.01227721110 9.ZanlucaC.de MeloV.C.A.MosimannA.L.P.dos SantosG.I.V.dos SantosC.N.D.LuzK.First report of autochthonous transmission of" exact="Zika" post="virus in BrazilMemórias do Instituto Oswaldo Cruz201511056957210.1590/0074-0276015019226061233 10.HeukelbachJ.AlencarC.H.KelvinA.A.De OliveiraW.K.Pamplona"/>
   <result pre="sexually transmitted pathogen?Lancet Infect. Dis.20161640510.1016/S1473-3099(16)00138-9 14.CoelhoF.C.DurovniB.SaraceniV.LemosC.CodeçoC.T.CamargoS.De CarvalhoL.M.BastosL.ArduiniD.VillelaD.A.et al.Higher incidence of" exact="Zika" post="in adult women than adult men in Rio de"/>
   <result pre="to womenInt. J. Infect. Dis.20165112813210.1016/j.ijid.2016.08.02327664930 15.DavidsonA.SlavinskiS.KomotoK.RakemanJ.WeissD.Suspected Female-to-Male Sexual Transmission of" exact="Zika" post="Virus—New York City, 2016MMWR Morb. Mortal. Wkly. Rep.20166571671710.15585/mmwr.mm6528e227442327 16.DeckardD.T.ChungW.M.BrooksJ.T.SmithJ.C.WoldaiS.HennesseyM.KwitN.MeadP.Male-to-Male"/>
   <result pre="City, 2016MMWR Morb. Mortal. Wkly. Rep.20166571671710.15585/mmwr.mm6528e227442327 16.DeckardD.T.ChungW.M.BrooksJ.T.SmithJ.C.WoldaiS.HennesseyM.KwitN.MeadP.Male-to-Male Sexual Transmission of" exact="Zika" post="Virus—Texas, January 2016MMWR Morb. Mortal. Wkly. Rep.20166537237410.15585/mmwr.mm6514a327078057 17.TowersS.BrauerF.Castillo-ChavezC.FalconarA.K.MubayiA.Romero-VivasC.M.Estimate of"/>
   <result pre="Wkly. Rep.20166537237410.15585/mmwr.mm6514a327078057 17.TowersS.BrauerF.Castillo-ChavezC.FalconarA.K.MubayiA.Romero-VivasC.M.Estimate of the reproduction number of the 2015" exact="Zika" post="virus outbreak in Barranquilla, Colombia, and estimation of the"/>
   <result pre="the relative role of sexual transmissionEpidemics201617505510.1016/j.epidem.2016.10.00327846442 18.GaoD.LouY.HeD.PorcoT.C.KuangY.ChowellG.RuanS.Prevention and control of" exact="Zika" post="fever as a mosquito-borne and sexually transmitted disease: A"/>
   <result pre="Modeling AnalysisSci. Rep.201662807010.1038/srep2807027312324 19.Baca-CarrascoD.Velasco-HernándezJ.X.Sex, Mosquitoes and Epidemics: An Evaluation of" exact="Zika" post="Disease DynamicsBull. Math. Biol.2016782228224210.1007/s11538-016-0219-427743310 20.IseaR.LonngrenK.E.A Preliminary Mathematical Model for"/>
   <result pre="20.IseaR.LonngrenK.E.A Preliminary Mathematical Model for the Dynamic Transmission of Dengue," exact="Chikungunya" post="and ZikaAm. J. Mod. Phys. Appl.201631115 21.BastosM.M.CoelhoF.C.Estimating under-observation and"/>
   <result pre="Appl.201631115 21.BastosM.M.CoelhoF.C.Estimating under-observation and the full size of the 2016" exact="Zika" post="epidemic in Rio de JaneiroPLoS ONE201813e020500110.1371/journal.pone.020500130312300 22.CoelhoF.C.CodeçoC.T.GomesM.G.M.A bayesian framework"/>
   <result pre="countries, 1990–2013: A systematic reviewAIDS Behav.2017212811283410.1007/s10461-017-1799-128555317 29.AtkinsonB.ThorburnF.PetridouC.BaileyD.HewsonR.SimpsonA.J.BrooksT.J.AaronsE.J.Presence and persistence of" exact="Zika" post="virus RNA in semen, United Kingdom, 2016Emerg. Infect. Dis.20172361110.3201/eid2304.16169227997333"/>
   <result pre="United Kingdom, 2016Emerg. Infect. Dis.20172361110.3201/eid2304.16169227997333 30.KimC.R.CounotteM.BernsteinK.DealC.MayaudP.LowN.BroutetN.Investigating the sexual transmission of" exact="Zika" post="virusLancet Glob. Health20186e24e2510.1016/S2214-109X(17)30419-929241605 31.FolkersK.M.CaplanA.L.IgelL.H.Zika, sexual transmission and prudent public"/>
   <result pre="is worth noticing that the reported excess cases reported for" exact="Zika" post="in women are possible both during epidemics and off-season"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6527025\results\search\tropicalVirus\results.xml">
   <result pre="RNA polymerase (RdRp) before protein translation. Among arboviruses, 390 million" exact="Dengue" post="(DEN) infections are reported globally each year, of which"/>
   <result pre="as severe clinical forms of the disease [12]. In 2015," exact="Zika" post="virus (ZIKV) was reported to cause microcephaly and microencephaly"/>
   <result pre="are infected by viruses from the same family, such as" exact="DENV" post="and ZIKV, may be very similar, which affects proper"/>
   <result pre="Viruses like cytomegalovirus (CMV – a herpesvirus) and Flaviviruses (DENV," exact="ZIKV" post="and Japanese encephalitis virus (JEV)) induce the host UPR"/>
   <result pre="of intracellular oxidative stress, are also used by viruses like" exact="ZIKV" post="and influenza virus to promote viral replication and increase"/>
   <result pre="replication [120]. There are also multiple viruses that exploit lipophagy." exact="DENV" post="infection increases the number of lipid droplets per cell."/>
   <result pre="a platform for nucleocapsid formation and viral replication [127]. Moreover," exact="DENV" post="infection induces lipophagy, which depletes stored triglycerides and increases"/>
   <result pre="membranes both for replication and exocytosis through multivesicular bodies (MVBs)." exact="DENV" post="reduces p62, an autophagy receptor, via proteasomal degradation, to"/>
   <result pre="yields through LC3-I- and EDEM1-containing membranes [153]. The replication of" exact="DENV" post="is positively linked to autophagy induction by which the"/>
   <result pre="initiation of autophagy is enhanced in DENV-infected cells [154,155]. However," exact="DENV" post="replication is cell-specific and it would be limited in"/>
   <result pre="cell lines [157]. Some evidence supports upregulation of autophagy by" exact="WNV" post="[158,159], whereas some other evidence does not [157]. A"/>
   <result pre="viral replication and virus-induced autophagy also has been shown in" exact="Chikungunya" post="virus (CHIKV)-infected HEK293 (human embryonic kidney) cells [148]. Epizootic"/>
   <result pre="upon autophagy stimulation [162]. The amphisomes play major roles in" exact="DENV" post="entry and translation/replication [152]. DENV-2 interacts with amphisomes while"/>
   <result pre="both amphisomes and autophagolysosomes for their translation/replication (Figure 1) [152]." exact="CHIKV" post="also increases autophagosome formation as a site for aggregation"/>
   <result pre="studies have shown the presence of viral replication/translation complexes of" exact="DENV" post="and JEV in both the autophagosome and the endosome,"/>
   <result pre="it has been demonstrated that autophagy postpones apoptosis and promotes" exact="CHIKV" post="propagation by inducing the IRE1α–XBP-1 pathway in conjunction with"/>
   <result pre="modulating viral replication which include: a) some arboviruses such as" exact="DENV" post="and JEV can use amphisome formation for their entry"/>
   <result pre="and replication; b) several arboviruses such as DENV, ZIKV, JEV," exact="CHIKV" post="and TBEV exert diverse mechanisms to induce autophagosome formation"/>
   <result pre="mechanisms to induce autophagosome formation to enhance viral replication/translation complexes." exact="DENV" post="is associated with NS4A in up-regulating PI3K-dependent autophagy. CHIKV"/>
   <result pre="complexes. DENV is associated with NS4A in up-regulating PI3K-dependent autophagy." exact="CHIKV" post="induces the IRE1α–XBP-1 pathway in conjunction with ROS-mediated mTOR"/>
   <result pre="the IRE1α–XBP-1 pathway in conjunction with ROS-mediated mTOR inhibition; c)" exact="DENV" post="benefits from autophagy activation by using lipid droplets as"/>
   <result pre="energy source for replication; d) Viruses such as DENV-2 and" exact="CHIKV" post="can increase their replication by prolonging cell survival and"/>
   <result pre="an effective virus-suppressing immune response [modified from [131]] . DENV:" exact="Dengue" post="virus; ZIKV: Zika virus; JEV: Japanese encephalitis virus; CHIKV:"/>
   <result pre="immune response [modified from [131]] . DENV: Dengue virus; ZIKV:" exact="Zika" post="virus; JEV: Japanese encephalitis virus; CHIKV: Chikungunya virus; TBEV:"/>
   <result pre="Dengue virus; ZIKV: Zika virus; JEV: Japanese encephalitis virus; CHIKV:" exact="Chikungunya" post="virus; TBEV: tick-borne encephalitis virus; VSV: vesicular stomatitis virus."/>
   <result pre="a major role for the phosphatidylserine receptor AXL as a" exact="ZIKV" post="entry receptor, and cellular autophagy in enhancing ZIKV replication"/>
   <result pre="as a ZIKV entry receptor, and cellular autophagy in enhancing" exact="ZIKV" post="replication in permissive cells [172]. Thus, ZIKV is able"/>
   <result pre="autophagy in enhancing ZIKV replication in permissive cells [172]. Thus," exact="ZIKV" post="is able to increase its replication via induction of"/>
   <result pre="was infected with Brazilian ZIKV. It was demonstrated that Brazilian" exact="ZIKV" post="crosses the placenta and causes microcephaly by targeting cortical"/>
   <result pre="for Drosophila stimulator of interferon genes (dSTING)-dependent autophagy to restrict" exact="ZIKV" post="infection and to control neuronal infection [175]. Tick-borne encephalitis"/>
   <result pre="activation to facilitate virus replication [156] Studied the replication of" exact="DENV" post="DENV replication is cell-specific and it would be limited"/>
   <result pre="to facilitate virus replication [156] Studied the replication of DENV" exact="DENV" post="replication is cell-specific and it would be limited in"/>
   <result pre="as a main component of the DENV2 replication complexes [167]" exact="DENV" post="replication/translation is associated with NS4A in up-regulating PI3K-dependent autophagy,"/>
   <result pre="participate in autophagy during persistent infection of mosquito cells with" exact="DENV" post="[157] Studied WNV replication DENV replication was shown to"/>
   <result pre="during persistent infection of mosquito cells with DENV [157] Studied" exact="WNV" post="replication DENV replication was shown to be autophagy independent;"/>
   <result pre="infection of mosquito cells with DENV [157] Studied WNV replication" exact="DENV" post="replication was shown to be autophagy independent; however, it"/>
   <result pre="it still induced autophagy [158,159] supported upregulation of autophagy by" exact="WNV" post="[160] mapped the genetic determinants of autophagy regulation in"/>
   <result pre="WNV [160] mapped the genetic determinants of autophagy regulation in" exact="WNV" post="infected cells Amino acid substitutions in the NS 4A"/>
   <result pre="modulate the induction of autophagy in WNV-infected cells [148] Studied" exact="CHIKV" post="replication Showed the relation between up-regulation of viral replication"/>
   <result pre="of viral replication and virus-induced autophagy in CHIKV-infected cells [148,163]" exact="CHIKV" post="also increases autophagosome formation as a site for aggregation"/>
   <result pre="of viral translation/replication complexes [168] Autophagy postpones apoptosis and promotes" exact="CHIKV" post="propagation by inducing the IRE1α–XBP-1 pathway in conjunction with"/>
   <result pre="of RIG, and MDA5 can promote VSV replication [172] Studied" exact="ZIKV" post="replication Showed a major role for the phosphatidylserine receptor"/>
   <result pre="a major role for the phosphatidylserine receptor AXL as a" exact="ZIKV" post="entry receptor, and cellular autophagy in enhancing ZIKV replication"/>
   <result pre="as a ZIKV entry receptor, and cellular autophagy in enhancing" exact="ZIKV" post="replication in permissive cells [173] Used murine experimental model"/>
   <result pre="cells [173] Used murine experimental model to infect with Brazillian" exact="ZIKV" post="ZIKV replication is enhanced via induction of autophagy in"/>
   <result pre="[173] Used murine experimental model to infect with Brazillian ZIKV" exact="ZIKV" post="replication is enhanced via induction of autophagy in infected"/>
   <result pre="autophagy in infected skin fibroblasts. It was demonstrated that Brazilian" exact="ZIKV" post="crosses the placenta and causes microcephaly [175] Studied Drosophila"/>
   <result pre="system Suggested an essential role for dSTING-dependent autophagy to restrict" exact="ZIKV" post="infection and to control neuronal infection [176,177] Studied TBEV"/>
   <result pre="cells inducing neuronal dysfunction, membrane rearrangements and autophagosome formation CHIKV:" exact="Chikungunya" post="virus; DENV: Dengue virus; EHDV: Epizootic hemorrhagic disease virus;"/>
   <result pre="dysfunction, membrane rearrangements and autophagosome formation CHIKV: Chikungunya virus; DENV:" exact="Dengue" post="virus; EHDV: Epizootic hemorrhagic disease virus; JEV: Japanese encephalitis"/>
   <result pre="virus; TBEV: Tick-borne encephalitis virus; VSV: Vesicular stomatitis virus; WNV:" exact="West Nile" post="virus; ZIKV: Zika virus. Arboviruses and apoptosis Arboviruses such"/>
   <result pre="virus; VSV: Vesicular stomatitis virus; WNV: West Nile virus; ZIKV:" exact="Zika" post="virus. Arboviruses and apoptosis Arboviruses such as SINV, WNV,"/>
   <result pre="ovarian epithelium, and Pan02, derived from a pancreatic adenocarcinoma [185]." exact="CHIKV" post="triggers the apoptosis pathway to evade the immune system"/>
   <result pre="system and facilitate its dissemination by infecting neighboring cells [186]." exact="CHIKV" post="infection triggers both apoptosis and autophagy. However, based on"/>
   <result pre="upregulation of Bax, HRK, PUMA, and Noxa. WNV, JEV and" exact="DENV" post="block or delay apoptosis via activating PI3K/Akt signaling. WNV"/>
   <result pre="and DENV block or delay apoptosis via activating PI3K/Akt signaling." exact="WNV" post="can trigger apoptosis after several rounds of replication through"/>
   <result pre="apoptosis. JEV may affect Bcl-2 expression to increase anti-apoptotic response." exact="DENV" post="may subvert apoptosis by inhibiting NF-kB. DENV reduces immune"/>
   <result pre="increase anti-apoptotic response. DENV may subvert apoptosis by inhibiting NF-kB." exact="DENV" post="reduces immune responses by activation of p53-dependent apoptosis. RVFV"/>
   <result pre="signaling. The BTV-induced apoptosis involves NF-kB [modified from [131]]. DENV:" exact="Dengue" post="virus; ZIKV: Zika virus; WNV: West Nile virus; JEV:"/>
   <result pre="apoptosis involves NF-kB [modified from [131]]. DENV: Dengue virus; ZIKV:" exact="Zika" post="virus; WNV: West Nile virus; JEV: Japanese encephalitis virus;"/>
   <result pre="[modified from [131]]. DENV: Dengue virus; ZIKV: Zika virus; WNV:" exact="West Nile" post="virus; JEV: Japanese encephalitis virus; CHIKV: Chikungunya virus; CCHFV:"/>
   <result pre="virus; WNV: West Nile virus; JEV: Japanese encephalitis virus; CHIKV:" exact="Chikungunya" post="virus; CCHFV: Crimean Congo hemorrhagic fever virus; RVFV: Rift"/>
   <result pre="another investigation showed a positive relationship between IL-8 induction and" exact="DENV" post="infection [187–189]. In contrast to SINV, CHIKV and CCHFV"/>
   <result pre="IL-8 induction and DENV infection [187–189]. In contrast to SINV," exact="CHIKV" post="and CCHFV replication in infected cells are necessary for"/>
   <result pre="a nucleolar multifunctional chaperone, plays a critical role in restricting" exact="CHIKV" post="replication [193]. Studies of mouse models comparing the East"/>
   <result pre="the East Central South African (ECSA) and Asian strains of" exact="CHIKV" post="have shown that both strains can spread to astrocytes"/>
   <result pre="to p38 MAPK activation and did not affect JEV and" exact="DENV" post="viral particle production [190]. In 2001, it was demonstrated"/>
   <result pre="virus-induced cell death in K562 and Neuro-2a cells [196]. The" exact="WNV" post="capsid protein has anti-apoptotic functions which can block or"/>
   <result pre="PI3-kinase, can directly phosphorylate Bad at position Ser136 [197]. However," exact="WNV" post="can trigger apoptosis after several rounds of replication through"/>
   <result pre="positively or negatively. One such miRNA is Hs_154, which limits" exact="WNV" post="replication in HEK293 and SK-N-MC cells by inhibition of"/>
   <result pre="of JEV [207]. Several studies have confirmed the effect of" exact="DENV" post="on apoptosis in a wide variety of mammalian cells"/>
   <result pre="Dendritic cells are believed to be the primary targets for" exact="DENV" post="and play central roles in supporting active replication for"/>
   <result pre="for virus pathogenesis. However, a study reported that replication of" exact="DENV" post="in monocyte-derived dendritic cells (mdDCs) was positively correlated with"/>
   <result pre="TNFα and apoptosis [208]. To achieve high rates of replication," exact="DENV" post="may subvert apoptosis in macrophages, hepatoma, and dendritic cells,"/>
   <result pre="cells, by inhibiting NF-kB in response to TNFα stimulation [201,209]." exact="DENV" post="replication was positively affected by inhibiting apoptosis by the"/>
   <result pre="modulating cyclophilin-binding ligand (CAML) [201]. Activation of p53-dependent apoptosis by" exact="DENV" post="may contribute to the inhibition of inflammation and reduction"/>
   <result pre="line, H1299, and on a p53-knockin cell line [210]. Following" exact="DENV" post="infection in these cell lines, a microarray analysis revealed"/>
   <result pre="necessary for up-regulation of different immune response genes [210]. The" exact="WNV" post="capsid protein was shown to be capable of inducing"/>
   <result pre="catalyzes trans-splicing of the 5ʹ conserved target sequences of the" exact="DENV" post="and CHIKV genomes to a 3ʹΔN Bax exon, to"/>
   <result pre="of the 5ʹ conserved target sequences of the DENV and" exact="CHIKV" post="genomes to a 3ʹΔN Bax exon, to effectively induce"/>
   <result pre="using Class II TE mariner MosI. They targeted the conserved" exact="DENV" post="and CHIKV sequences, which then could lead to viral"/>
   <result pre="II TE mariner MosI. They targeted the conserved DENV and" exact="CHIKV" post="sequences, which then could lead to viral RNA trans-splicing"/>
   <result pre="could lead to viral RNA trans-splicing and cell apoptosis [219]." exact="ZIKV" post="infection in epidermal keratinocytes caused the appearance of cytoplasmic"/>
   <result pre="of apoptotic cells [172]. The South Pacific epidemic strain of" exact="ZIKV" post="(PF-25,013–18) can replicate in A549 cells. This infection enhanced"/>
   <result pre="which triggers apoptosis and attenuates neurogenesis [221]. Different strains of" exact="ZIKV" post="make use of different structural proteins which affects the"/>
   <result pre="line plays roles in apoptosis of the mosquito cells during" exact="DENV" post="infection. Ub3881 overexpression targeted DENV envelope protein and reduced"/>
   <result pre="of the mosquito cells during DENV infection. Ub3881 overexpression targeted" exact="DENV" post="envelope protein and reduced virion production. The loss of"/>
   <result pre="loss of Ub3881 function reduced the level of apoptosis during" exact="DENV" post="infection [228]. This suggests it would be worthwhile to"/>
   <result pre="would be worthwhile to test Ub3881 peptides as inhibitors of" exact="DENV" post="infection in mosquitoes. As indicated above, several studies have"/>
   <result pre="then dsRNA-dependent protein kinase (PKR) recognizes these particles [186] Studied" exact="CHIKV" post="replication The CHIKV triggers the apoptosis to evade immune"/>
   <result pre="kinase (PKR) recognizes these particles [186] Studied CHIKV replication The" exact="CHIKV" post="triggers the apoptosis to evade immune system and facilitate"/>
   <result pre="system and facilitate its dissemination by infecting neighboring cells [168]" exact="CHIKV" post="infection can induce apoptotic cell death via intrinsic and"/>
   <result pre="spread [193] The proteomic analysis in astrocytic cells infected with" exact="CHIKV" post="It showed that Nucleophosmin (NPM1)/B23, a nucleolar multifunctional chaperone,"/>
   <result pre="a nucleolar multifunctional chaperone, plays a critical role in restricting" exact="CHIKV" post="replication [194] Studied mouse models comparing African and Asian"/>
   <result pre="[194] Studied mouse models comparing African and Asian strains of" exact="CHIKV" post="Both strains can spread to astrocytes and neurons, however,"/>
   <result pre="to p38 MAPK activation and did not affect JEV and" exact="DENV" post="viral particle productionNecrosis and apoptosis were clearly noticed as"/>
   <result pre="clearly noticed as cytopathic effects of DENV-2 infection [197] Studied" exact="WNV" post="replication Akt can directly phosphorylate Bad at position Ser"/>
   <result pre="Akt can directly phosphorylate Bad at position Ser 136 in" exact="WNV" post="infected cells [190,201] Studied expression of multiple miRNAs in"/>
   <result pre="of multiple miRNAs in JEV infection One miRNA, Hs_154, limits" exact="WNV" post="replication by inhibition of two anti-apoptotic proteins like CCCTC"/>
   <result pre="are crucial steps in the pathogenesis of JEV [208] Studied" exact="DENV" post="replication Replication of DENV in monocyte-derived dendritic cells was"/>
   <result pre="the pathogenesis of JEV [208] Studied DENV replication Replication of" exact="DENV" post="in monocyte-derived dendritic cells was positively correlated with TNFα"/>
   <result pre="was necessary for up-regulation of different immune response genes following" exact="DENV" post="infection [210] microarray analysis [199,211] Studied RVFV replication NSs"/>
   <result pre="phenotypes in the vector mosquito Aedes aegypti Targeted the conserved" exact="DENV" post="and CHIKV sequences, which then led to viral RNA"/>
   <result pre="the vector mosquito Aedes aegypti Targeted the conserved DENV and" exact="CHIKV" post="sequences, which then led to viral RNA trans-splicing and"/>
   <result pre="to viral RNA trans-splicing and cell apoptosis [172] Studied on" exact="ZIKV" post="infection ZIKV infection in epidermal keratinocytes caused the appearance"/>
   <result pre="RNA trans-splicing and cell apoptosis [172] Studied on ZIKV infection" exact="ZIKV" post="infection in epidermal keratinocytes caused the appearance of cytoplasmic"/>
   <result pre="indicative for apoptotic cells [220] South Pacific epidemic strain of" exact="ZIKV" post="(PF-25,013–18) can replicate in A549 cells. This infection enhanced"/>
   <result pre="Type-I IFNs, ISGs, pro-inflammatory cytokines and delayed mitochondrial apoptosis [221]" exact="ZIKV" post="which infects neural progenitor cells in organoid and neurosphere"/>
   <result pre="which triggers apoptosis and attenuates neurogenesis [222] Different strains of" exact="ZIKV" post="take use of different structural proteins which affect the"/>
   <result pre="Ub3881 plays role in apoptosis of the mosquito cells during" exact="DENV" post="infection. The Ub3881 overexpression targeted DENV envelope protein and"/>
   <result pre="the mosquito cells during DENV infection. The Ub3881 overexpression targeted" exact="DENV" post="envelope protein and reduced virion production. The loss of"/>
   <result pre="loss of Ub3881 function reduced the level of apoptosis during" exact="DENV" post="infection AHSV: African horse sickness virus; CCHFV: Crimean Congo"/>
   <result pre="horse sickness virus; CCHFV: Crimean Congo hemorrhagic fever virus; CHIKV:" exact="Chikungunya" post="virus; DENV: Dengue virus; EHDV: Epizootic hemorrhagic disease virus;"/>
   <result pre="CCHFV: Crimean Congo hemorrhagic fever virus; CHIKV: Chikungunya virus; DENV:" exact="Dengue" post="virus; EHDV: Epizootic hemorrhagic disease virus; JEV: Japanese encephalitis"/>
   <result pre="virus; TBEV: Tick-borne encephalitis virus; VSV: Vesicular stomatitis virus; WNV:" exact="West Nile" post="virus; ZIKV: Zika virus. Arboviruses and UPR WNV activates"/>
   <result pre="virus; VSV: Vesicular stomatitis virus; WNV: West Nile virus; ZIKV:" exact="Zika" post="virus. Arboviruses and UPR WNV activates multiple UPR pathways"/>
   <result pre="WNV: West Nile virus; ZIKV: Zika virus. Arboviruses and UPR" exact="WNV" post="activates multiple UPR pathways which cause activation of several"/>
   <result pre="genes [200]. The XBP1 pathway was shown not necessary for" exact="WNV" post="replication; however, ATF6 was degraded by the proteasome and"/>
   <result pre="the pro-apoptotic protein CHOP (Figure 3) [200]. Cells infected with" exact="WNV" post="showed signs of apoptosis including induction of growth arrest"/>
   <result pre="of growth arrest and activation of caspase-3 and PARP. The" exact="WNV" post="titer was also significantly increased in a CHOP−/- deficient"/>
   <result pre="wild type MEF cells [200]. The host mechanism to counteract" exact="WNV" post="infection involved activation of CHOP-dependent cell death [200]. The"/>
   <result pre="death [200]. The evidence confirmed the activation of UPR in" exact="WNV" post="infection via ATF6/IRE1 pathways [200,229]. However, there was no"/>
   <result pre="that the UPR PERK pathway was not activated [229]. The" exact="WNV" post="Kunjin strain NS4A and NA4B proteins were recognized as"/>
   <result pre="C1008 cells [229]. These results showed that hydrophobic residues of" exact="WNV" post="Kunjin strain NS proteins activate UPR signaling. The results"/>
   <result pre="same study group showed that ATF6 signaling is required for" exact="WNV" post="replication by promoting cell survival and innate immune response"/>
   <result pre="response inhibition [230]. The ATF6-deficient cells showed a decrease in" exact="WNV" post="Kunjin strain protein and virion production. These cells also"/>
   <result pre="necessity of ATF6 for inhibition of innate immune response [230]." exact="CHIKV" post="and SINV also cause frequent epidemics of febrile illness"/>
   <result pre="that they have definite control over the host’s UPR system." exact="CHIKV" post="specifically activates the ATF6 and IRE1 cascades and suppresses"/>
   <result pre="ATF6 and IRE1 cascades and suppresses the PERK pathway [231]." exact="CHIKV" post="NSp4 expression in mammalian cells suppresses eIF2α phosphorylation, which"/>
   <result pre="neuroblastoma N18 cells were infected with the arboviruses JEV and" exact="DENV" post="[232]. This was seen by splicing of XBP1 mRNA"/>
   <result pre="cellular apoptosis [232]. These results suggest that both JEV and" exact="DENV" post="trigger the XBP1 signaling pathway and take advantage of"/>
   <result pre="that alpha-glucosidase inhibitors Celgosivir (an iminosugar) and Castanospermine can inhibit" exact="DENV" post="production via inhibition of ER-resident alpha-glucosidase in primary human"/>
   <result pre="Another study showed that A547 ovarian cancer cells infected with" exact="DENV" post="elicited the UPR signaling response [235]. This was confirmed"/>
   <result pre="of eIF2α. It was also shown that different serotypes of" exact="DENV" post="activate other UPR pathways such as ATF6 and IRE1."/>
   <result pre="ATF6 and IRE1. These results showed that different serotypes of" exact="DENV" post="have the capacity to modulate different UPR pathways. This"/>
   <result pre="activate different UPR pathways [235]. This report also indicated that" exact="DENV" post="induces the expression of the protein complex (containing the"/>
   <result pre="protein complex dephosphorylated eIF2α, dramatically reduced GADD34 and subsequently reduced" exact="DENV" post="infection [235]. Thus, specific virus-induced UPR pathway usage depends"/>
   <result pre="Summary of the study Conclusions [200] Studied UPR involvement in" exact="WNV" post="infection WNV activates multiple UPR pathways.XBP1 pathway was not"/>
   <result pre="the study Conclusions [200] Studied UPR involvement in WNV infection" exact="WNV" post="activates multiple UPR pathways.XBP1 pathway was not necessary for"/>
   <result pre="WNV activates multiple UPR pathways.XBP1 pathway was not necessary for" exact="WNV" post="replication; however, ATF6 was degraded by the proteasome and"/>
   <result pre="and induced the pro-apoptotic protein CHOP.The host mechanism to counteract" exact="WNV" post="infection involved activation of CHOP-dependent cell death. [200,229] WNV"/>
   <result pre="counteract WNV infection involved activation of CHOP-dependent cell death. [200,229]" exact="WNV" post="infection activatied UPR via ATF6/IRE1 pathways. [229] UPR PERK"/>
   <result pre="via ATF6/IRE1 pathways. [229] UPR PERK pathway was not activated.The" exact="WNV" post="Kunjin strain NS4A and NA4B proteins are potent inducers"/>
   <result pre="of hydrophobic domains of NS4A decreased UPR activation.Hydrophobic residues of" exact="WNV" post="Kunjin strain NS proteins activate UPR signaling.In contrast, upon"/>
   <result pre="innate immune response. [232] Studied UPR involvement in JEV and" exact="DENV" post="infection JEV and DENV infection activated XBP1 pathway in"/>
   <result pre="Studied UPR involvement in JEV and DENV infection JEV and" exact="DENV" post="infection activated XBP1 pathway in neuoroblastoma N18 cells.Applying small"/>
   <result pre="the two viruses but enhanced the cellular apoptosis.Both JEV and" exact="DENV" post="trigger the XBP1 signaling pathway. [231] Studied UPR involvement"/>
   <result pre="trigger the XBP1 signaling pathway. [231] Studied UPR involvement in" exact="CHIKV" post="and SINV infection CHIKV specifically activates the ATF6 and"/>
   <result pre="pathway. [231] Studied UPR involvement in CHIKV and SINV infection" exact="CHIKV" post="specifically activates the ATF6 and IRE1 cascades and suppresses"/>
   <result pre="eIF2α and activation of CHOP [235] Studied UPR involvement in" exact="DENV" post="infection Showed that A547 ovarian cancer cells infected with"/>
   <result pre="DENV infection Showed that A547 ovarian cancer cells infected with" exact="DENV" post="elicited the UPR signaling responseDifferent serotypes of DENV have"/>
   <result pre="infected with DENV elicited the UPR signaling responseDifferent serotypes of" exact="DENV" post="have the capacity to modulate different UPR pathways. This"/>
   <result pre="EGR1 was also induced in a PERK dependent manner. CHIKV:" exact="Chikungunya" post="virus; DENV: Dengue virus; JEV: Japanese encephalitis virus; RVFV:"/>
   <result pre="induced in a PERK dependent manner. CHIKV: Chikungunya virus; DENV:" exact="Dengue" post="virus; JEV: Japanese encephalitis virus; RVFV: Rift Valley fever"/>
   <result pre="TBEV: Tick-borne encephalitis virus; VEEV: Venezuelan equine encephalitis virus; WNV:" exact="West Nile" post="viruss. Influenza virus and autophagy The autophagy pathway is"/>
   <result pre="de FreitasCS, et alThe clinically approved antiviral drug sofosbuvir inhibits" exact="Zika" post="virus replication. Sci Rep. 2017;7:40920. [15]DuffyMR, ChenTH, HancockWT, et"/>
   <result pre="[33]Gladwyn-NgI, Cordon-BarrisL, AlfanoC, et alStress-induced unfolded protein response contributes to" exact="Zika" post="virus-associated microcephaly. Nat Neurosci. 2018;21:63-+. [34]PrestonCM, NichollMJInduction of cellular"/>
   <result pre="alAutophagy inhibits viral genome replication and gene expression stages in" exact="West Nile" post="virus infection. Virus Res. 2014;191:83–91.25091564 [160]BlázquezAB, Martín-AcebesMA, SaizJ-CAmino acid"/>
   <result pre="proteins 4A or 4B modulate the induction of autophagy in" exact="West Nile" post="virus infected cells independently of the activation of the"/>
   <result pre="of Sciences104 (2007) 14050–14055 [172]HamelR, DejarnacO, WichitS, et alBiology of" exact="Zika" post="Virus infection in human skin cells. J Virol. 2015;89:8880–8896.26085147"/>
   <result pre="cells. J Virol. 2015;89:8880–8896.26085147 [173]CugolaFR, FernandesIR, RussoFB, et alThe Brazilian" exact="Zika" post="virus strain causes birth defects in experimental models. Nature."/>
   <result pre="3-dependent cell death of neurons contributes to the pathogenesis of" exact="West Nile" post="virus encephalitis. J Virol. 2007;81:2614–2623.17192305 [180]SunJ, YuY, DeubelVJapanese encephalitis"/>
   <result pre="Proteome Res. 2017;16:4144–4155.28959884 [194]ChiamCW, ChanYF, OngKC, et alNeurovirulence comparison of" exact="Chikungunya" post="virus isolates of the Asian and East/Central/South African genotypes"/>
   <result pre="African genotypes from Malaysia. J Gen Virol. 2015;96:3243–3254.26276497 [195]UrbanowskiMD, HobmanTCThe" exact="West Nile" post="virus capsid protein blocks apoptosis through a phosphatidylinositol 3-kinase-dependent"/>
   <result pre="Death Dis. 2012;3:e264.22297296 [198]ChuJ, NgMThe mechanism of cell death during" exact="West Nile" post="virus infection is dependent on initial infectious dose. J"/>
   <result pre="GreyFE, UhrlaubJL, et alInduction of the cellular microRNA, Hs_154, by" exact="West Nile" post="virus contributes to virus-mediated apoptosis through repression of antiapoptotic"/>
   <result pre="Cell. 2017;49:86–94.28034555 [218]CarterJR, TaylorS, FraserTS, et alSuppression of the arboviruses" exact="Dengue" post="and Chikungunya using a dual-acting group-I intron coupled with"/>
   <result pre="[218]CarterJR, TaylorS, FraserTS, et alSuppression of the arboviruses Dengue and" exact="Chikungunya" post="using a dual-acting group-I intron coupled with conditional expression"/>
   <result pre="[220]FrumenceE, RocheM, Krejbich-TrototP, et alThe south pacific epidemic strain of" exact="Zika" post="virus replicates efficiently in human epithelial A549 cells leading"/>
   <result pre="et alThe structural proteins of epidemic and historical strains of" exact="Zika" post="virus differ in their ability to initiate viral infection"/>
   <result pre="J Virol. 2011;85:2723–2732.21191014 [230]AmbroseRL, MackenzieJMATF6 signaling is required for efficient" exact="West Nile" post="virus replication by promoting cell survival and inhibition of"/>
   <result pre="J Virol. 2013;87:2206–2214.23221566 [231]RathoreAP, NgML, VasudevanSGDifferential unfolded protein response during" exact="Chikungunya" post="and Sindbis virus infection: CHIKV nsP4 suppresses eIF2alpha phosphorylation."/>
   <result pre="VasudevanSGDifferential unfolded protein response during Chikungunya and Sindbis virus infection:" exact="CHIKV" post="nsP4 suppresses eIF2alpha phosphorylation. Virol J. 2013;10:36.23356742 [232]YuCY, HsuYW,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6531038\results\search\tropicalVirus\results.xml">
   <result pre="The challenge of the laboratory diagnosis in a confirmed congenital" exact="Zika" post="virus syndrome in uteroA case report SulleiroElenaMDabFrickMarie AntoinetteMDabRodóCarlotaPhDabEspasaMateuMDaThorneClairePhDbcEspiauMaríaPhDabMartín-NaldaAndreaMDabSuyAnnaPhDabGiaquintoCarloPhDbdMelendoSusanaMDaRandoAriadnaMDaAlarcónAnaPhDbeMartinón-TorresFedericoPhDbfPumarolaTomásPhDaSoler-PalacínPerePhDaSoriano-ArandesAntoniPhDab∗ NA.[a],"/>
   <result pre="commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0medi-98-e15532.pdf Abstract Abstract Introduction:" exact="Zika" post="virus (ZIKV) has caused one of the most challenging"/>
   <result pre="concerns: A 2-year-old girl, born to a mother with confirmed" exact="ZIKV" post="infection during pregnancy, with a confirmed ZIKV infection in"/>
   <result pre="mother with confirmed ZIKV infection during pregnancy, with a confirmed" exact="ZIKV" post="infection in utero, showed at birth a severe microcephaly"/>
   <result pre="characteristics of fetal brain disruption sequence compatible with a congenital" exact="ZIKV" post="syndrome (CZS). Diagnosis: ZIKV-RNA and ZIKV-IgM serological response performed"/>
   <result pre="Serial serologic ZIKV-IgG tests were performed to assess the laboratory" exact="ZIKV" post="diagnosis, ZIKV-IgG seroreversion was observed at 21 months of"/>
   <result pre="diagnosis, ZIKV-IgG seroreversion was observed at 21 months of age." exact="ZIKV" post="diagnosis of this baby had to be relied on"/>
   <result pre="report. Conclusion: We presume that as a consequence of prenatal" exact="ZIKV" post="infection, the fetal brain and other organs are damaged"/>
   <result pre="understanding of the mechanisms taking part in the pathogenesis of" exact="ZIKV" post="congenital infection is needed. This finding might change our"/>
   <result pre="finding might change our paradigm regarding serological response in the" exact="ZIKV" post="congenital infection. Keywords arboviruses microcephaly serologic test syndrome ZIKA"/>
   <result pre="Keywords arboviruses microcephaly serologic test syndrome ZIKA Virus 1 Introduction" exact="Zika" post="virus (ZIKV) has caused one of the most challenging"/>
   <result pre="(e.g., syphilis).[7] 2 Case report We here describe a congenital" exact="Zika" post="syndrome (CZS) case of a 2-year-old girl born in"/>
   <result pre="2-year-old girl born in Barcelona to a mother infected with" exact="ZIKV" post="during pregnancy, who presented a complete seroreversion of ZIKV-IgG"/>
   <result pre="Control and Prevention (CDC) protocol,[8] the mother was tested for" exact="ZIKV" post="and other flaviviruses to assess the risk of fetal"/>
   <result pre="and other flaviviruses to assess the risk of fetal involvement." exact="ZIKV" post="infection was confirmed at 11 weeks of gestation, when"/>
   <result pre="at 11 weeks of gestation, when she tested positive for" exact="ZIKV" post="RNA by reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay (RealStar Zika Virus RT-PCR"/>
   <result pre="tested positive for ZIKV RNA by reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay (RealStar" exact="Zika" post="Virus RT-PCR Kit 1.0, Altona Diagnostics) in serum, and"/>
   <result pre="for ZIKV-IgG (IIFT, Arboviral fever Mosaic, Euroimmun, Germany), and for" exact="ZIKV" post="plaque reduction neutralization test (PRNT) achieving a maximum titer"/>
   <result pre="(serum, urine, cerebrospinal fluid [CSF], and saliva) were negative for" exact="ZIKV" post="(Table 1). In the first 24 h of life ZIKV"/>
   <result pre="for ZIKV (Table 1). In the first 24 h of life" exact="ZIKV" post="immunoglobulin M (ZIKV-IgM) (IIFT, Arboviral fever Mosaic, Euroimmun, Germany)"/>
   <result pre="urine. Table 1 Clinical and laboratory results of the Congenital" exact="Zika" post="Syndrome case. Microcephaly (Table 1), and features of fetal"/>
   <result pre="ZIKV-infected mothers (PR(AMI)103/2016). 3 Discussion CZS due to mother-to-child transmitted" exact="ZIKV" post="infection has been documented extensively in the recent epidemic.[1,2]"/>
   <result pre="mother was infected, at least once, in early pregnancy as" exact="ZIKV" post="was detected in serum in association with clinical symptoms."/>
   <result pre="serum in association with clinical symptoms. Indeed, the detection of" exact="ZIKV" post="RNA in the AF confirmed the involvement of the"/>
   <result pre="prenatal infection in this child. There are important challenges for" exact="ZIKV" post="laboratory diagnosis, partly due to the narrow time-frame for"/>
   <result pre="due to the narrow time-frame for the detection of the" exact="ZIKV" post="RNA. Additionally, the considerable antigenic homology between ZIKV and"/>
   <result pre="of the ZIKV RNA. Additionally, the considerable antigenic homology between" exact="ZIKV" post="and DENV can cause cross-reactivity in serological assays. In"/>
   <result pre="ZIKV RNA. Additionally, the considerable antigenic homology between ZIKV and" exact="DENV" post="can cause cross-reactivity in serological assays. In our case,"/>
   <result pre="serological assays. In our case, we were unable to demonstrate" exact="ZIKV" post="congenital infection by RT-PCR or ZIKV-IgM in postnatal samples."/>
   <result pre="in serum as the best serological marker to confirm congenital" exact="ZIKV" post="infection due to the lack of evidence from other"/>
   <result pre="knowledge, this is the first description of a case of" exact="ZIKV" post="congenital infection showing a non-permanent serological IgG response alongside"/>
   <result pre="that we have described the true serological response to prenatal" exact="ZIKV" post="infection in early fetal life. We hypothesize that the"/>
   <result pre="mechanisms could explain our findings. First, the low and transient" exact="ZIKV" post="viremia, compared to reported DENV infections,[9] could lead to"/>
   <result pre="First, the low and transient ZIKV viremia, compared to reported" exact="DENV" post="infections,[9] could lead to a lack of ZIKV levels"/>
   <result pre="to reported DENV infections,[9] could lead to a lack of" exact="ZIKV" post="levels of antigen detection, and additionally to the absence"/>
   <result pre="strong immune response. Second, the specific and direct tropism of" exact="ZIKV" post="for the central nervous system and other organs (i.e.,"/>
   <result pre="other organs (i.e., female and male genital tract) may provide" exact="ZIKV" post="with the ability to escape the immune system, becoming"/>
   <result pre="becoming a silent virus for the host response. And finally," exact="ZIKV" post="may be able to avoid triggering a strong innate"/>
   <result pre="post-natal infection or reinfections, which could be very common in" exact="ZIKV" post="endemic countries. This case underscores the importance of the"/>
   <result pre="diagnosis of CZS, given the challenges in laboratory ascertainment of" exact="ZIKV" post="infection in the perinatal period. Therefore, an approach from"/>
   <result pre="4 Conclusion We presume that as a consequence of prenatal" exact="ZIKV" post="infection, the fetal brain and other organs are damaged"/>
   <result pre="understanding of the mechanisms taking part in the pathogenesis of" exact="ZIKV" post="congenital infection is needed. Author contributions Conceptualization: Elena Sulleiro,"/>
   <result pre="= amniotic fluid, CSF = cerebrospinal fluid, CZS = Congenital" exact="ZIKV" post="syndrome, DENV = dengue virus, HIV = Human immunodeficiency"/>
   <result pre="fluid, CSF = cerebrospinal fluid, CZS = Congenital ZIKV syndrome," exact="DENV" post="= dengue virus, HIV = Human immunodeficiency virus, IgG"/>
   <result pre="rubella virus, cytomegalovirus, herpes virus I and II, and HIV," exact="ZIKV" post="= Zika virus. ES and AS-A contributed equally to"/>
   <result pre="cytomegalovirus, herpes virus I and II, and HIV, ZIKV =" exact="Zika" post="virus. ES and AS-A contributed equally to this work."/>
   <result pre="References References [1]MooreCAStaplesJEDobynsWBet al.Characterizing the pattern of anomalies in congenital" exact="Zika" post="syndrome for pediatric clinicians. JAMA Pediatr2017;171:288–95.27812690 [2]Del CampoMFeitosaIMRibeiroEMet al.The"/>
   <result pre="clinicians. JAMA Pediatr2017;171:288–95.27812690 [2]Del CampoMFeitosaIMRibeiroEMet al.The phenotypic spectrum of congenital" exact="Zika" post="syndrome. Am J Med Genet A2017;173:841–57.28328129 [3]Soriano-ArandesARivero-CalleINastouliEet al.What we"/>
   <result pre="al.What we know and what we don’t know about perinatal" exact="Zika" post="virus infection: a systematic review. Expert Rev Anti Infect"/>
   <result pre="Dis J2013;32:199–202.22976052 [8]PetersenEEStaplesJEMeaney-DelmanDet al.Interim guidelines for pregnant women during a" exact="Zika" post="virus outbreak—United States, 2016. MMWR2016;65:30–3.26796813 [9]MussoDRouaultETeissierAet al.Molecular detection of"/>
   <result pre="Zika virus outbreak—United States, 2016. MMWR2016;65:30–3.26796813 [9]MussoDRouaultETeissierAet al.Molecular detection of" exact="Zika" post="virus in blood and RNA load determination during the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6542824\results\search\tropicalVirus\results.xml">
   <result pre="Chair in Natural Sciences, University of California, San Diego. Introduction" exact="Dengue" post="is a systemic viral infection with an estimated 390"/>
   <result pre="allows for stochastic jumps of random sizes, at random times." exact="Dengue" post="in San Juan, Puerto Rico We demonstrate the approach"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6544329\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Tropical Diseases"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : People and Places : Geographical Locations :"/>
   <result pre="provided the original author and source are credited.pntd.0007376.pdf Abstract Background" exact="Chikungunya" post="virus (CHIKV) is an emerging mosquito-borne pathogen circulating in"/>
   <result pre="reported in Australia, there is a potential risk of local" exact="CHIKV" post="outbreaks due to the presence of suitable vectors, global"/>
   <result pre="used to investigate the seasonality and trend of monthly imported" exact="CHIKV" post="cases. This pattern was compared with the seasonality and"/>
   <result pre="was applied to examine the transient relationships between monthly imported" exact="CHIKV" post="cases and southern oscillation index (SOI) in time-frequency space."/>
   <result pre="the number and geographical distribution of countries of acquisition for" exact="CHIKV" post="in travellers to Australia has increased in recent years."/>
   <result pre="has increased in recent years. The number of monthly imported" exact="CHIKV" post="cases displayed an unstable increased trend compared with a"/>
   <result pre="stable linear increased trend in monthly overseas arrivals. Both imported" exact="CHIKV" post="cases and overseas arrivals showed substantial seasonality, with the"/>
   <result pre="coherence analysis identified four significant transient relationships between monthly imported" exact="CHIKV" post="cases and 6-month lagged moving average SOI, in the"/>
   <result pre="2012, 2014 and 2015–2016. Conclusion/Significance High seasonal peaks of imported" exact="CHIKV" post="cases were consistent with the high seasonal peaks of"/>
   <result pre="indicates that El Niño Southern Oscillation (ENSO) variation may impact" exact="CHIKV" post="epidemics in endemic regions, in turn influencing the pattern"/>
   <result pre="in turn influencing the pattern of imported cases. Author summary" exact="Chikungunya" post="virus (CHIKV) is mosquito-borne virus circulating in tropical and"/>
   <result pre="of imported cases is required to facilitate risk assessment of" exact="CHIKV" post="outbreaks. We investigated the temporal pattern of imported CHIKV"/>
   <result pre="of CHIKV outbreaks. We investigated the temporal pattern of imported" exact="CHIKV" post="cases relative to the pattern of overseas arrivals. We"/>
   <result pre="El Niño Southern Oscillation (ENSO) can predict the import of" exact="CHIKV" post="cases in Australia. We found that the number of"/>
   <result pre="in Australia. We found that the number of monthly imported" exact="CHIKV" post="cases displayed an unstable increased trend versus the stable"/>
   <result pre="observed in monthly overseas arrivals. Both the numbers of imported" exact="CHIKV" post="cases and overseas arrivals showed substantial seasonality. High seasonal"/>
   <result pre="overseas arrivals showed substantial seasonality. High seasonal peaks of imported" exact="CHIKV" post="cases were consistent with the high seasonal peaks of"/>
   <result pre="also identified four significant transient relationships between ENSO variability and" exact="CHIKV" post="importation. Our results suggest ENSO may impact the occurrence"/>
   <result pre="importation. Our results suggest ENSO may impact the occurrence of" exact="CHIKV" post="epidemics in endemic regions, in turn influencing the pattern"/>
   <result pre="are within the manuscript and its Supporting Information files. Introduction" exact="Chikungunya" post="virus (CHIKV) is a mosquito-borne viral pathogen transmitted by"/>
   <result pre="or specific antiviral drug treatments for the disease [2, 3]." exact="CHIKV" post="has circulated almost continuously in Asia since 1950’s, with"/>
   <result pre="2.4 million suspected and confirmed cases since December 2013 [6]." exact="CHIKV" post="outbreaks have been occurring in the Pacific since 2011"/>
   <result pre="since 2011 [7]. There has been substantial geographic expansion of" exact="CHIKV" post="outbreaks in the past decade, at least in part"/>
   <result pre="number of international travellers, global trade and evolutionary adaptation of" exact="CHIKV" post="to new vector species [8–10]. Infected travellers from affected"/>
   <result pre="species [8–10]. Infected travellers from affected areas can initiate new" exact="CHIKV" post="epidemics in countries where vector mosquitoes are present [11]."/>
   <result pre="CHIKV epidemics in countries where vector mosquitoes are present [11]." exact="CHIKV" post="epidemics triggered by imported CHIKV cases have occurred in"/>
   <result pre="vector mosquitoes are present [11]. CHIKV epidemics triggered by imported" exact="CHIKV" post="cases have occurred in the United States, France and"/>
   <result pre="changes in climate may also influence geographical distribution of the" exact="CHIKV" post="vector mosquitoes Ae. aegypti and Ae. albopictus [11, 17–20]."/>
   <result pre="and Ae. albopictus [11, 17–20]. Further, the global potential of" exact="CHIKV" post="epidemics could be affected by weather variation because virus"/>
   <result pre="climate change might cause an increase in the frequency of" exact="CHIKV" post="outbreaks [22–25]. Although no locally acquired CHIKV cases have"/>
   <result pre="the frequency of CHIKV outbreaks [22–25]. Although no locally acquired" exact="CHIKV" post="cases have been reported to date in Australia, the"/>
   <result pre="(ENSO) [34–36]. Previous studies have suggested that the occurrence of" exact="CHIKV" post="outbreaks might be associated with El Niño events in"/>
   <result pre="Niño events in India and Indonesia [37, 38]. To facilitate" exact="CHIKV" post="risk assessment, it is important to understand the pattern"/>
   <result pre="Australia. We aimed to investigate the temporal pattern of imported" exact="CHIKV" post="cases relative to the pattern of overseas arrivals, as"/>
   <result pre="identify whether variability in ENSO can predict the import of" exact="CHIKV" post="cases in Australia. Methods Data collection CHIKV is a"/>
   <result pre="the import of CHIKV cases in Australia. Methods Data collection" exact="CHIKV" post="is a notifiable disease in Australia and suspected cases"/>
   <result pre="Australia and suspected cases are laboratory confirmed [32]. Monthly imported" exact="CHIKV" post="cases were collected from the National Notifiable Diseases Surveillance"/>
   <result pre="Government Department of Health website (http://www9.health.gov.au/cda/source/cda-index.cfm). Data on yearly imported" exact="CHIKV" post="cases by country of acquisition were only available from"/>
   <result pre="of Health website (http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-vectorborne-overseas-acquired.htm). We also obtained the monthly imported" exact="CHIKV" post="cases from New South Wales (NSW), Queensland (Qld), South"/>
   <result pre="in order to explore the spatiotemporal patterns of monthly imported" exact="CHIKV" post="cases among different states and territories across Australia. The"/>
   <result pre="2008 and December 2017. In Australia, the majority of imported" exact="CHIKV" post="cases were acquired from the Pacific region, Southeast Asia"/>
   <result pre="potential impact of ENSO events on the dynamics of imported" exact="CHIKV" post="cases in Australia. The monthly SOI is available from"/>
   <result pre="to detect the seasonality and the trends for monthly imported" exact="CHIKV" post="cases and monthly overseas arrivals. The model is given"/>
   <result pre="[44, 45] and can quantify the temporal evolution of imported" exact="CHIKV" post="cases with different periodic components. The Morlet wavelet φ(τ)"/>
   <result pre="continuous wavelet transform Wx(s,δ) and Wy(s,δ) for the monthly imported" exact="CHIKV" post="cases time series x(t) and the monthly overseas arrivals"/>
   <result pre="smoothing operator. Following established methods, the number of monthly imported" exact="CHIKV" post="cases were converted into a normal distribution by a"/>
   <result pre="the wavelet analysis, we examined the correlations between monthly imported" exact="CHIKV" post="cases and 2–6 month lagged moving averages of SOI,"/>
   <result pre="using SPSS software to examine the relationships between monthly imported" exact="CHIKV" post="cases and 2–6 month lagged moving average. The 6-month"/>
   <result pre="wavelet coherence analysis. Results Descriptive analysis There were 730 imported" exact="CHIKV" post="cases from 2008 to 2017 in Australia. The largest"/>
   <result pre="to 2017 in Australia. The largest number of monthly imported" exact="CHIKV" post="cases was 31 cases in January 2015. The largest"/>
   <result pre="cases in January 2015. The largest number of annual imported" exact="CHIKV" post="cases occurred in 2013 (134 cases), followed by 2016"/>
   <result pre="cases) and 2014 (110 cases). The mean of monthly imported" exact="CHIKV" post="cases was 6.08 (range: 0–31) during the study period"/>
   <result pre="NSW and VIC had the highest means of monthly imported" exact="CHIKV" post="cases when compared with the other states (Fig 1)."/>
   <result pre="the largest populations. The frequency of the months with imported" exact="CHIKV" post="cases per year has increased since 2013 in NSW"/>
   <result pre="provenance, the five countries most frequently reported as location of" exact="CHIKV" post="acquisition from 2013 to 2017 were Indonesia (33.27% of"/>
   <result pre="However, after 2013, the number of source countries of imported" exact="CHIKV" post="cases substantially increased and ranged from 15 to 24"/>
   <result pre="(Fig 2). Fig 1 Heat map of the monthly imported" exact="CHIKV" post="cases by the states, from January 2008 to December"/>
   <result pre="2017 in Australia. Fig 2 Spatiotemporal variability of annual imported" exact="CHIKV" post="cases by countries, from 2013 to 2017 in Australia."/>
   <result pre="2013 to 2017 in Australia. The confirmed number of annual" exact="CHIKV" post="cases by the countries were presented in S1 Table."/>
   <result pre="10.6. 10.1371/journal.pntd.0007376.t001Table 1 Summary statistics of number of monthly imported" exact="CHIKV" post="cases from January 2008 to December 2017 across states"/>
   <result pre="1.23 1.91 0 11 Temporal variabilities of the monthly imported" exact="CHIKV" post="cases and the monthly overseas arrivals from the Pacific"/>
   <result pre="Fig 3. An increase in the number of monthly imported" exact="CHIKV" post="cases has occurred from the beginning of 2013 (Fig"/>
   <result pre="2013 (Fig 3A). Although increased trends for both monthly imported" exact="CHIKV" post="cases and monthly overseas arrivals were observed over the"/>
   <result pre="the study period (Fig 3B), the average of monthly imported" exact="CHIKV" post="cases increased by 605.3% from 2012 to 2013, while"/>
   <result pre="Fig 3 Temporal variation in the numbers of monthly imported" exact="CHIKV" post="cases (A) and the monthly overseas arrivals from the"/>
   <result pre="Seasonal decomposition analysis showed that the monthly number of imported" exact="CHIKV" post="cases displayed an increased trend from 2008 to 2015,"/>
   <result pre="also indicated that there was significant seasonality for monthly imported" exact="CHIKV" post="cases (Fig 4B). For the monthly imported CHIKV cases,"/>
   <result pre="monthly imported CHIKV cases (Fig 4B). For the monthly imported" exact="CHIKV" post="cases, the strongest positive seasonal effects were found in"/>
   <result pre="the trend (A) and seasonal factor (B) of monthly imported" exact="CHIKV" post="cases, from January 2008 to December 2017. In contrast"/>
   <result pre="from January 2008 to December 2017. In contrast to imported" exact="CHIKV" post="cases, the monthly number of overseas arrivals exhibited a"/>
   <result pre="coherence analysis captured some significant transient relationships between monthly imported" exact="CHIKV" post="cases and the 6-month lagged moving average SOI in"/>
   <result pre="a given point in time. The monthly imported number of" exact="CHIKV" post="cases was significantly positively associated with the 6-month lagged"/>
   <result pre="6). There were significant negative relationships between the monthly imported" exact="CHIKV" post="cases and the 6-month lagged moving average SOI, with"/>
   <result pre="with a slight lead phase. The numbers of monthly imported" exact="CHIKV" post="cases were significantly and positively related to the 6-month"/>
   <result pre="June 2016. Fig 6 Squared wavelet coherence between monthly imported" exact="CHIKV" post="cases and 6-month lagged moving average SOI. The vertical"/>
   <result pre="randomizations). Arrow denotes a specific phase relationship between monthly imported" exact="CHIKV" post="cases and 6-month lagged moving average SOI. Discussion An"/>
   <result pre="SOI. Discussion An increased number of countries of acquisition for" exact="CHIKV" post="cases imported into Australia was observed during the study"/>
   <result pre="the study period, supporting previous reports of global expansion of" exact="CHIKV" post="endemicity [1, 48, 49]. The Pacific region and Southeast/South/Central"/>
   <result pre="and Southeast/South/Central Asia were the most frequent sources of imported" exact="CHIKV" post="cases in Australia, particularly Indonesia and India. From 2014,"/>
   <result pre="linear increasing trend over the study period, the monthly imported" exact="CHIKV" post="cases did not follow the same trend and displayed"/>
   <result pre="instability. It is likely that the trend of monthly imported" exact="CHIKV" post="cases reflects the most recent dynamics of CHIKV epidemics"/>
   <result pre="monthly imported CHIKV cases reflects the most recent dynamics of" exact="CHIKV" post="epidemics in the most frequent countries of acquisition and"/>
   <result pre="epidemics observed in those regions. For example, there were massive" exact="CHIKV" post="outbreaks in the Americas in 2014 [50], along with"/>
   <result pre="in the U.S. Virgin Islands [52]. These outbreaks coincided with" exact="CHIKV" post="importation into Australia in 2014 from Barbados, Dominican Republic,"/>
   <result pre="Grenada, Jamaica, United States of America and Venezuela. A major" exact="CHIKV" post="outbreak was reported in Papua New Guinea in 2013"/>
   <result pre="2013 [7], which resulted in the largest number of imported" exact="CHIKV" post="cases into Australia during the period of 2013–2017. Samoa"/>
   <result pre="during the period of 2013–2017. Samoa and Tonga experienced large" exact="CHIKV" post="outbreaks in 2014 which corresponded to the high numbers"/>
   <result pre="in 2014 which corresponded to the high numbers of imported" exact="CHIKV" post="cases into Australia in 2014 [7]. A substantial CHIKV"/>
   <result pre="imported CHIKV cases into Australia in 2014 [7]. A substantial" exact="CHIKV" post="outbreak was reported in India in 2016 [53], which"/>
   <result pre="India in 2016 [53], which also led to 54.39% of" exact="CHIKV" post="cases into Australia originating in India that year. Bangladesh"/>
   <result pre="2017 [54], with Australia observing the largest number of imported" exact="CHIKV" post="cases in 2017 being from Bangladesh. Moreover, it is"/>
   <result pre="was an increase in the frequency and number of imported" exact="CHIKV" post="cases into Australia over the study period, suggesting that"/>
   <result pre="seasonal decomposition analysis, although the seasonal patterns of monthly imported" exact="CHIKV" post="cases and monthly overseas arrivals were not fully synchronized,"/>
   <result pre="fully synchronized, we observed the seasonal effects on both imported" exact="CHIKV" post="cases and overseas arrivals to be strongest each January,"/>
   <result pre="the summer holiday period might facilitate the number of imported" exact="CHIKV" post="cases due to returning international travellers during the peak"/>
   <result pre="difference. For example, the weakest seasonal effects on monthly imported" exact="CHIKV" post="cases occurred each August, followed by May and September,"/>
   <result pre="production and survival rate of vectors, decreasing the likelihood of" exact="CHIKV" post="outbreaks [56]. Overall, the results confirmed that temporal variation"/>
   <result pre="[56]. Overall, the results confirmed that temporal variation in imported" exact="CHIKV" post="cases might be driven not only by the behaviour"/>
   <result pre="behaviour of international travellers but also by the dynamics of" exact="CHIKV" post="outbreaks and epidemics in the source countries. To our"/>
   <result pre="the first study to explore the impact of ENSO on" exact="CHIKV" post="importation to non-endemic areas. The wavelet analysis revealed significant"/>
   <result pre="wavelet analysis revealed significant positive relationships between the monthly imported" exact="CHIKV" post="cases and the 6-month lagged moving average SOI during"/>
   <result pre="main acquisition countries included Indonesia, India and Malaysia [26]. Large" exact="CHIKV" post="outbreaks were reported across India in 2010 [58], and"/>
   <result pre="and 2010 (53,899 reported cases) [38]. A large number of" exact="CHIKV" post="cases were observed in 2010 in Bali, Indonesia, [38],"/>
   <result pre="weather conditions [57]. Moderate to high temperatures could facilitate increased" exact="CHIKV" post="transmission because increasing temperature leads to a higher biting"/>
   <result pre="events [62]. Thus, the positive relationship between the monthly imported" exact="CHIKV" post="cases and the 6-month lagged moving average SOI suggested"/>
   <result pre="observed significant negative relationships between the number of monthly imported" exact="CHIKV" post="cases and the 6-month lagged moving average SOI for"/>
   <result pre="SOI was likely to decrease the number of monthly imported" exact="CHIKV" post="cases under neutral ENSO conditions (i.e. absence of La"/>
   <result pre="could flush out mosquito breeding sites [63], leading to lowered" exact="CHIKV" post="transmission risk. Conversely, neutral ENSO conditions that lead to"/>
   <result pre="conditions with low to moderate rainfall may lead to increased" exact="CHIKV" post="transmission risk. It is interesting that in the period"/>
   <result pre="interesting that in the period from 2012–2014 a series of" exact="CHIKV" post="epidemics occurred in the Pacific [7, 64], which led"/>
   <result pre="Pacific [7, 64], which led to large numbers of imported" exact="CHIKV" post="cases into Australia. Our results suggest that ENSO behaviours"/>
   <result pre="conditions, which lead to changes in the patterns of local" exact="CHIKV" post="epidemics in different endemic regions. Limitations Some limitations of"/>
   <result pre="limitations of this study should be acknowledged. First, the imported" exact="CHIKV" post="cases used in this analysis were only from laboratory"/>
   <result pre="Therefore, we could not provide the spatiotemporal distribution of imported" exact="CHIKV" post="cases by countries across the whole study period. We"/>
   <result pre="parts of the world. Using aggregated data on monthly imported" exact="CHIKV" post="cases from all source countries in the study could"/>
   <result pre="not fully reveal the associations between ENSO behaviours and imported" exact="CHIKV" post="cases. Future studies may address the problem by using"/>
   <result pre="Future studies may address the problem by using the imported" exact="CHIKV" post="cases by countries or by a group of countries"/>
   <result pre="events, such as El Niño and La Niña, on local" exact="CHIKV" post="transmission in endemic countries. The overall trend of increased"/>
   <result pre="in endemic countries. The overall trend of increased number of" exact="CHIKV" post="imports suggests that Australia remains at risk of a"/>
   <result pre="CHIKV imports suggests that Australia remains at risk of a" exact="CHIKV" post="outbreak. The patterns of importation we observed for Australia"/>
   <result pre="to be mirrored in other countries that are non-endemic for" exact="CHIKV" post="and have strong travel links with the countries of"/>
   <result pre="Australian health authorities have acknowledged the increasing risk of local" exact="CHIKV" post="outbreaks, particularly in North Queensland, through the development of"/>
   <result pre="particularly in North Queensland, through the development of the Queensland" exact="Chikungunya" post="Management Plan in 2014 [65]. Conclusions We found that"/>
   <result pre="has expanded significantly, with the frequency and number of imported" exact="CHIKV" post="cases into Australia increasing in recent years. Although the"/>
   <result pre="study can provide useful information for understanding the seasonality of" exact="CHIKV" post="risk and guide surveillance for health authorities at corresponding"/>
   <result pre="suggest that climate could be a potential important driver of" exact="CHIKV" post="epidemics and that ENSO behaviours could be a useful"/>
   <result pre="countries. Supporting information S1 Table Confirmed number of annual imported" exact="CHIKV" post="cases by countries, from 2013 to 2017, in Australia."/>
   <result pre="Bureau of Statistics for providing the data on the imported" exact="CHIKV" post="cases and overseas arrivals, respectively. References References 1WeaverSC, LecuitM."/>
   <result pre="CHIKV cases and overseas arrivals, respectively. References References 1WeaverSC, LecuitM." exact="Chikungunya" post="Virus and the Global Spread of a Mosquito-Borne Disease."/>
   <result pre="journal of medicine. 2015;372(13):1231–9. 10.1056/NEJMra140603525806915 2Leparc-GoffartI, NougairedeA, CassadouS, PratC, LamballerieXd." exact="Chikungunya" post="in the Americas. The Lancet. 2014;383:514. 3PowersAM. How Chikungunya"/>
   <result pre="LamballerieXd. Chikungunya in the Americas. The Lancet. 2014;383:514. 3PowersAM. How" exact="Chikungunya" post="Virus Virology Affects Its Epidemiology and Transmission: Implications for"/>
   <result pre="HoyD, DuituturagaS, BenyonE, et al.Concurrent outbreaks of dengue, chikungunya and" exact="Zika" post="virus infections–an unprecedented epidemic wave of mosquito-borne viruses in"/>
   <result pre="BeierkuhnleinC, SemenzaJC. Modelling the effects of global climate change on" exact="Chikungunya" post="transmission in the 21(st) century. Sci Rep. 2017;7(1):381310.1038/s41598-017-03566-328630444 9DepoortereE,"/>
   <result pre="21(st) century. Sci Rep. 2017;7(1):381310.1038/s41598-017-03566-328630444 9DepoortereE, SalmasoS, PompaMG, GuglielmettiP, CoulombierD." exact="Chikungunya" post="in Europe. The Lancet. 2008;371(9614):72310.1016/S0140-6736(08)60336-0 10TabachnickWJ. Challenges in predicting"/>
   <result pre="changing world. J Exp Biol. 2010;213(6):946–54. 10.1242/jeb.03756420190119 11CharrelRN, LamballerieXd, RaoultD." exact="Chikungunya" post="Outbreaks—The Globalization of Vectorborne Diseases. N Engl J Med."/>
   <result pre="Emerg Infect Dis. 2006;12(10):1493–9. 10.3201/eid1210.06061017176562 13KendrickK, StanekD, BlackmoreC. Transmission of" exact="Chikungunya" post="Virus in the Continental United States—Florida, 2014. Centers for"/>
   <result pre="Ae. albopictus. Elife. 2015;4:e0834710.7554/eLife.0834726126267 18RussellRC, CurrieBJ, LindsayMD, MackenzieJS, RitchieSA, WhelanPI." exact="Dengue" post="and climate change in Australia: predictions for the future"/>
   <result pre="Trans R Soc Lond B Biol Sci. 2015;370(1665). 10.1098/rstb.2014.013525688023 22EpsteinPR." exact="Chikungunya" post="fever resurgence and global warming. Am J Trop Med"/>
   <result pre="ThomasSM, SukJE, SudreB, HessA, TjadenNB, et al.Climate change effects on" exact="Chikungunya" post="transmission in Europe: geospatial analysis of vector’s climatic suitability"/>
   <result pre="J Health Geogr. 2013;12:5110.1186/1476-072X-12-5124219507 24RoizD, BoussèsP, SimardF, PaupyC, FontenilleD. Autochthonous" exact="Chikungunya" post="Transmission and Extreme Climate Events in Southern France. PLoS"/>
   <result pre="Australia. Commun Dis Intell Q Rep. 2013;37(2):E136–43. .24168087 27SuhrbierA, DevineG." exact="Chikungunya" post="virus, risks and responses for Australia. Aust N Z"/>
   <result pre="J Public Health. 2016;40(3):207–9. 10.1111/1753-6405.1251527028514 28HuangX, WilliamsG, ClementsAC, HuW. Imported" exact="Dengue" post="Cases, Weather Variation and Autochthonous Dengue Incidence in Cairns,"/>
   <result pre="WilliamsG, ClementsAC, HuW. Imported Dengue Cases, Weather Variation and Autochthonous" exact="Dengue" post="Incidence in Cairns, Australia. PloS ONE. 2013;8(12):e8188710.1371/journal.pone.008188724349148 29HuW, ClementsA,"/>
   <result pre="ClementsA, WilliamsG, TongS, MengersenK. Spatial Patterns and Socioecological Drivers of" exact="Dengue" post="Fever Transmission in Queensland, Australia. Environ Health Perspect. 2012;120(2):260–6."/>
   <result pre="BlagroveMSC, SolomonT, et al.Global risk model for vector-borne transmission of" exact="Zika" post="virus reveals the role of El Niño 2015. PNAS."/>
   <result pre="India. Sci Total Environ. 2019;647:66–74. 10.1016/j.scitotenv.2018.07.46130077856 38YoshikawaMJ, KusriastutiR. Surge of" exact="Dengue" post="Virus Infection and Chikungunya Fever in Bali in 2010:"/>
   <result pre="2019;647:66–74. 10.1016/j.scitotenv.2018.07.46130077856 38YoshikawaMJ, KusriastutiR. Surge of Dengue Virus Infection and" exact="Chikungunya" post="Fever in Bali in 2010: The Burden of Mosquito-Borne"/>
   <result pre="PickettBE, ShrivastavaS, GreshL, BalmasedaA, AmedeoP, et al.Differing epidemiological dynamics of" exact="Chikungunya" post="virus in the Americas during the 2014–2015 epidemic. PLoS"/>
   <result pre="52FeldsteinLR, EllisEM, Rowhani-RahbarA, HalloranME, EllisBR. The First Reported Outbreak of" exact="Chikungunya" post="in the U.S. Virgin Islands, 2014–2015. Am J Trop"/>
   <result pre="Hasan MR, et al.Clinical and Laboratory Characteristics of an Acute" exact="Chikungunya" post="Outbreak in Bangladesh in 2017. Am J Trop Med"/>
   <result pre="Seasonal temperature variation influences climate suitability for dengue, chikungunya, and" exact="Zika" post="transmission. PLoS Negl Trop Dis. 2018;12(5):e0006451 Epub 2018/05/11. 10.1371/journal.pntd.000645129746468"/>
   <result pre="58ShrinetJ, JainS, SharmaA, SinghSS, MathurK, RanaV, et al.Genetic characterization of" exact="Chikungunya" post="virus from New Delhi reveal emergence of a new"/>
   <result pre="Virology Journal. 2012;9(1):10010.1186/1743-422x-9-10022632412 59Mohd ZimMA, SamIC, OmarSFS, ChanYF, AbuBakarS, KamarulzamanA." exact="Chikungunya" post="infection in Malaysia: Comparison with dengue infection in adults"/>
   <result pre="Pastore-PionttiA, ChinazziM, MistryD, DeanNE, et al.Quantifying the risk of local" exact="Zika" post="virus transmission in the contiguous US during the 2015–2016"/>
   <result pre="Zika virus transmission in the contiguous US during the 2015–2016" exact="ZIKV" post="epidemic. BMC Medicine. 2018;16(1):19510.1186/s12916-018-1185-530336778 61YangHMY, MacorisMLG, GalvaniKC, AndrighettiMTM, WanderleyDMV."/>
   <result pre="Breeding Habitats of Aedes aegypti (L.) Prior to the Low" exact="Dengue" post="Season in Singapore. PLoS Negl Trop Dis. 2016;10(7):e0004842 Epub"/>
   <result pre="10.1371/journal.pntd.000484227459322 64HorwoodPF, ReimerLJ, DaginaR, SusapuM, BandeG, KatuseleM, et al.Outbreak of" exact="Chikungunya" post="Virus Infection, Vanimo, Papua New Guinea. Emerging Infectious Diseases."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6548069\results\search\tropicalVirus\results.xml">
   <result pre="doi: 10.26633/RPSP.2019.49 : Original Research Co-circulation of dengue, chikungunya, and" exact="Zika" post="viruses in Colombia from 2008 to 2018Cocirculación de los"/>
   <result pre="2018Cocirculación de los virus del dengue, el chikunguña y el" exact="Zika" post="en Colombia del 2008 al 2018Co-circulação dos vírus dengue,"/>
   <result pre="Colombia del 2008 al 2018Co-circulação dos vírus dengue, chikungunya e" exact="Zika" post="na Colômbia, 2008–2018 Rico-MendozaAlejandro1AlexandraPorras-Ramírez1ChangAileen2EncinalesLiliana3LynchRebecca4[1], Grupo de Medicina Comunitaria y"/>
   <result pre="the two other diseases. In 2016, when the circulation of" exact="Zika" post="virus was first found, the incidence was 296.4 cases"/>
   <result pre="Establecer las características de la cocirculación de tres virus (dengue," exact="Zika" post="y chikunguña) en Colombia desde el 2008 hasta el"/>
   <result pre="RESUMO Objetivo. Identificar padrões de co-circulação de três vírus (dengue," exact="Zika" post="e chikungunya) na Colômbia de 2008 a 2018 mediante"/>
   <result pre="pode indicar proteção cruzada. Este achado requer análise adicional. Keywords" exact="Zika" post="virus dengue virus chikungunya virus coinfection Colombia Palabras clave"/>
   <result pre="virus dengue virus chikungunya virus coinfection Colombia Palabras clave Virus" exact="Zika" post="virus del dengue virus chikungunya coinfección; Colombia Palavras-chave Zika"/>
   <result pre="Virus Zika virus del dengue virus chikungunya coinfección; Colombia Palavras-chave" exact="Zika" post="virus vírus da dengue vírus chikungunya coinfecção Colômbia fig-count:"/>
   <result pre="epidemics of mosquito-borne arboviruses, including the chikungunya virus (CHIKV) and" exact="Zika" post="virus (ZIKV), combined with the preexistence of the dengue"/>
   <result pre="and has infected over one million individuals since then (5)." exact="ZIKV" post="is a flavivirus that emerged in the Americas in"/>
   <result pre="Americas in 2015 and 2016. An estimated 80% of acute" exact="ZIKV" post="infections are asymptomatic, and the remaining 20% ​​clinically resemble"/>
   <result pre="ZIKV infections are asymptomatic, and the remaining 20% ​​clinically resemble" exact="CHIKV" post="and DENV infection, including with symptoms of fever, rash,"/>
   <result pre="are asymptomatic, and the remaining 20% ​​clinically resemble CHIKV and" exact="DENV" post="infection, including with symptoms of fever, rash, headache, and"/>
   <result pre="Neurological complications, including  Guillain–Barré syndrome, have also been reported after" exact="ZIKV" post="infection (8, 9). Importantly, ZIKV infection during pregnancy is"/>
   <result pre="have also been reported after ZIKV infection (8, 9). Importantly," exact="ZIKV" post="infection during pregnancy is associated with severe teratogenic effects,"/>
   <result pre="study aims to describe the co-circulation of DENV, CHIKV, and" exact="ZIKV" post="in Colombia, in order to identify epidemiological patterns that"/>
   <result pre="below, three SIVIGILA case definitions were used for data collection." exact="Dengue" post="cases were defined as all people with acute febrile"/>
   <result pre="the following manifestations: headache, retro-orbital pain, myalgia, arthralgia, or rash." exact="Dengue" post="cases of concern included anyone who met the above"/>
   <result pre="drop in platelet levels (&amp;lt; 100 000) associated with hemoconcentration." exact="Zika" post="cases were defined as all people with laboratory- confirmed natural"/>
   <result pre="were defined as all people with laboratory- confirmed natural circulation of" exact="ZIKV" post="two weeks before the onset of symptoms and who"/>
   <result pre="included the detection of Zika-specific IgM antibodies in the serum." exact="Chikungunya" post="cases were defined as all people who presented with"/>
   <result pre="must have resided or visited a municipality with evidence of" exact="CHIKV" post="circulation or a municipality within 30 km of a"/>
   <result pre="reviewed since the 1970s to understand the historical behavior of" exact="DENV" post="circulation in Colombia. For CHIKV and ZIKV, data obtained"/>
   <result pre="understand the historical behavior of DENV circulation in Colombia. For" exact="CHIKV" post="and ZIKV, data obtained since these viruses first circulated"/>
   <result pre="or sensitive aspects of their behavior could be revealed. RESULTS" exact="Dengue" post="virus In 2016, 101 016 dengue cases were reported"/>
   <result pre="Guainía, Casanare, and Nariño departments had the highest proportions of" exact="DENV" post="cases without warning signs; Cesar, La Guajira, and Santa"/>
   <result pre="759 were laboratory confirmed (84.4%; 95% CI: 81.9%–86.6%). Of the" exact="DENV" post="cases, 50% (95% CI: 49.6%–50.3%) occurred in men, with"/>
   <result pre="particularly affected. For example, 24.8% (95% CI: 23.9%–25.1%) of total" exact="DENV" post="cases and 35.5% (95% CI: 34.9%–35.8%) of severe DENV"/>
   <result pre="total DENV cases and 35.5% (95% CI: 34.9%–35.8%) of severe" exact="DENV" post="cases were reported in children less than 15 years"/>
   <result pre="2 186 in Afro-Colombians (2.2%; 95% CI: 2.07%–2.25%). Of the" exact="DENV" post="cases, 84.5% (95% CI: 84.0%–85.1%) were reported from 10"/>
   <result pre="0.9%–1.2%) severe dengue cases. Additionally, 57.4% (95% CI: 56.4%–57.6%) of" exact="DENV" post="cases occurred in men. Again, DENV had a special"/>
   <result pre="(95% CI: 56.4%–57.6%) of DENV cases occurred in men. Again," exact="DENV" post="had a special effect on young children, with 12.5%"/>
   <result pre="on young children, with 12.5% (95% CI: 12.0%–13.1%) ​​of total" exact="DENV" post="cases and 15.4% (95% CI: 14.9%–15.9%) of severe DENV"/>
   <result pre="total DENV cases and 15.4% (95% CI: 14.9%–15.9%) of severe" exact="DENV" post="cases reported in children under 5 years of age."/>
   <result pre="CI: 62.5%–64.5%) were hospitalized in 2017, and 21 deaths from" exact="DENV" post="were confirmed. Through epidemiological week 4 of 2018, 2"/>
   <result pre="were confirmed. Through epidemiological week 4 of 2018, 2 182" exact="DENV" post="cases were reported, including 1 114 (51.0%; 95% CI:"/>
   <result pre="CI: 1.2%–2.3%) with severe dengue. Additionally, eight deaths due to" exact="DENV" post="were reported. Chikungunya virus In Colombia, the first laboratory-confirmed"/>
   <result pre="severe dengue. Additionally, eight deaths due to DENV were reported." exact="Chikungunya" post="virus In Colombia, the first laboratory-confirmed autochthonous cases of"/>
   <result pre="Chikungunya virus In Colombia, the first laboratory-confirmed autochthonous cases of" exact="CHIKV" post="were reported in September 2014. These cases occurred in"/>
   <result pre="areas in Bolívar department. From 2014 to 2016, 19 435" exact="CHIKV" post="cases were reported in Colombia. Of these cases, 202"/>
   <result pre="cases were reported each week in 2016. During the epidemic," exact="CHIKV" post="circulation was confirmed via virological testing in 758 municipalities"/>
   <result pre="municipalities and 4 districts of the country. Of the reported" exact="CHIKV" post="cases, 63.4% (95% CI: 63.1%–64.0%) occurred in women, and"/>
   <result pre="(1.6%; 95% CI: 1.4%–2.1%). In 2016, the national incidence of" exact="CHIKV" post="in urban populations was 72.4 cases per 100 000"/>
   <result pre="per 100 000 inhabitants. In addition, 12 deaths associated with" exact="CHIKV" post="infection were reported. In 2017, SIVIGILA was notified of"/>
   <result pre="clinically confirmed and 3 (5.4%; 95% CI: 1.4%–14.1%) were suspected." exact="Zika" post="virus From 9 August 2015 through 2 April 2016,"/>
   <result pre="2 April 2016, a total of 65 726 cases of" exact="ZIKV" post="were reported in Colombia, with 2 485 (4%) that"/>
   <result pre="of the 11 944 pregnant women. The number of reported" exact="ZIKV" post="cases steadily increased from October 2015 through January 2016,"/>
   <result pre="to 6 February (epidemiologic week 5) In 2017, 1 750" exact="ZIKV" post="cases were reported, of which 57 were laboratory confirmed."/>
   <result pre="which 57 were laboratory confirmed. The departments with the most" exact="ZIKV" post="cases were Valle del Cauca, Santander, Tolima, Cundinamarca, and"/>
   <result pre="identified in pregnant women who reported having symptoms compatible with" exact="ZIKV" post="infection. Pregnant women represented 22.1% (95% CI: 20.2-24.1%) of"/>
   <result pre="infection. Pregnant women represented 22.1% (95% CI: 20.2-24.1%) of all" exact="ZIKV" post="cases, and 38 (14.3%; 95% CI: 13.9%–15.1%) of the"/>
   <result pre="and 2016, of the cases exhibiting neurological syndromes associated with" exact="ZIKV" post="(Guillain–Barré syndrome, ascending polyneuropathies, or other similar neurological conditions),"/>
   <result pre="270 cases with a history of febrile illness compatible with" exact="ZIKV" post="infection were reported. In 2017, only 77 cases were"/>
   <result pre="1 Number and percentage (with 95% confidence interval (CI)) of" exact="Zika" post="cases with neurological syndrome by age group and sex"/>
   <result pre="this article by the authors. Co-circulation of DENV, CHIKV, and" exact="ZIKV" post="in Colombia Colombia is a hyperendemic country for DENV"/>
   <result pre="and ZIKV in Colombia Colombia is a hyperendemic country for" exact="DENV" post="transmission (1). In 2014, the situation was further complicated"/>
   <result pre="transmission (1). In 2014, the situation was further complicated with" exact="CHIKV" post="circulation (2), followed by ZIKV circulation in 2015 (3)."/>
   <result pre="situation was further complicated with CHIKV circulation (2), followed by" exact="ZIKV" post="circulation in 2015 (3). This combination of similar viruses"/>
   <result pre="case confirmation, given the similar clinical presentations and cross-reactivity of" exact="DENV" post="and ZIKV in serologic tests. As shown in Table"/>
   <result pre="given the similar clinical presentations and cross-reactivity of DENV and" exact="ZIKV" post="in serologic tests. As shown in Table 2, two"/>
   <result pre="with the highest incidence generally reported for dengue. In 2015," exact="CHIKV" post="had the highest incidence of the three viruses, whereas"/>
   <result pre="of the three viruses, whereas by 2016, the rate of" exact="ZIKV" post="had increased and dengue circulation had decreased compared with"/>
   <result pre="1). TABLE 2 Incidence of dengue (DENV), chikungunya (CHIKV), and" exact="Zika" post="(ZIKV), per 100 000 individuals in Colombia, from 2008"/>
   <result pre="100 000 individuals in Colombia, from 2008 to 2018 Year" exact="DENV" post="CHIKV ZIKV 2008 161.6 0.0 0.0 2009 225.2 0.0"/>
   <result pre="000 individuals in Colombia, from 2008 to 2018 Year DENV" exact="CHIKV" post="ZIKV 2008 161.6 0.0 0.0 2009 225.2 0.0 0.0"/>
   <result pre="individuals in Colombia, from 2008 to 2018 Year DENV CHIKV" exact="ZIKV" post="2008 161.6 0.0 0.0 2009 225.2 0.0 0.0 2010"/>
   <result pre="FIGURE 1 Departments of Colombia with co-circulation of dengue (DENV)," exact="Zika" post="(ZIKV), and chikungunya (CHIKV), 2015 to 2018 DISCUSSION DENV,"/>
   <result pre="and chikungunya (CHIKV), 2015 to 2018 DISCUSSION DENV, CHIKV, and" exact="ZIKV" post="are arboviruses of great concern because of their impact"/>
   <result pre="public health, particularly in countries such as Colombia. Based on" exact="DENV" post="endemicity patterns, transmission patterns of these newer arboviruses can"/>
   <result pre="patterns, transmission patterns of these newer arboviruses can be determined." exact="DENV" post="has been the most prevalent arbovirus in Colombia for"/>
   <result pre="most prevalent arbovirus in Colombia for the last several decades." exact="DENV" post="is a public health priority in Colombia for multiple"/>
   <result pre="intense transmission, with an increasing tendency toward frequent and severe" exact="DENV" post="outbreaks, are particularly concerning. The simultaneous circulation of different"/>
   <result pre="at less than 2 200 m above sea level make" exact="DENV" post="circulation challenging to control. Furthermore, the introduction of Aedes"/>
   <result pre="violent conflicts in multiple areas further complicate dengue control. Finally," exact="DENV" post="tends to erupt in epidemic cycles every two to"/>
   <result pre="cases. The 2010 outbreak is considered the most massive registered" exact="DENV" post="epidemic in Colombia, with more than 150 000 confirmed"/>
   <result pre="simultaneous circulation of all four serotypes. Interestingly, the number of" exact="DENV" post="cases reported in 2015 decreased during the large-scale CHIKV"/>
   <result pre="of DENV cases reported in 2015 decreased during the large-scale" exact="CHIKV" post="and ZIKV epidemics. Various possibilities might explain this phenomenon."/>
   <result pre="cases reported in 2015 decreased during the large-scale CHIKV and" exact="ZIKV" post="epidemics. Various possibilities might explain this phenomenon. For example,"/>
   <result pre="example, there may have been underreporting of cases during the" exact="Zika" post="epidemic because the only institution in Colombia that could"/>
   <result pre="possibility is that mosquitoes are unable to transport and transmit" exact="DENV" post="simultaneously with CHIKV and ZIKV. DENV infection occurs more"/>
   <result pre="mosquitoes are unable to transport and transmit DENV simultaneously with" exact="CHIKV" post="and ZIKV. DENV infection occurs more frequently in the"/>
   <result pre="to transport and transmit DENV simultaneously with CHIKV and ZIKV." exact="DENV" post="infection occurs more frequently in the youngest age groups"/>
   <result pre="the high endemicity of the country, in which people acquire" exact="DENV" post="infection at an early age, generating immunity after the"/>
   <result pre="episode. Similar trends can be expected in the future for" exact="CHIKV" post="and ZIKV in several Colombian municipalities because of the"/>
   <result pre="trends can be expected in the future for CHIKV and" exact="ZIKV" post="in several Colombian municipalities because of the similar DENV,"/>
   <result pre="several Colombian municipalities because of the similar DENV, ZIKV, and" exact="CHIKV" post="transmission cycles that create the endemic establishment of these"/>
   <result pre="is present. Campos et al. (7) reported an association of" exact="ZIKV" post="infection in 42% of selected patients in northeastern Brazil."/>
   <result pre="selected patients in northeastern Brazil. The same study also revealed" exact="CHIKV" post="co-circulation in 12.5% of investigated cases. Several studies have"/>
   <result pre="the co-circulation of DENV-1 and DENV-2 and infections with concurrent" exact="ZIKV" post="(16). This created epidemiological conditions for the coinfections. In"/>
   <result pre="the coinfections. In this outbreak, 12 cases of coinfection by" exact="DENV" post="and ZIKV were identified. Related data also come from"/>
   <result pre="In this outbreak, 12 cases of coinfection by DENV and" exact="ZIKV" post="were identified. Related data also come from a cross-sectional"/>
   <result pre="DENV-2. Among cases that were positive for DENV, coinfection with" exact="CHIKV" post="was identified in 6 patients (3.68%) and coinfection with"/>
   <result pre="CHIKV was identified in 6 patients (3.68%) and coinfection with" exact="ZIKV" post="was identified in one patient (0.61%). In 2014, two"/>
   <result pre="In 2014, two patients from New Caledonia were coinfected with" exact="DENV" post="and ZIKV (14). Evidence for chikungunya- dengue co-infection has also"/>
   <result pre="two patients from New Caledonia were coinfected with DENV and" exact="ZIKV" post="(14). Evidence for chikungunya- dengue co-infection has also been found"/>
   <result pre="Yemen (17). In addition, a case with dengue, chikungunya, and" exact="Zika" post="was reported in Colombia (18). The synergistic effects of"/>
   <result pre="throughout various countries (11, 12). The same conditions that favor" exact="DENV" post="endemicity are likely to contribute to and facilitate the"/>
   <result pre="to contribute to and facilitate the introduction and emergence of" exact="ZIKV" post="and CHIKV. For example, there is increased displacement of"/>
   <result pre="In Colombia in 2015, there was a higher incidence of" exact="CHIKV" post="than of ZKV and DENV. In 2016, the incidence"/>
   <result pre="ZKV increased, with a subsequent decrease in the frequency of" exact="DENV" post="and CHIKV. This situation may reflect a synergistic effect"/>
   <result pre="Nelson CA, Valencia D, Tolosa N, Farr SL, et al." exact="Zika" post="virus disease in Colombia—preliminary report. N Engl J Med."/>
   <result pre="Bahia, BrazilEmerg Infect Dis2015211018856264017197. Campos G, Bandeira A, Sardi S." exact="Zika" post="virus outbreak, Bahia, Brazil. Emerg Infect Dis. 2015;21(10):1885–6. 8Barba-SpaethGDejnirattisaiWRouvinskiAVaneyMMeditsISharmaAet"/>
   <result pre="potent Zika–dengue virus antibody cross-neutralization. Nature. 2016;536(7614):48–53. 9PriyamvadaLHudsonWAhmedRWrammertJHumoral cross-reactivity between" exact="Zika" post="and dengue viruses: implications for protection and pathologyEmerg Microbes"/>
   <result pre="L, Hudson W, Ahmed R, Wrammert J. Humoral cross-reactivity between" exact="Zika" post="and dengue viruses: implications for protection and pathology. Emerg"/>
   <result pre="disease caused by co-circulation and co-infection of dengue, chikungunya, and" exact="Zika" post="in the AmericasTravel Med Infect Dis201614317792722447112. Rodriguez-Morales A, Villamil-Gómez"/>
   <result pre="disease caused by co-circulation and co-infection of dengue, chikungunya, and" exact="Zika" post="in the Americas. Travel Med Infect Dis. 2016;14(3):177–9. 13CostaSBrancoMAquino"/>
   <result pre="Sao Paulo. 2018 Oct 25;60:e62. doi: 10.1590/S1678-9946201860062. 14Dupont-RouzeyrolMO’ConnorOCalvezEDaurèsMJohnMGrangeonJet al.Co-infection with" exact="Zika" post="and dengue viruses in 2 patients, New Caledonia, 2014Emerg"/>
   <result pre="Daurès M, John M, Grangeon J, et al. Co-infection with" exact="Zika" post="and dengue viruses in 2 patients, New Caledonia, 2014."/>
   <result pre="New Caledonia, 2014. Emerg Infect Dis. 2015;21(2):381–2. 15Villamil-GómezWGonzález-CamargoORodriguez-AyubiJZapata-SerpaDRodriguez-MoralesADengue, chikungunya and" exact="Zika" post="co-infection in a patient from ColombiaJ Infect Public Health20169568462675420115."/>
   <result pre="O, Rodriguez-Ayubi J, Zapata-Serpa D, Rodriguez-Morales A. Dengue, chikungunya and" exact="Zika" post="co-infection in a patient from Colombia. J Infect Public"/>
   <result pre="Infect Public Health. 2016;9(5):684–6. 16EstofoleteCTerzianAColomboTde Freitas GuimarãesGFerrazHda SilvaRet al.Co-infection between" exact="Zika" post="and different dengue serotypes during DENV outbreak in BrazilJ"/>
   <result pre="GuimarãesGFerrazHda SilvaRet al.Co-infection between Zika and different dengue serotypes during" exact="DENV" post="outbreak in BrazilJ Infect Public Health2019122178813030170116. Estofolete C, Terzian"/>
   <result pre="G, Ferraz H, da Silva R, et al. Co-infection between" exact="Zika" post="and different dengue serotypes during DENV outbreak in Brazil."/>
   <result pre="et al. Co-infection between Zika and different dengue serotypes during" exact="DENV" post="outbreak in Brazil. J Infect Public Health. 2019;12(2):178–81. 17Furuya-KanamoriLLiangSMilinovichGSoares"/>
   <result pre="dengue viruses. BMC Infect Dis. 2016;16:84. 18Mercado-ReyesMAcosta-ReyesJNavarro-LechugaECorchueloSRicoAParraEet al.Dengue, chikungunya and" exact="Zika" post="virus coinfection: results of the national surveillance during the"/>
   <result pre="Zika virus coinfection: results of the national surveillance during the" exact="Zika" post="epidemic in ColombiaEpidemiol Infect2019147e771710.1017/S095026881800359X18. Mercado-Reyes M, Acosta-Reyes J, Navarro-Lechuga"/>
   <result pre="S, Rico A, Parra E, et al. Dengue, chikungunya and" exact="Zika" post="virus coinfection: results of the national surveillance during the"/>
   <result pre="Zika virus coinfection: results of the national surveillance during the" exact="Zika" post="epidemic in Colombia. Epidemiol Infect. 2019;147(e77):1–7. 10.1017/S095026881800359X"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6553702\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Anatomy :"/>
   <result pre="Sequencing Increased growth ability and pathogenicity of American- and Pacific-subtype" exact="Zika" post="virus (ZIKV) strains compared with a Southeast Asian-subtype ZIKV"/>
   <result pre="Pacific-subtype Zika virus (ZIKV) strains compared with a Southeast Asian-subtype" exact="ZIKV" post="strain Growth characteristics and pathogenicity of Asian/American lineage Zika"/>
   <result pre="Asian-subtype ZIKV strain Growth characteristics and pathogenicity of Asian/American lineage" exact="Zika" post="virus strains KawaiYasuhiroConceptualizationData curationFormal analysisInvestigationMethodologyProject administrationValidationWriting – original draftWriting"/>
   <result pre="investigated the growth properties and virulence in mice of three" exact="Zika" post="virus (ZIKV) strains of Asian/American lineage, PRVABC59, ZIKV/Hu/Chiba/S36/2016 (ChibaS36),"/>
   <result pre="than in mice infected with the other two strains. Lastly," exact="ZIKV" post="NS1 antigen was detected in the damaged testes of"/>
   <result pre="vivo and to induce testis damage in mice. Author summary" exact="Zika" post="virus (ZIKV) is classified into two lineages, African and"/>
   <result pre="lineages, African and Asian/American. Phylogenetic analyses have revealed that Asian/American-lineage" exact="ZIKV" post="strains can be divided into three distinct subtypes, the"/>
   <result pre="in vitro and in vivo growth of three Asian/American lineage" exact="ZIKV" post="strains belonging to the three subtypes. The American-subtype strain"/>
   <result pre="growth potential in vitro, respectively, and mice infected with these" exact="ZIKV" post="strains also showed the highest and lowest viremia levels"/>
   <result pre="Data Availability All relevant data are within the manuscript. Introduction" exact="Zika" post="virus (ZIKV; genus: Flavivirus; family: Flaviviridae) was first isolated"/>
   <result pre="was first isolated from a sentinel rhesus monkey in the" exact="Zika" post="forest of Uganda in 1947 [1]. ZIKV infection in"/>
   <result pre="monkey in the Zika forest of Uganda in 1947 [1]." exact="ZIKV" post="infection in humans was first identified in Uganda and"/>
   <result pre="and the United Republic of Tanzania in 1952, and human" exact="ZIKV" post="infections (ZIKV disease, ZVD) have been sporadically detected in"/>
   <result pre="since the initial isolation [2]. The first large outbreak of" exact="ZIKV" post="infection in humans was identified in Yap Island in"/>
   <result pre="in Southeast Asia, including Singapore, Thailand, Vietnam, and the Philippines." exact="ZIKV" post="is transmitted to humans mainly through the bite of"/>
   <result pre="through the bite of Aedes mosquitoes and non-vector transmission of" exact="ZIKV" post="has also been reported to occur through blood transfusion,"/>
   <result pre="transplantation, and sexual intercourse [6–8]. The clinical symptoms caused by" exact="ZIKV" post="infection are generally self-limiting and include fever, rash, headache,"/>
   <result pre="are infected with ZIKV, the fetus can be infected with" exact="ZIKV" post="through the placenta, which can cause congenital neurological malformations"/>
   <result pre="symptoms: microcephaly, sensorineural abnormalities, cerebral calcification, and abortion [9, 10]." exact="ZIKV" post="infection also causes a severe neurological complication, Guillain–Barré syndrome,"/>
   <result pre="infection also causes a severe neurological complication, Guillain–Barré syndrome, and" exact="ZIKV" post="has demonstrated the ability to infect diverse cell types"/>
   <result pre="diverse cell types including neuronal cells [9, 11, 12]. The" exact="ZIKV" post="genome is comprised of a single-stranded, positive-sense RNA that"/>
   <result pre="NS4A, NS4B, and NS5) in one open reading frame [13]." exact="ZIKV" post="is classified into two lineages, African and Asian/American; the"/>
   <result pre="and the Americas were caused by the spread of Asian/American-lineage" exact="ZIKV" post="from Southeast Asia [14, 15]. Phylogenetic analyses performed using"/>
   <result pre="from Southeast Asia [14, 15]. Phylogenetic analyses performed using complete" exact="ZIKV" post="genomes indicate that ZIKV strains in the Asian/American lineage"/>
   <result pre="15]. Phylogenetic analyses performed using complete ZIKV genomes indicate that" exact="ZIKV" post="strains in the Asian/American lineage can be divided into"/>
   <result pre="17]. Studies conducted using a mouse model showed that American-subtype" exact="ZIKV" post="strains induce more severe neurological disorders and marked immune"/>
   <result pre="findings raise the possibility that recent genetic changes in the" exact="ZIKV" post="genome altered the properties of the virus, such as"/>
   <result pre="tissue tropism, and also contributed to the spread of the" exact="ZIKV" post="endemic area and the increase in the cases of"/>
   <result pre="endemic area and the increase in the cases of congenital" exact="ZIKV" post="infections in Pacific regions and the Americas [17]. Accordingly,"/>
   <result pre="cells [18, 20–24]. However, only a limited number of Asia/American-lineage" exact="ZIKV" post="strains were previously used for evaluating virulence; thus, further"/>
   <result pre="evaluating virulence; thus, further analyses must be conducted using additional" exact="ZIKV" post="isolates to elucidate the relationship between genetic variation and"/>
   <result pre="examined the in vitro and in vivo growth of three" exact="ZIKV" post="strains that belong to the three distinct subtypes in"/>
   <result pre="the Asian/American lineage. Recent studies have demonstrated that Asian/American lineage" exact="ZIKV" post="infection in mice is not lethal, but causes testis"/>
   <result pre="ZIKV-infected mice can be used as an index for assessing" exact="ZIKV" post="pathogenicity [26–33]. Therefore, in this study we pathologically evaluated"/>
   <result pre="three strains to determine the differences in pathogenicity among these" exact="ZIKV" post="strains. Methods Ethics statement Mouse experiments were performed in"/>
   <result pre="to minimize any potential pain and distress. Mice infected with" exact="ZIKV" post="were observed daily for adverse reactions and signs of"/>
   <result pre="of organ samples, mice were euthanized by using isoflurane. The" exact="ZIKV" post="strains used in this study were previously published and"/>
   <result pre="culture, plaque assay, and growth kinetics assay We used four" exact="ZIKV" post="strains: MR766-NIID (MR766; accession no. LC002520), ZIKV/Hu/Chiba/S36/2016 (ChibaS36; accession"/>
   <result pre="ZIKV/Hu/NIID123/2016 (NIID123; accession no. LC219720) [16] (Table 1). 10.1371/journal.pntd.0007387.t001Table 1" exact="Zika" post="virus strains used in this study. Strain name Lineage"/>
   <result pre="NIID123 were originally isolated from, respectively, a patient infected with" exact="ZIKV" post="in Fiji in 2016 and a patient infected with"/>
   <result pre="ZIKV in Fiji in 2016 and a patient infected with" exact="ZIKV" post="in Vietnam in 2016 [16, 34, 35]. PRVABC59 was"/>
   <result pre="a positive control when evaluating the growth ability of Asian/American-lineage" exact="ZIKV" post="in mice [34]. These viruses were propagated in Vero"/>
   <result pre="6-well culture plates (3 × 105 cells/well) and infected with" exact="ZIKV" post="at a multiplicity of infection of 0.01 plaque-forming units"/>
   <result pre="medium were collected periodically and the titer of the infectious" exact="ZIKV" post="in each aliquot was determined using a plaque assay"/>
   <result pre="To construct a phylogenetic tree, the nucleotide sequences of 33" exact="ZIKV" post="strains were aligned and analyzed using the maximum likelihood"/>
   <result pre="the MEGA7 program [37]. Complete amino acid sequences of the" exact="ZIKV" post="strains were aligned using GENETYX gene-analysis software (Genetyx Corp.,"/>
   <result pre="sample as previously described [30, 40]. Briefly, to pre-amplify infectious" exact="ZIKV" post="in the organ samples using C6/36 cells, the organ"/>
   <result pre="Blue solution to visualize the cytopathic effect induced by the" exact="ZIKV" post="infection. Viral titers were statistically compared using either BellCurve"/>
   <result pre="Pure Viral RNA Purification Kit (Roche Diagnostics, Indianapolis, IN, USA)." exact="ZIKV" post="RNA was quantified by performing quantitative real-time RT-PCR with"/>
   <result pre="One-Step Master Mix (Thermo Fisher Scientific, Waltham, MA, USA). The" exact="ZIKV" post="genome was amplified using the following primers: ZIKV 1086"/>
   <result pre="USA). The ZIKV genome was amplified using the following primers:" exact="ZIKV" post="1086 (5′-CCGCTGCCCAACACAAG-3′), ZIKV 1162c (5′-CCACTAACGTTCTTTTGCAGACAT-3′), and Probe ZIKV 1107-FAM"/>
   <result pre="genome was amplified using the following primers: ZIKV 1086 (5′-CCGCTGCCCAACACAAG-3′)," exact="ZIKV" post="1162c (5′-CCACTAACGTTCTTTTGCAGACAT-3′), and Probe ZIKV 1107-FAM (5′FAM-AGCCTACCTTGACAAGCAGTCAGACACTCAA-TAMRA3′) [14]. Genome"/>
   <result pre="following primers: ZIKV 1086 (5′-CCGCTGCCCAACACAAG-3′), ZIKV 1162c (5′-CCACTAACGTTCTTTTGCAGACAT-3′), and Probe" exact="ZIKV" post="1107-FAM (5′FAM-AGCCTACCTTGACAAGCAGTCAGACACTCAA-TAMRA3′) [14]. Genome copy numbers were statistically compared"/>
   <result pre="(DAKO Cytomation, Glostrup, Denmark). Results Phylogenetic analysis of three Asian/American-lineage" exact="ZIKV" post="strains: PRVABC59, ZIKV/Hu/Chiba/S36/2016, and ZIKV/Hu/NIID123/2016 The phylogenetic analysis results"/>
   <result pre="and ZIKV/Hu/NIID123/2016 The phylogenetic analysis results indicated that the three" exact="ZIKV" post="strains, PRVABC59, ChibaS36, and NIID123, belong to distinct subtypes"/>
   <result pre="Asian subtype (Fig 1). Fig 1 Phylogenetic analysis of Asian/American-lineage" exact="ZIKV" post="strains based on the nucleotide sequences of the entire"/>
   <result pre="in S1 Table. In vitro growth of African- and Asian/American-lineage" exact="ZIKV" post="strains The plaques formed on Vero cells by NIID123"/>
   <result pre="2A). NIID123 also replicated more slowly than the other three" exact="ZIKV" post="strains in Vero cells (Fig 2B). The growth kinetics"/>
   <result pre="PRVABC59 (Fig 2C). Fig 2 In vitro growth of four" exact="ZIKV" post="strains: MR766-NIID, PRVABC59, ZIKV/Hu/Chiba/S36/2016, and ZIKV/Hu/NIID123/2016. A) Plaques formed"/>
   <result pre="two-way ANOVA (***P &amp;lt; 0.001). Growth of African- and Asian/American-lineage" exact="ZIKV" post="strains in IFNAR1-KO mice No statistically significant differences in"/>
   <result pre="most of the mice infected with each of the four" exact="ZIKV" post="strains. Infectious virus was detected in the spleen in"/>
   <result pre="test (*P &amp;lt; 0.05). Next, we analyzed the three Asian/American-lineage" exact="ZIKV" post="in further detail. The time course of change in"/>
   <result pre="to 8 days post-infection (**P &amp;lt; 0.01). Growth of Asian/American-lineage" exact="ZIKV" post="strains in the male genital tract of IFNAR1-KO mice"/>
   <result pre="serum in any of the mice infected with each Asian/American-lineage" exact="ZIKV" post="strain (Fig 5A). Infectious virus was detected at similar"/>
   <result pre="from all mice infected with PRVABC59 or ChibaS36, whereas infectious" exact="ZIKV" post="was not detected in the samples from NIID123-infected mice."/>
   <result pre="of testis and epididymis in mice infected with each Asian/American-lineage" exact="ZIKV" post="strain At 2 weeks post-inoculation, no weight loss was"/>
   <result pre="was observed in the testis of mice infected with each" exact="ZIKV" post="strain (Fig 6A and S2 Table). However, at 6"/>
   <result pre="cells were not observed in the testis (Fig 8A). The" exact="ZIKV" post="NS1 antigen was detected in the seminiferous tubules and"/>
   <result pre="and then euthanized at 2 weeks post-inoculation. Panel D inset:" exact="ZIKV" post="antigen-positive cells in the damaged seminiferous tubule. Scale bars:"/>
   <result pre="right panels. HE: hematoxylin and eosin staining; Anti-ZIKV: immunohistochemistry of" exact="ZIKV" post="NS1 antigen. Fig 8 Histological analysis of testes and"/>
   <result pre="panels (epididymides). HE: hematoxylin and eosin staining; Anti-ZIKV: immunohistochemistry of" exact="ZIKV" post="NS1 antigen. Discussion Previously, we reported that Asian/American-lineage ZIKV"/>
   <result pre="of ZIKV NS1 antigen. Discussion Previously, we reported that Asian/American-lineage" exact="ZIKV" post="strains can be classified into three subtypes based on"/>
   <result pre="American subtype [16]. In the present study we showed that" exact="ZIKV" post="strains of these three subtypes exhibited distinct growth properties"/>
   <result pre="subtypes exhibited distinct growth properties in vitro and in vivo." exact="ZIKV" post="NIID123, which belongs to the Southeast Asian subtype, showed"/>
   <result pre="and epididymis of mice compared with the other two strains." exact="ZIKV" post="PRVABC59 showed the highest growth capacity both in vitro"/>
   <result pre="of the three strains. These results raise the possibility that" exact="ZIKV" post="have acquired elevated proliferative capacity and pathogenicity during the"/>
   <result pre="the African-lineage strain causes more acute infection than the other" exact="ZIKV" post="strains [41, 42]. However, this does not exclude the"/>
   <result pre="evidence that persistent infection of testis with American- or Pacific-subtype" exact="ZIKV" post="might represent the cause of testis damage in ZIKV-infected"/>
   <result pre="6 months post-inoculation (S2 Table), which suggests that in humans," exact="ZIKV" post="infection might affect reproductive ability over an extended period."/>
   <result pre="over an extended period. However, a recent report indicated that" exact="ZIKV" post="infection produced no clear adverse effect on morphology or"/>
   <result pre="overt testis damage was observed in a primate model of" exact="ZIKV" post="infection, suggesting that the integrity of the host immune"/>
   <result pre="might be associated with the sensitivity of the testis to" exact="ZIKV" post="infection [44]. Comparison of the amino acid sequences of"/>
   <result pre="infection [44]. Comparison of the amino acid sequences of Asian/American-subtype" exact="ZIKV" post="strains revealed differences in several amino acid residues between"/>
   <result pre="This site has been shown to be involved in the" exact="ZIKV" post="proliferative activity in neural progenitor cells that causes microcephaly"/>
   <result pre="fetal brain and male reproductive organs; thus, pathogenesis caused by" exact="ZIKV" post="infection in the fetal brain does not necessarily equate"/>
   <result pre="which differ among the three strains, might be associated with" exact="ZIKV" post="proliferation and the pathogenic effect on the testis and"/>
   <result pre="and Table 2) [17, 46]. Point-by-point analysis performed using a" exact="ZIKV" post="reverse-genetics system is required in order to identify the"/>
   <result pre="the site(s) responsible for efficient proliferation and persistent infection of" exact="ZIKV" post="in male reproductive organs. Fig 9 Alignment of partial"/>
   <result pre="organs. Fig 9 Alignment of partial amino acid sequences of" exact="ZIKV" post="strains. Three partial sequences of the M, NS3, and"/>
   <result pre="ZIKV/Hu/Chiba/S36/2016, and ZIKV/Hu/NIID123/2016a. Amino acid position Gene Amino acid in" exact="ZIKV" post="strain PRVABC59 ZIKV/Hu/Chiba/S36/2016 ZIKV/Hu /NIID123/2016 80 C T I"/>
   <result pre="In this study, we used only one strain for each" exact="ZIKV" post="subtype. Several variations might exist among the strains in"/>
   <result pre="further evaluation must be conducted using an increased number of" exact="ZIKV" post="strains for each subtype to elucidate the differences in"/>
   <result pre="each subtype to elucidate the differences in characteristics among the" exact="ZIKV" post="subtypes. Supporting information S1 Table List of ZIKV strains"/>
   <result pre="among the ZIKV subtypes. Supporting information S1 Table List of" exact="ZIKV" post="strains used for phylogenetic analysis and comparison of amino"/>
   <result pre="wish to thank Dr. Beth Bell (US CDC) for providing" exact="ZIKV" post="strain PRVABC59. In addition, we thank Takuya Inagaki and"/>
   <result pre="Pathology, NIID) for their technical assistance. References References 1LazearHM, DiamondMS." exact="Zika" post="Virus: New Clinical Syndromes and Its Emergence in the"/>
   <result pre="Hemisphere. Journal of virology. 2016;90(10):4864–75. 10.1128/JVI.00252-16 .26962217 2DickGW, KitchenSF, HaddowAJ." exact="Zika" post="virus. I. Isolations and serological specificity. Transactions of the"/>
   <result pre="New England journal of medicine. 2009;360(24):2536–43. 10.1056/NEJMoa0805715 .19516034 4MussoD, GublerDJ." exact="Zika" post="Virus. Clinical microbiology reviews. 2016;29(3):487–524. 10.1128/CMR.00072-15 .27029595 5MussoD, NillesEJ,"/>
   <result pre="2016;29(3):487–524. 10.1128/CMR.00072-15 .27029595 5MussoD, NillesEJ, Cao-LormeauVM. Rapid spread of emerging" exact="Zika" post="virus in the Pacific area. Clinical microbiology and infection:"/>
   <result pre="of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit" exact="Zika" post="virus. BMC infectious diseases. 2015;15:49210.1186/s12879-015-1231-2 .26527535 7FoyBD, KobylinskiKC, Chilson"/>
   <result pre="BlitvichBJ, Travassos da RosaA, HaddowAD, et al.Probable non-vector-borne transmission of" exact="Zika" post="virus, Colorado, USA. Emerging infectious diseases. 2011;17(5):880–2. 10.3201/eid1705.101939 .21529401"/>
   <result pre=".21529401 8MussoD, NhanT, RobinE, RocheC, BierlaireD, ZisouK, et al.Potential for" exact="Zika" post="virus transmission through blood transfusion demonstrated during an outbreak"/>
   <result pre="MonsS, LastereS, RocheC, VanhomwegenJ, et al.Guillain-Barre Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control study. Lancet."/>
   <result pre="LavenJJ, VelezJO, LambertAJ, JohnsonAJ, et al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007."/>
   <result pre="10.3201/eid1408.080287 .18680646 15LanciottiRS, LambertAJ, HolodniyM, SaavedraS, Signor LdelC. Phylogeny of" exact="Zika" post="Virus in Western Hemisphere, 2015. Emerging infectious diseases. 2016;22(5):933–5."/>
   <result pre=".27088323 16HashimotoT, KutsunaS, TajimaS, NakayamaE, MaekiT, TaniguchiS, et al.Importation of" exact="Zika" post="Virus from Vietnam to Japan, November 2016. Emerging infectious"/>
   <result pre=".28445122 17PetterssonJH, EldholmV, SeligmanSJ, LundkvistA, FalconarAK, GauntMW, et al.How Did" exact="Zika" post="Virus Emerge in the Pacific Islands and Latin America?mBio."/>
   <result pre="YuJY, et al.A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephaly. Science. 2017;358(6365):933–6. 10.1126/science.aam7120 .28971967"/>
   <result pre="19ZhangF, WangHJ, WangQ, LiuZY, YuanL, HuangXY, et al.American Strain of" exact="Zika" post="Virus Causes More Severe Microcephaly Than an Old Asian"/>
   <result pre="of the NS1 A188V substitution responsible for recent enhancement of" exact="Zika" post="virus Asian genotype infectivity. Memorias do Instituto Oswaldo Cruz."/>
   <result pre="21LiuY, LiuJ, DuS, ShanC, NieK, ZhangR, et al.Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoes. Nature. 2017;545(7655):482–6. 10.1038/nature22365"/>
   <result pre="YangK, ZhaoQ, et al.A Mutation Identified in Neonatal Microcephaly Destabilizes" exact="Zika" post="Virus NS1 Assembly in Vitro. Scientific reports. 2017;7:4258010.1038/srep42580 .28198446"/>
   <result pre="ShanC, MuruatoAE, NunesBTD, MedeirosDBA, et al.An evolutionary NS1 mutation enhances" exact="Zika" post="virus evasion of host interferon induction. Nature communications. 2018;9(1):41410.1038/s41467-017-02816-2"/>
   <result pre="Nature communications. 2018;9(1):41410.1038/s41467-017-02816-2 .29379028 25RossiSL, EbelGD, ShanC, ShiPY, VasilakisN. Did" exact="Zika" post="Virus Mutate to Cause Severe Outbreaks?Trends in microbiology. 2018;26(10):877–85."/>
   <result pre="WarnerBM, MajerA, HaganM, AudetJ, et al.DNA vaccination protects mice against" exact="Zika" post="virus-induced damage to the testes. Nature communications. 2017;8:1574310.1038/ncomms15743 .28589934"/>
   <result pre="al.A vaccinia-based single vector construct multi-pathogen vaccine protects against both" exact="Zika" post="and chikungunya viruses. Nature communications. 2018;9(1):123010.1038/s41467-018-03662-6 .29581442 31ShanC, MuruatoAE,"/>
   <result pre="JaggerBW, RichnerJ, NunesBTD, MedeirosDBA, et al.A single-dose live-attenuated vaccine prevents" exact="Zika" post="virus pregnancy transmission and testis damage. Nature communications. 2017;8(1):67610.1038/s41467-017-00737-8"/>
   <result pre="et al.Human polyclonal antibodies produced in transchromosomal cattle prevent lethal" exact="Zika" post="virus infection and testicular atrophy in mice. Antiviral research."/>
   <result pre="LuX, XieY, et al.Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against" exact="Zika" post="Virus Infection and Testis Damage. Journal of virology. 2018;92(6)."/>
   <result pre="ShibasakiK, et al.Characterization of large and small-plaque variants in the" exact="Zika" post="virus clinical isolate ZIKV/Hu/S36/Chiba/2016. Scientific reports. 2017;7(1):1616010.1038/s41598-017-16475-2 .29170504 35TairaM,"/>
   <result pre="OgawaT, NishijimaH, YamamotoK, HottaC, AkitaM, et al.The First Case of" exact="Zika" post="Virus Isolated from a Japanese Patient Who Returned to"/>
   <result pre="de VrijFMS, et al.Phenotypic Differences between Asian and African Lineage" exact="Zika" post="Viruses in Human Neural Progenitor Cells. mSphere. 2017;2(4). Epub"/>
   <result pre="RockxB, SalinasS. Differential virulence between Asian and African lineages of" exact="Zika" post="virus. PLoS neglected tropical diseases. 2017;11(9):e000582110.1371/journal.pntd.0005821 .28934211 43MatusaliG, HouzetL,"/>
   <result pre="2018;128(10):4697–710. 10.1172/JCI121735 .30063220 44StassenL, ArmitageCW, van der HeideDJ, BeagleyKW, FrentiuFD." exact="Zika" post="Virus in the Male Reproductive Tract. Viruses. 2018;10(4). 10.3390/v10040198"/>
   <result pre="et al.Case of Microcephaly after Congenital Infection with Asian Lineage" exact="Zika" post="Virus, Thailand. Emerging infectious diseases. 2018;24(9). 10.3201/eid2409.180416 .29985788 46DuggalNK,"/>
   <result pre="Weger-LucarelliJ, HawksSA, RitterJM, RomoH, et al.Mutations present in a low-passage" exact="Zika" post="virus isolate result in attenuated pathogenesis in mice. Virology."/>
   <result pre="al.Fetal Brain Infection Is Not a Unique Characteristic of Brazilian" exact="Zika" post="Viruses. Viruses. 2018;10(10). 10.3390/v10100541 .30282919 48YunSI, SongBH, FrankJC, JulanderJG,"/>
   <result pre="of Viral and Host Genetic Variations on the Outcome of" exact="Zika" post="Virus Infection. Viruses. 2018;10(8). 10.3390/v10080422 .30103523 49SmithDR, SpragueTR, HollidgeBS,"/>
   <result pre="49SmithDR, SpragueTR, HollidgeBS, ValdezSM, PadillaSL, BellancaSA, et al.African and Asian" exact="Zika" post="Virus Isolates Display Phenotypic Differences Both In Vitro and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6555941\results\search\tropicalVirus\results.xml">
   <result pre="BiosciCell &amp;amp; Bioscience2045-3701BioMed CentralLondon pmcid: 6555941308 doi: 10.1186/s13578-019-0308-9 : Research" exact="Zika" post="virus antagonizes interferon response in patients and disrupts RIG-I–MAVS"/>
   <result pre="Background The emerging threat to global health associated with the" exact="Zika" post="virus (ZIKV) epidemics and its link to severe complications"/>
   <result pre="role of type I interferon (IFN-I) in protecting hosts from" exact="ZIKV" post="infection lies in the findings that ZIKV has evolved"/>
   <result pre="protecting hosts from ZIKV infection lies in the findings that" exact="ZIKV" post="has evolved various strategies to subvert the host defense"/>
   <result pre="subsequent IFN signaling. Yet, mechanisms underlying the counter-IFN capability of" exact="ZIKV" post="and its proteins, which might contribute to the well-recognized"/>
   <result pre="inactive as compared to those of healthy donors, suggesting that" exact="ZIKV" post="was able to suppress the induction of IFN-I during"/>
   <result pre="in humans. Furthermore, by analyzing the molecular interaction in a" exact="ZIKV" post="NS4A-overexpression system, or in the context of actual ZIKV"/>
   <result pre="a ZIKV NS4A-overexpression system, or in the context of actual" exact="ZIKV" post="infection, we identified that ZIKV NS4A directly bound MAVS"/>
   <result pre="in the context of actual ZIKV infection, we identified that" exact="ZIKV" post="NS4A directly bound MAVS and thereby interrupted the RIG-I/MAVS"/>
   <result pre="attenuated production of IFN-I. Conclusions Our findings collectively revealed that" exact="ZIKV" post="NS4A targeted MAVS and contributed to ZIKV immune evasion"/>
   <result pre="collectively revealed that ZIKV NS4A targeted MAVS and contributed to" exact="ZIKV" post="immune evasion through abrogating MAVS-mediated IFN production. These findings"/>
   <result pre="new knowledge and molecular details to our understanding regarding how" exact="ZIKV" post="mediates suppression of the IFN-I system and may provide"/>
   <result pre="contains supplementary material, which is available to authorized users. Keywords" exact="Zika" post="virus Nonstructural protein 4A Interferon RIG-I MAVS Background Zika"/>
   <result pre="Keywords Zika virus Nonstructural protein 4A Interferon RIG-I MAVS Background" exact="Zika" post="virus (ZIKV) is an emerging mosquito-borne pathogen belonging to"/>
   <result pre="virus (JEV), dengue virus (DENV), yellow fever virus (YFV) and" exact="West Nile" post="virus (WNV) [1]. While ZIKV was originally identified in"/>
   <result pre="fever virus (YFV) and West Nile virus (WNV) [1]. While" exact="ZIKV" post="was originally identified in the Zika forest of Uganda"/>
   <result pre="virus (WNV) [1]. While ZIKV was originally identified in the" exact="Zika" post="forest of Uganda in 1947 and the first human"/>
   <result pre="human infection case was documented in 1954, the most serious" exact="Zika" post="pandemic to date began in the Americas in 2013–2014"/>
   <result pre="over 86 countries and territories have reported cases of active" exact="ZIKV" post="transmission [3]. Clinically, although most Zika cases are asymptomatic"/>
   <result pre="reported cases of active ZIKV transmission [3]. Clinically, although most" exact="Zika" post="cases are asymptomatic or only manifest as an influenza-like"/>
   <result pre="or only manifest as an influenza-like illness, severe forms of" exact="ZIKV" post="infection such as microcephaly and other neurological abnormalities in"/>
   <result pre="based on which severe diseases develop as a result of" exact="ZIKV" post="infection is key to developing strategies against ZIKV-associated conditions."/>
   <result pre="in the prM [5] and NS1 [6] proteins might enable" exact="ZIKV" post="to become more virulent and/or transmissible, mounting evidence suggests"/>
   <result pre="suggests that innate immunity is involved in the governance of" exact="ZIKV" post="replication and pathogenesis [1, 7]. The interferon (IFN) system,"/>
   <result pre="constitutes the first line of defense against viral infection, including" exact="ZIKV" post="[7]. A vital role for the IFN system in"/>
   <result pre="[7]. A vital role for the IFN system in abrogating" exact="ZIKV" post="infection in the host was revealed by the fact"/>
   <result pre="infection in the host was revealed by the fact that" exact="ZIKV" post="is pathogenic in IFN receptor knockout mice but not"/>
   <result pre="mice [8–10]. Moreover, Smith et al. demonstrated the neuropathogenesis of" exact="ZIKV" post="in a highly susceptible immunocompetent mouse model after the"/>
   <result pre="that in order for a pathogenic infection to be established," exact="ZIKV" post="needs to attenuate the production of IFNs or the"/>
   <result pre="two of the most important PRRs for the detection of" exact="ZIKV" post="infection [7, 15]. RIG-I recognizes cytosolic viral RNA of"/>
   <result pre="in responding to infection of positive-sense, single-stranded RNA viruses, including" exact="ZIKV" post="[17]. STING has also been found to interact with"/>
   <result pre="and the downstream signaling pathways. Currently available data suggest that" exact="ZIKV" post="infection can inhibit type I IFN responses in dendritic"/>
   <result pre="yet the interferon response in other cell types remains unknown." exact="ZIKV" post="genome codes for a single polyprotein that is post-translationally,"/>
   <result pre="(NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) [1]. The" exact="ZIKV" post="nonstructural proteins NS1, NS2B3, NS4B, and NS5 have been"/>
   <result pre="NS4B, and NS5 have been implicated to be engaged in" exact="ZIKV" post="immuno pathogenicity through diverse strategies. For example, NS1 and"/>
   <result pre="pathogenicity through diverse strategies. For example, NS1 and NS4B of" exact="ZIKV" post="inhibit RLR-induced IFN-β production via interacting with TBK1 and"/>
   <result pre="facilitating proteasomal degradation of Jak1 [19] and STING [17]. Furthermore," exact="ZIKV" post="NS5 has been found to bind and degrade host"/>
   <result pre="MAVS signaling is essential for inducing an IFN production during" exact="ZIKV" post="infection, it is plausible that viruses may hijack this"/>
   <result pre="facilitate infection of the host. Our previous findings revealed that" exact="DENV" post="NS4A protein played an important role in suppressing interferon"/>
   <result pre="of the flavivirus group, ZIKV. This current study found that" exact="ZIKV" post="interfered with the RIG-I–MAVS signaling to attenuate type I"/>
   <result pre="type I IFN production. More specifically, our results suggest that" exact="ZIKV" post="NS4A targets MAVS and interrupts the RLR–MAVS interaction, leading"/>
   <result pre="interaction, leading to reduced induction of type I IFNs. Results" exact="ZIKV" post="suppresses type I interferon production in human subjects and"/>
   <result pre="in human subjects and in host cells To assess whether" exact="ZIKV" post="infection influences the production of type I IFN in"/>
   <result pre="previous study [23]. The clinical characteristics of three individuals with" exact="ZIKV" post="infection and the background of three healthy donors are"/>
   <result pre="undetected (TREX1 and DCP1A). To further investigate the ability of" exact="ZIKV" post="to block IFN production in response to general viral"/>
   <result pre="cultured human cells, we infected HFF-1 and SV-HUC-1 cells with" exact="ZIKV" post="and then used SeV or poly(I:C) to secondarily infect"/>
   <result pre="induced drastic production of IFN-β, pre-infection of the cells with" exact="ZIKV" post="robustly lowered the level of IFN-β produced in response"/>
   <result pre="the same RNA expression level of SeV in each group." exact="ZIKV" post="infection in HFF-1 and SV-HUC-1 was validated by western"/>
   <result pre="SV-HUC-1 was validated by western blotting analysis to detect the" exact="ZIKV" post="envelope protein (E) (Fig. 1h, i). These data demonstrated"/>
   <result pre="envelope protein (E) (Fig. 1h, i). These data demonstrated that" exact="ZIKV" post="could actively suppress the type-I IFN response in host"/>
   <result pre="in host cells and patients, warranting further investigation of how" exact="ZIKV" post="suppresses IFN production in human host cells. Fig. 1"/>
   <result pre="ZIKV suppresses IFN production in human host cells. Fig. 1" exact="ZIKV" post="abrogates the activation of type I IFN signaling. a"/>
   <result pre="statistical significance of the differential gene expression. b–e Infection with" exact="ZIKV" post="reduces type I IFN production after a secondary infection."/>
   <result pre="infection. HFF-1 and SV-HUC-1 cells were infected with mock or" exact="ZIKV" post="at an MOI of 1, and 24 h later,"/>
   <result pre="and for Western blotting analysis to determine the levels of" exact="ZIKV" post="envelope protein (E) and GAPDH protein (h, i). Data"/>
   <result pre="from three repeatedexperiments. *p &amp;lt; 0.05, and **indicates p &amp;lt; 0.01 (Student’s t test)" exact="ZIKV" post="NS4A protein abrogates IFN-I signaling Our previous finding that"/>
   <result pre="through targeting RIG-I–MAVS-mediated signaling [22] prompted us to ask whether" exact="ZIKV" post="NS4A protein is also able to interfere with RLR–MAVS-dependent"/>
   <result pre="two-hybrid analysis was performed to identify possible molecular interactions between" exact="ZIKV" post="NS4A and components along the RIG-I signaling pathway. Specifically,"/>
   <result pre="and components along the RIG-I signaling pathway. Specifically, we used" exact="ZIKV" post="NS4A to transfect 293T cells, together with, respectively, one"/>
   <result pre="by Western blotting (Additional file 3: Figure S1, A–D). When" exact="DENV" post="NS4A and ZIKV prM were used as a positive"/>
   <result pre="(Additional file 3: Figure S1, A–D). When DENV NS4A and" exact="ZIKV" post="prM were used as a positive and negative control,"/>
   <result pre="MAVS and ZIKV-NS4A, DENV2-NS4A (Fig. 2b), whereas no interaction between" exact="ZIKV" post="prM, NS4A and RIG-I, TBK1 orIKKε was found (Fig."/>
   <result pre="suggesting that MAVS might represent a specific interaction partner of" exact="ZIKV" post="NS4A. Fig. 2 Molecular interaction between ZIKV NS4A protein"/>
   <result pre="interaction partner of ZIKV NS4A. Fig. 2 Molecular interaction between" exact="ZIKV" post="NS4A protein and the type I IFN induction pathway."/>
   <result pre="screening assays were performed to identify the molecular targets of" exact="ZIKV" post="proteins in RIG-I signaling. 293T cells in 24-well plates"/>
   <result pre="(BIND) vector expressing a fusion protein of GAL4-BD and individual" exact="ZIKV" post="prM, NS4A or DENV NS4A proteins, and a pFN10A"/>
   <result pre="fusion protein of GAL4-BD and individual ZIKV prM, NS4A or" exact="DENV" post="NS4A proteins, and a pFN10A (ACT) vector expressing a"/>
   <result pre="**p &amp;lt; 0.01 (Student’s t test) To verify the above finding that" exact="ZIKV" post="NS4A interacts with MAVS, we examined whether NS4A of"/>
   <result pre="ZIKV NS4A interacts with MAVS, we examined whether NS4A of" exact="Zika" post="virus co-localizes with MAVS by performing confocal microscopy in"/>
   <result pre="induction by targeting MAVS, was employed as a positive control," exact="ZIKV" post="NS4A or PB1-F2, respectively, but not ZIKV prM, was"/>
   <result pre="a positive control, ZIKV NS4A or PB1-F2, respectively, but not" exact="ZIKV" post="prM, was found to co-localize with MAVS, supporting the"/>
   <result pre="was found to co-localize with MAVS, supporting the notion that" exact="ZIKV" post="NS4A interacts with MAVS in host cells. Fig. 3"/>
   <result pre="ZIKV NS4A interacts with MAVS in host cells. Fig. 3" exact="ZIKV" post="NS4A co-localizes and interacts with MAVS. a HeLa cells"/>
   <result pre="a HeLa cells transfected with plasmids expressing Flag-tagged NS4A, Flag-tagged" exact="ZIKV" post="prM or influenza Flag-tagged PB1-F2 were stained with anti-Flag"/>
   <result pre="NS4A were used in a co-IP assay to address whether" exact="ZIKV" post="NS4A protein physically interacts with MAVS. Cell lysates were"/>
   <result pre="antibody by Western blotting. e HFF-1 cells were infected with" exact="ZIKV" post="at an MOI of 5 followed by immunoprecipitation using"/>
   <result pre="(co-IP) assay was performed to reveal a physical interaction between" exact="ZIKV" post="NS4A and MAVS. 293T cells were co-transfected with Myc-tagged"/>
   <result pre="and MAVS, we also performed an endogenous IP assay upon" exact="ZIKV" post="infection. When HFF-1 cells were infected with ZIKV and"/>
   <result pre="assay upon ZIKV infection. When HFF-1 cells were infected with" exact="ZIKV" post="and the cell lysates were subsequently precipitated using an"/>
   <result pre="results revealed that an antibody against MAVS could pull down" exact="ZIKV" post="NS4A (Fig. 3e), suggesting that NS4A and MAVS were"/>
   <result pre="MAVS was demonstrated, strongly suggesting that NS4A directly bound MAVS." exact="ZIKV" post="NS4A interacts with both the CL and TM domains"/>
   <result pre="domains in the interaction between NS4A and MAVS. Fig. 4" exact="ZIKV" post="NS4A interacts with both the CL and TM domains"/>
   <result pre="RIG-I, modulated the downstream signaling, and consequently suppressed IFN production." exact="ZIKV" post="NS4A-MAVS interaction inhibits IFN induction and viral infection As"/>
   <result pre="induction and viral infection As the aforementioned data showed that" exact="ZIKV" post="NS4A interacts with MAVS, we next sought to determine"/>
   <result pre="production, together with increasing amounts of the expression vector containing" exact="ZIKV" post="NS4A plus the IFN-β luciferase reporter cassette. Our results"/>
   <result pre="the IFN-β luciferase reporter cassette. Our results demonstrated that when" exact="ZIKV" post="prM was used as a negative control and the"/>
   <result pre="negative control and the PB1-F2 protein of influenza virus and" exact="DENV" post="NS4A were used as a positive control, overexpression of"/>
   <result pre="DENV NS4A were used as a positive control, overexpression of" exact="ZIKV" post="NS4A indeed inhibited the reporter luciferase activity driven by"/>
   <result pre="and Additional file 3: Figure S4 A–C). Furthermore, PB1-F2 or" exact="DENV" post="NS4A, but not prM, significantly decreased the IFN-β reporter"/>
   <result pre="of interfering with the promoter activity of IFN-β. Fig. 5" exact="ZIKV" post="NS4A negatively regulates IFN production. a Lysates of 293T"/>
   <result pre="of 293T cells co-transfected with RIG-I(N), IFN-β reporter, together with" exact="ZIKV" post="NS4A (250, or 500 ng), DENV NS4A (250, or"/>
   <result pre="IFN-β reporter, together with ZIKV NS4A (250, or 500 ng)," exact="DENV" post="NS4A (250, or 500 ng), ZIKV prM (500 ng)"/>
   <result pre="(250, or 500 ng), DENV NS4A (250, or 500 ng)," exact="ZIKV" post="prM (500 ng) or PB1-F2 (500 ng)were analyzed for"/>
   <result pre="activity. 293T cells were transfected with IFN-β reporter, together with" exact="ZIKV" post="NS4A (250, or 500 ng), DENV NS4A (250, or"/>
   <result pre="IFN-β reporter, together with ZIKV NS4A (250, or 500 ng)," exact="DENV" post="NS4A (250, or 500 ng), ZIKV prM (500 ng)"/>
   <result pre="(250, or 500 ng), DENV NS4A (250, or 500 ng)," exact="ZIKV" post="prM (500 ng) or PB1-F2 (500 ng), b then"/>
   <result pre="were transfected with blank control vector or a vector expressing" exact="ZIKV" post="NS4A (500 ng), DENV NS4A (500 ng), ZIKV prM"/>
   <result pre="control vector or a vector expressing ZIKV NS4A (500 ng)," exact="DENV" post="NS4A (500 ng), ZIKV prM (500 ng) or PB1-F2"/>
   <result pre="vector expressing ZIKV NS4A (500 ng), DENV NS4A (500 ng)," exact="ZIKV" post="prM (500 ng) or PB1-F2 (500 ng), respectively, and"/>
   <result pre="and **p &amp;lt; 0.01 (Student’s t-test) To further examine the effect of" exact="ZIKV" post="NS4A on IFN-β production induced by viral infection, we"/>
   <result pre="poly(I:C) as an IFN stimulus and found that expression of" exact="ZIKV" post="NS4A, DENV NS4A or influenza PB1-F2, but not ZIKV"/>
   <result pre="an IFN stimulus and found that expression of ZIKV NS4A," exact="DENV" post="NS4A or influenza PB1-F2, but not ZIKV prM, markedly"/>
   <result pre="of ZIKV NS4A, DENV NS4A or influenza PB1-F2, but not" exact="ZIKV" post="prM, markedly inhibited the activities of IFN-β reporters upon"/>
   <result pre="in infected cells, and we found that ectopic expression of" exact="ZIKV" post="NS4A reduced IFN-β production stimulated by SeV (Fig. 5d)or"/>
   <result pre="by poly(I:C) (Fig. 5f). Taken together, these data indicated that" exact="ZIKV" post="can efficiently blocked the type-I IFN response, and that"/>
   <result pre="and ISGs (Fig. 5g, h), suggesting a pivotal role for" exact="ZIKV" post="NS4A in suppressing type I IFN signaling via interacting"/>
   <result pre="IFN signaling via interacting with MAVS. To further validate that" exact="ZIKV" post="NS4A is an antagonist of IFN production, we employed"/>
   <result pre="virus system in our study, and our data displayed that" exact="ZIKV" post="NS4A, DENV NS4A or IVA PB1-F2 remarkably reduced the"/>
   <result pre="in our study, and our data displayed that ZIKV NS4A," exact="DENV" post="NS4A or IVA PB1-F2 remarkably reduced the IFN-β reporter"/>
   <result pre="revealed that the recombinant VSV-GFP virus in 293T cells expressing" exact="ZIKV" post="NS4A, DENV NS4A or IVA PB1-F2 exhibited a high-degree"/>
   <result pre="the recombinant VSV-GFP virus in 293T cells expressing ZIKV NS4A," exact="DENV" post="NS4A or IVA PB1-F2 exhibited a high-degree replication (Fig."/>
   <result pre="replication (Fig. 6b, c), suggesting that the inhibitory effect of" exact="ZIKV" post="NS4A on IFN production could occur in the scenario"/>
   <result pre="occur in the scenario of actual viral infection. Fig. 6" exact="ZIKV" post="NS4A blocks VSV-induced IFN production. a 293T cells transfected"/>
   <result pre="microscope (c) Discussion The recent extensive epidemic out breaks of" exact="ZIKV" post="infection and its dissemination to various regions of the"/>
   <result pre="global health [1]. The rapidly emerging health crisis associated with" exact="ZIKV" post="infection highlights a growing need to understand the mechanisms"/>
   <result pre="highlights a growing need to understand the mechanisms by which" exact="ZIKV" post="accesses human hosts. Evidence for a crucial role of"/>
   <result pre="IFN response in preventing infection lies in the fact that" exact="ZIKV" post="has evolved a variety of strategies to subvert the"/>
   <result pre="present study, we demonstrated that by utilizing its NS4A protein," exact="ZIKV" post="could suppress IFN production through disrupting the RIG-I–MAVS signaling"/>
   <result pre="pathway. This finding broadens and deepens our knowledge of how" exact="ZIKV" post="has developed diverse strategies to evade the action of"/>
   <result pre="work revealed that NS4A proteins derived from various serotypes of" exact="DENV" post="blocked type I IFN production through targeting MAVS-mediated signaling"/>
   <result pre="MAVS-mediated signaling pathways [22]. Recently, Ma et al. reported that" exact="ZIKV" post="NS4A in particular as a suppressor of the RLR"/>
   <result pre="RLR–MAVS interaction, preventing induction of type I IFNs and inhibiting" exact="ZIKV" post="replication [25]. Toward understanding the counter-IFN capability of ZIKV"/>
   <result pre="inhibiting ZIKV replication [25]. Toward understanding the counter-IFN capability of" exact="ZIKV" post="in depth, our current work is featured in several"/>
   <result pre="we here provide the first and direct evidence demonstrating that" exact="ZIKV" post="NS4A directly binds MAVS protein and there by impair"/>
   <result pre="there by impair IFN production. Secondly, we have documented that" exact="ZIKV" post="is a weak inducer of type I interferon in"/>
   <result pre="in our study, serial experiments in the context of actual" exact="ZIKV" post="infection were performed, and clearly demonstrated that NS4A inhibited"/>
   <result pre="the molecular level, while antagonism of IFN-mediated signal transduction by" exact="ZIKV" post="NS4A shares multiple similarities with that of DENV NS4A,"/>
   <result pre="transduction by ZIKV NS4A shares multiple similarities with that of" exact="DENV" post="NS4A, our findings revealed that ZIKV NS4A bound MAVS"/>
   <result pre="similarities with that of DENV NS4A, our findings revealed that" exact="ZIKV" post="NS4A bound MAVS through specifically interacting with both the"/>
   <result pre="protect barrier cells of the human placenta called trophoblasts from" exact="ZIKV" post="infection. Type III IFN utilizes different cell-surface receptors than"/>
   <result pre="regulate its production [26]. Thus, it is highly likely that" exact="ZIKV" post="can also evade type III IFN signaling through targeting"/>
   <result pre="MAVS by NS4A, which may contribute to the ability of" exact="ZIKV" post="to cross the placenta during pregnancy and consequently cause"/>
   <result pre="between two proteins. Ding et al. revealed residues critical for" exact="ZIKV" post="NS2B3-mediated cleavage to R78 and G79 in the cytoplasmic"/>
   <result pre="be equally important to further map the amino acids of" exact="ZIKV" post="NS4A involved in IFN antagonism, which should allow generation"/>
   <result pre="known what has triggered the surge of recent epidemics of" exact="ZIKV" post="and the associated severe diseases [1]. Mechanistically, aberrant suppression"/>
   <result pre="of the antiviral property of IFNs might facilitate infection of" exact="ZIKV" post="as well as viral spreading in human populations. ZIKV"/>
   <result pre="of ZIKV as well as viral spreading in human populations." exact="ZIKV" post="is largely a mosquito-borne virus and can also be"/>
   <result pre="transplantation, and potentially via urine or saliva as well. Moreover," exact="ZIKV" post="may be transmitted from pregnant women to fetuses by"/>
   <result pre="route [1]. In consistence with such a dynamic transmission pattern," exact="ZIKV" post="exhibits a broad tropism and ability to persist in"/>
   <result pre="that immunocompromised human subjects or mice have increased susceptibility to" exact="ZIKV" post="infection and are more vulnerable to developing severe disease"/>
   <result pre="Moreover, it has been well documented that nonstructural proteins of" exact="ZIKV" post="play important roles in the life cycle of ZIKV"/>
   <result pre="of ZIKV play important roles in the life cycle of" exact="ZIKV" post="and that several of them, including NS1, NS2B/3, NS4A,"/>
   <result pre="of putative entry receptors on host cells being a key" exact="ZIKV" post="infection mechanism, the ability of ZIKV to defeat the"/>
   <result pre="cells being a key ZIKV infection mechanism, the ability of" exact="ZIKV" post="to defeat the host IFN system, possibly through expressing"/>
   <result pre="cellular tropism and intracellular persistence. Hence, collaborative actions among different" exact="ZIKV" post="nonstructural proteins need to be better understood, and further"/>
   <result pre="summary, the current findings revealed an innate immunity evasion by" exact="ZIKV" post="and the possible underlying molecular mechanisms. We demonstrated that"/>
   <result pre="and the possible underlying molecular mechanisms. We demonstrated that the" exact="ZIKV" post="NS4A protein plays an important role in suppressing interferon"/>
   <result pre="the RIG-I–MAVS interaction in host cells. The identified function of" exact="ZIKV" post="NS4A as an IFN antagonist might enable it to"/>
   <result pre="play an important role in the pathogenesis and spread of" exact="ZIKV" post="in humans. This work has not only found a"/>
   <result pre="son, or patients A, B, and C) were diagnosed with" exact="ZIKV" post="infection at Enping People’s Hospital in 2016. Clinical and"/>
   <result pre="publication [23]. The control subjects were three healthy volunteers without" exact="ZIKV" post="infection. All human subjects gave written, informed consent to"/>
   <result pre="is summarized and compared in Additional file 1: Table S1." exact="Zika" post="virus strain ZG-01 (GenBank accession number KY379148.1) was isolated"/>
   <result pre="as previously described [22]. Plasmids The cDNA coding for each" exact="ZIKV" post="protein, including prM, NS4A and NS4A-Flag (with a C-terminal"/>
   <result pre="coding for RIG-I (100 ng) together with a plasmid expressing" exact="ZIKV" post="NS4A, ZIKV prM, DENV NS4A or IVA PB1-F2. Empty"/>
   <result pre="RIG-I (100 ng) together with a plasmid expressing ZIKV NS4A," exact="ZIKV" post="prM, DENV NS4A or IVA PB1-F2. Empty pcDNA3 vector"/>
   <result pre="ng) together with a plasmid expressing ZIKV NS4A, ZIKV prM," exact="DENV" post="NS4A or IVA PB1-F2. Empty pcDNA3 vector was used"/>
   <result pre="stimulus, 293T cells transfected with IFN-β reporter, pRL-TK, together with" exact="ZIKV" post="NS4A, ZIKV prM, DENV NS4A or IVA PB1-F2, were"/>
   <result pre="cells transfected with IFN-β reporter, pRL-TK, together with ZIKV NS4A," exact="ZIKV" post="prM, DENV NS4A or IVA PB1-F2, were infected with"/>
   <result pre="with IFN-β reporter, pRL-TK, together with ZIKV NS4A, ZIKV prM," exact="DENV" post="NS4A or IVA PB1-F2, were infected with or without"/>
   <result pre="of pFN11A (BIND) vector expressing GAL4-BD fused with each individual" exact="Zika" post="virus protein, and plasmid pFN10A (ACT) expressing the transcriptional"/>
   <result pre="the protocol provided by the manufacturer. For SPR analysis, recombinant" exact="Zika" post="virus NS4A protein was purified using a Ni–NTA affinity"/>
   <result pre="62.5, 125, 250, 500, 1000, and 2000 nM) of purified" exact="ZIKV" post="NS4A or prM protein, or 100 microliters of blank"/>
   <result pre="1: Table S1. The clinical characteristics of three individuals with" exact="ZIKV" post="infection and the backgrounds of three healthy donors. LINK"/>
   <result pre="vivo. LINK Additional file 3. Additional figures and table. Abbreviations" exact="ZIKV" post="Zika virus IFN interferon JEV Japanese encephalitis virus DENV"/>
   <result pre="LINK Additional file 3. Additional figures and table. Abbreviations ZIKV" exact="Zika" post="virus IFN interferon JEV Japanese encephalitis virus DENV dengue"/>
   <result pre="Abbreviations ZIKV Zika virus IFN interferon JEV Japanese encephalitis virus" exact="DENV" post="dengue virus YFV yellow fever virus WNV West Nile"/>
   <result pre="virus IFN interferon JEV Japanese encephalitis virus DENV dengue virus" exact="YFV" post="yellow fever virus WNV West Nile virus IVA influenza"/>
   <result pre="Japanese encephalitis virus DENV dengue virus YFV yellow fever virus" exact="WNV" post="West Nile virus IVA influenza PAMPs pathogen-associated molecular patterns"/>
   <result pre="encephalitis virus DENV dengue virus YFV yellow fever virus WNV" exact="West Nile" post="virus IVA influenza PAMPs pathogen-associated molecular patterns PRRs pathogen"/>
   <result pre="they have no competing interests. References References 1.PiersonTCDiamondMSThe emergence of" exact="Zika" post="virus and its new clinical syndromesNature2018560772057358110.1038/s41586-018-0446-y30158602 2.MartinesRBBhatnagarJde Oliveira RamosAMDaviHPIgleziasSDKanamuraCTKeatingMKHaleGSilva-FlanneryLMuehlenbachsAet"/>
   <result pre="its new clinical syndromesNature2018560772057358110.1038/s41586-018-0446-y30158602 2.MartinesRBBhatnagarJde Oliveira RamosAMDaviHPIgleziasSDKanamuraCTKeatingMKHaleGSilva-FlanneryLMuehlenbachsAet al.Pathology of congenital" exact="Zika" post="syndrome in Brazil: a case seriesLancet20163881004789890410.1016/S0140-6736(16)30883-227372395 3.http://www.who.int/emergencies/zika-virus/en/. 4.LiHSaucedo-CuevasLShrestaSGleesonJGThe neurobiology"/>
   <result pre="syndrome in Brazil: a case seriesLancet20163881004789890410.1016/S0140-6736(16)30883-227372395 3.http://www.who.int/emergencies/zika-virus/en/. 4.LiHSaucedo-CuevasLShrestaSGleesonJGThe neurobiology of" exact="Zika" post="virusNeuron201692594995810.1016/j.neuron.2016.11.03127930910 5.YuanLHuangXYLiuZYZhangFZhuXLYuJYJiXXuYPLiGLiCet al.A single mutation in the prM protein"/>
   <result pre="virusNeuron201692594995810.1016/j.neuron.2016.11.03127930910 5.YuanLHuangXYLiuZYZhangFZhuXLYuJYJiXXuYPLiGLiCet al.A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephalyScience2017358636593393610.1126/science.aam712028971967 6.XiaHLuoHShanCMuruatoAENunesBTDMedeirosDBAZouJXieXGiraldoMIVasconcelosPFCet al.An evolutionary NS1"/>
   <result pre="contributes to fetal microcephalyScience2017358636593393610.1126/science.aam712028971967 6.XiaHLuoHShanCMuruatoAENunesBTDMedeirosDBAZouJXieXGiraldoMIVasconcelosPFCet al.An evolutionary NS1 mutation enhances" exact="Zika" post="virus evasion of host interferon inductionNat Commun20189141410.1038/s41467-017-02816-229379028 7.XieXShanCShiPYRestriction of"/>
   <result pre="Zika virus evasion of host interferon inductionNat Commun20189141410.1038/s41467-017-02816-229379028 7.XieXShanCShiPYRestriction of" exact="Zika" post="virus by host innate immunityCell Host Microbe201619556656710.1016/j.chom.2016.04.01927173920 8.AliotaMTCaineEAWalkerECLarkinKECamachoEOsorioJECharacterization of"/>
   <result pre="virus by host innate immunityCell Host Microbe201619556656710.1016/j.chom.2016.04.01927173920 8.AliotaMTCaineEAWalkerECLarkinKECamachoEOsorioJECharacterization of lethal" exact="Zika" post="virus infection in AG129 micePLoS Negl Trop Dis2016104e000468210.1371/journal.pntd.000468227093158 9.LazearHMGoveroJSmithAMPlattDJFernandezEMinerJJDiamondMSA"/>
   <result pre="in AG129 micePLoS Negl Trop Dis2016104e000468210.1371/journal.pntd.000468227093158 9.LazearHMGoveroJSmithAMPlattDJFernandezEMinerJJDiamondMSA mouse model of" exact="Zika" post="virus pathogenesisCell Host Microbe201619572073010.1016/j.chom.2016.03.01027066744 10.TripathiSBalasubramaniamVRBrownJAMenaIGrantABardinaSVMaringerKSchwarzMCMaestreAMSourisseauMet al.A novel Zika virus"/>
   <result pre="model of Zika virus pathogenesisCell Host Microbe201619572073010.1016/j.chom.2016.03.01027066744 10.TripathiSBalasubramaniamVRBrownJAMenaIGrantABardinaSVMaringerKSchwarzMCMaestreAMSourisseauMet al.A novel" exact="Zika" post="virus mouse model reveals strain specific differences in virus"/>
   <result pre="pathogenesis and host inflammatory immune responsesPLoS Pathog2017133e100625810.1371/journal.ppat.100625828278235 11.SmithDRHollidgeBDayeSZengXBlancettCKuszpitKBocanTKoehlerJWCoyneSMinogueTet al.Neuropathogenesis of" exact="Zika" post="virus in a highly susceptible immunocompetent mouse model after"/>
   <result pre="interferonPLoS Negl Trop Dis2017111e000529610.1371/journal.pntd.000529628068342 12.JaggerBWMinerJJCaoBAroraNSmithAMKovacsAMysorekarIUCoyneCBDiamondMSGestational stage and IFN-lambda signaling regulate" exact="ZIKV" post="infection in uteroCell Host Microbe201722336637610.1016/j.chom.2017.08.01228910635 13.BayerALennemannNJOuyangYBramleyJCMoroskySMarquesETJrCherrySSadovskyYCoyneCBType III interferons produced"/>
   <result pre="III interferons produced by human placental trophoblasts confer protection against" exact="Zika" post="virus infectionCell Host Microbe201619570571210.1016/j.chom.2016.03.00827066743 14.CasazzaRLLazearHMAntiviral immunity backfires: Pathogenic effects"/>
   <result pre="over TRIF adaptor proteins in early innate immune response against" exact="Zika" post="virus in miceJ Gen Virol201899220921810.1099/jgv.0.00099229297844 17.DingQGaskaJMDouamFWeiLKimDBalevMHellerBPlossASpecies-specific disruption of STING-dependent"/>
   <result pre="Virol201899220921810.1099/jgv.0.00099229297844 17.DingQGaskaJMDouamFWeiLKimDBalevMHellerBPlossASpecies-specific disruption of STING-dependent antiviral cellular defenses by the" exact="Zika" post="virus NS2B3 proteaseProc Natl Acad Sci USA201811527E6310E631810.1073/pnas.180340611529915078 18.SunXHuaSChenHROuyangZEinkaufKTseSArdKCiaranelloAYawetzSSaxPet al.Transcriptional"/>
   <result pre="Natl Acad Sci USA201811527E6310E631810.1073/pnas.180340611529915078 18.SunXHuaSChenHROuyangZEinkaufKTseSArdKCiaranelloAYawetzSSaxPet al.Transcriptional changes during naturally acquired" exact="Zika" post="virus infection render dendritic cells highly conducive to viral"/>
   <result pre="MAVSJ Virol201690167219723010.1128/JVI.00221-1627252539 23.YinYXuYSuLZhuXChenMZhuWXiaHHuangXGongSEpidemiologic investigation of a family cluster of imported" exact="ZIKV" post="cases in Guangdong, China: probable human-to-human transmissionEmerg Microbes Infect201659e10027599469"/>
   <result pre="viremia in whole-blood specimensEmerg Infect Dis201723586386510.3201/eid2305.16163128257281 28.MurrayKOGorchakovRCarlsonARBerryRLaiLNatrajanMGarciaMNCorreaAPatelSMAagaardKet al.Prolonged detection of" exact="Zika" post="virus in vaginal secretions and whole bloodEmerg Infect Dis20172319910110.3201/eid2301.16139427748649"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6559644\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : People and places : Geographical locations :"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Biology and Life Sciences : Evolutionary Biology"/>
   <result pre="and the clinical features associated with infection. To better understand" exact="CHIKV" post="dynamics in Rio de Janeiro, we generated 11 near-complete"/>
   <result pre="virus isolates obtained directly from clinical samples. To better understand" exact="CHIKV" post="dynamics in Rio de Janeiro, we generated 11 near-complete"/>
   <result pre="lineage in Rio de Janeiro. Time-measured phylogenetic analysis combined with" exact="CHIKV" post="notified case numbers revealed the ECSA lineage was introduced"/>
   <result pre="circulating unnoticed for 5 months before the first reports of" exact="CHIKV" post="autochthonous transmissions in Rio de Janeiro, in November 2015."/>
   <result pre="numbers MK244632 - MK244642) are available in figsharerepository (https://doi.org/10.6084/m9.figshare.8192237). Introduction" exact="Chikungunya" post="virus (CHIKV) infections have been reported worldwide since the"/>
   <result pre="was first isolated in Tanzania in 1953 [1]. Over 70" exact="CHIKV" post="epidemics have been reported around the world between 1959"/>
   <result pre="notified in 2017, with Brazil reporting 185,593 cases [3, 4]." exact="CHIKV" post="is an Alphavirus from the Togaviridae family that is"/>
   <result pre="of infected Aaedes aegypti and Aedes albopictus mosquitoes [5, 6]." exact="CHIKV" post="infection results in a dengue-like febrile disease, whose acute"/>
   <result pre="or relapse symptoms of arthropathy [7]. As the majority of" exact="CHIKV" post="infected patients are symptomatic with varying degrees of joint"/>
   <result pre="degrees of joint or musculoskeletal pains and require long-term treatment," exact="CHIKV" post="represents a serious burden inflected on both public health"/>
   <result pre="both public health and economic sector [7–9]. There are four" exact="CHIKV" post="genotypes (or lineages), which have been named based on"/>
   <result pre="northern region [15]. Seven days later, a new cluster of" exact="CHIKV" post="infections was notified in the city of Feira de"/>
   <result pre="compared with the Asian lineage circulating in the Caribbean [16–21]." exact="CHIKV" post="infections in Brazil accounted for 277,882 and 185,593 suspected"/>
   <result pre="60.4%) [4]. In 2016, Rio de Janeiro state reported 18,516" exact="CHIKV" post="suspected cases until epidemiological week 52 [22]. The epidemic"/>
   <result pre="most affected by the epidemic [4]. The first cases of" exact="CHIKV" post="autochthonous transmissions in Rio de Janeiro were registered in"/>
   <result pre="late 2015, although there is some serological evidence of imported" exact="CHIKV" post="infections acquired abroad in 2010 [23–25]. Limited molecular and"/>
   <result pre="[23–25]. Limited molecular and evolutionary information are available on the" exact="CHIKV" post="epidemic in Rio de Janeiro state, although sequencing of"/>
   <result pre="Nevertheless, there is limited information about the genomic epidemiology of" exact="CHIKV" post="circulating in Rio de Janeiro from genomic surveillance studies."/>
   <result pre="of complete genomic sequences available impairs our understanding of the" exact="CHIKV" post="introduction and establishment in the region. Thus, to better"/>
   <result pre="Q5 High Fidelity Hot-Start DNA Polymerase (New England Biolabs) and" exact="CHIKV" post="sequencing primers scheme (primers are divided into two separated"/>
   <result pre="New sequences were aligned to 229 complete or almost complete" exact="CHIKV" post="genomic sequences (&amp;gt;10,000 bp), retrieved from NCBI in November"/>
   <result pre="10% as burn-in. Epidemiological data assembly Data of weekly notified" exact="CHIKV" post="cases in Brazil were supplied by Brazilian Ministry of"/>
   <result pre="(The R Foundation). Results To better understand the diversity of" exact="CHIKV" post="in some of most affected municipalities from Rio de"/>
   <result pre="most affected municipalities from Rio de Janeiro, we generated 11" exact="CHIKV" post="near-complete genomes (coverage range 62%-83%, mean = 73%) from"/>
   <result pre="quantification cycle threshold value. To investigate the phylogenetic relationship of" exact="CHIKV" post="in the southeast region of Brazil we estimated Maximum"/>
   <result pre="for a dataset comprising 240 international sequences of the four" exact="CHIKV" post="lineages. We also investigated the Brazilian ECSA clade in"/>
   <result pre="region [16]. Our ML phylogeny revealed that the newly generated" exact="CHIKV" post="isolates from Rio de Janeiro belong to the ECSA"/>
   <result pre="Janeiro clade (Fig 1). The observed clustering of the 2016–2017" exact="CHIKV" post="isolates reported here probably reflects geographical proximity of the"/>
   <result pre="Rio de Janeiro. Fig 1 Molecular clock phylogeny of the" exact="CHIKV" post="circulating in Rio de Janeiro state. Molecular clock phylogeny"/>
   <result pre="de Janeiro state. Molecular clock phylogeny obtained using 11 new" exact="CHIKV" post="near-complete genomic sequences from the 2016–2018 epidemic in Rio"/>
   <result pre="unnoticed for approximately 5 months before the first reports of" exact="CHIKV" post="autochthonous transmissions in Rio de Janeiro, in November 2015"/>
   <result pre="cases in 2016 and 2017, respectively. Fig 3 Weekly notified" exact="Chikungunya" post="fever cases in the north-eastern and south-eastern regions of"/>
   <result pre="a notable reduction in 2017, followed by an increase in" exact="CHIKV" post="transmission in 2018 accounting for 39,208 reported cases until"/>
   <result pre="north-eastern region in 2018, the south-eastern region kept experiencing increased" exact="CHIKV" post="transmission (Fig 3). In general, CHIKV cases peaked in"/>
   <result pre="region kept experiencing increased CHIKV transmission (Fig 3). In general," exact="CHIKV" post="cases peaked in the early months of the represented"/>
   <result pre="by performing real-time portable nanopore sequencing, we generated 11 new" exact="CHIKV" post="near-complete genomic sequences from 2016–2018 collected in several municipalities"/>
   <result pre="the virus for 5 months before the first reports of" exact="CHIKV" post="transmission in Rio de Janeiro [23, 24]. According to"/>
   <result pre="[23, 24]. According to the Ministry of Health epidemiological bulletin," exact="CHIKV" post="autochthony in Rio de Janeiro was reported in the"/>
   <result pre="a larger and updated dataset including recently published 18 new" exact="CHIKV" post="ECSA sequences from northern region of Brazil. The substantial"/>
   <result pre="vectors and climate conditions in those geographical areas [15, 44]." exact="CHIKV" post="ECSA lineage spread to other north-eastern states, such as"/>
   <result pre="in our samples any of those mutations associated with increased" exact="CHIKV" post="transmission in Ae. albopictus mosquitos [11, 13, 14]. However,"/>
   <result pre="future investigation of the fitness, viral infectivity and evolution of" exact="CHIKV" post="in mosquito populations, together with continued genomic surveillance, will"/>
   <result pre="Brazil [15–17]. Sequencing and phylogenetic analysis of 54 genomes of" exact="ZIKV" post="sampled during the 2015–2017 epidemic provided estimates of the"/>
   <result pre="rejecting the hypothesis of urban transmissions. Together, our results indicate" exact="CHIKV" post="ECSA lineage might have spread to Rio de Janeiro"/>
   <result pre="de dengue, febre de chikungunya e doença aguda pelo vírus" exact="Zika" post="até a Semana Epidemiológica 52 de 2018. Ministério da"/>
   <result pre="syndrome, pathogenesis and therapy. Antiviral Res. 2013;99(3):345–70. 10.1016/j.antiviral.2013.06.00923811281 8WeaverSC, LecuitM." exact="Chikungunya" post="virus and the global spread of a mosquito-borne disease."/>
   <result pre="10.1056/NEJMra140603525806915 9BastosMLA, AbreuFS, Silva JuniorGBD. Inability to work due to" exact="Chikungunya" post="virus infection: impact on public service during the first"/>
   <result pre="Infect Dis. 2018;22(3):248–9. 10.1016/j.bjid.2018.05.00229842872 10PowersAM, BraultAC, TeshRB, WeaverSC. Re-emergence of" exact="Chikungunya" post="and O'nyong-nyong viruses: evidence for distinct geographical lineages and"/>
   <result pre="PLoS Med. 2006;3(7):e26310.1371/journal.pmed.003026316700631 12PowersAM. Genomic evolution and phenotypic distinctions of" exact="Chikungunya" post="viruses causing the Indian Ocean outbreak. Exp Biol Med"/>
   <result pre="Pathog. 2007;3(12):e20110.1371/journal.ppat.003020118069894 14VazeilleM, MoutaillerS, CoudrierD, RousseauxC, KhunH, HuerreM, et al.Two" exact="Chikungunya" post="isolates from the outbreak of La Reunion (Indian Ocean)"/>
   <result pre="KraemerMU, de OliveiraLF, et al.Emergence and potential for spread of" exact="Chikungunya" post="virus in Brazil. BMC Med. 2015;13:10210.1186/s12916-015-0348-x25976325 16NavecaFG, ClaroI, GiovanettiM,"/>
   <result pre="JesusJG, XavierJ, IaniFCM, et al.Genomic, epidemiological and digital surveillance of" exact="Chikungunya" post="virus in the Brazilian Amazon. PLoS Negl Trop Dis."/>
   <result pre="da CostaA, ThézéJ, KomninakisSCV, Sanz-DuroRL, FelintoMRL, MouraLCC, et al.Spread of" exact="Chikungunya" post="Virus East/Central/South African Genotype in Northeast Brazil. Emerg Infect"/>
   <result pre="al.Epidemiological Evidence for Lineage-specific Differences in the Risk of Inapparent" exact="Chikungunya" post="Virus Infection. J Virol. 2018. 20Lessa-AquinoC, TrintaKS, PestanaCP, RibeiroMO,"/>
   <result pre="PestanaCP, RibeiroMO, SucupiraMVF, BoiaMN, et al.Detection of East/Central/South African genotype" exact="Chikungunya" post="virus during an outbreak in a southeastern state of"/>
   <result pre="SantosECD, MarquesJ, BorgesAA, LimaMC, et al.Report of East-Central South African" exact="Chikungunya" post="virus genotype during the 2016 outbreak in the Alagoas"/>
   <result pre="casos de dengue, febre de chikungunya e febre pelo vírus" exact="Zika" post="até a Semana Epidemiológica 52, 2017. Ministério da Saúde."/>
   <result pre="Monitoramento dos casos dedengue, febre de chikungunya efebre pelo vírus" exact="Zika" post="até a SemanaEpidemiológica 47, 2015. Ministério da Saúde. Secretaria"/>
   <result pre="2015. Report No.: 42. 24Brasil. Boletim Epidemiológico Arboviroses. Cenário Epidemiológico:Dengue," exact="Chikungunya" post="E Zika No Estado RJ. Rio de Janeiro—Brazil: Secretaria"/>
   <result pre="No.: 42. 24Brasil. Boletim Epidemiológico Arboviroses. Cenário Epidemiológico:Dengue, Chikungunya E" exact="Zika" post="No Estado RJ. Rio de Janeiro—Brazil: Secretaria De Estado"/>
   <result pre="MedagliaMLG, CasottoME, AlbanoRM, et al.Autochthonous Transmission of East/Central/South African Genotype" exact="Chikungunya" post="Virus, Brazil. Emerg Infect Dis. 2017;23(10):1737–9. 10.3201/eid2310.16185528930027 27SouzaTM, AzeredoEL,"/>
   <result pre="et al.First Report of the East-Central South African Genotype of" exact="Chikungunya" post="Virus in Rio de Janeiro, Brazil. PLoS Curr. 2017;9."/>
   <result pre="et al.Multiplex PCR method for MinION and Illumina sequencing of" exact="Zika" post="and other virus genomes directly from clinical samples. Nat"/>
   <result pre="Barbosa-LimaG, LuizRLF, VizzoniA, et al.Emergence of the East-Central-South-African genotype of" exact="Chikungunya" post="virus in Brazil and the city of Rio de"/>
   <result pre="SomasekarS, et al.Genomic Epidemiology Reconstructs the Introduction and Spread of" exact="Zika" post="Virus in Central America and Mexico. Cell Host Microbe."/>
   <result pre="casos de dengue, febre de chikungunya e febre pelo vírus" exact="Zika" post="até a Semana Epidemiológica 52, 2016. Ministério da Saúde."/>
   <result pre="AbiodunGJ, HalaiUA, et al.Behavioral, climatic, and environmental risk factors for" exact="Zika" post="and Chikungunya virus infections in Rio de Janeiro, Brazil,"/>
   <result pre="et al.Behavioral, climatic, and environmental risk factors for Zika and" exact="Chikungunya" post="virus infections in Rio de Janeiro, Brazil, 2015–16. PLoS"/>
   <result pre="ThézéJ, de JesusJG, GiovanettiM, et al.Establishment and cryptic transmission of" exact="Zika" post="virus in Brazil and the Americas. Nature. 2017;546(7658):406–10. 10.1038/nature2240128538727"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6560071\results\search\tropicalVirus\results.xml">
   <result pre="A Recombinant Subviral Particle-Based Vaccine Protects Magpie (Pica pica) Against" exact="West Nile" post="Virus Infection Jiménez de OyaNereida1†Escribano-RomeroEstela1†CamachoMaría-Cruz2†BlazquezAna-Belén1Martín-AcebesMiguel A.1HöfleUrsula2SaizJuan-Carlos1*[], 1Departamento de Biotecnología,"/>
   <result pre="which does not comply with these terms. Abstract The mosquito-borne" exact="West Nile" post="virus (WNV) is a highly neurovirulent Flavivirus currently representing"/>
   <result pre="a highly neurovirulent Flavivirus currently representing an emergent zoonotic concern." exact="WNV" post="cycles in nature between mosquito vectors and birds that"/>
   <result pre="and play an essential role in virus ecology, being, thus," exact="WNV" post="a threat to many species. Availability of an efficient"/>
   <result pre="outbreaks. Avian vaccination would be also of interest to limit" exact="WNV" post="spillover to humans or horses from susceptible bird species"/>
   <result pre="have addressed the efficacy of a single dose of a" exact="WNV" post="recombinant subviral particle (RSP) vaccine in susceptible magpie (Pica"/>
   <result pre="with 5 × 103 plaque forming units of a neurovirulent" exact="WNV" post="strain. A significant improvement in survival rates of immunized"/>
   <result pre="protective efficacy of the RSP-based vaccine in susceptible birds against" exact="WNV" post="infection and its value in controlling the spread of"/>
   <result pre="its value in controlling the spread of the virus. flavivirus" exact="West Nile" post="virus birds vaccines transmission protection herd immunity Funding INIARTA2015-009E-RTA20017-003-C02"/>
   <result pre="currently spreading worldwide, as exemplified by the recent pandemic of" exact="Zika" post="virus (Saiz et al., 2016) and the increasing outbreaks"/>
   <result pre="virus (Saiz et al., 2016) and the increasing outbreaks of" exact="WNV" post="(Martin-Acebes and Saiz, 2012; Munoz et al., 2018). Therefore,"/>
   <result pre="of efficient vaccines to control them is an urgent need." exact="WNV" post="is a highly neurovirulent pathogen naturally maintained in an"/>
   <result pre="(Yaremych et al., 2004; Jimenez-Clavero et al., 2008). To date," exact="WNV" post="licensed vaccines are only available for use in equids."/>
   <result pre="hosts and virus amplifiers can be very useful to control" exact="WNV" post="outbreaks. Herein, we have assayed the effectiveness of a"/>
   <result pre="land and suburban areas, and that is highly susceptible to" exact="WNV" post="and possibly a transmission competent species (Jimenez de Oya"/>
   <result pre="from the co-expression of the prM and E glycoproteins of" exact="WNV" post="and mimics immunogenic properties of the whole virion. RSPs"/>
   <result pre="RSPs have already shown their potential as vaccine candidates for" exact="WNV" post="(Merino-Ramos et al., 2014), tick-borne virus encephalitis (Heinz et"/>
   <result pre="the criteria established for humanitarian endpoint (e.g., severe signs of" exact="WNV" post="neuropathology, excessive weight loss, acute deviation of behavior, etc.),"/>
   <result pre="and molt patterns, sampled, and tested for the presence of" exact="WNV" post="neutralizing antibodies (NAbs) in their sera by plaque reduction"/>
   <result pre="Real time RT-PCR was used to test the presence of" exact="WNV" post="genome in serum and feather follicles, as described previously"/>
   <result pre="27 juvenile (less than 1 year old) magpies negative for" exact="WNV" post="NAbs and WNV genome was transported to our biosafety"/>
   <result pre="than 1 year old) magpies negative for WNV NAbs and" exact="WNV" post="genome was transported to our biosafety level 3 (BSL-3)"/>
   <result pre="patagium) with 5 × 103 plaque forming units (pfu)/animal of" exact="WNV" post="strain NY-99 (GenBank accession no. KC407666, Merino-Ramos et al.,"/>
   <result pre="as above, starting from a filtered 1/10 dilution. Detection of" exact="WNV" post="NAbs in sera was performed by plaque reduction neutralization"/>
   <result pre="weight measurements of non-vaccinated (vehicle) and vaccinated (RSP) magpies after" exact="WNV" post="challenge expressed as the percentage of the initial body"/>
   <result pre="Survival rates of non-vaccinated (vehicle) and vaccinated (RSP) magpies after" exact="WNV" post="challenge. Statistically significant differences are represented by an asterisk"/>
   <result pre="of the birds presented anti-WNV NAbs, measured as PRNT90, nor" exact="WNV" post="genome prior to immunization. The RSP-based vaccine elicited detectable"/>
   <result pre="WNV genome prior to immunization. The RSP-based vaccine elicited detectable" exact="WNV" post="NAbs in five vaccinated birds at day 14 after"/>
   <result pre="five vaccinated birds at day 14 after immunization (Figure 4)." exact="WNV" post="challenge induced humoral immunity in both vaccinated and non-vaccinated"/>
   <result pre="test (PRNT90) at different time points previous to and after" exact="WNV" post="challenge. Data are presented as mean ± SEM. Statistically"/>
   <result pre="as a competent host to transmit the virus to most" exact="WNV" post="competent mosquito vectors (Komar et al., 2003). At 4"/>
   <result pre="follicles (D) in non-vaccinated (vehicle) and vaccinated (RSP) magpies after" exact="WNV" post="challenge. Data are presented as mean ± SEM. Statistically"/>
   <result pre="included in the vaccinated group was infected. Figure 6 Bird-to-bird" exact="WNV" post="transmission occurs only in non-vaccinated magpies. Percentage of animals"/>
   <result pre="There is a current (re)-emergence of arthropod-borne viruses, such as" exact="West Nile," post="dengue, or Zika virus, due to the arrival and"/>
   <result pre="(re)-emergence of arthropod-borne viruses, such as West Nile, dengue, or" exact="Zika" post="virus, due to the arrival and establishment of their"/>
   <result pre="in non-endemic areas, as evidenced by the recent pandemic of" exact="Zika" post="virus in America (Saiz et al., 2016) or dengue"/>
   <result pre="(Saiz et al., 2016) or dengue cases in European countries.1" exact="WNV" post="has a worldwide distribution and had been associated mainly"/>
   <result pre="been described around the world. In fact, the number of" exact="WNV" post="human cases in Europe has worryingly increased during 2018"/>
   <result pre="was claimed to act as a potential barrier from subsequent" exact="WNV" post="infections (Chang et al., 2007). In most of these"/>
   <result pre="and domestic avian species have been described as susceptible to" exact="WNV" post="infection (Komar et al., 2003), being corvids highly prone"/>
   <result pre="Reisen et al., 2006; Hinton et al., 2015). In fact," exact="WNV" post="epidemics in the US were associated with high crow"/>
   <result pre="al., 2015). Corvids seem to be also involved in the" exact="WNV" post="endemic cycle in human habitats in Europe (Calistri et"/>
   <result pre="highly susceptible to viral infection and a possible source of" exact="WNV" post="transmission (Jimenez de Oya et al., 2018), making of"/>
   <result pre="2018), making of this bird species an interesting player in" exact="WNV" post="ecoepidemiology. Similar to American Yellow-billed magpies (Pica nutalli) and"/>
   <result pre="roosts outside the breeding season that could be important for" exact="WNV" post="persistence during winter by bird-to-bird transmission, as has been"/>
   <result pre="RSPs vaccine to protect magpies against a lethal dose of" exact="WNV" post="NY-99 strain, which is highly virulent in American crows"/>
   <result pre="2018), are similar to those of currently circulating lineage 2" exact="WNV" post="strains in Europe (Petrovic et al., 2013). RSPs are"/>
   <result pre="RSP vaccine candidate used here protects mice experimentally infected with" exact="WNV" post="strains of different lineages (Merino-Ramos et al., 2014). Now"/>
   <result pre="of vaccine not only partially protected magpies from a lethal" exact="WNV" post="infection, but also significantly reduced viremia. Viremia levels were"/>
   <result pre="transmission. This could be of importance for the control of" exact="WNV" post="persistence if herd immunity is induced in communal roosting"/>
   <result pre="a natural virus amplifier host with a key role in" exact="WNV" post="ecology. The vaccine has demonstrated to be safe for"/>
   <result pre="type of vaccine could be used without interfering with ongoing" exact="WNV" post="surveillance programs since it could enable the differentiation between"/>
   <result pre="the criteria established for humanitarian endpoint (e.g., severe signs of" exact="WNV" post="neuropathology, excessive weight loss, acute deviation of behavior, etc.),"/>
   <result pre="References AngenvoortJ.FischerD.FastC.ZieglerU.EidenM.de la FuenteJ. G.et al.. (2014). Limited efficacy of" exact="West Nile" post="virus vaccines in large falcons (Falco spp.). Vet. Res.45:41."/>
   <result pre="Res.45:41. 10.1186/1297-9716-45-41, PMID: 24708385 Banet-NoachC.SimanovL.MalkinsonM. (2003). Direct (non-vector) transmission of" exact="West Nile" post="virus in geese. Avian Pathol.32, 489–494. 10.1080/030794503100015408014522704 BraultA. C.HuangC."/>
   <result pre="A.KinneyR. M.BowenR. A.RameyW. N.et al.. (2007). A single positively selected" exact="West Nile" post="viral mutation confers increased virogenesis in American crows. Nat."/>
   <result pre="A.BowenR. A.PanellaN. A.BiggerstaffB. J.MillerB. R.et al.. (2004). Differential virulence of" exact="West Nile" post="strains for American crows. Emerg. Infect. Dis.10, 2161–2168. 10.3201/eid1012.040486,"/>
   <result pre="crow (Corvus brachyrhynchos) provides partial protection against lethal challenge with" exact="West Nile" post="virus. Avian Dis.51, 573–577. 10.1637/0005-2086(2007)51[573:DVOTAC]2.0.CO;2, PMID: 17626486 CalistriP.GiovanniniA.HubalekZ.IonescuA.MonacoF.SaviniG.et al.."/>
   <result pre="Dis.51, 573–577. 10.1637/0005-2086(2007)51[573:DVOTAC]2.0.CO;2, PMID: 17626486 CalistriP.GiovanniniA.HubalekZ.IonescuA.MonacoF.SaviniG.et al.. (2010). Epidemiology of" exact="West Nile" post="in Europe and in the mediterranean basin. Open Virol."/>
   <result pre="endangered California condors (Gymnogyps californianus) protects this species from lethal" exact="West Nile" post="virus infection. Vaccine25, 2325–2330. 10.1016/j.vaccine.2006.11.056, PMID: 17224209 DiamondM. S.ShresthaB.MarriA.MahanD.EngleM."/>
   <result pre="critical roles in the immediate defense of disseminated infection by" exact="West Nile" post="encephalitis virus. J. Virol.77, 2578–2586. 10.1128/JVI.77.4.2578-2586.2003, PMID: 12551996 DochertyD."/>
   <result pre="DochertyD. E.LongR. R.GriffinK. M.SaitoE. K. (2004). Corvidae feather pulp and" exact="West Nile" post="virus detection. Emerg. Infect. Dis.10, 907–909. 10.3201/eid1005.030825, PMID: 15200828"/>
   <result pre="needles�? in a haystack: the advantages of passive surveillance for" exact="West Nile" post="virus. Ann. N. Y. Acad. Sci.951, 38–53. 10.1111/j.1749-6632.2001.tb02683.x, PMID:"/>
   <result pre="al. (2001a). Crow deaths as a sentinel surveillance system for" exact="West Nile" post="virus in the northeastern United States, 1999. Emerg. Infect."/>
   <result pre="(2001b). Dead bird surveillance as an early warning system for" exact="West Nile" post="virus. Emerg. Infect. Dis.7, 631–635. 10.3201/eid0704.01040511585524 ErnestH. B.WoodsL. W.HoarB."/>
   <result pre="631–635. 10.3201/eid0704.01040511585524 ErnestH. B.WoodsL. W.HoarB. R. (2010). Pathology associated with" exact="West Nile" post="virus infections in the yellow-billed magpie (Pica nuttalli): a"/>
   <result pre="J.et al.. (2013). Protection of red-legged partridges (Alectoris rufa) against" exact="West Nile" post="virus (WNV) infection after immunization with WNV recombinant envelope"/>
   <result pre="rufa) against West Nile virus (WNV) infection after immunization with" exact="WNV" post="recombinant envelope protein E (rE). Vaccine31, 4523–4527. 10.1016/j.vaccine.2013.07.071, PMID:"/>
   <result pre="FischerD.AngenvoortJ.ZieglerU.FastC.MaierK.ChabierskiS.et al.. (2015). DNA vaccines encoding the envelope protein of" exact="West Nile" post="virus lineages 1 or 2 administered intramuscularly, via electroporation"/>
   <result pre="(Falco spp.). Vet. Res.46:87. 10.1186/s13567-015-0220-1, PMID: 26282836 FossL.PadgettK.ReisenW. K.KjemtrupA.OgawaJ.KramerV. (2015)." exact="West Nile" post="virus-related trends in avian mortality in California, USA, 2003-12."/>
   <result pre="1636–1642. 10.1016/0264-410X(95)00133-L, PMID: 8719513 HintonM. G.ReisenW. K.WheelerS. S.TownsendA. K. (2015)." exact="West Nile" post="virus activity in a winter roost of American crows"/>
   <result pre="IyerA. V.KousoulasK. G. (2013). A review of vaccine approaches for" exact="West Nile" post="virus. Int. J. Environ. Res. Public Health10, 4200–4223. 10.3390/ijerph10094200,"/>
   <result pre="I.LiebermanM. M.HofmeisterE.NerurkarV. R.WongT.Weeks-LevyC. (2008). Protective efficacy of a recombinant subunit" exact="West Nile" post="virus vaccine in domestic geese (Anser anser). Vaccine26, 5338–5344."/>
   <result pre="(Pica pica) to experimental infection with lineage 1 and 2" exact="West Nile" post="virus. PLoS Negl. Trop. Dis.12:e0006394. 10.1371/journal.pntd.0006394, PMID: 29634743 Jimenez-ClaveroM."/>
   <result pre="Trop. Dis.12:e0006394. 10.1371/journal.pntd.0006394, PMID: 29634743 Jimenez-ClaveroM. A.SoteloE.Fernandez-PineroJ.LlorenteF.BlancoJ. M.Rodriguez-RamosJ.et al.. (2008)." exact="West Nile" post="virus in golden eagles, Spain, 2007. Emerg. Infect. Dis.14,"/>
   <result pre="north American birds with the New York 1999 strain of" exact="West Nile" post="virus. Emerg. Infect. Dis.9, 311–322. 10.3201/eid0903.020628, PMID: 12643825 KroegerM."/>
   <result pre="Virol.147, 1155–1172. 10.1007/s00705-002-0809-3, PMID: 12111426 LaDeauS. L.KilpatrickA. M.MarraP. P. (2007)." exact="West Nile" post="virus emergence and large-scale declines of North American bird"/>
   <result pre="carrion crows to experimental infection with lineage 1 and 2" exact="West Nile" post="viruses. Emerg. Infect. Dis.21, 1357–1365. 10.3201/2108.140714, PMID: 26197093 LudwigG."/>
   <result pre="P.MangiaficoJ. A.RaphaelB. L.DannerD. K.HileJ. A.et al.. (2002). An outbreak of" exact="West Nile" post="virus in a New York city captive wildlife population."/>
   <result pre="Use of live and inactivated vaccines in the control of" exact="West Nile" post="fever in domestic geese. Ann. N. Y. Acad. Sci.951,"/>
   <result pre="A single amino acid substitution in the core protein of" exact="West Nile" post="virus increases resistance to acidotropic compounds. PLoS One8:e69479. 10.1371/journal.pone.0069479,"/>
   <result pre="PMID: 23874963 Martin-AcebesM. A.Merino-RamosT.BlazquezA. B.CasasJ.Escribano-RomeroE.SobrinoF.et al.. (2014). The composition of" exact="West Nile" post="virus lipid envelope unveils a role of sphingolipid metabolism"/>
   <result pre="J. Virol.88, 12041–12054. 10.1128/JVI.02061-14, PMID: 25122799 Martin-AcebesM. A.SaizJ. C. (2012)." exact="West Nile" post="virus: a re-emerging pathogen revisited. World J. Virol.1, 51–70."/>
   <result pre="24175211 McMurtreyC. P.LelicA.PiazzaP.ChakrabartiA. K.YablonskyE. J.WahlA.et al.. (2008). Epitope discovery in" exact="West Nile" post="virus infection: identification and immune recognition of viral epitopes."/>
   <result pre="Merino-RamosT.BlazquezA. B.Escribano-RomeroE.Canas-ArranzR.SobrinoF.SaizJ. C.et al.. (2014). Protection of a single dose" exact="West Nile" post="virus recombinant subviral particle vaccine against lineage 1 or"/>
   <result pre="PLoS One9:e108056. 10.1371/journal.pone.0108056, PMID: 25229345 Montecino-LatorreD.BarkerC. M. (2018). Overwintering of" exact="West Nile" post="virus in a bird community with a communal crow"/>
   <result pre="Neurol.38, 163–175. 10.1055/s-0038-1647247, PMID: 29791942 PetrovicT.BlazquezA. B.LupulovicD.LazicG.Escribano-RomeroE.FabijanD.et al. (2013). Monitoring" exact="West Nile" post="virus (WNV) infection in wild birds in Serbia during"/>
   <result pre="birds in Serbia during 2012: first isolation and characterisation of" exact="WNV" post="strains from Serbia. Euro Surveill.18, pii: 20622. 10.2807/1560-7917.ES2013.18.44.20622 PitoisetF.VazquezT.BellierB."/>
   <result pre="RedigP. T.TullyT. N.RitchieB. W.RoyA. F.BaudenaM. A.ChangG. J. (2011). Effect of" exact="West Nile" post="virus DNA-plasmid vaccination on response to live virus challenge"/>
   <result pre="S.WilsonJ. L.et al.. (2006). Role of corvids in epidemiology of" exact="West Nile" post="virus in southern California. J. Med. Entomol.43, 356–367. 10.1093/jmedent/43.2.356,"/>
   <result pre="Entomol.43, 356–367. 10.1093/jmedent/43.2.356, PMID: 16619622 RizzoliA.BolzoniL.ChadwickE. A.CapelliG.MontarsiF.GrisentiM.et al.. (2015). Understanding" exact="West Nile" post="virus ecology in Europe: Culex pipiens host feeding preference"/>
   <result pre="Parasit. Vectors8:213. 10.1186/s13071-015-0831-4, PMID: 25888754 SaizJ. C.Vazquez-CalvoA.BlazquezA. B.Merino-RamosT.Escribano-RomeroE.Martin-AcebesM. A. (2016)." exact="Zika" post="virus: the latest newcomer. Front. Microbiol.7:496. 10.3389/fmicb.2016.00496, PMID: 27148186"/>
   <result pre="newcomer. Front. Microbiol.7:496. 10.3389/fmicb.2016.00496, PMID: 27148186 SaminaI.KhinichY.SimanovM.MalkinsonM. (2005). An inactivated" exact="West Nile" post="virus vaccine for domestic geese-efficacy study and a summary"/>
   <result pre="myocarditis in young domestic geese (Anser anser domesticus) caused by" exact="West Nile" post="virus. Emerg. Infect. Dis.7, 751–753. 10.3201/eid0704.010429, PMID: 11585545 TanM.JiangX."/>
   <result pre="PMID: 24662314 TurellM. J.BunningM.LudwigG. V.OrtmanB.ChangJ.SpeakerT.et al.. (2003). DNA vaccine for" exact="West Nile" post="virus infection in fish crows (Corvus ossifragus). Emerg. Infect."/>
   <result pre="1077–1081. 10.3201/eid0909.030025, PMID: 14519243 Vazquez-CalvoA.BlazquezA. B.Escribano-RomeroE.Merino-RamosT.SaizJ. C.Martin-AcebesM. A.et al. (2017)." exact="Zika" post="virus infection confers protection against West Nile virus challenge"/>
   <result pre="C.Martin-AcebesM. A.et al. (2017). Zika virus infection confers protection against" exact="West Nile" post="virus challenge in mice. Emerg. Microbes Infect.6:e81. 10.1038/emi.2017.6828928416 WardM."/>
   <result pre="WardM. R.StallknechtD. E.WillisJ.ConroyM. J.DavidsonW. R. (2006). Wild bird mortality and" exact="West Nile" post="virus surveillance: biases associated with detection, reporting, and carcass"/>
   <result pre="in protecting Western scrub-jays (Aphelocoma californica) from experimental infection with" exact="West Nile" post="virus: implications for vaccination of Island scrub-jays (Aphelocoma insularis)."/>
   <result pre="insularis). Vector BorneZoonotic Dis.11, 1069–1080. 10.1089/vbz.2010.0173, PMID: 21438693 WunschmannA.ZieglerA. (2006)." exact="West Nile" post="virus-associated mortality events in domestic Chukar partridges (Alectoris chukar)"/>
   <result pre="456–459. 10.1637/7507-012106R.1, PMID: 17039851 YaremychS. A.WarnerR. E.MankinP. C.BrawnJ. D.RaimA.NovakR. (2004)." exact="West Nile" post="virus and high death rate in American crows. Emerg."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6560413\results\search\tropicalVirus\results.xml">
   <result pre="can persist for months or years and impact life quality." exact="Chikungunya" post="virus is the most well-known member of this family"/>
   <result pre="and the Pacific island countries and territories [1] (Table 1)." exact="CHIKV" post="emergence in the Indian Ocean islands in 2005–2006 [2,3]"/>
   <result pre="change. In this work, we review the current knowledge on" exact="CHIKV" post="and compare it to these three less-described alphaviruses (ONNV,"/>
   <result pre="the near future. 2. Historical Description and Main Epidemics 2.1." exact="Chikungunya" post="Virus Robinson first described chikungunya fever in 1955, after"/>
   <result pre="in 50 countries [4]. A particular and recent concern about" exact="CHIKV" post="is its potential to cause outbreaks in temperate regions"/>
   <result pre="New Caledonia (33%) [73,74,75]. 3. Sylvatic Versus Urban Cycle 3.1." exact="Chikungunya" post="Virus Between outbreaks, CHIKV circulates in a sylvatic cycle"/>
   <result pre="3. Sylvatic Versus Urban Cycle 3.1. Chikungunya Virus Between outbreaks," exact="CHIKV" post="circulates in a sylvatic cycle where non-human primates are"/>
   <result pre="Interestingly, while Aedes aegypti is usually the main vector of" exact="CHIKV" post="in African urban cycles, Aedes albopictus (widely present on"/>
   <result pre="alphavirus infections are symptomatic with rates ranging from 72–97% for" exact="CHIKV" post="[30,117,118,119,120] (only one study reporting an unusually low symptomatic"/>
   <result pre="period (range of 2–12 days) [7,162], the acute phase of" exact="CHIKV" post="infection is characterized by a brutal onset of symptoms"/>
   <result pre="with dengue fever [19,129,165,166], it is now clearly established that" exact="CHIKV" post="infection can carry potentially lethal neurologic and cardiologic involvement"/>
   <result pre="is very well described and represents the major burden of" exact="CHIKV" post="infection because it can be responsible for very heavy"/>
   <result pre="linked to CHIKV. This rate seems to depend on which" exact="CHIKV" post="strain is involved [171]. In a recent prospective cohort"/>
   <result pre="been isolated from chronic swollen joints, it is thought that" exact="CHIKV" post="acute infection might trigger host autoimmunity [172,174,175]. However, it"/>
   <result pre="longer detect virus seven days after onset of symptoms for" exact="CHIKV" post="[32,184] (even though one patient had a positive RT-PCR"/>
   <result pre="cases, something that is mandatory for RRV in Australia and" exact="CHIKV" post="in many other countries, leading to the early detection"/>
   <result pre="effectiveness is still not clearly demonstrated [200]. 6.1.2. Vaccination Because" exact="CHIKV" post="infection produces a life-lasting protection against a second infection"/>
   <result pre="antigenic variability of the virus, one might think that a" exact="CHIKV" post="vaccine should be relatively easy to produce, or at"/>
   <result pre="dengue virus vaccine [204]. Nevertheless, there are still no licensed" exact="CHIKV" post="vaccines available, although many candidates have been tested including"/>
   <result pre="DNA- [217,218] or mRNA-based vaccines [219], and subunit formulations of" exact="CHIKV" post="[220]. Two candidates are currently in Phase II clinical"/>
   <result pre="The first one is a recombinant measles virus encoding the" exact="CHIKV" post="structural proteins. The first results of the Phase II"/>
   <result pre="tolerability [209]. The second candidate is a VLP vaccine containing" exact="CHIKV" post="structural proteins that is immunogenic and protective against a"/>
   <result pre="number of studies suggest that protection against one strain of" exact="CHIKV" post="protects against all others [223,224,225,226]. Interestingly, Partidos et al."/>
   <result pre="that passive monoclonal antibodies after immunization of mice with a" exact="CHIKV" post="vaccine protect against ONNV infection (the closest related alphavirus)"/>
   <result pre="Because there are no vaccine candidates for ONN, a broad-spectrum" exact="CHIKV" post="vaccine is of particular interest; that should also be"/>
   <result pre="has shown efficiency against cartilage damage in mice both with" exact="CHIKV" post="and RRV, and a Phase II trial is now"/>
   <result pre="approach is to use hyper-immune intravenous anti-CHIKV immunoglobulins to prevent" exact="CHIKV" post="infection in neonates, who often develop very severe forms"/>
   <result pre="1), and they are currently more geographically restrained than the" exact="CHIKV" post="vector: Anopheles sp. for ONNV in Africa and the"/>
   <result pre="vector and trigger a worldwide epidemic, as has happened for" exact="CHIKV" post="(during the La Reunion epidemic with the A226V mutation"/>
   <result pre="types? Can these infections be directly or indirectly lethal? Since" exact="CHIKV" post="is more of a global concern, fundamental knowledge on"/>
   <result pre="protection across all arthritogenic alphaviruses. Indeed, broad neutralizing antibodies against" exact="CHIKV" post="can neutralize MAYV and ONNV by inhibiting entry and"/>
   <result pre="have gone or are currently going through clinical trials for" exact="CHIKV" post="and RRV, and it is reasonable to expect a"/>
   <result pre="CHIKV and RRV, and it is reasonable to expect a" exact="CHIKV" post="vaccine in the years to come. The immunity triggered"/>
   <result pre="not licensed. In conclusion, enriched by lessons learned from recent" exact="CHIKV" post="outbreaks, it is undeniable that ONN, MAYV, or RRV"/>
   <result pre="to tackle a starting epidemic. Hopefully, the availability of a" exact="CHIKV" post="vaccine might enable a broad-spectrum activity on all arthritogenic"/>
   <result pre="and Blockades to Evolutionary Convergence on the Road to Predicting" exact="Chikungunya" post="Virus EvolutionAnnu. Rev. Virol.2017418120010.1146/annurev-virology-101416-04175728961411 5.GrootH.MoralesA.VidalesH.VIRUS ISOLATIONS FROM FOREST MOSQUITOES"/>
   <result pre="distant evolutionary relationshipsJ. Gen. Virol.20008147147910.1099/0022-1317-81-2-47110644846 9.VolkS.M.ChenR.TsetsarkinK.A.AdamsA.P.GarciaT.I.SallA.A.NasarF.SchuhA.J.HolmesE.C.HiggsS.et al.Genome-Scale Phylogenetic Analyses of" exact="Chikungunya" post="Virus Reveal Independent Emergences of Recent Epidemics and Various"/>
   <result pre="Epidemics and Various Evolutionary RatesJ. Virol.2010846497650410.1128/JVI.01603-0920410280 10.RodgerL.M.An outbreak of suspected" exact="Chikungunya" post="fever in Northern RhodesiaS. Afr. Med. J.19613512612813742532 11.McIntoshB.M.HarwinR.M.PatersonH.E.WestwaterM.L.An Epidemic"/>
   <result pre="fever in Northern RhodesiaS. Afr. Med. J.19613512612813742532 11.McIntoshB.M.HarwinR.M.PatersonH.E.WestwaterM.L.An Epidemic of" exact="Chikungunya" post="in South-Eastern Southern RhodesiaCent. Afr. J. Med.1963935135914061785 12.TomoriO.FagbamiA.FabiyiA.The 1974"/>
   <result pre="South-Eastern Southern RhodesiaCent. Afr. J. Med.1963935135914061785 12.TomoriO.FagbamiA.FabiyiA.The 1974 epidemic of" exact="Chikungunya" post="fever in children in IbadanTrop. Geogr. Med.1975274134171216323 13.FilipeA.F.PintoM.R.Arbovirus studies"/>
   <result pre="studies during an outbreak of dengue-like disease caused by the" exact="Chikungunya" post="virusBull. World Health Organ.19734937404545155 14.FourieE.D.MorrisonJ.G.Rheumatoid arthritic syndrome after chikungunya"/>
   <result pre="syndrome after chikungunya feverS. Afr. Med. J.197956130132494034 15.Muyembe-TamfumJ.J.PeyrefitteC.N.YogoleloR.Mathina BasisyaE.KoyangeD.PukutaE.MashakoM.TolouH.DurandJ.P.[Epidemic of" exact="Chikungunya" post="virus in 1999 and 200 in the Democratic Republic"/>
   <result pre="the Congo]Med. Trop. Rev. Corps Sante Colon.200363637638 16.PastorinoB.Muyembe-TamfumJ.J.BessaudM.TockF.TolouH.DurandJ.P.PeyrefitteC.N.Epidemic resurgence of" exact="Chikungunya" post="virus in democratic Republic of the Congo: Identification of"/>
   <result pre="a new central African strainJ. Med. Virol.20047427728210.1002/jmv.2016815332277 17.SaluzzoJ.F.CornetM.DigoutteJ.P.[Outbreak of a" exact="Chikungunya" post="virus epidemic in western Senegal in 1982]Dakar Med.1983284975006323109 18.DialloM.ThonnonJ.Traore-LamizanaM.FontenilleD.Vectors"/>
   <result pre="virus epidemic in western Senegal in 1982]Dakar Med.1983284975006323109 18.DialloM.ThonnonJ.Traore-LamizanaM.FontenilleD.Vectors of" exact="Chikungunya" post="virus in Senegal: Current data and transmission cyclesAm. J."/>
   <result pre="J. Trop. Med. Public Health2001325 26.PorterK.R.TanR.IstaryY.SuharyonoW.SutaryoWidjajaS.Ma’RoefC.ListiyaningsihE.KosasihH.HuestonL.et al.A serological study of" exact="Chikungunya" post="virus transmission in Yogyakarta, Indonesia: Evidence for the first"/>
   <result pre="Febrile Illness, Haiti, 2015Emerg. Infect. Dis.2016222000200210.3201/eid2211.16101527767924 62.WeberJ.On a outbreak of" exact="Dengue" post="feverAust. Med. J.18868291293 63.WolstenholmeJ.Ross River virus disease—The first recorded"/>
   <result pre="hosts of chikungunya virusBull. World Health Organ.1966358920604287 77.EastwoodG.SangR.C.GuerboisM.TarachaE.L.N.WeaverS.C.Enzootic Circulation of" exact="Chikungunya" post="Virus in East Africa: Serological Evidence in Non-human Kenyan"/>
   <result pre="R. Soc. Trop. Med. Hyg.19585225326210.1016/0035-9203(58)90084-113556869 79.HarrisonV.R.MarshallJ.D.GuilloudN.B.The Presence of Antibody to" exact="Chikungunya" post="and Other Serologically Related Viruses in the Sera of"/>
   <result pre="Sub-Human Primate Imports to the United StatesJ. Immunol.1966985 80.McIntoshB.M.Antibody against" exact="Chikungunya" post="virus in wild primates in Southern AfricaS. Afr. J."/>
   <result pre="chikungunya viruses causing the Indian Ocean outbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 84.VazeilleM.MoutaillerS.CoudrierD.RousseauxC.KhunH.HuerreM.ThiriaJ.DehecqJ.-S.FontenilleD.SchuffeneckerI.et al.Two" exact="Chikungunya" post="isolates from the outbreak of La Reunion (Indian Ocean)"/>
   <result pre="Mansonia venezuelensisScience196013198610.1126/science.131.3405.986 97.MaiaL.M.S.BezerraM.C.F.CostaM.C.S.SouzaE.M.OliveiraM.E.B.RibeiroA.L.M.MiyazakiR.D.SlhessarenkoR.D.Natural vertical infection by dengue virus serotype 4," exact="Zika" post="virus and Mayaro virus in Aedes (Stegomyia) aegypti and"/>
   <result pre="and Transmission Potential of the Virus in Mixed Infections With" exact="Chikungunya" post="VirusJ. Med. Entomol.20195683284310.1093/jme/tjy24130668762 103.WalshM.G.Ecological and life history traits are"/>
   <result pre="River virusJ. Am. Mosq. Control Assoc.198731421472849637 115.SubissiL.Daudens-VaysseE.CassadouS.LedransM.BompardP.GustaveJ.AubryM.Cao-LormeauV.-M.MalletH.-P.Revising rates of asymptomatic" exact="Zika" post="virus infection based on sentinel surveillance data from French"/>
   <result pre="116.GrangeL.Simon-LoriereE.SakuntabhaiA.GreshL.PaulR.HarrisE.Epidemiological Risk Factors Associated with High Global Frequency of Inapparent" exact="Dengue" post="Virus InfectionsFront. Immunol.2014528010.3389/fimmu.2014.0028024966859 117.MoroM.L.GagliottiC.SilviG.AngeliniR.SambriV.RezzaG.MassimilianiE.MattiviA.GrilliE.FinarelliA.C.et al.Chikungunya virus in North-Eastern Italy:"/>
   <result pre="seroprevalence surveyAm. J. Trop. Med. Hyg.20108250851110.4269/ajtmh.2010.09-032220207883 118.BrouardC.BernillonP.QuatresousI.PillonelJ.AssalA.De ValkH.DesenclosJ.-C.Estimated risk of" exact="Chikungunya" post="viremic blood donation during an epidemic on Reunion Island"/>
   <result pre="and persistent presentations). November 2014Médecine Mal. Infect.20154524326310.1016/j.medmal.2015.05.007 120.AubryM.TeissierA.HuartM.MerceronS.VanhomwegenJ.MapotoekeM.Mariteragi-HelleT.RocheC.VialA.-L.TeururaiS.et al.Seroprevalence of" exact="Dengue" post="and Chikungunya Virus Antibodies, French Polynesia, 2014–2015Emerg. Infect. Dis.20182455856110.3201/eid2403.17114929460745"/>
   <result pre="presentations). November 2014Médecine Mal. Infect.20154524326310.1016/j.medmal.2015.05.007 120.AubryM.TeissierA.HuartM.MerceronS.VanhomwegenJ.MapotoekeM.Mariteragi-HelleT.RocheC.VialA.-L.TeururaiS.et al.Seroprevalence of Dengue and" exact="Chikungunya" post="Virus Antibodies, French Polynesia, 2014–2015Emerg. Infect. Dis.20182455856110.3201/eid2403.17114929460745 121.YoonI.-K.AleraM.T.LagoC.B.Tac-AnI.A.VillaD.FernandezS.ThaisomboonsukB.KlungthongC.LevyJ.W.VelascoJ.M.et al.High"/>
   <result pre="River Virus Be the Next Zika?J. Travel Med.201910.1093/jtm/taz003 128.BorgheriniG.PoubeauP.StaikowskyF.LoryM.MoullecN.L.BecquartJ.P.WenglingC.MichaultA.PaganinF.Outbreak of" exact="Chikungunya" post="on Reunion Island: Early Clinical and Laboratory Features in"/>
   <result pre="by imagingTrans. R. Soc. Trop. Med. Hyg.201010439239910.1016/j.trstmh.2010.01.01120171708 132.StaikowskyF.TalarminF.GrivardP.SouabA.SchuffeneckerI.RouxK.L.LecuitM.MichaultA.Prospective Study of" exact="Chikungunya" post="Virus Acute Infection in the Island of La Réunion"/>
   <result pre="an inception cohort followed for six monthsMed. J. Aust.200217735235512358576 150.EconomopoulouA.DominguezM.HelynckB.SissokoD.WichmannO.QuenelP.GermonneauP.QuatresousI.Atypical" exact="Chikungunya" post="virus infections: Clinical manifestations, mortality and risk factors for"/>
   <result pre="RéunionEpidemiol. Infect.200913753410.1017/S095026880800116718694529 151.MazaudR.SalaünJ.J.MontaboneH.GoubeP.BazillioR.[Acute neurologic and sensorial disorders in dengue and" exact="Chikungunya" post="fever]Bull. Soc. Pathol. Exot. Fil.1971642230 152.OehlerE.FournierE.Leparc-GoffartI.LarreP.CubizolleS.SookhareeaC.LastèreS.GhawcheF.Increase in cases of"/>
   <result pre="Exot. Fil.1971642230 152.OehlerE.FournierE.Leparc-GoffartI.LarreP.CubizolleS.SookhareeaC.LastèreS.GhawcheF.Increase in cases of Guillain-Barré syndrome during a" exact="Chikungunya" post="outbreak, French Polynesia, 2014 to 2015Eurosurveillance2015203007910.2807/1560-7917.ES.2015.20.48.3007926690898 153.MohiteA.A.Agius-FernandezA.Chikungunya fever presenting"/>
   <result pre="and chikungunya fever—A follow-up studyAm. Heart J.19738518619410.1016/0002-8703(73)90459-64688831 156.DorléansF.HoenB.NajioullahF.Herrmann-StorckC.SchepersK.M.AbelS.LamauryI.FagourL.CésaireR.GuyomardS.et al.Outbreak of" exact="Chikungunya" post="in the French Caribbean Islands of Martinique and Guadeloupe:"/>
   <result pre="Trop. Med. Hyg.2018981819182510.4269/ajtmh.16-071929692295 157.Evans-GilbertT.Chikungunya and Neonatal Immunity: Fatal Vertically Transmitted" exact="Chikungunya" post="InfectionAm. J. Trop. Med. Hyg.20179691391510.4269/ajtmh.16-049128167590 158.FraserJ.R.CunninghamA.L.MullerH.K.SinclairR.A.StandishH.G.Glomerulonephritis in the acute"/>
   <result pre="Ross River virus?Aust. N. Z. J. Med.19992926827010.1111/j.1445-5994.1999.tb00695.x10342029 162.GallianP.Leparc-GoffartI.RichardP.MaireF.FlusinO.DjoudiR.ChiaroniJ.CharrelR.TiberghienP.de LamballerieX.Epidemiology of" exact="Chikungunya" post="Virus Outbreaks in Guadeloupe and Martinique, 2014: An Observational"/>
   <result pre="DonorsPLoS Negl. Trop. Dis.201711e000525410.1371/journal.pntd.000525428081120 163.RobinS.RamfulD.ZettorJ.BenhamouL.Jaffar-BandjeeM.-C.RivièreJ.-P.MarichyJ.EzzedineK.AlessandriJ.-L.Severe bullous skin lesions associated with" exact="Chikungunya" post="virus infection in small infantsEur. J. Pediatr.2010169677210.1007/s00431-009-0986-019401826 164.GargT.SankeS.AhmedR.ChanderR.BasuS.Stevens-Johnson syndrome"/>
   <result pre="meta-analysisTrans. R. Soc. Trop. Med. Hyg.201811230131630007303 172.BouquillardE.FianuA.BangilM.CharletteN.RibéraA.MichaultA.FavierF.SimonF.FlipoR.-M.Rheumatic manifestations associated with" exact="Chikungunya" post="virus infection: A study of 307 patients with 32-month"/>
   <result pre="Dis.20137e213710.1371/annotation/850ee20f-2641-46ac-b0c6-ef4ae79b6de623556021 174.BouquillardÉ.CombeB.A report of 21 cases of rheumatoid arthritis following" exact="Chikungunya" post="fever. A mean follow-up of two yearsJoint Bone Spine20097665465710.1016/j.jbspin.2009.08.00519945329"/>
   <result pre="al.Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of" exact="Chikungunya" post="Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable"/>
   <result pre="RouxK.GrivardP.VernetG.MichaultA.Evaluation of real-time nucleic acid sequence-based amplification for detection of" exact="Chikungunya" post="virus in clinical samplesJ. Med. Microbiol.2009581168117210.1099/jmm.0.010736-019528148 189.WaggonerJ.HeathC.J.NdengaB.MutukuF.SahooM.K.Mohamed-HadleyA.VululeJ.MukokoD.Desiree LaBeaudA.PinskyB.A.Development of"/>
   <result pre="urineJ. Clin. Virol.2018981410.1016/j.jcv.2017.11.00629172075 191.BozzaF.A.Moreira-SotoA.RockstrohA.FischerC.NascimentoA.D.CalheirosA.S.DrostenC.BozzaP.T.SouzaT.M.L.UlbertS.et al.Differential Shedding and Antibody Kinetics of" exact="Zika" post="and Chikungunya Viruses, BrazilEmerg. Infect. Dis.20192531131510.3201/eid2502.18016630666934 192.MalvyD.EzzedineK.Mamani-MatsudaM.AutranB.TolouH.ReceveurM.-C.PistoneT.RambertJ.MoynetD.MossalayiD.Destructive arthritis in"/>
   <result pre="Virol.2018981410.1016/j.jcv.2017.11.00629172075 191.BozzaF.A.Moreira-SotoA.RockstrohA.FischerC.NascimentoA.D.CalheirosA.S.DrostenC.BozzaP.T.SouzaT.M.L.UlbertS.et al.Differential Shedding and Antibody Kinetics of Zika and" exact="Chikungunya" post="Viruses, BrazilEmerg. Infect. Dis.20192531131510.3201/eid2502.18016630666934 192.MalvyD.EzzedineK.Mamani-MatsudaM.AutranB.TolouH.ReceveurM.-C.PistoneT.RambertJ.MoynetD.MossalayiD.Destructive arthritis in a patient"/>
   <result pre="with persistent specific IgM antibodiesBMC Infect. Dis.2009920010.1186/1471-2334-9-20020003320 193.AzamiN.A.M.MoiM.L.TakasakiT.Neutralization Assay for" exact="Chikungunya" post="Virus Infection: Plaque Reduction Neutralization TestHumana PressNew York, NY,"/>
   <result pre="Saúde201827e2017127 198.TrentiniF.PolettiP.BaldacchinoF.DragoA.MontarsiF.CapelliG.RizzoliA.RosàR.RizzoC.MerlerS.et al.The containment of potential outbreaks triggered by imported" exact="Chikungunya" post="cases in Italy: A cost utility epidemiological assessment of"/>
   <result pre="of infection and LandScan dataEpidemiol. Infect.20161443108311910.1017/S095026881600135727334542 204.ErasmusJ.H.RossiS.L.WeaverS.C.Development of Vaccines for" exact="Chikungunya" post="FeverJ. Infect. Dis.2016214S488S49610.1093/infdis/jiw27127920179 205.EdelmanR.TacketC.O.WassermanS.S.BodisonS.A.PerryJ.A.PerryJ.G.Phase II safety and immunogenicity study"/>
   <result pre="vaccineJ. Virol.20138739540210.1128/JVI.01860-1223077320 211.ChattopadhyayA.AguilarP.V.BoppN.E.YarovinskyT.O.WeaverS.C.RoseJ.K.A recombinant virus vaccine that protects against both" exact="Chikungunya" post="and Zika virus infectionsVaccine2018363894390010.1016/j.vaccine.2018.05.09529807712 212.HarrisonV.R.EckelsK.H.HamptonC.Production and Evaluation of a"/>
   <result pre="211.ChattopadhyayA.AguilarP.V.BoppN.E.YarovinskyT.O.WeaverS.C.RoseJ.K.A recombinant virus vaccine that protects against both Chikungunya and" exact="Zika" post="virus infectionsVaccine2018363894390010.1016/j.vaccine.2018.05.09529807712 212.HarrisonV.R.EckelsK.H.HamptonC.Production and Evaluation of a Formalin-Killed Chikungunya"/>
   <result pre="and Zika virus infectionsVaccine2018363894390010.1016/j.vaccine.2018.05.09529807712 212.HarrisonV.R.EckelsK.H.HamptonC.Production and Evaluation of a Formalin-Killed" exact="Chikungunya" post="VaccineJ. Immunol.19711076 213.TiwariM.ParidaM.SanthoshS.R.KhanM.DashP.K.RaoP.V.L.Assessment of immunogenic potential of Vero adapted"/>
   <result pre="adapted formalin inactivated vaccine derived from novel ECSA genotype of" exact="Chikungunya" post="virusVaccine2009272513252210.1016/j.vaccine.2009.02.06219368794 214.AkahataW.YangZ.-Y.AndersenH.SunS.HoldawayH.A.KongW.-P.LewisM.G.HiggsS.RossmannM.G.RaoS.et al.A virus-like particle vaccine for epidemic Chikungunya"/>
   <result pre="of Chikungunya virusVaccine2009272513252210.1016/j.vaccine.2009.02.06219368794 214.AkahataW.YangZ.-Y.AndersenH.SunS.HoldawayH.A.KongW.-P.LewisM.G.HiggsS.RossmannM.G.RaoS.et al.A virus-like particle vaccine for epidemic" exact="Chikungunya" post="virus protects nonhuman primates against infectionNat. Med.20101633433810.1038/nm.210520111039 215.MetzS.W.MartinaB.E.van den"/>
   <result pre="mouse model compared to glycoprotein E1 or E2 subunitsVaccine2013316092609610.1016/j.vaccine.2013.09.04524099875 216.MetzS.W.GardnerJ.GeertsemaC.LeT.T.GohL.VlakJ.M.SuhrbierA.PijlmanG.P.Effective" exact="Chikungunya" post="Virus-like Particle Vaccine Produced in Insect CellsPLoS Negl. Trop."/>
   <result pre="Insect CellsPLoS Negl. Trop. Dis.20137e212410.1371/journal.pntd.000212423516657 217.MallilankaramanK.ShedlockD.J.BaoH.KawalekarO.U.FagoneP.RamanathanA.A.FerraroB.StabenowJ.VijayachariP.SundaramS.G.et al.A DNA Vaccine against" exact="Chikungunya" post="Virus Is Protective in Mice and Induces Neutralizing Antibodies"/>
   <result pre="Negl. Trop. Dis.20115e92810.1371/journal.pntd.000092821264351 218.TretyakovaI.HearnJ.WangE.WeaverS.PushkoP.DNA Vaccine Initiates Replication of Live Attenuated" exact="Chikungunya" post="Virus In Vitro and Elicits Protective Immune Response in"/>
   <result pre="Immunogenicity of VAL-181388 in Healthy Adults in a Non Endemic" exact="Chikungunya" post="Region—ICH GCP—Clinical Trials RegistryAvailable online: https://ichgcp.net/clinical-trials-registry/NCT03325075(accessed on 2 April"/>
   <result pre="2019) 220.KhanM.DhanwaniR.RaoP.V.L.ParidaM.Subunit vaccine formulations based on recombinant envelope proteins of" exact="Chikungunya" post="virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in"/>
   <result pre="1 dose-escalation trialLancet20143842046205210.1016/S0140-6736(14)61185-525132507 222.DeZureA.D.BerkowitzN.M.GrahamB.S.LedgerwoodJ.E.Whole-Inactivated and Virus-Like Particle Vaccine Strategies for" exact="Chikungunya" post="VirusJ. Infect. Dis.2016214S497S49910.1093/infdis/jiw35227920180 223.GooL.DowdK.A.LinT.-Y.MascolaJ.R.GrahamB.S.LedgerwoodJ.E.PiersonT.C.A Virus-Like Particle Vaccine Elicits Broad"/>
   <result pre="Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All" exact="Chikungunya" post="Virus GenotypesJ. Infect. Dis.20162141487149110.1093/infdis/jiw43127655868 224.AuerswaldH.BoussiouxC.InS.MaoS.OngS.HuyR.LeangR.ChanM.DuongV.LyS.et al.Broad and long-lasting immune"/>
   <result pre="Infect. Dis.20162141487149110.1093/infdis/jiw43127655868 224.AuerswaldH.BoussiouxC.InS.MaoS.OngS.HuyR.LeangR.ChanM.DuongV.LyS.et al.Broad and long-lasting immune protection against various" exact="Chikungunya" post="genotypes demonstrated by participants in a cross-sectional study in"/>
   <result pre="Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by" exact="Chikungunya" post="Virus InfectionJ. Virol.20158958159310.1128/JVI.02034-1425339772 242.RulliN.E.GuglielmottiA.ManganoG.RolphM.S.ApicellaC.ZaidA.SuhrbierA.MahalingamS.Amelioration of alphavirus-induced arthritis and myositis"/>
   <result pre="PathwayJ. Virol.201892e01913-1710.1128/JVI.01913-1729263267 246.NerisR.L.S.FigueiredoC.M.HigaL.M.AraujoD.F.CarvalhoC.A.M.VerçozaB.R.F.SilvaM.O.L.CarneiroF.A.TanuriA.GomesA.M.O.et al.Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika," exact="Chikungunya" post="and other arboviruses by targeting the viral envelopeSci. Rep.20188980510.1038/s41598-018-27855-729955082"/>
   <result pre="targeting the viral envelopeSci. Rep.20188980510.1038/s41598-018-27855-729955082 247.BhatS.M.MudgalP.P.NS.ArunkumarG.Spectrum of candidate molecules against" exact="Chikungunya" post="virus—An insight into the antiviral screening platformsExpert Rev. Anti-Infect."/>
   <result pre="Dis.2008883783910.1089/vbz.2008.004918620511 249.RoquesP.ThibervilleS.-D.Dupuis-MaguiragaL.LumF.-M.LabadieK.MartinonF.GrasG.LebonP.NgL.F.P.de LamballerieX.et al.Paradoxical Effect of Chloroquine Treatment in Enhancing" exact="Chikungunya" post="Virus InfectionViruses20181026810.3390/v10050268 250.RavichandranR.ManianM.Ribavirin therapy for Chikungunya arthritisJ. Infect. Dev."/>
   <result pre="Chloroquine Treatment in Enhancing Chikungunya Virus InfectionViruses20181026810.3390/v10050268 250.RavichandranR.ManianM.Ribavirin therapy for" exact="Chikungunya" post="arthritisJ. Infect. Dev. Ctries.2008214014210.3855/T2.2.14019738340 251.HerreroL.J.FooS.-S.ShengK.-C.ChenW.ForwoodM.R.BucalaR.MahalingamS.Pentosan Polysulfate: A Novel Glycosaminoglycan-Like"/>
   <result pre="Cartilage Destruction and Inflammatory DiseaseJ. Virol.2015898063807610.1128/JVI.00224-1526018160 252.CoudercT.KhandoudiN.GrandadamM.VisseC.GangneuxN.BagotS.ProstJ.-F.LecuitM.Prophylaxis and therapy for" exact="Chikungunya" post="virus infectionJ. Infect. Dis.200920051652310.1086/60038119572805 253.Prevention of Chikungunya Infection in"/>
   <result pre="and therapy for Chikungunya virus infectionJ. Infect. Dis.200920051652310.1086/60038119572805 253.Prevention of" exact="Chikungunya" post="Infection in Neonates: Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous"/>
   <result pre="of RNA viral quasispeciesGene200534727328210.1016/j.gene.2004.12.03315777632 265.StaplefordK.A.MoratorioG.HenningssonR.ChenR.MatheusS.EnfissiA.Weissglas-VolkovD.IsakovO.BlancH.MounceB.C.et al.Whole-Genome Sequencing Analysis from the" exact="Chikungunya" post="Virus Caribbean Outbreak Reveals Novel Evolutionary Genomic ElementsPLoS Negl."/>
   <result pre="PavoniJ.H.Gomes NavecaF.Dezengrini SlhessarenkoR.Arbovirus investigation in patients from Mato Grosso during" exact="Zika" post="and Chikungunya virus introdution in Brazil, 2015-2016Acta Trop.201919039540210.1016/j.actatropica.2018.12.01930552880 270.LiuJ.OchiengC.WiersmaS.StröherU.TownerJ.S.WhitmerS.NicholS.T.MooreC.C.KershG.J.KatoC.et"/>
   <result pre="SlhessarenkoR.Arbovirus investigation in patients from Mato Grosso during Zika and" exact="Chikungunya" post="virus introdution in Brazil, 2015-2016Acta Trop.201919039540210.1016/j.actatropica.2018.12.01930552880 270.LiuJ.OchiengC.WiersmaS.StröherU.TownerJ.S.WhitmerS.NicholS.T.MooreC.C.KershG.J.KatoC.et al.Development of"/>
   <result pre="field-based real-time reverse transcription-polymerase chain reaction assays for detection of" exact="Chikungunya" post="and O’nyong’nyong viruses in mosquitoesAm. J. Trop. Med. Hyg.20098167968410.4269/ajtmh.2009.09-013819815886"/>
   <result pre="publications for each virus reported in PubMed through the years." exact="CHIKV" post="publications were rare before 2006 (under 10 per year),"/>
   <result pre="ONNV, O’nyong’nyong virus; MAYV, Mayaro virus; RRV, Ross River virus." exact="CHIKV" post="ONNV MAYV RRV Other Name Uruma virus Igbo-Ora virus"/>
   <result pre="infection symptoms, range of frequency reported in the listed studies." exact="CHIKV" post="Median Min Max ONNV Median Min Max MAYV Median"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6562360\results\search\tropicalVirus\results.xml">
   <result pre="Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following" exact="Dengue" post="Virus Infection LyskiZoe L.MesserWilliam B.*[], Department of Molecular Microbiology"/>
   <result pre="B cell immune response against viral pathogens in general and" exact="DENV" post="specifically. Including strengths, limitations, and future directions. Single-cell approaches"/>
   <result pre="limitations, and future directions. Single-cell approaches could help uncover the" exact="DENV" post="specific MBC antibody repertoire, and improved methods for isolating"/>
   <result pre="DENV specific MBC antibody repertoire, and improved methods for isolating" exact="DENV" post="specific monoclonal antibodies from human peripheral blood cells would"/>
   <result pre="viral pathogens, including HIV (11), RSV (12), influenza (13), human" exact="DENV" post="MBC derived antibodies were not fully characterized until 2010"/>
   <result pre="antibodies were not fully characterized until 2010 (14, 15). Mosquito-transmitted" exact="DENV" post="is responsible for ~100 million symptomatic cases and 35,000"/>
   <result pre="it the most common and serious vector-borne disease affecting humans." exact="DENV" post="is an enveloped positive sense RNA virus, that circulates"/>
   <result pre="60–85% shared sequence homology (17). Repeat infections often occur in" exact="DENV" post="endemic regions–Asia, Latin America, Africa, and parts of Oceana."/>
   <result pre="and spread of the vector have led to increasing epidemics." exact="DENV" post="infection causes symptoms that include high fever and rash."/>
   <result pre="vaccines that preferentially elicit potently neutralizing antibodies against all 4" exact="DENV" post="serotypes while avoiding potentially enhancing antibodies. Analyses of human"/>
   <result pre="avoiding potentially enhancing antibodies. Analyses of human antibody response to" exact="DENV" post="infection have traditionally characterized serum antibodies, a product of"/>
   <result pre="(28). Only recently have these methods been employed in the" exact="DENV" post="field. Here we review the leading approaches for characterizing"/>
   <result pre="field. Here we review the leading approaches for characterizing human" exact="DENV" post="MBCs, evaluating their strengths, limitations and potential for further"/>
   <result pre="to EDIII (1M7) or complex (1F4) epitopes on intact virions." exact="DENV" post="specific MBC frequency similar between primary and secondary donors"/>
   <result pre="MBC frequency similar between primary and secondary donors at 14–18" exact="DENV" post="specific MBC per thousand B cells.15 of the isolated"/>
   <result pre="labeled secondary antibodiesIsolated double positive MBCs 20 million PBMCs, 148" exact="DENV" post="E+ MBCs sorted. 1 from an endemic region Serum"/>
   <result pre="from an endemic region Serum neutralized all 4 serotypes 9" exact="DENV" post="E specific MBCs are present in naturally infected donors."/>
   <result pre="are present in naturally infected donors. Authors isolated and characterized" exact="DENV" post="neutralizing mAbs from MBCs against envelope domain I and"/>
   <result pre="culture 64% were positive for IgG, 20% were positive for" exact="DENV" post="by ELISA, 8% secreted DENV2 specific mAbsOf the 9"/>
   <result pre="Appanna et al. (28) FACS using fluorescently labeled DENV3. Isolated" exact="DENV" post="positive MBCs N/A 42° 19 40–60% of the DENV-specific"/>
   <result pre="developed multifunctional FluoroSpot assays allow enumeration of cross-reactive and type-specific" exact="DENV" post="and Zika MBCs following natural infection and vaccination (19,"/>
   <result pre="FluoroSpot assays allow enumeration of cross-reactive and type-specific DENV and" exact="Zika" post="MBCs following natural infection and vaccination (19, 38). This"/>
   <result pre="humans and mice recognize distinct and different epitopes on the" exact="DENV" post="virion following immunization in mice or natural infection in"/>
   <result pre="surface of whole virions (44, 45), in contrast to the" exact="DENV" post="neutralizing antibody response in mice, where the majority of"/>
   <result pre="HIV (47), SARS coronavirus (48), Influenza (49), RSV (50), and" exact="DENV" post="(14, 15, 51). Another technique employed to immortalize MBCs"/>
   <result pre="recognize RSV (52), Hepatitis C virus (54), influenza (55), and" exact="DENV" post="(56). Strengths and Limitations Immortalized B-cells have a plasmablast-like"/>
   <result pre="human immune donors. Recognizing the complex and quaternary nature of" exact="DENV" post="neutralizing epitopes (45) Authors Woda and Mathew (26) and"/>
   <result pre="(26) and Appanna et al. (28) used fluorescently labeled whole" exact="DENV" post="virus (62) as a probe to detect DENV-specific MBCs"/>
   <result pre="in immune donors while Cox et al. (25) used biotinylated" exact="DENV" post="envelope protein as a probe along with dual labeled"/>
   <result pre="a probe along with dual labeled streptavidin antibodies to identify" exact="DENV" post="envelope-specific MBCs. This method enabled researchers to isolate 8"/>
   <result pre="donor (Table 1). Strengths and Limitations Antigen choice is important," exact="DENV" post="neutralizing epitopes are comprised of complex conformational structures and"/>
   <result pre="developed with other pathogens would be expected to advance the" exact="DENV" post="field as well. High-throughput droplet microfluidic approaches (65) allow"/>
   <result pre="(2008) 453:667–71. 10.1038/nature0689018449194 14.BeltramelloMWilliamsKLSimmonsCPMacagnoASimonelliLQuyenNTet al.. The human immune response to" exact="Dengue" post="virus is dominated by highly cross-reactive antibodies endowed with"/>
   <result pre="for dengue vaccine. J Virol. (2018) 92:e00556–18. 10.1128/JVI.00556-1830185598 23.RautRCorbettKSTennekoonRNPremawansaSWijewickramaAPremawansaGet al.." exact="Dengue" post="type 1 viruses circulating in humans are highly infectious"/>
   <result pre="future innovations. Ann Med Surg. (2014) 3:113–6. 10.1016/j.amsu.2014.09.00125568796 43.WahalaWMKrausAAHaymoreLBAccavitti-LoperMAde SilvaAM." exact="Dengue" post="virus neutralization by human immune sera: role of envelope"/>
   <result pre="J Immunol Methods. (2009) 343:65–7. 10.1016/j.jim.2008.11.01219100741 61.WodaMFribergHCurrierJRSrikiatkhachornAMacareoLRGreenSet al.. Dynamics of" exact="Dengue" post="Virus (DENV)-specific B cells in the response to DENV"/>
   <result pre="of Dengue Virus (DENV)-specific B cells in the response to" exact="DENV" post="serotype 1 infections, using flow cytometry with labeled virions."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563321\results\search\tropicalVirus\results.xml">
   <result pre="element (cHP) is a critical determinant of dengue virus and" exact="West Nile" post="virus RNA synthesisVirology200837931432310.1016/j.virol.2008.06.03418676000 57.KozakM.Downstream secondary structure facilitates recognition of"/>
   <result pre="flaviviruses. We were able to identify the West-Nile Virus (WNV)," exact="Dengue" post="Virus 1 (DENV1), Japanese Encephalitis Virus (JEV), Yellow Fever"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563844\results\search\tropicalVirus\results.xml">
   <result pre="IFITM proteins mediate cellular resistance to influenza A H1N1 virus," exact="West Nile" post="virus, and dengue virus. Cell. (2009) 139:1243–54. 10.1016/j.cell.2009.12.01720064371 19.KarlasAMachuyNShinYPleissnerKPArtariniAHeuerDet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6564047\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Tropical Diseases"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Biology and Life Sciences : Anatomy :"/>
   <result pre="RT-LAMP in a single reaction tube. Using this system, the" exact="CHIKV" post="genome was effectively amplified under isothermal conditions, and used"/>
   <result pre="validated with RNAs and serum samples from recent outbreaks of" exact="CHIKV" post="patients in Brazil. The obtained sequence data confirmed the"/>
   <result pre="CHIKV patients in Brazil. The obtained sequence data confirmed the" exact="CHIKV" post="outbreaks and identified the genotype. In summary, our established"/>
   <result pre="detection and sequencing system is applicable for both diagnosis of" exact="CHIKV" post="infected patients and genotyping of the CHIKV virus in"/>
   <result pre="both diagnosis of CHIKV infected patients and genotyping of the" exact="CHIKV" post="virus in future outbreak in remote areas. Author summary"/>
   <result pre="CHIKV virus in future outbreak in remote areas. Author summary" exact="Chikungunya" post="virus has re-emerged as an important pathogen causing several"/>
   <result pre="DDBJ Sequence Read Archive (DRA) under accession number: DRA007513. Introduction" exact="Chikungunya" post="is a mosquito-borne febrile disease caused by chikungunya virus"/>
   <result pre="and infection is now a major public health concern [11–13]." exact="CHIKV" post="are phylogenetically classified into three major genotypes, the West"/>
   <result pre="has been reported that phylogenetic diversification and infectivity differences among" exact="CHIKV" post="may be correlated [17] and the evolution of CHIKV"/>
   <result pre="among CHIKV may be correlated [17] and the evolution of" exact="CHIKV" post="may be related to the viral adaptation in mosquito"/>
   <result pre="of chikungunya are similar to other mosquito-borne febrile diseases, including" exact="Dengue" post="fever, Zika fever and malaria, the differential diagnosis of"/>
   <result pre="are similar to other mosquito-borne febrile diseases, including Dengue fever," exact="Zika" post="fever and malaria, the differential diagnosis of these diseases"/>
   <result pre="in a simple and rapid way. Specifically, the genomes of" exact="CHIKV" post="in a drop of human blood would be amplified"/>
   <result pre="infectious diseases in remote areas. Materials and methods Virus samples" exact="Chikungunya" post="virus SL11131 (AB455493) and SL10571 (AB455494), which are members"/>
   <result pre="a biosafety level (BSL)-3 until use. Preparation of in-house dried" exact="CHIKV" post="RT-LAMP (CHIKV-CZC-LAMP) system The in-house dried CHIKV RT-LAMP system"/>
   <result pre="of in-house dried CHIKV RT-LAMP (CHIKV-CZC-LAMP) system The in-house dried" exact="CHIKV" post="RT-LAMP system was produced by using a trehalose vitrification"/>
   <result pre="inside of the tube lid. The LAMP primer sets for" exact="CHIKV" post="[24] were prepared in deionized distilled water. FIP and"/>
   <result pre="Chemical) in an aluminium bag at ambient temperature. Detection of" exact="CHIKV" post="genome in whole blood using the CHIKV-CZC-LAMP system The"/>
   <result pre="ambient temperatures and were emplaced in the RT-LAMP reaction for" exact="CHIKV" post="genome detection. Prior to the reaction, reaction buffer (23"/>
   <result pre="from healthy human volunteer were used. RNAs were extracted from" exact="CHIKV" post="when titers were determined by plaque forming units per"/>
   <result pre="specificity was judged by Tm (melting temperature) value. Detection of" exact="CHIKV" post="genome from clinical samples using CHIKV-CZC-LAMP Our assay was"/>
   <result pre="RNA mini kit (Qiagen, Germany). Detection of the genome of" exact="CHIKV" post="by the CHIKV-CZC-LAMP was performed using directly the serum"/>
   <result pre="Nanopore Technologies, Oxford Science Park, UK) was initially used for" exact="CHIKV" post="SL10571 and S27 in which one sample was analyzed"/>
   <result pre="BLASTN program was employed with obtained reads as queries against" exact="CHIKV" post="SL11131 (AB455493) reference at position of 10,317–10,472, which corresponds"/>
   <result pre="All the blastn hit regions were clipped and aligned to" exact="CHIKV" post="SL11131 by Bowtie2 [26], and IGV and IGVtools [27]"/>
   <result pre="by a Neighbor joining (NJ) -based method with the reference" exact="CHIKV" post="sequences [11, 16, 28, 29] using MEGA7 software [30]."/>
   <result pre="Brazilian sample were performed at this laboratory. Results Detection of" exact="CHIKV" post="genome in blood samples using dried RT-LAMP system We"/>
   <result pre="established the dried RT-LAMP system for the detection of the" exact="CHIKV" post="genome (CHIKV-CZC-LAMP) from clinical samples, containing dried-reagents in the"/>
   <result pre="sensitivity of the CHIKV-CZC-LAMP was evaluated using purified RNAs from" exact="CHIKV" post="pulsed with or without 1 μl of human blood."/>
   <result pre="(B) Representative view of CHIKV-CZC-LAMP results. The decreasing concentration of" exact="CHIKV" post="in 1 μl of RNA or 1 μl RNA"/>
   <result pre="human blood were tested. As a negative control, blood without" exact="CHIKV" post="RNA was used. Upper panel shows fluorescent signals detected"/>
   <result pre="with FAM channel, and the calculated sensitivity for serially diluted" exact="CHIKV" post="RNA with or without blood were shown. The same"/>
   <result pre="values. The time required for the amplification of 50 PFU" exact="CHIKV" post="genome was 15 to 18 min in the absence"/>
   <result pre="the absence of blood, and 18 to 23 min for" exact="CHIKV" post="genome in the presence of blood (Fig 1C). The"/>
   <result pre="the presence of blood (Fig 1C). The reaction time of" exact="CHIKV" post="genome with blood was delayed a few minutes compared"/>
   <result pre="effect by the blood color. The sensitivity of CHIKV-CZC-LAMP using" exact="CHIKV" post="genome at the end points of the reaction (45"/>
   <result pre="end points of the reaction (45 minutes) was &amp;lt;50 PFU" exact="CHIKV" post="per reaction, showing 100% sensitivity (95% CI: 54%-100%) at"/>
   <result pre="at 5 PFU of CHIKV. Addition of blood to the" exact="CHIKV" post="genome had no inhibitory effect on sensitivity of the"/>
   <result pre="of CHIKV, and 50% sensitivity (95% CI:12%-88%) at 5 PFU" exact="CHIKV" post="(Fig 1C). The sensitivity and Ct value of qRT-PCR"/>
   <result pre="same RNA templates, and was revealed to be &amp;lt;0.5 PFU" exact="CHIKV" post="per reaction (Fig 1C). Evaluation of CHIKV-CZC-LAMP system using"/>
   <result pre="the same patient were examined by the CHIKV-CZC-LAMP. Among 33" exact="CHIKV" post="qRT-PCR positive samples, 23 RNA samples and 19 serum"/>
   <result pre="2). After mapping the reads to the reference sequence of" exact="CHIKV" post="SL11131, the mapped read number of each nucleotide was"/>
   <result pre="already established primer sets [24] which targeted E1 region of" exact="CHIKV" post="genome. Other primer sets targeting the 6K-E1 regions [33]"/>
   <result pre="the sensitivity of the amplification [34]. For the diagnosis of" exact="CHIKV" post="infection, RNA detection methods are recommended before 6 days"/>
   <result pre="genotypes. It has been reported that high viral load of" exact="CHIKV" post="(107−109 viral particles/ml) was detected in the patient’s blood"/>
   <result pre="load may be caused by delayed onset of symptoms after" exact="CHIKV" post="infection. The undetectable RNA samples showed Ct value of"/>
   <result pre="high viral titer samples in the early phase of the" exact="CHIKV" post="infection. Therefore, we propose that our system can be"/>
   <result pre="consistent with the previous report [10,16]. As a proof-of-concept, laboratory" exact="CHIKV" post="strains (SL10571 and S27) were also sequenced and showed"/>
   <result pre="induced by primer dimers [36]. We confirmed the sequence of" exact="CHIKV" post="genome in the samples, demonstrating that the obtained sequence"/>
   <result pre="us definitive and reliable information from epidemic clinical samples. Distinguishing" exact="CHIKV" post="from Dengue fever or Zika fever is also important,"/>
   <result pre="and reliable information from epidemic clinical samples. Distinguishing CHIKV from" exact="Dengue" post="fever or Zika fever is also important, but it"/>
   <result pre="from epidemic clinical samples. Distinguishing CHIKV from Dengue fever or" exact="Zika" post="fever is also important, but it is often challenging"/>
   <result pre="symptoms. The evidence of the co-circulation of dengue virus (DENV)," exact="Zika" post="virus (ZIKV) and CHIKV has been also reported [37,38]."/>
   <result pre="the co-circulation of dengue virus (DENV), Zika virus (ZIKV) and" exact="CHIKV" post="has been also reported [37,38]. Hence, multiplex or panel"/>
   <result pre="will be also required. The RT-LAMP methods for ZIKAV and" exact="DENV" post="has been available [39,40,41], and the MinION analysis from"/>
   <result pre="DENV has been available [39,40,41], and the MinION analysis from" exact="DENV" post="RT-LAMP had been also been established [42]. Thus, we"/>
   <result pre="large urban epidemics. It was also reported that ECSA genotype" exact="CHIKV" post="infection provoked high viral load in the patient [12],"/>
   <result pre="in the patient [12], suggesting that adaptive mutation in the" exact="CHIKV" post="envelope causes high replication efficiency [17]. In addition, acquired"/>
   <result pre="causes high replication efficiency [17]. In addition, acquired immunity after" exact="CHIKV" post="infection has been reported to be critical for further"/>
   <result pre="has been reported to be critical for further protection against" exact="CHIKV" post="infection [44]. The immunity is long-lasting and suggested to"/>
   <result pre="reduced. In summary, a one-step, easy gene amplification assay for" exact="CHIKV" post="genome detection was successfully developed. The assay was evaluated"/>
   <result pre="assay was evaluated with RNA and serum samples from 16" exact="CHIKV" post="serology positive patients during recent chikungunya outbreaks in Rio"/>
   <result pre="In combination with MinION sequencing technology, we also identified the" exact="CHIKV" post="genotypes with a laptop computer. The developed CHIK-CZC-LAMP diagnostics"/>
   <result pre="References 1SergonK, NjugunaC, KalaniR, OfulaV, OnyangoC, KonongoiLS, et al.Seroprevalence of" exact="Chikungunya" post="virus (CHIKV) infection on Lamu Island, Kenya, October 2004."/>
   <result pre="da CostaA, ThézéJ, KomninakisSCV, Sanz-DuroRL, FelintoMRL, MouraLCC, et al.Spread of" exact="Chikungunya" post="Virus East/Central/South African Genotype in Northeast Brazil. Emerg Infect"/>
   <result pre="MedagliaMLG, CasottoME, AlbanoRM, et al.Autochthonous Transmission of East/Central/South African Genotype" exact="Chikungunya" post="Virus, Brazil. Emerg Infect Dis. 2017;23:1737–1739. 10.3201/eid2310.16185528930027 11NunesMRT, FariaNR,"/>
   <result pre="KraemerMU, de OliveiraLF, et al.Emergence and potential for spread of" exact="Chikungunya" post="virus in Brazil. BMC Med. 2015;13:10210.1186/s12916-015-0348-x25976325 12ParolaP, de LamballerieX,"/>
   <result pre="et al.First Report of the East-Central South African Genotype of" exact="Chikungunya" post="Virus in Rio de Janeiro, Brazil. PLoS Curr. 2017;9."/>
   <result pre="and in vitro infectivity differences among Cosmopolitan genotype strains of" exact="Chikungunya" post="virus. Infect Genet Evol. 2016;37:174–184. 10.1016/j.meegid.2015.11.01926611825 18NotomiT, OkayamaH, MasubuchiH,"/>
   <result pre="DashPK, TripathiNK, LakshmiV, MamidiN, et al.Rapid and real-time detection of" exact="Chikungunya" post="virus by reverse transcription loop-mediated isothermal amplification assay. J"/>
   <result pre="S, BorgesAA, LimaMC de, et al.Report of East-Central South African" exact="Chikungunya" post="virus genotype during the 2016 outbreak in the Alagoas"/>
   <result pre="al.Development of a single-tube one-step RT-LAMP assay to detect the" exact="Chikungunya" post="virus genome. PLoS Negl Trop Dis. Public Library of"/>
   <result pre="Sci. 2011;12: 9108–24. 10.3390/ijms1212910822272122 35JohnsonBW, RussellBJ, GoodmanCH. Laboratory Diagnosis of" exact="Chikungunya" post="Virus Infections and Commercial Sources for Diagnostic Assays. J"/>
   <result pre="BarbosaLS, SouzaTMA, Badolato-CorrêaJ, Sánchez-ArcilaJC, et al.Clinical and Laboratory Profile of" exact="Zika" post="and Dengue Infected Patients: Lessons Learned From the Co-circulation"/>
   <result pre="Badolato-CorrêaJ, Sánchez-ArcilaJC, et al.Clinical and Laboratory Profile of Zika and" exact="Dengue" post="Infected Patients: Lessons Learned From the Co-circulation of Dengue,"/>
   <result pre="Dengue Infected Patients: Lessons Learned From the Co-circulation of Dengue," exact="Zika" post="and Chikungunya in Brazil. PLoS Curr. 2018;10. pii: ecurrents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5."/>
   <result pre="Patients: Lessons Learned From the Co-circulation of Dengue, Zika and" exact="Chikungunya" post="in Brazil. PLoS Curr. 2018;10. pii: ecurrents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5. 38Carrillo-HernándezMY, Ruiz-SaenzJ,"/>
   <result pre="2018;18:6110.1186/s12879-018-2976-129382300 39SabalzaM, YasminR, BarberCA, CastroT, MalamudD, KimBJ, et al.Detection of" exact="Zika" post="virus using reverse-transcription LAMP coupled with reverse dot blot"/>
   <result pre="40LambLE, BartoloneSN, TreeMO, ConwayMJ, RossignolJ, SmithCP, et al.Rapid Detection of" exact="Zika" post="Virus in Urine Samples and Infected Mosquitos by Reverse"/>
   <result pre="al.Development and evaluation of a rapid molecular diagnostic test for" exact="Zika" post="virus infection by reverse transcription loop-mediated isothermal amplification. Sci"/>
   <result pre="Rep. 2017;7:351010.1038/s41598-017-03734-528615658 43VazeilleM, MoutaillerS, CoudrierD, RousseauxC, KhunH, HuerreM, et al.Two" exact="Chikungunya" post="Isolates from the Outbreak of La Reunion (Indian Ocean)"/>
   <result pre="AleraMT, LagoCB, Tac-AnIA, VillaD, FernandezS, et al.High Rate of Subclinical" exact="Chikungunya" post="Virus Infection and Association of Neutralizing Antibody with Protection"/>
   <result pre="OngS, HuyR, et al.Broad and long-lasting immune protection against various" exact="Chikungunya" post="genotypes demonstrated by participants in a cross-sectional study in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6572267\results\search\tropicalVirus\results.xml">
   <result pre="mosquitoes for real-time PCR analysis for yellow fever, chikungunya, mayaro," exact="Zika" post="and dengue viruses. The yellow fever infection rate was"/>
   <result pre="near large urban centers. arboviruses yellow fever mosquitoes 1. Introduction" exact="Yellow fever" post="(YF) is a severe acute disease with high lethality"/>
   <result pre="yellow fever virus (YFV), dengue virus (DENV), chikungunya virus (CHIKV)," exact="Zika" post="virus (ZIKV) and mayaro virus (MAYV). 2. Materials and"/>
   <result pre="and probes described in Table 1. Multiplex reactions targeted YFV," exact="CHIKV" post="and DENV in the first reaction, and ZIKV and"/>
   <result pre="described in Table 1. Multiplex reactions targeted YFV, CHIKV and" exact="DENV" post="in the first reaction, and ZIKV and MAYV in"/>
   <result pre="targeted YFV, CHIKV and DENV in the first reaction, and" exact="ZIKV" post="and MAYV in the second reaction, and were performed"/>
   <result pre="WI, USA), RT-enzyme solution (Promega, Madison, WI, USA), 1 μM" exact="YFV" post="primer (For + Rev) (IDT, Coralville, IA, USA), 0.2"/>
   <result pre="primer (For + Rev) (IDT, Coralville, IA, USA), 0.2 μM" exact="YFV" post="probe (IDT, Coralville, IA, USA), 0.5 μM other primers"/>
   <result pre="as the negative control, whereas for the positive control, a" exact="YFV" post="gene fragment (5’-NC [17]) cloned into the pGemP plasmid"/>
   <result pre="WI, USA) was used. The quantification of viral RNA from" exact="YFV" post="infected mosquitoes were performed in comparison with serial dilution"/>
   <result pre="to a Ct value of 36. 2.4. Virus Isolation All" exact="YFV" post="positive samples (n = 13) were selected for viral"/>
   <result pre="described above for the squash buffer solution. Next, RT-qPCR for" exact="YFV" post="was performed, using the primers described in Table 1,"/>
   <result pre="158, 18.2%). Molecular analyses of the 778 mosquitoes revealed 13" exact="YFV" post="positives, all of which were Haemagogus janthinomys (Figure 2)."/>
   <result pre="Positive mosquitoes possessed, on average, 7.54 × 107 copies of" exact="YFV" post="viral RNA. None of the collected mosquitoes were found"/>
   <result pre="RNA of the other viruses tested (dengue, chikungunya, mayaro and" exact="Zika" post="virus). All YFV RNA-positive samples of the primary screening"/>
   <result pre="other viruses tested (dengue, chikungunya, mayaro and Zika virus). All" exact="YFV" post="RNA-positive samples of the primary screening were isolated and"/>
   <result pre="cases were reported in the studied areas. Confirmation of the" exact="YFV" post="infection through the virus isolation technique confirmed that the"/>
   <result pre="species of Sabethes spp. were collected (n = 42 specimens)," exact="YFV" post="infection was not detected in any of them. Among"/>
   <result pre="Theobald, 1903 has been found to be naturally infected by" exact="YFV" post="in South America [26]. It is likely that more"/>
   <result pre="Sabethes than those already incriminated play a secondary role in" exact="YFV" post="maintenance [5,27]. Haemagogus (Conopostegus) leucocelaenus (Dyar &amp;amp; Shannon, 1924)"/>
   <result pre="(Dyar &amp;amp; Shannon, 1924) is considered the main vector of" exact="YFV" post="in the South Region of Brazil [5], with most"/>
   <result pre="Region of Brazil [5], with most recent studies having detected" exact="YFV" post="in this species [28,29] which is more easily found"/>
   <result pre="a study carried out in 2008 in southern Brazil, a" exact="YFV" post="infection rate of 1.88% was found for Aedes (Ochlerotatus)"/>
   <result pre="positive for YFV. Two factors could explain the detection of" exact="YFV" post="in Ae. serratus infected in Cardoso [28]. The first"/>
   <result pre="as a YF vector. The lack of detection of either" exact="DENV" post="or CHIKV in the collected mosquitoes, despite recurrent epidemics"/>
   <result pre="YF vector. The lack of detection of either DENV or" exact="CHIKV" post="in the collected mosquitoes, despite recurrent epidemics in the"/>
   <result pre="aegypti specimens. Although NHP carcasses were found naturally infected by" exact="ZIKV" post="in Minas Gerais between 2016 and 2017 [33], no"/>
   <result pre="Minas Gerais between 2016 and 2017 [33], no copies of" exact="ZIKV" post="viral RNA were detected in any mosquito collected in"/>
   <result pre="further studies are needed to identify if there is a" exact="Zika" post="sylvatic cycle occurring. However, since it was not the"/>
   <result pre="January 2018 in Nova Lima. Although the three areas where" exact="YFV" post="were isolated (Areas 2, 3 and 4) are not"/>
   <result pre="a versatile mosquito. After feeding on a host infected with" exact="YFV" post="and after the intrinsic period of infection, it is"/>
   <result pre="corridors, making these residential condominiums important areas of risk for" exact="YFV" post="transmission and, therefore, they should receive special attention from"/>
   <result pre="Ae. aegypti have not been found to be infected with" exact="YFV" post="during the 2016–2018 epidemic, the risk of re-urbanization of"/>
   <result pre="the risk of outbreaks and the re-emergence of urban YF." exact="Yellow fever" post="is a disease with high lethality, yet an effective"/>
   <result pre="vaccination coverage of 80%, it is expected to interrupt local" exact="YFV" post="transmission [7]. In Brazil, the recommended areas for vaccination"/>
   <result pre="Haemagogus favored the propagation of wild epizootic waves of the" exact="YFV" post="to this region and, consequently, human infection. However, further"/>
   <result pre="However, further research is needed to understand the dynamic of" exact="YFV" post="spread through vast geographic extensions. It has been suggested"/>
   <result pre="through vast geographic extensions. It has been suggested that the" exact="YFV" post="had an average dispersion of about 3 km per"/>
   <result pre="estimated as 600 km in six months [42]. Associated with" exact="YFV" post="dispersion, mosquitoes can disperse the virus over long distances,"/>
   <result pre="values, Table S2: Viral quantification and Ct value of the" exact="YFV" post="positive samples, Table S3: Viral quantification and Ct values"/>
   <result pre="de dengue, febre de chikungunya e doença aguda pelo vírus" exact="Zika" post="até a Semana Epidemiológica 44 de 2018Available online: http://portalarquivos2.saude.gov.br/images/pdf/2018/novembro/23/Publicacao-2018-57-SE44.pdf(accessed"/>
   <result pre="RNA extraction step for the detection and quantification of African" exact="Chikungunya" post="virusesJ. Virol. Methods2005124657110.1016/j.jviromet.2004.11.00215664052 20.PacidônioE.C.CaragataE.P.AlvesD.M.MarquesJ.T.MoreiraL.A.The impact of Wolbachia infection on"/>
   <result pre="in Brazilian Aedes aegyptiParasites Vectors2017101610.1186/s13071-017-2236-z28049510 21.LanciottiR.S.KosoyO.L.LavenJ.J.VelezJ.O.LambertA.J.JohnsonA.J.StanfieldS.M.DuffyM.R.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007Emerg."/>
   <result pre="Dengue, Chikungunya, and PlasmodiumCell200913910.1016/j.cell.2009.11.04220064373 33.TerzianA.C.B.ZiniN.SacchettoL.RochaR.F.ParraM.C.P.Del SartoJ.L.DiasA.C.F.CoutinhoF.RayraJ.da SilvaR.A.et al.Evidence of natural" exact="Zika" post="virus infection in neotropical non-human primates in BrazilSci. Rep.2018811510.1038/s41598-018-34423-629311619"/>
   <result pre="in December 2017. Figure 3 (a) Quantification by RT-qPCR of" exact="YFV" post="RNA copies per mosquito (Hg. janthinomys) by area. Area"/>
   <result pre="= reverse primer and P = probe). Virus Sequence Reference" exact="Yellow fever" post="virus (YFV) F-5’/GCT AAT TGA GGT GYA TTG GTC"/>
   <result pre="CAA MGA ACG/3’ P-5’/FAM/ATC GAG TTG/ZEN/CTA GGC AAT AAA CAC/3lAbRQSp/3’" exact="Chikungunya" post="virus (CHIKV) F-5’/AAG CTY CGC GTC CTT TAC CAA"/>
   <result pre="CTT CCT/3’ P-5´/5HEX/CCA ATG TCY/ZEN/TCM GCC TGG ACA CCT TT/3IABkFQ/3´" exact="Dengue" post="virus (DENV) F-5´/GGA AGC TGT ACC TTG GTG GTA"/>
   <result pre="P-5’/TEX615/AAC AGC ATA TTG ACG CTG GGA GAG ACC AGA/3IAbRQSp/3’" exact="Zika" post="virus (ZIKV) F-5’/TTG GTC ATG ATA CTG CTG ATT"/>
   <result pre="(28.7%) 544 (62.7%) 21 (2.4%) 867 (100%) insects-10-00136-t003_Table 3Table 3" exact="YFV" post="infection rate for Haemagogus janthinomys by area. Sampled Areas"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6572372\results\search\tropicalVirus\results.xml">
   <result pre="doi: 10.3390/ijerph16101759ijerph-16-01759 : Article Spatiotemporal Heterogeneity in the Distribution of" exact="Chikungunya" post="and Zika Virus Case Incidences during their 2014 to"/>
   <result pre=": Article Spatiotemporal Heterogeneity in the Distribution of Chikungunya and" exact="Zika" post="Virus Case Incidences during their 2014 to 2016 Epidemics"/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Chikungunya" post="virus (CHIKV) and Zika virus (ZIKV) have recently emerged"/>
   <result pre="Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Chikungunya virus (CHIKV) and" exact="Zika" post="virus (ZIKV) have recently emerged as globally important infections."/>
   <result pre="aimed to explore the spatiotemporal heterogeneity in the occurrence of" exact="CHIKV" post="and ZIKV outbreaks throughout the major international seaport city"/>
   <result pre="explore the spatiotemporal heterogeneity in the occurrence of CHIKV and" exact="ZIKV" post="outbreaks throughout the major international seaport city of Barranquilla,"/>
   <result pre="epidemics. Neighbourhoods in the northern region were hotspots for both" exact="CHIKV" post="and ZIKV outbreaks. Additional hotspots occurred in the southwestern"/>
   <result pre="in the northern region were hotspots for both CHIKV and" exact="ZIKV" post="outbreaks. Additional hotspots occurred in the southwestern and some"/>
   <result pre="a neighbourhood near a major road as risk factors for" exact="ZIKV" post="case incidences. These findings will help to appropriately focus"/>
   <result pre="in Barranquilla and throughout the world’s tropical and subtropical regions." exact="Chikungunya" post="virus Zika virus spatial clustering Bayesian Poisson models conditional"/>
   <result pre="and throughout the world’s tropical and subtropical regions. Chikungunya virus" exact="Zika" post="virus spatial clustering Bayesian Poisson models conditional autoregressive models"/>
   <result pre="Since 2013, the two emerging arboviruses, chikungunya virus (CHIKV) and" exact="Zika" post="virus (ZIKV), transmitted by the same vector species (Aedes"/>
   <result pre="dengue viruses (DENVs), have caused major outbreaks throughout the Americas." exact="CHIKV" post="is thought to have first arrived in the Caribbean"/>
   <result pre="regions of Central and South America [1,2,3]. The first autochthonous" exact="ZIKV" post="cases were reported in the northeastern region of Brazil"/>
   <result pre="in late 2014 [4]. By February 2016, local transmission of" exact="ZIKV" post="was reported in over 20 countries in the Americas,"/>
   <result pre="disability adjusted life years (DALYs) in the affected populations [6,7,8]." exact="CHIKV" post="infections are characterised by a high fever and debilitating"/>
   <result pre="or chronic joint disease [6,8,9,10]. By stark contrast, 80% of" exact="ZIKV" post="infections are asymptomatic, and symptomatic patients display lower fevers"/>
   <result pre="rash, nonpurulent conjunctivitis and oedema [10,11]. However, in the Americas," exact="ZIKV" post="infections have been implicated in causing severe congenital abnormalities,"/>
   <result pre="curb epidemics [18,19,20]. Studies have found similar transmission dynamics in" exact="CHIKV" post="prevalence. For example, Sissoko et al. found that seroprevalence"/>
   <result pre="prevalence. For example, Sissoko et al. found that seroprevalence of" exact="CHIKV" post="antibodies in Mayotte was mainly associated with lower socioeconomic"/>
   <result pre="that the seasonal and regional transmission patterns were similar in" exact="CHIKV" post="compared with DENV [22]. Similarly, the spread of ZIKV"/>
   <result pre="and regional transmission patterns were similar in CHIKV compared with" exact="DENV" post="[22]. Similarly, the spread of ZIKV through the Americas"/>
   <result pre="in CHIKV compared with DENV [22]. Similarly, the spread of" exact="ZIKV" post="through the Americas was predicted by models that accounted"/>
   <result pre="This city has been an epicentre of recent outbreaks of" exact="CHIKV" post="and ZIKV [6,28]. A four-decade history of combatting DENVs"/>
   <result pre="has been an epicentre of recent outbreaks of CHIKV and" exact="ZIKV" post="[6,28]. A four-decade history of combatting DENVs has led"/>
   <result pre="to establish a highly functional surveillance system (SIVIGILA) for reportable" exact="DENV" post="infections [29]. Case incidences of CHIKV and ZIKV were"/>
   <result pre="system (SIVIGILA) for reportable DENV infections [29]. Case incidences of" exact="CHIKV" post="and ZIKV were monitored by the same reporting system"/>
   <result pre="for reportable DENV infections [29]. Case incidences of CHIKV and" exact="ZIKV" post="were monitored by the same reporting system [30,31]. Previous"/>
   <result pre="study, we assessed the spatial and temporal heterogeneity in the" exact="CHIKV" post="and ZIKV case incidences in the neighbourhoods of Barranquilla"/>
   <result pre="assessed the spatial and temporal heterogeneity in the CHIKV and" exact="ZIKV" post="case incidences in the neighbourhoods of Barranquilla between 2014"/>
   <result pre="during their epidemics in Barranquilla. 2. Materials and Methods 2.1." exact="CHIKV" post="and ZIKV Incidence Data The National Health Institute and"/>
   <result pre="epidemics in Barranquilla. 2. Materials and Methods 2.1. CHIKV and" exact="ZIKV" post="Incidence Data The National Health Institute and Public Health"/>
   <result pre="(described below) and laboratory test confirmations. The clinical criteria for" exact="CHIKV" post="and ZIKV infections have been regularly used along with"/>
   <result pre="and laboratory test confirmations. The clinical criteria for CHIKV and" exact="ZIKV" post="infections have been regularly used along with confirmatory laboratory"/>
   <result pre="and ZIKV-Infected Case Definitions For the Colombian public health system," exact="CHIKV" post="or ZIKV infections were identified based on clinically-assessed criteria"/>
   <result pre="Case Definitions For the Colombian public health system, CHIKV or" exact="ZIKV" post="infections were identified based on clinically-assessed criteria with or"/>
   <result pre="or without laboratory-test confirmations. The criteria for clinical confirmation of" exact="CHIKV" post="infection included having a fever (&amp;gt;38 °C), sudden onset"/>
   <result pre="virological methods had previously occurred [50]. As such, laboratory confirmed" exact="CHIKV" post="cases included viral isolation or an RT-PCR positive result"/>
   <result pre="cases included viral isolation or an RT-PCR positive result for" exact="CHIKV" post="cDNA, an anti-CHIKV IgM antibody positive result in an"/>
   <result pre="other, as described [50]. The criteria for clinical diagnosis of" exact="ZIKV" post="infections included exanthema (rash) and fever (38 °C), and"/>
   <result pre="fever (38 °C), and residence in a municipality with confirmed" exact="ZIKV" post="transmission [51]. Additionally, ZIKV infection was considered when the"/>
   <result pre="residence in a municipality with confirmed ZIKV transmission [51]. Additionally," exact="ZIKV" post="infection was considered when the patient had visited a"/>
   <result pre="metres above sea level in Colombia with confirmation of local" exact="ZIKV" post="circulation, and had one or more of the following"/>
   <result pre="confirmation was achieved by obtaining a RT-PCR positive result for" exact="ZIKV" post="cDNA, as described [14,50]. For both CHIKV and ZIKV,"/>
   <result pre="positive result for ZIKV cDNA, as described [14,50]. For both" exact="CHIKV" post="and ZIKV, we included all clinically suspected cases, epidemiologically"/>
   <result pre="DANE website [26]. The population data and monthly incidence of" exact="CHIKV" post="and ZIKV cases were linked within a Geographical Information"/>
   <result pre="[26]. The population data and monthly incidence of CHIKV and" exact="ZIKV" post="cases were linked within a Geographical Information System (GIS)"/>
   <result pre="of neighbourhoods in Barranquilla along with the monthly incidence of" exact="CHIKV" post="and ZIKV cases. Previous studies have shown that vegetation"/>
   <result pre="in Barranquilla along with the monthly incidence of CHIKV and" exact="ZIKV" post="cases. Previous studies have shown that vegetation coverage and"/>
   <result pre="them in our multivariate regression models. 2.5. Statistical Analysis 2.5.1." exact="CHIKV" post="and ZIKV Incidence Rate The total incidence of surveillance-defined"/>
   <result pre="our multivariate regression models. 2.5. Statistical Analysis 2.5.1. CHIKV and" exact="ZIKV" post="Incidence Rate The total incidence of surveillance-defined or laboratory-confirmed"/>
   <result pre="ZIKV Incidence Rate The total incidence of surveillance-defined or laboratory-confirmed" exact="CHIKV" post="and ZIKV cases over the study period was linked"/>
   <result pre="Rate The total incidence of surveillance-defined or laboratory-confirmed CHIKV and" exact="ZIKV" post="cases over the study period was linked to the"/>
   <result pre="per 10,000 persons at risk. The incidence was calculated for" exact="CHIKV" post="and ZIKV for each individual monthly. The spatial structure"/>
   <result pre="persons at risk. The incidence was calculated for CHIKV and" exact="ZIKV" post="for each individual monthly. The spatial structure of CHIKV"/>
   <result pre="and ZIKV for each individual monthly. The spatial structure of" exact="CHIKV" post="and ZIKV case incidences over the study period of"/>
   <result pre="for each individual monthly. The spatial structure of CHIKV and" exact="ZIKV" post="case incidences over the study period of 2014 to"/>
   <result pre="existence of overall spatial autocorrelation for the total incidence of" exact="CHIKV" post="and ZIKV cases throughout Barranquilla, whereas LISA analysis was"/>
   <result pre="overall spatial autocorrelation for the total incidence of CHIKV and" exact="ZIKV" post="cases throughout Barranquilla, whereas LISA analysis was implemented to"/>
   <result pre="the following time period. These analyses were performed for the" exact="CHIKV" post="and ZIKV cases for each month of their epidemics:"/>
   <result pre="time period. These analyses were performed for the CHIKV and" exact="ZIKV" post="cases for each month of their epidemics: July 2014"/>
   <result pre="month of their epidemics: July 2014 to April 2015 for" exact="CHIKV" post="and October 2015 to June 2016 for ZIKV cases"/>
   <result pre="2015 for CHIKV and October 2015 to June 2016 for" exact="ZIKV" post="cases (Figures S8 and S9). GeoDa software was used"/>
   <result pre="and Environmental Data Table 1 shows the total incidence of" exact="CHIKV" post="and ZIKV during the 2014–2016 period and a summary"/>
   <result pre="Data Table 1 shows the total incidence of CHIKV and" exact="ZIKV" post="during the 2014–2016 period and a summary of descriptive"/>
   <result pre="110) and 10.5% (n = 746) of the patients with" exact="CHIKV" post="or ZIKV infections, respectively. 3.2. Analysis of Chikungunya Virus"/>
   <result pre="10.5% (n = 746) of the patients with CHIKV or" exact="ZIKV" post="infections, respectively. 3.2. Analysis of Chikungunya Virus Outbreaks During"/>
   <result pre="patients with CHIKV or ZIKV infections, respectively. 3.2. Analysis of" exact="Chikungunya" post="Virus Outbreaks During the study period, there were a"/>
   <result pre="study period, there were a total of 1865 cases of" exact="CHIKV" post="in Barranquilla. The total incidence of CHIKV during the"/>
   <result pre="1865 cases of CHIKV in Barranquilla. The total incidence of" exact="CHIKV" post="during the study period was 16.4 per 10,000 persons,"/>
   <result pre="and 2016, respectively. There was a single distinct peak of" exact="CHIKV" post="cases that began in the 4th quarter of 2014,"/>
   <result pre="of the 1st quarter of 2015 (Figure S3). When the" exact="CHIKV" post="incidence rate was displayed in maps by neighbourhoods (Figure"/>
   <result pre="time (differential LISA analysis) showed a clear evolution of the" exact="CHIKV" post="epidemic during the months of peak incidence from July"/>
   <result pre="rate increased sharply (Figure 3). The Bayesian Poisson model of" exact="CHIKV" post="SIR values fitted with the explanatory variables (SES, population"/>
   <result pre="1 approach showed a spatial structure on the distribution of" exact="CHIKV" post="SIR values across Barranquilla, we assessed the persisting spatial"/>
   <result pre="our model selection. Figure 4 shows the crude and fitted" exact="CHIKV" post="SIR values throughout Barranquilla. Table 3 shows the regression"/>
   <result pre="regression coefficients for the spatial fixed effects considered to fit" exact="CHIKV" post="SIR values, based on the model 3 approach. Risk"/>
   <result pre="SIR values, based on the model 3 approach. Risk of" exact="CHIKV" post="case incidences appeared to slightly decrease with increasing percentage"/>
   <result pre="levels of SES (quantiles), were the most at risk for" exact="CHIKV" post="infections (reference low SES, medium SES coefficient 0.40, 95%"/>
   <result pre="of these associations were, however, statistically significant. 3.3. Analysis of" exact="Zika" post="Virus Outbreaks During the study period, there were a"/>
   <result pre="of 7029 ZIKV-infected cases in Barranquilla. The total incidence of" exact="ZIKV" post="was 61.7 cases per 10,000 persons at risk. The"/>
   <result pre="61.7 cases per 10,000 persons at risk. The incidence of" exact="ZIKV" post="was 0, 12.3 and 49.4 cases per 10,000 persons"/>
   <result pre="and 2016, respectively. There was a single distinct peak of" exact="ZIKV" post="cases that began at the beginning of the 4th"/>
   <result pre="of 2016 (Figure S6). The map that displayed the total" exact="ZIKV" post="incidence rate by neighbourhood showed a focus of high"/>
   <result pre="global univariate Moran’s I statistic for the total incidence of" exact="ZIKV" post="during the study period was 0.031 (pseudo p-value 0.191);"/>
   <result pre="the city (Figure S8). The clustering of cases during the" exact="ZIKV" post="outbreak was less dramatic compared to that of the"/>
   <result pre="ZIKV outbreak was less dramatic compared to that of the" exact="CHIKV" post="epidemic, as revealed by the differential LISA analysis. However,"/>
   <result pre="northeastern area of the city (Figure 5). As with the" exact="CHIKV" post="SIR values, the Bayesian Poisson model of the ZIKV"/>
   <result pre="the CHIKV SIR values, the Bayesian Poisson model of the" exact="ZIKV" post="SIR values fitted with the explanatory variables and with"/>
   <result pre="approach (Text S2) to capture the remaining variability. Unlike the" exact="CHIKV" post="SIR model 2, we did not find any significant"/>
   <result pre="scale (Moran’s I statistic: 0.0101, p-value: 0.329) upon fitting the" exact="ZIKV" post="SIR value data based on the model 2 approach."/>
   <result pre="967.6) (Table 2). Figure 6 shows the crude and fitted" exact="ZIKV" post="SIR values throughout Barranquilla. Table 4 displays the regression"/>
   <result pre="coefficients for the spatial fixed effects considered to fit the" exact="ZIKV" post="SIR values based on the model 4 approach. The"/>
   <result pre="values based on the model 4 approach. The risk for" exact="ZIKV" post="case incidences did not vary or varied very little"/>
   <result pre="residents also did not appear to be associated with the" exact="ZIKV" post="case incidence. However, the richest neighbourhoods (SES 5 and"/>
   <result pre="(SES 5 and 6) were significantly more at risk for" exact="ZIKV" post="infections compared to those of the low and medium"/>
   <result pre="distance from major roads also significantly decreased the risk of" exact="ZIKV" post="case incidence (Table 4 and Figure 1). 4. Discussion"/>
   <result pre="city. The monthly analysis of local autocorrelation showed that the" exact="CHIKV" post="epidemic began within hotspots in the northern area and"/>
   <result pre="of the city became important hotspots. It seemed that the" exact="ZIKV" post="epidemic spread to the eastern part of the city"/>
   <result pre="evidence that lower SES was associated with higher SIR of" exact="CHIKV" post="infection. We, however, found very strong evidence that higher"/>
   <result pre="living nearer to main roads had a higher risk for" exact="ZIKV" post="infection. We believe this is the first report that"/>
   <result pre="that living in higher SES is a risk factor for" exact="ZIKV" post="case incidences. Furthermore, the northern neighbourhoods of Barranquilla are"/>
   <result pre="report high infection incidences and appeared to drive both the" exact="CHIKV" post="and ZIKV outbreaks. Unfortunately, the local health authority’s vector"/>
   <result pre="infection incidences and appeared to drive both the CHIKV and" exact="ZIKV" post="outbreaks. Unfortunately, the local health authority’s vector surveillance and"/>
   <result pre="sites in these areas may have accounted for their higher" exact="ZIKV" post="case incidence. Alternatively, these findings may indicate a reporting"/>
   <result pre="The issue of reporting bias was likely exacerbated during the" exact="ZIKV" post="epidemic by the widespread media coverage drawn by the"/>
   <result pre="by the widespread media coverage drawn by the association of" exact="ZIKV" post="with congenital defects, sexual transmission and severe autoimmune diseases"/>
   <result pre="to clinic with milder symptoms and receive the diagnosis of" exact="ZIKV" post="as it was sweeping through the city. In addition,"/>
   <result pre="prenatal healthcare, where there is already an over diagnosis of" exact="ZIKV" post="[67]. This is in stark contrast to the presentation"/>
   <result pre="[67]. This is in stark contrast to the presentation of" exact="CHIKV" post="infection, which results in very high fever and debilitating"/>
   <result pre="be supported by finding that poverty was associated with reduced" exact="ZIKV" post="case reporting in another recent study [49]. Thus, the"/>
   <result pre="study sites [68,69,70]. The two groups at most risk for" exact="DENV" post="infections in Itaipu, Brazil were the lowest-income population and"/>
   <result pre="[71]. The evidence we present here indicates that either the" exact="CHIKV" post="and ZIKV epidemics occurred in different ecological niches or"/>
   <result pre="evidence we present here indicates that either the CHIKV and" exact="ZIKV" post="epidemics occurred in different ecological niches or the case"/>
   <result pre="occurred in different ecological niches or the case reporting of" exact="ZIKV" post="infection was novel amongst the arboviral infections. Through conversations"/>
   <result pre="residents living in apartments were at a reduced risk for" exact="DENV" post="infections [33,41,73], probably due to reduced availability of suitable"/>
   <result pre="of houses (Figure 2A), was an important hotspot during the" exact="CHIKV" post="outbreak (Figure 3). Much lower combined Aedes spp. premise"/>
   <result pre="in Kuala Lumpur, Malaysia [75]. Drawing spatial distinctions between the" exact="CHIKV" post="and ZIKV cases assumed that the infected cases reported"/>
   <result pre="Lumpur, Malaysia [75]. Drawing spatial distinctions between the CHIKV and" exact="ZIKV" post="cases assumed that the infected cases reported for these"/>
   <result pre="these methods were used and found that only 1% of" exact="ZIKV" post="and 1.7% of CHIKV-infected cases were laboratory confirmed [30,31]."/>
   <result pre="1.7% of CHIKV-infected cases were laboratory confirmed [30,31]. Since the" exact="CHIKV" post="and ZIKV outbreaks occurred in separate time periods, any"/>
   <result pre="CHIKV-infected cases were laboratory confirmed [30,31]. Since the CHIKV and" exact="ZIKV" post="outbreaks occurred in separate time periods, any possible misclassifications"/>
   <result pre="cross-reactivity of IgM and IgG antibodies generated by patients with" exact="DENV" post="and ZIKV (both flaviviruses) infections [78,79], all the laboratory-confirmed"/>
   <result pre="IgM and IgG antibodies generated by patients with DENV and" exact="ZIKV" post="(both flaviviruses) infections [78,79], all the laboratory-confirmed ZIKV cases"/>
   <result pre="DENV and ZIKV (both flaviviruses) infections [78,79], all the laboratory-confirmed" exact="ZIKV" post="cases in our study were identified by a positive"/>
   <result pre="risk factors discussed above with those of recent outbreaks of" exact="CHIKV" post="and ZIKV. Our spatial exploration clearly identified neighbourhoods that"/>
   <result pre="had been hotspots responsible for driving the epidemic waves of" exact="CHIKV" post="and ZIKV. It is therefore essential that these hotspots"/>
   <result pre="in and surrounding them when any cases of CHIV or" exact="ZIKV" post="are reported. The risk factor analysis provided strong evidence"/>
   <result pre="residence closer to the main roads were risk factors for" exact="ZIKV" post="case incidence. In Barranquilla, the Public Health Department should"/>
   <result pre="differences in vector breeding, dispersal and disease transmission. During the" exact="CHIKV" post="epidemic, the possible introduction of the virus into (a)"/>
   <result pre="conditioning was a major factor accounting for the much lower" exact="DENV" post="sero-positivity for the residents in a study site in"/>
   <result pre="Magdalena River. As no effective treatments or vaccines exist for" exact="CHIKV" post="and ZIKV, prevention is still the primary method of"/>
   <result pre="use to efficiently target the drivers of future epidemics of" exact="CHIKV" post="and ZIKV infections. Our spatial analysis identified key areas"/>
   <result pre="efficiently target the drivers of future epidemics of CHIKV and" exact="ZIKV" post="infections. Our spatial analysis identified key areas of Barranquilla"/>
   <result pre="of Barranquilla that acted as hotspots during the outbreaks of" exact="CHIKV" post="and ZIKV. Furthermore, we clearly showed that living in"/>
   <result pre="living in the high SES was a risk factor for" exact="ZIKV" post="case incidence, though this may have been driven by"/>
   <result pre="supervised classification and calculation of MNDWI. Figure S3. Incidence of" exact="CHIKV" post="case infected case notifications to SIVIGILA (N.B. the case"/>
   <result pre="Moran’s I analysis on the residuals resulting from fitting the" exact="ZIKV" post="SIR values with spatial explanatory variables and independent random"/>
   <result pre="declare no conflict of interest. Abbreviations CAR conditional autoregressive models" exact="DENV" post="dengue virus CHIKV chikungunya virus DANE National Administrative Department"/>
   <result pre="of interest. Abbreviations CAR conditional autoregressive models DENV dengue virus" exact="CHIKV" post="chikungunya virus DANE National Administrative Department of Statistics DIC"/>
   <result pre="of the normalised difference water index SIR standardised incidence rate" exact="ZIKV" post="Zika virus References References 1.CassadouS.BoucauS.Petit-SinturelM.HucP.Leparc-GoffartI.LedransM.Emergence of chikungunya fever on"/>
   <result pre="the normalised difference water index SIR standardised incidence rate ZIKV" exact="Zika" post="virus References References 1.CassadouS.BoucauS.Petit-SinturelM.HucP.Leparc-GoffartI.LedransM.Emergence of chikungunya fever on the"/>
   <result pre="Dis.20152155756110.3201/eid2104.14172325816211 4.ZanlucaC.de MeloV.C.A.MosimannA.L.P.dos SantosG.I.V.dos SantosC.N.D.LuzK.First report of autochthonous transmission of" exact="Zika" post="virus in BrazilMem. Inst. Oswaldo Cruz201511056957226061233 5.Alvis-GuzmanN.Zakzuk-SierraJ.Vargas-MoranthR.Alcocer-OlacireguiA.Parra-PadillaD.Dengue, Chikunguna y"/>
   <result pre="Zika virus in BrazilMem. Inst. Oswaldo Cruz201511056957226061233 5.Alvis-GuzmanN.Zakzuk-SierraJ.Vargas-MoranthR.Alcocer-OlacireguiA.Parra-PadillaD.Dengue, Chikunguna y" exact="Zika" post="en Colombia 2015–2016Revista MVZ Cordoba2017225994600310.21897/rmvz.1069 6.Cardona-OspinaJ.A.Villamil-GomezW.E.Jimenez-CanizalesC.E.Castañeda-HernåndezD.M.Rodriguez-MoralesA.J.Estimating the burden of"/>
   <result pre="Trop. Med. Hyg.201510979380210.1093/trstmh/trv09426626342 7.CuevasE.L.Preliminary report of microcephaly potentially associated with" exact="Zika" post="virus infection during pregnancy—Colombia, January–November 2016Morb. Mortal. Wkly. Rep.2016651409141310.15585/mmwr.mm6549e1"/>
   <result pre="for causalityN. Engl. J. Med.20163741981198710.1056/NEJMsr160433827074377 14.MussoD.GublerD.J.Zika virusClin. Microbiol. Rev.20162948752410.1128/CMR.00072-1527029595 15.KrauerF.RiesenM.ReveizL.OladapoO.T.Martinez-VegaR.PorgoT.V.HaefligerA.BroutetN.J.LowN.WHO" exact="Zika" post="Causality Working Group Zika virus infection as a cause"/>
   <result pre="Med.20163741981198710.1056/NEJMsr160433827074377 14.MussoD.GublerD.J.Zika virusClin. Microbiol. Rev.20162948752410.1128/CMR.00072-1527029595 15.KrauerF.RiesenM.ReveizL.OladapoO.T.Martinez-VegaR.PorgoT.V.HaefligerA.BroutetN.J.LowN.WHO Zika Causality Working Group" exact="Zika" post="virus infection as a cause of congenital brain abnormalities"/>
   <result pre="reviewPLoS Med.201714e100220310.1371/journal.pmed.100220328045901 16.TowersS.BrauerF.Castillo-ChavezC.FalconarA.K.MubayiA.Romero-VivasC.M.Estimate of the reproduction number of the 2015" exact="Zika" post="virus outbreak in Barranquilla, Colombia, and estimation of the"/>
   <result pre="transmissionEpidemics201617505510.1016/j.epidem.2016.10.00327846442 17.LiX.MaW.WongG.MaS.LiS.BiY.GaoG.F.A new threat to human reproduction system posed by" exact="Zika" post="virus (ZIKV): From clinical investigations to experimental studiesVirus Res.2018254101410.1016/j.virusres.2017.09.00528893652"/>
   <result pre="invasion of the AmericasPLoS Curr.2015710.1371/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc 23.BogochI.I.BradyO.J.KraemerM.U.GermanM.CreatoreM.I.KulkarniM.A.BrownsteinJ.S.MekaruS.R.HayS.I.GrootE.Anticipating the international spread of" exact="Zika" post="virus from BrazilLancet201638733533610.1016/S0140-6736(16)00080-526777915 24.SamyA.M.ThomasS.M.WahedA.A.E.CohoonK.P.PetersonA.T.Mapping the global geographic potential of"/>
   <result pre="Zika virus from BrazilLancet201638733533610.1016/S0140-6736(16)00080-526777915 24.SamyA.M.ThomasS.M.WahedA.A.E.CohoonK.P.PetersonA.T.Mapping the global geographic potential of" exact="Zika" post="virus spreadMemórias do Instituto Oswaldo Cruz201611155956010.1590/0074-0276016014927653360 25.PazS.SemenzaJ.C.El Niño and"/>
   <result pre="25.PazS.SemenzaJ.C.El Niño and climate change—contributing factors in the dispersal of" exact="Zika" post="virus in the Americas?The Lancet201638774510.1016/S0140-6736(16)00256-7 26.Departamento Administrativo Nacional de"/>
   <result pre="colombianas de Barranquilla y CartagenaLecturas de Economía20148018320810.17533/udea.le.n80a7 28.PerkinsT.A.SirajA.S.RuktanonchaiC.W.KraemerM.U.TatemA.J.Model-based projections of" exact="Zika" post="virus infections in childbearing women in the AmericasNat. Microbiol.201611612610.1038/nmicrobiol.2016.12627562260"/>
   <result pre="epidemics in Barranquilla (Colombia)Revista de Salud Publica20192113 30.WalkerN.Investigation of the" exact="Chikungunya" post="Virus Outbreak in Barranquilla, Colombia, and Evaluation of the"/>
   <result pre="in Barranquilla, Colombia, and Evaluation of the Surveillance System for" exact="Chikungunya" post="in Place During the OutbreakThe London School of Hygiene"/>
   <result pre="Hygiene and Tropical MedicineLondon, UK2014 31.NixC.Investigation into the transmission of" exact="Zika" post="virus in Barranquilla, ColombiaThe London School of Hygiene and"/>
   <result pre="Malaysia using Boosted Regression TreesSpat. Spatio-Temporal Epidemiol.201410758410.1016/j.sste.2014.05.002 48.HuangC.TamT.ChernY.LungS.ChenN.WuC.Spatial Clustering of" exact="Dengue" post="Fever Incidence and Its Association with Surrounding GreennessInt. J."/>
   <result pre="Public Health201815186910.3390/ijerph1509186930158475 49.ReesE.E.PetukhovaT.MascarenhasM.PelcatY.OgdenN.H.Environmental and social determinants of population vulnerability to" exact="Zika" post="virus emergence at the local scaleParasites Vectors20181129010.1186/s13071-018-2867-829739467 50.BoteroD.S.BocanegraD.Protocolo de"/>
   <result pre="NS: Not significant (grey colour). Figure 4 Crude and modelled" exact="CHIKV" post="standardised incidence rate (SIR) values by neighbourhood during its"/>
   <result pre="correlated random effects. Figure 5 Differential monthly LISA clusters of" exact="ZIKV" post="cases during the period of peak incidence (October 2015–April"/>
   <result pre="NS: Not significant (grey colour). Figure 6 Crude and modelled" exact="ZIKV" post="standardised incidence rate (SIR) values by neighbourhood during its"/>
   <result pre="The descriptive statistics of the neighbourhoods (n = 140) for" exact="Chikungunya" post="virus (CHIKV)- and Zika virus (ZIKV)-infected cases and risk"/>
   <result pre="the neighbourhoods (n = 140) for Chikungunya virus (CHIKV)- and" exact="Zika" post="virus (ZIKV)-infected cases and risk factors that were included"/>
   <result pre="available. Median Percentile NA, % (n) 5th 95th Incidence of" exact="CHIKV" post="per 10,000 residents 10.6 0 48.4 0.00 (0) Incidence"/>
   <result pre="per 10,000 residents 10.6 0 48.4 0.00 (0) Incidence of" exact="ZIKV" post="per 10,000 residents 50.3 0 157 0.00 (0) Socioeconomic"/>
   <result pre="Methods Section 2.5.4 for model details. Type of Fitted Models" exact="CHIKV" post="ZIKV Model 1: No random effects 1718.3 2815.7 Model"/>
   <result pre="Section 2.5.4 for model details. Type of Fitted Models CHIKV" exact="ZIKV" post="Model 1: No random effects 1718.3 2815.7 Model 2:"/>
   <result pre="for the fixed effects of the final model for the" exact="CHIKV" post="standardised incidence rate (SIR) values in 2014–2016. These parameters"/>
   <result pre="for the fixed effects of the final model for the" exact="ZIKV" post="standardised incidence rate (SIR) values in 2014–2015. These parameters"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6585104\results\search\tropicalVirus\results.xml">
   <result pre="viruses are rare [3]. Also transmission of other viruses including" exact="West Nile" post="virus (WNV), human T cell lymphotropic virus (HTLV), rabies"/>
   <result pre="HTLV Human T cell lymphotropic virus NAT Nucleic acid testing" exact="WNV" post="West Nile virus Publisher’s Note Springer Nature remains neutral"/>
   <result pre="Human T cell lymphotropic virus NAT Nucleic acid testing WNV" exact="West Nile" post="virus Publisher’s Note Springer Nature remains neutral with regard"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6594658\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences: Public and Occupational"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus Downgrading disease transmission risk estimates using terminal importations"/>
   <result pre="As emerging and re-emerging infectious arboviruses like dengue, chikungunya, and" exact="Zika" post="threaten new populations worldwide, officials scramble to assess local"/>
   <result pre="We demonstrate this approach by estimating the spatiotemporal risks of" exact="Zika" post="virus transmission throughout Texas, a high-risk region in the"/>
   <result pre="six of 254 Texas counties deemed capable of sustaining a" exact="Zika" post="epidemic—and they are consistent with the number of autochthonous"/>
   <result pre="reach. Author summary When novel infectious diseases like chikungunya or" exact="Zika" post="emerge and threaten global spread, public health officials worldwide"/>
   <result pre="We demonstrate our approach by estimating local transmission risk for" exact="Zika" post="throughout the state of Texas. Our findings suggest that"/>
   <result pre="majority of Texas counties face little risk for sustaining a" exact="Zika" post="epidemic, and successfully predict the number of locally transmitted"/>
   <result pre="dataset to evaluate the method. Introduction The explosive emergence of" exact="Zika" post="virus (ZIKV) in the Americas in 2016 caught the"/>
   <result pre="newly introduced pathogen spreads can vary enormously though, particularly for" exact="ZIKV" post="and other pathogens with multi-faceted drivers of their transmission"/>
   <result pre="on either side of the Texas-Mexico border indicated far higher" exact="DENV" post="exposure in the Mexican community, despite virtually identical climatic"/>
   <result pre="on environmental suitability. For example, as the first importations of" exact="ZIKV" post="arrived in the US in 2016, early attempts to"/>
   <result pre="In particular, this work was motivated by recent introductions of" exact="ZIKV" post="into the continental US. As hundreds of cases arrived"/>
   <result pre="regions in the southern US. However, given the novelty of" exact="ZIKV" post="and the large proportion of ZIKV cases that go"/>
   <result pre="given the novelty of ZIKV and the large proportion of" exact="ZIKV" post="cases that go undetected, early ecological estimates had high"/>
   <result pre="almost complete absence of secondary transmission following 298 importations of" exact="ZIKV" post="into the state of Texas in 2016 and 2017"/>
   <result pre="a priori county-month R0 distributions using published ecological models of" exact="ZIKV" post="transmission [4, 6], and (2) using these as Bayesian"/>
   <result pre="importations and subsequent local transmission. Data We analyzed all known" exact="ZIKV" post="importations into Texas from January 2016 to September 2017,"/>
   <result pre="available at dx.doi.org/10.18738/T8/HYZ53B. In all, six mosquito-borne, autochthonous cases of" exact="ZIKV" post="were reported in Texas in 2016 and one was"/>
   <result pre="our 2017 importation data. A priori county-month R0 estimates For" exact="ZIKV" post="to be locally transmitted in a location, a mosquito"/>
   <result pre="do not consider the near-term effects of precipitation on local" exact="ZIKV" post="transmission risk, but one could be included in future"/>
   <result pre="Superspreading dynamics are known to occur with mosquito-borne diseases like" exact="ZIKV" post="[33, 34]. We assume that ZIKV secondary case distributions"/>
   <result pre="with mosquito-borne diseases like ZIKV [33, 34]. We assume that" exact="ZIKV" post="secondary case distributions are the same as that of"/>
   <result pre="describe the relationship between regional R0 and the percentage of" exact="DENV" post="imported cases that generate over 20 secondary infections (p20),"/>
   <result pre="uncertain estimates with real-time case data from the emergence of" exact="Zika" post="in Texas. The results are structured as such: we"/>
   <result pre="importations and baseline transmission risk estimates for 2016-17. (A) Initial" exact="ZIKV" post="R0 estimates using ecological risk models parameterized with actual"/>
   <result pre="threshold for county-month epidemic risk (R0 = 1). (B) Daily" exact="ZIKV" post="importations into Texas. Blue arrows indicate importations that produced"/>
   <result pre="2 Posterior median county R0 estimates for Texas, based on" exact="ZIKV" post="importations through January 2017. This assumes that all importations"/>
   <result pre="3 Evolving posterior distribution of statewide scaling factor for R0." exact="Zika" post="importations, both with and without subsequent detected autochthonous transmission,"/>
   <result pre="The temporal mismatch between the model predictions and the observed" exact="ZIKV" post="local transmission in November and December might stem from"/>
   <result pre="the model does not account for potential time lags between" exact="ZIKV" post="environmental suitability and eventual emergence of locally acquired cases."/>
   <result pre="model yielded estimates that are more consistent with the observed" exact="ZIKV" post="local transmission, although posterior risk estimates were remarkably consistent"/>
   <result pre="of importations went undetected (bottom). Discussion The global expansion of" exact="ZIKV" post="was declared a Public Health Emergency of International Concern"/>
   <result pre="or probable cases and over 3,352 documented cases of congenital" exact="Zika" post="syndrome. Although it is receding in most regions of"/>
   <result pre="and South America [37–39]. Differentiating regions that can sustain a" exact="ZIKV" post="epidemic (R0 &amp;gt; 1) from those that cannot is"/>
   <result pre="as a starting point, we applied the method to update" exact="ZIKV" post="R0 estimates for each of the 254 counties in"/>
   <result pre="the 254 counties were previously thought to be vulnerable to" exact="ZIKV" post="outbreaks, and even counties still at risk for epidemics"/>
   <result pre="been between zero and one detected case of locally acquired" exact="ZIKV" post="between January and September of 2017, which corresponds to"/>
   <result pre="There is a discrepancy between our model predictions and the" exact="ZIKV" post="case data: our final model predicts the highest local"/>
   <result pre="the summer across the state, but most cases of local" exact="ZIKV" post="transmission occurred in the winter (6 out of 7)."/>
   <result pre="support these time lags as a crucial element for predicting" exact="ZIKV" post="risk, and highlight the need for future research into"/>
   <result pre="detected imported cases, as imported cases primarily helped to downgrade" exact="Zika" post="risk in the absence of local transmission. This provides"/>
   <result pre="importation and local case data, this approach could readily update" exact="ZIKV" post="transmission risk estimates for any county in the continental"/>
   <result pre="several simplifying assumptions, which we divide into those concerning this" exact="ZIKV" post="test case of the updating procedure, and those concerning"/>
   <result pre="more likely to receive care that limits transmission, although most" exact="ZIKV" post="cases are inapparent or mild and do not require"/>
   <result pre="from a single detected importation. In this case, the low" exact="ZIKV" post="detection rate suggests that both primary importations and secondary"/>
   <result pre="posterior risk estimates S15 Fig. During the height of the" exact="ZIKV" post="threat, public health agencies in the US rapidly implemented"/>
   <result pre="health response was sufficient to mitigate the threat of a" exact="ZIKV" post="epidemic across the state. Our method cannot disentangle the"/>
   <result pre="can conclude neither that all initial ecological risk assessments for" exact="ZIKV" post="will overestimate risk, although this seems to be the"/>
   <result pre="overestimate risk, although this seems to be the case for" exact="ZIKV" post="in Texas and elsewhere in the US [9], nor"/>
   <result pre="US [9], nor that public health preparations and interventions for" exact="ZIKV" post="are no longer necessary in Texas or the southern"/>
   <result pre="or the southern US. Rather, our results suggest that sustained" exact="ZIKV" post="outbreaks are unlikely, but not impossible (3% of the"/>
   <result pre="epidemic risk), and provide more robust and localized estimates of" exact="ZIKV" post="risk that can inform more targeted surveillance and reactions"/>
   <result pre="that can inform more targeted surveillance and reactions to future" exact="ZIKV" post="importations. While our method provides an avenue to improve"/>
   <result pre="mosquito populations or mosquito-human interactions could raise or lower the" exact="Zika" post="risk in Texas [3, 46]. This framework is novel"/>
   <result pre="importations, with or without secondary transmission. As we demonstrated for" exact="ZIKV" post="in Texas, large numbers of terminal importations can profoundly"/>
   <result pre="in the midst of an outbreak. Although the threat of" exact="ZIKV" post="emergence in the continental US motivated this study, this"/>
   <result pre="Consider a hypothetical scenario in which the first 15 terminal" exact="ZIKV" post="importations into Texas arrive in Harris county (which includes"/>
   <result pre="Fig Posterior median county R0 estimates for Texas, based on" exact="ZIKV" post="importations through January 2017. This assumes that all importations"/>
   <result pre="would like to acknowledge Texas DSHS for providing the county-level" exact="ZIKV" post="importation data used in this analysis. We would also"/>
   <result pre="http://www.tacc.utexas.edu. References References 1GrillsA, MorrisonS, NelsonB, MiniotaJ, WattsA, CetronMS. Projected" exact="Zika" post="Virus Importation and Subsequent Ongoing Transmission after Travel to"/>
   <result pre="et al.Environmental and Social Change Drive the Explosive Emergence of" exact="Zika" post="Virus in the Americas. PLOS Neglected Tropical Diseases. 2017;11(2):1–16."/>
   <result pre="10.3201/eid0901.02022012533286 4CastroLA, FoxSJ, ChenX, LiuK, BellanSE, DimitrovNB, et al.Assessing real-time" exact="Zika" post="risk in the United States. BMC Infect Dis. 2017;17(1):28410.1186/s12879-017-2394-928468671"/>
   <result pre="DoughertyER, GetzW. An Ecological Assessment of the Pandemic Threat of" exact="Zika" post="Virus. PLoS Negl Trop Dis. 2016;10(8):e000496810.1371/journal.pntd.000496827564232 6Alex PerkinsT, SirajAS,"/>
   <result pre="2016;10(8):e000496810.1371/journal.pntd.000496827564232 6Alex PerkinsT, SirajAS, RuktanonchaiCW, KraemerMUG, TatemAJ. Model-based projections of" exact="Zika" post="virus infections in childbearing women in the Americas. Nature"/>
   <result pre="BootsM, GetzW, RyanSJ. Consensus and conflict among ecological forecasts of" exact="Zika" post="virus outbreaks in the United States. Sci Rep. 2018;8(1):492110.1038/s41598-018-22989-029563545"/>
   <result pre="BradyOJ, PigottDM, ShearerFM, WeissDJ, et al.Mapping global environmental suitability for" exact="Zika" post="virus. Elife. 2016;510.7554/eLife.1527227090089 18NordhausWD. Geography and macroeconomics: new data"/>
   <result pre="Elife. 2015;4:e0834710.7554/eLife.0834726126267 22Texas Department of State Health and Human Services." exact="Zika" post="in Texas; 2017. 23MordecaiEA, CohenJM, EvansMV, GudapatiP, JohnsonLR, MiazgowiczK,"/>
   <result pre="2017;11:e000556810.1371/journal.pntd.000556828448507 24TeslaB, DemakovskyLR, MordecaiEA, BondsMH, NgonghalaCN, BrindleyMA, et al.Temperature drives" exact="Zika" post="virus transmission: evidence from empirical and mathematical models. Proceedings"/>
   <result pre="Warren Ruktanonchai C, Kraemer M, Tatem A. Model-based projections of" exact="Zika" post="virus infections in childbearing women in the Americas. bioRxiv."/>
   <result pre="Med Hyg. 1998;58(3):277–282. 10.4269/ajtmh.1998.58.2779546403 31ChanM, JohanssonMA. The incubation periods of" exact="Dengue" post="viruses. PLoS One. 2012;7(11):e5097210.1371/journal.pone.005097223226436 32ZhangQ, SunK, ChinazziM, Pastore Y"/>
   <result pre="SunK, ChinazziM, Pastore Y PionttiA, DeanNE, RojasDP, et al.Spread of" exact="Zika" post="virus in the Americas. Proc Natl Acad Sci U"/>
   <result pre="variation in viremia on mosquito susceptibility, infectiousness, and R0 of" exact="Zika" post="in Aedes aegypti. PLOS Neglected Tropical Diseases. 2018;12(8):1–19. 10.1371/journal.pntd.0006733"/>
   <result pre="Trop Dis. 2012;6(8):e179910.1371/journal.pntd.000179922953017 36Stewart-ibarraAM, LoweR. Climate and Non-Climate Drivers of" exact="Dengue" post="Epidemics in Southern Coastal Ecuador. Am J Trop Med"/>
   <result pre="10.4269/ajtmh.12-047823478584 37SirajAS, Alex PerkinsT. Assessing the population at risk of" exact="Zika" post="virus in Asia—is the emergency really over?BMJ Global Health."/>
   <result pre="to predict areas in the Americas with increased likelihood of" exact="Zika" post="virus transmission in 2017; 2017. 39Colón-GonzálezFJ, PeresCA, Steiner São"/>
   <result pre="39Colón-GonzálezFJ, PeresCA, Steiner São BernardoC, HunterPR, LakeIR. After the epidemic:" exact="Zika" post="virus projections for Latin America and the Caribbean. PLoS"/>
   <result pre="2017;11(11):e000600710.1371/journal.pntd.000600729091713 40ThomasDL, SantiagoGA, AbeytaR, HinojosaS, Torres-VelasquezB, AdamJK, et al.Reemergence of" exact="Dengue" post="in Southern Texas, 2013. Emerg Infect Dis. 2016;22(6):1002–1007. 10.3201/eid2206.15200027191223"/>
   <result pre="AlthouseBM, Hébert-DufresneL, ScarpinoSV. The risk of sustained sexual transmission of" exact="Zika" post="is underestimated. PLoS Pathog. 2017;13(9):e100663310.1371/journal.ppat.100663328934370 42Oidtman RJ, Lai S,"/>
   <result pre="DudasG, TanAL, GangavarapuK, et al.Genomic epidemiology reveals multiple introductions of" exact="Zika" post="virus into the United States. Nature. 2017;546(7658):401–405. 10.1038/nature2240028538723 45Centers"/>
   <result pre="Nature. 2017;546(7658):401–405. 10.1038/nature2240028538723 45Centers for Disease Control and Prevention. CDC" exact="Zika" post="Interim Response Plan; 2016. 46HotezPJ, Jackson LeeS. US Gulf"/>
   <result pre="47DinhL, ChowellG, MizumotoK, NishiuraH. Estimating the subcritical transmissibility of the" exact="Zika" post="outbreak in the State of Florida, USA, 2016. Theor"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6595446\results\search\tropicalVirus\results.xml">
   <result pre="Development of an Enzyme-Linked Immunosorbent Assay for Rapid Detection of" exact="Dengue" post="Virus (DENV) NS1 and Differentiation of DENV Serotypes during"/>
   <result pre="Rapid Detection of Dengue Virus (DENV) NS1 and Differentiation of" exact="DENV" post="Serotypes during Early Infection ELISA for DENV NS1 Lai"/>
   <result pre="and Differentiation of DENV Serotypes during Early Infection ELISA for" exact="DENV" post="NS1 Lai et al. LaiSzu-ChiaaHuangYu-YineaShuPei-YunbChangShu-FenbHsiehPo-ShiuanaWeyJiunn-JyeaTsaiMeng-HungaBenRen-JycHsuYi-MingcFangYi-ChiendHsiaoMei-LingeLinChang-Chia[a], Institute of Preventive Medicine,"/>
   <result pre="rapid detection of dengue virus (DENV) NS1 and differentiation of" exact="DENV" post="serotypes during early infection. J Clin Microbiol 57:e00221-19. https://doi.org/10.1128/JCM.00221-19."/>
   <result pre="the terms of the Creative Commons Attribution 4.0 International license.JCM.00221-19.pdf" exact="Dengue" post="fever, caused by infections with the dengue virus (DENV),"/>
   <result pre="well as decrease the risk of wider outbreaks. Abstract ABSTRACT" exact="Dengue" post="fever, caused by infections with the dengue virus (DENV),"/>
   <result pre="rapid detection of NS1 antigens and the simultaneous differentiation of" exact="DENV" post="serotypes. A total of 146 serum samples obtained from"/>
   <result pre="from patients suspected to be in the acute phase of" exact="DENV" post="infection were used to evaluate the clinical application of"/>
   <result pre="sensitivity rates for serotyping were as follows: 88.2% (15/17) for" exact="DENV" post="serotype 1 (DENV1), 94.7% (18/19) for DENV2, 75% (12/16)"/>
   <result pre="stages of infection. These results indicate that our ELISA for" exact="DENV" post="NS1 is a convenient tool that may help elucidate"/>
   <result pre="a convenient tool that may help elucidate the epidemiology of" exact="DENV" post="outbreaks and facilitate the clinical management of DENV infections."/>
   <result pre="epidemiology of DENV outbreaks and facilitate the clinical management of" exact="DENV" post="infections. KEYWORDS dengue ELISA NS1 clinical diagnosis serotype typing"/>
   <result pre="and indirect) has been estimated to be $8.9 billion (7)." exact="Dengue" post="fever can be caused by any one of four"/>
   <result pre="of the onset of fever), in which the serotype of" exact="DENV" post="can be confirmed; however, these methods require special equipment"/>
   <result pre="provides a wide window for dengue virus detection (25, 29)." exact="Dengue" post="virus NS1 detection systems (ELISA and lateral flow assays)"/>
   <result pre="particular serotype of dengue virus) to create our ELISA for" exact="DENV" post="NS1 that can simultaneously detect the NS1 antigen and"/>
   <result pre="The clinical diagnostic benefits and utilities of our ELISA for" exact="DENV" post="NS1 include the identification of patients at risk of"/>
   <result pre="in areas where multiple serotypes cocirculate. As our ELISA for" exact="DENV" post="NS1 is a simple and straightforward assay that has"/>
   <result pre="(JEV) strain SA14-14-2 was propagated in BHK-21 cells, and the" exact="Zika" post="virus (ZIKV) ATCC VR 1843 strain was propagated in"/>
   <result pre="containing 2% FBS at 37°C for 2 to 3 days. (3)" exact="DENV" post="and JEV titers were determined via plaque assays in"/>
   <result pre="JEV titers were determined via plaque assays in BHK-21 cells." exact="ZIKV" post="titers were determined via plaque assays in Vero cells."/>
   <result pre="assays in Vero cells. Process of development of ELISA for" exact="DENV" post="NS1. The full details and methods of the process"/>
   <result pre="methods of the process of development of our ELISA for" exact="DENV" post="NS1 can be found in Fig. 1 and in"/>
   <result pre="the selection of MAb pairs to assemble our ELISA for" exact="DENV" post="NS1, the serotype-cross-reactive MAb that we named MAb53-1.1 was"/>
   <result pre="detection antibodies. FIG 1 Procedures in development of ELISA for" exact="DENV" post="NS1 (Dengue-type NS1 ELISA). Clinical samples. A total of"/>
   <result pre="a dengue virus-specific IgM/IgG capture ELISA, the commercially available Platelia" exact="Dengue" post="NS1 Ag ELISA kit (Bio-Rad, Marnes-la-Coquette, France), and our"/>
   <result pre="Ag ELISA kit (Bio-Rad, Marnes-la-Coquette, France), and our ELISA for" exact="DENV" post="NS1. Negative results for non-dengue viral infections were obtained"/>
   <result pre="RT-PCR, the dengue virus-specific IgM/IgG capture ELISA, and the Platelia" exact="Dengue" post="NS1 Ag ELISA. The study protocol was approved by"/>
   <result pre="rate of 0.1°C/s, during which the fluorescence was continuously read." exact="Dengue" post="virus-specific IgM/IgG capture ELISA. Each of the microplate wells"/>
   <result pre="the methods previously described by Shu et al. (38). Platelia" exact="Dengue" post="NS1 Ag ELISA. DENV NS1 proteins were detected in"/>
   <result pre="by Shu et al. (38). Platelia Dengue NS1 Ag ELISA." exact="DENV" post="NS1 proteins were detected in clinical serum samples using"/>
   <result pre="detected in clinical serum samples using the commercially available Platelia" exact="Dengue" post="NS1 Ag ELISA kit (Bio-Rad, Marnes-la-Coquette, France) in accordance"/>
   <result pre="were obtained. Testing clinical serum samples using the ELISA for" exact="DENV" post="NS1. Microwell plates were coated with 100 μl of 10-μg/ml"/>
   <result pre="50 negative serum samples were tested using our ELISA for" exact="DENV" post="NS1 by a second operator on a different day."/>
   <result pre="The sensitivity and specificity of serotyping by our ELISA for" exact="DENV" post="NS1 were compared with those of serotyping by RT-PCR."/>
   <result pre="serotyping by RT-PCR. The overall performances of our ELISA for" exact="DENV" post="NS1 and the Platelia Dengue NS1 Ag ELISA were"/>
   <result pre="performances of our ELISA for DENV NS1 and the Platelia" exact="Dengue" post="NS1 Ag ELISA were compared with the results from"/>
   <result pre="of 23 of these MAbs to the NS1 proteins of" exact="DENV" post="(5 MAbs against DENV1 NS1, 5 MAbs against DENV2"/>
   <result pre="from C6/36 cells infected with DENV. Establishment of ELISA for" exact="DENV" post="NS1. Our ELISA for DENV NS1 was established by"/>
   <result pre="DENV. Establishment of ELISA for DENV NS1. Our ELISA for" exact="DENV" post="NS1 was established by identifying the optimal MAb combinations,"/>
   <result pre="infected with DENVs) and specificity (ability to differentiate among the" exact="DENV" post="serotypes). As shown in Fig. 2, we selected four"/>
   <result pre="sensitivity and a high specificity to establish our ELISA for" exact="DENV" post="NS1. The four MAbs presenting serotype-specific reactivity to DENVs"/>
   <result pre="provided strong specificity in differentiating among the four serotypes of" exact="DENV" post="and presented no signs of reactivity with JEV or"/>
   <result pre="DENV and presented no signs of reactivity with JEV or" exact="ZIKV" post="NS1 (Fig. 3A to H). We subsequently selected MAb53-1.1"/>
   <result pre="was assessed in terms of the ability to differentiate among" exact="DENV" post="serotypes: DENV1 (MAb12-4.1), DENV2 (MAb33-7.1), DENV3 (MAb43-1.3), and DENV4"/>
   <result pre="1 Characterization of reactions between MAb and NS1 proteins of" exact="DENV" post="Hybridoma Isotype Type of epitope Reactivity of the four"/>
   <result pre="DENV Hybridoma Isotype Type of epitope Reactivity of the four" exact="DENV" post="serotypes by: Specificity Western blottinga ELISAb DENV1 DENV2 DENV3"/>
   <result pre="Vero cells infected with DENV1, DENV2, DENV3, DENV4, JEV, or" exact="ZIKV" post="were used as NS1 antigen sources, and the supernatant"/>
   <result pre="To determine the baseline detection limits of our ELISA for" exact="DENV" post="NS1, we performed 2-fold serial dilutions of immunoaffinity-purified DENV"/>
   <result pre="for DENV NS1, we performed 2-fold serial dilutions of immunoaffinity-purified" exact="DENV" post="NS1 proteins using blocking buffer, in which bovine serum"/>
   <result pre="supplemental material). The minimum detection levels of our ELISA for" exact="DENV" post="NS1 were determined to be between 1 and 4 ng/ml,"/>
   <result pre="contrast, the minimum detection levels achieved by the commercial Platelia" exact="Dengue" post="NS1 Ag ELISA, which were determined at the same"/>
   <result pre="demonstrates the superiority of our ELISA for the detection of" exact="DENV" post="NS1 in terms of sensitivity. TABLE 2 Detection limits"/>
   <result pre="terms of sensitivity. TABLE 2 Detection limits of ELISA for" exact="DENV" post="NS1 and Platelia Dengue NS1 Ag ELISAa NS1 detection"/>
   <result pre="2 Detection limits of ELISA for DENV NS1 and Platelia" exact="Dengue" post="NS1 Ag ELISAa NS1 detection assay Minimum detectable concn"/>
   <result pre="of NS1 proteins from: DENV1 DENV2 DENV3 DENV4 ELISA for" exact="DENV" post="NS1 1.953 3.906 3.906 0.977 Platelia Dengue NS1 Ag"/>
   <result pre="DENV4 ELISA for DENV NS1 1.953 3.906 3.906 0.977 Platelia" exact="Dengue" post="NS1 Ag ELISA 3.906 31.250 0.977 7.813 aThe sensitivities"/>
   <result pre="3.906 31.250 0.977 7.813 aThe sensitivities of the ELISA for" exact="DENV" post="NS1 and the commercial Platelia Dengue NS1 Ag ELISA"/>
   <result pre="of the ELISA for DENV NS1 and the commercial Platelia" exact="Dengue" post="NS1 Ag ELISA for NS1 detection were determined. The"/>
   <result pre="also evaluated the specificity and sensitivity of our ELISA for" exact="DENV" post="NS1 using clinical serum samples. The analysis involved the"/>
   <result pre="real-time RT-PCR, the dengue virus-specific IgM/IgG capture ELISA, the Platelia" exact="Dengue" post="NS1 Ag ELISA, and our ELISA for DENV NS1."/>
   <result pre="the Platelia Dengue NS1 Ag ELISA, and our ELISA for" exact="DENV" post="NS1. Following RT-PCR analysis, we found that 61 serum"/>
   <result pre="with the dengue virus-specific IgM/IgG capture ELISA and the Platelia" exact="Dengue" post="NS1 Ag ELISA, and our ELISA for DENV NS1"/>
   <result pre="the Platelia Dengue NS1 Ag ELISA, and our ELISA for" exact="DENV" post="NS1 method subsequently identified these to be positive for"/>
   <result pre="RT-PCR, the dengue virus-specific IgM/IgG capture ELISA, and the Platelia" exact="Dengue" post="NS1 Ag ELISA (Table 3). Among the 146 serum"/>
   <result pre="Platelia NS1 Ag ELISA was used, whereas our ELISA for" exact="DENV" post="NS1 identified 56 positive samples (15, 23, 12, and"/>
   <result pre="from the serotyping RT-PCR, the sensitivities of our ELISA for" exact="DENV" post="NS1 were as follows: 88.2% (15/17), 94.7% (18/19), 75%"/>
   <result pre="indicating a serotype specificity of 100%. Furthermore, our ELISA for" exact="DENV" post="NS1 correctly identified all 80 serum samples from patients"/>
   <result pre="These results clearly demonstrate the efficacy of our ELISA for" exact="DENV" post="NS1 method for the detection of DENV NS1 and"/>
   <result pre="our ELISA for DENV NS1 method for the detection of" exact="DENV" post="NS1 and its ability to discriminate among serotypes of"/>
   <result pre="DENV NS1 and its ability to discriminate among serotypes of" exact="DENV" post="in serum specimens, even during the acute phase of"/>
   <result pre="DENV in serum specimens, even during the acute phase of" exact="DENV" post="infection, as early as day 1 after the onset"/>
   <result pre="of illness (Table 3). Despite the fact that the Platelia" exact="Dengue" post="NS1 Ag ELISA and our ELISA for DENV NS1"/>
   <result pre="the Platelia Dengue NS1 Ag ELISA and our ELISA for" exact="DENV" post="NS1 achieved similar sensitivities (55 and 56 positive serum"/>
   <result pre="clinical serum samples by serotyping RT-PCR, IgM/IgG capture ELISA, Platelia" exact="Dengue" post="NS1 Ag ELISA, and ELISA for DENV NS1 Day"/>
   <result pre="capture ELISA, Platelia Dengue NS1 Ag ELISA, and ELISA for" exact="DENV" post="NS1 Day after onset of illness that serum was"/>
   <result pre="ELISAc Platelia dengue NS1 Ag ELISA (total n = 55)" exact="Dengue" post="viral infectionsd Non-dengue viral infectionse ELISA for DENV NS1"/>
   <result pre="= 55) Dengue viral infectionsd Non-dengue viral infectionse ELISA for" exact="DENV" post="NS1 (total n = 56) DENV1 DENV2 DENV3 DENV4"/>
   <result pre="using a dengue virus-specific IgM/IgG capture ELISA and the Platelia" exact="Dengue" post="NS1 Ag ELISA. dPositive results were obtained using RT-PCR"/>
   <result pre="or a dengue virus-specific IgM/IgG capture ELISA and the Platelia" exact="Dengue" post="NS1 Ag ELISA. eNegative results were obtained using RT-PCR,"/>
   <result pre="RT-PCR, a dengue virus-specific IgM/IgG capture ELISA, and the Platelia" exact="Dengue" post="NS1 Ag ELISA. TABLE 4 Performance of ELISA for"/>
   <result pre="Dengue NS1 Ag ELISA. TABLE 4 Performance of ELISA for" exact="DENV" post="NS1 and Platelia Dengue NS1 ELISA for detection of"/>
   <result pre="TABLE 4 Performance of ELISA for DENV NS1 and Platelia" exact="Dengue" post="NS1 ELISA for detection of NS1 in acute-phase sera"/>
   <result pre="serum samples No. of serum samples positive by: ELISA for" exact="DENV" post="NS1 (n = 56) Platelia Dengue NS1 Ag ELISA"/>
   <result pre="positive by: ELISA for DENV NS1 (n = 56) Platelia" exact="Dengue" post="NS1 Ag ELISA (n = 55) DENV1 D2ENV DENV3"/>
   <result pre="using a dengue virus-specific IgM/IgG capture ELISA and the Platelia" exact="Dengue" post="NS1 Ag ELISA. cNegative results were obtained using the"/>
   <result pre="RT-PCR, the dengue virus-specific IgM/IgG capture ELISA, and the Platelia" exact="Dengue" post="NS1 Ag ELISA. TABLE 5 Serotype specificity and sensitivity"/>
   <result pre="ELISA. TABLE 5 Serotype specificity and sensitivity of ELISA for" exact="DENV" post="NS1 for the detection of NS1 in acute-phase sera"/>
   <result pre="DENV NS1 for the detection of NS1 in acute-phase sera" exact="DENV" post="serotype No. of serum samples with the following results:"/>
   <result pre="6 illustrates the overall diagnostic performances of our ELISA for" exact="DENV" post="NS1 method and the Platelia Dengue NS1 Ag ELISA"/>
   <result pre="of our ELISA for DENV NS1 method and the Platelia" exact="Dengue" post="NS1 Ag ELISA (of the 146 clinical serum samples,"/>
   <result pre="were from patients with non-dengue viral infections). Our ELISA for" exact="DENV" post="NS1 achieved a diagnostic accuracy of 93.15% (95% CI,"/>
   <result pre="88.89% (95% CI, 80.51 to 94.54%). In contrast, the Platelia" exact="Dengue" post="NS1 Ag ELISA achieved a diagnostic accuracy of 92.47%"/>
   <result pre="TABLE 6 Overall diagnostic accuracy and sensitivity of ELISA for" exact="DENV" post="NS1 and Platelia dengue NS1 Ag ELISAa ELISA No."/>
   <result pre="PPV (% [95% CI]) NPV (% [95% CI]) ELISA for" exact="DENV" post="NS1 56 84.85 (73.9–92.49) 100 (95.49–100) 93.15 (87.76–96.67) 100"/>
   <result pre="Reproducibility. Clinical serum samples were retested with our ELISA for" exact="DENV" post="NS1 by a second operator on a different day."/>
   <result pre="tested a total of 57 samples that were positive for" exact="DENV" post="(16, 17, 16, and 8 samples positive for DENV1"/>
   <result pre="negative result, thereby illustrating the reproducibility of our ELISA for" exact="DENV" post="NS1. DISCUSSION Dengue virus infections range from asymptomatic or"/>
   <result pre="illustrating the reproducibility of our ELISA for DENV NS1. DISCUSSION" exact="Dengue" post="virus infections range from asymptomatic or mild to severe"/>
   <result pre="disease. The capture ELISA and the lateral flow assay for" exact="DENV" post="NS1 are easy to use, highly specific, and inexpensive,"/>
   <result pre="paired with a DENV-cross-reactive MAb to enable the detection of" exact="DENV" post="NS1. The use of multiplexed fluorescent microsphere beads, however,"/>
   <result pre="of the four serotype-specific MAbs-HRP to create our ELISA for" exact="DENV" post="NS1. As a result, we established a serotyping assay"/>
   <result pre="study are outlined in the following. (i) Our ELISA for" exact="DENV" post="NS1 was sensitive, with the lowest detectable concentration of"/>
   <result pre="4 ng/ml. (ii) The assay was specific, as our ELISA for" exact="DENV" post="NS1 was able to discriminate the four dengue virus"/>
   <result pre="mutual cross-reactivity and no cross-reactivity with Japanese encephalitis virus or" exact="Zika" post="virus (determined using supernatants of Vero cell cultures infected"/>
   <result pre="virus (determined using supernatants of Vero cell cultures infected with" exact="DENV" post="serotypes 1 to 4, JEV, and ZIKV). (iii) We"/>
   <result pre="We evaluated the sensitivity and accuracy of our ELISA for" exact="DENV" post="NS1 by applying it to clinical serum samples from"/>
   <result pre="DENV1 to DENV4, respectively. In other words, our ELISA for" exact="DENV" post="NS1 was able to identify the specific serotype of"/>
   <result pre="positive following analysis by the dengue IgM/IgG test and Platelia" exact="Dengue" post="NS1 Ag ELISA kit. Our ELISA for DENV NS1"/>
   <result pre="and Platelia Dengue NS1 Ag ELISA kit. Our ELISA for" exact="DENV" post="NS1 then determined that all five of these samples"/>
   <result pre="cross-reactivity with the NS1 proteins of Japanese encephalitis virus or" exact="Zika" post="virus derived from the supernatant from cells in culture,"/>
   <result pre="with viruses other than DENV, such as Japanese encephalitis virus," exact="Zika" post="virus, or West Nile virus. At present, there are"/>
   <result pre="than DENV, such as Japanese encephalitis virus, Zika virus, or" exact="West Nile" post="virus. At present, there are no West Nile cases"/>
   <result pre="virus, or West Nile virus. At present, there are no" exact="West Nile" post="cases and only a few imported Zika cases in"/>
   <result pre="are no West Nile cases and only a few imported" exact="Zika" post="cases in Taiwan. This is a limitation of our"/>
   <result pre="is a limitation of our study. Moreover, our ELISA for" exact="DENV" post="NS1 could be a tool to determine the number"/>
   <result pre="be a tool to determine the number and identity of" exact="DENV" post="serotypes during situations of DENV coinfection. In Taiwan, there"/>
   <result pre="the number and identity of DENV serotypes during situations of" exact="DENV" post="coinfection. In Taiwan, there have been reports of local"/>
   <result pre="local dengue outbreaks caused by different serotypes and genotypes of" exact="DENV" post="as well as by the cocirculation of more than"/>
   <result pre="as well as by the cocirculation of more than one" exact="DENV" post="serotype at any given time (43–46). The Centers for"/>
   <result pre="region, which is ideally suited to the spread of different" exact="DENV" post="serotypes brought in by travelers returning from regions in"/>
   <result pre="serotype only partially neutralize other serotypes. In fact, an initial" exact="DENV" post="infection increases the likelihood that a second DENV infection"/>
   <result pre="an initial DENV infection increases the likelihood that a second" exact="DENV" post="infection with another serotype will develop into severe disease"/>
   <result pre="It is worth noting that the chance of a second" exact="DENV" post="infection developing into severe dengue disease is also associated"/>
   <result pre="typically presents the greatest danger. Interestingly, a third or fourth" exact="DENV" post="infection usually presents as only a mild or asymptomatic"/>
   <result pre="in regions with limited resources are difficult. Our ELISA for" exact="DENV" post="NS1 is capable of detecting DENV NS1 antigens rapidly"/>
   <result pre="difficult. Our ELISA for DENV NS1 is capable of detecting" exact="DENV" post="NS1 antigens rapidly in the early stage and identifying"/>
   <result pre="commercial NS1 diagnostic tests. We believe that our ELISA for" exact="DENV" post="NS1 could be especially beneficial in regions where medical"/>
   <result pre="severe dengue disease. Finally, the implementation of our ELISA for" exact="DENV" post="NS1 could improve epidemiological surveillance, outbreak monitoring, clinical management,"/>
   <result pre="history. Trends Microbiol22:138–146. doi:10.1016/j.tim.2013.12.011.24468533 15.YamashitaA, SakamotoT, SekizukaT, KatoK, TakasakiT, KurodaM2016DGV:" exact="Dengue" post="Genographic Viewer. Front Microbiol7:75. doi:10.3389/fmicb.2016.00875.26925032 16.GuzmanMG, HalsteadSB, ArtsobH, BuchyP,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6608929\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and life sciences : Organisms :"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and life sciences : Organisms :"/>
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus Contrasting the value of targeted versus area-wide mosquito"/>
   <result pre="Juan, Recife, and Jakarta) that have recently been exposed to" exact="Zika" post="and/or dengue infections and consider whether the distribution of"/>
   <result pre="and prevention of Aedes-transmitted viruses, such as dengue, chikungunya, or" exact="Zika" post="relies heavily on vector control approaches. Given the effort"/>
   <result pre="costs associated with those efforts. In the case of dengue," exact="Zika" post="or chikungunya, such transmission clusters likely emerge from the"/>
   <result pre="vector control implementation scenarios using a simplified spatial model of" exact="Zika" post="transmission by Ae. aegypti. Despite their simplifications, patch-based models"/>
   <result pre="locations where Ae. aegypti has or could potentially lead to" exact="Zika" post="epidemics. Methods Model description We developed a discrete, stochastic"/>
   <result pre="a reasonable assumption for arboviruses such as dengue, chikungunya, or" exact="Zika" post="viruses, transmitted by Aedes aegypti in many urban tropical"/>
   <result pre="urban tropical areas [30]. The model parameterization is based on" exact="Zika" post="virus (S1 Table). The human (host) and mosquito (vector)"/>
   <result pre="configuration of the model on three areas where dengue and/or" exact="Zika" post="virus epidemics have been known to occur in recent"/>
   <result pre="to an extent. The implications of varying the trigger for" exact="Zika" post="control has been investigated recently [48]. Although costs are"/>
   <result pre="Colombia. Journal of Theoretical Biology. 2018;453:14–39. 10.1016/j.jtbi.2018.05.01529775680 25OoiE, GohK, GublerD." exact="Dengue" post="prevention and 35 years of vector control in Singapore."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6610691\results\search\tropicalVirus\results.xml">
   <result pre="for some arboviruses, the most clinically relevant neurotropic flaviviruses include" exact="Dengue" post="virus and Zika virus. Flaviviruses cause diseases ranging from"/>
   <result pre="the most clinically relevant neurotropic flaviviruses include Dengue virus and" exact="Zika" post="virus. Flaviviruses cause diseases ranging from mild or sub-clinical"/>
   <result pre="cerebrospinal fluid children dengue virus flavivirus Saint Louis encephalitis virus" exact="Zika" post="virus Introduction Aseptic meningoencephalitis is an important cause of"/>
   <result pre="transmitted by mosquitoes and classically classified as neurotropic viruses, including" exact="West Nile" post="virus (WNV) and Saint Louis encephalitis virus (SLEV) [4]."/>
   <result pre="However, in recent years, other members of this genus, primarily" exact="Dengue" post="virus (DENV) and Zika virus (ZIKV), have been associated"/>
   <result pre="other members of this genus, primarily Dengue virus (DENV) and" exact="Zika" post="virus (ZIKV), have been associated with CNS infections [4],"/>
   <result pre="[6]. In Brazil, flaviviruses considered neurotropic agents, such as as" exact="WNV" post="and Rocio virus, have been described as circulating but"/>
   <result pre="in children [7], [8]. Some other potential neurotropic flaviviruses, including" exact="DENV" post="and ZIKV, circulate in epidemics; however, there are few"/>
   <result pre="primarily through the bite of infected mosquitoes. Some flaviviruses, including" exact="ZIKV" post="and DENV, have two distinct transmission cycles: an enzootic,"/>
   <result pre="urban cycle, between humans and peridomestic/domestic Aedes spp. [9]. Both" exact="WNV" post="and SLEV are transmitted to humans and other mammals"/>
   <result pre="they generally do not generate sufficient viraemia to infect mosquitoes." exact="WNV" post="can also be transmitted between humans via organ transplants,"/>
   <result pre="and infectious maternal milk [11]. Some findings have suggested that" exact="ZIKV" post="can be transmitted from mother to fetus during pregnancy"/>
   <result pre="to cross the placental barrier was also previously suggested for" exact="WNV" post="[13]. However, the mechanism by which these viruses cross"/>
   <result pre="barrier remains unclear. Flaviviruses as aetiological agents of CNS infections" exact="Dengue" post="virus Dengue virus causes high morbidity and mortality in"/>
   <result pre="unclear. Flaviviruses as aetiological agents of CNS infections Dengue virus" exact="Dengue" post="virus causes high morbidity and mortality in children living"/>
   <result pre="Brazil and, up to October, 203 157 probable cases of" exact="DENV" post="infection had been notified in 2018 [15]. The number"/>
   <result pre="in Minas Gerais State, Brazil and analysed cerebrospinal fluid (CSF);" exact="DENV" post="RNA was detected in approximately 6% (unpublished data). Viruses"/>
   <result pre="CNS infections in Brazil. Few studies in Brazil have related" exact="DENV" post="to CNS infections in children. Marinho et al.[17] (Table"/>
   <result pre="children. Marinho et al.[17] (Table 1) reported seven cases where" exact="DENV" post="RNA was found in CSF samples from children with"/>
   <result pre="using samples from 70 children from the same hospital detected" exact="DENV" post="by PCR or CSF serology in 11.7% of cases"/>
   <result pre="in Ceará State from 2005–2008 found three children positive for" exact="DENV" post="in CSF by serological tests [19]. Other studies in"/>
   <result pre="and Espírito Santo [21] analysed samples from individuals with suspected" exact="DENV" post="infection. The study carried out in Rio de Janeiro"/>
   <result pre="Santo State, Domingues et al. described two children infected with" exact="DENV" post="and with CNS involvement. In both cases, DENV-3 serotype"/>
   <result pre="Virus Number of cases Viral diagnosis CNS manifestation State References" exact="Dengue" post="virus 1 serological encephalitis Rio de Janeiro Soares et"/>
   <result pre="3 PCR meningoencephalitis São Paulo Mondini et al. 2007 [32]" exact="Zika" post="virus 1 PCR encephalitis — Silva Vieira et al."/>
   <result pre="a study carried out in the Amazon region looking for" exact="DENV" post="in CSF samples found five children positive for DENV"/>
   <result pre="for DENV in CSF samples found five children positive for" exact="DENV" post="by serology or PCR and diagnosed with meningitis/encephalitis. All"/>
   <result pre="All children presented cytological CSF characteristic of viral meningoencephalitis [23]." exact="Zika" post="virus The circulation of ZIKV has been described in"/>
   <result pre="characteristic of viral meningoencephalitis [23]. Zika virus The circulation of" exact="ZIKV" post="has been described in Brazil since 2015 [24] and"/>
   <result pre="cases in 2018 [15]. Infections of the CNS related to" exact="ZIKV" post="have been described, not only in fetuses [4], [6],"/>
   <result pre="of encephalitis has been described in an 8-year-old child with" exact="ZIKV" post="infection and reactivation of varicella zoster virus. All CSF"/>
   <result pre="CSF parameters were normal and this sample was positive for" exact="ZIKV" post="by PCR [26]. In our study with 299 CSF"/>
   <result pre="3% of CSF samples from children with suspected meningoencephalitis were" exact="ZIKV" post="positive by PCR. Although studies have primarily focused on"/>
   <result pre="outbreak in 2006, 54 serum samples that were negative for" exact="DENV" post="and Yellow fever virus were analysed and SLEV was"/>
   <result pre="2006, 54 serum samples that were negative for DENV and" exact="Yellow fever" post="virus were analysed and SLEV was found in three"/>
   <result pre="Petersen et al.[33] reviewed some of the potential pathways for" exact="WNV" post="entry into the CNS, including direct infection of the"/>
   <result pre="be toxic to neurons [34], [36]. Souza et al.[37] studying" exact="DENV" post="3 neurovirulence in mice found that increased levels of"/>
   <result pre="50% of patients, particularly children [11]. Neurological manifestations associated with" exact="DENV" post="and ZIKV were recently reviewed by Li et al.[14]."/>
   <result pre="patients, particularly children [11]. Neurological manifestations associated with DENV and" exact="ZIKV" post="were recently reviewed by Li et al.[14]. The neurological"/>
   <result pre="al.[20] had 57% of the cases of meningitis caused by" exact="DENV" post="with normal chemocytological CSF. Other studies also found positivity"/>
   <result pre="with normal chemocytological CSF. Other studies also found positivity for" exact="DENV" post="and SLEV without changes in CSF [17], [18], [21],"/>
   <result pre="urine and saliva have been used to detect flaviviruses, including" exact="ZIKV" post="and WNV. This sample collection is non-invasive and may"/>
   <result pre="surveillance and research involving infants and young children [38]. Further," exact="ZIKV" post="RNA has been detected in urine at higher levels"/>
   <result pre="Infect Dis Rep15201357658224136412 11GouldE.A.SolomonT.Pathogenic flavivirusesLancet371200850050918262042 12CalvetG.AguiarR.S.MeloA.S.O.SampaioS.A.de FilippisI.FabriA.Detection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
   <result pre="in Brazil: a case studyLancet Infect Dis16201665366026897108 13O'LearyD.R.KuhnS.KnissK.L.HinckleyA.F.RasmussenS.A.PapeW.J.Birth outcomes following" exact="West Nile" post="Virus infection of pregnant women in the United States:"/>
   <result pre="RegionMem Inst Oswaldo Cruz1142018e180450 24ZanlucaC.MeloV.C.MosimannA.L.SantosG.I.SantosC.N.LuzK.First report of autochthonous transmission of" exact="Zika" post="virus in BrazilMem Inst Oswaldo Cruz110201556957226061233 25da SilvaI.R.F.FronteraJ.A.Bispo de"/>
   <result pre="the zika virus in Brazilian adultsJAMA Neurol7420171190119828806453 26VieiraM.A.D.C.CastroA.A.S.HenriquesD.F.SilvaE.V.P.D.TavaresF.N.MartinsL.C.Encephalitis associated with" exact="Zika" post="virus infection and reactivation of the varicella-zoster virus in"/>
   <result pre="Toxin. Incl Trop Dis2020149 30Pauvolid-CorrêaA.CamposZ.JulianoR.VelezJ.NogueiraR.M.KomarN.Serological evidence of widespread circulation of" exact="West Nile" post="virus and other flaviviruses in equines of the Pantanal,"/>
   <result pre="in children with acquired zika virus infectionPediatr Neurol852018162030343688 39GourinatA.C.O'ConnorO.CalvezE.GoarantC.Dupont-RouzeyrolM.Detection of" exact="Zika" post="virus in urineEmerg Infect Dis212015848625530324 40BhoiS.K.NaikS.KumarS.PhadkeR.V.KalitaJ.MisraU.K.Cranial imaging findings in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6611972\results\search\tropicalVirus\results.xml">
   <result pre="annulirostris dengue virus French Polynesia mosquito vectors Ross River virus" exact="Zika" post="virus French Polynesia (FP) is a French overseas territory"/>
   <result pre="Islands. Several arthropod-borne viruses (arboviruses) have been described in FP." exact="Dengue" post="virus (DENV) has been circulating in FP since the"/>
   <result pre="clinical descriptions of epidemics mentioned in old written works [1]." exact="Zika" post="virus (ZIKV) and chikungunya virus (CHIKV) were introduced in"/>
   <result pre="the presence of competent mosquito vectors. Vector-borne transmission of DENV," exact="ZIKV" post="and CHIKV in FP Two diurnal species belonging to"/>
   <result pre="of competent mosquito vectors. Vector-borne transmission of DENV, ZIKV and" exact="CHIKV" post="in FP Two diurnal species belonging to the genus"/>
   <result pre="Aedes, sub-genus Stegomyia, are incriminated in the transmission of DENV," exact="ZIKV" post="and CHIKV in FP: the indigenous Aedes polynesiensis and"/>
   <result pre="Stegomyia, are incriminated in the transmission of DENV, ZIKV and" exact="CHIKV" post="in FP: the indigenous Aedes polynesiensis and the worldwide"/>
   <result pre="population to transmit the virus [9], [10], [19]. For example," exact="ZIKV" post="isolates collected from the explosive outbreaks that occurred from"/>
   <result pre="in mosquitoes [19]. This may have facilitated the spread of" exact="ZIKV" post="during the outbreak in FP. There is worldwide disagreement"/>
   <result pre="potential ability of the mosquito species Culex quinquefasciatus to transmit" exact="DENV" post="and ZIKV [20], [21]. Although no investigation with any"/>
   <result pre="of the mosquito species Culex quinquefasciatus to transmit DENV and" exact="ZIKV" post="[20], [21]. Although no investigation with any FP population"/>
   <result pre="the ability of Culex species from various countries to transmit" exact="DENV" post="or ZIKV, and the unexpected slowness of ZIKV dissemination"/>
   <result pre="to transmit DENV or ZIKV, and the unexpected slowness of" exact="ZIKV" post="dissemination in experiments conducted in laboratory conditions on Aedes"/>
   <result pre="population of the species was demonstrated to be susceptible to" exact="CHIKV" post="[40]. Recently, experimental infections in wild-caught American mosquitoes showed"/>
   <result pre="in wild-caught American mosquitoes showed moderate to high susceptibility to" exact="ZIKV" post="and low ability to transmit the virus [41], [42]."/>
   <result pre="of the mosquito to become infected and to transmit DENV," exact="CHIKV" post="and ZIKV [44], [46]. In the same manner, replacement"/>
   <result pre="mosquito to become infected and to transmit DENV, CHIKV and" exact="ZIKV" post="[44], [46]. In the same manner, replacement in A."/>
   <result pre="been shown to reduce the susceptibility of the vector for" exact="DENV" post="infection [46]. Another strategy consists of releasing only Wolbachia-modified"/>
   <result pre="may transmit Japanese encephalitis virus [51] and, with A. vexans," exact="West Nile" post="virus [43], [52]. Aedes aegypti is a vector of"/>
   <result pre="control using a Wolbachia-based autocidal strategyParasit Vectors520128022531297 19LiuY.LiuJ.DuS.ShanC.NieK.ZhangR.Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoesNature545201748248628514450 20EpelboinY.TalagaS.EpelboinL.DusfourI.Zika virus: an"/>
   <result pre="J Trop Med Hyg60199931932110072159 22RichardV.PaoaafaiteT.Cao-LormeauV.M.Acquittal of Culex quinquefasciatus in transmitting" exact="Zika" post="virus during the French Polynesian outbreakActa Tropica173201720020128476603 23KnechtH.RichardsS.L.BalanayJ.A.G.WhiteA.V.Impact of"/>
   <result pre="factors influencing Culex pipiens quinquefasciatus (Diptera: Culicidae) vector competence for" exact="West Nile" post="VirusAm J Trop Med Hyg83201012613420595491 25KramerL.D.EbelG.D.Dynamics of flavivirus infection"/>
   <result pre="a Northern Population of Aedes vexans (Diptera: Culicidae) to transmit" exact="Zika" post="virusJ Med Entomol5420171354135928499036 43TurellM.J.DohmD.J.SardelisM.R.OguinnM.L.AndreadisT.G.BlowJ.A.An update on the potential of"/>
   <result pre="the potential of north American mosquitoes (Diptera: Culicidae) to transmit" exact="West Nile" post="VirusJ Med Entomol422005576215691009 44FloresH.A.O'NeillS.L.Controlling vector-borne diseases by releasing modified"/>
   <result pre="Australian mosquito species in the transmission of endemic and exotic" exact="West Nile" post="virus strainsInt J Environ Res Public Health1020133735375223965926 53KlittingR.GouldE.A.PaupyC.de LamballerieX.What"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6612077\results\search\tropicalVirus\results.xml">
   <result pre="CentralLondon pmcid: 66120774226 doi: 10.1186/s12879-019-4226-6 : Research Article Prevalence of" exact="Zika" post="virus in blood donations: a systematic review and meta-analysis"/>
   <result pre="available in this article, unless otherwise stated. Abstract Background Transfusion-Transmitted" exact="Zika" post="virus (TT-ZIKV) has become an emerging threat to world"/>
   <result pre="to world blood banks due to the fast spread of" exact="ZIKV" post="epidemics and high rate of asymptomatic infections. For the"/>
   <result pre="high rate of asymptomatic infections. For the risk assessment of" exact="ZIKV" post="infection in blood products, relevant studies in blood donations"/>
   <result pre="relevant studies in blood donations or blood donors tested for" exact="ZIKV" post="were collected and analyzed systematically. The overall prevalence of"/>
   <result pre="ZIKV were collected and analyzed systematically. The overall prevalence of" exact="ZIKV" post="infection were estimated through meta-analysis and potential risk factors"/>
   <result pre="blood screening tests. Methods Relevant articles about the rate of" exact="ZIKV" post="detected in blood samples were identified from PubMed, Scopus"/>
   <result pre="samples) were included for meta-analysis. The overall pooled prevalence of" exact="ZIKV" post="(RNA and antibody) in blood donations was 1.02% (95%CI"/>
   <result pre="blood donations was 1.02% (95%CI 0.36–1.99). The pooled prevalence of" exact="ZIKV" post="RNA in blood donations was 0.85% (95%CI 0.21–1.88) less"/>
   <result pre="were more than two times likely to be infected by" exact="ZIKV" post="in Zika epidemic period (1.37, 95%CI 0.91–1.91) than in"/>
   <result pre="than two times likely to be infected by ZIKV in" exact="Zika" post="epidemic period (1.37, 95%CI 0.91–1.91) than in non-epidemic period"/>
   <result pre="antibodies (1.61, 95%CI 0.03–5.21) was almost twice as much as" exact="ZIKV" post="nucleic acid detected in blood donations (0.85, 95%CI 0.21–1.88)."/>
   <result pre="statistically significant differences were not observed. A total of 122" exact="ZIKV" post="positive blood donors were followed, of which 48 (39%)"/>
   <result pre="the 13 followed recipients reported any clinical symptoms related to" exact="Zika" post="infection posttransfusion. Conclusion The pooled prevalence of Zika infection"/>
   <result pre="related to Zika infection posttransfusion. Conclusion The pooled prevalence of" exact="Zika" post="infection in blood donations was 1.02%. The prevalence varied"/>
   <result pre="contains supplementary material, which is available to authorized users. Keywords" exact="Zika" post="virus (ZIKV) Blood donors/donations Blood screening tests Funding the"/>
   <result pre="China 31872499 Background As a zoonotic pathogens and reemerging arbovirus," exact="Zika" post="virus (ZIKV) has caught extensive attention since its outbreak"/>
   <result pre="caught extensive attention since its outbreak in Brazil 2015 [1]." exact="ZIKV" post="belongs to the genus Flavivirus, family Flaviviridae. It shares"/>
   <result pre="members such as dengue virus (DENV), yellow fever virus (YFV)," exact="West Nile" post="virus (WNV) and Japanese encephalitis virus (JEV) [2]. Approximately"/>
   <result pre="(WNV) and Japanese encephalitis virus (JEV) [2]. Approximately 80% of" exact="Zika" post="infections are asymptomatic [3, 4], the remainder usually develop"/>
   <result pre="fever, rash, arthralgia, myalgia, conjunctivitis and headache [5]. Nevertheless, sometimes" exact="ZIKV" post="infection can lead to much severer neurological complications, such"/>
   <result pre="Syndrome in adults [6, 7] and microcephaly in neonates [8]." exact="ZIKV" post="is transmitted to humans mainly through Aedes mosquitoes bite,"/>
   <result pre="activities, maternal-fetal pathway, physical contact and blood transfusion [3, 9]." exact="ZIKV" post="RNA has been detected in blood, semen, saliva, urine"/>
   <result pre="urine and other biofluids samples, but the viremia period of" exact="ZIKV" post="is not definite. It was estimated that the median"/>
   <result pre="the virus was detectable in blood for 9.9 days [10]. Notably," exact="ZIKV" post="RNA can persist in serum up to 54 days in"/>
   <result pre="infectors in viremia period can be a nonnegligible source of" exact="ZIKV" post="transmission and largely increase the risk that blood donations"/>
   <result pre="import of blood from low-risk regions; screening blood donations by" exact="ZIKV" post="NAT (Nucleic Acid Tests) and/or treating them with PRT"/>
   <result pre="PRT (Pathogen Reduction/inactivation Technology). On March 30, 2016, the first" exact="ZIKV" post="NAT assay for blood screening was permitted by FDA"/>
   <result pre="However, there are opposite attitudes towards mandating routine screening of" exact="ZIKV" post="in blood collections because it is time-consuming and costly."/>
   <result pre="time-consuming and costly. Some consider that the TT risk of" exact="Zika" post="in their country is low [15, 16], and there"/>
   <result pre="urgent need to introduce universal screening of donated blood for" exact="ZIKV" post="[17]. On the other hand, some studies mentioned that"/>
   <result pre="present measures were not effective enough to prevent transfusion of" exact="ZIKV" post="RNA-reactive blood products, and ZIKV NAT should be used"/>
   <result pre="enough to prevent transfusion of ZIKV RNA-reactive blood products, and" exact="ZIKV" post="NAT should be used [18, 19]. Their attitudes varied"/>
   <result pre="Their attitudes varied greatly depend on the prevalence rate of" exact="ZIKV" post="considered as low or high by different public health"/>
   <result pre="in different areas, but the cut-off value hasn’t been revealed." exact="ZIKV" post="TT risk modeling is not yet available to date"/>
   <result pre="to the absence of critical parameters [20] and US FDA" exact="Zika" post="guidance remained to be evaluated by a formal risk"/>
   <result pre="factors, but the foremost factor is the infection rate of" exact="ZIKV" post="in blood components, which should be a topic for"/>
   <result pre="first systematic review and meta-analysis to assess the prevalence of" exact="ZIKV" post="in blood donors or blood donations and find out"/>
   <result pre="eligible for next inspection as long as the survey of" exact="ZIKV" post="or arboviruses in human blood samples was mentioned in"/>
   <result pre="we went full-text screening and included studies that focused on" exact="ZIKV" post="infection in blood donors or donations. The detection of"/>
   <result pre="ZIKV infection in blood donors or donations. The detection of" exact="ZIKV" post="was confirmed by molecular or serological methods with RNA"/>
   <result pre="the time is during local Zika-epidemic), study area, number of" exact="ZIKV" post="infected samples (Event), total number of samples tested (Number),"/>
   <result pre="high quality = 8–11. Statistical analysis The proportion of samples infected with" exact="ZIKV" post="in each study was combined to give a pooled"/>
   <result pre="each study was combined to give a pooled prevalence of" exact="ZIKV" post="in blood donations. All analyses were performed with R"/>
   <result pre="2 largest blood centers 4 monthsa Puerto Rico 190 21,468 Cobas" exact="Zika" post="ID-NAT NM 7 p3 Gake2015 blood donors from six"/>
   <result pre="laboratories 2 months several states of United State 5 466,834 Procleix" exact="ZIKV" post="assay, RT-PCR, CDC IgM/IgG-ELISA 102 IU 7 p5 Borena2016 blood"/>
   <result pre="p6 Gallian2016 consecutive blood donations 5 monthsa Martinique 76 4129 RealStar" exact="Zika" post="virus RT-PCR Kit_1.1 2.1–6.5log10 copies/ml 6 p7 Slavov2016 volunteer"/>
   <result pre="Kuehnert2016 screened blood donations 2 monthsa Puerto Rico 68 12,777 Cobas" exact="Zika" post="NAT assay NM 4 p9 Adams2016 screened blood donations"/>
   <result pre="Adams2016 screened blood donations 3 monthsa Puerto Rico 143 18,163 Cobas" exact="Zika" post="NAT assay NM 4 p10 Aubry2013 volunteer blood donors"/>
   <result pre="ELISA NM 5 Note: aepidemic: the study period is during" exact="Zika" post="epidemic period NM not mentioned Of the 10 included"/>
   <result pre="(Cameroon):1 study. As to the detection methods, 7 studies detected" exact="ZIKV" post="RNA and 2 studies detected anti-ZIKV antibodies. One research"/>
   <result pre="moderate quality (mean score 5.4) (Table 1). Overall prevalence of" exact="Zika" post="virus in blood donations A total of 528,947 blood"/>
   <result pre="blood samples were tested in 10 literatures, the prevalence of" exact="Zika" post="virus in blood donations range from 0 to 4.89%,"/>
   <result pre="virus in blood donations range from 0 to 4.89%, and" exact="ZIKV" post="RNA detection rate range from 0 to 2.79%, ZIKV"/>
   <result pre="and ZIKV RNA detection rate range from 0 to 2.79%," exact="ZIKV" post="antibody seroprevalence range from 0.40 to 4.89%. All studies"/>
   <result pre="model was used to estimate the overall pooled prevalence of" exact="ZIKV" post="(RNA and antibody) in blood donations as 1.02% (95%CI"/>
   <result pre="2). Fig. 2 Forest plot of the pooled prevalence of" exact="ZIKV" post="in blood donations Prevalence of Zika virus in blood"/>
   <result pre="the pooled prevalence of ZIKV in blood donations Prevalence of" exact="Zika" post="virus in blood donations in different conditions As to"/>
   <result pre="it would be hard to deduce the prevalence trend of" exact="ZIKV" post="in recent years. But since the prevalence of Zika"/>
   <result pre="of ZIKV in recent years. But since the prevalence of" exact="Zika" post="virus in blood is presumably influenced by local endemic"/>
   <result pre="is identified in those studies: study conducted in areas where" exact="ZIKV" post="infection cases have been reported long ago but no"/>
   <result pre="cases have been reported (p5); and study collected samples before" exact="ZIKV" post="emergence (p10). Six studies (p1,p2,p6,p7,p8,p9) were performed when Zika"/>
   <result pre="before ZIKV emergence (p10). Six studies (p1,p2,p6,p7,p8,p9) were performed when" exact="Zika" post="is circulating and the pooled prevalence of Zika virus"/>
   <result pre="performed when Zika is circulating and the pooled prevalence of" exact="Zika" post="virus in blood donations was 1.37% (95%CI 0.91–1.91). Five"/>
   <result pre="in Asia. Stratified by detection method, the pooled prevalence of" exact="ZIKV" post="RNA in blood donations was 0.85% (95%CI 0.21–1.88) less"/>
   <result pre="of follow-ups In all included studies, a total of 122" exact="ZIKV" post="reactive blood donors were followed in three studies (p1:42,"/>
   <result pre="(p1, p4) have traced down to the recipients to whom" exact="ZIKV" post="reactive blood donations were transfused. Overall, among the 13"/>
   <result pre="(p1). None of recipients reported any clinical symptoms consistent with" exact="ZIKV" post="infection within 2 months of posttransfusion. Discussion Flavivirus transmission through"/>
   <result pre="Discussion Flavivirus transmission through blood transfusion has been recorded for" exact="Dengue" post="virus [33], West Nile virus [34], Yellow Fever vaccine"/>
   <result pre="through blood transfusion has been recorded for Dengue virus [33]," exact="West Nile" post="virus [34], Yellow Fever vaccine virus [35] and Zika"/>
   <result pre="West Nile virus [34], Yellow Fever vaccine virus [35] and" exact="Zika" post="virus [9, 36]. The major challenges in preventing transfusion-associated"/>
   <result pre="[9, 36]. The major challenges in preventing transfusion-associated transmission of" exact="ZIKV" post="are the high rate of asymptomatic infections and the"/>
   <result pre="a great threat to blood supply system with viremia of" exact="Zika" post="virus reaching to a high level exceeding 108copies/mL [27]."/>
   <result pre="high level exceeding 108copies/mL [27]. Therefore, an extensive investigation of" exact="ZIKV" post="prevalence in blood donations is quite essential to provide"/>
   <result pre="transfusion. Through this meta-analysis, we concluded the overall prevalence of" exact="ZIKV" post="in blood donations was 1.02%, which is higher than"/>
   <result pre="ZIKV in blood donations was 1.02%, which is higher than" exact="DENV" post="RNA (around 0.19% [38]~ 0.4% [39]) and CHIKV RNA (0.36–0.42%"/>
   <result pre="is higher than DENV RNA (around 0.19% [38]~ 0.4% [39]) and" exact="CHIKV" post="RNA (0.36–0.42% [40]) detected in blood donors, and much"/>
   <result pre="in terms of threats to US transfusion recipient safety [42]." exact="Zika" post="virus should also be classified as high-risk agent according"/>
   <result pre="its possible permanent neurological damage. Routine nucleic acid testing for" exact="WNV" post="was performed for all US donations in 2003 and"/>
   <result pre="for all US donations in 2003 and prevented thousands of" exact="WNV" post="transfusion-transmissions, more than 27 million donations were tested during"/>
   <result pre="27 million donations were tested during transmission periods with 1576" exact="WNV" post="RNA-positive donations identified [43], which is much lower than"/>
   <result pre="identified [43], which is much lower than the rate of" exact="ZIKV" post="prevalence in blood donations we summarized here. The virus"/>
   <result pre="in blood donations we summarized here. The virus load of" exact="ZIKV" post="in blood donations in included studies ranged from 102~107"/>
   <result pre="excluding vectorial transmission, the virus load is much higher than" exact="WNV" post="screened in blood donations [43]. Thus, since routine blood"/>
   <result pre="since routine blood screening test was already implemented for WNV," exact="ZIKV" post="should also be taken into consideration, especially in ZIKV-endemic"/>
   <result pre="(1.61%) in blood donation was almost twice as much as" exact="ZIKV" post="RNA prevalence (0.85%), this may due to antibodies can"/>
   <result pre="represent recent infections. On the contrary, a mere absence of" exact="ZIKV" post="nucleic acid in blood samples does not absolutely rule"/>
   <result pre="not absolutely rule out the existence of virus. So, both" exact="ZIKV" post="RNA and antibodies in blood donations implied risks in"/>
   <result pre="supply system. Here we calculated the overall pooled prevalence of" exact="ZIKV" post="including both ZIKV RNA and antibody, and then computed"/>
   <result pre="we calculated the overall pooled prevalence of ZIKV including both" exact="ZIKV" post="RNA and antibody, and then computed separately within each"/>
   <result pre="limited amount of studies in antibody detection. The prevalence of" exact="ZIKV" post="in blood donations during epidemic period (1.37%) was more"/>
   <result pre="infected because of the donors may have travel history to" exact="ZIKV" post="endemic areas, and get infected without notice before donation."/>
   <result pre="and get infected without notice before donation. Another possibility that" exact="ZIKV" post="has already transmitted into the study areas where are"/>
   <result pre="conducted in non-epidemic period, and three of them were detected" exact="ZIKV" post="antibodies. So, it’s also a possibility that false-positive results"/>
   <result pre="result shows that South America has the highest prevalence of" exact="ZIKV" post="in blood donations (2.17%), which is consistent with the"/>
   <result pre="donations (2.17%), which is consistent with the geographic distribution of" exact="Zika" post="infection [45, 46] and Brazil contributed most of the"/>
   <result pre="which can be attributed to the sporadic circulation history of" exact="Zika" post="in Africa [45]. Because of the high volume of"/>
   <result pre="to remote areas, as well as quickly-spread and large-scale of" exact="Zika" post="virus epidemics, it is not practical to import blood"/>
   <result pre="needed to guard blood supply safety. The existing blood donor-screening" exact="ZIKV" post="NAT assays demonstrate excellent sensitivity [47] and effectiveness. The"/>
   <result pre="assays demonstrate excellent sensitivity [47] and effectiveness. The risk of" exact="ZIKV" post="TT infection can be reduced greatly of 29% by"/>
   <result pre="that amustaline/glutathione treatment for red blood cells can effectively inactivate" exact="Zika" post="[48], Dengue [49] and Chikungunya virus [50], and other"/>
   <result pre="treatment for red blood cells can effectively inactivate Zika [48]," exact="Dengue" post="[49] and Chikungunya virus [50], and other methods aimed"/>
   <result pre="blood cells can effectively inactivate Zika [48], Dengue [49] and" exact="Chikungunya" post="virus [50], and other methods aimed at red blood"/>
   <result pre="Blood donations NAT screening and PRT were strongly suggested in" exact="Zika" post="virus-endemic areas. Given 39% of asymptomatic donors showed symptoms"/>
   <result pre="sanitary conditions and most importantly, the method used to detect" exact="ZIKV" post="infection and the diagnostic cutoffs adopted. In addition, the"/>
   <result pre="detailed subgroup analyses, we believe that the pooled prevalence of" exact="ZIKV" post="in blood donations calculated in this study are of"/>
   <result pre="(plasma, platelet, red cell and whole blood). With attention on" exact="ZIKV" post="increases, more research data are expected in the future"/>
   <result pre="intensive research. Conclusions Based on this meta-analysis, the prevalence of" exact="Zika" post="infection in blood donations is at high-risk level of"/>
   <result pre="areas. NAT blood screening tests and PRT are recommended in" exact="Zika" post="virus-endemic regions and appropriate strategies should be made according"/>
   <result pre="file 1: Figure S1. Forest plot of the prevalence of" exact="ZIKV" post="in blood donations in different epidemic situations of Zika."/>
   <result pre="file 2: Figure S2. Forest plot of the prevalence of" exact="ZIKV" post="in blood donations in different areas. (DOCX 84 kb)"/>
   <result pre="file 3: Figure S3. Forest plot of the prevalence of" exact="ZIKV" post="in blood donations detected by different methods. (DOCX 70"/>
   <result pre="NAT Nucleic Acid Test PRT Pathogen Reduction/inactivation Technology TT Transfusion-Transmitted/Transmission" exact="ZIKV" post="Zika virus Publisher’s Note Springer Nature remains neutral with"/>
   <result pre="Nucleic Acid Test PRT Pathogen Reduction/inactivation Technology TT Transfusion-Transmitted/Transmission ZIKV" exact="Zika" post="virus Publisher’s Note Springer Nature remains neutral with regard"/>
   <result pre="and preventionFront Microbiol20171108114 4.MoghadasSMShoukatAEspindolaALPereiraRSAbdirizakFet al.Asymptomatic transmission and the dynamics of" exact="Zika" post="infectionSci Rep201771582910.1038/s41598-017-05013-928724972 5.PetersenLRJamiesonDJPowersAMHoneinMAZika VirusN Engl J Med2016374161552156310.1056/NEJMra160211327028561 6.BritoFMAntunesDBCMoreiraAde MoraisMMHenriques-SouzaAet"/>
   <result pre="MoraisMMHenriques-SouzaAet al.Guillain-Barre syndrome, acute disseminated encephalomyelitis and encephalitis associated with" exact="Zika" post="virus infection in Brazil: detection of viral RNA and"/>
   <result pre="infectionAm J Trop Med Hyg20179751405140910.4269/ajtmh.17-010629140242 7.RozeBNajioullahFFergeJLDorleansFApetseKBarnayJLet al.Guillain-Barre syndrome associated with" exact="Zika" post="virus infection in Martinique in 2016: a prospective studyClin"/>
   <result pre="Dis20176591462146810.1093/cid/cix58829020245 8.MussoDGublerDJZika VirusClin Microbiol Rev201629348752410.1128/CMR.00072-1527029595 9.MottaIJSpencerBRCordeiroDSSArrudaMBDobbinJAet al.Evidence for transmission of" exact="Zika" post="virus by platelet transfusionN Engl J Med2016375111101110310.1056/NEJMc160726227532622 10.LesslerJOttCTCarcelenACKonikoffJMWilliamsonJBiQet al.Times"/>
   <result pre="transfusionN Engl J Med2016375111101110310.1056/NEJMc160726227532622 10.LesslerJOttCTCarcelenACKonikoffJMWilliamsonJBiQet al.Times to key events in" exact="Zika" post="virus infection and implications for blood donation: a systematic"/>
   <result pre="S.DoyleKateMunoz-JordanJorgeSantiagoGilberto A.KleinLiorePerez-PadillaJaniceMedinaFreddy A.WatermanStephen H.AdamsLaura E.LozierMatthew J.Bertrán-PasarellJorgeGarcia GubernCarlosAlvaradoLuisa I.SharpTyler M.Persistence of" exact="Zika" post="Virus in Body Fluids — Final ReportNew England Journal"/>
   <result pre="Medicine2018379131234124310.1056/NEJMoa161310828195756 12.WHO. Maintaining a safe and adequate blood supply during" exact="Zika" post="virus outbreaks. Interim guidance. February,2016. http://apps.who.int/iris/bitstream/handle/10665/204436/WHO_ZIKV_HS_16.1_eng.pdf.(accessed March 25, 2018)."/>
   <result pre="and product management to reduce the risk of transfusion-transmission of" exact="Zika" post="virus. https://strac.org/files/Infection%20Prevention/Zika_Guidance_for_Donors_Screening%202016,%20Feb.pdf. (accessed April 25, 2016). 14.US Food and"/>
   <result pre="Allows use of investigational test to screen blood donations for" exact="Zika" post="virus. March 2016. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm493081.htm. (accessed March 25, 2018). 15.Watson-BrownPViennetEHoadVCFlowerRFaddyHMIs"/>
   <result pre="Zika virus. March 2016. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm493081.htm. (accessed March 25, 2018). 15.Watson-BrownPViennetEHoadVCFlowerRFaddyHMIs" exact="Zika" post="virus a potential threat to the Australian blood supply?Aust"/>
   <result pre="infectious disease agents and blood safety in Australia: spotlight on" exact="Zika" post="virusMed J Aust20172061045546010.5694/mja16.0083328566073 17.BorenaWHoferTStiasnyKAberleSWGaberMvon LaerDet al.No molecular or serological"/>
   <result pre="to regions where Aedes albopictus circulatesPLoS One2017125e017817510.1371/journal.pone.017817528542611 18.MussoDNhanTRobinERocheCBierlaireDZisouKShan YanACao-LormeauVBroultJPotential for" exact="Zika" post="virus transmission through blood transfusion demonstrated during an outbreak"/>
   <result pre="Puerto Rico, April–august 2016Emerg Infect Dis201723579079510.3201/eid2305.16187328263141 26.GakeBVernetMALeparc-GoffartIDrexlerJFGouldEAGallianPet al.Low seroprevalence of" exact="Zika" post="virus in Cameroonian blood donorsBraz J Infect Dis201721448148310.1016/j.bjid.2017.03.01828549857 27.WilliamsonPCLinnenJMKesslerDAShazBHKamelHet"/>
   <result pre="Cameroonian blood donorsBraz J Infect Dis201721448148310.1016/j.bjid.2017.03.01828549857 27.WilliamsonPCLinnenJMKesslerDAShazBHKamelHet al.First cases of" exact="Zika" post="virus-infected US blood donors outside states with areas of"/>
   <result pre="Paulo state, Brazil, 2016Transfusion201757122897290110.1111/trf.1432228921551 30.KuehnertMJBasavarajuSVMoseleyRRPateLLGalelSAet al.Screening of blood donations for" exact="Zika" post="virus infection - Puerto Rico, April 3-June 11, 2016MMWR"/>
   <result pre="3-June 11, 2016MMWR Morb Mortal Wkly Rep2016652462762810.15585/mmwr.mm6524e227337368 31.AdamsLBello-PaganMLozierMRyffKREspinetCTorresJet al.Update: Ongoing" exact="Zika" post="Virus Transmission - Puerto Rico, November 1, 2015-July 7,"/>
   <result pre="transmitted by blood transfusionN Engl J Med2008359141526152710.1056/NEJMc070867318832256 34.PealerLNMarfinAAPetersenLRLanciottiRSPagePLet al.Transmission of" exact="West Nile" post="virus through blood transfusion in the United States in"/>
   <result pre="Mortal Wkly Rep, 2010. 59(2): p. 34–7. 36.Barjas-CastroMLAngeramiRNCunhaMSSuzukiANogueiraJSet al.Probable transfusion-transmitted" exact="Zika" post="virus in BrazilTransfusion20165671684168810.1111/trf.1368127329551 37.DuffyMRChenTHHancockWTPowersAMKoolJLet al.Zika virus outbreak on Yap"/>
   <result pre="threat to transfusion safetyTransfusion200949Suppl 21S29S10.1111/j.1537-2995.2009.02279.x19686562 43.DoddRYFosterGAStramerSLKeeping blood transfusion safe from" exact="West Nile" post="virus: American red Cross experience, 2003 to 2012Transfus Med"/>
   <result pre="2012Transfus Med Rev201529315316110.1016/j.tmrv.2015.03.00125841631 44.de VasconcelosZFMAzevedoRCThompsonNGomesLGuidaLet al.Challenges for molecular and serological" exact="ZIKV" post="infection confirmationChilds Nerv Syst2018341798410.1007/s00381-017-3641-529110196 45.BasileKKokJDwyerDEZika virus: what, where from"/>
   <result pre="45.BasileKKokJDwyerDEZika virus: what, where from and where to?Pathology201749769870610.1016/j.pathol.2017.08.00229050846 46.HillsSLFischerMPetersenLREpidemiology of" exact="Zika" post="virus infectionJ Infect Dis2017216suppl_10S868S87410.1093/infdis/jix43429267914 47.StoneMLanteriMCBakkourSDengXGalelSALinnenJMet al.Relative analytical sensitivity of"/>
   <result pre="and diagnostic real-time polymerase chain reaction assays for detection of" exact="Zika" post="virus RNATransfusion2017573pt273474710.1111/trf.1403128194799 48.LaughhunnASantaMFBroultJLanteriMCStassinopoulosAMussoDet al.Amustaline (S-303) treatment inactivates high levels"/>
   <result pre="virus RNATransfusion2017573pt273474710.1111/trf.1403128194799 48.LaughhunnASantaMFBroultJLanteriMCStassinopoulosAMussoDet al.Amustaline (S-303) treatment inactivates high levels of" exact="Zika" post="virus in red blood cell componentsTransfusion2017573pt277978910.1111/trf.1399328164306 49.AubryMLaughhunnASantaMFLanteriMCStassinopoulosAMussoDPathogen inactivation of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6614477\results\search\tropicalVirus\results.xml">
   <result pre="661447746291 doi: 10.1038/s41598-019-46291-9 : Article Human Polyclonal Antibodies Prevent Lethal" exact="Zika" post="Virus Infection in Mice BrancheEmilie1SimonAyo Yila2SheetsNicholas1KimKenneth1BarkerDouglas2NguyenAnh-Viet T.1SahotaHarpreet3YoungMatthew Perry1SalgadoRebecca1MamidiAnila1ViramontesKarla M.1CarnelleyTrevor2QiuHongyu2Elong"/>
   <result pre="To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract" exact="Zika" post="virus (ZIKV) is an emerging mosquito-borne flavivirus that represents"/>
   <result pre="mosquito-borne flavivirus that represents a major threat to global health." exact="ZIKV" post="infections in adults are generally asymptomatic or present with"/>
   <result pre="asymptomatic or present with mild symptoms. However, recent outbreaks of" exact="ZIKV" post="have revealed that it can cause Congenital Zika Syndrome"/>
   <result pre="outbreaks of ZIKV have revealed that it can cause Congenital" exact="Zika" post="Syndrome in neonates and Guillain-Barré syndrome in adults. Currently,"/>
   <result pre="with high neutralizing anti-ZIKV titers as a therapeutic candidate against" exact="ZIKV" post="infection using a model of ZIKV infection in Ifnar1−/−"/>
   <result pre="a therapeutic candidate against ZIKV infection using a model of" exact="ZIKV" post="infection in Ifnar1−/− mice. ZIKV-IG successfully protected mice from"/>
   <result pre="infection in Ifnar1−/− mice. ZIKV-IG successfully protected mice from lethal" exact="ZIKV" post="challenge. In particular, ZIKV-IG treatment at 24 hours after lethal"/>
   <result pre="ZIKV challenge. In particular, ZIKV-IG treatment at 24 hours after lethal" exact="ZIKV" post="infection improved survival by reducing weight loss and tissue"/>
   <result pre="viable candidate for further development as a treatment against human" exact="ZIKV" post="infection. Subject terms Protein vaccines Viral infection Funding Emergent"/>
   <result pre="Viral infection Funding Emergent BioSolutions Canada Inc, Winnipeg, Canada Introduction" exact="Zika" post="virus (ZIKV) is an arthropod-borne virus belonging to the"/>
   <result pre="arthropod-borne virus belonging to the family Flaviviridae, similar to dengue," exact="West Nile," post="Japanese encephalitis, and yellow fever viruses1. ZIKV was first"/>
   <result pre="to dengue, West Nile, Japanese encephalitis, and yellow fever viruses1." exact="ZIKV" post="was first identified in a sentinel rhesus monkey in"/>
   <result pre="was first identified in a sentinel rhesus monkey in the" exact="Zika" post="Forest of Uganda in 1947 and was isolated from"/>
   <result pre="1947 and was isolated from mosquitoes (Aedes africanus) in 19482." exact="ZIKV" post="is transmitted through the bite of infected female Ae."/>
   <result pre="sexual transmission12. From the 1950’s to 1990’s, serological evidence of" exact="ZIKV" post="was reported in multiple Asian13–16 and African17–22 countries, but"/>
   <result pre="countries, but no outbreaks and only 14 cases of human" exact="ZIKV" post="disease were described17,22–25. The first ZIKV outbreak was observed"/>
   <result pre="14 cases of human ZIKV disease were described17,22–25. The first" exact="ZIKV" post="outbreak was observed in 2007 on Yap Island in"/>
   <result pre="after these outbreaks in part due to the emergence of" exact="ZIKV" post="outside its previously known geographic range, showing the potential"/>
   <result pre="is present. In addition, prior to the French Polynesia outbreak," exact="ZIKV" post="was known to be asymptomatic or cause only mild"/>
   <result pre="maculopapular rashes, and conjunctivitis). However, since 2007, severe complications of" exact="ZIKV" post="infection, in particular Guillain–Barré Syndrome in adults31,32 and Congenital"/>
   <result pre="ZIKV infection, in particular Guillain–Barré Syndrome in adults31,32 and Congenital" exact="Zika" post="Syndrome in babies born to ZIKV-infected women7,8,33–36 have been"/>
   <result pre="have been observed. These findings led the WHO to declare" exact="ZIKV" post="a public health emergency of international concern in 2016"/>
   <result pre="studies have demonstrated that mAbs can provide therapeutic protection against" exact="ZIKV" post="in various human and mouse models44, only a single"/>
   <result pre="therapeutic potential of human pAbs produced from transchromosomal cows against" exact="ZIKV" post="infection in mice. As no study has as yet"/>
   <result pre="evaluate the therapeutic potential of ZIKV-IG. Prior to the recent" exact="ZIKV" post="epidemics, only a few studies had been performed in"/>
   <result pre="performed in mice and these required many serial passages of" exact="ZIKV" post="in mice to produce consistent disease phenotypes45–47. Within the"/>
   <result pre="substantial efforts have been focused on generating new mouse models." exact="ZIKV" post="evades the anti-viral type I interferon (IFN) response, in"/>
   <result pre="I IFN receptor (Ifnar) signaling in a species-specific manner by" exact="ZIKV" post="explains the more severe pathogenesis of ZIKV infection in"/>
   <result pre="species-specific manner by ZIKV explains the more severe pathogenesis of" exact="ZIKV" post="infection in mice with immature or compromised immune systems"/>
   <result pre="of the Ifnar1 signaling increases susceptibility of mice to lethal" exact="ZIKV" post="infection. Accordingly, wild type mice treated with blocking anti-Ifnar1"/>
   <result pre="II IFN receptors59–61 have been widely used as models of" exact="ZIKV" post="infection. We measured the effectiveness of ZIKV-IG therapy on"/>
   <result pre="liver, sciatic nerves and brain, of Ifnar1−/− mice following lethal" exact="ZIKV" post="challenge. ZIKV-IG treatment at 24 hrs post-infection increased survival"/>
   <result pre="that a single dose of ZIKV-IG is efficacious against lethal" exact="Zika" post="disease in a highly stringent mouse challenge model. Results"/>
   <result pre="Ifnar1−/− mice To evaluate the therapeutic efficacy of ZIKV-IG against" exact="ZIKV" post="infection, Ifnar1−/− mice were infected with ZIKV (strain FSS13025,"/>
   <result pre="of ZIKV-IG against ZIKV infection, Ifnar1−/− mice were infected with" exact="ZIKV" post="(strain FSS13025, 1.0 × 103 FFU/mouse, retro-orbital (r.o.) route) and then"/>
   <result pre="used for this study exhibits high neutralization activity against multiple" exact="ZIKV" post="strains, including strain FSS13025 (Supplementary Fig. S1). Animals were"/>
   <result pre="A dose-dependent effect on mortality, weight changes and severity of" exact="ZIKV" post="disease was observed in ZIKV-IG treated animals compared to"/>
   <result pre="dose is the most efficacious of the doses tested against" exact="ZIKV" post="infection in this mouse model. Figure 1 ZIKV-IG treatment"/>
   <result pre="of Ifnar1−/− mice (n = 8) were infected with 1.0 × 103 FFU of" exact="ZIKV" post="strain FSS13025 via a retro-orbital (r.o.) route. At 24"/>
   <result pre="reduces viral burden in sera and key target organs of" exact="ZIKV" post="tropism (spleen, kidneys, liver, sciatic nerves, and brain). Ifnar1−/−"/>
   <result pre="liver, sciatic nerves, and brain). Ifnar1−/− mice were infected with" exact="ZIKV" post="(strain FSS13025, 1.0 × 103 FFU/mouse, r.o. route) followed by treatment"/>
   <result pre="levels of viral RNA but lower levels of BHK cell-infectious" exact="ZIKV" post="(−1.3-fold, p = 0.009) than control mice at day 3 p.i."/>
   <result pre="treatment decreases viral burden in key non-neuronal target organs of" exact="ZIKV" post="in mice. Groups of Ifnar1−/− mice (n = 6) were infected"/>
   <result pre="of Ifnar1−/− mice (n = 6) were infected with 1.0 × 103 FFU of" exact="ZIKV" post="strain FSS13025 (via r.o. route). At 24 hrs p.i.,"/>
   <result pre="standard error of the mean. As the major consequences of" exact="ZIKV" post="infection are related to infection of the nervous system,"/>
   <result pre="vs. control mice. At day 3 p.i., similar levels of" exact="ZIKV" post="RNA and infectious particles were present in the sciatic"/>
   <result pre="7 p.i., both viral RNA (−2.6-fold, p = 0.009) and BHK cell-infectious" exact="ZIKV" post="(−3.2-fold, p = 0.009) levels were reduced in the sciatic nerves"/>
   <result pre="and Supplementary Tables S2). Only low levels of BHK cell-infectious" exact="ZIKV" post="were detected at day 3 p.i. in the brains"/>
   <result pre="from 50 mg/kg ZIKV-IG-treated mice contained reduced levels of BHK cell-infectious" exact="ZIKV" post="relative to control mice (−3.5-fold, p = 0.009) (Fig. 3B and"/>
   <result pre="Supplementary Table S2). Viral RNA (−1.3-fold, p = 0.009) and BHK cell-infectious" exact="ZIKV" post="(−1.8-fold, p = 0.009) levels were also decreased the day 7"/>
   <result pre="the sciatic nerves and brain being major target organs of" exact="ZIKV" post="at a later time point post infection in this"/>
   <result pre="of Ifnar1−/− mice (n = 6) were infected with 1.0 × 103 FFU of" exact="ZIKV" post="strain FSS13025 (via r.o. route). At 24 hrs p.i.,"/>
   <result pre="route) with vehicle (circle) or 50 (square) mg/kg ZIKV-IG. (A)" exact="ZIKV" post="RNA levels, as measured by qRT-PCR and (B) infectious"/>
   <result pre="ZIKV RNA levels, as measured by qRT-PCR and (B) infectious" exact="ZIKV" post="levels, as determined by FFA analyses in the sciatic"/>
   <result pre="To confirm the robust efficacy of 50 mg/kg ZIKV-IG treatment against" exact="ZIKV" post="infection in this mouse model, we next localized ZIKV"/>
   <result pre="against ZIKV infection in this mouse model, we next localized" exact="ZIKV" post="in tissues by performing immunohistochemistry (IHC) for expression of"/>
   <result pre="ZIKV in tissues by performing immunohistochemistry (IHC) for expression of" exact="ZIKV" post="nonstructural protein 2B (NS2B), which is absent in virions"/>
   <result pre="(p = 0.006) (Fig. 4D). Thus, 50 mg/kg ZIKV-IG treatment is effective against" exact="ZIKV" post="infection in this highly stringent challenge model, as assessed"/>
   <result pre="50 mg/kg ZIKV-IG, lower doses of ZIKV-IG are less effective against" exact="ZIKV" post="infection, reducing viral burden in select tissues. Figure 4"/>
   <result pre="viral burden in select tissues. Figure 4 ZIKV-IG treatment decreases" exact="ZIKV" post="NS2B expression in the liver and brain of ZIKV-infected"/>
   <result pre="of Ifnar1−/− mice (n = 8) were infected with 1.0 × 103 FFU of" exact="ZIKV" post="strain FSS13025 (via r.o. route). At 24 hrs p.i.,"/>
   <result pre="ZIKV-IG. At day 7 p.i., tissues were harvested to detect" exact="ZIKV" post="NS2B expression via IHC. (A) NS2B expression in the"/>
   <result pre="other signs of injury in ZIKV-IG-treated and control mice following" exact="ZIKV" post="infection, hematoxylin &amp;amp; eosin-stained brain slide sections were examined"/>
   <result pre="the therapeutic potential of human anti-ZIKV pAb (ZIKV-IG) against lethal" exact="ZIKV" post="infection in a highly stringent mouse model. ZIKV-IG treatment"/>
   <result pre="of ZIKV-IG as a candidate for prophylaxis or treatment of" exact="Zika" post="disease. A variety of Abs, including mAbs isolated from"/>
   <result pre="in transchromosomal bovines65 were shown to have therapeutic potential against" exact="ZIKV" post="infection in mice. Similarly, transfer of convalescent sera from"/>
   <result pre="of convalescent sera from a human to pregnant mice prevented" exact="ZIKV" post="infection and associated fetal birth defects66, and convalescent human"/>
   <result pre="ZIKV-infected individuals were able to neutralize both African and Asian" exact="ZIKV" post="strains in vitro67. Here, we report that a single"/>
   <result pre="at 24 hrs post-infection in Ifnar1−/− mouse model of lethal" exact="ZIKV" post="infection prevented both severe disease development and mortality. In"/>
   <result pre="both severe disease development and mortality. In addition, ZIKV-IG reduced" exact="ZIKV" post="burden and ZIKV-induced tissue damage in target organs, confirming"/>
   <result pre="ZIKV-induced tissue damage in target organs, confirming therapeutic potential against" exact="ZIKV" post="infection. Recent outbreaks of several emerging and re-emerging viral"/>
   <result pre="was purified using a validated hyperimmune platform manufacturing process68. Although," exact="ZIKV" post="strains have been phylogenetically characterized into African and Asian/American"/>
   <result pre="premise is supported by the report that primary infection with" exact="ZIKV" post="African strain in macaques protected the animals from secondary"/>
   <result pre="in macaques protected the animals from secondary heterologous re-challenge with" exact="ZIKV" post="Asian strain69. Thus, an effective ZIKV therapeutic candidate could"/>
   <result pre="secondary heterologous re-challenge with ZIKV Asian strain69. Thus, an effective" exact="ZIKV" post="therapeutic candidate could potentially neutralize infection with any of"/>
   <result pre="therapeutic candidate could potentially neutralize infection with any of the" exact="ZIKV" post="virus lineages. Our in vitro potency based on anti-ZIKV"/>
   <result pre="vivo mouse results provide evidence that ZIKV-IG can effectively neutralize" exact="ZIKV" post="infection. Development of Ab products intended for use as"/>
   <result pre="of Ab products intended for use as a therapy against" exact="ZIKV" post="infection should consider the risk of antibody dependent enhancement"/>
   <result pre="the ADE process, pre-existing non- or sub-neutralizing Abs that recognize" exact="DENV" post="enhance subsequent DENV infection and pathogenesis76–78. ZIKV is antigenically"/>
   <result pre="pre-existing non- or sub-neutralizing Abs that recognize DENV enhance subsequent" exact="DENV" post="infection and pathogenesis76–78. ZIKV is antigenically and genetically similar"/>
   <result pre="Abs that recognize DENV enhance subsequent DENV infection and pathogenesis76–78." exact="ZIKV" post="is antigenically and genetically similar to DENV with ~56%"/>
   <result pre="infection and pathogenesis76–78. ZIKV is antigenically and genetically similar to" exact="DENV" post="with ~56% genome sequence homology79, with in vitro and"/>
   <result pre="and in vivo mouse studies demonstrating that Ab response to" exact="DENV" post="and ZIKV can cross-react and cross-enhance infection and pathogenesis"/>
   <result pre="vivo mouse studies demonstrating that Ab response to DENV and" exact="ZIKV" post="can cross-react and cross-enhance infection and pathogenesis of each"/>
   <result pre="macaque and mouse studies have provided further support for pre-existing" exact="ZIKV" post="Ab-mediated enhancement of subsequent DENV infection and disease severity84–86,"/>
   <result pre="provided further support for pre-existing ZIKV Ab-mediated enhancement of subsequent" exact="DENV" post="infection and disease severity84–86, passive transfer of vaccine-induced Abs"/>
   <result pre="infection and disease severity84–86, passive transfer of vaccine-induced Abs before" exact="ZIKV" post="challenge did not result in ZIKV infection enhancement or"/>
   <result pre="of vaccine-induced Abs before ZIKV challenge did not result in" exact="ZIKV" post="infection enhancement or disease in non-pregnant mice and monkeys87,88."/>
   <result pre="sub-protective doses of ZIKV-IG showed no evidence for ADE of" exact="ZIKV" post="infection in our mouse model as suggested by both"/>
   <result pre="mode of infection. Whether ADE is clinically relevant to human" exact="Zika" post="disease is currently unknown, and thus, the possibility of"/>
   <result pre="currently unknown, and thus, the possibility of ZIKV-IG-mediated ADE for" exact="Zika" post="clinical disease remains a theoretical question for the development"/>
   <result pre="performed to assess whether ZIKV-IG has the potential to enhance" exact="DENV" post="infection when given under pre-exposure setting. In summary, we"/>
   <result pre="of ZIKV-IG 24 hrs after infection protected mice against lethal" exact="ZIKV" post="infection. Non-protective doses of ZIKV-IG did not induce ADE"/>
   <result pre="infection. Non-protective doses of ZIKV-IG did not induce ADE of" exact="ZIKV" post="infection. These results provide the evidence that, at appropriate"/>
   <result pre="treatment could be effective at preventing the deleterious effects of" exact="ZIKV" post="in humans. Therefore, further testing in relevant pregnancy models"/>
   <result pre="in this study are outlined in Supplementary Table S3. Virus" exact="ZIKV" post="strains MR766, FSS13025, and PRVABC59 were obtained from the"/>
   <result pre="with 5% CO2 for 1 hr with either 1 × 105 FFU of" exact="ZIKV" post="strain FSS13025, 2 × 104 FFU of ZIKV strain MR766, or"/>
   <result pre="either 1 × 105 FFU of ZIKV strain FSS13025, 2 × 104 FFU of" exact="ZIKV" post="strain MR766, or 1 × 104 FFU of ZIKV strain PRVABC59."/>
   <result pre="2 × 104 FFU of ZIKV strain MR766, or 1 × 104 FFU of" exact="ZIKV" post="strain PRVABC59. Standard flow cytometry-based neutralization assays using U937-DC-SIGN"/>
   <result pre="cells were then performed as described previously58,86,93. Mice and lethal" exact="ZIKV" post="infection model Ifnar1−/− mice (C57BL/6 mice deficient in type"/>
   <result pre="intravenously via the retro-orbital (r.o.) route with 1.0 × 103 FFU of" exact="ZIKV" post="FSS13025. Testing of drug product and treatments ZIKV-IG was"/>
   <result pre="using a microneutralization assay that measured the cytopathic effect of" exact="ZIKV" post="strain PRVABC59 on Vero E6 cells using an xCELLigence®"/>
   <result pre="electric current passing through the electrodes. An equal volume of" exact="ZIKV" post="PRVABC59, diluted to 100 TCID50, was incubated for one"/>
   <result pre="for ZIKV-IG product was 18,480, indicating a high degree of" exact="Zika" post="virus neutralization. Naïve-ZIKV-IG was manufactured using the same processes"/>
   <result pre="or 0.1 mg/kg ZIKV-IG (100 μL/mouse) at 24 hrs following lethal" exact="ZIKV" post="infection. Clinical monitoring of mice and euthanasia criteria Following"/>
   <result pre="Mini Kit (Qiagen) and the RNeasy Mini Kit (Qiagen), respectively." exact="ZIKV" post="RNA levels in sera and tissues were quantified by"/>
   <result pre="Tissue RNA levels were normalized to 18S as described for" exact="Dengue" post="RNA91 and expressed as genome equivalent per 18S (GE/18S),"/>
   <result pre="serum RNA levels were expressed as GE/mL. Quantification of infectious" exact="ZIKV" post="by FFA FFA procedures were performed as previously described52."/>
   <result pre="and serological specificityTrans R Soc Trop Med Hyg19524650952010.1016/0035-9203(52)90042-412995440 3.MarchetteNJGarciaRRudnickAIsolation of" exact="Zika" post="virus from Aedes aegypti mosquitoes in MalaysiaAm J Trop"/>
   <result pre="Cao-Lormeau, V. &amp;amp; Musso, D. Evidence of perinatal transmission of" exact="Zika" post="virus, French Polynesia, December 2013 and February 2014. Euro"/>
   <result pre="February 2014. Euro Surveill19 (2014). 6.CalvetGet al.Detection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
   <result pre="the Evidence for CausalityN Engl J Med20163741981198710.1056/NEJMsr160433827074377 9.Barjas-CastroMLet al.Probable transfusion-transmitted" exact="Zika" post="virus in BrazilTransfusion2016561684168810.1111/trf.1368127329551 10.MottaIJet al.Evidence for Transmission of Zika"/>
   <result pre="transfusion-transmitted Zika virus in BrazilTransfusion2016561684168810.1111/trf.1368127329551 10.MottaIJet al.Evidence for Transmission of" exact="Zika" post="Virus by Platelet TransfusionN Engl J Med20163751101110310.1056/NEJMc160726227532622 11.MussoDNhanTRobinERocheCBierlaireDZisouKShan YanACao-LormeauVBroultJPotential"/>
   <result pre="Virus by Platelet TransfusionN Engl J Med20163751101110310.1056/NEJMc160726227532622 11.MussoDNhanTRobinERocheCBierlaireDZisouKShan YanACao-LormeauVBroultJPotential for" exact="Zika" post="virus transmission through blood transfusion demonstrated during an outbreak"/>
   <result pre="seroepidemiological investigations in Oyo StateJ Hyg (Lond)19798321321910.1017/S0022172400025997489960 24.FilipeARMartinsCMRochaHLaboratory infection with" exact="Zika" post="virus after vaccination against yellow feverArch Gesamte Virusforsch19734331531910.1007/BF015561474799154 25.OlsonJGKsiazekTGSuhandimanTriwibowoZika"/>
   <result pre="Infect Dis2014201085108610.3201/eid2006.14013824856001 28.PetersenLRJamiesonDJPowersAMHoneinMAZika VirusN Engl J Med20163741552156310.1056/NEJMra160211327028561 29.ZhangQet al.Spread of" exact="Zika" post="virus in the AmericasProc Natl Acad Sci USA2017114E4334E434310.1073/pnas.162016111428442561 30.Colon-GonzalezFJPeresCASteiner"/>
   <result pre="AmericasProc Natl Acad Sci USA2017114E4334E434310.1073/pnas.162016111428442561 30.Colon-GonzalezFJPeresCASteiner Sao BernardoCHunterPRLakeIRAfter the epidemic:" exact="Zika" post="virus projections for Latin America and the CaribbeanPLoS Negl"/>
   <result pre="the CaribbeanPLoS Negl Trop Dis201711e000600710.1371/journal.pntd.000600729091713 31.BrasilPet al.Guillain-Barre syndrome associated with" exact="Zika" post="virus infectionLancet2016387148210.1016/S0140-6736(16)30058-727115821 32.BautistaLESethiAKAssociation between Guillain-Barre syndrome and Zika virus"/>
   <result pre="associated with Zika virus infectionLancet2016387148210.1016/S0140-6736(16)30058-727115821 32.BautistaLESethiAKAssociation between Guillain-Barre syndrome and" exact="Zika" post="virus infectionLancet20163872599260010.1016/S0140-6736(16)30844-327353815 33.de AraujoTVBet al.Association between microcephaly, Zika virus"/>
   <result pre="syndrome and Zika virus infectionLancet20163872599260010.1016/S0140-6736(16)30844-327353815 33.de AraujoTVBet al.Association between microcephaly," exact="Zika" post="virus infection, and other risk factors in Brazil: final"/>
   <result pre="of a case-control studyLancet Infect Dis20181832833610.1016/S1473-3099(17)30727-229242091 34.MartinesRBet al.Pathology of congenital" exact="Zika" post="syndrome in Brazil: a case seriesLancet201638889890410.1016/S0140-6736(16)30883-227372395 35.LuceyDCumminsHSholtsSCongenital Zika Syndrome"/>
   <result pre="of congenital Zika syndrome in Brazil: a case seriesLancet201638889890410.1016/S0140-6736(16)30883-227372395 35.LuceyDCumminsHSholtsSCongenital" exact="Zika" post="Syndrome in 2017JAMA20173171368136910.1001/jama.2017.155328384812 36.MenesesJDAet al.Lessons Learned at the Epicenter"/>
   <result pre="2017JAMA20173171368136910.1001/jama.2017.155328384812 36.MenesesJDAet al.Lessons Learned at the Epicenter of Brazil’s Congenital" exact="Zika" post="Epidemic: Evidence From 87 Confirmed CasesClin Infect Dis2017641302130810.1093/cid/cix16628329257 37.LukeTCKilbaneEMJacksonJLHoffmanSLMeta-analysis:"/>
   <result pre="Q., Yan, J. &amp;amp; Gao, G. F. Monoclonal Antibodies against" exact="Zika" post="Virus: Therapeutics and Their Implications for Vaccine Design. J"/>
   <result pre="50.DingQet al.Species-specific disruption of STING-dependent antiviral cellular defenses by the" exact="Zika" post="virus NS2B3 proteaseProc Natl Acad Sci USA2018115E6310E631810.1073/pnas.180340611529915078 51.GoveroJet al.Zika"/>
   <result pre="and Role of the CD8(+) T Cell Response During Primary" exact="Zika" post="Virus Infection in MiceCell Host Microbe201721354610.1016/j.chom.2016.12.01028081442 53.WenJet al.Dengue virus-reactive"/>
   <result pre="53.WenJet al.Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent" exact="Zika" post="virus challengeNat Commun20178145910.1038/s41467-017-01669-z29129917 54.Regla-NavaJAet al.Cross-reactive Dengue virus-specific CD8(+) T"/>
   <result pre="mediate cross-protection against subsequent Zika virus challengeNat Commun20178145910.1038/s41467-017-01669-z29129917 54.Regla-NavaJAet al.Cross-reactive" exact="Dengue" post="virus-specific CD8(+) T cells protect against Zika virus during"/>
   <result pre="Commun20178145910.1038/s41467-017-01669-z29129917 54.Regla-NavaJAet al.Cross-reactive Dengue virus-specific CD8(+) T cells protect against" exact="Zika" post="virus during pregnancyNat Commun20189304210.1038/s41467-018-05458-030072692 55.LazearHMet al.A Mouse Model of"/>
   <result pre="Zika virus during pregnancyNat Commun20189304210.1038/s41467-018-05458-030072692 55.LazearHMet al.A Mouse Model of" exact="Zika" post="Virus PathogenesisCell Host Microbe20161972073010.1016/j.chom.2016.03.01027066744 56.MinerJJet al.Zika Virus Infection during"/>
   <result pre="with Shedding of Virus in TearsCell Rep2016163208321810.1016/j.celrep.2016.08.07927612415 58.WenJet al.Identification of" exact="Zika" post="virus epitopes reveals immunodominant and protective roles for dengue"/>
   <result pre="CD8(+) T cellsNat Microbiol201721703610.1038/nmicrobiol.2017.3628288094 59.DowallSDet al.A Susceptible Mouse Model for" exact="Zika" post="Virus InfectionPLoS Negl Trop Dis201610e000465810.1371/journal.pntd.000465827149521 60.RossiSLet al.Characterization of a"/>
   <result pre="Dis201610e000465810.1371/journal.pntd.000465827149521 60.RossiSLet al.Characterization of a Novel Murine Model to Study" exact="Zika" post="VirusAm J Trop Med Hyg2016941362136910.4269/ajtmh.16-011127022155 61.TangWWet al.A Mouse Model"/>
   <result pre="VirusAm J Trop Med Hyg2016941362136910.4269/ajtmh.16-011127022155 61.TangWWet al.A Mouse Model of" exact="Zika" post="Virus Sexual Transmission and Vaginal Viral ReplicationCell Rep2016173091309810.1016/j.celrep.2016.11.07028009279 62.WangQet"/>
   <result pre="of human neutralizing antibodies isolated from a patient infected with" exact="Zika" post="virusSci Transl Med20168369ra17910.1126/scitranslmed.aai833627974667 63.SapparapuGet al.Neutralizing human antibodies prevent Zika"/>
   <result pre="with Zika virusSci Transl Med20168369ra17910.1126/scitranslmed.aai833627974667 63.SapparapuGet al.Neutralizing human antibodies prevent" exact="Zika" post="virus replication and fetal disease in miceNature201654044344710.1038/nature2056427819683 64.LiCet al.A"/>
   <result pre="64.LiCet al.A Single Injection of Human Neutralizing Antibody Protects against" exact="Zika" post="Virus Infection and Microcephaly in Developing Mouse EmbryosCell Rep2018231424143410.1016/j.celrep.2018.04.00529719255"/>
   <result pre="65.SteinDRet al.Human polyclonal antibodies produced in transchromosomal cattle prevent lethal" exact="Zika" post="virus infection and testicular atrophy in miceAntiviral Res201714616417310.1016/j.antiviral.2017.09.00528893603 66.WangSet"/>
   <result pre="Res201714616417310.1016/j.antiviral.2017.09.00528893603 66.WangSet al.Transfer of convalescent serum to pregnant mice prevents" exact="Zika" post="virus infection and microcephaly in offspringCell Res20172715816010.1038/cr.2016.14427922617 67.DowdKAet al.Broadly"/>
   <result pre="and microcephaly in offspringCell Res20172715816010.1038/cr.2016.14427922617 67.DowdKAet al.Broadly Neutralizing Activity of" exact="Zika" post="Virus-Immune Sera Identifies a Single Viral SerotypeCell Rep2016161485149110.1016/j.celrep.2016.07.04927481466 68.KammanadimintiSet"/>
   <result pre="model of inhalational anthraxPLoS One20149e10639310.1371/journal.pone.010639325226075 69.AliotaMTet al.Heterologous Protection against Asian" exact="Zika" post="Virus Challenge in Rhesus MacaquesPLoS Negl Trop Dis201610e000516810.1371/journal.pntd.000516827911897 70.GuzmanMGet"/>
   <result pre="antibody responses after dengue virus infection are highly cross-reactive to" exact="Zika" post="virusProc Natl Acad Sci USA20161137852785710.1073/pnas.160793111327354515 82.StettlerKet al.Specificity, cross-reactivity, and"/>
   <result pre="USA20161137852785710.1073/pnas.160793111327354515 82.StettlerKet al.Specificity, cross-reactivity, and function of antibodies elicited by" exact="Zika" post="virus infectionScience201635382382610.1126/science.aaf850527417494 83.BardinaSVet al.Enhancement of Zika virus pathogenesis by"/>
   <result pre="of antibodies elicited by Zika virus infectionScience201635382382610.1126/science.aaf850527417494 83.BardinaSVet al.Enhancement of" exact="Zika" post="virus pathogenesis by preexisting antiflavivirus immunityScience201735617518010.1126/science.aal436528360135 84.GeorgeJet al.Prior Exposure"/>
   <result pre="virus pathogenesis by preexisting antiflavivirus immunityScience201735617518010.1126/science.aal436528360135 84.GeorgeJet al.Prior Exposure to" exact="Zika" post="Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus MacaquesSci"/>
   <result pre="Enhances Peak Dengue-2 Viremia in Rhesus MacaquesSci Rep201771049810.1038/s41598-017-10901-128874759 85.WatanabeSTanNWWChanKWKVasudevanSGDengue and" exact="Zika" post="Virus Serological Cross-reactivity and their Impact on Pathogenesis in"/>
   <result pre="Impact on Pathogenesis in MiceJ Infect Dis201810.1093/infdis/jiy482 86.FowlerAMet al.Maternally Acquired" exact="Zika" post="Antibodies Enhance Dengue Disease Severity in MiceCell Host Microbe201824743750"/>
   <result pre="in MiceJ Infect Dis201810.1093/infdis/jiy482 86.FowlerAMet al.Maternally Acquired Zika Antibodies Enhance" exact="Dengue" post="Disease Severity in MiceCell Host Microbe201824743750 e74510.1016/j.chom.2018.09.01530439343 87.AbbinkPet al.Protective"/>
   <result pre="Microbe201824743750 e74510.1016/j.chom.2018.09.01530439343 87.AbbinkPet al.Protective efficacy of multiple vaccine platforms against" exact="Zika" post="virus challenge in rhesus monkeysScience20163531129113210.1126/science.aah615727492477 88.LaroccaRAet al.Vaccine protection against"/>
   <result pre="Zika virus challenge in rhesus monkeysScience20163531129113210.1126/science.aah615727492477 88.LaroccaRAet al.Vaccine protection against" exact="Zika" post="virus from BrazilNature201653647447810.1038/nature1895227355570 89.HeangVet al.Zika virus infection, Cambodia, 2010Emerg"/>
   <result pre="al.Zika virus infection, Cambodia, 2010Emerg Infect Dis20121834935110.3201/eid1802.11122422305269 90.LanciottiRSLambertAJHolodniyMSaavedraSSignor LdelCPhylogeny of" exact="Zika" post="Virus in Western Hemisphere, 2015Emerg Infect Dis20162293393510.3201/eid2205.16006527088323 91.PrestwoodTRPrigozhinDMShararKLZellwegerRMShrestaSA mouse-passaged"/>
   <result pre="al.CD4+ T cells promote humoral immunity and viral control during" exact="Zika" post="virus infectionPLoS Pathog201915e100747410.1371/journal.ppat.100747430677097"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6620336\results\search\tropicalVirus\results.xml">
   <result pre="UKLondon pmcid: 662033645981 doi: 10.1038/s41598-019-45981-8 : Article Genomic epidemiology of" exact="Chikungunya" post="virus in Colombia reveals genetic variability of strains and"/>
   <result pre="To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract" exact="Chikungunya" post="virus (CHIKV) is considered a public health problem due"/>
   <result pre="study was carried out using sera of patients infected with" exact="Chikungunya" post="during the outbreak in Colombia. The whole genomes of"/>
   <result pre="Chikungunya during the outbreak in Colombia. The whole genomes of" exact="CHIKV" post="(n = 16) were sequenced with an Illumina Hi-seq 2500 and"/>
   <result pre="carried out with 157 strains of worldwide origin. The Colombian" exact="CHIKV" post="sequences were grouped in the Asian genotype; however, three"/>
   <result pre="nsp2-G720A; nsP3-L458P; Capside R78Q), that may have functional consequences for" exact="CHIKV" post="biology and pathogenesis. These same mutations may affect the"/>
   <result pre="pathogenesis. These same mutations may affect the efficacy of potential" exact="CHIKV" post="vaccines. Subject terms Phylogenetics Alphaviruses Molecular biology Funding -Colciencias"/>
   <result pre="sustainability program for researching groups, 2016-2017 (Cod. FMV-01-16, FMV-01-17). Introduction" exact="Chikungunya" post="virus (CHIKV) is an alphavirus of the Togaviridae family,"/>
   <result pre="of mosquitoes of the species Aedes aegypti and A. albopictus1." exact="CHIKV" post="is considered a public health problem due to its"/>
   <result pre="burden and collapse in health systems1. The local transmission of" exact="CHIKV" post="has been reported in more than 100 countries and"/>
   <result pre="suspected and confirmed3. The study of whole genome sequences of" exact="CHIKV" post="isolates from different regions of the world has facilitated"/>
   <result pre="evolutionary history of this virus4. The first phylogenetic studies of" exact="CHIKV" post="identified three geographically associated genotypes: West Africa (WA), East/Central/South"/>
   <result pre="subcontinent6,7. Since the outbreaks in India and the Indian Ocean," exact="CHIKV" post="has spread worldwide, and the locations of epidemics have"/>
   <result pre="in the Caribbean island of Saint Martin10. In January 2015" exact="CHIKV" post="was disseminated to 42 countries or territories in the"/>
   <result pre="public health problems13. The first case of local transmission of" exact="CHIKV" post="in Colombia was notified in August 2014 in the"/>
   <result pre="notified between 2016 and August 2018, demonstrating the endemicity of" exact="Chikungunya" post="in Colombia18. The rapid distribution of CHIKV could be"/>
   <result pre="the endemicity of Chikungunya in Colombia18. The rapid distribution of" exact="CHIKV" post="could be related to the mobility of people and"/>
   <result pre="of genes nsP1, E1, and E2 in Colombia, found that" exact="CHIKV" post="was similar to the Asian genotype and was related"/>
   <result pre="genetic diversity, phylogenetic relationships, and possible routes of introduction of" exact="CHIKV" post="strains isolated in Colombia and the Americas. Results Viral"/>
   <result pre="strains isolated in Colombia and the Americas. Results Viral isolation" exact="CHIKV" post="was isolated from 96.5% (54/57) of the sera, 65.4%"/>
   <result pre="lysis between 3–4 days. Genome structure and genetic variability of" exact="CHIKV" post="isolated in Colombia For each sequence, an average of"/>
   <result pre="value of the coding regions of the genome (ORF) of" exact="CHIKV" post="was 28.8% adenine (A), 25.9% guanine (G), 20.6% thymine"/>
   <result pre="Figure 1 Number of mutations detected in the strains of" exact="CHIKV" post="isolated in the present study. Each gene has a"/>
   <result pre="for this analysis. Molecular fingerprint and phylogenetic relationship of Colombian" exact="CHIKV" post="Within the Caribbean American clade (CAC), the Colombian strains"/>
   <result pre="adenine. Black represents mixed bases within the sequences. Figure 4" exact="Chikungunya" post="virus spread in the Americas based on the phylogenetic"/>
   <result pre="Table 1 Relevant amino acid substitutions identified in the Colombian" exact="CHIKV" post="isolates. Gene Nt positióna Shift Shift AA (gen)b Panama"/>
   <result pre="in Colombia and found that there was a relationship with" exact="CHIKV" post="from Mexico, Brazil, Virgin Islands, and Saint Martin14. Other"/>
   <result pre="the first country to report cases of indigenous transmission of" exact="CHIKV" post="(February 2014)26 followed by Puerto Rico (May 2014)3, USA,"/>
   <result pre="people)28. Therefore, it is possible that the Panamanian strain of" exact="CHIKV" post="has entered through Cartagena (Bolivar) and not through SJ-Mahates"/>
   <result pre="information also allows us to suggest that the introduction of" exact="CHIKV" post="to the Colombian Caribbean may have come from Venezuela"/>
   <result pre="migration of Venezuelans to Colombia and all the cases of" exact="CHIKV" post="that were imported from Venezuela to Colombia before and"/>
   <result pre="the Caribbean islands; it is possible that the strains of" exact="CHIKV" post="mutated in their movement from Sant Martin December 2013,"/>
   <result pre="who traveled to Bogotá D.C and had a co-infection with" exact="Zika" post="virus and CHIKV32. The altitude of Bogotá at 2600"/>
   <result pre="of CHIKV17,18. In this sense, our study suggests that the" exact="CHIKV" post="of Saint Barts circulates in Cundinamarca or nearby departments."/>
   <result pre="than two years apart (2014 to 2016), suggests that the" exact="CHIKV" post="of Saint Bart and Colombia is a variant within"/>
   <result pre="to a recombination event, which has already been reported for" exact="CHIKV" post="and other alphaviruses. In this study, we have no"/>
   <result pre="in the same individual and found that the majority of" exact="CHIKV" post="polymorphisms occurred in non-structural proteins and 3′UTR34. The biological"/>
   <result pre="The biological function of synonymous and non-synonymous substitutions in Colombian" exact="CHIKV" post="is unknown, and it would be interesting to carry"/>
   <result pre="hand, E2-I211T increases the infectivity in Ae. albopictus of strains" exact="CHIKV" post="E1-226V, but does not affect Ae. Aegypti37,38. It is"/>
   <result pre="the genetic diversity and polymorphism in several American countries of" exact="CHIKV" post="genomes implied evolutionary diversification and possible adaptation to human"/>
   <result pre="subclades showed different non-synonymous mutations with likely functional consequences for" exact="CHIKV" post="biology and pathogenesis. Methods Ethical approval and informed consent"/>
   <result pre="had complete clinical and epidemiological records and were positive for" exact="CHIKV" post="by qRT-PCR (LightMix Chikungunya Virus Kit, Roche, USA). The"/>
   <result pre="epidemiological records and were positive for CHIKV by qRT-PCR (LightMix" exact="Chikungunya" post="Virus Kit, Roche, USA). The viral loads ranged between"/>
   <result pre="or potentially infectious material. RNA extraction, RT-PCR, and confirmation of" exact="CHIKV" post="The RNA was obtained from 140 μl of the supernatant"/>
   <result pre="Random Primers (0.5 μg/μl, Promega) were used. For the confirmation of" exact="CHIKV" post="in viral cultures, TaqMan Fast Universal PCR Master Mix"/>
   <result pre="and 5 µl of cDNA. As positive controls, a culture of" exact="CHIKV" post="confirmed by conventional PCR was used; ultra-pure water served"/>
   <result pre="or equal to 38 were considered positive Amplification of the" exact="CHIKV" post="genome by PCR 16 viral isolates of CHIKV were"/>
   <result pre="of the CHIKV genome by PCR 16 viral isolates of" exact="CHIKV" post="were selected based on their geographical origin: Cartagena n = 7,"/>
   <result pre="Department of Huila n = 1 (Table 2). For amplification of the" exact="CHIKV" post="genome, twelve sets of primers previously reported by Stapleford"/>
   <result pre="sequences assembled in this study and 157 complete genomes of" exact="CHIKV" post="available in GenBank. The GenBank sequences belonged to the"/>
   <result pre="Health Organization, World Health Organization. Number of reported cases of" exact="Chikungunya" post="fever in the Americas: Epidemiological Week 1–52, 2014, https://www.paho.org/hq/index.php?option = com_topics&amp;amp;view = rdmore&amp;amp;cid = 7928&amp;amp;item = chikungunya&amp;amp;cat = statistics&amp;amp;type = 2014-7928&amp;amp;Itemid = 40931&amp;amp;lang = en"/>
   <result pre="and in vitro infectivity differences among Cosmopolitan genotype strains of" exact="Chikungunya" post="virusInfection, genetics and evolution20163717418410.1016/j.meegid.2015.11.01926611825 6.ShragaiTTeslaBMurdockCHarringtonLCZika and chikungunya: mosquito-borne viruses"/>
   <result pre="considerations in development of vaccines to prevent disease caused by" exact="Chikungunya" post="virusVaccine2017354851485810.1016/j.vaccine.2017.07.06528760614 11.VuDMJungkindDAngelle DesireeLChikungunya VirusClinics in laboratory medicine20173737138210.1016/j.cll.2017.01.00828457355 12.WeberCet al.Identification"/>
   <result pre="in laboratory medicine20173737138210.1016/j.cll.2017.01.00828457355 12.WeberCet al.Identification of Functional Determinants in the" exact="Chikungunya" post="Virus E2 ProteinPLoS neglected tropical diseases201711e000531810.1371/journal.pntd.000531828114368 13.MendezNOviedo-PastranaMMattarSCaicedo-CastroIArrietaGZika virus disease,"/>
   <result pre="syndrome in Colombia: epidemiological situation during 21 months of the" exact="Zika" post="virus outbreak, 2015-2017Archives of public health=Archives belges de sante"/>
   <result pre="public health=Archives belges de sante publique2017756510.1186/s13690-017-0233-529118981 14.Laiton-DonatoKet al.Phylogenetic analysis of" exact="Chikungunya" post="virus in Colombia: Evidence of purifying selection in the"/>
   <result pre="Nacional de Salud201536253410.7705/biomedica.v36i0.299027622790 15.Pan American Healt Organization. Geographic Spread of" exact="Chikungunya" post="in the Americas for december 2013–December 2017. http://ais.paho.org/phip/viz/ed_chikungunya_amro.asp (2017)."/>
   <result pre="Boletin epidemiológico 37 de 2014. https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2014%20Boletin%20epidemiologico%20semana%2037.pdf (2014). 20.MattarSet al.Outbreak of" exact="Chikungunya" post="virus in the north Caribbean area of Colombia: clinical"/>
   <result pre="ratesJournal of virology2010846497650410.1128/JVI.01603-0920410280 22.NunesMRet al.Emergence and potential for spread of" exact="Chikungunya" post="virus in BrazilBMC medicine20151310210.1186/s12916-015-0348-x25976325 23.ChenRet al.Comprehensive Genome Scale Phylogenetic"/>
   <result pre="Phylogenetic Study Provides New Insights on the Global Expansion of" exact="Chikungunya" post="VirusJournal of virology201690106001061110.1128/JVI.01166-1627654297 24.RodasJDet al.Genetic Characterization of Northwestern Colombian"/>
   <result pre="Chikungunya VirusJournal of virology201690106001061110.1128/JVI.01166-1627654297 24.RodasJDet al.Genetic Characterization of Northwestern Colombian" exact="Chikungunya" post="Virus Strains from the 2014-2015 EpidemicThe American journal of"/>
   <result pre="journal of tropical medicine and hygiene20169440040310.4269/ajtmh.15-049726643533 32.Cherabuddi, K. et al." exact="Zika" post="and Chikungunya virus co-infection in a traveller returning from"/>
   <result pre="tropical medicine and hygiene20169440040310.4269/ajtmh.15-049726643533 32.Cherabuddi, K. et al. Zika and" exact="Chikungunya" post="virus co-infection in a traveller returning from Colombia, 2016:"/>
   <result pre="Instituto Nacional de Salud20163630330810.7705/biomedica.v36i2.330127622492 34.StaplefordKAet al.Whole-Genome Sequencing Analysis from the" exact="Chikungunya" post="Virus Caribbean Outbreak Reveals Novel Evolutionary Genomic ElementsPLoS neglected"/>
   <result pre="in the E2 Glycoprotein and the 3′ Untranslated Region Enhance" exact="Chikungunya" post="Virus Virulence in Mice. Journal of virology, 10.1128/JVI.00816-17 (2017)."/>
   <result pre="Medical Research Involving Human Subjects. https://www.wma.net/wp-content/uploads/2016/11/DoH-Oct2013-JAMA.pdf (2013). 41.Paternina-CaicedoAet al.Features of" exact="Dengue" post="and Chikungunya Infections of Colombian Children under 24 Months"/>
   <result pre="Involving Human Subjects. https://www.wma.net/wp-content/uploads/2016/11/DoH-Oct2013-JAMA.pdf (2013). 41.Paternina-CaicedoAet al.Features of Dengue and" exact="Chikungunya" post="Infections of Colombian Children under 24 Months of Age"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6624372\results\search\tropicalVirus\results.xml">
   <result pre="Modell20102212152410.1016/j.ecolmodel.2009.10.009 28.TjadenNBet al.Modelling the effects of global climate change on" exact="Chikungunya" post="transmission in the 21st centurySci Rep20177381310.1038/s41598-017-03566-328630444 29.MillerRobin H.MasuokaPennyKleinTerry A.KimHeung-ChulSomerToddGriecoJohnEcological"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6629778\results\search\tropicalVirus\results.xml">
   <result pre="study three mosquito-borne flaviviruses that cause neurological disease in humans:" exact="West Nile," post="Dengue, and Zika. We also propose a roadmap for"/>
   <result pre="on mosquito-borne flavivirus neuropathogenesis, prevention, and treatment. mosquito-borne flavivirus flaviviridae" exact="Zika" post="virus (ZIKV) West Nile virus (WNV) Dengue virus (DENV)"/>
   <result pre="neuropathogenesis, prevention, and treatment. mosquito-borne flavivirus flaviviridae Zika virus (ZIKV)" exact="West Nile" post="virus (WNV) Dengue virus (DENV) neuropathogenesis in vitro in"/>
   <result pre="mosquito-borne flavivirus flaviviridae Zika virus (ZIKV) West Nile virus (WNV)" exact="Dengue" post="virus (DENV) neuropathogenesis in vitro in silico fig-count: table-count:"/>
   <result pre="that have recently emerged in the Western world, such as" exact="Dengue" post="virus (DENV), Zika virus (ZIKV), and West Nile virus"/>
   <result pre="emerged in the Western world, such as Dengue virus (DENV)," exact="Zika" post="virus (ZIKV), and West Nile virus (WNV), deserve attention"/>
   <result pre="world, such as Dengue virus (DENV), Zika virus (ZIKV), and" exact="West Nile" post="virus (WNV), deserve attention due to the unexpected high"/>
   <result pre="affected regions (Sips et al., 2012; Muñoz et al., 2017)." exact="WNV" post="was endemic in some regions in Europe, Asia and"/>
   <result pre="(Chancey et al., 2015). One in 150 individuals infected by" exact="WNV" post="experience a neurological disease characterized by encephalitis, meningoencephalitis, meningitis,"/>
   <result pre="et al., 2001; Mostashari et al., 2001). Mortality due to" exact="WNV" post="encephalitis ranges between 10 and 17% and increases with"/>
   <result pre="increases with age and immunosuppression state (Petersen et al., 2013)." exact="DENV" post="is the second most common mosquito-borne infection and is"/>
   <result pre="21% of cases in some reports (Domingues et al., 2008)." exact="ZIKV" post="is the most recent emerging MBF in the Americas."/>
   <result pre="in newborns and Guillain-Barré syndrome (GBS) in adults infected with" exact="ZIKV" post="was reported (do Rosário et al., 2016). Today, it"/>
   <result pre="(do Rosário et al., 2016). Today, it is known that" exact="ZIKV" post="causes fetal brain malformations and triggers GBS (Beckham et"/>
   <result pre="and triggers GBS (Beckham et al., 2016). WNV, DENV, and" exact="ZIKV" post="RNA have been found in the cerebrospinal fluid of"/>
   <result pre="MBF drug candidates are scarce. Several candidates of a human" exact="WNV" post="vaccine have undergone pre-clinical testing mainly in mice, horses,"/>
   <result pre="has been licensed for use in humans. Clinical trials for" exact="ZIKV" post="vaccines are still in the early stages. Only one"/>
   <result pre="or &quot;Dengvaxia,�? a recombinant, chimeric, live attenuated tetravalent vaccine for" exact="DENV" post="has been licensed. The manufacturing and licensing of antiviral"/>
   <result pre="The development of experimental models of neuropathogenesis following WNF and" exact="ZIKV" post="infection has thus been a central focus in preclinical"/>
   <result pre="of this virus (Chan et al., 2015). However, neuropathgogenesis of" exact="DENV" post="is generally less well studies and not a focus"/>
   <result pre="novel vaccines for MBFs has been demonstrated in primates for" exact="DENV" post="(Guirakhoo et al., 2004), WNV (Petersen et al., 2013),"/>
   <result pre="been demonstrated in primates for DENV (Guirakhoo et al., 2004)," exact="WNV" post="(Petersen et al., 2013), and ZIKV (Abbink et al.,"/>
   <result pre="(Guirakhoo et al., 2004), WNV (Petersen et al., 2013), and" exact="ZIKV" post="(Abbink et al., 2016), but their efficacy in humans"/>
   <result pre="demonstrated to favor resistance to disease after peripheral inoculation with" exact="DENV" post="and ZIKV (Clark et al., 2012; Zompi and Harris,"/>
   <result pre="favor resistance to disease after peripheral inoculation with DENV and" exact="ZIKV" post="(Clark et al., 2012; Zompi and Harris, 2012), so"/>
   <result pre="in vitro and in silico research on DENV, WNV, and" exact="ZIKV" post="and to define a roadmap for 21st century biomedical"/>
   <result pre="reduce the global burden of neurological disease caused by flavivirus." exact="DENV" post="continues its steady expansion and constitutes the most common"/>
   <result pre="expansion and constitutes the most common mosquito-borne viral disease worldwide." exact="WNV" post="is the most widespread flavivirus causing neurological disease in"/>
   <result pre="and exemplifies the potential transmission of flaviviruses outside tropical regions." exact="ZIKV" post="recently caused an unpredicted epidemic in the Americas is"/>
   <result pre="the mainstay intervention to prevent flavivirus infection. Though an efficient" exact="WNV" post="vaccine for humans is not available, vaccination of equine"/>
   <result pre="2003; El Garch et al., 2008). This is possible because" exact="WNV" post="primary reservoirs are birds and horses, while humans are"/>
   <result pre="and horses, while humans are dead-end hosts for the virus." exact="WNV" post="live attenuated vaccines are the most advanced and had"/>
   <result pre="al., 2007; Ledgerwood et al., 2011). The development of a" exact="DENV" post="vaccine has been a complex task to accomplish for"/>
   <result pre="there is no an adequate animal model that recapitulates human" exact="DENV" post="infection. Second, DENV has four antigenically different serotypes, each"/>
   <result pre="an adequate animal model that recapitulates human DENV infection. Second," exact="DENV" post="has four antigenically different serotypes, each with intrinsic genetic"/>
   <result pre="the humoral response fails to neutralize the other serotypes. Third," exact="DENV" post="heterotypic infections have been associated with an increased likelihood"/>
   <result pre="Metz, 2017). Due to these concerns the development of a" exact="DENV" post="tetravalent vaccine has been the focus over the 21st"/>
   <result pre="Villar et al., 2015). There are no approved vaccines against" exact="ZIKV" post="infection. Tebas et al. conducted a phase I clinical"/>
   <result pre="There are some phase I and II clinical trials on" exact="ZIKV" post="vaccine. However, the preliminary results will be available a"/>
   <result pre="CYD-TDV vaccine was demonstrated in naïve and seropositive patients to" exact="DENV" post="infection in India in 2016 (Dubey et al., 2016)."/>
   <result pre="a live attenuated tetravalent vaccine, in regions with 70% of" exact="DENV" post="seroprevalence. To date Dengvaxia is licensed in 11 countries"/>
   <result pre="in individuals who completed 2 or 3 doses of vaccination." exact="DENV" post="vaccine development has been limited by the lack of"/>
   <result pre="the infection and the risks attributed to past exposure to" exact="DENV" post="infections, other flaviviruses or similar vaccines. Drugs Human clinical"/>
   <result pre="prevent flavivirus infection. There are no current treatments available for" exact="DENV" post="infection. In 2016, a clinical trial testing celgosivir, an"/>
   <result pre="cultures, microphysiological system, microphysiological systems OR AND OR Zika, ZIKV," exact="West Nile," post="WNV, Dengue, DENV QSAR, molecular mechanism, molecular mechanisms, systems"/>
   <result pre="systems OR AND OR Zika, ZIKV, West Nile, WNV, Dengue," exact="DENV" post="QSAR, molecular mechanism, molecular mechanisms, systems biology, pathway, pathways,"/>
   <result pre="a high-content screening platform to study possible antiviral candidates for" exact="ZIKV" post="was developed, in which human neural progenitor cells (NPCs)"/>
   <result pre="in which human neural progenitor cells (NPCs) were treated, following" exact="ZIKV" post="infection, with over 1,000 US FDA approved drugs and"/>
   <result pre="of reviewed in vitro studies focused on DENV, followed by" exact="WNV" post="(111/412 studies) and ZIKV (73/412 studies) (Figure 1B). DENV"/>
   <result pre="studies focused on DENV, followed by WNV (111/412 studies) and" exact="ZIKV" post="(73/412 studies) (Figure 1B). DENV is considered the most"/>
   <result pre="by WNV (111/412 studies) and ZIKV (73/412 studies) (Figure 1B)." exact="DENV" post="is considered the most common mosquito-borne infection after malaria;"/>
   <result pre="common mosquito-borne infection after malaria; therefore, it was expected that" exact="DENV" post="would be the most studied MBF in the in"/>
   <result pre="There were fewer studies on ZIKV, which is understandable, because" exact="ZIKV" post="outbreaks have only raised concern in recent years. Several"/>
   <result pre="have been used to study the activation of pDC after" exact="DENV" post="infection and their potential antiviral role (Gandini et al.,"/>
   <result pre="the studies that used iPSC cells were developed to study" exact="ZIKV" post="in 3D in vitro models of the brain, such"/>
   <result pre="Such models have emerged in response to new epidemics of" exact="ZIKV" post="in the Americas and around the world as well"/>
   <result pre="studies utilized monolayer cultures (400/412 studies) and were performed on" exact="WNV" post="and DENV, while only a few papers used 3D"/>
   <result pre="3D cultures (24/412 studies), and these were mostly focused on" exact="ZIKV" post="(Cugola et al., 2016; Dang et al., 2016; Wells"/>
   <result pre="Models of Brain Pathology in MBF Infection ZIKV, DENV, and" exact="WNV" post="infection can lead to severe neurological problems. These include"/>
   <result pre="human brain was used to understand the replicative properties of" exact="WNV" post="in each cell population. It was determined that WNV"/>
   <result pre="of WNV in each cell population. It was determined that" exact="WNV" post="mainly replicates in neurons and astrocytes and that following"/>
   <result pre="Arlotta, 2017; Sloan et al., 2017). The recent outbreak of" exact="ZIKV" post="has also generated an increase in the number of"/>
   <result pre="publications focused on brain models as a platform to study" exact="ZIKV" post="(Cugola et al., 2016; Dang et al., 2016; Nowakowski"/>
   <result pre="Hartung, 2017; Booij et al., 2019) including their use for" exact="ZIKV" post="research (da Silva et al., 2018; Majolo et al.,"/>
   <result pre="more susceptible to altered cell cycle and cell death following" exact="ZIKV" post="infection (Cugola et al., 2016; Dang et al., 2016;"/>
   <result pre="Moreover, studies in cerebral organoids have shown that exposure to" exact="ZIKV" post="at early stages of differentiation disrupts organoid expansion and"/>
   <result pre="et al., 2017). Other cerebral organoid studies have shown that" exact="ZIKV" post="targets and replicates in proliferating ventricular zone (VZ) apical"/>
   <result pre="et al., 2016) and to explore the oncolytic potential of" exact="ZIKV" post="(Zhu et al., 2017). Other iPSC-derived 3D models have"/>
   <result pre="WNV, six studies on DENV, and only one study on" exact="ZIKV" post="were retrieved in this literature review). Although the current"/>
   <result pre="BBB models have been used to study membrane integrity following" exact="DENV" post="infection of endothelial cells, and these studies demonstrated an"/>
   <result pre="and these studies demonstrated an increase in vascular permeability after" exact="DENV" post="infection (Dewi et al., 2004; Talavera et al., 2004)."/>
   <result pre="(Dewi et al., 2004; Talavera et al., 2004). In addition," exact="DENV" post="has been demonstrated to induce IL-6 and IL-8 production"/>
   <result pre="al., 1998). Endothelial cells have also been used to study" exact="WNV" post="(Verma et al., 2009; Roe et al., 2014). The"/>
   <result pre="al., 2014). The majority of papers retrieved involving BBB and" exact="WNV" post="employed simplistic, monolayer cultures of human brain microvascular endothelial"/>
   <result pre="al., 2014; Roe et al., 2014; Lazear et al., 2015)." exact="ZIKV" post="presented a limited bibliography, with only one paper for"/>
   <result pre="et al., 2017). Infection studies using this model demonstrated that" exact="ZIKV" post="did not easily infect the HBMEC model, but that"/>
   <result pre="exposure to TNF-α could enhance infection (Bramley et al., 2017)." exact="ZIKV" post="has also been studied using models of other biological"/>
   <result pre="mainly used to study DENV, with fewer studies found for" exact="WNV" post="or ZIKV. Most in vitro studies on MBF infection"/>
   <result pre="role in connecting the vertebrate neuronal and immune systems in" exact="WNV" post="pathogenesis (Sultana et al., 2012). The majority of papers"/>
   <result pre="3D iPSC derived model in order to study inflammation after" exact="ZIKV" post="infection (Abreu et al., 2018). However, integrating the wider,"/>
   <result pre="1B). The majority of in silico studies were focused on" exact="DENV" post="(180/253 studies), followed by WNV (75/253 studies), and ZIKV"/>
   <result pre="silico studies were focused on DENV (180/253 studies), followed by" exact="WNV" post="(75/253 studies), and ZIKV (66/253 studies) (Figure 1B). There"/>
   <result pre="on DENV (180/253 studies), followed by WNV (75/253 studies), and" exact="ZIKV" post="(66/253 studies) (Figure 1B). There were also studies labeled"/>
   <result pre="al., 2016) or the RNA dependent RNA polymerase domain of" exact="DENV" post="(Anusuya et al., 2016; Elfiky, 2016; Manvar et al.,"/>
   <result pre="screened for their binding affinity to the structures of the" exact="ZIKV" post="protease, helicase, methyltransferase, and polymerase (Byler et al., 2016)."/>
   <result pre="their ability to bind to the viral envelope proteins of" exact="DENV" post="(Li et al., 2008; Zhou et al., 2008; Wang"/>
   <result pre="Computational approaches have been used to build on naturally occurring" exact="DENV" post="sequences, predicting novel peptide structures that display increased target"/>
   <result pre="et al., 2010). More recently, a homology model of the" exact="ZIKV" post="envelope protein was resolved, and a simulation-based approach was"/>
   <result pre="was used to demonstrate that a monoclonal antibody that neutralizes" exact="DENV" post="and WNV in vitro and in in vivo mouse"/>
   <result pre="to demonstrate that a monoclonal antibody that neutralizes DENV and" exact="WNV" post="in vitro and in in vivo mouse studies binds"/>
   <result pre="evidence that an antiviral compound binds to and inhibits the" exact="DENV" post="capsid protein (Scaturro et al., 2014). Structure-activity relationships have"/>
   <result pre="been used to identify the inhibitory functional groups of a" exact="DENV" post="NS2B-NS3 protease inhibitor identified with cell culture experiments (Tomlinson"/>
   <result pre="the stereo-electronic properties that allowed these compounds to also confer" exact="DENV" post="antiviral activity in cell culture (Balasubramanian et al., 2017)."/>
   <result pre="For example, molecular modeling of the protease-inhibitor complex of potential" exact="ZIKV" post="antivirals was used to identify structural scaffolds for allosteric"/>
   <result pre="to identify structural scaffolds for allosteric small-molecule inhibitors of the" exact="ZIKV" post="NS2B-NS3 protease, and the most potent inhibitors were then"/>
   <result pre="in vivo in mice and found to demonstrate inhibition of" exact="ZIKV" post="propagation (Shiryaev et al., 2017). Overall, the recent computational"/>
   <result pre="first step in the design of epitope-based peptide vaccines for" exact="DENV" post="(Lund et al., 2011; Jones et al., 2017), WNV"/>
   <result pre="for DENV (Lund et al., 2011; Jones et al., 2017)," exact="WNV" post="(Larsen et al., 2010), and ZIKV (Alam et al.,"/>
   <result pre="Jones et al., 2017), WNV (Larsen et al., 2010), and" exact="ZIKV" post="(Alam et al., 2016; Dikhit et al., 2016; Ali"/>
   <result pre="a tetravalent protein subunit vaccine for all four serotypes of" exact="DENV" post="(Fahimi et al., 2016). A mathematical model that simulates"/>
   <result pre="the role of both viral and human microRNA in congenital" exact="ZIKV" post="microcephaly (Pylro et al., 2016). In addition to studies"/>
   <result pre="have also been used to explore the mechanism by which" exact="DENV" post="infects and replicates within host cells (Anglero-Rodriguez et al.,"/>
   <result pre="et al., 2014), and to predict human protein interactions with" exact="DENV" post="(Doolittle and Gomez, 2011). Computational methods have also been"/>
   <result pre="also been used to identify patterns in inter-individual variation in" exact="DENV" post="viral load following infection (Ben-Shachar et al., 2016). Also,"/>
   <result pre="plasticity. Computer-based prediction of the intrinsically disordered proteins (IDP) in" exact="DENV" post="revealed a positive correlation between the level of IDP"/>
   <result pre="revealed a positive correlation between the level of IDP in" exact="DENV" post="and WNV capsid and membrane proteins and virulence (Goh"/>
   <result pre="positive correlation between the level of IDP in DENV and" exact="WNV" post="capsid and membrane proteins and virulence (Goh et al.,"/>
   <result pre="and vector life cycle model inputs to predict transmission of" exact="WNV" post="(Bouden et al., 2008; Laperriere et al., 2011; Manore"/>
   <result pre="2008; Laperriere et al., 2011; Manore et al., 2014) and" exact="DENV" post="(Fan et al., 2010; Chowell et al., 2011; Otero"/>
   <result pre="search trends or other web-based data sources for epidemics of" exact="DENV" post="(Yang et al., 2017) and ZIKV (Majumder et al.,"/>
   <result pre="sources for epidemics of DENV (Yang et al., 2017) and" exact="ZIKV" post="(Majumder et al., 2016; Wang et al., 2016; McGough"/>
   <result pre="infection is considered a major public health concern, and DENV," exact="ZIKV" post="and WNV, in particular, present a high burden of"/>
   <result pre="diagnose MBF infection and elucidate MBF reservoirs (e.g., urine in" exact="ZIKV" post="infection). Table 2 Problems and possible solutions for MBF"/>
   <result pre="T.BoydM.et al.. (2016). Protective efficacy of multiple vaccine platforms against" exact="Zika" post="virus challenge in rhesus monkeys. Science353, 1129–1132. 10.1126/science.aah615727492477 AbreuC."/>
   <result pre="vaccine: in silico approach for the epitope-based peptide vaccine against" exact="Zika" post="virus envelope glycoprotein. Immunology149, 386–399. 10.1111/imm.1265627485738 AlepeeN.BahinskiA.DaneshianM.De WeverB.FritscheE.GoldbergA.et al.."/>
   <result pre="Biol.76, 697–717. 10.1007/s11538-014-9939-524619807 AmannaI. J.SlifkaM. K. (2014). Current trends in" exact="West Nile" post="virus vaccine development. Expert Rev. Vaccines13, 589–608. 10.1586/14760584.2014.90630924689659 AmorimJ."/>
   <result pre="dengue virus infection. Virology263, 70–77. 10.1006/viro.1999.988710544083 Anglero-RodriguezY. I.PantojaP.SariolC. A. (2014)." exact="Dengue" post="virus subverts the interferon induction pathway via NS2B/3 protease-IkappaB"/>
   <result pre="B.WangG.OmaluB. I.TeshR. B.GyureK. A.ChuteD. J.et al.. (2007). Systemic distribution of" exact="West Nile" post="virus infection: postmortem immunohistochemical study of six cases. Brain"/>
   <result pre="system. Proc. Natl. Acad. Sci. U.S.A.104, 9540–9545. 10.1073/pnas.061068510417519336 AvirutnanP.MalasitP.SeligerB.BhakdiS.HusmannM. (1998)." exact="Dengue" post="virus infection of human endothelial cells leads to chemokine"/>
   <result pre="activities of selected antimalarials against dengue virus type 2 and" exact="Zika" post="virus. Antiviral Res.137, 141–150. 10.1016/j.antiviral.2016.11.01527889529 BangS.LeeS. R.KoJ.SonK.TahkD.AhnJ.et al.. (2017)."/>
   <result pre="Am. J. Trop. Med. Hyg.93, 441–453. 10.4269/ajtmh.14-062526175027 BearcroftW. G. (1956)." exact="Zika" post="virus infection experimentally induced in a human volunteer. Trans."/>
   <result pre="clinical trial. Vaccine.29, 960–968. 10.1016/j.vaccine.2010.11.05021111785 BeckhamJ. D.PastulaD. M.MasseyA.TylerK. L. (2016)." exact="Zika" post="virus as an emerging global pathogen: neurological complications of"/>
   <result pre="multicenter study to investigate the immunogenicity and safety of a" exact="West Nile" post="virus vaccine in healthy adults. J. Infect. Dis.203, 75–84."/>
   <result pre="SLAS Discov. 24, 615–627. 10.1177/247255521983008730817892 BoudenM.MoulinB.GosselinP. (2008). The geosimulation of" exact="West Nile" post="virus propagation: a multi-agent and climate sensitive tool for"/>
   <result pre="(2014). Emergency department management of mosquito-borne illness: malaria, dengue, and" exact="West Nile" post="virus. Emerg Med Pract16, 23–24. 25207355 CarteauxG.MaquartM.BedetA.ContouD.BrugièresP.FouratiS.et al.. (2016)."/>
   <result pre="Nile virus. Emerg Med Pract16, 23–24. 25207355 CarteauxG.MaquartM.BedetA.ContouD.BrugièresP.FouratiS.et al.. (2016)." exact="Zika" post="virus associated with meningoencephalitis. N. Engl. J. Med.374, 1595–1596."/>
   <result pre="5–14. 10.1016/j.antiviral.2015.08.01326304704 ChanceyC.GrinevA.VolkovaE.RiosM. (2015). The global ecology and epidemiology of" exact="West Nile" post="virus. Biomed Res. Int.2015:376230. 10.1155/2015/37623025866777 ChanprasopchaiP.PongsumpunP.TangI. M. (2017). Effect"/>
   <result pre="K.LokensgardJ. R. (2005). Differential responses of human brain cells to" exact="West Nile" post="virus infection. J. Neurovirol.11, 512–524. 10.1080/1355028050038498216338745 ChoH.SeoJ. H.WongK. H.TerasakiY.ParkJ.BongK.et"/>
   <result pre="Dis.11:164. 10.1186/1471-2334-11-16421651779 ChowersM. Y.LangR.NassarF.Ben-DavidD.GiladiM.RubinshteinE.et al.. (2001). Clinical characteristics of the" exact="West Nile" post="fever outbreak, Israel, 2000. Emerging Infect. Dis.7, 675–678. 10.3201/eid0704.01741411585531"/>
   <result pre="1519–1536. 10.1016/j.clinthera.2017.07.00128754189 CorreaA. R.BerbelA. C.PapaM. P.MoraisA. T.PeçanhaL. M.ArrudaL. B. (2015)." exact="Dengue" post="virus directly stimulates polyclonal B cell activation. PLoS ONE10:e0143391."/>
   <result pre="R.FernandesI. R.RussoF. B.FreitasB. C.DiasJ. L.GuimarãesK. P.et al.. (2016). The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental models. Nature534,"/>
   <result pre="virus treatment. Viruses10:255. 10.3390/v1005025529758005 DangJ.TiwariS. K.LichinchiG.QinY.PatilV. S.EroshkinA. M.et al.. (2016)." exact="Zika" post="virus depletes neural progenitors in human cerebral organoids through"/>
   <result pre="Computational prediction and analysis of potential antigenic CTL epitopes in" exact="Zika" post="virus: a first step towards vaccine development. Infect. Genet."/>
   <result pre="187–197. 10.1016/j.meegid.2016.08.03727590716 DinizJ. A.Da RosaA. P.GuzmanH.XuF.XiaoS. Y.PopovV. L.et al.. (2006)." exact="West Nile" post="virus infection of primary mouse neuronal and neuroglial cells:"/>
   <result pre="36–40. 10.1016/j.jns.2007.09.04017959198 DoolittleJ. M.GomezS. M. (2011). Mapping protein interactions between" exact="Dengue" post="virus and its human and insect hosts. PLoS Negl."/>
   <result pre="cell localization and fate within the central nervous system during" exact="West Nile" post="Virus encephalitis. J. Immunol.193, 4095–4106. 10.4049/jimmunol.140119225200953 DwivediV. D.TripathiI. P.MishraS."/>
   <result pre="Trop. Dis.10:e0005023. 10.1371/journal.pntd.000502327764115 El GarchH.MinkeJ. M.RehderJ.RichardS.Edlund ToulemondeC.DinicS.et al.. (2008). A" exact="West Nile" post="virus (WNV) recombinant canarypox virus vaccine elicits WNV- specific"/>
   <result pre="the horse. Vet. Immunol. Immunopathol.123, 230–239. 10.1016/j.vetimm.2008.02.00218372050 ElfikyA. A. (2016)." exact="Zika" post="viral polymerase inhibition using anti-HCV drugs both in market"/>
   <result pre="impact of maturation delay of mosquitoes on the transmission of" exact="West Nile" post="virus. Math. Biosci.228, 119–126. 10.1016/j.mbs.2010.08.01020828577 FangY.EglenR. M. (2017). Three-dimensional"/>
   <result pre="Cell Stem Cell20, 397–406.e395. 10.1016/j.stem.2016.12.00528132835 GandiniM.GrasC.AzeredoE. L.PintoL. M.SmithN.DespresP.et al.. (2013)." exact="Dengue" post="virus activates membrane TRAIL relocalization and IFN-alpha production by"/>
   <result pre="10.1371/journal.pntd.000225723755314 GarcezP. P.NascimentoJ. M.de VasconcelosJ. M.Madeiro da CostaR.DelvecchioR.TrindadeP.et al.. (2017)." exact="Zika" post="virus disrupts molecular fingerprinting of human neurospheres. Sci. Rep.7:40780."/>
   <result pre="evasion. Mol. Biosyst.12, 1881–1891. 10.1039/C6MB00228E27102744 GoodfellowF. T.TeslaB.SimchickG.ZhaoQ.HodgeT.BrindleyM. A.et al.. (2016)." exact="Zika" post="virus induced mortality and microcephaly in chicken embryos. Stem"/>
   <result pre="infection. BMC Genomics11:380. 10.1186/1471-2164-11-38020553610 HasebeR.SuzukiT.MakinoY.IgarashiM.YamanouchiS.MaedaA.et al.. (2010). Transcellular transport of" exact="West Nile" post="virus-like particles across human endothelial cells depends on residues"/>
   <result pre="Biosci. Eng.6, 301–319. 10.3934/mbe.2009.6.30119364154 HuangC.SlaterB.RuddR.ParchuriN.HullR.DupuisM.et al.. (2002). First Isolation of" exact="West Nile" post="virus from a patient with encephalitis in the United"/>
   <result pre="dengue human monoclonal antibody prevents severe pathologies and death from" exact="Zika" post="virus infections. JCI Insight2:8. 10.1172/jci.insight.9242828422757 KimuraT.SasakiM.OkumuraM.KimE.SawaH. (2010). Flavivirus encephalitis:"/>
   <result pre="Simulation of the seasonal cycles of bird, equine and human" exact="West Nile" post="virus cases. Prev. Vet. Med.98, 99–110. 10.1016/j.prevetmed.2010.10.01321093946 LarsenM. V.LelicA.ParsonsR.NielsenM.HoofI.LamberthK.et"/>
   <result pre="al.. (2010). Identification of CD8+ T cell epitopes in the" exact="West Nile" post="virus polyprotein by reverse-immunology using NetCTL. PLoS ONE5:e12697. 10.1371/journal.pone.001269720856867"/>
   <result pre="M.DanielsB. P.PintoA. K.HuangA. C.VickS. C.DoyleS. E.et al.. (2015). Interferon-lambda restricts" exact="West Nile" post="virus neuroinvasion by tightening the blood-brain barrier. Sci. Transl."/>
   <result pre="Med.7:284ra259. 10.1126/scitranslmed.aaa430425904743 LedgerwoodJ. E.PiersonT. C.HubkaS. A.DesaiN.RuckerS.GordonI. J.et al.. (2011). A" exact="West Nile" post="virus DNA vaccine utilizing a modified promoter induces neutralizing"/>
   <result pre="J. Med. Chem.51, 4660–4671. 10.1021/jm800412d18610998 LiangQ.LuoZ.ZengJ.ChenW.FooS. S.LeeS. A.et al.. (2016)." exact="Zika" post="Virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in"/>
   <result pre="A relevant in vitro human model for the study of" exact="Zika" post="virus antibody-dependent enhancement. J. Gen. Virol.98, 1702–1712. 10.1099/jgv.0.00083328691657 LucasM.MashimoT.FrenkielM."/>
   <result pre="LucasM.MashimoT.FrenkielM. P.Simon-ChazottesD.MontagutelliX.CeccaldiP. E.et al.. (2003). Infection of mouse neurones by" exact="West Nile" post="virus is modulated by the interferon-inducible 2′-5′ oligoadenylate synthetase"/>
   <result pre="organoids in modeling the congenital infection and neuropathogenesis induced by" exact="Zika" post="virus. J. Med. Virol.91, 525–532. 10.1002/jmv.2534530357854 MajumderM. S.SantillanaM.MekaruS. R.McGinnisD."/>
   <result pre="375–390. 10.1016/j.cell.2015.06.03426186191 MartinJ. E.PiersonT. C.HubkaS.RuckerS.GordonI. J.EnamaM. E.et al.. (2007). A" exact="West Nile" post="virus DNA vaccine induces neutralizing antibody in healthy adults"/>
   <result pre="Trop. Med. Hyg.93, 454–460. 10.4269/ajtmh.14-081926149862 MaximovaO. A.BernbaumJ. G.PletnevA. G. (2016)." exact="West Nile" post="virus spreads transsynaptically within the pathways of motor control:"/>
   <result pre="Negl. Trop. Dis.10:e0004980. 10.1371/journal.pntd.000498027617450 McGoughS. F.BrownsteinJ. S.HawkinsJ. B.SantillanaM. (2017). Forecasting" exact="Zika" post="incidence in the 2016 Latin America outbreak combining traditional"/>
   <result pre="MoserL. A.LimP. Y.StyerL. M.KramerL. D.BernardK. A. (2016). Parameters of mosquito-enhanced" exact="West Nile" post="virus infection. J. Virol.90, 292–299. 10.1128/JVI.02280-1526468544 MostashariF.BunningM. L.KitsutaniP. T.SingerD."/>
   <result pre="292–299. 10.1128/JVI.02280-1526468544 MostashariF.BunningM. L.KitsutaniP. T.SingerD. A.NashD.CooperM. J.et al.. (2001). Epidemic" exact="West Nile" post="encephalitis, New York, 1999: results of a household-based seroepidemiological"/>
   <result pre="Immunol.61, 305–317. 10.1111/1348-0421.1249728603864 NgT.HathawayD.JenningsN.ChampD.ChiangY. W.ChuH. J. (2003). Equine vaccine for" exact="West Nile" post="virus. Dev. Biol.114, 221–227. 14677692 NowakowskiT. J.PollenA. A.Di LulloE.Sandoval-EspinosaC.BershteynM.KriegsteinA."/>
   <result pre="Cell Stem Cell18, 591–596. 10.1016/j.stem.2016.03.01227038591 OhY.ZhangF.WangY.LeeE. M.ChoiI. Y.LimH.et al.. (2017)." exact="Zika" post="virus directly infects peripheral neurons and induces cell death."/>
   <result pre="of culex pipiens complex populations and assessing abatement strategies for" exact="West Nile" post="Virus. PLoS ONE9:e108452. 10.1371/journal.pone.010845225268229 PetersenL. R.BraultA. C.NasciR. S. (2013)."/>
   <result pre="Nile Virus. PLoS ONE9:e108452. 10.1371/journal.pone.010845225268229 PetersenL. R.BraultA. C.NasciR. S. (2013)." exact="West Nile" post="virus: review of the literature. JAMA310, 308–315. 10.1001/jama.2013.804223860989 PhamM."/>
   <result pre="in dendritic cells from older donors infected in vitro with" exact="West Nile" post="virus. J. Infect. Dis.203, 1415–1424. 10.1093/infdis/jir04821398396 QianX.NguyenH. N.SongM. M.HadionoC.OgdenS."/>
   <result pre="M.HadionoC.OgdenS. C.HammackC.et al.. (2016). Brain-region-specific organoids using mini-bioreactors for modeling" exact="ZIKV" post="exposure. Cell165, 1238–1254. 10.1016/j.cell.2016.04.03227118425 QuadratoG.ArlottaP. (2017). Present and future"/>
   <result pre="organoids. Curr. Opin. Cell Biol.49, 47–52. 10.1016/j.ceb.2017.11.01029227864 RaekiansyahM.Espada-MuraoL. A.OkamotoK.KuboT.MoritaK. (2014)." exact="Dengue" post="virus neither directly mediates hyperpermeability nor enhances tumor necrosis"/>
   <result pre="J.SetohY. X.EdmondsJ. H.KhromykhA. A. (2015). Comparison of attenuated and virulent" exact="West Nile" post="virus strains in human monocyte-derived dendritic cells as a"/>
   <result pre="Oswaldo Cruz102, 983–990. 10.1590/S0074-0276200700080001418209938 RetallackH.Di LulloE.AriasC.KnoppK. A.LaurieM. T.Sandoval-EspinosaC.et al.. (2016)." exact="Zika" post="virus cell tropism in the developing human brain and"/>
   <result pre="azithromycin. Proc. Natl. Acad. Sci. U.S.A.113, 14408–14413. 10.1073/pnas.161802911327911847 RoeK.OrilloB.VermaS. (2014)." exact="West Nile" post="virus-induced cell adhesion molecules on human brain microvascular endothelial"/>
   <result pre="V.MirandaM.et al. (2017). The clinically approved antiviral drug sofosbuvir inhibits" exact="Zika" post="virus replication. Sci. Rep.7:4092010.1038/srep4092028098253 SahuR.VermaR.JainA.GargR. K.SinghM. K.MalhotraH. S.et al.."/>
   <result pre="cell-derived dorsomedial telencephalic tissue. Nat. Commun.6:9896. 10.1038/ncomms989626573335 SambriV.CapobianchiM.CharrelR.FyodorovaM.GaibaniP.GouldE.et al.. (2013)." exact="West Nile" post="virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention."/>
   <result pre="Virol.88, 11540–11555. 10.1128/JVI.01745-1425056895 ShaoQ.HerrlingerS.ZhuY. N.YangM.GoodfellowF.SticeS. L.et al.. (2017). The African" exact="Zika" post="virus MR-766 is more virulent and causes more severe"/>
   <result pre="10.1242/dev.15675228993398 ShiryaevS. A.FarhyC.PintoA.HuangC. T.SimonettiN.Elong NgonoA.et al.. (2017). Characterization of the" exact="Zika" post="virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric"/>
   <result pre="10.1016/j.antiviral.2017.04.01528461069 ShresthaB.GottliebD.DiamondM. S. (2003). Infection and injury of neurons by" exact="West Nile" post="encephalitis virus. J. Virol.77, 13203–13213. 10.1128/JVI.77.24.13203-13213.200314645577 SiemannD. N.StrangeD. P.MaharajP."/>
   <result pre="J. Virol.77, 13203–13213. 10.1128/JVI.77.24.13203-13213.200314645577 SiemannD. N.StrangeD. P.MaharajP. N.ShiP. Y.VermaS. (2017)." exact="Zika" post="virus infects human Sertoli cells and modulates the integrity"/>
   <result pre="L.AlbrightR. G.KramerL. D.BernardK. A. (2011). Mosquito saliva causes enhancement of" exact="West Nile" post="virus infection in mice. J. Virol.85, 1517–1527. 10.1128/JVI.01112-1021147918 SuH."/>
   <result pre="G.MontgomeryR. R.AndersonJ. F.KoskiR. A.et al.. (2012). Semaphorin 7A contributes to" exact="West Nile" post="virus pathogenesis through TGF-beta1/Smad6 signaling. J. Immunol.189, 3150–3158. 10.4049/jimmunol.120114022896629"/>
   <result pre="Hum. Vacc. Immunother.13, 1059–1072. 10.1080/21645515.2016.126177028281864 TsaiT. F.PopoviciF.CernescuC.CampbellG. L.NedelcuN. I. (1998)." exact="West Nile" post="encephalitis epidemic in southeastern Romania. Lancet352, 767–771. 10.1016/S0140-6736(98)03538-79737281 TsaiY."/>
   <result pre="flaviviruses. QJM105, 219–223. 10.1093/qjmed/hcs01322367423 van den PolA. N.MaoG.YangY.OrnaghiS.DavisJ. N. (2017)." exact="Zika" post="virus targeting in the developing brain. J. Neurosci.37, 2161–2175."/>
   <result pre="WHO/NIH meeting report on approaches to development and licensure of" exact="Zika" post="vaccine candidates. Vaccine37, 863–868. 10.1016/j.vaccine.2018.12.04030639461 VermaS.KumarM.GurjavU.LumS.NerurkarV. R. (2010). Reversal"/>
   <result pre="vaccine candidates. Vaccine37, 863–868. 10.1016/j.vaccine.2018.12.04030639461 VermaS.KumarM.GurjavU.LumS.NerurkarV. R. (2010). Reversal of" exact="West Nile" post="virus-induced blood-brain barrier disruption and tight junction proteins degradation"/>
   <result pre="by matrix metalloproteinases inhibitor. Virology397, 130–138. 10.1016/j.virol.2009.10.03619922973 VermaS.LoY.ChapagainM.LumS.KumarM.GurjavU.et al.. (2009)." exact="West Nile" post="virus infection modulates human brain microvascular endothelial cells tight"/>
   <result pre="1896–1901. 10.1073/pnas.25278449912578971 WichapongK.NueangaudomA.PianwanitS.SipplW.KokpolS. (2013). Identification of potential hit compounds for" exact="Dengue" post="virus NS2B/NS3 protease inhibitors by combining virtual screening and"/>
   <result pre="XuM.LeeE. M.WenZ.ChengY.HuangW. K.QianX.et al.. (2016). Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
   <result pre="765–775. 10.1021/cb800176t19053243 ZhuZ.GormanM. J.McKenzieL. D.ChaiJ. N.HubertC. G.PragerB. C.et al. (2017)." exact="Zika" post="virus has oncolytic activity against glioblastoma stem cells. J."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6630949\results\search\tropicalVirus\results.xml">
   <result pre="hepaciviruses, Ebola virus, arenaviruses, herpesviruses, and the flaviviruses (Zika virus," exact="West Nile" post="virus and Tick-borne encephalitis virus) [119,120,121]. Currently, phase III"/>
   <result pre="Chemother.2007513168317610.1128/AAC.00356-0717606691 108.MorreyJ.D.TaroB.S.SiddharthanV.WangH.SmeeD.F.ChristensenA.J.FurutaY.Efficacy of orally administered T-705 pyrazine analog on lethal" exact="West Nile" post="virus infection in rodentsAntivir. Res.20088037737910.1016/j.antiviral.2008.07.00918762216 109.Rocha-PereiraJ.JochmansD.DallmeierK.LeyssenP.NascimentoM.S.NeytsJ.Favipiravir (T-705) inhibits in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631207\results\search\tropicalVirus\results.xml">
   <result pre="pmcid: 6631207 doi: 10.3390/ph12020060pharmaceuticals-12-00060 : Review Late Neurological Consequences of" exact="Zika" post="Virus Infection: Risk Factors and Pharmaceutical Approaches SouzaIsis N."/>
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Zika" post="virus (ZIKV) infection was historically considered a disease with"/>
   <result pre="congenitally-exposed babies and in adult patients, have been reported after" exact="ZIKV" post="infection, especially after the 2015 epidemics in the American"/>
   <result pre="that genetic, epigenetic, and environmental factors may contribute to determine" exact="ZIKV" post="infection outcomes. This reinforces the importance that individuals exposed"/>
   <result pre="infection outcomes. This reinforces the importance that individuals exposed to" exact="ZIKV" post="are submitted to long-term clinical surveillance and highlights the"/>
   <result pre="screening pregnancy Food and Drug Administration (FDA) encephalitis 1. Introduction" exact="Zika" post="virus (ZIKV) has been known since 1947 [1], and"/>
   <result pre="in humans. In 2013, this view started to change when" exact="ZIKV" post="occurrence in French Polynesia was associated to development of"/>
   <result pre="It is predicted that over 800,000 people were infected by" exact="ZIKV" post="in the American continent between 2015 and 2018 [2]."/>
   <result pre="Following this epidemic, several studies endorsed a causal relationship between" exact="ZIKV" post="infection and neurological disorders, both in congenitally-exposed newborns and"/>
   <result pre="discuss experimental and clinical evidence of potential therapeutic approaches. 2." exact="ZIKV" post="Infection Is Associated to Late Detrimental Effects to the"/>
   <result pre="neuropathological conditions has been reported in newborn babies exposed to" exact="ZIKV" post="in uterus, being microcephaly the most severe outcome. Infants"/>
   <result pre="focused on unraveling the mechanisms of congenital microcephaly induced by" exact="ZIKV" post="[6,7,8]. However, increasing evidence from clinical and experimental studies"/>
   <result pre="According to US hospital records, 6% of children infected with" exact="ZIKV" post="in uterus showed malformations detectable at birth. Importantly, the"/>
   <result pre="and studies suggest that 60% of normocephalic babies exposed to" exact="ZIKV" post="in uterus present seizures at some stage of development"/>
   <result pre="cerebrospinal fluid space and ventricle enlargement [12]. Infants exposed to" exact="ZIKV" post="during the epidemic in the American continent are still"/>
   <result pre="underlying late ZIKV-induced neurological damage. Using a mouse model of" exact="ZIKV" post="infection, our group was able to predict possible long-term"/>
   <result pre="the second and third trimester of pregnancy [13,14,15], we performed" exact="ZIKV" post="infection shortly after birth (post-natal day 3). Indeed, we"/>
   <result pre="that closely resembled those seen in brains of babies after" exact="ZIKV" post="congenital infection. Over 90% of mice showed spontaneous seizures"/>
   <result pre="episodes resolved when animals became adults, mice infected neonatally with" exact="ZIKV" post="remained more susceptible to chemically-induced seizures. Besides, ZIKV-infected mice"/>
   <result pre="in which authors demonstrated that early-life infection with an African" exact="ZIKV" post="strain results in persistent memory impairments in mice [16]."/>
   <result pre="and decreased hippocampal growth in ZIKV-infected animals. Neurological complications following" exact="ZIKV" post="infection are not limited to cases of congenital infection"/>
   <result pre="cases of congenital infection [18]. Mounting clinical evidence show that" exact="ZIKV" post="infection in adult patients may result in encephalitis [18,19,20],"/>
   <result pre="not yet fully recovered [25]. Collectively, these reports demonstrate that" exact="ZIKV" post="infection is also detrimental to the mature nervous system"/>
   <result pre="mortality. Whether these neurological consequences are a direct effect of" exact="ZIKV" post="replication or are secondary to the host immune response"/>
   <result pre="following sections. Another matter of concern involves the ability of" exact="ZIKV" post="to persist in certain organs and tissues, since the"/>
   <result pre="tissues, since the late consequences of viral persistence remain unknown." exact="ZIKV" post="usually reaches detectable levels in the serum of patients"/>
   <result pre="and up to 200 days after infection, detectable levels of" exact="ZIKV" post="RNA were found in placenta of pregnant women [27]."/>
   <result pre="ZIKV RNA were found in placenta of pregnant women [27]." exact="ZIKV" post="was also shown to persists in semen samples up"/>
   <result pre="of symptoms, reinforcing the high risk of sexual transmission [28,29]." exact="ZIKV" post="RNA was found in brains of babies exposed in"/>
   <result pre="brain of a 5-month-old infected infant [5]. The ability of" exact="ZIKV" post="to replicate for long periods in specific tissues has"/>
   <result pre="found in immunocompetent mice infected during the neonatal period, where" exact="ZIKV" post="negative RNA strand was detectable in the brain into"/>
   <result pre="active viral replication [32]. Altogether, these results provide evidence that" exact="ZIKV" post="is capable of persisting in certain tissues long after"/>
   <result pre="contribute to the development of late neurological damage associated to" exact="ZIKV" post="infection, and what are the precise mechanisms involved. It"/>
   <result pre="is crucial to prevention and treatment of such severe sequelae." exact="ZIKV" post="strains isolated from different geographical regions are derived from"/>
   <result pre="is more cytotoxic and neurovirulent in experimental settings [33,34], the" exact="ZIKV" post="strain responsible for the outbreak in the Americas is"/>
   <result pre="neurovirulence [36]. Interestingly, this substitution emerged in the Southeast Asian" exact="ZIKV" post="strain shortly before the 2013 outbreak and was maintained"/>
   <result pre="in the subsequent epidemics in the Americas [36]. Mutations in" exact="ZIKV" post="genome may also promote host immune system evasion and"/>
   <result pre="the virus. African and Asian populations were highly exposed to" exact="ZIKV" post="historically [39,40,41,42,43], and it has been speculated that prior"/>
   <result pre="or insufficient. While type III IFN response is protective against" exact="ZIKV" post="infection [48], type I response is related to miscarriage"/>
   <result pre="during mid-gestation [49]. Several signaling pathways were shown to modulate" exact="ZIKV" post="infection and individual differences in their expression may confer"/>
   <result pre="differences in their expression may confer variable risk to congenital" exact="Zika" post="syndrome (CZS) and other neurological outcomes: TAM receptors (TYRO3,"/>
   <result pre="TAM receptors (TYRO3, AXL, and MER) are important in mediating" exact="ZIKV" post="persistence through type I IFN downregulation [50,51,52,53,54,55]; toll-like receptors"/>
   <result pre="or concomitant infection by other mosquito-borne viruses is high in" exact="ZIKV" post="endemic regions and co-infections might modulate the hosts’ immune"/>
   <result pre="way [60,61,62,63,64]. Experimental evidence suggest that mosquitoes previously infected with" exact="Chikungunya" post="virus have enhanced ZIKV infectivity and vector competence [65]."/>
   <result pre="suggest that mosquitoes previously infected with Chikungunya virus have enhanced" exact="ZIKV" post="infectivity and vector competence [65]. In line with this,"/>
   <result pre="derived from three independent donors were infected in vitro with" exact="ZIKV" post="(Mexico isolate). The virus was shown to replicate and"/>
   <result pre="were induced from salivary cells obtained from twins exposed to" exact="ZIKV" post="in uterus [67]. Even though the study was performed"/>
   <result pre="derived from CZS-fetuses produced more infectious particles when exposed to" exact="ZIKV" post="in vitro than those from non-CZS infants. RNA sequencing"/>
   <result pre="woman’s individual response to infection influences the efficiency with which" exact="ZIKV" post="crosses the placental barrier. Trophoblasts, placental barrier cells, are"/>
   <result pre="the placental barrier. Trophoblasts, placental barrier cells, are permissive to" exact="ZIKV" post="only during a narrow time-frame, likely in the first"/>
   <result pre="III IFN released could be related to the efficacy of" exact="ZIKV" post="infection in these cells. In addition, other events known"/>
   <result pre="to limit IFN response, like concomitant viral infections, could enhance" exact="ZIKV" post="infectivity. Accordingly, concomitant infection with Herpes Simplex 2 virus"/>
   <result pre="Herpes Simplex 2 virus (HSV-2) increases susceptibility of trophoblasts to" exact="ZIKV" post="[53]. Alternatively, to direct transport, it is possible that"/>
   <result pre="direct transport, it is possible that maternal antibody-mediated transcytosis drives" exact="ZIKV" post="transportation across the placental barrier. Indeed, experimental evidence has"/>
   <result pre="the placental barrier. Indeed, experimental evidence has shown that placental" exact="ZIKV" post="replication is enhanced by previous infection with Dengue virus"/>
   <result pre="that placental ZIKV replication is enhanced by previous infection with" exact="Dengue" post="virus [60,71]. In addition to trophoblasts, placenta villous macrophages"/>
   <result pre="placenta villous macrophages (Hofbauer cells) and fibroblasts are susceptible to" exact="ZIKV" post="infection [68,72]. When exposed to ZIKV, Hofbauer cells become"/>
   <result pre="that the intensity of placental immune response influences how much" exact="ZIKV" post="actually reach the fetus [68]. Despite factors specific to"/>
   <result pre="other factors can have contributed to the unforeseen scale of" exact="ZIKV" post="neurological damage seen in recent years. An interesting study"/>
   <result pre="study in immunodeficient mice has suggested that sexual transmission of" exact="ZIKV" post="favors congenital infection and the development of malformations of"/>
   <result pre="may also play a role in the severity of congenital" exact="ZIKV" post="syndrome [73]. As recently reviewed by Barbeito-Andrés and colleagues"/>
   <result pre="neurological outcome of infection. In Brazil, although the incidence of" exact="ZIKV" post="infection was similar in all regions in 2015, congenital"/>
   <result pre="ZIKV infection was similar in all regions in 2015, congenital" exact="ZIKV" post="syndrome was significantly higher in the northeast region, a"/>
   <result pre="to determine the higher rate of neurological complications due to" exact="ZIKV" post="infection in specific geographical regions. 4. Promising Therapeutic Approaches"/>
   <result pre="Similar to other mosquito-borne diseases, clinical management of patients with" exact="ZIKV" post="infection is largely based on alleviating symptoms of the"/>
   <result pre="on testing prophylactic drugs and creating vaccines to prevent new" exact="ZIKV" post="epidemics. Nevertheless, some effort has also been directed to"/>
   <result pre="development, which have shown promising results in different models of" exact="ZIKV" post="infection. These substances act either during acute stages of"/>
   <result pre="or have shown potential to prevent the late complications of" exact="ZIKV" post="infection (Table 1 and Supplementary Figure S1). 5. Antiviral"/>
   <result pre="prodrug clinically used against hepatitis C virus (HCV), to inhibit" exact="ZIKV" post="replication [100,101]. Later, two independent groups published experimental evidence"/>
   <result pre="effectively inhibited infection and replication by both African and American" exact="ZIKV" post="strains in different in vitro models: placental and neuroblastoma"/>
   <result pre="of viral genetic mutations, indicating a possible secondary mechanism of" exact="ZIKV" post="replication blockage. Experiments performed in animal models also showed"/>
   <result pre="synergic antiviral activity was observed against several different strains of" exact="ZIKV" post="[105], proving that a combination strategy might be beneficial."/>
   <result pre="Although mathematical modeling indicated that the expected dose needed for" exact="ZIKV" post="inhibition would be twice the therapeutic dose used for"/>
   <result pre="Favipiravir Another RNA polymerase inhibitor that has been proposed as" exact="ZIKV" post="therapeutic is favipiravir (FAV; T-705). Early reports indicated its"/>
   <result pre="T-705). Early reports indicated its ability to inhibit seven different" exact="ZIKV" post="strains in preliminary tests in vitro [88,89]. Conflicting results,"/>
   <result pre="were found in studies designed to evaluate whether FAV inhibits" exact="ZIKV" post="replication in more complex models. While one group reported"/>
   <result pre="[90], another study showed that FAV induced efficient reduction in" exact="ZIKV" post="protein expression in human neural progenitor cells derived from"/>
   <result pre="derivation. FAV has been shown to cause significant mutation in" exact="ZIKV" post="genome, indicating yet another possible mechanism for its antiviral"/>
   <result pre="of cytotoxicity in Vero cells [110]. In silico models of" exact="ZIKV" post="infection using non-human primate pharmacokinetic parameters, indicate that 150"/>
   <result pre="a strong candidate for further pre-clinical and clinical testing for" exact="ZIKV" post="treatment. Furthermore, its analog, T-1105, has also presented antiviral"/>
   <result pre="its analog, T-1105, has also presented antiviral activity against SZ01" exact="ZIKV" post="strain [89], indicating it might be a good scaffold"/>
   <result pre="RNA copies in the brain and reduced monocyte infiltration following" exact="ZIKV" post="infection [83]. AZT is an FDA category B drug,"/>
   <result pre="considerably low cost makes AZT an interesting candidate for post-exposure" exact="ZIKV" post="treatment. No studies so far have investigated the precise"/>
   <result pre="lacking interferon-mediated immune response (IFN-α/βR−/− mice) infected with the Brazilian" exact="ZIKV" post="strain: daily oral treatment with 30 mg/kg of ME"/>
   <result pre="[117]. Further studies are necessary to determine its efficacy in" exact="ZIKV" post="management in other animal models and in human subjects."/>
   <result pre="the extensive pro-inflammatory profile of brain tissue during and after" exact="ZIKV" post="infection, anti-inflammatory therapy might be of help to alleviate"/>
   <result pre="(IFX) (20 μg/day) is able to prevent long-term consequences of" exact="ZIKV" post="infection in neonatal (post-natal day 3) Swiss mice [32]."/>
   <result pre="that is currently considered a potential drug candidate to treat" exact="ZIKV" post="infection. PHA showed antiviral activity against two different ZIKV"/>
   <result pre="treat ZIKV infection. PHA showed antiviral activity against two different" exact="ZIKV" post="strains in human astrocytes derived from iPSCs and human"/>
   <result pre="also tested, nine of which presented submicromolar IC50 concentrations against" exact="ZIKV" post="replication in culture. These findings open new avenues for"/>
   <result pre="viability of human astrocytes and hNPCs infected with several different" exact="ZIKV" post="strains [87]. This strong neuroprotective effect was not due"/>
   <result pre="significantly improving cell viability of human astrocyte cultures exposed to" exact="ZIKV" post="when compared to the effects of both isolated substances."/>
   <result pre="consequences of HCV infection [120], being a good candidate for" exact="ZIKV" post="management, especially in combination with other drugs. 6.5. Niclosamide"/>
   <result pre="there might be other mechanisms by which the drug mitigates" exact="ZIKV" post="infection. Several groups have developed innovative formulations in order"/>
   <result pre="and colleagues tested CQ against African and Brazilian strains of" exact="ZIKV" post="in human neural progenitor cells, human brain microvascular endothelial"/>
   <result pre="2016). CQ also reduced mortality and weight loss caused by" exact="ZIKV" post="infection in adult AG129 mice, when administered in drinking"/>
   <result pre="(AQ). A high-content screening study identified its ability to prevent" exact="ZIKV" post="infection and its toxicity in human pluripotent stem cell-derived"/>
   <result pre="showed comparable results to CQ when tested against Asian PLCal_ZV" exact="ZIKV" post="strain in Vero cells [81]. In an adult immunodeficient"/>
   <result pre="of treatment with AQ (40 mg/kg/day s.c.) led to lower" exact="ZIKV" post="RNA levels and decreased levels of ZIKV E-protein in"/>
   <result pre="led to lower ZIKV RNA levels and decreased levels of" exact="ZIKV" post="E-protein in the brain [80]. Three AQ derivatives, quinacrine,"/>
   <result pre="to Vero cells infected separately with two different strains of" exact="ZIKV" post="[96,97]. Previous reports had already indicated that NITD008 has"/>
   <result pre="others viruses in previous studies, and was recently tested against" exact="ZIKV" post="[133]. It was able to reduce cytopathic effect and"/>
   <result pre="and RD cell lines infected with African, Asian, or American" exact="ZIKV" post="strains [92]. Furthermore, in a model of lethal infection"/>
   <result pre="report, RIB was able to inhibit replication of several different" exact="ZIKV" post="strains in vitro [88]. Such result was confirmed by"/>
   <result pre="Therefore, its use might be limited to severe consequences of" exact="ZIKV" post="infection exclusively in otherwise healthy adults. 6.11. Other Reported"/>
   <result pre="is a synthetic peptide derived from the stem region of" exact="ZIKV" post="envelope protein which showed potent anti-ZIKV activity. Z2 was"/>
   <result pre="was able to inhibit infection and diminish cytotoxic effects of" exact="ZIKV" post="on Vero and BHK21 cells. In pregnant ICR mice,"/>
   <result pre="up to 120 mg/kg. It also blocked vertical transmission of" exact="ZIKV" post="in this same mouse model at 10 mg/kg i.v."/>
   <result pre="development. Finally, a single study proposed natural products as possible" exact="ZIKV" post="inhibitors. The flavonoids Myricetin and Quercetin were able to"/>
   <result pre="The flavonoids Myricetin and Quercetin were able to inhibit the" exact="ZIKV" post="NS2B-NS3 pro protein complex with sub- and micromolar concentrations"/>
   <result pre="Conclusions The unprecedented high number of neurological symptoms associated to" exact="ZIKV" post="infection after its landing in the Americas in 2015"/>
   <result pre="social consequences that cannot be fully estimated. The observation that" exact="ZIKV" post="infection leads to late neurological burden both in congenitally-exposed"/>
   <result pre="have gathered efforts in order to identify the mechanisms underlying" exact="ZIKV" post="neurotoxicity and to search for drug candidates that can"/>
   <result pre="polymerase inhibitors and several antimalarial quinines have been tested against" exact="ZIKV" post="replication and its neurological damage. However, despite the promising"/>
   <result pre="vitro results, none of them has reached clinical trials for" exact="ZIKV" post="infection yet. In silico drug design should also be"/>
   <result pre="are available online at https://www.mdpi.com/1424-8247/12/2/60/s1, Figure S1: Possible candidates for" exact="ZIKV" post="infection treatment. These drugs, either repurposed or under development,"/>
   <result pre="repurposed or under development, have shown promising results in treating" exact="ZIKV" post="infection in both adult and vertical transmission or neonatal"/>
   <result pre="Med. Hyg.19524650952010.1016/0035-9203(52)90042-412995440 2.collab: PAHO/WHOZika Cases and Congenital Syndrome Associated with" exact="Zika" post="Virus Reported by Countries and Territories in the Americas"/>
   <result pre="al.Early Growth and Neurologic Outcomes of Infants with Probable Congenital" exact="Zika" post="Virus SyndromeEmerg. Infect. Dis.2016221953195610.3201/eid2211.16095627767931 4.CarvalhoM.D.C.G.de Miranda-FilhoD.B.van der LindenV.SobralP.F.RamosR.C.F.RochaM.Â.W.CordeiroM.T.de AlencarS.P.NunesM.L.Sleep"/>
   <result pre="Miranda-FilhoD.B.van der LindenV.SobralP.F.RamosR.C.F.RochaM.Â.W.CordeiroM.T.de AlencarS.P.NunesM.L.Sleep EEG patterns in infants with congenital" exact="Zika" post="virus syndromeClin. Neurophysiol.201712820421410.1016/j.clinph.2016.11.00427923187 5.ChimelliL.PoneS.M.Avvad-PortariE.VasconcelosZ.F.M.ZinA.A.CunhaD.P.ThompsonN.R.MoreiraM.E.L.WileyC.A.da PoneM.V.S.Persistence of Zika virus after"/>
   <result pre="infants with congenital Zika virus syndromeClin. Neurophysiol.201712820421410.1016/j.clinph.2016.11.00427923187 5.ChimelliL.PoneS.M.Avvad-PortariE.VasconcelosZ.F.M.ZinA.A.CunhaD.P.ThompsonN.R.MoreiraM.E.L.WileyC.A.da PoneM.V.S.Persistence of" exact="Zika" post="virus after birth: Clinical, virological, neuroimaging, and neuropathological documentation"/>
   <result pre="neuroimaging, and neuropathological documentation in a 5-month infant with congenital" exact="Zika" post="syndromeJ. Neuropathol. Exp. Neurol.20187719319810.1093/jnen/nlx11629346650 6.CugolaF.R.FernandesI.R.RussoF.B.FreitasB.C.DiasJ.L.M.GuimarãesK.P.BenazzatoC.AlmeidaN.PignatariG.C.RomeroS.et al.The Brazilian Zika virus"/>
   <result pre="with congenital Zika syndromeJ. Neuropathol. Exp. Neurol.20187719319810.1093/jnen/nlx11629346650 6.CugolaF.R.FernandesI.R.RussoF.B.FreitasB.C.DiasJ.L.M.GuimarãesK.P.BenazzatoC.AlmeidaN.PignatariG.C.RomeroS.et al.The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental modelsNature201653426727110.1038/nature1829627279226 7.van"/>
   <result pre="Virus Targeting in the Developing BrainJ. Neurosci.2017372161217510.1523/JNEUROSCI.3124-16.201728123079 8.WuK.-Y.ZuoG.-L.LiX.-F.YeQ.DengY.-Q.HuangX.-Y.CaoW.-C.QinC.-F.LuoZ.-G.Vertical transmission of" exact="Zika" post="virus targeting the radial glial cells affects cortex development"/>
   <result pre="Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital" exact="Zika" post="Virus Infection—U.S. Territories and Freely Associated States, 2018Morb. Mortal."/>
   <result pre="of 13 Infants Born During October 2015–January 2016 With Congenital" exact="Zika" post="Virus Infection Without Microcephaly at Birth—BrazilMMWR. Morb. Mortal. Wkly."/>
   <result pre="Microcephaly at Birth—BrazilMMWR. Morb. Mortal. Wkly. Rep.2016651343134810.15585/mmwr.mm6547e227906905 12.Prata-BarbosaA.MartinsM.M.GuastavinoA.B.da CunhaA.J.L.A.Effects of" exact="Zika" post="infection on growthJ. Pediatr (Rio J)201810.1016/j.jped.2018.10.016 13.SempleB.D.BlomgrenK.GimlinK.FerrieroD.M.Noble-HaeussleinL.J.Brain development in"/>
   <result pre="betterFront. Behav. Neurosci.2015926510.3389/fnbeh.2015.0026526500515 16.FerreiraA.C.Zaverucha-do-ValleC.ReisP.A.Barbosa-LimaG.VieiraY.R.MattosM.de SilvaP.SacramentoC.de Castro Faria NetoH.C.CampanatiL.et al.Sofosbuvir protects" exact="Zika" post="virus-infected mice from mortality, preventing short- and long-term sequelaeSci."/>
   <result pre="from mortality, preventing short- and long-term sequelaeSci. Rep.20177940910.1038/s41598-017-09797-828842610 17.MavignerM.RaperJ.Kovacs-BalintZ.GumberS.O’NealJ.T.BhaumikS.K.ZhangX.HabibJ.MattinglyC.McDonaldC.E.et al.Postnatal" exact="Zika" post="virus infection is associated with persistent abnormalities in brain"/>
   <result pre="Transl. Med.201810eaao697510.1126/scitranslmed.aao697529618564 18.da SilvaI.R.F.FronteraJ.A.de FilippisA.M.B.do NascimentoO.J.M.Neurologic Complications Associated With the" exact="Zika" post="Virus in Brazilian AdultsJAMA Neurol.2017741190119810.1001/jamaneurol.2017.170328806453 19.MuñozL.S.BarrerasP.PardoC.A.Zika Virus-Associated Neurological Disease"/>
   <result pre="MachadoM.�?.Henriques-SouzaA.CordeiroM.T.de MarquesE.T.PenaL.J.Guillain-Barré Syndrome, Acute Disseminated Encephalomyelitis and Encephalitis Associated with" exact="Zika" post="Virus Infection in Brazil: Detection of Viral RNA and"/>
   <result pre="Crit. Care20174227528110.1016/j.jcrc.2017.07.03828806562 22.WillisonH.JacobsB.van DoornP.Guillain-Barré SyndromeLancet2016231295130910.1016/S0140-6736(16)00339-1 23.ParraB.LizarazoJ.Jiménez-ArangoJ.A.Zea-VeraA.F.González-ManriqueG.VargasJ.AngaritaJ.A.ZuñigaG.Lopez-GonzalezR.BeltranC.L.et al.Guillain–Barré Syndrome Associated with" exact="Zika" post="Virus Infection in ColombiaN. Engl. J. Med.20163751513152310.1056/NEJMoa160556427705091 24.AzevedoR.S.S.AraujoM.T.Martins FilhoA.J.OliveiraC.S.NunesB.T.D.CruzA.C.R.NascimentoA.G.P.A.C.MedeirosR.C.CaldasC.A.M.AraujoF.C.et"/>
   <result pre="Zika-associated Guillain-Barré syndromeEmerg. Microbes Infect.201874710.1038/s41426-018-0151-929323108 26.LanciottiR.S.KosoyO.L.LavenJ.J.VelezJ.O.LambertA.J.JohnsonA.J.StanfieldS.M.DuffyM.R.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007Emerg."/>
   <result pre="Infect. Dis.20172340541410.3201/eid2303.16149927959260 28.MedinaF.A.TorresG.AcevedoJ.FonsecaS.CasianoL.De León-RodríguezC.M.SantiagoG.A.DoyleK.SharpT.M.AlvaradoL.I.et al.Duration of the Presence of Infectious" exact="Zika" post="Virus in Semen and SerumJ. Infect. Dis.2018219314010.1093/infdis/jiy462 29.Oliveira SoutoI.Alejo-CanchoI.Gascón"/>
   <result pre="SerumJ. Infect. Dis.2018219314010.1093/infdis/jiy462 29.Oliveira SoutoI.Alejo-CanchoI.Gascón BrustengaJ.Peiró MestresA.Muñoz GutiérrezJ.Martínez YoldiM.J.Persistence of" exact="Zika" post="virus in semen 93 days after the onset of"/>
   <result pre="tissuesPLoS Pathog.201713e100621910.1371/journal.ppat.100621928278237 32.SouzaI.N.O.FrostP.S.FrançaJ.V.Nascimento-VianaJ.B.NerisR.L.S.FreitasL.PinheiroD.J.L.L.NogueiraC.O.NevesG.ChimelliL.et al.Acute and chronic neurological consequences of early-life" exact="Zika" post="virus infection in miceSci. Transl. Med.201810eaar274910.1126/scitranslmed.aar274929875203 33.SimoninY.LoustalotF.DesmetzC.FoulongneV.ConstantO.Fournier-WirthC.LeonF.MolèsJ.-P.GoubaudA.LemaitreJ.-M.et al.Zika Virus"/>
   <result pre="Display Different Infectious Profiles in Human Neural CellsEBioMedicine20161216116910.1016/j.ebiom.2016.09.02027688094 34.ShaoQ.HerrlingerS.ZhuY.-N.YangM.GoodfellowF.SticeS.L.QiX.-P.BrindleyM.A.ChenJ.-F.The African" exact="Zika" post="virus MR-766 is more virulent and causes more severe"/>
   <result pre="virusDevelopment20171444114412410.1242/dev.15675228993398 35.CalvetG.AguiarR.S.MeloA.S.O.SampaioS.A.de FilippisI.FabriA.AraujoE.S.M.de SequeiraP.C.de MendonçaM.C.L.de OliveiraL.et al.Detection and sequencing of" exact="Zika" post="virus from amniotic fl uid of fetuses with microcephaly"/>
   <result pre="Dis20161665366010.1016/S1473-3099(16)00095-526897108 36.YuanL.HuangX.-Y.LiuZ.-Y.ZhangF.ZhuX.-L.YuJ.-Y.JiX.XuY.-P.LiG.LiC.et al.A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephalyScience201735893393610.1126/science.aam712028971967 37.LiuY.LiuJ.DuS.ShanC.NieK.ZhangR.LiX.-F.ZhangR.WangT.QinC.-F.et al.Evolutionary enhancement of"/>
   <result pre="Zika virus contributes to fetal microcephalyScience201735893393610.1126/science.aam712028971967 37.LiuY.LiuJ.DuS.ShanC.NieK.ZhangR.LiX.-F.ZhangR.WangT.QinC.-F.et al.Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoesNature201754548210.1038/nature2236528514450 38.XiaH.LuoH.ShanC.MuruatoA.E.NunesB.T.D.MedeirosD.B.A.ZouJ.XieX.GiraldoM.I.VasconcelosP.F.C.et al.An evolutionary"/>
   <result pre="in Aedes aegypti mosquitoesNature201754548210.1038/nature2236528514450 38.XiaH.LuoH.ShanC.MuruatoA.E.NunesB.T.D.MedeirosD.B.A.ZouJ.XieX.GiraldoM.I.VasconcelosP.F.C.et al.An evolutionary NS1 mutation enhances" exact="Zika" post="virus evasion of host interferon inductionNat. Commun.2018941410.1038/s41467-017-02816-229379028 39.Adekolu-JohnE.O.FagbamiA.H.Arthropod-borne virus"/>
   <result pre="Brain and Alters ProliferationCell Stem Cell20161959359810.1016/j.stem.2016.08.00527545505 46.LazearH.M.GoveroJ.SmithA.M.PlattD.J.FernandezE.MinerJ.J.DiamondM.S.A Mouse Model of" exact="Zika" post="Virus PathogenesisCell Host Microbe20161972073010.1016/j.chom.2016.03.01027066744 47.SmithD.R.HollidgeB.DayeS.ZengX.BlancettC.KuszpitK.BocanT.KoehlerJ.W.CoyneS.MinogueT.et al.Neuropathogenesis of Zika Virus"/>
   <result pre="Model of Zika Virus PathogenesisCell Host Microbe20161972073010.1016/j.chom.2016.03.01027066744 47.SmithD.R.HollidgeB.DayeS.ZengX.BlancettC.KuszpitK.BocanT.KoehlerJ.W.CoyneS.MinogueT.et al.Neuropathogenesis of" exact="Zika" post="Virus in a Highly Susceptible Immunocompetent Mouse Model after"/>
   <result pre="III Interferons Produced by Human Placental Trophoblasts Confer Protection against" exact="Zika" post="Virus InfectionCell Host Microbe20161970571210.1016/j.chom.2016.03.00827066743 49.YockeyL.J.JuradoK.A.AroraN.MilletA.RakibT.MilanoK.M.HastingsA.K.FikrigE.KongY.HorvathT.L.et al.Type I interferons instigate"/>
   <result pre="Host Microbe20161970571210.1016/j.chom.2016.03.00827066743 49.YockeyL.J.JuradoK.A.AroraN.MilletA.RakibT.MilanoK.M.HastingsA.K.FikrigE.KongY.HorvathT.L.et al.Type I interferons instigate fetal demise after" exact="Zika" post="virus infectionSci. Immunol.20183eaao1680b10.1126/sciimmunol.aao168029305462 50.OjhaC.R.RodriguezM.KaruppanM.K.M.LapierreJ.KashanchiF.El-HageN.Toll-like receptor 3 regulates Zika virus"/>
   <result pre="demise after Zika virus infectionSci. Immunol.20183eaao1680b10.1126/sciimmunol.aao168029305462 50.OjhaC.R.RodriguezM.KaruppanM.K.M.LapierreJ.KashanchiF.El-HageN.Toll-like receptor 3 regulates" exact="Zika" post="virus infection and associated host inflammatory response in primary"/>
   <result pre="Not Protect Human Neural Progenitor Cells and Cerebral Organoids from" exact="Zika" post="Virus InfectionCell Stem Cell20161970370810.1016/j.stem.2016.11.01127912091 52.LimontaD.JovelJ.KumarA.AiroA.M.HouS.SaitoL.BrantonW.Ka-Shu WongG.MasonA.PowerC.et al.Human Fetal Astrocytes"/>
   <result pre="InfectionCell Stem Cell20161970370810.1016/j.stem.2016.11.01127912091 52.LimontaD.JovelJ.KumarA.AiroA.M.HouS.SaitoL.BrantonW.Ka-Shu WongG.MasonA.PowerC.et al.Human Fetal Astrocytes Infected with" exact="Zika" post="Virus Exhibit Delayed Apoptosis and Resistance to Interferon: Implications"/>
   <result pre="Apoptosis and Resistance to Interferon: Implications for PersistenceViruses20181064610.3390/v1011064630453621 53.AldoP.YouY.SzigetiK.HorvathT.L.LindenbachB.MorG.HSV-2 enhances" exact="ZIKV" post="infection of the placenta and induces apoptosis in first-trimester"/>
   <result pre="J. Reprod. Immunol.20167634835710.1111/aji.1257827613665 54.HastingsA.K.YockeyL.J.JaggerB.W.HwangJ.UrakiR.GaitschH.F.ParnellL.A.CaoB.MysorekarI.U.RothlinC.V.et al.TAM Receptors Are Not Required for" exact="Zika" post="Virus Infection in MiceCell Rep.20171955856810.1016/j.celrep.2017.03.05828423319 55.ChenJ.YangY.YangY.ZouP.ChenJ.HeY.ShuiS.CuiY.BaiR.LiangY.et al.AXL promotes Zika"/>
   <result pre="for Zika Virus Infection in MiceCell Rep.20171955856810.1016/j.celrep.2017.03.05828423319 55.ChenJ.YangY.YangY.ZouP.ChenJ.HeY.ShuiS.CuiY.BaiR.LiangY.et al.AXL promotes" exact="Zika" post="virus infection in astrocytes by antagonizing type I interferon"/>
   <result pre="antagonizing type I interferon signallingNat. Microbiol.2018330230910.1038/s41564-017-0092-429379210 56.LiuY.Gordesky-GoldB.Leney-GreeneM.WeinbrenN.L.TudorM.CherryS.Inflammation-Induced, STING-Dependent Autophagy Restricts" exact="Zika" post="Virus Infection in the Drosophila BrainCell Host Microbe201824576810.1016/j.chom.2018.05.02229934091 57.ChiramelA.I.BestS.M.Role"/>
   <result pre="in the Drosophila BrainCell Host Microbe201824576810.1016/j.chom.2018.05.02229934091 57.ChiramelA.I.BestS.M.Role of autophagy in" exact="Zika" post="virus infection and pathogenesisVirus Res.2018254344010.1016/j.virusres.2017.09.00628899653 58.DelgadoF.G.TorresK.I.CastellanosJ.E.Romero-SánchezC.Simon-LorièreE.SakuntabhaiA.RothC.Improved Immune Responses Against"/>
   <result pre="Zika virus infection and pathogenesisVirus Res.2018254344010.1016/j.virusres.2017.09.00628899653 58.DelgadoF.G.TorresK.I.CastellanosJ.E.Romero-SánchezC.Simon-LorièreE.SakuntabhaiA.RothC.Improved Immune Responses Against" exact="Zika" post="Virus After Sequential Dengue and Zika Virus Infection in"/>
   <result pre="pathogenesisVirus Res.2018254344010.1016/j.virusres.2017.09.00628899653 58.DelgadoF.G.TorresK.I.CastellanosJ.E.Romero-SánchezC.Simon-LorièreE.SakuntabhaiA.RothC.Improved Immune Responses Against Zika Virus After Sequential" exact="Dengue" post="and Zika Virus Infection in HumansViruses20181048010.3390/v10090480 59.WenJ.Elong NgonoA.Regla-NavaJ.A.KimK.GormanM.J.DiamondM.S.ShrestaS.Dengue virus-reactive"/>
   <result pre="58.DelgadoF.G.TorresK.I.CastellanosJ.E.Romero-SánchezC.Simon-LorièreE.SakuntabhaiA.RothC.Improved Immune Responses Against Zika Virus After Sequential Dengue and" exact="Zika" post="Virus Infection in HumansViruses20181048010.3390/v10090480 59.WenJ.Elong NgonoA.Regla-NavaJ.A.KimK.GormanM.J.DiamondM.S.ShrestaS.Dengue virus-reactive CD8+ T"/>
   <result pre="59.WenJ.Elong NgonoA.Regla-NavaJ.A.KimK.GormanM.J.DiamondM.S.ShrestaS.Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent" exact="Zika" post="virus challengeNat. Commun.20178145910.1038/s41467-017-01669-z29129917 60.BrownJ.A.SinghG.AcklinJ.A.LeeS.DuehrJ.E.ChokolaA.N.FrereJ.J.HoffmanK.W.FosterG.A.KrysztofD.et al.Dengue Virus Immunity Increases Zika"/>
   <result pre="subsequent Zika virus challengeNat. Commun.20178145910.1038/s41467-017-01669-z29129917 60.BrownJ.A.SinghG.AcklinJ.A.LeeS.DuehrJ.E.ChokolaA.N.FrereJ.J.HoffmanK.W.FosterG.A.KrysztofD.et al.Dengue Virus Immunity Increases" exact="Zika" post="Virus-Induced Damage during PregnancyImmunity201910.1016/j.immuni.2019.01.005 61.BardinaS.V.BunducP.TripathiS.DuehrJ.FrereJ.J.BrownJ.A.NachbagauerR.FosterG.A.KrysztofD.TortorellaD.et al.Enhancement of Zika virus"/>
   <result pre="Immunity Increases Zika Virus-Induced Damage during PregnancyImmunity201910.1016/j.immuni.2019.01.005 61.BardinaS.V.BunducP.TripathiS.DuehrJ.FrereJ.J.BrownJ.A.NachbagauerR.FosterG.A.KrysztofD.TortorellaD.et al.Enhancement of" exact="Zika" post="virus pathogenesis by preexisting antiflavivirus immunityScience201735617518010.1126/science.aal436528360135 62.DejnirattisaiW.SupasaP.WongwiwatW.RouvinskiA.Barba-SpaethG.DuangchindaT.SakuntabhaiA.Cao-LormeauV.-M.MalasitP.ReyF.A.et al.Dengue virus"/>
   <result pre="infection with zika virusNat. Immunol.2016171102110810.1038/ni.351527339099 63.De AraújoP.S.R.de Silva JúniorM.L.Jr.TenórioM.dos SantosF.G.T.Co-infection" exact="ZIKV" post="and HSV-1 associated with meningoencephalitis: Case report and literature"/>
   <result pre="Infect. Dis.201719e1270010.1111/tid.12700 65.MagalhaesT.RobisonA.YoungM.BlackW.FoyB.EbelG.RückertC.MagalhaesT.RobisonA.YoungM.C.et al.Sequential Infection of Aedes aegypti Mosquitoes with" exact="Chikungunya" post="Virus and Zika Virus Enhances Early Zika Virus TransmissionInsects2018917710.3390/insects904017730513725"/>
   <result pre="al.Sequential Infection of Aedes aegypti Mosquitoes with Chikungunya Virus and" exact="Zika" post="Virus Enhances Early Zika Virus TransmissionInsects2018917710.3390/insects904017730513725 66.McgrathE.L.RossiS.L.GaoJ.WidenS.G.GrantA.C.DunnT.J.AzarS.R.RoundyC.M.XiongY.PrusakD.J.et al.Differential Responses"/>
   <result pre="aegypti Mosquitoes with Chikungunya Virus and Zika Virus Enhances Early" exact="Zika" post="Virus TransmissionInsects2018917710.3390/insects904017730513725 66.McgrathE.L.RossiS.L.GaoJ.WidenS.G.GrantA.C.DunnT.J.AzarS.R.RoundyC.M.XiongY.PrusakD.J.et al.Differential Responses of Human Fetal Brain"/>
   <result pre="al.Differential Responses of Human Fetal Brain Neural Stem Cells to" exact="Zika" post="Virus InfectionStem Cell Rep.2017871572710.1016/j.stemcr.2017.01.00828216147 67.Caires-JuniorL.C.GoulartE.MeloU.S.AraujoB.H.S.AlviziL.Soares-SchanoskiA.de OliveiraD.F.KobayashiG.S.Griesi-OliveiraK.MussoC.M.et al.Discordant congenital Zika"/>
   <result pre="to Zika Virus InfectionStem Cell Rep.2017871572710.1016/j.stemcr.2017.01.00828216147 67.Caires-JuniorL.C.GoulartE.MeloU.S.AraujoB.H.S.AlviziL.Soares-SchanoskiA.de OliveiraD.F.KobayashiG.S.Griesi-OliveiraK.MussoC.M.et al.Discordant congenital" exact="Zika" post="syndrome twins show differential in vitro viral susceptibility of"/>
   <result pre="Placenta-Fetus Model Demonstrating Maternal–Fetal Transmission and Fetal Neural Toxicity of" exact="Zika" post="VirusAnn. Biomed. Eng.2018461963197410.1007/s10439-018-2090-y30003503 70.RibeiroM.R.MoreliJ.B.MarquesR.E.PapaM.P.MeurenL.M.RahalP.de ArrudaL.B.OlianiA.H.OlianiD.C.M.V.OlianiS.M.et al.Zika-virus-infected human full-term placental"/>
   <result pre="productively infects primary human placenta-specific macrophagesJCI Insight20161e8846110.1172/jci.insight.8846127595140 73.DuggalN.K.McdonaldE.M.RitterJ.M.BraultA.C.Sexual transmission of" exact="Zika" post="virus enhances in utero transmission in a mouse model"/>
   <result pre="transmission in a mouse model OPENSci. Rep.20188451010.1038/s41598-018-22840-629540804 74.Barbeito-AndrésJ.Schuler-FacciniL.GarcezP.P.Why is congenital" exact="Zika" post="syndrome asymmetrically distributed among human populations?PLoS Biol.201816e200659210.1371/journal.pbio.200659230142150 75.de OliveiraW.K.de"/>
   <result pre="OliveiraW.K.de FrançaG.V.A.CarmoE.H.DuncanB.B.de Souza KuchenbeckerR.SchmidtM.I.Infection-related microcephaly after the 2015 and 2016" exact="Zika" post="virus outbreaks in Brazil: A surveillance-based analysisLancet201739086187010.1016/S0140-6736(17)31368-528647172 76.SouzaA.I.de SiqueiraM.T.FerreiraA.L.C.G.de"/>
   <result pre="A surveillance-based analysisLancet201739086187010.1016/S0140-6736(17)31368-528647172 76.SouzaA.I.de SiqueiraM.T.FerreiraA.L.C.G.de FreitasC.U.BezerraE.V.RibeiroA.G.NardocciA.C.Geography of Microcephaly in the" exact="Zika" post="Era: A Study of Newborn Distribution and Socio-environmental Indicators"/>
   <result pre="Brazil, 2015-2016Public Health Rep.201813346147110.1177/003335491877725629920225 77.Center for Disease Control and Prevention" exact="Zika" post="Virus TreatmentAvailable online: https://www.cdc.gov/zika/symptoms/treatment.html(accessed on 23 January 2019) 78.collab:"/>
   <result pre="al.High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit" exact="Zika" post="Virus Infection in Fetal-like Organoids and Adult BrainCell Stem"/>
   <result pre="azithromycinProc. Natl. Acad. Sci. USA2016113144081441310.1073/pnas.161802911327911847 83.WuY.H.TsengC.K.LinC.K.WeiC.K.LeeJ.C.YoungK.C.ICR suckling mouse model of" exact="Zika" post="virus infection for disease modeling and drug validationPLoS Negl."/>
   <result pre="Negl. Trop. Dis.201812e000684810.1371/journal.pntd.000684830356305 84.DelvecchioR.HigaL.PezzutoP.ValadãoA.GarcezP.MonteiroF.LoiolaE.DiasA.SilvaF.AliotaM.et al.Chloroquine, an Endocytosis Blocking Agent, Inhibits" exact="Zika" post="Virus Infection in Different Cell ModelsViruses2016832210.3390/v8120322 85.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing of"/>
   <result pre="Cell ModelsViruses2016832210.3390/v8120322 85.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing of the anti-malaria drug chloroquine for" exact="Zika" post="Virus treatment and prophylaxisSci. Rep.201771577110.1038/s41598-017-15467-629150641 86.LiC.ZhuX.JiX.QuanquinN.DengY.-Q.TianM.AliyariR.ZuoX.YuanL.AfridiS.K.et al.Chloroquine, a FDA-approved"/>
   <result pre="treatment and prophylaxisSci. Rep.201771577110.1038/s41598-017-15467-629150641 86.LiC.ZhuX.JiX.QuanquinN.DengY.-Q.TianM.AliyariR.ZuoX.YuanL.AfridiS.K.et al.Chloroquine, a FDA-approved Drug, Prevents" exact="Zika" post="Virus Infection and its Associated Congenital Microcephaly in MiceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372"/>
   <result pre="Congenital Microcephaly in MiceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372 87.XuM.LeeE.M.WenZ.ChengY.HuangW.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.et al.Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
   <result pre="screenNat. Med.2016221101110710.1038/nm.418427571349 88.BazM.GoyetteN.GriffinB.D.KobingerG.P.BoivinG.In vitro susceptibility of geographically and temporally distinct" exact="Zika" post="viruses to favipiravir and ribavirinAntivir. Ther.20172261361810.3851/IMP318028694390 89.CaiL.SunY.SongY.XuL.BeiZ.ZhangD.DouY.WangH.Viral polymerase inhibitors"/>
   <result pre="89.CaiL.SunY.SongY.XuL.BeiZ.ZhangD.DouY.WangH.Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of" exact="Zika" post="virus replicationArch. Virol.20171622847285310.1007/s00705-017-3436-828597088 90.LankoK.EggermontK.PatelA.KapteinS.DelangL.VerfaillieC.M.NeytsJ.Replication of the Zika virus in"/>
   <result pre="potential inhibitors of Zika virus replicationArch. Virol.20171622847285310.1007/s00705-017-3436-828597088 90.LankoK.EggermontK.PatelA.KapteinS.DelangL.VerfaillieC.M.NeytsJ.Replication of the" exact="Zika" post="virus in different iPSC-derived neuronal cells and implications to"/>
   <result pre="modelsViruses2018107210.3390/v1002007229425176 92.JulanderJ.G.SiddharthanV.EvansJ.TaylorR.TolbertK.ApuliC.StewartJ.CollinsP.GebreM.NeilsonS.et al.Efficacy of the broad-spectrum antiviral compound BCX4430 against" exact="Zika" post="virus in cell culture and in a mouse modelAntivir."/>
   <result pre="Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with" exact="Zika" post="VirusOpen Forum Infectious Diseases201610.1093/ofid/ofw195.05 94.CostaV.V.Del SartoJ.L.RochaR.F.SilvaF.R.DoriaJ.G.OlmoI.G.MarquesR.E.Queiroz-JuniorC.M.FoureauxG.AraújoJ.M.S.et al.N-Methyl-d-Aspartate (NMDA) Receptor"/>
   <result pre="SartoJ.L.RochaR.F.SilvaF.R.DoriaJ.G.OlmoI.G.MarquesR.E.Queiroz-JuniorC.M.FoureauxG.AraújoJ.M.S.et al.N-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by" exact="Zika" post="Virus InfectionMBio20178e00350-1710.1128/mBio.00350-1728442607 95.CairnsD.M.BoorguD.S.S.K.LevinM.KaplanD.L.Niclosamide rescues microcephaly in a humanized in"/>
   <result pre="95.CairnsD.M.BoorguD.S.S.K.LevinM.KaplanD.L.Niclosamide rescues microcephaly in a humanized in vitro model of" exact="Zika" post="infection using human induced neural stem cellsBiol. Open20187bio03180710.1242/bio.03180729378701 96.DengY.ZhangN.LiC.TianM.HaoJ.XieX.-P.ShiP.-Y.QinC.-F.Adenosine"/>
   <result pre="cellsBiol. Open20187bio03180710.1242/bio.03180729378701 96.DengY.ZhangN.LiC.TianM.HaoJ.XieX.-P.ShiP.-Y.QinC.-F.Adenosine Analog NITD008 Is a Potent Inhibitor of" exact="Zika" post="VirusOpen Forum Infect. Dis.20163ofw17510.1093/ofid/ofw17527747251 97.AdcockR.S.ChuY.K.GoldenJ.E.ChungD.H.Evaluation of anti-Zika virus activities"/>
   <result pre="of dengue virusProc. Natl. Acad. Sci. USA2009106204352043910.1073/pnas.090701010619918064 99.KamiyamaN.SomaR.HidanoS.WatanabeK.UmekitaH.FukudaC.NoguchiK.GendoY.OzakiT.SonodaA.et al.Ribavirin inhibits" exact="Zika" post="virus (ZIKV) replication in vitro and suppresses viremia in"/>
   <result pre="Cells and Radial GliaCell Rep.2016162576259210.1016/j.celrep.2016.08.03827568284 102.Bullard-FeibelmanK.M.GoveroJ.ZhuZ.SalazarV.VeselinovicM.DiamondM.S.GeissB.J.The FDA-approved drug sofosbuvir inhibits" exact="Zika" post="virus infectionAntiviral Res.201713713414010.1016/j.antiviral.2016.11.02327902933 103.SacramentoC.Q.De MeloG.R.De FreitasC.S.RochaN.HoelzL.V.B.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.et al.The clinically approved"/>
   <result pre="103.SacramentoC.Q.De MeloG.R.De FreitasC.S.RochaN.HoelzL.V.B.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.et al.The clinically approved antiviral drug sofosbuvir inhibits" exact="Zika" post="virus replicationSci. Rep.201774092010.1038/srep4092028098253 104.YuY.DengY.Q.ZouP.WangQ.DaiY.YuF.DuL.ZhangN.N.TianM.HaoJ.N.et al.A peptide-based viral inactivator inhibits"/>
   <result pre="Zika virus replicationSci. Rep.201774092010.1038/srep4092028098253 104.YuY.DengY.Q.ZouP.WangQ.DaiY.YuF.DuL.ZhangN.N.TianM.HaoJ.N.et al.A peptide-based viral inactivator inhibits" exact="Zika" post="virus infection in pregnant mice and fetusesNat. Commun.201781567210.1038/ncomms1567228742068 105.SnyderB.GoebelS.KoideF.PtakR.KalkeriR.Synergistic"/>
   <result pre="activity of Sofosbuvir and type-I interferons (α and β) against" exact="Zika" post="virusJ. Med. Virol.20189081210.1002/jmv.2493228851097 106.ChappellC.collab: Gilead Sciencescollab: University of NebraskaStudy"/>
   <result pre="March 2019) 107.WiwanitkitS.WiwanitkitV.Doubled dosage of sofosbuvir is expected for inhibiting" exact="Zika" post="virus infectionAsian Pac. J. Trop. Med.20171061261310.1016/j.apjtm.2017.06.01228756928 108.collab: Gilead Sciences"/>
   <result pre="Res.2016130464910.1016/j.antiviral.2016.03.01327016316 133.EyerL.ZouharováD.ŠirmarováJ.FojtíkováM.ŠtefánikM.HaviernikJ.NenckaR.de ClercqE.RůžekD.Antiviral activity of the adenosine analogue BCX4430 against" exact="West Nile" post="virus and tick-borne flavivirusesAntivir. Res.2017142636710.1016/j.antiviral.2017.03.01228336346 134.collab: BioCryst PharmaceuticalsA Study"/>
   <result pre="Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting" exact="Zika" post="VirusAntimicrob. Agents Chemother.201862e00725-1810.1128/AAC.00725-1830061280 136.collab: FDACopegus Packet InsertFDASilver Spring, MD,"/>
   <result pre="USA2011 137.LeonardiW.ZilbermintzL.ChengL.W.ZozayaJ.TranS.H.ElliottJ.H.PolukhinaK.ManasherobR.LiA.ChiX.et al.Bithionol blocks pathogenicity of bacterial toxins, ricin, and" exact="Zika" post="virusSci. Rep.201663447510.1038/srep3447527686742 138.RoyA.LimL.SrivastavaS.LuY.SongJ.Solution conformations of Zika NS2B-NS3pro and its"/>
   <result pre="bacterial toxins, ricin, and Zika virusSci. Rep.201663447510.1038/srep3447527686742 138.RoyA.LimL.SrivastavaS.LuY.SongJ.Solution conformations of" exact="Zika" post="NS2B-NS3pro and its inhibition by natural products from edible"/>
   <result pre="update: Improved access to chemical dataNucleic Acids Res.201947D1102D110910.1093/nar/gky103330371825 Figure 1" exact="Zika" post="virus (ZIKV) infection is associated to late detrimental effects"/>
   <result pre="late detrimental effects to the developing and mature nervous systems." exact="ZIKV" post="infection during the perinatal period (a) and in adult"/>
   <result pre="to ZIKV. pharmaceuticals-12-00060-t001_Table 1Table 1 Drug Candidates for management of" exact="ZIKV" post="infection and its late neurologic complications. Drug Proposed Mechanism"/>
   <result pre="Drug Administration (FDA) Approved? FDA Category Refs. Amodiaquine Unknown for" exact="ZIKV" post="(antimalarial) Vero cell linehuman pluripotent stem cell-derived neural progenitors"/>
   <result pre="to adult SCID-beige mice Discontinued - [80,81] Azithromycin Unknown for" exact="ZIKV" post="(antibiotic) U87 glial cell line 10 mg/kg i.p.to neonatal"/>
   <result pre="i.p.to neonatal ICR mice Yes B [82,83] Chloroquine Unknown for" exact="ZIKV" post="(antimalarial) human neural progenitor cellshuman brain microvascular endothelial cellsmouse"/>
   <result pre="- [104] B.i.d.: bis in die (twice a day); ZIKV:" exact="Zika" post="virus; s.c.: subcutaneous; i.m. intramuscular; i.p.: intraperitoneal; p.o.: per"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6632129\results\search\tropicalVirus\results.xml">
   <result pre="Medicine and Infectious Disease2414-6366MDPI pmcid: 6632129 doi: 10.3390/tropicalmed4020095tropicalmed-04-00095 : Communication" exact="Dengue" post="in New Caledonia: Knowledge and Gaps https://orcid.org/0000-0003-1933-1515InizanCatherine1https://orcid.org/0000-0002-6946-7958TarantolaArnaud2O’ConnorOlivia1https://orcid.org/0000-0003-4146-3784MangeasMorgan3PocquetNicolas4ForfaitCarole5DesclouxElodie6GourinatAnn-Claire7PfannstielAnne5Klement-FrutosElise6https://orcid.org/0000-0002-1457-9696MenkesChristophe3Dupont-RouzeyrolMyrielle1*[1], cinizan@pasteur.ncooconnor@pasteur.nc[2], atarantola@pasteur.nc[3],"/>
   <result pre="advantages of conducting studies on arboviruses dynamics in NC. 2." exact="Dengue" post="Circulation was Detected Every Year in New Caledonia over"/>
   <result pre="arbovirus circulating in the Pacific region [1]. Over earlier decades," exact="DENV" post="circulation in NC displayed a 3–4 year cyclical pattern"/>
   <result pre="between epidemic peaks during epidemic years [2]. Since 2008 however," exact="DENV" post="circulation has increased in NC, causing recurrent outbreaks with"/>
   <result pre="in NC, causing recurrent outbreaks with cases detected every year." exact="DENV" post="caused three major outbreaks in NC in 2008–2009, 2012–2013"/>
   <result pre="observed major changes in the epidemiology of dengue, with uninterrupted" exact="DENV" post="circulation causing cases detected every year and even during"/>
   <result pre="every year and even during the cool season. Along with" exact="DENV" post="circulation, Zika virus (ZIKV) was detected in NC in"/>
   <result pre="and even during the cool season. Along with DENV circulation," exact="Zika" post="virus (ZIKV) was detected in NC in 2014, causing"/>
   <result pre="2015 [1] (https://dass.gouv.nc/votre-sante/documents-rapports-etudes) (Figure 1B). No signs of circulation of" exact="CHIKV" post="or ZIKV were detected prior to these outbreaks. 3."/>
   <result pre="(https://dass.gouv.nc/votre-sante/documents-rapports-etudes) (Figure 1B). No signs of circulation of CHIKV or" exact="ZIKV" post="were detected prior to these outbreaks. 3. Impact of"/>
   <result pre="outbreak occurrence. Unlike that of ZIKV, however, the introduction of" exact="CHIKV" post="did not lead to major outbreaks. DENV-1 has been"/>
   <result pre="showed that Ae. aegypti from NC is competent for DENV," exact="ZIKV" post="and CHIKV. The Extrinsic Incubation Period, however, is three"/>
   <result pre="CHIKV. The Extrinsic Incubation Period, however, is three days for" exact="CHIKV" post="[5], seven days for DENV [6] and nine days"/>
   <result pre="however, is three days for CHIKV [5], seven days for" exact="DENV" post="[6] and nine days for ZIKV [7]. Furthermore, transmission"/>
   <result pre="[5], seven days for DENV [6] and nine days for" exact="ZIKV" post="[7]. Furthermore, transmission efficiencies at 14 days post-infection are"/>
   <result pre="Furthermore, transmission efficiencies at 14 days post-infection are 30% for" exact="CHIKV" post="[5], &amp;lt;10% for DENV [6] and 5% for ZIKV"/>
   <result pre="14 days post-infection are 30% for CHIKV [5], &amp;lt;10% for" exact="DENV" post="[6] and 5% for ZIKV [7]. Although transmission efficiency"/>
   <result pre="for CHIKV [5], &amp;lt;10% for DENV [6] and 5% for" exact="ZIKV" post="[7]. Although transmission efficiency was highest for CHIKV, this"/>
   <result pre="NC. 5. Cimate Oscillation is An Important Parameter to Forecast" exact="Dengue" post="Outbreaks in New Caledonia The climate of NC can"/>
   <result pre="arbovirus is introduced during a favorable time of year. Interestingly," exact="DENV" post="and ZIKV are both flaviviruses and both caused outbreaks"/>
   <result pre="introduced during a favorable time of year. Interestingly, DENV and" exact="ZIKV" post="are both flaviviruses and both caused outbreaks in NC."/>
   <result pre="are both flaviviruses and both caused outbreaks in NC. Neither" exact="CHIKV" post="over the last decade nor Ross River Virus (RRV)"/>
   <result pre="the NC context. Genotype, clade and strain replacements may impact" exact="DENV" post="epidemiological profile by modulating viral replicative fitness [15]. As"/>
   <result pre="DENV epidemiological profile by modulating viral replicative fitness [15]. As" exact="DENV" post="serotypes are not antigenically homogeneous [16], it can also"/>
   <result pre="type-1 in New Caledonia, South Pacific, 2001–2013Virol. J.2014116110.1186/1743-422X-11-6124684835 3.Dupont-RouzeyrolM.O’ConnorO.CalvezE.Co-infection with" exact="Zika" post="and dengue viruses in 2 patients, New Caledonia, 2014Emerg."/>
   <result pre="cases per 1000 inhabitants per month are indicated for dengue," exact="Zika" post="and chikungunya (http://www.institutpasteur.nc/wp-content/uploads/2016/12/)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6635310\results\search\tropicalVirus\results.xml">
   <result pre="2014–15 (34). Pourmahdi Borujeni et al. showed the existence of" exact="WNV" post="infection in Khuzestan (35). In a research in Mahshahr"/>
   <result pre="35.Pourmahdi BorujeniMGhadrdan MashadiARSeifi Abad ShapouriMRZeinvandM.A serological survey on antibodies against" exact="West Nile" post="virus in horses of Khuzestan province. Iran J Vet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6646355\results\search\tropicalVirus\results.xml">
   <result pre="Publishing Group UKLondon pmcid: 664635546218 doi: 10.1038/s41598-019-46218-4 : Article Modeling" exact="Zika" post="Virus Transmission Dynamics: Parameter Estimates, Disease Characteristics, and Prevention"/>
   <result pre="much remains uncertain about parameters related to transmission dynamics of" exact="Zika" post="virus (ZIKV). Estimating a large number of parameters from"/>
   <result pre="we developed a method that utilizes a mathematical model of" exact="ZIKV" post="dynamics and the complex-step derivative approximation technique to identify"/>
   <result pre="available data. Applying our method to epidemic data from the" exact="ZIKV" post="outbreaks in French Polynesia and Yap Island, we identified"/>
   <result pre="final outbreak-size is predicted to be negligible, thereby successfully controlling" exact="ZIKV" post="epidemics. Subject terms Applied mathematics Infectious diseases Funding https://doi.org/10.13039/100000181United"/>
   <result pre="start-up fund from San Diego State University (NKV) Introduction The" exact="Zika" post="virus (ZIKV) was first isolated in a Ugandan forest"/>
   <result pre="febrile rhesus monkey in 19471. The first major outbreaks of" exact="ZIKV" post="arose in Yap and Micronesia between April and July"/>
   <result pre="French Polynesia between October 2013 and April 20143. In 2015," exact="ZIKV" post="raised to prominence in American countries, more specifically in"/>
   <result pre="Brazil and Colombia4–6, the areas where the epidemic form of" exact="ZIKV" post="was previously uncommon. In February 2016, the World Health"/>
   <result pre="uncommon. In February 2016, the World Health Organization (WHO) declared" exact="ZIKV" post="to be a public health emergency of international concern7,"/>
   <result pre="flourish in tropical areas similar to the French Polynesian landscape." exact="ZIKV" post="symptoms include fever, myalgia/arthralgia, edema of extremities, maculopapular rash,"/>
   <result pre="extremities, maculopapular rash, retro-orbital pain, conjunctivitis, and lymphadenopathies9, while many" exact="ZIKV" post="infected individuals do not show any symptoms at all."/>
   <result pre="not show any symptoms at all. Growing evidence shows that" exact="ZIKV" post="is linked to several neurological disorders, such as Guillain-Barre"/>
   <result pre="microcephaly in infants born to mothers who were infected with" exact="ZIKV" post="during pregnancy12,13. Unfortunately, there is no specific treatment for"/>
   <result pre="absence of treatment and vaccines, the immediate control strategy of" exact="ZIKV" post="will rely on the control of mosquito and/or human-mosquito"/>
   <result pre="thus critical to get insights into the transmission dynamics of" exact="ZIKV" post="in the population and properly evaluate potential control strategies."/>
   <result pre="and control measures for infectious diseases14–19. Previous modeling studies on" exact="ZIKV" post="have advanced our understanding of the ZIKV infection and"/>
   <result pre="modeling studies on ZIKV have advanced our understanding of the" exact="ZIKV" post="infection and related parameters2,20,21, but limited experimental and theoretical"/>
   <result pre="set and related estimable parameters may not be reasonable for" exact="ZIKV" post="transmission dynamics. Given the lack of detailed analysis on"/>
   <result pre="on the current parameter estimates, the key epidemiological parameters of" exact="ZIKV" post="transmission, including the basic reproduction number, still remain uncertain."/>
   <result pre="addition, there is a lack of detailed evaluation on potential" exact="ZIKV" post="control strategies. Such studies based on prior analysis of"/>
   <result pre="For this, we formulated mathematical models of transmission dynamics of" exact="ZIKV" post="infection and employed complex-step derivative based sensitivity analysis to"/>
   <result pre="and standard errors. Using our method, we identified the estimable" exact="ZIKV" post="related parameters that can be more confidently estimated from"/>
   <result pre="data sets (Supplementary Table S4 and Fig. S4). Characteristics of" exact="ZIKV" post="transmission dynamics Note that the mosquito-to-human transmission rate, \documentclass[12pt]{minimal}"/>
   <result pre="all islands, indicate that only a small portion of predicted" exact="Zika" post="infection was reported to the health sentinel sites. The"/>
   <result pre="Yap. This shows that an actual epidemic size of the" exact="ZIKV" post="could be significantly higher than that seemed in the"/>
   <result pre="is in agreement with the fact that individuals infected with" exact="ZIKV" post="usually do not show any symptoms or show only"/>
   <result pre="The model predicts R0 &amp;gt; 1 in each island, and there were" exact="ZIKV" post="epidemics, which is consistent with the observations in the"/>
   <result pre="on reducing mosquito lifespan can be more effective for avoiding" exact="ZIKV" post="infection. To a lesser extent, R0 is also sensitive"/>
   <result pre="The model also suggests that after approximately 20 weeks, the" exact="ZIKV" post="epidemic will be over, even if no prevention program"/>
   <result pre="that almost the entire island population can be infected with" exact="ZIKV" post="during the epidemic period. Figure 4 Mean prevalence of"/>
   <result pre="epidemic period. Figure 4 Mean prevalence of infection during the" exact="ZIKV" post="epidemic. Effect of prevention programs on disease outcomes We"/>
   <result pre="at least 60% (i.e., when ϕ ≥ 0.6)would decrease the prevalence of" exact="ZIKV" post="to an almost negligible level (Fig. 5). In this"/>
   <result pre="λ m . With such prevention programs, the prevalence of" exact="ZIKV" post="decreases to a negligible level when mosquito death is"/>
   <result pre="analysis based method, which utilizes the transmission dynamics model of" exact="ZIKV" post="infection and the recently expanded complex-step approximation technique22,33, to"/>
   <result pre="this technique, we also computed the basic reproduction number for" exact="ZIKV" post="transmission dynamics and performed analysis and simulation of the"/>
   <result pre="disease outcomes and the effectiveness of prevention programs on controlling" exact="ZIKV" post="infections. Implementing our technique to seven island data (six"/>
   <result pre="across all islands may not provide reasonable information about the" exact="ZIKV" post="transmission dynamics. Identification of parameters that can be estimated"/>
   <result pre="may help to obtain important information about parameters related to" exact="ZIKV" post="transmission dynamics. As a result, our method provides reasonably"/>
   <result pre="from island to island (Table 2) and reflects that the" exact="ZIKV" post="spreads rapidly throughout the islands. Based on a sensitivity"/>
   <result pre="investigation on prevalence and infection provided some valuable implications to" exact="ZIKV" post="epidemics. The prevalence started to increase at the beginning"/>
   <result pre="were recovering from the virus than those with the new" exact="ZIKV" post="infections. Our study found that almost 100% of the"/>
   <result pre="peak prevalence and final outbreak size and almost eradicate the" exact="ZIKV" post="infection (Fig. 5). The outcome is almost identical with"/>
   <result pre="time points. We have also ignored potential stochastic effects in" exact="ZIKV" post="transmission, which may be important, particularly during the early"/>
   <result pre="modeling is necessary to accurately evaluate the stochastic effects on" exact="ZIKV" post="dynamics of these islands. The main goals of this"/>
   <result pre="were to gain deeper insight into the epidemiological parameters of" exact="ZIKV" post="transmission and to evaluate appropriate prevention strategies. The results"/>
   <result pre="of the information contained in the data in estimating the" exact="ZIKV" post="related parameters from the available limited data. This work"/>
   <result pre="the available limited data. This work offered novel insights into" exact="ZIKV" post="related parameters as well as ZIKV infection dynamics and"/>
   <result pre="offered novel insights into ZIKV related parameters as well as" exact="ZIKV" post="infection dynamics and effect of prevention programs on disease"/>
   <result pre="study, we utilized the published data containing number of suspected" exact="ZIKV" post="infections from six main regions (Tahiti, Iles Sous-le-vent, Moorea,"/>
   <result pre="reported weekly between April 2007 and July 20079. In the" exact="ZIKV" post="outbreak data of French Polynesia, clinical cases were defined"/>
   <result pre="four health centers on Yap to identify patients with suspected" exact="ZIKV" post="disease9. Suspected cases had the following characteristics: acute onset"/>
   <result pre="tested on Yap Island, 185 cases were identified as suspected" exact="ZIKV" post="disease, which we extrapolated for the whole population of"/>
   <result pre="model We developed a compartmental mathematical model to describe the" exact="ZIKV" post="transmission dynamics, similar to the ones previously used for"/>
   <result pre="extrinsic (mosquito) incubation periods. Figure 6 Schematic representation of human-mosquito" exact="ZIKV" post="transmission. In the model system, Sh represents the number"/>
   <result pre="is the number of humans that have recovered from the" exact="ZIKV" post="infection. Similarly, Sm, Em, and Im represent the susceptible,"/>
   <result pre="exposed, and infectious mosquito populations, respectively. The dynamics of our" exact="ZIKV" post="epidemiological model are governed by the following system: 3"/>
   <result pre="the model with frequency-dependent rate. Since the death due to" exact="ZIKV" post="was not reported during the period of epidemics, we"/>
   <result pre="e m − i m , thereby reducing the population-wide" exact="ZIKV" post="model to the following five-dimensional system: 5 \documentclass[12pt]{minimal} \usepackage{amsmath}"/>
   <result pre="reported) are required to be estimated using epidemic data from" exact="ZIKV" post="outbreaks in Yap island and the islands of French"/>
   <result pre="procedure of sensitivity driven estimation is as follows. Solve the" exact="ZIKV" post="model system with m estimated parameters. If the ratio"/>
   <result pre="no competing interests. References References 1.MussoDet al.Potential sexual transmission of" exact="Zika" post="virusEmerg. Infect. Dis.20152135936110.3201/eid2102.14136325625872 2.GaoDet al.Prevention and control of Zika"/>
   <result pre="of Zika virusEmerg. Infect. Dis.20152135936110.3201/eid2102.14136325625872 2.GaoDet al.Prevention and control of" exact="Zika" post="as a mosquito-borne and sexually transmitted disease: A mathematical"/>
   <result pre="mathematical modelingAnalysis. Sci. Rep.201662807010.1038/srep2807027312324 3.D’OrtenzioEet al.Evidence of sexual transmission of" exact="Zika" post="virusN. Engl. J. Med.20163742195219810.1056/NEJMc160444927074370 4.Chouin-CarneiroTet al.Differential susceptibilities of Aedes"/>
   <result pre="of Aedes aegypti and Aedes albopictus from the Americas to" exact="Zika" post="virusVirus. PLoS Negl. Trop. Dis.201610e000454310.1371/journal.pntd.000454326938868 5.Freire, C. C. d."/>
   <result pre="&amp;amp; Zanotto, P. M. d. A. Spread of the pandemic" exact="Zika" post="virus lineage is associated with NS1 codon usage adaptation"/>
   <result pre="meeting of the International Health Regulations (2005) Emergency Committee on" exact="Zika" post="virus and observed increase in neurological disorders and neonatal"/>
   <result pre="Emergency Operations Center moves to highest level of activation for" exact="Zika" post="response, February 3, 2016 (2016). 9.DuffyMRet al.Zika virus outbreak"/>
   <result pre="Med.20093602536254310.1056/NEJMoa080571519516034 10.OehlerEet al.Increase in cases of Guillain-Barre syndrome during a" exact="Chikungunya" post="outbreak, French Polynesia, 2014 to 2015Euro Surveill.2015203007910.2807/1560-7917.es.2015.20.48.3007926690898 11.Oehler, E."/>
   <result pre="French Polynesia, 2014 to 2015Euro Surveill.2015203007910.2807/1560-7917.es.2015.20.48.3007926690898 11.Oehler, E. et al." exact="Zika" post="virus infection complicated by Guillain-Barre syndrome–case report, French Polynesia,"/>
   <result pre="December 2013. Euro Surveill. 19 (2014). 12.Schuler-FacciniLet al.Possible association between" exact="Zika" post="virus infection and microcephaly - Brazil, 2015MMWR Morb. Mortal."/>
   <result pre="sulfadoxine-pyrimethamine protection from malariaBull. Math. Biol.2012742733275110.1007/s11538-012-9775-423081725 20.ZhangQet al.Projected spread of" exact="Zika" post="virus in the AmericasbioRxiv201610.1101/066456 21.KucharskiAJet al.Transmission dynamics of Zika"/>
   <result pre="of Zika virus in the AmericasbioRxiv201610.1101/066456 21.KucharskiAJet al.Transmission dynamics of" exact="Zika" post="virus in island populations: A modelling analysis of the"/>
   <result pre="Sciences20152821806201503472015034710.1098/rspb.2015.0347 29.LesslerJet al.Times to key events in the course of" exact="Zika" post="infection and their implications for surveillance: A systematic review"/>
   <result pre="simple technique for infection of mosquitoes with viruses; transmission of" exact="Zika" post="virusTrans. R. Soc. Trop. Med. Hyg.19565023824210.1016/0035-9203(56)90029-313337908 41.AndraudMHensNMaraisCBeutelsPDynamic epidemiological models"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6648004\results\search\tropicalVirus\results.xml">
   <result pre="medium, provided the original work is properly cited. Abstract ABSTRACT" exact="Yellow fever" post="is one of the most important mosquito-borne diseases, which"/>
   <result pre="provide a better clinical control for patients with yellow fever." exact="Yellow fever" post="Acute kidney injury Epidemics Pathophysiology fig-count: table-count: equation-count: ref-count:"/>
   <result pre="of some of the most pathogenic human viruses (Arboviruses), including" exact="Dengue" post="virus (DENV), Yellow fever virus (YFV), Zika virus (ZIKV)"/>
   <result pre="the most pathogenic human viruses (Arboviruses), including Dengue virus (DENV)," exact="Yellow fever" post="virus (YFV), Zika virus (ZIKV) and West Nile virus"/>
   <result pre="viruses (Arboviruses), including Dengue virus (DENV), Yellow fever virus (YFV)," exact="Zika" post="virus (ZIKV) and West Nile virus (WNV), among others1"/>
   <result pre="virus (DENV), Yellow fever virus (YFV), Zika virus (ZIKV) and" exact="West Nile" post="virus (WNV), among others1 - 4 . These are"/>
   <result pre="humans and non-humans, as hosts1 , 3 , 5 ." exact="Yellow fever" post="virus, the etiological agent of YF, belongs to the"/>
   <result pre="8 . The production of a single polyprotein of the" exact="YFV" post="occurs after the virus infects a host cell, thus"/>
   <result pre="the viral genome. The thi protein is cleaved by the" exact="YFV" post="proteases of the host, producing viral proteins that are"/>
   <result pre="of disease dissemination12 . The severe viscerotropic disease caused by" exact="YFV" post="has a high mortality rate, ranging from 25% to"/>
   <result pre="fatal (30,000 deaths)2 , 14 , 16 , 17 ." exact="Yellow fever" post="causes a pan-systemic febrile illness, with hepatic, renal and"/>
   <result pre="epidemiology There is convincing evidence to the hypothesis that sylvatic" exact="YFV" post="was introduced in the New World about four centuries"/>
   <result pre="during the slave trafficking period17 . It seems that the" exact="YFV" post="could only have been introduced through people presenting with"/>
   <result pre="28 , 29 . Since the 1950s, the transmission of" exact="YFV" post="in the Americas occurred mainly through a sylvatic cycle"/>
   <result pre="involving primates and mosquitoes ( Haemagogus and Sabethes genera )." exact="YFV" post="is extremely pathogenic to primates and non-immune people24 ,"/>
   <result pre="al .30 point out that the first probable exposure to" exact="YFV" post="infection occurred 500 years ago, in 1585, in West"/>
   <result pre="considered a public health threat. Moreover, the dissemination of the" exact="YFV" post="in Brazil was associated to trans-oceanic migrations, because these"/>
   <result pre="such as Africa and the Americas are considered areas of" exact="YFV" post="epidemic threat, due to their historical epidemic records even"/>
   <result pre="geographic distribution includes mainly African and South American tropical areas." exact="Yellow fever" post="sporadically disappears during the winter period18 . According to"/>
   <result pre="environment for mosquitoes propagation in large Brazilian cities. If the" exact="YFV" post="is circulating in the forest, primates can be infected,"/>
   <result pre="a new endemic area for sylvatic yellow fever. Therefore, the" exact="YFV" post="moves forward through the forest areas, reaching cities that"/>
   <result pre="Argentina, Paraguay, Bolivia, and Peru) and African regions have notified" exact="YFV" post="circulation34 , and the displacement of asymptomatic patients infected"/>
   <result pre="risk of yellow fever transmission23 , 25 , 33 ." exact="Yellow fever" post="was initially described only in Africa, and then the"/>
   <result pre="especially the liver, heart and kidneys. In humans, the wild-type" exact="YFV" post="infection is mainly viscerotropic and affects firstly the liver,"/>
   <result pre="hemorrhage and acute hepatic and renal dysfunction. In humans, the" exact="YFV" post="mainly affects the liver, promoting hepatic dysfunction and subsequently"/>
   <result pre="and probes specifically designed to target and differentiate ZIKV, DENV," exact="CHIKV" post="and YFV1 , 5 . Another method that can"/>
   <result pre="laboratory equipment40 . POC has been used to detect ZIKV," exact="CHIKV" post="and DENV due its portability, specificity and sensitivity, using"/>
   <result pre=". POC has been used to detect ZIKV, CHIKV and" exact="DENV" post="due its portability, specificity and sensitivity, using accessible samples"/>
   <result pre="humans. Rhesus primates were sacrificed after the 5th day of" exact="YFV" post="infection and modifications in liver functions were detected up"/>
   <result pre="of death cases involving liver and kidney failure due to" exact="YFV" post="is a significant high rate that should not be"/>
   <result pre="reference laboratoriesJ Clin Microbiol2012504054406023052311 3HigueraARamírezJDMolecular epidemiology of dengue, yellow fever," exact="Zika" post="and Chikungunya arboviruses: an updateActa Trop20191909911130444971 4StockNKEscadafalCAchaziKCisséMNiedrigMDevelopment and characterization"/>
   <result pre="Clin Microbiol2012504054406023052311 3HigueraARamírezJDMolecular epidemiology of dengue, yellow fever, Zika and" exact="Chikungunya" post="arboviruses: an updateActa Trop20191909911130444971 4StockNKEscadafalCAchaziKCisséMNiedrigMDevelopment and characterization of polyclonal"/>
   <result pre="and characterization of polyclonal peptide antibodies for the detection of" exact="Yellow fever" post="virus proteinsJ Virol Methods201522211011626086983 5WuWWangJYuNYanJZhuoZChenMet al.Development of multiplex real-time"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6653809\results\search\tropicalVirus\results.xml">
   <result pre="human arboviruses worldwide (dengue viruses 1, 2, 3, and 4," exact="Chikungunya" post="virus, and Zika virus) can infect wild animals and"/>
   <result pre="(dengue viruses 1, 2, 3, and 4, Chikungunya virus, and" exact="Zika" post="virus) can infect wild animals and transfer from urban"/>
   <result pre="anthropophilic mosquito Aedes aegypti and cause epidemics throughout Brazil. The" exact="YFV" post="is the oldest example of an urban arbovirus that"/>
   <result pre="publications reporting evidence of sylvatic cycles of dengue, Chikungunya, and" exact="Zika" post="virus in South America. Indeed, it is almost unfeasible"/>
   <result pre="as dengue viruses 1, 2, 3, and 4 (DENV 1-4)," exact="Chikungunya" post="virus (CHIKV), and Zika virus (ZIKV) can infect wild"/>
   <result pre="2, 3, and 4 (DENV 1-4), Chikungunya virus (CHIKV), and" exact="Zika" post="virus (ZIKV) can infect wild animals and transfer to"/>
   <result pre="and case fatalities. In around 10% of the infected individuals," exact="YFV" post="can cause severe hepatitis and hemorrhagic fever (Vasconcelos, 2003)."/>
   <result pre="cause severe hepatitis and hemorrhagic fever (Vasconcelos, 2003). All 4" exact="DENV" post="are causes of acute febrile illness and, in few"/>
   <result pre="leads to shock and death (WHO, 2009). Patients infected with" exact="ZIKV" post="virus generally present an acute febrile illness. However, 4"/>
   <result pre="system was found in Brazilian children from mothers infected with" exact="ZIKV" post="during pregnancy (França et al., 2016). CHIKV virus is"/>
   <result pre="mothers infected with ZIKV during pregnancy (França et al., 2016)." exact="CHIKV" post="virus is also a causative agent of acute febrile"/>
   <result pre="on the quality of life (Nunes et al., 2015). YFV," exact="DENV" post="1-4, and ZIKV belong to the Flavivirus genera, and"/>
   <result pre="of life (Nunes et al., 2015). YFV, DENV 1-4, and" exact="ZIKV" post="belong to the Flavivirus genera, and CHIKV to the"/>
   <result pre="DENV 1-4, and ZIKV belong to the Flavivirus genera, and" exact="CHIKV" post="to the Alphavirus genera, all of which are enveloped"/>
   <result pre="introduced into the Americas producing large outbreaks. YFV, ZIKV, and" exact="CHIKV" post="were initially found in African primates, being transmitted by"/>
   <result pre="found in African primates, being transmitted by tree canopy-inhabiting mosquitoes." exact="DENV" post="1-4 were originally viruses from primates of Southeast Asia"/>
   <result pre="text, also highlighting arbovirus infections reported at each mentioned site." exact="YFV" post="was introduced into the Americas in the 16th century"/>
   <result pre="century, presumably as a consequence of more than one spill-over," exact="YFV" post="began to infect sylvatic primates and be transmitted by"/>
   <result pre="be transmitted by Haemagogus mosquitoes from tree canopies (Franco, 1976)." exact="DENV" post="has been the cause of a Brazilian catastrophe, with"/>
   <result pre="large outbreaks throughout the country (Fonseca and Figueiredo, 2010). Currently," exact="DENV" post="1, 2, 3, and 4 are all fostering alternated"/>
   <result pre="in different regions of Brazil. Regarding the sylvatic maintenance cycles," exact="DENV" post="1-4 were reported to have infected neotropical forest mammals"/>
   <result pre="not clearly shown, it is possible that sylvatic cycles of" exact="DENV" post="occur in South America, although more studies are required"/>
   <result pre="although more studies are required to prove such a hypothesis." exact="CHIKV" post="was introduced twice into Brazil. In 2013, the Asian"/>
   <result pre="introduced twice into Brazil. In 2013, the Asian lineage of" exact="CHIKV" post="entered the North, whereas, the eastern, central, and southern"/>
   <result pre="in 2014, and reported in Bahia State. A sequence of" exact="CHIKV" post="outbreaks has stricken different regions of Brazil (Figueiredo, 2017)."/>
   <result pre="Aedes terrens have proven to become easily orally infected with" exact="CHIKV" post="in the laboratory, suggesting high dissemination rates. H. leucocelaenus"/>
   <result pre="blood meal. The competence of these sylvatic mosquitoes to transmit" exact="CHIKV" post="was similar to those of several American Aedes aegypti"/>
   <result pre="urban and peri-urban areas of Bahia State, 11 animals showed" exact="CHIKV" post="neutralizing antibodies. However, two CHIKV-positive samples were also positive"/>
   <result pre="that belongs to the same Semliki Forest antigenic complex of" exact="CHIKV" post="that also causes cases of febrile illness with joint"/>
   <result pre="Midwest Brazil (Moreira-Soto et al., 2018). The differential diagnosis between" exact="CHIKV" post="and MAYV is crucial in Brazil (Figueiredo, 2015) to"/>
   <result pre="Brazil (Figueiredo, 2015) to determine if sylvatic maintenance cycles of" exact="CHIKV" post="could occur in South America. Further studies are required"/>
   <result pre="required to prove such an assumption. The Asian lineage of" exact="ZIKV" post="was introduced into Brazil in 2013 and has affected"/>
   <result pre="from Bahia State, 6 animals (Atelidae, Callitrichidae, and Cebidae) presented" exact="ZIKV" post="neutralizing antibodies. However, 2 ZIKV-positive samples were also positive"/>
   <result pre="mathematic modeling revealed a high probability of establishment of sylvatic" exact="ZIKV" post="based on a broad range of parameters. The sylvatic"/>
   <result pre="vector populations, in addition to the force of infection of" exact="ZIKV" post="(Althouse et al., 2016). Studies on the competence of"/>
   <result pre="competence of New World monkeys and other small mammals as" exact="ZIKV" post="hosts and on that of Sabethes and Haemagogus as"/>
   <result pre="on that of Sabethes and Haemagogus as vectors are needed." exact="YFV" post="is the oldest Brazilian example of an urban arbovirus"/>
   <result pre="Brazil (Brazilian Ministry of Health, 2019). The urban transmission of" exact="YFV" post="by Aedes aegypti has not been reported during this"/>
   <result pre="public health authorities were significantly concerned regarding the spill-back of" exact="YFV" post="returning to its urban cycle transmitted by Aedes aegypti"/>
   <result pre="Aedes albopictus are highly susceptible to both American and African" exact="YFV" post="strains. Indeed, the reemergence of urban epidemics of YFV"/>
   <result pre="African YFV strains. Indeed, the reemergence of urban epidemics of" exact="YFV" post="in South America could occur if the viruses were"/>
   <result pre="in 2017–2018. Similar to YFV, sylvatic cycles may occur with" exact="DENV" post="1-4, CHIKV, and ZIKV. In order for this to"/>
   <result pre="it is possible that the immunity of the primate against" exact="YFV" post="could hinder infections by DENV and ZIKV and, thus,"/>
   <result pre="immunity of the primate against YFV could hinder infections by" exact="DENV" post="and ZIKV and, thus, avoid their sylvatic cycles. Also,"/>
   <result pre="the primate against YFV could hinder infections by DENV and" exact="ZIKV" post="and, thus, avoid their sylvatic cycles. Also, the competitive"/>
   <result pre="at any moment, infecting human populations. Sylvatic transmission cycles for" exact="CHIKV" post="and ZIKV involving non-human primates were reported in Africa,"/>
   <result pre="moment, infecting human populations. Sylvatic transmission cycles for CHIKV and" exact="ZIKV" post="involving non-human primates were reported in Africa, causing the"/>
   <result pre="to anticipate that potential sylvatic cycles of DENV-1-4, CHIKV, and" exact="ZIKV" post="re-originate urban transmission by Aedes aegypti. One critical factor"/>
   <result pre="essential to vaccinate more than 80% of the population against" exact="DENV" post="1-4, CHIKV, and ZIKV. However, since no vaccines are"/>
   <result pre="Hepatitis C, is also effective against YFV, DENV, CHIKV, and" exact="ZIKV" post="(Bonotto et al., 2018; Freitas et al., 2019). In"/>
   <result pre="the establishment of sylvatic maintenance cycles of DENV, CHIKV, and" exact="ZIKV" post="is possible and could already be taking place in"/>
   <result pre="References References AlthouseB. M.VasilakisN.SallA. A.DialloM.WeaverS. C.HanleyK. A. (2016). Potential for" exact="Zika" post="virus to establish a sylvatic transmission cycle in the"/>
   <result pre="Brazilian Ministry of Health (2019). Epidemiological Bulletin. CalderónA.GuzmánC.MattarS.RodriguezV.MartínezC.VioletL.et al.. (2019)." exact="Dengue" post="virus in bats from Córdoba and Sucre, Colombia. Vector"/>
   <result pre="Soc. Bras. Med. Trop.48, 233–234. 10.1590/0037-8682-0179-201526107998 FigueiredoL. T. M. (2017)." exact="Chikungunya" post="virus emerged in Brazil producing large outbreaks that revealed"/>
   <result pre="FrançaG. V. A.Schuler-FacciniL.OliveiraW. K.HenriquesC. M. P.CarmoE. H.PediV. D. (2016). Congenital" exact="Zika" post="virus syndrome in Brazil: a case series of the"/>
   <result pre="da Saúde. FreitasC. S.HigaL. M.SacramentoC. Q.FerreiraA. C.ReisP. A.DelvecchioR.et al.. (2019)." exact="Yellow fever" post="virus is susceptible to sofosbuvir both in vitro and"/>
   <result pre="Americas. PLoS Negl. Trop. Dis.11:e0005698. 10.1371/journal.pntd.000569828662031 MonathT. P.VasconcelosP. F. (2015)." exact="Yellow fever." post="J. Clin. Virol.64, 160–173. 10.1016/j.jcv.2014.08.03025453327 Moreira-SotoA.TorresM. C.MendonçaM. C. L.Mares-GuiaM."/>
   <result pre="G.de OliveiraL. F. (2015). Emergence and potential for spread of" exact="Chikungunya" post="virus in Brazil. BMC Med.13:102. 10.1186/s12916-015-0348-x25976325 ShearerF. M.MoyesC. L.PigottD."/>
   <result pre="retrospective analysis. Lancet Infect. Dis.17, 1209–1217. 10.1016/S1473-3099(17)30419-X28822780 ThoisyB.LacosteV.GermainA.Muñoz-JordánJ.ColónC.MauffreyJ.et al.. (2009)." exact="Dengue" post="infection in neotropical forest mammals. Vec. Born. Zoon. Dis.9,"/>
   <result pre="Rev. Soc. Bras. Med. Trop.36, 275–293. 10.1590/S0037-8682200300020001212806465 collab: WHO (2009)." exact="Dengue" post="Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6658116\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="West Nile" post="virus : Biology and life sciences : Microbiology :"/>
   <result pre="Medical microbiology : Microbial pathogens : Viral pathogens : Flaviviruses:" exact="West Nile" post="virus : Medicine and health sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial pathogens : Viral pathogens : Flaviviruses:" exact="West Nile" post="virus : Biology and life sciences : Organisms :"/>
   <result pre="sciences : Organisms : Viruses : Viral pathogens : Flaviviruses:" exact="West Nile" post="virus : Biology and Life Sciences : Biochemistry :"/>
   <result pre=": Sequence Analysis: Sequence Motif Analysis N-linked glycosylation of the" exact="West Nile" post="virus envelope protein is not a requisite for avian"/>
   <result pre="is not a requisite for avian virulence or vector competence" exact="WNV" post="N-linked glycosylation and host/vector competence http://orcid.org/0000-0002-4157-4479MaharajPayal D.Data curationFormal analysisInvestigationMethodologyWriting"/>
   <result pre="amino acid position 154–156 of the envelope (E) protein of" exact="West Nile" post="virus (WNV) is linked to enhanced murine neuroinvasiveness, avian"/>
   <result pre="with altered E protein glycosylation patterns have been observed in" exact="WNV" post="isolates; however, the specific effects of these polymorphisms on"/>
   <result pre="KYS and deletion (A’DEL), were reverse engineered into a parental" exact="WNV" post="(NYS) cDNA infectious clone to generate WNV glycosylation mutant"/>
   <result pre="into a parental WNV (NYS) cDNA infectious clone to generate" exact="WNV" post="glycosylation mutant viruses. These WNV glycosylation mutant viruses were"/>
   <result pre="cDNA infectious clone to generate WNV glycosylation mutant viruses. These" exact="WNV" post="glycosylation mutant viruses were characterized for in vitro growth,"/>
   <result pre="vector competence phenotypes independent of E-protein glycosylation status. Author summary" exact="West Nile" post="virus (WNV) has been responsible for the largest human"/>
   <result pre="States. Avians and Culex mosquitoes are the primary hosts for" exact="WNV" post="natural transmission cycles. The envelope (E) protein for WNV"/>
   <result pre="for WNV natural transmission cycles. The envelope (E) protein for" exact="WNV" post="contains a variable N-linked glycosylation motif which influences avian"/>
   <result pre="motif which influences avian replication, mosquito infectivity and vector competence." exact="WNV" post="isolates with variable E protein glycosylation motifs that have"/>
   <result pre="associated with human cases of disease, were selected to generate" exact="WNV" post="glycosylation mutant viruses via reverse genetics. Replication capacity and"/>
   <result pre="viruses via reverse genetics. Replication capacity and host competence of" exact="WNV" post="glycosylation mutant viruses were compared in vitro and in"/>
   <result pre="data demonstrated that N-linked glycosylation was not as crucial for" exact="WNV" post="transmission and host competence as previously reported. Rather the"/>
   <result pre="identities of the glycosylation motif were more important in dictating" exact="WNV" post="virulence phenotypes in both avian and mosquito host. Funding"/>
   <result pre="manuscript. Introduction Since its identification in North America in 1999," exact="West Nile" post="virus (WNV) has caused large human encephalitis epidemics in"/>
   <result pre="First isolated in 1937 from a febrile patient in the" exact="West Nile" post="district of northern Uganda[1], the virus is now known"/>
   <result pre="in Africa, Asia, Europe, North America, South America and Australia[2–4]." exact="WNV" post="is a member of the Flaviviridae family and is"/>
   <result pre="encephalitis virus (JEV) serocomplex[5, 6]. The natural reservoir/amplification hosts of" exact="WNV" post="are avian species with Culex spp. mosquitoes serving as"/>
   <result pre="not develop sufficiently high viremias to be infectious for mosquitoes." exact="WNV" post="has a single-stranded positive-sense RNA genome that is transcribed"/>
   <result pre="proteins to dimerize and create a lattice-like structure around mature" exact="WNV" post="virus particles during viral maturation and release[8]. The E"/>
   <result pre="only the prM N-linked glycosylation site is highly conserved among" exact="WNV" post="isolates[7]. The WNV E protein N-linked glycosylation motif (asparagine-tyrosine-serine/threonine;"/>
   <result pre="N-linked glycosylation site is highly conserved among WNV isolates[7]. The" exact="WNV" post="E protein N-linked glycosylation motif (asparagine-tyrosine-serine/threonine; N-Y-S/T) lies between"/>
   <result pre="this motif[9–11]. The N-linked glycosylation motif is present in most" exact="WNV" post="strains that have been isolated during significant outbreaks of"/>
   <result pre="North America and globally (Table 1)[7, 12–14]. Glycosylation of the" exact="WNV" post="E protein has been previously implicated as an important"/>
   <result pre="murine neuroinvasive phenotype[15–18] with higher viremia and increased avian pathogenicity[19–21]." exact="WNV" post="virus-like particles (VLPs) with mutations that prevent glycosylation at"/>
   <result pre="exposed Cx. pipiens. Similarly, oral infectivity of the parental glycosylated" exact="WNV" post="was found to infect Cx. quinquefasciatus more efficiently than"/>
   <result pre="than the NYI mutant [22, 23]. Other flaviviruses such as" exact="Zika" post="virus (ZIKV) also exhibit lower oral infectivity and vector"/>
   <result pre="the envelope protein via mutagenesis[24, 25]. 10.1371/journal.pntd.0007473.t001Table 1 Summary of" exact="West Nile" post="virus strains including origin of isolation, glycosylation status and"/>
   <result pre="(-) NYP Many of the newly emergent and more virulent" exact="WNV" post="strains, including the North American isolates, possess the E"/>
   <result pre="AYS both of which have not been associated with any" exact="WNV" post="isolate[22, 23]. However, the effect of naturally occurring WNV"/>
   <result pre="any WNV isolate[22, 23]. However, the effect of naturally occurring" exact="WNV" post="amino acid polymorphisms on maintenance of transmission cycles has"/>
   <result pre="were reverse engineered and infectious clone-derived viruses generated. An additional" exact="WNV" post="glycosylation mutant virus (NYT) was generated that was designed"/>
   <result pre="Avian host, vector competence and viral growth capacity of these" exact="WNV" post="infectious clone-derived glycosylation mutant viruses were assessed in vitro"/>
   <result pre="assays in this study. Viruses Assembly and rescue of the" exact="WNV" post="infectious clone derived virus (WNV.IC) has been described previously[28]."/>
   <result pre="were designed based on the glycosylation motif of the different" exact="WNV" post="isolates (Table 1). Glycosylation mutant WNV plasmids were generated"/>
   <result pre="motif of the different WNV isolates (Table 1). Glycosylation mutant" exact="WNV" post="plasmids were generated using a QuikChange site-directed mutagenesis kit"/>
   <result pre="from five representative plaques for comparison. 10.1371/journal.pntd.0007473.t002Table 2 Summary of" exact="West Nile" post="virus infectious cDNA clone derived glycosylation mutant viruses that"/>
   <result pre="generated. Parental Virusα Nucleotide Substitutions made to parental WNV.ICβ Rescued" exact="WNV" post="Glycosylation Mutant Virus Amino Acid Motif Amino Acid Translationβ"/>
   <result pre="parental WNV.IC envelope protein was mutagenized to generate seven new" exact="WNV" post="glycosylation mutant viruses that are described in the third"/>
   <result pre="protein In order to confirm the glycosylation status of the" exact="WNV" post="mutants, Vero cells were inoculated with the parental and"/>
   <result pre="plotted by hpi. pH sensitivity assay The parental strain and" exact="WNV" post="glycosylation mutants were diluted to 105 PFU/well and exposed"/>
   <result pre="that AMCRs and HOSPs had not previously been exposed to" exact="WNV" post="or another endemic flavivirus, St. Louis encephalitis virus (SLEV),"/>
   <result pre="sera of any AMCR or HOSP to either SLEV or" exact="WNV" post="excluded the bird for use in vivo experiments. All"/>
   <result pre="Six HOSPs were similarly inoculated with 1,500 PFU of each" exact="WNV" post="glycosylation mutant, including a mutant lacking the E αA’"/>
   <result pre="of each mutant virus compared to the parental glycosylated NYS" exact="WNV" post="in mosquitoes. Ethics statement California and Colorado birds were"/>
   <result pre="Lab at Colorado State University. Results Generation and characterization of" exact="WNV" post="mutants WNV mutants (Table 2) were harvested from transfected"/>
   <result pre="Colorado State University. Results Generation and characterization of WNV mutants" exact="WNV" post="mutants (Table 2) were harvested from transfected BHK-21 supernatants"/>
   <result pre="SYS plaques (Fig 1C). Fig 1 In vitro characterization of" exact="WNV" post="glycosylation mutant viruses. (A) Plaque morphology of WNV mutants"/>
   <result pre="characterization of WNV glycosylation mutant viruses. (A) Plaque morphology of" exact="WNV" post="mutants on Vero cells at 3 dpi and sequenced"/>
   <result pre="digestion (Endo F) was used to assess presence/ absence of" exact="WNV" post="envelope protein glycosylation. Purified E proteins were digested with"/>
   <result pre="4–20% SDS-PAGE gel and performing a Western blot with the" exact="WNV" post="E-glycoprotein specific monoclonal antibody, 3.67G. (C) Plaque diameters were"/>
   <result pre="virus (D)Virus growth was assessed in Vero cells with the" exact="WNV" post="parental virus and mutants at an MOI of 0."/>
   <result pre="(LOD) shown by dashed line. (E) The parental strain and" exact="WNV" post="glycosylation mutants were diluted to 105 PFU/well and exposed"/>
   <result pre="function of the pH treatment. Differential in vitro growth of" exact="WNV" post="mutants Growth profiles of glycosylation competent viruses (NYS, NYT)"/>
   <result pre="(p&amp;lt;0.05) growth in C6/36 cells in comparison with the other" exact="WNV" post="mutants. Serial passaging was performed to assess genetic stability"/>
   <result pre="to T/CCC (Ser/Pro). Fig 2 Virus growth of parental and" exact="WNV" post="glycosylation mutant viruses. (A) mosquito cells (C6/36) (B) HD11"/>
   <result pre="populations have been implicated in the amplification and dissemination of" exact="WNV" post="in avian infections[35, 36], mutants were compared in cultured"/>
   <result pre="host competence[37]. As such, DEF cells growth phenotypes of the" exact="WNV" post="mutants were assessed at 37°C/44°C (Fig 2C and 2D)."/>
   <result pre="highly susceptible to WNV[29, 38], the impact of the various" exact="WNV" post="mutants on avian survivorship was assessed. All crows inoculated"/>
   <result pre="motif when compared to the inoculum consensus sequences. Fig 3" exact="WNV" post="glycosylation mutant virus growth and survivorship in American crows"/>
   <result pre="(AMCR). Seven AMCRs were inoculated with 1,500 PFU of parental" exact="WNV" post="and mutants. Graphs represent (A) survivorship and (B) mean"/>
   <result pre="sera. LODs are shown by dashed line. Viremia profiles of" exact="WNV" post="glycosylation mutants in HOSPs The viremia response to the"/>
   <result pre="also not performed due to the aforementioned reason. Fig 4" exact="WNV" post="glycosylation mutant virus growth and survivorship in house sparrows"/>
   <result pre="mutant. LODs are shown by dashed lines. Vector competence of" exact="WNV" post="glycosylation mutants in Culex mosquitoes Culex quinquefasciatus were orally"/>
   <result pre="mutants in Culex mosquitoes Culex quinquefasciatus were orally exposed to" exact="WNV" post="parental (NYS) and mutant viruses, NYT, NYP, NYF, SYS,"/>
   <result pre="were not significantly different. Fig 5 Vector competence assessment of" exact="WNV" post="glycosylation mutant viruses in Culex quinquefasciatus. Culex quinquefasciatus were"/>
   <result pre="individual artificial blood meals containing 7 log10 PFU/mL of the" exact="WNV" post="parental (NYS) or glycosylation mutant viruses (NYT, NYP, NYF,"/>
   <result pre="body titers (100% for all viruses; Fig 6B) for any" exact="WNV" post="in IT-inoculated mosquitoes. No significant differences (p&amp;gt;0.05) were observed"/>
   <result pre="Fig 6 Viral growth in Culex quinquefasciatus intrathoracically inoculated with" exact="WNV" post="glycosylation mutant viruses. Culex quinquefasciatus were intrathoracically inoculated with"/>
   <result pre="were intrathoracically inoculated with 0.14μL of 6 log10 PFU/mL of" exact="WNV" post="parental and WNV glycosylation mutant viruses (NYT, NYP, NYF,"/>
   <result pre="with 0.14μL of 6 log10 PFU/mL of WNV parental and" exact="WNV" post="glycosylation mutant viruses (NYT, NYP, NYF, SYS, SYP, KYS,"/>
   <result pre="to determine its relative effect in another important North American" exact="WNV" post="enzootic vector species (Fig 7). Similarly, the infection (Fig"/>
   <result pre="bodies, legs and saliva. Fig 7 Vector competence assessment of" exact="WNV" post="glycosylation mutant viruses in Culex tarsalis. Culex tarsalis were"/>
   <result pre="individual artificial blood meals containing 7 log10 PFU/mL of parental" exact="WNV" post="(NYS) or WNV glycosylation mutant virus (NYP). After the"/>
   <result pre="meals containing 7 log10 PFU/mL of parental WNV (NYS) or" exact="WNV" post="glycosylation mutant virus (NYP). After the extrinsic incubation period"/>
   <result pre="by dashed lines. Discussion The N-linked glycosylation motif within the" exact="WNV" post="E protein at position 154–156 has been implicated previously"/>
   <result pre="transmissibility in Culex mosquitoes[22, 23]. In this study, we investigated" exact="WNV" post="viral replication, WNV-vector interactions, avian virulence and vector competence"/>
   <result pre="the amino acid identity at either E-154 or E-156 modulated" exact="WNV" post="viral growth, avian virulence and vector competence independent of"/>
   <result pre="of the predicted glycosylation of WNV-E protein. In previous reports," exact="WNV" post="mutants with abolished E-protein glycosylation such as NYF[27], QYS[7]"/>
   <result pre="amino acid polymorphisms at either E-154 or E-156 differentially modulated" exact="WNV" post="growth in C6/36 cells. Although many of the nonglycosylated"/>
   <result pre="has been associated with lessened avian virulence phenotypes of other" exact="WNV" post="variants/mutants[28, 37], many of the nonglycosylated WNV mutants (NYF"/>
   <result pre="phenotypes of other WNV variants/mutants[28, 37], many of the nonglycosylated" exact="WNV" post="mutants (NYF and SYS) that were highly sensitive for"/>
   <result pre="avian competence. Unlike previous studies in which the growth of" exact="WNV" post="mutants in AMCR monocytes predicted viremia potential and virulence[35],"/>
   <result pre="cells from alternative avian sources with lessened susceptibility (chickens) to" exact="WNV" post="to model avian virulence phenotypes in highly susceptible birds"/>
   <result pre="cells had demonstrated restricted growth for a Mexican isolate of" exact="WNV" post="lacking a glycosylation motif (NYP) with limited avian virulence"/>
   <result pre="viral loads in young chicks inoculated with a non-glycosylated (NYP)" exact="WNV" post="plaque variant when compared to glycosylated (NYS) WNV have"/>
   <result pre="non-glycosylated (NYP) WNV plaque variant when compared to glycosylated (NYS)" exact="WNV" post="have also been reported[19] leading the investigators to ascribe"/>
   <result pre="SYS, SYP and KYS viruses when compared with NYS parental" exact="WNV" post="in Cx. quinquefasciatus. Even after bypassing the midgut barrier"/>
   <result pre="nature[19, 21]. While NYP avian serum titers could presumably overcome" exact="WNV" post="oral infection thresholds[42] in highly competent avian hosts[21], AMCRs"/>
   <result pre="NYS and NYF, SYS, SYP and KYS viruses suggests that" exact="WNV" post="N-linked glycosylation is not a critical determinant of vector"/>
   <result pre="at E154 or E-156 and potential other sites on the" exact="WNV" post="E protein could be critical for modulation of mosquito"/>
   <result pre="rates remained similar to NYS. While no naturally occurring NYT" exact="WNV" post="variants have been described, other flaviviruses such as Zika"/>
   <result pre="NYT WNV variants have been described, other flaviviruses such as" exact="Zika" post="(NDT), dengue (NET), Wesselbron (NHT), Sepik (NHT), Rocio (NYT),"/>
   <result pre="acid of the N-linked glycosylation motif[24]. Other flaviviruses such as" exact="Yellow fever" post="virus and St. Louis encephalitis viruses do not encode"/>
   <result pre="others have also demonstrated variable vector competence rates with non-glycosylated" exact="WNV" post="isolates[49, 50] and in this study, with the exception"/>
   <result pre="demonstrate transmissibility in Cx quinquefasciatus. Data presented herein indicates that" exact="WNV" post="E154-156 motif amino identity, rather than specific N-linked glycosylation,"/>
   <result pre="and the effect of a particular E154-156 moiety expressed on" exact="WNV" post="avian and vector competence was species-dependent. The isolation of"/>
   <result pre="with the findings here indicates the strong possibility that non-glycosylated" exact="WNV" post="variants could circulate at relatively high frequency. The frequency"/>
   <result pre="variants could circulate at relatively high frequency. The frequency of" exact="WNV" post="genotypes to express a particular E-glycosylation motif (E154-E156) is"/>
   <result pre="Native of Uganda. Am J Trop Med. 1940;s1-20(4):471–92. 2HubalekZ, HalouzkaJ." exact="West Nile" post="fever—a reemerging mosquito-borne viral disease in Europe. Emerg Infect"/>
   <result pre="1999;5(5):643–50. 10.3201/eid0505.99050510511520 3MarfinAA, PetersenLR, EidsonM, MillerJ, HadlerJ, FarelloC, et al.Widespread" exact="West Nile" post="virus activity, eastern United States, 2000. Emerg Infect Dis."/>
   <result pre="Wilkins. 7HannaSL, PiersonTC, SanchezMD, AhmedAA, MurtadhaMM, DomsRW. N-Linked Glycosylation of" exact="West Nile" post="Virus Envelope Proteins Influences Particle Assembly and Infectivity. Journal"/>
   <result pre="Virology. 2005;79(21):13262–74. 10.1128/JVI.79.21.13262-13274.200516227249 8MukhopadhyayS, KimB-S, ChipmanPR, RossmannMG, KuhnRJ. Structure of" exact="West Nile" post="Virus. Science. 2003;302(5643):248–. 10.1126/science.108931614551429 9BerthetFX, ZellerHG, DrouetMT, RauzierJ, DigoutteJP,"/>
   <result pre="changes and deletions within the envelope glycoprotein gene of Euro-African" exact="West Nile" post="viruses. Journal of General Virology. 1997;78(9):2293–7. 10.1099/0022-1317-78-9-22939292017 10AdamsSC, BroomAK,"/>
   <result pre="11EbelG, CarricaburuJ, YoungD, BernardK, KramerL. Genetic and phenotypic variation of" exact="West Nile" post="virus in New York, 2000–2003. Am J Trop Med"/>
   <result pre="12LanciottiR, RoehrigJ, DeubelV, SmithJ, ParkerM, SteeleK, et al.Origin of the" exact="West Nile" post="virus responsible for an outbreak of encephalitis in the"/>
   <result pre="Y Acad Sci. 2001;951:127–42. 10.1111/j.1749-6632.2001.tb02691.x11797770 14MurgueB, MurriS, TrikiH, DeubelV, ZellerHG." exact="West Nile" post="in the Mediterranean Basin: 1950–2000. Annals of the New"/>
   <result pre="Glycosylation Status Influences Mouse Neuroinvasion Phenotype of Genetic Lineage 1" exact="West Nile" post="Virus Strains. J Virol. 2005;79(13):8339–47. 10.1128/JVI.79.13.8339-8347.200515956579 16ShiratoK, MiyoshiH, GotoA,"/>
   <result pre="determinant of the neuroinvasiveness of the New York strain of" exact="West Nile" post="virus. J Gen Virol. 2004;85(12):3637–45. 10.1099/vir.0.80247-015557236 17BeasleyD, DavisC, Estrada-FrancoJ,"/>
   <result pre="Navarro-LopezR, Campomanes-CortesA, TeshR, et al.Genome sequence and attenuating mutations in" exact="West Nile" post="virus isolate from Mexico. Emerg Infect Dis. 2004;10(12):2221–4. 10.3201/eid1012.04064715663867"/>
   <result pre="role in the high pathogenicity of European–Mediterranean IS98 strain of" exact="West Nile" post="virus. Virology. 2016;492(Supplement C):53–65. 10.1016/j.virol.2016.02.009.26896935 19MurataR, EshitaY, MaedaA, MaedaJ,"/>
   <result pre="19MurataR, EshitaY, MaedaA, MaedaJ, AkitaS, TanakaT, et al.Glycosylation of the" exact="West Nile" post="Virus Envelope Protein Increases In Vivo and In Vitro"/>
   <result pre="2010;82(4):696–704. 10.4269/ajtmh.2010.09-026220348522 20KariwaH, MurataR, TotaniM, YoshiiK, TakashimaI. Increased Pathogenicity of" exact="West Nile" post="Virus (WNV) by Glycosylation of Envelope Protein and Seroprevalence"/>
   <result pre="Virus (WNV) by Glycosylation of Envelope Protein and Seroprevalence of" exact="WNV" post="in Wild Birds in Far Eastern Russia. International Journal"/>
   <result pre="mutations mediate diminished avian growth and virulence of a Mexican" exact="West Nile" post="virus isolate. Journal of General Virology. 201110.1099/vir.0.035535-0 22MoudyRM, ZhangB,"/>
   <result pre="isolate. Journal of General Virology. 201110.1099/vir.0.035535-0 22MoudyRM, ZhangB, ShiP-Y, KramerLD." exact="West Nile" post="virus envelope protein glycosylation is required for efficient viral"/>
   <result pre="2009;387(1):222–8. 10.1016/j.virol.2009.01.03819249803 23MoudyRM, PayneAF, DodsonBL, KramerLD. Requirement of Glycosylation of" exact="West Nile" post="Virus Envelope Protein for Infection of, but Not Spread"/>
   <result pre="LuoH, MuruatoAE, MedeirosDBA, MaysE, et al.Functional Analysis of Glycosylation of" exact="Zika" post="Virus Envelope Protein. Cell Reports. 2017;21(5):1180–90. 10.1016/j.celrep.2017.10.01629091758 26LanciottiRS, EbelGD,"/>
   <result pre="MurriS, MeyerR, et al.Complete Genome Sequences and Phylogenetic Analysis of" exact="West Nile" post="Virus Strains Isolated from the United States, Europe, and"/>
   <result pre="virulence and thermostable replication of the North American strain of" exact="West Nile" post="virus. J Gen Virol. 2006;87(Pt 12):3611–22. 10.1099/vir.0.82299-0 .17098976 29BraultAC,"/>
   <result pre="29BraultAC, LangevinSA, BowenRA, PanellaNA, BiggerstaffBJ, MillerBR, et al.Differential virulence of" exact="West Nile" post="strains for American crows. Emerg Infect Dis. 2004;10(12):2161–8. Epub"/>
   <result pre="10.3201/eid1012.04048615663854 30SbranaE, TonryJH, XiaoS-Y, Da RosaAPAT,HiggsS, TeshRB. Oral transmission of" exact="West Nile" post="virus in a hamster model. Am J Trop Med"/>
   <result pre="ReisenWK, BraultAC. Genetic determinants of differential oral infection phenotypes of" exact="West Nile" post="and St. Louis encephalitis viruses in Culex spp. mosquitoes."/>
   <result pre="33FrostMJ, ZhangJ, EdmondsJH, ProwNA, GuX, DavisR, et al.Characterization of Virulent" exact="West Nile" post="Virus Kunjin Strain, Australia, 2011. Emerging Infectious Diseases. 2012;18(5):792–800."/>
   <result pre="BowenRA, BraultAC. An ex vivo avian leukocyte culture model for" exact="West Nile" post="virus infection. J Virol Methods. 2015;218:19–22. 10.1016/j.jviromet.2015.03.004 .25783683 36DietrichEA,"/>
   <result pre="et al. Host competence and helicase activity differences exhibited by" exact="West Nile" post="viral variants expressing NS3-249 amino acid polymorphisms. PLoS One."/>
   <result pre="North American birds with the New York 1999 strain of" exact="West Nile" post="virus. Emerg Infect Dis. 2003;9(3):311–22. 10.3201/eid0903.020628 .12643825 39LiJ, BhuvanakanthamR,"/>
   <result pre="HoweJ, NgM-L. The glycosylation site in the envelope protein of" exact="West Nile" post="virus (Sarafend) plays an important role in replication and"/>
   <result pre="General Virology. 2006;87(3):613–22. 10.1099/vir.0.81320-016476982 40AndradeCC, MaharajPD, ReisenWK, BraultAC. North American" exact="West Nile" post="virus genotype isolates demonstrate differential replicative capacities in response"/>
   <result pre="mutations mediate diminished avian growth and virulence of a Mexican" exact="West Nile" post="virus isolate. Journal of General Virology. 2011;92(12):2810–20. 10.1099/vir.0.035535-021865445 42MaharajPD,"/>
   <result pre="ReisenWK, BraultAC. Genetic Determinants of Differential Oral Infection Phenotypes of" exact="West Nile" post="and St. Louis Encephalitis Viruses in Culex spp. Mosquitoes."/>
   <result pre="LanciottiRS, BraultAC, GuzmanH, SiirinM, et al.Phylogenetic analysis of North American" exact="West Nile" post="virus isolates, 2001–2004: Evidence for the emergence of a"/>
   <result pre="MeolaMA, MoudyRM, KramerLD. Temperature, Viral Genetics, and the Transmission of" exact="West Nile" post="Virus by Culex pipiens Mosquitoes. PLOS Pathogens. 2008;4(6):e100009210.1371/journal.ppat.100009218584026 45KasturiL,"/>
   <result pre="47MossentaM, MarcheseS, PoggianellaM, Slon CamposJL, BurroneOR. Role of N-glycosylation on" exact="Zika" post="virus E protein secretion, viral assembly and infectivity. Biochemical"/>
   <result pre="Lineages 1, 2, Koutango and a Putative New Lineage of" exact="West Nile" post="virus. The American Journal of Tropical Medicine and Hygiene."/>
   <result pre="OwensN, Bosco-LauthAM, NagasakiT, et al.Programmed Ribosomal Frameshift Alters Expression of" exact="West Nile" post="Virus Genes and Facilitates Virus Replication in Birds and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6659212\results\search\tropicalVirus\results.xml">
   <result pre="Report European Aedes caspius mosquitoes are experimentally unable to transmit" exact="Zika" post="virus NúñezAna I.anaisabel.nunez@irta.cat1TalaveraSandrasandra.talavera@irta.cat1ArandaCarlescaranda@elbaixllobregat.cat12BirnbergLottylotty.birnberg@irta.cat1RivasRaquelraquel.rivas@irta.cat1PujolNúrianuria.pujol@irta.cat1VerdúnMartamarta.verdun@irta.cat1FaillouxAnna-Bellaanna-bella.failloux@pasteur.fr3http://orcid.org/0000-0001-5246-8260BusquetsNúrianuria.busquets@irta.cat1[1], grid.7080.fInstitut de Recerca i Tecnologia Agroalimentàries"/>
   <result pre="the transmission cycle of certain diseases in Europe such as" exact="Zika" post="virus (ZIKV). Concerning vector competence for ZIKV, studies related"/>
   <result pre="for ZIKV, studies related to Ae. caspius are still scarce." exact="ZIKV" post="is an arbovirus that has provoked a widespread epidemic"/>
   <result pre="in the Pacific region (2007–2013) and in the Americas (2015–2016)." exact="ZIKV" post="is associated with serious neurological injuries (e.g. microcephaly) and"/>
   <result pre="neurological injuries (e.g. microcephaly) and Guillain-Barré syndrome. Due to the" exact="ZIKV" post="epidemics in the American continent, some viraemic travellers coming"/>
   <result pre="susceptibility of autochthonous mosquito species such as Ae. caspius for" exact="ZIKV" post="in order to improve arbovirus surveillance and control programmes."/>
   <result pre="a European population of Ae. caspius was evaluated for two" exact="ZIKV" post="lineages, the Suriname ZIKV strain (Asian lineage) and the"/>
   <result pre="Ae. caspius was evaluated for two ZIKV lineages, the Suriname" exact="ZIKV" post="strain (Asian lineage) and the MR766 ZIKV strain (African"/>
   <result pre="lineages, the Suriname ZIKV strain (Asian lineage) and the MR766" exact="ZIKV" post="strain (African I lineage). Females were tested at 7,"/>
   <result pre="a positive control. Results Aedes caspius presented low susceptibility to" exact="ZIKV" post="infection and the virus was only detected by RT-qPCR"/>
   <result pre="infection, dissemination and transmission rates were calculated for the Suriname" exact="ZIKV" post="strain (Asian lineage) at each time point. For the"/>
   <result pre="strain (Asian lineage) at each time point. For the MR766" exact="ZIKV" post="strain (African I lineage), while only infection rates were"/>
   <result pre="unlikely that European Ae. caspius mosquitoes could be involved in" exact="ZIKV" post="transmission if ZIKV was introduced into Europe. This information"/>
   <result pre="Ae. caspius mosquitoes could be involved in ZIKV transmission if" exact="ZIKV" post="was introduced into Europe. This information may help in"/>
   <result pre="for ZIKV. Keywords Aedes caspius Saliva Transmission Arbovirus Vector competence" exact="Zika" post="virus Funding http://dx.doi.org/10.13039/501100007601Horizon 2020 734548BusquetsNúria Background Aedes caspius (Pallas,"/>
   <result pre="from Camargue and from Andalusia (Spain) were unable to transmit" exact="West Nile" post="virus (WNV) [7] and Zika virus (ZIKV) [8], respectively."/>
   <result pre="were unable to transmit West Nile virus (WNV) [7] and" exact="Zika" post="virus (ZIKV) [8], respectively. The ZIKV is an arthropod-borne"/>
   <result pre="virus (WNV) [7] and Zika virus (ZIKV) [8], respectively. The" exact="ZIKV" post="is an arthropod-borne virus belonging to the genus Flavivirus"/>
   <result pre="non-human primates in Africa, although sexual [9] and perinatal [10]" exact="ZIKV" post="transmission have also been confirmed in humans. The virus"/>
   <result pre="and congenital malformations including microcephaly [11] and Guillain-Barré syndrome [12]." exact="ZIKV" post="was isolated for the first time from a rhesus"/>
   <result pre="the first time from a rhesus macaque monkey in the" exact="Zika" post="forest (Uganda) in 1947 [13]. The virus was subsequently"/>
   <result pre="in the 1960s. In 2007 there was an outbreak of" exact="ZIKV" post="in Yap Island, Micronesia [14], which spread to Pacific"/>
   <result pre="lineages: Asian; African I; and West African II [17, 18]." exact="ZIKV" post="has been isolated from numerous African mosquito species in"/>
   <result pre="Aedes aegypti is considered to be the main vector of" exact="ZIKV" post="in urban areas [20]. In addition, several Aedes species"/>
   <result pre="Aedes polynesiensis [21] and Ae. albopictus [22–26]. Due to the" exact="ZIKV" post="epidemics in the American continent, some viraemic travellers coming"/>
   <result pre="susceptibility of autochthonous mosquito species such as Ae. caspius for" exact="ZIKV" post="to improve arbovirus surveillance and control programmes. For this"/>
   <result pre="population from El Prat de Llobregat (Catalonia, Spain) for two" exact="ZIKV" post="lineages, Suriname (Asian lineage) and MR766 (African I lineage)"/>
   <result pre="MR766 (African I lineage) to measure its potential role in" exact="ZIKV" post="transmission. Methods Mosquito rearing Aedes caspius larvae were collected"/>
   <result pre="the same conditions and used as a positive control of" exact="ZIKV" post="vector. Virus production and titration Suriname and African MR766"/>
   <result pre="ZIKV vector. Virus production and titration Suriname and African MR766" exact="ZIKV" post="strains provided by the European EVAg project were used"/>
   <result pre="EVAg project were used in the present work. The Suriname" exact="ZIKV" post="strain (EVAg no. 011V-01621; Asian lineage) was isolated from"/>
   <result pre="in Netherlands in 2016 who came from Suriname during the" exact="ZIKV" post="epidemic [29] and the African MR766 ZIKV strain (African"/>
   <result pre="Suriname during the ZIKV epidemic [29] and the African MR766" exact="ZIKV" post="strain (African I lineage) was isolated from a rhesus"/>
   <result pre="samples in 0.190 ml of DMEM at − 80 °C until" exact="ZIKV" post="detection. Infection (IR), disseminated infection (DIR) and transmission rates"/>
   <result pre="BLS3 facilities. Table 1 Summary of assays Mosquito species tested" exact="ZIKV" post="strain tested Titer of ZIKV (TCID50/ml) No. of mosquitoes"/>
   <result pre="of assays Mosquito species tested ZIKV strain tested Titer of" exact="ZIKV" post="(TCID50/ml) No. of mosquitoes tested per time point 7"/>
   <result pre="No virus – – 11 11 Abbreviation: dpe, days post-exposure" exact="ZIKV" post="detection Virus detection from leg, wing and body samples"/>
   <result pre="RNA Virus (Macherey-Nagel, Düren, Germany) according to the manufacturer’s protocol." exact="Zika" post="RNA was detected by reverse-transcription quantitative PCR (RT-qPCR) using"/>
   <result pre="TCID50/reaction for detection of MR766 and 0.035 TCID50/reaction for Suriname" exact="ZIKV" post="strains. Results Feeding rates were 56% (280/500) and 77.45%"/>
   <result pre="caspius and Ae. aegypti, respectively. For the Ae. caspius population," exact="ZIKV" post="was detected by RT-qPCR only in body samples for"/>
   <result pre="the infection rate (IR) in Ae. caspius for the Suriname" exact="ZIKV" post="strain was 3.33% and 10% at 14 and 21"/>
   <result pre="14 and 21 days post-exposure (dpe), respectively. For the MR766" exact="ZIKV" post="strain, the IR was only 3.33% at 7 dpe."/>
   <result pre="IR was only 3.33% at 7 dpe. In addition, both" exact="ZIKV" post="strains were unable to induce a disseminated infection and"/>
   <result pre="Ae. aegypti PAEA populations artificially fed with Suriname and MR766" exact="ZIKV" post="strains at a titer of 7 log10 TCID50/ml. Viral"/>
   <result pre="PAEA strain), infection was detected at 7 dpe for both" exact="ZIKV" post="strains tested by RT-qPCR and cytopathic effect while dissemination"/>
   <result pre="while dissemination and transmission were only found for the Suriname" exact="ZIKV" post="strain at 14 and 21 dpe (Table 1 and"/>
   <result pre="The transmission efficiency (TE) of Ae. aegypti for the Suriname" exact="ZIKV" post="strain based on the cytopathic effect in Vero cells"/>
   <result pre="from Catalonia was unable to transmit the Suriname and MR766" exact="ZIKV" post="strains, belonging to the Asian and African I phylogenetic"/>
   <result pre="since at 7 dpe we found infected bodies of MR766" exact="ZIKV" post="strain by RT-qPCR as well as at 14 and"/>
   <result pre="as well as at 14 and 21 dpe to the" exact="ZIKV" post="Asian strain but neither the disseminated infection nor the"/>
   <result pre="in which another Ae. caspius population was assayed for a" exact="ZIKV" post="strain of the Asian lineage (Puerto Rico, 2015) under"/>
   <result pre="be noted that in our experiment, apart from testing a" exact="ZIKV" post="strain of Asian lineage, we also assayed a ZIKV"/>
   <result pre="a ZIKV strain of Asian lineage, we also assayed a" exact="ZIKV" post="strain of the African I lineage (MR766) with cycled"/>
   <result pre="behavior of Ae. caspius, its role in the transmission of" exact="ZIKV" post="seems unlikely. Aedes aegypti from PAEA (French Polynesia), selected"/>
   <result pre="was able to transmit the Suriname strain (Asian lineage). Suriname" exact="ZIKV" post="infection, dissemination and transmission were observed at 14 and"/>
   <result pre="with other experiments reported on Ae. aegypti vector competence for" exact="ZIKV" post="[35, 36]. However, the MR766 strain (African I lineage;"/>
   <result pre="to disseminate and be transmitted in this mosquito species. This" exact="ZIKV" post="strain is an old strain that has suffered several"/>
   <result pre="transmission in Ae. aegypti (PAEA strain) exposed to the MR766" exact="ZIKV" post="strain were in agreement with previous results reported by"/>
   <result pre="competence experiments in which dissemination and transmission of the MR766" exact="ZIKV" post="strain were reported for Ae. aegypti [26, 35, 36,"/>
   <result pre="mosquito species infected with other arboviruses (e.g. dengue virus (DENV)," exact="CHIKV" post="[40] or WNV [41–43]). A recent study showed that"/>
   <result pre="with other arboviruses (e.g. dengue virus (DENV), CHIKV [40] or" exact="WNV" post="[41–43]). A recent study showed that temperature may directly"/>
   <result pre="study showed that temperature may directly affect vector competence for" exact="ZIKV" post="rendering the Ae. aegypti population tested at low temperature"/>
   <result pre="higher dissemination and transmission were observed in the Ae. aegypti-MR766" exact="ZIKV" post="pairing, the assays were performed at a temperature of"/>
   <result pre="determine the transmission efficacy. Conclusions Given the high risk of" exact="ZIKV" post="introduction in Europe via infected travelers coming from endemic"/>
   <result pre="populations are able to transmit this virus and sustain a" exact="ZIKV" post="outbreak. Our results indicate that it is unlikely that"/>
   <result pre="particularly from Catalonia, could be involved in the transmission of" exact="ZIKV" post="if it was introduced. Therefore, Ae. caspius is not"/>
   <result pre="relevant species to be monitored and controlled in case of" exact="ZIKV" post="introduction. This is useful and crucial information for the"/>
   <result pre="the risk of arbovirus transmission in a specific area. Abbreviations" exact="ZIKV" post="Zika virus dpe days post exposure IR infection rate"/>
   <result pre="risk of arbovirus transmission in a specific area. Abbreviations ZIKV" exact="Zika" post="virus dpe days post exposure IR infection rate DIR"/>
   <result pre="TR transmission rate TE transmission efficiency MEB midgut escape barrier" exact="CHIKV" post="chikungunya virus DENV dengue virus RVFV Rift Valley fever"/>
   <result pre="TE transmission efficiency MEB midgut escape barrier CHIKV chikungunya virus" exact="DENV" post="dengue virus RVFV Rift Valley fever phlebovirus Publisher's Note"/>
   <result pre="al.Vector competence of some French Culex and Aedes mosquitoes for" exact="West Nile" post="virusVector Borne Zoonotic Dis2008858959610.1089/vbz.2007.026618447623 8.Gutiérrez-LópezRBialosukniaSMCiotaATMontalvoTMartínez-de la PuenteJGangosoLet al.Vector competence"/>
   <result pre="al.Vector competence of Aedes caspius and Ae. albopictus mosquitoes for" exact="Zika" post="Virus, SpainEmerg Infect Dis20192534634810.3201/eid2502.17112330666939 9.MansuyJMDutertreMMengelleCFourcadeCMarchouBDelobelPet al.Zika virus: high infectious"/>
   <result pre="sexually transmitted pathogen?Lancet Infect Dis20161640510.1016/S1473-3099(16)00138-9 10.BesnardMLastèreSTeissierACao-LormeauVMussoDEvidence of perinatal transmission of" exact="Zika" post="virus, French Polynesia, December 2013 and February 2014Euro Surveill2014192075110.2807/1560-7917.ES2014.19.13.2075124721538"/>
   <result pre="Polynesia, December 2013 and February 2014Euro Surveill2014192075110.2807/1560-7917.ES2014.19.13.2075124721538 11.CauchemezSBesnardMBompardPDubTGuillemette-ArturPEyrolle-GuignotDet al.Association between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013–15: a retrospective"/>
   <result pre="2013–15: a retrospective studyLancet20163872125213210.1016/S0140-6736(16)00651-626993883 12.Cao-LormeauV-MBlakeAMonsSLastèreSRocheCVanhomwegenJet al.Guillain-Barré Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case–control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 13.DickGWAKitchenSFHaddowAJZika"/>
   <result pre="States of MicronesiaN Engl J Med20093602536254310.1056/NEJMoa080571519516034 15.MussoDNillesEJCao-LormeauVMRapid spread of emerging" exact="Zika" post="virus in the Pacific areaClin Microbiol Infect201420O595O59610.1111/1469-0691.1270724909208 16.ZanlucaCde MeloVCAMosimannALPdos"/>
   <result pre="Infect201420O595O59610.1111/1469-0691.1270724909208 16.ZanlucaCde MeloVCAMosimannALPdos SantosGIVdos SantosCNDLuzKFirst report of autochthonous transmission of" exact="Zika" post="virus in BrazilMem Inst Oswaldo Cruz201511056957210.1590/0074-0276015019226061233 17.LiYHeLHeRLYauSS-TZika and flaviviruses"/>
   <result pre="SantosCNDZika virus—an overviewMicrobes Infect20161829530110.1016/j.micinf.2016.03.00326993028 20.BoyerSCalvezEChouin-CarneiroTDialloDFaillouxA-BAn overview of mosquito vectors of" exact="Zika" post="virusMicrobes Infect20182064666010.1016/j.micinf.2018.01.00629481868 21.RichardVPaoaafaiteTCao-LormeauV-MVector competence of French Polynesian Aedes aegypti"/>
   <result pre="competence of French Polynesian Aedes aegypti and Aedes polynesiensis for" exact="Zika" post="virusPLoS Negl Trop Dis201610e000502410.1371/journal.pntd.000502427654962 22.PomponJMorales-VargasRManuelMHuat TanCVialTHao TanJet al.A Zika"/>
   <result pre="for Zika virusPLoS Negl Trop Dis201610e000502410.1371/journal.pntd.000502427654962 22.PomponJMorales-VargasRManuelMHuat TanCVialTHao TanJet al.A" exact="Zika" post="virus from America is more efficiently transmitted than an"/>
   <result pre="LucaMSeveriniFTomaLBoccoliniDRomiRRemoliMEet al.Experimental studies of susceptibility of Italian Aedes albopictus to" exact="Zika" post="virusEuro Surveill2016213022310.2807/1560-7917.ES.2016.21.18.30223 24.CiotaATBialosukniaSMZinkSDBrecherMEhrbarDJMorrissetteMNet al.Effects of Zika virus strain and"/>
   <result pre="Italian Aedes albopictus to Zika virusEuro Surveill2016213022310.2807/1560-7917.ES.2016.21.18.30223 24.CiotaATBialosukniaSMZinkSDBrecherMEhrbarDJMorrissetteMNet al.Effects of" exact="Zika" post="virus strain and Aedes mosquito species on vector competenceEmerg"/>
   <result pre="of Aedes aegypti and Aedes albopictus from the Americas to" exact="Zika" post="virusPLoS Negl Trop Dis201610e000454310.1371/journal.pntd.000454326938868 26.WongP-SJLiMIChongC-SNgL-CTanC-HAedes (Stegomyia) albopictus (Skuse): a"/>
   <result pre="Trop Dis201610e000454310.1371/journal.pntd.000454326938868 26.WongP-SJLiMIChongC-SNgL-CTanC-HAedes (Stegomyia) albopictus (Skuse): a potential vector of" exact="Zika" post="virus in SingaporePLoS Negl Trop Dis20137e234810.1371/journal.pntd.000234823936579 27.MilletJ-PMontalvoTBueno-MaríRRomero-TamaritAPrats-UribeAFernándezLet al.Imported Zika"/>
   <result pre="of Zika virus in SingaporePLoS Negl Trop Dis20137e234810.1371/journal.pntd.000234823936579 27.MilletJ-PMontalvoTBueno-MaríRRomero-TamaritAPrats-UribeAFernándezLet al.Imported" exact="Zika" post="virus in a European city: how to prevent local"/>
   <result pre="al.Assessing seasonal risks for the introduction and mosquito-borne spread of" exact="Zika" post="virus in EuropeEBioMedicine2016925025610.1016/j.ebiom.2016.06.00927344225 29.van der EijkAAvan GenderenPJVerdijkRMReuskenCBMöglingRvan KampenJJAet al.Miscarriage"/>
   <result pre="in EuropeEBioMedicine2016925025610.1016/j.ebiom.2016.06.00927344225 29.van der EijkAAvan GenderenPJVerdijkRMReuskenCBMöglingRvan KampenJJAet al.Miscarriage associated with" exact="Zika" post="virus infectionN Engl J Med20163751002100410.1056/NEJMc160589827463941 30.DubrulleMMoussonLMoutailierSVazeilleMFaillouxABChikungunya virus and Aedes"/>
   <result pre="Valley fever phlebovirusParasit Vectors20181131010.1186/s13071-018-2887-429792223 32.LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007Emerg"/>
   <result pre="LunaSMFauverJRet al.Vector competence of American mosquitoes for three strains of" exact="Zika" post="virusPLoS Negl Trop Dis201610e000510110.1371/journal.pntd.000510127783679 36.LiMIWongPSJNgLCTanCHOral susceptibility of Singapore Aedes"/>
   <result pre="Dis201610e000510110.1371/journal.pntd.000510127783679 36.LiMIWongPSJNgLCTanCHOral susceptibility of Singapore Aedes (Stegomyia) aegypti (Linnaeus) to" exact="Zika" post="virusPLoS Negl Trop Dis20126e179210.1371/journal.pntd.000179222953014 37.DiagneCTDialloDFayeOBaYFayeOGayeAet al.Potential of selected Senegalese"/>
   <result pre="of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit" exact="Zika" post="virusBMC Infect Dis20151549210.1186/s12879-015-1231-226527535 38.Hall-MendelinSPykeATMoorePRMackayIMMcMahonJLRitchieSAet al.Assessment of local mosquito species"/>
   <result pre="mosquito species incriminates Aedes aegypti as the potential vector of" exact="Zika" post="virus in AustraliaPLoS Negl Trop Dis201610e000495910.1371/journal.pntd.000495927643685 39.CalvezEO’ConnorOPolMRoussetDFayeORichardVet al.Differential transmission"/>
   <result pre="Negl Trop Dis201610e000495910.1371/journal.pntd.000495927643685 39.CalvezEO’ConnorOPolMRoussetDFayeORichardVet al.Differential transmission of Asian and African" exact="Zika" post="virus lineages by Aedes aegypti from New CaledoniaEmerg Microbes"/>
   <result pre="al.Experimental evaluation of infection, dissemination, and transmission rates for two" exact="West Nile" post="virus strains in European Aedes japonicus under a fluctuating"/>
   <result pre="(Aedes albopictus) populations as vectors for lineage 1 and 2" exact="West Nile" post="virus in EuropeMed Vet Entomol20163016617310.1111/mve.1216426890285 43.VogelsCBGöertzGPPijlmanGPKoenraadtCJVector competence of European"/>
   <result pre="in EuropeMed Vet Entomol20163016617310.1111/mve.1216426890285 43.VogelsCBGöertzGPPijlmanGPKoenraadtCJVector competence of European mosquitoes for" exact="West Nile" post="virusEmerg Microbes Infect20176e9610.1038/emi.2017.8229116220 44.HeitmannAJansenSLühkenRLeggewieMBaduscheMPluskotaBet al.Experimental transmission of Zika virus"/>
   <result pre="for West Nile virusEmerg Microbes Infect20176e9610.1038/emi.2017.8229116220 44.HeitmannAJansenSLühkenRLeggewieMBaduscheMPluskotaBet al.Experimental transmission of" exact="Zika" post="virus by mosquitoes from central EuropeEuro Surveill2017223034710.2807/1560-7917.ES.2017.22.2.30437"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6667926\results\search\tropicalVirus\results.xml">
   <result pre="10.1073/pnas.081323410619218453 4.YockeyLJJuradoKAAroraNMilletARakibTMilanoKMet al.. Type I interferons instigate fetal demise after" exact="Zika" post="virus infection. Sci Immunol. (2018) 3:eaao1680. 10.1126/sciimmunol.aao168029305462 5.VersteegGAGarcia-SastreA. Viral"/>
   <result pre="infection. Nat Med. (2000) 6:816–20. 10.1038/7755310888933 31.HamelRDejarnacOWichitSEkchariyawatPNeyretALuplertlopNet al.. Biology of" exact="Zika" post="virus infection in human skin cells. J Virol. (2015)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6669682\results\search\tropicalVirus\results.xml">
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Zika" post="virus (ZIKV) causes congenital neurologic birth defects, notably microcephaly,"/>
   <result pre="here, we analyzed the effect of human breast milk on" exact="ZIKV" post="infection. We observed that fresh human breast milk had"/>
   <result pre="temperatures. The viral titer of milk that was spiked with" exact="ZIKV" post="decreased considerably upon storage at 37 °C for 8"/>
   <result pre="−20 °C. This suggests that cold storage of milk inactivates" exact="ZIKV" post="and that the antiviral factor in milk may also"/>
   <result pre="of ZIKV. zika virus breast milk transmission breastfeeding 1. Introduction" exact="Zika" post="virus (ZIKV) is a (re-)emerging virus that was originally"/>
   <result pre="the Americas [4]. To date, 84 countries or territories reported" exact="ZIKV" post="transmissions [5]. Initially considered a harmless infection in humans,"/>
   <result pre="ZIKV transmissions [5]. Initially considered a harmless infection in humans," exact="ZIKV" post="may cause disease in adults, including meningoencephalitis [6], myelitis"/>
   <result pre="[8], and Guillain–Barré syndrome [9,10]. It is now established that" exact="ZIKV" post="can be transmitted from mother to child during pregnancy,"/>
   <result pre="develop in up to 46% of the cases [12]. Thus," exact="ZIKV" post="infection poses a high risk for human health, as"/>
   <result pre="for human health, as vaccines and therapeutics are not available." exact="ZIKV" post="is mainly transmitted to people through the bite of"/>
   <result pre="mosquito [13]. This vector-dependent route of transmission mainly restricts the" exact="ZIKV" post="pandemic to regions where the Ae. aegypti and Ae."/>
   <result pre="the Ae. aegypti and Ae. albopictus mosquitoes are endemic [13]." exact="ZIKV" post="transmission has also been reported to occur through sexual"/>
   <result pre="via breastfeeding [15,20,21,22,23,24,25]. There are three reported cases of probable" exact="ZIKV" post="transmission via breast milk [20,22,23,25], but final evidence and"/>
   <result pre="risk, the WHO recommends mothers with suspected, probable or confirmed" exact="ZIKV" post="infection or in areas of ongoing ZIKV transmission to"/>
   <result pre="probable or confirmed ZIKV infection or in areas of ongoing" exact="ZIKV" post="transmission to routinely continue breastfeeding [26]. Nevertheless, there are"/>
   <result pre="routinely continue breastfeeding [26]. Nevertheless, there are clear data that" exact="ZIKV" post="is present in various body fluids [15,27] including breast"/>
   <result pre="in various body fluids [15,27] including breast milk, that contains" exact="ZIKV" post="genomic RNA [15,20,21,22,23,24,25,28,29] and infectious particles [15,21,22,23,24,25,28,29]. However, although"/>
   <result pre="viral infectivity [31,33]. A recent study analyzed the stability of" exact="ZIKV" post="in breast milk at 4 °C and found that"/>
   <result pre="ZIKV in breast milk at 4 °C and found that" exact="ZIKV" post="is inactivated upon prolonged storage [34]. Here, we aimed"/>
   <result pre="[34]. Here, we aimed to expand this finding and explored" exact="ZIKV" post="stability at physiological temperatures and how breast milk may"/>
   <result pre="at physiological temperatures and how breast milk may directly affect" exact="ZIKV" post="infection. We show that fresh human milk had no"/>
   <result pre="show that fresh human milk had no significant effect on" exact="ZIKV" post="infection, however, storage of milk resulted in the generation"/>
   <result pre="gastrointestinal tract of babies upon breastfeeding. This might explain why" exact="ZIKV" post="transmission via breastfeeding is hardly observed. 2. Materials and"/>
   <result pre="humidified incubator. 2.2. Virus Strains and Virus Propagation The African" exact="ZIKV" post="strain MR766 was isolated in 1947 from a sentinel"/>
   <result pre="E6 cells in 175 cm²-cell culture flasks were inoculated with" exact="ZIKV" post="in 5 ml medium for 2 h, before 40"/>
   <result pre="had been signed. None of the mothers reported stays in" exact="ZIKV" post="endemic regions or previous infections with flaviviruses. Samples were"/>
   <result pre="Titration To determine the tissue culture infectious dose 50 (TCID50)," exact="ZIKV" post="stocks were serially diluted 10-fold and used to inoculate"/>
   <result pre="80 µL fresh medium was added. Next, 20 µL titrated" exact="ZIKV" post="of each dilution was used for inoculation, resulting in"/>
   <result pre="of each dilution was used for inoculation, resulting in final" exact="ZIKV" post="dilutions of 1:101 to 1:109 on the cells in"/>
   <result pre="TCID50/mL was calculated according to Reed and Muench. 2.6. Cell-Based" exact="ZIKV" post="Immunodetection Assay For infection, 6000 Vero E6 cells were"/>
   <result pre="medium, incubated overnight, and then topped to 180 µL medium." exact="ZIKV" post="stocks were diluted to the desired multiplicity of infection"/>
   <result pre="with the breast milk samples for 10 min, followed by" exact="ZIKV" post="inoculation (&quot;cell treatment�?). Two days post infection, the flavivirus"/>
   <result pre="µL fresh medium. Cells were then inoculated with 20 µL" exact="ZIKV" post="that was treated for 10 min with thawed human"/>
   <result pre="was collected. 2.9. RT-qPCR Detection of Viral RNA of Intact" exact="ZIKV" post="Particles To determine the amount of intact ZIKV virions"/>
   <result pre="of Intact ZIKV Particles To determine the amount of intact" exact="ZIKV" post="virions and their destruction by breast milk or detergents,"/>
   <result pre="as previously described for HCV [35]. To this end, a" exact="ZIKV" post="MR766 stock containing ~1010 genomic RNA copies/mL was incubated"/>
   <result pre="3.1. Stored Human Breast Milk Is a Potent Inhibitor of" exact="ZIKV" post="Infection As ZIKV is shed into human breast milk"/>
   <result pre="Breast Milk Is a Potent Inhibitor of ZIKV Infection As" exact="ZIKV" post="is shed into human breast milk [15,20,21,22,23,24,25,28,29], we analyzed"/>
   <result pre="[15,20,21,22,23,24,25,28,29], we analyzed the effect of this body fluid on" exact="ZIKV" post="infection. For this, three virus strains were used: the"/>
   <result pre="2 h, the inoculum was replaced with fresh medium, and" exact="ZIKV" post="infection rates were quantified 2 days later by a"/>
   <result pre="ZIKV infection rates were quantified 2 days later by a" exact="ZIKV" post="E antigen specific cell-based immunodetection assay. To detect possible"/>
   <result pre="donors. Strikingly, thawed milk efficiently inhibited infection by the three" exact="ZIKV" post="isolates with average IC50s of only 0.46 ± 0.03%"/>
   <result pre="virion treatment (Figure 1a, Figure S1a). The complete inhibition of" exact="ZIKV" post="infectivity was achieved by only 1–2% of milk during"/>
   <result pre="test whether milk acts on the virus or the cell," exact="ZIKV" post="was incubated with up to 20% of pooled breast"/>
   <result pre="at concentrations of up to 2% for 10 min, before" exact="ZIKV" post="was added (&quot;cell treatment�?). Thus, in both treatments the"/>
   <result pre="was quantified 2 days later. Under both conditions, milk inhibited" exact="ZIKV" post="infection (Figure 2a). However, milk concentrations during virion treatment"/>
   <result pre="degrade free genomic viral RNA released from destroyed virions. Next," exact="ZIKV" post="RNA (total and remaining) was quantified by RT-qPCR. As"/>
   <result pre="was determined upon detergent treatment. Next, we analyzed how fast" exact="ZIKV" post="is inactivated by milk. We found that incubating ZIKV"/>
   <result pre="fast ZIKV is inactivated by milk. We found that incubating" exact="ZIKV" post="with 0.5% milk for only one minute did not"/>
   <result pre="show that the antiviral factor in breast milk interacts with" exact="Zika" post="virions in a way that results in the rapid"/>
   <result pre="of the viral particles, explaining loss of infectivity. 3.3. The" exact="ZIKV" post="Inhibitory Factor is Present in the Cream Fraction of"/>
   <result pre="3a). We tested the effect of the milk fractions on" exact="ZIKV" post="infection and found that only the cream fraction led"/>
   <result pre="found that only the cream fraction led to a reduced" exact="ZIKV" post="infectivity (IC50 of 0.85 ± 0.15% during virion treatment)"/>
   <result pre="no effect (Figure 3b). 3.4. Fresh Milk Does Not Inhibit" exact="ZIKV" post="Infection but Becomes Antivirally Active in a Time-Dependent Manner"/>
   <result pre="at 37 °C for several hours, all milk samples reduced" exact="ZIKV" post="infection in a dose-dependent manner (Figure 5a). We observed"/>
   <result pre="after 1–2 h whereas the milk of donor 3 inhibited" exact="ZIKV" post="only when incubated for 8 hours or longer (Figure"/>
   <result pre="h (Figure S2). Thus, fresh human milk does not affect" exact="ZIKV" post="infection but its storage results in a donor- and"/>
   <result pre="time-dependent generation of factor(s) that inactivate ZIKV. 3.5. Loss of" exact="ZIKV" post="Infectivity in Milk Stored at 4 °C We next"/>
   <result pre="in milk during storage. Pfaender et al., analyzed storage of" exact="ZIKV" post="in milk at 4 °C and pasteurization at 63"/>
   <result pre="freshly donated milk (or PBS as control) was spiked with" exact="ZIKV" post="MR766, GWUH or PRV, and incubated for up to"/>
   <result pre="determined at indicated time points by TCID50 analysis showing that" exact="ZIKV" post="that was incubated in PBS remained fully infectious, even"/>
   <result pre="incubation for 8 days (Figure 6). Similarly, the incubation of" exact="ZIKV" post="in milk at 22 °C did not affect ZIKV"/>
   <result pre="of ZIKV in milk at 22 °C did not affect" exact="ZIKV" post="infectivity (Figure 6b). In contrast, the incubation of ZIKV"/>
   <result pre="affect ZIKV infectivity (Figure 6b). In contrast, the incubation of" exact="ZIKV" post="in milk for 8 h at 37 °C resulted"/>
   <result pre="These data show that under physiological conditions of 37 °C," exact="ZIKV" post="may be inactivated in breast milk. Next, we assessed"/>
   <result pre="inactivated in breast milk. Next, we assessed whether storage of" exact="ZIKV" post="contaminated milk in the fridge or the freezer may"/>
   <result pre="or the freezer may allow virus inactivation. Thus, the three" exact="ZIKV" post="strains were spiked into fresh milk or buffer and"/>
   <result pre="°C for 2 days led to an entire loss of" exact="ZIKV" post="infectivity in both milk samples (Figure 6c), confirming previous"/>
   <result pre="viral titers (Figure 6d). Thus, storage of milk from a" exact="ZIKV" post="infected mother at 4 °C but not at −20"/>
   <result pre="°C reduces viral titers over time and should thus limit" exact="ZIKV" post="transmission by breast milk feeding. 4. Discussion Besides ZIKV"/>
   <result pre="limit ZIKV transmission by breast milk feeding. 4. Discussion Besides" exact="ZIKV" post="transmission through bites of infected mosquitoes, the virus may"/>
   <result pre="human breast milk obtained from individual donors does not affect" exact="ZIKV" post="infection (Figure 4), which was somewhat surprising given the"/>
   <result pre="milk and how is it generated? We can exclude that" exact="ZIKV" post="neutralizing antibodies in milk are responsible as the fresh"/>
   <result pre="that the antiviral activity in milk is directed against the" exact="ZIKV" post="particle (Figure 2a) and results in a rapid destruction"/>
   <result pre="for the generation of free fatty acids that destroy the" exact="ZIKV" post="membrane. Moreover, the fat composition of milk also differs"/>
   <result pre="high levels of antiviral fatty acids and thus inactivation of" exact="ZIKV" post="in the infant’s stomach and subsequently reduced rates of"/>
   <result pre="other enveloped viruses. Besides determining the effect of milk on" exact="ZIKV" post="infection, we also analyzed how milk affects ZIKV infectivity"/>
   <result pre="milk on ZIKV infection, we also analyzed how milk affects" exact="ZIKV" post="infectivity that was spiked into the body fluid, a"/>
   <result pre="2 h at 37 °C, suggesting that similar rates of" exact="ZIKV" post="inactivation may also occur in the mother. Incubation at"/>
   <result pre="inactive at this temperature. We also analyzed how storage of" exact="ZIKV" post="contaminated milk in the fridge (4 °C) or freezer"/>
   <result pre="resulted in an entire loss of infectivity of the three" exact="ZIKV" post="strains tested (Figure 6c), with the exception of a"/>
   <result pre="by Pfaender et al. showing effective inactivation of the African" exact="ZIKV" post="strain MP-7051 and the Puerto Rican strain PRVABC59 in"/>
   <result pre="thawing. As observed in Figure 2c, long-term frozen milk inactivates" exact="ZIKV" post="within 10–30 min. When performing experiments with milk that"/>
   <result pre="(Figure 1a), this was the time frame of incubation with" exact="ZIKV" post="before inoculation of cells. In the spiking setup (Figure"/>
   <result pre="the majority of cases reduce or even eliminate risk of" exact="ZIKV" post="transmission to the infant. Thus, storage of milk in"/>
   <result pre="to their children and did not find evidence for efficient" exact="ZIKV" post="transmission via breastfeeding, despite the presence of virus in"/>
   <result pre="line with the findings in a mouse model, where infectious" exact="ZIKV" post="was detected in breast milk but did not result"/>
   <result pre="to pups [61]. The finding by others and us that" exact="ZIKV" post="is inactivated in milk before and after feeding provides"/>
   <result pre="https://www.mdpi.com/1999-4915/11/7/591/s1, Figure S1: The effect of freeze-stored breast milk on" exact="ZIKV" post="infection. Figure S2: Cytotoxicity of the fresh and incubated"/>
   <result pre="fresh and incubated breast milk samples. Figure S3: Kinetics of" exact="ZIKV" post="inhibition by incubated individual breast milk samples at different"/>
   <result pre="samples at different temperatures. Figure S4: Bar diagram of dose-dependent" exact="ZIKV" post="inhibition by incubated breast milk sample of donor 1."/>
   <result pre="sample of donor 1. Figure S5: Bar diagram of dose-dependent" exact="ZIKV" post="inhibition by incubated breast milk sample of donor 2."/>
   <result pre="sample of donor 2. Figure S6: Bar diagram of dose-dependent" exact="ZIKV" post="inhibition by incubated breast milk sample of donor 3."/>
   <result pre="French polynesia, South pacific, 2013Emerg. Infect. Dis.2014201085108610.3201/eid2011.14138024856001 4.World Health Organization" exact="Zika" post="Virus Situation Report—5th February 2016Available online: http://www.who.int/emergencies/zika-virus/situation-report/5-february-2016/en/(accessed on 16"/>
   <result pre="2016Available online: http://www.who.int/emergencies/zika-virus/situation-report/5-february-2016/en/(accessed on 16 May 2019) 5.World Health Organization" exact="Zika" post="Situation Report—10 March 2017Available online: https://www.who.int/emergencies/zika-virus/situation-report/10-march-2017/en/(accessed on 16 May"/>
   <result pre="Associated with MeningoencephalitisN. Engl. J. Med.20163741595159610.1056/NEJMc160296426958738 7.MécharlesS.HerrmannC.PoullainP.TranT.-H.DeschampsN.MathonG.LandaisA.BreurecS.LannuzelA.Acute myelitis due to" exact="Zika" post="virus infectionLancet2016387148110.1016/S0140-6736(16)00644-926946926 8.KarimiO.GoorhuisA.SchinkelJ.CodringtonJ.VredenS.G.S.VermaatJ.S.StijnisC.GrobuschM.P.Thrombocytopenia and subcutaneous bleedings in a patient"/>
   <result pre="virus infectionLancet2016387148110.1016/S0140-6736(16)00644-926946926 8.KarimiO.GoorhuisA.SchinkelJ.CodringtonJ.VredenS.G.S.VermaatJ.S.StijnisC.GrobuschM.P.Thrombocytopenia and subcutaneous bleedings in a patient with" exact="Zika" post="virus infectionLancet201638793994010.1016/S0140-6736(16)00502-X26906627 9.Cao-LormeauV.-M.BlakeA.MonsS.LastèreS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-Barré Syndrome outbreak associated with Zika"/>
   <result pre="with Zika virus infectionLancet201638793994010.1016/S0140-6736(16)00502-X26906627 9.Cao-LormeauV.-M.BlakeA.MonsS.LastèreS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-Barré Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 10.KrauerF.RiesenM.ReveizL.OladapoO.T.Martínez-VegaR.PorgoT.V.HaefligerA.BroutetN.J.LowN.collab:"/>
   <result pre="virus infection in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 10.KrauerF.RiesenM.ReveizL.OladapoO.T.Martínez-VegaR.PorgoT.V.HaefligerA.BroutetN.J.LowN.collab: WHO" exact="Zika" post="Causality Working GroupZika Virus Infection as a Cause of"/>
   <result pre="transmission focusing on ZikaCurr. Opin. Virol.201722303510.1016/j.coviro.2016.11.00727936448 14.MussoD.RocheC.RobinE.NhanT.TeissierA.Cao-LormeauV.-M.Potential Sexual Transmission of" exact="Zika" post="VirusEmerg. Infect. Dis.20152135936110.3201/eid2102.14136325625872 15.GrischottF.PuhanM.HatzC.SchlagenhaufP.Non-vector-borne transmission of Zika virus: A"/>
   <result pre="Sexual Transmission of Zika VirusEmerg. Infect. Dis.20152135936110.3201/eid2102.14136325625872 15.GrischottF.PuhanM.HatzC.SchlagenhaufP.Non-vector-borne transmission of" exact="Zika" post="virus: A systematic reviewTravel Med. Infect. Dis.20161431333010.1016/j.tmaid.2016.07.00227425793 16.MoreiraJ.PeixotoT.M.SiqueiraA.M.LamasC.C.Sexually acquired"/>
   <result pre="Zika virus: A systematic reviewTravel Med. Infect. Dis.20161431333010.1016/j.tmaid.2016.07.00227425793 16.MoreiraJ.PeixotoT.M.SiqueiraA.M.LamasC.C.Sexually acquired" exact="Zika" post="virus: A systematic reviewClin. Microbiol. Infect.20172329630510.1016/j.cmi.2016.12.02728062314 17.CounotteM.J.KimC.R.WangJ.BernsteinK.DealC.D.BroutetN.J.N.LowN.Sexual transmission of"/>
   <result pre="Zika virus: A systematic reviewClin. Microbiol. Infect.20172329630510.1016/j.cmi.2016.12.02728062314 17.CounotteM.J.KimC.R.WangJ.BernsteinK.DealC.D.BroutetN.J.N.LowN.Sexual transmission of" exact="Zika" post="virus and other flaviviruses: A living systematic reviewPLoS Med.201815e100261110.1371/journal.pmed.100261130040845"/>
   <result pre="other flaviviruses: A living systematic reviewPLoS Med.201815e100261110.1371/journal.pmed.100261130040845 18.MussoD.NhanT.RobinE.RocheC.BierlaireD.ZisouK.Shan YanA.Cao-LormeauV.BroultJ.Potential for" exact="Zika" post="virus transmission through blood transfusion demonstrated during an outbreak"/>
   <result pre="Brain AbnormalitiesN. Engl. J. Med.20163742142215110.1056/NEJMoa160182427028667 20.BesnardM.LastèreS.TeissierA.Cao-LormeauV.MussoD.Evidence of perinatal transmission of" exact="Zika" post="virus, French Polynesia, December 2013 and February 2014Eurosurveillance2014192075110.2807/1560-7917.ES2014.19.13.2075124721538 21.CavalcantiM.G.Cabral-CastroM.J.GonçalvesJ.L.S.SantanaL.S.PimentaE.S.PeraltaJ.M.Zika"/>
   <result pre="infection?Int. J. Infect. Dis.201757707210.1016/j.ijid.2017.01.04228188933 22.BlohmG.M.LednickyJ.A.MárquezM.WhiteS.K.LoebJ.C.PachecoC.A.NolanD.J.PaisieT.SalemiM.Rodríguez-MoralesA.J.et al.Complete Genome Sequences of Identical" exact="Zika" post="virus Isolates in a Nursing Mother and Her InfantGenome"/>
   <result pre="and Her InfantGenome Announc.201752310.1128/genomeA.00231-1728450510 23.BlohmG.M.LednickyJ.A.MárquezM.WhiteS.K.LoebJ.C.PachecoC.A.NolanD.J.PaisieT.SalemiM.Rodríguez-MoralesA.J.et al.Evidence for Mother-to-Child Transmission of" exact="Zika" post="Virus Through Breast MilkClin. Infect. Dis.2018661120112110.1093/cid/cix96829300859 24.ColtS.Garcia-CasalM.N.Peña-RosasJ.P.FinkelsteinJ.L.Rayco-SolonP.Weise PrinzoZ.C.MehtaS.Transmission of"/>
   <result pre="Zika Virus Through Breast MilkClin. Infect. Dis.2018661120112110.1093/cid/cix96829300859 24.ColtS.Garcia-CasalM.N.Peña-RosasJ.P.FinkelsteinJ.L.Rayco-SolonP.Weise PrinzoZ.C.MehtaS.Transmission of" exact="Zika" post="virus through breast milk and other breastfeeding-related bodily-fluids: A"/>
   <result pre="25.MannT.Z.HaddadL.B.WilliamsT.R.HillsS.L.ReadJ.S.DeeD.L.DziubanE.J.Pérez-PadillaJ.JamiesonD.J.HoneinM.A.et al.Breast milk transmission of flaviviruses in the context of" exact="Zika" post="virus: A systematic reviewPaediatr. Perinat. Epidemiol.20183235836810.1111/ppe.1247829882971 26.World Health Organization,"/>
   <result pre="Perinat. Epidemiol.20183235836810.1111/ppe.1247829882971 26.World Health Organization, Infant Feeding in Areas of" exact="Zika" post="Virus Transmission—Guideline2016Available online: https://www.who.int/nutrition/publications/guidelines/infantfeeding_zikavirus_transmission/en/(accessed on 27 June 2019) 27.Paz-BaileyG.RosenbergE.S.DoyleK.Munoz-JordanJ.SantiagoG.A.KleinL.Perez-PadillaJ.MedinaF.A.WatermanS.H.GubernC.G.et"/>
   <result pre="Transmission—Guideline2016Available online: https://www.who.int/nutrition/publications/guidelines/infantfeeding_zikavirus_transmission/en/(accessed on 27 June 2019) 27.Paz-BaileyG.RosenbergE.S.DoyleK.Munoz-JordanJ.SantiagoG.A.KleinL.Perez-PadillaJ.MedinaF.A.WatermanS.H.GubernC.G.et al.Persistence of" exact="Zika" post="Virus in Body Fluids — Preliminary ReportN. Engl. J."/>
   <result pre="in Body Fluids — Preliminary ReportN. Engl. J. Med.20173791234124310.1056/NEJMoa161310828195756 28.Dupont-RouzeyrolM.BironA.O’ConnorO.HuguonE.DesclouxE.Infectious" exact="Zika" post="viral particles in breastmilkLancet2016387105110.1016/S0140-6736(16)00624-3 29.SoteloJ.R.SoteloA.B.SoteloF.J.B.DoiA.M.PinhoJ.R.R.OliveiraR.D.C.BezerraA.M.P.S.DeutschA.D.Villas-BoasL.S.FelixA.C.et al.Persistence of Zika Virus"/>
   <result pre="Med.20173791234124310.1056/NEJMoa161310828195756 28.Dupont-RouzeyrolM.BironA.O’ConnorO.HuguonE.DesclouxE.Infectious Zika viral particles in breastmilkLancet2016387105110.1016/S0140-6736(16)00624-3 29.SoteloJ.R.SoteloA.B.SoteloF.J.B.DoiA.M.PinhoJ.R.R.OliveiraR.D.C.BezerraA.M.P.S.DeutschA.D.Villas-BoasL.S.FelixA.C.et al.Persistence of" exact="Zika" post="Virus in Breast Milk after Infection in Late Stage"/>
   <result pre="infectionClin. Perinatol.20043150152810.1016/j.clp.2004.03.01915325535 33.BallardO.MorrowA.L.Human Milk CompositionPediatr. Clin. N. Am.201360497410.1016/j.pcl.2012.10.002 34.PfaenderS.VielleN.J.EbertN.SteinmannE.AlvesM.P.ThielV.Inactivation of" exact="Zika" post="virus in human breast milk by prolonged storage or"/>
   <result pre="Virus Infectivity by Human Breast MilkJ. Infect. Dis.20132081943195210.1093/infdis/jit51924068703 36.LanciottiR.S.LambertA.J.HolodniyM.SaavedraS.SignorL.d.C.C.Phylogeny of" exact="Zika" post="Virus in Western Hemisphere, 2015Emerg. Infect. Dis.20162293393510.3201/eid2205.16006527088323 37.MüllerJ.A.HarmsM.KrügerF.GroßR.JoasS.HaynM.DietzA.N.LippoldS.von EinemJ.SchubertA.et"/>
   <result pre="in Western Hemisphere, 2015Emerg. Infect. Dis.20162293393510.3201/eid2205.16006527088323 37.MüllerJ.A.HarmsM.KrügerF.GroßR.JoasS.HaynM.DietzA.N.LippoldS.von EinemJ.SchubertA.et al.Semen inhibits" exact="Zika" post="virus infection of cells and tissues from the anogenital"/>
   <result pre="cells and tissues from the anogenital regionNat. Commun.20189220710.1038/s41467-018-04442-y29880824 38.AubryM.RichardV.GreenJ.BroultJ.MussoD.Inactivation of" exact="Zika" post="virus in plasma with amotosalen and ultraviolet A illuminationTransfusion201656334010.1111/trf.1327126283013"/>
   <result pre="for the feeding of preterm infantsArch. Dis. Child.19825765866210.1136/adc.57.9.6587125685 61.Regla-NavaJ.A.ViramontesK.M.VozdolskaT.HuynhA.-T.VillaniT.GardnerG.JohnsonM.FerroP.J.ShrestaS.KimK.Detection of" exact="Zika" post="virus in mouse mammary gland and breast milkPLoS Negl."/>
   <result pre="Dis.201913e000708010.1371/journal.pntd.000708030742628 Figure 1 Effect of long-term frozen breast milk on" exact="ZIKV" post="infection. (a) ZIKV MR766, GWUH or PRV (MR766: 1.58,"/>
   <result pre="Effect of long-term frozen breast milk on ZIKV infection. (a)" exact="ZIKV" post="MR766, GWUH or PRV (MR766: 1.58, GWUH: 2.51, PRV:"/>
   <result pre="Thawed breast milk from four individual donors was incubated with" exact="ZIKV" post="MR766 (1.58 × 107 TCID50/mL) at indicated concentrations before"/>
   <result pre="from triplicate infections ± standard deviations. Figure 2 Mechanism of" exact="ZIKV" post="inhibition by long-term freeze-stored breast milk. (a) For cell"/>
   <result pre="with indicated concentrations of breast milk, and thereafter inoculated with" exact="ZIKV" post="MR766. For virion treatment (virion), ZIKV MR766 (1.58 ×"/>
   <result pre="and thereafter inoculated with ZIKV MR766. For virion treatment (virion)," exact="ZIKV" post="MR766 (1.58 × 107 TCID50/mL) was incubated 1:1 for"/>
   <result pre="immunodetection assay that enzymatically quantifies the flavivirus protein E. (b)" exact="ZIKV" post="MR766 was incubated with PBS (90%), SDS (0.5%), Triton"/>
   <result pre="A (10 U) for 1 h at 37 °C. Remaining" exact="ZIKV" post="RNA copy numbers were determined by RT-qPCR. (c) PBS"/>
   <result pre="RT-qPCR. (c) PBS or breast milk (5%) were incubated with" exact="ZIKV" post="MR766 for the indicated time at room temperature before"/>
   <result pre="Effect of fractions derived from long-term freeze-stored breast milk on" exact="ZIKV" post="infection. (a) Pooled long-term stored breast milk was defatted"/>
   <result pre="(b) Breast milk and its components were mixed 1:1 with" exact="ZIKV" post="MR766 (1.58 × 107 TCID50/mL) for 10 min before"/>
   <result pre="± standard deviations. Figure 4 Effect of fresh milk on" exact="ZIKV" post="infection. Fresh breast milk was received from three donors"/>
   <result pre="three donors and, after 30 min, was mixed 1:1 with" exact="ZIKV" post="MR766 (1.58 × 107 TCID50/mL) at indicated concentrations and"/>
   <result pre="three donors and, after 30 min, was mixed 1:1 with" exact="ZIKV" post="MR766 (1.58 × 107 TCID50/mL) at indicated concentrations and"/>
   <result pre="(d) −20 °C for indicated time points before mixing with" exact="ZIKV" post="and inoculation of Vero E6 cells. Infection rates were"/>
   <result pre="deviations. See also Figures S3–S6. Figure 6 Determination of the" exact="ZIKV" post="titer after the incubation of the virions in breast"/>
   <result pre="incubation of the virions in breast milk at different temperatures." exact="ZIKV" post="MR766, GWUH, or PRV were spiked into buffer or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6670050\results\search\tropicalVirus\results.xml">
   <result pre="of Epidemiology Force of Infection and True Infection Rate of" exact="Dengue" post="in Singapore: Implications for Dengue Control and Management TanLi"/>
   <result pre="and True Infection Rate of Dengue in Singapore: Implications for" exact="Dengue" post="Control and Management TanLi Kiang1LowSwee Ling1SunHaoyang2ShiYuan1LiuLilac1LamSally3TanHwee Huang3AngLi Wei4WongWing Yan1ChuaRachel1TeoDiana3NgLee"/>
   <result pre="National Medical Research Council10.13039/501100001349 Singapore Population Health Improvement CentreNMRC/CG/C026/2017_NUHS page-count:" exact="Dengue" post="viral infection is a major threat to global health."/>
   <result pre="million in 2008 and 3 million in 2013 (1, 2)." exact="Dengue" post="notifications have been likened to the tip of an"/>
   <result pre="thrice the figure provided by the World Health Organization (11)." exact="Dengue" post="is endemic to the equatorial city-state of Singapore, where"/>
   <result pre="was determined by enzyme-linked immunosorbent assay (ELISA) using the Panbio" exact="Dengue" post="IgG Indirect ELISA (Alere Inc., Waltham, Massachusetts), according to"/>
   <result pre="in 2013 and n = 4,002 in 2017) were analyzed." exact="Dengue" post="IgG prevalence was weighted to adjust for age as"/>
   <result pre="+ α ) } . Table 1. Summary of 5" exact="Dengue" post="Serosurveys in Singapore, 2004–2017 Survey Agency or Institution Age"/>
   <result pre="No.)) National Health Surveyb MOH 18–74 4,152 September–December 2004 Panbio" exact="Dengue" post="IgG Indirect ELISAc Yew, 2009 (24) National Paediatric Seroprevalence"/>
   <result pre="2009 seroprevalence surveyb NEA/EHI 16–60 3,627 December 2009–February 2010 Panbio" exact="Dengue" post="IgG Indirect ELISA Low, 2015 (21) 2013 seroprevalence survey"/>
   <result pre="2013 seroprevalence survey NEA/EHI 16–71 3,813 December 2013–February 2014 Panbio" exact="Dengue" post="IgG Indirect ELISA Present study 2017 seroprevalence survey NEA/EHI"/>
   <result pre="study 2017 seroprevalence survey NEA/EHI 16–74 4,002 June–August 2017 Panbio" exact="Dengue" post="IgG Indirect ELISA Present study Abbreviations: EHI, Environmental Health"/>
   <result pre="factor was based on a locally conducted study, the Early" exact="Dengue" post="Infection and Outcome (EDEN) Study, which revealed almost equal"/>
   <result pre="IgG in the serum samples was determined using the Panbio" exact="Dengue" post="IgG Indirect ELISA (Alere Inc., Waltham, Massachusetts). Confidence intervals"/>
   <result pre="Table 2. Goodness-of-Fit Tests of Reconstructed and Empirical Prevalence From" exact="Dengue" post="Serosurveys in Singapore, 2004–2017 Year Age Range for Data"/>
   <result pre="group showed a decrease from 2009 to 2017. Figure 4." exact="Dengue" post="seroprevalence by age and year among residents of Singapore,"/>
   <result pre="infection IgG immunoglobulin G. References REFERENCES 1collab: World Health Organization" exact="Dengue" post="and severe dengue. (Fact sheet no. 117). 2017http://www.who.int/mediacentre/factsheets/fs117/en/. Accessed"/>
   <result pre="Accessed October 30, 2017. 2collab: World Health OrganizationGlobal Strategy for" exact="Dengue" post="Prevention and Control, 2012–2020 Geneva, Switzerland: World Health Organization;"/>
   <result pre="Int Health. 2006;11(6):935–942.16772016 8GordonA, KuanG, MercadoJC, et al.The Nicaraguan Pediatric" exact="Dengue" post="Cohort Study: incidence of inapparent and symptomatic dengue virus"/>
   <result pre="1998. Epidemiol News Bull. 1999;25:1–3. 15collab: Singapore Ministry of Health" exact="Dengue" post="fever/dengue haemorrhagic fever (DF/DHF). In: Communicable Diseases Surveillance in"/>
   <result pre="https://www.moh.gov.sg/docs/librariesprovider5/resources-statistics/reports/vector_borne_diseases.pdf. Accessed November 1, 2018. 16collab: Singapore Ministry of Health" exact="Dengue" post="fever/dengue haemorrhagic fever. In: Communicable Diseases Surveillance in Singapore"/>
   <result pre="https://www.moh.gov.sg/docs/librariesprovider5/resources-statistics/reports/vector-borne_diseases.pdf. Accessed November 1, 2018. 17collab: Singapore Ministry of Health" exact="Dengue" post="fever/dengue haemorrhagic fever (DF/DHF). In: Communicable Diseases Surveillance in"/>
   <result pre="https://www.moh.gov.sg/docs/librariesprovider5/resources-statistics/reports/vector-borne-diseasesfd4c6200e7f04f3680bdd172c387953a.pdf. Accessed November 1, 2018. 18collab: Singapore Ministry of Health" exact="Dengue" post="fever/dengue haemorrhagic fever (DF/DHF). In: Communicable Diseases Surveillance in"/>
   <result pre="PLoS Negl Trop Dis. 2015;9(4):e0003719.25881272 27LowJG, OoiEE, TolfvenstamT, et al.Early" exact="Dengue" post="Infection and Outcome Study (EDEN)—study design and preliminary findings."/>
   <result pre="suppress dengue transmission. Nature. 2011;476(7361):454–457.21866160 44collab: Singapore Ministry of Health" exact="Dengue" post="fever/dengue haemorrhagic fever (DF/DHF). In: Communicable Diseases Surveillance in"/>
   <result pre="https://www.moh.gov.sg/docs/librariesprovider5/resources-statistics/reports/vector-borne-diseases(3).pdf. Accessed November 1, 2018. 45collab: Singapore Ministry of Health" exact="Dengue" post="fever/dengue haemorrhagic fever (DF/DHF). In: Communicable Diseases Surveillance in"/>
   <result pre="Ann Acad Med Singapore. 2013;42(8):373–375.24045371 47collab: Singapore Ministry of Health" exact="Dengue" post="fever/dengue haemorrhagic fever (DF/DHF). In: Communicable Diseases Surveillance in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6676504\results\search\tropicalVirus\results.xml">
   <result pre="human genetic variability. A phenomenon that controls the kinetics of" exact="DENV" post="infection, antibody-dependent enhancement, best explains the correlation of the"/>
   <result pre="the correlation of the vascular permeability syndrome with second heterotypic" exact="DENV" post="infections and infection in the presence of passively acquired"/>
   <result pre="on growing evidence in vivo and in vitro, the tissue-damaging" exact="DENV" post="non-structural protein 1 (NS1) is responsible for most of"/>
   <result pre="why is the risk of severe disease during second heterotypic" exact="DENV" post="infection so low, why is the onset of vascular"/>
   <result pre="Hill, North Carolina, USA No competing interests were disclosed. Introduction" exact="Dengue" post="viruses (DENVs) are relatively new pathogens. Transmission of virus"/>
   <result pre="development. The four DENVs are genetically related and biologically similar." exact="Dengue" post="is not the only human viral pathogen to circulate"/>
   <result pre="groups, most such outcomes are not well studied or understood." exact="Dengue" post="differs for researchers, a clear-eyed view of the observed"/>
   <result pre="5% of dengue hospitalizations of children 14– 17. Clinical responses" exact="Dengue" post="clinical responses are subject to constraints imposed by infecting"/>
   <result pre="immune status, and human genetic makeup. These are reviewed briefly." exact="Dengue" post="disease severity differs by infection parity. Disease may accompany"/>
   <result pre="children are at higher risk of fatal outcome with heterotypic" exact="DENV" post="infections 33. Exposure to DENV at intervals of less"/>
   <result pre="of fatal outcome with heterotypic DENV infections 33. Exposure to" exact="DENV" post="at intervals of less than 2 years may inhibit"/>
   <result pre="severity 19, 34. Short-term protection and ultimately enhanced second heterotypic" exact="DENV" post="infection outcome may be controlled by natural declines or"/>
   <result pre="or changes in heterotypic antibodies (or both) following a first" exact="DENV" post="infection 35, 36. An increase in disease severity was"/>
   <result pre="first and second infections and the identity of first infecting" exact="DENV" post="type. A subset of severe dengue cases, hemophagocytic lymphohistiocytosis"/>
   <result pre="in Peru successfully tracked household members throughout the city during" exact="DENV" post="transmission seasons 58. For individuals, the risk of DENV"/>
   <result pre="during DENV transmission seasons 58. For individuals, the risk of" exact="DENV" post="infection is controlled by the presence or absence of"/>
   <result pre="(for example, markets or homes of friends or relatives) 59." exact="DENV" post="is not spread significantly by sick individuals. Those who"/>
   <result pre="silent infections may contribute as much as 84% of total" exact="DENV" post="transmission. In persons who do develop dengue disease, most"/>
   <result pre="not simply because of its unexpected linkage to Guillain–Barré syndrome;" exact="Zika" post="infection of pregnant women also caused a congenital Zika"/>
   <result pre="syndrome; Zika infection of pregnant women also caused a congenital" exact="Zika" post="syndrome in infants. There were additional fears that Zika"/>
   <result pre="congenital Zika syndrome in infants. There were additional fears that" exact="Zika" post="infections might enhance DENV infections or vice versa. An"/>
   <result pre="infants. There were additional fears that Zika infections might enhance" exact="DENV" post="infections or vice versa. An entirely unsuspected outcome has"/>
   <result pre="or vice versa. An entirely unsuspected outcome has been that" exact="Zika" post="behaves like a highly effective dengue vaccine. The Zika"/>
   <result pre="that Zika behaves like a highly effective dengue vaccine. The" exact="Zika" post="epidemic of 2015 to 2016 was followed by a"/>
   <result pre="studies in Salvador, Brazil 66, 67. It is suspected that" exact="Zika" post="infection may have served to protect an epidemiologically and"/>
   <result pre="epidemiologically and clinically important group, monotypic dengue-immunes, responsible for secondary" exact="DENV" post="clinical disease 68. A mystery in the global dengue"/>
   <result pre="made to answer this question. A search for a sylvatic" exact="DENV" post="cycle was initiated in a forested area of the"/>
   <result pre="for virus and for antibody conversions with no evidence of" exact="DENV" post="72. Pathogenesis Soon after the DVPS was identified, clinical"/>
   <result pre="clinical and epidemiological data strongly associated it with second heterotypic" exact="DENV" post="infections and also with primary DENV infections of infants"/>
   <result pre="it with second heterotypic DENV infections and also with primary" exact="DENV" post="infections of infants born to dengue-immune mothers 11, 73."/>
   <result pre="dengue-immune mothers 11, 73. Pathology studies have consistently demonstrated human" exact="DENV" post="infection target cells to be of myeloid lineage 74."/>
   <result pre="infection target cells to be of myeloid lineage 74. When" exact="DENV" post="infections occur in vitro or in vivo in the"/>
   <result pre="severity 26, 76, 77. This phenomenon, antibody-dependent enhancement (ADE) of" exact="DENV" post="infection of Fc receptor–bearing cells, differs from infection of"/>
   <result pre="(extrinsic ADE) or an increase in the intracellular production of" exact="DENV" post="(intrinsic ADE) 78. DENV ADE has been observed in"/>
   <result pre="increase in the intracellular production of DENV (intrinsic ADE) 78." exact="DENV" post="ADE has been observed in animal models. Second heterotypic"/>
   <result pre="Efforts to reliably achieve vascular permeability disease during second heterotypic" exact="DENV" post="infections in animals, including mice, have not been successful"/>
   <result pre="in animals, including mice, have not been successful 80. When" exact="DENV" post="antibodies were passively transferred to rhesus monkeys prior to"/>
   <result pre="polyclonal dengue antibodies to mice has regularly resulted in enhanced" exact="DENV" post="infections accompanied by vascular permeability and other features of"/>
   <result pre="to a weakened ability of secondary T cells to contain" exact="DENV" post="infection because of the original antigenic sin phenomenon, (2)"/>
   <result pre="endothelium-damaging secondary infection T-cell cytokines and chemokines, (3) to the" exact="DENV" post="non-structural protein 1 (NS1) heterophile antibodies raised during first"/>
   <result pre="DENV non-structural protein 1 (NS1) heterophile antibodies raised during first" exact="DENV" post="infections that damage platelets, endothelial cells, or blood clotting"/>
   <result pre="passively acquired dengue antibodies. It was long known that fatal" exact="DENV" post="infections of mice could be prevented by anti-NS1 87."/>
   <result pre="prevented by anti-NS1 87. NS1 is produced during all four" exact="DENV" post="infections as well as those of other pathogenic flaviviruses"/>
   <result pre="severe dengue might activate complement to mediate vascular permeability 90." exact="Dengue" post="NS1 has been shown to activate complement by the"/>
   <result pre="complement by the alternative pathway, target liver cells promoting intracellular" exact="DENV" post="infection, complex with thrombin in acute-phase blood of severe"/>
   <result pre="the cellular biology of bacterial lipopolysaccharides (LPSs) and that of" exact="DENV" post="NS1 was discovered 94. Each interacts with TLR4 on"/>
   <result pre="death from lethal DENV2 challenge. Mice immunized with all four" exact="DENV" post="NS1 proteins were completely protected against homologous DENV challenges,"/>
   <result pre="all four DENV NS1 proteins were completely protected against homologous" exact="DENV" post="challenges, whereas immunization with DENV1 NS1 partially protected against"/>
   <result pre="with DENV1 NS1 partially protected against heterologous DENV2 challenge. Furthermore," exact="DENV" post="NS1 was shown to directly alter the barrier function"/>
   <result pre="had been shown to correlate with plasma leakage during severe" exact="DENV" post="infection in humans 97, 98. More recently, the contribution"/>
   <result pre="in humans 97, 98. More recently, the contribution of these" exact="DENV" post="NS1-induced endothelial cell–intrinsic pathways to NS1-mediated vascular leakage was"/>
   <result pre="endothelial glycocalyx components both in vitro and in vivo99. A" exact="DENV" post="NS1 vaccine is taking shape 100. In conclusion, NS1"/>
   <result pre="mechanism of vascular permeability in mice and is controlled by" exact="DENV" post="production in cells and, in turn, by ADE 88."/>
   <result pre="described, DVPS is a rare outcome of a second heterotypic" exact="DENV" post="infection. Identifying those at risk and understanding why they"/>
   <result pre="were collected from children prior to their experiencing second heterotypic" exact="DENV" post="infections, whether overt or silent. Cultured pre-infection PBMCs were"/>
   <result pre="six had elevated responses in children who experienced silent second" exact="DENV" post="infections and three had elevated responses in children who"/>
   <result pre="elevated responses in children who developed symptoms during a subsequent" exact="DENV" post="infection. Significant differences were found in cytokine production based"/>
   <result pre="found in cytokine production based on both the type of" exact="DENV" post="used for stimulation and the occurrence of clinical illness."/>
   <result pre="significantly higher by PBMCs of subjects who later developed symptomatic" exact="DENV" post="infection. These studies are beginning to show how genetic"/>
   <result pre="the Global Advisory Committee on Vaccine Safety, and the WHO" exact="Dengue" post="Vaccine Working Group in 2016 recommended that vaccine be"/>
   <result pre="with known past dengue infection or to populations with 80%" exact="DENV" post="seroprevalence 106. Why did Dengvaxia fail to protect seronegative"/>
   <result pre="children? When vaccinated children developed dengue disease despite circulating tetravalent" exact="DENV" post="neutralizing antibodies, this provided solid evidence that conventionally measured"/>
   <result pre="of virus were attributable to the maturation state 111. Might" exact="DENV" post="maturation status affect biological outcomes of DENV–antibody interactions, such"/>
   <result pre="raised by vaccine may be poorly matched to the specific" exact="DENV" post="genotypes in circulation. Two groups found genetic differences in"/>
   <result pre="cross-protective antibodies analogous to antibodies that develop after natural second" exact="DENV" post="infections with a heterologous serotype 116. These antibodies, which"/>
   <result pre="multifunctional CD8 + T-cell responses were correlated with protection from" exact="DENV" post="disease 117. Functional CD8 + T-cell responses were directed"/>
   <result pre="epitopes on non-structural proteins contribute importantly to homotypic and heterotypic" exact="DENV" post="protective immunity 118, 119. These observations were extended to"/>
   <result pre="to human CD4 + T cells that are primed by" exact="DENV" post="capsid, NS3 and NS5 antigens 120, 121. CD4 +"/>
   <result pre="vaccine mediated efficient viral clearance and superior protection against wild-type" exact="DENV" post="challenge 124. Dengvaxia does not present non-structural DENV proteins"/>
   <result pre="against wild-type DENV challenge 124. Dengvaxia does not present non-structural" exact="DENV" post="proteins to the immune system. Might this absence contribute"/>
   <result pre="DENV2 backbone. The developers hope for successful protection against all" exact="DENV" post="infection/disease on the basis of the broad neutralizing antibody"/>
   <result pre="product, the live-attenuated tetravalent dengue vaccine (LATV), consists of mutated" exact="DENV" post="1, 3 and 4 and a chimera of structural"/>
   <result pre="DENV 1, 3 and 4 and a chimera of structural" exact="DENV" post="2 on a DENV 4 backbone 135– 137. Following"/>
   <result pre="4 and a chimera of structural DENV 2 on a" exact="DENV" post="4 backbone 135– 137. Following a single dose of"/>
   <result pre="123. Finally, LATV contains genes for three of the four" exact="DENV" post="NS1 proteins. LATV is in the third year of"/>
   <result pre="data has been delayed because of an 80% reduction of" exact="DENV" post="cases following the Zika virus epidemic of 2016–17 in"/>
   <result pre="because of an 80% reduction of DENV cases following the" exact="Zika" post="virus epidemic of 2016–17 in Brazil 143. The outlook"/>
   <result pre="World War II.Am J Trop Med Hyg.1952;1(1):30–50. 10.4269/ajtmh.1952.1.3014903434 11NimmannityaSHalsteadSBCohenSNet al.:" exact="Dengue" post="and chikungunya virus infection in man in Thailand, 1962-1964."/>
   <result pre="VI. Hypotheses and discussion.Yale J Biol Med.1970;42:350–62. 5419208 14HalsteadSBLanNTMyintTTet al.:" exact="Dengue" post="hemorrhagic fever in infants: research opportunities ignored.Emerg Infect Dis.2002;8(12):1474–9."/>
   <result pre="in infants: research opportunities ignored.Emerg Infect Dis.2002;8(12):1474–9. 10.3201/eid0812.02017012498666 15ChauTNQuyenNTThuyTTet al.:" exact="Dengue" post="in Vietnamese infants--results of infection-enhancement assays correlate with age-related"/>
   <result pre="F1000 Recommendation 16ChauTNAndersKLLe LienBet al.: Clinical and virological features of" exact="Dengue" post="in Vietnamese infants.PLoS Negl Trop Dis.2010;4(4):e657. 10.1371/journal.pntd.000065720405057 17ClaphamHCummingsDANisalakAet al.:"/>
   <result pre="infants.PLoS Negl Trop Dis.2010;4(4):e657. 10.1371/journal.pntd.000065720405057 17ClaphamHCummingsDANisalakAet al.: Epidemiology of Infant" exact="Dengue" post="Cases Illuminates Serotype-Specificity in the Interaction between Immunity and"/>
   <result pre="Thailand, 1994-2010.BMC Public Health.2015;15:250. 10.1186/s12889-015-1590-z25886528 20NisalakALesslerJTKlungthongCet al.: Forty Years of" exact="Dengue" post="Surveillance at a Tertiary Pediatric Hospital in Bangkok, Thailand,"/>
   <result pre="Recommendation 25ThaiKTPhuongHLThanh NgaTTet al.: Clinical, epidemiological and virological features of" exact="Dengue" post="virus infections in Vietnamese patients presenting to primary care"/>
   <result pre="care facilities with acute undifferentiated fever.J Infect.2010;60(3):229–37. 10.1016/j.jinf.2010.01.00320080126 26VaughnDWGreenSKalayanaroojSet al.:" exact="Dengue" post="viremia titer, antibody response pattern, and virus serotype correlate"/>
   <result pre="Playa municipality, Havana, Cuba, 2001–2002.Int J Infect Dis.2012;16(3):e198–e203. 10.1016/j.ijid.2011.09.02622277259 32HubertBHalsteadSB:" exact="Dengue" post="1 virus and dengue hemorrhagic fever, French Polynesia, 2001.Emerg"/>
   <result pre="Rico, 2008 - 2013.PLoS Negl Trop Dis.2016;10(8):e0004939. 10.1371/journal.pntd.000493927556807 48GiangHTNBannoKMinhLHNet al.:" exact="Dengue" post="hemophagocytic syndrome: A systematic review and meta-analysis on epidemiology,"/>
   <result pre="and risk factors.Rev Med Virol.2018;28(6):e2005. 10.1002/rmv.200530109914 49Wan JamaludinWFPeriyasamyPWan MatWRet al.:" exact="Dengue" post="infection associated hemophagocytic syndrome: Therapeutic interventions and outcome.J Clin"/>
   <result pre="work?PLoS Negl Trop Dis.2013;7(12):e2592. 10.1371/journal.pntd.000259224349598 51LumLCAbdel-LatifMel-AGohAYet al.: Preventive transfusion in" exact="Dengue" post="shock syndrome-is it necessary?J Pediatr.2003;143(5):682–4. 10.1067/S0022-3476(03)00503-114615749 52WhitehornJRodriguez RocheRGuzmanMGet al.:"/>
   <result pre="61QuyenDLThanh LeNVan AnhCTet al.: Epidemiological, Serological, and Virological Features of" exact="Dengue" post="in Nha Trang City, Vietnam.Am J Trop Med Hyg.2018;98(2):402–9."/>
   <result pre="J Trop Med Hyg.2018;98(2):402–9. 10.4269/ajtmh.17-063029313471 62IndrianiCAhmadRAWiratamaBSet al.: Baseline Characterization of" exact="Dengue" post="Epidemiology in Yogyakarta City, Indonesia, before a Randomized Controlled"/>
   <result pre="arms.PLoS One.2019;14(1):e0210041. 10.1371/journal.pone.021004130682037 F1000 Recommendation 66RibeiroGSKikutiMTauroLBet al.: Does immunity after" exact="Zika" post="virus infection cross-protect against dengue?Lancet Glob Health.2018;6(2):e140–e141. 10.1016/S2214-109X(17)30496-529389533 67PerezFLlauAGutierrezGet"/>
   <result pre="of multiple hypotheses.Trop Med Int Health.2019;24(4):442–53. 10.1111/tmi.1320030624838 68RibeiroGSKikutiMTauroLBet al.: Can" exact="Zika" post="virus antibodies cross-protect against dengue virus? - Authors' reply.Lancet"/>
   <result pre="10.1016/j.jcv.2014.08.03025453327 72TurellMJGozaloASGuevaraCet al.: Lack of Evidence of Sylvatic Transmission of" exact="Dengue" post="Viruses in the Amazon Rainforest Near Iquitos, Peru.Vector Borne"/>
   <result pre="virus infections.J Infect Dis.2002;185(9):1213–21. 10.1086/34036512001037 77LamPKTamDTDietTVet al.: Clinical characteristics of" exact="Dengue" post="shock syndrome in Vietnamese children: a 10-year prospective study"/>
   <result pre="CD8 +T Lymphocytes in an Immunocompetent Mouse Model of Secondary" exact="Dengue" post="Virus Infection.EBioMedicine.2017;20:202–16. 10.1016/j.ebiom.2017.04.03328483582 81ZellwegerRMShrestaS: Mouse models to study dengue"/>
   <result pre="late endosomes: implications for viral infectivity.J Virol.2005;79(17):11403–11. 10.1128/JVI.79.17.11403-11411.200516103191 92LinSWChuangYCLinYSet al.:" exact="Dengue" post="virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits"/>
   <result pre="and inhibits prothrombin activation.J Infect.2012;64(3):325–34. 10.1016/j.jinf.2011.11.02322138554 F1000 Recommendation 93ChaoCHWuWCLaiYCet al.:" exact="Dengue" post="virus nonstructural protein 1 activates platelets via Toll-like receptor"/>
   <result pre="4, leading to thrombocytopenia and hemorrhage.PLoS Pathog.2019;15(4):e1007625. 10.1371/journal.ppat.100762531009511 94ModhiranNWattersonDMullerDAet al.:" exact="Dengue" post="virus NS1 protein activates cells via Toll-like receptor 4"/>
   <result pre="cell monolayer integrity.Sci Transl Med.2015;7(304):304ra142. 10.1126/scitranslmed.aaa386326355031 F1000 Recommendation 95BeattyPRPuerta-GuardoHKillingbeckSSet al.:" exact="Dengue" post="virus NS1 triggers endothelial permeability and vascular leak that"/>
   <result pre="prevented by NS1 vaccination.Sci Transl Med.2015;7(304):304ra141. 10.1126/scitranslmed.aaa378726355030 F1000 Recommendation 96Puerta-GuardoHGlasnerDRHarrisE:" exact="Dengue" post="Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability.PLoS"/>
   <result pre="Tight and Adherens Junctions With Severity of Plasma Leakage in" exact="Dengue" post="Infection.J Infect Dis.2017;215(6):992–9. 10.1093/infdis/jix04128453844 98TangTHAlonsoSNgLFet al.: Increased Serum Hyaluronic"/>
   <result pre="98TangTHAlonsoSNgLFet al.: Increased Serum Hyaluronic Acid and Heparan Sulfate in" exact="Dengue" post="Fever: Association with Plasma Leakage and Disease Severity.Sci Rep.2017;7:"/>
   <result pre="Plasma Leakage and Disease Severity.Sci Rep.2017;7: 46191. 10.1038/srep4619128393899 99GlasnerDRRatnasiriKPuerta-GuardoHet al.:" exact="Dengue" post="virus NS1 cytokine-independent vascular leak is dependent on endothelial"/>
   <result pre="on endothelial glycocalyx components.PLoS Pathog.2017;13(11):e1006673. 10.1371/journal.ppat.100667329121099 100EspinosaDABeattyPRReinerGLet al.: Cyclic Dinucleotide-Adjuvanted" exact="Dengue" post="Virus Nonstructural Protein 1 Induces Protective Antibody and T"/>
   <result pre="F1000 Recommendation 102HadinegoroSRArredondo-GarcíaJLCapedingMRet al.: Efficacy and Long-Term Safety of a" exact="Dengue" post="Vaccine in Regions of Endemic Disease.N Engl J Med.2015;373(13):1195–206."/>
   <result pre="to dengue virus.J Virol Methods.2018;257:48–57. 10.1016/j.jviromet.2018.03.00729567514 105SridharSLuedtkeALangevinEet al.: Effect of" exact="Dengue" post="Serostatus on Dengue Vaccine Safety and Efficacy.N Engl J"/>
   <result pre="Virol Methods.2018;257:48–57. 10.1016/j.jviromet.2018.03.00729567514 105SridharSLuedtkeALangevinEet al.: Effect of Dengue Serostatus on" exact="Dengue" post="Vaccine Safety and Efficacy.N Engl J Med.2018;379(4):327–40. 10.1056/NEJMoa180082029897841 F1000"/>
   <result pre="and Efficacy.N Engl J Med.2018;379(4):327–40. 10.1056/NEJMoa180082029897841 F1000 Recommendation 106collab: WHO:" exact="Dengue" post="vaccine: WHO position paper - September 2018.Wkly Epidemiol Rec.2018;93(36):457–76."/>
   <result pre="10.1056/NEJMoa141103725365753 F1000 Recommendation 110KatzelnickLCHarrisE, collab: Participants in the Summit on" exact="Dengue" post="Immune Correlates of Protection: Immune correlates of protection for"/>
   <result pre="State of the art and research agenda.Vaccine.2017;35(36):4659–69. 10.1016/j.vaccine.2017.07.04528757058 111RautRCorbettKSTennekoonRNet al.:" exact="Dengue" post="type 1 viruses circulating in humans are highly infectious"/>
   <result pre="Human Memory B Cell and Serum Neutralizing Antibody Responses to" exact="Dengue" post="Virus Serotype 4 Infection and Vaccination.J Virol.2017;91(5): pii: e02041-16"/>
   <result pre="pii: e02041-16 10.1128/JVI.02041-1628031369 F1000 Recommendation 115GallichotteENBaricTJNivarthiUet al.: Genetic Variation between" exact="Dengue" post="Virus Type 4 Strains Impacts Human Antibody Binding and"/>
   <result pre="Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent" exact="Dengue" post="Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.J Infect Dis.2017;215(3):351–358."/>
   <result pre="in Naive and Dengue-Exposed Individuals.J Infect Dis.2017;215(3):351–358. 10.1093/infdis/jiw57627932620 117WeiskopfDBangsDJSidneyJet al.:" exact="Dengue" post="virus infection elicits highly polarized CX3CR1 + cytotoxic CD4"/>
   <result pre="118WeiskopfDCerpasCAngeloMAet al.: Human CD8 + T-Cell Responses Against the 4" exact="Dengue" post="Virus Serotypes Are Associated With Distinct Patterns of Protein"/>
   <result pre="NgonoAChenHWTangWWet al.: Protective Role of Cross-Reactive CD8 T Cells Against" exact="Dengue" post="Virus Infection.EBioMedicine.2016;13:284–293. 10.1016/j.ebiom.2016.10.00627746192 F1000 Recommendation 120GrifoniAAngeloMALopezBet al.: Global Assessment"/>
   <result pre="Virus Infection.EBioMedicine.2016;13:284–293. 10.1016/j.ebiom.2016.10.00627746192 F1000 Recommendation 120GrifoniAAngeloMALopezBet al.: Global Assessment of" exact="Dengue" post="Virus-Specific CD4 + T Cell Responses in Dengue-Endemic Areas.Front"/>
   <result pre="121TianYSetteAWeiskopfD: Cytotoxic CD4 T Cells: Differentiation, Function, and Application to" exact="Dengue" post="Virus Infection.Front Immunol.2016;7:531. 10.3389/fimmu.2016.0053128003809 122WeiskopfDAngeloMABangsDJet al.: The human CD8"/>
   <result pre="Human CD4 + T Cell Responses to an Attenuated Tetravalent" exact="Dengue" post="Vaccine Parallel Those Induced by Natural Infection in Magnitude,"/>
   <result pre="Restriction, and Antigen Specificity.J Virol.2017;91(5): pii: e02147-16. 10.1128/JVI.02147-1627974563 124LamJHChuaYLLeePXet al.:" exact="Dengue" post="vaccine-induced CD8 + T cell immunity confers protection in"/>
   <result pre="137KirkpatrickBDDurbinAPPierceKKet al.: Robust and Balanced Immune Responses to All 4" exact="Dengue" post="Virus Serotypes Following Administration of a Single Dose of"/>
   <result pre="Administration of a Single Dose of a Live Attenuated Tetravalent" exact="Dengue" post="Vaccine to Healthy, Flavivirus-Naive Adults.J Infect Dis.2015;212(5):702–10. 10.1093/infdis/jiv08225801652 F1000"/>
   <result pre="of the National Institute of Allergy and Infectious Diseases Tetravalent" exact="Dengue" post="Vaccine Induces a Robust Neutralizing Antibody Response.J Infect Dis.2016;214(6):832–5."/>
   <result pre="F1000 Recommendation 141TsaiWYDurbinATsaiJJet al.: Complexity of Neutralizing Antibodies against Multiple" exact="Dengue" post="Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed"/>
   <result pre="Specificity of Antibodies Induced by National Institutes of Health Monovalent" exact="Dengue" post="Virus Vaccines.J Infect Dis.2019;220(2):219–27. 10.1093/infdis/jiz10930895307 143LopesTRRSilvaCSPastorAFet al.: Dengue in"/>
   <result pre="Health Monovalent Dengue Virus Vaccines.J Infect Dis.2019;220(2):219–27. 10.1093/infdis/jiz10930895307 143LopesTRRSilvaCSPastorAFet al.:" exact="Dengue" post="in Brazil in 2017: what happened?Rev Inst Med Trop"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6679168\results\search\tropicalVirus\results.xml">
   <result pre="J.1998172494250310.1093/emboj/17.9.24949564032 179.HeatonN.S.MoshkinaN.FenouilR.GardnerT.J.AguirreS.ShahP.S.ZhaoN.ManganaroL.HultquistJ.F.NoelJ.et al.Targeting Viral Proteostasis Limits Influenza Virus, HIV, and" exact="Dengue" post="Virus InfectionImmunity201644465810.1016/j.immuni.2015.12.01726789921 180.WangL.FuB.LiW.PatilG.LiuL.DorfM.E.LiS.Comparative influenza protein interactomes identify the role"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6687121\results\search\tropicalVirus\results.xml">
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences: Epidemiology : Medicine"/>
   <result pre="are within the manuscript and its Supporting Information files. Introduction" exact="Dengue" post="is an arthropod-borne viral disease that results in a"/>
   <result pre="can lead to dengue shock syndrome (DSS) and death [1]." exact="Dengue" post="has become a major public health problem since its"/>
   <result pre="points separated by the distance interval h. The basic model" exact="Dengue" post="virus is maintained in an endemic–epidemic cycle involving human"/>
   <result pre="GGuzman,EvaHarris. Dengue. Lancet. 2015;385,453–65. 10.1016/S0140-6736(14)60572-9 .25230594 3GuzmanMaria G.,GublerDuane J.,AlienysIzquierdo1,EricMartinez,ScottB. Halstead." exact="Dengue" post="infection. Nature reviews disease primers. 2016;55,210.1038/nrdp.2016.55 .27525287 4BhattS, GethingPW,"/>
   <result pre="Nature.2013;496,504–507. 10.1038/nature12060 .23563266 5collab: World Health Organization. Global Strategy for" exact="Dengue" post="Prevention and Control 2012–2020,Geneva2012WHO Press;2013. 6ShepardD. S.,UndurragaE. A.,HalasaY. A.,StanawayJ."/>
   <result pre="and the Timing of Imported Cases as Determinants of the" exact="Dengue" post="Outbreak in Guangzhou, 2014: Evidence from a Mathematical Model."/>
   <result pre="YanJY, YaoWW, PanJH, YangZN, et al.Epidemiological Characterization of the 2017" exact="Dengue" post="Outbreak in Zhejiang, China and Molecular Characterization of the"/>
   <result pre="28WangT, WangM, ShuB, ChenXQ, LuoL, WangJY, et al.Evaluation of Inapparent" exact="Dengue" post="Infections During an Outbreak in Southern China. PLoS Negl"/>
   <result pre="J. Trop. Med. Hyg.2018;98, 913–919. 10.4269/ajtmh.17-0284 .29260651 41OoiE-E, GohK-T, GublerDJ." exact="Dengue" post="prevention and 35 years of vector control in Singapore."/>
   <result pre="J Infect Dis.2010;201,5–14. 10.1086/648592 .19929380 47LuzPM, VanniT, MedlockJ, PaltielAD, GalvaniAP." exact="Dengue" post="vector control strategies in an urban setting: an economic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6688121\results\search\tropicalVirus\results.xml">
   <result pre="well-established epidemics of e.g., Human Immunodeficiency Virus Type 1 (HIV-1)," exact="Dengue" post="virus (DENV) or Hepatitis C virus (HCV), and as"/>
   <result pre="virus (HCV), and as emerging or re-emerging epidemics of e.g.," exact="Zika" post="virus (ZIKV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Measles"/>
   <result pre="to SpreaD3 (40). Shown here is the current situation for" exact="Zika" post="virus evolution, based on analyses of 506 genomes sampled"/>
   <result pre="(48) visualization of a phylogenetic tree constructed from publicly available" exact="Zika" post="virus (ZIKV) genomes. ggtree allows similar advanced customized visualization"/>
   <result pre="visualization of the ancestral reconstruction of state locations of the" exact="ZIKV" post="dataset used in Figure 6. The top-down visualization corresponds"/>
   <result pre="data alongside visualization for a number of pathogens such as" exact="West Nile" post="virus, Ebola virus, and Zika virus. For the latter"/>
   <result pre="of pathogens such as West Nile virus, Ebola virus, and" exact="Zika" post="virus. For the latter virus, we provide the currently"/>
   <result pre="showing a color-coded time-scaled maximum-likelihood tree alongside an animation of" exact="Zika" post="geographic transmissions over time as well as the genetic"/>
   <result pre="can span from hundreds of years [e.g., HCV (103) and" exact="DENV" post="(104)] to decades [e.g., HIV-1 (3)]. RNA viruses are"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6689664\results\search\tropicalVirus\results.xml">
   <result pre="by mosquitoes or ticks (Table 1). The most significant are" exact="West Nile" post="virus (WNV) and Japanese encephalitis virus (JEV).1 West Nile"/>
   <result pre="are West Nile virus (WNV) and Japanese encephalitis virus (JEV).1" exact="West Nile" post="virus West Nile virus is the flavivirus with the"/>
   <result pre="virus (WNV) and Japanese encephalitis virus (JEV).1 West Nile virus" exact="West Nile" post="virus is the flavivirus with the widest distribution, which"/>
   <result pre="distribution, which includes all continents (Table 2). In affected regions," exact="WNV" post="is maintained in an enzootic cycle between mosquitoes and"/>
   <result pre="infected horses develop neurological signs, but they can be lethal.24" exact="WNV" post="was first isolated in Africa in 1937 and spread"/>
   <result pre="more frequent outbreaks have occurred in the Mediterranean Basin and" exact="WNV" post="appeared for the first time in North America in"/>
   <result pre="subsequently spreading across the continent.25,26 Since 2008, a re-emergence of" exact="WNV" post="in Central and Southeastern Europe has been observed, with"/>
   <result pre="has been observed, with both lineage 1 and lineage 2" exact="WNV" post="involved in outbreaks.27 In Australia, WNV was named Kunjin"/>
   <result pre="1 and lineage 2 WNV involved in outbreaks.27 In Australia," exact="WNV" post="was named Kunjin virus, which was endemic in northern"/>
   <result pre="because of enhanced vector transmission.28,29Table 2 Recently published seroprevalence of" exact="West Nile" post="virus in some countries Country Seroprevalence Year Test used"/>
   <result pre="recent study, it was estimated that the cost of a" exact="WNV" post="epidemic in Belgium would be over 30 million euros"/>
   <result pre="there are equine vaccines against WNV, there is no human" exact="WNV" post="vaccine. Although live-attenuated and inactivated virus vaccines have successfully"/>
   <result pre="virus (MLV) VEE vaccine has been released during previous outbreaks" exact="West Nile" post="Inactivated whole virusModified live (canarypox vector expressing prM and"/>
   <result pre="\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n} \DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext} \begin{document} $$ \lt 1 $$ \end{document} &amp;lt; 1then" exact="WNV" post="would die out.72 Wonham et al (2004) predicted that"/>
   <result pre="New York mosquito population was 40–70% smaller, the outbreak of" exact="WNV" post="in 2000 could have been prevented.73 In contrast, reducing"/>
   <result pre="Dis. 2012;6:2003–2010. doi:10.1371/journal.pntd.0001875 23.DavidS, AbrahamAM. Epidemiological and clinical aspects on" exact="West Nile" post="virus, a globally emerging pathogen. Infect Dis (Lond). 2016;48:571–586."/>
   <result pre="24.BunningML, BowenRA, CroppCB, et al. Experimental infection of horses with" exact="West Nile" post="virus. Emerg Infect Dis. 2002;8:380–386. doi:10.3201/eid0804.01023911971771 25.KramerLD, StyerLM, EbelGD."/>
   <result pre="25.KramerLD, StyerLM, EbelGD. A global perspective on the epidemiology of" exact="West Nile" post="virus. Annu Rev Entomol. 2008;53:61–81.17645411 26.HofmeisterEK. West Nile virus:"/>
   <result pre="epidemiology of West Nile virus. Annu Rev Entomol. 2008;53:61–81.17645411 26.HofmeisterEK." exact="West Nile" post="virus: north American experience. Integr Zool. 2011;6:279–289. doi:10.1111/j.1749-4877.2011.00251.x21910847 27.BakonyiT,"/>
   <result pre="ErdelyiK, et al. Lineage 1 and 2 strains of encephalitic" exact="West Nile" post="virus, central Europe. Emerg Infect Dis. 2006;12:618–623. doi:10.3201/eid1204.05137916704810 28.van"/>
   <result pre="et al. Role of enhanced vector transmission of a new" exact="West Nile" post="virus strain in an outbreak of equine disease in"/>
   <result pre="doi:10.1186/1756-3305-7-2325499981 29.ProwNA, EdmondsJH, WilliamsDT, et al. Virulence and evolution of" exact="West Nile" post="Virus, Australia, 1960-2012. Emerg Infect Dis. 2016;22:1353–1362. doi:10.3201/eid2208.15171927433830 30.KumarK,"/>
   <result pre="economic impact of a possible equine and human epidemic of" exact="West Nile" post="virus infection in Belgium. Euro Surveill. 2016;21(31):pii=30309. doi:10.2807/1560-7917.ES.2016.21.31.30309 62.WeeseJS."/>
   <result pre="WuJ, ZhuH. A mathematical model for assessing control strategies against" exact="West Nile" post="virus. Bull Math Biol. 2005;67:1107–1133. doi:10.1016/j.bulm.2005.01.00215998497 73.WonhamMJ, de-Camino-BeckT, LewisMA."/>
   <result pre="Biol. 2005;67:1107–1133. doi:10.1016/j.bulm.2005.01.00215998497 73.WonhamMJ, de-Camino-BeckT, LewisMA. An epidemiological model for" exact="West Nile" post="virus: invasion analysis and control applications. Proc Biol Sci."/>
   <result pre="AMCA. 2000;16:28–35. 82.ZouL, MillerSN, SchmidtmannET. A GIS tool to estimate" exact="West Nile" post="virus risk based on a degree-day model. Environ Monit"/>
   <result pre="review. AJAVA. 2014;9:123–133. 103.LafriI, PratCM, BitamI, et al. Seroprevalence of" exact="West Nile" post="virus antibodies in equids in the North-East of Algeria"/>
   <result pre="2017;50:8–12. doi:10.1016/j.cimid.2016.11.00528131384 104.SilvaJR, MedeirosLC, ReisVP, et al. Serologic survey of" exact="West Nile" post="virus in horses from Central-West, Northeast and Southeast Brazil."/>
   <result pre="dogs. Epidemiol Infect. 2017;145:2940–2948. doi:10.1017/S095026881700220528956525 107.CabreO, GrandadamM, MarieJL, et al." exact="West Nile" post="Virus in horses, sub-Saharan Africa. Emerg Infect Dis. 2006;12:1958–1960."/>
   <result pre="Dis. 2006;12:1958–1960. doi:10.3201/eid1212.06004217326952 108.BarbicL, ListesE, KaticS, et al. Spreading of" exact="West Nile" post="virus infection in Croatia. Vet Microbiol. 2012;159:504–508. doi:10.1016/j.vetmic.2012.04.03822609103 109.DurandB,"/>
   <result pre="Microbiol. 2012;159:504–508. doi:10.1016/j.vetmic.2012.04.03822609103 109.DurandB, DauphinG, ZellerH, et al. Serosurvey for" exact="West Nile" post="virus in horses in southern France. Vet Rec. 2005;157:711–713."/>
   <result pre="Dis. 2016;63:e219–e227. doi:10.1111/tbed.1233425660661 111.Ludu OslobanuEL, Mihu-PintilieA, AnitaD, AnitaA, LecollinetS, SavutaG." exact="West Nile" post="virus reemergence in Romania: a serologic survey in host"/>
   <result pre="Borne Zoonotic Dis. 2014;14:330–337. doi:10.1089/vbz.2013.140524745699 112.CalistriP, GiovanniniA, SaviniG, et al." exact="West Nile" post="virus transmission in 2008 in north-eastern Italy. Zoonoses Public"/>
   <result pre="Health. 2010;57:211–219. doi:10.1111/j.1863-2378.2009.01303.x20042066 113.Ibarra-JuarezL, EisenL, BollingBG, et al. Detection of" exact="West Nile" post="virus-specific antibodies and nucleic acid in horses and mosquitoes,"/>
   <result pre="2012;26:351–354. doi:10.1111/j.1365-2915.2012.01014.x22490106 114.BenjellounA, El HarrakM, CalistriP, et al. Seroprevalence of" exact="West Nile" post="virus in horses in different Moroccan regions. Vet Med"/>
   <result pre="2017;3:198–207. doi:10.1002/vms3.7129152314 115.ZohaibA, SaqibM, BeckC, et al. High prevalence of" exact="West Nile" post="virus in equines from the two provinces of Pakistan."/>
   <result pre="116.BazanowB, Jansen van VurenP, SzymanskiP, et al. A survey on" exact="West Nile" post="and Usutu viruses in horses and birds in Poland."/>
   <result pre="Poland. Viruses. 2018;10:E87. doi:10.3390/v1002008729462983 117.HemidaMG, PereraR, ChuDKW, KoRLW, AlnaeemAA, PeirisM." exact="West Nile" post="virus infection in horses in Saudi Arabia (in 2013-2015)."/>
   <result pre="Arenas-MontesA, NappS, et al. Seroprevalence and risk factors associated to" exact="West Nile" post="virus in horses from Andalusia, Southern Spain. Vet Microbiol."/>
   <result pre="doi:10.1016/j.vetmic.2012.06.02722776513 120.BargaouiR, LecollinetS, LancelotR. Mapping the serological prevalence rate of" exact="West Nile" post="fever in equids, Tunisia. Transbound Emerg Dis. 2015;62:55–66. doi:10.1111/tbed.1207723906318"/>
   <result pre="al. Serological, molecular and entomological surveillance demonstrates widespread circulation of" exact="West Nile" post="virus in Turkey. PLoS Negl Trop Dis. 2014;8(7):e3028. doi:10.1371/journal.pntd.000302825058465"/>
   <result pre="Ukraine. Viruses. 2013;5:2469–2482. doi:10.3390/v510246924100889 123.FransonJC, HofmeisterEK, CollinsGH, DusekRJ. Seroprevalence of" exact="West Nile" post="virus in feral horses on Sheldon National Wildlife Refuge,"/>
   <result pre="Trop Med Hyg. 2011;84:637–640. doi:10.4269/ajtmh.2011.10-046721460023 124.BoschI, HerreraF, NavarroJC, et al." exact="West Nile" post="virus, Venezuela. Emerg Infect Dis. 2007;13:651–653. doi:10.3201/eid1304.06138317561567"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6695095\results\search\tropicalVirus\results.xml">
   <result pre="a pro-viral role for autophagy is not without precedent. In" exact="Dengue" post="virus infection, autophagy has been reported to support viral"/>
   <result pre="in infected cells. J Virol87: 13107–13114. 10.1128/JVI.02148-1324027311 68HeatonNS, RandallG (2011)" exact="Dengue" post="virus and autophagy. Viruses3: 1332–1341. 10.3390/v308133221994782 69HeatonNS, RandallG (2010)"/>
   <result pre="Dengue virus and autophagy. Viruses3: 1332–1341. 10.3390/v308133221994782 69HeatonNS, RandallG (2010)" exact="Dengue" post="virus-induced autophagy regulates lipid metabolism. Cell Host Microbe8: 422–432."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6695175\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Evolutionary Biology"/>
   <result pre="medium, provided the original author and source are credited.pone.0221179.pdf Abstract" exact="Dengue" post="fever is caused by dengue viruses (DENV) from the"/>
   <result pre="the Flavivirus genus and is the most prevalent arboviral disease." exact="DENV" post="exists in four immunogenically distinct and genetically-related serotypes (DENV-1"/>
   <result pre="each subdivided in genotypes. Despite the endemicity of all four" exact="DENV" post="serotypes in Thailand, no prior study has characterized the"/>
   <result pre="in Thailand, no prior study has characterized the circulation of" exact="DENV" post="in the southern provinces of the country. To determine"/>
   <result pre="provinces of the country. To determine the genetic diversity of" exact="DENV" post="circulating in Southern Thailand in 2015 and 2016, we"/>
   <result pre="investigated 46 viruses from 182 patients’ sera confirmed positive for" exact="DENV" post="by serological and Nested RT-PCR tests. Our dataset included"/>
   <result pre="found genotype III and genotype I in Southern Thailand. All" exact="DENV" post="genotype identified in this study were closely related to"/>
   <result pre="results provide new insights into the co-circulation of all four" exact="DENV" post="serotypes in Southern Thailand, confirming the hyperendemicity of DENV"/>
   <result pre="four DENV serotypes in Southern Thailand, confirming the hyperendemicity of" exact="DENV" post="in the region. These findings also suggest a new"/>
   <result pre="findings also suggest a new trend of dissemination for some" exact="DENV" post="serotypes with a possible shift in genotype distribution; as"/>
   <result pre="numbers are shown in Table 1 of the manuscript. Introduction" exact="Dengue" post="viruses (DENV) have become the most prevalent arboviruses in"/>
   <result pre="have become the most prevalent arboviruses in the world [1]." exact="DENV" post="pose a significant public health and economic burden worldwide"/>
   <result pre="impairment [3]. Despite the availability of a licensed vaccine against" exact="DENV" post="in several countries, the poor efficacy of the vaccine"/>
   <result pre="vaccination program. Additionally, there are no specific antiviral treatment against" exact="DENV" post="infection [4]. DENV belong to the genus Flavivirus of"/>
   <result pre="there are no specific antiviral treatment against DENV infection [4]." exact="DENV" post="belong to the genus Flavivirus of the Flaviviridae family."/>
   <result pre="the Flaviviridae family. There are four immunogenically and genetically distinct" exact="DENV" post="serotypes (DENV-1 to 4). Each of the DENV serotypes"/>
   <result pre="genetically distinct DENV serotypes (DENV-1 to 4). Each of the" exact="DENV" post="serotypes are further classified into 3–5 genotypes based on"/>
   <result pre="divergence [5]. While all four serotypes are commonly observed in" exact="DENV" post="endemic regions around the world, genotypes within each of"/>
   <result pre="endemic regions around the world, genotypes within each of the" exact="DENV" post="serotypes are usually separated geographically. In Thailand, all four"/>
   <result pre="DENV serotypes are usually separated geographically. In Thailand, all four" exact="DENV" post="serotypes are endemic and more than 80,000 cases were"/>
   <result pre="of Thailand were reported in 1949 [7]. Major outbreaks of" exact="Dengue" post="have been reported since the 1960’s associated with different"/>
   <result pre="have been reported since the 1960’s associated with different serotypes." exact="Dengue" post="continues to cause regular epidemics and still remains a"/>
   <result pre="the movement of inhabitants are conducive to the maintenance of" exact="DENV" post="and to the emergence of outbreaks in the human"/>
   <result pre="each serotype [9, 10]. This situation is not unique as" exact="DENV" post="serotypes are endemic in many countries, resulting in so"/>
   <result pre="and the 1990’s, respectively [22, 23]. Despite the presence of" exact="DENV" post="in the four regions of Thailand, Limkittikul et al"/>
   <result pre="Southeast Asia (SEA) on the other hand. Phylogenetic analysis of" exact="DENV" post="sequences collected through surveillance allows monitoring of the spatiotemporal"/>
   <result pre="local epidemics. Here we used a phylogenetic approach to investigate" exact="DENV" post="circulation in the southern provinces of Thailand during 2015–2016"/>
   <result pre="and determine the origins and routes of introduction of the" exact="DENV" post="strains. While previous studies focused on a single serotype"/>
   <result pre="the first time, the local genetic diversity of the four" exact="DENV" post="serotypes and determine whether new strains are emerging or"/>
   <result pre="testing was performed on patient blood samples using a rapid" exact="DENV" post="non-structural protein 1 (NS1) antibody test (SD BIOLINE Dengue"/>
   <result pre="rapid DENV non-structural protein 1 (NS1) antibody test (SD BIOLINE" exact="Dengue" post="Duo rapid test; Abbot Laboratories, Bangkok, Thailand). Description of"/>
   <result pre="Table. Fig 1 Map of Thailand showing surveillance region and" exact="DENV" post="types detected. Participating provinces are highlighted in orange. Location"/>
   <result pre="the patients originated are marked on the map along with" exact="DENV" post="serotype: Purple triangles, DENV-2; green diamond, DENV-3; red square,"/>
   <result pre="map was annotated using QGIS software. RT-PCR amplification, serotyping and" exact="DENV" post="envelope gene sequencing Serotyping was conducted on all NS1"/>
   <result pre="entire gene and avoid discrepancies. Phylogenetic analysis To characterize the" exact="DENV" post="isolated from clinical cases in Southern Thailand, the sequences"/>
   <result pre="E were subject to robust phylogenetic analyses, along with representative" exact="DENV" post="sequences obtained from the NCBI GenBank database (S3 Table)."/>
   <result pre="a broad geographical area and includes sequences from countries where" exact="DENV" post="circulation were reported from several decades. All sequences were"/>
   <result pre="iterations. Phylogenetic trees were edited with FigTree v1.4.3 software (http://tree.bio.ed.ac.uk/software/figtree/)." exact="DENV" post="serotypes 1, 2, 3 and 4 were classified following"/>
   <result pre="Table 1. 10.1371/journal.pone.0221179.t001Table 1 Information on dengue-infected patients from whom" exact="DENV" post="E protein gene were sequenced. Code of samples Age*"/>
   <result pre="determined by nested RT-PCR, revealing the co-circulation of all four" exact="DENV" post="serotypes in Southern Thailand (Table 1; DENV1, 2; DENV2,"/>
   <result pre="are highlighted in light orange. Annotation on the right denote" exact="DENV" post="genotype. Of the twenty DENV-2 samples, ten belonged to"/>
   <result pre="are highlighted in light orange. Annotation on the right denote" exact="DENV" post="genotype. Out of the nine DENV-3 samples, three were"/>
   <result pre="are highlighted in light orange. Annotation on the right denote" exact="DENV" post="genotype. Similar to other serotypes, DENV-4 samples collected from"/>
   <result pre="are highlighted in light orange. Annotation on the right denote" exact="DENV" post="genotype. Discussion Screening of dengue samples collected from patients"/>
   <result pre="to hospitals in southern Thailand during 2015–2016 identified all four" exact="DENV" post="serotypes, highlighting the hyperendemicity in Southern Thailand. To determine"/>
   <result pre="the hyperendemicity in Southern Thailand. To determine the genotypes of" exact="DENV" post="and the relationships with other DENV strains, particularly from"/>
   <result pre="determine the genotypes of DENV and the relationships with other" exact="DENV" post="strains, particularly from Thailand and Southeast Asia, we generated"/>
   <result pre="particularly from Thailand and Southeast Asia, we generated sequences of" exact="DENV" post="envelope gene directly from patient serum samples and conducted"/>
   <result pre="between countries in Southeast Asia–highlighting the importance of continuously monitoring" exact="DENV" post="in Southern Thailand. While the Asian/American genotype was displaced"/>
   <result pre="first time, the genetic diversity of all four serotypes of" exact="DENV" post="in Southern Thailand, providing important insights into their distributions"/>
   <result pre="insights into their distributions in the region. We demonstrated that" exact="DENV" post="is hyperendemic in Southern Thailand, rendering coinfection between serotypes"/>
   <result pre="We observed the co-circulation of multiple genotypes within DENV-2 to" exact="DENV" post="4: DENV-2 Cosmopolitan genotype co-circulated with Asian-I; DENV-3 genotype"/>
   <result pre="re-emergence of several genotypes suggests constant movement and introduction of" exact="DENV" post="strains in Southern Thailand. Our study urges further in"/>
   <result pre="South of Thailand. Our data highlights the high incidence of" exact="DENV" post="serotype and genotype co-circulation, particularly in urban area, such"/>
   <result pre="(PDF) LINK Click here for additional data file. S3 Table" exact="Dengue" post="virus sequences used in present study. (PDF) LINK Click"/>
   <result pre="LINK Click here for additional data file. References References 1WHO." exact="Dengue" post="and severe dengue 2018. Available from: http://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. 2LeeJS, MogasaleV,"/>
   <result pre="2017/10/30. 10.1371/journal.pntd.000603729084220 3MullerDA, DepelsenaireAC, YoungPR. Clinical and Laboratory Diagnosis of" exact="Dengue" post="Virus Infection. J Infect Dis. 2017;215(suppl_2):S89–S95. 10.1093/infdis/jiw649 .28403441 4FlascheS,"/>
   <result pre="Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated" exact="Dengue" post="Vaccine (Dengvaxia): A Model Comparison Study. PLoS Med. 2016;13(11):e1002181"/>
   <result pre="dengue virus. Trends Microbiol. 2000;8(2):74–7. .10664600 6HealthMoP. Bureau of Epidemiology," exact="Dengue" post="fever. Nonthaburi: Department of Disease Control Ministry of Public"/>
   <result pre="of Public Health. 2016, Accessed 22 Feb 2016. 10.1186/s12889-016-3382-5 7HammonWM." exact="Dengue" post="hemorrhagic fever—do we know its cause?Am J Trop Med"/>
   <result pre="cause?Am J Trop Med Hyg. 1973;22(1):82–91. 10.4269/ajtmh.1973.22.82 .4567852 8OoiEE, GublerDJ." exact="Dengue" post="in Southeast Asia: epidemiological characteristics and strategic challenges in"/>
   <result pre="10NisalakA, ClaphamHE, KalayanaroojS, KlungthongC, ThaisomboonsukB, FernandezS, et al.Forty Years of" exact="Dengue" post="Surveillance at a Tertiary Pediatric Hospital in Bangkok, Thailand,"/>
   <result pre="HasanZ, NgLC, et al.Evolution and heterogeneity of multiple serotypes of" exact="Dengue" post="virus in Pakistan, 2006–2011. Virol J. 2013;10:275 Epub 2013/09/04."/>
   <result pre="Health. 2013;6(4):302–6. Epub 2013/04/03. 10.1016/j.jiph.2013.01.004 .23806706 17CucunawangsihLugito NPH. Trends of" exact="Dengue" post="Disease Epidemiology. Virology (Auckl). 2017;8:1178122X17695836. Epub 2017/03/15. 10.1177/1178122X1769583628579763 18TanKK,"/>
   <result pre="25DrumondBP, FagundesLG, RochaRP, FumagalliMJ, ArakiCS, ColomboTE, et al.Phylogenetic analysis of" exact="Dengue" post="virus 1 isolated from South Minas Gerais, Brazil. Braz"/>
   <result pre="in Thailand. PLoS One. 2018;13(11):e0207220 Epub 2018/11/12. 10.1371/journal.pone.020722030419004 30collab: WHO." exact="Dengue" post="and severe dengue, Fact sheet n°117: World Health Organization;"/>
   <result pre="HsuTC, SuCL, LinCC, ShuPY. Laboratory-Based Surveillance and Molecular Characterization of" exact="Dengue" post="Viruses in Taiwan, 2014. Am J Trop Med Hyg."/>
   <result pre="JansenS, GüntherS, FrankC, et al.Genetic Diversity and New Lineages of" exact="Dengue" post="Virus Serotypes 3 and 4 in Returning Travelers, Germany,"/>
   <result pre="55SuciptoTH, KotakiT, MulyatnoKC, ChurrotinS, LabiqahA, SoegijantoS, et al.Phylogenetic Analysis of" exact="Dengue" post="Virus in Bangkalan, Madura Island, East Java Province, Indonesia."/>
   <result pre="2018;2018:8127093 Epub 2018/02/15. 10.1155/2018/812709329666658 56MoorePR, van den HurkAF, MackenzieJS, PykeAT." exact="Dengue" post="viruses in Papua New Guinea: evidence of endemicity and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6695206\results\search\tropicalVirus\results.xml">
   <result pre="distribution and epidemic disease pattern. Newly emerging dengue virus genotypes," exact="West Nile" post="virus clades, or Zika virus strains exhibited an enhancement"/>
   <result pre="Newly emerging dengue virus genotypes, West Nile virus clades, or" exact="Zika" post="virus strains exhibited an enhancement in mosquito vector competence."/>
   <result pre="(HPI) (S1A, S1B, S1D and S1E Fig). The newly evolved" exact="WNV" post="genotype (WN02) showed an ability to adapt to mosquitoes"/>
   <result pre="not in mosquito vectors. Mutation in the NS1 protein of" exact="Zika" post="virus and the NS3 protein of HCV has been"/>
   <result pre="of NS1 protein has recently been identified in newly emerging" exact="Zika" post="viruses associated with the current epidemics [46]. In contrast"/>
   <result pre="amplifying hosts was observed at elevated temperatures (Fig 3A–3F). A" exact="West Nile" post="virus study found that thermostability of replication was associated"/>
   <result pre="MeolaMA, MoudyRM, KramerLD. Temperature, viral genetics, and the transmission of" exact="West Nile" post="virus by Culex pipiens mosquitoes. PLoS pathogens. 2008;4(6):e1000092 Epub"/>
   <result pre="FilomatoriCV, De MaioFA, GamarnikAV. A Proline-Rich N-Terminal Region of the" exact="Dengue" post="Virus NS3 Is Crucial for Infectious Particle Production. Journal"/>
   <result pre="10.1099/jgv.0.000892 .28840803 28ZouG, ZhangB, LimPY, YuanZ, BernardKA, ShiPY. Exclusion of" exact="West Nile" post="virus superinfection through RNA replication. Journal of virology. 2009;83(22):11765–76."/>
   <result pre="29LiuY, LiuJ, DuS, ShanC, NieK, ZhangR, et al.Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoes. Nature. 2017;545(7655):482–6. 10.1038/nature22365"/>
   <result pre="31MoudyRM, MeolaMA, MorinLL, EbelGD, KramerLD. A newly emergent genotype of" exact="West Nile" post="virus is transmitted earlier and more efficiently by Culex"/>
   <result pre="development. Antiviral research. 2015;118:148–58. 10.1016/j.antiviral.2015.03.014 .25842996 43KaoYT, LaiMMC, YuCY. How" exact="Dengue" post="Virus Circumvents Innate Immunity. Frontiers in immunology. 2018;9:286010.3389/fimmu.2018.0286030564245 44DingQ,"/>
   <result pre="et al.Species-specific disruption of STING-dependent antiviral cellular defenses by the" exact="Zika" post="virus NS2B3 protease. Proceedings of the National Academy of"/>
   <result pre="ShanC, MuruatoAE, NunesBTD, MedeirosDBA, et al.An evolutionary NS1 mutation enhances" exact="Zika" post="virus evasion of host interferon induction. Nat Commun. 2018;9(1):41410.1038/s41467-017-02816-229379028"/>
   <result pre="virulence and thermostable replication of the North American strain of" exact="West Nile" post="virus. The Journal of general virology. 2006;87(Pt 12):3611–22. 10.1099/vir.0.82299-0"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6701881\results\search\tropicalVirus\results.xml">
   <result pre="doi: 10.1590/0074-0276019015000345 : Original Article Genetic and biological characterisation of" exact="Zika" post="virus isolates from different Brazilian regions StrottmannDaisy Maria1ZanlucaCamila1MosimannAna Luiza"/>
   <result pre="manuscript; CZ performed the virus isolation procedures; NCA amplified the" exact="ZIKV" post="genome, and HF performed the sequencing; DMS, CZ, ACK,"/>
   <result pre="out the experiments; DMS and ALPM analysed and compared the" exact="ZIKV" post="genomes; ALPM performed the phylogenetic analyses. All authors read"/>
   <result pre="the terms of the Creative Commons Attribution License Abstract BACKGROUND" exact="Zika" post="virus (ZIKV) infections reported in recent epidemics have been"/>
   <result pre="linked to clinical complications that had never been associated with" exact="ZIKV" post="before. Adaptive mutations could have contributed to the successful"/>
   <result pre="Adaptive mutations could have contributed to the successful emergence of" exact="ZIKV" post="as a global health threat to a nonimmune population."/>
   <result pre="to a nonimmune population. However, the causal relationships between the" exact="ZIKV" post="genetic determinants, the pathogenesis and the rapid spread in"/>
   <result pre="OBJECTIVES The aim of this study was to characterise three" exact="ZIKV" post="isolates obtained from patient samples during the 2015/2016 Brazilian"/>
   <result pre="from patient samples during the 2015/2016 Brazilian epidemics. METHODS The" exact="ZIKV" post="genomes of these strains were completely sequenced and in"/>
   <result pre="differences in their infectivity rates when compared to the well-established" exact="ZIKV" post="strains (MR766 and PE243), especially in their abilities to"/>
   <result pre="infect mammalian cells. MAIN CONCLUSIONS Genomic analysis of three recent" exact="ZIKV" post="isolates revealed some nonsynonymous substitutions, which could have an"/>
   <result pre="the viral fitness in mammalian and insect cells. Key words:" exact="Zika" post="virus Flavivirus molecular markers biological characterisation fig-count: table-count: ref-count:"/>
   <result pre="Zika virus Flavivirus molecular markers biological characterisation fig-count: table-count: ref-count:" exact="ZIKV" post="is a flavivirus (belonging to the family Flaviviridae, genus"/>
   <result pre="explosive epidemic occurred in Brazil in 2015.2 Prior to 2007," exact="ZIKV" post="had silently circulated in many countries from African and"/>
   <result pre="been reported, and the epidemic profile and self-limiting character of" exact="Zika" post="disease were dramatically altered.3 After ZIKV introduction to Brazil,"/>
   <result pre="and self-limiting character of Zika disease were dramatically altered.3 After" exact="ZIKV" post="introduction to Brazil, the virus raged on in South"/>
   <result pre="to the selection and spread of new epidemic variants of" exact="ZIKV" post="through a naïve population in tropical and subtropical areas."/>
   <result pre="in tropical and subtropical areas. Currently, the occurrence of human" exact="ZIKV" post="infections has dramatically decreased in Latin America. This decrease"/>
   <result pre="be partially due to the population’s previous experience with natural" exact="ZIKV" post="infection and the subsequent development of immunity.5 Additionally, other"/>
   <result pre="by studies on other infectious agents.6 Although a decrease in" exact="ZIKV" post="transmission has been observed in the last two years,"/>
   <result pre="possibility of a new epidemic event. Clarifying the dynamic of" exact="ZIKV" post="infections between animals, human hosts and vectors should aid"/>
   <result pre="preventing new epidemic outbreaks and in developing strategies for controlling" exact="ZIKV" post="infections. The ZIKV genome consists of single-stranded, positive-sense RNA"/>
   <result pre="outbreaks and in developing strategies for controlling ZIKV infections. The" exact="ZIKV" post="genome consists of single-stranded, positive-sense RNA of approximately 11"/>
   <result pre="and immune system evasion.7 Phylogenetic studies have demonstrated that after" exact="ZIKV" post="emerged in Uganda, the virus spread independently and evolved"/>
   <result pre="to distinct clinical complications in the human host.8 In accordance," exact="ZIKV" post="genomic characterisation suggests that during the geographical spread, the"/>
   <result pre="and the occurrence of new clinical entities associated with the" exact="ZIKV" post="infections during the 2015/2016 outbreak.9 A better understanding of"/>
   <result pre="paramount importance to design prophylactic or therapeutic strategies to control" exact="ZIKV" post="infections. Here, we describe the isolation and present a"/>
   <result pre="present a comparative genetic and biological characterisation of three Brazilian" exact="ZIKV" post="clinical isolates selected from two different epidemic periods. Sequence"/>
   <result pre="We identified nonsynonymous mutations in the genomes of these Brazilian" exact="ZIKV" post="isolates and the biological characterisations of the viruses showed"/>
   <result pre="showed that the mammalian cell lines were more permissive to" exact="ZIKV" post="infections than the insect cell lines. MATERIALS AND METHODS"/>
   <result pre="(DMEM/F12) (Gibco/Invitrogen) supplemented with 100 IU/μg/mL penicillin/streptomycin and 10% FBS." exact="ZIKV" post="isolation and sequencing -The serum samples were obtained from"/>
   <result pre="of Human Experimentation (CAAE: 42481115.7.0000.5248). The laboratory diagnosis of acute" exact="ZIKV" post="infection was confirmed by reverse transcription-quantitative polymerase chain reaction"/>
   <result pre="enzyme-linked immunosorbent assay (ELISA) based on a previously described methodology.11" exact="ZIKV" post="was isolated from human serum samples by direct inoculation"/>
   <result pre="To perform an in vitro biological characterisation of the three" exact="ZIKV" post="isolates, we first amplified the ZIKV ZV BR 2015/15098,"/>
   <result pre="characterisation of the three ZIKV isolates, we first amplified the" exact="ZIKV" post="ZV BR 2015/15098, ZV BR 2015/15261 and ZV BR"/>
   <result pre="from a previously described protocol.13 The complete genomes of the" exact="ZIKV" post="isolates were obtained by sequencing the overlapping PCR products."/>
   <result pre="an Applied Biosystems 3730xl DNA Analyzer (Applied Biosystems) using specific" exact="ZIKV" post="primers [Supplementary data(Table II)]. The ZIKV RNA genomes were"/>
   <result pre="(Applied Biosystems) using specific ZIKV primers [Supplementary data(Table II)]. The" exact="ZIKV" post="RNA genomes were assembled using Phred/Phrap/Consed software (http://www.phrap.org/phredphrapconsed.html), and"/>
   <result pre="infection - To perform the biological characterisation studies of recent" exact="ZIKV" post="clinical isolates we used two well-characterised ZIKV strains, MR766"/>
   <result pre="studies of recent ZIKV clinical isolates we used two well-characterised" exact="ZIKV" post="strains, MR766 and PE243, as reference viruses. The African"/>
   <result pre="ZIKV strains, MR766 and PE243, as reference viruses. The African" exact="ZIKV" post="MR766 strain (GenBank accession number NC_012532) was originally isolated"/>
   <result pre="originally isolated in 1947 from a rhesus monkey. The Asian" exact="ZIKV" post="PE243 (GenBank accession number KX197192) was isolated in Recife"/>
   <result pre="isolated in Recife from a patient with classical symptoms of" exact="ZIKV" post="infection in 2015. The ZIKV strains ZV BR 2015/15098,"/>
   <result pre="patient with classical symptoms of ZIKV infection in 2015. The" exact="ZIKV" post="strains ZV BR 2015/15098, ZV BR 2015/15261, ZV BR"/>
   <result pre="Vero E6, Huh7.5 and A549 cells were infected with the" exact="ZIKV" post="strains using an MOI of 0.1 and a period"/>
   <result pre="48 h. AP61 and C6/36 cells were infected with the" exact="ZIKV" post="strains using an MOI of 1 and a period"/>
   <result pre="and the total RNA was extracted from cells for subsequent" exact="ZIKV" post="genome RNA quantification. For all the experiments, the mock-infected"/>
   <result pre="in C6/36 cells using an anti-flavivirus monoclonal antibody (mAb 4G2).13" exact="ZIKV" post="genomic RNA quantification - RNA was extracted from mock-"/>
   <result pre="using the RNeasy Mini Kit (Qiagen) according to manufacturer’s recommendation." exact="ZIKV" post="RT-qPCR was performed in a 20 μL reaction master"/>
   <result pre="were included in all analyses for data normalisation. The relative" exact="ZIKV" post="genomic RNA expression level was determined by calculating the"/>
   <result pre="at p ≤ 0.05. Human monocyte-derived Dendritic Cell culture and" exact="ZIKV" post="infection - The peripheral blood samples were obtained by"/>
   <result pre="and anti-CD14-BV450 antibodies (all from BD Bioscience, CA, USA). For" exact="ZIKV" post="infection of mdDCs, 105 cells/well were distributed into 96-well"/>
   <result pre="with ZV BR 2015/15098, ZV BR 2015/15261, ZV BR 2016/16288," exact="ZIKV" post="PE243 and ZIKV MR766 at an MOI of 10."/>
   <result pre="2015/15098, ZV BR 2015/15261, ZV BR 2016/16288, ZIKV PE243 and" exact="ZIKV" post="MR766 at an MOI of 10. After removal of"/>
   <result pre="cell pellets (RNeasy mini kit - Qiagen) to quantify the" exact="ZIKV" post="genomic RNA. The ZIKV infections of mdDCs were evaluated"/>
   <result pre="kit - Qiagen) to quantify the ZIKV genomic RNA. The" exact="ZIKV" post="infections of mdDCs were evaluated by flow cytometry using"/>
   <result pre="Pharmingen, CA, USA) and their respective isotype controls. For intracellular" exact="ZIKV" post="envelope protein detection, the mdDCs were permeabilised with Cytofix/Cytoperm"/>
   <result pre="values of p ≤ 0.05 were considered significant. RESULTS The" exact="ZIKV" post="isolates reported in this study were obtained from the"/>
   <result pre="sera of three Brazilian patients who presented mild symptoms of" exact="ZIKV" post="infection (malaise, exanthema, mild fever, headache, muscle pain, and"/>
   <result pre="exanthema, mild fever, headache, muscle pain, and periorbital pain). The" exact="ZIKV" post="ZV BR 2015/15098 isolate was obtained from the serum"/>
   <result pre="March 2015, in the beginning of the epidemic caused by" exact="ZIKV" post="in Brazil. The ZIKV ZV BR 2015/15261 isolate was"/>
   <result pre="beginning of the epidemic caused by ZIKV in Brazil. The" exact="ZIKV" post="ZV BR 2015/15261 isolate was obtained from the serum"/>
   <result pre="patient from RN State collected later in June 2015. The" exact="ZIKV" post="ZV BR 2016/16288 was obtained from a serum sample"/>
   <result pre="one year after the confirmation of the first cases of" exact="ZIKV" post="in the country. TABLE I Zika virus (ZIKV) isolates"/>
   <result pre="the first cases of ZIKV in the country. TABLE I" exact="Zika" post="virus (ZIKV) isolates described in this study ZIKV isolate"/>
   <result pre="TABLE I Zika virus (ZIKV) isolates described in this study" exact="ZIKV" post="isolate name GenBank accession number Patient sample information Date"/>
   <result pre="summary with information about the patient samples used for the" exact="ZIKV" post="isolations and the GenBank accession numbers is presented in"/>
   <result pre="cell culture supernatant at passage three were fully sequenced. All" exact="ZIKV" post="full-length genome sequencing resulted in a 10,807 nucleotide (nt)"/>
   <result pre="analyses of either the complete sequence (Fig. 1) or the" exact="ZIKV" post="ORF [Supplementary data(Fig. 1)] grouped ZV BR 2015/15098 and"/>
   <result pre="the biological characterisation experiments. Fig. 1: midpoint-rooted consensus tree of" exact="Zika" post="virus (ZIKV) complete genome sequences inferred through Bayesian methodology"/>
   <result pre="A genomic analysis comparing the P3 sequences of the two" exact="ZIKV" post="isolates recovered from the patients’ serum from the Brazilian"/>
   <result pre="studied, mapping at NS1 and NS4B proteins. Additionally, only the" exact="ZIKV" post="ZV BR 2015/15098 showed a nucleotide substitution at 3’"/>
   <result pre="secondary structure. TABLE III Nonsynonymous mutations among the 2015/2016 Brazilian" exact="Zika" post="virus (ZIKV) isolates Polyprotein position Protein position ZV BR"/>
   <result pre="P3: passage 3. To study the biological characteristics of the" exact="ZIKV" post="Brazilian isolates ZV BR 2015/15098, ZV BR 2015/15261 and"/>
   <result pre="and to compare them to the extensively studied and well-characterised" exact="ZIKV" post="strains such as MR766 and PE243, different mammalian and"/>
   <result pre="cell line was demonstrated to have low susceptibility to the" exact="ZIKV" post="isolates tested (Fig. 2B). Fig. 2: in vitro growth"/>
   <result pre="tested (Fig. 2B). Fig. 2: in vitro growth kinetics of" exact="Zika" post="virus (ZIKV) isolates in (A) mammalian cell lines (A549,"/>
   <result pre="are the means from triplicate experiments. The abilities of the" exact="ZIKV" post="isolates to infect the different cell lines were evaluated"/>
   <result pre="compared to the MR766 and PE243 strains, the three Brazilian" exact="ZIKV" post="isolates (ZV BR 2015/15098, ZV BR 2015/15261 and ZV"/>
   <result pre="higher during MR766 infection compared to the three recent Brazilian" exact="ZIKV" post="strains in A549 and Huh7.5 cells at 48 h.p.i."/>
   <result pre="similar among the strains studied. The differences between the Brazilian" exact="ZIKV" post="isolates and the MR766 and PE243 strains were less"/>
   <result pre="the infected insect cells. Fig. 3: biological characterisation of different" exact="Zika" post="virus (ZIKV) strains in mammalian (A, C, E) and"/>
   <result pre="ZIKV-infected cells (4G2+) was determined by indirect immunofluorescence. (C-D) The" exact="ZIKV" post="progeny in the cell culture supernatant from the ZIKV-infected"/>
   <result pre="quantified using a focus-forming assay in C6/36 cells. (E-F) The" exact="ZIKV" post="replication was determined by reverse transcription-quantitative polymerase chain reaction"/>
   <result pre="transcription-quantitative polymerase chain reaction (RT-qPCR) on the ZIKV-infected cells. The" exact="ZIKV" post="E RNA was quantified using the housekeeping genes RNase"/>
   <result pre="in those cells. Aiming to evaluate the ability of different" exact="ZIKV" post="isolates from Brazil to infect a primary human cell"/>
   <result pre="possible to demonstrate the presence of envelope protein (4G2+) of" exact="ZIKV" post="in mdDCs infected with the three clinical isolates of"/>
   <result pre="ZIKV in mdDCs infected with the three clinical isolates of" exact="ZIKV" post="(Fig. 4A-B). Flow cytometry analysis showed that the frequency"/>
   <result pre="± 21.12) was similar to the frequency of infection with" exact="ZIKV" post="PE243 (27.47% ± 16.98) and ZIKV MR766 (24.84% ±"/>
   <result pre="frequency of infection with ZIKV PE243 (27.47% ± 16.98) and" exact="ZIKV" post="MR766 (24.84% ± 20.49). Conversely, the ZIKV strains ZV"/>
   <result pre="± 16.98) and ZIKV MR766 (24.84% ± 20.49). Conversely, the" exact="ZIKV" post="strains ZV BR 2015/15098 (8.31% ± 6.29), that presented"/>
   <result pre="h in insect cells, the mdDC infection rates with all" exact="ZIKV" post="strains tested decreased over time (data not shown). The"/>
   <result pre="(Fig. 4C). Fig. 4: infection of human mdDCs with different" exact="Zika" post="virus (ZIKV) strains. (A) A representative density plot containing"/>
   <result pre="ZIKV-infection (4G2+) of mdDCs (CD11c+CD14-CD209+) with five different strains of" exact="ZIKV" post="(MOI of 10) after 24 h. (B) The frequency"/>
   <result pre="ZIKV-infected mdDCs (CD11c+CD14-CD209+4G2+) was determined by flow cytometry. (C) The" exact="ZIKV" post="progeny in cell culture supernatants from mdDCs infected with"/>
   <result pre="cell culture supernatants from mdDCs infected with different strains of" exact="ZIKV" post="were quantified using a focus-forming assay in C6/36 cells."/>
   <result pre="were quantified using a focus-forming assay in C6/36 cells. (D)" exact="ZIKV" post="replication was determined by reverse transcription-quantitative polymerase chain reaction"/>
   <result pre="reaction (RT-qPCR) on mdDCs infected with ZIKV. The quantification of" exact="ZIKV" post="E RNA using the housekeeping gene RNase P for"/>
   <result pre="productive infection in mdDC. As a whole, however, the reference" exact="ZIKV" post="strains, MR766 and PE243, and ZV BR 2016/16288 showed"/>
   <result pre="the idea that throughout its evolution, the single-stranded positive-sense RNA" exact="ZIKV" post="has accumulated genetic changes that may have ensured some"/>
   <result pre="selective advantage for virus adaptation and recent epidemic spread of" exact="ZIKV" post="Asian lineage. Several studies have experimentally investigated the role"/>
   <result pre="a correlation between genetic changes and the increased pathogenicity of" exact="ZIKV" post="in recent outbreaks was suggested.16,17 All three ZIKV clinical"/>
   <result pre="pathogenicity of ZIKV in recent outbreaks was suggested.16,17 All three" exact="ZIKV" post="clinical isolates characterised in this study present the N139V982V2634"/>
   <result pre="present the N139V982V2634 (numbering from the start codon of the" exact="ZIKV" post="genome) signature characteristic of the American isolates. The substitutions"/>
   <result pre="prM and A982V at NS1 arose during the course of" exact="ZIKV" post="spread from Asia to the Americas and were associated"/>
   <result pre="protein had the higher number of positions under selective pressure." exact="ZIKV" post="NS2A protein has been previously reported to play a"/>
   <result pre="glial cells in the mouse cortex.19 A single mutation at" exact="ZIKV" post="NS2A (A175V), which has been shown to decrease virus"/>
   <result pre="in vitro, was associated with an attenuated phenotype in a" exact="ZIKV" post="mouse model.20 Based on a study by Xie et"/>
   <result pre="or valine. Additionally, when the UTRs of the three new" exact="ZIKV" post="isolates were compared, one single nucleotide change downstream of"/>
   <result pre="stop codon of the NS5 gene was detected in the" exact="ZIKV" post="ZV BR 2015/15098 strain. This mutation was mapped to"/>
   <result pre="variability at 3’HVR of DENV-1 and DENV-2 are associated with" exact="DENV" post="fitness gain or loss in mammalian and insect cells.23,24"/>
   <result pre="the synergistic effect of the mutations identified in each Brazilian" exact="ZIKV" post="isolate, we first compared the ability of recent ZIKV"/>
   <result pre="Brazilian ZIKV isolate, we first compared the ability of recent" exact="ZIKV" post="isolates and a representative of the African ZIKV lineage"/>
   <result pre="of recent ZIKV isolates and a representative of the African" exact="ZIKV" post="lineage to infect mammalian and insect cells. We observed"/>
   <result pre="to infect mammalian and insect cells. We observed that the" exact="ZIKV" post="prototypes (MR766 and PE243) exhibit more protein expression and"/>
   <result pre="more protein expression and viral particle production than the recent" exact="ZIKV" post="isolates in all mammalian cells tested. However, among the"/>
   <result pre="one year after the detection of the first case of" exact="ZIKV" post="in Brazil, is less infective when compared with the"/>
   <result pre="ZIKV in Brazil, is less infective when compared with the" exact="ZIKV" post="prototypes and the 2015 isolates in all cell lineages"/>
   <result pre="similar viral growth when compared with the other two recent" exact="ZIKV" post="isolates. The ZIKV ZV BR 2016/16288 showed one nonconservative"/>
   <result pre="when compared with the other two recent ZIKV isolates. The" exact="ZIKV" post="ZV BR 2016/16288 showed one nonconservative point mutation at"/>
   <result pre="of NS1 protein that should play an important role in" exact="ZIKV" post="infectivity, live virus release and viral RNA replication. NS1"/>
   <result pre="associated with a single mutation at E protein in a" exact="ZIKV" post="strain was found to alter viral fitness in cell"/>
   <result pre="general, more susceptible than the Aedes cells to the tested" exact="ZIKV" post="strains. It is important to emphasize that all three"/>
   <result pre="strains. It is important to emphasize that all three recent" exact="ZIKV" post="isolates presented similar profiles of patterns of focus formation"/>
   <result pre="types. Given the observed genotypic and phenotypic differences among the" exact="ZIKV" post="isolates, the variations in the amino acid composition of"/>
   <result pre="ZIKV isolates, the variations in the amino acid composition of" exact="ZIKV" post="proteins could influence the manner by which the viral"/>
   <result pre="epidermal keratinocytes, dermal fibroblasts and mdDCs29 are also susceptible to" exact="ZIKV" post="infection in vitro. Several receptors are involved in ZIKV"/>
   <result pre="to ZIKV infection in vitro. Several receptors are involved in" exact="ZIKV" post="infection, such as AXL, Tyro3, TIM-1, and DC-SIGN, which"/>
   <result pre="CD209.29 An analysis of the patients’ blood cells infected by" exact="ZIKV" post="revealed that monocytes and myeloid dendritic cells were the"/>
   <result pre="and fluids.30 To characterise the infective profile of the different" exact="ZIKV" post="strains in a more relevant cell type in ZIKV"/>
   <result pre="different ZIKV strains in a more relevant cell type in" exact="ZIKV" post="pathogenesis, we infected the human mdDCs primary cells. In"/>
   <result pre="infection of human dendritic cells. In conclusion, we successfully isolated" exact="ZIKV" post="from serum samples of patients from two different periods"/>
   <result pre="observed significant differences between the clinical isolates and the well-established" exact="ZIKV" post="strains (MR766 and PE243) with an emphasis on the"/>
   <result pre="cells. Although there is an increasing amount of data from" exact="ZIKV" post="genomic analyses, especially after the 2015/2016 outbreak, there is"/>
   <result pre="human mdDCs. Those future studies could help the understanding of" exact="ZIKV" post="replication efficiency and could contribute to the studies of"/>
   <result pre="equally to this work. References REFERENCES 1MussoDNillesEJCao-LormeauVMRapid spread of emerging" exact="Zika" post="virus in the Pacific areaClin Microbiol Infect20142010O595O59624909208 2ZanlucaCde MeloVCAMosimannALPdos"/>
   <result pre="Infect20142010O595O59624909208 2ZanlucaCde MeloVCAMosimannALPdos SantosGIVdos SantosCNDLuzKFirst report of autochthonous transmission of" exact="Zika" post="virus in BrazilMem Inst Oswaldo Cruz2015110456957226061233 3CalvetGAguiarRSMeloASOSampaioSAde FilippisIFabriADetection and"/>
   <result pre="in BrazilMem Inst Oswaldo Cruz2015110456957226061233 3CalvetGAguiarRSMeloASOSampaioSAde FilippisIFabriADetection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
   <result pre="in Brazil a case studyLancet Infect Dis201616665366026897108 4RussoFBBeltrão-BragaPCBThe impact of" exact="Zika" post="virus in the brainBiochem Biophys Res Commun2017492460360728108286 5Rodriguez-BarraquerICostaFNascimentoENeryNJCastanhaPSacramentoGAImpact of"/>
   <result pre="brainBiochem Biophys Res Commun2017492460360728108286 5Rodriguez-BarraquerICostaFNascimentoENeryNJCastanhaPSacramentoGAImpact of preexisting dengue immunity on" exact="Zika" post="virus emergence in a dengue endemic regionScience2019363642760761030733412 6AltizerSDobsonAHosseiniPHudsonPPascualMRohaniPSeasonality and"/>
   <result pre="Williams &amp;amp; Wilkins2013712746 8ZhuZChanJTeeKChoiGLauSWooPCComparative genomic analysis of pre-epidemic and epidemic" exact="Zika" post="virus strains for virological factors potentially associated with the"/>
   <result pre="9YokoyamaSStarmerWTPossible roles of new mutations shared by Asian and American" exact="Zika" post="virusesMol Biol Evol201734352553428087772 10LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJGenetic and serologic properties of Zika"/>
   <result pre="American Zika virusesMol Biol Evol201734352553428087772 10LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJGenetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap state, Micronesia, 2007Emerg"/>
   <result pre="X-YLiu Z-YZhangFZhu X-LYuJYA single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephalyScience2017358636593393628971967 17XiaHLuoHShanCMuruatoAENunesBTDMedeirosDBAAn evolutionary NS1 mutation"/>
   <result pre="virus contributes to fetal microcephalyScience2017358636593393628971967 17XiaHLuoHShanCMuruatoAENunesBTDMedeirosDBAAn evolutionary NS1 mutation enhances" exact="Zika" post="virus evasion of host interferon inductionNat Commun20189141441429379028 18Liu Z-YShi"/>
   <result pre="host interferon inductionNat Commun20189141441429379028 18Liu Z-YShi W-FQin C-FThe evolution of" exact="Zika" post="virus from Asia to the AmericasNat Rev Microbiol201917313113930617340 19Yoon"/>
   <result pre="Stem Cell201721334935828826723 20Márquez-JuradoSNogalesA�?vila-PérezGIborraFMartínez-SobridoLAlmazánFAn alanine-to-valine substitution in the residue 175 of" exact="Zika" post="virus NS2A protein affects viral RNA synthesis and attenuates"/>
   <result pre="22ShrivastavaSPuriVDilleyKANgouajioEShifflettJOldfieldLMWhole genome sequencing, variant analysis, phylogenetics, and deep sequencing of" exact="Zika" post="virus strainsSci Rep201881158431584330367096 23VillordoSMFilomatoriCVSánchez-VargasIBlairCDGamarnikAVDengue virus RNA structure specialization facilitates"/>
   <result pre="1 virusJ Gen Virol20078882214222217622625 25Alpuche-LazcanoSMcCulloghCDel CorpoORanceEScarboroughRMoulandAJHigher cytopathic effects of a" exact="Zika" post="virus Brazilian isolate from Bahia compared to a Canadian-imported"/>
   <result pre="to a Canadian-imported thai strainViruses2018102e5329382068 26DuggalNKMcDonaldEMWeger-LucarelliJHawksSARitterJMRomoHMutations present in a low-passage" exact="Zika" post="virus isolate result in attenuated pathogenesis in miceVirology2019530192630763872 27LiYKimYMZouJWang"/>
   <result pre="replication complex proteins, and HCV RNA replicationJ Virol20047820113931140015452261 29HamelRDejarnacOWichitSEkchariyawatPNeyretALuplertlopNBiology of" exact="Zika" post="virus infection in human skin cellsJ Virol201589178880889626085147 30MichlmayrDAndradePGonzalezKBalmasedaAHarrisECD14+CD16+ monocytes"/>
   <result pre="skin cellsJ Virol201589178880889626085147 30MichlmayrDAndradePGonzalezKBalmasedaAHarrisECD14+CD16+ monocytes are the main target of" exact="Zika" post="virus infection in peripheral blood mononuclear cells in a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711306\results\search\tropicalVirus\results.xml">
   <result pre="predict human risk of yellow fever virus spillover in Brazil" exact="Yellow fever" post="spillover in Brazil http://orcid.org/0000-0002-8597-2161ChildsMarissa L.1http://orcid.org/0000-0001-8585-1215NovaNicole2ColvinJustine2http://orcid.org/0000-0002-4402-5547MordecaiErin A.2[1], Emmett Interdisciplinary Program"/>
   <result pre="requirements to identify when conditions will align for pathogen spillover." exact="Yellow fever" post="in Brazil presents an ideal opportunity to test this"/>
   <result pre="America have occurred via spillover from the sylvatic cycle [10,11]." exact="Yellow fever" post="virus is a mosquito-borne Flavivirus that mainly persists in"/>
   <result pre="January 2001 (l–o). (Online version in colour.) (a) Spillover model" exact="Yellow fever" post="spillover risk was first estimated monthly from December 2000"/>
   <result pre="in need of further study to improve prediction of spillover." exact="Yellow fever" post="is an ancient, historically important human disease that played"/>
   <result pre="(10.2307/2402401) 106TeslaB, DemakovskyLR, MordecaiEA, RyanSJ, BondsMH, NgonghalaCN, BrindleyMA, MurdockCC2018Temperature drives" exact="Zika" post="virus transmission: evidence from empirical and mathematical models. Proc."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711314\results\search\tropicalVirus\results.xml">
   <result pre="humans [15,16] Canine parvovirus (CPV) carnivore to dog pandemic [17]" exact="Zika" post="virus primate to human, adaptation to mosquito vector and"/>
   <result pre="RodriguezM, BissetJA, Lourenço-de-OliveiraR, WeaverSC, VasilakisN, Vega-RúaA2019Vector-borne transmission and evolution of" exact="Zika" post="virus. Nat. Ecol. Evol.3, 561–569. (10.1038/s41559-019-0836-z)30886369 19HumphreysM2018The influenza of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711507\results\search\tropicalVirus\results.xml">
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Dengue" post="Fever Why should we apply ABM for decision analysis"/>
   <result pre="transmission modeling using dengue fever as an exemplary infectious disease." exact="Dengue" post="is a mosquito-borne tropical infectious disease caused by the"/>
   <result pre="increased number of cases is observed during rainy season [13]." exact="Dengue" post="resurged in the 20th century and received public awareness"/>
   <result pre="experiences with model calibration and model analysis. Case example dengue" exact="Dengue" post="is a mosquito-borne tropical disease that can result in"/>
   <result pre="transmission, a mosquito becomes infectious after an incubation period [30]." exact="Dengue" post="is not harmful to mosquitoes; they simply remain infectious"/>
   <result pre="be on model calibration and validation. Supporting information S1 File" exact="Dengue" post="case data. Hospitalized dengue cases. Data about all hospitalized"/>
   <result pre="(XLSX) LINK Click here for additional data file. S2 File" exact="Dengue" post="computations. Computations of parameters. Computations of dengue case numbers"/>
   <result pre="(XLSX) LINK Click here for additional data file. S5 File" exact="Dengue" post="model documentation. A detailed documentation of the dengue model."/>
   <result pre="Thanlyin Township, Yangon City, Myanmar. Tropical biomedicine. 2011;28:302–11. 22041749 14GublerDJ." exact="Dengue" post="and Dengue Hemorrhagic Fever. Clinical Microbiology Reviews. 1998;11(3):480–96. 10.1128/cmr.11.3.4809665979"/>
   <result pre="Yangon City, Myanmar. Tropical biomedicine. 2011;28:302–11. 22041749 14GublerDJ. Dengue and" exact="Dengue" post="Hemorrhagic Fever. Clinical Microbiology Reviews. 1998;11(3):480–96. 10.1128/cmr.11.3.4809665979 15BhattS, GethingPW,"/>
   <result pre="countries. 2009;3:711–22. 19858573 19CoudevilleL, GarnettGP. Transmission Dynamics of the Four" exact="Dengue" post="Serotypes in Southern Vietnam and the Potential Impact of"/>
   <result pre="Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated" exact="Dengue" post="Vaccine (Dengvaxia): A Model Comparison Study. PLoS medicine. 2016;13(11):e100218110.1371/journal.pmed.100218127898668"/>
   <result pre="22HladishTJ, PearsonCA, ChaoDL, RojasDP, RecchiaGL, Gomez-DantesH, et al.Projected Impact of" exact="Dengue" post="Vaccination in Yucatan, Mexico. PLoS Negl Trop Dis. 2016;10(5):e0004661"/>
   <result pre="Epub 2012/09/20. 10.1177/0272989X12454941 .22990083 26ChanM, JohanssonMA. The incubation periods of" exact="Dengue" post="viruses. PloS one. 2012;7:e5097210.1371/journal.pone.005097223226436 27ChastelC. Eventual Role of Asymptomatic"/>
   <result pre="PloS one. 2012;7:e5097210.1371/journal.pone.005097223226436 27ChastelC. Eventual Role of Asymptomatic Cases of" exact="Dengue" post="for the Introduction and Spread of Dengue Viruses in"/>
   <result pre="Asymptomatic Cases of Dengue for the Introduction and Spread of" exact="Dengue" post="Viruses in Non-Endemic Regions. Frontiers in Physiology. 2012;310.3389/fphys.2012.0007022479252 28EndyTP,"/>
   <result pre="Thailand. American journal of epidemiology. 2002;156:40–51. 10.1093/aje/kwf00512076887 29NormileD. Surprising New" exact="Dengue" post="Virus Throws a Spanner in Disease Control Efforts. Science."/>
   <result pre="Spanner in Disease Control Efforts. Science. 2013;342:415-. 10.1126/science.342.6157.41524159024 30McBrideWJ, Bielefeldt-OhmannH." exact="Dengue" post="viral infections; pathogenesis and epidemiology. Microbes and infection /"/>
   <result pre="Negl Trop Dis. 2015;9(5):e0003655 Epub 2015/05/08. 10.1371/journal.pntd.0003655 .25951103 32AngelRMd, ValleJR-d." exact="Dengue" post="Vaccines: Strongly Sought but Not a Reality Just Yet."/>
   <result pre="NolanT. Population Perspectives and World Health Organization Recommendations for CYD-TDV" exact="Dengue" post="Vaccine. J Infect Dis. 2016;214(12):1796–9. Epub 2016/08/09. 10.1093/infdis/jiw341 .27496977"/>
   <result pre="of the World Health Organization. 1972;46(2):211–26. Epub 1972/01/01. .4537483 50GublerDJ." exact="Dengue" post="and dengue hemorrhagic fever. Clinical microbiology reviews. 1998;11:480–96. 9665979"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6714416\results\search\tropicalVirus\results.xml">
   <result pre="Kluwer - MedknowIndia pmcid: 6714416JISPCD-9-316 doi: 10.4103/jispcd.JISPCD_433_18 : Review Article" exact="Zika" post="Virus: A Global Public Health Menace: A Comprehensive Update"/>
   <result pre="the new creations are licensed under the identical terms. Abstract" exact="Zika" post="virus (ZIKV) is a RNA virus and belongs to"/>
   <result pre="virus was first discovered from a febrile primate from the" exact="Zika" post="forests of Uganda in 1947 and the first human"/>
   <result pre="case was documented in 1954. The nonspecific clinical manifestations of" exact="ZIKV" post="pose diagnostic dilemmas and delays early and effective treatment."/>
   <result pre="and supportive care and no vaccine exist till date. Recent" exact="ZIKV" post="outbreaks and increase association of microcephaly with congenital ZIKV"/>
   <result pre="Recent ZIKV outbreaks and increase association of microcephaly with congenital" exact="ZIKV" post="and neurological complications (Guillain-Barré syndrome) has drawn global public"/>
   <result pre="syndrome microcephaly pregnancy public health menace zika virus I NTRODUCTION" exact="Zika" post="virus (ZIKV) is a single-stranded RNA virus and belongs"/>
   <result pre="and belongs to the Flavivirus genus and Flaviviridae family.[12] Phylogenetically," exact="ZIKV" post="is linked to African and the Asian lineage, with"/>
   <result pre="American epidemic.[34] The year of 1947 marks the isolation of" exact="ZIKV" post="from a surveillant macaque in the course of yellow"/>
   <result pre="macaque in the course of yellow fever surveillance in Uganda's" exact="Zika" post="forests, thus, deriving the name of the virus.[5] Soon"/>
   <result pre="in Aedes africanus mosquitoes.[6] In Africa, the life cycle of" exact="ZIKV" post="usually involves propagation between the various simian species (such"/>
   <result pre="Asian subcontinent, humans have probably become the main host.[78] Infrequently," exact="ZIKV" post="transmission may also occur through various nonmosquito modes such"/>
   <result pre="have also been reported the incidence of the spread of" exact="ZIKV" post="by blood transfusion,[1213] animal bites,[14] and laboratory exposure.[15] The"/>
   <result pre="animal bites,[14] and laboratory exposure.[15] The two major forms of" exact="ZIKV" post="infection are-Zika fever and congenital ZIKV syndrome. Zika fever"/>
   <result pre="two major forms of ZIKV infection are-Zika fever and congenital" exact="ZIKV" post="syndrome. Zika fever has nonspecific manifestations ranging from asymptomatic"/>
   <result pre="forms of ZIKV infection are-Zika fever and congenital ZIKV syndrome." exact="Zika" post="fever has nonspecific manifestations ranging from asymptomatic infections (80%"/>
   <result pre="arthritis/arthralgia with small joint edema, myalgia, asthenia, and vertigo. Congenital" exact="Zika" post="syndrome most frequently manifest as microcephaly.[1617181920] The laboratory diagnosis"/>
   <result pre="syndrome most frequently manifest as microcephaly.[1617181920] The laboratory diagnosis of" exact="ZIKV" post="infection is confirmed by the demonstration of viral RNA"/>
   <result pre="treatment or vaccination for ZIKV. The principal preventive methods for" exact="ZIKV" post="spread are as avoidance of insect bites along with"/>
   <result pre="insect bites along with abstinence and barrier protection to avoid" exact="ZIKV" post="dissemination through sexual mode (especially during pregnancy).[21] Universal precautions"/>
   <result pre="a complete knowledge is attained regarding the possible means of" exact="ZIKV" post="dissemination.[22] ZIKV has emerged as a public health menace"/>
   <result pre="knowledge is attained regarding the possible means of ZIKV dissemination.[22]" exact="ZIKV" post="has emerged as a public health menace owing to"/>
   <result pre="geographic dissemination, along with a distressing increased incidence of congenital" exact="ZIKV" post="infections (manifesting as microcephaly), and serious neurological complications.[23] Various"/>
   <result pre="being implemented by Government and Public Health Agencies to combat" exact="ZIKV" post="infection and possible complications. The &quot;World Health Organization (WHO)"/>
   <result pre="ZIKV infection and possible complications. The &quot;World Health Organization (WHO)" exact="Zika" post="App�? has been launched of late by the WHO"/>
   <result pre="public health disaster.[24] T RANSMISSION In urban and suburban settings," exact="ZIKV" post="dissemination involves human – mosquito – human cycle, with"/>
   <result pre="elephants, zebras, and rats, may also serve as the likely" exact="ZIKV" post="pool.[25] ZIKV has a predisposition to occur in any"/>
   <result pre="and rats, may also serve as the likely ZIKV pool.[25]" exact="ZIKV" post="has a predisposition to occur in any natural habitat"/>
   <result pre="their peculiar features.[731323334353637] Table 1 Various mosquito species associated with" exact="Zika" post="virus Mosquito species Features Aedes hensilii Yap island Zika"/>
   <result pre="with Zika virus Mosquito species Features Aedes hensilii Yap island" exact="Zika" post="virus epidemic (2007)[31] Ae. Aegypti Brazil Zika virus epidemic"/>
   <result pre="hensilii Yap island Zika virus epidemic (2007)[31] Ae. Aegypti Brazil" exact="Zika" post="virus epidemic (2015)[32] Aedes africanus Uganda Zika virus epidemic[3334]"/>
   <result pre="Ae. Aegypti Brazil Zika virus epidemic (2015)[32] Aedes africanus Uganda" exact="Zika" post="virus epidemic[3334] Aedes. aegypti and Aedes albopictus Zika virus"/>
   <result pre="africanus Uganda Zika virus epidemic[3334] Aedes. aegypti and Aedes albopictus" exact="Zika" post="virus vector in Asian continent[7] Ae. Albopictus Invasive mosquito"/>
   <result pre="RANSMISSION Although mosquitoes serve as the primary vector agency for" exact="ZIKV" post="spread, various nonvector means of virus spread have also"/>
   <result pre="of virus spread have also been proposed. Sexual mode of" exact="ZIKV" post="spread has been suggested by Foy et al. in"/>
   <result pre="sex on his visit to the US.[38] Sexual mode of" exact="ZIKV" post="spread has been reinforced by the fact that the"/>
   <result pre="acute illness and 62 days after the symptoms sets in.[1139]" exact="ZIKV" post="demonstration from the semen emphasize the avoidance of unprotected"/>
   <result pre="practices and necessitates condom usage (primarily throughout pregnancy), thus preventing" exact="ZIKV" post="spread by sexual mode.[40] ZIKV spread via perinatal route"/>
   <result pre="(primarily throughout pregnancy), thus preventing ZIKV spread by sexual mode.[40]" exact="ZIKV" post="spread via perinatal route has attracted significant attention due"/>
   <result pre="increase in microcephaly cases in congenital ZIKV-infected newborns. Isolation of" exact="ZIKV" post="RNA from the maternal serum up to 5 days"/>
   <result pre="infant up to 6 days, reinforce the perinatal mode of" exact="ZIKV" post="spread.[10] Transfusion with contaminated blood and blood products has"/>
   <result pre="products has also been suggested as a likely mode of" exact="ZIKV" post="spread. Demonstration of ZIKV RNA in roughly 3% of"/>
   <result pre="suggested as a likely mode of ZIKV spread. Demonstration of" exact="ZIKV" post="RNA in roughly 3% of asymptomatic blood donors during"/>
   <result pre="disease transmission.[12] Till date, there is no published literature reporting" exact="ZIKV" post="spread through saliva. However, the viral RNA has been"/>
   <result pre="been demonstrated in saliva during the acute infectious phase. 20" exact="ZIKV" post="RNA concentration was found to be greater in saliva"/>
   <result pre="was equal to that present in urine.[41] Salivary detection of" exact="ZIKV" post="requires considerable attention, especially in dental clinics, where salivary"/>
   <result pre="frequent with droplets and aerosol generation during varied dental procedures.[42]" exact="ZIKV" post="RNA has also been identified in breast milk, amniotic"/>
   <result pre="fetal tissues; although, there has been no published evidence of" exact="ZIKV" post="spread via these routes.[24] Figure 1 depicts the possible"/>
   <result pre="via these routes.[24] Figure 1 depicts the possible modes of" exact="ZIKV" post="transmission. Figure 1 Possible modes of Zika virus transmission"/>
   <result pre="possible modes of ZIKV transmission. Figure 1 Possible modes of" exact="Zika" post="virus transmission E PIDEMIOLOGY History of ZIKV isolation and"/>
   <result pre="Possible modes of Zika virus transmission E PIDEMIOLOGY History of" exact="ZIKV" post="isolation and detection goes back to the year 1947,"/>
   <result pre="this virus during the surveillance of yellow fever virus in" exact="Zika" post="forests of Uganda.[54344] The first human case of ZIKV"/>
   <result pre="in Zika forests of Uganda.[54344] The first human case of" exact="ZIKV" post="infection was documented in Nigeria and Tanzania during 1952–1954."/>
   <result pre="infection was documented in Nigeria and Tanzania during 1952–1954. Further," exact="ZIKV" post="dissemination to the Asian subcontinent alarmed the public health"/>
   <result pre="alarmed the public health officials about the impending likelihood of" exact="ZIKV" post="epidemics.[4445] The year of 2007 marks the documentation of"/>
   <result pre="2007 marks the documentation of the first epidemic outburst of" exact="ZIKV" post="from Yap State, Federated States of Micronesia. More than"/>
   <result pre="Yap State, Federated States of Micronesia. More than 49 confirmed" exact="ZIKV" post="infected patients presented maculo-papular exanthema (rash), bilateral nonpurulent conjunctivitis"/>
   <result pre="over the 13 weeks duration of the epidemic.[31] An additional" exact="ZIKV" post="epidemic outburst was recognized in the French Polynesian population"/>
   <result pre="French Polynesian population in 2013, marking the first documentation of" exact="ZIKV" post="and Guillain-Barré syndrome (GBS). However, majority of the affected"/>
   <result pre="of the affected population presented with mild manifestations.[4647] Soon, the" exact="ZIKV" post="cases were noticed in Canada, Germany, Japan, Italy, Australia,"/>
   <result pre="reported epidemic of ZIKV.[4849] The first incidence of microcephaly with" exact="ZIKV" post="was documented in October 2015 in Brazil. ZIKV was"/>
   <result pre="microcephaly with ZIKV was documented in October 2015 in Brazil." exact="ZIKV" post="was affirmed a public health emergency of international concern"/>
   <result pre="Data till February 2, 2017, revealed that vector-borne transmission of" exact="ZIKV" post="has been documented in 70 countries.[51] Figure 2 shows"/>
   <result pre="in 70 countries.[51] Figure 2 shows geographical representation of areas" exact="ZIKV" post="dissemination. Figure 2 Geographical distribution of Zika virus Table"/>
   <result pre="representation of areas ZIKV dissemination. Figure 2 Geographical distribution of" exact="Zika" post="virus Table 2 depicts summary of the historical milestones"/>
   <result pre="virus Table 2 depicts summary of the historical milestones of" exact="ZIKV" post="discovery and epidemics.[52] Table 2 Historical milestones of Zika"/>
   <result pre="of ZIKV discovery and epidemics.[52] Table 2 Historical milestones of" exact="Zika" post="virus Year ZIKV feature Affected population 1947 ZIKV was"/>
   <result pre="and epidemics.[52] Table 2 Historical milestones of Zika virus Year" exact="ZIKV" post="feature Affected population 1947 ZIKV was first discovered in"/>
   <result pre="milestones of Zika virus Year ZIKV feature Affected population 1947" exact="ZIKV" post="was first discovered in Zika forests of Uganda 1952"/>
   <result pre="ZIKV feature Affected population 1947 ZIKV was first discovered in" exact="Zika" post="forests of Uganda 1952 ZIKV first human infection in"/>
   <result pre="ZIKV was first discovered in Zika forests of Uganda 1952" exact="ZIKV" post="first human infection in Nigeria 2007 First epidemic in"/>
   <result pre="Micronesia 49 confirmed cases 2008 First Sexually transmitted case of" exact="Zika" post="virus 2013 Second epidemic in French Polynesia &amp;gt;400 cases"/>
   <result pre="in French Polynesia &amp;gt;400 cases 2013 First reported case of" exact="Zika" post="virus with Guillain-Barré syndrome 2015 Third epidemic in South"/>
   <result pre="&amp;gt;1.5 million cases October 2015 First incidence of microcephaly with" exact="ZIKV" post="February 2016 WHO declared ZIKV a public health emergency"/>
   <result pre="First incidence of microcephaly with ZIKV February 2016 WHO declared" exact="ZIKV" post="a public health emergency of International Concern ZIKV=Zika virus,"/>
   <result pre="not clearly elicited, the general consensus proposes that replication of" exact="ZIKV" post="takes place in skin dendritic cells after inoculation following"/>
   <result pre="degeneration, cellular infiltration, and alleviation in the brain, thus explaining" exact="ZIKV" post="neurotropism and the related neurological complications (microcephaly in congenital"/>
   <result pre="ZIKV neurotropism and the related neurological complications (microcephaly in congenital" exact="ZIKV" post="infection).[17] Viremia usually occurs within 3–4 days of the"/>
   <result pre="3 shows the pathogenesis of ZIKV. Figure 3 Pathogenesis of" exact="Zika" post="virus C LINICAL F EATURES AND D IFFERENTIAL D"/>
   <result pre="EATURES AND D IFFERENTIAL D IAGNOSIS The clinical spectrum of" exact="ZIKV" post="infection mimics that of dengue and Chikungunya viral infection"/>
   <result pre="clinical spectrum of ZIKV infection mimics that of dengue and" exact="Chikungunya" post="viral infection (especially during the acute phase), thus necessitating"/>
   <result pre="for a period of 4–5 days.[315657] The typical rash of" exact="ZIKV" post="is usually seen within the 1st or 2nd day"/>
   <result pre="bilateral, nonpurulent conjunctivitis, which usually shows resolution within 1–2 weeks.[3157]" exact="ZIKV" post="may also present with uncommon manifestations such as a"/>
   <result pre="uncommon manifestations such as a headache, retro-orbital pain and myalgia.[57]" exact="ZIKV" post="is associated with less intense muscle and joint pain"/>
   <result pre="lymphadenopathy may also be seen in a few cases of" exact="ZIKV" post="infection.[57] Criteria defining the suspected and confirmed cases of"/>
   <result pre="ZIKV infection.[57] Criteria defining the suspected and confirmed cases of" exact="ZIKV" post="infection by the Brazilian health ministry are:[60] Suspected case:"/>
   <result pre="following positive test or demonstration of a particular response for" exact="ZIKV" post="evaluation: Viral RNA identification RT technique demonstrating ZIKV RNA"/>
   <result pre="response for ZIKV evaluation: Viral RNA identification RT technique demonstrating" exact="ZIKV" post="RNA Immunoglobulin M (IgM) serological reaction (may exhibit false"/>
   <result pre="false positive reaction if a dengue virus infection co-exists) Confirming" exact="ZIKV" post="acute cases by incorporating various clinical-epidemiological measures. ZIKV infection"/>
   <result pre="co-exists) Confirming ZIKV acute cases by incorporating various clinical-epidemiological measures." exact="ZIKV" post="infection is usually mild and severe forms are rarely"/>
   <result pre="and chikungunya. Table 3 Differentiating features of Zika, Dengue, and" exact="Chikungunya" post="Features Dengue Zika Chikungunya Incubation period 3-14 days 3-12"/>
   <result pre="Table 3 Differentiating features of Zika, Dengue, and Chikungunya Features" exact="Dengue" post="Zika Chikungunya Incubation period 3-14 days 3-12 days 1-12"/>
   <result pre="3 Differentiating features of Zika, Dengue, and Chikungunya Features Dengue" exact="Zika" post="Chikungunya Incubation period 3-14 days 3-12 days 1-12 days"/>
   <result pre="Differentiating features of Zika, Dengue, and Chikungunya Features Dengue Zika" exact="Chikungunya" post="Incubation period 3-14 days 3-12 days 1-12 days Etiology"/>
   <result pre="Flavivirus of family Flaviviridae. (4 different serological types exists -" exact="DENV" post="1, 2, 3 and 4) Mostly, Infection with one"/>
   <result pre="after infection with one type has not been reported in" exact="Zika" post="virus infections RNA virus of genus Alphavirusof the family"/>
   <result pre="NSAIDS can increase risk of bleeding Acceptable to use in" exact="Zika" post="virus infection as long as dengue has been excluded"/>
   <result pre="May or may not be present The oral manifestations in" exact="ZIKV" post="are not a frequent occurrence; although, Foy et al."/>
   <result pre="Polynesian epidemic. However, the data supporting other oral features in" exact="ZIKV" post="infection is scarce.[6263] Hyperemia and petechial lesions on the"/>
   <result pre="may have a significant function in the human-to-human spread of" exact="ZIKV" post="and salivary diagnostics may serve as an important investigative"/>
   <result pre="salivary diagnostics may serve as an important investigative tool for" exact="ZIKV" post="infection.[67] Table 4 depicts summary of reported orofacial features"/>
   <result pre="infection.[67] Table 4 depicts summary of reported orofacial features in" exact="ZIKV" post="infection. Table 4 Summary of reported orofacial features in"/>
   <result pre="ZIKV infection. Table 4 Summary of reported orofacial features in" exact="Zika" post="virus infection Author and year Reported orofacial feature Foy"/>
   <result pre="on the hard palate of a female patient with acute" exact="Zika" post="virus C ONGENITAL Z IKA S YNDROME ZIKV has"/>
   <result pre="with acute Zika virus C ONGENITAL Z IKA S YNDROME" exact="ZIKV" post="has drawn global public health attention due to its"/>
   <result pre="frequency of microcephalic babies was documented in females residing in" exact="ZIKV" post="endemic regions of Brazil, thus, raising the question of"/>
   <result pre="a total of 2366 confirmed cases of microcephaly associated with" exact="ZIKV" post="infection have been noted in Brazil.[68] In cases of"/>
   <result pre="symptoms in the mother. Various proposed mechanisms for microcephaly in" exact="ZIKV" post="infection are: (1) Increased occurrence of microcephaly cases associated"/>
   <result pre="infection are: (1) Increased occurrence of microcephaly cases associated with" exact="ZIKV" post="epidemics (2) 2 Documented cases of pregnant females with"/>
   <result pre="2 Documented cases of pregnant females with features coherent with" exact="ZIKV" post="infection, fetal microcephaly, and RT-PCR showing ZIKV positivity in"/>
   <result pre="features coherent with ZIKV infection, fetal microcephaly, and RT-PCR showing" exact="ZIKV" post="positivity in amniotic fluid.[70] N EUROLOGICAL C OMPLICATIONS GBS"/>
   <result pre="were documented in Brazilian patients with a recent history of" exact="ZIKV" post="infection in the Bahia state. 26 patients out of"/>
   <result pre="of the 42 established GBS patients had features coherent with" exact="ZIKV" post="infection.[61] L ABORATORY D IAGNOSIS As ZIKV infection presents"/>
   <result pre="features coherent with ZIKV infection.[61] L ABORATORY D IAGNOSIS As" exact="ZIKV" post="infection presents with atypical features, mimicking other arboviral infections,"/>
   <result pre="or arthralgia after recent (previous 2 weeks) trip to a" exact="ZIKV" post="endemic region should be assessed simultaneously for ZIKV infection.[56]"/>
   <result pre="to a ZIKV endemic region should be assessed simultaneously for" exact="ZIKV" post="infection.[56] Laboratory diagnosis of ZIKV infections mostly relies on"/>
   <result pre="should be assessed simultaneously for ZIKV infection.[56] Laboratory diagnosis of" exact="ZIKV" post="infections mostly relies on molecular biology and serology.[5372] Viral"/>
   <result pre="and IgG antibodies from the 4th to 12th day of" exact="ZIKV" post="infection, respectively.[7374] P REVENTION OF Z IKA V IRUS"/>
   <result pre="suggested that rainfall had a positive and negative predilection on" exact="ZIKV" post="and dengue isolation, respectively.[78] Various preventive measures to mitigate"/>
   <result pre="thuringiensis israelensis Other preventive measures include avoiding a visit to" exact="Zika" post="endemic areas and transfusion-related ZIKV spread, and adopting safe"/>
   <result pre="include avoiding a visit to Zika endemic areas and transfusion-related" exact="ZIKV" post="spread, and adopting safe sexual practices using condoms.[24] A"/>
   <result pre="be done by employing a validated RT-PCR to demonstrate the" exact="ZIKV" post="in semen.[80] Table 6 shows the UK guidelines on"/>
   <result pre="ZIKV.[51] Table 6 UK guidelines on preventing sexual transmission of" exact="Zika" post="virus Population group exposed to ZIKV (by travel or"/>
   <result pre="preventing sexual transmission of Zika virus Population group exposed to" exact="ZIKV" post="(by travel or sexual contact) Recommended period of abstinence/safe"/>
   <result pre="travelled to an area with moderate or high risk of" exact="Zika" post="transmission, barrier methods or abstinence should be practised for"/>
   <result pre="travelling to an area with moderate or high risk of" exact="Zika" post="transmission and: For 8 weeks from last possible exposure"/>
   <result pre="the border) may serve as an important preventive tool for" exact="ZIKV" post="infection import. However, border quarantine is associated with low"/>
   <result pre="may play an essential role in preventing the spread of" exact="ZIKV" post="in healthcare background, including dental settings.[24] The center for"/>
   <result pre="has proposed intervening measures for assessment of newborns with congenital" exact="ZIKV" post="infection. The guidelines comprise serial monitoring of fetal ultrasounds"/>
   <result pre="monitoring of fetal ultrasounds and the evaluation of mothers for" exact="ZIKV" post="infection. ZIKV evaluation is suggested in following cases: (1)"/>
   <result pre="fetal ultrasounds and the evaluation of mothers for ZIKV infection." exact="ZIKV" post="evaluation is suggested in following cases: (1) infants with"/>
   <result pre="women who traveled to or reside in an area with" exact="ZIKV" post="transmission while pregnant or (2) infants born to mothers"/>
   <result pre="born to mothers with positive or inconclusive test results for" exact="ZIKV" post="infection.[83] P HARMACOLOGICAL I NTERVENTION One of the major"/>
   <result pre="HARMACOLOGICAL I NTERVENTION One of the major challenges to combat" exact="ZIKV" post="is the lack of a ZIKV vaccine. However, extensive"/>
   <result pre="major challenges to combat ZIKV is the lack of a" exact="ZIKV" post="vaccine. However, extensive researches are being carried out on"/>
   <result pre="ZIKV vaccine. However, extensive researches are being carried out on" exact="ZIKV" post="vaccine development by the Butantan laboratory in San Paulo,"/>
   <result pre="sites may serve as a probable mode to alleviate the" exact="ZIKV" post="transmission. Although, this is still a conceptual idea, inherited"/>
   <result pre="have demonstrated that Amotosalen and ultraviolet light A may inactivate" exact="ZIKV" post="in vitro. The use of these medications may also"/>
   <result pre="discovery of effective anti-ZIKV drugs.[89] T REATMENT The management of" exact="ZIKV" post="mainly relies on the supportive and symptomatic therapy,[9091] and"/>
   <result pre="and symptomatic therapy,[9091] and till date, no antiviral medications for" exact="ZIKV" post="exist. The management protocol entails complete bed rest, antipyretics"/>
   <result pre="for fever. Prescribing Aspirin and other nonsteroidal anti-inflammatory drugs in" exact="ZIKV" post="is usually not acceptable, but may be prescribed cautiously"/>
   <result pre="itching in patients with an exanthematous rash. Suspected cases of" exact="ZIKV" post="infection must be shielded from additional insect contact through"/>
   <result pre="care admission.[47] Pregnant female with a positive laboratory test for" exact="ZIKV" post="should be immediately referred to an expert gynecologist or"/>
   <result pre="with a travel history to regions with moderate-to-high risk of" exact="ZIKV" post="transmission.[51] Figure 4 Evaluation of pregnant female with a"/>
   <result pre="with a travel history to regions with moderate-high risk of" exact="Zika" post="virus transmission C ONCLUSION ZIKV was a neglected tropical"/>
   <result pre="regions with moderate-high risk of Zika virus transmission C ONCLUSION" exact="ZIKV" post="was a neglected tropical disease over the last 50"/>
   <result pre="insect bite, abstinence and use of condoms, avoiding travel to" exact="ZIKV" post="endemic regions play an important role. Adopting universal infection"/>
   <result pre="advancements are being carried out in the form of effective" exact="ZIKV" post="vaccine and anti-ZIKV drugs. However, Rapid geographic dissemination, nonspecific"/>
   <result pre="Sci Tech20153447326601449 3WangLValderramosSGWuAOuyangSLiCBrasilPet al.From mosquitos to humans: Genetic evolution of" exact="Zika" post="virusCell Host Microbe201619561527091703 4PetterssonJHEldholmVSeligmanSJLundkvistŠFalconarAKGauntMWet al.How did Zika virus emerge"/>
   <result pre="Genetic evolution of Zika virusCell Host Microbe201619561527091703 4PetterssonJHEldholmVSeligmanSJLundkvistŠFalconarAKGauntMWet al.How did" exact="Zika" post="virus emerge in the pacific islands and Latin America?MBio20167pii:"/>
   <result pre="the pacific islands and Latin America?MBio20167pii: e01239-16 5IoosSMalletHPLeparc GoffartIGauthierVCardosoTHeridaMet al.Current" exact="Zika" post="virus epidemiology and recent epidemicsMed Mal Infect201444302725001879 6DickGWKitchenSFHaddowAJZika virus."/>
   <result pre="specificityTrans R Soc Trop Med Hyg1952465092012995440 7HaddowADSchuhAJYasudaCYKasperMRHeangVHuyRet al.Genetic characterization of" exact="Zika" post="virus strains: Geographic expansion of the Asian lineagePLoS Negl"/>
   <result pre="Trop Dis20126e147722389730 8Rodriguez-MoralesAJBandeiraACFranco-ParedesCThe expanding spectrum of modes of transmission of" exact="Zika" post="virus: A global concernAnn Clin Microbiol Antimicrob2016151326939897 9Oliveira MeloASMalingerGXimenesRSzejnfeldPOAlves"/>
   <result pre="of the iceberg?Ultrasound Obstet Gynecol2016476726731034 10BesnardMLastereSTeissierACao-LormeauVMussoDEvidence of perinatal transmission of" exact="Zika" post="virus, French Polynesia, December 2013 and February 2014Euro Surveill201419pii:"/>
   <result pre="and February 2014Euro Surveill201419pii: 20751 11MussoDRocheCRobinENhanTTeissierACao-LormeauVMet al.Potential sexual transmission of" exact="Zika" post="virusEmerg Infect Dis2015213596125625872 12MussoDNhanTRobinERocheCBierlaireDZisouKet al.Potential for Zika virus transmission"/>
   <result pre="sexual transmission of Zika virusEmerg Infect Dis2015213596125625872 12MussoDNhanTRobinERocheCBierlaireDZisouKet al.Potential for" exact="Zika" post="virus transmission through blood transfusion demonstrated during an outbreak"/>
   <result pre="Product Management to Reduce the Risk of Transfusion Transmission of" exact="Zika" post="Virus, Recommendations for IndustryUS Food and Drug Administration2016216 14LeungGHBairdRWDruceJAnsteyNMZika"/>
   <result pre="are the implications?Travel Med Infect Dis201614162026876061 17ChanJFChoiGKYipCCChengVCYuenKYZika fever and congenital" exact="Zika" post="syndrome: An unexpected emerging arboviral diseaseJ Infect2016725072426940504 18CalvetGAFilippisAMMendonçaMCSequeiraPCSiqueiraAMVelosoVGet al."/>
   <result pre="emerging arboviral diseaseJ Infect2016725072426940504 18CalvetGAFilippisAMMendonçaMCSequeiraPCSiqueiraAMVelosoVGet al. First detection of autochthonous" exact="Zika" post="virus transmission in a HIV-infected patient in Rio De"/>
   <result pre="in Rio De Janeiro, BrazilJ Clin Virol2016741326615388 19GautretPSimonFDengue, chikungunya and" exact="Zika" post="and mass gatherings: What happened in Brazil, 2014Travel Med"/>
   <result pre="happened in Brazil, 2014Travel Med Infect Dis2016147826778293 20MussoDRocheCNhanTXRobinETeissierACao-LormeauVMet al.Detection of" exact="Zika" post="virus in salivaJ Clin Virol20156853526071336 21OsterAMBrooksJTStrykerJEKachurREMeadPPesikNTet al.Interim guidelines for"/>
   <result pre="Virol20156853526071336 21OsterAMBrooksJTStrykerJEKachurREMeadPPesikNTet al.Interim guidelines for prevention of sexual transmission of" exact="Zika" post="virus – United States, 2016MMWR Morb Mortal Wkly Rep201665120126866485"/>
   <result pre="Virus Res200359236114696326 26HayesEBZika virus outside AfricaEmerg Infect Dis20091513475019788800 27MarchetteNJGarciaRRudnickAIsolation of" exact="Zika" post="virus from Aedes Aegypti mosquitoes in MalaysiaAm J Trop"/>
   <result pre="seroepidemiological investigations in Oyo stateJ Hyg (Lond)1979832139489960 30McCraeAWKiryaBGYellow fever and" exact="Zika" post="virus epizootics and enzootics in UgandaTrans R Soc Trop"/>
   <result pre="simple technique for infection of mosquitoes with viruses; transmission of" exact="Zika" post="virusTrans R Soc Trop Med Hyg1956502384213337908 34WeinbrenMPWilliamsMCZika virus: Further"/>
   <result pre="Soc Trop Med Hyg1956502384213337908 34WeinbrenMPWilliamsMCZika virus: Further isolations in the" exact="Zika" post="area, and some studies on the strains isolatedTrans R"/>
   <result pre="the state of São Paulo, Brazil and the risk of" exact="West Nile" post="fever and other arbovirus infectionRev Soc Bras Med Trop20114449650321860898"/>
   <result pre="Soc Bras Med Trop20114449650321860898 38FoyBDKobylinskiKCChilson FoyJLBlitvichBJTravassosdaRosaAHaddowADet al.Probable non-vector-borne transmission of" exact="Zika" post="virus, Colorado, USAEmerg Infect Dis201117880221529401 39AtkinsonBHearnPAfroughBLumleySCarterDAaronsEJet al.Detection of Zika"/>
   <result pre="of Zika virus, Colorado, USAEmerg Infect Dis201117880221529401 39AtkinsonBHearnPAfroughBLumleySCarterDAaronsEJet al.Detection of" exact="Zika" post="virus in semenEmerg Infect Dis20162294027088817 40D'OrtenzioEMatheronSYazdanpanahYde LamballerieXHubertBPiorkowskiGet al.Evidence of"/>
   <result pre="semenEmerg Infect Dis20162294027088817 40D'OrtenzioEMatheronSYazdanpanahYde LamballerieXHubertBPiorkowskiGet al.Evidence of sexual transmission of" exact="Zika" post="virusN Engl J Med20163742195827074370 41BinghamAMConeMMockVHeberlein-LarsonLStanekDBlackmoreCet al.Comparison of test results"/>
   <result pre="virusN Engl J Med20163742195827074370 41BinghamAMConeMMockVHeberlein-LarsonLStanekDBlackmoreCet al.Comparison of test results for" exact="Zika" post="virus RNA in urine, serum, and saliva specimens from"/>
   <result pre="in urine, serum, and saliva specimens from persons with travel-associated" exact="Zika" post="virus disease – Florida, 2016MMWR Morb Mortal Wkly Rep201665475827171533"/>
   <result pre="virus in the dental settingsDecis Dent20162403 43SikkaVChattuVKPopliRKGalwankarSCKelkarDSawickiSGet al.The emergence of" exact="Zika" post="virus as a global health security threat: A Review"/>
   <result pre="protocol and response to the occurrence of microcephaly related to" exact="Zika" post="virus infection2015BrasíliaMinistry of Health55 46HancockWTMarfelMBelMZika virus, French Polynesia, South"/>
   <result pre="spread of a mosquito-borne virusBull World Health Organ201694675686C27708473 51PerryHKhalilAAaronsERussellKO'BrienPManagement of" exact="Zika" post="virus in pregnancy: A reviewBr Med Bull20171241576929253151 52AbushoukAINegidaAAhmedHAn updated"/>
   <result pre="in pregnancy: A reviewBr Med Bull20171241576929253151 52AbushoukAINegidaAAhmedHAn updated review of" exact="Zika" post="virusJ Clin Virol20168453827721110 53LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.Genetic and serologic properties of"/>
   <result pre="Zika virusJ Clin Virol20168453827721110 53LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.Genetic and serologic properties of" exact="Zika" post="virus associated with an Epidemic, Yap state, Micronesia, 2007Emerg"/>
   <result pre="arboviruses in BrazilRev Pan Am Saude201455564 56PlourdeARBlochEMA literature review of" exact="Zika" post="virusEmerg Infect Dis20162211859227070380 57MalletHVialAMussoDAssessment of the zika virus outbreak"/>
   <result pre="subsequentlyHealth, Epidemiological and Health Information Bulletin201520-2136773 58MondolfiPABlohmGMHernandez-PerezMLarrazabalAMoyaDMarquezMet al.Cutaneous features of" exact="Zika" post="virus infection: a clinicopathological overviewClin Exp Dermatol20194413930267436 59WaddellLAGreigJDScoping review"/>
   <result pre="infection: a clinicopathological overviewClin Exp Dermatol20194413930267436 59WaddellLAGreigJDScoping review of the" exact="Zika" post="virus literaturePLoS One201611e015637627244249 60De OliveiraWKCortez-EscalanteJDe OliveiraWTCarmoGMHenriqueCMCoelhoGEet al.Increase in reported"/>
   <result pre="in infants born to women living in areas with confirmed" exact="Zika" post="virus transmission during the first trimester of pregnancy –"/>
   <result pre="61collab: European Centre for Disease Prevention and ControlRapid Risk Assessment:" exact="Zika" post="Virus Epidemic in the Americas: potential Association with Microcephaly"/>
   <result pre="Centre for Disease Prevention and Control 62ScullyCRobinsonACheck before you travel:" exact="Zika" post="virus – Another emerging global health threatBr Dent J2016220265726964604"/>
   <result pre="– Another emerging global health threatBr Dent J2016220265726964604 63ShakibKEpidemic of" exact="Zika" post="virus and maxillofacial surgeryBr J Oral Maxillofac Surg201654355726907929 64BrasilPCalvetGAde"/>
   <result pre="maxillofacial surgeryBr J Oral Maxillofac Surg201654355726907929 64BrasilPCalvetGAde SouzaRVSiqueiraAMExanthema associated with" exact="Zika" post="virus infectionLancet Infect Dis20161686627352763 65ChenLHOral lesions in a patient"/>
   <result pre="infectionLancet Infect Dis20161686627352763 65ChenLHOral lesions in a patient with confirmed" exact="Zika" post="virus infectionJ Travel Med20182512 66DerringtonSMCelluraAPMcDermottLEGubitosiTSonstegardAMChenSet al.Mucocutaneous findings and course"/>
   <result pre="Med20182512 66DerringtonSMCelluraAPMcDermottLEGubitosiTSonstegardAMChenSet al.Mucocutaneous findings and course in an adult with" exact="Zika" post="virus infectionJAMA Dermatol2016152691327168495 67SiqueiraWLZuanazziDKhurshidZKhanRSOliveriraTMPaulaKet al.Oral clinical manifestations of patients"/>
   <result pre="infectionJAMA Dermatol2016152691327168495 67SiqueiraWLZuanazziDKhurshidZKhanRSOliveriraTMPaulaKet al.Oral clinical manifestations of patients infected with" exact="Zika" post="virusOral Health201612 68collab: World Health OrganizationZika Virus, Microcephaly and"/>
   <result pre="syndromeN Engl J Med2012366229430422694000 72FayeOFayeODialloDDialloMWeidmannMSallAAet al.Quantitative real-time PCR detection of" exact="Zika" post="virus and evaluation with field-caught mosquitoesVirol J20131031124148652 73collab: World"/>
   <result pre="the International Health Regulations (2005) (IHR 2005) Emergency Committee on" exact="Zika" post="Virus and Observed Increase in Neurological Disorders and Neonatal"/>
   <result pre="Neonatal MalformationsWorld Health Organization201621 74RabeIBStaplesJEVillanuevaJHummelKBJohnsonJARoseLet al.Interim guidance for interpretation of" exact="Zika" post="virus antibody test resultsMMWR Morb Mortal Wkly Rep201665543627254248 75HealyKHamiltonGCrepeauTHealySUnluIFarajollahiAet"/>
   <result pre="J Trop Med Hyg201592889725404071 79ThompsonSJPearceJMRameyAMVectors, Hosts, and Control Measures for" exact="Zika" post="Virus in the AmericasEco Health2017148213929150828 80BaudDMussoDVougaMAlvesMPVulliemozNZika virus: A new"/>
   <result pre="for the evaluation and testing of infants with possible congenital" exact="Zika" post="virus infection – United States, 2016MMWR Morb Mortal Wkly"/>
   <result pre="and immunogenicity results from three trials of a purified inactivated" exact="Zika" post="virus vaccine candidate: Phase 1, randomised, double-blind, placebo-controlled clinical"/>
   <result pre="placebo-controlled clinical trialsLancet20183915637129217375 86GaudinskiMRHouserKVMorabitoKMHuZYamshchikovGRothwellRSet al.Safety, tolerability, and immunogenicity of two" exact="Zika" post="virus DNA vaccine candidates in healthy adults: Randomised, open-label,"/>
   <result pre="mosquito Aedes aegyptiAm J Trop Med Hyg1991453994071659238 88MeghaniZBoëteCGenetically engineered mosquitoes," exact="Zika" post="and other arboviruses, community engagement, costs, and patents: Ethical"/>
   <result pre="costs, and patents: Ethical issuesPLoS Negl Trop Dis201812e000650130048441 89AubryMRichardVGreenJBroultJMussoDInactivation of" exact="Zika" post="virus in plasma with amotosalen and ultraviolet A illuminationTransfusion201656334026283013"/>
   <result pre="Disease Control and PreventionCDC Health Advisory: Recognizing, Managing, and Reporting" exact="Zika" post="Virus Infections in Travelers Returning from Central America, South"/>
   <result pre="24Available from: http://www.emergency.cdc.gov/han/han00385. asp 92TappeDRisslandJGabrielMEmmerichPGuntherSHeldGet al. First case of laboratory-confirmed" exact="Zika" post="virus infection imported into Europe, November 2013Euro Surveill201419pii: 20685"/>
   <result pre="Surveill201419pii: 20685 93PetersenEEStaplesJEMeaney-DelmanDFischerMEllingtonSRCallaghanWMet al.Interim guidelines for pregnant women during a" exact="Zika" post="virus outbreak – United states, 2016MMWR Morb Mortal Wkly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6718459\results\search\tropicalVirus\results.xml">
   <result pre="Immunization Strategies Be an Alternative and Promising Vaccine Approach Against" exact="Dengue" post="Virus? ValdésIrisLazoLauraHermidaLissetGuillénGerardoGilLázaro*[], Vaccine Department, Center for Genetic Engineering and"/>
   <result pre="is permitted which does not comply with these terms. Abstract" exact="Dengue" post="is one of the most important diseases transmitted by"/>
   <result pre="mucosal surfaces, in case of some pathogens (6, 9, 10)." exact="Dengue" post="is a mosquito-transmitted viral infection of high incidence worldwide"/>
   <result pre="million infections and 20,000 deaths annually around the world (14)." exact="DENV" post="are transmitted mainly by Aedes aegypti mosquitoes, and the"/>
   <result pre="These chimeric viruses only induce neutralizing antibodies against the four" exact="DENV" post="after three doses given 6 month apart (22). Unfortunately,"/>
   <result pre="Infectious Diseases (NIAID). This vaccine combined the molecular attenuation of" exact="DENV" post="by deletions in the 3′ untranslated region and structural"/>
   <result pre="against different viral diseases, such as: HCV, HSV, HIV, and" exact="HPV" post="(8). Complementary prime-boost immunization strategies have also been developed"/>
   <result pre="the experimentation. Complementary Prime-Boost Immunization Strategies For The Development Of" exact="Dengue" post="Vaccines In the specific case of DENV, prime-boost immunization"/>
   <result pre="unfortunately there is no a safe and efficacy vaccine against" exact="DENV" post="neither antiviral drugs for the treatment of infected patients."/>
   <result pre="DIIIC successfully recalled memory B and T cells generated after" exact="DENV" post="infection Monkeys (75) Table 2 Posted clinical trials evaluating"/>
   <result pre="DENV infection Monkeys (75) Table 2 Posted clinical trials evaluating" exact="Dengue" post="vaccine candidates in a prime-boost regime. Vaccine candidate Status"/>
   <result pre="induction of neutralizing antibodies and T-cell specific response to both" exact="DENV" post="serotypes (67). Unfortunately, this study did not evaluate the"/>
   <result pre="conducted to investigate the effect of the pre-existing immunity to" exact="DENV" post="or YFV on the immunogenicity of a tetravalent live-attenuated"/>
   <result pre="investigate the effect of the pre-existing immunity to DENV or" exact="YFV" post="on the immunogenicity of a tetravalent live-attenuated vaccine in"/>
   <result pre="Furthermore, viremia in individuals that were primed with the monovalent" exact="DENV" post="vaccine was lower than those measured in the group"/>
   <result pre="Additionally, the immune response generated by the non-structural protein from" exact="YFV" post="play a role controlling the viremia too. However, the"/>
   <result pre="be discussed below. Tetra DIIIC: A Subunit Vaccine Candidate Against" exact="DENV" post="and Its Potential Use in Complementary Prime-Boost Strategies Experimental"/>
   <result pre="by a Cuban group that developed a vaccine candidate against" exact="DENV" post="based on the DIII of E protein and also"/>
   <result pre="the potentiality of Tetra DIIIC as a vaccine candidate against" exact="DENV" post="and also its usefulness in prime-boost immunization strategies employing"/>
   <result pre="developed neutralizing antibodies and protective immune responses against the four" exact="DENV" post="serotypes. Additionally, the immune response generated by Tetra DIIIC"/>
   <result pre="demonstrating that this formulation induces neutralizing antibodies against the four" exact="DENV" post="serotypes in &amp;gt;90% of those vaccinated in the absence"/>
   <result pre="maturation and duration of the immune response against the four" exact="DENV" post="serotypes. Conclusions Despite the introduction of Dengvaxia®, a vaccine"/>
   <result pre="With this scenario and knowing the complexity associated to a" exact="DENV" post="vaccine due to the immunopathological phenomena that produce the"/>
   <result pre="into account the lessons learned from previous studies conducted with" exact="DENV" post="and other human pathogens, complementary prime-boost immunization strategy must"/>
   <result pre="microorganism and infected cells. Besides, in the specific case of" exact="DENV" post="a good memory B and T-cell responses should be"/>
   <result pre="on the immunogenicity and efficacy role of prime-boost strategies against" exact="DENV" post="will be available. Further studies will be addressed to"/>
   <result pre="a prime-boost immunization regimen could be a potential solution for" exact="DENV" post="vaccine, which is unsolved today. Author Contributions IV, LL,"/>
   <result pre="10.1093/infdis/jiv08225801652 88.ValdésIIzquierdoACobasKThaoPAnhDHDucLHet al.. A heterologous prime-boost strategy for immunization against" exact="Dengue" post="virus combining the Tetra DIIIC subunit vaccine candidate with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6722215\results\search\tropicalVirus\results.xml">
   <result pre="al.. (2018). NS1 codon usage adaptation to humans in pandemic" exact="Zika" post="virus. Mem. Inst. Oswaldo Cruz113:e170385. 10.1590/0074-0276017038529768530 FuruseY.SuzukiA.OshitaniH. (2010). Origin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6724460\results\search\tropicalVirus\results.xml">
   <result pre="on dengue in the state of Ceará continues to increase." exact="Dengue" post="Aedes Aegypti Aedes Albopictus Virus INTRODUCTION The first dengue"/>
   <result pre="2015) 12,13. Ceará has 184 municipalities, 167 of which reported" exact="DENV" post="transmission in 2015. From 1986 until 2016, 302,015 dengue"/>
   <result pre="2016, 302,015 dengue cases were reported in the state 14." exact="Dengue" post="has therefore been endemic to Ceará for 30 years,"/>
   <result pre="alternatives to vector measures for dengue vector control 64. CONCLUSION" exact="Dengue" post="remains a serious public health problem and constitutes a"/>
   <result pre="serum surveyRev Saude Publica199832(5)4475410.1590/S0034-8910199800050000710030061 22Da CunhaRVMiagostovichMPPetrolaZDe AraújoESMCortezDPomboVet al.Retrospective Study on" exact="Dengue" post="in Fortaleza, State of Ceará, BrazilMem Inst Oswaldo Cruz199893(2)155910.1590/S0074-027619980002000039698884"/>
   <result pre="the State of8 Ceará, BrazilBiomedica201535(4)5576226844445 39CavalcantiLPBragaDNda SilvaLMAguiarMGCastiglioniMSilva-JuniorJUet al.Postmortem Diagnosis of" exact="Dengue" post="as an Epidemiological Surveillance ToolAm J Trop Med Hyg201694(1)1879210.4269/ajtmh.15-039226598561"/>
   <result pre="a case of aplastic anemia induced by dengue virus infection." exact="Dengue" post="can induce aplastic anemia by directly invading the bone"/>
   <result pre="positive laboratory results in CSF may indicate the presence of" exact="DENV" post="and lead to the consideration of CNS invasion in"/>
   <result pre="the prevalence of dengue in patients with suspected viral meningitis." exact="Dengue" post="should be suspected in patients in endemic areas with"/>
   <result pre="due to dengue, which is rarely diagnosed. Myocarditis caused by" exact="DENV" post="occurred in four confirmed cases. Therefore, there is a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6728053\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="dengue epidemics in coastal Mombasa compared to Kisumu. Author summary" exact="Dengue" post="is a viral disease of global public health significance"/>
   <result pre="deposited in GenBank under accession numbers MH410177 – MH410212 Introduction" exact="Dengue" post="virus (DENV) is a global public health threat with"/>
   <result pre="with epidemics mostly reported in urban and semi-urban areas [1,2]." exact="Dengue" post="virus consists of four related serotypes (DENV-1-4), belonging to"/>
   <result pre="with DENV-2 responsible for the highest number of epidemics [4,5]." exact="Dengue" post="epidemics have been linked to urbanization, globalization, climate change,"/>
   <result pre="extrinsic incubation period (EIP), and vector competence that can affect" exact="DENV" post="transmission [10–17]. Whilst determination of individual factors is valuable,"/>
   <result pre="may be critical to fully understanding the complex interrelationships influencing" exact="DENV" post="transmission risk. Studies investigating the various dengue risk factors"/>
   <result pre="cities. Previous entomological studies in Kenya have examined risk of" exact="DENV" post="transmission by studying vector density/abundance and vector competence data"/>
   <result pre="unexplained. In this study, different risk parameters related to the" exact="DENV" post="vector in the three major cities of Kenya; Mombasa,"/>
   <result pre="used in the vector competence study for all three cities." exact="Dengue" post="virus strain and assay The DENV-2 strain used in"/>
   <result pre="in Aedes aegypti populations To determine possible genetic differences between" exact="DENV" post="susceptible and non-susceptible Ae. aegypti mosquito populations from the"/>
   <result pre="However, there are currently no suitable animal models to estimate" exact="DENV" post="transmission [33]. Because the methods of virus exposure and"/>
   <result pre="the most prevalent serotype, and further studies on the other" exact="DENV" post="serotypes (DENV-1 and -3) circulating in Kenya [18,34,35] are"/>
   <result pre="significantly reduce vector density/human-vector contact, consequently lowering the risk of" exact="DENV" post="transmission by Ae. aegypti mosquitoes in an area [37]."/>
   <result pre="interpreted individually, may not sufficiently inform risk of transmission of" exact="DENV" post="and must therefore be evaluated collectively. Although the risk"/>
   <result pre="and must therefore be evaluated collectively. Although the risk of" exact="DENV" post="transmission is high in Mombasa, and low in Kisumu"/>
   <result pre="Mombasa, and low in Kisumu and Nairobi, continued monitoring of" exact="DENV" post="transmission risk and vector surveillance, as well as monitoring"/>
   <result pre="consensus. PLoS Negl Trop Dis. 2012;6(8):e176010.1371/journal.pntd.000176022880140 2collab: World Health Organisation." exact="Dengue" post="and severe dengue. 2018 Available from http://www.who.int/mediacentre/factsheets/fs117/en/ Cited 23"/>
   <result pre="2015 Nov 24];33(4):330–42. Available from: http://www.sciencedirect.com/science/article/pii/S018844090200378812234522 4AmarasingheA, KuritskJN, LetsonGW, MargolisHS." exact="Dengue" post="virus infection in Africa. Emerg Infect Dis. 2011;17(8):1349–54. 10.3201/eid1708.10151521801609"/>
   <result pre="infection in Africa. Emerg Infect Dis. 2011;17(8):1349–54. 10.3201/eid1708.10151521801609 5Sang RC." exact="Dengue" post="in Africa. In:Report of the scientific working group meeting"/>
   <result pre="indices. PLoS Negl Trop Dis. 2017;11(8):e000585810.1371/journal.pntd.000585828817563 11AghaSB, TchouassiDP, BastosADS, SangR." exact="Dengue" post="and yellow fever virus vectors: seasonal abundance, diversity and"/>
   <result pre="and the influence of temperature. Parasit Vectors. 2014;7(1):1–8.24411014 13EbiKL, NealonJ." exact="Dengue" post="in a changing climate. Environ Res. 2016;151:115–23. 10.1016/j.envres.2016.07.02627475051 14KramerLD,"/>
   <result pre="computing; 2012 2015. Available from: https://www.r-project.org/. 30AkhterR, HayesCG, BaqarS, ReisenWK." exact="West Nile" post="virus in Pakistan. III. Comparative vector capability of Culex"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6729038\results\search\tropicalVirus\results.xml">
   <result pre="of emerging and re-emerging viral threats to Europe, such as" exact="West Nile" post="virus, Toscana virus, measles and enteroviruses [1, 2]. The"/>
   <result pre="CNS infections [12]. This is ilustrated by the re-emergence of" exact="West Nile" post="virus (WNV) in south-eastern Europe and the emergence of"/>
   <result pre="Children: HSV-1, HSV-2, enteroviruses, EBV, parechovirus (&amp;lt; 3 years), Mycoplasma pneumoniae, TBEV," exact="WNV" post="(S. Europe), TOSV (S. Europe) Adults: HSV-1, HSV-2, enteroviruses,"/>
   <result pre="Adults: HSV-1, HSV-2, enteroviruses, VZV, Treponema pallidum, Cryptococcus, HIV, TBEV," exact="WNV" post="(S. Europe), TOSV (S. Europe) Others based on epidemiological"/>
   <result pre="EFNS^ Unspecified: HSV-1, HSV-2, VZV, HHV 6/7, CMV, EBV, JCV," exact="Dengue" post="virus, respiratory viruses, RSV, HIV, adenovirus, influenza A and"/>
   <result pre="TBE, mumps, EBV, rubella, enterovirus 71, HIV, parvovirus B19, HHV-6," exact="Dengue" post="virus, FSME, rabies, vaccinia, Lassa virus, Japanese encephalitis, WNV,"/>
   <result pre="virus, mumps virus, rubella virus, EBV, HHV 6, B virus," exact="WNV" post="(transfusion transplantation, breast feeding), HIV, Nipah virus, rabies virus"/>
   <result pre="VZV, enteroviruses, parechovirus, measles virus, mumps virus, TBEV (eastern Europe)," exact="WNV" post="(southern Europe), HIV, EBV (immunocompromised), CMV (immunocompromised) influenza virus"/>
   <result pre="6/7, measles virus, mumps virus, rotavirus, HIV, TBEV (eastern Europe)," exact="WNV" post="(southern Europe), HIV, EBV (immunocompromised), CMV (immunocompromised) influenza virus"/>
   <result pre="Epstein-Barr virus, RSV respiratory syncytial virus, TBEV tick-borne encephalitis virus," exact="WNV" post="West Nile virus, JEV Japanese encephalitis virus, IEC International"/>
   <result pre="virus, RSV respiratory syncytial virus, TBEV tick-borne encephalitis virus, WNV" exact="West Nile" post="virus, JEV Japanese encephalitis virus, IEC International Encephalitis Consortium,"/>
   <result pre="United Kingdom UKJSS UK Joint Specialist Societies VZV Varicella-zoster virus" exact="WNV" post="West Nile virus Publisher’s Note Springer Nature remains neutral"/>
   <result pre="Kingdom UKJSS UK Joint Specialist Societies VZV Varicella-zoster virus WNV" exact="West Nile" post="virus Publisher’s Note Springer Nature remains neutral with regard"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6739551\results\search\tropicalVirus\results.xml">
   <result pre="the nucleic acid of LASV (according to Olschlager et al.17)," exact="Dengue" post="virus (according to Drosten et al.18) and yellow fever"/>
   <result pre="as listed in Table 1. Separate reaction mixtures for Lassa," exact="Dengue" post="and yellow fever viruses were prepared and cycled as"/>
   <result pre="2.0 (Biometra, Goettingen, Germany). TABLE 1 Primers used for Lassa," exact="Dengue" post="and yellow fever investigation, Lagos, Nigeria, March 2018. Virus"/>
   <result pre="320 LVS-339-rev 5’ ACC GGG GAT CCTAGG CAT TT 3’" exact="Dengue" post="fever virus25 DenS 5’GGA TAG ACC AGA GAT CCT"/>
   <result pre="DenAs+ 5’ CAG CAT CAT TCC AGG CAC AG 3’" exact="Yellow fever" post="virus (in-house) YF fwd 5’ ATG GCA CTG TTG"/>
   <result pre="accession number GU481078 NIG 08-A47 2008 IRRUA, while those for" exact="Dengue" post="and YFV assays were both tissue cultured inactivated samples"/>
   <result pre="GU481078 NIG 08-A47 2008 IRRUA, while those for Dengue and" exact="YFV" post="assays were both tissue cultured inactivated samples all from"/>
   <result pre="and Agarose gel analysis of the Lassa, yellow fever and" exact="Dengue" post="viruses Among the 70 samples, 5 (7.1%) were positive"/>
   <result pre="positive for LASV, while none (0%) was positive for both" exact="Yellow fever" post="and Dengue viruses. The expected amplicon band size of"/>
   <result pre="while none (0%) was positive for both Yellow fever and" exact="Dengue" post="viruses. The expected amplicon band size of approximately 320"/>
   <result pre="CTRL). FIGURE 2 Reverse transcription polymerase chain reaction detection of" exact="Dengue" post="virus, Lagos, Nigeria, March 2018. The gel lanes represent"/>
   <result pre="control (-VE CTRL) while a tissue culture inactivated sample of" exact="Dengue" post="virus from the Virology Unit Laboratory of the Bernhard"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6742212\results\search\tropicalVirus\results.xml">
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Biology and life sciences : Organisms :"/>
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : People and places : Geographical locations :"/>
   <result pre="to publish, or preparation of the manuscript. fig-count: table-count: page-count:" exact="Chikungunya" post="is caused by an arbovirus RNA of the genus"/>
   <result pre="the genus alphavirus (CHIKV) of Togaviridae family [1]. Symptomatic acute" exact="CHIKV" post="infection is mainly characterized by high fever and severe"/>
   <result pre="American and Caribbean preparedness and response to the introduction of" exact="CHIKV" post="was precarious; as of 2017, only Canada, Cuba, and"/>
   <result pre="and Brazil (after 2016), the countries that recorded the largest" exact="CHIKV" post="epidemics, along with the Dominican Republic. Nonetheless, if a"/>
   <result pre="considered, more than 35,000 deaths caused primarily or secondarily by" exact="CHIKV" post="infection may have occurred in the Americas and the"/>
   <result pre="On the one hand, chikungunya deaths caused primarily by acute" exact="CHIKV" post="infection with direct impairment of organs (hepatitis, meningoencephalitis, myocarditis/pericarditis,"/>
   <result pre="death in order to try to establish an association between" exact="CHIKV" post="infection and the recorded cause of death of each"/>
   <result pre="diagnosis substantially reduced the underreporting of deaths due to dengue," exact="Zika" post="virus, and chikungunya in Fortaleza [17]. Unfortunately, very few"/>
   <result pre="for further studies to establish a definite causal link between" exact="CHIKV" post="and mortality, current evidence suggest that chikungunya may be"/>
   <result pre="disease, chikungunya does not always have a self-limited clinical course." exact="CHIKV" post="infection and its complications can be the underlying cause"/>
   <result pre="mitigate mortality, particularly among elderly patients with specific comorbidities. Currently," exact="CHIKV" post="transmission in the Americas is very low. Yet it"/>
   <result pre="will be foretold. Time will tell. References References 1WeaverSC, LecuitM." exact="Chikungunya" post="Virus and the Global Spread of a Mosquito-Borne Disease."/>
   <result pre="New England Journal of Medicine. 2015;372(13):1231–9. 10.1056/NEJMra1406035 .25806915 2CunhaRVD, TrintaKS." exact="Chikungunya" post="virus: clinical aspects and treatment—A Review. Memorias do Instituto"/>
   <result pre="10.1016/S1473-3099(07)70294-3 .18156079 5EconomopoulouA, DominguezM, HelynckB, SissokoD, WichmannO, QuenelP, et al.Atypical" exact="Chikungunya" post="virus infections: clinical manifestations, mortality and risk factors for"/>
   <result pre="2007/11/06. .17978079 7SissokoD, MalvyD, EzzedineK, RenaultP, MoscettiF, LedransM, et al.Post-epidemic" exact="Chikungunya" post="disease on Reunion Island: course of rheumatic manifestations and"/>
   <result pre="diseases. 2008;14(3):412–5. Epub 2008/03/08. 10.3201/eid1403.07072018325255 9BeesoonS, FunkhouserE, KoteaN, SpielmanA, RobichRM." exact="Chikungunya" post="fever, Mauritius, 2006. Emerging infectious diseases. 2008;14(2):337–8. Epub 2008/02/09."/>
   <result pre=".30085307 13FreitasARR, CavalcantiL, Von ZubenAP, DonalisioMR. Excess Mortality Related to" exact="Chikungunya" post="Epidemics in the Context of Co-circulation of Other Arboviruses"/>
   <result pre="CheahWK. A Two-Year Review on Epidemiology and Clinical Characteristics of" exact="Dengue" post="Deaths in Malaysia, 2013–2014. PLoS Negl Trop Dis. 2016;10(5):e0004575"/>
   <result pre="BragaDN, da SilvaLM, AguiarMG, CastiglioniM, Silva-JuniorJU, et al.Postmortem Diagnosis of" exact="Dengue" post="as an Epidemiological Surveillance Tool. The American journal of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6745427\results\search\tropicalVirus\results.xml">
   <result pre="Gulf countries are still free from the threat of a" exact="Zika" post="virus epidemic. This article provides a vision of integrated"/>
   <result pre="sites, dengue, and other arboviral infections. Keywords: Mosquito Vectors Aedes" exact="Zika" post="Virus Arboviruses Dengue Information Dissemination Saudi Arabia Introduction With"/>
   <result pre="other arboviral infections. Keywords: Mosquito Vectors Aedes Zika Virus Arboviruses" exact="Dengue" post="Information Dissemination Saudi Arabia Introduction With people in Saudi"/>
   <result pre="threat of sudden outspread of mosquito vectors of dengue and" exact="Zika" post="virus.1 A total of 2926 confirmed cases of dengue"/>
   <result pre="feed indoors and outdoors, which increases transmission in Saudi Arabia.1-3" exact="Dengue" post="is closely related to other mosquito-borne flaviviruses within the"/>
   <result pre="flaviviruses within the Flaviviridae family such as Zika, yellow fever," exact="West Nile," post="and Japanese encephalitis.1,3-5 In 2006, a total of 10"/>
   <result pre="million at risk in 2016 in more than 130 countries." exact="Zika" post="virus causal factor infection is associated with congenital malformations"/>
   <result pre="other emerging arboviral asymptomatic carriers, antigenic diversity and phylogenetic of" exact="DENV" post="1-4 and other arboviral diseases in Saudi Arabia, Yemen,"/>
   <result pre="the GCC announced that all Gulf countries are free from" exact="Zika" post="virus, innovative preventive and control methods are encouraged.11 A"/>
   <result pre="tailored cost-effective community-based programs. Importantly, safe and effective dengue and" exact="Zika" post="drugs and vaccines discovery for pilgrims/traveler immunization programs should"/>
   <result pre="of mosquito vectors: past, present, and future.Insects2016 Oct;7(4):E52. 10.3390/insects704005227706105 2WHO." exact="Dengue" post="control. Biological control. 2016 [cited 2016 October 24]. Available"/>
   <result pre="2016 October 24]. Available from: http://www.who.int/denguecontrol/control_strategies/biological_control/en/. 3PetersenLRHayesEBWestward ho?ƒ??The spread of" exact="West Nile" post="virus.N Engl J Med2004 Nov;351(22):2257-2259. 10.1056/NEJMp04826115564540 4TamboEChuisseuPDNgogangJYKhaterEIDeciphering emerging Zika"/>
   <result pre="West Nile virus.N Engl J Med2004 Nov;351(22):2257-2259. 10.1056/NEJMp04826115564540 4TamboEChuisseuPDNgogangJYKhaterEIDeciphering emerging" exact="Zika" post="and dengue viral epidemics: Implications for global maternal-child health"/>
   <result pre="of colloidal silver nanoparticles using Hugonia mystax: larvicidal potential against" exact="Zika" post="virus, dengue, and malaria vector mosquitoes.Artif Cells Nanomed Biotechnol2017"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6746389\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Tropical Diseases"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Biology and Life Sciences : Microbiology :"/>
   <result pre="Biology and Life Sciences : Microbiology : Virology: Viral Genomics" exact="Chikungunya" post="virus requires cellular chloride channels for efficient genome replication"/>
   <result pre="for efficient genome replication Modulation of cellular chloride channels inhibits" exact="CHIKV" post="replication MüllerMariettaConceptualizationData curationFormal analysisInvestigationMethodologyWriting – original draftWriting – review"/>
   <result pre="medium, provided the original author and source are credited.pntd.0007703.pdf Abstract" exact="Chikungunya" post="virus (CHIKV) is a re-emerging, pathogenic alphavirus that is"/>
   <result pre="pain, with frequent long-term health implications and high morbidity. The" exact="CHIKV" post="lifecycle is poorly understood and specific antiviral therapeutics or"/>
   <result pre="we investigated the role of host-cell chloride (Cl-) channels on" exact="CHIKV" post="replication.We demonstrate that specific pharmacological Cl- channel inhibitors significantly"/>
   <result pre="replication.We demonstrate that specific pharmacological Cl- channel inhibitors significantly inhibit" exact="CHIKV" post="replication in a dose-dependent manner, suggesting that Cl-channels are"/>
   <result pre="cells. Further analysis of the effect of the inhibitors on" exact="CHIKV" post="attachment, entry, viral protein expression and replicon replication demonstrated"/>
   <result pre="replication demonstrated that Cl- channels are specifically required for efficient" exact="CHIKV" post="genome replication. This was conserved in mosquito cells, where"/>
   <result pre="CHIKV genome replication. This was conserved in mosquito cells, where" exact="CHIKV" post="replication and genome copy number was significantly reduced following"/>
   <result pre="and 4 (CLIC1 and CLIC4, respectively) as required for efficient" exact="CHIKV" post="replication and protein affinity chromatography showed low levels of"/>
   <result pre="affinity chromatography showed low levels of CLIC1 in complex with" exact="CHIKV" post="nsP3, an essential component of the viral replication machinery."/>
   <result pre="the first time we demonstrate that efficient replication of the" exact="CHIKV" post="genome depends on cellular Cl- channels, in both human"/>
   <result pre="mosquito cells and identifies CLIC1 and CLIC4 as agonists of" exact="CHIKV" post="replication in human cells. We observe a modest interaction,"/>
   <result pre="that CLIC1 may play a role in the formation/maintenance of" exact="CHIKV" post="replication complexes. These findings advance our molecular understanding of"/>
   <result pre="CHIKV replication complexes. These findings advance our molecular understanding of" exact="CHIKV" post="replication and identify potential druggable targets for the treatment"/>
   <result pre="identify potential druggable targets for the treatment and prevention of" exact="CHIKV" post="mediated disease. Author summary Chikungunya virus (CHIKV) is a"/>
   <result pre="the treatment and prevention of CHIKV mediated disease. Author summary" exact="Chikungunya" post="virus (CHIKV) is a mosquito-borne virus that infects humans"/>
   <result pre="urgently required. Since its initial isolation in Tanzania in 1952," exact="CHIKV" post="has spread widely across tropical/sub-tropical and more temperate regions."/>
   <result pre="resulting in high morbidity and financial burden. Despite this, the" exact="CHIKV" post="lifecycle is poorly understood. Here, we demonstrate for the"/>
   <result pre="poorly understood. Here, we demonstrate for the first time that" exact="CHIKV" post="requires host-cell ion channels that mediate chloride ion (Cl-)"/>
   <result pre="with viral non-structural protein 3 (nsP3)—an essential component of the" exact="CHIKV" post="replicase complex. These findings advance our understanding of CHIKV"/>
   <result pre="the CHIKV replicase complex. These findings advance our understanding of" exact="CHIKV" post="replication and identify potential druggable targets for the treatment"/>
   <result pre="identify potential druggable targets for the treatment and prevention of" exact="CHIKV" post="mediated disease. Funding http://dx.doi.org/10.13039/501100000265Medical Research Council MR/NO1054X/1http://orcid.org/0000-0003-2524-707XTuplinAndrew Royal societyRG140704http://orcid.org/0000-0003-2524-707XTuplinAndrew"/>
   <result pre="are within the manuscript and its Supporting Information files. Introduction" exact="Chikungunya" post="virus (CHIKV) is a mosquito-borne virus of the Alphavirus"/>
   <result pre="expanded globally to include almost 40 countries [2]. Following transmission," exact="CHIKV" post="replicates in the fibroblasts of the dermis and disseminates"/>
   <result pre="to several tissues including muscle, joints and the liver [3]." exact="CHIKV" post="causes chikungunya fever which is characterized by high fever,"/>
   <result pre="and sequela that persist for up to 3 years [8]," exact="CHIKV" post="has a major impact on morbidity and loss of"/>
   <result pre="with no licensed vaccines or direct acting antivirals currently available." exact="CHIKV" post="is a small, enveloped virus, with a single-stranded positive-sense"/>
   <result pre="E1. Virus attachment onto mammalian cells is mediated by the" exact="CHIKV" post="E2 protein and the cell adhesion molecule Mxra8 [10]."/>
   <result pre="although clathrin-independent pathways have also been identified [10, 11]. Following" exact="CHIKV" post="trafficking to early endosomes, the E1 glycoprotein facilitates endosomal"/>
   <result pre="pro-viral factor in a genome-wide loss of function screen during" exact="CHIKV" post="infection [22]. In this study, we used a panel"/>
   <result pre="a panel of ion channel modulating compounds to demonstrate that" exact="CHIKV" post="requires Cl- channel activity during its lifecycle, in both"/>
   <result pre="channels, CLIC1 and CLIC4, were identified as pro-viral factors for" exact="CHIKV" post="replication, with CLIC1 potentially interacting with CHIKV nsP3—further implicating"/>
   <result pre="pro-viral factors for CHIKV replication, with CLIC1 potentially interacting with" exact="CHIKV" post="nsP3—further implicating this channel as a significant host cell"/>
   <result pre="implicating this channel as a significant host cell factor during" exact="CHIKV" post="infection. These findings expand our understanding of CHIKV pathogenesis"/>
   <result pre="factor during CHIKV infection. These findings expand our understanding of" exact="CHIKV" post="pathogenesis and reveal Cl- channels as a potential host"/>
   <result pre="potential host cell target for the development of much needed" exact="CHIKV" post="antivirals. Materials and methods Cells and viruses Huh7 cells"/>
   <result pre="Fisher Scientific) and 100 units/ml penicillin, 100 μg/ml streptomycin. The" exact="CHIKV" post="ICRES and CHIKV-Fluc replicon (SGR), in which the ORF-2"/>
   <result pre="isolate LR2006 OPY1, representing the East Central South African genotype." exact="CHIKV" post="TST-nsP3 was generated by synthesizing a 129 bp DNA"/>
   <result pre="The TST-nsP3 fragment was then excised and cloned into the" exact="CHIKV" post="ICRES plasmids using the unique KfII and the AgeI"/>
   <result pre="using the unique KfII and the AgeI restriction sites. All" exact="CHIKV" post="plasmids were linearized using NotI and in vitro transcribed"/>
   <result pre="at room temperature (RT), aliquoted and stored at -80°C. The" exact="CHIKV" post="titer was determined by standard plaque assay on BHK-21"/>
   <result pre="of mammalian and invertebrate cells with compounds and infection with" exact="CHIKV" post="Huh7 cells were treated with MNTDs of Ribavirin, DIDS,"/>
   <result pre="12 well plates at 100 000 cells/well. The next day," exact="CHIKV" post="at MOI 2 (2xPFU as determined on BHK-21 monolayers/Huh7"/>
   <result pre="in DMEM/compound. Supernatant was then harvested the titer of released" exact="CHIKV" post="determined by plaque assay. To determine the virucidal activity"/>
   <result pre="determine the virucidal activity of the compounds, the inhibitors and" exact="CHIKV" post="were diluted into 150 μl with complete DMEM and"/>
   <result pre="to the cells. Treatment with DEPC was conducted by diluting" exact="CHIKV" post="and DEPC (2 mM final concentration) in PBS and"/>
   <result pre="concentration) in PBS and incubating at RT in the dark." exact="CHIKV" post="and compounds were adsorbed to cells for 1 hr"/>
   <result pre="12 hpi in complete DMEM. The supernatants were harvested and" exact="CHIKV" post="titer determined by standard plaque assay. The impact of"/>
   <result pre="by standard plaque assay. The impact of the compounds on" exact="CHIKV" post="attachment to the cell surface was investigated by performing"/>
   <result pre="CHIKV attachment to the cell surface was investigated by performing" exact="CHIKV" post="adsorption in the presence of the inhibitors at 4°C"/>
   <result pre="in complete DMEM. At 24 hpi supernatants were harvested and" exact="CHIKV" post="titer determined by standard plaque assay at 24 hpi."/>
   <result pre="assay at 24 hpi. The first two hours of the" exact="CHIKV" post="lifecycle were investigated by treating the cells with the"/>
   <result pre="200 000 cells/well. The next day, cells were infected with" exact="CHIKV" post="at MOI 2 (2xPFU as determined on BHK-21 monolayers/C6/36"/>
   <result pre="as described for Huh7 cells. The supernatants were harvested and" exact="CHIKV" post="titer determined at 24 hpi. All experiments were performed"/>
   <result pre="300 000 cells/well. The next day, cells were infected with" exact="CHIKV" post="(MOI 0.1, 2, 10) in the presence of the"/>
   <result pre="promotor [23]; therefore, detection of Fluc activity is indicative of" exact="CHIKV" post="genome replication. The plasmid was linearized using NotI and"/>
   <result pre="comparing each sample to the untreated sample. Strand-specific Quantification of" exact="CHIKV" post="RNA Huh7 cells were infected with CHIKV and treated"/>
   <result pre="Strand-specific Quantification of CHIKV RNA Huh7 cells were infected with" exact="CHIKV" post="and treated with inhibitory compounds as described above. At"/>
   <result pre="primers (S1 Table) amplifying a 94 bp region of the" exact="CHIKV" post="nsP1 encoding sequence using the following PCR program: 95°C"/>
   <result pre="by the Mx3005P thermal cycler (Agilent technologies). In vitro transcribed" exact="CHIKV" post="ICRES RNA was reverse transcribed and a cDNA dilution"/>
   <result pre="comparing each sample to the untreated control sample. Quantification of" exact="CHIKV" post="genome copy numbers C6/36 cells were infected with CHIKV"/>
   <result pre="of CHIKV genome copy numbers C6/36 cells were infected with" exact="CHIKV" post="(MOI 2) and treated with inhibitory compounds as described"/>
   <result pre="Biosystems) with primers amplifying a 78 bp region of the" exact="CHIKV" post="nsP1 encoding sequence (fwd primer: 5’CCGACTCAACCATCCTGGAT’3, rev primer: 5’GGCAGACGCAGTGGTACTTCCT’3),"/>
   <result pre="and a PCR program as described above. In vitro transcribed" exact="CHIKV" post="ICRES RNA was reverse transcribed and a cDNA dilution"/>
   <result pre="At 48 hrs post initial transfection, cells were infected with" exact="CHIKV" post="(MOI 10) as described above and a sample harvested"/>
   <result pre="transfected into the cells. Three independent repeats were performed and" exact="CHIKV" post="titers of CLIC1/CLIC4 knock down samples were expressed as"/>
   <result pre="control sample. Strep-Tactin affinity chromatography Huh7 cells were infected with" exact="CHIKV" post="ICRES TST-nsP3 (MOI 10) as described above. At 24"/>
   <result pre="blots as described above. Results Inhibition of Cl- channels decreases" exact="CHIKV" post="replication We first assessed well-characterized Cl- channel blockers—including diisothiocyanostilbene-2,20-disulfonic"/>
   <result pre="(IAA-94) and 5-nitro-2-3-phenylpropylamino benzoic acid (NPPB) for their effects on" exact="CHIKV" post="infection. For these assays, maximal non-toxic doses (MNTD) for"/>
   <result pre="MTT assay (S1 Fig). Next, Huh7 cells were infected with" exact="CHIKV" post="(MOI 2) in the presence of the MNTD of"/>
   <result pre="determined. Treatment with NPPB resulted in an 18-fold reduction in" exact="CHIKV" post="progeny compared to untreated cells, while treatment with DIDS"/>
   <result pre="with DIDS and 9-ACA led to an 8-fold decrease in" exact="CHIKV" post="titer (p ≤ 0.05) (Fig 1A). IAA-94 had no"/>
   <result pre="no detectable effects. Ribavirin, shown previously to be active against" exact="CHIKV" post="[27, 28], was included as a positive control and"/>
   <result pre="included as a positive control and significantly inhibited production of" exact="CHIKV" post="virions (56-fold decrease). Fig 1 Inhibition of Cl- channels"/>
   <result pre="virions (56-fold decrease). Fig 1 Inhibition of Cl- channels decreases" exact="CHIKV" post="replication. A) Huh7 cells were infected with CHIKV (MOI"/>
   <result pre="channels decreases CHIKV replication. A) Huh7 cells were infected with" exact="CHIKV" post="(MOI 2) in the presence of the MNTD of"/>
   <result pre="hpi, (n = 3). B) Huh7 cells were infected with" exact="CHIKV" post="(MOI 10) and expression levels of CHIKV nsP1 and"/>
   <result pre="were infected with CHIKV (MOI 10) and expression levels of" exact="CHIKV" post="nsP1 and capsid were determined by western blot at"/>
   <result pre="titer was determined at 12 hpi, (n ≥ 3). D)" exact="CHIKV" post="was incubated with the compounds at 37°C (except for"/>
   <result pre="prior to adsorption to Huh7 cells (MOI 2). The released" exact="CHIKV" post="harvested and titred at 12 hpi, (n = 3)."/>
   <result pre="p≤0.01, *** p≤0.001. To confirm these findings, the expression of" exact="CHIKV" post="nsP1 and capsid protein in the presence each Cl-"/>
   <result pre="unaffected. DIDS, 9-ACA, NPPB and Ribavirin were found to inhibit" exact="CHIKV" post="replication in a dose dependent manner (Fig 1Ci–1Civ). This"/>
   <result pre="further implies that functional Cl- channels are required during the" exact="CHIKV" post="lifecycle. The inhibitory effect on viral protein expression was"/>
   <result pre="Fig). To exclude any direct virucidal activity of the compounds," exact="CHIKV" post="virions were incubated with the MNTD of each compound"/>
   <result pre="as it has previously been shown to modify histidine’s on" exact="CHIKV" post="glycoproteins, preventing viral fusion [29]. Treatment with DIDS, 9-ACA,"/>
   <result pre="9-ACA, NPPB and Ribavirin had no significant effects on the" exact="CHIKV" post="titer following direct virion treatment, implying that the compounds"/>
   <result pre="for DIDS-, 9-ACA- and NPPB-sensitive cellular Cl- channels during the" exact="CHIKV" post="lifecycle. Cl- channels are required during post-attachment/internalization stages of"/>
   <result pre="lifecycle. Cl- channels are required during post-attachment/internalization stages of the" exact="CHIKV" post="lifecycle We next sought to identify the stage of"/>
   <result pre="lifecycle We next sought to identify the stage of the" exact="CHIKV" post="lifecycle that is sensitive to Cl- channel inhibition. The"/>
   <result pre="CHIKV lifecycle that is sensitive to Cl- channel inhibition. The" exact="CHIKV" post="lifecycle begins with virus attachment to host cells mediated"/>
   <result pre="begins with virus attachment to host cells mediated by the" exact="CHIKV" post="E2 protein. To analyze cell attachment, CHIKV (MOI 2)"/>
   <result pre="mediated by the CHIKV E2 protein. To analyze cell attachment," exact="CHIKV" post="(MOI 2) was adsorbed onto cells at 4°C (to"/>
   <result pre="at physiological temperature. Thus, cell supernatants were assayed for infectious" exact="CHIKV" post="progeny at 24 hpi (Fig 2A), rather than 12"/>
   <result pre="Treatment with 9-ACA, NPPB and Ribavirin had no influence on" exact="CHIKV" post="titers, indicating that these compounds do not impact CHIKV"/>
   <result pre="on CHIKV titers, indicating that these compounds do not impact" exact="CHIKV" post="E2 mediated cell surface attachment. DIDS had a modest"/>
   <result pre="Cl- channels are mainly required during post-attachment/early stages of the" exact="CHIKV" post="lifecycle. A) Huh7 cells were treated with the Cl-"/>
   <result pre="Cl- channel inhibitors for 1 hr prior to adsorption of" exact="CHIKV" post="(MOI 2) at 4°C to facilitate attachment but prevent"/>
   <result pre="virus, cells were returned to 37°C and titer of released" exact="CHIKV" post="was determined at 24 hpi (n = 3). B)"/>
   <result pre="the compounds for one further hour. The titer of released" exact="CHIKV" post="was determined at 12 hpi (n = 3). C)"/>
   <result pre="*p≤0.05; ** p≤0. 01, *** p≤0.001, **** p≤0.0001. The first" exact="CHIKV" post="particles fuse with endosomal membranes as early as 2"/>
   <result pre="with endosomal membranes as early as 2 mins post-infection, making" exact="CHIKV" post="entry a rapid process (12). Indeed it has been"/>
   <result pre="process (12). Indeed it has been reported that almost all" exact="CHIKV" post="particles escape the endosomal system within the initial 22"/>
   <result pre="of Cl- channels during this early lifecycle stage by adsorbing" exact="CHIKV" post="onto pre-treated cells for 1 hr at 37°C (MOI"/>
   <result pre="compound for a further 1 hr and after their removal," exact="CHIKV" post="titers were assessed at 12 hpi. As shown in"/>
   <result pre="Fig 2B, 9-ACA, NPPB and Ribavirin had no effect on" exact="CHIKV" post="infection when treatment was limited to the early lifecycle"/>
   <result pre="to the early lifecycle stages. DIDS-treated cells, however, displayed reduced" exact="CHIKV" post="titers (p ≤ 0.05), consistent with its modest effects"/>
   <result pre="together, these data indicate that neither 9-ACA or NPPB inhibit" exact="CHIKV" post="at the stages of virus attachment or internalization, whilst"/>
   <result pre="the stages of virus attachment or internalization, whilst DIDS inhibits" exact="CHIKV" post="early attachment and internalization. Efficient CHIKV RNA replication requires"/>
   <result pre="internalization, whilst DIDS inhibits CHIKV early attachment and internalization. Efficient" exact="CHIKV" post="RNA replication requires functional cellular Cl- channels We then"/>
   <result pre="investigated the effects of the Cl- channel inhibitors on efficient" exact="CHIKV" post="RNA replication using a CHIKV-Fluc SGR (Fig 3A) and"/>
   <result pre="SGR (Fig 3A) and Fluc luminescence as a proxy of" exact="CHIKV" post="RNA synthesis. For these assays, cells were briefly pre-treated"/>
   <result pre="control for differences in transfection efficiency. Cells were assessed for" exact="CHIKV" post="replication by the measurement of luciferase activity 6 hrs"/>
   <result pre="SGR replication (Fig 3B). To confirm these findings, we quantified" exact="CHIKV" post="genomic (Fig 3C) and intermediate complimentary minus-strand (Fig 3D)"/>
   <result pre="RNA extracted at 6 hpi. Significantly lower levels of the" exact="CHIKV" post="genomic RNA were observed in cells treated with DIDS"/>
   <result pre="treatment. From this data, we inferred that the efficiency of" exact="CHIKV" post="genome replication is dependent on the function of Cl−"/>
   <result pre="and NPPB–via either a direct role in replication of the" exact="CHIKV" post="genome or indirectly through upregulation of ORF-1 translation. Fig"/>
   <result pre="genome or indirectly through upregulation of ORF-1 translation. Fig 3" exact="CHIKV" post="genome replication requires functional Cl- channels. A) Schematic of"/>
   <result pre="genome replication requires functional Cl- channels. A) Schematic of the" exact="CHIKV" post="genome (top) and the CHIKV-Fluc SGR (bottom). B) Huh7"/>
   <result pre="Total RNA was extracted from Huh7 cells 6 hpi with" exact="CHIKV" post="(MOI 2) and treatment with the Cl- channel inhibitors."/>
   <result pre="CHIKV (MOI 2) and treatment with the Cl- channel inhibitors." exact="CHIKV" post="positive-strand genomic (C) and minus-strand intermediate (D) RNA was"/>
   <result pre="p≤0.01, *** p≤0.001, **** p≤0.0001. Cl- intracellular channels (CLICs) facilitate" exact="CHIKV" post="replication All of the Cl- channel compounds used in"/>
   <result pre="polyomavirus [21, 32]. Initially, we confirmed by western blot that" exact="CHIKV" post="infection did not induce expression of CLIC1 or CLIC4"/>
   <result pre="silenced using siRNA (Fig 4Ai), cells were then infected with" exact="CHIKV" post="(MOI 10) and released virus titers determined at 24"/>
   <result pre="those with reduced CLIC1 or CLIC4 expression levels, replication of" exact="CHIKV" post="was significantly inhibited (p ≤ 0.05 and p ≤"/>
   <result pre="confirming a role for both CLIC1 and CLIC4 in efficient" exact="CHIKV" post="replication. Co-silencing of both CLIC1 and CLIC4 (Fig 4Aii)"/>
   <result pre="CLIC4 (Fig 4Aii) did not result in synergistic inhibition of" exact="CHIKV" post="replication (Fig 4B), implying that both channels are required"/>
   <result pre="the virus lifecycle. Fig 4 Chloride intracellular channels (CLICs) facilitate" exact="CHIKV" post="replication. A) (i) CLIC1 and CLIC4, respectively, as well"/>
   <result pre="48 hrs after initial siRNA transfection, cells were infected with" exact="CHIKV" post="(MOI 10) and released CHIKV and titered at 24"/>
   <result pre="transfection, cells were infected with CHIKV (MOI 10) and released" exact="CHIKV" post="and titered at 24 hpi (n = 3). Viral"/>
   <result pre="deviation. *p≤0.05; ** p≤0.01, *** p≤0.001. C) TST-tagged nsP3 from" exact="CHIKV" post="infected (MOI 10) Huh7 cells (24 hpi) was pulled-down"/>
   <result pre="proteins. Given the inhibitory effects of chloride channel inhibition on" exact="CHIKV" post="genome replication (Fig 3), we reasoned that the channels"/>
   <result pre="virus replicase complex. To assess this, cells were infected with" exact="CHIKV" post="twin-strep-tag nsP3 (CHIKV TST-nsP3) (MOI 10), which encodes a"/>
   <result pre="selectively binds to Strep-Tactin Sepharose. Following elution, proteins interacting with" exact="CHIKV" post="nsP3 were identified by western blot analysis. Negative controls"/>
   <result pre="Negative controls for this analyses included cells infected with wild-type" exact="CHIKV" post="(i.e. expressing untagged nsP3) and uninfected cells. We observed"/>
   <result pre="an nsP3 interacting partner, suggesting an independent function outwith the" exact="CHIKV" post="replicase complex. Previously published immunoprecipitation studies demonstrated an interaction"/>
   <result pre="directly or indirectly with nsP3, an essential component of the" exact="CHIKV" post="replication machinery. Inhibition of Cl- channels reduces CHIKV replication"/>
   <result pre="of the CHIKV replication machinery. Inhibition of Cl- channels reduces" exact="CHIKV" post="replication in invertebrate cells As an arbovirus, CHIKV infects"/>
   <result pre="channels reduces CHIKV replication in invertebrate cells As an arbovirus," exact="CHIKV" post="infects both humans and mosquitos. We thus investigated if"/>
   <result pre="humans and mosquitos. We thus investigated if the dependency of" exact="CHIKV" post="on cellular Cl- channels is limited to human cells"/>
   <result pre="derived from the larva of Ae. albopictus were infected with" exact="CHIKV" post="in the presence of the MNTD (S1B Fig) of"/>
   <result pre="channel inhibitor that exhibited the most significant inhibitory effects on" exact="CHIKV" post="replication in mammalian cells (Figs 1 and 3). A"/>
   <result pre="mammalian cells (Figs 1 and 3). A 357-fold reduction in" exact="CHIKV" post="titer, following infection (MOI 2) of NPPB-treated C6/36 cells,"/>
   <result pre="≤ 0.001), implying that Cl- channels are required during the" exact="CHIKV" post="lifecycle in mosquito host cells. Ribavirin-treatment, used as a"/>
   <result pre="as a positive control, led to a 39-fold decrease in" exact="CHIKV" post="titer (p ≤ 0.001) (Fig 5A). The effects of"/>
   <result pre="(S4 Fig). Only DIDS-treatment led to a significant reduction in" exact="CHIKV" post="replication at 24 hpi. As this could have been"/>
   <result pre="CHIKV-Fluc SGR transfection in combination with NPPB-treatment prevented replicon analysis," exact="CHIKV" post="RNA copy numbers could still be determined by reverse"/>
   <result pre="data demonstrate that NPPB-sensitive Cl- channels are involved in the" exact="CHIKV" post="lifecycle in both human and mosquito host cells. Fig"/>
   <result pre="mosquito host cells. Fig 5 Inhibition of Cl- channels reduces" exact="CHIKV" post="replication in invertebrate cells. C6/36 cells were infected with"/>
   <result pre="CHIKV replication in invertebrate cells. C6/36 cells were infected with" exact="CHIKV" post="(MOI 2) in the presence of the MNTD of"/>
   <result pre="respectively. A) The viral titer (n = 3) and B)" exact="CHIKV" post="RNA copy number (n = 3) were determined at"/>
   <result pre="that cellular Cl- channels have a significant pro-viral role during" exact="CHIKV" post="infection. Our data shows that Cl- channel modulators inhibit"/>
   <result pre="infection. Our data shows that Cl- channel modulators inhibit efficient" exact="CHIKV" post="RNA synthesis and that the intracellular Cl- channels CLIC1"/>
   <result pre="intracellular Cl- channels CLIC1 and CLIC4 are specifically required for" exact="CHIKV" post="replication. CLIC1 was found in complex with CHIKV nsP3,"/>
   <result pre="required for CHIKV replication. CLIC1 was found in complex with" exact="CHIKV" post="nsP3, albeit to low levels, suggesting a direct involvement"/>
   <result pre="nsP3, albeit to low levels, suggesting a direct involvement in" exact="CHIKV" post="replication complex formation or nsP3-mediated viral functions. For the"/>
   <result pre="data highlight the requirement of cellular ion channels during the" exact="CHIKV" post="lifecycle. Cl- channels at the cell membrane regulate an"/>
   <result pre="for three out of four assessed Cl- channel inhibitors on" exact="CHIKV" post="replication in mammalian cells (Fig 1A). The tested compounds"/>
   <result pre="inhibitors on the CHIKV-Fluc SGR and copy number of the" exact="CHIKV" post="genomic and intermediate minus-strand RNA (Fig 3). NPPB-sensitive Cl-"/>
   <result pre="inhibitor to infected C6/36 cells led to a reduction in" exact="CHIKV" post="replication (Fig 5). To identify specific Cl- channels required"/>
   <result pre="replication (Fig 5). To identify specific Cl- channels required for" exact="CHIKV" post="replication, we focused on two CLIC family members, namely"/>
   <result pre="activity [32]. In this study, CLIC1 and CLIC4 silencing inhibited" exact="CHIKV" post="replication and, given that these effects mirrored those of"/>
   <result pre="a potential interacting partner of nsP3—an essential component of the" exact="CHIKV" post="replication complex. We thus speculate that CLIC1 is in"/>
   <result pre="maintain complex stability and genome integrity. In addition, isolation of" exact="CHIKV" post="replication complexes has shown that all proteins needed for"/>
   <result pre="and CLIC4 did not have a synergistic effect on inhibiting" exact="CHIKV" post="replication (Fig 4B) and CLIC4 was not observed to"/>
   <result pre="with nsP3. These results imply that, although required for efficient" exact="CHIKV" post="replication, CLIC4 functions through an alternative mechanism or different"/>
   <result pre="in a genome-wide loss of function screen performed with a" exact="CHIKV" post="reporter virus [22]. This raises possibility that further Cl-"/>
   <result pre="further Cl- channels are involved in the replication of the" exact="CHIKV" post="genome or other stages of the virus lifecycle. For"/>
   <result pre="that CLIC1, as an nsP3 interacting protein, is required for" exact="CHIKV" post="genome replication for a similar mechanism. Interestingly, CLIC-dependent Cl-"/>
   <result pre="recently been shown that the NLRP3 inflammasome is activated in" exact="CHIKV" post="infected humans [40]. A small molecule inhibitor of the"/>
   <result pre="the inflammasome abrogated inflammatory pathology in mice without influencing the" exact="CHIKV" post="titer. This could imply that CLIC Cl- channel function"/>
   <result pre="channel function is also involved in the inflammatory response to" exact="CHIKV" post="infection, in addition to its role in efficient CHIKV"/>
   <result pre="to CHIKV infection, in addition to its role in efficient" exact="CHIKV" post="genome replication. Inhibitors specific to CLIC1 and CLIC4 may"/>
   <result pre="specific to CLIC1 and CLIC4 may hold potential as both" exact="CHIKV" post="antivirals and inhibitors of the CHIKV inflammatory response. Specific"/>
   <result pre="hold potential as both CHIKV antivirals and inhibitors of the" exact="CHIKV" post="inflammatory response. Specific inhibitors would exclude possible off-target effects"/>
   <result pre="identifies Cl- channels as essential host cell factors for efficient" exact="CHIKV" post="replication and in conjunction with other recent studies highlights"/>
   <result pre="other Cl- channels are required at various stages of the" exact="CHIKV" post="lifecycle. In general, Cl- channels may represent a potential"/>
   <result pre="additional data file. S2 Fig Inhibition of Cl- channels decreases" exact="CHIKV" post="protein expression after infection at different MOIs. Huh7 cells"/>
   <result pre="after infection at different MOIs. Huh7 cells were infected with" exact="CHIKV" post="at an MOI 10 (A) and MOI 0.1 (B),"/>
   <result pre="MOI 0.1 (B), respectively, and the intracellular expression levels of" exact="CHIKV" post="nsP1 and capsid determined by western blot at 24"/>
   <result pre="(TIF) LINK Click here for additional data file. S3 Fig" exact="CHIKV" post="infection does not affect expression of pro-viral proteins CLIC1"/>
   <result pre="pro-viral proteins CLIC1 and CLIC4. Huh7 cells were infected with" exact="CHIKV" post="(MOI 2) and cellular proteins analysed by western blot"/>
   <result pre="data file. S4 Fig Effect of Cl- channel inhibitors on" exact="CHIKV" post="replication in invertebrate cells. C6/36 cells were infected with"/>
   <result pre="CHIKV replication in invertebrate cells. C6/36 cells were infected with" exact="CHIKV" post="(MOI 2) in the presence of the MNTD of"/>
   <result pre="Primer sequences for the reverse transcription and quantitative PCRs for" exact="CHIKV" post="strand-specific detection. (DOCX) LINK Click here for additional data"/>
   <result pre="2018;557(7706):570–4. 10.1038/s41586-018-0121-329769725 11van Duijl-RichterMK, HoornwegTE, Rodenhuis-ZybertIA, SmitJM. Early Events in" exact="Chikungunya" post="Virus Infection—From Virus CellBinding to Membrane Fusion. Viruses. 2015;7(7):3647–74."/>
   <result pre="van Duijl-RichterMKS, Ayala NunezNV, AlbulescuIC, van HemertMJ, SmitJM. Dynamics of" exact="Chikungunya" post="Virus Cell Entry Unraveled by Single-Virus Tracking in Living"/>
   <result pre="GötteB, RheinemannL, et al.Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and" exact="Chikungunya" post="Viruses Is Dependent on nsP3 and Connected to Replication"/>
   <result pre="al.Inhibitors of Alphavirus Entry and Replication Identified with a Stable" exact="Chikungunya" post="Replicon Cell Line and Virus-Based Assays. PLOS ONE. 2011;6(12):e2892310.1371/journal.pone.002892322205980"/>
   <result pre="2015;10(5):e012636010.1371/journal.pone.012636025970853 28BriolantS, GarinD, ScaramozzinoN, JouanA, CranceJ. In vitro inhibition of" exact="Chikungunya" post="and Semliki Forest viruses replication by antiviral compounds: synergistic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6750865\results\search\tropicalVirus\results.xml">
   <result pre="Resistance1178-6973Dove pmcid: 6750865209213 doi: 10.2147/IDR.S209213 : Perspectives Cell Death And" exact="Zika" post="Virus: An Integrated Network Of The Mechanisms Of Cell"/>
   <result pre="paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Abstract Abstract" exact="Zika" post="virus (ZIKV) is an arbovirus that is transmitted by"/>
   <result pre="serum of a sentinel Rhesus monkey (Macaca mulatta) in the" exact="Zika" post="forest of Uganda. As a member of the genus"/>
   <result pre="Uganda. As a member of the genus Flavivirus, family Flaviviridae," exact="ZIKV" post="is enveloped and icosahedral and possesses a single-stranded, positive-sense"/>
   <result pre="positive-sense RNA genome of approximately 10.7 kb. Epidemiologically, infection by" exact="ZIKV" post="has become a global health concern in recent years"/>
   <result pre="many gaps in our understanding of the mechanisms that induce" exact="ZIKV" post="infection-associated microcephaly. However, some studies already demonstrated that underlying"/>
   <result pre="various mechanisms of cell injury involved in the immunopathogenesis of" exact="ZIKV" post="infection and discussed its relationship with the death of"/>
   <result pre="death of neuronal and glial cells development and microcephaly. Keywords" exact="ZIKV" post="microcephaly neuroinflammatory response cell death fig-count: ref-count: page-count: Perspectives"/>
   <result pre="ZIKV microcephaly neuroinflammatory response cell death fig-count: ref-count: page-count: Perspectives" exact="Zika" post="virus (ZIKV) is a member of the family Flaviviridae"/>
   <result pre="in 1947 from a febrile sentinel rhesus monkey in the" exact="Zika" post="forest (Uganda).1 In 2015, the World Health Organization (WHO)"/>
   <result pre="(Uganda).1 In 2015, the World Health Organization (WHO) declared the" exact="Zika" post="epidemic a public health emergency in Brazil owing to"/>
   <result pre="growth of reported cases of microcephaly and other congenital defects.1,2" exact="ZIKV" post="exhibits extreme versatility and modulates mechanisms of immune evasion;"/>
   <result pre="mechanisms of immune evasion; recent experimental advances have shown that" exact="ZIKV" post="infects different cell types in several organs and tissues,"/>
   <result pre="belonging to the TIM and TAM families, particularly AXL, facilitate" exact="ZIKV" post="entry in cells.4 Considering the concept of immune privilege"/>
   <result pre="mechanisms of cell injury are involved in the immunopathogenesis of" exact="ZIKV" post="infection. These studies suggest that there is a link"/>
   <result pre="components of the necroptotic cell death pathway to limit neuronal" exact="Zika" post="virus infection.10,11 In cortical neurons, the activation of Z-DNA-binding"/>
   <result pre="AIM2, receptors that recognize pathogen-associated molecular patterns (PAMPs) of the" exact="ZIKV" post="and induce the release of caspase 1 to activate"/>
   <result pre="(IL-33) lymphocytes.7,20 Recently in experimental in vitro was showed that" exact="ZIKV" post="enhance proinflammatory response to promote NLRP3 inflammasome activation by"/>
   <result pre="IFN signaling.21 Paraptosis As an immune escape mechanism and adaptation," exact="ZIKV" post="uses the cellular machinery to transform the cell into"/>
   <result pre="PI3K/Akt signaling. Therefore, the paraptosis makes the cell a dangerous" exact="ZIKV" post="reservoir via the massive cytoplasmic vacuolization, functional alterations of"/>
   <result pre="of ROS; accordingly, it can contribute to cell destruction and" exact="ZIKV" post="dissemination. Autophagy In addition to paraptosis, another cell death"/>
   <result pre="is autophagy.23 Autophagy regulation in the brain is associated with" exact="ZIKV" post="tropism by several CNS cells. In vitro the infection"/>
   <result pre="the infection of human fetal neural stem cells (fNSCs) with" exact="ZIKV" post="leads to impaired neurosphere formation and elevated autophagy. Infection"/>
   <result pre="leads to impaired neurosphere formation and elevated autophagy. Infection with" exact="ZIKV" post="strains MR766 and IbH30656 efficiently induced LC3-I to LC3-II"/>
   <result pre="lysosome inhibitor bafilomycin A1. Interesting that in this process two" exact="ZIKV" post="proteins (NS4A and NS4B) inhibit AKt and consequently the"/>
   <result pre="of NS4A and NS4B to modulate the immune evasion of" exact="ZIKV" post="in the viral pathogenesis. Conclusion And Future Direction Many"/>
   <result pre="Conclusion And Future Direction Many questions about microcephaly induced by" exact="ZIKV" post="remain. However, investigations of several mechanisms of cell injury"/>
   <result pre="several mechanisms of cell injury involved in the immunopathogenesis of" exact="ZIKV" post="infection suggest that there is a link between microcephaly"/>
   <result pre="autophagy can directly impact on the development of microcephaly during" exact="ZIKV" post="congenital infection or in the death of glial cells"/>
   <result pre="destruction of neurons and glial cells by necrosis induced by" exact="ZIKV" post="in microcephaly cases. Another type of cell death associated"/>
   <result pre="pyroptosis. In the inflammasome, receptors (e.g., NLRP3 and AIM2) recognize" exact="ZIKV" post="PAMPs and release caspase 1, which, once activated, promotes"/>
   <result pre="ATF-6, endoplasmic reticulum stress, and ROS. Finally, during autophagy, two" exact="ZIKV" post="proteins (NS4A and NS4B) modulate the PIK3/AKt1 pathway, inhibiting"/>
   <result pre="conflict of interest. References References 1.ScreatonG, MongkolsapayaJ. Evolution of neurovirulent" exact="Zika" post="virus. Science. 2017;358:863–864. doi:10.1126/science.aaq129729146794 2.PossasC, BrasilP, MarzochiMC, et al."/>
   <result pre="Zika virus. Science. 2017;358:863–864. doi:10.1126/science.aaq129729146794 2.PossasC, BrasilP, MarzochiMC, et al." exact="Zika" post="puzzle in Brazil: peculiar conditions of viral introduction and"/>
   <result pre="a review. Mem Inst Oswaldo Cruz. 2017;112:319–327. doi:10.1590/0074-0276016051028443985 3.MinerJJ, DiamondMS." exact="Zika" post="virus pathogenesis and tissue tropism. Cell Host Microbe. 2017;21:134–142."/>
   <result pre="responses. Cell Rep. 2017;18:324–333. doi:10.1016/j.celrep.2016.12.04528076778 5.QuickeKM, BowenJR, JohnsonEL, et al." exact="Zika" post="virus infects human placental macrophages. Cell Host Microbe. 2016;20:83–90."/>
   <result pre="Cell Host Microbe. 2016;20:83–90. doi:10.1016/j.chom.2016.05.01527247001 6.SiemannDN, StrangeDP, MaharajPN, ShiPY, VermaS." exact="Zika" post="virus infects human sertoli cells and modulates the integrity"/>
   <result pre="damage in central nervous system of fatal cases microcephaly by" exact="Zika" post="virus. Sci Rep. 2018;1:1. doi:10.1038/s41598-017-17765-5 8.SolomonIH, MilnerDA, FolkerthRD. Neuropathology"/>
   <result pre="virus. Sci Rep. 2018;1:1. doi:10.1038/s41598-017-17765-5 8.SolomonIH, MilnerDA, FolkerthRD. Neuropathology of" exact="Zika" post="virus. J Neuroinfect Dis. 2016;7:220. doi:10.4172/2314-7326.100022027525286 9.ChimelliL, Avvad-PortariE. Congenital"/>
   <result pre="Zika virus. J Neuroinfect Dis. 2016;7:220. doi:10.4172/2314-7326.100022027525286 9.ChimelliL, Avvad-PortariE. Congenital" exact="Zika" post="virus infection: a neuropathological review. Childs Nerv Syst. 2018;34:95–99."/>
   <result pre="et al. Selective activation of type II interferon signaling by" exact="Zika" post="virus NS5 protein. J Virol. 2017;91:e00163–17. doi:10.1128/JVI.00163-1728468880 11.DanielsBP, KofmanSB,"/>
   <result pre="situ immune response in fatal cases of microcephaly caused by" exact="Zika" post="virus. Am J Pathol. 2018;9440:30153–30156. 13.Ghosh RoyS, SadighB, DatanE,"/>
   <result pre="Chem. 2014;5:93–105. doi:10.4331/wjbc.v5.i2.9324921001 14.CugolaFR, FernandesIR, RussoFB, et al. The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental models. Nature."/>
   <result pre="experimental models. Nature. 2016;534:267–271. doi:10.1038/nature1829627279226 15.SouzaBS, SampaioGL, PereiraCS, et al." exact="Zika" post="virus infection induces mitosis abnormalities and apoptotic cell death"/>
   <result pre="17.HeZ, ChenJ, AnS, et al. The NLRP3 inflammasome activation mediates" exact="Zika" post="virus associated inflammation. J Infect Dis. 2018;217:1942–1951. doi:10.1093/infdis/jiy12929518228 18.WangW,"/>
   <result pre="Infect Dis. 2018;217:1942–1951. doi:10.1093/infdis/jiy12929518228 18.WangW, LiG, De WuLZ, et al." exact="Zika" post="virus infection induces host inflammatory responses by facilitating NLRP3"/>
   <result pre="Commun. 2018;9:106. doi:10.1038/s41467-017-02645-329317641 19.HamelR, DejarnacO, WichitS, et al. Biology of" exact="Zika" post="virus infection in human skin cells. J Virol. 2015;89:8880–8896."/>
   <result pre="in severe damage to the central nervous system in fatal" exact="Zika" post="virus microcephaly cases. Cytokine. 2018;111:255–264. doi:10.1016/j.cyto.2018.08.00830199767 21.ZhengY, LiuQ, WuY,"/>
   <result pre="microcephaly cases. Cytokine. 2018;111:255–264. doi:10.1016/j.cyto.2018.08.00830199767 21.ZhengY, LiuQ, WuY, et al." exact="Zika" post="virus elicits inflammation to evade antiviral response by cleaving"/>
   <result pre="axis. Embo J. 2018;37:e99347. doi:10.15252/embj.20189934730065070 22.MonelB, ComptonAA, BruelT, et al." exact="Zika" post="virus induces massive cytoplasmic vacuolization and paraptosis-like death in"/>
   <result pre="cells. Embo J. 2017;36:1653–1668. doi:10.15252/embj.20169559728473450 23.LiangQ, LuoZ, ZengJ, et al." exact="Zika" post="virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6751421\results\search\tropicalVirus\results.xml">
   <result pre="fever, dengue, polio, rabies, hepatitis A and C, HIV, and" exact="Zika" post="infection, and parvovirus B19 [3, 4, 5, 6, 7]."/>
   <result pre="6NtusiNAHIV and myocarditisCurr Opin HIV AIDS20171112(6)561528832366 7MinhasA. M.NayabA.IyerS.et al.Association of" exact="Zika" post="virus with myocarditis, heart failure, and arrhythmias: a literature"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6754462\results\search\tropicalVirus\results.xml">
   <result pre="Reports2045-2322Nature Publishing Group UKLondon pmcid: 675446250135 doi: 10.1038/s41598-019-50135-x : Article" exact="Dengue" post="virus infection in people residing in Africa: a systematic"/>
   <result pre="this systematic review and meta-analysis to determine the prevalence of" exact="DENV" post="infection in Africa. We searched PubMed, EMBASE, African Journals"/>
   <result pre="of bias. In apparently healthy individuals, the pooled prevalence of" exact="DENV" post="was 15.6% (95% confidence interval 9.9–22.2), 3.5% (0.8–7.8), and"/>
   <result pre="the distribution between different regions of Africa. The prevalence of" exact="DENV" post="infection is high in the African continent. Dengue fever"/>
   <result pre="prevalence of DENV infection is high in the African continent." exact="Dengue" post="fever therefore deserves more attention from healthcare workers, researchers,"/>
   <result pre="from healthcare workers, researchers, and health policy makers. Subject terms" exact="Dengue" post="virus Viral infection Epidemiology Introduction The incidence of dengue"/>
   <result pre="worldwide among which 96 million (25%) clinically manifest the disease1." exact="DENV" post="is one of the most common arboviruses. It is"/>
   <result pre="arboviruses. It is a tropical and subtropical mosquito bone-viral disease2,3." exact="DENV" post="is transmitted by two main epidemic vectors: Aedes aegypti"/>
   <result pre="water supply, sewer, poor waste management system, and international travel2,3." exact="DENV" post="infection is asymptomatic in more than 50% of cases"/>
   <result pre="no treatment for dengue infection. The main method of controlling" exact="DENV" post="transmission is through the active monitoring and surveillance of"/>
   <result pre="Before 1970, only 9 countries had experienced severe dengue epidemics." exact="Dengue" post="fever is now endemic in more than 100 countries"/>
   <result pre="date there is no study accurately investigating the epidemiology of" exact="DENV" post="infection among febrile and apparently healthy populations in this"/>
   <result pre="and meta-analysis with the aim to determine the prevalence of" exact="DENV" post="infection in Africa. This review would help better characterize"/>
   <result pre="considered observational studies (cross-sectional, case-control, and cohort). Studies in which" exact="DENV" post="infection were imported were excluded. Studies had to be"/>
   <result pre="excluded. Studies had to be conducted out of outbreak periods." exact="DENV" post="infection had to be diagnosed by the detection of"/>
   <result pre="diagnosed by the detection of the three biological markers of" exact="DENV" post="including RNA, Immunoglobulins (Ig) M, or G; among people"/>
   <result pre="Medicus was conducted to identify all relevant articles published on" exact="DENV" post="infection among people living in Africa from January 1st,"/>
   <result pre="data as recommended by Barendregt and colleagues14. The prevalence of" exact="DENV" post="infection has been recalculated on the basis of crude"/>
   <result pre="participants were included in the 76 studies. The prevalence of" exact="DENV" post="infection varied widely depending on clinical presentation and biomarkers"/>
   <result pre="(Fig. 2; Table 1). Sensitivity analysis considering only study with" exact="DENV" post="infection confirmation by PNRT test yielded findings in the"/>
   <result pre="neutralization test. Figure 2 Meta-analysis of immunoglobulins G seroprevalence of" exact="Dengue" post="virus in Africa. The prevalence of IgM seroprevalence in"/>
   <result pre="Table 1). Figure 3 Meta-analysis of immunoglobulins M seroprevalence of" exact="Dengue" post="virus in Africa. The DENV RNA prevalence in febrile"/>
   <result pre="of immunoglobulins M seroprevalence of Dengue virus in Africa. The" exact="DENV" post="RNA prevalence in febrile participants 8.4% (95%CI 3.7–14.4) was"/>
   <result pre="p &amp;lt; 0.0001 (Fig. 4; Table 1). Figure 4 Meta-analysis prevalence of" exact="Dengue" post="virus ribonucleic acid in Africa. We found substantial heterogeneity"/>
   <result pre="in sub-regions of africa There was a wide variation of" exact="DENV" post="infection prevalence between sub-regions in Africa. There was difference"/>
   <result pre="prevalence between sub-regions in Africa. There was difference in the" exact="DENV" post="infection IgG seroprevalence between regions for participants with fever,"/>
   <result pre="Africa; Supplementary Fig. 6). There was a difference in the" exact="DENV" post="infection IgG seroprevalence between regions in apparently healthy participants,"/>
   <result pre="This first systematic review with meta-analysis of the prevalence of" exact="DENV" post="infection among people residing in Africa depicted a relatively"/>
   <result pre="of seroprevalence between IgG and IgM. In addition, RNA of" exact="DENV" post="was not considered. The high prevalence we found in"/>
   <result pre="of urbanization in the continent can also explain the high" exact="DENV" post="infection prevalence. Indeed, high urbanization rate with poor infrastructure"/>
   <result pre="tropical and subtropical regions is associated with high burden of" exact="DENV" post="infection2,3. The mechanism would be the increase of mosquitoes"/>
   <result pre="favor the expansion of dengue vectors in Africa25–28. One of" exact="DENV" post="vectors, Aedes albopictus, originally came from tropical and subtropical"/>
   <result pre="IgG and IgM production), especially in the endemic context for" exact="DENV" post="like Africa. During a new acute infection (a second"/>
   <result pre="are needed to deeply investigate the heterogeneity of epidemiology of" exact="DENV" post="infection between and within countries of the continent. It"/>
   <result pre="It would be better to have the geospatial distribution of" exact="DENV" post="vectors in the continent to better understand the distribution"/>
   <result pre="vectors in the continent to better understand the distribution of" exact="DENV" post="infection among humans. Heterogeneity in the prevalence of dengue"/>
   <result pre="rates below 1% and there is no specific treatment against" exact="DENV" post="infection7. It would be also interesting to explore the"/>
   <result pre="also interesting to explore the implementation of routine diagnostic of" exact="DENV" post="infection in endemic countries with the aim to make"/>
   <result pre="Africa, it will be difficult to implement routine diagnostic of" exact="DENV" post="infection at a large scale as most of countries"/>
   <result pre="Our findings call for cost-effective strategies to curb the burden" exact="DENV" post="infection in Africa since severe dengue fever can rapidly"/>
   <result pre="in primary studies, include the difference in the prevalence of" exact="DENV" post="in vectors, the difference in the immunity of humans,"/>
   <result pre="first review with meta-analysis summarizing data on the epidemiology of" exact="DENV" post="infection in febrile and apparently healthy populations living in"/>
   <result pre="that of sensitivity analysis considering only studies with PNRT for" exact="DENV" post="confirmation; highlighting the robustness of our findings. We can"/>
   <result pre="our findings. We can definitely conclude that the prevalence of" exact="DENV" post="infection is high in the African continent although this"/>
   <result pre="the 70 year historyTrends in microbiology20142213814610.1016/j.tim.2013.12.01124468533 5.GuoCet al.Global Epidemiology of" exact="Dengue" post="Outbreaks in 1990–2015: A Systematic Review and Meta-AnalysisFrontiers in"/>
   <result pre="in Colombia (2000–2011): a systematic reviewPLoS Negl Trop Dis20159e000349910.1371/journal.pntd.000349925790245 7.WHO." exact="Dengue" post="and severe dengue, https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue (2019). 8.PabalanNet al.Associations of tumor"/>
   <result pre="of Aedes albopictus and Aedes aegypti in the Emergence of" exact="Dengue" post="and Chikungunya in Central AfricaVector-Borne and Zoonotic Diseases20101025926610.1089/vbz.2009.000519725769 29.KruegerAHagenRMShort"/>
   <result pre="albopictus and Aedes aegypti in the Emergence of Dengue and" exact="Chikungunya" post="in Central AfricaVector-Borne and Zoonotic Diseases20101025926610.1089/vbz.2009.000519725769 29.KruegerAHagenRMShort communication: First"/>
   <result pre="in endemic countriesWorld journal of virology2017691610.5501/wjv.v6.i1.928239567 38.Jaenisch, T. et al." exact="Dengue" post="expansion in Africa-not recognized or not happening? Emerg Infect"/>
   <result pre="recombinant tetravalent dengue vaccine: a meta-analysis of randomized trialsVaccine2014324885489210.1016/j.vaccine.2014.07.00825045816 40.WHO." exact="Dengue" post="control: Control strategies, https://www.who.int/denguecontrol/control_strategies/en/ (2019)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6759257\results\search\tropicalVirus\results.xml">
   <result pre="are reported each year in Australia (1,20). Although transmission of" exact="CHIKV" post="does not occur in Australia, clinical infections have been"/>
   <result pre="the epidemic potential of the virus. The recent experience with" exact="Zika" post="and chikungunya viruses underscores the serious threat posed to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6759472\results\search\tropicalVirus\results.xml">
   <result pre="Microbiology: Original Research Selective Disruption of the Blood–Brain Barrier by" exact="Zika" post="Virus LedaAna Rachel1*BertrandLuc1AndrasIbolya Edit1El-HageNazira2NairMadhavan2ToborekMichal1*[], 1Department of Biochemistry and Molecular"/>
   <result pre="and the central nervous system (CNS). Here, we hypothesize that" exact="Zika" post="virus (ZIKV) infects the brain via a disrupted BBB"/>
   <result pre="microvascular endothelial cells (BMECs) were productively infected by all studied" exact="ZIKV" post="strains at MOI 0.01, and were analyzed by plaque"/>
   <result pre="studied viral strains. Interestingly, BMEC permeability was not disturbed by" exact="ZIKV" post="infection, even in the presence of a very high"/>
   <result pre="of a very high viral load (MOI 10). All studied" exact="ZIKV" post="strains productively infected wild-type C57BL/J mice after intravenous infection"/>
   <result pre="was significantly disturbed in ZIKV-H-infected animals. Our results suggest that" exact="ZIKV" post="penetrates the brain parenchyma early after infection with concurrent"/>
   <result pre="and disruption of the BBB permeability in a strain-dependent manner." exact="Zika" post="virus blood–brain barrier endothelial cells tight junctions neuroinfection Funding"/>
   <result pre="(HCV) (Liu et al., 2009; Crema et al., 2015), and" exact="West Nile" post="virus (WNV) (Neal, 2014; Suen et al., 2014) infections."/>
   <result pre="major human pathogens, including Japanese encephalitis virus, dengue virus, and" exact="Zika" post="virus (ZIKV), are members of the Flaviviridae family of"/>
   <result pre="significant neuroinvasive characteristics and are regarded as neurotropic (Neal, 2014)." exact="Zika" post="virus is an enveloped, mosquito-borne flavivirus, containing a single-stranded"/>
   <result pre="human epidemics (Weaver et al., 2016). Compared to other flavivirus," exact="ZIKV" post="is less neuroinvasive, rarely causing meningitis and encephalitis (Carteaux"/>
   <result pre="neuroinvasive, rarely causing meningitis and encephalitis (Carteaux et al., 2016)." exact="ZIKV" post="can infect a variety of cells, including neural progenitor"/>
   <result pre="et al., 2016). Human and animal model studies have observed" exact="ZIKV" post="virions and ZIKV nucleic acid in the semen, saliva,"/>
   <result pre="Human and animal model studies have observed ZIKV virions and" exact="ZIKV" post="nucleic acid in the semen, saliva, tears, urine, eyes,"/>
   <result pre="brain, testes, and female genital tract (Miner and Diamond, 2017)." exact="ZIKV" post="infects endothelial cells derived from the aorta, brain, and"/>
   <result pre="Richard et al., 2017). In brain microvascular endothelial cells (BMEC)," exact="ZIKV" post="infection persists, despite innate antiviral responses, functioning as a"/>
   <result pre="into neuronal compartments (Retallack et al., 2016). In recent years," exact="ZIKV" post="has been recognized as the cause of severe neurological"/>
   <result pre="al., 2016a, b; Schuler-Faccini et al., 2016). Unlike other flavivirus," exact="ZIKV" post="can be transmitted via sexual contact (Foy et al.,"/>
   <result pre="products (Barjas-Castro et al., 2016; Motta et al., 2016). Therefore," exact="ZIKV" post="stands as an emerging virus with multiple routes of"/>
   <result pre="characterize the role of the BBB in the onset of" exact="ZIKV" post="infection of the CNS, and to characterize possible differences"/>
   <result pre="Systems), at 37°C with 5% CO2. Virus Propagation and Tittering" exact="Zika" post="virus strains R103451 (ATCC VR-1848, Honduras 2015, ZIKV-H), PRVABC9"/>
   <result pre="were purchased from Jackson Laboratory and randomly assigned to various" exact="ZIKV" post="infection groups. Mice were anesthetized intraperitoneally with a mixture"/>
   <result pre="min to obtain plasma and stored at –80°C. Assessment of" exact="ZIKV" post="Infection Total RNA was isolated from 200 μL of"/>
   <result pre="total RNA samples was performed using primers specific for all" exact="ZIKV" post="strains evaluated in the present study (5′-CCG CTG CCC"/>
   <result pre="diluted standard curves of plasmids containing the target region of" exact="ZIKV" post="(108 to 101 viral copies) and the mouse housekeeping"/>
   <result pre="Upon 80% confluency, cells were infected with different strains of" exact="ZIKV" post="(ZIKV-H, ZIKV-PR, ZIKV-U, or mock-infected controls) at MOI 0.01"/>
   <result pre="were incubated overnight at 4°C with rabbit antibodies against the" exact="ZIKV" post="NS-1 protein (GeneTex; #GTX133307) (diluted 1:100 in 4% BSA"/>
   <result pre="in PBS) (Thermo Fisher Scientific) were used for detection of" exact="ZIKV" post="NS-1 protein and cell nuclei, respectively. Imaging was performed"/>
   <result pre="days after seeding, cells were inoculated with different strains of" exact="ZIKV" post="at MOI 10, diluted in the appropriate media, in"/>
   <result pre="total of 32 animals were infected with different strains of" exact="ZIKV" post="(ZIKV-H, ZIKV-PR, ZIKV-U) or vehicle to characterize the impact"/>
   <result pre="significance value at p &amp;lt; 0.05. Results Different Strains of" exact="ZIKV" post="Productively Infect BMEC We hypothesized that ZIKV, as other"/>
   <result pre="approach was to verify the infectivity of different strains of" exact="ZIKV" post="in BMECs, the main component of the BBB. Primary"/>
   <result pre="2, 4, and 6 dpi, and submitted to RNA extraction." exact="ZIKV" post="levels were assessed by RT-qPCR in cell culture supernatants"/>
   <result pre="1A, left and right panels, respectively). At 2 dpi, 108" exact="ZIKV" post="RNA copies/mL were detected in both supernatants and cell"/>
   <result pre="viral burden reached a peak at 4 dpi (approximately 1010" exact="ZIKV" post="RNA copies/mL in the supernatants and cell lysates), and"/>
   <result pre="cell viability (data not shown). FIGURE 1 Different strains of" exact="ZIKV" post="productively infect brain microvascular endothelial cells (BMECs). Primary human"/>
   <result pre="days. Mock-infected controls (Mock) were treated with virus-free media. (A)" exact="ZIKV" post="quantification by RT-qPCR, expressed as ZIKV RNA copies per"/>
   <result pre="with virus-free media. (A) ZIKV quantification by RT-qPCR, expressed as" exact="ZIKV" post="RNA copies per mL in cell culture supernatant (left"/>
   <result pre="graph) and cell culture lysates (right graph). (B) Detection of" exact="ZIKV" post="NS-1 protein expression by immunoblotting in BMEC culture lysates."/>
   <result pre="culture lysates. (C) Confocal images of ZIKV-infected BMECs stained for" exact="ZIKV" post="NS-1 protein (red; arrows). Cell nuclei were stained with"/>
   <result pre="proteins. ZIKV-infected BMEC lysates were submitted to immunoblotting for NS-1" exact="ZIKV" post="protein (Figure 1B). NS-1 was detected as early as"/>
   <result pre="detected in ZIKV-H-infected cells (Figure 1B). On the other hand," exact="ZIKV" post="infection of BMECs by immunofluorescence was detected in cultures"/>
   <result pre="BMECs by immunofluorescence was detected in cultures exposed to all" exact="ZIKV" post="strains employed in this study. In these experiments, BMECs"/>
   <result pre="infected at 80% confluency and MOI 0.01, and stained for" exact="ZIKV" post="NS1 protein (red) and DAPI (blue) at 2 dpi"/>
   <result pre="next demonstrated that BMECs are not only permissive to productive" exact="ZIKV" post="infection, but these cells also produce infectious viral particles."/>
   <result pre="agarose overlay and crystal violet staining (Figure 1D). Impact of" exact="ZIKV" post="Infection on Endothelial Permeability and TJ Protein Expression in"/>
   <result pre="TJ Protein Expression in vitro To evaluate the impact of" exact="ZIKV" post="infection on endothelial permeability, human primary BMECs were grown"/>
   <result pre="compartment was detected using a plate reader. Infection with all" exact="ZIKV" post="strains employed in the current study did not induce"/>
   <result pre="did not induce significant differences in endothelial permeability. FIGURE 2" exact="ZIKV" post="infection impact on endothelial cell permeability and tight junction"/>
   <result pre="increase over mock-infected control. ∗p &amp;lt; 0.05 vs. mock-infected. Intriguingly," exact="ZIKV" post="infection caused alterations of the levels of TJ proteins."/>
   <result pre="at 4 and 6 dpi in ZIKV-PR-infected cells (Figure 2B)." exact="ZIKV" post="Infection of Immunocompetent Mice Following the in vitro analyses,"/>
   <result pre="the in vitro analyses, we next evaluated the impact of" exact="ZIKV" post="infection on BBB permeability and TJ protein expression in"/>
   <result pre="expression in vivo. In order to assess the kinetics of" exact="ZIKV" post="infection, immunocompetent C57BL/6J male mice were infected with 107"/>
   <result pre="= 4). Systemic infection was verified by the presence of" exact="ZIKV" post="RNA in spleen tissue homogenates and plasma samples by"/>
   <result pre="and plasma samples by ZIKV-specific RT-qPCR. In brain tissue homogenates," exact="ZIKV" post="RNA levels peaked at 2 dpi (Figure 3). Therefore,"/>
   <result pre="animal experiments were performed at this time point. FIGURE 3" exact="ZIKV" post="infection kinetics in immunocompetent mice. C57BL/6J mice were infected"/>
   <result pre="dpi (n = 4), and 8 dpi (n = 4)." exact="ZIKV" post="RNA quantification was assessed in plasma (in red; expressed"/>
   <result pre="ZIKV-PR, ZIKV-U, vehicle) were infected intravenously with 107 PFU of" exact="ZIKV" post="and euthanized at 2 dpi. Plasma, spleen and brain"/>
   <result pre="tissues were collected and processed for RNA extraction, followed by" exact="ZIKV" post="detection by RT-qPCR. Figure 4 depicts the RNA quantification"/>
   <result pre="the RNA quantification for each tissue analyzed and for individual" exact="ZIKV" post="strains. No differences were observed between male and female"/>
   <result pre="and female mice were combined. FIGURE 4 Different strains of" exact="ZIKV" post="infect immunocompetent mice. C57BL/6J mice were infected intravenously with"/>
   <result pre="after 48 h. Mock-infected controls were injected intravenously with PBS." exact="ZIKV" post="RNA quantification was assessed in plasma (A; expressed as"/>
   <result pre="were considered undetectable and were plotted as equal to zero." exact="ZIKV" post="RNA was detected for all animals in plasma and"/>
   <result pre="(n = 8 per group). Brain homogenates were positive for" exact="ZIKV" post="RNA in 3/8, 3/8, and 5/8 animals infected with"/>
   <result pre="ZIKV-H, ZIKV-PR, and ZIKV-U, respectively. Data are mean ± SEM." exact="Zika" post="virus RNA levels in plasma samples ranged from 6.5"/>
   <result pre="One female mouse infected with ZIKV-U had undetectable levels of" exact="ZIKV" post="RNA in the plasma, and this animal was excluded"/>
   <result pre="this animal was excluded from further analyzes. Spleen levels of" exact="ZIKV" post="RNA were the highest compared to the other tissues"/>
   <result pre="out of 6 mice infected with ZIKV-U. Mean levels of" exact="ZIKV" post="RNA showed tendency to be slightly lower in ZIKV-H-infected"/>
   <result pre="suggest that immunocompetent mice are a feasible model to study" exact="ZIKV" post="infection, including neuroinfection. Brain Infection by ZIKV-H Correlates With"/>
   <result pre="Our next series of experiments focused on the impact of" exact="ZIKV" post="infection on BBB permeability as assessed by the NaF"/>
   <result pre="to high in-group variability (Figure 5). FIGURE 5 Impact of" exact="ZIKV" post="infection in BBB permeability in vivo. C57BL/6J mice were"/>
   <result pre="in Figure 3 indicated that 11/24 (45.8%) mice subjected to" exact="ZIKV" post="infection developed brain infection and/or disruption of the BBB."/>
   <result pre="infection developed brain infection and/or disruption of the BBB. Because" exact="ZIKV" post="may infect the brain as the result of penetration"/>
   <result pre="evident association, suggesting strain-specific effects for ZIKV-H infection. Impact of" exact="ZIKV" post="Infection on the Expression of TJ Proteins in vivo"/>
   <result pre="by immunoblotting. Mice were grouped according to the detection of" exact="ZIKV" post="RNA in their brain, and the analyses were performed"/>
   <result pre="claudin-5 expression reaching statistically significant values (Figure 6). FIGURE 6" exact="ZIKV" post="infection impact on tight junction proteins expression in vivo."/>
   <result pre="&amp;lt; 0.05 vs. not infected (ANOVA + Dunnett). Impact of" exact="ZIKV" post="Infection on Transcriptome of Brain Microvessels Our studies on"/>
   <result pre="Transcriptome of Brain Microvessels Our studies on the impact of" exact="ZIKV" post="infection on brain microvasculature and the BBB were completed"/>
   <result pre="were included as negative controls. As illustrated in Figure 3," exact="ZIKV" post="titers in the brain show biphasic response, with the"/>
   <result pre="upregulated (in blue) and downregulated (in red) genes according to" exact="ZIKV" post="strain and compared to mock-infected controls. Samples are grouped"/>
   <result pre="upregulated (in blue) and downregulated (in red) genes according to" exact="ZIKV" post="strain and compared to mock-infected controls. The transcriptome of"/>
   <result pre="The present study aimed to identify the mechanisms by which" exact="ZIKV" post="crosses the BBB to infect CNS cells, a condition"/>
   <result pre="syndrome in adults. Here we used an animal model of" exact="ZIKV" post="infection of immunocompetent adult mice to verify possible damages"/>
   <result pre="the adult population. We chose to analyze different strains of" exact="ZIKV" post="in order to verify possible differences in neurovirulence, and"/>
   <result pre="during the 2000 decade, as a consequent spread of the" exact="ZIKV" post="burden from Africa (Duffy et al., 2009). African strains"/>
   <result pre="burden from Africa (Duffy et al., 2009). African strains of" exact="ZIKV" post="have not been associated with human neuropathogenesis and the"/>
   <result pre="Therefore, we analyzed the impact of three different strains of" exact="ZIKV" post="in BBB integrity: the Honduras and Puerto Rico strains,"/>
   <result pre="Uganda strain representing the African lineage. Our data show that" exact="ZIKV" post="infects and replicates in BMECs, the main component of"/>
   <result pre="efficiency among different strains in these cells, as shown by" exact="ZIKV" post="RNA quantification from both cell culture supernatants and cell"/>
   <result pre="(Bramley et al., 2017). In contrast, the Asian strains of" exact="ZIKV" post="were demonstrated to have faster replication kinetics in human"/>
   <result pre="studies were performed using between 103 or 106 copies of" exact="ZIKV" post="at MOI 0.01 or 10, respectively. In addition, 107"/>
   <result pre="MOI 0.01 or 10, respectively. In addition, 107 PFU of" exact="ZIKV" post="were employed for in vivo BBB permeability assays. We"/>
   <result pre="infection. These factors constitute limiting aspects of our in vitro" exact="ZIKV" post="model. Similar lack of endothelial permeability changes was reported"/>
   <result pre="endothelial permeability changes was reported for the ZIKV-U and a" exact="ZIKV" post="strain from Brazil (PE243) (Papa et al., 2017). These"/>
   <result pre="Thus, our assay was more sensitive, strengthening the conclusion that" exact="ZIKV" post="is able to reach the CNS without disrupting the"/>
   <result pre="without disrupting the BBB. Instead, invasion of the CNS by" exact="ZIKV" post="might be associated with endothelial transcytosis (Papa et al.,"/>
   <result pre="such as tick-borne encephalitis virus (Palus et al., 2017) and" exact="West Nile" post="virus (Roe et al., 2012) were also reported as"/>
   <result pre="Interestingly, when we evaluated the expression of TJ proteins after" exact="ZIKV" post="infection, significant changes starting at 2 dpi, and at"/>
   <result pre="important future direction of research on the BBB involvement in" exact="ZIKV" post="entry into the CNS. After the recent Zika epidemic,"/>
   <result pre="involvement in ZIKV entry into the CNS. After the recent" exact="Zika" post="epidemic, the development of animal models to study the"/>
   <result pre="a research priority. There are approximately 20 mouse models of" exact="ZIKV" post="infection published in the literature (Morrison and Diamond, 2017);"/>
   <result pre="et al., 2016; Yockey et al., 2016). Among these studies," exact="ZIKV" post="was detected in blood (Larocca et al., 2016), testes"/>
   <result pre="for the development of more robust animal models associated with" exact="ZIKV" post="pathogenesis in adults, such as Guillain-Barré syndrome (Morrison and"/>
   <result pre="Guillain-Barré syndrome (Morrison and Diamond, 2017). It is well-established that" exact="ZIKV" post="infects neural progenitor cells, mature neurons, astrocytes, and brain"/>
   <result pre="the CNS. In addition, it has been recently reported that" exact="ZIKV" post="infection of microglia cells leads to modulation of the"/>
   <result pre="apoptosis, virion architecture, and viral replication. In the same study," exact="ZIKV" post="infection was associated with concomitant secretion of inflammatory mediators"/>
   <result pre="permeability, such as IL-6, TNF-α, IL-1β, iNOS, and NO. Furthermore," exact="ZIKV" post="infection resulted in upregulation of the expression of the"/>
   <result pre="the present study were independent of the infection by individual" exact="ZIKV" post="strains, detailed genetic studies of different strains may reveal"/>
   <result pre="and neurotropism, with approximately 40–50% of infected animals having detectable" exact="ZIKV" post="RNA in their brain tissue (Figure 4). These results"/>
   <result pre="Tripathi et al., 2017). In conclusion, our results indicate that" exact="ZIKV" post="penetrates the brain parenchyma early after infection resulting in"/>
   <result pre="Barjas-CastroM. L.AngeramiR. N.CunhaM. S.SuzukiA.NogueiraJ. S.RoccoI. M.et al. (2016). Probable transfusion-transmitted" exact="Zika" post="virus in Brazil.Transfusion561684–1688. 10.1111/trf.1368127329551 BertrandL.ChoH. J.ToborekM. (2019a). Blood-brain barrier"/>
   <result pre="blood-brain barrier.mSphere2:e00206-17. 10.1128/mSphere.00206-1728656176 BrasilP.CalvetG. A.SiqueiraA. M.WakimotoM.de SequeiraP. C.NobreA.et al. (2016a)." exact="Zika" post="virus outbreak in rio de janeiro, brazil: clinical characterization,"/>
   <result pre="Trop. Dis.10:e0004636. 10.1371/journal.pntd.000463627070912 BrasilP.PereiraJ. P.Jr.MoreiraM. E.Ribeiro NogueiraR. M.DamascenoL.WakimotoM.et al. (2016b)." exact="Zika" post="virus infection in pregnant women in rio de janeiro.N."/>
   <result pre="regulation of tight junctions.Biochim. Biophys. Acta1788864–871. 10.1016/j.bbamem.2008.08.02718952050 CarteauxG.MaquartM.BedetA.ContouD.BrugieresP.FouratiS.et al. (2016)." exact="Zika" post="virus associated with meningoencephalitis.N. Engl. J. Med.3741595–1596.26958738 ChoH. J.KuoA."/>
   <result pre="City, 2016.MMWR Morb. Mortal. Wkly. Rep.65716–717. 10.15585/mmwr.mm6528e227442327 DiopF.VialT.FerrarisP.WichitS.BengueM.HamelR.et al. (2018)." exact="Zika" post="virus infection modulates the metabolomic profile of microglial cells.PLoS"/>
   <result pre="A.RaynerE.HunterL.AtkinsonB.PearsonG.et al. (2017). Lineage-dependent differences in the disease progression of" exact="Zika" post="virus infection in type-I interferon receptor knockout (A129) mice.PLoS"/>
   <result pre="10.1371/journal.pntd.000570428672028 DuffyM. R.ChenT. H.HancockW. T.PowersA. M.KoolJ. L.LanciottiR. S.et al. (2009)." exact="Zika" post="virus outbreak on yap island, federated states of micronesia.N."/>
   <result pre="LesslerJ.ChaissonL. H.KucirkaL. M.BiQ.GrantzK.SaljeH.et al. (2016). Assessing the global threat from" exact="Zika" post="virus.Science353:aaf8160. 10.1126/science.aaf816027417495 LiaoX.DengJ.DaiW.ZhangT.YanJ. (2017). Rare variants of RNF213 and"/>
   <result pre="of immediate and delayed neuropathology.Acta Neuropathol.131159–184. 10.1007/s00401-015-1511-326659576 MaW.LiS.MaS.JiaL.ZhangF.ZhangY.et al. (2016)." exact="Zika" post="virus causes testis damage and leads to male infertility"/>
   <result pre="the blood brain barrier.Tissue Barriers4:e1143543. 10.1080/21688370.2016.114354327141423 MinerJ. J.DiamondM. S. (2017)." exact="Zika" post="virus pathogenesis and tissue tropism.Cell Host Microb.21134–142. 10.1016/j.chom.2017.01.00428182948 MladinichM."/>
   <result pre="and tissue tropism.Cell Host Microb.21134–142. 10.1016/j.chom.2017.01.00428182948 MladinichM. C.SchwedesJ.MackowE. R. (2017)." exact="Zika" post="virus persistently infects and is basolaterally released from primary"/>
   <result pre="Engl. J. Med.3751101–1103.27532622 MussoD.RocheC.RobinE.NhanT.TeissierA.Cao-LormeauV. M. (2015). Potential sexual transmission of" exact="Zika" post="virus.Emerg. Infect. Dis21359–361. 10.3201/eid2102.14136325625872 NauR.RibesS.DjukicM.EiffertH. (2014). Strategies to increase"/>
   <result pre="barrier in claudin-5-deficient mice.J. Cell Biol.161653–660. 10.1083/jcb.20030207012743111 OehlerE.WatrinL.LarreP.Leparc-GoffartI.LastereS.ValourF.et al. (2014)." exact="Zika" post="virus infection complicated by guillain-barre syndrome–case report, french polynesia,"/>
   <result pre="P.MeurenL. M.CoelhoS. V. A.LucasC. G. O.MustafaY. M.Lemos MatassoliF.et al. (2017)." exact="Zika" post="virus infects, activates, and crosses brain microvascular endothelial cells,"/>
   <result pre="disease tropism.Cell Rep.26:e8. 10.1016/j.celrep.2019.01.03630726741 RetallackH.Di LulloE.AriasC.KnoppK. A.LaurieM. T.Sandoval-EspinosaC.et al. (2016)." exact="Zika" post="virus cell tropism in the developing human brain and"/>
   <result pre="al. (2017). AXL-dependent infection of human fetal endothelial cells distinguishes" exact="Zika" post="virus from other pathogenic flaviviruses.Proc. Natl. Acad. Sci. U.S.A.1142024–2029."/>
   <result pre="pathogenic flaviviruses.Proc. Natl. Acad. Sci. U.S.A.1142024–2029. 10.1073/pnas.162055811428167751 RoeK.KumarM.LumS.OrilloB.NerurkarV. R.VermaS. (2012)." exact="West Nile" post="virus-induced disruption of the blood-brain barrier in mice is"/>
   <result pre="virus neuroinvasion: a critical appraisal.Viruses62796–2825. 10.3390/v607279625046180 TangH.HammackC.OgdenS. C.WenZ.QianX.LiY.et al. (2016)." exact="Zika" post="virus infects human cortical neural progenitors and attenuates their"/>
   <result pre="Neurobiol.25181–199. 10.1007/s10571-004-1383-x15962513 TripathiS.BalasubramaniamV. R.BrownJ. A.MenaI.GrantA.BardinaS. V.et al. (2017). A novel" exact="Zika" post="virus mouse model reveals strain specific differences in virus"/>
   <result pre="french polynesia.Medicine95:e3257. 10.1097/MD.000000000000325727057874 WeaverS. C.CostaF.Garcia-BlancoM. A.KoA. I.RibeiroG. S.SaadeG.et al. (2016)." exact="Zika" post="virus: History, emergence, biology, and prospects for control.Antiviral Res.13069–80."/>
   <result pre="leads to fetal brain infection.Cell1661247–1256.e4. 10.1016/j.cell.2016.08.00427565347 YunS. I.LeeY. M. (2017)." exact="Zika" post="virus: an emerging flavivirus.J. Microbiol.55204–219. 10.1007/s12275-017-7063-628243937 ZhongY.ZhangB.EumS. Y.ToborekM. (2012)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6763598\results\search\tropicalVirus\results.xml">
   <result pre="in important chapters of both, World and Brazilian epidemiology histories." exact="Yellow fever" post="virus (YFV), Dengue virus (DENV) and Zika virus (ZIKV)"/>
   <result pre="both, World and Brazilian epidemiology histories. Yellow fever virus (YFV)," exact="Dengue" post="virus (DENV) and Zika virus (ZIKV) were sequentially imported"/>
   <result pre="epidemiology histories. Yellow fever virus (YFV), Dengue virus (DENV) and" exact="Zika" post="virus (ZIKV) were sequentially imported to Brazil and South"/>
   <result pre="urban areas (2). In 1981, the first epidemic caused by" exact="DENV" post="was confirmed in Brazil (3). Since then, many epidemics"/>
   <result pre="annually by one of its four serotypes (DENV1-4) (5). Thus," exact="DENV" post="is considered as the flavivirus of highest epidemiologic relevance"/>
   <result pre="flavivirus of highest epidemiologic relevance of the world. But recently," exact="ZIKV" post="which was a pathogen previously associated with mild infections"/>
   <result pre="Guillain-Barré syndrome in the Americas (6). The first cases of" exact="ZIKV" post="infection were reported in early 2015, in the Brazilian"/>
   <result pre="worldwide epidemiological importance or which are highly pathogenic. Examples are" exact="West Nile" post="virus (WNV), Japanese encephalitis virus (JEV), Saint Louis encephalitis"/>
   <result pre="as antibody-dependent enhancement (ADE), is observed in some cases of" exact="DENV" post="infection. Immunoglobulins produced in a first infection by a"/>
   <result pre="cells by non-neutralizing antibodies, which facilitates penetration and replication of" exact="DENV" post="(1, 11). Increased viral replication leads to increased viral"/>
   <result pre="cytokine storm (11, 12). ADE has also been described between" exact="DENV" post="and ZIKV in vitro (8, 13–15). This phenomenon does"/>
   <result pre="(11, 12). ADE has also been described between DENV and" exact="ZIKV" post="in vitro (8, 13–15). This phenomenon does not explain"/>
   <result pre="were those of highest epidemiological relevance in Brazil and worldwide:" exact="Dengue" post="virus (DENV), Zika virus (ZIKV), Yellow fever virus (YFV),"/>
   <result pre="highest epidemiological relevance in Brazil and worldwide: Dengue virus (DENV)," exact="Zika" post="virus (ZIKV), Yellow fever virus (YFV), West Nile virus"/>
   <result pre="in Brazil and worldwide: Dengue virus (DENV), Zika virus (ZIKV)," exact="Yellow fever" post="virus (YFV), West Nile virus (WNV), Japanese encephalitis virus"/>
   <result pre="Dengue virus (DENV), Zika virus (ZIKV), Yellow fever virus (YFV)," exact="West Nile" post="virus (WNV), Japanese encephalitis virus (JEV), Saint Louis encephalitis"/>
   <result pre="were: CD4+ T cell, CD8+ T cell, epitopes, protection, immunity," exact="Dengue" post="virus, Zika virus, Yellow Fever virus, West Nile virus,"/>
   <result pre="T cell, CD8+ T cell, epitopes, protection, immunity, Dengue virus," exact="Zika" post="virus, Yellow Fever virus, West Nile virus, Japanese encephalitis"/>
   <result pre="epitopes, protection, immunity, Dengue virus, Zika virus, Yellow Fever virus," exact="West Nile" post="virus, Japanese encephalitis virus, Saint Louis encephalitis virus, Rocio"/>
   <result pre="Virusb Epitope sequence/location Conservancy (≥90%) 100% identityc Protein location 110534" exact="WNV" post="W101, G104, G106 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="W101, G104, G106 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 161539 DENV W101, G106, L107, F108 99.34%"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 161539" exact="DENV" post="W101, G106, L107, F108 99.34% DENV1, DENV2, DENV3, DENV4,"/>
   <result pre="G106, L107, F108 99.34% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 178102 DENV W101, L107,G109 99.67% DENV1, DENV2,"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 178102" exact="DENV" post="W101, L107,G109 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV,"/>
   <result pre="DENV W101, L107,G109 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 191061 DENV T76, W101, G106, L107, F108"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 191061" exact="DENV" post="T76, W101, G106, L107, F108 90.43% DENV1, DENV2, DENV3,"/>
   <result pre="W101, G106, L107, F108 90.43% DENV1, DENV2, DENV3, DENV4, ZIKV," exact="WNV" post="E protein 191066 DENV W101, G106, F108 99.67% DENV1,"/>
   <result pre="90.43% DENV1, DENV2, DENV3, DENV4, ZIKV, WNV E protein 191066" exact="DENV" post="W101, G106, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="W101, G106, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 191060 DENV T76, L107, F108 90.76% DENV1,"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 191060" exact="DENV" post="T76, L107, F108 90.76% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="DENV T76, L107, F108 90.76% DENV1, DENV2, DENV3, DENV4, ZIKV," exact="WNV" post="E protein 191068 DENV W101, L107, F108 99.67% DENV1,"/>
   <result pre="90.76% DENV1, DENV2, DENV3, DENV4, ZIKV, WNV E protein 191068" exact="DENV" post="W101, L107, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="W101, L107, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 191062 DENV T76, W101, L107, F108 90.76%"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 191062" exact="DENV" post="T76, W101, L107, F108 90.76% DENV1, DENV2, DENV3, DENV4,"/>
   <result pre="T76, W101, L107, F108 90.76% DENV1, DENV2, DENV3, DENV4, ZIKV," exact="WNV" post="E protein 191057 DENV G78, W101, L107, F108 99.67%"/>
   <result pre="90.76% DENV1, DENV2, DENV3, DENV4, ZIKV, WNV E protein 191057" exact="DENV" post="G78, W101, L107, F108 99.67% DENV1, DENV2, DENV3, DENV4,"/>
   <result pre="W101, L107, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 238073 DENV R99, G102, G106, L107 99.34%"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 238073" exact="DENV" post="R99, G102, G106, L107 99.34% DENV1, DENV2, DENV3, DENV4,"/>
   <result pre="G102, G106, L107 99.34% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 504083 DENV R73, G78, E79 91.42% DENV1,"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 504083" exact="DENV" post="R73, G78, E79 91.42% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="DENV R73, G78, E79 91.42% DENV1, DENV2, DENV3, DENV4, ZIKV," exact="WNV" post="E protein 161528 DENV K307, K310, L389 100.00% DENV1,"/>
   <result pre="91.42% DENV1, DENV2, DENV3, DENV4, ZIKV, WNV E protein 161528" exact="DENV" post="K307, K310, L389 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="K307, K310, L389 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 161534 DENV T303, T329, G383 100.00% DENV1,"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 161534" exact="DENV" post="T303, T329, G383 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="T303, T329, G383 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 191056 DENV G78, W101, F108 100.00% DENV1,"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 191056" exact="DENV" post="G78, W101, F108 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="G78, W101, F108 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 504090 DENV W101, L107, G111 100.00% DENV1,"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 504090" exact="DENV" post="W101, L107, G111 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="W101, L107, G111 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 504074 DENV N103, G104, G111 100.00% DENV1,"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 504074" exact="DENV" post="N103, G104, G111 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="N103, G104, G111 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 504080 DENV G100, W101, F108 100.00% DENV1,"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 504080" exact="DENV" post="G100, W101, F108 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="G100, W101, F108 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 530626 DENV D378, R379, W381 100.00% DENV1,"/>
   <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 530626" exact="DENV" post="D378, R379, W381 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
   <result pre="D378, R379, W381 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein aNumber of epitope ID at IEDB website."/>
   <result pre="of highly conserved neutralizing epitopes in flaviviruses. (A) Model of" exact="DENV" post="envelope glycoprotein arranged as a dimer [(33), PDB number"/>
   <result pre="of selected epitopes into species-specific polyprotein datasets. Epitopes sequences DENV1" exact="DENV" post="2 DENV3 DENV4 ZIKV YFV WNV SLEV JEV IGUV"/>
   <result pre="species-specific polyprotein datasets. Epitopes sequences DENV1 DENV 2 DENV3 DENV4" exact="ZIKV" post="YFV WNV SLEV JEV IGUV ILHV ROCV APTRVVAAEMa,b 90%"/>
   <result pre="polyprotein datasets. Epitopes sequences DENV1 DENV 2 DENV3 DENV4 ZIKV" exact="YFV" post="WNV SLEV JEV IGUV ILHV ROCV APTRVVAAEMa,b 90% 100%"/>
   <result pre="datasets. Epitopes sequences DENV1 DENV 2 DENV3 DENV4 ZIKV YFV" exact="WNV" post="SLEV JEV IGUV ILHV ROCV APTRVVAAEMa,b 90% 100% 100%"/>
   <result pre="The locations of epitopes are shown in two different models:" exact="DENV" post="NS3 protein (A,B) and ZIKV NS5 protein (C,D). (A)"/>
   <result pre="shown in two different models: DENV NS3 protein (A,B) and" exact="ZIKV" post="NS5 protein (C,D). (A) The helicase domain of the"/>
   <result pre="ZIKV NS5 protein (C,D). (A) The helicase domain of the" exact="DENV" post="NS3 protein is shown in olive, while its protease"/>
   <result pre="alanine prevents membrane fusion (56). In addition, natural infection by" exact="DENV" post="was hypothesized to generate anti-DENV antibodies with cross-neutralizing activity"/>
   <result pre="selected B cell epitopes were show to be important in" exact="DENV" post="neutralization (57, 61–63). Of course, a physic validation regarding"/>
   <result pre="This is in accordance with the highest genetic distance of" exact="YFV" post="serocomplex with regard to other flavivirus serocomplexes (23). An"/>
   <result pre="flaviviruses may arise from this observation. For example, vaccination against" exact="YFV" post="in Brazil is not currently related to protection against"/>
   <result pre="YFV in Brazil is not currently related to protection against" exact="DENV" post="and ZIKV epidemics. However, DENV and JEV serocomplexes share"/>
   <result pre="Brazil is not currently related to protection against DENV and" exact="ZIKV" post="epidemics. However, DENV and JEV serocomplexes share most of"/>
   <result pre="currently related to protection against DENV and ZIKV epidemics. However," exact="DENV" post="and JEV serocomplexes share most of epitopes identified in"/>
   <result pre="of epitopes identified in this work. It seems immunity to" exact="DENV" post="precludes viruses of JEV serocomplex of circulating in South"/>
   <result pre="South America. Recent studies showed evidences of cross-protective immunity between" exact="DENV" post="and JEV serocomplexes (23, 54). The same does not"/>
   <result pre="by the set of epitopes, but there is co-circulation of" exact="DENV" post="and JEV serocomplexes in that country. In addition, most"/>
   <result pre="population coverage of our set of epitopes, present co-circulation of" exact="DENV" post="and JEV serocomplexes. The explanation for this is probably"/>
   <result pre="CD8+ T limphocytes capable of producing IFN-γ and TNF-α against" exact="DENV" post="infection (24, 27). In addition, the peptide APTRVVAAEM is"/>
   <result pre="In addition, the peptide APTRVVAAEM is involved in cross-protection against" exact="DENV" post="and ZIKV. The epitopes TDTTPFGQQRVFKEK, EFGKAKGSRAIWYMW, and AKGSRAIWYMWLGAR are"/>
   <result pre="which are involved in elicitation of protective immune memory against" exact="YFV" post="(40). The epitope MTTEDMLQVW is involved in protection against"/>
   <result pre="currently approved for use in humans is a chimera between" exact="DENV" post="and YFV. Its structural antigens are representative of DENV"/>
   <result pre="between DENV and YFV. Its structural antigens are representative of" exact="DENV" post="proteins, while non-structural antigens are representative of YFV proteins."/>
   <result pre="representative of DENV proteins, while non-structural antigens are representative of" exact="YFV" post="proteins. In addition, the JEV vaccine is based on"/>
   <result pre="http://www.cdc.gov/zika/geo/ (accessed March 15, 2016). 7.de BritoCAACordeiroMTOne year after the" exact="Zika" post="virus outbreak in Brazil: from hypotheses to evidence. Rev"/>
   <result pre="antibody responses after dengue virus infection are highly cross-reactive to" exact="Zika" post="virus. Proc Natl Acad Sci USA. (2016) 113:7852–7. 10.1073/pnas.160793111327354515"/>
   <result pre="virus. Proc Natl Acad Sci USA. (2016) 113:7852–7. 10.1073/pnas.160793111327354515 9.WikanNSmithDR." exact="Zika" post="virus: history of a newly emerging arbovirus. Lancet Infect"/>
   <result pre="Lancet Infect Dis. (2016) 16:e119–26. 10.1016/S1473-3099(16)30010-X27282424 10.De MelloMRezendeDAdelinoRAlvesACamposFIaniDMet al.Persistence of" exact="Yellow fever" post="virus outside the Amazon Basin, causing epidemics in Southeast"/>
   <result pre="10.1038/nri301421760609 13.CastanhaPMNascimentoEJMCynthiaBCordeiroMTde CarvalhoOVdeMendonça LRet al.Dengue virus (DENV)-specific antibodies enhance Brazilian" exact="Zika" post="virus (ZIKV) infection. J Infect Dis. (2016) 215:781–5. 10.1093/infdis/jiw638"/>
   <result pre="(ZIKV) infection. J Infect Dis. (2016) 215:781–5. 10.1093/infdis/jiw638 14.DejnirattisaiWSupasaPWongwiwatWRouvinskiABarba-SpaethGDuangchindaTet al.." exact="Dengue" post="virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika"/>
   <result pre="with zika virus. Nat Immunol. (2016) 17:1102–8. 10.1038/ni.351527339099 15.PaulLMCarlinERJenkinsMMTanALBarcellonaCMNicholsonCOet al.." exact="Dengue" post="virus antibodies enhance Zika virus infection. Clin Transl Immunol."/>
   <result pre="Immunol. (2016) 17:1102–8. 10.1038/ni.351527339099 15.PaulLMCarlinERJenkinsMMTanALBarcellonaCMNicholsonCOet al.. Dengue virus antibodies enhance" exact="Zika" post="virus infection. Clin Transl Immunol. (2016) 5:e117. 10.1038/cti.2016.7228090318 16.MansfieldKLHortonDLJohnsonNLiLBarrettADTSmithDJet"/>
   <result pre="cells. Sci Adv. (2018) 4:eaar4297. 10.1126/sciadv.aar429729978039 24.WenJTangWWSheetsNEllisonJSetteAKimKet al.. Identification of" exact="Zika" post="virus epitopes reveals immunodominant and protective roles for dengue"/>
   <result pre="Microbiol. (2017) 2:17036. 10.1038/nmicrobiol.2017.3628288094 25.ReynoldsCJSuleymanOMOrtega-PrietoAMSkeltonJKBonnesoeurPBlohmAet al.. T cell immunity to" exact="Zika" post="virus targets immunodominant epitopes that show cross-reactivity with other"/>
   <result pre="Flaviviruses. Sci Rep. (2018) 8:672. 10.1038/s41598-017-18781-129330423 26.Regla-NavaJAElong NgonoAViramontesKMHuynhATWangYTNguyenAVTet al.. Cross-reactive" exact="Dengue" post="virus-specific CD8+ T cells protect against Zika virus during"/>
   <result pre="NgonoAViramontesKMHuynhATWangYTNguyenAVTet al.. Cross-reactive Dengue virus-specific CD8+ T cells protect against" exact="Zika" post="virus during pregnancy. Nat Commun. (2018) 9:3042. 10.1038/s41467-018-05458-030072692 27.WeiskopfDAngeloMABangsDJSidneyJPaulSPetersBet"/>
   <result pre="epitopes. J Virol. (2015) 89:120–8. 10.1128/JVI.02129-1425320311 28.WeiskopfDBangsDJSidneyJKollaRVDe SilvaADde SilvaAMet al.." exact="Dengue" post="virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T"/>
   <result pre="10.1186/1471-2105-8-36117897458 35.dos Santos FrancoLOliveira VidalPAmorimJH. In silico design of a" exact="Zika" post="virus non-structural protein 5 aiming vaccine protection against zika"/>
   <result pre="10.4049/jimmunol.130150724058176 42.DuanZLLiuHFHuangXWangSNYangJLChenXYet al.. Identification of conserved and HLA-A*2402-restricted epitopes in" exact="Dengue" post="virus serotype 2. Virus Res. (2015) 196:5–12. 10.1016/j.virusres.2014.10.02225449574 43.TurtleLBaliTBuxtonGChibSChanSSoniMet"/>
   <result pre="Cross-protection induced by Japanese encephalitis vaccines against different genotypes of" exact="Dengue" post="viruses in mice. Sci Rep. (2016) 6:19953. 10.1038/srep1995326818736 55.CockburnJJBNavarro"/>
   <result pre="cells. J Virol. (2001) 75:7769–73. 10.1128/JVI.75.16.7769-7773.200111462053 60.NybakkenGEOliphantTJohnsonSBurkeSDiamondMSFremontDH. Structural basis of" exact="West Nile" post="virus neutralization by a therapeutic antibody. Nature. (2005) 437:764–9."/>
   <result pre="MAbs. (2016) 8:574–84. 10.1080/19420862.2016.114885026905804 64.LiS-HLiX-FZhaoHJiangTDengY-QYuX-Det al.. Cross protection against lethal" exact="West Nile" post="virus challenge in mice immunized with recombinant E protein"/>
   <result pre="138:156–60. 10.1016/j.imlet.2011.04.00321515306 65.ChowdhuryPKhanSAChowdhuryPBorahJDuttaPCross-protective immunity against circulating Japanese encephalitis virus and" exact="West Nile" post="Virus by live attenuated Japanese encephalitis vaccine SA 14-14-2."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6769590\results\search\tropicalVirus\results.xml">
   <result pre="includes dengue fever virus (DENV), yellow fever virus (YFV) and" exact="West Nile" post="virus (WNV). The gene named NS4-fs encodes a potential"/>
   <result pre="Klinik (Munich)199994Suppl. 32610.1007/BF0304218110554520 190.VermaS.MolinaY.LoY.Y.CroppB.NakanoC.YanagiharaR.NerurkarV.R.In vitro effects of selenium deficiency on" exact="West Nile" post="virus replication and cytopathogenicityVirol. J.200856610.1186/1743-422X-5-6618513435 191.ZhongH.TaylorE.W.Structure and dynamics of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6770471\results\search\tropicalVirus\results.xml">
   <result pre="occasional outbreaks of emerging and re-emerging viral diseases such as" exact="Dengue" post="fever, West Nile Fever, Zika virus disease, Chikungunya disease,"/>
   <result pre="of emerging and re-emerging viral diseases such as Dengue fever," exact="West Nile" post="Fever, Zika virus disease, Chikungunya disease, Middle east respiratory"/>
   <result pre="re-emerging viral diseases such as Dengue fever, West Nile Fever," exact="Zika" post="virus disease, Chikungunya disease, Middle east respiratory syndrome, Ebola"/>
   <result pre="such as Dengue fever, West Nile Fever, Zika virus disease," exact="Chikungunya" post="disease, Middle east respiratory syndrome, Ebola virus disease and"/>
   <result pre="There is no clear idea whether emerging viruses such as" exact="Zika" post="virus, Ebola virus, West Nile virus, Dengue virus and"/>
   <result pre="idea whether emerging viruses such as Zika virus, Ebola virus," exact="West Nile" post="virus, Dengue virus and many others owe part of"/>
   <result pre="viruses such as Zika virus, Ebola virus, West Nile virus," exact="Dengue" post="virus and many others owe part of their evolution"/>
   <result pre="as emerging and re-emerging pathogens such as dengue virus (DENV)," exact="West Nile" post="Virus (WNV), Zika Virus (ZIKV) and these viruses pose"/>
   <result pre="pathogens such as dengue virus (DENV), West Nile Virus (WNV)," exact="Zika" post="Virus (ZIKV) and these viruses pose a global threat"/>
   <result pre="NS2A, NS2B and NS4A and NS4B (Figure 2B) [33]. 3.1." exact="Dengue" post="Virus (DENV) Dengue is a re-emerging arboviral infection transmitted"/>
   <result pre="NS4A and NS4B (Figure 2B) [33]. 3.1. Dengue Virus (DENV)" exact="Dengue" post="is a re-emerging arboviral infection transmitted by Aedes mosquitoes"/>
   <result pre="and 25,000 deaths yearly [37]. A previous study compared a" exact="DENV" post="vaccine candidate strain, DENV-3 PGMK30FRhL3 (PGMK30), which produced acute"/>
   <result pre="(PGMK30), which produced acute febrile illnesses with another clinically safe" exact="DENV" post="vaccine candidate DENV-2PDK53 (PDK53). Using in vitro and in"/>
   <result pre="gene sequence was investigated using the plasma samples of six" exact="DENV" post="infected patients. The first account of viral quasispecies of"/>
   <result pre="DENV infected patients. The first account of viral quasispecies of" exact="DENV" post="in vivo was reported using clonal sequencing analysis whereby"/>
   <result pre="of quasispecies could lead to the rational design of a" exact="DENV" post="vaccine. 3.2. Zika Virus (ZIKV) Zika Virus was first"/>
   <result pre="lead to the rational design of a DENV vaccine. 3.2." exact="Zika" post="Virus (ZIKV) Zika Virus was first discovered in 1947"/>
   <result pre="rational design of a DENV vaccine. 3.2. Zika Virus (ZIKV)" exact="Zika" post="Virus was first discovered in 1947 when it was"/>
   <result pre="It belongs to the Flavivirus genus within the Flaviviridae family." exact="Zika" post="infections have been reported in Egypt [43], East Africa"/>
   <result pre="mutation was produced using an infectious molecular clone of the" exact="ZIKV" post="MR766 strain. The plaque size produced by the recombinant"/>
   <result pre="and virulence in mice [48]. The quasispecies distribution of a" exact="ZIKV" post="strain (ZIKV-SL1602) isolated from a 29-year-old female traveler was"/>
   <result pre="clade stems from the island of French Polynesia [49]. 3.3." exact="West Nile" post="Virus (WNV) West Nile Virus was first characterized in"/>
   <result pre="island of French Polynesia [49]. 3.3. West Nile Virus (WNV)" exact="West Nile" post="Virus was first characterized in 1937 in the West"/>
   <result pre="West Nile Virus was first characterized in 1937 in the" exact="West Nile" post="district of Uganda and was taxonomically placed in the"/>
   <result pre="spread to other parts of the USA between 1999–2001 [50]." exact="WNV" post="survives naturally in a mosquito-bird-mosquito transmission cycle involving the"/>
   <result pre="small-plaque (SP) variant was picked from a mutant population of" exact="WNV" post="isolated from an American crow in New York in"/>
   <result pre="isolate to the wild-type phenotype [52]. The genetic diversity of" exact="WNV" post="in the avian host was also investigated using next-generation"/>
   <result pre="and wild juvenile carrion crows. Data collected revealed that the" exact="WNV" post="population showed significant heterogeneity diverging from the quasispecies structure"/>
   <result pre="the variations in genetic diversity. It was demonstrated that the" exact="WNV" post="genetic diversifications varied significantly from the inoculum in crows"/>
   <result pre="to genetic diversifications. NGS technologies have enabled the analysis of" exact="WNV" post="quasispecies dynamics, leading to a better understanding of the"/>
   <result pre="four non-structural proteins (NSP1, NSP2, NSP3 and NSP4) (Figure 3B)." exact="Chikungunya" post="Virus (CHIKV) Chikungunya virus (CHIKV) is an arthropod-borne virus"/>
   <result pre="(NSP1, NSP2, NSP3 and NSP4) (Figure 3B). Chikungunya Virus (CHIKV)" exact="Chikungunya" post="virus (CHIKV) is an arthropod-borne virus transmitted to humans"/>
   <result pre="significant human morbidity in many parts of the world [56]." exact="Chikungunya" post="virus causes an acute febrile illness with high fever,"/>
   <result pre="be prolonged from months to years [57,58]. Some cases of" exact="CHIKV" post="disease were associated with neurological complications [59]. The virus"/>
   <result pre="2 million people [60]. The original geographical distributions of the" exact="CHIKV" post="indicated that there are 3 distinct groups and phylogenetic"/>
   <result pre="virus in the Americas [62,64,65,66,67]. Even though a number of" exact="CHIKV" post="vaccine candidates are being developed, no effective vaccine is"/>
   <result pre="[68]. Similar to other RNA viruses with extensive mutation rates," exact="CHIKV" post="produces populations of genetically diverse genomes within a host."/>
   <result pre="al. investigated the intra-host genetic diversity of high and low-fidelity" exact="CHIKV" post="variants using murine models. Both the high and low"/>
   <result pre="low fidelity variants were expected to lower the virulence of" exact="CHIKV" post="as compared to the wild-type (CHIKV-WT). However, the high-fidelity"/>
   <result pre="CHIKV-WT at 3- and 4-days post-infection (dpi). Moreover, the high-fidelity" exact="CHIKV" post="(CHIKV-HiFi) infected mice also displayed higher peaks of disease"/>
   <result pre="In high-fidelity variants, nsp2 G641D and nsp4 C483Y mutations increased" exact="CHIKV" post="virulence in the adult mice. The NGS data showed"/>
   <result pre="is a common feature of viral characterization. Primary isolates of" exact="CHIKV" post="containing variants with different plaque sizes were previously reported"/>
   <result pre="small and large plaques had been reported in the 2005" exact="CHIKV" post="outbreak isolates [72]. It is curious how small plaque"/>
   <result pre="In order to explore the virulence of the small plaque" exact="CHIKV" post="variant in vivo, the pathogenicity of the purified small"/>
   <result pre="the pathogenicity of the purified small plaque variant of the" exact="CHIKV" post="virus isolated from the sera of the patient in"/>
   <result pre="infection with the wild-type virus. The small plaque variant of" exact="CHIKV" post="obtained by plaque purifications exhibited decreased virulence that makes"/>
   <result pre="appropriate to serve as candidates for live-attenuated vaccine development. The" exact="CHIKV" post="variant with the small plaque size formed a major"/>
   <result pre="the small plaque size formed a major subpopulation in the" exact="CHIKV" post="primary isolate during multiple passages in C6/36 cells. This"/>
   <result pre="Comparative sequence alignment of large and small plaque variants of" exact="CHIKV" post="primary isolates from the Comoros Island showed two amino"/>
   <result pre="However, these particular amino acid residues were observed in other" exact="CHIKV" post="isolates previously [71] and the significance of these specific"/>
   <result pre="Abeyratne et al. investigated the role of the capsid in" exact="CHIKV" post="virulence by studying the nucleolar localization sequence (NoLS) [74]."/>
   <result pre="NoLS is a region in the N-terminal part of the" exact="CHIKV" post="capsid protein, between residues 58 and 110 and is"/>
   <result pre="amino acids [75,76]. Mutations in the NoLS capsid of the" exact="CHIKV" post="led to the development of a unique live-attenuated CHIKV"/>
   <result pre="the CHIKV led to the development of a unique live-attenuated" exact="CHIKV" post="vaccine candidate designated as CHIKV-NoLS. The P5 CHIKV-NoLS clone"/>
   <result pre="the CHIKV-NoLS-immunized mice were able to produce long-term immunity against" exact="CHIKV" post="infection following immunization with a single dose of the"/>
   <result pre="in immunized mice and produced sera which could effectively neutralize" exact="CHIKV" post="infection in vitro, it could serve as a promising"/>
   <result pre="vaccine candidate needed to control the explosive large-scale outbreaks of" exact="CHIKV" post="[76]. 5. Filoviridae Viruses found within the Filoviridae family"/>
   <result pre="and Severe DengueAvailable online: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue(accessed on 15 April 2019) 36.HenchalE.A.PutnakJ.R.The" exact="Dengue" post="virusesClin. Microbiol. Rev.1990337639610.1128/CMR.3.4.3762224837 37.WhitehornJ.SimmonsC.P.The pathogenesis of DengueVaccine2011297221722810.1016/j.vaccine.2011.07.02221781999 38.GohK.C.M.TangC.K.NortonD.C.GanE.S.TanH.C.SunB.SyeninaA.YousufA.OngX.M.KamarajU.S.et al.Molecular"/>
   <result pre="38.GohK.C.M.TangC.K.NortonD.C.GanE.S.TanH.C.SunB.SyeninaA.YousufA.OngX.M.KamarajU.S.et al.Molecular determinants of plaque size as an indicator of" exact="Dengue" post="virus attenuationSci. Rep.201662610010.1038/srep2610027185466 39.WangW.-K.LinS.-R.LeeC.-M.KingC.-C.ChangS.-C.Dengue type 3 virus in plasma"/>
   <result pre="closely related genomes: quasispeciesJ. Virol.2002764662466510.1128/JVI.76.9.4662-4665.200211932434 40.ParameswaranP.WangC.TrivediS.B.EswarappaM.MontoyaM.BalmasedaA.HarrisE.Intrahost selection pressures drive rapid" exact="Dengue" post="virus microevolution in acute human infectionsCell Host Microbe20172240041010.1016/j.chom.2017.08.00328910637 41.LoveH.Investigation"/>
   <result pre="J. Hyg.19545915716313138582 48.KatoF.TajimaS.NakayamaE.KawaiY.TaniguchiS.ShibasakiK.TairaM.MaekiT.LimC.K.TakasakiT.Characterization of large and small-plaque variants in the" exact="Zika" post="virus clinical isolate ZIKV/Hu/S36/Chiba/2016Sci. Rep.201771616010.1038/s41598-017-16475-229170504 49.van BoheemenS.TasA.AnvarS.Y.van GrootveldR.AlbulescuI.C.BauerM.P.FeltkampM.C.BredenbeekP.J.van HemertM.J.Quasispecies"/>
   <result pre="49.van BoheemenS.TasA.AnvarS.Y.van GrootveldR.AlbulescuI.C.BauerM.P.FeltkampM.C.BredenbeekP.J.van HemertM.J.Quasispecies composition and evolution of a typical" exact="Zika" post="virus clinical isolate from SurinameSci. Rep.20177236810.1038/s41598-017-02652-w28539654 50.CampbellG.L.MarfinA.A.LanciottiR.S.GublerD.J.West Nile VirusLancet"/>
   <result pre="50.CampbellG.L.MarfinA.A.LanciottiR.S.GublerD.J.West Nile VirusLancet Infect. Dis.2002251952910.1016/S1473-3099(02)00368-712206968 51.TurellM.J.SardelisM.R.DohmD.J.O’GuinnM.L.Potential North American vectors of" exact="West Nile" post="virusAnn. N. Y. Acad. Sci.200195131732410.1111/j.1749-6632.2001.tb02707.x11797788 52.JiaY.MoudyR.M.DupuisA.P.NgoK.A.MaffeiJ.G.JerzakG.V.FrankeM.A.KauffmanE.B.KramerL.D.Characterization of a small"/>
   <result pre="Y. Acad. Sci.200195131732410.1111/j.1749-6632.2001.tb02707.x11797788 52.JiaY.MoudyR.M.DupuisA.P.NgoK.A.MaffeiJ.G.JerzakG.V.FrankeM.A.KauffmanE.B.KramerL.D.Characterization of a small plaque variant of" exact="West Nile" post="virus isolated in New York in 2000Virology200736733934710.1016/j.virol.2007.06.00817617432 53.DridiM.RosseelT.OrtonR.JohnsonP.LecollinetS.MuylkensB.LambrechtB.Van BormS.Next-generation"/>
   <result pre="isolated in New York in 2000Virology200736733934710.1016/j.virol.2007.06.00817617432 53.DridiM.RosseelT.OrtonR.JohnsonP.LecollinetS.MuylkensB.LambrechtB.Van BormS.Next-generation sequencing shows" exact="West Nile" post="virus quasispecies diversification after a single passage in a"/>
   <result pre="Primates in Biomedical ResearchAbeeC.MansfieldK.TardifS.MorrisT.Academic PressCambridge, MA, USA2012Volume 21104 56.WeaverS.C.Arrival of" exact="Chikungunya" post="virus in the new world: prospects for spread and"/>
   <result pre="J. Infect. Dis.201115e671e67610.1016/j.ijid.2011.06.00221775183 63.SreekumarE.IssacA.NairS.HariharanR.JankiM.B.ArathyD.S.ReguR.MathewT.AnoopM.NiyasK.P.et al.Genetic characterization of 2006–2008 isolates of" exact="Chikungunya" post="virus from Kerala, South India, by whole genome sequence"/>
   <result pre="analysisVirus Genes2009401410.1007/s11262-009-0411-919851853 64.SudeepA.ParasharD.Chikungunya: an overviewJ. Biosci.20083344344910.1007/s12038-008-0063-219208970 65.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="Chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 66.ShalauddinA.LorraineF.RickettsR.P.TrudyC.KarenP.-E.BabatundeO.Chikungunya"/>
   <result pre="Pathog.20073e20110.1371/journal.ppat.003020118069894 66.ShalauddinA.LorraineF.RickettsR.P.TrudyC.KarenP.-E.BabatundeO.Chikungunya virus outbreak, Dominica, 2014Emerging Infect. Dis.20152190925898214 67.SamI.C.KümmererB.M.ChanY.-F.RoquesP.DrostenC.AbuBakarS.Updates on" exact="Chikungunya" post="epidemiology, clinical disease and diagnosticsVector Borne Zoonotic Dis.20151522323010.1089/vbz.2014.168025897809 68.PowersA.M.Vaccine"/>
   <result pre="diagnosticsVector Borne Zoonotic Dis.20151522323010.1089/vbz.2014.168025897809 68.PowersA.M.Vaccine and therapeutic options to control" exact="Chikungunya" post="virusClin. Microbiol. Rev.20183110.1128/CMR.00104-16 69.RiemersmaK.K.SteinerC.SingapuriA.CoffeyL.L.Chikungunya virus fidelity variants exhibit differential"/>
   <result pre="with different characteristicsAm. J. Trop. Med. Hyg.20098186586810.4269/ajtmh.2009.09-000919861623 71.WasongaC.InoueS.RumberiaC.MichukiG.KimothoJ.OngusJ.R.SangR.MusilaL.Genetic divergence of" exact="Chikungunya" post="virus plaque variants from the Comoros Island (2005)Virus Genes20155132332810.1007/s11262-015-1243-426347221"/>
   <result pre="variants from the Comoros Island (2005)Virus Genes20155132332810.1007/s11262-015-1243-426347221 72.SergonK.YahayaA.A.BrownJ.BedjaS.A.MlindasseM.AgataN.AllarangerY.BallM.D.PowersA.M.OfulaV.et al.Seroprevalence of" exact="Chikungunya" post="virus infection on Grande Comore Island, union of the"/>
   <result pre="2005Am. J. Trop. Med. Hyg.2007761189119310.4269/ajtmh.2007.76.118917556634 73.JaimipakT.YoksanS.UbolS.PulmanausahakulR.Small plaque size variant of" exact="Chikungunya" post="primary isolate showed reduced virulence in miceAsian Pac. J."/>
   <result pre="J. Allergy Immunol.20183620120528938842 74.AbeyratneE.FreitasJ.R.ZaidA.MahalingamS.TaylorA.Attenuation and stability of CHIKV-NoLS, a live-attenuated" exact="Chikungunya" post="virus vaccine candidateVaccines20187210.3390/vaccines701000230583514 75.FavreD.StuderE.MichelM.Two nucleolar targeting signals present in"/>
   <result pre="virus capsid proteinArch. Virol.199413714915510.1007/BF013111817979988 76.TaylorA.LiuX.ZaidA.GohL.Y.H.Hobson-PetersJ.HallR.A.MeritsA.MahalingamS.Mutation of the N-terminal region of" exact="Chikungunya" post="virus capsid protein: implications for vaccine designMBio20178e01970-1610.1128/mBio.01970-1628223458 77.LeeS.OwenK.E.ChoiH.-K.LeeH.LuG.WenglerG.BrownD.T.RossmannM.G.KuhnR.J.Identification of"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
